10-K

Large accelerated filer þ

Accelerated filer ¨

Non-accelerated filer ¨

Smaller reporting company ¨

(Do not check if a smaller reporting company)

0001628280-15-008984.txt : 20151125 0001628280-15-008984.hdr.sgml : 20151125 20151125113536 ACCESSION NUMBER: 0001628280-15-008984 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20150930 FILED AS OF DATE: 20151125 DATE AS OF CHANGE: 20151125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BECTON DICKINSON & CO CENTRAL INDEX KEY: 0000010795 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 220760120 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-04802 FILM NUMBER: 151254970 BUSINESS ADDRESS: STREET 1: ONE BECTON DR CITY: FRANKLIN LAKES STATE: NJ ZIP: 07417-1880 BUSINESS PHONE: 2018476800 MAIL ADDRESS: STREET 1: ONE BECTON DR CITY: FRANKLIN LAKE STATE: NJ ZIP: 07417 10-K 1 bdx2015-09x3010xk.htm 10-K 10-K

Table of Contents

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-K

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2015

COMMISSION FILE NUMBER 1-4802

BECTON, DICKINSON AND COMPANY

(Exact name of registrant as specified in its charter)



New Jersey		22-0760120
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

1 Becton Drive Franklin Lakes, New Jersey (Address of principal executive offices)		07417-1880 (Zip code)

(201) 847-6800

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:



Title of Each Class		Name of Each Exchange on Which Registered
Common Stock, par value $1.00		New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act:

None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes þ No ¨

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ¨ No þ

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No þ

As of March 31, 2015, the aggregate market value of the registrant’s outstanding common stock held by non-affiliates of the registrant was approximately $30,013,657,226.

Table of Contents

As of October 31, 2015, 210,736,542 shares of the registrant’s common stock were outstanding.

Documents Incorporated by Reference

Portions of the registrant’s Proxy Statement for the Annual Meeting of Shareholders to be held January 26, 2016 are incorporated by reference into Part III hereof.

Table of Contents

TABLE OF CONTENTS




PART I	1
Item 1. Business	1
Item 1A. Risk Factors	6
Item 1B. Unresolved Staff Comments	11
Item 2. Properties	11
Item 3. Legal Proceedings	12
Item 4. Mine Safety Disclosures	12
Executive Officers of the Registrant	13
PART II	14
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	14
Item 6. Selected Financial Data	15
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations	16
Item 7A. Quantitative and Qualitative Disclosures About Market Risk	33
Item 8. Financial Statements and Supplementary Data	34
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure	79
Item 9A. Controls and Procedures	79
Item 9B. Other Information	79
PART III	79
Item 10. Directors, Executive Officers and Corporate Governance	79
Item 11. Executive Compensation	80
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	80
Item 13. Certain Relationships and Related Transactions, and Director Independence	80
Item 14. Principal Accounting Fees and Services	80
PART IV	80
Item 15. Exhibits, Financial Statement Schedules	80
SIGNATURES	81
EXHIBIT INDEX	83

Table of Contents

PART I

Item 1. Business.

General

Becton, Dickinson and Company (also known as “BD”) was incorporated under the laws of the State of New Jersey in November 1906, as successor to a New York business started in 1897. BD’s executive offices are located at 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880, and its telephone number is (201) 847-6800. All references in this Form 10-K to “BD” refer to Becton, Dickinson and Company and its domestic and foreign subsidiaries, unless otherwise indicated by the context.

BD is a global medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. We provide customer solutions that are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology and respiratory care; enhancing the diagnosis of infectious diseases and cancers; advancing cellular research and applications; and supporting the management of diabetes.

On March 17, 2015, BD completed the acquisition of CareFusion Corporation (“CareFusion”), a global medical technology company with a comprehensive portfolio of products in the areas of medication management, infection prevention, operating room and procedural effectiveness, and respiratory care. The CareFusion acquisition positions BD as a global leader in medication management. CareFusion product lines are included in our Medical Segment, which is discussed below.

Business Segments

BD’s operations consist of two worldwide business segments: BD Medical and BD Life Sciences. Information with respect to BD’s business segments is included in Note 6 to the consolidated financial statements contained in Item 8, Financial Statements and Supplementary Data, and is incorporated herein by reference.

BD Medical

BD Medical produces a broad array of medical devices that are used in a wide range of healthcare settings. The primary customers served by BD Medical are hospitals and clinics; physicians’ office practices; consumers and retail pharmacies; governmental and nonprofit public health agencies; pharmaceutical companies; and healthcare workers. BD Medical consists of the following business units:



Business Unit	Principal Product Lines
Diabetes Care	Syringes and pen needles for the injection of insulin and other drugs used in the treatment of diabetes.
Medication and Procedural Solutions	Needles, syringes and intravenous catheters for medication delivery (including safety-engineered and auto-disable devices); prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentation; and generic prefilled injectables.
Medication Management Solutions	Intravenous medication safety and infusion therapy delivery systems, including infusion pumps and dedicated disposables; and automated medication dispensing and supply management systems.
Pharmaceutical Systems	Prefillable drug delivery systems provided to pharmaceutical companies and sold to end-users as drug/device combinations.
Respiratory Solutions	Respiratory ventilation and diagnostics equipment and consumables used during respiratory diagnostics and therapy; and consumables used for patient monitoring and anesthesia delivery.

BD Life Sciences

BD Life Sciences provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections (“HAIs”) and cancers. In addition, BD Life Sciences produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes. That information is used to aid the discovery and development of new drugs and vaccines, and to improve the diagnosis and management of diseases. The primary customers served by BD Life Sciences are hospitals, laboratories and clinics; blood banks; healthcare workers; public health agencies; physicians’ office practices; academic and government institutions; and pharmaceutical and biotechnology companies. BD Life Sciences consists of the following business units:

Table of Contents



Business Unit	Principal Product Lines
Preanalytical Systems	Integrated systems for specimen collection; safety-engineered blood collection products and systems.
Diagnostic Systems	Automated blood culturing and tuberculosis culturing systems; molecular testing systems for infectious diseases and women’s health; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation; and plated media.
Biosciences	Fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological (HIV) and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing.

Acquisitions

CareFusion Corporation. As previously mentioned, on March 17, 2015, pursuant to a definitive agreement entered into on October 5, 2014, BD acquired a 100% interest in CareFusion, a global medical technology company with a comprehensive portfolio of products in the areas of medication management, infection prevention, operating room and procedural effectiveness, and respiratory care. The fair value of consideration transferred was $12.538 billion in the form of cash and BD common stock.

Other Transactions. During the first quarter of fiscal year 2015, BD acquired GenCell Biosystems, a privately-held Irish biotechnology company that has developed proprietary technologies that address key biological analysis protocols including library preparation of Next Generation Sequencing and genotyping applications. During the second quarter of fiscal year 2015, BD acquired CRISI Medical Systems, Inc., a San Diego-based medical technology company dedicated to improving the safety and delivery of IV injectable medications. During the third quarter of fiscal year 2015, BD acquired the ARX group of companies, a leading pharmacy automation distributor in Western Europe. During the fourth quarter of fiscal year 2015, BD acquired Cellular Research, Inc., a biotechnology research and development company that has developed advanced tools for massively parallel single cell genetic analysis based on their proprietary Molecular Indexing™ technology to enable gene expression profiles from single cells.

Additional information regarding these acquisitions is contained in Note 9 to the consolidated financial statements contained in Item 8, Financial Statements and Supplementary Data, which is incorporated herein by reference.

International Operations

BD’s products are manufactured and sold worldwide. For reporting purposes, we organize our operations outside the United States as follows: Europe, EMA (which includes the Commonwealth of Independent States, the Middle East and Africa); Greater Asia (which includes Japan and Asia Pacific); Latin America (which includes Mexico, Central America, the Caribbean and South America); and Canada. The principal products sold by BD outside the United States are hypodermic needles and syringes; insulin syringes and pen needles; BD Hypak™ brand prefillable syringe systems; infusion therapy products including Alaris® infusion pumps; pharmacy automation equipment; respiratory equipment and disposable products; BD Vacutainer™ brand blood collection products; diagnostic systems and laboratory equipment and products; flow cytometry instruments and reagents. BD has manufacturing operations outside the United States in Bosnia and Herzegovina, Brazil, Canada, China, Dominican Republic, France, Germany, Hungary, India, Ireland, Italy, Japan, Mexico, the Netherlands, Singapore, Spain, and the United Kingdom. Geographic information with respect to BD’s operations is included under the heading “Geographic Information” in Note 6 to the consolidated financial statements included in Item 8, Financial Statements and Supplementary Data, and is incorporated herein by reference.

Foreign economic conditions and exchange rate fluctuations have caused the profitability related to foreign revenues to fluctuate more than the profitability related to domestic revenues. BD believes its activities in some countries outside the United States involve greater risk than its domestic business due to the factors cited herein, as well as the economic environment, local commercial and economic policies and political uncertainties. See further discussion of this risk in Item 1A. Risk Factors.

Distribution

BD’s products are marketed in the United States and internationally through independent distribution channels and directly to end-users by BD and independent sales representatives. Order backlog is not material to BD’s business inasmuch as orders for BD products generally are received and filled on a current basis, except for items temporarily out of stock. BD’s worldwide sales are not generally seasonal, with the exception of certain medical devices in the Medication and Procedural

Table of Contents

Solutions and Respiratory Solutions Business Units, and respiratory and flu diagnostic products in the Diagnostic Systems Business Unit, which relate to seasonal diseases such as influenza.

Raw Materials

BD purchases many different types of raw materials, including plastics, glass, metals, textiles, paper products, agricultural products, electronic and mechanical sub-assemblies and various biological, chemical and petrochemical products. BD seeks to ensure continuity of raw material supply by securing multiple options for sourcing. However, there are situations where raw materials are only available from one supplier, which are referred to as sole sourced. The use of sole sourced materials may be due to sourcing of proprietary and/or patented technology and processes that are intended to provide a unique market differentiation to our product. In other cases, while a raw material can be sourced from multiple manufacturers, only one supplier is qualified due to quality assurance, cost or other considerations. In order to provide alternate sources of raw materials, BD must complete a rigorous qualification process, which most often includes completion of regulatory registration and approval. If clinical trials are not required, this qualification process can take 3-18 months depending on the criticality of the change. When clinical trials are required, this process may lengthen the qualification phase from one to three years. BD continuously assesses its sole sourced raw materials and maintains business continuity plans with our suppliers. BD’s continuity plans may include securing secondary supply with alternate suppliers, qualification of alternate manufacturing facilities, maintaining contingency stock, internal development of supply and establishment of technology escrow accounts. While BD works closely with its suppliers, there may nonetheless be events that cause supply interruption, reduction or termination that adversely impacts BD’s ability to manufacture and sell certain products.

Research and Development

BD conducts its research and development (“R&D”) activities at its operating units and at BD Technologies in Research Triangle Park, North Carolina. The majority of BD’s R&D activities are conducted in North America. Outside North America, BD conducts R&D activities in China, France, India, Ireland and Singapore. BD also collaborates with certain universities, medical centers and other entities on R&D programs, and retains individual consultants to support its efforts in specialized fields. BD spent approximately $632 million, $550 million, and $494 million on research and development during the fiscal years ended September 30, 2015, 2014, and 2013, respectively. Post-acquisition R&D spend from legacy CareFusion businesses was $115 million in fiscal year 2015.

Intellectual Property and Licenses

BD owns significant intellectual property, including patents, patent applications, technology, trade secrets, know-how, copyrights and trademarks in the United States and other countries. BD is also licensed under domestic and foreign patents, patent applications, technology, trade secrets, know-how, copyrights and trademarks owned by others. In the aggregate, these intellectual property assets and licenses are of material importance to BD’s business. BD believes, however, that no single patent, technology, trademark, intellectual property asset or license is material in relation to BD’s business as a whole, or to any business segment.

Competition

BD operates in the increasingly complex and challenging medical technology marketplace. Technological advances and scientific discoveries have accelerated the pace of change in medical technology, the regulatory environment of medical products is becoming more complex and vigorous, and economic conditions have resulted in a challenging market. Companies of varying sizes compete in the global medical technology field. Some are more specialized than BD with respect to particular markets, and some have greater financial resources than BD. New companies have entered the field, particularly in the areas of molecular diagnostics, safety-engineered devices and in the life sciences, and established companies have diversified their business activities into the medical technology area. Other firms engaged in the distribution of medical technology products have become manufacturers of medical devices and instruments as well. Acquisitions and collaborations by and among companies seeking a competitive advantage also affect the competitive environment. In addition, the entry into the market of manufacturers located in China and other low-cost manufacturing locations are creating increased pricing pressures, particularly in developing markets. Some competitors have also established manufacturing sites or have contracted with suppliers located in these countries as a means to lower their costs.

BD competes in this evolving marketplace on the basis of many factors, including price, quality, innovation, service, reputation, distribution and promotion. The impact of these factors on BD’s competitive position varies among BD’s various product offerings. In order to remain competitive in the industries in which it operates, BD continues to make investments in research and development, quality management, quality improvement, product innovation and productivity improvement in support of its core strategy - to increase revenue growth by focusing on products that deliver greater benefits to patients, healthcare workers and researchers.

Table of Contents

Third-Party Reimbursement

Most of our customers and healthcare providers typically rely on third-party payers, including government programs and private health insurance plans, to reimburse some or all of the cost of the procedures, products and services they provide. Our devices are subject to worldwide regulations regarding reimbursement developed by government agencies, including the Centers for Medicare and Medicaid Services (CMS) in the United States; the National Health Service in the United Kingdom; the Joint Federal Committee in Germany; the Commission d’Evaluation des Produits et prestations in France; the Ministry for Health, Labor and Welfare in Japan; the Ministry of Health and the National Development and Reform Commission in China; among many others. In addition, our devices are also subject to reimbursement policies issued by private insurance companies and managed care organizations. The manner and level of reimbursement in any given case may depend on the site of care, the procedure(s) performed, the final patient diagnosis, the device(s) and/or drug(s) utilized, the available budget, or a combination of these factors, and coverage and payment levels are determined at each payer’s discretion. The coverage policies and reimbursement levels of these third-party payers may impact the decisions of healthcare providers and facilities regarding which medical products they purchase and the prices they are willing to pay for those products. Thus, changes in reimbursement levels or methods may either positively or negatively impact sales of BD products.

While BD is actively engaged in promoting the value propositions of its products for payer, provider, and patient stakeholders, and it employs various efforts and resources to positively impact coverage, coding and payment processes in this regard, it has no direct control over payer decision-making with respect to coverage and payment levels for BD products. Many third-party payers are seeking to control the growth of healthcare expenditures and have developed specific payment and delivery mechanisms to support these cost control efforts. These mechanisms include payment reductions, pay for performance measures, quality-based performance payments, restrictive coverage policies, bidding and tender mechanics, studies to compare the effectiveness of therapies and use of technology assessments. These changes have created an increased emphasis on the delivery of more cost-effective and quality-driven healthcare. As government programs, including CMS and many other national healthcare programs, seek to expand healthcare coverage for their citizens, they have at the same time sought to control costs by limiting the amount of reimbursement they will pay for particular procedures, products or services.

As BD’s product offerings are diverse across many healthcare settings, they are affected to varying degrees by the many payment systems. Therefore, individual countries, product lines or product classes may be impacted by changes to these systems. Governments and payers around the world are altering healthcare delivery and payment pathways to focus on paying for value. Traditional procurement processes are evolving to drive “value for money” with specific priorities focused on reducing costs and creating efficiencies in the healthcare systems.

The Patient Protection and Affordable Care Act (“PPACA”) has created substantive changes to U.S. healthcare payment systems. With respect to Medicare, the law initially focused on Medicare provisions aimed at improving quality and decreasing costs through a variety of value based payment methodologies. Medicare is now moving beyond payment penalties and seeking to create alternative payment models such as bundled payments to continue to drive improved value. The Department of Health and Human Services (“HHS”) announced earlier this year an initiative designed to actively move the Medicare program toward paying providers based on the quality, rather than the quantity of care they give patients. This initiative continues the shift toward reimbursing providers via bundled payments based upon quality and outcomes. As a result, HHS predicts that by 2018, 90% of all fee-for-service Medicare payments will be linked to quality outcomes through programs such as the Hospital Value Based Purchasing and the Hospital Readmissions Reduction programs. Of these quality-based payments, 50% will be tied to alternate payment models that promote shared savings like Accountable Care Organizations and bundled payment arrangements.

We see other governments around the world considering similar bundling reform measures, including the development of the Diagnosis Related Group (“DRG”) as a payment mechanism to drive toward quality and resource based reimbursement.

See Item 1A. Risk Factors for a further discussion.

Regulation

BD’s medical technology products and operations are subject to regulation by the U.S. Food and Drug Administration (“FDA”) and various other federal and state agencies, as well as by foreign governmental agencies. These agencies enforce laws and regulations that govern the development, testing, manufacturing, labeling, advertising, marketing and distribution, and market surveillance of BD’s medical products. The scope of the activities of these agencies, particularly in the Europe, Japan, and Asia Pacific regions in which BD operates, has been increasing.

BD actively maintains FDA/ISO Quality Systems that establish standards for its product design, manufacturing, and distribution processes. Prior to marketing or selling most of its products, BD must secure approval from the FDA and counterpart non-U.S. regulatory agencies. Following the introduction of a product, these agencies engage in periodic reviews and inspections of BD’s quality systems, as well as product performance and advertising and promotional materials. These regulatory controls, as well as any changes in FDA policies, can affect the time and cost associated with the development, introduction and continued availability of new products. Where possible, BD anticipates these factors in its product

Table of Contents

development and planning processes. These agencies possess the authority to take various administrative and legal actions against BD, such as product recalls, product seizures and other civil and criminal sanctions. BD also undertakes voluntary compliance actions such as voluntary recalls.

BD also is subject to various federal and state laws, and laws outside the United States, concerning healthcare fraud and abuse (including false claims laws and anti-kickback laws), global anti-corruption, transportation, safety and health, and customs and exports. Many of the agencies enforcing these laws have increased their enforcement activities with respect to medical device manufacturers in recent years. This appears to be part of a general trend toward increased regulation and enforcement activity within and outside the United States.

In addition, as part of PPACA, the federal government has enacted the Sunshine Act provisions requiring BD to publicly report gifts and payments made to physicians and teaching hospitals. Many of these provisions are new and uncertain, and failure to comply could result in a range of fines, penalties and/or other sanctions.

Our infusion pump business unit is operating under an amended consent decree entered into by CareFusion with the FDA in 2007. CareFusion’s consent decree with the FDA related to its Alaris SE infusion pumps. In February 2009, CareFusion and the FDA amended the consent decree to include all infusion pumps manufactured by or for CareFusion 303, Inc., the business unit that manufactures and sells infusion pumps in the United States. The amended consent decree does not apply to intravenous administration sets and accessories.

While this BD business unit remains subject to the amended consent decree, which includes the requirements of the original consent decree, it has made substantial progress in its compliance efforts. However, we cannot predict the outcome of this matter, and the amended consent decree authorizes the FDA, in the event of any violations in the future, to order us to cease manufacturing and distributing infusion pumps, recall products and take other actions. We may be required to pay damages of $15,000 per day per violation if we fail to comply with any provision of the amended consent decree, up to $15 million per year.

We also cannot currently predict whether additional monetary investment will be incurred to resolve this matter or the matter’s ultimate impact on our business. We may be obligated to pay more costs in the future because, among other things, the FDA may determine that we are not fully compliant with the amended consent decree and therefore impose penalties under the amended consent decree, and/or we may be subject to future proceedings and litigation relating to the matters addressed in the amended consent decree. As of September 30, 2015, we do not believe that a loss is probable in connection with the amended consent decree, and accordingly, we have no accruals associated with compliance with the amended consent decree.

See also Item 3. Legal Proceedings.

Employees

As of September 30, 2015, BD had 49,517 employees, of which 18,596 were employed in the U.S. (including Puerto Rico). BD believes that its employee relations are satisfactory.

Available Information

BD maintains a website at www.bd.com. BD also makes available its Annual Reports on Form 10-K, its Quarterly Reports on Form 10-Q, and its Current Reports on Form 8-K (and amendments to those reports) as soon as reasonably practicable after those reports are electronically filed with, or furnished to, the Securities and Exchange Commission (“SEC”). These filings may be obtained and printed free of charge at www.bd.com/investors. In addition, the written charters of the Audit Committee, the Compensation and Management Development Committee, the Corporate Governance and Nominating Committee, the Executive Committee and the Science, Marketing, Innovation and Technology Committee of the Board of Directors, BD’s Corporate Governance Principles and its Code of Conduct, are available at BD’s website at www.bd.com/investors/corporate_governance/. Printed copies of these materials, this 2015 Annual Report on Form 10-K, and BD’s reports and statements filed with, or furnished to, the SEC, may be obtained, without charge, by contacting the Corporate Secretary, BD, 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880, telephone 201-847-6800. In addition, the SEC maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC at www.sec.gov.

BD also routinely posts important information for investors on its website at www.bd.com/investors. BD may use this website as a means of disclosing material, non-public information and for complying with its disclosure obligations under Regulation FD adopted by the SEC. Accordingly, investors should monitor the Investor Relations portion of BD’s website noted above, in addition to following BD’s press releases, SEC filings, and public conference calls and webcasts. Our website and the information contained therein or connected thereto shall not be deemed to be incorporated into this Annual Report.

Table of Contents

Forward-Looking Statements

BD and its representatives may from time-to-time make certain forward-looking statements in publicly-released materials, both written and oral, including statements contained in filings with the SEC and in its reports to shareholders. Additional information regarding BD’s forward-looking statements is contained in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Item 1A. Risk Factors.

An investment in BD involves a variety of risks and uncertainties. The following describes some of the significant risks that could adversely affect BD’s business, financial condition, operating results or cash flows.

Risks Relating to the Company

Global economic conditions could continue to adversely affect our operations.

In recent years, we have been faced with very challenging global economic conditions. Deterioration in the global economic environment, particularly in emerging markets and countries with government-sponsored healthcare systems, may result in decreased demand for our products and services, increased competition, downward pressure on the prices for our products, longer sales cycles, and slower adoption of new technologies. A weakening of macroeconomic conditions may also adversely affect our suppliers, which could result in interruptions in supply in the future. We have also previously experienced delays in collecting receivables in certain countries in Western Europe, and we may experience similar delays in the future in these and other countries or regions experiencing liquidity problems.

We are subject to foreign currency exchange risk.

A substantial amount of our revenues are derived from international operations, and we anticipate that a significant portion of our sales will continue to come from outside the U.S. in the future. The revenues we report with respect to our operations outside the United States may be adversely affected by fluctuations in foreign currency exchange rates. A discussion of the financial impact of exchange rate fluctuations and the ways and extent to which we may attempt to address any impact is contained in Item 7., Management’s Discussion of Financial Condition and Results of Operations. Any hedging activities we engage in may only offset a portion of the adverse financial impact resulting from unfavorable changes in foreign currency exchange rates. We cannot predict with any certainty changes in foreign currency exchange rates or the degree to which we can mitigate these risks.

Changes in reimbursement practices of third-party payers could affect the demand for our products and the prices at which they are sold.

Our sales depend, in part, on the extent to which healthcare providers and facilities are reimbursed by government authorities, private insurers and other third-party payers for the costs of our products. The coverage policies and reimbursement levels of third-party payers, which can vary among public and private sources and by country, may affect which products customers purchase and the prices they are willing to pay for those products in a particular jurisdiction. Reimbursement rates can also affect the acceptance rate of new technologies and products. Legislative or administrative reforms to reimbursement systems in the United States or abroad, changes in reimbursement rates by private payers, or adverse decisions relating to our products by administrators of these systems could significantly reduce reimbursement for procedures using our products or result in denial of reimbursement for those products, which would adversely affect customer demand or the price customers are willing to pay for such products. See “Third-Party Reimbursement” under Item 1., Business.

Federal healthcare reform may adversely affect our results of operations.

The PPACA was enacted in March 2010. The PPACA imposes on medical device manufacturers, such as BD, a 2.3% excise tax on U.S. sales of certain medical devices. We cannot predict with any certainty what other impact the PPACA may have on our business. The PPACA, among other things, reduces Medicare and Medicaid payments to hospitals, clinical laboratories and pharmaceutical companies, and could otherwise reduce the volume of medical procedures. These factors, in turn, could result in reduced demand for our products and increased downward pricing pressure. It is also possible that the PPACA will result in lower reimbursement rates for our products. Other provisions in the law may significantly change the practice of health care and could adversely affect aspects of our business.

Consolidation in the healthcare industry could adversely affect our future revenues and operating income.

The medical technology industry has experienced a significant amount of consolidation. As a result of this consolidation, competition to provide goods and services to customers has increased. Health care systems and other health care companies are also consolidating, resulting in greater purchasing power for these companies and competition among medical device suppliers to provide goods and services. Group purchasing organizations and integrated health delivery networks have also

Table of Contents

served to concentrate purchasing decisions for some customers, which has also placed pricing pressure on medical device suppliers. Further consolidation in the industry could exert additional pressure on the prices of our products.

Cost volatility could adversely affect our operations.

Our results of operations could be negatively impacted by volatility in the cost of raw materials, components, freight and energy. In particular, we purchase supplies of resins, which are oil-based components used in the manufacture of certain products. Any significant increases in resin costs could adversely impact future operating results. Increases in the price of oil can also increase our costs for packaging and transportation. New laws or regulations adopted in response to climate change could also increase energy costs as well as the costs of certain raw materials and components. We may not be able to offset increases in these costs through other cost reductions.

Breaches of our information technology systems could have a material adverse effect on our operations.

We rely on information technology systems to process, transmit, and store electronic information in our day-to-day operations. Our information technology systems have been subjected to computer viruses or other malicious codes, and cyber- or phishing- attacks, and we have experienced instances of unauthorized access to our systems in the past. We expect to be subject to similar attacks in the future. In addition to our own information, we store certain information with third parties that could be subject to these types of attacks. These attacks could result in our intellectual property and other confidential information being lost or stolen, disruption of our operations, and other negative consequences, such as increased costs for security measures or remediation costs, diversion of management attention, and adverse impact on our relationships with vendors and customers. While we will continue to implement additional protective measures to reduce the risk of and detect future cyber incidents, cyber-attacks are becoming more sophisticated and frequent, and the techniques used in such attacks change rapidly. There can be no assurances that our protective measures will prevent future attacks that could have a significant impact on our business.

Our future growth is dependent in part upon the development of new products, and there can be no assurance that such products will be developed.

A significant element of our strategy is to increase revenue growth by focusing on products that deliver greater benefits to patients, healthcare workers and researchers. The development of these products requires significant investment in research and development, clinical trials and regulatory approvals. The results of our product development efforts may be affected by a number of factors, including our ability to anticipate customer needs, innovate and develop new products, complete clinical trials, obtain regulatory approvals and reimbursement in the United States and abroad, manufacture products in a cost-effective manner, obtain appropriate intellectual property protection for our products, and gain and maintain market approval of our products. In addition, patents attained by others can preclude or delay our commercialization of a product. There can be no assurance that any products now in development or that we may seek to develop in the future will achieve technological feasibility, obtain regulatory approval or gain market acceptance.

We cannot guarantee that any of our strategic acquisitions, investments or alliances will be successful.

As part of our strategy to increase revenue growth, we seek to supplement our internal growth through strategic acquisitions, investments and alliances. Such transactions are inherently risky., and the integration of any newly-acquired business requires significant effort and management attention. The success of any acquisition, investment or alliance may be affected by a number of factors, including our ability to properly assess and value the potential business opportunity or to successfully integrate any business we may acquire into our existing business. There can be no assurance that any past or future transaction will be successful.

The medical technology industry is very competitive.

We face significant competition from a wide range of companies. These include large medical device companies with multiple product lines, some of which may have greater financial and marketing resources than we do, and firms that are more specialized than we are with respect to particular markets or product lines. We face competition across our product lines and in each market in which our products are sold on the basis of product features, clinical outcomes, product quality, price, services and other factors. In addition, we face changing customer preferences and requirements, including increased customer demand for more environmentally-friendly products.

The medical technology industry is also subject to rapid technological change and discovery. The development of new or improved products, processes or technologies by other companies (such as needle-free injection technology) may render our products or proposed products obsolete or less competitive. In some instances, competitors, including pharmaceutical companies, also offer, or are attempting to develop, alternative therapies for disease states that may be delivered without a medical device. The entry into the market of manufacturers located in China and other low-cost manufacturing locations has also created pricing pressure, particularly in developing markets.

Table of Contents

The international operations of our business may subject us to certain business risks.

A substantial amount of our sales come from our operations outside the United States, and we intend to continue to pursue growth opportunities in foreign markets, especially in emerging markets. Our foreign operations subject us to certain risks, including the effects of fluctuations in foreign currency exchange (discussed above), the effects of local economic conditions, foreign regulatory requirements or changes in such requirements, local product preferences and product requirements, difficulty in establishing, staffing and managing foreign operations, differing labor regulations, changes in tax laws, potential political instability, weakening or loss of the protection of intellectual property rights in some countries, import or export licensing requirements, trade protection and restrictions on the transfer of capital across borders. The success of our operations outside the United States depends, in part, on our ability to acquire or form and maintain alliances with local companies and make necessary infrastructure enhancements to, among other things, our production facilities and sales and distribution networks.

In addition, our international operations are governed by the U.S. Foreign Corrupt Practices Act and similar anti-corruption laws outside the U.S. Global enforcement of anti-corruption laws has increased substantially in recent years, with more enforcement proceedings by U.S. and foreign governmental agencies and the imposition of significant fines and penalties. While we have implemented policies and procedures to enhance compliance with these laws, our international operations, which often involve customer relationships with foreign governments, create the risk that there may be unauthorized payments or offers of payments by employees, consultants, sales agents or distributors. Any alleged or actual violations of these laws may subject us to government investigations, significant criminal or civil sanctions and other liabilities, and negatively affect our reputation.

Under the U.S. tax code, we may also be subject to additional taxation to the extent we repatriate earnings from our foreign operations to the U.S. In the event we require more capital in the United States than is generated by our U.S. operations to fund acquisitions or other activities and elect to repatriate earnings from foreign jurisdictions, our effective tax rate may be higher as a result.

Reductions in customers’ research budgets or government funding may adversely affect our BD Biosciences business.

Our BD Biosciences business sells products to researchers at pharmaceutical and biotechnology companies, academic institutions, government laboratories and private foundations. Research and development spending of our customers can fluctuate based on spending priorities and general economic conditions. A number of these customers are also dependent for their funding upon grants from U.S. government agencies, such as the U.S. National Institutes of Health (“NIH”) and agencies in other countries. The level of government funding of research and development is unpredictable. There have been instances where NIH grants have been frozen or otherwise unavailable for extended periods. The availability of governmental research funding may also continue to be adversely affected by economic conditions and governmental spending reductions. Any reduction or delay in governmental funding could cause our customers to delay or forego purchases of our products.

A reduction or interruption in the supply of certain raw materials and components would adversely affect our manufacturing operations and related product sales.

We purchase many different types of raw materials and components. Certain raw materials and components are not available from multiple sources. In addition, for quality assurance, cost-effectiveness and other reasons, we elect to purchase certain raw materials and components from sole suppliers. The supply of these materials can be disrupted for a number of reasons, including economic conditions as described above. While we work with suppliers to ensure continuity of supply, no assurance can be given that these efforts will be successful. In addition, due to regulatory requirements relating to the qualification of suppliers, we may not be able to establish additional or replacement sources on a timely basis or without excessive cost. The termination, reduction or interruption in supply of these sole-sourced raw materials and components could adversely impact our ability to manufacture and sell certain of our products.

Interruption of our manufacturing operations could adversely affect our future revenues and operating income.

We have manufacturing sites all over the world. In some instances, however, the manufacturing of certain of our product lines is concentrated in one or more of our plants. Damage to one or more of our facilities from weather or natural disasters, or issues in our manufacturing arising from failure to follow internal protocols and procedures, equipment failure or other factors could adversely affect our ability to manufacture our products, resulting in lost revenues and damage to our relationships with customers.

We are subject to lawsuits.

We are or have been a defendant in a number of lawsuits, including purported class action lawsuits for, among other things, alleged antitrust violations and suits alleging patent infringement, and could be subject to additional lawsuits in the future. A more detailed description of these lawsuits is contained in note 5 to the consolidated financial statements included in

Table of Contents

Item 8., Financial Statements and Supplementary Data. Given the uncertain nature of litigation generally, we are not able in all cases to estimate the amount or range of loss that could result from an unfavorable outcome of the litigation to which we are a party. In view of these uncertainties, we could incur charges in excess of any currently established accruals and, to the extent available, excess liability insurance. Any such future charges, individually or in the aggregate, could have a material adverse effect on our results of operations and cash flows.

We are subject to extensive regulation.

Our operations are global and are affected by various state, federal and international healthcare, environmental, antitrust, anti-corruption, fraud and abuse (including anti-kickback and false claims laws), employment and other laws. Violations of these laws can result in criminal or civil sanctions, including substantial fines and, in some cases, exclusion from participation in health care programs such as Medicare and Medicaid. The enactment of additional laws in the future may increase our compliance costs or otherwise adversely impact our operations.

We are also subject to extensive regulation by the FDA pursuant to the Federal Food, Drug and Cosmetic Act, by comparable agencies in foreign countries, and by other regulatory agencies and governing bodies. Most of our products must receive clearance or approval from the FDA or counterpart regulatory agencies in other countries before they can be marketed or sold. The process for obtaining marketing approval or clearance may take a significant period of time and require the expenditure of substantial resources, and these have been increasing due to increased requirements from the FDA for supporting data for submissions. The process may also require changes to our products or result in limitations on the indicated uses of the products. Governmental agencies may also impose new requirements regarding registration, labeling or prohibited materials that may require us to modify or re-register products already on the market or otherwise impact our ability to market our products in those countries. Once clearance or approval has been obtained for a product, there is an obligation to ensure that all applicable FDA and other regulatory requirements continue to be met. Following the introduction of a product, these agencies also periodically review our manufacturing processes and product performance. Our failure to comply with the applicable good manufacturing practices, adverse event reporting, clinical trial and other requirements of these agencies could delay or prevent the production, marketing or sale of our products and result in fines, delays or suspensions of regulatory clearances, closure of manufacturing sites, seizures or recalls of products and damage to our reputation. More stringent oversight by the FDA and other agencies in recent years has resulted in increased enforcement activity, which increases the compliance risk for us and other companies in our industry.

As a result of the CareFusion acquisition, we are operating under a consent decree with the FDA that was entered into by CareFusion in 2009, that affects our infusion pump business in the United States. For more information regarding the consent decree, see “Regulation” under Item 1, “Business”.

Product defects could adversely affect the results of our operations.

The design, manufacture and marketing of medical devices involve certain inherent risks. Manufacturing or design defects, unapproved use of our products, or inadequate disclosure of risks or other information relating to the use of our products can lead to injury or other adverse events. These events could lead to recalls or safety alerts relating to our products (either voluntary or required by the FDA or similar governmental authorities in other countries), and could result, in certain cases, in the removal of a product from the market. A recall could result in significant costs, as well as negative publicity and damage to our reputation that could reduce demand for our products. Personal injuries relating to the use of our products can also result in significant product liability claims being brought against us. In some circumstances, such adverse events could also cause delays in regulatory approval of new products.

Our operations are dependent in part on patents and other intellectual property assets.

Many of our businesses rely on patent, trademark and other intellectual property assets. These intellectual property assets, in the aggregate, are of material importance to our business. We can lose the protection afforded by these intellectual property assets through patent expirations, legal challenges or governmental action. Patents attained by competitors, particularly as patents on our products expire, may also adversely affect our competitive position. In addition, competitors may claim that our products infringe upon their intellectual property, which could result in the payment of significant legal fees, damage awards and past or future royalties, as well as injunctions against future sales of our products. We also operate in countries that do not protect intellectual property rights to the same extent as in the U.S., which could make it easier for competitors to compete with us in those countries. The loss of a significant portion of our portfolio of intellectual property assets may have an adverse effect on our earnings, financial condition or cash flows.

Natural disasters, war and other events could adversely affect our future revenues and operating income.

Natural disasters (including pandemics), war, terrorism, labor disruptions and international conflicts, and actions taken by the United States and other governments or by our customers or suppliers in response to such events, could cause significant

Table of Contents

economic disruption and political and social instability in the United States and areas outside of the United States in which we operate. These events could result in decreased demand for our products, adversely affect our manufacturing and distribution capabilities, or increase the costs for or cause interruptions in the supply of materials from our suppliers.

We need to attract and retain key employees to be competitive.

Our ability to compete effectively depends upon our ability to attract and retain executives and other key employees, including people in technical, marketing, sales and research positions. Competition for experienced employees, particularly for persons with specialized skills, can be intense. Our ability to recruit such talent will depend on a number of factors, including compensation and benefits, work location and work environment. If we cannot effectively recruit and retain qualified executives and employees, our business could be adversely affected.

Risks Relating To Our Acquisition of CareFusion

The integration process with CareFusion may be more difficult, costly or time consuming than expected and the anticipated benefits and cost savings of the merger may not be realized.

The success of our acquisition of CareFusion, including anticipated benefits and cost savings, will depend, in part, on our ability to successfully combine and integrate our business with the business of CareFusion. It is possible that the integration process could result in the loss of key employees, higher than expected costs, diversion of management attention and resources, the disruption of ongoing businesses or inconsistencies in standards, controls, procedures and policies that adversely affect the combined company’s ability to maintain relationships with customers, vendors and employees or to achieve the anticipated benefits and cost savings of the merger. As part of the integration process, we intend to move assets within our combined company to create efficiencies and may seek to opportunistically divest certain assets of the combined company, which may change the profile of the combined company, and which may not be possible on favorable terms, or at all. If we experience difficulties with the integration process, the anticipated benefits of the merger may not be realized fully or at all, or may take longer to realize than expected. These integration matters could have an adverse effect on the combined company for an undetermined period going forward. In addition, the actual cost savings of the merger could be less than anticipated.

In connection with the CareFusion transactions, we incurred and assumed significant additional indebtedness, which could adversely affect us, including by decreasing our business flexibility.

We have substantially increased indebtedness following completion of the CareFusion acquisition in comparison to that of BD on a recent historical basis, which has increased our interest expense and could have the effect, among other things, of reducing our flexibility to respond to changing business and economic conditions. The amount of cash required to pay interest on our increased indebtedness following the merger, and thus the demands on our cash resources, is greater than the amount of cash flows required to service our indebtedness prior to the acquisition. Our increased levels of indebtedness could also reduce funds available for working capital, capital expenditures, acquisitions, funding research and development or future expansion of our business, and other general corporate purposes and may create competitive disadvantages for BD relative to other companies with lower debt levels. If we do not achieve the expected benefits and cost savings from the transaction, or if the financial performance of the combined company does not meet current expectations, then our ability to service this indebtedness may be adversely impacted.

Certain of the indebtedness incurred in connection with the merger bears interest at variable interest rates. If interest rates increase, variable rate debt will create higher debt service requirements, which could adversely affect our cash flows.

In addition, our credit ratings affect the cost and availability of future borrowings and, accordingly, our cost of capital. Our ratings reflect each rating organization’s opinion of our financial strength, operating performance and ability to meet our debt obligations. Our ratings were downgraded in connection with the indebtedness incurred and assumed in the acquisition of CareFusion, and there can be no assurance that we will achieve a particular rating or maintain a particular rating in the future. Moreover, we may be required to raise substantial additional financing to fund working capital, capital expenditures, acquisitions or other general corporate requirements. Our ability to arrange additional financing or refinancing will depend on, among other factors, our financial position and performance, as well as prevailing market conditions and other factors beyond our control. There can be no assurance that we will be able to obtain additional financing or refinancing on terms acceptable to us or at all.

Table of Contents

The agreements that govern the indebtedness incurred or assumed in connection with the acquisition contain various covenants that impose restrictions on us and certain of our subsidiaries that may affect our ability to operate our businesses.

The agreements that govern the indebtedness incurred or assumed in connection with the CareFusion transaction contain various affirmative and negative covenants that may, subject to certain significant exceptions, restrict our ability and the ability of certain of our subsidiaries (including CareFusion) to, among other things, have liens on their property, transact business with affiliates and/or merge or consolidate with any other person or sell or convey certain of our assets to any one person. In addition, some of the agreements that govern our indebtedness contain financial covenants that will require us to maintain certain financial ratios. Our ability and the ability of our subsidiaries to comply with these provisions may be affected by events beyond our control. Failure to comply with these covenants could result in an event of default, which, if not cured or waived, could accelerate our repayment obligations.

Uncertainties associated with our CareFusion integration efforts may cause a loss of management personnel and other key employees, which could adversely affect the future business and operations of the combined company.

The successful integration of CareFusion and BD will depend in part upon our ability to retain key management personnel and other key employees of both companies. Current and prospective employees of the combined company may experience uncertainty about their future roles during the integration process, which may materially adversely affect our ability to attract and retain key personnel. No assurance can be given that the combined company will be able to retain key management personnel and other key employees.

Item 1B. Unresolved Staff Comments.

None.

Item 2. Properties.

BD’s executive offices are located in Franklin Lakes, New Jersey. As of October 6, 2015, BD owned or leased 326 facilities throughout the world, comprising approximately 19,954,024 square feet of manufacturing, warehousing, administrative and research facilities. The U.S. facilities, including those in Puerto Rico, comprise approximately 7,894,098 square feet of owned and 3,444,667 square feet of leased space. The international facilities comprise approximately 6,810,151 square feet of owned and 1,805,108 square feet of leased space. Sales offices and distribution centers included in the total square footage are also located throughout the world.

Operations in each of BD’s business segments are conducted at both U.S. and international locations. Particularly in the international marketplace, facilities often serve more than one business segment and are used for multiple purposes, such as administrative/sales, manufacturing and/or warehousing/distribution. BD generally seeks to own its manufacturing facilities, although some are leased. The following table summarizes property information by business segment.



Sites	Corporate	BD Lifesciences	BD Medical	Mixed(A)	Total
Leased	14	18	119	93	244
Owned	4	27	39	12	82
Total	18	45	158	105	326
Square feet	1,395,035	4,240,503	10,558,257	3,760,229	19,954,024


(A)	Facilities used by more than one business segment.

BD believes that its facilities are of good construction and in good physical condition, are suitable and adequate for the operations conducted at those facilities, and are, with minor exceptions, fully utilized and operating at normal capacity.

The U.S. facilities are located in Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, New Jersey, New Mexico, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, Washington, D.C., Washington, Wisconsin and Puerto Rico.

The international facilities are as follows:

- Europe, Middle East, Africa, which includes facilities in Austria, Belgium, Bosnia and Herzegovina, the Czech Republic, Denmark, England, Finland, France, Germany, Ghana, Hungary, Ireland, Italy, Kenya, Luxembourg, Netherlands, Norway, Poland, Portugal, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, the United Arab Emirates and Zambia.

- Greater Asia, which includes facilities in Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, New Zealand, Pakistan, the Philippines, Singapore, South Korea, Taiwan, Thailand and Vietnam.

Table of Contents

- Latin America, which includes facilities in Argentina, Brazil, Chile, Colombia, Mexico, Peru and the Dominican Republic.

- Canada.

Item 3. Legal Proceedings.

Information with respect to certain legal proceedings is included in Note 5 to the consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data, and is incorporated herein by reference.

Item 4. Mine Safety Disclosures.

Not applicable.

Table of Contents

Executive Officers of the Registrant

The following is a list of the executive officers of BD, their ages and all positions and offices held by each of them during the past five years. There is no family relationship between any executive officer or director of BD.



Name	Age	Position
Vincent A. Forlenza	62	Chairman since July 2012; Chief Executive Officer since October 2011; President since January 2009; Chief Operating Officer from July 2010 to October 2011; and prior thereto, Executive Vice President.
Gary M. Cohen	56	Executive Vice President and President, Global Health.
Alexandre Conroy	52	Executive Vice President and President, Europe, EMA and the Americas since June 2012; and prior thereto, President, Western Europe.
Jerome V. Hurwitz	61	Executive Vice President and Chief Human Resource Officer since September 2013; and prior thereto, Vice President, Change Management.
William A. Kozy	63	Chief Operating Officer since November 2012; and Executive Vice President since June 2006.
James Lim	51	Executive Vice President and President, Greater Asia since June 2012; and prior thereto, Vice President/General Manager, Central Asia Pacific and Operations.
Thomas E. Polen	42	Executive Vice President and President - Medical since October 1, 2014; Group President from October 2013 to October 2014; and Worldwide President - BD Diagnostic Systems from October 2010 to October 2013.
Christopher R. Reidy	58	Executive Vice President, Chief Financial Officer and Chief Administrative Officer since July 15, 2013; and prior thereto, Vice President and Chief Financial Officer of ADP Corporation.
Nabil Shabshab	50	Executive Vice President and Chief Marketing Officer since August 2011; and prior thereto, Executive Vice President, Global Portfolio Management of Diversey, Inc.
Jeffrey S. Sherman	60	Executive Vice President and General Counsel.
Stephen Sichak	58	Executive Vice President, Integrated Supply Chain.
Ellen R. Strahlman, M.D.	58	Executive Vice President, Research and Development and Chief Medical Officer since April 2013; Senior Vice President, Office of the CEO and Global Head, Neglected Tropical Diseases of GlaxoSmithKline from March 2012 to May 2012, and prior thereto, Chief Medical Officer of GlaxoSmithKline plc.
Linda M. Tharby	47	Executive Vice President and President - Life Sciences since October 1, 2014; Group President from October 2013 to October 2014; and prior thereto, Worldwide President - BD Medical, Diabetes Care.

Table of Contents

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

BD’s common stock is listed on the New York Stock Exchange. As of October 31, 2015, there were approximately 14,474 shareholders of record.

Market and Market Prices of Common Stock (per common share)



	2014		2015
By Quarter	High	Low	High	Low
First	$ 110.60	$ 98.33	$ 141.26	$ 113.60
Second	117.08	105.40	149.50	138.08
Third	120.33	111.18	145.57	137.93
Fourth	120.21	112.63	153.86	130.40

Dividends (per common share)



By Quarter	2014	2015
First	$ 0.545	$ 0.600
Second	0.545	0.600
Third	0.545	0.600
Fourth	0.545	0.600

Issuer Purchases of Equity Securities

The table below sets forth certain information regarding BD’s purchases of its common stock during the fiscal quarter ended September 30, 2015.



Period	Total Number of Shares Purchased(1)	Average Price Paid per Share	Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2)	Maximum Number of Shares that May Yet be Purchased Under the Plans or Programs(2)
July 1-31, 2015	1,959	$ 142.89	—	9,147,060
August 1-31, 2015	756	152.84	—	9,147,060
September 1-30, 2015	—	—	—	9,147,060
Total	2,715	$ 145.66	—	9,147,060


(1)	Includes 2,715 shares purchased during the quarter in open market transactions by the trust relating to BD’s Deferred Compensation and Retirement Benefit Restoration Plan and 1996 Directors’ Deferral Plan.


(2)	Any repurchases would be made pursuant to the repurchase program authorized by the Board of Directors on September 24, 2013 for 10 million shares, for which there is no expiration date.

Table of Contents

Item 6. Selected Financial Data.

FIVE-YEAR SUMMARY OF SELECTED FINANCIAL DATA

Becton, Dickinson and Company



	Years Ended September 30
	2015				2014				2013				2012				2011
	Dollars in millions, except share and per share amounts
Operations
Revenues	$	10,282			$	8,446			$	8,054			$	7,708			$	7,584
Gross Margin	4,695				4,301				4,171				3,953				3,959
Research and Development Expense	632				550				494				472				470
Operating Income	1,074				1,606				1,254				1,558				1,666
Interest Expense, Net	356				89				98				84				41
Income From Continuing Operations Before Income Taxes	739			(A)	1,522			(B)	1,165			(C)	1,472			(D)	1,618			(D)
Income Tax Provision	44				337				236				363				417
Income from Continuing Operations	695			(A)	1,185			(B)	929			(C)	1,110			(D)	1,201			(D)
Net Income	695				1,185				1,293				1,170				1,271
Basic Earnings Per Share from Continuing Operations	3.43				6.13				4.76				5.40				5.43
Diluted Earnings Per Share from Continuing Operations	3.35			(A)	5.99			(B)	4.67			(C)	5.30			(D)	5.31			(D)
Dividends Per Common Share	2.40				2.18				1.98				1.80				1.64
Financial Position
Total Current Assets	$	6,045			$	6,131			$	5,873			$	5,322			$	4,668
Total Current Liabilities	4,386				2,235				2,130				1,978				1,823
Total PPE, Net	4,060				3,605				3,476				3,304				3,211
Total Assets	26,820				12,447				12,149				11,361				10,430
Total Long-Term Debt	11,370				3,768				3,763				3,761				2,485
Total Shareholders’ Equity	7,164				5,053				5,043				4,136				4,828
Book Value Per Common Share	34.00				26.33				25.99				21.00				22.48
Financial Relationships
Gross Profit Margin	45.7		%		50.9		%		51.8		%		51.3		%		52.2		%
Return on Revenues(E)	6.8		%		14.0		%		11.5		%		14.4		%		15.8		%
Return on Total Assets(E)(F)	5.7		%		13.5		%		11.1		%		14.7		%		17.0		%
Return on Equity(E)	11.4		%		23.5		%		20.2		%		24.8		%		23.4		%
Debt to Capitalization(E)(G)	58.4		%		43.4		%		43.1		%		49.7		%		35.8		%
Additional Data
Number of Employees	49,500				30,600				30,000				29,600				29,400
Number of Shareholders	14,547				8,210				8,412				8,696				8,713
Average Common and Common Equivalent Shares Outstanding — Assuming Dilution (millions)	207.5				197.7				199.2				209.2				226.3
Depreciation and Amortization	$	891			$	562			$	546			$	511			$	494
Capital Expenditures	596				592				522				487				509


(A)	Includes impact of specified items of $1.186 billion ($786 million after-tax), or $3.79 diluted earnings per share from continuing operations, which affects comparisons of results across periods presented.


(B)	Includes impact of specified items of $153 million ($101 million after-tax), or $0.51 diluted earnings per share from continuing operations, which affects comparisons of results across periods presented.

Table of Contents


(C)	Includes impact of specified items of $442 million ($279 million after-tax), or $1.40 diluted earnings per share from continuing operations, which affects comparisons of results across periods presented.


(D)	There were no amounts reflected in the results of operations for the period which would significantly affect the comparisons of results across periods presented.


(E)	Excludes discontinued operations.


(F)	Earnings before interest expense and taxes as a percent of average total assets.


(G)	Total debt as a percent of the sum of total debt, shareholders’ equity and non-current deferred income tax liabilities.

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following commentary should be read in conjunction with the consolidated financial statements and accompanying notes. Within the tables presented throughout this discussion, certain columns may not add due to the use of rounded numbers for disclosure purposes. Percentages and earnings per share amounts presented are calculated from the underlying amounts. References to years throughout this discussion relate to our fiscal years, which end on September 30.

Company Overview

Description of the Company and Business Segments

Becton, Dickinson and Company (“BD”) is a global medical technology company engaged principally in the development, manufacture and sale of a broad range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. Effective October 1, 2014, BD’s organizational structure was realigned to better complement its customer-focused solutions strategy and is now based upon two worldwide business segments, BD Medical (“Medical”) and BD Life Sciences (“Life Sciences”). The composition of the Medical segment was not changed by this realignment and the Life Sciences segment consists of the former BD Diagnostics and BD Biosciences segments. The commentary provided further below reflects this two-segment organizational structure and additional discussion regarding this organization realignment is provided in Note 6 to the consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data. CareFusion Corporation (“CareFusion”), which was acquired on March 17, 2015, operates as part of our Medical segment, as further discussed below.

BD’s products are manufactured and sold worldwide. Our products are marketed in the United States and internationally through independent distribution channels and directly to end-users by BD and independent sales representatives. We organize our operations outside the United States as follows: Europe, EMA (which includes the Commonwealth of Independent States, the Middle East and Africa); Greater Asia (which includes Japan and Asia Pacific); Latin America (which includes Mexico, Central America, the Caribbean, and South America) and Canada. We continue to pursue growth opportunities in emerging markets, which include the following geographic regions: Eastern Europe, the Middle East, Africa, Latin America and Asia Pacific. We are particularly focused on certain countries whose economic and healthcare sectors are growing rapidly, in particular: China, India and Turkey.

Strategic Objectives

BD remains focused on delivering sustainable growth and shareholder value, while making appropriate investments for the future. BD management operates the business consistent with the following core strategies:


•	To increase revenue growth by focusing on our core products, services and solutions that deliver greater benefits to patients, healthcare workers and researchers;


•	To increase investment in research and development for platform extensions and innovative new products;


•	To make significant investments in growing our operations in emerging markets;


•	To improve operating effectiveness and balance sheet productivity;


•	To drive an efficient capital structure and strong shareholder returns.

Our strategy focuses on four specific areas within healthcare and life sciences:


•	Enabling safer, simpler and more effective parenteral drug delivery;


•	Improving clinical outcomes through new, more accurate and faster diagnostics;


•	Providing tools and technologies to the research community that facilitate the understanding of the cell, cellular diagnostics and cell therapy;


•	Enhancing disease management in diabetes, women’s health and cancer, and infection control.

We continue to strive to improve the efficiency of our capital structure and follow these guiding principles:


•	To maintain an investment grade rating;


•	To ensure access to the debt market for strategic opportunities;

Table of Contents


•	To optimize the cost of capital based on market conditions.

In assessing the outcomes of these strategies as well as BD’s financial condition and operating performance, management generally reviews quarterly forecast data, monthly actual results, segment sales and other similar information. We also consider trends related to certain key financial data, including gross profit margin, selling and administrative expense, investment in research and development, return on invested capital, and cash flows.

Acquisition of CareFusion

On March 17, 2015, pursuant to a definitive agreement entered into on October 5, 2014, BD acquired a 100% interest in CareFusion for total consideration of approximately $12.5 billion to create a global leader in medication management and patient safety solutions. The operating activities of CareFusion from the acquisition date through March 31, 2015 were not material to BD’s consolidated results of operations and as such, CareFusion’s operating results were included in BD’s consolidated results of operations beginning on April 1, 2015. CareFusion operates as part of our Medical segment, which now includes the following organizational units, in addition to the Diabetes Care and Pharmaceutical Systems units: Medication and Procedural Solutions, which encompasses BD’s former Medical Surgical Systems unit; Medication Management Solutions; and Respiratory Solutions. Additional discussion regarding this acquisition is provided in Note 9 to the consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data. Disclosures regarding BD’s financing arrangements relating to this transaction are provided in Note 15 to the consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data.

Summary of Financial Results

Worldwide revenues in 2015 of $10.282 billion increased 21.7% from the prior year, compared with an increase of 4.9% in 2014. The components of the total worldwide revenue growth in 2015 and 2014 were as follows:



	2015 vs. 2014		2014 vs. 2013
CareFusion	24.1	%	—	%
Volume	5.1	%	5.0	%
Other acquisitions	—	%	0.2	%
Price (including product mix)	—	%	—	%
Foreign exchange translation	(7.5	)%	(0.3	)%
	21.7	%	4.9	%

Worldwide revenue growth in 2015 reflected the inclusion of CareFusion’s sales in the Company's results as of April 1, 2015, as discussed above. Revenue growth in 2015 was also attributable to consistent performance of our legacy products, the benefit of our diverse geographic and product portfolio, as well as sales in emerging markets. Medical segment revenue growth in 2015 reflected the inclusion of CareFusion’s sales for the second half of the current year, growth in the Medication and Procedural Solutions unit's international sales of safety-engineered products and growth in the Diabetes Care unit's sales of pen needles. Life Sciences segment revenue growth in 2015 was largely driven by sales of safety-engineered products in the Preanalytical Systems unit as well as by growth in the Diagnostic Systems unit.

Revenues in the United States of $5.069 billion in 2015 increased 48.4% from 2014. International revenues in 2015 grew 3.6% to $5.213 billion, which includes an estimated unfavorable foreign exchange translation impact of 12.6%. In addition to the inclusion of CareFusion's sales in results for the second half of the current year, U.S. revenue growth reflected strength in the Medical segment's overall legacy product portfolio, the Diagnostic Systems unit's benefit from a stronger than normal flu season, and growth in the Biosciences unit’s research reagent sales and instrument placements. In addition to growth attributable to the CareFusion acquisition, international revenues for 2015 reflected growth from both segments due to sales in emerging markets and of safety-engineered products. Worldwide sales of safety-engineered products reflected the inclusion of CareFusion's sales of safety-engineered products for the second half of the fiscal year, as well as growth that was attributable to BD's legacy safety-engineered products. U.S. sales of safety-engineered products in 2015 of $1.471 billion increased 21.8% compared with 2014 and international safety-engineered products revenues of $1.128 billion grew 10.9%, which reflected the estimated unfavorable impact of foreign currency translation of 14%.

We continue to invest in research and development, geographic expansion, and new product promotions to drive further revenue and profit growth. Our ability to sustain our long-term growth will depend on a number of factors, including our ability to expand our core business (including geographical expansion), develop innovative new products, and continue to improve operating efficiency and organizational effectiveness, including the integration of CareFusion. While the economic environment for the healthcare industry has stabilized, pricing pressures continue for some of our products. Healthcare utilization has stabilized and slightly improved in the United States; however, any destabilization in the future could adversely impact our U.S. businesses. Additionally, macroeconomic challenges in Europe continue to constrain healthcare utilization, although we

Table of Contents

currently view the environment as stable. In emerging markets, the Company’s growth is dependent primarily on government funding for healthcare systems.

Our financial position remains strong, with cash flows from operating activities totaling $1.73 billion in 2015. At September 30, 2015, we had $1.44 billion in cash and equivalents and short-term investments. We continued to return value to our shareholders in the form of dividends. During fiscal year 2015, we paid cash dividends of $485 million. No shares were repurchased during fiscal year 2015 due to the suspension of our share repurchase program for the near term, in connection with the CareFusion acquisition, as our focus subsequent to closing the acquisition has been on the reduction of debt levels and the payment of dividends.

Each reporting period, we face currency exposure that arises from translating the results of our worldwide operations to the U.S. dollar at exchange rates that fluctuate from the beginning of such period. The ongoing strength of the U.S. dollar resulted in an unfavorable foreign currency translation impact to our revenue growth during the year, as discussed above. We evaluate our results of operations on both a reported and a foreign currency-neutral basis, which excludes the impact of fluctuations in foreign currency exchange rates. We calculate foreign currency-neutral percentages by converting our current-period local currency financial results using the prior-period foreign currency exchange rates and comparing these adjusted amounts to our current-period reported results. From time to time, we may purchase forward contracts and options to partially protect against adverse foreign exchange rate movements. Gains or losses on our derivative instruments are largely offset by the gains or losses on the underlying hedged transactions. We do not enter into derivative instruments for trading or speculative purposes. For further discussion, refer to Note 13 to the consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data.

Results of Continuing Operations

Comparisons of income from continuing operations between 2015 and 2014, as well as between 2014 and 2013, are affected by the specified items detailed below that are reflected in our financial results.



	2015				2014			2013
	(Millions of dollars)
Financing costs ^(A)	$	107			$	—		$	—
Transaction costs ^(A)	59				6			—
Integration costs ^(A)	95				—			—
Restructuring costs ^(A)	271				—			—
Purchase accounting adjustments	645			(B)	74		(C)	73		(C)
Employee termination-related amounts ^(D)	(5		)		36			—
Research and development charges ^(E)	—				26			—
Litigation-related charges ^(F)	12				—			363
Pension settlement charges ^(G)	—				3			6
Other specified items, net ^(H)	—				8			—
Total specified items	1,186				153			442
Tax impact of specified items	400				52			163
After-tax impact of specified items	$	786			$	101		$	279

(A)

Represents financing, transaction, integration and restructuring costs primarily associated with the CareFusion acquisition. The financing costs were recorded in Interest expense. The transaction, integration and restructuring costs were recorded in Acquisition-related costs. For further discussion, refer to Note 9 to the consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data.

(B)

Represents non-cash amortization expense of $336 million pre-tax associated with acquisition-related identifiable intangible assets, including CareFusion, as well as the net impact of purchase accounting adjustments of $318 million pre-tax to reflect CareFusion’s inventory, fixed assets, debt and deferred revenue balances at fair value as of the acquisition date. BD’s amortization expense is primarily recorded in Cost of products sold. The adjustment also reflected a pre-tax acquisition-date accounting gain of $9 million on the previously held investment in CRISI Medical Systems, Inc. ("CRISI"), a company BD fully acquired in March 2015.


(C)	Represents the non-cash expense associated with the amortization of acquisition-related identifiable intangible assets.


(D)	The amount in 2014 represents a charge for employee termination costs recorded relative to workforce reduction actions taken in the fourth quarter of fiscal year 2014. The amount in 2015 represents an adjustment to decrease this

Table of Contents

liability. For further discussion, refer to Note 8 to the consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data.

(E)

Includes a $6 million charge associated with the decision to terminate a research and development program in the Medical segment; the charge relates to program asset write-offs and obligations. The amount additionally includes a $20 million charge recorded by our Life Sciences segment for asset write-offs primarily resulting from the discontinuance of an instrument product development program. The asset write-offs were largely attributable to capitalized product software, but also included a lesser amount attributable to fixed assets.

(F)

The amount in 2013 represented a pre-tax charge of $341 million relating to an unfavorable verdict in the lawsuit filed against BD by Retractable Technologies, Inc. (“RTI”) and a pre-tax charge of $22 million associated with a litigation settlement related to indirect purchaser antitrust class action cases. The amount in 2015 represents a charge for RTI’s attorneys’ fees. For further discussion of these charges, which were recorded in Selling and administrative expense, refer to Note 5 to the consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data.


(G)	Represents non-cash charges primarily resulting from lump sum benefit payments made from BD’s U.S. supplemental pension plan. For further discussion, refer to Note 8 to the consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data.

(H)

Includes an $11 million charge recorded by our Life Sciences segment in Selling and administrative expense for contract termination costs that resulted from the early termination of a European distributor arrangement. Also includes a $5 million charge in Cost of products sold resulting from the adjustment to the carrying amount of an asset that is being held for sale, and a gain of $8 million in Other income (expense), net, resulting from the sale of a company in which we held a small equity ownership interest.

Medical Segment

The following is a summary of Medical revenues by organizational unit:



								2015 vs. 2014 (A)				2014 vs. 2013 (A)
	2015			2014		2013		Total Change		Estimated FX Impact		Total Change		Estimated FX Impact
	(Millions of dollars)
Medication and Procedural Solutions	$	2,850		$	2,307	$	2,196	23.5	%	(6.4	)%	5.1	%	(0.9	)%
Medication Management Solutions	1,033			—		—		NM		NM		NA		NA
Diabetes Care	1,012			1,037		969		(2.4	)%	(6.7	)%	7.0	%	(1.0	)%
Pharmaceutical Systems	1,167			1,229		1,142		(5.0	)%	(10.1	)%	7.6	%	2.0	%
Respiratory Solutions	419			—		—		NM		NM		NA		NA
Deferred revenue adjustment (B)	(20		)	—		—		NM		NM		NA		NA
	$	6,460		$	4,573	$	4,306	41.3	%	(8.5	)%	6.2	%	(0.1	)%


(A)	"NM" denotes that the percentage is not meaningful; "NA" denotes that the percentage is not applicable.


(B)	Represents the amortization of the acquisition-date write-down of CareFusion’s deferred revenue balance to reflect a fair value measurement as of the acquisition date. The write-down primarily related to software maintenance contracts in the United States. Revenues for these contracts is typically deferred and recognized over the term of the contracts.

Overall Medical segment revenue growth in 2015 largely reflected the inclusion of CareFusion’s sales in the current period’s results beginning on April 1, 2015. Revenue growth in our Medication and Procedural Solutions unit, which includes our former Medical Surgical Systems unit, additionally reflected growth in international sales of safety-engineered products. Segment revenue growth in 2014 also reflected the Medical Surgical unit's sales of international safety-engineered product sales, as well as sales in emerging markets. The Diabetes Care unit’s revenue growth in 2015 and 2014 reflected sales of pen needles. The Pharmaceutical Systems unit’s 2015 revenues reflected the favorable timing of ordering patterns, as well as international sales of safety-engineered products, and revenue growth for this unit in 2014 benefited from the annualized impact of the first quarter fiscal year 2013 Safety Syringes acquisition. Global sales of safety-engineered products in 2015, 2014 and 2013 were $1.5 billion, $1.1 billion and $1.0 billion, respectively. Growth of safety-engineered product sales in 2015 and 2014 reflected estimated unfavorable impacts of $74 million and $7 million, respectively, due to foreign currency translation.



	2015			2014			2013
Medical segment operating income (Millions of dollars)	$	1,530		$	1,291		$	1,233
Segment operating income as % of Medical revenues	23.7		%	28.2		%	28.6		%

Table of Contents

Medical segment's gross profit margin as a percentage of revenues was lower in 2015 as compared with 2014 primarily due to the amortization of intangible assets acquired in the CareFusion transaction and the amortization of the acquisition-date write-down of CareFusion’s deferred revenue balance, as previously discussed. These unfavorable impacts on gross margin were partially offset primarily by lower manufacturing costs resulting from continuous improvement projects. Gross profit margin as a percentage of revenues was lower in 2014 as compared with 2013 primarily due to unfavorable foreign currency translation, higher start-up costs and costs associated with the fiscal year 2014 workforce reduction actions, previously discussed. Gross profit margin was also unfavorably impacted in 2014 by costs to remediate a quality issue, including incremental investment in manufacturing processes, within the Pharmaceutical Systems unit. These unfavorable impacts were partially offset by lower manufacturing costs resulting from continuous improvement projects. Aggregate selling and administrative expense in 2015 primarily reflected the inclusion of CareFusion’s spending in the second half of the current year’s results. Medical segment selling and administrative expense in 2015 also included the depreciation of fixed assets acquired in the CareFusion acquisition which were recorded at fair value. In 2014, Medical segment selling and administrative expense as a percentage of revenues was relatively flat compared with 2013. Research and development expenses in 2015 increased $85 million, or 46% from 2014, primarily due to the inclusion of CareFusion's costs in the second half of the current year's results. Research and development expenses in 2014 increased $11 million, or 6% from 2013, reflecting the program termination charge and the workforce reduction charge, both previously discussed. The increase of research and development expenses in 2014 also reflected ongoing investment in new products and platforms.

Life Sciences Segment

The following is a summary of Life Sciences revenues by organizational unit:



							2015 vs. 2014				2014 vs. 2013
	2015		2014		2013		Total Change		Estimated FX Impact		Total Change		Estimated FX Impact
	(Millions of dollars)
Preanalytical Systems	$	1,391	$	1,412	$	1,352	(1.5	)%	(6.4	)%	4.4	%	(0.7	)%
Diagnostic Systems	1,299		1,301		1,294		(0.2	)%	(6.5	)%	0.6	%	(0.8	)%
Biosciences	1,132		1,159		1,102		(2.4	)%	(6.0	)%	5.2	%	(0.3	)%
	$	3,822	$	3,872	$	3,748	(1.3	)%	(6.3	)%	3.3	%	(0.6	)%

Life Sciences segment revenue growth in 2015 was largely driven by sales of safety-engineered products in the Preanalytical Systems unit as well growth in the Diagnostic Systems unit's sales. Life Sciences segment revenue growth in 2014 was largely driven by sales of safety-engineered products in the Preanalytical Systems unit as well as by growth in the Biosciences unit’s revenues. The Preanalytical Systems unit’s global sales of safety-engineered products were $1.1 billion in 2015, 2014 and 2013. Revenues from safety-engineered products in 2015 and 2014 reflected unfavorable impacts due to foreign currency translation of $69 million and $7 million, respectively. The Diagnostic Systems unit's 2015 revenues reflected growth in worldwide sales of its BD Veritor™ platform, due to a stronger than normal influenza season, as well as growth in its automated platforms, including BD Kiestra™, BD MAX^TM, and BD BACTEC^TM blood culture systems. The Diagnostic Systems unit's 2014 revenues reflected growth in sales of the BD Kiestra™, BD MAX^TM, BD BACTEC^TM and BD Phoenix^TM systems, as well as growth attributable to new product launches, but was unfavorably impacted by weaker sales of the Women’s Health and Cancer platform due to guidelines providing for increased Pap smear testing intervals in the United States. Share losses related to the BD ProbeTec™ and BD Viper™ system unfavorably impacted the Diagnostic System unit's revenues in both 2015 and 2014. The Biosciences unit’s revenue growth in 2015 was driven by research instrument and reagent sales in the United States, partially offset by weaker international sales due to lower levels of research funding in Japan. The Biosciences unit’s revenue growth in 2014 was driven by double-digit growth of sales in emerging markets and was also driven by clinical reagent sales in all regions, as well as by instrument placements in both Asia and the United States.



	2015			2014			2013
Life Sciences segment operating income (Millions of dollars)	$	839		$	861		$	907
Segment operating income as % of Life Sciences revenues	21.9		%	22.2		%	24.2		%

Life Sciences segment's gross profit margin as a percentage of revenues was lower in fiscal year 2015 compared with 2014 primarily due to unfavorable foreign currency translation, as well as various immaterial items. Gross profit margin as a percentage of revenues in the Life Sciences segment was lower in 2014 compared with 2013 primarily due to the impact of unfavorable product mix, unfavorable foreign currency translation, costs associated with plant shutdowns and various immaterial items. Selling and administrative expense as a percentage of Life Sciences revenues decreased in 2015 compared with 2014 as the prior-year period reflected the previously discussed charge relating to the early termination of a distributor

Table of Contents

arrangement. A decrease of selling and administrative expense as a percent of revenues in 2014 reflected the net favorable impact of various immaterial items, partially offset by the distributor arrangement termination charge. Research and development expense in 2015 was flat compared with research and development expense in 2014, which reflected an increase of $20 million, or 8%, compared with spending in 2013. Research and development expense in 2015 reflected increased investment in new products and platforms, including the BD Viper^TM and BD Max^TM platforms, and increased spending relating to the acquisitions of GenCell Biosystems ("GenCell") and Cellular Research, Inc. ("Cellular Research") in the first and fourth quarters of fiscal year 2015, respectively. These increases in 2015 spending were lower in comparison to the increased spending in 2014, which reflected the $20 million asset write-off and costs associated with workforce reduction actions, as previously discussed.

Geographic Revenues

BD’s worldwide revenues by geography in fiscal years 2015, 2014 and 2013 were as follows:



							2015 vs. 2014				2014 vs. 2013
	2015		2014		2013		Total Change		Estimated FX Impact		Total Change		Estimated FX Impact
	(Millions of dollars)
United States	$	5,069	$	3,417	$	3,353	48.4	%	—		1.9	%	—
International	5,213		5,029		4,701		3.6	%	(12.6	)%	7.0	%	(0.6	)%
Total Revenues	$	10,282	$	8,446	$	8,054	21.7	%	(7.5	)%	4.9	%	(0.3	)%

The Medical segment's U.S. revenue growth reflected the inclusion of CareFusion’s U.S. sales of approximately $1.5 billion in the results for the second half of fiscal year 2015, as well as overall strength in the segment's legacy product portfolio, which was particularly driven by sales of flush and safety-engineered products. U.S. Life Sciences revenue growth in 2015 benefited from a stronger than normal influenza season, as discussed previously, and growth in the Biosciences unit’s research reagents and instrument placements, reflecting a favorable funding environment in the U.S. market. U.S. Life Sciences growth in 2015 was unfavorably impacted by share losses related to the BD ProbeTec™ and BD Viper™ systems. U.S. revenue growth for our Medical segment in 2014 reflected sales of pen needles in the Diabetes Care unit. The Pharmaceutical Systems unit’s revenue growth in 2014 benefited from the annualized impact of the Safety Syringes acquisition. U.S. Life Sciences revenue growth in 2014 benefited from growth in the Biosciences unit’s clinical reagents and instrument placements. U.S. Life Sciences growth in 2014 was unfavorably impacted by a decline in Women’s Health and Cancer platform sales, as previously discussed, and by share losses related to the BD ProbeTec™ and BD Viper™ systems.

International revenue growth in the Medical segment in 2015 reflected the inclusion of CareFusion’s sales in results for the second half of the current year, as well as growth of sales in emerging markets and sales of safety-engineered products in the Medication and Procedural Solutions and Pharmaceutical Systems units. The Medical segment's international revenue growth additionally reflected sales of flush products as well as sales of pen needles in the Diabetes Care unit. International Life Sciences revenue growth in 2015 was largely driven by growth in emerging markets as well as by sales of safety-engineered products. International Life Sciences revenue growth in 2015 also benefited from growth in sales of microbiology products, including lab automation products, but was partially offset by weaker Biosciences unit sales primarily due to lower levels of research funding in Japan. Emerging market revenues in 2015 of $2.143 million represented an increase of 0.9% over fiscal year 2014, including a 8.3% unfavorable impact due to foreign currency translation, and accounted for approximately 21% of our total revenues. International revenues in 2014 reflected growth in both segments. International Medical and Life Sciences revenue growth in 2014 was largely driven by emerging market growth as well as by sales of safety-engineered products. International Life Sciences revenue growth in 2014 also benefited from the KIESTRA acquisition. Emerging market revenues in 2014 of $2.123 billion represented an increase of 9.3% over the prior year, including a 3.0% unfavorable impact due to foreign currency translation, and accounted for approximately 25% of our total revenues.

Table of Contents

Gross Profit Margin and Operating Expenses

Gross profit margin, selling and administrative expense and research and development expense as percentages of revenues in 2015, 2014 and 2013 were as follows:



										Increase (decrease) in basis points
	2015			2014			2013			2015 vs. 2014		2014 vs. 2013
Gross profit margin %	45.7		%	50.9		%	51.8		%	(520	)	(90	)

Selling and administrative expense (Millions of dollars)	$	2,563		$	2,145		$	2,422
% of revenues	24.9		%	25.4		%	30.1		%	(50	)	(470	)

Research and development expense (Millions of dollars)	$	632		$	550		$	494
% of revenues	6.1		%	6.5		%	6.1		%	(40	)	40

Gross profit margin

The decrease in gross profit margin in 2015 compared with 2014 reflected an unfavorable impact of 550 basis points due to purchase accounting adjustments to reflect CareFusion's inventory at fair value on the acquisition date, as well as the amortization and depreciation impacts of intangible and fixed assets, respectively, that were acquired in the CareFusion acquisition. Gross margin for the current-year period also reflected an estimated unfavorable impact of 50 basis points relating to foreign currency translation and a favorable operating performance impact of approximately 80 basis points, which primarily reflected lower manufacturing costs from continuous improvement projects.

The decrease in gross profit margin in 2014 compared with 2013 reflected an estimated unfavorable impact of 60 basis points relating to foreign currency translation. Operating performance reflected benefits of 100 basis points relating to lower manufacturing costs from continuous improvement projects and lower pension costs. These benefits were more than offset by unfavorable impacts of approximately 130 basis points, including unfavorable product mix and the costs to remediate a quality issue, as previously discussed. The unfavorable impact to operating performance also reflected higher start-up and raw material costs, as well as the employee termination costs resulting from workforce reduction actions, also previously discussed.

Selling and administrative

Aggregate expenses in 2015 reflected the inclusion of CareFusion’s selling and administrative expenses in the second half of the current year’s results, as well as the depreciation of fixed assets acquired in the CareFusion acquisition which were recorded at fair value. Selling and administrative expense in 2015 was favorably impacted by foreign currency translation of approximately $138 million. Aggregate expenses in 2015 also included increased spending of $39 million relating to the expansion of our business in emerging markets, as well as a $12 million charge relating to the RTI litigation matter, as previously discussed.

Aggregate expenses in 2014 were lower in comparison to 2013 which included charges of $363 million relating to the litigation matters previously discussed. Aggregate expenses in 2014 also reflected the favorable impact of lower pension costs, lower legal costs and favorable foreign currency translation totaling $54 million. Aggregate expenses in 2014 were unfavorably impacted by $30 million of specified items, primarily the workforce reduction charge and the contract termination charge, as previously discussed. Aggregate spending in 2014 also included $41 million relating to the expansion of our business in emerging markets and an incremental first quarter impact of the medical device excise tax of $14 million.

Research and development

Research and development expense in 2015 reflected the inclusion of CareFusion’s research and development expenses in the results for the second half of fiscal year 2015. Research and development expense as a percentage of revenues in 2015 was lower in comparison to the prior-year period’s expense, which included a workforce reduction charge, asset write-offs and program termination charges. In addition to these items, research and development expense in 2014 reflected ongoing investment in new products and platforms within the Medical segment.

Acquisition-related costs

Acquisition-related costs incurred of $426 million in fiscal year 2015 substantially related to the CareFusion acquisition and consisted of transaction, integration and restructuring costs of $59 million, $95 million and $271 million, respectively. The transaction and integration costs reflected advisory, legal, and other costs incurred in connection with the CareFusion acquisition. The restructuring costs in 2015 reflected employee termination costs, share-based compensation expense, asset write-offs and other restructuring costs relating to the acquisition. For further discussion regarding these costs, refer to Notes 7, 8 and 9 to the consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data.

Table of Contents

Net Interest Expense



	2015		2014		2013
	(Millions of dollars)
Interest expense	$	371	$	135	$	138
Interest income	15		46		40
Net interest expense	$	356	$	89	$	98

The increase in interest expense in 2015 compared with 2014 primarily reflected increased financing costs associated with the CareFusion acquisition, including interest on $6.2 billion of senior unsecured notes issued in December 2014, in anticipation of closing the CareFusion acquisition. Interest expense in fiscal year 2015 additionally included commitment fees for a bridge loan facility entered into concurrently with the execution of the agreement to acquire CareFusion to ensure our ability to fund the cash portion of consideration due under the acquisition agreement. These increases in interest expense in fiscal year 2015 were partially offset by $16 million due to the favorable amortization of the acquisition-date fair value step-up recorded on CareFusion’s long-term debt. Additional disclosures regarding the debt issuance, bridge loan facility and debt assumed are provided in Note 15 to the consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data. The decrease in interest expense in 2014 compared with 2013 primarily reflected lower levels of long-term fixed-rate debt and a reduction of interest payments through fixed-to-floating interest rate swap agreements. For further discussion regarding these swap arrangements, refer to Note 13 to the consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data.

The decrease in interest income in 2015 compared with 2014 reflected lower cash levels outside of the United States as well as investment losses on assets related to our deferred compensation plan. The offsetting movement in the deferred compensation plan liability was recorded in Selling and administrative expense. The increase in interest income in 2014 compared with 2013 reflected higher interest rates on investments outside the United States, partially offset by the impact of lower investment gains on assets related to our deferred compensation plan.

Income Taxes

The effective tax rate in 2015 was 5.9% as compared with the 2014 rate of 22.1%. The impact on BD’s income mix of the previously discussed specified items reduced the effective income tax rate in 2015 by 1,720 basis points as the tax benefits on these specified items were primarily incurred in higher tax jurisdictions. The decrease in the income tax rate in fiscal year 2015 additionally reflected the extension of the U.S. research and development income tax credit, which was partially offset by the unfavorable impact of one-time discrete items. The effective income tax rate in 2014 reflected our decision to change our position of permanent reinvestment with respect to the unremitted earnings of Brazil and certain other Latin American jurisdictions, the impact of which was more than offset by the benefits resulting from discrete one-time items and geographic mix. The effective income tax rate in 2013 of 20.2% reflected the favorable impact from various tax settlements in multiple jurisdictions and the reinstatement of the U.S. research and development tax credit, partially offset by a lower benefit on foreign earnings.

Income and Diluted Earnings per Share from Continuing Operations



	2015		2014		2013
Income from continuing operations (Millions of dollars)	$	695	$	1,185	$	929
Diluted earnings per share from continuing operations	$	3.35	$	5.99	$	4.67

Diluted earnings per share from continuing operations in 2015 reflected an unfavorable impact of $3.79 relating to the previously discussed specified items as well as an estimated unfavorable impact of $0.69 due to foreign currency translation. Additionally, diluted earnings per share for 2015 reflected a dilutive impact of $0.02 from the shares BD issued, as part of the total consideration transferred upon the closing of the CareFusion acquisition, prior to the inclusion of CareFusion in our consolidated results of operations. The previously discussed specified items recorded in 2014 decreased diluted earnings per share from continuing operations by $0.51. In addition, the medical device excise tax was in effect for an additional quarter in 2014 compared with 2013, the impact of which was $0.05. Earnings in 2014 additionally reflected an estimated $0.22 unfavorable impact compared with 2013 from foreign currency translation. The previously discussed specified items recorded in 2013 decreased diluted earnings per share from continuing operations in 2013 by $1.40.

Table of Contents

Financial Instrument Market Risk

We selectively use financial instruments to manage market risk, primarily foreign currency exchange risk and interest rate risk relating to our ongoing business operations. The counterparties to these contracts are highly rated financial institutions. We do not enter into financial instruments for trading or speculative purposes.

Foreign Exchange Risk

BD and its subsidiaries transact business in various foreign currencies throughout Europe, Greater Asia, Canada and Latin America. We face foreign currency exposure from the effect of fluctuating exchange rates on payables and receivables relating to transactions that are denominated in currencies other than our functional currency. These payables and receivables primarily arise from intercompany transactions. We hedge substantially all such exposures, primarily through the use of forward contracts. We also face currency exposure that arises from translating the results of our worldwide operations, including sales, to the U.S. dollar at exchange rates that have fluctuated from the beginning of a reporting period. From time to time, we may purchase forward contracts and options to hedge certain forecasted transactions that are denominated in foreign currencies in order to partially protect against a reduction in the value of future earnings resulting from adverse foreign exchange rate movements. Gains or losses on derivative instruments are largely offset by the gains or losses on the underlying hedged transactions. We did not enter into contracts to hedge cash flows against foreign currency fluctuations in fiscal year 2015 or 2014.

Derivative financial instruments are recorded on our balance sheet at fair value. For foreign currency derivatives, market risk is determined by calculating the impact on fair value of an assumed change in foreign exchange rates relative to the U.S. dollar. Fair values were estimated based upon observable inputs, specifically spot currency rates and foreign currency prices for similar assets and liabilities.

With respect to the foreign currency derivative instruments outstanding at September 30, 2015 and 2014, the impact changes in the U.S. dollar would have on pre-tax earnings was estimated as follows:



	Increase (decrease)
	2015			2014
	(Millions of dollars)
10% appreciation in U.S. dollar	$	(28	)	$	(19	)
10% depreciation in U.S. dollar	$	28		$	19

These calculations do not reflect the impact of exchange gains or losses on the underlying transactions that would substantially offset the results of the derivative instruments.

Interest Rate Risk

Our primary interest rate risk relates to U.S. dollar borrowings which are partially offset by U.S. dollar cash investments. When managing interest rate exposures, we strive to achieve an appropriate balance between fixed and floating rate instruments. We may enter into interest rate swaps to help maintain this balance and manage debt and interest-bearing investments in tandem, since these items have an offsetting impact on interest rate exposure. For interest rate derivative instruments, fair values are measured based upon the present value of expected future cash flows using market-based observable inputs including credit risk and interest rate yield curves. Market risk for these instruments is determined by calculating the impact to fair value of an assumed change in interest rates across all maturities. At September 30, 2015 and 2014, we had interest rate derivative contracts to convert interest payments on certain long-term debt notes from fixed rates to floating rates.

With respect to the interest rate derivatives outstanding at September 30, 2015 and 2014, the impact changes in the interest rate would have on the fair value of these derivatives was estimated as follows:



	Increase (decrease)
	2015			2014
	(Millions of dollars)
10% increase in interest rates	$	(3	)	$	(6	)
10% decrease in interest rates	$	3		$	6

Based on our overall interest rate exposure at September 30, 2015 and 2014, a 10% change in interest rates would not have a material effect on our earnings or cash flows over a one-year period.

Table of Contents

Other Risks

From time to time, the Company has managed price risks associated with commodity purchases through derivative contracts. At September 30, 2015, we had cash-settled forward contracts to hedge a portion of our global resin purchase volumes throughout fiscal years 2015 and 2016. A change in the underlying commodity price would not materially affect the value of our commodity derivative instruments outstanding at September 30, 2015.

Liquidity and Capital Resources

Net Cash Flows from Continuing Operating Activities

Net cash provided by continuing operating activities was $1.73 billion, $1.75 billion and $1.72 billion in 2015, 2014 and 2013, respectively, and was primarily attributable to income from continuing operations, as adjusted for depreciation and amortization. The fiscal year 2015 change in operating assets and liabilities was a net source of cash and primarily reflected lower levels of inventory and higher levels of accounts payable and accrued expenses, partially offset by higher levels of prepayments. The lower levels of inventory reflected the impact, primarily recognized in the third quarter of fiscal year 2015, of the acquisition fair value step-up adjustment recorded relative to CareFusion’s inventory on the acquisition date. Net cash provided by operating activities in 2015 increased by changes in the pension obligation as current-year expense was partially offset by discretionary contributions of $40 million. The 2014 change in operating assets and liabilities was a net use of cash and primarily reflected higher levels of inventory and prepaid expenses, partially offset by higher levels of accounts payable and accrued expenses. The 2014 change in operating liabilities included the payment of $22 million under a settlement agreement related to indirect purchaser antitrust class action cases. The change in accounts receivable includes a $36 million payment of government receivables balances in Spain. Net cash provided by continuing operating activities in 2014 was reduced by changes in the pension obligation resulting primarily from discretionary cash contributions of $75 million.

Net Cash Flows from Continuing Investing Activities

Net cash used for continuing investing activities was $8.32 billion, $948 million and $311 million in 2015, 2014 and 2013, respectively.

Capital Expenditures

Our investments in capital expenditures are focused on projects that enhance our cost structure and manufacturing capabilities, and support our strategy of geographic expansion with select investments in growing markets. Capital spending in 2015, 2014 and 2013 related primarily to manufacturing capacity expansions and details of spending by segment are contained in Note 6 to the consolidated financial statements contained in Item 8. Financial Statements and Supplementary Data.

Investments

Cash inflows from the sales of investments of $840 million in 2015 were attributable to the maturities of time deposits in Europe, Latin America and Asia Pacific.

Acquisitions of Businesses

Cash outflows relating to acquisitions were $8.41 billion, $40 million and $136 million in 2015, 2014 and 2013, respectively. Cash outflows relating to acquisitions in 2015 were primarily attributable to the completion of the CareFusion acquisition in the second quarter of fiscal year 2015. Cash outflows relating to acquisitions in 2015 also included cash payments relating to other acquisitions, including GenCell, CRISI, the ARX group of companies and Cellular Research in the first, second, third and fourth quarters of fiscal year 2015, respectively. Cash outflows relating to acquisitions in 2014 represented cash paid to acquire Alverix, Inc. in the second quarter of fiscal year 2014. Cash outflows in 2013 included $124 million relating to the Safety Syringes acquisition and $14 million associated with the Cato acquisition in the first and second quarters of fiscal year 2013, respectively. For further discussion, refer to Note 9 to the consolidated financial statements contained in Item 8, Financial Statements and Supplementary Data.

Divestiture

The cash inflow from divestiture of businesses in 2013 represents the first quarter fiscal year 2013 divestiture of the Life Sciences’ Discovery Labware unit, excluding its Advanced Bioprocessing platform. We received approximately $740 million in total gross proceeds from the sale. For further discussion, refer to Note 10 to the consolidated financial statements contained in Item 8, Financial Statements and Supplementary Data.

Table of Contents

Net Cash Flows from Continuing Financing Activities

Net cash provided by (used for) continuing financing activities was $6.19 billion, $(807) million and $(968) million in 2015, 2014 and 2013, respectively.

Debt-Related Activities

Net cash provided by financing activities in 2015 included the proceeds from $6.2 billion of notes issued in December 2014 as well as $500 million total proceeds from net borrowings under commercial paper programs. These proceeds were used to finance the completion of our acquisition of CareFusion in March 2015. For additional information regarding these financing arrangements, refer to Note 15 to the consolidated financial statements contained in Item 8, Financial Statements and Supplementary Data and for additional information regarding the CareFusion acquisition, refer to Note 9 to the consolidated financial statements contained in Item 8, Financial Statements and Supplementary Data. In 2013, net cash used for financing activities reflected the repayment of $200 million of 4.55% notes due on April 15, 2013. Total debt was $12.8 billion at September 30, 2015 and $4.0 billion at September 30, 2014 and 2013. Measures relating to this debt are as follows:



	2015		2014		2013
Short-term debt as a percentage of total debt	11.3	%	5.1	%	5.2	%
Weighted average cost of total debt	3.3	%	3.7	%	3.8	%
Total debt as a percentage of total capital (A)	58.4	%	43.4	%	43.1	%


(A)	Represents shareholders’ equity, net non-current deferred income tax liabilities, and debt

The ratio of short-term debt as a percentage of total debt at September 30, 2015 reflected the reclassification, from long-term debt to short-term debt, of $750 million of floating rate notes due on June 15, 2016.

Repurchase of Common Stock

There were no share repurchases in 2015 as our share repurchase program was suspended in connection with our announced agreement to acquire CareFusion. We repurchased approximately 3.6 million shares of our common stock for $400 million in 2014 and 5.5 million shares for $450 million in 2013. At September 30, 2015, a total of approximately 9.1 million common shares remained available for purchase under the Board of Directors’ September 2013 share repurchase authorization.

Cash and Short-term Investments

At September 30, 2015, total worldwide cash and short-term investments were $1.4 billion, of which $1.1 billion was held in jurisdictions outside of the United States. We regularly review the amount of cash and short-term investments held outside the United States and currently intend to use such amounts to fund our international operations and their growth initiatives. In addition, if these amounts were repatriated from foreign jurisdictions to the United States, there could be adverse tax consequences.

Credit Facilities

In January 2015 and in connection with our agreement to acquire CareFusion, we entered into a commercial paper program which allows us to issue a maximum of $1 billion in notes. A former commercial paper program which had been in place to meet short-term financing needs was terminated in February 2015 and the outstanding borrowings of $200 million under the former program were rolled into the new commercial paper program. At September 30, 2015, subsequent to the completion of the CareFusion acquisition on March 17, 2015, borrowings outstanding under the current commercial paper program were $700 million. Also in connection with the CareFusion acquisition, we entered into a 364-day term loan agreement in December 2014 that provided for a $1.0 billion term loan facility. At September 30, 2015, the term loan was fully repaid with no borrowings outstanding, reflecting principal payments of $650 million, $250 million and $100 million made in April, July and September 2015, respectively. The $9.1 billion of fully committed bridge financing we secured in the first quarter of fiscal year 2015, concurrently with our execution of the agreement to acquire CareFusion, was terminated upon completion of the acquisition. Additional disclosures regarding BD’s financing arrangements relating to the CareFusion acquisition are provided in Note 15 to the consolidated financial statements contained in Item 8, Financial Statements and Supplementary Data.

We have available a $1 billion syndicated credit facility. This credit facility, under which there were no borrowings outstanding at September 30, 2015, provides backup support for our commercial paper program and can also be used for other general corporate purposes. It includes a provision that enables BD, subject to additional commitments made by the lenders, to access up to an additional $500 million in financing through the facility, for a maximum aggregate commitment of $1.5 billion. During the third quarter of fiscal year 2014, we extended the expiration date of this credit facility to May 2018 from the original expiration date of May 2017. The credit facility includes a single financial covenant that requires BD to maintain an interest expense coverage ratio (ratio of earnings before income taxes, depreciation and amortization to interest expense) of not less

Table of Contents

than 5-to-1 for the most recent four consecutive fiscal quarters. We were in compliance with this covenant as of September 30, 2015. In addition, we have informal lines of credit outside the United States.

CareFusion Debt Assumed

Upon the closing of the CareFusion acquisition in March 2015, BD assumed senior unsecured notes issued by CareFusion with an aggregate principal amount of $2 billion. Subsequent to closing the acquisition, BD commenced offers to exchange these CareFusion notes for notes issued by BD and this exchange offer expired in April 2015. Additional disclosures regarding this exchange offer are provided in Note 15 to the consolidated financial statements contained in Item 8, Financial Statements and Supplementary Data.

Access to Capital and Credit Ratings

Our ability to generate cash flow from operations, issue debt, enter into other financing arrangements and attract long-term capital on acceptable terms could be adversely affected in the event there was a material decline in the demand for our products, deterioration in our key financial ratios or credit ratings, or other significantly unfavorable changes in conditions.

BD’s credit ratings at September 30, 2015 were as follows:



	Standard & Poor’s	Moody’s
Ratings:
Senior Unsecured Debt	BBB+	Baa2
Commercial Paper	A-2	P-2
Outlook	Stable	Stable

Subsequent to BD’s announcement regarding our acquisition of CareFusion, the two major corporate debt rating organizations, Moody’s Investors Service (Moody’s) and Standard & Poor’s Ratings Services (S&P), provided guidance that they expected to downgrade our debt ratings as a result of the anticipated increase in BD’s net leverage. In December 2014, S&P downgraded BD’s long-term debt and commercial paper ratings from A to BBB+ and from A-1 to A-2, respectively. Following our announced completion of the CareFusion acquisition on March 17, 2015, Moody’s converted its provisional downgrade of BD’s long-term debt rating, from A3 to Baa2, to a definitive downgrade. Concurrently with these downgrade actions, BD’s ratings with both S&P and Moody’s were removed from further review.

BD’s credit ratings remain investment grade after these downgrades. As such, we do not expect these downgrades to have a significant impact on our liquidity or future flexibility to access additional liquidity given our strong balance sheet, our syndicated credit facility, and our commercial paper program. While such downgrades in our credit ratings may increase the costs associated with maintaining and borrowing under our existing credit arrangements, the downgrades do not affect our ability to draw on these credit facilities, nor do they result in an acceleration of the scheduled maturities of any outstanding debt. We believe that given our debt ratings, our financial management policies, our ability to generate cash flow and the non-cyclical, geographically diversified nature of our businesses, we would have access to additional short-term and long-term capital should the need arise. A rating reflects only the view of a rating agency and is not a recommendation to buy, sell or hold securities. Ratings can be revised upward or downward at any time by a rating agency if such rating agency decides that circumstances warrant such a change.

Table of Contents

Contractual Obligations

In the normal course of business, we enter into contracts and commitments that obligate us to make payments in the future. The table below sets forth BD’s significant contractual obligations and related scheduled payments as of September 30, 2015:



	Total		2016		2017 to 2018		2019 to 2020		2021 and Thereafter
	(Millions of dollars)
Short-term debt	$	759	$	759	$	—	$	—	$	—
Long-term debt(A)	15,783		409		3,010		3,047		9,316
Operating leases	246		80		98		44		24
Purchase obligations(B)	958		628		230		92		8
Unrecognized tax benefits(C)	—		—		—		—		—
Total(D)	$	17,745	$	1,876	$	3,338	$	3,183	$	9,348


(A)	Long-term debt obligations include expected principal and interest obligations.


(B)	Purchase obligations are for purchases made in the normal course of business to meet operational and capital requirements.


(C)	Unrecognized tax benefits at September 30, 2015 of $575 million were all long-term in nature. Due to the uncertainty related to the timing of the reversal of these tax positions, the related liability has been excluded from the table.


(D)	Required funding obligations for 2016 relating to pension and other postretirement benefit plans are not expected to be material.

Critical Accounting Policies

The following discussion supplements the descriptions of our accounting policies contained in Note 1 to the consolidated financial statements contained in Item 8, Financial Statements and Supplementary Data. The preparation of the consolidated financial statements requires management to use estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as well as the disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Some of those judgments can be subjective and complex and, consequently, actual results could differ from those estimates. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. For any given estimate or assumption made by management, it is possible that other people applying reasonable judgment to the same facts and circumstances could develop different estimates. Actual results that differ from management’s estimates could have an unfavorable effect on our consolidated financial statements. Management believes the following critical accounting policies reflect the more significant judgments and estimates used in the preparation of the consolidated financial statements:

Revenue Recognition

Some of our sales transactions qualify as multiple-element arrangements which require us to identify separate units of accounting within the arrangement and allocate the transaction consideration across these separate accounting units. For arrangements that include software and non-software elements, the transaction consideration is allocated to the software elements as a group as well as to the individual non-software elements that have been separately identified. The identification of accounting units and the allocation of total transaction consideration for multiple-element arrangements may be subjective and requires a degree of management judgment. Management’s judgments relative to multiple-element arrangements may significantly affect the timing of revenue recognition.

Transaction consideration for separately identified non-software units of accounting within an arrangement is recognized upon the completion of each deliverable based on its relative selling price. When applying the relative selling price method, the selling price of each deliverable is determined based upon the following hierarchy of evidence: vendor-specific objective evidence, which is generally based upon historical prices in stand-alone transactions; third-party evidence, which is generally based on market data on sales of similar products and services, if available; and management’s best estimate of selling price. Management’s best estimate of selling price is generally based upon the following considerations: stand-alone sales prices, established price lists, costs to produce, profit margins for similar products, market conditions, and customer stratification.

For software and software-related products, we use the relative fair value method to allocate transaction consideration to each unit of accounting; whereby the evidence used in the determination of fair value estimates are based solely on vendor-specific objective evidence. To the extent that vendor specific objective evidence does not exist for delivered elements of the transaction, we apply the residual method.

Table of Contents

The revenue allocated to equipment or instruments in multiple-element arrangements is recognized upon transfer of title and risk of loss to the customer. The revenue allocated to extended warranty contracts and software maintenance contracts is deferred and recognized as these deliverables are performed under the arrangement. The majority of deferred revenue relating to extended warranty contracts is generally recognized within a few years whereas deferred revenue relating to software maintenance contracts is generally recognized over several years.

Accounting for Sales-Type Leases

Our accounting for sales-type leases is based upon certain assumptions including the economic life of our leased products and the fair value of our leased products, which is used to determine the interest rate implicit to the lease. These assumptions affect that amount of gross investment in the lease, unearned income, and the sales price that is recognized relative to each sales-type lease transaction. Based upon our anticipation of future technological advances of our products or that of our competitors, the economic life of our leased products is five years as this is the estimated period during which the leased product is expected to be economically usable, without limitation by the lease term. Additionally, five years represents the most frequent contractual lease term for our leased products. Our product configurations are customized for each customer’s specifications, and as such, there is no significant after-market for our used equipment. Residual values, if any, are established at lease inception using estimates of the fair value of reclaimable component parts of the products at the end of the lease term.

The fair value of our leased products is estimated on a quarterly basis, based upon transacted cash sales prices during the preceding 12-month period, and represents normal selling price, reflecting any volume or trade discounts that may apply. Because our products are sold as part of customized systems to a diverse range of customers, many of which are affiliated with a group purchasing organization or integrated delivery network, there is a wide range of negotiated cash selling prices for our products. Accordingly, we stratify our cash selling transactions based on product configuration and customer class to determine a best estimate of fair value for each product specific, within determined customer classes. Based upon this stratification, we calculate the weighted average selling price of each configured product using the interquartile range methodology and remove outliers from the population of normal cash selling prices, which narrows the range of selling prices within each stratified customer class. The resulting weighted average selling price is the single point estimate of fair value that we use as the normal selling price and this fair value estimate is used to determine the implicit interest rate for each product subject to a sales-type lease arrangement. In certain instances, we do not have sufficient corresponding historical cash selling transactions to support fair values of specific combinations of product configurations and customer classes. In these instances, fair value is estimated by applying the average discount percentage given to the respective customer class, over the trailing 12 months, to the list price of the products whose fair value was not determined using the interquartile range methodology described above. The resulting fair value(s) is then used to derive the implicit rate of the lease. The interest rate implicit to the lease is then used to determine the amount of revenue recognized at the inception of the lease and the revenue recognized over the life of the lease.

Our net investment in sales-type leases primarily arises from the leasing of dispensing equipment and as such, the methodology for determining the relating allowance for credit losses is based on the collective population and is not stratified by class or portfolio segment. The allowance for credit losses is based on historical experience loss rates as well as on management’s judgments regarding the potential impact of anticipated changes in business practices, market dynamics, and economic conditions. These assumptions are inherently subjective and it is possible that we will experience actual credit losses that are different from our current estimates.

Accounting for Software Products

We sell and lease products with embedded software and as such, we must evaluate these products to determine if industry-specific revenue recognition requirements apply to these sales transactions. This evaluation process is often complex and subject to significant judgment. If software is considered not essential to the non-software elements of a product but is considered more than incidental to a product as a whole, the product’s software elements must be separated from its non-software elements under the requirements relating to multiple-element arrangements. The product’s software elements must be accounted for under software industry-specific revenue recognition requirements and the application of these requirements may significantly affect the timing and amount of revenue recognized.

We have determined that the software embedded within our infusion products, when sold with safety software, patient identification products, and certain diagnostic equipment, as well as the software embedded within our research and clinical instruments sold by our Biosciences unit, is more than incidental to these product offerings as a whole. However, we have determined that the non-software elements and software elements in these product offerings work together to deliver the essential functionality of these products as a whole. As such, the accounting for these product offerings does not fall within the scope of software industry-specific accounting requirements. We have determined the embedded software within certain other products, primarily dispensing and respiratory products, is incidental to the products as a whole and therefore the accounting for these products also falls outside the scope of software-specific requirements. Generally, our standalone software application sales and any related post-contract support related to these sales are accounted for under the software industry-specific revenue recognition requirements.

Table of Contents

Impairment of Assets

Goodwill and in-process research and development assets are subject to impairment reviews at least annually, or whenever indicators of impairment arise. Intangible assets with finite lives, including developed technology, and other long-lived assets, are periodically reviewed for impairment when impairment indicators are present.

We assess goodwill for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. Our reporting units generally represent one level below reporting segments and we aggregate components within an operating segment that have similar economic characteristics. Potential impairment of goodwill is identified by comparing the fair value of a reporting unit with its carrying value. Our annual goodwill impairment test performed on July 1, 2015 did not result in any impairment charges, as the fair value of each reporting unit exceeded its carrying value. We reassessed our reporting units upon the previously discussed realignment of BD’s organizational structure, from a three-segment to a two-segment structure, on October 1, 2014 and upon our acquisition of CareFusion on March 17, 2015. While the segment realignment did not change BD's reporting units for purposes of goodwill impairment testing, the reporting units within the Medical segment were redefined as a result of the CareFusion acquisition.

We generally use the income approach to derive the fair value for impairment assessments. This approach calculates fair value by estimating future cash flows attributable to the assets and then discounting these cash flows to a present value using a risk-adjusted discount rate. We selected this method because we believe the income approach most appropriately measures our income producing assets. This approach requires significant management judgment with respect to future volume, revenue and expense growth rates, changes in working capital use, appropriate discount rates and other assumptions and estimates. The estimates and assumptions used are consistent with BD’s business plans. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of the asset, and potentially result in different impacts to BD’s results of operations. Actual results may differ from management’s estimates.

Income Taxes

BD maintains valuation allowances where it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances are included in our tax provision in the period of change. In determining whether a valuation allowance is warranted, management evaluates factors such as prior earnings history, expected future earnings, carry back and carry forward periods, and tax strategies that could potentially enhance the likelihood of realization of a deferred tax asset.

BD conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of tax jurisdictions. In evaluating the exposure associated with various tax filing positions, we record accruals for uncertain tax positions based on the technical support for the positions, our past audit experience with similar situations, and the potential interest and penalties related to the matters. BD’s effective tax rate in any given period could be impacted if, upon resolution with taxing authorities, we prevailed in positions for which reserves have been established, or we were required to pay amounts in excess of established reserves.

BD has reviewed its needs in the U.S. for possible repatriation of undistributed earnings of its foreign subsidiaries and, with exception for certain countries, continues to invest foreign subsidiaries earnings outside of the U.S. to fund foreign investments or meet foreign working capital and property, plant and equipment expenditure needs. Deferred taxes are not provided on undistributed earnings of foreign subsidiaries that are indefinitely reinvested. At September 30, 2015, the cumulative amount of such undistributed earnings indefinitely reinvested outside the United States was $7.5 billion. The determination of the amount of the unrecognized deferred tax liability related to the undistributed earnings is not practicable because of the complexities associated with its hypothetical calculation.

Contingencies

We are involved, both as a plaintiff and a defendant, in various legal proceedings that arise in the ordinary course of business, including, without limitation, product liability, antitrust and environmental matters, as further discussed in Note 5 to the consolidated financial statements contained in Item 8, Financial Statements and Supplementary Data. We assess the likelihood of any adverse judgments or outcomes to these matters as well as potential ranges of probable losses. We establish accruals to the extent probable future losses are estimable (in the case of environmental matters, without considering possible third-party recoveries). A determination of the amount of accruals, if any, for these contingencies is made after careful analysis of each individual issue and, when appropriate, is developed after consultation with outside counsel. The accruals may change in the future due to new developments in each matter or changes in our strategy in dealing with these matters.

Given the uncertain nature of litigation generally, we are not able in all cases to estimate the amount or range of loss that could result from an unfavorable outcome of the litigation to which we are a party. In view of these uncertainties, we could incur charges in excess of any currently established accruals and, to the extent available, excess liability insurance. In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on BD’s consolidated results of operations and consolidated net cash flows.

Table of Contents

Benefit Plans

We have significant net pension and other postretirement and postemployment benefit costs that are measured using actuarial valuations. These benefit costs include assumptions for the discount rate. Pension benefit costs also include an assumption for the expected return on plan assets. These assumptions have a significant effect on the amounts reported. In addition to the analysis below, see Note 8 to the consolidated financial statements contained in Item 8, Financial Statements and Supplementary Data for additional discussion.

The discount rate is selected each year based on investment grade bonds and other factors as of the measurement date (September 30). Specifically for the U.S. pension plan, we will use a discount rate of 4.15% for 2016, which was based on an actuarially-determined, company-specific yield curve to measure liabilities as of the measurement date. To calculate the pension expense in 2016, we will apply the individual spot rates along the yield curve that correspond with the timing of each future cash outflow for benefit payments in order to calculate interest cost and service cost. Additional disclosures regarding the method to be used in calculating the interest cost and service cost components of pension expense for 2016 are provided in Note 8 to the consolidated financial statements contained in Item 8, Financial Statements and Supplementary Data. The expected long-term rate of return on plan assets assumption, although reviewed each year, changes less frequently due to the long-term nature of the assumption. This assumption does not impact the measurement of assets or liabilities as of the measurement date; rather, it is used only in the calculation of pension expense. To determine the expected long-term rate of return on pension plan assets, we consider many factors, including our historical assumptions compared with actual results; benchmark data; expected returns on various plan asset classes, as well as current and expected asset allocations. We will use a long-term expected rate of return on plan assets assumption of 7.50% for the U.S. pension plan in 2016. We believe our discount rate and expected long-term rate of return on plan assets assumptions are appropriate based upon the above factors.

Sensitivity to changes in key assumptions for our U.S. pension and other postretirement and postemployment plans are as follows:

•

Discount rate — A change of plus (minus) 25 basis points, with other assumptions held constant, would have an estimated $4 million favorable (unfavorable) impact on the total U.S. net pension and other postretirement and postemployment benefit plan costs. This estimate assumes no change in the shape or steepness of the company-specific yield curve used to plot the individual spot rates that will be applied to the future cash outflows for future benefit payments in order to calculate interest and service cost.


•	Expected return on plan assets — A change of plus (minus) 25 basis points, with other assumptions held constant, would have an estimated $3 million favorable (unfavorable) impact on U.S. pension plan costs.

Share-Based Compensation

Compensation cost relating to share-based payment transactions is recognized in net income using a fair value measurement method. All share-based payments to employees, including grants of employee stock options, are recognized in the statement of operations as compensation expense (based on their fair values) over the vesting period of the awards. We determine the fair value of certain share-based awards using a lattice-based binomial option valuation model that incorporates certain assumptions, such as the risk-free interest rate, expected volatility, expected dividend yield and expected life of the options. See Note 7 to the consolidated financial statements contained in Item 8, Financial Statements and Supplementary Data for additional discussion.

Cautionary Statement Regarding Forward-Looking Statements

BD and its representatives may from time to time make certain forward-looking statements in publicly released materials, both written and oral, including statements contained in filings with the Securities and Exchange Commission, press releases, and our reports to shareholders. Forward-looking statements may be identified by the use of words such as “plan,” “expect,” “believe,” “intend,” “will,” “anticipate,” “estimate” and other words of similar meaning in conjunction with, among other things, discussions of future operations and financial performance, as well as our strategy for growth, product development, regulatory approvals, market position and expenditures. All statements that address operating performance or events or developments that we expect or anticipate will occur in the future — including statements relating to volume growth, sales and earnings per share growth, cash flows or uses, and statements expressing views about future operating results — are forward-looking statements.

Forward-looking statements are based on current expectations of future events. The forward-looking statements are, and will be, based on management’s then-current views and assumptions regarding future events, developments and operating performance, and speak only as of their dates. Investors should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from our expectations and projections. Investors are therefore cautioned not to place undue reliance on any forward-looking statements. Furthermore, we undertake no obligation to update or revise any forward-looking statements after the date they are made, whether as a result of new information, future events and developments or otherwise, except as required by applicable law or regulations.

Table of Contents

The following are some important factors that could cause our actual results to differ from our expectations in any forward-looking statements. For further discussion of certain of these factors, see Item 1A. Risk Factors.


•	Weakness in the global economy and financial markets, and the potential adverse effect on the cost of operating our business, the demand for our products and services, the prices for our products and services due to increases in pricing pressure, or our ability to produce our products, including the impact on developing countries.


•	Deficit reduction efforts or other adverse changes in the availability of government funding for healthcare and research, particularly in the United States and Europe, that could further weaken demand for our products and result in additional pricing pressures, as well as create potential collection risks associated with such sales.

•

Risks relating to our acquisition of CareFusion, including our ability to successfully combine and integrate the CareFusion operations in order to obtain the anticipated benefits and costs savings from the transaction, and the significant additional indebtedness we incurred in connection with the financing of the acquisition and the impact this increased indebtedness may have on our ability to operate the combined company.


•	The consequences of the Patient Protection and Affordable Care Act in the United States, which implemented an excise tax on U.S. sales of certain medical devices, and which could result in reduced demand for our products, increased pricing pressures or otherwise adversely affect our business.


•	Future healthcare reform in the countries in which we do business that may involve changes in government pricing and reimbursement policies or other cost containment reforms.

•

Changes in domestic and foreign healthcare industry practices that result in a reduction in procedures using our products or increased pricing pressures, including the continued consolidation among healthcare providers and trends toward managed care and healthcare cost containment. For example, changes to guidelines providing for increased cervical cancer screening intervals has and may continue to negatively impact sales of our Women’s Health and Cancer platform.


•	Changes in reimbursement practices of third-party payers.

•

Our ability to penetrate emerging markets, which depends on local economic and political conditions, and how well we are able to acquire or form strategic business alliances with local companies and make necessary infrastructure enhancements to production facilities and distribution networks. Our international operations also increase our compliance risks, including risks under the Foreign Corrupt Practices Act and other anti-corruption laws.


•	Political conditions in international markets, including civil unrest, terrorist activity, governmental changes, trade barriers, restrictions on the ability to transfer capital across borders and expropriation of assets by a government.


•	Security breaches of our computer and communications systems, including computer viruses, “hacking” and “cyber-attacks,” which could impair our ability to conduct business, or result in the loss of BD trade secrets or otherwise compromise sensitive information of BD or its customers, suppliers and other business partners.


•	Fluctuations in the cost and availability of oil-based resins and other raw materials, as well as certain components, the ability to maintain favorable supplier arrangements and relationships (particularly with respect to sole-source suppliers), and the potential adverse effects of any disruption in the availability of such items.


•	Regional, national and foreign economic factors, including inflation, deflation, fluctuations in interest rates and, in particular, foreign currency exchange rates, and the potential effect on our revenues, expenses, margins and credit ratings.

•

New or changing laws and regulations affecting our domestic and foreign operations, or changes in enforcement practices, including laws relating to trade, monetary and fiscal policies, taxation (including tax reforms that could adversely impact multinational corporations), sales practices, environmental protection, price controls and licensing and regulatory requirements for new products and products in the postmarketing phase. In particular, the U.S. and other countries may impose new requirements regarding registration, labeling or prohibited materials that may require us to re-register products already on the market or otherwise impact our ability to market our products. Environmental laws, particularly with respect to the emission of greenhouse gases, are also becoming more stringent throughout the world, which may increase our costs of operations or necessitate changes in our manufacturing plants or processes or those of our suppliers, or result in liability to BD.

•

Product efficacy or safety concerns regarding our products resulting in product recalls, regulatory action on the part of the U.S. Food and Drug Administration (FDA) or foreign counterparts, declining sales and product liability claims, particularly in light of the current regulatory environment, including increased enforcement activity by the FDA. As a result of the CareFusion acquisition, we are operating under a consent decree with the FDA relating to our U.S. infusion pump business. The consent decree authorizes the FDA, in the event of any violations in the future, to order us to cease manufacturing and distributing products, recall products or take other actions, and we may be required to pay significant monetary damages if we fail to comply with any provision of the consent decree.

Table of Contents

•

Competitive factors that could adversely affect our operations, including new product introductions (for example, new forms of drug delivery) by our current or future competitors, increased pricing pressure due to the impact of low-cost manufacturers as certain competitors have established manufacturing sites or have contracted with suppliers in low-cost manufacturing locations as a means to lower their costs, patents attained by competitors (particularly as patents on our products expire), and new entrants into our markets.


•	The effects of events that adversely impact our ability to manufacture our products (particularly where production of a product line is concentrated in one or more plants) or our ability to source materials or components from suppliers (including sole-source suppliers) that are needed for such manufacturing, including pandemics, natural disasters, or environmental factors.

•

Difficulties inherent in product development, including the potential inability to successfully continue technological innovation, complete clinical trials, obtain regulatory approvals in the United States and abroad, obtain intellectual property protection for our products, obtain coverage and adequate reimbursement for new products, or gain and maintain market approval of products, as well as the possibility of infringement claims by competitors with respect to patents or other intellectual property rights, all of which can preclude or delay commercialization of a product. Delays in obtaining necessary approvals or clearances from the FDA or other regulatory agencies or changes in the regulatory process may also delay product launches and increase development costs.


•	Fluctuations in the demand for products we sell to pharmaceutical companies that are used to manufacture, or are sold with, the products of such companies, as a result of funding constraints, consolidation or otherwise.


•	Fluctuations in university or U.S. and international governmental funding and policies for life sciences research.


•	Our ability to achieve our projected level or mix of product sales, as our earnings forecasts are based on projected sales volumes and pricing of many product types, some of which are more profitable than others.


•	Our ability to complete the implementation of our ongoing upgrade of our enterprise resource planning system, as any delays or deficiencies in completing the implementation could adversely affect our business.


•	Pending and potential future litigation or other proceedings adverse to BD, including antitrust, product liability, environmental and patent infringement, and the availability or collectability of insurance relating to any such claims.


•	The effect of adverse media exposure or other publicity regarding BD’s business or operations, including the effect on BD’s reputation or demand for its products.


•	The effect of market fluctuations on the value of assets in BD’s pension plans and on actuarial interest rate and asset return assumptions, which could require BD to make additional contributions to the plans or increase our pension plan expense.


•	The impact of business combinations, including any volatility in earnings relating to acquired in-process research and development assets, and our ability to successfully integrate any business we may acquire.


•	Our ability to obtain the anticipated benefits of restructuring programs, if any, that we may undertake.


•	Issuance of new or revised accounting standards by the Financial Accounting Standards Board or the Securities and Exchange Commission.

The foregoing list sets forth many, but not all, of the factors that could impact our ability to achieve results described in any forward-looking statements. Investors should understand that it is not possible to predict or identify all such factors and should not consider this list to be a complete statement of all potential risks and uncertainties.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

The information required by this item is included in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, and in Notes 1, 13 and 14 to the consolidated financial statements contained in Item 8, Financial Statements and Supplementary Data, and is incorporated herein by reference.

Table of Contents

Item 8. Financial Statements and Supplementary Data.

Reports of Management

Management’s Responsibilities

The following financial statements have been prepared by management in conformity with U.S. generally accepted accounting principles and include, where required, amounts based on the best estimates and judgments of management. The integrity and objectivity of data in the financial statements and elsewhere in this Annual Report are the responsibility of management.

In fulfilling its responsibilities for the integrity of the data presented and to safeguard the Company’s assets, management employs a system of internal accounting controls designed to provide reasonable assurance, at appropriate cost, that the Company’s assets are protected and that transactions are appropriately authorized, recorded and summarized. This system of control is supported by the selection of qualified personnel, by organizational assignments that provide appropriate delegation of authority and division of responsibilities, and by the dissemination of written policies and procedures. This control structure is further reinforced by a program of internal audits, including a policy that requires responsive action by management.

The Board of Directors monitors the internal control system, including internal accounting and financial reporting controls, through its Audit Committee, which consists of eight independent Directors. The Audit Committee meets periodically with the independent registered public accounting firm, the internal auditors and management to review the work of each and to satisfy itself that they are properly discharging their responsibilities. The independent registered public accounting firm and the internal auditors have full and free access to the Audit Committee and meet with its members, with and without management present, to discuss the scope and results of their audits including internal control, auditing and financial reporting matters.

Management’s Report on Internal Control Over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the Securities Act of 1934. Management conducted an assessment of the effectiveness of internal control over financial reporting based on the criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Based on this assessment and those criteria, management concluded that internal control over financial reporting was effective as of September 30, 2015.

The financial statements and internal control over financial reporting have been audited by Ernst & Young LLP, an independent registered public accounting firm. Ernst & Young’s reports with respect to fairness of the presentation of the financial statements, and the effectiveness of internal control over financial reporting, are included herein.




/s/ Vincent A. Forlenza	/s/ Christopher Reidy	/s/ John Gallagher
Vincent A. Forlenza	Christopher Reidy	John Gallagher
Chairman, Chief Executive Officer and President	Executive Vice President, Chief Financial Officer and Chief Administrative Officer	Senior Vice President, Corporate Finance, Controller and Treasurer

Table of Contents

Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Directors of

Becton, Dickinson and Company

We have audited the accompanying consolidated balance sheets of Becton, Dickinson and Company as of September 30, 2015 and 2014, and the related consolidated statements of income, comprehensive income and cash flows for each of the three years in the period ended September 30, 2015. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Becton, Dickinson and Company at September 30, 2015 and 2014, and the consolidated results of its operations and its cash flows for each of the three years in the period ended September 30, 2015, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Becton, Dickinson and Company’s internal control over financial reporting as of September 30, 2015, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated November 25, 2015 expressed an unqualified opinion thereon.



		/s/ ERNST & YOUNG LLP
New York, New York
November 25, 2015

Table of Contents

Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Directors of

Becton, Dickinson and Company

We have audited Becton, Dickinson and Company’s internal control over financial reporting as of September 30, 2015, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). Becton, Dickinson and Company’s management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, Becton, Dickinson and Company maintained, in all material respects, effective internal control over financial reporting as of September 30, 2015, based on the COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Becton, Dickinson and Company as of September 30, 2015 and 2014, and the related consolidated statements of income, comprehensive income and cash flows for each of the three years in the period ended September 30, 2015 of Becton, Dickinson and Company, and our report dated November 25, 2015 expressed an unqualified opinion thereon.



		/s/ ERNST & YOUNG LLP
New York, New York
November 25, 2015

Table of Contents

Consolidated Statements of Income

Becton, Dickinson and Company

Years Ended September 30



Millions of dollars, except per share amounts	2015			2014			2013
Operations
Revenues	$	10,282		$	8,446		$	8,054
Cost of products sold	5,587			4,145			3,883
Selling and administrative expense	2,563			2,145			2,422
Research and development expense	632			550			494
Acquisition-related costs	426			—			—
Total Operating Costs and Expenses	9,207			6,840			6,800
Operating Income	1,074			1,606			1,254
Interest expense	(371		)	(135		)	(138		)
Interest income	15			46			40
Other income, net	21			5			9
Income From Continuing Operations
Before Income Taxes	739			1,522			1,165
Income tax provision	44			337			236
Income from Continuing Operations	695			1,185			929
Income from Discontinued Operations
Net of income tax provision of $0 in 2015, $0 in 2014 and $222 in 2013	—			—			364
Net Income	$	695		$	1,185		$	1,293
Basic Earnings per Share
Income from Continuing Operations	$	3.43		$	6.13		$	4.76
Income from Discontinued Operations	$	—		$	—		$	1.86
Basic Earnings per Share	$	3.43		$	6.13		$	6.63
Diluted Earnings per Share
Income from Continuing Operations	$	3.35		$	5.99		$	4.67
Income from Discontinued Operations	$	—		$	—		$	1.83
Diluted Earnings per Share	$	3.35		$	5.99		$	6.49

Amounts may not add due to rounding.

See notes to consolidated financial statements.

Table of Contents

Consolidated Statements of Comprehensive Income

Becton, Dickinson and Company

Years Ended September 30



Millions of dollars	2015			2014			2013
Net Income	$	695		$	1,185		$	1,293
Other Comprehensive (Loss) Income, Net of Tax
Foreign currency translation adjustments	(692		)	(344		)	23
Defined benefit pension and postretirement plans	(36		)	(147		)	257
Unrealized (losses) gains on cash flow hedges, net of amounts realized	(9		)	5			7
Other Comprehensive (Loss) Income, Net of Tax	(737		)	(486		)	286
Comprehensive (Loss) Income	$	(42	)	$	699		$	1,579

Amounts may not add due to rounding.

See notes to consolidated financial statements.

Table of Contents

Consolidated Balance Sheets

Becton, Dickinson and Company

September 30



Millions of dollars, except per share amounts and numbers of shares	2015			2014
Assets
Current Assets
Cash and equivalents	$	1,424		$	1,861
Short-term investments	20			884
Trade receivables, net	1,618			1,187
Current portion of net investment in sales-type leases	75			5
Inventories	1,959			1,495
Prepaid expenses, deferred taxes and other	950			698
Total Current Assets	6,045			6,131
Property, Plant and Equipment, Net	4,060			3,605
Goodwill	7,537			1,090
Customer Relationships, Net	3,250			8
Developed Technology, Net	2,977			513
Other Intangibles, Net	797			239
Capitalized Software, Net	362			365
Net Investment in Sales-Type Leases, Less Current Portion	1,118			9
Other Assets	673			488
Total Assets	$	26,820		$	12,447
Liabilities and Shareholders’ Equity
Current Liabilities
Short-term debt	$	1,452		$	203
Accounts payable	631			401
Accrued expenses	1,624			1,053
Salaries, wages and related items	647			551
Income taxes	33			26
Total Current Liabilities	4,386			2,235
Long-Term Debt	11,370			3,768
Long-Term Employee Benefit Obligations	1,133			1,009
Deferred Income Taxes and Other	2,767			383
Commitments and Contingencies
Shareholders’ Equity
Common stock — $1 par value: authorized — 640,000,000 shares; issued — 332,662,160 shares in 2015 and 2014.	333			333
Capital in excess of par value	4,475			2,198
Retained earnings	12,314			12,105
Deferred compensation	20			19
Common stock in treasury — at cost — 121,966,516 shares in 2015 and 140,770,158 shares in 2014.	(8,239		)	(8,601		)
Accumulated other comprehensive loss	(1,738		)	(1,001		)
Total Shareholders’ Equity	7,164			5,053
Total Liabilities and Shareholders’ Equity	$	26,820		$	12,447

Amounts may not add due to rounding.

See notes to consolidated financial statements.

Table of Contents

Consolidated Statements of Cash Flows

Becton, Dickinson and Company

Years Ended September 30



Millions of dollars	2015			2014			2013
Operating Activities
Net income	$	695		$	1,185		$	1,293
Less: Income from discontinued operations, net	—			—			364
Income from continuing operations, net	695			1,185			929
Adjustments to income from continuing operations to derive net cash provided by continuing operating activities, net of amounts acquired:
Depreciation and amortization	891			562			546
Share-based compensation	166			113			100
Deferred income taxes	(336		)	(32		)	36
Change in operating assets and liabilities:
Trade receivables, net	(2		)	(7		)	(1		)
Net investment in sales-type leases	28			—			—
Inventories	200			(189		)	(145		)
Prepaid expenses, deferred taxes and other	(97		)	(120		)	(60		)
Accounts payable, income taxes and other liabilities	145			199			366
Pension obligation	28			(29		)	(51		)
Other, net	11			62			(1		)
Net Cash Provided by Continuing Operating Activities	1,730			1,746			1,717
Investing Activities
Capital expenditures	(596		)	(592		)	(522		)
Capitalized software	(37		)	(61		)	(66		)
Change in short-term investments	840			(171		)	(225		)
Acquisitions of businesses, net of cash acquired	(8,414		)	(40		)	(136		)
Divestiture of businesses	—			—			736
Other, net	(110		)	(84		)	(99		)
Net Cash Used for Continuing Investing Activities	(8,318		)	(948		)	(311		)
Financing Activities
Change in short-term debt	497			(4		)	(199		)
Proceeds from long-term debt	6,164			—			—
Payments of debt	(6		)	—			—
Repurchase of common stock	—			(400		)	(450		)
Issuance of common stock and other, net	(27		)	(9		)	44
Excess tax benefit from payments under share-based compensation plans	48			27			23
Dividends paid	(485		)	(421		)	(386		)
Net Cash Provided by (Used for) Continuing Financing Activities	6,190			(807		)	(968		)
Net Cash Used For Discontinued Operations	—			—			(212		)
Effect of exchange rate changes on cash and equivalents	(38		)	(20		)	(7		)
Net (Decrease) Increase in Cash and Equivalents	(436		)	(29		)	219
Opening Cash and Equivalents	1,861			1,890			1,671
Closing Cash and Equivalents	$	1,424		$	1,861		$	1,890

Amounts may not add due to rounding.

See notes to consolidated financial statements.

Table of Contents

Notes to Consolidated Financial Statements

Becton, Dickinson and Company

Millions of dollars, except per share amounts and numbers of shares

Note 1 — Summary of Significant Accounting Policies

Basis of Presentation

The accompanying Consolidated Financial Statements and Notes to Consolidated Financial Statements of Becton, Dickinson and Company (the “Company”) have been prepared in accordance with U.S. generally accepted accounting principles. Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes. Percentages and earnings per share amounts presented are calculated from the underlying amounts. Our fiscal year ends on September 30.

Principles of Consolidation

The consolidated financial statements include the Company’s accounts and those of its majority-owned subsidiaries after the elimination of intercompany transactions. The Company has no material interests in variable interest entities.

Cash Equivalents

Cash equivalents consist of all highly liquid investments with a maturity of three months or less at time of purchase.

Short-Term Investments

Short-term investments consist of time deposits with maturities greater than three months and less than one year when purchased.

Trade and Financing Receivables

The Company grants credit to customers in the normal course of business and the resulting trade receivables are stated at their net realizable value. The Company's portfolio of financing receivables arises from the leasing of dispensing equipment. The allowance for doubtful accounts represents the Company’s estimate of probable credit losses relating to trade receivables and is determined based on historical experience and other specific account data. Allowances for credit losses relating to financing receivables are also based on historical experience loss rates and the potential impact of anticipated changes in business practices, market dynamics, and economic conditions. Amounts are written off against the allowances for doubtful accounts or credit losses when the Company determines that a customer account is uncollectible.

Inventories

Inventories are stated at the lower of first-in, first-out cost or market.

Property, Plant and Equipment

Property, plant and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization are principally provided on the straight-line basis over estimated useful lives, which range from 20 to 45 years for buildings, four to 13 years for machinery and equipment and one to 12 years for leasehold improvements. Depreciation and amortization expense was $417 million, $369 million and $338 million in fiscal years 2015, 2014 and 2013, respectively.

Goodwill and Other Intangible Assets

The Company’s unamortized intangible assets include goodwill and in-process research and development assets which arise from acquisitions. The Company currently reviews all indefinite-lived assets, including goodwill, for impairment using quantitative models. Goodwill is reviewed at least annually for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. The Company’s reporting units generally represent one level below reporting segments, and components within an operating segment that have similar economic characteristics are aggregated. Potential impairment of goodwill is identified by comparing the fair value of a reporting unit, estimated using an income approach, with its carrying value. The annual impairment review performed on July 1, 2015 indicated that all identified reporting units’ fair values exceeded their respective carrying values.

The review for impairment of in-process research and development assets is performed by comparing the fair value of the technology or project assets, estimated using an income approach, with their carrying value. In-process research and development assets are considered indefinite-lived assets and are reviewed at least annually for impairment until projects are completed or abandoned. Certain trademarks that are considered to generate cash flows indefinitely are also considered to be indefinite-lived intangible assets and these assets are also reviewed at least annually for impairment.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

Amortized intangible assets include developed technology assets which arise from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date or acquired in-process research and development assets that are completed subsequent to acquisition. Developed technology assets are generally amortized over periods ranging from 15 to 20 years, using the straight-line method. Other intangibles with finite useful lives, which include patents, are amortized over periods principally ranging from one to 40 years, using the straight-line method. Finite-lived intangible assets, including developed technology assets, are periodically reviewed when impairment indicators are present to assess recoverability from future operations using undiscounted cash flows. The carrying values of these finite-lived assets are compared to the undiscounted cash flows they are expected to generate and an impairment loss is recognized in operating results to the extent any finite-lived intangible asset’s carrying value exceeds its calculated fair value.

Capitalized Software

Capitalized software, including costs for software developed or obtained for internal use, is stated at cost, less accumulated amortization. Amortization expense is principally provided on the straight-line basis over estimated useful lives, which do not exceed 10 years. The current balance largely includes capital software investments related to a global enterprise resource planning initiative to upgrade the Company’s business information systems. Amortization expense related to capitalized software was $65 million, $41 million and $38 million for 2015, 2014 and 2013, respectively.

Foreign Currency Translation

Generally, foreign subsidiaries’ functional currency is the local currency of operations and the net assets of foreign operations are translated into U.S. dollars using current exchange rates. The U.S. dollar results that arise from such translation, as well as exchange gains and losses on intercompany balances of a long-term investment nature, are included in the foreign currency translation adjustments in Accumulated other comprehensive income (loss).

Revenue Recognition

Revenue from product sales is typically recognized when all of the following criteria have been met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; product price is fixed or determinable; collection of the resulting receivable is reasonably assured. Certain sales arrangements contain multiple deliverables, including equipment and service deliverables, which requires the Company to determine the separate units of account. If the deliverable meets the criteria of a separate unit of accounting, the arrangement consideration is allocated to each element based upon its relative selling price. In determining the best evidence of selling price of a unit of account the Company utilizes vendor-specific objective evidence (“VSOE”), which is the price the Company charges when the deliverable is sold separately. When VSOE is not available, management uses relevant third-party evidence (“TPE”) of selling price, if available. When neither VSOE nor TPE of selling price exists, management uses its best estimate of selling price.

Revenue allocated to equipment deliverables is recognized upon customer acceptance, which occurs after the transfer of title and risk of loss to the customer and the completion of installation or training services. When related training services are considered inconsequential, delivery is deemed to occur upon the transfer of title and risk of loss, at which time revenue and the costs associated with installation and training are recognized.

For equipment lease revenue, transactions are evaluated and classified as either operating leases or sales-type leases. Lease income for products sold under sales-type leases is recognized as revenue upon the completion of installation activities in the amount of the present value of the minimum lease payments. The financing component of sales-type leases is recorded as revenue over the lease term. For products sold under operating leases, revenue is recognized at the contracted rate over the rental period, as defined within the customer agreement.

The Company’s domestic businesses sell products primarily to distributors that resell the products to end-user customers. Rebates are provided to distributors that sell to end-user customers at prices determined under a contract between the Company and the end-user customer. Provisions for rebates, as well as sales discounts and returns, are based upon estimates and are accounted for as a reduction of revenues when revenue is recognized.

Shipping and Handling Costs

Shipping and handling costs are included in Selling and administrative expense. Shipping expense was $351 million, $299 million and $285 million in 2015, 2014 and 2013, respectively.

Derivative Financial Instruments

All derivatives are recorded in the balance sheet at fair value and changes in fair value are recognized currently in earnings unless specific hedge accounting criteria are met.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

From time to time, derivative financial instruments are utilized by the Company in the management of its foreign currency, interest rate and commodity price exposures. The Company periodically purchases forward contracts and options to hedge certain forecasted transactions that are denominated in foreign currencies in order to partially protect against a reduction in the value of future earnings resulting from adverse foreign exchange rate movements. The Company also periodically utilizes interest rate swaps to maintain a balance between fixed and floating rate instruments. Additionally, the Company periodically manages price risks associated with resin purchase costs through commodity derivative forward contracts. The Company does not enter into derivative financial instruments for trading or speculative purposes.

Any deferred gains or losses associated with derivative instruments are recognized in income in the period in which the underlying hedged transaction is recognized. In the event a designated hedged item is sold, extinguished or matures prior to the termination of the related derivative instrument, such instrument would be closed and the resultant gain or loss would be recognized in income.

Income Taxes

United States income taxes are not provided on undistributed earnings of foreign subsidiaries where such undistributed earnings are indefinitely reinvested outside the United States. Deferred taxes are provided for earnings of foreign subsidiaries when those earnings are not considered indefinitely reinvested. Income taxes are provided and tax credits are recognized based on tax laws enacted at the dates of the financial statements.

The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of tax jurisdictions. In evaluating the exposure associated with various tax filing positions, the Company records accruals for uncertain tax positions, based on the technical support for the positions, past audit experience with similar situations, and the potential interest and penalties related to the matters.

The Company maintains valuation allowances where it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances are included in the tax provision in the period of change. In determining whether a valuation allowance is warranted, management evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods and tax strategies that could potentially enhance the likelihood of the realization of a deferred tax asset.

Earnings per Share

Basic earnings per share are computed based on the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.

Use of Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions. These estimates or assumptions affect reported assets, liabilities, revenues and expenses as reflected in the consolidated financial statements. Actual results could differ from these estimates.

Share-Based Compensation

The Company recognizes the fair value of share-based compensation in net income. Compensation expense is recognized on a straight-line basis over the requisite service period, which is generally the vesting period.

Note 2 — Accounting Changes

New Accounting Principle Adopted

In June 2013, the Financial Accounting Standards Board (“FASB”) issued guidance that requires the netting of unrecognized tax benefits against a deferred tax asset for a loss or other carryforward that would apply in settlement of the uncertain tax positions. In March 2013, the FASB issued amendments to resolve diversity in practice relating to the release of cumulative translation adjustments into earnings upon the occurrence of certain derecognition events involving a foreign entity. The Company prospectively adopted both accounting standard updates, which did not impact its consolidated financial statements, on October 1, 2014.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

New Accounting Principles Not Yet Adopted

In April 2014, the FASB issued amended requirements that limit the presentation of discontinued operations to only those disposals that represent a strategic shift that has had, or will have, a major effect on an entity’s operations and financial results. The amended requirements also expand the disclosure requirements relating to disposal transactions. The Company will prospectively apply the amended requirements to disposal transactions that occur on or after October 1, 2015.

In May 2014, the FASB issued a new revenue recognition standard. Under this standard, revenue will be recognized upon the transfer of goods or services to customers and the amount of revenue recognized will reflect the consideration to which a reporting entity expects to be entitled in exchange for those goods or services. The Company is currently evaluating the impact that this new revenue recognition standard will have on its consolidated financial statements and the Company currently intends to adopt the standard on October 1, 2018, as is allowed under the FASB's July 2015 amendment which deferred the effective date for this standard.

In April 2014, the FASB issued amended requirements that require debt issuance costs, related to a recognized debt liability, to be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The Company will apply the amended presentation requirements on October 1, 2016.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

Note 3 — Shareholders’ Equity

Changes in certain components of shareholders’ equity were as follows:



	Common Stock Issued at Par Value		Capital in Excess of Par Value		Retained Earnings			Deferred Compensation		Treasury Stock
(Millions of dollars)	Common Stock Issued at Par Value		Capital in Excess of Par Value		Retained Earnings			Deferred Compensation		Shares (in thousands)		Amount
Balance at September 30, 2012	$	333	$	1,920	$	10,435		$	19	(135,751	)	$	(7,769	)
Net income	—		—		1,293			—		—		—
Cash dividends:
Common ($1.98 per share)	—		—		(386		)	—		—		—
Common stock issued for:
Share-based compensation and other plans, net	—		50		—			—		2,537		15
Share-based compensation	—		98		—			—		—		—
Common stock held in trusts, net	—		—		—			—		36		—
Repurchase of common stock	—		—		—			—		(5,485	)	(450		)
Balance at September 30, 2013	$	333	$	2,068	$	11,342		$	19	(138,663	)	$	(8,204	)
Net income	—		—		1,185			—		—		—
Cash dividends:
Common ($2.18 per share)	—		—		(421		)	—		—		—
Common stock issued for:
Share-based compensation and other plans, net	—		19		—			—		1,431		3
Share-based compensation	—		111		—			—		—		—
Common stock held in trusts, net	—		—		—			—		36		—
Repurchase of common stock	—		—		—			—		(3,574	)	(400		)
Balance at September 30, 2014	$	333	$	2,198	$	12,105		$	19	(140,770	)	$	(8,601	)
Net income	—		—		695			—		—		—
Cash dividends:
Common ($2.40 per share)	—		—		(485		)	—		—		—
Common stock issued for:
Share-based compensation and other plans, net	—		30		(2		)	1		2,839		(6		)
Acquisitions	—		2,083		—			—		15,959		368
Share-based compensation	—		164		—			—		—		—
Common stock held in trusts, net	—		—		—			—		5		—
Repurchase of common stock	—		—		—			—		—		—
Balance at September 30, 2015	$	333	$	4,475	$	12,314		$	20	(121,967	)	$	(8,239	)

Common stock held in trusts represents rabbi trusts in connection with deferred compensation under the Company’s employee salary and bonus deferral plan and directors’ deferral plan.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

The components and changes of Accumulated other comprehensive income (loss) were as follows:



(Millions of dollars)	Total			Foreign Currency Translation Adjustments			Benefit Plans Adjustments			Unrealized Losses on Cash Flow Hedges
Balance at September 30, 2012	$	(802	)	$	51		$	(815	)	$	(38	)
Other comprehensive income before reclassifications, net of taxes	228			23			203			2
Amounts reclassified into income, net of taxes (A)	59			—			54			4
Balance at September 30, 2013	$	(516	)	$	74		$	(558	)	$	(31	)
Other comprehensive income before reclassifications	(524		)	(344		)	(180		)	—
Amounts reclassified into income, net of taxes (A)	38			—			33			5
Balance at September 30, 2014	$	(1,001	)	$	(270	)	$	(705	)	$	(26	)
Other comprehensive income before reclassifications, net of taxes	(787		)	(692		)	(80		)	(16		)
Amounts reclassified into income, net of taxes (A)	50			—			44			6
Balance at September 30, 2015	$	(1,738	)	$	(961	)	$	(741	)	$	(36	)

(A)

The benefit plan-related amount is not reclassified into income in its entirety. The reclassifications from accumulated other comprehensive (loss) income are included in the computation of net periodic pension cost and additional details are provided in Note 8. The reclassification amounts related to cash flow hedges in fiscal years 2015, 2014, and 2013 were primarily recorded in Interest Expense. Additional details regarding the reclassifications from accumulated other comprehensive (loss) income related to cash flow hedges are provided in Note 13.

The loss in foreign currency translation adjustments for the fiscal year ended September 30, 2015 was primarily attributable to the weakening of the Euro and currencies in Latin America and Asia Pacific against the U.S. dollar during the period.

The income tax (benefit) provision for net (losses) gains recorded in other comprehensive income for defined benefit pension, postretirement plans and postemployment plans in fiscal years 2015, 2014 and 2013 was $(47) million, $(86) million and $121 million, respectively. The income tax benefits associated with the benefit plan-related reclassification adjustments for amortization of prior service credit and amortization of net actuarial losses for the fiscal years ended September 30, 2015, 2014 and 2013 were $23 million, $17 million and $30 million, respectively.

The income tax benefit recorded for losses recognized in other comprehensive income relating to cash flow hedges for the fiscal year ended September 30, 2015 was $10 million. Additional disclosures regarding these losses are provided in Note 13. There were no net gains or losses recorded in other comprehensive income relating to cash flow hedges in fiscal year 2014 and gains recorded in 2013 were immaterial. Reclassification adjustments for realized amounts relating to cash flow hedges were immaterial in fiscal years 2015, 2014, and 2013.

Note 4 — Earnings per Share

The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) for the years ended September 30 were as follows:



	2015	2014	2013
Average common shares outstanding	202,537	193,299	195,157
Dilutive share equivalents from share-based plans	4,972	4,410	4,036
Average common and common equivalent shares outstanding — assuming dilution	207,509	197,709	199,193

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

Upon closing the acquisition of CareFusion Corporation (“CareFusion”) on March 17, 2015, the Company issued approximately 15.9 million of its common shares as part of the purchase consideration. Additional disclosures regarding this acquisition are provided in Note 9.

Options to purchase shares of common stock are excluded from the calculation of diluted earnings per share when their inclusion would have an anti-dilutive effect on the calculation. For the years ended September 30, 2015, 2014 and 2013 there were no options to purchase shares of common stock which were excluded from the diluted earnings per share calculation.

Note 5 — Commitments and Contingencies

Commitments

Rental expense for all operating leases amounted to $89 million in 2015, $71 million in 2014 and $70 million in 2013. Future minimum rental commitments on noncancelable leases are as follows: 2016 — $80 million; 2017 — $62 million; 2018 — $36 million; 2019 — $26 million; 2020 — $18 million and an aggregate of $24 million thereafter.

As of September 30, 2015, the Company has certain future purchase commitments aggregating to approximately $958 million, which will be expended over the next several years.

Contingencies

Given the uncertain nature of litigation generally, the Company is not able in all cases to estimate the amount or range of loss that could result from an unfavorable outcome of the litigation to which the Company is a party. In accordance with U.S. generally accepted accounting principles, the Company establishes accruals to the extent probable future losses are estimable (in the case of environmental matters, without considering possible third-party recoveries). In view of the uncertainties discussed below, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance. In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company’s consolidated results of operations and consolidated cash flows.

In June 2007, Retractable Technologies, Inc. (“RTI”) filed a complaint against the Company under the caption Retractable Technologies, Inc. vs. Becton Dickinson and Company (Civil Action No. 2:07-cv-250, U.S. District Court, Eastern District of Texas). RTI alleges that the BD Integra™ syringes infringe patents licensed exclusively to RTI. In its complaint, RTI also alleges that the Company engaged in false advertising with respect to certain of the Company’s safety-engineered products in violation of the Lanham Act; acted to exclude RTI from various product markets and to maintain its market share through, among other things, exclusionary contracts in violation of state and federal antitrust laws; and engaged in unfair competition. In January 2008, the court severed the patent and non-patent claims into separate cases, and stayed the non-patent claims during the pendency of the patent claims at the trial court level. RTI seeks money damages and injunctive relief. On April 1, 2008, RTI filed a complaint against BD under the caption Retractable Technologies, Inc. and Thomas J. Shaw v. Becton Dickinson and Company (Civil Action No.2:08-cv-141, U.S. District Court, Eastern District of Texas). RTI alleges that the BD Integra™ syringes infringe another patent licensed exclusively to RTI. RTI seeks money damages and injunctive relief. On August 29, 2008, the court ordered the consolidation of the patent cases. On November 9, 2009, at a trial of these consolidated cases, the jury rendered a verdict in favor of RTI on all but one of its infringement claims, but did not find any willful infringement, and awarded RTI $5 million in damages, which has been paid. On May 19, 2010, the court granted RTI’s motion for a permanent injunction against the continued sale by the Company of its BD Integra™ products in their current form, but stayed the injunction for the duration of the Company’s appeal. At the same time, the court lifted a stay of RTI’s non-patent claims. On July 8, 2011, the Court of Appeals for the Federal Circuit reversed the District Court judgment that the Company’s 3ml BD Integra™ products infringed the asserted RTI patents and affirmed the District Court judgment of infringement against the Company’s discontinued 1ml BD Integra™ products. On October 31, 2011, the Federal Circuit Court of Appeals denied RTI’s request for an en banc rehearing. In January 2013, RTI’s petition for review with the U.S. Supreme Court was denied. BD’s motion for further proceedings on damages was denied by the District Court on the grounds that the District Court did not have authority to modify the $5 million damage award. BD appealed this ruling to the Federal Circuit Court of Appeals, and on July 7, 2014, the Court affirmed the District Court ruling leaving the damages award intact. On September 19, 2014, the Federal Circuit Court of Appeals denied BD’s request for an en banc rehearing. On January 16, 2015, BD filed a petition for U.S. Supreme Court review of the Federal Circuit Court of Appeals decision leaving the damages award intact. On April 20, 2015, the U.S. Supreme Court denied BD’s petition.

On September 19, 2013, a jury returned a verdict against BD with respect to certain of RTI’s non-patent claims. The verdict was unfavorable to BD with respect to RTI’s Lanham Act claim and claim for attempted monopolization based on deception in the safety syringe market. The jury awarded RTI $113.5 million for its attempted monopolization claim (which

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

will be trebled under the antitrust statute). The jury’s verdict rejected RTI’s monopolization claims in the markets for safety syringes, conventional syringes and safety IV catheters; its attempted monopolization claims in the markets for conventional syringes and safety IV catheters; and its claims for contractual restraint of trade and exclusive dealing in the markets for safety syringes, conventional syringes and safety IV catheters. In connection with the verdict, the Company recorded a pre-tax charge of approximately $341 million in the fourth quarter of fiscal year 2013. On September 30, 2014, the Court issued a ruling denying BD’s post-trial motion for judgment as a matter of law. On November 10, 2014, the Court issued a ruling denying RTI’s request for disgorgement of BD profits for false advertising on the ground that any profit to which RTI is entitled is included within the amount of the antitrust damage award. The Court granted RTI’s request that BD be ordered to issue certain corrective statements regarding its advertising and enjoined from making certain advertising claims. The Court denied RTI’s request for injunctive relief relating to BD’s contracting practices and BD’s safety syringe advertising, finding that RTI failed to prove that BD’s contracting practices violated the antitrust laws or that BD’s safety syringe advertising is false. The Court concluded that RTI is entitled to certain categories of attorneys’ fees that it requested, but that its total fee recovery should be reduced by 50%. On January 14, 2015, the Court granted in part and denied in part BD’s motion for a stay of the injunction. The Court held that, pending appeal, BD would not be required to send the corrective advertising notices to end-user customers, but only to employees, distributors and Group Purchasing Organizations. The Court otherwise upheld its November 10, 2014 Order regarding the injunction. On January 15, 2015, the Court entered its Final Judgment in the case. In the Final Judgment, the Court ordered that RTI recovers $341 million for its attempted monopolization claim and $12 million for attorneys’ fees, and awarded pre and post-judgment interest and costs. On February 3, 2015, the Court of Appeals for the Fifth Circuit denied BD’s motion for a stay of the injunction pending the final appeal. On April 23, 2015, the Court granted BD’s motion to eliminate the award of pre-judgment interest, and entered a new Final Judgment. BD has filed its appeal to the Court of Appeals challenging the entirety of the Final Judgment.

On November 4, 2013, the Secretariat of Foreign Trade of the Federal Republic of Brazil initiated an administrative anti-dumping investigation of imports of vacuum plastic tubes for blood collection into Brazil from the United States, the United Kingdom of Great Britain and Northern Ireland, the Federal Republic of Germany and the People’s Republic of China during the period from January 2008 through December 2012. BD, through its United States and international subsidiaries, exports vacuum plastic tubes for blood collection into Brazil from the United States and the United Kingdom of Great Britain and Northern Ireland and cooperated with the investigation. On April 30, 2015, the Brazilian Foreign Trade Board (“CAMEX”) issued a decision determining the application of anti-dumping measures including, without limitation, the imposition of duties on such vacuum plastic tubes imported into Brazil of 45.3% for products from the United States of America and 71.5% for products from the United Kingdom of Great Britain and Northern Ireland. These anti-dumping measures, effective from April 30, 2015, will last for a minimum period of five years. Subsequent to the decision, CAMEX initiated a proceeding to assess the effect of the duties from a public interest perspective. BD’s administrative appeal of the CAMEX decision was denied on August 5, 2015. CAMEX announced on November 5, 2015, following the conclusion of its proceeding, that it is not modifying its original decision. BD does not believe that the CAMEX decision will materially affect its results of operations.

On October 5, 2014, CareFusion and the Company entered into an Agreement and Plan of Merger (which we refer to as the merger agreement) that provides for the acquisition of CareFusion by the Company. Under the terms of the merger agreement, a subsidiary of the Company (“the merger subsidiary”) merged with and into CareFusion on March 17, 2015, with CareFusion surviving the merger as a wholly owned subsidiary of the Company. Several putative class action lawsuits have been filed against CareFusion, its directors, the Company and the merger subsidiary in the Delaware Court of Chancery and in the Superior Court of California, San Diego County. These lawsuits generally allege that the members of the board of directors of CareFusion breached their fiduciary duties in connection with the merger by, among other things, carrying out a process that plaintiffs allege did not ensure adequate and fair consideration to CareFusion stockholders. The plaintiffs in these actions further allege that CareFusion and the Company aided and abetted the individual defendants’ breaches of their fiduciary duties. The plaintiffs seek, among other things, equitable relief to enjoin consummation of the merger, rescission of the merger and/or rescissory damages, and attorneys’ fees and costs.

On December 30, 2014, the parties to the actions filed in the Delaware Court of Chancery (the “Delaware Actions”) entered into an agreement in principle to settle the Delaware Actions on the basis of additional disclosures made in a CareFusion Schedule 14A, filed with the SEC on January 5, 2015. The settlement terms are reflected in a Memorandum of Understanding (“MOU”). On December 31, 2014, plaintiffs’ counsel notified the Delaware Court of Chancery of the settlement and MOU. The parties to the Delaware Actions entered into a stipulation and agreement of compromise, settlement and release and presented the matter to the Delaware Court of Chancery for approval. The Delaware Court of Chancery approved the settlement on September 17, 2015 and the Delaware Actions are now concluded. On October 27, 2015, the Superior Court of California granted plaintiffs' request for voluntary dismissal of the California actions.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

On July 17, 2015, a class action complaint was filed against the Company in the U.S. District Court for the Southern District of Georgia. The plaintiffs, Glynn-Brunswick Hospital Authority, trading as Southeast Georgia Health System, and Southeast Georgia Health System, Inc., seek to represent a class of acute care purchasers of BD syringes and IV catheters. The complaint alleges that BD monopolized the markets for syringes and IV catheters through contracts, theft of technology, false advertising, acquisitions, and other conduct. The complaint seeks treble damages but does not specify the amount of alleged damages. The Company has filed a motion to dismiss the complaint.

The Company believes that it has meritorious defenses to each of the above-mentioned suits pending against the Company and is engaged in a vigorous defense of each of these matters.

The Company is also involved both as a plaintiff and a defendant in other legal proceedings and claims that arise in the ordinary course of business.

The Company is a party to a number of federal proceedings in the United States brought under the Comprehensive Environment Response, Compensation and Liability Act, also known as “Superfund,” and similar state laws. The affected sites are in varying stages of development. In some instances, the remedy has been completed, while in others, environmental studies are commencing. For all sites, there are other potentially responsible parties that may be jointly or severally liable to pay all cleanup costs.

Note 6 — Segment Data

Effective October 1, 2014, the Company’s organizational structure was realigned to better complement its customer-focused solutions strategy and is based upon two principal business segments: BD Medical (“Medical”) and BD Life Sciences (“Life Sciences”). The composition of the Medical segment did not change from its historical composition as a result of this realignment. The Life Sciences segment consists of the former BD Diagnostics and BD Biosciences segments. Beginning on October 1, 2014, decisions about resource allocation and performance assessment are made separately for the Medical and Life Sciences segments. Prior-period information presented for comparative purposes has been revised to reflect the new two-segment organizational structure. CareFusion, which was acquired on March 17, 2015, operates as part of the Company’s Medical segment. The Company’s two principal business segments are strategic businesses that are managed separately because each one develops, manufactures and markets distinct products and services.

The Medical segment produces a broad array of medical devices that are used in a wide range of healthcare settings. The principal product lines in the Medical segment include syringes and pen needles for the injection of insulin and other drugs used in the treatment of diabetes; needles, syringes and intravenous catheters for medication delivery (including safety-engineered and auto-disable devices); prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentation; generic prefilled injectables; intravenous medication safety and infusion therapy delivery systems, including infusion pumps and dedicated disposables; automated medication dispensing and supply management systems; prefillable drug delivery systems provided to pharmaceutical companies and sold to end-users as drug/device combinations; respiratory ventilation and diagnostics equipment and consumables used during respiratory diagnostics and therapy; and consumables used for patient monitoring and anesthesia delivery.

The Life Sciences segment produces products for the safe collection and transport of diagnostics specimens, as well as instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections (“HAIs”) and cancers. The segment also produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes. The principal products and services in the Life Sciences segment include integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing and tuberculosis culturing systems; molecular testing systems for infectious diseases and women’s health; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation; plated media; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological (HIV) and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing.

The Company evaluates performance of its business segments and allocates resources to them primarily based upon operating income. Segment operating income represents revenues reduced by product costs and operating expenses.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

Distribution of products is primarily through independent distribution channels, and directly to end-users by BD and independent sales representatives. No customer accounted for 10% or more of revenues in any of the three years presented.



(Millions of dollars)	2015				2014				2013
Revenues (A)
Medical	$	6,460		(B)	$	4,573			$	4,306
Life Sciences	3,822				3,872				3,748
Total Revenues	$	10,282			$	8,446			$	8,054
Segment Operating Income
Medical	$	1,530		(C)	$	1,291		(D)	$	1,233
Life Sciences	839				861			(E)	907
Total Segment Operating Income	2,368				2,152				2,140
Unallocated Items (F)	(1,629		)	(G)	(630		)	(H)	(976		)	(I)
Income From Continuing Operations Before Income Taxes	$	739			$	1,522			$	1,165
Segment Assets
Medical	$	20,055			$	4,668			$	4,582
Life Sciences	3,932				3,783				3,776
Total Segment Assets	23,987				8,451				8,357
Corporate and All Other (J)	2,833				3,997				3,792
Total Assets	$	26,820			$	12,447			$	12,149
Capital Expenditures
Medical	$	414			$	420			$	354
Life Sciences	168				155				158
Corporate and All Other	14				16				9
Total Capital Expenditures	$	596			$	592			$	522
Depreciation and Amortization
Medical	$	619			$	293			$	259
Life Sciences	256				251				267
Corporate and All Other	17				18				19
Total Depreciation and Amortization	$	891			$	562			$	546


(A)	Intersegment revenues are not material.


(B)	Includes $20 million in amortization of the acquisition-date write-down of CareFusion’s deferred revenue balance that was recorded to reflect a fair value measurement as of the acquisition date.

(C)

Includes an increase of $284 million in non-cash amortization expense relating to the identifiable intangible assets acquired in the CareFusion transaction as well as depreciation expense relating to the fixed assets acquired in the transaction. Additional disclosures regarding the assets acquired in this acquisition are provided in Note 9. Also includes a $5 million adjustment to decrease the liability for employee termination costs recorded relative to certain workforce reduction actions taken in the fourth quarter of fiscal year 2014. Additional disclosures regarding these actions are provided in Note 8.


(D)	Includes $21 million of the charge associated with workforce reduction actions noted above. Also, includes a $6 million charge associated with the decision to terminate a research and development program; the charge relates to program asset write-offs and obligations. Additionally includes $4 million of acquisition-related transaction costs recorded in Selling and administrative expense.

(E)

Includes a $20 million charge primarily resulting from the discontinuance of an instrument product development program. The charge is largely attributable to capitalized product software, but also includes a lesser amount attributable to fixed assets. Also, includes an $11 million charge that resulted from the early termination of a European distributor agreement and $10 million of the charge associated with the workforce reduction actions noted above.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

Additionally includes a $5 million charge due to an adjustment to the carrying amount of an asset that is being held for sale and $1 million of acquisition-related transaction costs recorded in Selling and administrative expense.


(F)	Includes primarily interest, net; foreign exchange; corporate expenses; and share-based compensation expense.

(G)

Includes financing, transaction, integration and restructuring costs associated with the CareFusion acquisition. Also includes $293 million in recognition of the fair value step-up adjustment recorded relative to CareFusion’s inventory on the acquisition date as well as $16 million of favorable amortization relating to the acquisition-date fair value step-up recorded on CareFusion’s long-term debt. Additional disclosures regarding this acquisition are provided in Note 9. Also includes a $12 million charge for RTI’s attorneys’ fees associated with the unfavorable verdict returned in the antitrust and false advertising lawsuit RTI filed against BD. For further discussion, refer to Note 5. Additionally includes an acquisition-date accounting gain of $9 million on the previously held investment in CRISI Medical Systems, Inc. (“CRISI”), which the Company fully acquired during the second quarter of 2015.


(H)	Includes an $8 million gain resulting from the Company’s receipt of cash proceeds from the sale of a company in which it held a small equity ownership interest. Also includes $5 million of the charge associated with the workforce reductions noted above.


(I)	Includes the $341 million charge associated with the unfavorable verdict returned in the antitrust and false advertising lawsuit filed against the Company by RTI as well as a $22 million charge associated with a litigation settlement related to indirect purchaser antitrust class action cases. Additional disclosures regarding legal matters are provided in Note 5.


(J)	Includes cash and investments and corporate assets.

Geographic Information

The countries in which the Company has local revenue-generating operations have been combined into the following geographic areas: the United States (including Puerto Rico); Europe; Greater Asia (which includes Japan and Asia Pacific); and Other, which is comprised of Latin America, Canada, and EMA (which includes the Commonwealth of Independent States, Middle East and Africa).

Revenues to unaffiliated customers are based upon the source of the product shipment. Long-lived assets, which include net property, plant and equipment, are based upon physical location.



(Millions of dollars)	2015		2014		2013
Revenues
United States	$	5,069	$	3,417	$	3,353
Europe	2,434		2,383		2,189
Greater Asia	1,545		1,437		1,344
Other	1,234		1,210		1,168
	$	10,282	$	8,446	$	8,054
Long-Lived Assets
United States	$	15,513	$	3,126	$	3,251
Europe	3,876		1,790		1,649
Greater Asia	569		555		519
Other	484		505		505
Corporate	332		340		350
	$	20,774	$	6,317	$	6,276

Note 7 — Share-Based Compensation

The Company grants share-based awards under the 2004 Employee and Director Equity-Based Compensation Plan (“2004 Plan”), which provides long-term incentive compensation to employees and directors consisting of: stock appreciation rights (“SARs”), stock options, performance-based restricted stock units, time-vested restricted stock units and other stock awards.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

The fair value of share-based payments is recognized as compensation expense in net income. The amounts and location of compensation cost relating to share-based payments included in consolidated statements of income is as follows:



(Millions of dollars)	2015		2014		2013
Cost of products sold	$	23	$	23	$	20
Selling and administrative expense	82		74		66
Research and development expense	17		16		14
Acquisition-related costs	44		—		—
	$	166	$	113	$	100

The associated income tax benefit recognized was $59 million, $40 million and $35 million in fiscal years 2015, 2014 and 2013, respectively. Share-based compensation attributable to discontinued operations in 2013 was not material.

Certain pre-acquisition equity awards of CareFusion were converted into BD restricted stock awards or BD stock options with accelerated vesting terms at the acquisition date. In addition, as an incentive to encourage post-acquisition employee retention, certain pre-acquisition equity awards of CareFusion were converted into either BD restricted stock awards or BD stock options, as applicable, as of the acquisition date, with substantially the same terms and conditions as were applicable under such CareFusion awards immediately prior to the acquisition date. The compensation expense associated with these replacement awards was recorded in Acquisition-related costs.

Stock Appreciation Rights

SARs represent the right to receive, upon exercise, shares of common stock having a value equal to the difference between the market price of common stock on the date of exercise and the exercise price on the date of grant. SARs vest over a four-year period and have a ten-year term. The fair value was estimated on the date of grant using a lattice-based binomial option valuation model that uses the following weighted-average assumptions:



	2015	2014	2013
Risk-free interest rate	2.20%	2.31%	1.33%
Expected volatility	19.0%	19.0%	21.0%
Expected dividend yield	1.78%	2.00%	2.60%
Expected life	7.6 years	7.8 years	8.0 years
Fair value derived	$24.82	$19.90	$12.08

Expected volatility is based upon historical volatility for the Company’s common stock and other factors. The expected life of SARs granted is derived from the output of the lattice-based model, using assumed exercise rates based on historical exercise and termination patterns, and represents the period of time that SARs granted are expected to be outstanding. The risk-free interest rate used is based upon the published U.S. Treasury yield curve in effect at the time of grant for instruments with a similar life. The dividend yield is based upon the most recently declared quarterly dividend as of the grant date. The total intrinsic value of SARs exercised during 2015, 2014 and 2013 was $96 million, $69 million and $54 million, respectively. The Company issued 691 thousand shares during 2015 to satisfy the SARs exercised. The actual tax benefit realized during 2015, 2014 and 2013 for tax deductions from SAR exercises totaled $34 million, $26 million and $19 million, respectively. The total fair value of SARs vested during 2015, 2014 and 2013 was $22 million, $25 million and $30 million, respectively.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

A summary of SARs outstanding as of September 30, 2015 and changes during the year then ended is as follows:



	SARs (in thousands)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (Millions of dollars)
Balance at October 1	7,852		$	78.49
Granted	1,037		134.73
Exercised	(1,458	)	72.88
Forfeited, canceled or expired	(167	)	103.50
Balance at September 30	7,264		$	87.07	5.96	$	333
Vested and expected to vest at September 30	7,010		$	86.34	5.88	$	327
Exercisable at September 30	4,725		$	76.18	4.81	$	267

Stock Options

The Company has not granted stock options since 2005. As previously discussed, certain pre-acquisition equity awards of CareFusion were converted on March 17, 2015 into BD stock options with accelerated vesting terms.

A summary of stock options outstanding as of September 30, 2015 and changes during the year then ended is as follows:



	Stock Options (in thousands)		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (Millions of dollars)
Balance at October 1	74		$	54.57
Acquisition-related conversions (A)	1,971		82.32
Exercised	(900	)	83.70
Forfeited, canceled or expired	(7	)	73.41
Balance at September 30	1,139		$	79.47	4.31	$	61
Vested at September 30	1,111		$	79.10	4.29	$	60
Exercisable at September 30	865		$	74.82	3.99	$	50


(A)	Represents options granted upon the conversion of pre-acquisition equity awards of CareFusion, as previously discussed.

Cash received from the exercising of stock options in 2015, 2014 and 2013 was $75 million, $17 million and $64 million, respectively. The actual tax benefit realized for tax deductions from stock option exercises totaled $20 million, $7 million and $21 million, respectively. The total intrinsic value of stock options exercised during the years 2015, 2014 and 2013 was $52 million, $21 million and $65 million, respectively.

Performance-Based Restricted Stock Units

Performance-based restricted stock units cliff vest three years after the date of grant. These units are tied to the Company’s performance against pre-established targets over a three-year performance period. The performance measures for fiscal years 2015, 2014 and 2013 were relative total shareholder return (measures the Company’s stock performance during the performance period against that of peer companies) and average annual return on invested capital. Under the Company’s long-term incentive program, the actual payout under these awards may vary from zero to 200% of an employee’s target payout, based on the Company’s actual performance over the three-year performance period. The fair value is based on the market price of the Company’s stock on the date of grant. Compensation cost initially recognized assumes that the target payout level will be achieved and is adjusted for subsequent changes in the expected outcome of performance-related conditions. For units for which the performance conditions are modified after the date of grant, any incremental increase in the fair value of the modified units, over the original units, is recorded as compensation expense on the date of the modification for vested units, or over the remaining performance period for units not yet vested.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

A summary of performance-based restricted stock units outstanding as of September 30, 2015 and changes during the year then ended is as follows:



	Stock Units (in thousands)		Weighted Average Grant Date Fair Value
Balance at October 1	1,255		$	83.47
Granted	352		148.04
Distributed	(139	)	72.12
Forfeited or canceled	(330	)	79.12
Balance at September 30(A)	1,139		$	106.07
Expected to vest at September 30(B)	542		$	97.09


(A)	Based on 200% of target payout.


(B)	Net of expected forfeited units and units in excess of the expected performance payout of 68 thousand and 528 thousand shares, respectively.

The weighted average grant date fair value of performance-based restricted stock units granted during the years 2014 and 2013 was $110.58 and $72.14, respectively. The total fair value of performance-based restricted stock units vested during 2015 was $16 million and the fair value of units vested during 2014 was $10 million. Based on the Company’s results during the performance period, compared with the established performance targets for payout, there was no payout of performance-based restricted stock units in fiscal year 2013. At September 30, 2015, the weighted average remaining vesting term of performance-based restricted stock units is 1.04 years.

Time-Vested Restricted Stock Units

Time-vested restricted stock unit awards granted after January 2015 vest on a graded basis over a three-year period. Time-vested restricted stock units granted before January 2015 cliff vest three years after the date of grant, except for certain key executives of the Company, including the executive officers, for which such units generally vest one year following the employee’s retirement. The related share-based compensation expense is recorded over the requisite service period, which is the vesting period or in the case of certain key executives is based on retirement eligibility. The fair value of all time-vested restricted stock units is based on the market value of the Company’s stock on the date of grant. The impact of this change in accounting policy was not material to reported stock-based compensation expense for the year ended September 30, 2015.

A summary of time-vested restricted stock units outstanding as of September 30, 2015 and changes during the year then ended is as follows:



	Stock Units (in thousands)		Weighted Average Grant Date Fair Value
Balance at October 1	3,015		$	80.03
Granted (A)	1,946		136.30
Distributed	(1,128	)	99.07
Forfeited or canceled	(766	)	107.50
Balance at September 30	3,067		$	101.88
Expected to vest at September 30	2,878		$	100.65


(A)	Includes approximately 1 million units granted upon the conversion of pre-acquisition equity awards of CareFusion, as previously discussed.

The weighted average grant date fair value of time-vested restricted stock units granted during the years 2014 and 2013 was $102.74 and $70.99, respectively. The total fair value of time-vested restricted stock units vested during 2015, 2014 and 2013 was $181 million, $45 million and $52 million, respectively. At September 30, 2015, the weighted average remaining vesting term of the time-vested restricted stock units is 1.08 years.

The amount of unrecognized compensation expense for all non-vested share-based awards as of September 30, 2015, is approximately $156 million, which is expected to be recognized over a weighted-average remaining life of approximately 1.84 years. Included in the unrecognized compensation expense is $38 million associated with the CareFusion replacement awards previously described. As of September 30, 2015, there were approximately 1.5 million of such replacement awards outstanding.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

At September 30, 2015, 7,242 thousand shares were authorized for future grants under the 2004 Plan. The Company has a policy of satisfying share-based payments through either open market purchases or shares held in treasury. At September 30, 2015, the Company has sufficient shares held in treasury to satisfy these payments.

Other Stock Plans

The Company has a Stock Award Plan, which allows for grants of common shares to certain key employees. Distribution of 25% or more of each award is deferred until after retirement or involuntary termination, upon which the deferred portion of the award is distributable in five equal annual installments. The balance of the award is distributable over five years from the grant date, subject to certain conditions. In February 2004, this plan was terminated with respect to future grants upon the adoption of the 2004 Plan. At September 30, 2015 and 2014, awards for 50 thousand and 58 thousand shares, respectively, were outstanding.

The Company has a Directors’ Deferral Plan, which provides a means to defer director compensation, from time to time, on a deferred stock or cash basis. As of September 30, 2015, 119 thousand shares were held in trust, of which three thousand shares represented Directors’ compensation in 2015, in accordance with the provisions of the plan. Under this plan, which is unfunded, directors have an unsecured contractual commitment from the Company.

The Company also has a Deferred Compensation Plan that allows certain highly-compensated employees, including executive officers, to defer salary, annual incentive awards and certain equity-based compensation. As of September 30, 2015, 345 thousand shares were issuable under this plan.

Note 8 — Benefit Plans

The Company has defined benefit pension plans covering certain employees in the United States and certain foreign locations. The Company also provides certain postretirement healthcare and life insurance benefits to qualifying domestic retirees. Other postretirement benefit plans in foreign countries are not material. The measurement date used for the Company’s employee benefit plans is September 30.

Effective April 1, 2014, the Company replaced its current post-65 group medical coverage with a new approach for retirees age 65 and older and their eligible dependents to access post-65 retiree medical and prescription drug coverage in the U.S. Such changes were communicated to active employees and retirees in early January 2014 and as such, the Company remeasured its U.S. postretirement healthcare benefit plan as of January 1, 2014. The impact of this plan change and remeasurement was immaterial to the Company’s consolidated financial results. The plan design changes included, among other modifications, a replacement of the Company-sponsored healthcare coverage program for post-65 retirees with contributions to a health reimbursement account that can be used to purchase coverage through a Medicare insurance exchange.

Effective January 1, 2013, all plan participants’ benefits in the U.S. defined benefit traditional pension plan were converted to a defined benefit cash balance pension plan. Upon conversion, each individual plan participant received an opening balance equal to the actuarial equivalent of individual benefits accrued under the defined benefit traditional pension plan through December 31, 2012. Following conversion, participants accrue benefits under the cash balance plan through monthly pay credits based upon the plan participant’s age and length of service.

Net pension and other postretirement cost for the years ended September 30 included the following components:



	Pension Plans									Other Postretirement Benefits
(Millions of dollars)	2015			2014			2013			2015			2014			2013
Service cost	$	77		$	71		$	84		$	3		$	3		$	6
Interest cost	87			93			87			7			9			10
Expected return on plan assets	(123		)	(126		)	(116		)	—			—			—
Amortization of prior service credit	(15		)	(15		)	(13		)	(5		)	(4		)	(1		)
Amortization of loss	68			49			75			3			2			4
Curtailment/settlement loss	—			3			6			—			—			—
Net pension and postretirement cost	$	93		$	74		$	123		$	9		$	10		$	19

The amounts provided above for amortization of prior service credit and amortization of loss represent the reclassifications of prior service credits and net actuarial losses that were recognized in Accumulated other comprehensive

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

income (loss) in prior periods. Net pension cost attributable to foreign plans included in the preceding table was $32 million, $25 million and $33 million in 2015, 2014 and 2013, respectively.

The settlement losses recorded in 2014 and 2013 included lump sum benefit payments associated with the Company’s U.S. supplemental pension plan. The Company recognizes pension settlements when payments from the supplemental plan exceed the sum of service and interest cost components of net periodic pension cost associated with this plan for the fiscal year. The settlement losses recorded in 2014 and 2013 also included settlements associated with certain foreign plans.

The change in benefit obligation, change in fair value of plan assets, funded status and amounts recognized in the Consolidated Balance Sheets for these plans were as follows:



	Pension Plans						Other Postretirement Benefits
(Millions of dollars)	2015			2014			2015			2014
Change in benefit obligation:
Beginning obligation	$	2,366		$	2,076		$	201		$	243
Service cost	77			71			3			3
Interest cost	87			93			7			9
Plan amendments	(2		)	(1		)	—			(37		)
Benefits paid	(138		)	(142		)	(18		)	(24		)
Benefit obligations assumed in acquisition	67			—			—			—
Actuarial loss (gain)	49			318			(11		)	—
Settlements	—			(7		)	—			—
Other, includes translation	(81		)	(42		)	3			6
Benefit obligation at September 30	2,426			2,366			186			201
Change in fair value of plan assets:
Beginning fair value	1,829			1,785			—			—
Actual return on plan assets	(21		)	119			—			—
Employer contribution	65			104			—			—
Benefits paid	(138		)	(142		)	—			—
Plan assets acquired in acquisition	54			—			—			—
Settlements	—			(7		)	—			—
Other, includes translation	(58		)	(29		)	—			—
Plan assets at September 30	$	1,732		$	1,829		$	—		$	—
Funded Status at September 30:
Unfunded benefit obligation	$	(694	)	$	(537	)	$	(186	)	$	(201	)
Amounts recognized in the Consolidated Balance Sheets at September 30:
Other	$	7		$	3		$	—		$	—
Salaries, wages and related items	(10		)	(8		)	(15		)	(16		)
Long-term Employee Benefit Obligations	(691		)	(531		)	(171		)	(184		)
Net amount recognized	$	(694	)	$	(537	)	$	(186	)	$	(201	)
Amounts recognized in Accumulated other comprehensive income (loss) before income taxes at September 30:
Net transition asset	$	—		$	—		$	—		$	—
Prior service credit	103			119			37			42
Net actuarial loss	(1,124		)	(1,030		)	(30		)	(44		)
Net amount recognized	$	(1,021	)	$	(911	)	$	7		$	(2	)

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

Foreign pension plan assets at fair value included in the preceding table were $575 million and $574 million at September 30, 2015 and 2014, respectively. The foreign pension plan projected benefit obligations were $780 million and $765 million at September 30, 2015 and 2014, respectively. The benefit obligations assumed and plan assets acquired relate to the Company's acquisition of CareFusion. Additional disclosures regarding this acquisition are provided in Note 9.

Pension plans with accumulated benefit obligations in excess of plan assets and plans with projected benefit obligations in excess of plan assets consist of the following at September 30:



	Accumulated Benefit Obligation Exceeds the Fair Value of Plan Assets				Projected Benefit Obligation Exceeds the Fair Value of Plan Assets
(Millions of dollars)	2015		2014		2015		2014
Projected benefit obligation	$	2,339	$	2,267	$	2,394	$	2,324
Accumulated benefit obligation	$	2,265	$	2,186
Fair value of plan assets	$	1,650	$	1,738	$	1,693	$	1,784

The estimated net actuarial loss and prior service credit for pension benefits that will be amortized from Accumulated other comprehensive income (loss) into net pension costs over the next fiscal year are expected to be $(79) million and $15 million, respectively. The estimated net actuarial loss and prior service credit for other postretirement benefits that will be amortized from Accumulated other comprehensive income (loss) into net other postretirement costs over the next fiscal year are expected to be $(2) million and $5 million, respectively.

The weighted average assumptions used in determining pension plan information were as follows:



	2015		2014		2013
Net Cost
Discount rate:
U.S. plans (A)	4.15	%	4.95	%	3.90	%
Foreign plans	3.14		3.87		3.94
Expected return on plan assets:
U.S. plans	7.50		7.75		7.75
Foreign plans	5.45		5.68		5.68
Rate of compensation increase:
U.S. plans (A)	4.25		4.25		4.25
Foreign plans	2.49		2.46		3.28
Benefit Obligation
Discount rate:
U.S. plans (B)	4.15		4.15		4.95
Foreign plans	2.84		3.14		3.87
Rate of compensation increase:
U.S. plans (A)	4.25		4.25		4.25
Foreign plans	2.33		2.49		2.46


(A)	Also used to determine other postretirement and postemployment benefit plan information.


(B)	The discount rates used to determine other postretirement benefit plan information in fiscal years 2015, 2014 and 2013 were 3.95%, 3.85% and 4.40%, respectively. The discount rates used to determine postemployment benefit plan information in fiscal years 2015, 2014 and 2013 were 3.75%, 3.75% and 4.00%, respectively.

Effective September 30, 2015, the approach used to calculate the service and interest components of net periodic benefit cost for benefit plans in the United States was changed to provide a more precise measurement of service and interest costs. Historically, the Company calculated these service and interest components utilizing a single weighted-average discount rate derived from the yield curve used to measure the benefit obligation at the beginning of the period. Going forward, the Company has elected to utilize an approach that discounts the individual expected cash flows using the applicable spot rates derived from the yield curve over the projected cash flow period. For the U.S. benefit plans, the spot rates used to determine service and interest costs ranged from 0.56% to 4.87%. Based on current economic conditions, the Company estimates that the

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

service cost and interest cost for these U.S. benefit plans will be reduced by approximately $18 million in 2016. The financial impact to plans outside the United States was not material. The Company has accounted for this change as a change in accounting estimate that is inseparable from a change in accounting principle and accordingly has accounted for it prospectively.

At September 30, 2015 the assumed healthcare trend rates were 6.8%, gradually decreasing to an ultimate rate of 4.0% beginning in 2024. At September 30, 2014 the assumed healthcare trend rates were 7.0% pre and post age 65, gradually decreasing to an ultimate rate of 5.0% beginning in 2024. A one percentage point increase in assumed healthcare cost trend rates in each year would not materially impact the accumulated postretirement benefit obligation as of September 30, 2015 or the aggregate of the service cost and interest cost components of 2015 annual expense. Similarly, a one percentage point decrease in the assumed healthcare cost trend rates in each year would not materially impact the accumulated postretirement benefit obligation as of September 30, 2015 or the aggregate of the 2015 service cost and interest cost.

Expected Rate of Return on Plan Assets

The expected rate of return on plan assets is based upon expectations of long-term average rates of return to be achieved by the underlying investment portfolios. In establishing this assumption, the Company considers many factors, including historical assumptions compared with actual results; benchmark data; expected returns on various plan asset classes, as well as current and expected asset allocations.

Expected Funding

The Company’s funding policy for its defined benefit pension plans is to contribute amounts sufficient to meet legal funding requirements, plus any additional amounts that may be appropriate considering the funded status of the plans, tax consequences, the cash flow generated by the Company and other factors. The Company does not anticipate any significant required contributions to its pension plans in 2016.

Expected benefit payments are as follows:



(Millions of dollars)	Pension Plans		Other Postretirement Benefits
2016	$	163	$	15
2017	164		15
2018	164		15
2019	177		15
2020	175		15
2021-2025	870		67

As previously discussed, the Company replaced its Company-sponsored healthcare coverage program for post-65 retirees with a health reimbursement plan on April 1, 2014. As such, the Company no longer receives subsidies under the Medicare Prescription Drug Improvement and Modernization Act of 2003.

Investments

The Company’s primary objective is to achieve returns sufficient to meet future benefit obligations. It seeks to generate above market returns by investing in more volatile asset classes such as equities while at the same time controlling risk through diversification in non-correlated asset classes and through allocations to more stable asset classes like fixed income.

U.S. Plans

The Company’s U.S. pension plans comprise 67% of total benefit plan investments, based on September 30, 2015 market values and have a target asset mix of 35% fixed income, 34% diversifying investments and 31% equities. This mix was established based on an analysis of projected benefit payments and estimates of long-term returns, volatilities and correlations for various asset classes. The asset allocations to diversifying investments include high-yield bonds, hedge funds, real estate, infrastructure, commodities, leveraged loans and emerging markets bonds.

The actual portfolio investment mix may, from time to time, deviate from the established target mix due to various factors such as normal market fluctuations, the reliance on estimates in connection with the determination of allocations and normal portfolio activity such as additions and withdrawals. Rebalancing of the asset portfolio on a quarterly basis is required to address any allocations that deviate from the established target allocations in excess of defined allowable ranges. The target

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

allocations are subject to periodic review, including a review of the asset portfolio’s performance, by the named fiduciary of the plans. Any tactical deviations from the established asset mix require the approval of the named fiduciary.

The U.S. plans may enter into both exchange traded and non-exchange traded derivative transactions in order to manage interest rate exposure, volatility, term structure of interest rates, and sector and currency exposures within the fixed income portfolios. The Company has established minimum credit quality standards for counterparties in such transactions.

The following table provides the fair value measurements of U.S. plan assets, as well as the measurement techniques and inputs utilized to measure fair value of these assets, at September 30, 2015 and 2014. The categorization of fund investments is based upon the categorization of these funds’ underlying assets.



(Millions of dollars)	Total U.S. Plan Asset Balances at September 30, 2015		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Fixed Income:
Mortgage and asset-backed securities	$	192	$	—	$	192	$	—
Corporate bonds	240		100		139		—
Government and agency-U.S.	78		53		24		—
Government and agency-Foreign	95		46		49		—
Equity securities	335		75		260		—
Cash and cash equivalents	96		96		—		—
Other	123		30		91		2
Fair value of plan assets	$	1,157	$	401	$	755	$	2



(Millions of dollars)	Total U.S. Plan Asset Balances at September 30, 2014		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Fixed Income:
Mortgage and asset-backed securities	$	150	$	—	$	150	$	—
Corporate bonds	213		105		108		—
Government and agency-U.S.	153		124		29		—
Government and agency-Foreign	126		74		51		—
Equity securities	393		56		337		—
Cash and cash equivalents	26		26		—		—
Other	193		96		93		4
Fair value of plan assets	$	1,255	$	483	$	768	$	4

Fixed Income Securities

U.S. pension plan assets categorized above as fixed income securities include fund investments comprised of mortgage-backed, corporate, government and agency and asset-backed instruments. Mortgage-backed securities consist of residential mortgage pass-through certificates. Investments in corporate bonds are diversified across industry and sector and consist of investment-grade, as well as high-yield debt instruments. U.S. government investments consist of obligations of the U.S. Treasury, other U.S. government agencies, state governments and local municipalities. Assets categorized as foreign government and agency debt securities included investments in developed and emerging markets.

The values of fixed income investments classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. A portion of the fixed income instruments classified within Level 2 are valued based upon estimated prices from independent vendors’ pricing models and these prices are derived from market observable sources including: benchmark yields, reported trades, broker/dealer quotes, issuer spreads, benchmark securities, bids, offers and other market-related data. Values of other instruments classified within Level 2 are based on the corroborated net asset value provided by the fund administrator, which is based on the value of the underlying assets owned by the fund, less its liabilities and then divided by the number of fund units outstanding.

Equity Securities

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

U.S. pension plan assets categorized as equity securities consist of fund investments in publicly-traded U.S. and non-U.S. equity securities. In order to achieve appropriate diversification, these portfolios are invested across market sectors, investment styles, capitalization weights and geographic regions. The values of equity securities classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. The values of equity security investments classified within Level 2 are based on the corroborated net asset value provided by the fund administrator.

Cash and Cash Equivalents

A portion of the U.S. plans’ assets consists of investments in cash and cash equivalents, primarily to accommodate liquidity requirements relating to trade settlement and benefit payment activity, and the values of these assets are based upon quoted market prices.

Other Securities

Other U.S. pension plan assets include fund investments comprised of underlying assets of real estate, infrastructure, commodities and hedge funds. The values of such instruments classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. Investments classified within Level 2 are valued based on the net asset value provided by the fund administrator when such net asset value represents the price at which the pension plan assets could be redeemed at period end. Investments classified within Level 3 are valued based on the net asset value provided by the fund administrator when the pension plan assets could not be redeemed at period end (for example, if the assets are subject to a lock-up period).

The following table summarizes the changes, for the years ended September 30, 2015 and 2014, in the fair value of U.S. pension assets measured using Level 3 inputs:



(Millions of dollars)	Other (Hedge Funds)
Balance at September 30, 2013	$	12
Actual return on plan assets:
Relating to assets held at September 30, 2013	1
Purchases, sales and settlements, net	4
Transfers (out) in from other categories	(13		)
Exchange rate changes	—
Balance at September 30, 2014	$	4
Actual return on plan assets:
Relating to assets held at September 30, 2014	—
Purchases, sales and settlements, net	1
Transfers (out) in from other categories	(3		)
Exchange rate changes	—
Balance at September 30, 2015	$	2

Foreign Plans

Foreign plan assets comprise 33% of the Company’s total benefit plan assets, based on market value at September 30, 2015. Such plans have local independent fiduciary committees, with responsibility for development and oversight of investment policy, including asset allocation decisions. In making such decisions, consideration is given to local regulations, investment practices and funding rules.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

The following table provides the fair value measurements of foreign plan assets, as well as the measurement techniques and inputs utilized to measure fair value of these assets, at September 30, 2015 and 2014.



(Millions of dollars)	Total Foreign Plan Asset Balances at September 30, 2015		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Fixed Income:
Corporate bonds	$	33	$	3	$	30	$	—
Government and agency-U.S.	1		1		—		—
Government and agency-Foreign	101		65		36		—
Other fixed income	48		46		2		—
Equity securities	206		187		19		—
Cash and cash equivalents	8		8		—		—
Real estate	13		—		13		—
Insurance contracts	90		—		—		90
Other	74		53		21		—
Fair value of plan assets	$	575	$	364	$	121	$	90



(Millions of dollars)	Total Foreign Plan Asset Balances at September 30, 2014		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Fixed Income:
Corporate bonds	$	35	$	—	$	35	$	—
Government and agency-U.S.	3		3		—		—
Government and agency-Foreign	100		59		41		—
Other fixed income	47		46		1		—
Equity securities	237		221		17		—
Cash and cash equivalents	15		15		—		—
Real estate	10		—		10		—
Insurance contracts	78		—		—		78
Other	47		12		35		—
Fair value of plan assets	$	574	$	357	$	138	$	78

Fixed Income Securities

Fixed income investments held by foreign pension plans include corporate, U.S. government and non-U.S. government securities. The values of fixed income securities classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. Values of investments classified within Level 2 are based upon estimated prices from independent vendors’ pricing models and these prices are derived from market observable sources.

Equity Securities

Equity securities included in the foreign plan assets consist of publicly-traded U.S. and non-U.S. equity securities. The values of equity securities classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. The values of equity security investments classified within Level 2 are based on the corroborated net asset value provided by the fund administrator.

Other Securities

The foreign plans hold a portion of assets in cash and cash equivalents, in order to accommodate liquidity requirements and the values are based upon quoted market prices. Real estate investments consist of investments in funds holding an interest in real properties and the corresponding values represent the estimated fair value based on the fair value of the underlying

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

investment value or cost, adjusted for any accumulated earnings or losses. The values of insurance contracts approximately represent cash surrender value. Other investments include fund investments for which values are based upon either quoted market prices or market observable sources.

The following table summarizes the changes, for the years ended September 30, 2015 and 2014, in the fair value of foreign pension assets measured using Level 3 inputs:



(Millions of dollars)	Real Estate			Insurance Contracts			Total Assets
Balance at September 30, 2013	$	1		$	81		$	83
Actual return on plan assets:
Relating to assets held at September 30, 2013	—			1			1
Purchases, sales and settlements, net	—			3			3
Transfers (out) in from other categories	(1		)	(2		)	(3		)
Exchange rate changes	—			(6		)	(6		)
Balance at September 30, 2014	$	—		$	78		$	78
Actual return on plan assets:
Relating to assets held at September 30, 2014	—			4			4
Purchases, sales and settlements, net	—			16			16
Transfers in from other categories	—			1			1
Exchange rate changes	—			(9		)	(9		)
Balance at September 30, 2015	$	—		$	90		$	90

Postemployment Benefits

The Company utilizes a service-based approach in accounting for most of its postemployment benefits. Under this approach, the costs of benefits are recognized over the eligible employees’ service period. The Company has elected to delay recognition of actuarial gains and losses that result from changes in assumptions.

Postemployment benefit costs for the years ended September 30 included the following components:



(Millions of dollars)	2015			2014			2013
Service cost	$	18		$	20		$	22
Interest cost	6			7			6
Amortization of prior service credit	(2		)	(2		)	(2		)
Amortization of loss	18			21			21
Net postemployment benefit cost	$	42		$	47		$	47

The changes in benefit obligation for these postemployment benefits were as follows:



	Postemployment benefits
(Millions of dollars)	2015			2014
Change in benefit obligation:
Beginning obligation	$	184		$	186
Service cost	18			20
Interest cost	6			7
Benefits paid	(25		)	(30		)
Actuarial (gain) loss	(22		)	1
Benefit obligation at September 30	$	163		$	184

The postemployment benefit plan obligations as of September 30, 2015 and 2014 were unfunded. The amounts recognized in Accumulated other comprehensive income (loss) before income taxes for the net actuarial loss were $107 million and $145 million at September 30, 2015 and 2014, respectively. The estimated net actuarial loss that will be amortized from the Accumulated other comprehensive income (loss) into postemployment benefit cost over the next fiscal year is $13 million.

During the fourth quarter of fiscal year 2014, the Company recognized a $36 million charge associated with unusually broad and significant workforce reduction actions that were not contemplated when the postemployment benefit plan obligation

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

was measured on September 30, 2013. As of September 30, 2015, the Company’s remaining liability relating to these workforce reductions, reflecting payments, foreign exchange and a change in estimate which decreased the liability by $5 million, was $4 million. During fiscal year 2015, the Company recognized charges of $126 million for employee termination costs substantially in connection with its acquisition of CareFusion. Additional disclosures regarding the CareFusion acquisition are provided in Note 9 and additional disclosures regarding the Company’s restructuring activities that relate to this acquisition are provided in Note 11.

Savings Incentive Plan

The Company has voluntary defined contribution plans covering eligible employees in the United States which provide for a Company match. The cost of these plans was $54 million in 2015, $39 million in 2014 and $36 million in 2013. The fiscal year 2015 increase in the cost associated with these plans is attributable to the Company's acquisition of CareFusion. The Company guarantees employees' contributions to the fixed income fund of one of these plans, which typically consists of high quality bonds, including U.S. government securities, corporate bonds, mortgage-backed and asset-backed securities and cash equivalents. The amount guaranteed was $235 million at September 30, 2015.

Note 9 – Acquisitions

CareFusion Corporation

Overview of Transaction and Consideration Transferred

On March 17, 2015, pursuant to a definitive agreement announced on October 5, 2014, the Company acquired a 100% interest in CareFusion, a global medical technology company with a comprehensive portfolio of products in the areas of medication management, infection prevention, operating room and procedural effectiveness, and respiratory care, to create a global leader in medication management and patient safety solutions. Under the terms of the transaction, CareFusion shareholders received $49.00 in cash and 0.0777 of a share of the Company for each share of CareFusion. The value of the total consideration transferred for accounting purposes was based on the closing share price of the Company’s stock on the last trading day prior to the closing date of the transaction. The fair value of consideration transferred was $12.538 billion and consisted of the components below.



(Millions of dollars)
Cash consideration	$	10,085
Noncash consideration-fair value of shares issued	2,269
Noncash consideration-fair value of stock options and other equity awards	184
Total consideration transferred	$	12,538

The acquisition date fair value of the Company’s ordinary shares issued to CareFusion shareholders was calculated per the following (shares in millions):



(Millions of dollars)
Total CareFusion shares outstanding	205.3
Conversion factor	0.0777
Number of the Company’s shares issued	15.9
Closing price of the Company’s stock on March 16, 2015	$	142.29
Fair value of the Company’s issued shares	$	2,269

Additional disclosures regarding the financing arrangements the Company entered into to fund the cash portion of the consideration transferred relative to this acquisition are provided in Note 15.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

Allocation of Consideration Transferred to Net Assets Acquired

The acquisition was accounted for under the acquisition method of accounting for business combinations. The allocations of the purchase price below represent the estimated fair values of assets acquired and liabilities assumed, based upon the information available as of September 30, 2015. These estimates could be adjusted if further information regarding events or circumstances which existed at the acquisition date becomes available by March 2016. Such adjustments may be significant.

All of the assets acquired and liabilities assumed in this acquisition have been allocated to the Company’s Medical segment.



(Millions of dollars)
Cash and equivalents	$	1,903
Trade receivables, net	530
Inventories	813
Net investment in sales-type leases	1,208
Property, plant and equipment	499
Customer relationships	3,360
Developed technology	2,510
Trademarks	380
Other intangible assets	185
Other assets	321
Total identifiable assets acquired	11,709

Long-term debt	(2,181		)
Deferred tax liabilities	(2,034		)
Other liabilities	(1,299		)
Total liabilities assumed	(5,514		)

Net identifiable assets acquired	6,195

Goodwill	6,343

Net assets acquired	$	12,538

Net Investment in Sales-Type Leases Acquired

The fair value of the net investment in sales-type leases acquired was based upon a determination that the interest rate implicit in the lease contract portfolio represented a market interest rate as well as a determination that the residual value of the overall lease contract portfolio represents fair market value.

Identifiable Intangible Assets Acquired

The customer relationships asset acquired represented CareFusion’s contractual relationships with its customers. The fair value of these customer relationships was determined based on the present value of projected cash flows utilizing an income approach with a risk-adjusted discount rate of 11%. The amortization period of the customer relationships was determined to be 15 years and this period corresponds with the weighted average of lives determined for the product technology which underlies the customer contracts.

The developed technology assets acquired represented CareFusion’s developed technologies in the areas of medication management, infection prevention, operating room and procedural effectiveness, and respiratory care. The technologies’ fair values were determined based on the present value of projected cash flows utilizing an income approach with a risk-adjusted discount rate of 11%. The technologies will be amortized over a weighted-average amortization period of 12 years, which is the weighted average period over which the technologies are expected to generate substantial cash flows.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

The trademark assets acquired represented the value of registered trademarks protecting the intellectual property underlying CareFusion’s product technologies. The fair value of the trademarks represents the present value of projected cash flows, specifically the estimated cost savings from not being required to pay royalties for use of these intellectual properties, utilizing an income approach with a risk-adjusted discount rate of 11%. The trademarks will be amortized over a weighted-average amortization period of 22 years, which is the weighted average period over which the trademarks are expected to generate substantial cash flows.

Other intangible assets acquired included $110 million relating to acquired in-process research and development assets representing development projects relating to various product technologies. The probability of success associated with the projects, based upon the applicable technological and commercial risk, was assumed to be 80% to 85%, depending upon the project. The projects’ fair values were determined based on the present value of projected cash flows utilizing an income approach with a risk-adjusted discount rate of 12%. The launches of the various projects are expected to occur from 2016 to 2022.

Other Liabilities Assumed

The balance of other liabilities assumed included a $36 million liability recorded due to a recall relating to AVEA® ventilators, which is one of CareFusion’s respiratory solutions products. The liability represents the costs expected to be incurred in connection with voluntary field corrections for a portion of the installed base of ventilators.

Goodwill

Goodwill typically results through expected synergies from combining operations of an acquiree and an acquirer, as well as from intangible assets that do not qualify for separate recognition. The goodwill recognized as a result of this acquisition includes, among other things, the value of combining the complementary product portfolios of the Company and CareFusion to offer integrated medication management solutions and smart devices. Synergies are expected from combining the two companies’ products to meet unmet needs in hospitals, hospital pharmacies and alternate sites of care to increase efficiencies, reduce medication administration errors and improve patient and healthcare worker safety. Synergies are also expected to result from solid positions in patient safety to maximize outcomes in infection prevention, respiratory care, and acute care procedural effectiveness. No portion of goodwill from this acquisition is currently expected to be deductible for tax purposes.

Financing, Transaction, Integration and Restructuring Costs

During the year ended September 30, 2015, the Company incurred financing, transaction, integration and restructuring costs which substantially related to the CareFusion acquisition. The financing costs totaled $107 million for the year ended September 30, 2015 and were recorded as Interest expense. Transaction costs of $59 million for the year ended September 30, 2015 were recorded as Acquisition-related costs, and consisted of legal, advisory and other costs.

Acquisition-related costs also included $95 million and $271 million of integration and restructuring costs, respectively, for the year ended September 30, 2015. See Note 11 for further discussion of restructuring activity relating to this acquisition. The Company is in the process of executing its integration plans to combine businesses, sales organizations, systems and locations and, as a result, the Company is expected to continue to incur fairly substantial integration costs through to fiscal year 2016.

Unaudited Pro Forma Information

The acquisition was accounted for under the acquisition method of accounting for business combinations. The operating activities from the acquisition date through March 31, 2015 were not material to the Company’s consolidated results of operations. As such, CareFusion’s operating results were included in the Company’s consolidated results of operations beginning on April 1, 2015. Revenues and Operating Income for the year ended September 30, 2015 include revenues and operating loss attributable to CareFusion of $2 billion and $242 million, respectively.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

The following table provides the pro forma results for the years ended September 30, 2015 and 2014 as if CareFusion had been acquired as of October 1, 2013.



(Millions of dollars, except per share data)
	2015		2014

Revenues	$	12,368	$	12,288

Net Income	$	1,276	$	1,191

Diluted Earnings per Share	$	5.92	$	5.55

The pro forma results above reflect the following adjustments, which were adjusted for the applicable tax impact to derive the net income amounts above:


•	Additional amortization expense related to the fair value of intangible assets acquired;


•	Additional depreciation expense related to the fair value of property, plant and equipment acquired;


•	Additional interest expense and financing costs associated with the Company’s financing arrangements relating to this acquisition, as well as the adjustment to interest expense relating to the fair value of long-term debt assumed;


•	Elimination of one-time financing fees, transaction, integration and restructuring costs incurred relative to this acquisition;


•	Exclusion of the income statement effects of the fair value adjustments to inventory and deferred revenue obligations acquired as such adjustments are not recurring in nature.

The pro forma results do not include any anticipated cost savings or other effects of the planned integration of CareFusion. Accordingly, the pro forma results above are not necessarily indicative of the results that would have been if the acquisition had occurred on the dates indicated, nor are the pro forma results indicative of results which may occur in the future.

Other Transactions

During the first quarter of fiscal year 2015, the Company acquired GenCell Biosystems (“GenCell”), a privately-held Irish biotechnology company that has developed proprietary technologies that address key biological analysis protocols including library preparation of Next Generation Sequencing and genotyping applications. During the second quarter of fiscal year 2015, the Company acquired CRISI, a San Diego-based medical technology company dedicated to improving the safety and delivery of IV injectable medications. During the third quarter of fiscal year 2015, the Company acquired the ARX group of companies (“ARX”), a leading pharmacy automation distributor in Western Europe. During the fourth quarter of fiscal year 2015, the Company acquired Cellular Research, Inc. (“Cellular Research”), a biotechnology research and development company that has developed advanced tools for massively parallel single cell genetic analysis based on their proprietary Molecular Indexing^TM technology to enable gene expression profiles from single cells.

During the second quarter of fiscal year 2014, the Company acquired Alverix, Inc. ("Alverix"), a privately-held diagnostic instrument company known for its optoelectronics expertise. During the first quarter of fiscal year 2013, the Company acquired Safety Syringes, Inc., a privately held California-based company that specializes in the development of anti-needlestick devices for prefilled syringes. During the second quarter of fiscal year 2013, the Company acquired Cato Software Solutions, a privately held Austria-based manufacturer of cato® and chemocato® software, a suite of comprehensive medication safety solutions for pharmacy intravenous medication preparation, physician therapy planning and nurse bedside documentation.

Note 10 — Divestiture

On October 31, 2012, the Company completed the sale of its Life Sciences—Discovery Labware unit, excluding its Advanced Bioprocessing platform. Gross cash proceeds from the sale were approximately $740 million, subject to post-closing adjustments. Total gross proceeds included a payment of approximately $16 million received in the third quarter of fiscal year 2013 as reimbursement of additional tax costs incurred by the Company as a result of the buyer’s treatment of the acquisition as an asset purchase for federal tax purposes. The Company recognized a pre-tax gain on sale from this divestiture of $577

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

million. The after-tax gain recognized from this divestiture was $355 million. As a result of this divestiture, the Company derecognized $17 million of goodwill, allocated based upon the relative fair values of the disposed assets.

The Company agreed to perform some contract manufacturing and other transition services for a defined period after the sale; however, the Company did not have the ability to exert significant influence over the Discovery Labware disposal group after the sale, and cash flows associated with these activities were not material. The net cash flows from these activities are reported in the Consolidated Statements of Income as Other income (expense), net.

The results of operations associated with the Discovery Labware disposal group are reported as discontinued operations for all periods presented in the accompanying Consolidated Statements of Income and Cash Flows and related disclosures.

Results of discontinued operations were as follows:



(Millions of dollars)	2015		2014		2013
Revenues	$	—	$	—	$	20
Income from discontinued operations before income taxes	—		—		586
Less income tax provision	—		—		222
Income from discontinued operations, net	$	—	$	—	$	364

Note 11 — Business Restructuring Charges

In connection with the CareFusion acquisition, the Company incurred restructuring costs throughout fiscal year 2015, which were recorded as Acquisition-related costs. Restructuring accrual activity in 2015 was as follows:




(Millions of dollars)		Employee Termination			Share-Based Compensation			Other (A)			Total
Balance at September 30, 2014	$	—		$	—		$	—		$	—
Assumed liability		19			—			—			19
Charged to expense		126			44			102			271
Cash payments		(74	)		—			(20	)		(94	)
Non-cash settlements		—			(44	)		—			(44	)
Other adjustments		(9	)		—			(81	)		(91	)
Balance at September 30, 2015	$	62		$	—		$	—		$	62


(A)	Amounts primarily relate to impairment charges for assets held for sale, primarily assets that will be sold as a result of an information technology infrastructure outsourcing project the Company will initiate in fiscal year 2016. Additional disclosures regarding these asset impairment charges are provided in Note 14.

Additional disclosures regarding these restructuring activities and the related costs are provided in Notes 7, 8 and 9.

Table of Contents

Note 12 — Intangible Assets

Intangible assets at September 30 consisted of:



	2015				2014
(Millions of dollars)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Amortized intangible assets
Customer relationships	$	3,370	$	120	$	10	$	2
Developed technology	3,487		510		893		379
Product rights	128		35		148		31
Trademarks	405		26		27		19
Patents and other	333		212		232		163
Amortized intangible assets	$	7,723	$	903	$	1,308	$	594

Unamortized intangible assets
Acquired in-process research and development	$	203			$	44
Trademarks	2				2
Unamortized intangible assets	$	205			$	46

Additional information regarding the increases to the intangible asset classes detailed above as a result of the CareFusion acquisition is provided in Note 9. The increase to developed technology assets additionally included $49 million of assets recognized upon the Company’s acquisition of CRISI in the second quarter of fiscal year 2015 as well as $42 million recognized upon the Company's acquisition of Cellular Research in the fourth quarter of fiscal year 2015. The increase in acquired in-process research and development project assets additionally included $81 million of assets recognized upon the Company’s acquisition of GenCell in the first quarter of fiscal year 2015 and $19 million of assets recognized upon the acquisition of Cellular Research. These increases were partially offset by the reclassification to Developed Technology, Net of $42 million, in the fourth quarter of fiscal year 2015, due to the Company's completion of project assets recognized upon its second quarter fiscal year 2011 acquisition of Accuri Cytometers, Inc.

Intangible amortization expense was $346 million, $84 million and $83 million in 2015, 2014 and 2013, respectively. The estimated aggregate amortization expense for the fiscal years ending September 30, 2016 to 2020 are as follows: 2016 — $558 million; 2017 — $535 million; 2018 — $523 million; 2019 — $519 million; 2020 — $518 million.

The following is a reconciliation of goodwill by business segment:



(Millions of dollars)	Medical				Life Sciences				Total
Goodwill as of September 30, 2013	$	511			$	598			$	1,109
Acquisitions	—				13			(A)	13
Currency translation/other (B)	(29		)		(3		)		(32		)
Goodwill as of September 30, 2014	$	482			$	608			$	1,090
Acquisitions	6,585			(C)	130			(D)	6,716
Currency translation/other (B)	(261		)		(8		)		(269		)
Goodwill as of September 30, 2015	$	6,807			$	730			$	7,537


(A)	Represents goodwill recognized upon the Company’s acquisition of Alverix in the second quarter of fiscal year 2014.


(B)	Includes amounts resulting from foreign currency translation as well as acquisition accounting adjustments.

(C)

Primarily represents goodwill recognized upon the Company’s acquisition of CareFusion in the second quarter of fiscal year 2015. Additional disclosures regarding the CareFusion acquisition are provided in Note 9. Also includes $22 million of goodwill associated with individually immaterial acquisitions, including the CRISI and ARX acquisitions in the second and third quarters of fiscal year 2015, respectively.


(D)	Represents goodwill recognized upon the Company’s acquisitions of GenCell and Cellular Research in the first and fourth quarters of fiscal year 2015, respectively.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

Note 13 — Derivative Instruments and Hedging Activities

The Company uses derivative instruments to mitigate certain exposures. The effects these derivative instruments and hedged items have on financial position, financial performance, and cash flows are provided below.

Foreign Currency Risks and Related Strategies

The Company has foreign currency exposures throughout Europe, Greater Asia, Canada and Latin America. Transactional currency exposures that arise from entering into transactions, generally on an intercompany basis, in non-hyperinflationary countries that are denominated in currencies other than the functional currency are mitigated primarily through the use of forward contracts and currency options. Hedges of the transactional foreign exchange exposures resulting primarily from intercompany payables and receivables are undesignated hedges. As such, the gains or losses on these instruments are recognized immediately in income. The offset of these gains or losses against the gains and losses on the underlying hedged items, as well as the hedging costs associated with the derivative instruments, is recognized in Other income (expense), net.

The total notional amounts of the Company’s outstanding foreign exchange contracts as of September 30, 2015 and 2014 were $2.2 billion and $1.8 billion, respectively.

Interest Rate Risks and Related Strategies

The Company’s primary interest rate exposure results from changes in U.S. dollar interest rates. The Company’s policy is to manage interest cost using a mix of fixed and variable rate debt. The Company periodically uses interest rate swaps to manage such exposures. Under these interest rate swaps, the Company exchanges, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. These swaps are designated as either fair value or cash flow hedges.

For interest rate swaps designated as fair value hedges (i.e., hedges against the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that is attributable to a particular risk), changes in the fair value of the interest rate swaps offset changes in the fair value of the fixed rate debt due to changes in market interest rates.

Changes in the fair value of the interest rate swaps designated as cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk) are offset by amounts recorded in Other comprehensive income (loss). If interest rate derivatives designated as cash flow hedges are terminated, the balance in Accumulated other comprehensive income (loss) attributable to those derivatives is reclassified into earnings over the remaining life of the hedged debt. The net realized loss related to terminated interest rate swaps expected to be reclassified and recorded in Interest expense within the next 12 months is $6 million, net of tax. The Company had no outstanding interest rate swaps designated as cash flow hedges as of September 30, 2015 and 2014.

The total notional amount of the Company’s outstanding interest rate swaps designated as fair value hedges was $375 million at September 30, 2015 and 2014. The outstanding swaps represent fixed-to-floating interest rate swap agreements the Company entered into, in March and September 2014, to convert the interest payments on $375 million of the Company’s 3.125% notes, due November 8, 2021, from the fixed rate to a floating interest rate based on LIBOR. Changes in the fair value of the interest rate swaps offset changes in the fair value of the fixed rate debt. The gain recorded on these fair value hedges and the offsetting loss recorded on the underlying debt instrument was $19 million and $3 million at September 30, 2015 and 2014, respectively.

Other Risk Exposures

The Company purchases resins, which are oil-based components used in the manufacture of certain products. Significant increases in world oil prices that lead to increases in resin purchase costs could impact future operating results. From time to time, the Company has managed price risks associated with these commodity purchases through commodity derivative forward contracts. In April 2015, the Company entered into cash-settled forward contracts to hedge approximately 13% of its expected global resin purchase volumes throughout fiscal years 2015 and 2016. These contracts were designated as cash flow hedges and the total notional amount of these contracts at September 30, 2015 was 49 million pounds ($25 million). The Company had no outstanding commodity derivative contracts designated as cash flow hedges as of September 30, 2014.

Effects on Consolidated Balance Sheets

The location and amounts of derivative instrument fair values in the consolidated balance sheet are segregated below between designated, qualifying hedging instruments and ones that are not designated for hedge accounting.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company



(Millions of dollars)	September 30, 2015		September 30, 2014
Asset derivatives-designated for hedge accounting
Interest rate swaps	$	19	$	3
Asset derivatives-undesignated for hedge accounting
Forward exchange contracts	$	13	$	20
Total asset derivatives (A)	$	32	$	23

Liability derivatives-designated for hedge accounting
Commodity forward contracts	$	10	$	—
Liability derivatives-undesignated for hedge accounting
Forward exchange contracts	$	21	$	14
Total liability derivatives (B)	$	30	$	14


(A)	All asset derivatives are included in Prepaid expenses, deferred taxes and other.


(B)	All liability derivatives are included in Accrued expenses.

Effects on Consolidated Statements of Income

Cash flow hedges

After-tax losses of $16 million were recognized in Other comprehensive income (loss) in 2015. These losses included a $7 million loss relating to the commodity forward contracts entered into in April 2015 to hedge the risk associated with resin purchases. These losses also included $8 million attributable to interest rate swaps with a total notional amount of $2.3 billion that were entered into during the first quarter of fiscal year 2015 to partially hedge interest rate risk associated with the anticipated issuance of senior unsecured notes in connection with the Company’s acquisition of CareFusion. These swaps were designated as hedges of the variability in interest payments attributable to changes in the benchmark interest rate during the period preceding the Company’s issuance of the notes. The swaps were terminated at losses, concurrent with the pricing of notes issued in December 2014, and the realized losses will be amortized over the lives of the notes with an offset to Interest expense. Additional disclosures regarding amounts recognized in the consolidated statements of income in fiscal years 2015, 2014 and 2013 relating to cash flow hedges are provided in Note 3. Additional disclosures regarding the acquisition of CareFusion are provided in Note 9 and additional disclosures regarding the Company’s debt issuance during the first quarter of fiscal year 2015 are provided in Note 15.

The Company’s designated derivative instruments are highly effective. As such, there were no gains or losses, related to hedge ineffectiveness or amounts excluded from hedge effectiveness testing, recognized immediately in income relative to derivative contracts outstanding in the periods presented.

Undesignated hedges

The location and amount of gains and losses recognized in income on derivatives not designated for hedge accounting for the years ended September 30 were as follows:



Derivatives Not Designated as For Hedge Accounting	Location of Gain (Loss) Recognized in Income on Derivatives	Amount of Gain (Loss) Recognized in Income on Derivative (Millions of dollars)
Derivatives Not Designated as For Hedge Accounting	Location of Gain (Loss) Recognized in Income on Derivatives	2015			2014			2013
Forward exchange contracts (A)	Other income (expense), net	$	(49	)	$	(3	)	$	(1	)


(A)	The gains and losses on forward contracts and currency options utilized to hedge the intercompany transactional foreign exchange exposures are largely offset by gains and losses on the underlying hedged items in Other income (expense), net.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

Note 14 — Financial Instruments and Fair Value Measurements

Recurring Fair Value Measurements

The fair values of financial instruments, including those not recognized on the statement of financial position at fair value, carried at September 30, 2015 and 2014 are classified in accordance with the fair value hierarchy in the following tables:



			Basis of Fair Value Measurement
(Millions of dollars)	September 30, 2015 Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets
Institutional money market investments	$	147	$	147	$	—	$	—
Interest rate swaps	19		—		19		—
Forward exchange contracts	13		—		13		—
Total Assets	$	179	$	147	$	32	$	—
Liabilities
Forward exchange contracts	$	21	$	—	$	21	$	—
Commodity forward contracts	10		—		10		—
Contingent consideration liabilities	77		—		—		77
Total Liabilities	$	108	$	—	$	30	$	77



			Basis of Fair Value Measurement
(Millions of dollars)	September 30, 2014 Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets
Institutional money market investments	$	1,040	$	1,040	$	—	$	—
Interest rate swaps	3		—		3		—
Forward exchange contracts	20		—		20		—
Total Assets	$	1,063	$	1,040	$	23	$	—
Liabilities
Forward exchange contracts	$	14	$	—	$	14	$	—
Contingent consideration liabilities	14		—		—		14
Total Liabilities	$	29	$	—	$	14	$	14

The Company’s institutional money market accounts permit daily redemption and the fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions. The Company’s remaining cash equivalents were $1.277 billion and $821 million at September 30, 2015 and 2014, respectively. Short-term investments are held to their maturities and are carried at cost, which approximates fair value. The cash equivalents consist of liquid investments with a maturity of three months or less and the short-term investments consist of instruments with maturities greater than three months and less than one year.

The Company measures the fair value of forward exchange contracts and interest rate swaps based upon the present value of expected future cash flows using market-based observable inputs including credit risk, interest rate yield curves, foreign currency spot prices and forward prices.

Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments, which are considered Level 2 inputs in the fair value hierarchy. The fair value of long-term debt was $11.6 billion and $4.1 billion at September 30, 2015 and 2014, respectively. During the third quarter of fiscal

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

year 2015, the Company reclassified $750 million of floating rates due on June 15, 2016 from Long-Term Debt to Short-term debt. The fair value of these notes was $750 million at September 30, 2015.

The contingent consideration liabilities were recognized as part of the consideration transferred by the Company for certain acquisitions. Additional disclosures regarding these acquisitions are included in Note 9. The fair values of the contingent consideration liabilities were estimated using probability-weighted discounted cash flow models that were based upon the probabilities assigned to the contingent events. The estimated fair values of the contingent consideration liabilities are remeasured at each reporting period based upon increases or decreases in the probability of the contingent payments. The increase to the total contingent consideration liability in fiscal year 2015 was mostly attributable to the recognition of contingent consideration liabilities of $36 million and $28 million in connection with the Company’s acquisitions of GenCell and Cellular Research in the first and fourth quarters, respectively.

The Company’s policy is to recognize any transfers into fair value measurement hierarchy levels and transfers out of levels at the beginning of each reporting period. There were no transfers in and out of Level 1, Level 2 or Level 3 measurements for the years ending September 30, 2015 and 2014.

Nonrecurring Fair Value Measurements

In the fourth quarter of fiscal year 2015, the Company recorded impairment charges of $72 million to Acquisition-related costs relating to assets held for sale. These asset impairment charges were recorded to adjust the carrying amounts of the assets held for sale to an estimate of the assets' fair values, less the estimated costs to sell these assets. The fair values of these assets were estimated, based upon a market participant's perspective, using a market approach and Level 2 inputs, including quoted prices for similar assets. The remaining carrying amounts of the assets held for sale are immaterial to the Company's consolidated balance sheet. Additional disclosures regarding these asset impairment charges are provided in Note 11.

Concentration of Credit Risk

The Company maintains cash deposits in excess of government-provided insurance limits. Such cash deposits are exposed to loss in the event of nonperformance by financial institutions. Substantially all of the Company’s trade receivables are due from public and private entities involved in the healthcare industry. Due to the large size and diversity of the Company’s customer base, concentrations of credit risk with respect to trade receivables are limited. The Company does not normally require collateral. The Company is exposed to credit loss in the event of nonperformance by financial institutions with which it conducts business. However, this loss is limited to the amounts, if any, by which the obligations of the counterparty to the financial instrument contract exceed the obligations of the Company. The Company also minimizes exposure to credit risk by dealing with a diversified group of major financial institutions.

The Company continually evaluates its accounts receivables for potential collection risks particularly those resulting from sales to government-owned or government-supported healthcare facilities in certain countries as payment may be dependent upon the financial stability and creditworthiness of those countries’ national economies. The Company continually evaluates all governmental receivables for potential collection risks associated with the availability of government funding and reimbursement practices. The Company believes the current reserves related to all governmental receivables are adequate and that this concentration of credit risk will not have a material adverse impact on its financial position or liquidity.

Note 15 — Debt

Short-term debt at September 30 consisted of:



(Millions of dollars)	2015		2014
Loans Payable
Domestic	$	700	$	200
Foreign	—		3
Current portion of long-term debt	752		—
	$	1,452	$	203

The weighted average interest rates for short-term debt were 0.64% and 0.40% at September 30, 2015 and 2014, respectively. Domestic loans payable consist of a commercial paper program the Company entered into in January 2015, in anticipation of the closing of the CareFusion acquisition, which is further discussed in Note 9. Under the program, the Company may issue up to $1 billion in short-term, unsecured commercial paper notes. A former commercial paper program which had been in place to meet short-term financing needs was terminated in February 2015 and the outstanding borrowings of

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

$200 million under the former program were rolled into the new commercial paper program. Borrowings of $700 million were outstanding under the current commercial paper program at September 30, 2015, of which $500 million was used to finance the Company’s acquisition of CareFusion and to pay related fees and expenses. Foreign loans payable consisted of short-term borrowings from financial institutions. The current portion of long-term debt includes $750 million of floating rates notes due on June 15, 2016. These floating rate notes, as well as additional senior unsecured notes, were issued in December 2014 as part of the Company's plan for financing the cash requirements relative to the CareFusion acquisition. The total aggregate principal amount of senior unsecured notes issued in December 2014 was $6.2 billion.

Also in December 2014, the Company entered into a 364-day term loan agreement that provided for a $1 billion term loan facility, the proceeds under which could only be used to pay the cash consideration due pursuant to the CareFusion acquisition agreement, as well as to pay financing fees, other related fees and other expenses associated with the CareFusion acquisition. At September 30, 2015, the term loan was fully repaid with no borrowings outstanding, reflecting principal payments of $650 million, $250 million and $100 million made in April, July and September 2015, respectively.

Concurrent with the execution of the agreement to acquire CareFusion, the Company secured $9.1 billion of fully committed bridge financing to ensure its ability to fund the cash portion of consideration due under the agreement, as well as to pay fees and expenses related to the acquisition. This bridge credit agreement was terminated upon the closing of the CareFusion acquisition in March 2015.

The Company has available a $1 billion syndicated credit facility. This credit facility, under which there were no borrowings outstanding at September 30, 2015, provides backup support for its commercial paper program and can also be used for other general corporate purposes. It includes a provision that enables the Company, subject to additional commitments made by the lenders, to access up to an additional $500 million in financing through the facility, for a maximum aggregate commitment of $1.5 billion. During the third quarter of fiscal year 2014, the Company extended the expiration date of this credit facility to May 2018 from the original expiration date of May 2017. The credit facility includes a single financial covenant that requires the Company to maintain an interest expense coverage ratio (ratio of earnings before income taxes, depreciation and amortization to interest expense) of not less than 5-to-1 for the most recent four consecutive fiscal quarters. The Company was in compliance with this covenant as of September 30, 2015. In addition, the Company has informal lines of credit outside of the United States.

Upon the closing of the CareFusion acquisition in March 2015, the Company assumed the indebtedness of CareFusion, including senior unsecured notes with an aggregate principal amount of $2 billion, which was recorded on the acquisition date at a fair value of $2.174 billion. In March 2015, subsequent to closing the acquisition of CareFusion, the Company commenced offers to exchange all validly tendered and accepted notes issued by CareFusion for notes to be issued by the Company. This offer expired in April 2015 and the aggregate principal amounts below of each series of the CareFusion notes were validly tendered and exchanged for notes issued by the Company.



	Aggregate Principal Amount		Percentage of Total Outstanding Principal Amount of such Series of Existing Notes
Interest Rate and Maturity	(Millions of dollars)
1.450% Notes due May 15, 2017	$	293	97.64	%
6.375% Notes due August 1, 2019	665		95.00	%
3.300% Notes due March 1, 2023	294		97.95	%
3.875% Notes due May 15, 2024	397		99.37	%
4.875% Notes due May 15, 2044	300		99.96	%
Total senior notes issued under exchange transaction	$	1,949

This exchange transaction was accounted for as a modification of the original debt instruments. As such, no gain or loss was recognized in the Company’s consolidated results of operations as a result of this exchange transaction. Following the exchange of the notes, the aggregate principal amount of CareFusion notes that remain outstanding across the five series is $51 million.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

Long-Term Debt at September 30 consisted of:



(Millions of dollars)	2015			2014
1.750% Notes due November 8, 2016	$	499		$	499
1.450% Notes due May 15, 2017	300		(A)	—
1.800% Notes due December 15, 2017	1,246		(B)	—
4.900% Notes due April 15, 2018	202			202
5.000% Notes due May 15, 2019	497			497
6.375% Notes due August 1, 2019	802		(A)	—
2.675% Notes due December 15, 2019	1,244		(B)	—
3.250% Notes due November 12, 2020	697			697
3.125% Notes due November 8, 2021	1,013			997
3.300% Notes due March 1, 2023	305		(A)	—
3.875% Notes due May 15, 2024	419		(A)	—
3.734% Notes due December 15, 2024	1,739		(B)	—
7.000% Debentures due August 1, 2027	168			168
6.700% Debentures due August 1, 2028	167			167
6.000% Notes due May 15, 2039	246			246
5.000% Notes due November 12, 2040	296			296
4.875% Notes due May 15, 2044	334		(A)	—
4.685% Notes due December 15, 2044	1,190		(B)	—
Other long-term debt	5			$	—
	$	11,370		$	3,768


(A)	Represents senior unsecured notes issued in the April 2015 exchange of all validly tendered and accepted CareFusion notes for notes issued by the Company, as further discussed above.


(B)	Represents senior unsecured notes issued in December 2014 in connection with the CareFusion acquisition, as further discussed above.

The aggregate annual maturities of long-term debt during the fiscal years ending September 30, 2016 to 2020 are as follows: 2016 — $750; 2017 — $800; 2018 — $1.45 billion; 2019 — $1.2 billion; 2020 — $1.25 billion.

The Company capitalizes interest costs as a component of the cost of construction in progress. A summary of interest costs and payments for the years ended September 30 is as follows:



(Millions of dollars)	2015		2014		2013
Charged to operations	$	371	$	135	$	138
Capitalized	30		32		33
Total interest costs	$	401	$	167	$	171
Interest paid, net of amounts capitalized	$	313	$	135	$	143

The amounts of interest charged to operations and interest paid include $107 million of financing costs associated with the CareFusion acquisition, including interest on the senior unsecured notes issued in December 2014 and commitment fees for the bridge loan facility entered into concurrently with the execution of the agreement to acquire CareFusion. Additional information regarding these costs is provided in Note 9.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

Note 16 — Income Taxes

The provision for income taxes from continuing operations for the years ended September 30 consisted of:



(Millions of dollars)	2015			2014			2013
Current:
Federal	$	50		$	225		$	177
State and local, including Puerto Rico	15			(11		)	(4		)
Foreign	252			217			179
	$	318		$	431		$	352
Deferred:
Domestic	$	(238	)	$	(59	)	$	(119	)
Foreign	(37		)	(35		)	3
	(274		)	(94		)	(116		)
	$	44		$	337		$	236

The components of Income From Continuing Operations Before Income Taxes for the years ended September 30 consisted of:



(Millions of dollars)	2015			2014		2013
Domestic, including Puerto Rico	$	(408	)	$	532	$	288
Foreign	1,147			990		877
	$	739		$	1,522	$	1,165

Deferred tax assets and liabilities are netted on the balance sheet by separate tax jurisdictions. At September 30, 2015 and 2014, net current deferred tax assets of $387 million and $355 million, respectively, were included in Prepaid expenses, deferred taxes and other. Net non-current deferred tax assets of $142 million and $100 million, respectively, were included in Other Assets. Net current deferred tax liabilities of $5 million and $10 million, respectively, were included in Current Liabilities — Income taxes. Net non-current deferred tax liabilities of $1.951 billion and $130 million, respectively, were included in Deferred Income Taxes and Other. Deferred taxes are not provided on undistributed earnings of foreign subsidiaries that are indefinitely reinvested. At September 30, 2015, the cumulative amount of such undistributed earnings indefinitely reinvested outside the United States was $7.5 billion. Determining the tax liability that would arise if these earnings were remitted is not practicable. Deferred taxes are provided for earnings outside the United States when those earnings are not considered indefinitely reinvested.

The table below summarizes the gross amounts of unrecognized tax benefits without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such unrecognized tax benefits were settled. The Company expects no significant increases or decreases in the amount of the unrecognized tax benefits to occur within the next twelve months.



(Millions of dollars)	2015			2014			2013
Balance at October 1	$	197		$	146		$	134
Increase due to acquisitions	314			—			—
Increase due to current year tax positions	58			51			80
Increase due to prior year tax positions	17			9			25
Decreases due to prior year tax positions	—			—			—
Decrease due to settlements and lapse of statute of limitations	(11		)	(9		)	(93		)
Balance at September 30	$	575		$	197		$	146

With the acquisition of CareFusion on March 17, 2015, the Company is now a party to a tax matters agreement with Cardinal Health resulting from Cardinal Health's spin-off of CareFusion in fiscal year 2010. Under the tax matters agreement, the Company is obligated to indemnify Cardinal Health for certain tax exposures and transaction taxes prior to CareFusion’s spin-off from Cardinal Health. The indemnification payable is approximately $217 million at September 30, 2015 and is included in Deferred Income Taxes and Other on the Consolidated Balance Sheet.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

The total amount of unrecognized tax benefits, if recognized, would favorably impact the effective tax rate. Accrued interest and penalties of $84 million, $10 million and $8 million at September 30, 2015, 2014 and 2013, respectively, are not included in the table above. During the fiscal years ended September 30, 2015, 2014 and 2013, the Company reported interest and penalties associated with unrecognized tax benefits of $8 million, $2 million and $2 million on the Consolidated Statements of Income as a component of Income tax provision.

The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of tax jurisdictions. The IRS has completed its audit for the tax years through 2011. For the Company’s other major tax jurisdictions where it conducts business, the Company’s tax years are generally open after 2009.

Deferred income taxes at September 30 consisted of:



	2015					2014 (A)
(Millions of dollars)	Assets			Liabilities		Assets			Liabilities
Compensation and benefits	$	647		$	—	$	546		$	—
Property and equipment	—			156		—			196
Intangibles	—			2,033		—			266
Loss and credit carryforwards	538			—		274			—
Other	634			606		398			195
	1,819			2,795		1,218			656
Valuation allowance	(452		)	—		(247		)	—
	$	1,367		$	2,795	$	971		$	656

(A)Certain amounts in the prior-year presentation have been reclassified to conform to the current-year presentation.

Generally, deferred tax assets have been established as a result of net operating losses and credit carryforwards with expiration dates from 2016 to an unlimited expiration date. Valuation allowances have been established as a result of an evaluation of the uncertainty associated with the realization of certain deferred tax assets on these losses and credit carryforwards. The valuation allowance for 2015 is primarily the result of foreign losses due to the Company’s global re-organization of its foreign entities and these generally have no expiration date. Valuation allowances are also maintained with respect to deferred tax assets for certain federal and state carryforwards that may not be realized and that principally expire between 2016 and 2019.

A reconciliation of the federal statutory tax rate to the Company’s effective tax rate was as follows:



	2015		2014		2013
Federal statutory tax rate	35.0	%	35.0	%	35.0	%
State and local income taxes, net of federal tax benefit	(3.6	)	(0.5	)	(1.2	)
Effect of foreign and Puerto Rico earnings and foreign tax credits	(24.5	)	(11.2	)	(9.7	)
Effect of Research Credits and Domestic Production Activities,	(1.6	)	(1.1	)	(3.8	)
Other, net	0.6		(0.1	)	(0.1	)
	5.9	%	22.1	%	20.2	%

The approximate amounts of tax reductions related to tax holidays in various countries in which the Company does business were $102 million, $108 million and $95 million, in 2015, 2014 and 2013, respectively. The tax holidays expire at various dates through 2026.

The Company made income tax payments, net of refunds, of $240 million in 2015, $330 million in 2014 and $454 million in 2013.

Note 17 — Sales-Type Leases and Financing Receivables

As disclosed in Note 9, the net assets acquired in the Company’s acquisition of CareFusion included a $1.208 billion net investment in sales-type leases which primarily arose from the leasing of dispensing equipment. The components of the net investment in sales-type leases, which predominantly have five-year terms and are generally collateralized by the underlying equipment, are as follows as of September 30, 2015.

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company



	September 30,
(Millions of dollars)	2015
Future minimum lease payments receivable	$	1,311
Unguaranteed residual values	29
Unearned income	(142		)
Allowance for uncollectible minimum lease payments receivable	(5		)
Net Investment in Sales-Type Leases	1,193
Less: Current portion of net investment in sales-type leases	75
Net Investment in Sales-Type Leases, Less Current Portion	$	1,118

Future minimum lease payments to be received pursuant to sales-type leases are as follows: 2016 — $413 million; 2017 — $355 million; 2018 — $275 million; 2019 — $187 million; 2020 — $79 million and an aggregate of $3 million thereafter.

The methodology for determining the allowance for credit losses for these financing receivables is based on the collective population and is not stratified by class or portfolio segment. Allowances for credit losses on the entire portfolio are recorded based on historical experience loss rates and the potential impact of anticipated changes in business practices, market dynamics, and economic conditions. The net investment in sales-type leases is predominantly evaluated for impairment on a collective basis; however, some immaterial allowances for individual balances are recorded based on the evaluation of customers’ specific circumstances. No interest is accrued on past due financing receivables, which are generally considered past due 30 days after the billing date. Amounts are written off against the allowance for credit losses when determined to be uncollectible. The allowance for credit losses on these financing receivables was immaterial at September 30, 2015.

Note 18 — Supplemental Financial Information

Other Income (Expense), Net

Other income (expense), net in 2015 was $21 million, which primarily included equity investment net income and proceeds from the sales of investments of $9 million, an acquisition-date accounting gain of $9 million on the previously held investment in CRISI, as disclosed in Note 6, and income from license and other agreements of $2 million.

Other income (expense), net in 2014 was $5 million, which primarily included equity investment net income and proceeds from the sales of investments of $13 million and income from license and other agreements of $3 million. Other income (expense), net in 2014 also included income of $3 million from contract manufacturing and other transition services relating to the Company’s sale of Discovery Labware in the first quarter of fiscal year 2013. Additional disclosures regarding this divestiture are included in Note 10. These amounts were partially offset by foreign exchange losses (inclusive of hedging costs) of $(13) million.

Other income (expense), net in 2013 was $9 million, which primarily included income of $11 million from contract manufacturing and other transition services relating to the sale of Discovery Labware, equity investment net income and proceeds from investments of $5 million and income from license and other agreements of $3 million. These amounts were partially offset by foreign exchange losses (inclusive of hedging costs) of $(10) million.

Trade Receivables, Net

The amounts recognized in 2015, 2014 and 2013 relating to allowances for doubtful accounts and cash discounts, which are netted against trade receivables, are provided in the following table:

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company



(Millions of dollars)	Allowance for Doubtful Accounts				Allowance for Cash Discounts			Total
Balance at September 30, 2012	$	36			$	9		$	45
Additions charged to costs and expenses	9				40			49
Deductions and other	(3		)	(A)	(41		)	(44		)
Balance at September 30, 2013	$	41			$	9		$	50
Additions charged to costs and expenses	6				41			46
Deductions and other	(16		)	(A)	(38		)	(54		)
Balance at September 30, 2014	$	30			$	12		$	42
Additions charged to costs and expenses	33				47			80
Deductions and other	(11		)	(A)	(50		)	(61		)
Balance at September 30, 2015	$	53			$	9		$	62


(A)	Accounts written off.

Inventories

Inventories at September 30 consisted of:



(Millions of dollars)	2015		2014
Materials	$	384	$	248
Work in process	280		260
Finished products	1,295		987
	$	1,959	$	1,495

Property, Plant and Equipment, Net

Property, Plant and Equipment, Net at September 30 consisted of:



(Millions of dollars)	2015		2014
Land	$	146	$	93
Buildings	2,414		2,313
Machinery, equipment and fixtures	5,602		5,271
Leasehold improvements	114		88
	8,277		7,765
Less accumulated depreciation and amortization	4,217		4,160
	$	4,060	$	3,605

Table of Contents

Notes to Consolidated Financial Statements — (Continued)

Becton, Dickinson and Company

SUPPLEMENTARY DATA (UNAUDITED)



Millions of dollars, except per share amounts	2015
	1^st		2^nd		3^rd		4^th		Year
Revenues	$	2,051	$	2,051	$	3,120	$	3,059	$	10,282
Gross Profit	1,045		1,046		1,174		1,430		4,695
Net Income	236		216		62		181		695
Earnings per Share:
Basic	1.22		1.10		0.30		0.86		3.43
Diluted	1.20		1.08		0.29		0.84		3.35



	2014
	1^st		2^nd		3^rd		4^th		Year
Revenues	$	2,015	$	2,072	$	2,157	$	2,202	$	8,446
Gross Profit	1,035		1,053		1,111		1,103		4,301
Net Income	271		287		326		301		1,185
Earnings per Share:
Basic	1.40		1.48		1.69		1.56		6.13
Diluted	1.37		1.45		1.65		1.53		5.99

Certain quarterly amounts may not add to the year-to-date totals due to rounding. The third quarter fiscal year 2015 gross profit amount reflects an acquisition-related reclassification. Earnings per share amounts are calculated from the underlying whole-dollar amounts. As of March 17, 2015, the weighted average common shares used in the computations of basic and diluted earnings per share reflect shares issued in connection with the CareFusion acquisition. Additional disclosures regarding this issuance of shares and the acquisition are provided in Notes 4 and 9.

Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.

None.

Item 9A. Controls and Procedures.

An evaluation was conducted by BD’s management, with the participation of BD’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of BD’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934) as of September 30, 2015. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the design and operation of these disclosure controls and procedures were, as of the end of the period covered by this report, effective and designed to ensure that material information relating to BD and its consolidated subsidiaries would be made known to them by others within these entities. On March 17, 2015, BD completed the acquisition of CareFusion. BD has extended its oversight and monitoring processes that support our internal control over financial reporting, as well as its disclosure controls and procedures, to include CareFusion’s operations. BD is continuing to integrate the acquired operations of CareFusion. There were no other changes in our internal control over financial reporting during the fiscal quarter ended June 30, 2015 identified in connection with the above-referenced evaluation that have materially affected, or are reasonably likely to materially affect, BD’s internal control over financial reporting.

Management’s Report on Internal Control Over Financial Reporting and the Report of Independent Registered Public Accounting Firm are contained in Item 8, Financial Statements and Supplementary Data, and are incorporated herein by reference.

Item 9B. Other Information.

None.

PART III

Item 10. Directors, Executive Officers and Corporate Governance.

Table of Contents

The information relating to directors and the Audit Committee of the BD Board of Directors required by this item will be contained under the captions “Proposal 1. Election of Directors” and “Board of Directors - Committee Membership and Function - Audit Committee” in a definitive proxy statement involving the election of directors, which the registrant will file with the SEC not later than 120 days after September 30, 2015 (the “2016 Proxy Statement”), and such information is incorporated herein by reference.

The information relating to executive officers required by this item is included herein in Part I under the caption “Executive Officers of the Registrant.”

Certain other information required by this item will be contained under the captions “Ownership of BD Common Stock - Section 16(a) Beneficial Ownership Reporting Compliance” and “Corporate Governance - Code of Conduct” in BD’s 2016 Proxy Statement, and such information is incorporated herein by reference.

Item 11. Executive Compensation.

The information required by this item will be contained under the captions “Board of Directors - Non-Management Directors’ Compensation,” “Compensation Discussion and Analysis,” “Report of the Compensation and Benefits Committee,” and “Compensation of Named Executive Officers” in BD’s 2016 Proxy Statement, and such information is incorporated herein by reference.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

The information required by this item will be contained under the caption “Ownership of BD Common Stock” in BD’s 2016 Proxy Statement, and such information is incorporated herein by reference.

Item 13. Certain Relationships and Related Transactions, and Director Independence.

The information required by this item will be contained under the caption “Corporate Governance - Director Independence; Policy Regarding Related Person Transactions” in BD’s 2016 Proxy Statement, and such information is incorporated herein by reference.

Item 14. Principal Accounting Fees and Services.

The information required by this item will be contained under the caption “Proposal 2. Ratification of Selection of Independent Registered Public Accounting Firm” in BD’s 2016 Proxy Statement, and such information is incorporated herein by reference.

PART IV

Item 15. Exhibits, Financial Statement Schedules.


(a)(1)	Financial Statements

The following consolidated financial statements of BD are included in Item 8 of this report:


•	Reports of Independent Registered Public Accounting Firm


•	Consolidated Statements of Income — Years ended September 30, 2015, 2014 and 2013


•	Consolidated Statements of Comprehensive Income — Years ended September 30, 2015, 2014 and 2013


•	Consolidated Balance Sheets — September 30, 2015 and 2014


•	Consolidated Statements of Cash Flows — Years ended September 30, 2015, 2014 and 2013


•	Notes to Consolidated Financial Statements


(2)	Financial Statement Schedules

See Note 18 to the Consolidated Financial Statements included in Item 8, Financial Statements and Supplementary Data.


(3)	Exhibits

See the Exhibit Index beginning on page __ hereof for a list of all management contracts, compensatory plans and arrangements required by this item, and all other Exhibits filed or incorporated by reference as a part of this report.

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

BECTON, DICKINSON AND COMPANY




	By:		/s/ GARY DEFAZIO
			Gary DeFazio
			Vice President and Corporate Secretary

Dated: November 25, 2015

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below on the 25^th day of November, 2015 by the following persons on behalf of the registrant and in the capacities indicated.



Name		Capacity

/S/ VINCENT A. FORLENZA		Chairman, Chief Executive Officer and President
Vincent A. Forlenza		(Principal Executive Officer)

/S/ CHRISTOPHER R. REIDY		Executive Vice President, Chief Financial Officer and
Christopher R. Reidy		Chief Administrative Officer
		(Principal Financial Officer)

/S/ JOHN GALLAGHER		Senior Vice President, Corporate Finance,
John Gallagher		Controller and Treasurer
		(Principal Accounting Officer)

Basil L. Anderson*		Director


Henry P. Becton, Jr.*		Director


Catherine M. Burzik*		Director


Edward F. DeGraan*		Director


Claire M. Fraser*		Director


Christopher Jones*		Director


Marshall O. Larsen*		Director

Table of Contents




Name		Capacity


Gary A. Mecklenburg*		Director


James F. Orr*		Director


Willard J. Overlock, Jr.*		Director


Claire Pomeroy*		Director


Rebecca W. Rimel*		Director


Bertram L. Scott*		Director




	*By:		/s/ GARY DEFAZIO
			Gary DeFazio
			Attorney-in-fact

Table of Contents

EXHIBIT INDEX




Exhibit Number	Description	Method of Filing
2.1	Agreement and Plan of Merger, dated as of October 5, 2014, among CareFusion Corporation, Becton, Dickinson and Company and Griffin Sub, Inc.	Incorporated by reference to Exhibit 2.1 to the registrant’s Current Report on Form 8-K dated October 6, 2014.
3(a)(i)	Restated Certificate of Incorporation, dated as of January 29, 2013.	Incorporated by reference to Exhibit 3(a) to the registrant’s Quarterly Report on Form 10-Q for the period ended March 31, 2013.
3(b)	By-Laws, as amended and restated as of July 28, 2015.	Incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K dated July 29, 2015.
4(a)	Indenture, dated as of March 1, 1997, between the registrant and The Bank of New York Mellon Trust Company, N.A. (as successor to JPMorgan Chase Bank)	Incorporated by reference to Exhibit 4(a) to Form 8-K filed by the registrant on July 31, 1997
4(b)	Indenture, dated July 21, 2009, between CareFusion Corporation and Deutsche Bank Trust Company Americas, as trustee.	Incorporated by reference to Exhibit 4.2 to Cardinal Health, Inc.’s Current Report on Form 8-K filed on July 22, 2009.
4(c)	Supplemental Indenture, dated July 21, 2009, between CareFusion Corporation and Deutsche Bank Trust Company Americas, as trustee.	Incorporated by reference to Exhibit 4.3 to Cardinal Health, Inc.’s Current Report on Form 8-K filed on July 22, 2009.
4(d)	Second Supplemental Indenture, dated March 11, 2013, between CareFusion Corporation and Deutsche Bank Trust Company Americas, as trustee.	Incorporated by reference to Exhibit 4.1 of the CareFusion Corporation Current Report on Form 8-K filed on March 11, 2013.
4(e)	Third Supplemental Indenture, dated May 22, 2014, between CareFusion Corporation and Deutsche Bank Trust Company Americas, as trustee.	Incorporated by reference to Exhibit 4.2 of the CareFusion Corporation Current Report on Form 8-K filed on May 22, 2014.
4(f)	Fourth Supplemental Indenture, dated as of April 24, 2015, between CareFusion Corporation and Deutsche Bank Trust Company Americas, as Trustee.	Incorporated by reference to Exhibit 4.1 of CareFusion’s Current Report on Form 8-K filed on April 29, 2015.
4(g)	Form of 7% Debentures due August 1, 2027.	Incorporated by reference to Exhibit 4(d) of the registrant’s Current Report on Form 8-K filed on July 31, 1997.
4(h)	Form of 6.70% Debentures due August 1, 2028.	Incorporated by reference to Exhibit 4(d) of the registrant’s Current Report on Form 8-K filed on July 29, 1999.
4(i)	Form of 4.90% Notes due April 15, 2018.	Filed with this report.
4(j)	Form of 5.00% Notes due May 15, 2019.	Incorporated by reference to Exhibit 4.1 of the registrant’s Current Report on Form 8-K filed on May 13, 2009.
4(k)	Form of 6.00% Notes due May 15, 2039.	Incorporated by reference to Exhibit 4.2 of the registrant’s Current Report on Form 8-K filed on May 13, 2009.
4(l)	Form of 3.25% Notes due November 12, 2020.	Incorporated by reference to Exhibit 4.1 of the registrant’s Current Report on Form 8-K filed on November 12, 2010.
4(m)	Form of 5.00% Notes due November 12, 2040.	Incorporated by reference to Exhibit 4.2 of the registrant’s Current Report on Form 8-K filed on November 12, 2010.

Table of Contents



4(n)	Form of 1.750% Notes due November 8, 2016.	Incorporated by reference to Exhibit 4.1 of the registrant’s Current Report on Form 8-K filed on November 8, 2011.
4(o)	Form of 3.125% Notes due November 8, 2021.	Incorporated by reference to Exhibit 4.2 of the registrant’s Current Report on Form 8-K filed on November 8, 2011.
4(p)	Form of 1.450% Senior Notes due May 15, 2017.	Incorporated by reference to Exhibit 4.2 of the registrant’s Current Report on Form 8-K filed on April 29, 2015.
4(q)	Form of 6.375% Senior Notes due August 1, 2019.	Incorporated by reference to Exhibit 4.3 of the registrant’s Current Report on Form 8-K filed on April 29, 2015.
4(r)	Form of 3.300% Senior Notes due March 1, 2023.	Incorporated by reference to Exhibit 4.4 of the registrant’s Current Report on Form 8-K filed on April 29, 2015.
4(s)	Form of 3.875% Senior Notes due May 15, 2024.	Incorporated by reference to Exhibit 4.5 of the registrant’s Current Report on Form 8-K filed on April 29, 2015.
4(t)	Form of 4.875% Senior Notes due May 15, 2044.	Incorporated by reference to Exhibit 4.6 of the registrant’s Current Report on Form 8-K filed on April 29, 2015.
10(a)(i)	Form of Employment Agreement with executive officers relating to employment following a change of control of the registrant (with tax reimbursement provisions).*	Incorporated by reference to Exhibit 10(a) to the registrant’s Quarterly Report on Form 10-Q for the period ended December 31, 2008.
10(a)(ii)	Form of Employment Agreement with executive officers relating to employment following a change of control of the registrant (without tax reimbursement provisions).*	Incorporated by reference to Exhibit 10(a)(ii) to the registrant’s Annual Report on Form 10-K for the fiscal year ended September 30, 2013.
10(b)	Stock Award Plan, as amended and restated as of January 31, 2006.*	Incorporated by reference to Exhibit 10(a) to the registrant’s Quarterly Report on Form 10-Q for the period ended December 31, 2005.
10(c)	Performance Incentive Plan, as amended and restated September 23, 2008.*	Incorporated by reference to Exhibit 10(c) to the registrant’s Current Report on Form 8-K dated September 26, 2008.
10(d)	Deferred Compensation and Retirement Benefit Restoration Plan, as amended and restated as of July 23, 2013.*	Incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K dated July 25, 2013.
10(e)	1996 Directors’ Deferral Plan, as amended and restated as of November 25, 2014.*	Incorporated by reference to Exhibit 10.2 to the registrant’s Current Report on Form 8-K dated December 2, 2014.
10(f)	Amended and Restated Aircraft Time Sharing Agreement between Becton, Dickinson and Company and Vincent A. Forlenza dated as of March 21, 2012.*	Incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K dated March 27, 2012.
10(g)(i)	2004 Employee and Director Equity-Based Compensation Plan, as amended and restated as of November 25, 2014.*	Incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K dated December 2, 2014.
10(g)(ii)	Terms of Awards under 2004 Employee and Director Equity-Based Compensation Plan.*	Filed with this report.

Table of Contents




Exhibit Number	Description	Method of Filing
10(h)	Retiree medical agreement between Becton, Dickinson and Company and Jeffrey S. Sherman.*	Incorporated by reference to Exhibit 10(n) to the registrant’s Annual Report on Form 10-K for the fiscal year ended September 30, 2012.
10(i)	Amended and Restated Five-Year Credit Agreement, dated as of May 18, 2012 and expiring May 18, 2018 among the registrant and the banks named therein.	Incorporated by reference to Exhibit 10 to the registrant’s Current Report on Form 8-K dated May 24, 2012.
10(j)	364-Day Bridge Term Loan Agreement dated November 14, 2014.	Incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed November 14, 2014.
10(k)	364-Day Term Loan Agreement, dated December 19, 2014, by and among Becton, Dickinson and Company, as borrower, Goldman Sachs Bank USA, as administrative agent, and the lenders party thereto.	Incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed on December 19, 2014.
10(l)	Form of Commercial Paper Dealer Agreement.	Incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed on January 6, 2015.
10(m)	Tax Matters Agreement, dated August 31, 2009, by and between Cardinal Health, Inc. and CareFusion Corporation.	Incorporated by reference to Exhibit 10.3 to Cardinal Health, Inc.’s Current Report on Form 8-K filed on September 4, 2009.
21	Subsidiaries of the registrant	Filed with this report
23	Consent of independent registered public accounting firm	Filed with this report
24	Power of Attorney	Filed with this report
31	Certifications of Chief Executive Officer and Chief Financial Officer, pursuant to SEC Rule 13(a)-14(a)	Filed with this report
32	Certifications of Chief Executive Officer and Chief Financial Officer, pursuant to Section 1350 of Chapter 63 of Title 18 of the U.S. Code	Filed with this report
101	The following materials from this report, formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Statements of Income, (ii) the Consolidated Statements of Comprehensive Income, (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Cash Flows, and (v) Notes to Consolidated Financial Statements.	Filed with this report


*	Denotes a management contract or compensatory plan or arrangement.

Copies of any Exhibits not accompanying this Form 10-K are available at a charge of 10 cents per page by contacting: Investor Relations, Becton, Dickinson and Company, 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880, Phone: 1-800-284-6845.

EX-4 2 a2015-09x30ex4i.htm EXHIBIT 4 Exhibit

EXHIBIT 4(i)

Unless this certificate is presented by an authorized representative of The Depository Trust Company, a New York corporation (“DTC”), to Issuer or its agent for registration of transfer, exchange, or payment, and any certificate issued is registered in the name of Cede & Co. or in such other name as is requested by an authorized representative of DTC (and any payment is made to Cede & Co. or to such other entity as is requested by an authorized representative of DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL inasmuch as the registered owner hereof, Cede & Co., has an interest herein.

BECTON, DICKINSON AND COMPANY

4.900% Notes due April 15, 2018

CUSIP No. [ ]

No. [ ] $[ ]

BECTON, DICKINSON AND COMPANY, a New Jersey corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred to, being herein called the “Company”), for value received, hereby promises to pay to Cede & Co., or registered assigns, the principal sum of $[ ] on April 15, 2018 and to pay interest, on April 15 and October 15 of each year, commencing October 15, 2003, on said principal sum at the rate of 4.900% per annum, from April 9, 2003 or from the most recent interest payment date to which interest has been paid or provided for, as the case may be, until payment of said principal sum has been made or duly provided for; provided, however, that payment of interest may be made at the option of the Company (i) by check mailed to the address of the person entitled thereto as such address shall appear on the register of Notes or (ii) by transfer in immediately available funds to an account maintained by the person entitled thereto as specified in the register of Notes. The interest so payable on any April 15 or October 15 will, subject to certain exceptions provided in the Indenture referred to on the reverse hereof, be paid to the person in whose name this Note is registered at the close of business on the April 1 or October 1 immediately preceding the applicable interest payment date.

Reference is made to the further provisions of this Note set forth on the reverse hereof. Such further provisions shall for all purposes have the same effect as though fully set forth at this place.

This Note shall not be valid or become obligatory for any purpose until the certificate of authentication hereon shall have been signed by the Trustee under the Indenture referred to on the reverse hereof.

IN WITNESS HEREOF, Becton, Dickinson and Company has caused this Note to be executed in its name and on its behalf by the signatures of two of its officers authorized to execute Securities pursuant to the Indenture and has caused its corporate seal to be affixed hereunto or imprinted hereon.

Dated: April 9, 2003



BECTON, DICKINSON AND COMPANY
By:
	Richard K. Berman
	Vice President and Treasurer

By:
	Bridget M. Healy
	Vice President, General Counsel and Secretary

TRUSTEE’S CERTIFICATE

OF AUTHENTICATION

This Note is one of the Securities of the series referred to herein issued pursuant to the within-mentioned Indenture.



JPMORGAN CHASE BANK, as Trustee
By:
	Authorized Officer

BECTON, DICKINSON AND COMPANY

4.900% Notes due April 15, 2018

This Note is one of a duly authorized issue of debentures, notes or other evidences of indebtedness of the Company (herein called the “Securities”) of the series hereinafter specified, all issued or to be issued under and pursuant to an Indenture, dated as of March 1, 1997 (as amended or supplemented, herein called the “Indenture”), duly executed and delivered by the Company and JPMorgan Chase Bank, as Trustee (herein called the “Trustee”), to which Indenture and all indentures supplemental thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties, obligations and immunities thereunder of the Company, the Trustee and the holders of the Securities. The Securities may be issued in one or more series, which different series may be issued in various aggregate principal amounts, may mature at different times, may bear interest (if any) at different rates, may be subject to different redemption provisions (if any), may be subject to different sinking, purchase or analogous funds (if any) and may otherwise vary as in the Indenture provided. This Note is one of a series designated as the 4.900% Notes due April 15, 2018 (the “Notes”) limited in aggregate principal amount to $[ ] (except as in the Indenture provided). The Company may, from time to time, without the consent of the existing holders of the Notes, issue additional notes under the Indenture having the same terms as the Notes in all respects, except for issue date, issue price and the initial interest payment date. Any such additional notes will be consolidated with and form a single series with the Notes. Terms defined in the Indenture have the same definitions herein unless otherwise specified.

In case an Event of Default, as defined in the Indenture, with respect to the Notes shall have occurred and be continuing, the principal hereof and interest hereon may be declared, and upon such declaration shall become, due and payable, in the manner, with the effect and subject to the conditions provided in the Indenture.

The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the holders of the Securities of any series at any time by the Company and the Trustee with the consent of the holders of a majority in aggregate principal amount of the outstanding Securities of such series, each affected series voting separately. The Indenture also contains provisions permitting the holders of a majority in aggregate principal amount of the outstanding Securities of any series, on behalf of the holders of all the Securities of such series, to waive certain past defaults under the Indenture and their consequences. Any such consent or waiver by or on behalf of the holder of this Note shall be conclusive and binding upon such holder and upon all future holders of this Note and of any Note issued upon the registration of transfer hereof or in exchange hereof or in lieu hereof whether or not notation of such consent or waiver is made upon this Note or such other Note.

Subject to the terms of the Indenture, the Company may elect either (i) to defease and be discharged from any and all obligations with respect to the Notes or (ii) to be released from its obligations with respect to certain covenants applicable to the Notes, upon compliance by the Company with certain conditions set forth therein, which provisions apply to this Note.

No reference herein to the Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and interest on this Note at the place, at the respective times, at the rate and in the coin or currency prescribed herein.

The Notes are redeemable as a whole or in part, at the option of the Company at any time, at a redemption price equal to the greater of (1) 100% of the principal amount of the Notes to be redeemed and (2) the sum of the present values of the Remaining Scheduled Payments on the Notes, discounted to the redemption date on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 15 basis points, plus in each case, accrued interest to the date of redemption on the principal balance of the Notes being redeemed. For the purposes hereof:

“Treasury Rate” means, for any redemption date, the annual rate equal to the semiannual equivalent yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue equal to the Comparable Treasury Price, expressed as a percentage of its principal amount, for such redemption date. The yield of the Comparable Treasury Issue shall be computed as of the second business day immediately preceding the redemption date.

“Comparable Treasury Issue” means the United States Treasury security selected by an Independent Investment Banker that would be used, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the applicable remaining term of the Notes.

“Independent Investment Banker” means one of the Reference Treasury Dealers appointed by the Trustee after consultation with the Company.

“Reference Treasury Dealer” means each of Goldman, Sachs & Co., Salomon Smith Barney Inc., J.P. Morgan Securities Inc. and Banc One Capital Markets, Inc., each of their successors, and any two other nationally recognized investment banking firms selected by the Company from time to time that are primary dealers of U.S. government securities in New York City; provided, however, that if any of the foregoing ceases to be a primary dealer of U.S. government securities in New York City, the Company shall substitute therefor another nationally recognized investment banking firm.

“Comparable Treasury Price” means, with respect to any redemption date, (1) the average of the Reference Treasury Dealer Quotations obtained by the Trustee for that redemption date after excluding the highest and lowest of those Reference Treasury Dealer Quotations; or (2) if the Trustee obtains fewer than four Reference Treasury Dealer Quotations, the average of all those quotations.

“Reference Treasury Dealer Quotation” means, with respect to any redemption date, the average, as determined by the Trustee, of the bid and asked prices for the Comparable Treasury Issue, expressed in each case as a percentage of its principal amount, quoted in writing to the Trustee by a Reference Treasury Dealer as of 3:30 p.m., New York time, on the third business day preceding that redemption date. The Trustee shall seek Reference Treasury Dealer Quotations in respect of any redemption date from each of the then-existing Reference Treasury Dealers.

“Remaining Scheduled Payments” means, with respect to each Note being redeemed, the remaining scheduled payments of principal and interest on that Note that would be due after the related redemption date but for the redemption; provided, however, that if the redemption date is not an interest payment date with respect to that Note, the amount of the next succeeding scheduled interest payment on that Note that would have been due shall be deemed reduced by the amount of interest accrued on the Note to the redemption date.

Notice of any redemption shall be mailed at least 30 days but not more than 60 days before the redemption date to each holder of the Notes or portions thereof called for redemption. On and after any redemption date, the Notes or any portion of the Notes called for redemption will stop accruing interest. If less than all of the Notes are redeemed, the Trustee will choose the Notes to be redeemed by any method that it deems fair and appropriate.

Upon the presentment for registration of transfer of this Note at the office or agency of the Company designated for such purpose pursuant to the Indenture, a new Note or Notes of authorized denominations for an equal aggregate principal amount will be issued to the transferee in exchange therefor, subject to the limitations provided in the Indenture, without charge except for any tax or other governmental charge imposed in connection therewith.

Prior to due presentment for registration of transfer of this Note, the Company, the Trustee or any Note registrar, co-registrar, paying agent or authenticating agent, may deem and treat the registered holder hereof as the absolute owner of this Note (whether or not this Note shall be overdue and notwithstanding any notation of ownership or other writing hereon), for the purpose of receiving payment hereof, or on account hereof, and for all other purposes, and the Company, the Trustee and any Note registrar, co-registrar, paying agent and authenticating agent shall not be affected by any notice to the contrary.

EX-10 3 a2015-09x30ex10gii.htm EXHIBIT 10 Exhibit

EXHIBIT 10(g)(ii)

Terms of Awards Under

2004 Employee and Director Equity-Based Compensation Plan (the “Plan”)

Capitalized terms used herein that are not defined shall have the same meaning as set forth in the Plan.

1. Stock Options

(a) Vesting Period: Ratably over four (4) years, with twenty-five percent (25%) becoming exercisable on each of the first, second, third and fourth anniversary of the grant date, except as provided in the Plan.

(b) Term: Ten (10) years from grant date.

(d) Form: Non-qualified stock options.

(e) Forfeiture: Subject to forfeiture if (a) the grantee violates any agreement of non-competition with BD, or any agreement of non-disclosure of confidential information of BD, or (b) if grantee commits acts or omissions that would have been the basis for termination for Cause during the grantee’s employment.

2. Stock Appreciation Rights (SARs)

(b) Term: Ten (10) years from grant date.

(d) Settlement: Upon exercise, the holder receives shares (or portion of a share) of BD common stock equal in value to the amount by which the market price of the BD common stock at the time of exercise exceeds the exercise price.

3. Performance Units

(a) Vesting Period: Third anniversary of grant date.

(b) Settlement: Performance Units are settled in shares of BD common stock. Performance Unit awards are given a share target. A formula determines the actual number of shares that will be issued upon vesting, which is based on BD’s performance against pre-established performance measures over the applicable performance period.

(d) Performance Measures: For awards prior to November 2012, consist primarily of BD’s revenue growth and return on invested capital during the performance period, with revenue growth weighted 60% or 70%, depending on the year of grant. For awards made in November 2012 and later, consist primarily of BD’s return on invested capital and relative total shareholder return compared to that of a select group of peer companies, each weighted 50%. Payouts may range from zero to 200% of the award’s share target.

(e) Dividend Equivalent Rights: Performance Units granted prior to November 2012 were issued in tandem with dividend equivalent rights.

(f) Termination prior to the completion of vesting period: Upon death or 409A Disability, grantee vests in a pro rata amount of the award’s share target. Upon Disability (other than a 409A Disability), Retirement or involuntary termination without Cause, grantee vests in a pro rata amount of the shares that would have been distributable under the award had the grantee remained employed with BD through the vesting period.

4. Time-Vested Units

(a) Vesting Period: For awards granted prior to January 1, 2015, third anniversary of grant date. For awards made on or after January 1, 2015, awards vest ratably over three (3) years, with one-third becoming exercisable on each of the first, second, and third anniversary of the grant date.

(b) Settlement: Each Time-Vested Unit entitles the grantee to one share of BD common stock upon vesting.

(c) Dividend Equivalent Rights: Time-Vested Units granted prior to November 2012 were issued in tandem with dividend equivalent rights.

(d) Termination prior to the completion of vesting period: Upon Retirement, death or Disability, the award vests in full. Upon involuntary termination without Cause, the grantee vests in a pro rata amount of the award.

5. Career Shares

(a) Vesting Period: First anniversary of the grantee’s Retirement from BD:

(b) Settlement: Each Career Share entitles the grantee to one share of BD common stock upon vesting:

(d) Termination prior to the completion of vesting period: Upon death, Disability or involuntary termination other than for Cause, Career Shares become fully vested.

(e) Forfeiture: Subject to forfeiture in the event, at any time prior to the first anniversary of the grantee’s Retirement, the grantee violates non-compete covenant with BD.

EX-21 4 a2015-09x30ex21.htm EXHIBIT 21 Exhibit

EXHIBIT 21

SUBSIDIARIES OF BECTON, DICKINSON AND COMPANY



Name of Subsidiary	State of Jurisdiction of Incorporation	Percentage of Voting Securities Owned
Accuri Cytometers, Inc.	Delaware	100%
Atto BioScience, Inc.	Delaware	100%
Alverix, Inc.	Delaware	100%
ARX BVBA	Belgium	100% (1)
ARX SA	Switzerland	100% (1)
ARX Automatizacion de Farmacias, S.L.U.	Spain	100% (1)
ARX Limited	United Kingdom	100% (1)
ARX SAS	France	100% (1)
ARX Automating Pharmacies Ltd.	Ireland	100% (1)
ARX Norge AS	Norway	100% (1)
B-D (Cambridge U.K.) Ltd.	United Kingdom	100% (1)
Becton Dickinson Biosciences, Systems and Reagents Inc.	California	100%
BD Holding S. de R.L. de C.V.	Mexico	100% (1)
Becton Dickinson Matrex Holdings, Inc.	Delaware	100%
BD Norge AS	Norway	100% (1)
BD Rapid Diagnostic (Suzhou) Co., Ltd.	China	100% (1)
BDIT Singapore Pte. Ltd.	Singapore	100% (1)
BD (West Africa) Limited	Ghana	100% (1)
BDX INO LLC	Delaware	100%
Becton Dickinson AcuteCare Holdings, Inc.	Delaware	100%
Becton Dickinson Advanced Pen Injection Systems GmbH	Switzerland	100% (1)
Becton Dickinson Argentina S.R.L.	Argentina	100% (1)
Becton Dickinson Asia Limited	Hong Kong	100% (1)
Becton Dickinson Asia Pacific Limited	British Virgin Islands	100%
Becton Dickinson Austria Holdings GmbH	Austria	100% (1)
Becton Dickinson Austria GmbH	Austria	100% (1)
Becton Dickinson Benelux N.V.	Belgium	100% (1)
Becton Dickinson Canada Inc.	Canada	100% (1)
Becton Dickinson Caribe Ltd.	Cayman Islands	100% (1)
Becton Dickinson Croatia d.o.o.	Croatia	100% (1)
Becton Dickinson de Colombia Ltda.	Colombia	100% (1)
Becton Dickinson Czechia s.r.o.	Czech Republic	100% (1)
Becton Dickinson del Uruguay S.A.	Uruguay	100% (1)
Becton Dickinson Distribution Center N.V.	Belgium	100% (1)
Becton Dickinson East Africa Ltd.	Kenya	100% (1)
Becton Dickinson Guatemala S.A.	Guatemala	100% (1)
Becton Dickinson Hellas S.A.	Greece	100% (1)
Becton Dickinson Hungary Kft.	Hungary	100% (1)
Becton Dickinson India Private Limited	India	100% (1)
Becton Dickinson Infusion Therapy AB	Sweden	100% (1)

SUBSIDIARIES OF BECTON, DICKINSON AND COMPANY



Name of Subsidiary	State of Jurisdiction of Incorporation	Percentage of Voting Securities Owned
Becton Dickinson A/S	Denmark	100% (1)
Becton Dickinson Infusion Therapy B.V.	Netherlands	100% (1)
Becton Dickinson Infusion Therapy Holdings AB	Sweden	100% (1)
Becton Dickinson Infusion Therapy Systems Inc., S.A. de C.V.	Mexico	100% (1)
Becton Dickinson Infusion Therapy UK	United Kingdom	100% (1)
Becton Dickinson Infusion Therapy Systems Inc.	Delaware	100%
Becton Dickinson Infusion Therapy Holdings UK Limited	United Kingdom	100% (1)
Becton Dickinson Insulin Syringe, Ltd.	Cayman Islands	100% (1)
Becton Dickinson Ithalat Ihracat Limited Sirketi	Turkey	100% (1)
Becton Dickinson Korea Holding, Inc.	Delaware	100%
Becton Dickinson Korea Ltd.	Korea	100% (1)
Becton Dickinson Malaysia, Inc.	Oregon	100%
Becton Dickinson (Mauritius) Limited	Mauritius	100%
Becton Dickinson Medical (S) Pte Ltd.	Singapore	100% (1)
Becton Dickinson Medical Devices Co. Shanghai Ltd.	P.R.C.	100% (1)
Becton Dickinson Medical Devices Co. Ltd., Suzhou	P.R.C.	100% (1)
Becton Dickinson Medical Products Pte. Ltd.	Singapore	100%
Becton Dickinson Ltd.	New Zealand	100% (1)
Becton Dickinson O.Y.	Finland	100% (1)
Becton Dickinson Overseas Services Ltd.	Nevada	100%
Becton Dickinson Pen Limited	Ireland	100% (1)
Becton Dickinson Penel Limited	Cayman Islands	100% (1)
Becton Dickinson Philippines, Inc.	Philippines	100% (1)
Becton Dickinson Polska Sp.z.o.o.	Poland	100% (1)
Becton Dickinson Pty. Ltd.	Australia	100% (1)
Becton Dickinson (Pty) Ltd.	South Africa	100% (1)
Becton Dickinson Sdn. Bhd.	Malaysia	100% (1)
Becton Dickinson Service (Pvt.) Ltd.	Pakistan	100%
Becton Dickinson Sample Collection GmbH	Switzerland	100% (1)
Becton Dickinson Slovakia s.r.o.	Slovakia	100% (1)
Becton Dickinson (Thailand) Limited	Thailand	100% (1)
Becton Dickinson Venezuela, C.A.	Venezuela	100% (1)
Becton Dickinson Venture LLC	Delaware	100%
BD Ventures LLC	New Jersey	100%
Becton Dickinson Vostok LLC	Russia	100% (1)
Becton Dickinson, S.A.	Spain	100% (1)
Becton Dickinson (Royston) Limited	United Kingdom	100% (1)
Becton, Dickinson A.G.	Switzerland	100% (1)
Becton, Dickinson Aktiebolag	Sweden	100% (1)
Becton, Dickinson and Company, Ltd.	Ireland	100% (1)
Becton, Dickinson B.V.	Netherlands	100% (1)

SUBSIDIARIES OF BECTON, DICKINSON AND COMPANY



Name of Subsidiary	State of Jurisdiction of Incorporation	Percentage of Voting Securities Owned
Becton, Dickinson de Mexico, S.A. de C.V.	Mexico	100% (1)
Becton Dickinson France S.A.S.	France	100% (1)
Becton Dickinson GmbH	Germany	100% (1)
Becton, Dickinson Industrias Cirurgicas, Ltda.	Brazil	100% (1)
Becton, Dickinson Italia S.p.A.	Italy	100% (1)
B-D U.K. Holdings Limited	United Kingdom	100% (1)
Becton Dickinson U.K. Limited	United Kingdom	100% (1)
Benex Ltd.	Ireland	100% (1)
BioVenture Centre Pte. Ltd.	Singapore	100%
CareFusion Corporation	Delaware	100%
CareFusion Australia 316 Pty Limited	Australia	100% (1)
CareFusion Austria 322 GmbH	Austria	100% (1)
CareFusion D.R. 203 Ltd.	Bermuda	100% (1)
CareFusion BH 335 d.o.o.	Bosnia	100% (1)
Intermed Equipamento Médico Hospitalar Ltda.	Brazil	100% (1)
STAR - Servicos de Assistencia Tecnica A Equipamento Medico Hospitalar Ltda.	Brazil	100% (1)
CareFusion Canada 307 ULC	Canada	100% (1)
Cardinal Health Trading (Shanghai) Co. Ltd.	China	100% (1)
CareFusion Asia (HK) Limited	Hong Kong	100% (1)
CareFusion (Shanghai) Commercial and Trading Co. Limited	China	100% (1)
CareFusion Hong Kong Limited	Hong Kong	100% (1)
Shenzhen Vital Signs - KTL Medical Instrument Co., Ltd.	China	100% (1)
Vital Signs Hong Kong Limited	Hong Kong	100% (1)
CareFusion Denmark 329 A/S	Denmark	100% (1)
CareFusion 323 DMCC	Dubai	100% (1)
CareFusion Finland 320 Oy	Finland	100% (1)
CareFusion France 309 S.A.S.	France	100% (1)
CareFusion Germany 234 GmbH	Germany	100% (1)
CareFusion Germany 277 GmbH	Germany	100% (1)
CareFusion Germany 318 GmbH	Germany	100% (1)
CareFusion Germany 326 GmbH	Germany	100% (1)
CareFusion Germany 506 GmbH	Germany	100% (1)
Cardinal Health India Private Limited	India	100% (1)
Care Fusion Development Private Limited	India	100% (1)
VIASYS Healthcare Ireland Limited	Ireland	100% (1)
CareFusion Israel 330 Ltd.	Israel	100% (1)
CareFusion Italy 237 S.p.A	Italy	100% (1)
CareFusion Italy 311 S.r.l.	Italy	100% (1)
CareFusion Italy 312 S.p.A.	Italy	100% (1)
CareFusion Italy 327 S.r.l.	Italy	100% (1)

SUBSIDIARIES OF BECTON, DICKINSON AND COMPANY



Name of Subsidiary	State of Jurisdiction of Incorporation	Percentage of Voting Securities Owned
CareFusion Japan 324 GK	Japan	100% (1)
CareFusion Korea 334 Limited	Korea	100% (1)
CareFusion Malaysia 325 Sdn Bhd	Malaysia	100% (1)
CareFusion Mexico 215 SA de CV	Mexico	100% (1)
Enturia de México S. de R.L. de C.V.	Mexico	100% (1)
Productos Urologos de México SA de C.V.	Mexico	100% (1)
Sistemas Médicos ALARIS, S.A. de C.V.	Mexico	100% (1)
CareFusion Netherlands 238 B.V.	Netherlands	100% (1)
CareFusion Netherlands 310 B.V.	Netherlands	100% (1)
CareFusion Netherlands 328 B.V.	Netherlands	100% (1)
CareFusion Netherlands 503 B.V.	Netherlands	100% (1)
CareFusion Netherlands 504 B.V.	Netherlands	100% (1)
CareFusion Netherlands Financing 283 C.V.	Netherlands	100% (1)
Dutch American Manufacturers (D.A.M.) B.V.	Netherlands	100% (1)
CareFusion New Zealand 313 Limited	New Zealand	100% (1)
CareFusion Norway 315 A/S	Norway	100% (1)
CareFusion Portugal 332 - Produtos Médicos, LDA	Portugal	100% (1)
CareFusion RUS 333 Limited Liability Company	Russia	100% (1)
CareFusion Singapore 243 Pte. Ltd.	Singapore	100% (1)
CareFusion S.A. 319 (Proprietary) Limited	South Africa	100% (1)
CareFusion Iberia 308 S.L.	Spain	100% (1)
Sendal, S.L.U.	Spain	100% (1)
CareFusion Sweden 314 AB	Sweden	100% (1)
CareFusion Switzerland 317, Sarl	Switzerland	100% (1)
CareFusion Turkey Tibbi Cihazlar Ticaret Anonim Sirketi	Turkey	100% (1)
CareFusion U.K. 232 Limited	United Kingdom	100% (1)
CareFusion U.K. 235 Limited	United Kingdom	100% (1)
CareFusion U.K. 236 Limited	United Kingdom	100% (1)
CareFusion U.K. 244 Limited	United Kingdom	100% (1)
CareFusion U.K. 305 Limited	United Kingdom	100% (1)
CareFusion U.K. 306 Limited	United Kingdom	100% (1)
Sendal U.K.	United Kingdom	100% (1)
U.K. Medical, Ltd.	United Kingdom	100% (1)
U.K. Medical Holdings Ltd.	United Kingdom	100% (1)
Bird Products Corporation	California	100% (1)
Medegen, LLC	California	100% (1)
SensorMedics Corporation	California	100% (1)
Cardal II, LLC	Delaware	100% (1)
CareFusion 202, Inc.	Delaware	100% (1)
CareFusion 203, Inc.	Delaware	100% (1)
CareFusion 206, Inc.	Delaware	100% (1)

SUBSIDIARIES OF BECTON, DICKINSON AND COMPANY



Name of Subsidiary	State of Jurisdiction of Incorporation	Percentage of Voting Securities Owned
CareFusion 207, Inc.	Delaware	100% (1)
CareFusion 211, Inc.	Delaware	100% (1)
CareFusion 213, LLC	Delaware	100% (1)
CareFusion 2200, Inc.	Delaware	100% (1)
CareFusion 2201, Inc.	Delaware	100% (1)
CareFusion 302, LLC	Delaware	100% (1)
CareFusion 303, Inc.	Delaware	100% (1)
CareFusion 304, LLC	Delaware	100% (1)
CareFusion Manufacturing, LLC	Delaware	100% (1)
CareFusion Resources, LLC	Delaware	100% (1)
CareFusion Solutions, LLC	Delaware	100% (1)
EME Medical, Inc.	Delaware	100% (1)
IVAC Overseas Holding L.P.	Delaware	100% (1)
VIASYS Holdings Inc.	Delaware	100% (1)
Vital Signs, Inc.	Delaware	100% (1)
CareFusion 205, Inc.	Illinois	100% (1)
Enturican, Inc.	Kansas	100% (1)
Vital Signs Sales Corporation	New Jersey	100% (1)
Surgical Site Solutions, Inc.	Wisconsin	100% (1)
Cell Analysis Systems, Inc.	Illinois	100% (1)
Clontech Laboratories UK Limited	United Kingdom	100% (1)
Corporativo BD de Mexico, S. de R.L. de C.V.	Mexico	100% (1)
Cytopeia	Washington	100%
D.L.D., Ltd.	Bermuda	100% (1)
Dantor S.A.	Uruguay	100% (1)
Difco Laboratories Incorporated	Michigan	100%
Difco Laboratories Limited	United Kingdom	100% (1)
Distribuidora BD Mexico, S.A. de C.V.	Mexico	100% (1)
Procesos para Esterilizacion, S.A. de C.V.	Mexico	100% (1)
Franklin Lakes Enterprises, L.L.C.	New Jersey	100%
GenCell USA, LLC	Wisconsin	100%
GenCell DX Limited	Ireland	100%
GenCell Biosystems Ltd.	Ireland	100%
GeneOhm Sciences Canada Inc.	Canada	100% (1)
Healthcare Holdings in Sweden AB	Sweden	100% (1)
HandyLab, Inc.	Delaware	100%
IBD Holdings LLC	Delaware	50% (1)
Staged Diabetes Management LLC	New Jersey	50% (1)
Matrex Salud, de R.L. de C.V.	Mexico	50% (1)
Med-Safe Systems, Inc.	California	100%
Nippon Becton Dickinson Company, Ltd.	Japan	100% (1)

SUBSIDIARIES OF BECTON, DICKINSON AND COMPANY



Name of Subsidiary	State of Jurisdiction of Incorporation	Percentage of Voting Securities Owned
PharMingen	California	100%
Phase Medical, Inc.	California	100% (1)
PreAnalytiX GmbH	Switzerland	50% (1)
Abastecedora de Dispositivos Medicos JL S.A. de C.V.	Mexico	100% (1)
TriPath Imaging, Inc.	Delaware	100%
Becton Dickinson Europe Holdings S.A.S.	France	100% (1)
Becton Dickinson Management GmbH & Co. KG	Germany	100% (1)
Becton Dickinson Verwaltungs GmbH	Germany	100% (1)
Becton Dickinson Ireland Holding Limited	Ireland	100% (1)
Becton Dickinson Luxembourg S.a.r.L.	Luxembourg	100% (1)
Becton Dickinson Holdings Pte Ltd.	Singapore	100% (1)
Becton Dickinson Luxembourg LLC	Delaware	100% (1)
Becton Dickinson Luxembourg II LLC	Delaware	100%
Becton Dickinson Luxembourg II S.C.S.	Luxembourg	95%/5% (1)
Becton Dickinson Luxembourg III LLC	Delaware	100% (1)
Becton Dickinson Luxembourg III LLC S.C.S.	Luxembourg	100% (1)
Becton Dickinson Luxembourg Holdings S.a.r.L	Luxembourg	100% (1)
Becton Dickinson Luxembourg Holdings II S.a.r.L	Luxembourg	100% (1)
Becton Dickinson Sweden Holdings AB	Sweden	100% (1)
Carmel Pharma AB	Sweden	100% (1)
Carmel Pharma GmbH	Germany	100% (1)
Becton Dickinson (Gibraltar) Management Limited	Gibraltar	100% (1)
Becton Dickinson Asia Holdings Ltd.	Gibraltar	100% (1)
Becton Dickinson Luxembourg LLC S.C.S.	Luxembourg	100% (1)
Becton Dickinson Worldwide Investments Sa.r.L.	Luxembourg	100% (1)
Becton Dickinson (Gibraltar) Holdings Ltd.	Gibraltar	100% (1)
Becton Dickinson Management S.a.r.L	Luxembourg	100% (1)
Becton Dickinson Bermuda L.P.	Bermuda	100% (1)
Becton Dickinson Luxembourg Finance S.a.r.L.	Luxembourg	100% (1)
Becton Dickinson (Gibraltar) Limited	Gibraltar	100% (1)
Becton Dickinson Netherlands Holdings B.V.	Netherlands	100% (1)
Becton Dickinson Netherlands Holdings II B.V.	Netherlands	100% (1)
Sirigen, Inc.	California	100%
Sirigen Limited	United Kingdom	100% (1)
Sirigen Group Limited	United Kingdom	100% (1)
Sirigen II Limited	United Kingdom	100% (1)
Safety Syringes, Inc.	California	100%
BD Rx Inc.	Delaware	100%
BD Kiestra BV	Netherlands	100% (1)
Kiestra Lab Automation U.K. Ltd.	United Kingdom	100% (1)
Chemocato LLC	Delaware	100% (1)

SUBSIDIARIES OF BECTON, DICKINSON AND COMPANY



Name of Subsidiary	State of Jurisdiction of Incorporation	Percentage of Voting Securities Owned
Cato Software Solutions Polska sp.z.o.o.	Poland	100% (1)
Becton Dickinson GSA Beteilgungs GmbH	Germany	100% (1)
Becton Dickinson Zambia	Zambia	100% (1)
PT Becton Dickinson Indonesia	Indonesia	100% (1)
Alverix (M) Sdn. Bhd.	Malaysia	100% (1)
CRISI Medical Systems, Inc.	Delaware	100% (1)
Cellular Research, Inc.	Delaware	100% (1)

(1) owned by a wholly-owned subsidiary of Becton, Dickinson and Company.

EX-23 5 a2015-09x30ex23.htm EXHIBIT 23 Exhibit

EXHIBIT 23

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the following Registration Statements:


(1)	Registration Statements on Form S-8 Nos. 33-23055, 33-33791, 33-64115, 333-11885, 333-16091, 333-118235, 333-147594, 333-161129, 333-161215, 333-170821 and 333-199830 of Becton, Dickinson and Company;


(2)	Registration Statements on Form S-3 Nos. 333-23559, 333-38193, 333-104019, 333-134143, 333-159102, 333-183059, 333-206020, 333-195887 and 333-195921 of Becton, Dickinson and Company; and


(3)	Registration Statements on Form S-4 Nos. 333-199830 and 333-203013 of Becton, Dickinson and Company;

of our reports dated November 25, 2015, with respect to the consolidated financial statements of Becton, Dickinson and Company and the effectiveness of internal control over financial reporting of Becton, Dickinson and Company included in this Annual Report (Form 10-K) of Becton, Dickinson and Company for the year ended September 30, 2015.

/s/ ERNST & YOUNG LLP

New York, New York

November 25, 2015

EX-24 6 a2015-09x30ex24.htm EXHIBIT 24 Exhibit

EXHIBIT 24

POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned, being a director of Becton, Dickinson and Company, a New Jersey corporation (the “Company”), hereby constitutes and appoints Vincent A. Forlenza, Christopher R. Reidy, Jeffrey S. Sherman and Gary DeFazio, and each of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign the Company’s Annual Report on Form 10-K for the Company’s fiscal year ended September 30, 2015, and any amendments thereto, each in such form as they or any one of them may approve, and to file the same with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done so that such Annual Report shall comply with the Securities Exchange Act of 1934, as amended, and the applicable Rules and Regulations adopted or issued pursuant thereto, as fully and to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them or their substitute or resubstitute, may lawfully do or cause to be done by virtue hereof.

This Power of Attorney shall not revoke any powers of attorney previously executed by the undersigned. This Power of Attorney shall not be revoked by any subsequent power of attorney that the undersigned may execute, unless such subsequent power of attorney specifically provides that it revokes this Power of Attorney by referring to the date of the undersigned’s execution of this Power of Attorney. For the avoidance of doubt, whenever two or more powers of attorney granting the powers specified herein are valid, the agents appointed on each shall act separately unless otherwise specified.

IN WITNESS WHEREOF, each of the undersigned has hereunto set his or her hand on this 24th day of November, 2015.




/s/ Basil L. Anderson		/s/ Marshall O. Larsen
Basil L. Anderson		Marshall O. Larsen

/s/ Henry P. Becton, Jr.		/s/ Gary A. Mecklenburg
Henry P. Becton, Jr.		Gary A. Mecklenburg

/s/ Catherine M. Burzik		/s/ James F. Orr
Catherine M. Burzik		James F. Orr

/s/ Edward F. DeGraan		/s/ Willard J. Overlock, Jr.
Edward F. DeGraan		Willard J. Overlock, Jr.

/s/ Vincent A. Forlenza		/s/ Rebecca W. Rimel
Vincent A. Forlenza		Rebecca W. Rimel

/s/ Claire M. Fraser		/s/ Rebecca W. Rimel
Claire M. Fraser		Rebecca W. Rimel

/s/ Christopher Jones		/s/ Bertram L. Scott
Christopher Jones		Bertram L. Scott

EX-31 7 a2015-09x30ex31.htm EXHIBIT 31 Exhibit

EXHIBIT 31

CERTIFICATION

I, Vincent A. Forlenza, certify that:

1. I have reviewed this Annual Report on Form 10-K of Becton, Dickinson and Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting, and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 25, 2015

/s/ Vincent A. Forlenza

Vincent A. Forlenza

Chairman, Chief Executive Officer and President

CERTIFICATION

I, Christopher R. Reidy, certify that:

1. I have reviewed this Annual Report on Form 10-K of Becton, Dickinson and Company;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 25, 2015

/s/ Christopher R. Reidy

Christopher R. Reidy

Executive Vice President, Chief Financial Officer and Chief Administrative Officer

EX-32 8 a2015-09x30ex32.htm EXHIBIT 32 Exhibit

EXHIBIT 32

CERTIFICATION

The certification set forth below is being submitted in connection with the Annual Report on Form 10-K of Becton, Dickinson and Company for the fiscal year ended September 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) for the purpose of complying with Rule 13a-14(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code.

I, Vincent A. Forlenza, the Chief Executive Officer of Becton, Dickinson and Company, certify that:

1. such Report fully complies with the requirements of Section 13(a) of the Exchange Act; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Becton, Dickinson and Company.

Date: November 25, 2015

/s/ Vincent A. Forlenza

Vincent A. Forlenza

Chief Executive Officer

CERTIFICATION

I, Christopher R. Reidy, the Chief Financial Officer of Becton, Dickinson and Company, certify that:

1. such Report fully complies with the requirements of Section 13(a) of the Exchange Act; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Becton, Dickinson and Company.

Date: November 25, 2015

/s/ Christopher R. Reidy

Christopher R. Reidy

Chief Financial Officer

EX-101.INS 9 bdx-20150930.xml XBRL INSTANCE DOCUMENT 0000010795 2014-10-01 2015-09-30 0000010795 2015-10-31 0000010795 2015-03-31 0000010795 2012-10-01 2013-09-30 0000010795 2013-10-01 2014-09-30 0000010795 2015-09-30 0000010795 2014-09-30 0000010795 2013-09-30 0000010795 2012-09-30 0000010795 us-gaap:MachineryAndEquipmentMember us-gaap:MinimumMember 2014-10-01 2015-09-30 0000010795 us-gaap:LeaseholdsAndLeaseholdImprovementsMember us-gaap:MaximumMember 2014-10-01 2015-09-30 0000010795 us-gaap:BuildingMember us-gaap:MinimumMember 2014-10-01 2015-09-30 0000010795 bdx:PatentsAndTrademarksMember us-gaap:MinimumMember 2014-10-01 2015-09-30 0000010795 us-gaap:LeaseholdsAndLeaseholdImprovementsMember us-gaap:MinimumMember 2014-10-01 2015-09-30 0000010795 us-gaap:MinimumMember 2014-10-01 2015-09-30 0000010795 us-gaap:BuildingMember us-gaap:MaximumMember 2014-10-01 2015-09-30 0000010795 bdx:PatentsAndTrademarksMember us-gaap:MaximumMember 2014-10-01 2015-09-30 0000010795 bdx:CoreTechnologiesMember us-gaap:MinimumMember 2014-10-01 2015-09-30 0000010795 us-gaap:MaximumMember 2014-10-01 2015-09-30 0000010795 us-gaap:MachineryAndEquipmentMember us-gaap:MaximumMember 2014-10-01 2015-09-30 0000010795 bdx:CoreTechnologiesMember us-gaap:MaximumMember 2014-10-01 2015-09-30 0000010795 us-gaap:DeferredCompensationShareBasedPaymentsMember 2013-10-01 2014-09-30 0000010795 us-gaap:TreasuryStockMember 2012-10-01 2013-09-30 0000010795 us-gaap:TreasuryStockMember 2014-10-01 2015-09-30 0000010795 us-gaap:TreasuryStockMember 2014-09-30 0000010795 us-gaap:RetainedEarningsMember 2015-09-30 0000010795 us-gaap:RetainedEarningsMember 2012-09-30 0000010795 us-gaap:RetainedEarningsMember 2014-10-01 2015-09-30 0000010795 us-gaap:AdditionalPaidInCapitalMember 2013-09-30 0000010795 us-gaap:AdditionalPaidInCapitalMember 2012-09-30 0000010795 us-gaap:AdditionalPaidInCapitalMember 2014-10-01 2015-09-30 0000010795 us-gaap:AdditionalPaidInCapitalMember 2014-09-30 0000010795 us-gaap:TreasuryStockMember 2012-09-30 0000010795 us-gaap:TreasuryStockMember 2013-10-01 2014-09-30 0000010795 us-gaap:RetainedEarningsMember 2014-09-30 0000010795 us-gaap:CommonStockMember 2012-09-30 0000010795 us-gaap:TreasuryStockMember 2015-09-30 0000010795 us-gaap:DeferredCompensationShareBasedPaymentsMember 2012-10-01 2013-09-30 0000010795 us-gaap:DeferredCompensationShareBasedPaymentsMember 2014-10-01 2015-09-30 0000010795 us-gaap:AdditionalPaidInCapitalMember 2012-10-01 2013-09-30 0000010795 us-gaap:AdditionalPaidInCapitalMember 2013-10-01 2014-09-30 0000010795 us-gaap:CommonStockMember 2013-09-30 0000010795 us-gaap:RetainedEarningsMember 2013-10-01 2014-09-30 0000010795 us-gaap:CommonStockMember 2013-10-01 2014-09-30 0000010795 us-gaap:DeferredCompensationShareBasedPaymentsMember 2012-09-30 0000010795 us-gaap:CommonStockMember 2014-10-01 2015-09-30 0000010795 us-gaap:RetainedEarningsMember 2013-09-30 0000010795 us-gaap:TreasuryStockMember 2013-09-30 0000010795 us-gaap:RetainedEarningsMember 2012-10-01 2013-09-30 0000010795 us-gaap:CommonStockMember 2014-09-30 0000010795 us-gaap:DeferredCompensationShareBasedPaymentsMember 2015-09-30 0000010795 us-gaap:CommonStockMember 2015-09-30 0000010795 us-gaap:CommonStockMember 2012-10-01 2013-09-30 0000010795 us-gaap:DeferredCompensationShareBasedPaymentsMember 2014-09-30 0000010795 us-gaap:AdditionalPaidInCapitalMember 2015-09-30 0000010795 us-gaap:DeferredCompensationShareBasedPaymentsMember 2013-09-30 0000010795 us-gaap:AccumulatedTranslationAdjustmentMember 2015-09-30 0000010795 us-gaap:AccumulatedTranslationAdjustmentMember 2012-10-01 2013-09-30 0000010795 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2012-10-01 2013-09-30 0000010795 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2014-09-30 0000010795 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2014-10-01 2015-09-30 0000010795 us-gaap:AccumulatedTranslationAdjustmentMember 2014-09-30 0000010795 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2013-10-01 2014-09-30 0000010795 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2014-10-01 2015-09-30 0000010795 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2013-09-30 0000010795 us-gaap:AccumulatedTranslationAdjustmentMember 2013-10-01 2014-09-30 0000010795 us-gaap:AccumulatedTranslationAdjustmentMember 2014-10-01 2015-09-30 0000010795 us-gaap:AccumulatedTranslationAdjustmentMember 2013-09-30 0000010795 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2015-09-30 0000010795 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2013-10-01 2014-09-30 0000010795 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2014-09-30 0000010795 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2012-10-01 2013-09-30 0000010795 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2012-09-30 0000010795 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2015-09-30 0000010795 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2012-09-30 0000010795 us-gaap:AccumulatedTranslationAdjustmentMember 2012-09-30 0000010795 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2013-09-30 0000010795 2015-03-17 2015-03-17 0000010795 bdx:RtiTechnologiesMember 2013-07-01 2013-09-30 0000010795 country:GB 2015-04-30 0000010795 country:US 2015-04-30 0000010795 bdx:RtiTechnologiesMember 2015-01-15 2015-01-15 0000010795 bdx:RtiTechnologiesMember 2009-11-09 2009-11-09 0000010795 bdx:RtiTechnologiesMember 2014-11-10 2014-11-10 0000010795 2015-04-01 2015-04-30 0000010795 bdx:RtiTechnologiesMember 2013-09-19 2013-09-19 0000010795 us-gaap:CorporateNonSegmentMember 2012-10-01 2013-09-30 0000010795 us-gaap:OperatingSegmentsMember bdx:LifeSciencesMember 2013-10-01 2014-09-30 0000010795 bdx:CareFusionCorporationMember us-gaap:CorporateNonSegmentMember 2014-10-01 2015-09-30 0000010795 bdx:MedicalMember 2013-10-01 2014-09-30 0000010795 bdx:CareFusionCorporationMember bdx:MedicalMember 2014-10-01 2015-09-30 0000010795 us-gaap:CorporateNonSegmentMember 2013-10-01 2014-09-30 0000010795 bdx:CrisiMedicalSystemsIncMember us-gaap:CorporateNonSegmentMember 2014-10-01 2015-09-30 0000010795 us-gaap:CorporateNonSegmentMember bdx:RtiTechnologiesMember 2014-10-01 2015-09-30 0000010795 us-gaap:OperatingSegmentsMember bdx:MedicalMember 2014-10-01 2015-09-30 0000010795 us-gaap:OperatingSegmentsMember 2015-09-30 0000010795 us-gaap:OperatingSegmentsMember bdx:MedicalMember 2012-10-01 2013-09-30 0000010795 us-gaap:OperatingSegmentsMember bdx:LifeSciencesMember 2012-10-01 2013-09-30 0000010795 us-gaap:OperatingSegmentsMember bdx:MedicalMember 2013-10-01 2014-09-30 0000010795 us-gaap:OperatingSegmentsMember 2013-10-01 2014-09-30 0000010795 us-gaap:CorporateNonSegmentMember 2014-10-01 2015-09-30 0000010795 us-gaap:OperatingSegmentsMember bdx:LifeSciencesMember 2014-10-01 2015-09-30 0000010795 us-gaap:CorporateNonSegmentMember 2014-09-30 0000010795 us-gaap:OperatingSegmentsMember bdx:MedicalMember 2014-09-30 0000010795 us-gaap:CorporateNonSegmentMember 2013-09-30 0000010795 us-gaap:OperatingSegmentsMember bdx:LifeSciencesMember 2013-09-30 0000010795 us-gaap:OperatingSegmentsMember 2012-10-01 2013-09-30 0000010795 us-gaap:OperatingSegmentsMember 2013-09-30 0000010795 us-gaap:CorporateNonSegmentMember 2015-09-30 0000010795 us-gaap:OperatingSegmentsMember bdx:MedicalMember 2013-09-30 0000010795 us-gaap:OperatingSegmentsMember 2014-09-30 0000010795 us-gaap:OperatingSegmentsMember bdx:MedicalMember 2015-09-30 0000010795 us-gaap:OperatingSegmentsMember 2014-10-01 2015-09-30 0000010795 us-gaap:OperatingSegmentsMember bdx:LifeSciencesMember 2014-09-30 0000010795 us-gaap:OperatingSegmentsMember bdx:LifeSciencesMember 2015-09-30 0000010795 us-gaap:AsiaMember 2013-09-30 0000010795 us-gaap:EuropeMember 2013-09-30 0000010795 us-gaap:AsiaMember 2014-09-30 0000010795 us-gaap:EuropeMember 2013-10-01 2014-09-30 0000010795 us-gaap:EuropeMember 2014-10-01 2015-09-30 0000010795 us-gaap:AsiaMember 2013-10-01 2014-09-30 0000010795 us-gaap:CorporateMember 2015-09-30 0000010795 bdx:OthersCountryMember 2014-09-30 0000010795 country:US 2014-09-30 0000010795 us-gaap:EuropeMember 2014-09-30 0000010795 bdx:OthersCountryMember 2014-10-01 2015-09-30 0000010795 us-gaap:CorporateMember 2014-09-30 0000010795 us-gaap:AsiaMember 2014-10-01 2015-09-30 0000010795 us-gaap:AsiaMember 2015-09-30 0000010795 bdx:OthersCountryMember 2013-10-01 2014-09-30 0000010795 us-gaap:AsiaMember 2012-10-01 2013-09-30 0000010795 country:US 2013-10-01 2014-09-30 0000010795 country:US 2015-09-30 0000010795 bdx:OthersCountryMember 2013-09-30 0000010795 bdx:OthersCountryMember 2012-10-01 2013-09-30 0000010795 country:US 2014-10-01 2015-09-30 0000010795 us-gaap:CorporateMember 2013-09-30 0000010795 us-gaap:EuropeMember 2012-10-01 2013-09-30 0000010795 country:US 2013-09-30 0000010795 country:US 2012-10-01 2013-09-30 0000010795 bdx:OthersCountryMember 2015-09-30 0000010795 us-gaap:EuropeMember 2015-09-30 0000010795 bdx:ReplacementAwardsMember bdx:CareFusionCorporationMember 2015-09-30 0000010795 bdx:RestrictedStockUnitsPerformancePsuMember us-gaap:MaximumMember 2014-10-01 2015-09-30 0000010795 bdx:CareFusionCorporationMember 2015-09-30 0000010795 us-gaap:RestrictedStockUnitsRSUMember 2012-10-01 2013-09-30 0000010795 bdx:RestrictedStockUnitsPerformancePsuMember 2014-10-01 2015-09-30 0000010795 us-gaap:RestrictedStockUnitsRSUMember 2014-10-01 2015-09-30 0000010795 us-gaap:RestrictedStockUnitsRSUMember bdx:CareFusionCorporationMember 2014-10-01 2015-09-30 0000010795 bdx:RestrictedStockUnitsPerformancePsuMember us-gaap:MinimumMember 2014-10-01 2015-09-30 0000010795 bdx:RestrictedStockUnitsPerformancePsuMember 2013-10-01 2014-09-30 0000010795 us-gaap:DirectorMember 2015-09-30 0000010795 us-gaap:RestrictedStockUnitsRSUMember 2013-10-01 2014-09-30 0000010795 bdx:RestrictedStockUnitsPerformancePsuMember 2012-10-01 2013-09-30 0000010795 us-gaap:RestrictedStockUnitsRSUMember us-gaap:ExecutiveOfficerMember 2014-10-01 2015-09-30 0000010795 us-gaap:CostOfSalesMember 2013-10-01 2014-09-30 0000010795 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2012-10-01 2013-09-30 0000010795 us-gaap:CostOfSalesMember 2012-10-01 2013-09-30 0000010795 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2014-10-01 2015-09-30 0000010795 bdx:AcquisitionRelatedMember 2012-10-01 2013-09-30 0000010795 us-gaap:ResearchAndDevelopmentExpenseMember 2014-10-01 2015-09-30 0000010795 us-gaap:ResearchAndDevelopmentExpenseMember 2013-10-01 2014-09-30 0000010795 us-gaap:ResearchAndDevelopmentExpenseMember 2012-10-01 2013-09-30 0000010795 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2013-10-01 2014-09-30 0000010795 bdx:AcquisitionRelatedMember 2014-10-01 2015-09-30 0000010795 bdx:AcquisitionRelatedMember 2013-10-01 2014-09-30 0000010795 us-gaap:CostOfSalesMember 2014-10-01 2015-09-30 0000010795 us-gaap:StockAppreciationRightsSARSMember 2012-10-01 2013-09-30 0000010795 us-gaap:StockAppreciationRightsSARSMember 2014-10-01 2015-09-30 0000010795 us-gaap:StockAppreciationRightsSARSMember 2013-10-01 2014-09-30 0000010795 us-gaap:RestrictedStockUnitsRSUMember 2014-09-30 0000010795 us-gaap:RestrictedStockUnitsRSUMember 2015-09-30 0000010795 bdx:RestrictedStockUnitsPerformancePsuMember 2015-09-30 0000010795 bdx:RestrictedStockUnitsPerformancePsuMember 2014-09-30 0000010795 bdx:InsuranceContractInvestmentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-09-30 0000010795 bdx:InsuranceContractInvestmentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-10-01 2015-09-30 0000010795 us-gaap:RealEstateMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2013-09-30 0000010795 us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-10-01 2015-09-30 0000010795 us-gaap:RealEstateMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-10-01 2015-09-30 0000010795 us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2013-10-01 2014-09-30 0000010795 us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2013-09-30 0000010795 bdx:InsuranceContractInvestmentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2013-09-30 0000010795 bdx:InsuranceContractInvestmentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2015-09-30 0000010795 us-gaap:RealEstateMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-09-30 0000010795 bdx:InsuranceContractInvestmentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2013-10-01 2014-09-30 0000010795 us-gaap:RealEstateMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2015-09-30 0000010795 us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-09-30 0000010795 us-gaap:RealEstateMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2013-10-01 2014-09-30 0000010795 us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2015-09-30 0000010795 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2015-09-30 0000010795 us-gaap:PensionPlansDefinedBenefitMember 2015-09-30 0000010795 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2014-10-01 2015-09-30 0000010795 us-gaap:ForeignPensionPlansDefinedBenefitMember 2014-10-01 2015-09-30 0000010795 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2014-10-01 2015-09-30 0000010795 us-gaap:PensionPlansDefinedBenefitMember 2012-10-01 2013-09-30 0000010795 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2013-10-01 2014-09-30 0000010795 us-gaap:PensionPlansDefinedBenefitMember 2014-10-01 2015-09-30 0000010795 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2012-10-01 2013-09-30 0000010795 us-gaap:PensionPlansDefinedBenefitMember 2013-10-01 2014-09-30 0000010795 us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2014-09-30 0000010795 us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2014-09-30 0000010795 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2014-09-30 0000010795 bdx:OtherPensionPlanInvestmentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2014-09-30 0000010795 us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2014-09-30 0000010795 us-gaap:CorporateDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2014-09-30 0000010795 bdx:InsuranceContractInvestmentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2014-09-30 0000010795 us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2014-09-30 0000010795 us-gaap:RealEstateMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2014-09-30 0000010795 us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2014-09-30 0000010795 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2014-09-30 0000010795 bdx:OtherFixedIncomeMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-09-30 0000010795 us-gaap:RealEstateMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2014-09-30 0000010795 us-gaap:EquitySecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2014-09-30 0000010795 bdx:OtherFixedIncomeMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2014-09-30 0000010795 bdx:OtherFixedIncomeMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2014-09-30 0000010795 us-gaap:ForeignPensionPlansDefinedBenefitMember 2014-09-30 0000010795 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2014-09-30 0000010795 bdx:OtherFixedIncomeMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2014-09-30 0000010795 bdx:OtherPensionPlanInvestmentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2014-09-30 0000010795 us-gaap:EquitySecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2014-09-30 0000010795 bdx:InsuranceContractInvestmentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2014-09-30 0000010795 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2014-09-30 0000010795 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2014-09-30 0000010795 us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-09-30 0000010795 bdx:OtherPensionPlanInvestmentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-09-30 0000010795 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-09-30 0000010795 us-gaap:CorporateDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2014-09-30 0000010795 bdx:OtherPensionPlanInvestmentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2014-09-30 0000010795 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-09-30 0000010795 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2014-09-30 0000010795 bdx:InsuranceContractInvestmentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2014-09-30 0000010795 us-gaap:CorporateDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-09-30 0000010795 us-gaap:EquitySecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-09-30 0000010795 us-gaap:EquitySecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2014-09-30 0000010795 us-gaap:CorporateDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2014-09-30 0000010795 us-gaap:RealEstateMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2014-09-30 0000010795 us-gaap:CashAndCashEquivalentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2015-09-30 0000010795 us-gaap:CashAndCashEquivalentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2015-09-30 0000010795 us-gaap:EquitySecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2015-09-30 0000010795 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2015-09-30 0000010795 us-gaap:EquitySecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2015-09-30 0000010795 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2015-09-30 0000010795 bdx:OtherPensionPlanInvestmentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2015-09-30 0000010795 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2015-09-30 0000010795 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2015-09-30 0000010795 us-gaap:CorporateDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2015-09-30 0000010795 us-gaap:CashAndCashEquivalentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2015-09-30 0000010795 us-gaap:AssetBackedSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2015-09-30 0000010795 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2015-09-30 0000010795 bdx:OtherPensionPlanInvestmentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2015-09-30 0000010795 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2015-09-30 0000010795 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2015-09-30 0000010795 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2015-09-30 0000010795 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2015-09-30 0000010795 us-gaap:CorporateDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2015-09-30 0000010795 us-gaap:EquitySecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2015-09-30 0000010795 bdx:OtherPensionPlanInvestmentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2015-09-30 0000010795 us-gaap:CorporateDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2015-09-30 0000010795 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2015-09-30 0000010795 us-gaap:AssetBackedSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2015-09-30 0000010795 us-gaap:EquitySecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2015-09-30 0000010795 us-gaap:CorporateDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2015-09-30 0000010795 bdx:OtherPensionPlanInvestmentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2015-09-30 0000010795 us-gaap:AssetBackedSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2015-09-30 0000010795 us-gaap:AssetBackedSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2015-09-30 0000010795 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2015-09-30 0000010795 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2015-09-30 0000010795 us-gaap:CashAndCashEquivalentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2015-09-30 0000010795 bdx:OtherPensionPlanInvestmentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-10-01 2015-09-30 0000010795 bdx:OtherPensionPlanInvestmentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-09-30 0000010795 bdx:OtherPensionPlanInvestmentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2013-10-01 2014-09-30 0000010795 bdx:OtherPensionPlanInvestmentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2013-09-30 0000010795 us-gaap:FixedIncomeFundsMember 2014-10-01 2015-09-30 0000010795 us-gaap:ForeignPensionPlansDefinedBenefitMember 2015-09-30 0000010795 us-gaap:EquitySecuritiesMember 2014-10-01 2015-09-30 0000010795 2014-07-01 2014-09-30 0000010795 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:MinimumMember 2015-09-30 2015-09-30 0000010795 us-gaap:ForeignPensionPlansDefinedBenefitMember 2013-10-01 2014-09-30 0000010795 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2014-09-30 0000010795 us-gaap:ChangeInAssumptionsForPensionPlansMember 2015-09-30 0000010795 bdx:CareFusionCorporationMember 2014-10-01 2015-09-30 0000010795 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2013-09-30 0000010795 us-gaap:ForeignPensionPlansDefinedBenefitMember 2012-10-01 2013-09-30 0000010795 bdx:DiversifiedMember 2014-10-01 2015-09-30 0000010795 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:MaximumMember 2015-09-30 2015-09-30 0000010795 us-gaap:CorporateDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2015-09-30 0000010795 bdx:OtherFixedIncomeMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2015-09-30 0000010795 us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2015-09-30 0000010795 bdx:OtherPensionPlanInvestmentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2015-09-30 0000010795 bdx:InsuranceContractInvestmentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2015-09-30 0000010795 us-gaap:EquitySecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2015-09-30 0000010795 bdx:OtherPensionPlanInvestmentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2015-09-30 0000010795 bdx:OtherFixedIncomeMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2015-09-30 0000010795 bdx:InsuranceContractInvestmentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2015-09-30 0000010795 us-gaap:CorporateDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2015-09-30 0000010795 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2015-09-30 0000010795 us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2015-09-30 0000010795 us-gaap:EquitySecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2015-09-30 0000010795 us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2015-09-30 0000010795 us-gaap:RealEstateMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2015-09-30 0000010795 us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2015-09-30 0000010795 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2015-09-30 0000010795 us-gaap:EquitySecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2015-09-30 0000010795 bdx:OtherPensionPlanInvestmentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2015-09-30 0000010795 us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2015-09-30 0000010795 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2015-09-30 0000010795 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2015-09-30 0000010795 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2015-09-30 0000010795 us-gaap:CorporateDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2015-09-30 0000010795 us-gaap:RealEstateMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2015-09-30 0000010795 us-gaap:CashAndCashEquivalentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2015-09-30 0000010795 bdx:OtherFixedIncomeMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2015-09-30 0000010795 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2015-09-30 0000010795 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2015-09-30 0000010795 bdx:OtherPensionPlanInvestmentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2015-09-30 0000010795 bdx:OtherFixedIncomeMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2015-09-30 0000010795 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2015-09-30 0000010795 us-gaap:EquitySecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2015-09-30 0000010795 us-gaap:RealEstateMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2015-09-30 0000010795 bdx:InsuranceContractInvestmentsMember us-gaap:ForeignPensionPlansDefinedBenefitMember 2015-09-30 0000010795 us-gaap:CorporateDebtSecuritiesMember us-gaap:ForeignPensionPlansDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2015-09-30 0000010795 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-09-30 0000010795 us-gaap:CorporateDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2014-09-30 0000010795 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2014-09-30 0000010795 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2014-09-30 0000010795 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-09-30 0000010795 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2014-09-30 0000010795 us-gaap:EquitySecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2014-09-30 0000010795 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2014-09-30 0000010795 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2014-09-30 0000010795 us-gaap:CashAndCashEquivalentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2014-09-30 0000010795 us-gaap:CorporateDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-09-30 0000010795 us-gaap:CorporateDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2014-09-30 0000010795 us-gaap:CorporateDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2014-09-30 0000010795 bdx:OtherPensionPlanInvestmentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2014-09-30 0000010795 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2014-09-30 0000010795 us-gaap:AssetBackedSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2014-09-30 0000010795 us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2014-09-30 0000010795 us-gaap:EquitySecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2014-09-30 0000010795 us-gaap:CashAndCashEquivalentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2014-09-30 0000010795 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2014-09-30 0000010795 us-gaap:USGovernmentAgenciesDebtSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2014-09-30 0000010795 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-09-30 0000010795 bdx:OtherPensionPlanInvestmentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel1Member 2014-09-30 0000010795 us-gaap:EquitySecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-09-30 0000010795 us-gaap:AssetBackedSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-09-30 0000010795 us-gaap:AssetBackedSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2014-09-30 0000010795 us-gaap:EquitySecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2014-09-30 0000010795 us-gaap:CashAndCashEquivalentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2014-09-30 0000010795 bdx:OtherPensionPlanInvestmentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel2Member 2014-09-30 0000010795 us-gaap:AssetBackedSecuritiesMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2014-09-30 0000010795 us-gaap:CashAndCashEquivalentsMember us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember us-gaap:FairValueInputsLevel3Member 2014-09-30 0000010795 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2012-10-01 2013-09-30 0000010795 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2013-10-01 2014-09-30 0000010795 us-gaap:ForeignPensionPlansDefinedBenefitMember 2013-09-30 0000010795 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2013-09-30 0000010795 us-gaap:PensionPlansDefinedBenefitMember 2014-09-30 0000010795 us-gaap:PensionPlansDefinedBenefitMember 2013-09-30 0000010795 bdx:CareFusionCorporationMember 2015-03-17 2015-03-17 0000010795 bdx:CareFusionCorporationMember 2015-03-17 0000010795 bdx:CareFusionCorporationMember 2015-03-16 0000010795 bdx:CareFusionCorporationMember us-gaap:TrademarksMember 2015-03-17 2015-03-17 0000010795 bdx:CareFusionCorporationMember us-gaap:InProcessResearchAndDevelopmentMember 2015-03-17 2015-03-17 0000010795 bdx:CareFusionCorporationMember us-gaap:InProcessResearchAndDevelopmentMember us-gaap:MinimumMember 2015-03-17 2015-03-17 0000010795 bdx:CareFusionCorporationMember us-gaap:CustomerRelationshipsMember 2015-03-17 2015-03-17 0000010795 bdx:CareFusionCorporationMember bdx:DevelopedTechnologyMember 2015-03-17 2015-03-17 0000010795 bdx:CareFusionCorporationMember us-gaap:InProcessResearchAndDevelopmentMember us-gaap:MaximumMember 2015-03-17 2015-03-17 0000010795 bdx:CareFusionCorporationMember us-gaap:InProcessResearchAndDevelopmentMember 2015-03-17 0000010795 bdx:CareFusionCorporationMember 2013-10-01 2014-09-30 0000010795 bdx:DiscoveryLabwareMember 2012-10-31 2012-10-31 0000010795 bdx:DiscoveryLabwareMember 2013-04-01 2013-06-30 0000010795 us-gaap:OtherRestructuringMember 2014-09-30 0000010795 us-gaap:OtherRestructuringMember 2014-10-01 2015-09-30 0000010795 us-gaap:EmployeeSeveranceMember 2014-10-01 2015-09-30 0000010795 bdx:ShareBasedCompensationMember 2014-10-01 2015-09-30 0000010795 us-gaap:EmployeeSeveranceMember 2014-09-30 0000010795 bdx:ShareBasedCompensationMember 2015-09-30 0000010795 us-gaap:OtherRestructuringMember 2015-09-30 0000010795 us-gaap:EmployeeSeveranceMember 2015-09-30 0000010795 bdx:ShareBasedCompensationMember 2014-09-30 0000010795 bdx:GenCellBiosystemsMember 2014-12-31 0000010795 bdx:CellularResearchMember 2015-09-30 0000010795 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember bdx:MedicalMember 2014-10-01 2015-09-30 0000010795 2015-07-01 2015-09-30 0000010795 bdx:CrisiMedicalSystemsIncMember 2015-03-31 0000010795 bdx:MedicalMember 2014-10-01 2015-09-30 0000010795 bdx:LifeSciencesMember 2013-09-30 0000010795 bdx:MedicalMember 2013-09-30 0000010795 bdx:MedicalMember 2014-09-30 0000010795 bdx:LifeSciencesMember 2013-10-01 2014-09-30 0000010795 bdx:MedicalMember 2015-09-30 0000010795 bdx:LifeSciencesMember 2014-09-30 0000010795 bdx:LifeSciencesMember 2015-09-30 0000010795 bdx:LifeSciencesMember 2014-10-01 2015-09-30 0000010795 us-gaap:CustomerRelationshipsMember 2015-09-30 0000010795 us-gaap:DevelopedTechnologyRightsMember 2015-09-30 0000010795 us-gaap:TrademarksMember 2014-09-30 0000010795 us-gaap:DevelopedTechnologyRightsMember 2014-09-30 0000010795 us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember 2014-09-30 0000010795 us-gaap:IntellectualPropertyMember 2014-09-30 0000010795 bdx:ProductRightsMember 2014-09-30 0000010795 bdx:ProductRightsMember 2015-09-30 0000010795 us-gaap:TrademarksMember 2015-09-30 0000010795 us-gaap:IntellectualPropertyMember 2015-09-30 0000010795 us-gaap:TrademarksMember 2014-09-30 0000010795 us-gaap:CustomerRelationshipsMember 2014-09-30 0000010795 us-gaap:TrademarksMember 2015-09-30 0000010795 us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember 2015-09-30 0000010795 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember bdx:OtherIncomeExpenseMember 2014-10-01 2015-09-30 0000010795 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember bdx:OtherIncomeExpenseMember 2012-10-01 2013-09-30 0000010795 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember bdx:OtherIncomeExpenseMember 2013-10-01 2014-09-30 0000010795 bdx:CareFusionCorporationMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2014-10-01 2015-09-30 0000010795 us-gaap:CommodityContractMember 2015-04-01 2015-04-30 0000010795 us-gaap:ForeignExchangeContractMember 2015-09-30 0000010795 us-gaap:ForeignExchangeContractMember 2014-09-30 0000010795 bdx:CareFusionCorporationMember us-gaap:InterestRateSwapMember 2014-12-31 0000010795 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2015-09-30 0000010795 us-gaap:CommodityContractMember 2014-10-01 2015-09-30 0000010795 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember 2014-10-01 2015-09-30 0000010795 bdx:FixedToFloatingMember 2015-09-30 0000010795 us-gaap:CommodityContractMember 2014-09-30 0000010795 us-gaap:CashFlowHedgingMember 2014-10-01 2015-09-30 0000010795 us-gaap:CommodityContractMember 2015-09-30 0000010795 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2015-09-30 0000010795 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-09-30 0000010795 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2014-09-30 0000010795 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2014-09-30 0000010795 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-09-30 0000010795 us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2014-09-30 0000010795 bdx:FixedToFloatingMember 2014-09-30 0000010795 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2014-09-30 0000010795 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-30 0000010795 us-gaap:FairValueMeasurementsRecurringMember 2015-09-30 0000010795 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-30 0000010795 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2015-09-30 0000010795 bdx:NotesDueJune2016Member 2015-09-30 0000010795 bdx:NotesDueJune2016Member 2015-06-30 0000010795 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-30 0000010795 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-30 0000010795 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2014-09-30 0000010795 us-gaap:FairValueMeasurementsRecurringMember 2014-09-30 0000010795 us-gaap:ForeignLineOfCreditMember 2015-09-30 0000010795 us-gaap:ForeignLineOfCreditMember 2014-09-30 0000010795 us-gaap:DomesticLineOfCreditMember 2015-09-30 0000010795 us-gaap:DomesticLineOfCreditMember 2014-09-30 0000010795 bdx:CareFusionCorporationMember bdx:CommercialPaperProgramMember 2015-09-30 0000010795 bdx:TermLoanFacilityMember 2015-04-01 2015-04-30 0000010795 us-gaap:BridgeLoanMember 2014-10-05 2014-10-05 0000010795 bdx:TermLoanFacilityMember 2015-09-30 0000010795 bdx:TermLoanFacilityMember 2015-09-01 2015-09-30 0000010795 bdx:CareFusionCorporationMember us-gaap:UnsecuredDebtMember 2015-03-31 0000010795 bdx:SyndicatedCreditFacilityMember bdx:DomesticDebtMember 2015-09-30 0000010795 bdx:SyndicatedCreditFacilityMember 2015-09-30 0000010795 us-gaap:UnsecuredDebtMember 2015-09-30 0000010795 bdx:TermLoanFacilityMember 2014-12-01 2014-12-31 0000010795 bdx:FormerCommercialPaperProgramMember 2015-02-28 0000010795 bdx:CommercialPaperProgramMember 2015-09-30 0000010795 bdx:SyndicatedCreditFacilityMember bdx:DomesticDebtMember 2014-10-01 2015-09-30 0000010795 bdx:TermLoanFacilityMember 2014-12-31 0000010795 bdx:CareFusionCorporationMember us-gaap:UnsecuredDebtMember 2015-03-17 0000010795 bdx:TermLoanFacilityMember 2015-07-01 2015-07-31 0000010795 bdx:CareFusionCorporationMember us-gaap:UnsecuredDebtMember 2015-09-30 0000010795 bdx:Notes1.450dueMay152017Member 2014-09-30 0000010795 bdx:Notes3.300dueMarch12023Member 2015-09-30 0000010795 bdx:Notes3.875dueMay152024Member 2015-09-30 0000010795 bdx:Notes4.685DueDecember142044Member 2015-09-30 0000010795 bdx:NotesDue2021Member 2015-09-30 0000010795 bdx:NotesDue2019Member 2014-09-30 0000010795 bdx:NotesDue2019Member 2015-09-30 0000010795 bdx:NotesDue2021Member 2014-09-30 0000010795 bdx:NotesDue2016Member 2015-09-30 0000010795 bdx:OtherLongtermDebtMember 2015-09-30 0000010795 bdx:NotesDue2016Member 2014-09-30 0000010795 bdx:Notes3.374DueDecember152024Member 2015-09-30 0000010795 bdx:DebenturesDue2027Member 2014-09-30 0000010795 bdx:Notes4.875DueMay152044Member 2014-09-30 0000010795 bdx:Notes4.875DueMay152044Member 2015-09-30 0000010795 bdx:Notes2.675dueDecember152019Member 2014-09-30 0000010795 bdx:DebenturesDue2028Member 2014-09-30 0000010795 bdx:Notes1.800dueDecember152017Member 2015-09-30 0000010795 bdx:NotesDue2018Member 2014-09-30 0000010795 bdx:NotesDue2039Member 2015-09-30 0000010795 bdx:Notes3.875dueMay152024Member 2014-09-30 0000010795 bdx:Notes1.800dueDecember152017Member 2014-09-30 0000010795 bdx:Notes4.685DueDecember142044Member 2014-09-30 0000010795 bdx:Notes6.375DueAugust12019Member 2014-09-30 0000010795 bdx:NotesDue2040Member 2015-09-30 0000010795 bdx:NotesDue2020Member 2015-09-30 0000010795 bdx:NotesDue2039Member 2014-09-30 0000010795 bdx:DebenturesDue2028Member 2015-09-30 0000010795 bdx:Notes1.450dueMay152017Member 2015-09-30 0000010795 bdx:DebenturesDue2027Member 2015-09-30 0000010795 bdx:Notes3.374DueDecember152024Member 2014-09-30 0000010795 bdx:NotesDue2020Member 2014-09-30 0000010795 bdx:NotesDue2040Member 2014-09-30 0000010795 bdx:Notes6.375DueAugust12019Member 2015-09-30 0000010795 bdx:Notes3.300dueMarch12023Member 2014-09-30 0000010795 bdx:NotesDue2018Member 2015-09-30 0000010795 bdx:OtherLongtermDebtMember 2014-09-30 0000010795 bdx:Notes2.675dueDecember152019Member 2015-09-30 0000010795 bdx:CareFusionCorporationMember bdx:Notes4.875DueMay152044Member 2015-09-30 0000010795 bdx:CareFusionCorporationMember bdx:Notes3.875dueMay152024Member 2015-09-30 0000010795 bdx:CareFusionCorporationMember bdx:Notes1.450dueMay152017Member 2015-09-30 0000010795 bdx:CareFusionCorporationMember bdx:Notes3.300dueMarch12023Member 2015-09-30 0000010795 bdx:CareFusionCorporationMember bdx:Notes6.375DueAugust12019Member 2015-09-30 0000010795 us-gaap:OtherNoncurrentLiabilitiesMember 2015-09-30 0000010795 bdx:DiscoveryLabwareMember 2012-10-01 2013-09-30 0000010795 bdx:DiscoveryLabwareMember 2013-10-01 2014-09-30 0000010795 us-gaap:ReserveForCashDiscountMember 2013-10-01 2014-09-30 0000010795 us-gaap:ReserveForCashDiscountMember 2012-09-30 0000010795 us-gaap:AllowanceForDoubtfulAccountsMember 2013-10-01 2014-09-30 0000010795 us-gaap:ReserveForCashDiscountMember 2014-10-01 2015-09-30 0000010795 us-gaap:AllowanceForDoubtfulAccountsMember 2012-10-01 2013-09-30 0000010795 us-gaap:AllowanceForDoubtfulAccountsMember 2013-09-30 0000010795 us-gaap:AllowanceForDoubtfulAccountsMember 2014-10-01 2015-09-30 0000010795 us-gaap:ReserveForCashDiscountMember 2014-09-30 0000010795 us-gaap:AllowanceForDoubtfulAccountsMember 2015-09-30 0000010795 us-gaap:ReserveForCashDiscountMember 2013-09-30 0000010795 us-gaap:AllowanceForDoubtfulAccountsMember 2014-09-30 0000010795 us-gaap:ReserveForCashDiscountMember 2015-09-30 0000010795 us-gaap:AllowanceForDoubtfulAccountsMember 2012-09-30 0000010795 us-gaap:ReserveForCashDiscountMember 2012-10-01 2013-09-30 0000010795 2015-04-01 2015-06-30 0000010795 2014-10-01 2014-12-31 0000010795 2015-01-01 2015-03-31 0000010795 2013-10-01 2013-12-31 0000010795 2014-01-01 2014-03-31 0000010795 2014-04-01 2014-06-30 bdx:installment iso4217:USD bdx:customer iso4217:USD xbrli:shares xbrli:pure bdx:segment xbrli:shares utreg:lb 20000000 16000000 145000000 107000000 205300000.0 49.00 184000000 0.0777 107000000 3360000000 49000000 42000000 2510000000 1299000000 380000000 1208000000 185000000 0 0 426000000 11000000 P5Y -18000000 5000000 5000000 0 10000000 0 10000000 36000 36000 5000 19000000 20000000 0 0 14000000 14000000 0 0 77000000 77000000 513000000 2977000000 3000 5 93000000 9000000 11000000 656000000 2795000000 0.0487 0.0056 0.715 0.453 235000000 68000 750000000 30000000 25000000 22000000 8000000 3250000000 42000000 217000000 500000000 P5Y 0.5 P1Y P3M 13000000 0 0 0 5 58000 50000 9100000000 0.67 0.33 0.13 2.00 0.9764 0.9795 0.9937 0.9996 0.9500 P5Y 0.25 -1000000 22000000 21000000 21000000 18000000 -2000000 -2000000 -2000000 30000000 25000000 6000000 7000000 6000000 22000000 20000000 18000000 0.0400 0.0375 0.0375 341000000 51000000 0.85 0.8 36000000 293000000 821000000 1277000000 19000000 0 19000000 0 542000 2878000 97.09 100.65 60000000 P4Y3M15D 79.10 P4Y 4725000 76.18 1458000 54000000 69000000 96000000 167000 1037000 134.73 333000000 7852000 7264000 78.49 87.07 P5Y11M16D P10Y 327000000 7010000 86.34 267000000 P4Y9M22D 72.88 103.50 P5Y10M17D 19000000 26000000 34000000 2 0 P3Y 345000 1000000000 1000000000 691000 528000 500000000 P10Y 36000000 5000000 10000000 21000000 4000000 false --09-30 FY 2015 2015-09-30 10-K 0000010795 210736542 Yes Large Accelerated Filer 30013657226 BECTON DICKINSON & CO No Yes 375000000 0 1800000000 0 2300000000 375000000 25000000 2200000000 0

401000000

631000000

26000000

33000000

1053000000

1624000000

4160000000

4217000000

-802000000

-815000000

-38000000

51000000

-516000000

-558000000

-31000000

74000000

-1001000000

-705000000

-26000000

-270000000

-1738000000

-741000000

-36000000

-961000000

P12Y

P15Y

P22Y

2198000000

4475000000

98000000

111000000

164000000

100000000

20000000

14000000

66000000

113000000

23000000

16000000

74000000

166000000

44000000

23000000

17000000

82000000

83000000

84000000

346000000

284000000

72000000

12149000000

3792000000

8357000000

3776000000

4582000000

12447000000

3997000000

8451000000

3783000000

4668000000

26820000000

2833000000

23987000000

3932000000

20055000000

6131000000

6045000000

1040000000

23000000

1063000000

147000000

32000000

179000000

2313000000

2414000000

5.55

5.92

1191000000

1276000000

12288000000

12368000000

1000000

4000000

59000000

12538000000

2269000000

36000000

28000000

95000000

-242000000

2000000000

11709000000

1903000000

321000000

530000000

2034000000

81000000

19000000

110000000

813000000

5514000000

6195000000

2181000000

2174000000

499000000

9000000

6000000

413000000

3000000

79000000

187000000

275000000

355000000

5000000

75000000

9000000

1118000000

75000000

1118000000

5000000

142000000

29000000

1311000000

38000000

41000000

65000000

20000000

365000000

362000000

1671000000

1890000000

1861000000

1424000000

1040000000

147000000

219000000

-29000000

-436000000

1.98

2.18

2.40

640000000

119000

332662160

333000000

1579000000

699000000

-42000000

3883000000

4145000000

5587000000

6800000000

6840000000

9207000000

177000000

225000000

50000000

179000000

217000000

252000000

352000000

431000000

318000000

-4000000

-11000000

15000000

203000000

1452000000

2000000000

750000000

6200000000.0

0.03125

0.07000

0.06700

0.01450

0.018

0.02675

0.0330

0.03734

0.03875

0.04685

0.04875

0.06375

0.01750

0.04900

0.05000

0.03250

0.03125

0.06000

0.05000

P364D

-119000000

-59000000

-238000000

3000000

-35000000

-37000000

-116000000

-94000000

-274000000

656000000

2795000000

1218000000

1819000000

971000000

1367000000

355000000

387000000

100000000

142000000

398000000

634000000

274000000

538000000

546000000

647000000

247000000

452000000

10000000

5000000

130000000

1951000000

195000000

606000000

266000000

2033000000

196000000

156000000

-2000000

-911000000

7000000

-1021000000

44000000

1030000000

30000000

1124000000

42000000

119000000

37000000

103000000

119000000

-21000000

1000000

4000000

-318000000

11000000

-49000000

-4000000

-75000000

-2000000

-49000000

-3000000

-68000000

-1000000

-13000000

-4000000

-15000000

-5000000

-15000000

-201000000

-537000000

-186000000

-694000000

3000000

7000000

0.0387

0.0440

0.0495

0.0314

0.0385

0.0415

0.0284

0.0395

0.0415

0.0246

0.0425

0.0249

0.0425

0.0233

0.0425

0.0394

0.0390

0.0387

0.0495

0.0314

0.0415

0.0568

0.0775

0.0568

0.0775

0.0545

0.0750

0.0328

0.0425

0.0246

0.0425

0.0249

0.0425

243000000

2076000000

765000000

201000000

2366000000

780000000

186000000

2426000000

24000000

142000000

18000000

138000000

67000000

54000000

104000000

65000000

67000000

870000000

15000000

163000000

15000000

175000000

15000000

177000000

15000000

164000000

15000000

164000000

116000000

126000000

123000000

81000000

12000000

1000000

83000000

1785000000

78000000

47000000

46000000

1000000

47000000

12000000

35000000

193000000

96000000

93000000

4000000

150000000

15000000

26000000

35000000

213000000

105000000

108000000

237000000

221000000

17000000

393000000

56000000

337000000

100000000

59000000

41000000

126000000

74000000

51000000

10000000

3000000

153000000

124000000

29000000

574000000

357000000

138000000

78000000

1829000000

1255000000

483000000

768000000

4000000

90000000

48000000

46000000

2000000

74000000

53000000

21000000

123000000

30000000

91000000

2000000

192000000

8000000

96000000

33000000

3000000

30000000

240000000

100000000

139000000

206000000

187000000

19000000

335000000

75000000

260000000

101000000

65000000

36000000

95000000

46000000

49000000

13000000

1000000

78000000

53000000

24000000

575000000

364000000

121000000

90000000

1732000000

1157000000

401000000

755000000

2000000

-6000000

-29000000

-9000000

-58000000

-201000000

-537000000

-186000000

-694000000

-2000000

-79000000

5000000

15000000

0.070

0.068

10000000

87000000

9000000

93000000

7000000

87000000

33000000

19000000

123000000

25000000

10000000

74000000

32000000

9000000

93000000

-6000000

42000000

-3000000

81000000

2186000000

2265000000

1738000000

1650000000

2267000000

2339000000

37000000

1000000

2000000

2324000000

2394000000

1784000000

1693000000

3000000

4000000

3000000

16000000

1000000

16000000

-6000000

-3000000

6000000

84000000

3000000

71000000

3000000

77000000

7000000

0.34

0.31

0.35

-2000000

-13000000

-1000000

-3000000

1000000

-3000000

1000000

0.050

0.040

36000000

39000000

54000000

338000000

369000000

417000000

546000000

19000000

267000000

259000000

562000000

18000000

251000000

293000000

891000000

17000000

256000000

619000000

23000000

20000000

3000000

32000000

13000000

19000000

14000000

30000000

10000000

21000000

-8000000

-7000000

-16000000

49000000

16000000

577000000

355000000

586000000

222000000

20000000

386000000

421000000

485000000

6.63

1.40

1.48

1.69

1.56

6.13

1.22

1.10

0.30

0.86

3.43

6.49

1.37

1.45

1.65

1.53

5.99

1.20

1.08

0.29

0.84

3.35

-7000000

-20000000

-38000000

0.202

0.221

0.059

0.350

-0.001

0.006

-0.012

-0.005

-0.036

0.097

0.112

0.245

0.038

0.011

0.016

551000000

647000000

156000000

38000000

P1Y10M4D

35000000

40000000

59000000

21000000

7000000

20000000

23000000

27000000

48000000

0.11

0.12

0.11

P20Y

P15Y

P40Y

P1Y

594000000

31000000

2000000

379000000

163000000

19000000

903000000

35000000

120000000

510000000

212000000

26000000

558000000

518000000

519000000

523000000

535000000

1308000000

148000000

10000000

893000000

232000000

27000000

7723000000

128000000

3370000000

3487000000

333000000

405000000

20000000

13000000

14000000

21000000

-10000000

-13000000

-1000000

-3000000

-49000000

8000000

1109000000

598000000

511000000

1090000000

608000000

482000000

7537000000

730000000

6807000000

6343000000

13000000

6716000000

22000000

130000000

6585000000

-32000000

-3000000

-29000000

-269000000

-8000000

-261000000

17000000

1035000000

1053000000

1111000000

1103000000

4301000000

1045000000

1046000000

1174000000

1430000000

4695000000

5000000

929000000

1185000000

695000000

288000000

532000000

-408000000

877000000

990000000

1147000000

1165000000

-976000000

2140000000

907000000

1233000000

1522000000

-630000000

2152000000

861000000

1291000000

739000000

-1629000000

2368000000

839000000

1530000000

4.76

6.13

3.43

4.67

5.99

3.35

364000000

1.86

0.00

1.83

0.00

5000000

13000000

9000000

236000000

337000000

44000000

95000000

108000000

102000000

454000000

330000000

240000000

1000000

7000000

2000000

366000000

199000000

145000000

-36000000

32000000

336000000

3000000

19000000

-28000000

145000000

189000000

-200000000

1000000

-62000000

-11000000

-51000000

-29000000

28000000

60000000

120000000

97000000

46000000

2000000

44000000

205000000

2000000

203000000

33000000

32000000

30000000

171000000

167000000

401000000

138000000

135000000

371000000

143000000

135000000

313000000

-6000000

3000000

19000000

987000000

1295000000

1495000000

1959000000

248000000

384000000

260000000

280000000

40000000

46000000

15000000

93000000

146000000

88000000

114000000

12447000000

26820000000

2235000000

4386000000

14000000

29000000

30000000

77000000

108000000

1000000000

1500000000

22000000

4100000000

11600000000

752000000

750000000

1250000000

1200000000

1450000000

800000000

3768000000

168000000

167000000

499000000

202000000

497000000

697000000

997000000

246000000

296000000

11370000000

1949000000

293000000

294000000

397000000

300000000

665000000

168000000

167000000

300000000

1246000000

1244000000

305000000

1739000000

419000000

1190000000

334000000

802000000

499000000

202000000

497000000

697000000

1013000000

246000000

296000000

5000000

958000000

12000000

5000000

113500000

341000000

5271000000

5602000000

-212000000

-968000000

-807000000

6190000000

-311000000

-948000000

-8318000000

1717000000

1746000000

1730000000

1293000000

271000000

287000000

326000000

301000000

1185000000

236000000

216000000

62000000

181000000

695000000

1193000000

6276000000

350000000

505000000

3251000000

519000000

1649000000

6317000000

340000000

505000000

3126000000

555000000

1790000000

20774000000

332000000

484000000

15513000000

569000000

3876000000

1254000000

1606000000

1074000000

80000000

18000000

26000000

36000000

62000000

24000000

70000000

71000000

89000000

698000000

950000000

488000000

673000000

121000000

-86000000

-47000000

-30000000

-17000000

-23000000

228000000

203000000

2000000

23000000

-524000000

-180000000

-344000000

-787000000

-80000000

-16000000

-692000000

7000000

5000000

-9000000

23000000

-344000000

-692000000

286000000

-486000000

-737000000

-257000000

147000000

36000000

-10000000

239000000

797000000

383000000

2767000000

11000000

3000000

9000000

5000000

21000000

884000000

20000000

99000000

84000000

110000000

225000000

171000000

-840000000

450000000

400000000

94000000

74000000

20000000

66000000

61000000

37000000

386000000

421000000

485000000

10085000000

136000000

40000000

8414000000

522000000

9000000

158000000

354000000

592000000

16000000

155000000

420000000

596000000

14000000

168000000

414000000

16000000

8000000

15000000

10000000

1009000000

184000000

531000000

1133000000

171000000

691000000

186000000

184000000

163000000

47000000

42000000

740000000

736000000

6164000000

44000000

-9000000

-27000000

-199000000

-4000000

497000000

64000000

17000000

75000000

7765000000

8277000000

3605000000

4060000000

P45Y

P20Y

P12Y

P1Y

P13Y

P4Y

1187000000

1618000000

-59000000

-54000000

-4000000

-38000000

-33000000

-5000000

-50000000

-44000000

-6000000

6000000

100000000

650000000

250000000

494000000

550000000

632000000

271000000

44000000

126000000

102000000

62000000

-91000000

-9000000

-81000000

44000000

12105000000

12314000000

3000000

2000000

8054000000

3748000000

4306000000

1168000000

3353000000

1344000000

2189000000

2015000000

2072000000

2157000000

2202000000

8446000000

3872000000

4573000000

1210000000

3417000000

1437000000

2383000000

2051000000

3120000000

3059000000

10282000000

3822000000

6460000000

1234000000

5069000000

1545000000

2434000000

2422000000

2145000000

2563000000

126000000

100000000

113000000

166000000

P3Y

P1Y

330000

766000

79.12

107.50

352000

1946000

1000000

72.14

70.99

12.08

110.58

102.74

19.90

148.04

136.30

24.82

1255000

3015000

1500000

1139000

3067000

83.47

80.03

106.07

101.88

P1Y0M15D

P1Y1M

139000

1128000

52000000

10000000

45000000

16000000

181000000

72.12

99.07

0.0260

0.0200

0.0178

0.210

0.190

0.0133

0.0231

0.0220

7242000

865000

74.82

65000000

21000000

52000000

7000

73.41

1971000

61000000

74000

1139000

54.57

79.47

83.70

82.32

142.29

P8Y

P7Y9M18D

P7Y7M9D

50000000

P3Y11M27D

P4Y3M22D

1111000

285000000

299000000

351000000

200000000

3000000

700000000

200000000

0.0040

0.0064

15900000

15959000

2537000

1431000

2839000

900000

2083000000

368000000

50000000

15000000

19000000

3000000

30000000

1000000

-2000000

-6000000

1920000000

333000000

19000000

10435000000

-7769000000

2068000000

333000000

19000000

11342000000

-8204000000

5053000000

2198000000

333000000

19000000

12105000000

-8601000000

7164000000

4475000000

333000000

20000000

12314000000

-8239000000

135751000

138663000

140770158

140770000

121966516

121967000

5485000

3574000

8601000000

8239000000

450000000

400000000

7500000000

134000000

146000000

197000000

575000000

8000000

10000000

84000000

2000000

8000000

314000000

80000000

51000000

58000000

25000000

9000000

17000000

45000000

36000000

9000000

50000000

41000000

9000000

42000000

30000000

12000000

62000000

53000000

9000000

49000000

9000000

40000000

46000000

6000000

41000000

80000000

33000000

47000000

44000000

3000000

41000000

54000000

16000000

38000000

61000000

11000000

50000000

4036000

4410000

4972000

199193000

197709000

207509000

195157000

193299000

202537000

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:center;text-indent:30px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:517px;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="385px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="119px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Future minimum lease payments receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,311</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unguaranteed residual values</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unearned income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(142</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for uncollectible minimum lease payments receivable</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Investment in Sales-Type Leases</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,193</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Current portion of net investment in sales-type leases</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Investment in Sales-Type Leases, Less Current Portion</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,118</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of interest costs and payments for the years ended September 30 is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="56%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Charged to operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">371</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capitalized</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total interest costs</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">401</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">171</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest paid, net of amounts capitalized</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">313</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">143</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Postemployment benefit costs for the years ended September 30 included the following components:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="57%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of prior service credit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net postemployment benefit cost</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides the fair value measurements of foreign plan assets, as well as the measurement techniques and inputs utilized to measure fair value of these assets, at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="37%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total Foreign</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Plan Asset</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balances at</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Active Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">for Identical</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets (Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs (Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs (Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed Income:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate bonds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government and agency-U.S.</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government and agency-Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other fixed income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">206</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">187</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Real estate</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of plan assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">575</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">364</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="37%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total Foreign<br clear="none"/>Plan Asset<br clear="none"/>Balances at<br clear="none"/>September 30,<br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in<br clear="none"/>Active Markets<br clear="none"/>for Identical<br clear="none"/>Assets (Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant<br clear="none"/>Other<br clear="none"/>Observable<br clear="none"/>Inputs (Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant<br clear="none"/>Unobservable<br clear="none"/>Inputs (Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed Income:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate bonds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government and agency-U.S.</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government and agency-Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other fixed income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">237</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">221</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Real estate</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of plan assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">574</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">357</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of consideration transferred was </font><font style="font-family:inherit;font-size:10pt;">$12.538 billion</font><font style="font-family:inherit;font-size:10pt;"> and consisted of the components below. </font></div><div style="line-height:120%;padding-top:6px;text-align:center;text-indent:16px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:592px;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="460px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="119px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,085</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncash consideration-fair value of shares issued</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,269</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncash consideration-fair value of stock options and other equity awards</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">184</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total consideration transferred</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,538</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of time-vested restricted stock units outstanding as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and changes during the year then ended is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="63%" rowspan="1" colspan="1"></td><td width="17%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Stock Units (in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Average Grant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Date Fair Value</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80.03</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted (A)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,946</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">136.30</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distributed</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,128</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.07</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited or canceled</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(766</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107.50</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,067</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.88</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected to vest at September 30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,878</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.65</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(A)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes approximately </font><font style="font-family:inherit;font-size:10pt;">1 million</font><font style="font-family:inherit;font-size:10pt;"> units granted upon the conversion of pre-acquisition equity awards of CareFusion, as previously discussed.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This offer expired in April 2015 and the aggregate principal amounts below of each series of the CareFusion notes were validly tendered and exchanged for notes issued by the Company.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;text-indent:30px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:529px;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="316px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="90px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="94px" rowspan="1" colspan="1"></td><td width="11px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Aggregate Principal Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Percentage of Total Outstanding Principal Amount of such Series of Existing Notes</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-top:12px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Interest Rate and Maturity</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Millions of dollars)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.450% Notes due May 15, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">293</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97.64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.375% Notes due August 1, 2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">665</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95.00</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.300% Notes due March 1, 2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">294</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97.95</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.875% Notes due May 15, 2024</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">397</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.37</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.875% Notes due May 15, 2044</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.96</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total senior notes issued under exchange transaction</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,949</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accounting Changes</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">New Accounting Principle Adopted</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2013, the Financial Accounting Standards Board (“FASB”) issued guidance that requires the netting of unrecognized tax benefits against a deferred tax asset for a loss or other carryforward that would apply in settlement of the uncertain tax positions. In March 2013, the FASB issued amendments to resolve diversity in practice relating to the release of cumulative translation adjustments into earnings upon the occurrence of certain derecognition events involving a foreign entity. The Company prospectively adopted both accounting standard updates, which did not impact its consolidated financial statements, on October 1, 2014.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">New Accounting Principles Not Yet Adopted</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2014, the FASB issued amended requirements that limit the presentation of discontinued operations to only those disposals that represent a strategic shift that has had, or will have, a major effect on an entity’s operations and financial results. The amended requirements also expand the disclosure requirements relating to disposal transactions. The Company will prospectively apply the amended requirements to disposal transactions that occur on or after October 1, 2015.</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued a new revenue recognition standard. Under this standard, revenue will be recognized upon the transfer of goods or services to customers and the amount of revenue recognized will reflect the consideration to which a reporting entity expects to be entitled in exchange for those goods or services. The Company is currently evaluating the impact that this new revenue recognition standard will have on its consolidated financial statements and the Company currently intends to adopt the standard on October 1, 2018, as is allowed under the FASB's July 2015 amendment which deferred the effective date for this standard.</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2014, the FASB issued amended requirements that require debt issuance costs, related to a recognized debt liability, to be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The Company will apply the amended presentation requirements on October 1, 2016.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying Consolidated Financial Statements and Notes to Consolidated Financial Statements of Becton, Dickinson and Company (the “Company”) have been prepared in accordance with U.S. generally accepted accounting principles. Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes. Percentages and earnings per share amounts presented are calculated from the underlying amounts. Our fiscal year ends on September 30.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides the pro forma results for the years ended September 30, 2015 and 2014 as if CareFusion had been acquired as of October 1, 2013.</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:678px;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="420px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="107px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="14px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="110px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Millions of dollars, except per share data)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,368</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,288</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,276</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,191</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted Earnings per Share</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.92</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.55</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Sales-Type Leases and Financing Receivables</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As disclosed in Note 9, the net assets acquired in the Company’s acquisition of CareFusion included a </font><font style="font-family:inherit;font-size:10pt;">$1.208 billion</font><font style="font-family:inherit;font-size:10pt;"> net investment in sales-type leases which primarily arose from the leasing of dispensing equipment. The components of the net investment in sales-type leases, which predominantly have </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">-year terms and are generally collateralized by the underlying equipment, are as follows as of September 30, 2015.</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:center;text-indent:30px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:517px;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="385px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="119px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">September 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Future minimum lease payments receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,311</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unguaranteed residual values</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unearned income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(142</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for uncollectible minimum lease payments receivable</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Investment in Sales-Type Leases</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,193</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Current portion of net investment in sales-type leases</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Investment in Sales-Type Leases, Less Current Portion</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,118</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Future minimum lease payments to be received pursuant to sales-type leases are as follows: 2016 — </font><font style="font-family:inherit;font-size:10pt;">$413 million</font><font style="font-family:inherit;font-size:10pt;">; 2017 — </font><font style="font-family:inherit;font-size:10pt;">$355 million</font><font style="font-family:inherit;font-size:10pt;">; 2018 — </font><font style="font-family:inherit;font-size:10pt;">$275 million</font><font style="font-family:inherit;font-size:10pt;">; 2019 — </font><font style="font-family:inherit;font-size:10pt;">$187 million</font><font style="font-family:inherit;font-size:10pt;">; 2020 — </font><font style="font-family:inherit;font-size:10pt;">$79 million</font><font style="font-family:inherit;font-size:10pt;"> and an aggregate of </font><font style="font-family:inherit;font-size:10pt;">$3 million</font><font style="font-family:inherit;font-size:10pt;"> thereafter.</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The methodology for determining the allowance for credit losses for these financing receivables is based on the collective population and is not stratified by class or portfolio segment. Allowances for credit losses on the entire portfolio are recorded based on historical experience loss rates and the potential impact of anticipated changes in business practices, market dynamics, and economic conditions. The net investment in sales-type leases is predominantly evaluated for impairment on a collective basis; however, some immaterial allowances for individual balances are recorded based on the evaluation of customers’ specific circumstances. No interest is accrued on past due financing receivables, which are generally considered past due 30 days after the billing date. Amounts are written off against the allowance for credit losses when determined to be uncollectible. The allowance for credit losses on these financing receivables was immaterial at September 30, 2015.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Given the uncertain nature of litigation generally, the Company is not able in all cases to estimate the amount or range of loss that could result from an unfavorable outcome of the litigation to which the Company is a party. In accordance with U.S. generally accepted accounting principles, the Company establishes accruals to the extent probable future losses are estimable (in the case of environmental matters, without considering possible third-party recoveries). In view of the uncertainties discussed below, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance. In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company’s consolidated results of operations and consolidated cash flows.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Share-Based Compensation</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes the fair value of share-based compensation in net income. Compensation expense is recognized on a straight-line basis over the requisite service period, which is generally the vesting period.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company maintains cash deposits in excess of government-provided insurance limits. Such cash deposits are exposed to loss in the event of nonperformance by financial institutions. Substantially all of the Company’s trade receivables are due from public and private entities involved in the healthcare industry. Due to the large size and diversity of the Company’s customer base, concentrations of credit risk with respect to trade receivables are limited. The Company does not normally require collateral. The Company is exposed to credit loss in the event of nonperformance by financial institutions with which it conducts business. However, this loss is limited to the amounts, if any, by which the obligations of the counterparty to the financial instrument contract exceed the obligations of the Company. The Company also minimizes exposure to credit risk by dealing with a diversified group of major financial institutions.</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company continually evaluates its accounts receivables for potential collection risks particularly those resulting from sales to government-owned or government-supported healthcare facilities in certain countries as payment may be dependent upon the financial stability and creditworthiness of those countries’ national economies. The Company continually evaluates all governmental receivables for potential collection risks associated with the availability of government funding and reimbursement practices. The Company believes the current reserves related to all governmental receivables are adequate and that this concentration of credit risk will not have a material adverse impact on its financial position or liquidity.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivative Instruments and Hedging Activities</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company uses derivative instruments to mitigate certain exposures. The effects these derivative instruments and hedged items have on financial position, financial performance, and cash flows are provided below.</font></div><div style="line-height:120%;padding-top:8px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Foreign Currency Risks and Related Strategies</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has foreign currency exposures throughout Europe, Greater Asia, Canada and Latin America. Transactional currency exposures that arise from entering into transactions, generally on an intercompany basis, in non-hyperinflationary countries that are denominated in currencies other than the functional currency are mitigated primarily through the use of forward contracts and currency options. Hedges of the transactional foreign exchange exposures resulting primarily from intercompany payables and receivables are undesignated hedges. As such, the gains or losses on these instruments are recognized immediately in income. The offset of these gains or losses against the gains and losses on the underlying hedged items, as well as the hedging costs associated with the derivative instruments, is recognized in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other income (expense), net</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The total notional amounts of the Company’s outstanding foreign exchange contracts as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> were </font><font style="font-family:inherit;font-size:10pt;">$2.2 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.8 billion</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:8px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Interest Rate Risks and Related Strategies</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s primary interest rate exposure results from changes in U.S. dollar interest rates. The Company’s policy is to manage interest cost using a mix of fixed and variable rate debt. The Company periodically uses interest rate swaps to manage such exposures. Under these interest rate swaps, the Company exchanges, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. These swaps are designated as either fair value or cash flow hedges.</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For interest rate swaps designated as fair value hedges (i.e., hedges against the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that is attributable to a particular risk), changes in the fair value of the interest rate swaps offset changes in the fair value of the fixed rate debt due to changes in market interest rates.</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in the fair value of the interest rate swaps designated as cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk) are offset by amounts recorded in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other comprehensive income (loss)</font><font style="font-family:inherit;font-size:10pt;">. If interest rate derivatives designated as cash flow hedges are terminated, the balance in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accumulated other comprehensive income (loss)</font><font style="font-family:inherit;font-size:10pt;"> attributable to those derivatives is reclassified into earnings over the remaining life of the hedged debt. The net realized loss related to terminated interest rate swaps expected to be reclassified and recorded in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Interest expense</font><font style="font-family:inherit;font-size:10pt;"> within the next 12 months is </font><font style="font-family:inherit;font-size:10pt;">$6 million</font><font style="font-family:inherit;font-size:10pt;">, net of tax. The Company had </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> outstanding interest rate swaps designated as cash flow hedges as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The total notional amount of the Company’s outstanding interest rate swaps designated as fair value hedges was </font><font style="font-family:inherit;font-size:10pt;">$375 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">. The outstanding swaps represent fixed-to-floating interest rate swap agreements the Company entered into, in March and September 2014, to convert the interest payments on </font><font style="font-family:inherit;font-size:10pt;">$375 million</font><font style="font-family:inherit;font-size:10pt;"> of the Company’s </font><font style="font-family:inherit;font-size:10pt;">3.125%</font><font style="font-family:inherit;font-size:10pt;"> notes, due </font><font style="font-family:inherit;font-size:10pt;">November 8, 2021</font><font style="font-family:inherit;font-size:10pt;">, from the fixed rate to a floating interest rate based on LIBOR. Changes in the fair value of the interest rate swaps offset changes in the fair value of the fixed rate debt. The gain recorded on these fair value hedges and the offsetting loss recorded on the underlying debt instrument was </font><font style="font-family:inherit;font-size:10pt;">$19 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$3 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:8px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Risk Exposures</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company purchases resins, which are oil-based components used in the manufacture of certain products. Significant increases in world oil prices that lead to increases in resin purchase costs could impact future operating results. From time to time, the Company has managed price risks associated with these commodity purchases through commodity derivative forward contracts. In April 2015, the Company entered into cash-settled forward contracts to hedge approximately </font><font style="font-family:inherit;font-size:10pt;">13%</font><font style="font-family:inherit;font-size:10pt;"> of its expected global resin purchase volumes throughout fiscal years 2015 and 2016. These contracts were designated as cash flow hedges and the total notional amount of these contracts at September 30, 2015 was </font><font style="font-family:inherit;font-size:10pt;">49 million</font><font style="font-family:inherit;font-size:10pt;"> pounds (</font><font style="font-family:inherit;font-size:10pt;">$25 million</font><font style="font-family:inherit;font-size:10pt;">). The Company had </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> outstanding commodity derivative contracts designated as cash flow hedges as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2014</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:8px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Effects on Consolidated Balance Sheets</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The location and amounts of derivative instrument fair values in the consolidated balance sheet are segregated below between designated, qualifying hedging instruments and ones that are not designated for hedge accounting.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset derivatives-designated for hedge accounting</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swaps</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset derivatives-undesignated for hedge accounting</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total asset derivatives (A)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liability derivatives-designated for hedge accounting</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commodity forward contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liability derivatives-undesignated for hedge accounting</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liability derivatives (B)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(A)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All asset derivatives are included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Prepaid expenses, deferred taxes and other</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(B)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All liability derivatives are included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accrued expenses</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><div style="line-height:120%;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Effects on Consolidated Statements of Income</font></div><div style="line-height:120%;padding-top:8px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cash flow hedges</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">After-tax losses of </font><font style="font-family:inherit;font-size:10pt;">$16 million</font><font style="font-family:inherit;font-size:10pt;"> were recognized in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other comprehensive income (loss)</font><font style="font-family:inherit;font-size:10pt;"> in 2015. These losses included a </font><font style="font-family:inherit;font-size:10pt;">$7 million</font><font style="font-family:inherit;font-size:10pt;"> loss relating to the commodity forward contracts entered into in April 2015 to hedge the risk associated with resin purchases. These losses also included </font><font style="font-family:inherit;font-size:10pt;">$8 million</font><font style="font-family:inherit;font-size:10pt;"> attributable to interest rate swaps with a total notional amount of </font><font style="font-family:inherit;font-size:10pt;">$2.3 billion</font><font style="font-family:inherit;font-size:10pt;"> that were entered into during the first quarter of fiscal year 2015 to partially hedge interest rate risk associated with the anticipated issuance of senior unsecured notes in connection with the Company’s acquisition of CareFusion. These swaps were designated as hedges of the variability in interest payments attributable to changes in the benchmark interest rate during the period preceding the Company’s issuance of the notes. The swaps were terminated at losses, concurrent with the pricing of notes issued in December 2014, and the realized losses will be amortized over the lives of the notes with an offset to </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Interest expense</font><font style="font-family:inherit;font-size:10pt;">. Additional disclosures regarding amounts recognized in the consolidated statements of income in fiscal years 2015, 2014 and 2013 relating to cash flow hedges are provided in Note 3. Additional disclosures regarding the acquisition of CareFusion are provided in Note 9 and additional disclosures regarding the Company’s debt issuance during the first quarter of fiscal year 2015 are provided in Note 15. </font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s designated derivative instruments are highly effective. As such, there were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> gains or losses, related to hedge ineffectiveness or amounts excluded from hedge effectiveness testing, recognized immediately in income relative to derivative contracts outstanding in the periods presented.</font></div><div style="line-height:120%;padding-top:8px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Undesignated hedges</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The location and amount of gains and losses recognized in income on derivatives not designated for hedge accounting for the years ended September 30 were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td width="28%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="26%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivatives Not</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Designated as</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">For Hedge Accounting</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Location of Gain (Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Recognized in Income on</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivatives</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain (Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Recognized in Income on</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivative</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward exchange contracts (A)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income (expense), net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(A)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The gains and losses on forward contracts and currency options utilized to hedge the intercompany transactional foreign exchange exposures are largely offset by gains and losses on the underlying hedged items in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other income (expense), net</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Share-Based Compensation</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company grants share-based awards under the 2004 Employee and Director Equity-Based Compensation Plan (“2004 Plan”), which provides long-term incentive compensation to employees and directors consisting of: stock appreciation rights (“SARs”), stock options, performance-based restricted stock units, time-vested restricted stock units and other stock awards.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of share-based payments is recognized as compensation expense in net income. The amounts and location of compensation cost relating to share-based payments included in consolidated statements of income is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="56%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of products sold</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling and administrative expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">166</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The associated income tax benefit recognized was </font><font style="font-family:inherit;font-size:10pt;">$59 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$40 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$35 million</font><font style="font-family:inherit;font-size:10pt;"> in fiscal years </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;">, respectively. Share-based compensation attributable to discontinued operations in 2013 was not material.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain pre-acquisition equity awards of CareFusion were converted into BD restricted stock awards or BD stock options with accelerated vesting terms at the acquisition date. In addition, as an incentive to encourage post-acquisition employee retention, certain pre-acquisition equity awards of CareFusion were converted into either BD restricted stock awards or BD stock options, as applicable, as of the acquisition date, with substantially the same terms and conditions as were applicable under such CareFusion awards immediately prior to the acquisition date. The compensation expense associated with these replacement awards was recorded in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Acquisition-related costs</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Stock Appreciation Rights</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">SARs represent the right to receive, upon exercise, shares of common stock having a value equal to the difference between the market price of common stock on the date of exercise and the exercise price on the date of grant. SARs vest over a </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;">-year period and have a </font><font style="font-family:inherit;font-size:10pt;">ten</font><font style="font-family:inherit;font-size:10pt;">-year term. The fair value was estimated on the date of grant using a lattice-based binomial option valuation model that uses the following weighted-average assumptions:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.20%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.31%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.33%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.0%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected dividend yield</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.78%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.00%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.60%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected life</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.6 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.8 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.0 years</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value derived</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$24.82</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$19.90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$12.08</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility is based upon historical volatility for the Company’s common stock and other factors. The expected life of SARs granted is derived from the output of the lattice-based model, using assumed exercise rates based on historical exercise and termination patterns, and represents the period of time that SARs granted are expected to be outstanding. The risk-free interest rate used is based upon the published U.S. Treasury yield curve in effect at the time of grant for instruments with a similar life. The dividend yield is based upon the most recently declared quarterly dividend as of the grant date. The total intrinsic value of SARs exercised during </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$96 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$69 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$54 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The Company issued </font><font style="font-family:inherit;font-size:10pt;">691 thousand</font><font style="font-family:inherit;font-size:10pt;"> shares during </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;"> to satisfy the SARs exercised. The actual tax benefit realized during </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> for tax deductions from SAR exercises totaled </font><font style="font-family:inherit;font-size:10pt;">$34 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$26 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$19 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The total fair value of SARs vested during </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$22 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$25 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$30 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of SARs outstanding as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and changes during the year then ended is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="37%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">SARs (in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercise Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Remaining</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Contractual Term</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Intrinsic</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">of dollars)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,852</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78.49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,037</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134.73</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,458</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.88</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited, canceled or expired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(167</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103.50</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,264</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87.07</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.96</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested and expected to vest at September 30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,010</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86.34</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.88</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">327</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at September 30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,725</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.18</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.81</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">267</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Stock Options</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has not granted stock options since 2005. As previously discussed, certain pre-acquisition equity awards of CareFusion were converted on March 17, 2015 into BD stock options with accelerated vesting terms.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of stock options outstanding as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and changes during the year then ended is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="37%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Stock</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Options (in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercise Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Remaining</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Contractual Term</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Intrinsic</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">of dollars)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related conversions (A)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,971</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82.32</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(900</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83.70</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited, canceled or expired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.41</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,139</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79.47</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested at September 30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,111</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79.10</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.29</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at September 30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">865</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.82</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.99</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(A)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents options granted upon the conversion of pre-acquisition equity awards of CareFusion, as previously discussed. </font></div></td></tr></table><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash received from the exercising of stock options in </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$75 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$17 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$64 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The actual tax benefit realized for tax deductions from stock option exercises totaled </font><font style="font-family:inherit;font-size:10pt;">$20 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$21 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The total intrinsic value of stock options exercised during the years </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$52 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$21 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$65 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Performance-Based Restricted Stock Units</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Performance-based restricted stock units cliff vest </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> years after the date of grant. These units are tied to the Company’s performance against pre-established targets over a </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">-year performance period. The performance measures for fiscal years </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> were relative total shareholder return (measures the Company’s stock performance during the performance period against that of peer companies) and average annual return on invested capital. Under the Company’s long-term incentive program, the actual payout under these awards may vary from </font><font style="font-family:inherit;font-size:10pt;">zero</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">200%</font><font style="font-family:inherit;font-size:10pt;"> of an employee’s target payout, based on the Company’s actual performance over the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">-year performance period. The fair value is based on the market price of the Company’s stock on the date of grant. Compensation cost initially recognized assumes that the target payout level will be achieved and is adjusted for subsequent changes in the expected outcome of performance-related conditions. For units for which the performance conditions are modified after the date of grant, any incremental increase in the fair value of the modified units, over the original units, is recorded as compensation expense on the date of the modification for vested units, or over the remaining performance period for units not yet vested.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of performance-based restricted stock units outstanding as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and changes during the year then ended is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="63%" rowspan="1" colspan="1"></td><td width="17%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Stock Units (in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Average Grant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Date Fair Value</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,255</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83.47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">352</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">148.04</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distributed</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited or canceled</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(330</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79.12</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30(A)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,139</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">106.07</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected to vest at September 30(B)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">542</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97.09</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(A)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on </font><font style="font-family:inherit;font-size:10pt;">200%</font><font style="font-family:inherit;font-size:10pt;"> of target payout.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(B)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net of expected forfeited units and units in excess of the expected performance payout of </font><font style="font-family:inherit;font-size:10pt;">68 thousand</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">528 thousand</font><font style="font-family:inherit;font-size:10pt;"> shares, respectively.</font></div></td></tr></table><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted average grant date fair value of performance-based restricted stock units granted during the years </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$110.58</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$72.14</font><font style="font-family:inherit;font-size:10pt;">, respectively. The total fair value of performance-based restricted stock units vested during </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$16 million</font><font style="font-family:inherit;font-size:10pt;"> and the fair value of units vested during </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$10 million</font><font style="font-family:inherit;font-size:10pt;">. Based on the Company’s results during the performance period, compared with the established performance targets for payout, there was </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> payout of performance-based restricted stock units in fiscal year </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;">. At </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;">, the weighted average remaining vesting term of performance-based restricted stock units is </font><font style="font-family:inherit;font-size:10pt;">1.04</font><font style="font-family:inherit;font-size:10pt;"> years.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Time-Vested Restricted Stock Units</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Time-vested restricted stock unit awards granted after January 2015 vest on a graded basis over a three-year period. Time-vested restricted stock units granted before January 2015 cliff vest </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> years after the date of grant, except for certain key executives of the Company, including the executive officers, for which such units generally vest </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> year following the employee’s retirement. The related share-based compensation expense is recorded over the requisite service period, which is the vesting period or in the case of certain key executives is based on retirement eligibility. The fair value of all time-vested restricted stock units is based on the market value of the Company’s stock on the date of grant. The impact of this change in accounting policy was not material to reported stock-based compensation expense for the year ended September 30, 2015.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of time-vested restricted stock units outstanding as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and changes during the year then ended is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="63%" rowspan="1" colspan="1"></td><td width="17%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Stock Units (in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Average Grant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Date Fair Value</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80.03</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted (A)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,946</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">136.30</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distributed</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,128</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.07</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited or canceled</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(766</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107.50</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,067</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.88</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected to vest at September 30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,878</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.65</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(A)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes approximately </font><font style="font-family:inherit;font-size:10pt;">1 million</font><font style="font-family:inherit;font-size:10pt;"> units granted upon the conversion of pre-acquisition equity awards of CareFusion, as previously discussed.</font></div></td></tr></table><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted average grant date fair value of time-vested restricted stock units granted during the years </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$102.74</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$70.99</font><font style="font-family:inherit;font-size:10pt;">, respectively. The total fair value of time-vested restricted stock units vested during </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$181 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$45 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$52 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. At </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;">, the weighted average remaining vesting term of the time-vested restricted stock units is </font><font style="font-family:inherit;font-size:10pt;">1.08</font><font style="font-family:inherit;font-size:10pt;"> years.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amount of unrecognized compensation expense for all non-vested share-based awards as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;">, is approximately </font><font style="font-family:inherit;font-size:10pt;">$156 million</font><font style="font-family:inherit;font-size:10pt;">, which is expected to be recognized over a weighted-average remaining life of approximately </font><font style="font-family:inherit;font-size:10pt;">1.84</font><font style="font-family:inherit;font-size:10pt;"> years. Included in the unrecognized compensation expense is </font><font style="font-family:inherit;font-size:10pt;">$38 million</font><font style="font-family:inherit;font-size:10pt;"> associated with the CareFusion replacement awards previously described. As of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;">, there were approximately </font><font style="font-family:inherit;font-size:10pt;">1.5 million</font><font style="font-family:inherit;font-size:10pt;"> of such replacement awards outstanding. </font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">7,242 thousand</font><font style="font-family:inherit;font-size:10pt;"> shares were authorized for future grants under the 2004 Plan. The Company has a policy of satisfying share-based payments through either open market purchases or shares held in treasury. At </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company has sufficient shares held in treasury to satisfy these payments.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Stock Plans</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has a Stock Award Plan, which allows for grants of common shares to certain key employees. Distribution of </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;"> or more of each award is deferred until after retirement or involuntary termination, upon which the deferred portion of the award is distributable in </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> equal annual installments. The balance of the award is distributable over </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> years from the grant date, subject to certain conditions. In February 2004, this plan was terminated with respect to future grants upon the adoption of the 2004 Plan. At </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">, awards for </font><font style="font-family:inherit;font-size:10pt;">50 thousand</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">58 thousand</font><font style="font-family:inherit;font-size:10pt;"> shares, respectively, were outstanding.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has a Directors’ Deferral Plan, which provides a means to defer director compensation, from time to time, on a deferred stock or cash basis. As of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">119 thousand</font><font style="font-family:inherit;font-size:10pt;"> shares were held in trust, of which </font><font style="font-family:inherit;font-size:10pt;">three thousand</font><font style="font-family:inherit;font-size:10pt;"> shares represented Directors’ compensation in </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, in accordance with the provisions of the plan. Under this plan, which is unfunded, directors have an unsecured contractual commitment from the Company.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company also has a Deferred Compensation Plan that allows certain highly-compensated employees, including executive officers, to defer salary, annual incentive awards and certain equity-based compensation. As of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">345 thousand</font><font style="font-family:inherit;font-size:10pt;"> shares were issuable under this plan.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial Instruments and Fair Value Measurements</font></div><div style="line-height:120%;padding-top:6px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recurring Fair Value Measurements</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair values of financial instruments, including those not recognized on the statement of financial position at fair value, carried at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> are classified in accordance with the fair value hierarchy in the following tables:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="32%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Basis of Fair Value Measurement</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September  30,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Active Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">for Identical</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets (Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs (Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs (Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Institutional money market investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swaps</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward exchange contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">179</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward exchange contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commodity forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="32%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Basis of Fair Value Measurement</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September  30,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Active Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">for Identical</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets (Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs (Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs (Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Institutional money market investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,040</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,040</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swaps</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward exchange contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,063</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,040</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward exchange contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s institutional money market accounts permit daily redemption and the fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions. The Company’s remaining cash equivalents were </font><font style="font-family:inherit;font-size:10pt;">$1.277 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$821 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">, respectively. Short-term investments are held to their maturities and are carried at cost, which approximates fair value. The cash equivalents consist of liquid investments with a maturity of </font><font style="font-family:inherit;font-size:10pt;">three months or less</font><font style="font-family:inherit;font-size:10pt;"> and the short-term investments consist of instruments with maturities greater than </font><font style="font-family:inherit;font-size:10pt;">three months</font><font style="font-family:inherit;font-size:10pt;"> and less than </font><font style="font-family:inherit;font-size:10pt;">one year</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company measures the fair value of forward exchange contracts and interest rate swaps based upon the present value of expected future cash flows using market-based observable inputs including credit risk, interest rate yield curves, foreign currency spot prices and forward prices.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments, which are considered Level 2 inputs in the fair value hierarchy. The fair value of long-term debt was </font><font style="font-family:inherit;font-size:10pt;">$11.6 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$4.1 billion</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">, respectively. During the third quarter of fiscal year 2015, the Company reclassified </font><font style="font-family:inherit;font-size:10pt;">$750 million</font><font style="font-family:inherit;font-size:10pt;"> of floating rates due on June 15, 2016 from </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Long-Term Debt</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Short-term debt</font><font style="font-family:inherit;font-size:10pt;">. The fair value of these notes was </font><font style="font-family:inherit;font-size:10pt;">$750 million</font><font style="font-family:inherit;font-size:10pt;"> at September 30, 2015.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The contingent consideration liabilities were recognized as part of the consideration transferred by the Company for certain acquisitions. Additional disclosures regarding these acquisitions are included in Note 9. The fair values of the contingent consideration liabilities were estimated using probability-weighted discounted cash flow models that were based upon the probabilities assigned to the contingent events. The estimated fair values of the contingent consideration liabilities are remeasured at each reporting period based upon increases or decreases in the probability of the contingent payments. The increase to the total contingent consideration liability in fiscal year </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;"> was mostly attributable to the recognition of contingent consideration liabilities of </font><font style="font-family:inherit;font-size:10pt;">$36 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$28 million</font><font style="font-family:inherit;font-size:10pt;"> in connection with the Company’s acquisitions of GenCell and Cellular Research in the first and fourth quarters, respectively.</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s policy is to recognize any transfers into fair value measurement hierarchy levels and transfers out of levels at the beginning of each reporting period. There were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> transfers in and out of Level 1, Level 2 or Level 3 measurements for the years ending </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Nonrecurring Fair Value Measurements</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth quarter of fiscal year 2015, the Company recorded impairment charges of </font><font style="font-family:inherit;font-size:10pt;">$72 million</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Acquisition-related costs</font><font style="font-family:inherit;font-size:10pt;"> relating to assets held for sale. These asset impairment charges were recorded to adjust the carrying amounts of the assets held for sale to an estimate of the assets' fair values, less the estimated costs to sell these assets. The fair values of these assets were estimated, based upon a market participant's perspective, using a market approach and Level 2 inputs, including quoted prices for similar assets. The remaining carrying amounts of the assets held for sale are immaterial to the Company's consolidated balance sheet. Additional disclosures regarding these asset impairment charges are provided in Note 11.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company maintains cash deposits in excess of government-provided insurance limits. Such cash deposits are exposed to loss in the event of nonperformance by financial institutions. Substantially all of the Company’s trade receivables are due from public and private entities involved in the healthcare industry. Due to the large size and diversity of the Company’s customer base, concentrations of credit risk with respect to trade receivables are limited. The Company does not normally require collateral. The Company is exposed to credit loss in the event of nonperformance by financial institutions with which it conducts business. However, this loss is limited to the amounts, if any, by which the obligations of the counterparty to the financial instrument contract exceed the obligations of the Company. The Company also minimizes exposure to credit risk by dealing with a diversified group of major financial institutions.</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company continually evaluates its accounts receivables for potential collection risks particularly those resulting from sales to government-owned or government-supported healthcare facilities in certain countries as payment may be dependent upon the financial stability and creditworthiness of those countries’ national economies. The Company continually evaluates all governmental receivables for potential collection risks associated with the availability of government funding and reimbursement practices. The Company believes the current reserves related to all governmental receivables are adequate and that this concentration of credit risk will not have a material adverse impact on its financial position or liquidity.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company measures the fair value of forward exchange contracts and interest rate swaps based upon the present value of expected future cash flows using market-based observable inputs including credit risk, interest rate yield curves, foreign currency spot prices and forward prices.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments, which are considered Level 2 inputs in the fair value hierarchy. The fair value of long-term debt was </font><font style="font-family:inherit;font-size:10pt;">$11.6 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$4.1 billion</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">, respectively. During the third quarter of fiscal year 2015, the Company reclassified </font><font style="font-family:inherit;font-size:10pt;">$750 million</font><font style="font-family:inherit;font-size:10pt;"> of floating rates due on June 15, 2016 from </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Long-Term Debt</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Short-term debt</font><font style="font-family:inherit;font-size:10pt;">. The fair value of these notes was </font><font style="font-family:inherit;font-size:10pt;">$750 million</font><font style="font-family:inherit;font-size:10pt;"> at September 30, 2015.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The contingent consideration liabilities were recognized as part of the consideration transferred by the Company for certain acquisitions. Additional disclosures regarding these acquisitions are included in Note 9. The fair values of the contingent consideration liabilities were estimated using probability-weighted discounted cash flow models that were based upon the probabilities assigned to the contingent events. The estimated fair values of the contingent consideration liabilities are remeasured at each reporting period based upon increases or decreases in the probability of the contingent payments. The increase to the total contingent consideration liability in fiscal year </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;"> was mostly attributable to the recognition of contingent consideration liabilities of </font><font style="font-family:inherit;font-size:10pt;">$36 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$28 million</font><font style="font-family:inherit;font-size:10pt;"> in connection with the Company’s acquisitions of GenCell and Cellular Research in the first and fourth quarters, respectively.</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s policy is to recognize any transfers into fair value measurement hierarchy levels and transfers out of levels at the beginning of each reporting period.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill and Other Intangible Assets</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s unamortized intangible assets include goodwill and in-process research and development assets which arise from acquisitions. The Company currently reviews all indefinite-lived assets, including goodwill, for impairment using quantitative models. Goodwill is reviewed at least annually for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. The Company’s reporting units generally represent one level below reporting segments, and components within an operating segment that have similar economic characteristics are aggregated. Potential impairment of goodwill is identified by comparing the fair value of a reporting unit, estimated using an income approach, with its carrying value. The annual impairment review performed on July 1, 2015 indicated that all identified reporting units’ fair values exceeded their respective carrying values.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The review for impairment of in-process research and development assets is performed by comparing the fair value of the technology or project assets, estimated using an income approach, with their carrying value. In-process research and development assets are considered indefinite-lived assets and are reviewed at least annually for impairment until projects are completed or abandoned. Certain trademarks that are considered to generate cash flows indefinitely are also considered to be indefinite-lived intangible assets and these assets are also reviewed at least annually for impairment.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortized intangible assets include developed technology assets which arise from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date or acquired in-process research and development assets that are completed subsequent to acquisition. Developed technology assets are generally amortized over periods ranging from </font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">20</font><font style="font-family:inherit;font-size:10pt;"> years, using the straight-line method. Other intangibles with finite useful lives, which include patents, are amortized over periods principally ranging from </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">40</font><font style="font-family:inherit;font-size:10pt;"> years, using the straight-line method. Finite-lived intangible assets, including developed technology assets, are periodically reviewed when impairment indicators are present to assess recoverability from future operations using undiscounted cash flows. The carrying values of these finite-lived assets are compared to the undiscounted cash flows they are expected to generate and an impairment loss is recognized in operating results to the extent any finite-lived intangible asset’s carrying value exceeds its calculated fair value.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">New Accounting Principle Adopted</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2013, the Financial Accounting Standards Board (“FASB”) issued guidance that requires the netting of unrecognized tax benefits against a deferred tax asset for a loss or other carryforward that would apply in settlement of the uncertain tax positions. In March 2013, the FASB issued amendments to resolve diversity in practice relating to the release of cumulative translation adjustments into earnings upon the occurrence of certain derecognition events involving a foreign entity. The Company prospectively adopted both accounting standard updates, which did not impact its consolidated financial statements, on October 1, 2014.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">New Accounting Principles Not Yet Adopted</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2014, the FASB issued amended requirements that limit the presentation of discontinued operations to only those disposals that represent a strategic shift that has had, or will have, a major effect on an entity’s operations and financial results. The amended requirements also expand the disclosure requirements relating to disposal transactions. The Company will prospectively apply the amended requirements to disposal transactions that occur on or after October 1, 2015.</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued a new revenue recognition standard. Under this standard, revenue will be recognized upon the transfer of goods or services to customers and the amount of revenue recognized will reflect the consideration to which a reporting entity expects to be entitled in exchange for those goods or services. The Company is currently evaluating the impact that this new revenue recognition standard will have on its consolidated financial statements and the Company currently intends to adopt the standard on October 1, 2018, as is allowed under the FASB's July 2015 amendment which deferred the effective date for this standard.</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2014, the FASB issued amended requirements that require debt issuance costs, related to a recognized debt liability, to be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The Company will apply the amended presentation requirements on October 1, 2016.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Summary of Significant Accounting Policies</font></div><div style="line-height:120%;padding-top:6px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying Consolidated Financial Statements and Notes to Consolidated Financial Statements of Becton, Dickinson and Company (the “Company”) have been prepared in accordance with U.S. generally accepted accounting principles. Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes. Percentages and earnings per share amounts presented are calculated from the underlying amounts. Our fiscal year ends on September 30.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Principles of Consolidation</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the Company’s accounts and those of its majority-owned subsidiaries after the elimination of intercompany transactions. The Company has no material interests in variable interest entities.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cash Equivalents</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash equivalents consist of all highly liquid investments with a maturity of </font><font style="font-family:inherit;font-size:10pt;">three months or less</font><font style="font-family:inherit;font-size:10pt;"> at time of purchase.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Short-Term Investments</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term investments consist of time deposits with maturities greater than </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months and less than </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> year when purchased.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Trade and Financing Receivables</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company grants credit to customers in the normal course of business and the resulting trade receivables are stated at their net realizable value. The Company's portfolio of financing receivables arises from the leasing of dispensing equipment. The allowance for doubtful accounts represents the Company’s estimate of probable credit losses relating to trade receivables and is determined based on historical experience and other specific account data. Allowances for credit losses relating to financing receivables are also based on historical experience loss rates and the potential impact of anticipated changes in business practices, market dynamics, and economic conditions. Amounts are written off against the allowances for doubtful accounts or credit losses when the Company determines that a customer account is uncollectible.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Inventories</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories are stated at the lower of first-in, first-out cost or market.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Property, Plant and Equipment</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization are principally provided on the straight-line basis over estimated useful lives, which range from </font><font style="font-family:inherit;font-size:10pt;">20</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">45</font><font style="font-family:inherit;font-size:10pt;"> years for buildings, </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">13</font><font style="font-family:inherit;font-size:10pt;"> years for machinery and equipment and </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">12</font><font style="font-family:inherit;font-size:10pt;"> years for leasehold improvements. Depreciation and amortization expense was </font><font style="font-family:inherit;font-size:10pt;">$417 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$369 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$338 million</font><font style="font-family:inherit;font-size:10pt;"> in fiscal years 2015, 2014 and 2013, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill and Other Intangible Assets</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s unamortized intangible assets include goodwill and in-process research and development assets which arise from acquisitions. The Company currently reviews all indefinite-lived assets, including goodwill, for impairment using quantitative models. Goodwill is reviewed at least annually for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. The Company’s reporting units generally represent one level below reporting segments, and components within an operating segment that have similar economic characteristics are aggregated. Potential impairment of goodwill is identified by comparing the fair value of a reporting unit, estimated using an income approach, with its carrying value. The annual impairment review performed on July 1, 2015 indicated that all identified reporting units’ fair values exceeded their respective carrying values.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The review for impairment of in-process research and development assets is performed by comparing the fair value of the technology or project assets, estimated using an income approach, with their carrying value. In-process research and development assets are considered indefinite-lived assets and are reviewed at least annually for impairment until projects are completed or abandoned. Certain trademarks that are considered to generate cash flows indefinitely are also considered to be indefinite-lived intangible assets and these assets are also reviewed at least annually for impairment.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortized intangible assets include developed technology assets which arise from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date or acquired in-process research and development assets that are completed subsequent to acquisition. Developed technology assets are generally amortized over periods ranging from </font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">20</font><font style="font-family:inherit;font-size:10pt;"> years, using the straight-line method. Other intangibles with finite useful lives, which include patents, are amortized over periods principally ranging from </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">40</font><font style="font-family:inherit;font-size:10pt;"> years, using the straight-line method. Finite-lived intangible assets, including developed technology assets, are periodically reviewed when impairment indicators are present to assess recoverability from future operations using undiscounted cash flows. The carrying values of these finite-lived assets are compared to the undiscounted cash flows they are expected to generate and an impairment loss is recognized in operating results to the extent any finite-lived intangible asset’s carrying value exceeds its calculated fair value.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Capitalized Software</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capitalized software, including costs for software developed or obtained for internal use, is stated at cost, less accumulated amortization. Amortization expense is principally provided on the straight-line basis over estimated useful lives, which do not exceed </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;"> years. The current balance largely includes capital software investments related to a global enterprise resource planning initiative to upgrade the Company’s business information systems. Amortization expense related to capitalized software was </font><font style="font-family:inherit;font-size:10pt;">$65 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$41 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$38 million</font><font style="font-family:inherit;font-size:10pt;"> for 2015, 2014 and 2013, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Foreign Currency Translation</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Generally, foreign subsidiaries’ functional currency is the local currency of operations and the net assets of foreign operations are translated into U.S. dollars using current exchange rates. The U.S. dollar results that arise from such translation, as well as exchange gains and losses on intercompany balances of a long-term investment nature, are included in the foreign currency translation adjustments in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accumulated other comprehensive income (loss).</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from product sales is typically recognized when all of the following criteria have been met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; product price is fixed or determinable; collection of the resulting receivable is reasonably assured. Certain sales arrangements contain multiple deliverables, including equipment and service deliverables, which requires the Company to determine the separate units of account. If the deliverable meets the criteria of a separate unit of accounting, the arrangement consideration is allocated to each element based upon its relative selling price. In determining the best evidence of selling price of a unit of account the Company utilizes vendor-specific objective evidence (“VSOE”), which is the price the Company charges when the deliverable is sold separately. When VSOE is not available, management uses relevant third-party evidence (“TPE”) of selling price, if available. When neither VSOE nor TPE of selling price exists, management uses its best estimate of selling price.</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue allocated to equipment deliverables is recognized upon customer acceptance, which occurs after the transfer of title and risk of loss to the customer and the completion of installation or training services. When related training services are considered inconsequential, delivery is deemed to occur upon the transfer of title and risk of loss, at which time revenue and the costs associated with installation and training are recognized.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For equipment lease revenue, transactions are evaluated and classified as either operating leases or sales-type leases. Lease income for products sold under sales-type leases is recognized as revenue upon the completion of installation activities in the amount of the present value of the minimum lease payments. The financing component of sales-type leases is recorded as revenue over the lease term. For products sold under operating leases, revenue is recognized at the contracted rate over the rental period, as defined within the customer agreement.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s domestic businesses sell products primarily to distributors that resell the products to end-user customers. Rebates are provided to distributors that sell to end-user customers at prices determined under a contract between the Company and the end-user customer. Provisions for rebates, as well as sales discounts and returns, are based upon estimates and are accounted for as a reduction of revenues when revenue is recognized.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Shipping and Handling Costs</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shipping and handling costs are included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Selling and administrative expense</font><font style="font-family:inherit;font-size:10pt;">. Shipping expense was </font><font style="font-family:inherit;font-size:10pt;">$351 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$299 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$285 million</font><font style="font-family:inherit;font-size:10pt;"> in 2015, 2014 and 2013, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Derivative Financial Instruments</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All derivatives are recorded in the balance sheet at fair value and changes in fair value are recognized currently in earnings unless specific hedge accounting criteria are met.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From time to time, derivative financial instruments are utilized by the Company in the management of its foreign currency, interest rate and commodity price exposures. The Company periodically purchases forward contracts and options to hedge certain forecasted transactions that are denominated in foreign currencies in order to partially protect against a reduction in the value of future earnings resulting from adverse foreign exchange rate movements. The Company also periodically utilizes interest rate swaps to maintain a balance between fixed and floating rate instruments. Additionally, the Company periodically manages price risks associated with resin purchase costs through commodity derivative forward contracts. The Company does not enter into derivative financial instruments for trading or speculative purposes.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any deferred gains or losses associated with derivative instruments are recognized in income in the period in which the underlying hedged transaction is recognized. In the event a designated hedged item is sold, extinguished or matures prior to the termination of the related derivative instrument, such instrument would be closed and the resultant gain or loss would be recognized in income.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States income taxes are not provided on undistributed earnings of foreign subsidiaries where such undistributed earnings are indefinitely reinvested outside the United States. Deferred taxes are provided for earnings of foreign subsidiaries when those earnings are not considered indefinitely reinvested. Income taxes are provided and tax credits are recognized based on tax laws enacted at the dates of the financial statements.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of tax jurisdictions. In evaluating the exposure associated with various tax filing positions, the Company records accruals for uncertain tax positions, based on the technical support for the positions, past audit experience with similar situations, and the potential interest and penalties related to the matters.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company maintains valuation allowances where it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances are included in the tax provision in the period of change. In determining whether a valuation allowance is warranted, management evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods and tax strategies that could potentially enhance the likelihood of the realization of a deferred tax asset.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Earnings per Share</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings per share are computed based on the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions. These estimates or assumptions affect reported assets, liabilities, revenues and expenses as reflected in the consolidated financial statements. Actual results could differ from these estimates.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Share-Based Compensation</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes the fair value of share-based compensation in net income. Compensation expense is recognized on a straight-line basis over the requisite service period, which is generally the vesting period.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Benefit Plans</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has defined benefit pension plans covering certain employees in the United States and certain foreign locations. The Company also provides certain postretirement healthcare and life insurance benefits to qualifying domestic retirees. Other postretirement benefit plans in foreign countries are not material. The measurement date used for the Company’s employee benefit plans is September 30.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective April 1, 2014, the Company replaced its current post-65 group medical coverage with a new approach for retirees age 65 and older and their eligible dependents to access post-65 retiree medical and prescription drug coverage in the U.S. Such changes were communicated to active employees and retirees in early January 2014 and as such, the Company remeasured its U.S. postretirement healthcare benefit plan as of January 1, 2014. The impact of this plan change and remeasurement was immaterial to the Company’s consolidated financial results. The plan design changes included, among other modifications, a replacement of the Company-sponsored healthcare coverage program for post-65 retirees with contributions to a health reimbursement account that can be used to purchase coverage through a Medicare insurance exchange.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective January 1, 2013, all plan participants’ benefits in the U.S. defined benefit traditional pension plan were converted to a defined benefit cash balance pension plan. Upon conversion, each individual plan participant received an opening balance equal to the actuarial equivalent of individual benefits accrued under the defined benefit traditional pension plan through December 31, 2012. Following conversion, participants accrue benefits under the cash balance plan through monthly pay credits based upon the plan participant’s age and length of service. </font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net pension and other postretirement cost for the years ended September 30 included the following components:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td width="35%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Postretirement Benefits</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(123</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(126</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(116</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of prior service credit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of loss</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Curtailment/settlement loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net pension and postretirement cost</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amounts provided above for amortization of prior service credit and amortization of loss represent the reclassifications of prior service credits and net actuarial losses that were recognized in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accumulated other comprehensive income (loss)</font><font style="font-family:inherit;font-size:10pt;"> in prior periods. Net pension cost attributable to foreign plans included in the preceding table was </font><font style="font-family:inherit;font-size:10pt;">$32 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$25 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$33 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The settlement losses recorded in </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> included lump sum benefit payments associated with the Company’s U.S. supplemental pension plan. The Company recognizes pension settlements when payments from the supplemental plan exceed the sum of service and interest cost components of net periodic pension cost associated with this plan for the fiscal year. The settlement losses recorded in </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> also included settlements associated with certain foreign plans.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The change in benefit obligation, change in fair value of plan assets, funded status and amounts recognized in the Consolidated Balance Sheets for these plans were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="44%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Postretirement</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefits</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Change in benefit obligation:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beginning obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,366</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,076</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">201</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">243</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plan amendments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefits paid</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(138</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(142</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefit obligations assumed in acquisition</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actuarial loss (gain)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">318</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other, includes translation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(81</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(42</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefit obligation at September 30</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,426</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,366</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">186</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">201</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of plan assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beginning fair value</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,829</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,785</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actual return on plan assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">119</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employer contribution</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefits paid</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(138</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(142</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plan assets acquired in acquisition</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other, includes translation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(58</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plan assets at September 30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,732</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,829</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Funded Status at September 30:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unfunded benefit obligation</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(694</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(537</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(186</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(201</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amounts recognized in the Consolidated Balance</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Sheets at September 30:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Salaries, wages and related items</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term Employee Benefit Obligations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(691</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(531</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(171</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(184</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net amount recognized</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(694</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(537</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(186</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(201</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amounts recognized in Accumulated other</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">comprehensive income (loss) before income taxes at September 30:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net transition asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior service credit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">119</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net actuarial loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,124</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,030</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(44</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net amount recognized</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,021</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(911</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign pension plan assets at fair value included in the preceding table were </font><font style="font-family:inherit;font-size:10pt;">$575 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$574 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">, respectively. The foreign pension plan projected benefit obligations were </font><font style="font-family:inherit;font-size:10pt;">$780 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$765 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">, respectively. The benefit obligations assumed and plan assets acquired relate to the Company's acquisition of CareFusion. Additional disclosures regarding this acquisition are provided in Note 9.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pension plans with accumulated benefit obligations in excess of plan assets and plans with projected benefit obligations in excess of plan assets consist of the following at September 30:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Benefit</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Obligation Exceeds the</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value of Plan  Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Projected Benefit</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Obligation Exceeds the</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value of Plan  Assets</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Projected benefit obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,339</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,267</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,394</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,324</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated benefit obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,265</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,186</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of plan assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,650</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,738</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,784</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The estimated net actuarial loss and prior service credit for pension benefits that will be amortized from </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accumulated other comprehensive income (loss)</font><font style="font-family:inherit;font-size:10pt;"> into net pension costs over the next fiscal year are expected to be </font><font style="font-family:inherit;font-size:10pt;">$(79) million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$15 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The estimated net actuarial loss and prior service credit for other postretirement benefits that will be amortized from </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accumulated other comprehensive income</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">(loss) </font><font style="font-family:inherit;font-size:10pt;">into net other postretirement costs over the next fiscal year are expected to be </font><font style="font-family:inherit;font-size:10pt;">$(2) million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$5 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted average assumptions used in determining pension plan information were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td width="55%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discount rate:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. plans (A)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.95</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.14</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.87</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.94</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.50</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.75</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.75</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign plans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.68</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.68</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rate of compensation increase:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. plans (A)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.49</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.46</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.28</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Benefit Obligation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discount rate:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. plans (B)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.95</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.84</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.14</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.87</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rate of compensation increase:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. plans (A)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.25</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.25</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.25</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign plans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.33</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(A)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Also used to determine other postretirement and postemployment benefit plan information.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(B)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The discount rates used to determine other postretirement benefit plan information in fiscal years 2015, 2014 and 2013 were </font><font style="font-family:inherit;font-size:10pt;">3.95%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">3.85%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">4.40%</font><font style="font-family:inherit;font-size:10pt;">, respectively. The discount rates used to determine postemployment benefit plan information in fiscal years 2015, 2014 and 2013 were </font><font style="font-family:inherit;font-size:10pt;">3.75%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">3.75%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">4.00%</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;padding-left:40px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective September 30, 2015, the approach used to calculate the service and interest components of net periodic benefit cost for benefit plans in the United States was changed to provide a more precise measurement of service and interest costs.  Historically, the Company calculated these service and interest components utilizing a single weighted-average discount rate derived from the yield curve used to measure the benefit obligation at the beginning of the period.  Going forward, the Company has elected to utilize an approach that discounts the individual expected cash flows using the applicable spot rates derived from the yield curve over the projected cash flow period.   For the U.S. benefit plans, the spot rates used to determine service and interest costs ranged from </font><font style="font-family:inherit;font-size:10pt;">0.56%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">4.87%</font><font style="font-family:inherit;font-size:10pt;">.  Based on current economic conditions, the Company estimates that the service cost and interest cost for these U.S. benefit plans will be reduced by approximately </font><font style="font-family:inherit;font-size:10pt;">$18 million</font><font style="font-family:inherit;font-size:10pt;"> in 2016.   The financial impact to plans outside the United States was not material.  The Company has accounted for this change as a change in accounting estimate that is inseparable from a change in accounting principle and accordingly has accounted for it prospectively. </font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> the assumed healthcare trend rates were </font><font style="font-family:inherit;font-size:10pt;">6.8%</font><font style="font-family:inherit;font-size:10pt;">, gradually decreasing to an ultimate rate of </font><font style="font-family:inherit;font-size:10pt;">4.0%</font><font style="font-family:inherit;font-size:10pt;"> beginning in 2024. At </font><font style="font-family:inherit;font-size:10pt;">September 30, 2014</font><font style="font-family:inherit;font-size:10pt;"> the assumed healthcare trend rates were </font><font style="font-family:inherit;font-size:10pt;">7.0%</font><font style="font-family:inherit;font-size:10pt;"> pre and post age </font><font style="font-family:inherit;font-size:10pt;">65</font><font style="font-family:inherit;font-size:10pt;">, gradually decreasing to an ultimate rate of </font><font style="font-family:inherit;font-size:10pt;">5.0%</font><font style="font-family:inherit;font-size:10pt;"> beginning in 2024. A one percentage point increase in assumed healthcare cost trend rates in each year would not materially impact the accumulated postretirement benefit obligation as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> or the aggregate of the service cost and interest cost components of </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;"> annual expense. Similarly, a one percentage point decrease in the assumed healthcare cost trend rates in each year would not materially impact the accumulated postretirement benefit obligation as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> or the aggregate of the </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;"> service cost and interest cost.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Expected Rate of Return on Plan Assets</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The expected rate of return on plan assets is based upon expectations of long-term average rates of return to be achieved by the underlying investment portfolios. In establishing this assumption, the Company considers many factors, including historical assumptions compared with actual results; benchmark data; expected returns on various plan asset classes, as well as current and expected asset allocations.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Expected Funding</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s funding policy for its defined benefit pension plans is to contribute amounts sufficient to meet legal funding requirements, plus any additional amounts that may be appropriate considering the funded status of the plans, tax consequences, the cash flow generated by the Company and other factors. The Company does not anticipate any significant required contributions to its pension plans in 2016.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected benefit payments are as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="67%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Postretirement</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefits</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">163</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">164</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">164</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">177</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">175</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021-2025</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">870</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As previously discussed, the Company replaced its Company-sponsored healthcare coverage program for post-65 retirees with a health reimbursement plan on April 1, 2014. As such, the Company no longer receives subsidies under the Medicare Prescription Drug Improvement and Modernization Act of 2003.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Investments</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s primary objective is to achieve returns sufficient to meet future benefit obligations. It seeks to generate above market returns by investing in more volatile asset classes such as equities while at the same time controlling risk through diversification in non-correlated asset classes and through allocations to more stable asset classes like fixed income.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">U.S. Plans</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s U.S. pension plans comprise </font><font style="font-family:inherit;font-size:10pt;">67%</font><font style="font-family:inherit;font-size:10pt;"> of total benefit plan investments, based on September 30, 2015 market values and have a target asset mix of </font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;"> fixed income, </font><font style="font-family:inherit;font-size:10pt;">34%</font><font style="font-family:inherit;font-size:10pt;"> diversifying investments and </font><font style="font-family:inherit;font-size:10pt;">31%</font><font style="font-family:inherit;font-size:10pt;"> equities. This mix was established based on an analysis of projected benefit payments and estimates of long-term returns, volatilities and correlations for various asset classes. The asset allocations to diversifying investments include high-yield bonds, hedge funds, real estate, infrastructure, commodities, leveraged loans and emerging markets bonds.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The actual portfolio investment mix may, from time to time, deviate from the established target mix due to various factors such as normal market fluctuations, the reliance on estimates in connection with the determination of allocations and normal portfolio activity such as additions and withdrawals. Rebalancing of the asset portfolio on a quarterly basis is required to address any allocations that deviate from the established target allocations in excess of defined allowable ranges. The target allocations are subject to periodic review, including a review of the asset portfolio’s performance, by the named fiduciary of the plans. Any tactical deviations from the established asset mix require the approval of the named fiduciary.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The U.S. plans may enter into both exchange traded and non-exchange traded derivative transactions in order to manage interest rate exposure, volatility, term structure of interest rates, and sector and currency exposures within the fixed income portfolios. The Company has established minimum credit quality standards for counterparties in such transactions.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides the fair value measurements of U.S. plan assets, as well as the measurement techniques and inputs utilized to measure fair value of these assets, at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">. The categorization of fund investments is based upon the categorization of these funds’ underlying assets.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="37%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total U.S.</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Plan Asset</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balances at</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Active Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">for Identical</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets (Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs (Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs (Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed Income:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mortgage and asset-backed securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">192</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">192</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate bonds</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">240</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government and agency-U.S.</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government and agency-Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">335</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">260</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of plan assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,157</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">401</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">755</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="38%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total U.S.</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Plan Asset</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balances at</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Active Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">for Identical</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets (Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs (Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs (Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed Income:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mortgage and asset-backed securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">150</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">150</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate bonds</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">213</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government and agency-U.S.</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">153</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">124</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government and agency-Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">126</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">393</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">337</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">193</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of plan assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,255</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">483</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">768</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Fixed Income Securities</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. pension plan assets categorized above as fixed income securities include fund investments comprised of mortgage-backed, corporate, government and agency and asset-backed instruments. Mortgage-backed securities consist of residential mortgage pass-through certificates. Investments in corporate bonds are diversified across industry and sector and consist of investment-grade, as well as high-yield debt instruments. U.S. government investments consist of obligations of the U.S. Treasury, other U.S. government agencies, state governments and local municipalities. Assets categorized as foreign government and agency debt securities included investments in developed and emerging markets.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The values of fixed income investments classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. A portion of the fixed income instruments classified within Level 2 are valued based upon estimated prices from independent vendors’ pricing models and these prices are derived from market observable sources including: benchmark yields, reported trades, broker/dealer quotes, issuer spreads, benchmark securities, bids, offers and other market-related data. Values of other instruments classified within Level 2 are based on the corroborated net asset value provided by the fund administrator, which is based on the value of the underlying assets owned by the fund, less its liabilities and then divided by the number of fund units outstanding.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Equity Securities</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. pension plan assets categorized as equity securities consist of fund investments in publicly-traded U.S. and non-U.S. equity securities. In order to achieve appropriate diversification, these portfolios are invested across market sectors, investment styles, capitalization weights and geographic regions. The values of equity securities classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. The values of equity security investments classified within Level 2 are based on the corroborated net asset value provided by the fund administrator.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Cash and Cash Equivalents</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A portion of the U.S. plans’ assets consists of investments in cash and cash equivalents, primarily to accommodate liquidity requirements relating to trade settlement and benefit payment activity, and the values of these assets are based upon quoted market prices.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Other Securities</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other U.S. pension plan assets include fund investments comprised of underlying assets of real estate, infrastructure, commodities and hedge funds. The values of such instruments classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. Investments classified within Level 2 are valued based on the net asset value provided by the fund administrator when such net asset value represents the price at which the pension plan assets could be redeemed at period end. Investments classified within Level 3 are valued based on the net asset value provided by the fund administrator when the pension plan assets could not be redeemed at period end (for example, if the assets are subject to a lock-up period).</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the changes, for the years ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">, in the fair value of U.S. pension assets measured using Level 3 inputs:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="83%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Hedge</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Funds)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actual return on plan assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Relating to assets held at September 30, 2013</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases, sales and settlements, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transfers (out) in from other categories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exchange rate changes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actual return on plan assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Relating to assets held at September 30, 2014</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases, sales and settlements, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transfers (out) in from other categories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exchange rate changes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Foreign Plans</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign plan assets comprise </font><font style="font-family:inherit;font-size:10pt;">33%</font><font style="font-family:inherit;font-size:10pt;"> of the Company’s total benefit plan assets, based on market value at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;">. Such plans have local independent fiduciary committees, with responsibility for development and oversight of investment policy, including asset allocation decisions. In making such decisions, consideration is given to local regulations, investment practices and funding rules.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides the fair value measurements of foreign plan assets, as well as the measurement techniques and inputs utilized to measure fair value of these assets, at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="37%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total Foreign</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Plan Asset</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balances at</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Active Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">for Identical</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets (Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs (Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs (Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed Income:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate bonds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government and agency-U.S.</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government and agency-Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other fixed income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">206</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">187</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Real estate</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of plan assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">575</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">364</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="37%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total Foreign<br clear="none"/>Plan Asset<br clear="none"/>Balances at<br clear="none"/>September 30,<br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in<br clear="none"/>Active Markets<br clear="none"/>for Identical<br clear="none"/>Assets (Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant<br clear="none"/>Other<br clear="none"/>Observable<br clear="none"/>Inputs (Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant<br clear="none"/>Unobservable<br clear="none"/>Inputs (Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed Income:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate bonds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government and agency-U.S.</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government and agency-Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other fixed income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">237</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">221</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Real estate</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insurance contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of plan assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">574</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">357</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Fixed Income Securities</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed income investments held by foreign pension plans include corporate, U.S. government and non-U.S. government securities. The values of fixed income securities classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. Values of investments classified within Level 2 are based upon estimated prices from independent vendors’ pricing models and these prices are derived from market observable sources.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Equity Securities</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity securities included in the foreign plan assets consist of publicly-traded U.S. and non-U.S. equity securities. The values of equity securities classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. The values of equity security investments classified within Level 2 are based on the corroborated net asset value provided by the fund administrator.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Other Securities</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The foreign plans hold a portion of assets in cash and cash equivalents, in order to accommodate liquidity requirements and the values are based upon quoted market prices. Real estate investments consist of investments in funds holding an interest in real properties and the corresponding values represent the estimated fair value based on the fair value of the underlying investment value or cost, adjusted for any accumulated earnings or losses. The values of insurance contracts approximately represent cash surrender value. Other investments include fund investments for which values are based upon either quoted market prices or market observable sources.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the changes, for the years ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">, in the fair value of foreign pension assets measured using Level 3 inputs:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="56%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Real</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Estate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Insurance</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actual return on plan assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Relating to assets held at September 30, 2013</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases, sales and settlements, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transfers (out) in from other categories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exchange rate changes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actual return on plan assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Relating to assets held at September 30, 2014</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases, sales and settlements, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transfers in from other categories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exchange rate changes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Postemployment Benefits</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company utilizes a service-based approach in accounting for most of its postemployment benefits. Under this approach, the costs of benefits are recognized over the eligible employees’ service period. The Company has elected to delay recognition of actuarial gains and losses that result from changes in assumptions.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Postemployment benefit costs for the years ended September 30 included the following components:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="57%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of prior service credit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net postemployment benefit cost</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The changes in benefit obligation for these postemployment benefits were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="67%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Postemployment benefits</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Change in benefit obligation:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beginning obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">184</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">186</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefits paid</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actuarial (gain) loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefit obligation at September 30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">163</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">184</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The postemployment benefit plan obligations as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> were unfunded. The amounts recognized in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accumulated other comprehensive income</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">(loss) </font><font style="font-family:inherit;font-size:10pt;">before income taxes for the net actuarial loss were </font><font style="font-family:inherit;font-size:10pt;">$107 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$145 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">, respectively. The estimated net actuarial loss that will be amortized from the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accumulated other comprehensive income</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">(loss) </font><font style="font-family:inherit;font-size:10pt;">into postemployment benefit cost over the next fiscal year is </font><font style="font-family:inherit;font-size:10pt;">$13 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the fourth quarter of fiscal year </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">, the Company recognized a </font><font style="font-family:inherit;font-size:10pt;">$36 million</font><font style="font-family:inherit;font-size:10pt;"> charge associated with unusually broad and significant workforce reduction actions that were not contemplated when the postemployment benefit plan obligation was measured on September 30, 2013. As of September 30, 2015, the Company’s remaining liability relating to these workforce reductions, reflecting payments, foreign exchange and a change in estimate which decreased the liability by </font><font style="font-family:inherit;font-size:10pt;">$5 million</font><font style="font-family:inherit;font-size:10pt;">, was </font><font style="font-family:inherit;font-size:10pt;">$4 million</font><font style="font-family:inherit;font-size:10pt;">. During fiscal year 2015, the Company recognized charges of </font><font style="font-family:inherit;font-size:10pt;">$126 million</font><font style="font-family:inherit;font-size:10pt;"> for employee termination costs substantially in connection with its acquisition of CareFusion. Additional disclosures regarding the CareFusion acquisition are provided in Note 9 and additional disclosures regarding the Company’s restructuring activities that relate to this acquisition are provided in Note 11.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Savings Incentive Plan</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has voluntary defined contribution plans covering eligible employees in the United States which provide for a Company match. The cost of these plans was </font><font style="font-family:inherit;font-size:10pt;">$54 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$39 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$36 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;">. The fiscal year 2015 increase in the cost associated with these plans is attributable to the Company's acquisition of CareFusion. The Company guarantees employees' contributions to the fixed income fund of one of these plans, which typically consists of high quality bonds, including U.S. government securities, corporate bonds, mortgage-backed and asset-backed securities and cash equivalents. The amount guaranteed was </font><font style="font-family:inherit;font-size:10pt;">$235 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue from product sales is typically recognized when all of the following criteria have been met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; product price is fixed or determinable; collection of the resulting receivable is reasonably assured. Certain sales arrangements contain multiple deliverables, including equipment and service deliverables, which requires the Company to determine the separate units of account. If the deliverable meets the criteria of a separate unit of accounting, the arrangement consideration is allocated to each element based upon its relative selling price. In determining the best evidence of selling price of a unit of account the Company utilizes vendor-specific objective evidence (“VSOE”), which is the price the Company charges when the deliverable is sold separately. When VSOE is not available, management uses relevant third-party evidence (“TPE”) of selling price, if available. When neither VSOE nor TPE of selling price exists, management uses its best estimate of selling price.</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue allocated to equipment deliverables is recognized upon customer acceptance, which occurs after the transfer of title and risk of loss to the customer and the completion of installation or training services. When related training services are considered inconsequential, delivery is deemed to occur upon the transfer of title and risk of loss, at which time revenue and the costs associated with installation and training are recognized.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For equipment lease revenue, transactions are evaluated and classified as either operating leases or sales-type leases. Lease income for products sold under sales-type leases is recognized as revenue upon the completion of installation activities in the amount of the present value of the minimum lease payments. The financing component of sales-type leases is recorded as revenue over the lease term. For products sold under operating leases, revenue is recognized at the contracted rate over the rental period, as defined within the customer agreement.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s domestic businesses sell products primarily to distributors that resell the products to end-user customers. Rebates are provided to distributors that sell to end-user customers at prices determined under a contract between the Company and the end-user customer. Provisions for rebates, as well as sales discounts and returns, are based upon estimates and are accounted for as a reduction of revenues when revenue is recognized.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pension plans with accumulated benefit obligations in excess of plan assets and plans with projected benefit obligations in excess of plan assets consist of the following at September 30:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Benefit</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Obligation Exceeds the</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value of Plan  Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Projected Benefit</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Obligation Exceeds the</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value of Plan  Assets</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Projected benefit obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,339</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,267</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,394</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,324</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated benefit obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,265</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,186</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of plan assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,650</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,738</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,693</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,784</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components and changes of </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accumulated other comprehensive income</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">(loss) </font><font style="font-family:inherit;font-size:10pt;">were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Foreign</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Currency</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Translation</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit Plans</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Losses on</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flow</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Hedges</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(802</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(815</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income before reclassifications, net of taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">228</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">203</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reclassified into income, net of taxes (A)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(516</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(558</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(524</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(344</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(180</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reclassified into income, net of</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">taxes (A)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,001</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(705</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income before reclassifications, net of taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(787</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(692</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(80</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reclassified into income, net of</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">taxes (A)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,738</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(961</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(741</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(A)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The benefit plan-related amount is not reclassified into income in its entirety. The reclassifications from accumulated other comprehensive (loss) income are included in the computation of net periodic pension cost and additional details are provided in Note 8. The reclassification amounts related to cash flow hedges in fiscal years </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> were primarily recorded in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Interest Expense.</font><font style="font-family:inherit;font-size:10pt;"> Additional details regarding the reclassifications from accumulated other comprehensive (loss) income related to cash flow hedges are provided in Note 13.</font></div></td></tr></table></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides the fair value measurements of U.S. plan assets, as well as the measurement techniques and inputs utilized to measure fair value of these assets, at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">. The categorization of fund investments is based upon the categorization of these funds’ underlying assets.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="37%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total U.S.</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Plan Asset</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balances at</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Active Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">for Identical</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets (Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs (Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs (Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed Income:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mortgage and asset-backed securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">192</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">192</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate bonds</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">240</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government and agency-U.S.</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government and agency-Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">335</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">260</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of plan assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,157</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">401</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">755</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="38%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total U.S.</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Plan Asset</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balances at</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Active Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">for Identical</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets (Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs (Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs (Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed Income:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mortgage and asset-backed securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">150</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">150</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate bonds</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">213</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government and agency-U.S.</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">153</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">124</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Government and agency-Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">126</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">393</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">337</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">193</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of plan assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,255</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">483</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">768</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The acquisition date fair value of the Company’s ordinary shares issued to CareFusion shareholders was calculated per the following (shares in millions): </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;text-indent:18px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:592px;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="460px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="119px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total CareFusion shares outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">205.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Conversion factor</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.0777</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of the Company’s shares issued</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Closing price of the Company’s stock on March 16, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">142.29</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of the Company’s issued shares</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,269</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the changes, for the years ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">, in the fair value of U.S. pension assets measured using Level 3 inputs:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="83%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Hedge</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Funds)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actual return on plan assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Relating to assets held at September 30, 2013</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases, sales and settlements, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transfers (out) in from other categories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exchange rate changes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actual return on plan assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Relating to assets held at September 30, 2014</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases, sales and settlements, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transfers (out) in from other categories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exchange rate changes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the changes, for the years ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">, in the fair value of foreign pension assets measured using Level 3 inputs:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="56%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Real</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Estate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Insurance</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actual return on plan assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Relating to assets held at September 30, 2013</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases, sales and settlements, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transfers (out) in from other categories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exchange rate changes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2014</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actual return on plan assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Relating to assets held at September 30, 2014</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchases, sales and settlements, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transfers in from other categories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exchange rate changes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amounts and location of compensation cost relating to share-based payments included in consolidated statements of income is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="56%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of products sold</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling and administrative expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">166</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">113</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The provision for income taxes from continuing operations for the years ended September 30 consisted of:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="56%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">225</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">177</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State and local, including Puerto Rico</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">252</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">217</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">179</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">318</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">431</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">352</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Domestic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(238</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(119</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(37</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(274</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(94</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(116</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">337</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">236</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Long-Term Debt</font><font style="font-family:inherit;font-size:10pt;"> at September 30 consisted of:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.750% Notes due November 8, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">499</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">499</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.450% Notes due May 15, 2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(A)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.800% Notes due December 15, 2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,246</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(B)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.900% Notes due April 15, 2018</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">202</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">202</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.000% Notes due May 15, 2019</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">497</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">497</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.375% Notes due August 1, 2019</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">802</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(A)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.675% Notes due December 15, 2019</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,244</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(B)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.250% Notes due November 12, 2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">697</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">697</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.125% Notes due November 8, 2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,013</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">997</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.300% Notes due March 1, 2023</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">305</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(A)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.875% Notes due May 15, 2024</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(A)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.734% Notes due December 15, 2024</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,739</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(B)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.000% Debentures due August 1, 2027</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.700% Debentures due August 1, 2028</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.000% Notes due May 15, 2039</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">246</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">246</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.000% Notes due November 12, 2040</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">296</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">296</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.875% Notes due May 15, 2044</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(A)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.685% Notes due December 15, 2044</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,190</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(B)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,370</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,768</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(A)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents senior unsecured notes issued in the April 2015 exchange of all validly tendered and accepted CareFusion notes for notes issued by the Company, as further discussed above.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(B)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents senior unsecured notes issued in December 2014 in connection with the CareFusion acquisition, as further discussed above.</font></div></td></tr></table></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The location and amounts of derivative instrument fair values in the consolidated balance sheet are segregated below between designated, qualifying hedging instruments and ones that are not designated for hedge accounting.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September 30, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset derivatives-designated for hedge accounting</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swaps</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset derivatives-undesignated for hedge accounting</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total asset derivatives (A)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liability derivatives-designated for hedge accounting</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commodity forward contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liability derivatives-undesignated for hedge accounting</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liability derivatives (B)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(A)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All asset derivatives are included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Prepaid expenses, deferred taxes and other</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(B)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All liability derivatives are included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accrued expenses</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of the federal statutory tax rate to the Company’s effective tax rate was as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="56%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal statutory tax rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State and local income taxes, net of federal tax benefit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of foreign and Puerto Rico earnings and foreign tax credits</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of Research Credits and Domestic Production Activities,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> %</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair values of financial instruments, including those not recognized on the statement of financial position at fair value, carried at </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> are classified in accordance with the fair value hierarchy in the following tables:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="32%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Basis of Fair Value Measurement</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September  30,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Active Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">for Identical</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets (Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs (Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs (Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Institutional money market investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swaps</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward exchange contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">179</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward exchange contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commodity forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td width="32%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Basis of Fair Value Measurement</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September  30,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted Prices in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Active Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">for Identical</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Assets (Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs (Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs (Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Institutional money market investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,040</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,040</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swaps</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward exchange contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,063</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,040</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward exchange contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following is a reconciliation of goodwill by business segment:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.37231968810916%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Medical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Life Sciences</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill as of September 30, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">511</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">598</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,109</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisitions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(A)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency translation/other (B)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(32</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill as of September 30, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">482</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">608</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,090</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisitions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,585</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(C)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(D)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,716</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency translation/other (B)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(261</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(269</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill as of September 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,807</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">730</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,537</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(A)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents goodwill recognized upon the Company’s acquisition of Alverix in the second quarter of fiscal year 2014.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(B)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes amounts resulting from foreign currency translation as well as acquisition accounting adjustments.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(C)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Primarily represents goodwill recognized upon the Company’s acquisition of CareFusion in the second quarter of fiscal year 2015. Additional disclosures regarding the CareFusion acquisition are provided in Note 9. Also includes </font><font style="font-family:inherit;font-size:10pt;">$22 million</font><font style="font-family:inherit;font-size:10pt;"> of goodwill associated with individually immaterial acquisitions, including the CRISI and ARX acquisitions in the second and third quarters of fiscal year 2015, respectively.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(D)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents goodwill recognized upon the Company’s acquisitions of GenCell and Cellular Research in the first and fourth quarters of fiscal year 2015, respectively.</font></div></td></tr></table></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income From Continuing Operations Before Income Taxes</font><font style="font-family:inherit;font-size:10pt;"> for the years ended September 30 consisted of:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="56%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Domestic, including Puerto Rico</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(408</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">532</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">288</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,147</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">990</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">877</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">739</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,522</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,165</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net pension and other postretirement cost for the years ended September 30 included the following components:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td width="35%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Postretirement Benefits</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(123</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(126</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(116</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of prior service credit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of loss</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Curtailment/settlement loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net pension and postretirement cost</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The change in benefit obligation, change in fair value of plan assets, funded status and amounts recognized in the Consolidated Balance Sheets for these plans were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="44%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other Postretirement</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefits</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Change in benefit obligation:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beginning obligation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,366</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,076</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">201</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">243</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plan amendments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefits paid</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(138</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(142</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefit obligations assumed in acquisition</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actuarial loss (gain)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">318</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other, includes translation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(81</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(42</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefit obligation at September 30</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,426</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,366</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">186</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">201</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of plan assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Beginning fair value</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,829</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,785</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actual return on plan assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">119</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employer contribution</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefits paid</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(138</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(142</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plan assets acquired in acquisition</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other, includes translation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(58</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plan assets at September 30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,732</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,829</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Funded Status at September 30:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unfunded benefit obligation</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(694</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(537</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(186</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(201</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amounts recognized in the Consolidated Balance</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Sheets at September 30:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Salaries, wages and related items</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term Employee Benefit Obligations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(691</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(531</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(171</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(184</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net amount recognized</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(694</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(537</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(186</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(201</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amounts recognized in Accumulated other</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">comprehensive income (loss) before income taxes at September 30:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net transition asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior service credit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">119</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net actuarial loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,124</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,030</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(44</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net amount recognized</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,021</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(911</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The location and amount of gains and losses recognized in income on derivatives not designated for hedge accounting for the years ended September 30 were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td width="28%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="26%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivatives Not</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Designated as</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">For Hedge Accounting</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Location of Gain (Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Recognized in Income on</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivatives</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain (Loss)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Recognized in Income on</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivative</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward exchange contracts (A)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income (expense), net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(A)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The gains and losses on forward contracts and currency options utilized to hedge the intercompany transactional foreign exchange exposures are largely offset by gains and losses on the underlying hedged items in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other income (expense), net</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All of the assets acquired and liabilities assumed in this acquisition have been allocated to the Company’s Medical segment. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:592px;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="460px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="119px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,903</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade receivables, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">530</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">813</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net investment in sales-type leases</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,208</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">499</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,360</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Developed technology</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,510</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">380</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">185</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">321</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total identifiable assets acquired</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,709</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,181</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,034</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,299</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities assumed</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,514</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net identifiable assets acquired</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,195</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,343</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,538</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring accrual activity in 2015 was as follows:</font></div><div style="line-height:120%;text-align:center;text-indent:30px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:649px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="185px" rowspan="1" colspan="1"></td><td width="17px" rowspan="1" colspan="1"></td><td width="79px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="16px" rowspan="1" colspan="1"></td><td width="14px" rowspan="1" colspan="1"></td><td width="86px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="14px" rowspan="1" colspan="1"></td><td width="16px" rowspan="1" colspan="1"></td><td width="80px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="21px" rowspan="1" colspan="1"></td><td width="20px" rowspan="1" colspan="1"></td><td width="80px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Millions of dollars)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Employee Termination</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Share-Based Compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other (A)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2014</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assumed liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Charged to expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">126</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">271</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash payments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(74</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(20</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(94</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-cash settlements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(81</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(91</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(A)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts primarily relate to impairment charges for assets held for sale, primarily assets that will be sold as a result of an information technology infrastructure outsourcing project the Company will initiate in fiscal year 2016. Additional disclosures regarding these asset impairment charges are provided in Note 14.</font></div></td></tr></table></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues to unaffiliated customers are based upon the source of the product shipment. Long-lived assets, which include net property, plant and equipment, are based upon physical location.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="56%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenues</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,069</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,417</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,353</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,434</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,383</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,189</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Greater Asia</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,545</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,437</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,344</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,234</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,210</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,168</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,282</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,446</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,054</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Long-Lived Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,513</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,126</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,251</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,876</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,790</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,649</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Greater Asia</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">569</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">555</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">519</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">484</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">505</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">505</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">332</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">340</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">350</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,774</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,317</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,276</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distribution of products is primarily through independent distribution channels, and directly to end-users by BD and independent sales representatives. </font><font style="font-family:inherit;font-size:10pt;">No</font><font style="font-family:inherit;font-size:10pt;"> customer accounted for </font><font style="font-family:inherit;font-size:10pt;">10% or more</font><font style="font-family:inherit;font-size:10pt;"> of revenues in any of the three years presented.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.37231968810916%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td width="48%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenues (A)</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,460</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(B)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,573</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,306</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life Sciences</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,822</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,872</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,748</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,282</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,446</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,054</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment Operating Income</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,530</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(C) </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,291</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(D)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,233</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life Sciences</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">839</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">861</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(E)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">907</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Segment Operating Income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,368</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,152</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,140</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unallocated Items (F)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,629</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(G) </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(630</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(H) </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(976</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(I) </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income From Continuing Operations Before Income Taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">739</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,522</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,165</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,055</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,668</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,582</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life Sciences</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,932</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,783</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,776</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Segment Assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,987</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,451</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,357</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate and All Other (J)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,833</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,997</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,792</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,820</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,447</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,149</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Capital Expenditures</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">414</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">420</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">354</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life Sciences</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">155</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">158</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate and All Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Capital Expenditures</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">596</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">592</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">522</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Depreciation and Amortization</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">619</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">293</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">259</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life Sciences</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">256</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">251</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">267</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate and All Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Depreciation and Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">891</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">562</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">546</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(A)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intersegment revenues are not material.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(B)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes </font><font style="font-family:inherit;font-size:10pt;">$20 million</font><font style="font-family:inherit;font-size:10pt;"> in amortization of the acquisition-date write-down of CareFusion’s deferred revenue balance that was recorded to reflect a fair value measurement as of the acquisition date.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(C)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes an increase of </font><font style="font-family:inherit;font-size:10pt;">$284 million</font><font style="font-family:inherit;font-size:10pt;"> in non-cash amortization expense relating to the identifiable intangible assets acquired in the CareFusion transaction as well as depreciation expense relating to the fixed assets acquired in the transaction. Additional disclosures regarding the assets acquired in this acquisition are provided in Note 9. Also includes a </font><font style="font-family:inherit;font-size:10pt;">$5 million</font><font style="font-family:inherit;font-size:10pt;"> adjustment to decrease the liability for employee termination costs recorded relative to certain workforce reduction actions taken in the fourth quarter of fiscal year 2014. Additional disclosures regarding these actions are provided in Note 8.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(D)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes </font><font style="font-family:inherit;font-size:10pt;">$21 million</font><font style="font-family:inherit;font-size:10pt;"> of the charge associated with workforce reduction actions noted above. Also, includes a </font><font style="font-family:inherit;font-size:10pt;">$6 million</font><font style="font-family:inherit;font-size:10pt;"> charge associated with the decision to terminate a research and development program; the charge relates to program asset write-offs and obligations. Additionally includes </font><font style="font-family:inherit;font-size:10pt;">$4 million</font><font style="font-family:inherit;font-size:10pt;"> of acquisition-related transaction costs recorded in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Selling and administrative expense</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(E)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes a </font><font style="font-family:inherit;font-size:10pt;">$20 million</font><font style="font-family:inherit;font-size:10pt;"> charge primarily resulting from the discontinuance of an instrument product development program. The charge is largely attributable to capitalized product software, but also includes a lesser amount attributable to fixed assets. Also, includes an </font><font style="font-family:inherit;font-size:10pt;">$11 million</font><font style="font-family:inherit;font-size:10pt;"> charge that resulted from the early termination of a European distributor agreement and </font><font style="font-family:inherit;font-size:10pt;">$10 million</font><font style="font-family:inherit;font-size:10pt;"> of the charge associated with the workforce reduction actions noted above. Additionally includes a </font><font style="font-family:inherit;font-size:10pt;">$5 million</font><font style="font-family:inherit;font-size:10pt;"> charge due to an adjustment to the carrying amount of an asset that is being held for sale and </font><font style="font-family:inherit;font-size:10pt;">$1 million</font><font style="font-family:inherit;font-size:10pt;"> of acquisition-related transaction costs recorded in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Selling and administrative expense</font><font style="font-family:inherit;font-size:10pt;">. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(F)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes primarily interest, net; foreign exchange; corporate expenses; and share-based compensation expense.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(G)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes financing, transaction, integration and restructuring costs associated with the CareFusion acquisition. Also includes </font><font style="font-family:inherit;font-size:10pt;">$293 million</font><font style="font-family:inherit;font-size:10pt;"> in recognition of the fair value step-up adjustment recorded relative to CareFusion’s inventory on the acquisition date as well as </font><font style="font-family:inherit;font-size:10pt;">$16 million</font><font style="font-family:inherit;font-size:10pt;"> of favorable amortization relating to the acquisition-date fair value step-up recorded on CareFusion’s long-term debt. Additional disclosures regarding this acquisition are provided in Note 9. Also includes a </font><font style="font-family:inherit;font-size:10pt;">$12 million</font><font style="font-family:inherit;font-size:10pt;"> charge for RTI’s attorneys’ fees associated with the unfavorable verdict returned in the antitrust and false advertising lawsuit RTI filed against BD. For further discussion, refer to Note 5. Additionally includes an acquisition-date accounting gain of </font><font style="font-family:inherit;font-size:10pt;">$9 million</font><font style="font-family:inherit;font-size:10pt;"> on the previously held investment in CRISI Medical Systems, Inc. (“CRISI”), which the Company fully acquired during the second quarter of 2015.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(H)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes an </font><font style="font-family:inherit;font-size:10pt;">$8 million</font><font style="font-family:inherit;font-size:10pt;"> gain resulting from the Company’s receipt of cash proceeds from the sale of a company in which it held a small equity ownership interest. Also includes </font><font style="font-family:inherit;font-size:10pt;">$5 million</font><font style="font-family:inherit;font-size:10pt;"> of the charge associated with the workforce reductions noted above. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(I)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes the </font><font style="font-family:inherit;font-size:10pt;">$341 million</font><font style="font-family:inherit;font-size:10pt;"> charge associated with the unfavorable verdict returned in the antitrust and false advertising lawsuit filed against the Company by RTI as well as a </font><font style="font-family:inherit;font-size:10pt;">$22 million</font><font style="font-family:inherit;font-size:10pt;"> charge associated with a litigation settlement related to indirect purchaser antitrust class action cases. Additional disclosures regarding legal matters are provided in Note 5.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(J)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes cash and investments and corporate assets.</font></div></td></tr></table></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of performance-based restricted stock units outstanding as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and changes during the year then ended is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="63%" rowspan="1" colspan="1"></td><td width="17%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Stock Units (in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Average Grant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Date Fair Value</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,255</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83.47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">352</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">148.04</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distributed</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited or canceled</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(330</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79.12</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30(A)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,139</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">106.07</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected to vest at September 30(B)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">542</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97.09</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(A)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on </font><font style="font-family:inherit;font-size:10pt;">200%</font><font style="font-family:inherit;font-size:10pt;"> of target payout.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(B)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net of expected forfeited units and units in excess of the expected performance payout of </font><font style="font-family:inherit;font-size:10pt;">68 thousand</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">528 thousand</font><font style="font-family:inherit;font-size:10pt;"> shares, respectively.</font></div></td></tr></table></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of SARs outstanding as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and changes during the year then ended is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="37%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">SARs (in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercise Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Remaining</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Contractual Term</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Intrinsic</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">of dollars)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,852</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78.49</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,037</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134.73</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,458</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72.88</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited, canceled or expired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(167</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103.50</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,264</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87.07</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.96</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested and expected to vest at September 30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,010</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86.34</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.88</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">327</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at September 30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,725</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.18</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.81</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">267</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of stock options outstanding as of </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> and changes during the year then ended is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="37%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Stock</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Options (in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Exercise Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Weighted Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Remaining</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Contractual Term</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Aggregate</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Intrinsic</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">of dollars)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related conversions (A)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,971</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82.32</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(900</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83.70</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited, canceled or expired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.41</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,139</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79.47</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested at September 30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,111</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79.10</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.29</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable at September 30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">865</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.82</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.99</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(A)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Represents options granted upon the conversion of pre-acquisition equity awards of CareFusion, as previously discussed.</font></div></td></tr></table></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value was estimated on the date of grant using a lattice-based binomial option valuation model that uses the following weighted-average assumptions:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.20%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.31%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.33%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.0%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.0%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected dividend yield</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.78%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.00%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.60%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected life</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.6 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.8 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.0 years</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value derived</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$24.82</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$19.90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$12.08</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Short-term debt</font><font style="font-family:inherit;font-size:10pt;"> at September 30 consisted of:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="69%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loans Payable</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Domestic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">700</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current portion of long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">752</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,452</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">203</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in certain components of shareholders’ equity were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="23" rowspan="1"></td></tr><tr><td width="32%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Common</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Stock  Issued</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">at Par Value</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Capital in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Excess of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Par Value</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Retained</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Earnings</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Deferred</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Compensation</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Treasury Stock</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares (in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,920</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,435</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(135,751</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,769</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,293</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash dividends:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common ($1.98 per share)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(386</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock issued for:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based compensation and other plans, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,537</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock held in trusts, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repurchase of common stock</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,485</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(450</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,068</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,342</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(138,663</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,204</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,185</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash dividends:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common ($2.18 per share)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(421</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock issued for:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based compensation and other plans, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,431</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock held in trusts, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repurchase of common stock</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,574</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(400</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,198</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,105</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(140,770</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,601</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">695</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash dividends:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common ($2.40 per share)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(485</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock issued for:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based compensation and other plans, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,839</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisitions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,083</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,959</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">368</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">164</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock held in trusts, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repurchase of common stock</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,475</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,314</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(121,967</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,239</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below summarizes the gross amounts of unrecognized tax benefits without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such unrecognized tax benefits were settled. The Company expects no significant increases or decreases in the amount of the unrecognized tax benefits to occur within the next twelve months.</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="56%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at October 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">197</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">146</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increase due to acquisitions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">314</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increase due to current year tax positions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increase due to prior year tax positions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decreases due to prior year tax positions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decrease due to settlements and lapse of statute of limitations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(93</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">575</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">197</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">146</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amounts recognized in </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> relating to allowances for doubtful accounts and cash discounts, which are netted against trade receivables, are provided in the following table:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="55%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Allowance for</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Doubtful</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accounts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Allowance for</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Discounts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions charged to costs and expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deductions and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(A) </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(41</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(44</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions charged to costs and expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deductions and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(A) </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(38</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions charged to costs and expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deductions and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(A) </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(50</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(61</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(A)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts written off.</font></div></td></tr></table></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) for the years ended September 30 were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Average common shares outstanding</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">202,537</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">193,299</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">195,157</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dilutive share equivalents from share-based plans</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,972</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,410</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,036</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Average common and common equivalent shares outstanding — assuming dilution</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207,509</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">197,709</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199,193</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment Data</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective October 1, 2014, the Company’s organizational structure was realigned to better complement its customer-focused solutions strategy and is based upon two principal business segments: BD Medical (“Medical”) and BD Life Sciences (“Life Sciences”). The composition of the Medical segment did not change from its historical composition as a result of this realignment. The Life Sciences segment consists of the former BD Diagnostics and BD Biosciences segments. Beginning on October 1, 2014, decisions about resource allocation and performance assessment are made separately for the Medical and Life Sciences segments. Prior-period information presented for comparative purposes has been revised to reflect the new two-segment organizational structure. CareFusion, which was acquired on March 17, 2015, operates as part of the Company’s Medical segment. The Company’s </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> principal business segments are strategic businesses that are managed separately because each one develops, manufactures and markets distinct products and services.</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Medical segment produces a broad array of medical devices that are used in a wide range of healthcare settings. The principal product lines in the Medical segment include syringes and pen needles for the injection of insulin and other drugs used in the treatment of diabetes; needles, syringes and intravenous catheters for medication delivery (including safety-engineered and auto-disable devices); prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentation; generic prefilled injectables; intravenous medication safety and infusion therapy delivery systems, including infusion pumps and dedicated disposables; automated medication dispensing and supply management systems; prefillable drug delivery systems provided to pharmaceutical companies and sold to end-users as drug/device combinations; respiratory ventilation and diagnostics equipment and consumables used during respiratory diagnostics and therapy; and consumables used for patient monitoring and anesthesia delivery.</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Life Sciences segment produces products for the safe collection and transport of diagnostics specimens, as well as instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections (“HAIs”) and cancers. The segment also produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes. The principal products and services in the Life Sciences segment include integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing and tuberculosis culturing systems; molecular testing systems for infectious diseases and women’s health; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation; plated media; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological (HIV) and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing.</font></div><div style="line-height:120%;padding-top:6px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluates performance of its business segments and allocates resources to them primarily based upon operating income. Segment operating income represents revenues reduced by product costs and operating expenses.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distribution of products is primarily through independent distribution channels, and directly to end-users by BD and independent sales representatives. </font><font style="font-family:inherit;font-size:10pt;">No</font><font style="font-family:inherit;font-size:10pt;"> customer accounted for </font><font style="font-family:inherit;font-size:10pt;">10% or more</font><font style="font-family:inherit;font-size:10pt;"> of revenues in any of the three years presented.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.37231968810916%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td width="48%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenues (A)</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,460</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(B)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,573</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,306</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life Sciences</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,822</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,872</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,748</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,282</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,446</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,054</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment Operating Income</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,530</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(C) </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,291</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(D)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,233</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life Sciences</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">839</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">861</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(E)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">907</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Segment Operating Income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,368</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,152</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,140</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unallocated Items (F)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,629</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(G) </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(630</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(H) </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(976</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(I) </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income From Continuing Operations Before Income Taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">739</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,522</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,165</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,055</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,668</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,582</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life Sciences</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,932</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,783</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,776</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Segment Assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,987</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,451</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,357</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate and All Other (J)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,833</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,997</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,792</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,820</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,447</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,149</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Capital Expenditures</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">414</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">420</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">354</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life Sciences</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">155</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">158</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate and All Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Capital Expenditures</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">596</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">592</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">522</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Depreciation and Amortization</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">619</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">293</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">259</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life Sciences</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">256</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">251</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">267</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate and All Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Depreciation and Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">891</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">562</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">546</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(A)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intersegment revenues are not material.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(B)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes </font><font style="font-family:inherit;font-size:10pt;">$20 million</font><font style="font-family:inherit;font-size:10pt;"> in amortization of the acquisition-date write-down of CareFusion’s deferred revenue balance that was recorded to reflect a fair value measurement as of the acquisition date.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(C)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes an increase of </font><font style="font-family:inherit;font-size:10pt;">$284 million</font><font style="font-family:inherit;font-size:10pt;"> in non-cash amortization expense relating to the identifiable intangible assets acquired in the CareFusion transaction as well as depreciation expense relating to the fixed assets acquired in the transaction. Additional disclosures regarding the assets acquired in this acquisition are provided in Note 9. Also includes a </font><font style="font-family:inherit;font-size:10pt;">$5 million</font><font style="font-family:inherit;font-size:10pt;"> adjustment to decrease the liability for employee termination costs recorded relative to certain workforce reduction actions taken in the fourth quarter of fiscal year 2014. Additional disclosures regarding these actions are provided in Note 8.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(D)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes </font><font style="font-family:inherit;font-size:10pt;">$21 million</font><font style="font-family:inherit;font-size:10pt;"> of the charge associated with workforce reduction actions noted above. Also, includes a </font><font style="font-family:inherit;font-size:10pt;">$6 million</font><font style="font-family:inherit;font-size:10pt;"> charge associated with the decision to terminate a research and development program; the charge relates to program asset write-offs and obligations. Additionally includes </font><font style="font-family:inherit;font-size:10pt;">$4 million</font><font style="font-family:inherit;font-size:10pt;"> of acquisition-related transaction costs recorded in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Selling and administrative expense</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(E)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes a </font><font style="font-family:inherit;font-size:10pt;">$20 million</font><font style="font-family:inherit;font-size:10pt;"> charge primarily resulting from the discontinuance of an instrument product development program. The charge is largely attributable to capitalized product software, but also includes a lesser amount attributable to fixed assets. Also, includes an </font><font style="font-family:inherit;font-size:10pt;">$11 million</font><font style="font-family:inherit;font-size:10pt;"> charge that resulted from the early termination of a European distributor agreement and </font><font style="font-family:inherit;font-size:10pt;">$10 million</font><font style="font-family:inherit;font-size:10pt;"> of the charge associated with the workforce reduction actions noted above. Additionally includes a </font><font style="font-family:inherit;font-size:10pt;">$5 million</font><font style="font-family:inherit;font-size:10pt;"> charge due to an adjustment to the carrying amount of an asset that is being held for sale and </font><font style="font-family:inherit;font-size:10pt;">$1 million</font><font style="font-family:inherit;font-size:10pt;"> of acquisition-related transaction costs recorded in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Selling and administrative expense</font><font style="font-family:inherit;font-size:10pt;">. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(F)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes primarily interest, net; foreign exchange; corporate expenses; and share-based compensation expense.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(G)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes financing, transaction, integration and restructuring costs associated with the CareFusion acquisition. Also includes </font><font style="font-family:inherit;font-size:10pt;">$293 million</font><font style="font-family:inherit;font-size:10pt;"> in recognition of the fair value step-up adjustment recorded relative to CareFusion’s inventory on the acquisition date as well as </font><font style="font-family:inherit;font-size:10pt;">$16 million</font><font style="font-family:inherit;font-size:10pt;"> of favorable amortization relating to the acquisition-date fair value step-up recorded on CareFusion’s long-term debt. Additional disclosures regarding this acquisition are provided in Note 9. Also includes a </font><font style="font-family:inherit;font-size:10pt;">$12 million</font><font style="font-family:inherit;font-size:10pt;"> charge for RTI’s attorneys’ fees associated with the unfavorable verdict returned in the antitrust and false advertising lawsuit RTI filed against BD. For further discussion, refer to Note 5. Additionally includes an acquisition-date accounting gain of </font><font style="font-family:inherit;font-size:10pt;">$9 million</font><font style="font-family:inherit;font-size:10pt;"> on the previously held investment in CRISI Medical Systems, Inc. (“CRISI”), which the Company fully acquired during the second quarter of 2015.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(H)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes an </font><font style="font-family:inherit;font-size:10pt;">$8 million</font><font style="font-family:inherit;font-size:10pt;"> gain resulting from the Company’s receipt of cash proceeds from the sale of a company in which it held a small equity ownership interest. Also includes </font><font style="font-family:inherit;font-size:10pt;">$5 million</font><font style="font-family:inherit;font-size:10pt;"> of the charge associated with the workforce reductions noted above. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(I)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes the </font><font style="font-family:inherit;font-size:10pt;">$341 million</font><font style="font-family:inherit;font-size:10pt;"> charge associated with the unfavorable verdict returned in the antitrust and false advertising lawsuit filed against the Company by RTI as well as a </font><font style="font-family:inherit;font-size:10pt;">$22 million</font><font style="font-family:inherit;font-size:10pt;"> charge associated with a litigation settlement related to indirect purchaser antitrust class action cases. Additional disclosures regarding legal matters are provided in Note 5.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(J)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Includes cash and investments and corporate assets.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Geographic Information</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The countries in which the Company has local revenue-generating operations have been combined into the following geographic areas: the United States (including Puerto Rico); Europe; Greater Asia (which includes Japan and Asia Pacific); and Other, which is comprised of Latin America, Canada, and EMA (which includes the Commonwealth of Independent States, Middle East and Africa).</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues to unaffiliated customers are based upon the source of the product shipment. Long-lived assets, which include net property, plant and equipment, are based upon physical location.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="56%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenues</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,069</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,417</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,353</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,434</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,383</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,189</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Greater Asia</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,545</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,437</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,344</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,234</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,210</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,168</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,282</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,446</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,054</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Long-Lived Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,513</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,126</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,251</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,876</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,790</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,649</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Greater Asia</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">569</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">555</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">519</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">484</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">505</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">505</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">332</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">340</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">350</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,774</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,317</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,276</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Shipping and Handling Costs</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shipping and handling costs are included in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Selling and administrative expense</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shareholders’ Equity</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in certain components of shareholders’ equity were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="23" rowspan="1"></td></tr><tr><td width="32%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Common</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Stock  Issued</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">at Par Value</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Capital in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Excess of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Par Value</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Retained</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Earnings</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Deferred</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Compensation</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Treasury Stock</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares (in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,920</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,435</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(135,751</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,769</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,293</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash dividends:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common ($1.98 per share)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(386</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock issued for:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based compensation and other plans, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,537</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock held in trusts, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repurchase of common stock</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,485</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(450</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,068</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,342</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(138,663</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,204</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,185</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash dividends:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common ($2.18 per share)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(421</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock issued for:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based compensation and other plans, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,431</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock held in trusts, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repurchase of common stock</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,574</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(400</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,198</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,105</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(140,770</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,601</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">695</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash dividends:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common ($2.40 per share)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(485</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock issued for:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based compensation and other plans, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,839</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisitions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,083</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,959</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">368</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Share-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">164</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock held in trusts, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repurchase of common stock</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,475</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,314</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(121,967</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,239</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock held in trusts represents rabbi trusts in connection with deferred compensation under the Company’s employee salary and bonus deferral plan and directors’ deferral plan.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components and changes of </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accumulated other comprehensive income</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">(loss) </font><font style="font-family:inherit;font-size:10pt;">were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="41%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Millions of dollars)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Foreign</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Currency</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Translation</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Benefit Plans</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Losses on</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Cash Flow</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Hedges</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(802</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(815</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income before reclassifications, net of taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">228</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">203</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reclassified into income, net of taxes (A)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(516</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(558</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(524</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(344</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(180</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reclassified into income, net of</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">taxes (A)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,001</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(705</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income before reclassifications, net of taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(787</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(692</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(80</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reclassified into income, net of</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">taxes (A)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at September 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,738</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(961</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(741</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(36</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:6px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:42px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(A)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The benefit plan-related amount is not reclassified into income in its entirety. The reclassifications from accumulated other comprehensive (loss) income are included in the computation of net periodic pension cost and additional details are provided in Note 8. The reclassification amounts related to cash flow hedges in fiscal years </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> were primarily recorded in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Interest Expense.</font><font style="font-family:inherit;font-size:10pt;"> Additional details regarding the reclassifications from accumulated other comprehensive (loss) income related to cash flow hedges are provided in Note 13.</font></div></td></tr></table><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The loss in foreign currency translation adjustments for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> was primarily attributable to the weakening of the Euro and currencies in Latin America and Asia Pacific against the U.S. dollar during the period.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The income tax (benefit) provision for net (losses) gains recorded in other comprehensive income for defined benefit pension, postretirement plans and postemployment plans in fiscal years </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$(47) million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$(86) million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$121 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The income tax benefits associated with the benefit plan-related reclassification adjustments for amortization of prior service credit and amortization of net actuarial losses for the fiscal years ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> were </font><font style="font-family:inherit;font-size:10pt;">$23 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$17 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$30 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The income tax benefit recorded for losses recognized in other comprehensive income relating to cash flow hedges for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$10 million</font><font style="font-family:inherit;font-size:10pt;">. Additional disclosures regarding these losses are provided in Note 13. There were no net gains or losses recorded in other comprehensive income relating to cash flow hedges in fiscal year </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;"> and gains recorded in </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> were immaterial. Reclassification adjustments for realized amounts relating to cash flow hedges were immaterial in fiscal years </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2014</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>

EX-101.SCH 10 bdx-20150930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2102100 - Disclosure - Accounting Changes link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Acquisitions - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2409405 - Disclosure - Acquisitions - Fair Value of Assets and Liabilities Assumed (Detail) link:presentationLink link:calculationLink link:definitionLink 2409404 - Disclosure - Acquisitions - Fair Value of Company's Ordinary Shares Issued (Details) link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - Acquisitions - Fair Value of Consideration Transferred (Details) link:presentationLink link:calculationLink link:definitionLink 2409406 - Disclosure - Acquisitions - Summary of Pro Forma Results (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Acquisitions (Tables) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Benefit Plans link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - Benefit Plans - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - Benefit Plans - Change in Benefit Obligation, Change in Fair Value of Plan Assets (Detail) link:presentationLink link:calculationLink link:definitionLink 2408414 - Disclosure - Benefit Plans - Changes in Benefit Obligation for Postemployment Benefits (Detail) link:presentationLink link:calculationLink link:definitionLink 2408412 - Disclosure - Benefit Plans - Changes in Fair Value of Foreign Pension Assets Measured Using Level 3 Inputs (Detail) (Detail) link:presentationLink link:calculationLink link:definitionLink 2408410 - Disclosure - Benefit Plans - Changes in Fair Value of U.S. and Foreign Pension Assets Measured Using Level 3 Inputs (Detail) link:presentationLink link:calculationLink link:definitionLink 2408408 - Disclosure - Benefit Plans - Expected Benefit Payments (Detail) link:presentationLink link:calculationLink link:definitionLink 2408411 - Disclosure - Benefit Plans - Fair Value Measurements of Foreign Plan Assets (Detail) link:presentationLink link:calculationLink link:definitionLink 2408409 - Disclosure - Benefit Plans - Fair Value Measurements of U.S. Plan Assets (Detail) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Benefit Plans - Net Pension and Other Postretirement Cost (Detail) link:presentationLink link:calculationLink link:definitionLink 2408405 - Disclosure - Benefit Plans - Pension Plans with Accumulated Benefit Obligations (Detail) link:presentationLink link:calculationLink link:definitionLink 2408413 - Disclosure - Benefit Plans - Postemployment Benefit Costs (Detail) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Benefit Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 2408406 - Disclosure - Benefit Plans - Weighted Average Assumptions Determining Pension Plan (Detail) link:presentationLink link:calculationLink link:definitionLink 2408407 - Disclosure - Benefit Plans - Weighted Average Assumptions Determining Pension Plan Footnote (Detail) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Business Restructuring Charges link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - Business Restructuring Charges (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - Business Restructuring Charges (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2405401 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1003501 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Consolidated Statements of Income link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - Consolidated Statements of Income (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 2415403 - Disclosure - Debt - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2415404 - Disclosure - Debt - Schedule if Senior Unsecured Note Issued (Details) link:presentationLink link:calculationLink link:definitionLink 2415407 - Disclosure - Debt - Summary of Interest Costs and Payments (Detail) link:presentationLink link:calculationLink link:definitionLink 2415405 - Disclosure - Debt - Summary of Long-Term Debt (Detail) link:presentationLink link:calculationLink link:definitionLink 2415406 - Disclosure - Debt - Summary of Long-Term Debt (Detail II) link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - Debt - Summary of Short-Term Debt (Detail) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Derivative Instruments and Hedging Activities link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2413403 - Disclosure - Derivative Instruments and Hedging Activities - Effects on Consolidated Balance Sheets (Detail) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Derivative Instruments and Hedging Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 2413404 - Disclosure - Derivative Instruments and Hedging Activities - Undesignated Hedges (Detail) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Divestiture link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Divestiture - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - Divestiture - Results of Discontinued Operations (Detail) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Divestiture (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Earnings per Share link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Earnings per Share - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Earnings per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Earnings per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share (Detail) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Financial Instruments and Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2414403 - Disclosure - Financial Instruments and Fair Value Measurements - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Financial Instruments and Fair Value Measurements - Fair Values of Financial Instruments (Detail) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Financial Instruments and Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2416404 - Disclosure - Income Taxes - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2416403 - Disclosure - Income Taxes - Components of Income from Continuing Operations Before Income Taxes (Detail) link:presentationLink link:calculationLink link:definitionLink 2416406 - Disclosure - Income Taxes - Deferred Income Taxes (Detail) link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - Income Taxes - Provision for Income Taxes from Continuing Operations (Detail) link:presentationLink link:calculationLink link:definitionLink 2416407 - Disclosure - Income Taxes - Reconciliation of Federal Statutory Tax Rate to Company's Effective Tax Rate (Detail) link:presentationLink link:calculationLink link:definitionLink 2416405 - Disclosure - Income Taxes - Summary of Gross Amounts of Unrecognized Tax Benefits (Detail) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 2412403 - Disclosure - Intangible Assets - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - Intangible Assets - Components of Intangible Assets (Detail) link:presentationLink link:calculationLink link:definitionLink 2412404 - Disclosure - Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Sale-Type Leases and Financing Receivable link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - Sale-Type Leases and Financing Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 2417403 - Disclosure - Sale-Type Leases and Financing Receivable Sales-Type Leases and Financing Receivables (Details) link:presentationLink link:calculationLink link:definitionLink 2417403 - Disclosure - Sale-Type Leases and Financing Receivable Sales-Type Leases and Financing Receivables (Details) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - Sale-Type Leases and Financing Receivable Schedule of Capital Leased Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Segment Data link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Segment Data - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Segment Data - Financial Information for Company's Segments (Detail) link:presentationLink link:calculationLink link:definitionLink 2406404 - Disclosure - Segment Data - Financial Information for Company's Segments Footnote (Detail) link:presentationLink link:calculationLink link:definitionLink 2406405 - Disclosure - Segment Data - Revenues to Unaffiliated Customers and Long-lived Assets Including Property, Plant and Equipment (Detail) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Segment Data (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Share-Based Compensation link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Share-Based Compensation - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2407404 - Disclosure - Share-Based Compensation - Assumptions for Estimation of Fair Values of Stock Appreciation Rights Granted During Reporting Periods (Detail) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Share-Based Compensation - Compensation Cost Relating to Share-Based Payments (Detail) link:presentationLink link:calculationLink link:definitionLink 2407407 - Disclosure - Share-Based Compensation - Summary of Performance-Based Restricted Stock Units Outstanding (Detail) link:presentationLink link:calculationLink link:definitionLink 2407408 - Disclosure - Share-Based Compensation - Summary of Performance-Based Restricted Stock Units Outstanding Footnote (Detail) link:presentationLink link:calculationLink link:definitionLink 2407405 - Disclosure - Share-Based Compensation - Summary of SARs Outstanding (Detail) link:presentationLink link:calculationLink link:definitionLink 2407406 - Disclosure - Share-Based Compensation - Summary of Stock Options Outstanding (Detail) link:presentationLink link:calculationLink link:definitionLink 2407409 - Disclosure - Share-Based Compensation - Summary of Time-Vested Restricted Stock Units Outstanding (Detail) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Share-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 2403404 - Disclosure - Shareholders' Equity - Accumulated Other Comprehensive (Loss) Income (Detail) link:presentationLink link:calculationLink link:definitionLink 2403405 - Disclosure - Shareholders' Equity - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Detail) link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Shareholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2401402 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Supplemental Financial Information link:presentationLink link:calculationLink link:definitionLink 2418402 - Disclosure - Supplemental Financial Information - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2418404 - Disclosure - Supplemental Financial Information - Inventories (Detail) link:presentationLink link:calculationLink link:definitionLink 2418405 - Disclosure - Supplemental Financial Information - Property, Plant and Equipment, Net (Detail) link:presentationLink link:calculationLink link:definitionLink 2318301 - Disclosure - Supplemental Financial Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2418403 - Disclosure - Supplemental Financial Information - Trade Receivables, Allowances for Doubtful Accounts and Cash Discounts (Detail) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - Supplementary Data (Unaudited) link:presentationLink link:calculationLink link:definitionLink 2419402 - Disclosure - Supplementary Data (Unaudited) (Details) link:presentationLink link:calculationLink link:definitionLink 2319301 - Disclosure - Supplementary Data (Unaudited) (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 11 bdx-20150930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 12 bdx-20150930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 13 bdx-20150930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Segment Reporting [Abstract] Financial Information for Company's Segments Schedule of Segment Reporting Information, by Segment [Table Text Block] Revenues to Unaffiliated Customers and Long-lived Assets Including Property, Plant and Equipment Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Components of Intangible Assets Schedule of Intangible Assets and Goodwill [Table Text Block] Reconciliation of Goodwill by Business Segment Schedule of Goodwill [Table Text Block] Stockholders' Equity Note [Abstract] Common stock dividend per share (USD per share) Common Stock, Dividends, Per Share, Cash Paid Receivables [Abstract] Sale-Type Leases and Financing Receivable Capital Leases in Financial Statements of Lessor Disclosure [Text Block] Income Tax Disclosure [Abstract] Provision for Income Taxes from Continuing Operations Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Components of Income from Continuing Operations Before Income Taxes Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Summary of Gross Amounts of Unrecognized Tax Benefits Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Deferred Income Taxes Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Reconciliation of Federal Statutory Tax Rate to Company's Effective Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Income Statement [Abstract] Discontinued operations, income tax provision Discontinued Operation, Tax Effect of Discontinued Operation Federal Current Federal Tax Expense (Benefit) State and local, including Puerto Rico Current State and Local Tax Expense (Benefit) Foreign Current Foreign Tax Expense (Benefit) Total, Current Current Income Tax Expense (Benefit) Domestic Deferred Federal Income Tax Expense (Benefit) Foreign Deferred Foreign Income Tax Expense (Benefit) Total, Deferred Deferred Income Tax Expense (Benefit) Total Income Tax Expense (Benefit) Compensation and Retirement Disclosure [Abstract] Benefit Plans Pension and Other Postretirement Benefits Disclosure [Text Block] Document And Entity Information [Abstract] Document and Entity Information. Entity registrant name Entity Registrant Name Entity central index key Entity Central Index Key Current fiscal year end date Current Fiscal Year End Date Entity filer category Entity Filer Category Document type Document Type Document period end date Document Period End Date Document fiscal year focus Document Fiscal Year Focus Document fiscal period focus Document Fiscal Period Focus Amendment flag Amendment Flag Entity common stock, shares outstanding (shares) Entity Common Stock, Shares Outstanding Entity well-known seasoned issuer Entity Well-known Seasoned Issuer Entity voluntary filers Entity Voluntary Filers Entity current reporting status Entity Current Reporting Status Entity public float Entity Public Float Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Share-Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Statement of Comprehensive Income [Abstract] Net Income Net Income (Loss) Attributable to Parent Other Comprehensive (Loss) Income, Net of Tax Other Comprehensive Income (Loss), Net of Tax [Abstract] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Defined benefit pension and postretirement plans Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax Unrealized (losses) gains on cash flow hedges, net of amounts realized Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax Other Comprehensive (Loss) Income, Net of Tax Other Comprehensive Income (Loss), Net of Tax Comprehensive (Loss) Income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Fair Value Disclosures [Abstract] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Notes Due June 2016 Notes Due June 2016 [Member] Notes Due June 2016 [Member] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Gen Cell Biosystems Gen Cell Biosystems [Member] Gen Cell Biosystems [Member] Cellular Research Cellular Research [Member] Cellular Research [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Remaining cash equivalents Remaining Cash Equivalents Amounts of cash equivalents that are carried at cost and are not measured at fair value under the fair value measurement requirements for financial assets and liabilities. Maturity period of short-term investments at the time of purchase Maturity Period Of Short Term Investment The maturity period of time deposits classified as short-term investments in the consolidated balance sheet. Fair value of long-term debt Loans Payable, Fair Value Disclosure Debt instrument, face amount Debt Instrument, Face Amount Fair value of debt classified from long term to short term Fair Value Of Debt Classified From Long Term To Short Term Fair Value Of Debt Classified From Long Term To Short Term Fair value of contingent consideration Business Combination, Contingent Consideration, Liability Transfer of assets in and out of level 1, 2 and 3 measurements during the period Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net Transfer of liabilities in and out of level 1, 2 and 3 measurements during the period Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net Asset Impairment Charges Asset Impairment Charges Finite And Indefinite Lived Intangible Assets [Table] Finite And Indefinite Lived Intangible Assets [Table] Finite And Indefinite Lived Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Customer relationships Customer Relationships [Member] Developed technology Developed Technology Rights [Member] Product rights Product Rights [Member] Acquired technological intellectual property and know how, as well as product marketing rights. Trademarks Trademarks [Member] Patents and other Intellectual Property [Member] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Acquired in-process research and development Unclassified Indefinite-lived Intangible Assets [Member] Finite And Indefinite Lived Intangible Assets [Line Items] Finite And Indefinite Lived Intangible Assets [Line Items] Finite And Indefinite Lived Intangible Assets [Line Items] Gross Carrying Amount Finite-Lived Intangible Assets, Gross Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Unamortized intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) Debt Disclosure [Abstract] Summary of Short-Term Debt Schedule of Short-term Debt [Table Text Block] Summary of Notes Exchanged Schedule of Debt Exchanged [Table Text Block] Schedule of Debt Exchanged [Table Text Block] Summary of Long-Term Debt Schedule of Long-term Debt Instruments [Table Text Block] Summary of Interest Costs and Payments Interest Costs Incurred Table [Table Text Block] Tabular disclosure of interest costs and payments for the periods presented. Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] United States UNITED STATES Europe Europe [Member] Greater Asia Asia [Member] Other Others Country [Member] Others Country [Member] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Corporate Corporate Segment [Member] Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Revenues Revenue, Net Long-Lived Assets Long-Lived Assets Number of principal business segments (segments) Number of Operating Segments Number of customers accounted for 10% or more of revenues (customers) Number Of Customer Accounted For Ten Percent Or More Of Revenue Number Of Customer Accounted For Ten Percent Or More Of Revenue Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans [Axis] Defined Benefit Plans and Other Postretirement Benefit Plans [Axis] Defined Benefit Plan and Other Postretirement Benefit Plan [Domain] Defined Benefit Plan and Other Postretirement Benefit Plan [Domain] Foreign Plans Foreign Pension Plan [Member] Pension Plans Pension Plan [Member] Other Postretirement Benefits Other Postretirement Benefit Plan [Member] U.S. Plans United States Pension Plan of US Entity [Member] Change in Accounting Estimate by Type [Axis] Change in Accounting Estimate by Type [Axis] Change in Accounting Estimate, Type [Domain] Change in Accounting Estimate, Type [Domain] Change in Assumptions for Pension Plans Change in Assumptions for Pension Plans [Member] Defined Benefit Plan, Asset Categories [Axis] Defined Benefit Plan, Asset Categories [Axis] Plan Asset Categories [Domain] Plan Asset Categories [Domain] Fixed Income Funds Fixed Income Funds [Member] Diversified Diversified [Member] Diversified [Member] Equity securities Equity Securities [Member] Care Fusion Corporation Care Fusion Corporation [Member] Care Fusion Corporation [Member] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Net pension and postretirement cost Defined Benefit Plan, Net Periodic Benefit Cost Pension plan assets at fair value Defined Benefit Plan, Fair Value of Plan Assets Pension plan projected benefit obligations Defined Benefit Plan, Benefit Obligation Estimated net actuarial loss that will be amortized from accumulated other comprehensive income Defined Benefit Plan, Future Amortization of Gain (Loss) Estimated prior service credit costs that will be amortized from accumulated other comprehensive income Defined Benefit Plan, Future Amortization of Prior Service Cost (Credit) Defined benefit plan, spot rate used in calculating service and interest cost components, discount rate Defined Benefit Plan, Spot Rate Used Calculating Service and Interest Cost Components, Discount Rate The spot discount rate, derived from the yield curve over the projected cash flow period, that is applied to individual expected cash flows in order to determine the service and interest cost components of net periodic benefit cost. Change in accounting estimate, estimated amount of change in the next fiscal year Change in Accounting Estimate, Estimated Amount of Change in Next Fiscal Year Change in Accounting Estimate, Estimated Amount of Change in Next Fiscal Year Assumed health care trend rate Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year Ultimate health care trend rate beginning in 2024 Defined Benefit Plan, Ultimate Health Care Cost Trend Rate Percent of total assets domestic plans Percent Of Assets Domestic Plans Percentage of the Company's total plan assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits related to domestic pension plans. Company's Target allocation percentage for asset mix Defined Benefit Plan, Target Plan Asset Allocations Percent of total plan assets foreign plans Percent Of Plan Assets Foreign Plans Percentage of the Company's total plan assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits related to foreign pension plans. Amount recognized in Accumulated other comprehensive income before income taxes for net actuarial loss Amount Recognized In Accumulated And Other Comprehensive Income Before Income Taxes For Net Actuarial Loss The pretax net amount of gains and losses that are not yet recognized as a component of net periodic postemployment benefit cost, and that are recognized as increases or decreases in other comprehensive income as they arise. Gains and losses are due to changes in the value of either the benefit obligation or the plan assets resulting from experience different from that assumed or from a change in an actuarial assumption, or the consequence of a decision to temporarily deviate from the substantive plan. Accumulated other comprehensive income into post employment benefit cost Net Actuarial Loss Amortized From Accumulated Other Comprehensive Income To Post Employment Cost The amounts in accumulated other comprehensive income related to gains and losses that are not recognized immediately and are expected to be recognized as components of net periodic postemployment benefit cost over the next fiscal year that follows the most recent annual statement of financial position presented. Charge associated with workforce reduction actions Workforce Reduction Costs Costs associated with workforce reduction actions that were not contemplated when the post employment benefit plan obligation was measured for the current fiscal year. Change in estimate workforce reduction liability Change in Estimate Workforce Reduction Liability Change in Estimate Workforce Reduction Liability Change in workforce liability Workforce Reduction Costs Remaining Liability Remaining liability relating to workforce reduction costs that were not contemplated when the post employment benefit plan obligation was measured. Change in workforce related costs Severance Costs Cost of the savings incentive plan Defined Contribution Plan, Cost Recognized Employees contribution guaranteed by the company to the fixed income fund of the Savings Incentive Plan Employees Contribution Guaranteed By Company To Fixed Income Fund Of Savings Incentive Plan The guaranteed portion, representing employees' contributions to the fixed income fund of the Company's defined contribution plan, as of the balance sheet date. Business Combinations [Abstract] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Business Acquisition [Line Items] Revenues Business Acquisition, Pro Forma Revenue Net Income Business Acquisition, Pro Forma Net Income (Loss) Diluted Earnings per Share (USD per share) Business Acquisition, Pro Forma Earnings Per Share, Diluted Cash consideration Payments to Acquire Businesses, Gross Noncash consideration-fair value of shares issued Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Noncash consideration-fair value of stock options and other equity awards Business Combination Consideration Transferred Stock Options And Awards Business Combination Consideration Transferred Stock Options And Awards Total consideration transferred Business Combination, Consideration Transferred Quarterly Financial Information Disclosure [Abstract] Supplemental Financial Data (Unaudited) Quarterly Financial Information [Text Block] Operations Net Income (Loss) Attributable to Parent [Abstract] Cost of products sold Cost of Goods and Services Sold Selling and administrative expense Selling, General and Administrative Expense Research and development expense Research and Development Expense Acquisition-related costs Business Combination Transaction And Integration Related Costs Acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; business integration costs, systems integration and conversion costs, and severance and other employee-related costs; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Total Operating Costs and Expenses Costs and Expenses Operating Income Operating Income (Loss) Interest expense Interest Expense Interest income Investment Income, Interest Other income, net Other Nonoperating Income (Expense) Income from continuing operations before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Income tax provision Income from Continuing Operations Income (Loss) from Continuing Operations Attributable to Parent Net of income tax provision of $0 in 2015, $0 in 2014 and $222 in 2013 Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Net Income Basic Earnings per Share Earnings Per Share, Basic [Abstract] Income from Continuing Operations (USD per share) Income (Loss) from Continuing Operations, Per Basic Share Income from Discontinued Operations (USD per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share Basic Earnings per Share (USD per share) Earnings Per Share, Basic Diluted Earnings per Share Earnings Per Share, Diluted [Abstract] Income from Continuing Operations (USD per share) Income (Loss) from Continuing Operations, Per Diluted Share Income from Discontinued Operations (USD per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share Diluted Earnings per Share (USD per share) Earnings Per Share, Diluted Acquisitions Business Combination Disclosure [Text Block] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type [Axis] Equity Award [Domain] Equity Award [Domain] Performance-Based Restricted Stock Units Restricted Stock Units Performance Psu [Member] Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time and when specified performance conditions are met. Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Stock units, beginning balance (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Granted, sock units (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period EX-101.PRE 14 bdx-20150930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 15 R39.htm IDEA: XBRL DOCUMENT

Debt (Tables)

12 Months Ended

Sep. 30, 2015

Debt Disclosure [Abstract]

Summary of Short-Term Debt

Short-term debt at September 30 consisted of:



(Millions of dollars)	2015		2014
Loans Payable
Domestic	$	700	$	200
Foreign	—		3
Current portion of long-term debt	752		—
	$	1,452	$	203

Summary of Notes Exchanged

This offer expired in April 2015 and the aggregate principal amounts below of each series of the CareFusion notes were validly tendered and exchanged for notes issued by the Company.



	Aggregate Principal Amount		Percentage of Total Outstanding Principal Amount of such Series of Existing Notes
Interest Rate and Maturity	(Millions of dollars)
1.450% Notes due May 15, 2017	$	293	97.64	%
6.375% Notes due August 1, 2019	665		95.00	%
3.300% Notes due March 1, 2023	294		97.95	%
3.875% Notes due May 15, 2024	397		99.37	%
4.875% Notes due May 15, 2044	300		99.96	%
Total senior notes issued under exchange transaction	$	1,949

Summary of Long-Term Debt

Long-Term Debt at September 30 consisted of:



(Millions of dollars)	2015			2014
1.750% Notes due November 8, 2016	$	499		$	499
1.450% Notes due May 15, 2017	300		(A)	—
1.800% Notes due December 15, 2017	1,246		(B)	—
4.900% Notes due April 15, 2018	202			202
5.000% Notes due May 15, 2019	497			497
6.375% Notes due August 1, 2019	802		(A)	—
2.675% Notes due December 15, 2019	1,244		(B)	—
3.250% Notes due November 12, 2020	697			697
3.125% Notes due November 8, 2021	1,013			997
3.300% Notes due March 1, 2023	305		(A)	—
3.875% Notes due May 15, 2024	419		(A)	—
3.734% Notes due December 15, 2024	1,739		(B)	—
7.000% Debentures due August 1, 2027	168			168
6.700% Debentures due August 1, 2028	167			167
6.000% Notes due May 15, 2039	246			246
5.000% Notes due November 12, 2040	296			296
4.875% Notes due May 15, 2044	334		(A)	—
4.685% Notes due December 15, 2044	1,190		(B)	—
Other long-term debt	5			$	—
	$	11,370		$	3,768


(A)	Represents senior unsecured notes issued in the April 2015 exchange of all validly tendered and accepted CareFusion notes for notes issued by the Company, as further discussed above.


(B)	Represents senior unsecured notes issued in December 2014 in connection with the CareFusion acquisition, as further discussed above.

Summary of Interest Costs and Payments

A summary of interest costs and payments for the years ended September 30 is as follows:



(Millions of dollars)	2015		2014		2013
Charged to operations	$	371	$	135	$	138
Capitalized	30		32		33
Total interest costs	$	401	$	167	$	171
Interest paid, net of amounts capitalized	$	313	$	135	$	143

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 470

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(e),(f))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

+ Details

XML 16 R54.htm IDEA: XBRL DOCUMENT

Segment Data - Financial Information for Company's Segments Footnote (Detail) - USD ($) $ in Millions				3 Months Ended	12 Months Ended
	Jan. 15, 2015	Sep. 19, 2013	Nov. 09, 2009	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Segment Reporting Information [Line Items]
Amortization of identifiable intangible assets and depreciation of fixed assets					$ 346.0	$ 84.0	$ 83.0
Change in estimate workforce reduction liability					5.0
Workforce reduction charge				$ 36.0
Amortization of acquisition-date fair value step-up recorded on long-term debt acquired					16.0
RTI Technologies
Segment Reporting Information [Line Items]
Legal fees	$ 12.0
Pretax charge relating to an unfavorable litigation verdict	$ 341.0	$ 113.5	$ 5.0
Care Fusion Corporation
Segment Reporting Information [Line Items]
Acquisition-related costs					59.0
Corporate and All Other
Segment Reporting Information [Line Items]
Workforce reduction charge						5.0
Gain on sale of small equity ownership interest						8.0
Pretax charge relating to an unfavorable litigation verdict							341.0
Settlement amount							$ 22.0
Corporate and All Other \| RTI Technologies
Segment Reporting Information [Line Items]
Legal fees					12.0
Corporate and All Other \| Care Fusion Corporation
Segment Reporting Information [Line Items]
Inventory step-up adjustment					293.0
Corporate and All Other \| Crisi Medical Systems Inc
Segment Reporting Information [Line Items]
Business combination, step acquisition, equity Interest in acquiree, remeasurement gain					9.0
Medical
Segment Reporting Information [Line Items]
Workforce reduction charge						21.0
Charge associated with the decision to terminate a research and development program						6.0
Acquisition-related costs						4.0
Medical \| Care Fusion Corporation
Segment Reporting Information [Line Items]
Amortization of deferred revenue					20.0
Amortization of identifiable intangible assets and depreciation of fixed assets					284.0
Medical \| Operating Segments
Segment Reporting Information [Line Items]
Change in estimate workforce reduction liability					$ 5.0
Life Sciences \| Operating Segments
Segment Reporting Information [Line Items]
Workforce reduction charge						10.0
Acquisition-related costs						1.0
Charge from discontinuance						20.0
Charge resulted from termination						11.0
Charge due to adjustment to carrying amount of an asset held for sale						$ 5.0

XML 17 R48.htm IDEA: XBRL DOCUMENT

Shareholders' Equity - Additional Information (Detail) - USD ($)	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Stockholders' Equity Note [Abstract]
Income tax (benefit) provision for net (losses) gains recorded in other comprehensive income for defined benefit pension, postretirement plans and postemployment plans	$ (47,000,000)	$ (86,000,000)	$ 121,000,000
Tax benefits associated with reclassification adjustments	23,000,000	17,000,000	$ 30,000,000
Other comprehensive income (loss), derivatives qualifying as hedges, tax	$ (10,000,000)	$ 0

EXCEL 18 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`)-<>4>_?F]AI`(``,P_```3````6T-O;G1E;G1?5'EP97-= M+GAM;,W;W6Z;,!3`\5>I+=VTQN+F^NM>&]/4^NK3,3"MO5JH<6R;2KEF MZ,-]7Y^LNAS6ZZ;2]5#==WY*X'QJ_<''%U=WRK@OJO-+A(8[?-^)3J\\&O M8OVUU<)'[:LRG$[\6V5--S5M[#=_S)C.__%>3A[BOFMOC7IH3A+L+]:FZ1AT MJNG/M>IA,+L?P[![SVVBI[NJ=;TJ((74D MD#I22!T9I(X<4D[%````*P(```L```!?.0Q(OW[CMB`PD.MQ-*O M>X^NO`ZIK`XTHO8<4M?'5$Q^#*G*_=ITJK$"2+8CCVG!D4*>-BP>-9?20D0[ M8$NP+,L5R*V.V:SGVL7.U49V[M,41Y26M#;3"&>6X9MY6&3I//B)]!=C;IK> MTI;MR5/0!_ZS#0//>997'L=V+YRO+0O]C^AY%.!)T:'B1?4C9@,2[2F]@OIZ M`(4QOCLEFI2"(S>C@KN_V/P"4$L#!!0````(`)-<>4&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/%W,MJVT`8Q?%7"7Z`:.Z7 M$&>53;9M7T#8$]O$-R25-F]?UXOB7G3H(O#?V-B"F0.&'V+T'3\>1_/PJ>W[ M:7;S[?M@?QX?+]\O%=IK.#UTWKK;MT(_WIW,[7JZ^GH9#/UT^#ION MW*_>^DWKG#&I&V[763P]_KGVWUG9Q]Z4?-FU:+KZ=AK=QV]HT=MW_9X'+Y_=S^9_O3Z^MNU9Y/JZ^'=IS^D:+[M<&BFP_DY@,Y))"?#^210&$^ M4$`"Q?E`$0F4Y@,E)%">#Y210&4^4$$"U?E`%0EDC9#1,)$4UHS65G!M&:^M M`-LR8EM!MF7,M@)MRZAM!=N6<=L*N"TCMQ5T6\9N*_"VC-Y.Z.T8O9W0VT'W MVNIFF]';";T=H[<3>CM&;R?T=HS>3NCM&+V=T-LQ>CNAMV/T=D)OQ^CMA=Z> MT=L+O3VCMQ=Z>^BL1!V6,'I[H;=G]/9";\_H[87>GM';"[T]H[<7>GM&;R_T M]HS>0>@=&+V#T#LP>@>A=V#T#D+O`)UUJ\-N1N\@]`Z,WD'H'1B]@]`[,'H' MH7=@]`Y"[\#H'87>D=$["KTCHW<4>D=&[RCTCHS>4>@=H6>5ZF$EHW<4>D=& M[RCTCHS>4>@=&;VCT#LR>B>A=V+T3D+OQ.B=A-Z)T3L)O1.C=Q)Z)T;O)/1. MT*R)&C9A]$Y"[\3HG83>B=$[";T3HW<6>F=&[RSTSHS>6>B=&;VST#LS>F>A M=V;TSD+OS.B=A=X9FA54PX*,WEGHG1F]L]`[,WH7H7=A]"Y"[\+H783>A=&[ M"+T+HW<1>A=&[R+T+HS>1>A=&+V+T+M`L]YJV)O1NPB]"Z-W%7I71N\J]*Z, MWE7H71F]J]"[,GI7H7=E]*Y"[\KH787>E=&["KTKHW<5>E>HJZ/*.E1;1]9U MH+Z.484=`S5VC*KL&*BS8U1IQT"M':-J.P;J[1A5W#%0<\>HZHZ!NCM&E7<, MU-XQJKYCH/Z.404>`XDN"YA8`U-6,"'1;TN8X[8?VOKS-.R.F_&CX_RVN(YT MX_DXO>_;QV>YKJI#W/@]7;9JW?7UPW^EZZH_DW1__8/#TP]02P,$%`````@` MDUQY1VN:EH?I!```X1@``!````!D;V-0&ULO5E-<]LX#/TK M'%\V>W!M)VZ^)O6,$R?;SJ2[F=A-SXP$VYQ*I)>DO,[^^@4IV9$LDI)RV%XJ M47@$`3P`A'/#U?#Z28H-2,U`D5V:<'6-BU]Z:ZTWUX.!BM:04O4)13A^70J9 M4HVO.K)\JDFMQL]?46(BUD$::M_FB4 M8A&9H*N7!9Y/]<@K56`>O_2V5#+*=8\H]B^^GO9RM?FJ?4XV2LO)3R%_J36` M5C>#PZ)]+,N6G]EX,AJ-K`@^5D4'!],FA=\JAIN5!=,)J+^63U3J_\D7UJB] M)_#LO9+]^ST(Y3&YYQH)2;[Q7!>&K^R4P].=X$HD+$9ZQ62N\3^S@R)BB=!( M?`!SUA5C4J$99:F5+X9F3E;<8;Q0\:0 M:12)#+WNQ.P_\A7)L\YM@LWCM4ABS+C?R/W?&<;0*7A/)ER#.*R2Q"P<++TN?E;UQC"-AK`F2JE(]. M,Y!LBZ9M`6EMMGYWXU>(5T[,`^/(.D:3&N0!RP;QZ'G5GF-&(@6RH#M?K+"E M]$U=((^`\2@4Y4=`%WC(BRW-DAP/63YN7B>:,$A[PPQR\H/3+&:8-;]WSY'3 MB];D)R<+BG%2;BWU+`C+E\G=(.EA>8%J)GMX^S+KPY(E^H<%PWG@)D,M$1K. M$LJ(,W=0@QEQ=NG-B/!)RJG1$,A0CHQ'W7-D?/J!'/'E8B!)QN/V2=+?-Q6/ MGA!F?-X%@V?+TBP)M`8')HZ9MT,X4KA/?@);K4U'GK;'[+70I'LG)/WF:8/=TQGST\J&*>80L\0TNT($B[9;>BUO=?P@(8XX_.&*6RKAB3)MTQ MY\,/8#SU((CQU(,@QGU)KC:0/OD3\!F!!H:<;84Y(FDK3%X("./$?FF%V9\K M?_^G%>8]K;<@J?L&%<2<7[7"W.\V.(>9(U.(C%,XRFT2\V3+158_YU'QS:5D3CS`E%]CQKSOFPLV# M(&;:/'\4M:9HR3B!DX?&.UG=!>Y:5<7@'2U+\C%SQE3DFYY"5[I+-P_J5[J\ MN`MN6U]K3,FJUIAG0$LBEC#/'!&\/U[Z[H(AC)L'0V_]F7&!JOQ0?_2X\J/Y!8_(?4$L#!!0````(`)-< M>4?Q4*=R/@$``&D#```1````9&]C4')O<',O8V]R92YX;6S-DTU/PS`,AO\* MZKW+TFF3B+H>`'%B$A)#(&XA\;:PYD.)IZ[_GBSK6L:X[,:MKOT^?ATGI7!, M6`_/WCKPJ"#<['5M`A-NGFT0'2,DB`UH'D:QPL3DRGK-,89^31P76[X&4HS' M,Z(!N>3(R0&8NYZ85:443'C@:'V'EZ+'NYVO$TP*`C5H,!@('5&25:]F:VQC M2C+HJS(ZKGG`A95JI4#>M4/992IV1O`Z'.4@^_;I[Y\>4H9D7>4^J+ZJ:9I1 M,TEU<6!*WA=/+^EL&UL[5I; M<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M3A^%$5B-;'EDD81_OTV23;J;/`0LZ?O.14?GZ#AY\^XN8NB&B)3R> +]O6N[!3+UES@6QHO(];JM-O=5H1I;*$8 M1V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!$U=!)KF(M/+Y;,7\VMX^9<_I M.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9KQ]'22(""R7V4!;I)]J/3%0@R M#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2BW`A(5M>5`TR``6'!VULS2`Y9>*?IUE!K9';O= M05SP6.XYB1'^QL4$UFG2&98T1G*=D`4.`#?$T4Q0?*]!MHK@PI+27)#6SRFU M4!H(FLB!]4>"(<7K;YH]5Z%82=J$^!!&&N*<<^9ST6S[ M!Z5&T?95O-RCEU@5`9<8WS2J-2S%UGB5P/&MG#P=$Q+-E`L&08:7)"82J3E^ M34@3_BNEVOZKR2.FJW"$2M"/F(9-AIRM1:!MG&IA&!:$L;1>$[2 MM!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+D!&_'H8X2IKMHG%8!/V>7L-) MP>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T!Z.:60F]A%9JGZJ'-#ZH'C(* M!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+`.7\N?<^E[[GT/:'2MSAD6R4)RU3393>*$IY"&V[I4_5*E=?EK[DHN#Q; MY.FOH70^+,_Y/%_GM,T+,T.WF)&Y"M-2D&_#^>G%>!KB.=D$N7V8 M5VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#0X=Y>U^89Y7&4#04;6RL)"Q& MMV"XU_$L%.!D8"V@!X.O40+R4E5@,5O&`RN0HGQ,C$7H<.>77%_CT9+CVZ9E MM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55ORL+YJ/;053L_^6:W(GPP13A8+ M$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SCYL=Q3E.X$G:V#P(RN;LYJ7IE M,6>F\M\M#`DL6XA9$N)-7>W5YYNTB42%(JP#`4A%W+C[^^3:G>,U_HL@6V$5#)D MU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF8$O#>FZ=+2?_VU[4/;07/4;S MHYG@'K.'YA,L0Z1^P7V*BH`1JV*^NJ]/ M^26<.[1[\8$@F_S6VZ3VW>`,?-2K6J5D*Q$_2P=\'Y(&8XQ;]#1?CQ1BK::Q MK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!U4#E/]O4#6CV#30,9FV M-J/D3@H\W/[O#;#"Q([A[8N_`5!+`P04````"`"37'E'@P7IIU4"``#-"@`` M#0```'AL+W-T>6QE@BR?+F=-?/UU\20Q9VFP=R8N./IWSG4]'$(/DW?_ZR%NGL'W#CY,)GX3Q=W8WQJ%RX@`X= M$(?5,]@@JOT#XYX**B10^@QU'HMPQ+#SN$>4))(8,$>,T*V#YP:PQ][Z,<*% MM+E=AG&>F3]DDD420;_]O3Q=,K#;P6R/4+J_/0W$88F4PI(O]02T]FI;ZLUQ MP;$3:?V.>!<2;8/YU4Z`'73>1,@,RSYS`#LH#BG.E0Z0I%B;48G22!=*"::- MC*!"<$0-91?1&IHVQ90^FH_L1[['W>3`^9@S]B$P*CI3%Z(UAVM@B^KMLCGN M7=K3>$&3]PET-"I+NOU,2<$9=F(=M!3M[!A]<(`^#E''"M9"DF?M;RY"J@$L M(=A@J4BZB_R2J%SA1K4WV&OR0PI/W?);:OKW51O4Z"OXO\MS+^GR^OB1V:\3CF2^N3+3D,Y6VN)GJLRTZS/5MK-7TKSVH:QTY7V M>E*/@J0F5!'>:4#F%?%@=-.]=C'T(\V9-4,KLJL*)?IMN9=%DV4X1S55W\E& M*+L8P<'^:N0'B]YKU5-$<+"_X8S4[-8J&!ZP\6]02P,$%`````@`DUQY1RI@ MK4F.!P``^"$```\```!X;"]W;W)K8F]O:RYX;6R5FEMSV[861O\*1B]-'U3S M?O'4G;%CI\U,VN.)W?09)B$)4Y)0"=).^NO/!B4U'Z1MVGZR)9%+(+CP$=C0 MS_;\R?1_/QCSM_C:-IT][R\6FV'8GI^=V6JC6FE_,EO5T6]:N2@36FL7>YI]#R5KNU%J:)L=K)6Z6_SR MLSU?Z49]4;TEL)#;[1^R51>+K\U"--(.-[4>5'VQ2.BE>5+>&_VXO1IUXUZD M0;HX<[##I=[VHC*UVL'N-]K^M?]@(6JUDF,SW%-C#]][L0BC)(JR'<,=]D6K M)XM`]X:0U:`?U;U\N%@$"R''P7S0S:#Z:SFH7WLS;G6W)M9"K'1OASMWN=.1 MK>YTJ_]U[:97=F.>?C.]_M=T@VSNJMXTS726^V`ZB;[!_O<.M7'0E7?@(!\^ MNSMQL<@"`CYJJQ]THX=O%XOI_T:Y*SD[NI2I^[__)[JI])#-/HFOJB%G<#_7%8*\R*>)4! M4`2@Z*V@&$`Q@.(W@=Z;=@N@!$#)"Z`KV@N[%M9?_-G7BGUYVF$2])A,NJ,B.)`*`"0,4IZ'!&MQ;O M-[);*^R6$LXMF49L9*\VIJEI*/X@;OX924"4+D#K@M/S;V3?T1=;L56]F&!X MMNS+NT,Z0T?-*=6JE!W%+3GF-1B-#1LG+BKK;ZBG3\3P4,&0,O*84 MM)04H]_9J%O(^'8U6MTI:\5G.KL?*SI_KTSO*Q.B;R$CW$=*SF[M@DY<6NL/ MPQ"%"QGCKE6O'Z5+B$(3(\9$0%$@N4$DWOW9R7%ZVO^()'0S8MR< M#;4H1Q3Z&G'YR$23>$II1+`;%C;BHA(SA`#'J&C.Z/AQBB4->8T=7+'+8Q*'#,"(SAPP*\ISMC,J00>S[J&W.Q.1M'.!)BU#=F]#W) M([9!J&[,Q>I<,,6H;HSJQHRZL\$4%XA">6-&7A=,[.6@KC&C*R84!TA0UX33 M=2ZJDA!1J&O"Z#H;54F$*/0VX9[TLU&%VB1H<,)E\5Q6)0FBO!DJE\5<5BT/ MTS&O52ASPF7Q'"K)$(5&)UP8\RBZP+$=&YPH)6AT\MHP)E1=ZZ/Y4H)&)Z^+ MXZ7X2^GUQLVH+Q&%CB>,XRSJT";9X.H`;4\9VV>GHF*)*+0]Y6S'!P6V9R<\ MHM#V](5Y+:&.APZBT/:4LWT.E:+M*=J>,A694)CM&=J><;;/HC#;,[0]XVR?16'I(4/;,\9V?X*T%'_0 M)[?$F\I<78THM#U[:7UW.IX1A;9GC.W'J%VH"]V)Z1-$>54(QO9CU.'B=J^? M$(6V9]S"\`CU/8L?52]Q19:A[1EC^RPJ*Q&%MF>,[<>HFZ];54W%F^D#K+.@ M[3EC^S%J6AU^DO ML-UK58[9GJ/M^2MLOS5V4.VV,=^FR$<4VIZ_VG9[T!U1:'O.V.ZM5F8?J;E7 M=6-L/T)!KT^%242A[3E;>)M!Y6A[CK;GC.VSJ$M4M$#;"\;V(Q3,QT?7@7:7C"V^RA:\XW-KFAZK6WE32`+M+W@;)];.19H>X&V M%XSMIRO'W;S#=--$$%%H>_&J1:C78XA"VPO&=@[U65$O5;K17F6G0-L+QO;9 M16V!*]'"JS*S*]$Y%-I>H.W%6VN`)\G9[E;MWMB[VYA^6-ZKOA77&'TEVEYR=98=ZF3P[4M'B$+;2\;V0ZNJC:I' MDDM3LU2G34_3=JLJ1*'M)6/[Z05^,MWZ<'T/B$+;2[;N,H,JL>Y2HNTE:_LQ MBH:2ZBDF:%1;'#@EVEZR-6XHGRQ==+J]/>IQZGNB(LK;8GFI$N/ER]1`;[O% MWV]A?#^"S3P)P\#;?@D8XX]@T&^_]L9Z9?W`VX()7BB)$^Q:K53?TWQM_[X' M\_9E`L;Z(QBDG[L'QH-Y&S0!MUZ=J62%0>K!O$V;@%NQSL(R#^;MY`1LN?SY MPE@8Y![,V]\)V`W%.5CAP;PMGH!;M\["2@_F;?D$W,IU#A9BWH?^CB.WY3A7 M`0S#T(/Y&Y#A?E]^.F#:BJ]I@MJIVOU0P4Y?5,FFH#\3(4I2MZ/E7O]N M:OIV][.#A5B-3?.>WOM?]\E(=]R>?/B]PB__!U!+`P04````"`"37'E'>A*$ MM9`"``"""0``&````'AL+W=O M$?K!;AAS[[.N&K;U;YRWFR!@IQNN$7LA+6[$/Q=":\3%D%X#UE*,SHI45P$, MPS2H4=GX1:[FWFB1DSNOR@:_48_=ZQK1OSM"^O-RXG@B(/!MZY MK''#2M)X%%^V_BO8'$`F(0KQJ\0=&[U[,ODC(1]R\..\]4.9`Z[PB M>(^K2D82RG],T*>F)([?^^C?5+DB_2-B>$^JW^69WT2VH>^=\07=*_Y.NN_8 MU)#(@"=2,?7KG>Z,D[JG^%Z-/O6S;-2ST__$:T.S$Z`AP($`8RRV230(VL5CJD\?4I%@#YDN`6-HB?Q1A M'CQD&(.`(\1.(\"`"$3L00#:!"9TJ.AP7F"O$=$\XJ`1L3V%R)9"-*XQ4O3$ M3H]M]'A,CQ4]G>8W1NPT(K,+)(L"B:*OI@*)0C1:0"-`F*UGJD@715(58NVH M(C4B=H5L42'3?."0,!!HEU@M2JPT/W)(&,A,LZP7)=::GS@D#"2U2\A/SH(& M"'6$S+'E!@-#,+/EP&KNJ8[Q[LI13(]9SZA8'3Y5,18/72H&,_,9`5833U6T MBR&<7[-]CQ%&B=(DGFDSL&QYH!T-78W68V8Z#2S['FA;0U>O]9BY9ELV/M"^ MAIE+)777LFQ^H*T-O[1:.MJ>@\%$80C$]F3POZ*"T0E68WI55P'FG/ MT>QPW7B%Z@1\PHN\15?\$]%KV3#O2+@X1]6A=R&$8Y%'^"*VYB8N1,.@PA4=S2S`=`00```,3```8 M````>&PO=V]R:W-H965T&ULC9A-CZ,X$(;_"LI]`1MCH)6. M-(!6NX>11G/8/=.)\Z'A(PND,_/O%Z@BC=.X/)<.T$_9KXNR7^/MO6E_=&>E M>N=G5=;=Z^;<]]<7S^OV9U45G=M<53W\Y]BT5=$/M^W)ZZZM*@Y34%5ZW/>E M5Q67>K/;3L^^M;MM<^O+2ZV^M4YWJZJB_96JLKF_;MAF?O#] M<8=+I>KNTM1.JXZOFR_L)>=R1";BGXNZ=XMK9Q3_UC0_QIN_#Z\;?]2@2K7O MQR:*X>==9:HLQY:&GO_#1C_Z'`.7UW/K?T[#'>2_%9W*FO+?RZ$_#VK]C7-0 MQ^)6]M^;^U\*QQ".#>Z;LIO^.OM;US?5'+)QJN(G_%[JZ?<._XD8AJT'<`S@ MCP`FR8```X*/`$$&"`P03P$>#&5*1%[TQ6[;-G>GA;=W+<8B82]B2/7>Z::' M0PZZS0@,J=UMWW<\V7KO8SN(\`62`L(>A#H7>2;C4"T@8QI$9R@`23(1F*,?.XCA8ERNMUPQ+.96:%)D_@HA1FI%BU)S-/ZC8H'G5/G3-')<@ M2C,PC-"2S>V0.>;/^='5KOJ,KC;`N42I#7"5HM0"0R87D,2@U>YI#&Q&$`MJ MBDQ$E7F&$`LY,>Q\II@,#9+MML;0CRA?^PTF0R:@EL4<(;Y8YW6]=E]CX#64 M':7(R(2L7HG)B\F2D+A"FHK";FTLLDZ3%!EB%+&)K5VR^%@ M`R$S]Y,B\SG#L2:8&S*L:YXI::@K;O_`X6@8ACTMM]L!%ZMUI8\:OX/<9]O7 M1PU4Z"9$6_G>Z,KTCNQMP6)Y#8K:ER'S. ML#YSI2'#^LQ%9W'%LQ]XBZ."2K6GZ['+^_%T\>YSA<^'C4\/4_9 M2PZG,Q_-[+;7XJ2^%NWI4G?.6]/W336=.AR;IE>#,-\=LG]6Q>%Q4ZIC/UY& MPW4+9S1PTS?7^ZU^Q]02P,$%`````@`DUQY1^H0FQ?6`0``L@0``!@` M``!X;"]W;W)KIWG4+8-`'9T+O MH]:8?H>Q+EO@5#_)'H3=J:7BU-BE:K#N%=#*0YQA$L=;S&DGHB+WME=5Y'(P MK!/PJI`>.*?J[P&8'/=1$ET-;UW3&F?`18YGKNHX"-U)@134^^@EV9TRI_"" M7QV,>C%'+O>SE.]N\:/:1[%+`1B4QGF@=KC`$1ASCFS@/Y//6T@'+N=7[]]\ MM3;[,]5PE.QW5YG6)AM'J(*:#LR\R?$[3"5LG,-2,NV_J!RTD?R*1(C3CS!V MPH]CV'G.)FP=(!-`9B#9?@FD$Y#>@*\C9!.0W0$XE.(/XD0-+7(E1Z3"S^NI MNR/)+K-'72+MC?8,=.0$]FB+_%)LLAQ?G)])0A:20Y`DLP);YW,$LA;A$TX\ M3AX'.`9%&C^6G";)@R32M23299EI*'.SSF=K?+;DL\!O/Z>X]1(1Z@R2^+'B M^%_%*2@((7=YXL6OY:`:WR,:E7(0QIW4PCJWX0MQ5^/.?K#M&;KIYJ;(>]K` M3ZJ:3FATEL9>/']+:BD-V+3BITV$6ON`S`L&M7'39SM7H:?"PLC^^D+,SU3Q M#U!+`P04````"`"37'E'VIF:"70"``!:"```&````'AL+W=OKJ5N^=L]"7%:>Q\LS:3!_H1?2 MRB='RAHLY)"=/'YA!!^TJ*D]Y/N)U^"J=8M6,.OS8-9G\W MI*:WM1NX]XGWZG06:L(KV^!JM=X"M$$[\JT>9 MWU/ZH08_#FO75QY(34JA0F!Y^21;4MIXA@$]9`-($%'>#)XMP(:6^%)CK0<32^P M!2+TIY&=029,A&,FPGZ:(:2Y'-='8_JHKX^T/AJ4*=%("WD"DF3Q-+,%)@B6 M%FAG()2%XV[CV6QCR#8;UR>SV2:0RN"%Q/UL`5DD&9J&M@8*HV@:V@&$)I)- M9\VF8#:PF$V-C\3BU3#!\!T_>04(];;+D]GEK-DEF+44;0/((K-X!22V&`5B MPF8V:S,;?D#_VP1DD8:6>FT-%"TME=\!A'K,DUMUA,_8#7PH:VC9GH991,BR M/^^!LLRR/PT4Q.EP@WF]$[@A[*1;&7=*>FV%.M!ZLUV[?-5-93"_46U4G^R/ M,$5^P2?R$[-3U7)G3X7L#_HP/U(JB#3FO\BRGF6C[P8U.0IUF\I[!JT/!H)> M[IV\^SM1_`-02P,$%`````@`DUQY1YJSM!I/!```3!8``!@```!X;"]W;W)K M5Q54PJE1Q2M;6' MY,S8FK%KP3C`C#?_/D"W'>-%K;V,@7DM/@1Z2*PO3?NM.SC71]_KZM0]KPY] M?WZ*XVYW<'79?6[.[C3\Y[5IZ[(?=MNWN#NWKMQ/1745@U(FKLOC:;593\>^ MM)MU\]Y7QY/[TD;=>UV7[;];5S67YY5>70]\/;X=^O%`O%G'M[K]L7:G[MB< MHM:]/J]^T4\%VA&9B+^.[M+=;4=C^)>F^3;N_+%_7JDQ@ZO?#U>X MJAI;&L[\#S?Z_SG'POOM:^N_39<[Q'\I.UOY7O5?VTN MOSN^AG1L<-=4W?0WVKUW?5-?2U9177ZGW^-I^KW0?ZSBLN4"X`*X%>A$+$`N MP(>"F))-U_5KV9>;==M$,N]:I=SY,$<.>4`(0+>E&,\S00'!M;9A#$)X8I MSP.CPX[5),?,2%&(@3P3.X:H5*,G3%BSF@PIG69[97(Q"]L83+*TD76:,-/8+AA+K>W;# MUM7D2RMIEQDP5GPU,Z8A23SO1+UHW]E\1Y,V+2RW`&%I`JG.2M)D1B>I]-0Q M!V503]3_,C,UYN+^IT) M'$F:N6>!AF%GHN9IOK1FY77UXUV>KUE_A.99PLY$,ETN68J9X:TG+0>8`NU; MF>!/+.9)==*T;C2=-]!C*].-' MKWD>HE+OVQ_#\D2>*RJ0!KEWWCD?YOYY9WSWW>].JBEZ;OFWKZ MWO?:-+T;FE&?AXL\N')_VZG<:S]N9L-V2Q\[::=OSM=OM[RKNYX.LN-#(&BS#U_B78F-P@I^=722BWY@V`^^N5JV&C<*@I@TY M,?7.I^_4EY":P(HS:=]!=9**]Q=+&/3DT[7=8-O)?4DS;[MM@-X`9T.;Q#>N>J0-I)79(,C4#O5)&?BSA".3B; M(*^!"\VKT\!M1>D4*)HE0`/,%/`6!5I20$^1W`Y`MP*290#R`>D:$EO-X,KP MFFU%>:U8020/(1(/@==+I$L(I\%)Y)YM9;FE7$&E#Z%2#Y7=@7(:A"#&,,;W MH+:4*RC\$`I[J.<[4%X#XR\8I_&=/2V],HFR+(K3YRLHL#@6(SG2GT0%<49T4/>G<5E]\\X#11IENIOO"W05NH/AXN=GFZ[7X!U!+`P04 M````"`"37'E']-TU,"P%``"<'```&````'AL+W=O'^OFQ_MN2BZS:^JO+;/VW/7W9Y\OSV>BRIOO]2W MXMK_Y[5NJKSK?S9O?GMKBOPT%JI*GP>!\JO\]N.S;\UA7[]WY>5:?&LV M[7M5Y'W>?F5/F1R1 MD?CK4MS;V??-(/ZEKG\,/_XX/6^#04-1%L=NJ"+O/WX6:5&60TU]R_]0I1]M M#@7GWTWMOXW=[>6_Y&V1UN7?EU-W[M4&V\VI>,W?R^Y[??^]H#[LA@J/==F. M?S?'][:K*U-DNZGR7_KSO1N^3!)V)/L0WW0*H)$=B1C!"+"+$F0LS[*70?6+!> M@5RK0,XKD&,%,EQJ5"-RU1W5B(IW=B:5I","4$80C\6ZVIU3[8Z:8%*J=014(Y$*K6X[J0JBQQ7:C54,SC=;6AVS6&("R_H< M\KA#+0NH&2`E(<@3`@F>*!1>@H0EO&PU]RYF$Z/$RD)+%:NY==EIG1=5A/JL M&0]T)C5,B#I,C"4'L]4DO%1KLC"4JR$.F)08E)D^(4NQ[H3/=!8.02,),3Q` M690@CT4QTFLHN;-(=F=]IM-QB+(^,5X,ACHU$.,PQ$0I6Y#=Z9^9O`U"DQA( M(@,P4`R#K&C-VA;MJ@4L%9,'H,@D!.$Y'-*RA(()VMD6G=MR&'D.A[/"&!,2 MK!GH.<18[AE8\!7 MS6#1;TYFP-'6@"!O%R/[^J#04$W4+-)+T6[[X9Q$HRT"09Y`&<=`"LS`;((L MRY>[+8B3!7&T2R`HDFAV$>0QE&XS0W%N2>O<[43!M]H M&0H>-@GBS.)TTNUTDIQ.(J&4J%ECV)=/N=)+^3#WZW?+EO MH,<#VO+U/K-T;?E^GWWNFA;MS^YPJJ)Y&R_#VLVQ?K]VPXW([.ETX?:5#W=` M#\\3]I3I:[./:@[[6_Y6_)DW;Y=KNWFINZZNQNN@U[KNBEY8\*6/[;G(3]./ MLGCMAJ]A_[W1EV?Z1U??S%W@="%Y^`]02P,$%`````@`DUQY1S80@H.C`0`` ML0,``!@```!X;"]W;W)KV$`*[:'VF9)_[ZVN816O."9X9PS9WPI1K1OK@/P MY%TKXRZT\[X_,^:J#K1P#]B#"7\:M%KXD-J6N=Z"J!-)*\:S[)%I(0TMBU1[ ML66!@U?2P(LE;M!:V#]74#A>Z($NA5?9=CX66%FPE5=+#<9)-,1"8?*\O-(L60$'EHX((RQV>0:DH%!K_GC4_6D;B-E[4 MOZ9I@_N;L?1?,9I34T(A!^5<%$6%D=BIZWM13S!PYF'C:B(2\7@ MT-$("(.7Q;T\Y'G![E%HQO`-YCIC5@0+ZFL+OM?B'SI/=+Y//^[1CUN'Q]GA M:5\@WQ/(MP+Y_HA;S'7!//[7A&WV5(-MT]5QI,+!I(NZJ:ZW\XFG,_F`ET4O M6O@A;"N-(S?TX633,32('D+[[.%$21?>SYHH:'P,/X783E=J2CSVRP-97VGY M%U!+`P04````"`"37'E';;!LSZ0!``"Q`P``&````'AL+W=O9I.,&*1,HM7N8:4HA^3L@0:LV#2Q MS9#]^]CF$7;%!7Q=JSR3/LG9(M/!MB>ZV%^7L&A<.)[NA< M>)%UXT*!Y1E;>*74T%J)+3%0G>C#[GA.`R("7B4,=A63X/V"^!Z2W^6))L$" M*"A<4!!^N<(C*!6$?../2?.[92"NXUG]9YS6N[\("X^HWF3I&F\VH:2$2O3* MO>#P"Z81#D&P0&7CEQ2]=:AG"B5:?(ZK;.,ZC'\.?*)M$_A$X`OA+HG&QT;1 MYI-P(L\,#L2,6]N)<(*[(_<;41`;B]ZAI0'@!\^S:[Y+;S-V#4(3AJ\PYPFS M()A77UKPK1;_T'FD\VWZ?HN^7SO<3P[OM@72+8%T+9!NC[C&G&?,_7]-V&I/ M-9@Z7AU+"NS;>%%7U>5V/L1#9-_P/.M$#7^$J65KR06=/]EX#!6B`]\^N3E0 MTOCWLR0**A?"6Q^;\4J-B<-N?B#+*\V_`%!+`P04````"`"37'E'PE%=>J,! M``"Q`P``&0```'AL+W=OZ'"(B`7Y)&-PJ)M'[%?$U)C^J,\VB!5!0^J@@PG*#1U`J"H7&;Y/F1\M( M7,>S^K4?V6E6^#V8R2"FK1*_^"PW>81CA&P1*52U]2]LZCGBF4 M:/$^KM*D=1C_[.\GVC:!3P2^$+YFR?C8*-E\$EX4N<6!V'%K.Q%/<'?B82-* MXE(Q.'0T`L+@17XK=LFN-"T+&+LQ90%#DX*#2^&V$$I;OY=0.)X MI@>Z!%Y%V[D08&7!5EXM%&@K4!,#S9G>'TZ7/"`BX+>`T6YL$FJ_(KX%YZD^ MTR24`!(J%Q2X/V[P`%(&(9_X[ZSYD3(0M_:B_C-VZZN_<@L/*/^(VG6^V(22 M&AH^2/>*XR^86S@&P0JEC5]2#=:A6BB4*/X^G4+'D,R%="3\B M@4V)8IF/W/&R,#@2,UUMS\,$#Z?47T1%;`SZ"BT-`-]X6=S*PS$KV"T(S9AT M@[G,F!7!O/J:(MU+\8F>1GJZ3\_VZ-FVPFRN,-\7R/<$\JU`OM_B%G-9,,M_#,32NT)5=T?K)Q#`VB`Y\^ MN3M2TOGWLSH2&A?,[]XVTTI-CL-^>2#K*RW_`U!+`P04````"`"37'E'_;EP M0Z0!``"O`P``&0```'AL+W=O$0GP2\+H5C&)O5\0WV+RHS[1++8`"BH?%418KO`$2D6A8/P^:WY: M1N(ZOJE_2].&[B_"P1.JW[+V76@VHZ2&1@S*O^+X'>81#E&P0N72EU2#\ZAO M%$JT^)A6:=(Z3G\.?*9M$_A,X`OA2Y8:GXQ2F\_"B[*P.!([;6TOX@GNCCQL M1$5<*H8.'8V`,'A97,NOOJ#-#^`IRGB"[!<&"^.+`MQS^H?-$Y]OT_19] MOVYP/[D?[K<%\BV!?"V0;TZXAISSV>/A/P^VVE$-MDT7QY$*!Y.NZ:JZW,W' M=(3L$UX6O6CAI["M-(Y&UL;5/;;J,P$/T5RQ]0$R?IMA%!:KI:M0\K57W8 M?79@`*NVA[5-:/^^MB&4KGC!,\,Y9\[XD@]HWUP+X,F[5L8=:>M]=V#,E2UH MX6ZP`Q/^U&BU\"&U#7.=!5$EDE:,9]DMTT(:6N2I]F*+''NOI($72UROM;`? M)U`X'.F&7@NOLFE]++`B9S.ODAJ,DVB(A?I('S:'TRXB$N"/A,$M8A*]GQ'? M8O)<'6D6+8""TD<%$98+/()242@T_C=I?K6,Q&5\5?^5I@WNS\+!(ZJ_LO)M M,)M14D$M>N5?<7B":81]%"Q1N?0E9>\\ZBN%$BW>QU6:M`[C'WX_T=8)?"+P MF7"7)>-CHV3SI_"BR"T.Q(Y;VXEX@IL##QM1$I>*P:&C$1`&+_)+L=G?Y>P2 MA28,7V!.$V9&L*`^M^!K+;[1>:+S=?IVC;Y=.MQ.#N_7!79K`KNEP&Y]Q"7F M-&%NL_^:L,6>:K!-NCJ.E-B;=%$7U?EV/O!T)E_P(N]$`[^%;:1QY(P^G&PZ MAAK10VB?W>PI:+V!GO0_D^#1G'G4],RVQO@=20I MR;(DN6.*"TW+(M9>35G@X*30\&J('93BYL\9)(XGFM*E\";:SH4"*PNV\FJA M0%N!FAAH3O0Q/9[S@(B`GP)&NXE)\'Y!?`_)2WVB2;``$BH7%+A?KO`$4@8A MW_CWK/G5,A"W\:+^/4[KW5^XA2>4OT3M.F\VH:2&A@_2O>'X#/,(MT&P0FGC MEU2#=:@6"B6*?TRKT'$=IS_W^4S;)V0S(5L)#TDT/C6*-K]QQ\O"X$C,M+4] M#R>8'C._$16QL>@=6AH`?O"RN);I75JP:Q":,=D&*C!MO#J65#CH>%$W MU?5V/F;Q3+[@9='S%GYPTPIMR06=/]EX#`VB`]\^N;FEI//O9TTD-"Z$]SXV MTY6:$H?]\D#65UI^`E!+`P04````"`"37'E'I1C7+*,!``"Q`P``&0```'AL M+W=O;A$O9%2_$-N<2VIYIZUQW M8LR6+2AN[[`#[?_4:!1WWC4-LYT!7D62DBQ-DB-37&A:Y#'V9HH<>R>%AC=# M;*\4-W\N('$XTQV=`^^B:5T(L")G"Z\2"K05J(F!^DSO=Z=+%A`1\$O`8%(:IA4,0+%':^"5E;QVJF4*)XE_C*70\A_'/(9EH MVX1T(J0+X6)C@[I3ZBRB)C4%?H:4!X!LO\ENQ M.V8YNP6A"9.N,)<)LR"85U]2I%LI_J&GD9YNT_=;]/VZPOU4X6%;(-L2R-8" MV7:+:\QEQAS_2\)6=ZK`-'%U+"FQUW%15]%E.^_3.)-O>)%WO(%7;AJA+;FB M\Y.-8Z@1'?CTR=V!DM:_G\614+M@_O"V&5=J=!QV\P-97FGQ%U!+`P04```` M"`"37'E'%_Z47Z,!``"Q`P``&0```'AL+W=OZ2-<]V!,5LTH(6]P@Y:_Z="HX7SJ:F9[0R( M,I*T8CQ);I@6LJ5Y%FNO)L^P=TJV\&J([;46YM\)%`Y'NJ-SX4W6C0L%EF=L MX9520VLEML1`=:3WN\-I'Q`1\$?"8%2F/-`D60$'A@H+PRP4> M0*D@Y!M_3)I?+0-Q'<_J3W%:[_XL+#R@^BM+UWBS"24E5*)7[@V'9YA&N`Z" M!2H;OZ3HK4,]4RC1XG-<91O78?R3IA-MF\`G`E\(=TDT/C:*-A^%$WEF<"!F MW-I.A!/<';C?B(+86/0.+0T`/WB>7?+=S6W&+D%HPO`5YC1A%@3SZDL+OM7B M&YU'.M^FIUOT=.TPG1S>;0OLMP3V:X']]HAKS&G&_/K1A*WV5(.IX]6QI,"^ MC1=U55UNYSV/9_(%S[-.U/!;F%JVEIS1^9.-QU`A.O#MDZMK2AK_?I9$0>5" M>.MC,UZI,7'8S0]D>:7Y?U!+`P04````"`"37'E'3_QW4Z(!``"Q`P``&0`` M`'AL+W=OZ'"(B`7Y) M&-PJ)M'[%?$U)C^J,\VB!5!0^J@@PG*#1U`J"H7&;Y/F1\M(7,>S^K4?V6E6^#V8R2"FK1*_^"PW>81CA&P1*52U]2]LZCGBF4:/$^KM*D=1C_ M'&?:-H%/!+X0OF;)^-@HV7P27A2YQ8'8<6L[$4]P=^)A(TKB4C$X=#0"PN!% M?BMV]UG.;E%HPO`5YC)A%@0+ZDL+OM7B$YTG.M^F[[?H^[7#_>3P/_T/6P*' MM\0UYC)C_G7)5GNJP3;IZCA28F_215U5E]OYP-.9?,"+O!,-_!2VD<:1 M*_IPLND8:D0/H7UV=Z2D#>]G2134/H;W(;;CE1H3C]W\0)976OP%4$L#!!0` M```(`)-<>4>V),/NHP$``+$#```9````>&PO=V]R:W-H965T=3TS#; M&>!5)"G)TB3YQ107FA9YK#V;(L?>2:'AV1#;*\7-OS-('$YT1^?"BVA:%PJL MR-G"JX0";05J8J`^T?O=\9P%1`2\"ACL*B;!^P7Q/21_JA--@@604+J@P/UR MA0>0,@CYQA^3YE?+0%S'L_I3G-:[OW`+#RC?1.5:;S:AI(*:]]*]X/`;IA$. M0;!$:>.7E+UUJ&8*)8I_CJO0<1W&/]G=1-LFI!,A70AW230^-HHV'[GC16YP M(&;<(L".;5EQ;I M5HMO]#32TVWZ?HN^7SO<3PZS;8%L2R!;"V3;(ZXQYQES^-&$K?94@6GBU;&D MQ%['B[JJ+K?S/HUG\@4O\HXW\)>;1FA++NC\R<9CJ!$=^/;)S8&2UK^?)9%0 MNQ#>^MB,5VI,'';S`UE>:?$?4$L#!!0````(`)-<>4>)4SP^I`$``+$#```9 M````>&PO=V]R:W-H965T& M+"!.4;2'`D$.[9F65A(1DJN2E)7^?4GJ$;701=Q=S%;_FJ8- M[F_"P0NJ7[+R;3";45)!+7KEWW#X!M,(QRA8HG+I2\K>>=0SA1(M/L95FK0. MXY_C?J)M$_A$X`OA*4O&QT;)YA?A19%;'(@=M[83\01W9QXVHB0N%8-#1R,@ M#%[D]V)W>LS9/0I-&+["7"?,@F!!?6G!MUK\0^>)SK?I^RWZ?NUP/SD\;0L< MM@0.:X'#]HAKS'7&//W7A*WV5(-MTM5QI,3>I(NZJBZW\YFG,_F$%WDG&O@A M;".-(S?TX633,=2('D+[[.%(21O>SY(HJ'T,3R&VXY4:$X_=_$"65UK\!5!+ M`P04````"`"37'E'VZ;RR:4!``"Q`P``&0```'AL+W=O29'*![3OK@7PY$,KXXZT];X[,.;*%K1P-]B!"7]JM%KX MX-J&N`Z^R M:7T,L")G,Z^2&HR3:(B%^D@?-H?3+B(2X$W"X!8VB;6?$=^C\UP=:19+``6E MCPHB'!=X!*6B4$C\=]+\2AF)2_NJ_BMU&ZH_"P>/J/[(RK>AV(R2"FK1*_^* MPQ-,+=Q&P1*52U]2]LZCOE(HT>)C/*5)YS#^N=M/M'4"GPA\)NRS5/B8*)7Y M4WA1Y!8'8L>K[42Y)UHX+>PC32.G-&'R:8QU(@>0OKLYI:2 M-KR?V5%0^VC>!]N.*S4Z'KOK`YE?:?$)4$L#!!0````(`)-<>4>74W&*HP$` M`+$#```9````>&PO=V]R:W-H965TL`<3_C1HM?#!M2USO051)Y)6C&?9)Z:%-+0L M4NS%E@4.7DD#+Y:X06MA_UQ!X7BA![H$7F7;^1A@9<%67BTU&"?1$`O-A3X= MSM<$A+@IX31;6P2:[\AOD7G>WVA62P!%%0^*HAPW.$9E(I"(?'O6?,C921N M[47]:^HV5'\3#IY1_9*U[T*Q&24U-&)0_A7';S"W<(J"%2J7OJ0:G$>]4"C1 MXGTZI4GG./TY93-MG\!G`E$CXG`ID2IS"_"B[*P.!([76TOX@0/9QXNHB(N M!4.%CD9`:+PL[N7AD1?L'H5F#-]@KC-F1;"@OJ;@>RG^H?-$Y_OTXQ[]N*WP M.%=XW!?(]P3RK4"^W^(6HFNF[G$T\S^8"7 M12]:^"%L*XTC-_1ALFD,#:*'D#Y[.%'2A?>S.@H:'\W/P;;32DV.QWYY(.LK M+?\"4$L#!!0````(`)-<>4=7!QLII`$``+$#```9````>&PO=V]R:W-H965T M&+"!.4;2'`D$.[9F65A(1 MDJN2E)7^?4GJ$;701=Q=S%;_FJ8-[F_"P0NJ7[+R;3";45)! M+7KEWW#X!M,(QRA8HG+I2\K>>=0SA1(M/L95FK0.XQ]^FFC;!#X1^$)XRI+Q ML5&R^45X4>06!V+'K>U$/,'=F8>-*(E+Q>#0T0@(@Q?YO=@]'7-VCT(3AJ\P MUPFS(%A07UKPK1;_T'FB\VWZ?HN^7SO<3PX?MP4.6P*'M\0UYCIC3O\U M8:L]U6";='4<*;$WZ:*NJLOM?.;I3#[A1=Z)!GX(VTCCR`U].-ET##6BA]`^ M>SA2TH;WLR0*:A_#4XCM>*7&Q&,W/Y#EE19_`5!+`P04````"`"37'E'PKCB M::4!``"Q`P``&0```'AL+W=OV$`*[:'V&9)_[ZV80FM>,$SPSEGSOA2 MC&C?7`?@R8=6QIUHYWU_9,Q5'6CA[K`'$_XT:+7P(;4M<[T%42>25HQGV1>F MA32T+%+MQ98%#EY)`R^6N$%K8?^<0>%XHCMZ*[S*MO.QP,J"+;Q::C!.HB$6 MFA-]W!W/^XA(@%\21K>*2?1^07R+R8_Z1+-H`114/BJ(L%SA"92*0J'Q^ZSY MV3(2U_%-_5N:-KB_"`=/J'[+VG?!;$9)#8T8E'_%\3O,(]Q'P0J52U]2#)C6J5)ZSC]R?.9MDW@,X$OA$.6C$^-DLUGX4596!R)G;:V%_$$=T<> M-J(B+A6#0T%M=R=S@4[!J%9@Q?8M'"3V%;:1RYH`\GFXZA0?00VF=W]Y1TX?TLB8+&Q_!KB.UTI:;$ M8W][(,LK+?\"4$L#!!0````(`)-<>4<%B7H0HP$``+$#```9````>&PO=V]R M:W-H965T MVF+\@ MOH7DN3K1)%@`!:4+"L(O5W@`I8*0;_Q[UOQH&8C;>%%_C--Z]Q=AX0'5+UFY MUIM-**F@%H-RKS@^P3S";1`L4=GX)>5@'>J%0HD6[],JN[B.TY^,S[1]`I\) M?"5\3:+QJ5&T^5TX4>0&1V*FK>U%.,'TR/U&E,3&HG=H:0#XP8O\6J3?TIQ= M@]",X1O,><:L".;5UQ9\K\4G.H]TOD\_[-$/6X>'V>%_!+(]@6PKD.V/N,6< M%\SAGR9LLZ<:3!.OCB4E#EV\J)OJ>COOXR&R#WB1]Z*!'$TLK/D@LZ?;#R& M&M&!;Y_S)@IJ%\(O/C;3E9H2A_WR0-976OP%4$L#!!0````(`)-< M>4=Y"R^"H0$``+$#```9````>&PO=V]R:W-H965T0.)SHCLZ!%]&T+@18D;.%5PD% MV@K4Q$!]HG>[XSD+B`CX*V"P*YN$VB^(K\%YJDXT"26`A-(%!>Z/*]R#E$'( M)WZ;-+]2!N+:GM4?8K>^^@NW<(_RGZAE$2+\1V)@HEOF;.U[D!@=BQJOM>)C@ M[ICZBRB)C4%?H:4!X!LO\FNQ^Y7E[!J$)DRZPIPGS()@7GU)D6ZE^(^>1GJZ M3=]OT??K"O=3A8=M@6Q+(%L+9-LMKC'G&7/[+0E;W:D"T\35L:3$7L=%7467 M[;Q+XTR^X$7>\0;^<-,(;WS;A2 MH^.PFQ_(\DJ+3U!+`P04````"`"37'E'BXLL^*@!``"Q`P``&0```'AL+W=O MPUW$J7PPS?N_-&QB*$>V;ZP`\>=?*N!/MO.^/C+FJ M`RW<'?9@PI\&K18^A+9EKK<@ZD32BO$L^\*TD(:61,0N"!?6E!-\J\8G.$YUOT_=;]/W:X7YV^+`MD&$Y&N!?!9X M_-SB&G.>,&%L_RO"5F>JP;9I=!RI<#!I4%?993J?>+J3#WA9]**%G\*VTCAR M01]N-EU#@^@AE,_N#I1TX?TL@8+&Q^U]V-MII*;`8W][(,LK+?\!4$L#!!0` M```(`)-<>4?TLL[MPP(``,(+```9````>&PO=V]R:W-H965TK%3U8O?:29P$%7`6.TWW[=>/\FSHS)Z*-M.K&)SU)>'I-$[,^LI>*!7UBG?CGR MOJ52/?:G1%QZ1@\FJ&T22--ETM*ZBZO2O'OIJY)?95-W[*6/Q+5M:?]ORQI^ MV\0DMB]>Z]-9ZA=)529CW*%N62=JWD4].V[B)_*XA5Q+C.)WS6YB\X M?],//P^;.-5K8`W;2YV"JLL[>V9-HS,I\E],^LG4@=-[F_V[V:Y:_HX*]LR; M/_5!GM5JTS@ZL".]-O*5WWXPW,-")]SS1IB_T?XJ)&]M2!RU]&.XUIVYWH9? MBC6&S0<`!L`8L$K-P@>06>8W*FE5]OP6]<.WO5#]+R2/H#[$/A+FI5JAB+5` M;;PJWRM(29F\ZT2H@8EF.V@^%8G*/B)@#G$7#@-B/CR;"\^F*\P&>KZ83Y#/ M)>@74GAXUC1RL&9M?4])\,4:Q\'19`Z.&'W$[0V M$!_'BEQU$&X`!-T-WCJP(E<=A'L`08.#MPZLR%4'X39`!H^3E:\/H`C`T6U( MN!.0P>9DX?UNV`O`56_A9D#0ZN"M-Q1ECGJ#<#^`P>IDZ:LW%$'F.E3#_0#0 MZIGO6!M%CG,-POT`T.J9[V0;18ZC#<+]`-#JF>]P&T6.>H-P/P"T>N:KZU'T M]8!+)C-6R_J3&25%M.?7SDRND[?CN/H$9D;[E%?EA9[8+]J?ZDY$.R[5I&?& MLB/GDBE^^J#ZS5D-U.-#PXY2WQ;JOA]&S.%!\HN=F,>QO?H/4$L#!!0````( M`)-<>4<=A)5`L@$``!8$```9````>&PO=V]R:W-H965TVN'(R&F[D%0]95J4;+F81GCT)WZ7'<^$1`?"#P60V<^2S7Y1Z]8O'YH03'P$XU-8K4#=L^6[IB=OYHOX]=.O27ZB!>\5_LL;V+FR"40,M';E]4=,#S"V$A+7B M)CQ1/1JKQ$+!2-"W.#(9QBF^*?*9MD_(9D*V$KXF(7@T"C&_44NK4JL)Z?AI M!^IW,#UF[D/4R(2B2VBP![C&J_):97E2DJL7FC'9!G..F'1%$*>^6F1[%A_H M6;38IQ_VZ(=MPD-T+S[QS_<$\JU`/K>8?FQQBSDOF$]2%O\U*6:!PS],%DS^ MEPG9;)P`W87S:5"M1AENPZ:Z7H&[+&S\.[PJ!]K!$]4=DP9=E'7')^QUJY0% M9Y_4<@ MW+[KHP$``+$#```9````>&PO=V]R:W-H965TZ-[4/Y/HXUDSA]-2VQO@-61)`6A679+ M).,*ET6,/9NRT(,37,&S07:0DIG_9Q!Z/.$=G@,OO.U<")"R(`NOYA*4Y5HA M`\T)/^R.YSP@(N"5PVA7>Q1ROVC]'@Y_ZA/.0@H@H')!@?GE"H\@1!#RQO\F MS2_+0%SO9_5?L5J?_859>-3BC=>N\\EF&-70L$&X%SW^AJF$0Q"LM+#QBZK! M.BUG"D:2?:25J[B.Z<]]-M&V"70BT!\$DHQBFD_,L;(P>D0F76W/0@=W1^HO MHD(V!GV&%@>`+[PLKB7-#P6Y!J$)0U>8<\+L%@3QZHL%W;+X1J?)8IN^WZ+O MUQGND_LAWQ;(MP3RM4`^E7C[O<0UYCQC[GZ8D-6=2C!M'!V+*CVH.*BKZ#*= M#S3VY`M>%CUKX2\S+5<67;3SG8UM:+1VX.VSFP-&G7\_RT%`X\+VSN]-&JET M<+J?'\CR2LM/4$L#!!0````(`)-<>4=/+2B4LP$``!8$```9````>&PO=V]R M:W-H965TFT:=J'39H^ M[#XS>E12+A9P[/[[!;S4-F;W1>#P7R5[D#YG5H;R9Q?FH;8S@"K(DD*0I/DFDC&%2[R&'LQ1:Y[)[B"%X-L+R4S M?TX@]'#$*9X#K[QI70B0(B<+K^(2E.5:(0/U$=^EAU,6$!'PB\-@5W,4>/W2?/3,A#7\UG],5;KLS\S"_=:_.:5 M:WVR"485U*P7[E4/3S"5$#,LM;#QB\K>.BUG"D:2?8PC5W$@SM#@`?.%%?BGH_B8GER`T M8>@*Y5[(95=&F!.QHO_A-> MY!UKX"=:VU`V^?7/DJ6M^DRT)`[<+TAY^;\=V."Z>[N0N7 M7T'Q%U!+`P04````"`"37'E'[Q=1].H!``"J!0``&0```'AL+W=OK(*)_A=0:=FD39S/1_?O;K>F^AM5\"38GRK3 MI2G6]U`&.6V9?A'=#QBV$%K#5##EGBAME19\3/$0IV_]6-5N[/HW1W](6TX@ M0P+YE(![D"OS&]4TB:7HD.P_;4/M">[.Q'R(%"D7-!4JSPK,QI/XGI`PB/'= M&@T:,M-<>\UN4F#C/B'($N)#.ND1R^G!4GHPKS#HZ=$7!OLE@_W<8#]L#R[3!QDX7J&0JEH:]>A9M&I+3T2 M=QG?Y4G.<%@QR;:<',Y=]+^D7 M6C1C9YS:<_(?4$L#!!0````(`)-<>4>R3.-E.0(``/4'```9````>&PO=V]R M:W-H965T?8-]Q=+[Y?3UZ@/6"""ZDID!KN^`43HIF4\F]+^JFI`Z=SQ_[5'%?9 MOR"!7QCY55]EI=P&'KCB&^J(?&/]-VS/8!P6C`CS"XI.2$9=B`$$;L,.F\R'Y39&\)#BLB%I,$\R+1IDAD">"*B,,L7%>\*1);@MV*B,/LYT62 M39'$$D0K(@X3SXNDFR*I)5A+O,,L)/ZP*7*P!&N)MYAT(?'Z!=A0@8&E6$O] M"%K(/9RMYD<=6\[I6O9'T$+ZX6Q)/^K8FDZC!8KMLH:V9M-XS:H#)0LZVY4- M;=FF"W\1N%VW,/H?JPYT^$?'GSS+%//2=!\!"M8UIME-=L<.]QR:9_T3GF#"I&H.YB6_,2:QT@^>U#DJU8/'!<$WJ:>)FO.A*PT+R5K79,=. MG_\%4$L#!!0````(`)-<>4>:X%S5T0$``.`$```9````>&PO=V]R:W-H965T M\Z)^GL")H=C M$`5SX(4VK7$!7.1XX564@]!4"J2@/@8/T>&4.80'_*8PZ-4"9:2:?]%9:^-Y#,E0)R\CR,5?AS&/TDVT;8)\42(%\)] MZ!,?C7R:WXDA1:[D@-2XM1UQ)Q@=8KL1)=(^:#/4@0/8PHO\4L3?PAQ?G-"$ MB5>8TXB)%@2VZHM%O&7QB1Z/%MOTW19]M\YP-[JG]]L"R99`LA9(IA*CSR6N M,:<9\Y\L]S=-]I/`[HK)C$FV3=*;)NDDL+]B,F/2;9/LIDDV"6173&;,US/! MJRO(036^TS0J92]\7Z^B2S,_Q/X*?\"+O",-_"*JH4*CLS2V$?RMK:4T8.W# M.WL>K7UNE@6#VKAI9N=J[,!Q860WOR?+HU;\`U!+`P04````"`"37'E'S,O&MEW)&VWG<'QES9@A;N!CLPX4^-5@L?4MLPUUD052)IQ7B6?6-: M2$.+/-5>;)%C[Y4T\&*)Z[46]N\)%`Y'NJ%3X54VK8\%5N1LYE52@W$2#;%0 M'^G#YG#:140"_)(PN$5,8N]GQ+>8/%='FL460$'IHX((RP4>0:DH%(S_7#4_ M+2-Q&4_J/]*TH?NSL?!N:S2BIH!:]\J\X/,%UA'T4+%&Y]"5E[SSJ MB4*)%N_C*DU:A_'/?J*M$_B5P&?"798:'XU2F]^%%T5N<2!VW-I.Q!/<''C8 MB)*X5`P=.AH!8?`BOQ3\_CYGERATQ?`%YC1B-C."!?79@J]9?*'ST6*=OEVC M;Y<=;D?WV__X[]8$=DN!71+89MG7$9>8TX3YUX0M]E2#;=+5<:3$WJ2+NJC. MM_.!IS/YA!=Y)QKX*6PCC2-G].%DTS'4B!Z"?7:SIZ0-[V=.%-0^AK&UL;5/;;J0P#/V5*!_0,(%NJQ&#U.EJM7VH M5/6A?G9`*('N@1>9=.Z$&!%SE9>)35T5F)'#-0G^G`XGK.`B(`W":/=V"34 M?D'\",Y3=:))*`$4E"XH"']1SO?IZ1X]W5:83MGOLGV!;$\@VPID MC`IT]N;BEI_?M9'06U"^:=M\VT4I/CL%\>R/I*BW]02P,$%``` M``@`DUQY1R&3;O&U`0``%@0``!D```!X;"]W;W)K&ULA53+;IPP%/T5RQ\0,V;(I",&*9.H:A>5HBS:M0\$5_!DD.VE9.;/&80>3GB'Y$S;UH7"J3( MR<*KN`1EN5;(0'W"][OC.0N("/C)8;"K.0K9+UJ_A,7WZH23$`$$E"XH,#]< MX0&$"$+>^/>D^689B.OYK/XU=NO37YB%!RU^\*W.@! MF?'3=BSLX.Y(_8,;L%0;SZ8D&W M+-[1::33;7JZ14_7"=/1_7#8%MAO">S7`ONIQ=OW+:XQYQGS#Y/L4Y-L$KC[ MC\F,^?+!A*PV3H)IXOFTJ-2]BK=A55VNP#V-&_\&+_*.-?"#F88KBR[:^>,3 M][K6VH&W3VY\%ZV_I,M"0.W"].#G9CRWX\+I;KZ%RZ^@^`M02P,$%`````@` MDUQY1X/M4=>T`0``%@0``!D```!X;"]W;W)K&UL MA53;;J0@&'X5P@,4Q9GN9.*8=+K9M!>;-+W8O6;T5TDYN(!C]^T7\%#;V.Z- MP.]W^@7,!VU>;`O@T*L4RIYPZUQW),26+4AF;W0'RK^IM9',^:5IB.T,L"J2 MI"`T26Z)9%SA(H^U)U/DNG>"*W@RR/92,O/W#$(/)YSBN?#,F]:%`BERLO`J M+D%9KA4R4)_P77H\[P,B`GYQ&.QJCD+VB]8O8?%8G7`2(H"`T@4%YHGB`J868L-3" MQB^NTG"D82?8ZCES%<1C?W!XFVC:!3@2Z$`Y)##X:Q9C?F6-%;O2`S/AI M.Q9V,#U2_R%*9&/1)[0X`'SC17XMLC3)R34(31BZPIQ'3+H@B%=?+.B6Q3LZ MC72Z3<^VZ-DZ83:Z'Y)M@=V6P&XML)M:3-^WN,:<9\PG*??_-=E/`MD7)C-F M]\&$K#9.@FGB^;2HU+V*MV%57:[`'8T;_P8O\HXU$.9ABN++MKYXQ/WNM;: M@;=/;GP7K;^DRT)`[<+TFY^;\=R."Z>[^18NOX+B'U!+`P04````"`"37'E' MUOK:5JD!``"Q`P``&0```'AL+W=OQHDMA?E[`87CF:9T";S*IG4AP(J([3G^.7F;9/X#.!KX3')!8^)8IE?A5.%+G!D9CI:GL1 M)IB>N+^(DM@8]!5:&@"^\2*_%5EZS-DM",T8OL%<)DRZ(IA77U/PO12?Z#S2 M^3X]VZ-GVPJS*?MCMB]PV!,X;`4.DI/7O9W44U"Z8 M#]XVTTI-CL-^>2#K*RW^`5!+`P04````"`"37'E'563H4](!``#@!```&0`` M`'AL+W=O`EIXD."9QO,."LC;*,Q][47DF>\-9 M"R\*Z5X(JOZ<@E(R[GD_I77ZW- M_D(U/$O^BY6FL&RDF2H0$?1]'UOIQ M&/^DCX&V3B"!0&;"(?:)CT8^S2_4T#Q30` MMO`\N^9I_K171NYB?BK_`'/,\Z6L,/JFK6 M:G21QC:"O[65E`:L??Q@SZ.QS\V\X%`9-]W;N1H[<%P8V4WOR?RHY7\!4$L# M!!0````(`)-<>4>G'0I,WP$``$4%```9````>&PO=V]R:W-H965TP4M5#>W9@`*LV9FT3NF]? MV_R4KFARP?;P_JC==`QCT+GBCCT%M3'O`6.>5);*SG#6P)-"NA."JG\GX+(_!IM@"CRS MJC8N@+,4S[R""6@TDPU24!Z#A\WAE#B$![PPZ/5BCUSN9RG?W.%W<0Q"EP)P MR(U3H':YP"-P[H2L\=]1\]/2$9?[2?VGK]9F?Z8:'B5_986I;;)A@`HH:*2M$\A((#,A"7WB@Y%/ M\P1(ZT#]H,=>``MO`LO601B5-\<4(CABPPIP&S MF1'8JL\69,WB"YUX.EFG1VOT:)EA-+@G]^L"VS6![5)@.Y:8?"UQB3E-F&], M=C=-=H-`%%XQF3#?W.3^ILE^%"!73"9,M&X2WS2)1X'M%9,)LULW26Z:)*/` M_HK)A(G_,\&+_UR`JGP[:Y3+KO'#8Q&=)\8#\7WR"<_2EE;PAZJ*-1J=I;'= MYENCE-*`M0_O[$>O[4R;#QQ*X[:QW:NAS8>#D>TTM.;)F7T`4$L#!!0````( M`)-<>4?&4OG#I@$``+$#```9````>&PO=V]R:W-H965T5JIZV#UGP$#4)&:3,+1_WR0PE%;T M0FSSWK,=.\6(YL5V`(Z\*JGM@7;.]7O&;-6!XO8*>]#^3X-&<>==TS+;&^!U M)"G)TB3YP107FI9%C#V9LL#!2:'AR1`[*,7-VQ$DC@>ZHY?`LV@[%P*L+-C" MJX4";05J8J`YT+O=_I@'1`3\%3#:E4U"[2?$E^`\U@>:A!)`0N6"`O?'&>Y! MRB#D$_^?-3]2!N+:OJC_CMWZZD_/X`',+UT&P M0FGCEU2#=:@N%$H4?YU.H>,Y3G]NDIFV34AG0OJ%P*9$L8XXS)DR])V.I.%9@VKHXE M%0XZ+NHJNFSG71IG\@$OBYZW\(>;5FA+3NC\9.,8&D0'/GUR=4U)Y]_/XDAH M7#!_>MM,*S4Y#OO+`UE>:?D.4$L#!!0````(`)-<>4>W/^[6PP$``'D$```9 M````>&PO=V]R:W-H965TU#I2@/[3-KCR\*&!?P.OW[Q)%;D< M#>]Z>%)(CT(P]>\,7$XG?,!+X+EK6N,"I,C)RJLZ`;WN9(\4U"?\<#B>,X?P M@-\=3'HS1R[WBY0O;O&S.N'(I0`<2N,4F!VN\`B<.R%K_'?6O%DZXG:^J'_W MU=KL+TS#H^1_NLJT-MD(HPIJ-G+S+*0.L%2CM0>1(FT#]H,-78` M6WB17XLX.>3DZH1F#-U@S@%S0Q"KOEK0/8LW=.KI=)\>[]'C;89QP+)5B"92Z1O2]QBS@LFWC=)/S5)O' M139W0X!J?`MH5,JQ]PVWB:Y=]D#]W;K!BWQ@#?QBJNEZC2[2V!OJKU,MI0%K M']W9@VKM.[`N.-3&3>_M7(76"`LCAZ71U]>F^`]02P,$%`````@`DUQY1PL? MWMBH`0``L0,``!D```!X;"]W;W)K&UL;5/;;J0P M#/V5*!_0,!FFEQ&#U.EJM?NP4M6']CD#!J(FF$W"T/W[)N%2NN*%V.:<8SMV ML@'-NVT`'/G0JK4GVCC7'1FS10-:V!OLH/5_*C1:..^:FMG.@"@C22O&D^26 M:2%;FF:V'^G4'A<*([.@=>9-VX$&!YQA9>*36T5F)+ M#%0G^K@[GM.`B(!7"8-=V234?D%\#\[O\D234`(H*%Q0$/ZXPA,H%81\XK^3 MYE?*0%S;L_K/V*VO_B(L/*%ZDZ5K?+$))254HE?N!8=?,+5P"((%*AN_I.BM M0SU3*-'B8SQE&\]A_'-()]HV@4\$OA#NDUCXF"B6^4,XD6<&!V+&J^U$F.#N MR/U%%,3&H*_0T@#PC>?9-=^GMQF[!J$)PU>8\XC9+0CFU9<4?"O%-SJ/=+Y- MWV_1]^L*]V/VA_MM@71+(%T+I%.+=]];7&/.,^;_)&QUIQI,'5?'D@+[-B[J M*KILYR./,_F"YUDG:O@C3"U;2R[H_&3C&"I$!SY] M)E5]V)YIXB2H@#-PFN[?#X.A.+*YO`1PSKT^Q_A<&R=W4;\W%\ZE]UD65;/Q M+U)>GX*@.5QXF37?Q)57[3\G49>9;!_K<]!<:YX=NZ"R"'`8QD&9Y96?)EW; M2YTFXB:+O.(OM=?X;'_E#PVM^ODC5$*1),,8=\Y)732XJK^:G MC?^,GO:4*$B'^)WS>S.Y]Q3Y-R'>U\(-4*;+V\L%WO"A4IK;G MOSKI5Y\J<'H_9/_>R6WIOV4-WXGB3WZ4EY9MZ'M'?LINA7P5]Q]<:XA4PH,H MFN[7.]P:*#2`Z@'P%T-D`J@/H M0T#02^D&8I_)+$UJ@$1&TV<>.W&[#6&K.QD(Y!LI,D^#/H4LQTP MQ-Y)#'82ZP1T9D1Z3!R9D&@Z(+$>-#=DKWMR#`<#F3+--)IARN#WN^LQ>#WW M[C1F%=G)KD"R*TTDMB=8@U-]/3_554D$**!0IV`S\V<$.5X+LA8?LQ]=?:*U M(X6UN!AB$0;46DN#R4+7ACB<4SN`'!4(P14$#=;'CA167YMJ(T`M[%H4+U$[ M@!S%`<&>0]I0,76DL#K!5+L"U%J]8++09GBL0*;:`>2P'(8=@[498N9(836# MH1:C>;78:@:3!5Z@=@0Y?(MAQ^#!#`[?8JL93+444`LO%O!@AKF:/("<:F''8&T&YMIJ6;4$7AD(6E"E M1I##MP1V#-%F8(Z:3!;L+(&M)8%7!D*7J-4@YGBW!'8,T69@CII,K&8PU<:` M6GAE(&R!;P<0<^RC".P8HLW`7-,#WDH18"]%X96!A@O4#B#F6#XH[!BJS<`< M99W">RD*[*4HO#)0LD2M!K''Y2.8?,&6O#YW1P&-=Q"W2JKOP4GK>-SPC-47 M\$/[%CWM^T.#KS1I-Q3/H?4$L#!!0````(`)-<>4=X!\VX]`4```(E M```9````>&PO=V]R:W-H965TZU$YQ`#6#6=L+LVZ]-JQTW=,O*7`R'?)+5!^FW&D]/ M1?F[VN1Y/?JSWQVJN_&FKH^WDTGULLGW6?6M..:'YB^O1;G/ZN9C^3:ICF6> MK<]&^]V$>UXPV6?;PW@V/7_WLYQ-B_=ZMSWD/\M1];[?9^5_]_FN.-V-V5A_ M\6O[MJG;+R:SZ:2S6V_W^:':%H=1F;_>C?]BMZD,6^1,_+W-3U7O_:@-_KDH M?KR_U]X?S\-MPG_. MJGQ>[/[9KNM-$ZTW'JWSU^Q]5_\J3D\YC,%O';X4N^K\_^CEO:J+O389C_;9 M'_6Z/9Q?3^HOD0=F=@,.!KPS8!(U$&`@J`82#"35P`<#GVH0@$%`-0C!(*0: M1&`040UB,(BI!NV:JY7SR";=8C.RB5YN1EYOIA><7:[X1.W%\TY^R.IL-BV+ MTZA4Z7?,VBQGMXU5XWQ4G;]M=G$U;HDF.6;3CYF(O.GDH_4$#.\Q]YIA;F:N M&.XF'K07A/FN&.DF'K47X686P"!#>M)ND$O]T(SO9I::"=S,:G!JDN&`4T`^ MEV#2K'&WT-RZT**_T!PB#>T>A-6#['L0X"$RPPS.S$$MCV)\SQ=N:&6!C%CD M<"P28HG-R_C]6!1SPZ07AA[S(S>Z$\`<,1/S_@6A$R]"4P(7*M%0P]]MU,`E/(+E.S M#Z4`\=BQRX+AU0S4N&//O77N%A@%4FDJ^$Y"L%BL7`&Z5&,S M8.V)81$K*'9H&+2$6LQU.X750(":.RH/ MF;ZEQIB0R%W?BN8MH7E+->9)X3NF@="\<7OW9L;MZ$_,J%T-BAGT4(?""?+% M=8^"!JV@&XG%DW04QTJ,IOIG'F;4!,GANMW!RB)`-]QQ'8)<$A28D`*N&!( M`5YT&+IC5S1O"H68L5).^00A-0%RG$8*@N0(2=**YBVA>4LU%H:!:RH)`B%`(-"#9&&<$/5/^2R52;.-/@8"95=? M$M\P6_ZR?JASYRGDH*@'"*V5P-S815T@QP/)]H1MJ+0X3CNX"2A>9%*I"0Z M[0#Q2,3XG`/(I &N/O@B=LRT)^BBA0;G,#S-\!ETI'CM(;3`0N0TSXR;H MFP1]\[`[?CDL<(#<-/M6#L0-I-_2H%52:Q6:3=#%^+$?NU>"T,E(W(@ M8C>VZ#!4:E8T;PG-6_KIS7.<:4J",$O=&F&_F0"D?MX(T519=.RPRJR^X#?Y M@M^T8Z_42\W/I/?LPC%[R].L?-L>JM%S4=?%_OS(PFM1U'GCR_O6>-[DV;K[ ML,M?Z_9MV+POU2,ZZD-='/431]UC3[/_`5!+`P04````"`"37'E'@?#!)-T! M``"[!```&0```'AL+W=O0,WWNSB,-L$/)3 M-0`:?3'*U2YHM.ZV&*NB`4;42G3`S4DE)"/:F++&JI-`2D=B%,=A^(09:7F0 M9\[W+O-,])JV'-XE4CUC1/[;`Q7#+HB"B^.CK1MM'3C/\,0K6P9(FVQ]0B'.!W"X.:[9'-_23$IS7>RET0VA2`0J&M`C'+&0Y`J14R@?^.FM>0 MECC?7]1_NFI-]B>BX"#HG[;4C4DV#%`)%>FI_A##*XPEK*U@(:AR7U3T2@MV MH02(D2^_MMRM@S_9A"/M/B$>"?%$B)X>$I*1D%P)Z4-".A+2&P+VI;A&'(DF M>2;%@*3_>1VQ=R3:IJ;5!5+.:7J@`@LPK4.+[O)43.]5_A]02P,$%`````@`DUQY1ZF/#B>%`P``I!```!D` M``!X;"]W;W)K&ULC9A-24:J M:O0T]/P7G'[V.1JN[V?OWZ;A#O)?BXYDM/I3'OKSH-8QC0,Y%M>J_T5OWPF, M85*XIU4W_1K[:]?3>C8QC;KX8->RF:XW]D_D@)G8`(,!7@Q0H#1PP<#]-/"4 M!AX8>'<&-AO*-!%YT1=ITM*;T;*W=RG&($&/WC#5>Z.;&H,<^,00MA#]Z7+K"H"\X<3^98WD'&"->1(SD@$A&N2(2['J<+ MXPS$#CR1`V_MP`,'(2\RF)B&C90Q%G(<)*< M/]RL`63A4/6*@0I5X0B,+QDQ$A9&7C#:D#\`64&,58*!*W">LQK=3=D$4!6'"CR(YLI9=3D0*VBAI>L7P$0+`%( M4I*1L"9S>81\32+IZR0*MB12`(7]?EWG)PXHWU>5RYF*D"\1K2^9*-R23.&\ MYJDTSS531>5`84>63/J:B:(MR020(J\S8%Q7I9V-V03@!9]]M,7K&K+?6`2(H>UM=-[&W()("46AFB"LJY*XE6 M_:89^^(TXK;Y`%FN8@.?S=!]P'"[_,73_3[%7IWE:M*>ID-Q9^SIM>G'D]&J M=3EX/^'Q+'C7_CPRZ8Q7V@\GS>E8>*2T)X,NYV&8 MJ3,I#LM#18[]>!L.]RT[1+.'GE[F;P++AXGT/U!+`P04````"`"37'E''6SF M=18"```4!@``&0```'AL+W=O\YS2$,?KD_J;K5:[WQ`)*TY_-UM5:[-A@+:P(P>J/GG_#KZ$S`A6G$K[ MCZJ#5)R=*`%BY-M=F]9>>W?G)?2TZX38$^*!$.5W"8DG)&=">I>0>D(Z(6!7 MBFW$FBA2%H+W2+B'UQ'SCD3S5+>Z0M(&=0]D8`"ZM65Q+-,H+?#1"'E,/,(L M'28:$%BK#RGB:RDNZ+&EQ[<3K!PB"6]#UAYRPT1RS40RKC-Q-60W!-)K`NE8 M(/6-RBY-YA;3NDH=YBF=A?9W&[GRR)?\$7+MD%$<39`7]K.']C-O/[],E8WM M.TR<7/,T!JX<,'I8YCKS#_:>]_RA]]Q[G]UIO<,\1=-4_[?>(:=F\.CP,!![ M.X4DJOBA5>95'$6'0?<:F\,WB2_U`'3SZBQ3%AW9PT\B]DTKT88K?;3M.=QQ MKD";"I]U?VL]HH<-A9TRRYE>"S>UW$;Q[C2#AP]!^0]02P,$%`````@`DUQY M1^1U?",?`@``*`8``!D```!X;"]W;W)K&ULA57; M;J,P$/T5Q`?48&Y-1)":H-7NPTI5'W:?'6("JHVI[83NWZ]O$!H1^A+;PSEG MS@QXD@^,OXL&8^E]4M*)G=](V6\!$%6#*1)/K,>=>E(S3I%41WX&HN<8G0R) M$@"#(`44M9U?Y";VRHN<721I._S*/7&A%/%_>TS8L/-#?PR\M>=&Z@`HT]Z/C+WKPZ_3S@^T!4QP);4"4LL5 M'S`A6D@E_G":MY2:.-^/ZC],MY*-,AOXW@G7Z$+D&QM^8E=" MH@4K1H3Y]:J+D(R.%-^CZ-.N;6?6P3YY#AQMF0`=`4Z$,%TE1(X0W0CQ*B%V MA/B.`&PIIA$EDJC(.1L\;E]>C_0W$FYCU>K*$R:H>B!\#5"M+?)K$8?/.;AJ M(8>!,\S>8L()`93ZE`(NI?A"AX8.'RW+LC58 M.<(VZGWHS/^ MC?BY[81W9%)==W,W:\8D5LZ")^6S46-[.A!<2[W-U)[;268/DO7C7)[^'(K_ M4$L#!!0````(`)-<>4=5ST%+R@$``.`$```9````>&PO=V]R:W-H965TA4M6'W6<'AH!J8VH[ MH?W[]2V4K4A;'O#,<,Z9BXV+4DG,=Y#:"&W@I5@RKU1=51:\#,E0IR^^K7KW3KZ+S=QH"T3TD!()T)" M/B5D@9!]ET`"@7R7D`="_H&`?>]N4&PO=V]R:W-H965TI9&J/G2>W<1)4`%GP&DZ?S\8'S(D@\$OY9*US_:IO0VD)U%_-GO.I?-= M%E6SF?=)B]YU>2B M% MJM0Z_X:B_SR5<'C>5W_HVFV'_\$:OA+%KWPC]^UH?=?9\"T[%O)-G)XX]!"H M@FM1--U?9WULI"A[B>N4[%L?\ZH[GO0OL0^R<0$&`3X+$)T4$!`06P$%`;45 M!"`(;`4A"$);002"R%80@R"V%20@2&P%:L[US/E7$D]/>;=@[IAD65J+DU/K M57Y@*DSH%JDUN7::[FZ[6!I7$>T:S-*OC.(@];Y4)6#P@%GV3&AF5CT3F9F[ MGHG-S'W/)&;F`1CBFYE'S1!D1IXT@LW$,Q29\'GYS\=K__?G"<"C$T"&$X"A M&4,%,EJ!#BL0J'#52=@QE>Y5,W%B1IXU$B$S\@*(/SY4.C]4"D,EER;!<*B: MB0TFP;Q)`"9TPD0S(1XW">=-0C`))DPT0\)QDVC>)`*3<,)$,]A@$L^;Q&`2 M39AH!L7C)LF\20(F\82)9C`=-U&[WIQ+=UO93*SS)X"2P-`-&M\U+XU@"Z)7 M6P.]V*9ZR!!M-+X[7!K!]D`-*Q6-[P\7.PSJ-PC3."R"BR"YE$PUW$.F*;0( M+X+TTL!08SR;EPV',PU;1`]%-@WWD"%]R")^"/)'(T.-\71=-IQ,-XPMLH,A M.S0V9V<)$*%73XED`-T!A!"Y"`B"F%V"*%&%(8 M3,1]=89,1A:/<@Q1#2:>Y4N`T/66X`U>``]LQW^R>I=7C?,A9/LVV;WW;860 MO*WAW[11W++@F^E.HW:\UI_3N@+*0[]U]'Y$RW["U!+`P04````"`"3 M7'E'!\I^0^0!```:!0``&0```'AL+W=O<9[19L6W@22/6-$_-L!Y<,V6`5CX+VI:F4".,_P MQ#LU#%K9\!8)*+?!\VIS2`W"`GXW,,C9'!GO1\X_S.+UM`U"8P$H%,HH$#V< M80^4&B&=^*_7O*0TQ/E\5/]IJ]7NCT3"GM,_S4G5VFP8H!.4I*?JG0\OX$NP M#@M.I?VBHI>*LY$2($8^W=BT=AS[A)B3X@OA.@N(?&$ MY(J`72GV(`Y$D3P3?$#"_;R.F!Y9;1)]U`62-JC/0`8&H(\VS\YYDL89/ALA MCXEFF)W#K"8$UNI3BF@IQ1=ZY%,DMU/L1TQZ&W,8,8_+1N(E(_&\UMC5D3XM M"R1+`LE<(/$.UE]=IA;3NFH=)EI.D7Z;(O4I?MQ)X3#A;<3^6\3A&N%LXED+ M,1"5O8L2%;QOE?D;L^ATW9]M"U[%=_H9<+?V(I-G':G@%Q%5TTITY$HWN.W& MDG,%VE3XH"W6^J&:%A1*9:9K/1?N[KJ%XMWX$DW/8?X?4$L#!!0````(`)-< M>4?*>2'WY`0``&H:```9````>&PO=V]R:W-H965T5I]*2[RW/SGO2CS MM&Y^E@>WNI0RW7=&>>92SQ-NGI[.J^VFN_:CW&Z*:YV=SO)'Z537/$_+?^]E M5MSN5F2E+_P\'8YU>\'=;MS>;G_*Y;DZ%6>GE.]WJZ]DG3#:(AWQUTG>JL%W MIPW^M2A^M3^>]W'?)!9UGIJ1OX'G'Z.V1H.OVOONVZZ M3?BO:24?BNSOT[X^-M%Z*VY-EDY M>?I;?9[.W>=-_2?TP&S>@((![0WZ<>8-&!BP3P,?-?#!P+;T(F)JQ*K2\O'M$ZW MF[*X.:6JI4O:EBQ9-U:-9CZ_-HXWZTGH"A`^8>&.&9 MF1?%D)YPFQ#Z..AL'*,Q:&=/S2,\*(*%"/.H&-],?-->F)G9`8-,][MV@PSU MI!EN9IXU(Y"E75R:>#G@!!##!K'9#6+#1&&0!`8/_JP'?^C!5R%,5EYTR%EE M`2#>-!V'T`-`A'IFZ%%!U./$#'VS@78`48^:H>\`$1Z8H2<]7(!X>M80X6;H M14'$H]-J&%*QHD+?%V8H`(HP0@ M(OA\O&(Y7J&F3,RCW"N$BG":9$-JIRA"?3]`IF[E*[;RE6B*^-'\](/EZ0>P M70R)63$\$DC$FL%V"YC!CHZB#9>C#2%:'XE6,6&$[&BL&(XE:0+,H%Y&T4;+ MT480K2$YVP/"DM`2#U=:,M_51V$08E&2`%$F0F3=--64);)R/>5[AJCGSP#C MJ.ER80)#610B=;+3KORIM(]7P,I9;.4LT10;](#Q$LQWV?$2Z#9K2$$RWV?' M">0O))"%I!,^VZS'JZ<8\;^#X7CQH#OP`/&5:(IYIHE;Z#H1-ED/$LJGQZ5Q MU%IH,4U)>FJP3N.H+>28!!99'\"IP.,;P!C60D79,5"D6ED4Z$*^H,(BM8H8`([)"2:BDQ)RBQ4F7FS53IZ M+`(,#;&')SN@6!1A=Z-&7Z,%L/*5:"J(#,V?6=RK,&)1I0"AO5\S2%4DP!BZ M*+/H7HS.5^CH^0Q`!'D:%&LF-#.)9J;QNH-GO;DL#]TKC,IY*Z[GNBVMP=7^ M-LO9)VHER"?[K>;2WJ0?Z;EX72NG->BKHN\>YK\7A2U M;,+UOC1K?93IOO^1R?>Z_1HTWTOU*D3]J(N+?K/3OU[:_@=02P,$%`````@` MDUQY1UC.`>S5`P``CQ0``!D```!X;"]W;W)K&UL MC9C;(!#',`!I>LJK4=H[U(52H7V6LLC2PJP&@!6\G;AT.C@&MZ M6C<2H+]/0W_3B,W%-#_;D]:=]ZLJZ_;!/W7=^3X(VOU)5WE[9\ZZ[G\YFJ;* MN_ZT>0O:]5E3>_'W5I M+@\^\^<+WXNW4S=<"+:;X&IW*"I=MX6IO48?'_Q_V/U.)H-D5/PH]*5=''M# M\J_&_!Q._CT\^.&0@R[UOAMS]Y>QW#[] MU[S53Z;\KSATIS[;T/<.^IB_E]UW<]EIJ"$:'.Y-V8Z?WOZ][4PUF_A>E?^: MOHMZ_+Y,OZ@0S.P&'`SXU8!)IX$``W&K@00#>:M!!`;1K08Q&,2W&B1@D-QJ MH,!`?3((IMLQWLSGO,NWF\9.V=1/+=>.P;H@#87,@EP[$Y"#YE&0\:NJITDDC9(QKLDFC)"[9@438 M4Y5DJA)29>L8T3+521/90T1DB`A"<+R,+Y-&Q/88,1DCAAC"4<:D84B,A(R1 M3#%D8G>@R+Y2[KY*R0Q2J-+1$(^3AG%[C&'?)X*P$*)$CB@@$O)3WZ0+T1.( M&!-W#E_/($/ZBUGWN77&L/DDR*UE-/*,8)[1T#,@.G&T(&BB%(E"\\H`V%@A M+JP\KFN-B%IIW%AL9WI9;`8B[+[2P#$@+G$L:08B;#FL5*ZC*'N_+Z/L0+3L M]W4<&EXVTZL`#R*&-)"\X=^7I)$$#58+/9XD\)0ZNC0#$0:#I)F3 MP%SJF((9B!A6#7[]=WT'N?T#4$L#!!0````( M`)-<>4>-,MW__0,``#<4```9````>&PO=V]R:W-H965T:I&YBTYE,+[JOB2T?IH"\`GR(OZX?9L6G.<]^OMT=>9/47<>9E^Y^] MJ(JL:6^K@U^?*Y[M>E&1^P2AT"^R4SE;+OJVMVJY$)J8:?I\.QZ1K\Y<(?=+M3P+7^N;: MZX)_%^)W=_.Z>YBA+@:>\VW3663MSP=_XGG>.;4]_PNFGWUVPMMKY;[JA]N& M_Y[5_$GD_YQVS;&-%LV\'=]GE[SY*:XO',;`.L.MR.O^K[>]U(THE&3F%=D? M^7LJ^]^K_$^,0*87$!"003#THQ<$(`@^!=0JH""@K@(&`N8J"$$0N@HB$$2N M@A@$L:L@`4'B*NC67*X<^I2$=LFPV-BY%[7:MJS;VZ;VU3LIYU1)OIR\7'DB;!PO_HG(`A-\PC,"$R,VO)X('P MVQ"&.(@VCE$?I-<3(-#-+VS(OO.BJ=CB!T6((;=1RS3#PQ%EMEW\-DX^*3`,*0? M=3(]ZD2.FA*]0W<83TT]1O:YQ_H3=!0&QMJZ-IHT8!@*$\NT*2=JS=FA/Q88 M@M8?M^.@B4/*`(09PY;!K;`Z6TAHFP(GLXV36:HHP@P'&M:?:.,Y4$=:9/#0 MGVGC!*(3">10/C%S2"`H>C2PU3Q%_>_Q9CQY0.$X,03M4/9PZ))`(3S>1);% M7`&%H\16=YR\-DY>J:)":IH!?=D>SX"JV['!0U^XQ^D33Z2/0QG$B4/Z)+#Y MJ&6Y-HJB@;7^`!500]!$7WA'01/DD#X`,5O17"F(69S6+DX;%Z=40=B0.<3A MQ"#JI:, MWB,4=/]^-GJP!X@AVY.VB]/&Q2G50'+P_LV+>\&K0_\]JO:VXE(VW:K?M`[? MO+Z2[L7_KOT1SU^QIGV-YZG\HO5IOUR5_*XE;QIQ5I_IAF^%R[]02P,$%`````@`DUQY M1SKN,GN``@``?`D``!D```!X;"]W;W)K&ULC5;- M;J,P&'P5Q`/4F+^D$4%JB*KN8:6JA]VS0YR`"IBUG=!]^_5?"&0-]!)L,S,> M#_%G)QVAGZS`F#M?==6PK5MPWFX`8'F!:\2>2(L;\>9$:(VXZ-(S8"W%Z*A( M=05\SXM!C(_MWABG1;%[JW@8_R7'`Y`-($ M]+QC6>.&E:1Q*#YMW1>XV<-80A3B5XD[-F@[TOR!D$_9^7'(WN>4Q&'[IOZJEBOL'Q##&:E^ET=>"+>>ZQSQ"5TJ_D&Z M-VS6$$G!G%1,_3KYA7%2WRBN4Z,O_2P;]>STF[5G:':";PA^3]!)3!("0PCN MA'"6$!I"^$``>BDJB#WB*$THZ1RJOUZ+Y)\$;D(1=>XP-2@R8*X$B&C3Y)I& MGI>`JQ0R&'^`V6D,[!%`J/=3^+8I1G1?T?WI"3*-"&8\[`UDPD1@,Q$,UQF8 M=4X(A#:!<"@0&H&'=<0*T^B5:@R,XVE,9C`PF,;L#6;P449FHT6SD4XKM//C MQ;3B^;16BP96]K2B85H:XP?3D&P9LC>0B:C6BT[7.JK(SG]>C.IY/BI9@!8< M0.\;81G0>@:3&+%EV?7 M29,6G?%/1,]EPYP#X>($51=67]C^O957D3?NU>EO4UTKGA[Y1<5Y`'">+(C]=9NM5 M?^U[M5Z5[\WY=-'?JZA^+XJ\^F^CS^7M>29F]L*/T]NQZ2XLUJO%T.YP*O2E M/I67J-*OS[-OXFFG5(?TQ#\G?:M'GZ,N^9>R_-E]^>OP/(N['/19[YNNB[Q] M^]!;?3YW/;61?U&GGS&[AN//MO<_^G+;]%_R6F_+\[^G0W-LLXUGT4&_YN_G MYD=Y^U-3#7V&^_)<]W^C_7O=E(5M,HN*_+=Y/UWZ]YOY3Q93,W<#H`8P-)!9 ML`%2`QP:8!IL(*F!_&Q@AL:4T@_$+F_R]:HJ;U%E9N^:=S>)>)+M4.^CNK_8 MCD$]ZX!V:->KC[6*Y6KQT75$#(R8C6'$0"S:WH<0X`HQ:0X40OE#;"V3^)F= M95)W(NA*!,>U(G7@J42Z.I#C#B1UD$VS3'KF8JHE9AGW+S^X-:",.7!G0%1W MX"1WQ>:N*/?E--*8V1@&D\P=)&&#)":(B`-!$BH'W4%2-DA*041@%@RS3%R# MJ\:S8,#$.5UC<$=196@6,C;WC'('?Z1-1BD);YPE&V=)<3`P1H;!^XJ^CI$! M@1W,G0'%_6!.Q)2]#(P200!L^I:\%]#7_(G$>TU."W":ZK0`? MYD]6+])0_@0Y[Z")51/Y):VO7DUD$C1KP:\T@I81$5IJ"!+J7IG3:/S:(&AQ M$*'%P4+@B\,O#X+6!Q"A:3%0"A+\-?&KA"##!@C59"'/8B1X1Q=DZ1`T*X(\ M47@_%V3HH$+5&$A*WU:-MUX@ZX60\"W$J-YBF7<:@;=2("N%D)()0JG\H7C3 M`V,^,DT\7?`[3&"VF,`K'QY1/D&8A80/O/#!:MJSXP.GIJGC2AP>6>35@Z0>#)G@ M`'E,$'GI(.T74(;B`!.'7]>1](5W-IB.IX\@(;/Y_6/MF-M:3L1SE?FY'7$I MS$<;TFGFO*R19(U)0-8$">=.>[(CL23_]$BDYTY&WB.0/`+3T-Q:R&,DR&\. MD(P$0RY`D!"X#"\^%@3E7Q.0MR8<'OL\73@M9RKCC)$Q;R9(9B)%:`HL!.XX MDE_])3F.]"A4.AUG4JT4X6HE;R82'JAV@#R2E+R92#(3Z=F62:>JI]5*IEI> M7M(J)V31`^2;&%Y>TLHK9)T$"4SF&'!.B\4P3P,.NR,NC>?+;#EZ>8K@Y2C3 M!UR4()&QCVM;0J7S&7SZ(YS=HX1V7)+?@$B[`0FYJ86D9R+]15E_\?R$JWA_48R_*-Y?%#R@.((P\2A.\?ZBK+]XUD3% M^XMB_$4]\+NO>N!&($@HU\V]&)TK%+IZZP]HZFA?OE^:[B?ZT=7A$.@;=.<2 M=]='X8O M9_W:=!_3]G-E#G3,EZ:\VO.IX9!L_3]02P,$%`````@`DUQY1[9FTY9!`@`` M<@<``!D```!X;"]W;W)K&ULC97?CJ(P&,5?A?`` M`J4H&B09(9/9BTTF<[%[7;$*&:!L6V7V[;=_D3&`>R-M^9W3TU;Z)3VAGZS$ MF#M?3=VRO5MRWNT\CQ4E;A!;D0ZWXLV9T`9QT:47CW44HY,2-;4'?'_M-:AJ MW3118^\T3&>C=J.S'XDY%-V?ISVKB\CX!H77#H@\;CA#->U-!(3 M_S&>]RFE<-RV[J]JM2+]$3&*E".N[S@F?T;7F'Z1_PV8)D30L2,W4 MKU-<&2>-E;A.@[[TLVK5L]=O8M_(I@7`",`@`'!1$!I!>!=$BP)H!'`0!&H& M3R]%;42..$H32GJ'ZL/KD/R/!#LHMKIPF!H4>\!<"8BM39-;&L%MXMVDD6'` MB#EH)A@(3[@/4X"I*;[)@9*#^0DR383^/)(;9"9$.!4B'*\SU.OT9PS@E`$< M&T!M$#V$'#,'RP3S3&89,,_DE@FGPT9/PT;&`"Z$M4RT$/8_F-PRZ^FPZZ=A MU\9@LQ#6,O%"6,ML%\(:9NU/A]T\#;LQ!@M'?+#,PA%GE@D7PEH&3H>-GX:- MC<'#\6T4T^JPF@%P%8-Y*M-4L%UMYZ'<0&#EQP^)O='5U&!Z47<\C0QEY`?)J>Q@_B/*BJ\'=)DTZ=,$_$;U4+7..A(N+4]UR9T(X%L'\E?AB M2E$`ATZ-SUPV-Z)-=4W0'4XZ6^&&,IO^`U!+`P04````"`"37'E'*LVP"O<" M``#;"P``&0```'AL+W=OB2W;3`"Y2([3?U^!U@02))6#`?G5/BO$NVQQ MY?V+.#$FO;>VZ<3&/TEYO@M#L3NQMA(!/[-._7/@?5M)==L?0W'N6;4?)[5- MB*,H"]NJ[ORR&,<>^[+@%]G4'7OL/7%IVZK_NV4-OVY\Y-\&GNKC20X#85F$ MT[Q]W;).U+SS>G;8^/?H;HN303(J?M7L*F;7WI#\,^^#-[WHO3RK;R/?V[%!= M&OG$K]\9K"$=`NYX(\9?;W<1DK>W*;[75F_Z7'?C^:K_H1%,6Y^`80*>)L1D M3%R#QC2_5K(JBYY?O5X_VW,U;"&ZP^I![#PQ#JH,A3\(U,++XK5,LZP(7X=` MH,$SS59KT*0(5?0)@=<0B^D8$&0]0+P6()[G&$,`NAX@60N0S`,D$"!?+C(= M-9W.4FL(3?$Z)7524DTAD86B-2B*#0\CY@BD)6>9*%KEB\$20T'QV&*BK1EY2PW]1%XGR(;28LH M":+L/S;-70D0E`**;50MHED0&VR*W-4`03F@L>VEA'J0!8A&[X?AZX3:`?RL-KPY(#U8%2&^X]]8WDYULK/?7SY3]02P,$%`````@`DUQY1V!1 MJ3OF`@``T`L``!D```!X;"]W;W)K&ULC99-B2W;3`"Y2([3?U\A+00<),4'@\2[^ZPD M=MGB2OM7=B*$.^]MT[&->^+\?._[;'B:=>'*@?5MQ,>R//COWI-I+ MH[;Q<1`D?EO5G5L689>VK?I_6]+0Z\9%[CCQ7!]/?)CP MR\*?[/9U2SI6T\[IR6'C/J#[+8X&B53\KLF5S>Z=(?@72E^'P<_]Q@V&&$A# M=GQP48G+&WDD33-X$N2_X/2#.1C.[T?OW^5R1?@O%2./M/E3[_E)1!NXSIX< MJDO#G^GU!X$UQ(/#'6V8_'=V%\9I.YJX3EN]JVO=R>M5/G5WIZKX0C1/18;L7.8G!01,G<0B(67Q5L9YV'AOPV. M0(-GFJW2H$GA"^\3`J\A%N98(9)TW4&XYB"+G( M6&HZ%:72I!I&;&7$P$@,#*5!>:K9R\1*28"2&BA*#B)N/31:B0LY$7:PX8K:;MDA0"*5J2L@5)B3+L MA2B?_314>ZZC"*BQB:I$6>CIEF=/>!0#*#&!E"@-O4CW=MF3'B5`2DTD)4IS M+]*MR9[X*`529B*E(RG(OW!D]E*`,J#FIERE`4%M0#>U82[: M3B+=U\]>&S#4!H0-G$D4:CBKM6')@=J`(A-G%&EJ$+87$`P%!-V\]\G\M":1 M!F.O'ABJ!S)]ZD:1YDN'[>4"0[E`F6DUT$#<8OQ9Q]62_B@;2^;LZ*63?>QL M=FI>'[#LV#[D97&NCN17U1_KCCDOE(N^3S9I!THY$?C`$VL^B?9Z&C3DP(?; M5-SWJN%4`T[/8_\\-?'E?U!+`P04````"`"37'E'Q@JS1K("``#+"0``&0`` M`'AL+W=OV$8$:291 MU3Y4&LU#^^PD3H(&<&H[D^G?UUL(I"PO8)MS[CE>N+[%E?$/<:)4>E]-W8J5 M?Y+R_!R&8G>B#1$!.]-6?3DPWA"INOP8BC.G9&](31W"*$K"AE2M7Q9F[(V7 M!;O(NFKI&_?$I6D(__M*:W9=^<"_#;Q7QY/4`V%9A!UO7S6T%15K/4X/*_\% M/&]`HB$&\:NB5]%K>]K\EK$/W?FQ7_F1]D!KNI,Z!%&O3[JF=:TC*>4_+NA= M4Q/[[5OT;V:ZROZ6"+IF]>]J+T_*;>1[>WH@EUJ^L^MWZN80ZX`[5@OS]'87 M(5ESH_A>0[[LNVK-^VJ_9)&CC1.@(\".8%=BDH`<`=T)>):`'0$_$$([%;,0 M&R))67!V];C=O3/1AP0\8[74.T^80;4&PM<`M;1E\5DF("_"3QW(86`/\VHQ MH$.$*GHG`<``\%@#W`V"[ M4/#!9&PPK9VIQ0`8Q^,J\:)*[%3`C(K%H!B.BR2+(HD3@3,B%O,$4#ZNDBZJ MI$X%S:A8S!/J;?U`)5M4R9P*GE&Q&-"?RW^@=;:P=_FBE=Q9B6>L6$R,)_9. MIZN%@PPB&R)-)D*,_O,#H\#]]#`9.DW[3ATH0P%.)Y1&?_VA$G1*Z5`I&RA9 M$,!9$.%I1^L;#D1!G$WC-@Z7P@#@">>C^6+H'#GGV9QSU"E-;>AR8@&WS)+/ M*5E0FD\K+2<7X+++8Z(=*ED0B)(@2N=V(UX\'\N9"+A4A,#<2;2@/`VBQV04 M]JZ\AO*CJ1V$MV.75NH+I#?:U2&ULA539;IPP%/T5BP^(&;,T&C%(F515^U`IRD/[[('+HGBAMAG2OZ^W M(8R$FA=L7\YF\'6U2/6F!P"#WCD3^I0,QDQ'C'4S`*?Z04X@[)M.*DZ-7:H> MZTD!;3V),TS2M,2@3H,"O$1:]F2.7_2+EFUO\:$])ZB(`@\8X M!6J'*SP#8T[(&O^)FA^6CKB=W]2_^=W:]!>JX5FRWV-K!ALV35`+'9V9>97+ M=XA;*)Q@(YGV3]3,VDA^HR2(T_Q9W=!(MLGV!;$\@VV;,@G])]@7R/8%\*Y#'!/G])K>8<\`4>;YO4GQJ M4D23XMZD\!@13"+F,4W3?9OR4YLRVI3_L0F8@NSXX,TAX:!ZWPL:-7(6OO,V MU;7=GH@_9!_PNIIH#S^IZD>AT44:>U3]N>JD-&`3I`\VSV`OA'7!H#-N^L7. M5>B1L#!RNG7\>NW4_P!02P,$%`````@`DUQY1W<[KPO>`@``[0H``!D```!X M;"]W;W)K&ULC59=;YLP%/TKB/>";<"8BB"UB:;M M85+5A^V9)DZ""CC#3M/]^_F+!%(,RT.PS3GWW&O,X>87UKWS(Z7"^VSJEJ_\ MHQ"GQS#DVR-M2AZP$VWEG3WKFE+(:7<(^:FCY4Z3FCI$`."P*:O6+W*]]M(5 M.3N+NFKI2^?Q<].4W=]G6K/+RH=^O_!:'8Y"+81%'EYYNZJA+:]8ZW5TO_*? MX.,&9@JB$;\J>N&#L:>2?V/L74U^[%8^4#G0FFZ%"E'*RP==T[I6D:3R'QOT MIJF(PW$?_9LN5Z;_5G*Z9O7O:B>.,EO@>SNZ+\^U>&67[]36D*B`6U9S_>]M MSURPIJ?X7E-^FFO5ZNO%W"'`TJ8)R!+0E0#Q+"&RA.A&B&<)L27$=X30E*(W M8E.*LL@[=O$Z\_1.I3HD\#&66[WUN%Z4>\!]!9!;6^0?!8[2//Q0@2P#/ M!@.OB%!&OTJ@*8D1'6DZ<@NL#2(";LC&0AQ)1%-)1,,Z(\U/,)D.$$\%B(XN5C2T<<`C,"4^Q(\2D%XR2A=8,$!YGFPZSM2`"`A`YE"8M8:R$K-*= M[9"1D@'!"`>1.Z%U#P,H2&,W;F-Q*0@RD@U^CB(F+65<1&2+('-%&%"6!0#_ MA^JR#\'>B+(YU=CN21HD#J5E(X+6B>Y]>:QDK0C`@)"YIY0L'IMEQX+6LB(X M=T"QS0@$V%7\LF5!XT>Q\W6:-*/Q&TGFOSEPV3Y@[Q]S'P,+D@6#KP82#IJ" MAG8'W5UQ;\O.K5"?V,'JM8-[0JJIN%M_5IV=;C9N88K\5![HS[([5"WWWIB0 M+8ON+_:,"2IS`X',]"A[S^NDIGNAAJD<=Z8;,Q/!3GUS>>UPBW]02P,$%``` M``@`DUQY1[1*\8@C`P``10X``!D```!X;"]W;W)K&ULC9?!&>@``#SF!F`DRG/70FDT-[)K9L,P'D@ARG;U\)K0@D ML.K%@/AV]Y>0?DO)C76O_9E2;KTW==OO[#/GEP?'Z?=GVI3]/;O05KPYLJXI MN7CL3DY_Z6AY&(*:VO%<-W2:LFKM-!G:GKHT85=>5RU]ZJS^VC1E]S>C-;OM M;&+KAN?J=.:RP4D39XP[5`UM^XJU5D>/._N1/!2>*Y&!^%716S^YMZ3X%\9> MY<./P\YVI09:TSV7*4IQ>:,YK6N9253^`TD_:LK`Z;W._FWHKI#_4O8T9_7O MZL#/0JUK6P=Z+*\U?V:W[Q3ZL)$)]ZSNAU]K?^TY:W2(;37EN[I6[7"]J3>Q M"V'+`1X$>&,`"=$`'P+\CX``#0@@(/@4X*BN#`-1E+Q,DX[=K$Y]O4LI)PEY M",10[ZU^:!1CT-L2$$.;)F]IZ,>)\R83`>--F$PQ9"0`N)]@8%6P@`9GW,AR8 M5@V58J)H'S6*'8+ M8I$B&3`QHE4AP1:1JI!HLZQ4>KA!*G%!*_+Y,H!<1"L@V)35I5:T+CKN7"M8 M;H"LG0P@;/'DP$3(9"J`F4[^N=Y%^Y[K]4!OO))BT7QGWDE\W#S)HOW.56C_ M)=BH!:;/EYN10I=:T6IV>J*M'C-0@#`#!01;.8"0M8$UFSW1;H]Y*$#HTC$B MQ1=DKM5L]T3[/>:?`-UA_JD9=.EHNU^1:W9[HNT>;[2;/;>]KMD7U2!M!V'XZ4VCF\[[1F6RV M&]J=AE-+;^W9M>5RZSII'4]&CY[:'KF\C<1]ITXYZH&SBSZTC2?']!]02P,$ M%`````@`DUQY1ZQ4EY44!0``CAX``!D```!X;"]W;W)K&ULC9E-<^(X$(;_"L5]QM:G38I0M8"IW<-631&1NG4)F#QZU2VK7\GR^E8W/]I3472+7U5Y:9^7IZZ[/D51^WHJJKS] M6E^+2_^?M[JI\JZ_;-ZC]MH4^7%L5)41CV,=5?GYLMRLQ]^^-9MU_=&5YTOQ MK5FT'U65-_]NB[*^/2_9TOSP_?Q^ZH8?HLTZFML=SU5Q:<_U9=$4;\_+W]C3 M08_(2/QU+F[MW??%$/Q+7?\8+OXX/B_C(8:B+%Z[02+O/WX6NZ(L!Z6^YW]` M]/\^AX;WWXWZ84RW#_\E;XM=7?Y]/G:G/MIXN3@6;_E'V7VO;[\7D(,:!%_K MLAW_+EX_VJZN3)/EHLI_39_GR_AYF_Z3QM#,W8!#`SXW8!)M(*"!"&T@H8$, M;:"@@0IMH*&!?F@038,U#O4^[_+-NJEOBV::']=\F(;L2?9OUSXV6JW7T)"83E]ANQ@:.-D`F:*+Q^GY5GFS23NWHPV*P9.I"5B```Q[@N5 M]BL&AJ5]`^9T"#O;A,B6-@!F'`#SYAGRF#.C38"M0")U2W!GC=L+?JARXI#626^4)W%8&10#`EF90`Q9).P_\S8H=!%Q:=ZX:E/PEDO]H"LB&THO28*4R\) M8ML`"62YRH#AB/T?C(YG)R+HVA10=@FR*FX!4@D2RVZ&L)4^1"ES*-EIT58@ MC!4@^\DM0$F*[<,,I+&=:8A2YE"RTPIXR`%[2A!OVIA5;T(1]48OZ$*[)[!]IR>(QQJ[TP`)Y/EB'Z*4.93LM&A?%>"KPK,< M"JH ME&-/@D%:69#68=9*/08A:3N7QLX1?]T"Q"7'RL%0XG$C8P]`B%86I'4P5.Q[ M%)&T\4MC_.A=FZ`OB:>X).W$$OP3<_P]0,QW/P,.D\R3E<=C)>VQDO!827NL MU`$V`!`R[IDT)SC8)`#&=VMHZY1)2`V8[29:`@E,2.P0)40I\RE9!PL&DCX# MI/?`,@V9_A/TQ7?$2:\+THRC@* MMJ8`Q)A"2F1G**ZP,YT@KAEF'R`9ZW(I8.[@0INZMKKNB%XF_]O/Z5.3'^:(LWKKA:])_;Z;7I=-%5U_-V]_Y%?3F M/U!+`P04````"`"37'E'-?Z>!KP%``!J(@``&0```'AL+W=O/;?+Z!NQW)0-Y?8)H_$*ZGUTI)87^OF1WLLBF[QNRK/[?/RV'67I]6J MW1^+*F^_U)?BW/_GM6ZJO.M_-F^K]M(4^6$L5)4K&8;1JLI/Y^5F/5[[UFS6 M]7M7GL[%MV;1OE=5WORW+PX%[[]C[7^,S>WEO^1MD=7EOZ=#=^S5ALO%H7C-W\ON>WW] MLX`VF*'"?5VVX]_%_KWMZ@J++!=5_MM^GL[CY]7^)PFAV'0!"07DK8"(R`(* M"JB/`IHLH*&`?BBPLDT9.V*7=_EFW=3716-'[Y(/02*>=-_5^T4[7NS[H%T. M0-^UF_6O393$Z]6OH2)@Y!VSM8RX$:N^]MLMY-0MG.)R+"[]-\@LH4(_L@/$ M(T)-B5#W[530SF2Z`CU5@;ZO0$,%J2LR&IFS;:EE`B&4\E,94F&83HLQK!AC MQ2A/!1';'9&M(`VG*XA9!3%4(-R&FOONL(Q44>2',H#".)J6DK!2$BM%4U(L M$\>$$$"$?^1V%DGTM-*459J"4DDHM"*C%01P@!3 M6@$*""9#QC-SQ:1%N5+`HZ@&;P$*A$HH,4C=#8$K9]+.7#D2Y&A*#D#4,`+C MF8)BTM-<)6!JJ:&46$BGE!(%[NIQ1\';HP!_3(FYO@4HI*2`._HBE_=&`>:8 M$GV_!2A("-/($/(&RZ3/NF+0:(FHW`(DM:2,$BG23G=(>?U43'J[\W`0:.Z> MQXO@/5F`FX;$6&\!$HDD@Q.H.#$>.;SQBA3D4,\(@`))QH2%A/#TC>2M588@ MAK)6@")B:F?`B-#S0)*\M\HYWBIG>:ODO%7RWBHE=`TIQT*&\-],DMXJ>6^5 MZ*V4GP%$^1D@/C^3O+-*=%;*SP`*##E"`$E?[/+F*@T,$/7P`TC$BDH,D")G M_^Y6EV_V2S[9E1&(]E7!I[LRABK(<+!00*8&&5)&^6)BTE[=%B7T^2E7=#A6Y(S7R`F*!#RAMT:L826H$<7P?S7J8T5$%V,)\E?D)<(;R/*?`Q M*J"V``GJ:90AY$L(%)\D*O`G064G``5"2'*@$0N5KW=XMU/QG,"+\4YDPH18 M*GP3@<\F%2[Q?9$W:7=N\*;TCH?FC4KCDI@:)H`DE6EF"&F/:VK>JK28L>L! M$!6^/++#6WFT\CZFY8Q]#X"H1PT@5+H`B/"-,I_X:4S\2+%\X@=(X#-;.8LHHV8,4\1\LU3,VFV;GLP:?0L=@QO M@083/2JL`0KH443J?AA=.9,VZ+8(CUX\3W\SX[S$S%CL&-Z\/B&N$-Z\3,0O M=@QZ%[7WX\&(JP8IW]F(X3W,X)8AY6$`<5&7<%'' M)XP&MPP]41?Q"6.$&WU4!P-$1=TGQ!7"&U0D9JQV`%)4!@:,;X<;]]=O;T^\54.)_H/U[?B:6=?@OBH9K.^Y&_%WWGS=CJWBY>ZZ^IJ/-Q_ MK>NNZ&6%7_K^.A;YX?:C+%Z[X6O4=5]]I\^0$``-T%```9````>&PO=V]R:W-H965T#'Y1B$!H%0 M4BL3`>OF3BI"J0FD$__Q,?^G-,9E?XK^S5:KZ<]8DHK3W]U%M1HV#,"%-/A& MU0L?OQ-?0FH"UIQ*^P7U32K.)DL`&'YS;=?;=G0KN]#;U@VQ-\2S(4HV#<@; MT`<#=&2VKJ]8X;(0?`3"G<6`S9%'!Z1WK@;23NJ29&`$>J?*XE[F45S`NPGD M-?%"@"T%B!9!D"^#/0>,K.:WI7A M-#%"^\]%E1?%6;Z.DCQ$23Q*\CY+ND1)IBSIYZ+*BZ)=MHZ2/D1)/)%.=JMHV0/43*/DFV@9/Z`]AM;5TVB.%E'R1^BY!XEW_A7_@-02P,$%`````@`DUQY1S&.L2O.`@``.`P``!D```!X M;"]W;W)K&ULC9??$!"@'DCX/,5)F= MW8N=Z?1B]SK5J$R!V"1J]^TW"2$%&P(W`N%WOGQ)CL=C?L?DG9X18LYG4[=T MXYX9NZP]C^[/J('T"5]0R]\<,6D@XX_DY-$+0?`@@YK:"WP_]AI8M6Z1R[$7 M4N3XRNJJ12_$H=>F@>3?%M7XOG&!VP^\5JD7LZ[E`UJ*45;AV"CAOW M&:Q+D`I$$G\J=*>#>T>8?\/X73S\.FQ<7WA`-=HS(0'YY89VJ*Z%$I_Y0XE^ MS2D"A_>]^@^Y7&[_#5*TP_7?ZL#.W*WO.@=TA->:O>+[3Z36L!*">UQ3^>GL MKY3AI@]QG09^=M>JE==[]R;)5)@Y(%`!@0X`L34@5`'A5T!D#8A40/00X'5+ MD1M10@:+G."[0[K3NT"1)&`=\:W>.U0.\CV@K@#XUA;YK4A`FGLW(:288,!L M.P9HPN/J>HK`-,4H/)#AP?0$NXX(_6FD5,B$B=!D(AJN,^Q,I"NS0&02"(<" MD=JHS"RPFG6PZ@2"AU4.F6W/@&EFUS/!-%/V3&@V&\^:C:5`'(46L[&:)+*8 M[9F5Q>QW9F0VF36;*('88K9G$HO9!4SYG1F936?S*%4"J5D@FUUMMB"/L@5Y MM(`ILV^Y-C(KJNN,6^`O.!P-V4YG"50:H+%C8T4<.P:J5$R<$#!6O-$9@\!> M+,!\O0+A@F/64&;;-P4]EM?QOO701($%Q@(Y=APMJ!D*2D)+]=IIR*)4&J"Q MX_F*#%9+KL\;5EHEL9C.IF M^#D0_=G#^%8TR;)O^Y(I\@L\H=^0G*J6.F^8\>Y/MFI'C!GBOOPGGM!GWL;K MAQH=F;A-^#WI&MON@>%+WZ?K/PO%?U!+`P04````"`"37'E'^4H!G=4!``!6 M!0``&0```'AL+W=O&+-&YL5_1L__ MK[3"Y7QR_^:J->F/5,%>L-]MI1L3-@Q0!34],_TFAN\PEI!:PU(PY7Y1>59: M\$D2($X__-AV;AS\DY=PE*T+XE$0SX*(W!4DHR#YK(",`G(EP+X4UX@#U;3( MI1B0]']>3^T9B3;$M+I$RFV:'JC``J:U17XIGI,O.;Y8HY&)%\S.,_%M8N^) M)+R-'$8DFA%L,LY!X[6@R3)H[/09"=<-DC4#LC1(?*7D*N22V4U,=)O9?X(Y M>"9+R7I8\C`L&:M]63=('[8KO=^N[&&";"PSOM.NB4GNM&MBR)UV34QZ%18O M3G1/3_"3RE/;*704VGP<[B370F@P'N&3Z4EC+KEYP:#6=OILYM)_]WZA13_= M8O-56OP#4$L#!!0````(`)-<>4<+8Q^110(``&X(```9````>&PO=V]R:W-H M965TU%I=5>M-=. MX@2T!E/;"=NWKT]06!G(3;#-/_\W=F;B%#UE[[S"6'@?#6GYWJ^$Z)Z#@)\J MW"#^1#OW* M](^(XQ=*?M=G4`YD@=Q\KA>E!ER M7PGDQLOB7F8)+(*[,K*::*(Y#)ILU`32?X1$+D@RA43:`,8[MT'L,HBG!K$Q M2$*W0>(R2+5!:PP2;1"%X-,^X41T,"(`8SY4&PO M=V]R:W-H965T[% M2J.YV+UV@A/0`&9M)\R^_=JXS-+$U:=OPM_IHGSBX_IH>7FNZI_-MBS;V:_# M_M@\SK=M>WI8+)J7;7DHFB_5J3QVG[Q6]:%HNY?UVZ(YU66QN2PZ[!K6LWMO][EA^KV?-^^%0U/]^*_?5^7&>S\MFW_QF*U M7%S7;7:'\MCLJN.L+E\?YU_SAR=O>LE%\=>N/#Y+O?[OE+WS?]0T?^_LU]X^WRL_MOE<+OVGXNF7%?[OW>; M=MMUF\UGF_*U>-^W/ZKS[R4=@^X+OE3[YO)W]O+>M-5A7#*?'8I?P^/N>'D\ M#Y^XC)9-+Q"T0%P7Y"JZ0-("F;I`T0)UMV`Q',K%B*>B+5;+NCK/ZN&_=RKZ MDR1_4)W5+[/F\F;G03/O!9VUJ^7'RBJ_7'STA4@C;C3?!HW@%>M!(3->\D22 M_"I9=#U>&Q53CJ[)LU%42M=R.?#)H81(P`D60_"4]TR)R>"%ADA@"!YR0J48HB@1,N8(B;AS M1.`(BS'"G*N3R0LM,<`2/.R$3;%D$*DLCUE"(L=9@C,LQ@Q;IL1D\D)+/(`R M//-DEF`)B6+3]Y,D;`3G5X[Y=4P)C*@2,6H"I#*4&MI!!)I%#1E%S%51X@3+ M,<',=41B4)6`5"6>>#*%54FD8Y<1TN2"@0F)`RPIP(8[',RK$@"KQ`-/IB`K MB51LU(R%&$,4CJ^B^!KFIXS"R*H`LBH\\%0*LEY%$4-(PTT)A0.L*,"&^4&C M,+$J0*P*CSN50JPDBL((:3@843B^BN)KF$FE,+`J`*P*#SN5`JPDNM_&"`UQ M]Z:%K>#T*@J=85*G,:YJ@*L:CSN=@JM742PSH\@P@U/C_&J*IF%FE<;`J@&P M:CSN=`JPZI%%8[LBHXC;%M$XP9H2;)@336-@U0!8-9YW.@58291+'[.$1!EW MEN`,:\JP88!58V#5`%@-GG@F!5A)=$,:$UMGI&'@RN`,&Y`\@Y'5`&0U>.*9 M%&0ET?TV9Q;QJ`:]:/.]L"J^2 MR,>V`48-PU86I]=2>BW#JQ;SJ@6\:O&TLRF\2J+8X"4)0U869]=2=BWG**95 M"VC5XDEG4VB51+&X?)*$C>#<6LHM]PO1859U@%4=GG,NA55)%+/CDR1L!.?6 M46XMPZD.LZD';.KQ?/,,FP9W09!(\)(U210O>?+C M=NM=LXN;VU1.Q5OY9U&_[8[-[+EJV^IPN3WEM:K:LJN1?>E,V9;%YOIB7[ZV M_=.>*>KA9I[A15N=QGN3KC=(K?X#4$L#!!0````(`)-<>4=JRM_VP`(``$\+ M```9````>&PO=V]R:W-H965T?/,3*:\$OK.CAAS M[Z-K>[;VCYR?5D'`MD?<(?9$3K@7;_:$=HB++3T$[$0QVBFCK@U@&*9!AYK> MKTIU]D*KDIQYV_3XA7KLW'6(_MW@EES7/O!O!Z_-X`K&ZT]2?Z-D'>Y^;%;^Z'D@%N\Y=(%$H\+KG';2D\B M\A_C]#.F-!RO;]Z_J70%_3?$<$W:W\V.'P7;T/=V>(_.+7\EU^_8Y)!(AUO2 M,O7K;<^,D^YFXGL=^M#/IE?/JWZ3A\;,;@"-`1P,0.HTB(Q!]&D0JTPU,Y77 M5\1155)R]:B^C!.2=PY6D5!NZS%U*%)BO@0(I:KR4F5Y6`87Z1DG&430&@"2;IU(G"U3212JI\A`7A=U!MBAYYI8\ M7V20VR6?B*$QH(CL08K%(,4#BA=&S&@>4Q=N(K)I+#`!H::2P1D7UE*=2`Z` M6W-@+<4I"_B`Z@84ST2QEN,T2O2`[`8$':H;R!R1Y;(&IJZSF<\<6&MV*GJR M(/IRK8'T$='3NUPM]3S=5>4('_!/10],S[XUP,46ID6=/",>"5?@DQ#J*Z7;8M'C/Y3(3 M:ZKG/;WAY'0;7X<9NOH'4$L#!!0````(`)-<>4=&7YL3;@8``!&PO=V]R:W-H965T'TF^?VN*_[T]OCRZI[.S;UTWG1 M?K>JA+"K?;T]+#?K\V=?CIMU^][OMH?FRW'1O>_W]?'?S\VN_;A;RF7\X.OV MY;4?/EAMUJO+NJ?MOCETV_:P.#;/=\M?Y:<'68E![I1B*:';-8S_L49]>?C3WS6XW;'7ZT__0KO__T6'A]<]Q]]_.QWNJ M_UO=-??M[N_M4_]Z*E/[UW?[N.2 MY6)?_QQ?MX?SZ\?X&R]H67I!10NJRP*ILPL4+5"E"S0MT+,%J_%0SD8\U'V] M61_;C\5Q_/K>ZN$LD9_TR>K'17?^\.1!MQP$)VLWZQ\;Y^UZ]6/8B#35E>;S MJ*EXQ?VH4(*7/)!$7B2K4XV70JM4H>JZT.J\WFJ1WD"E-M#7&ZCQ2,VL2'O6 M',8C'37&&5YS'S4Z78B&A6@JI$IO8*`5)F^%A178M!7FVHI1HQ0ON2>)29?A M8!F.RE#I#3PTPN>-"+""4&#$J)$9'T8%9,J*EE@"8ERIPA))'3QD,:1:`*D6-SI;`JDDDE4. M0J)(,81I<78M9=%.YTHPE415S@\SN].9%H*3ZR*D,N#O,*0Z`*D.=SI7 M`JDDDB'G!VF8\#N<7$?)Y1XO>XRH'B"JQYW.ER`JB7+7CQO)M!"<7!\)E6FY M'A.J!X3J<9?S)83J"QZE1@U7"DZNCXS*M"B/&=4#1O6XR_D21O6846\DTT)P M""-9SIJP/D.E&]NE"!@B@V`8@/NA:&$8L/\.6K"L^RC MUH#3'2C=CCL-,<,&-!%0,!)0-!.`&?9&,IL**!D+H'P[YBY'BH+!`($F`T3! M:(`HF@T@5%JAY MB!J&VV3)4%"<"@KL&85A6$I`PS(]T#.KI(2'HRH+/)>M( M''/K+=.3/S/W`#S+].S/;-Z-P>?)1&A4933WMYJQF-750.Y;_=+\61]?MH=N M\:WM^W9_-PSB/K=MWYSV$+^4?SFT_/U00``#$>```9````>&PO=V]R:W-H M965TU::IZ7`,;!14;2'`HL]M&?% M'C^P>KB2$F^_?24-Q[&\XG`NL:W\AOR+,CDT9W-MVA_=R9@^^EF5=?>R.O7] MY3F.N]W)5$7WI;F8>OC/H6FKHA\^ML>XN[2FV$^+JC+F2:+CJCC7J^UFNO:M MW6Z:][X\U^9;&W7O556T_[V:LKF^K-C*7?A^/I[Z\4*\W<2W=?MS9>KNW-11 M:PXOJZ_L.==Z1";B[[.Y=G?OHU'\6]/\&#_\N7]9):,&4YI=/YHHAI2_%9W)F_*?\[X_#6J35;0WA^*][+\WUS\, MW(,:#>Z:LIO^1KOWKF\JMV055<5/^WJNI]>K_4^:P++E!1P6\-L"IKT+!"P0 MGPOD=*=6V71?OQ5]L=VTS35J[<.X%.,S9\]BB-PNZJ:+PRUUJQ$8(K7=?&S7 M6;:)/T9#P/`[YM4R[$;$@_6;"[[D8K:<3\LY[B"WA$B6/8@E#_+^)H3UD*;+ M!N22`7%O0$X&T@11H$@%RH;QSL#$Z(FI;1PLH]9RV8DFG6AP(N=.U+T3#4X4 M+B37?B%K4L@:PH5\)5(RWJD_WAFI(%N.]RP4EF&(CS'1"2R=2^'@A?ND6,CW:`#! M-G.Z!G"7WIZ"]PH0TSXEEL%"0I<)[K+;]W4%B/F$6.0)4T)7"0[;?ZI\2BST ME/FD`*,1*72/P$.:!("\M=,90FHGIZL6=VV"0DS0?0(G&@5.5Q(>TBH`Y(U' MYDL<07<3(@G(8(!\0GY!YD+HJB980`8#Y!7RB,R%T#5-\(`$!L@KQ")/V+,) M^`$A`A(8(*^21V0NA*YI(J3U`<@KY!&9"Z%+FG"-#U**!-WX"*+Q$70)$2&- MCX-\&S`P*?85H9LCD8:D;TINP(!@0NB")K*0],WH#1@89-N3=$6324#^`N3; M@`%Y0G[;2+JD21:0OP!Y-V#'(-]Z21;D$'G*0@W<+LO`8@CB,Y((]/)[X[B:M,>YQ.*+MH MU[S7_7CT=7?U=@KZE8\G>0_77]ES;L\R/\UL-Y?B:/XJVN.Y[J*WIN^;:CK4 M.S1-;P95R9&ULA97+CILP%(9?!;'O`.:J$4&:@*IV46DTBW;M$">@,9C:3IB^?7T+`0)D M$VSS_2(=:\>9$:`.YF-*S MPSJ*X%&)&NP`UXV=[4H+ M"*.2RPA0/*XH1QC+0&+COR;F?4LI'(]OT;^K;(7[`V0H)_A/?>25,.O:UA&= MX`7S#]+_0":%4`8L"6;JURHOC)/F)K&M!G[I9]VJ9Z_?Q(F1+0N`$8!!X$6; M`M\(_+L@V!0$1A#,!(Y.116B@!QF*26]1?6?UT%Y1KS70)2ZM)A:%#5@M@1$ M:;/TFB6>ESI7&<@P8,3L-7,G'!%]V`(L;3&1`R4'ZQODFO#==:0PR(H)?\F$ M/\[3USE$X7*`8"E`,`X0J`!1,"M4I)A69ZH9+UE'W;CV\A).*R`=O\ M_SF?C>V3]H1^L@HA;GWAIF4[N^*\VSH.*RN$(7LA'6K%EQ.A&'+1I6>'=13! MHS+AQ@&N&SD8UJV=I6KLG68IN?"F;M$[M=@%8TB_]Z@A_<[V[-O`1WVNN!QP MLM09?,<:HY;5I+4H.NWL5V];)%*A!']JU+-1VY+L!T(^9>?W<6>[$@$UJ.0R M`A2O*\I1T\A`(O$_$_.>4AK'[5OTGVJV@OX`&4U^TT33(.$J2*A!@B>0<`P2 MFB3SDEQ+@#N/6A@)F":-5DDC0PH62(UF`50K-O.*XCG&`^9F%7-C_JR_@*DU M/T"X`&HTHVW\`!*O@L1FCRXDV<<&9&%-\WCIO":K&(G!B!9VNM9XD;^PTY/U MTU`D,Z?!&=UE&-&S*@K,*LFEY?)F&(T.=><5R+OP:7POZI$N'_".%(8+DO8CTK43&'3H-.7#8WHDUU$=$=3KI;21SJ4<%$YEI40,``&`0```9````>&PO=V]R:W-H965T0G:2R/SXQA4E0$/PSBH\J+VMYOQW&.SW:BWKBQJ^=AX M[5M5Y^VM#WCO*4OY7=D[I^E]A#-"0\J+(=O[W#6]NI M:@KQO2K_T-NB'K=7_4L:8I@Y@&,`GP-8[`P`#(#/`#%VJBL;^_J:=_EVTZBK MU^B+<)!H5W89(DX>)CZ2PC63-D%8[.-(;Q"%+7W3)42K"Q$.FB-5VTI$,0 MQ$XRHYS79*AG'CMZ0Y"-Q:C6-0O*E2?VEO8(8F'B[(F6-M.Z!2>9QD29DXO6 M-A/86>HBTZ`LRT4;"T$G`8@K,Z`HK5V:9VY8Y+76.4@?N,.89!!8>6N4<50["Q8./ M[=@R$D[KG*/.(;*D,(IW_6`'8JJT)KFX9:J"F"HM1Q[=,M4(SLM44V*J],.69[=,=0(E9AZ@M0>3K&ROD$99K:8* MS#U5H!4#_(:ISB#+/00WO.ZBK(3#77<(8LSIY4`K$%!LJE)>#&<]/"ND+T)0]?<( M7(Z'*(GFB1=V[HR;P%6)E[J&">@UDSU2T!ZB;\G^F#N%%_QF,.I5'[GL)RE? MW>!GZPG5_=G_RJ[7I3U3#H^1_6&,Z M&S:.4`,MO7#S(L6];X=PYLBGLJV"\A4 M0)8"$H('D(_YG1I:E4J.2(6M':C[@LF>V(VHD?:3-J&.G,`NO"JO59'F);XZ MHTE#5IKCK+E?--CZ+Q"R!=FM(208),6VP6[+(%T;[*8$Q<>4N=?T(670)'%< M9-N8]"8FG3`/'S'9&A,TA.0/VY3L)B4+E"S^@A(T29%N0_*;D'R")%_L6-`D M)-M]_C!X=90&>H9?5)U9K]%)&GLJ_1%JI31@7>([&[RS=W\9<&B-Z][;O@K7 M(0R,'.;+O?QAJG]02P,$%`````@`DUQY1UK:KR\)`@``,@8``!D```!X;"]W M;W)K&ULC57;;ILP&'X5Q`/$!XZ)"-*::MHN)E6] MV*X=<`*JP=1V0O?V\P$HB5@H%\$VW^G_+3M9S\6;K"A5WD?#6KGW*Z6Z'0"R MJ&A#Y(9WM-5?3EPT1.FI.`/9"4I*2VH8P!#&H"%UZ^>977L1><8OBM4M?1&> MO#0-$7^?*./]WD?^N/!:GRME%D">@8E7U@UM9T ME[.Q9\(?.7\SDY_EWH5'BAC1DD[OP^BGYZ&.!^/ZM]MN3K^ MD4AZX.Q/7:I*IX6^5](3N3#UROL?=*@A,H(%9]+^>L5%*MZ,%-]KR(=[UZU] M]^Y+"@?:,@$/!#P14/B0$`R$X(X`7#);US-1),\$[SWA-J,C9L_1+M"=*SQI M%W5)TC<`W:D\N^9IA#-P-4(#!L\P3PX3I.C_F,.H$TP8H#-,0?!2D&`>!#L! ME"X+!$L"X5P@L`(A#FY31A;3NDH"&Y@D"9P]:-DU775-O["9Z1&ULC9=-W4\[:2 MM^+`._UD*_JV4OJRWT7RT/-J,P:U383CF$5M57=A68SWGONR$$?5U!U_[@-Y M;-NJ_W?/&W%:A2@\WWBI=WLUW(C*(KK$;>J6=[(67=#S[2K\ANZ>,!DDH^)W MS4]ROBOE>0/HOE3;]1>CS8.@PW?5L=&O8C3#PXUT"'A6C1R_`W61ZE$>PX) M@[;Z,,>Z&X\G\R2+(6PY`$,`O@2@Q!E`((!\-2"!@.2K`10"Z%5`9&H?9^ZQ M4E59].(4]&:Y#]7P5J$[JM=F'*H9,B\&F&)0M)R!+"9)I`C(F2)/Y M&-DHZ4RA(*$DM8L>C0C%>6P7/8%(JY:'FWB'FXP9DI0M)Z#>":/N"6/>$;`Q M`6/V,N^-!.4Q68:D7DAJ(-D<0J<0(Z&3MVO&R+R,S"QK[&!D,%F6.G(O(X<% M=Q4"&AQ;EF1P0`\&Q=#3+@Z(DMSR\J%%ZYASSMZ1NSC0TX19E@8MMO41O?T0`A%P@`G9HX_C[%B7`P2Z.$:&,6CB+[3WG0'\SXN(8$<$6 MVT5^%T`,.(F+`T:`4IOA(;\5H!1(U$4RHAN,,EM-?D-`T.[7WC8G94"*26(A M^6T!Y4!*720CND'8UK'8[PP8G,%II2"ZH119:L)^;\#@#\XMCO M#1@O?K+G'*-A)+%8-_9;`P9KN/Y"S#YU($*8DFO[CB:;LT.UX[^J?E=W,G@5 M2N_SQDW95@C%=9KX5H]^KW?XEXN&;]5PFNKSWNQYS842A_,6_O(_HOP/4$L# M!!0````(`)-<>4=@<^MN_`$``%@%```9````>&PO=V]R:W-H965TJVOB_+&AB1*]Y!J_^&2/BWQXH[W=>Z(V! M]Z:JE0GX>>9/O&/#H)4-;Y&`T\Y[#K=%:A`6\+N!7L[FR'@_>?\*0PF)$2PYE?:+RK-4G(T4#S'RZ<:FM6/O_FR"@;9,P`,!3X0P?4B( M!D)T)<2V4N?,UO6#*))G@O=(N+/HB#GR1F5]9S)P-D]83O@XH1E"0W3OS9C64@*ON2)2KYN57FBLRB M4[-XQN;&W\3WNHFX-W^5R;..5/"+B*II)3IPI=^3O?PGSA5H7\%*'T:MV]RT MH'!29KK6<^%>OELHWHU];&JF^7]02P,$%`````@`DUQY1_GU<;G3`0``(`4` M`!D```!X;"]W;W)K&ULA53)CILP&'X5Q`.,V4DC M@C1#5;6'2J,YM&<'?@(:&U/;"=.WKS#&D"A!41!DB.)^\,O"S+WRLF!G M2?H!7KDGSI1B_O<%")L.?NC/$V_]J9-Z`I4%6GA-3V$0/1L\#NW!?P[W5:X1 M!O"KATFL^I[.?F3L70]^-`<_T!&`0"VU`E;-!2H@1`LIXS].\[^E)J[[L_HW M4ZU*?\0"*D9^]XWL5-C`]QIH\9G(-S9]!U="J@5K1H3Y>O592$9GBN]1_&'; M?C#M9%=V@:-M$R)'B!9"F-PEQ(X0?R(@F\S4]15+7!:<31ZW9S%B?>3A/E8[ M5WO"3*J2A*\!:J?*XE+N\JA`%RWD,-$*\S)CXMN8:L8D"P:I#$N0:"M(O`X2 M.8%T6R#>$DC6`K$3R*Y39@8SV$HL)D^";9/DH4GB3/+;)I7%A-FV1_K0(W4> MNVN/=%V(Q:2K'%Z%^8E;QB0HB>!)I>[4<[4,"+12=W/5Y_8&VX%DX_P>+8]B M^0]02P,$%`````@`DUQY1Q<9A>D;`@``K@8``!D```!X;"]W;W)K&ULA55=CZ,@%/TKQ!\P6/QJ&FLRK=GL/FPRF8?=9ZJTF@%Q M@-;9?[]\U3J-K2\"UW,.YU[TD@]]#4)C@5!2*:.`]7`A>T*I$=(;?WK-VY:&.)U?U7_8;+7[`Y9DS^G?ME:- M-AL&H"9'?*;JG0\_B4\A,8(5I](^0766BK,K)0`,?[FQ[>PXN#?KT-/F"<@3 MT$A8I4\)D2=$-T+\E!![0GQ'@"X56X@2*USD@@]`N,/KL?E&5IM8E[H"T@9U M#61@`+JT17XIUNM5#B]&R&/0!+-SF!L":O5Q"S2WQ3(.]0T3A8TCI M(0],1',FHFF>DR`0SPG$4X'8&8B^>TPMI'.).DCX&+%?1)0.@<)YF\FB MS<2?YUVYDZG/9,[%%+%?1)0.D:S3>:/IHM'4&XV>&$T7C2XB2H=`",T;S1:- M9MYH_.3DL\637T24#A&E\9U1./FM&1$GVQ\EJ/BY4^8GF43'%OR*3%NXB^]T M:W:=]"93Y#T^D=]8G-I.@@-7NNG8#G'D7!%M*WS1U6STY3$N*#DJ,\WT7+A^ MZA:*]]?;8;RBBO]02P,$%`````@`DUQY1T?C4_&ULC9A-;Z,P$(;_"N*>@L=\1@2I[6JU>UBI MZF'W3!,G006B"3XD;[=W8FA'N?;=.QG7_F M_+(-`K8_D[9B#_1".O'-D?9MQ<5E?PK8I2?580QJFP#",`G:JN[\LAC77OJR MH%?>U!UYZ3UV;=NJ__=$&GK;^29-,V02SG]5 MTB_/(7!^?L_^?6Q7E/]6,?),FS_U@9]%M:'O'%46/;UYO;RW MEVK80K0%<2/V'AL7187,'P2B\;+X*+,L+H*/(9'2P$SS)#5H4@0B^V0!.HM% M.(SA:93J$V!=`CRO$:L:$WV"2)<@FB>(5()TV60R:CI9I=2$>HO8:A$KBVQI M$<\MI`;E>H_$ZI$HCWS%0VH@->Q6:C5)I4D>KIA(S2:/]":9U213)FC%1&HV MD<$DMYKDR@163'+5B>%V#7!;7%"H;/"*C1(E8+#10PG9<461`TQ*9*()V9%%L0-/2H3`=-/LV*+$`2DEVJ2F M_;63BU('JI3(M#EV=%'F@)42;4R;8X<7Y2Y8Y:M8@9U>D&"BQ/1VTY*YP`K0 M.E:@)7-9!3A@I42&G0,[O(`=L()5>,$.+T0.5"F1Z=D.=G@A=H!*B4S-V-&% MQ`$I)3*^J<".+J0.4,$JNF!'%S('II3(Y&(G%R2446Z`'VNI7/[@"]>1PO;W M)48.2"F1H5=L!Q>#`U)X%5QL!Q=C!Z24"(6&AR&VHXLC!Z:4:`.F?NSLXMB! M*KS*+K:SBQ,'II1HDQF>_]C.+D[U5"VF"ZQG-YB-;"WI3^-DRKP]O7;C(#Q; MG:;?1QA'OB]Y65RJ$_E5]:>Z8]X;Y6)P'*>\(Z6<"/?P0?1\%O/Y=-&0(Q]. M4W'>RXE57G!ZN0_@T[\`Y7]02P,$%`````@`DUQY1Q(%PU<>`P``]`X``!D` M``!X;"]W;W)K&ULC5?+CILP%/T5Q`<4;/,<$:0. M5=4N*HUFT:X]B9.@`9QB9S+]^QKL4#SU@TUXY-S+\3T^UW9UH^,K.Q/"@_>^ M&]@N/'-^>8@BMC^3'K-/]$(&\<^1CCWFXG$\1>PR$GR8@_HN@G&<13UNA["N MYG=/8UW1*^_:@3R-`;OV/1[_/)*.WG8A".\OGMO3F4\OHKJ*EKA#VY.!M70( M1G+\A8=#C=WEMA_EZD_\4L0HS!T`5`)<`D#@#D`I`'P(BR6P> MUQ?,<5V-]!:,4HP+GC0'#TA4;A^P^:48$@LG@*A47;W519E6T=N42&'@"O,H M,=".:"0"Q0LD$@06%M#$`JU90,4B,R=`I@3).@%2"7*=9#9C!CD,B2(Z64<`(W];^0(``&(,```9```` M>&PO=V]R:W-H965T\^>!PFIUI^\$.A'#OJZX: MMO0/G!\70<`V!U)C]D"/I!&_[&A;8RX>VWW`CBW!VTY45P$,PR2H<=GX>=:- MO;5Y1D^\*AORUGKL5->X_;]4WZU]@X/AQ[BQIRE*9&O'A_4P>":P4D+@[&2[R=X^$*Q_\>!0SAY"Q.- M*VT+:T"-%P9V\M?%(V.LV?S.S6[U>447T[@4>7HJCKZP/#5/PG;BE`T$$E\O MS*$CYZR?]DH0#FSOLU`Q.OZ;L,CQ]D&MRL[X!YG])1$[`:R=^ZQL$ESK\.T2 MM&4O)>A=N?W'&:;R%M;TCYX>NK;B17ESW)$P(KGYU4+D&;>)O[%18I"QX6%[ MO]*A>G3!E3%JS(^F7$2S*N.T2`$8Q;R<=:WM=KBYD:-#Y-&G]#4F32`=HU*D7J:$&\%W'B;D2^B1$(@9OZ M13DHIB.U%Z_\7B)+*1%7D5PQ`Q66'G13#PW)1N(((;[L/0-K2TP(FD2@*:LE MVKM((-6I$)'-U:Q[S MO>0H&E?;OMZMG,=7-4DF$4^99+=,QY>J\0W-OK"MN;:MD=#P:SAKT(+TF6:0 MH\E^5\=8]`(JX>@&^&#;_>:/%<7_"_2T#[*#+?W5Q!^E#3+%8#0>_B1OHPZ" M(E*N.E,*9ZNR^70`6OA/V6103L&E3# MH%Q)+' M4O:F-SVL2]B%J^+1R6XT'\UYH26?B/EW";\80U,MY*LL)GL,!:GV&N1*LD-, M&`L_'Y:VUV'T)W9.-"@9T&@3K/,S06@ZF_PGUPB`+)8D?SN7QOWP^XQ#!/ M@N(_!S-_A=M+K7V\R,O1A')-\8718.Z_(#S#_/0,ESM]X0YJ:L(<&CFEKZ[- M.!N6MJGE8.(_&S9U3DT=V:96@[)AS)"(BC!J)]@&^!+PC:;A+0L,TRU`B-"S MK4*A&HYMD]N%P@A:[)Z<5J.6SL'C13ZMYK9S4QY?6%JP'-6$U!2@VV]+:&?/0DZ6*-SC$=PAL;*[W\QN\$6XUF3PU7#4+, M@ZE&`6BU2(U372A+GL:IAK_K*Z#G`UQL5P=+HZ7K`&*`ZTP-7?8AM@J0[Q2FC3ES8)%,"-JC& M]'T&R\-T?(E5527L5=%)@C;#J3.D=R>4H@/E7+GLZ]72`EDY!#Y7,M1+@!%2 M[XA]72JHQM65;+<7ODTV/T.R_*(8>FQLO:BY&[:$NRK9NDQ:V6E;D6PPSOI` M5C`SRV+?\HR]`;:--17>/S[=6#CH18=A`8/2G!4Q7PM=]S_B=;_YL[[<+ZXL M0Z@M!BNWI*6[W3* M]WG)[@1II]?.];'>P8R\7]UNX$3+S@I*647B)>--*L>@/J'21=.X8E[PD`=D MS!@SLYD="]`>1G@3&V:S*2/<4XY?/BY+1OZ'R]^E`ERQW"#K910Q#3+MX*P; M/J;0#=K@B<&5N>/^%<[`_7)U:\+9NQSPQ$XH/H%EHCT4E#R;!DAGBL32]S$8 M)]U3@6:0YP/!H;N:5"@BD,@YTMDD5N8D08XK35881F>/PSK[5VG",73V&R?] M*0G3T?^P.<5@/BX"1.'JA#;9]>=M)2SG=YF.RV"F!&K*"FGVZ!NJ&L>=W-KD?F*C'RN.I(QB94PQK+2EXUK9 M7G!(X,H')4NR'0;9\R'/V0%+IYU&2WEG3=Q[!MOH%HLK.^V-C:@);8W`^7PU MF]/I71C7AO/T,8T&T;OP"T5QB?Q M!N@2<&G'4\T,7=<;IEGX9=XR+VG^2)K\Q9:1^A%%A/Q]X@_LU&1S8&ZFR,,(; MJ$]A7BH2[.90P]7^I%-ODV!?]H`BO0@@*Q8:10)%C+O/QW>J)L%,HV/%U<39-BYB_L)M-N!,>8J1=X< M!7C[>0><B<`:<[/IPW#%IT?KX4.\VQ[T.4;?X07@?1]\O'8YP*>'L&&/Q MH=A6+."&HP@25P)LU-7[#U2(,.#A.*.J)A3H$P]"'I7DJL5UI_AD8/*%HKT<#N=:.?5NZ;V96B]>-AS"PM5_`O7_$R4=4&_0QD?R[@SCP@W+\V@JOQ+]*AG@N(P7V9P, M>E@*#NMKDUDMRJ+-U84CX9R.*C$O.ANAT&1DTY)Y`\1%###3 ME==)GE0?714U9F_#LR:43! MHX/4>/=L*"9+?K5O6Y54CN?#8]+>R'"-+I="YBAYP3;8Z1UCP++D:V+=H`RA MK;;2%-S<#-.+.QO6O%?*8B@.+#+V^6;W>;%6/5@='".639J3F(:]EAPTINM- MSQD@5P!E54EL4KV,,N!2@Z85I#NQV&%K"`PL6#MT9<04`#Q6;Q24IDV`L8[C M^T>)WK!`T;2ZY-A$,7B18+:D8U@:P0KS9O=H=8K4.,>:1\1E'R+J-9=?C0<4 MU.#]"*R50=26V.U-H]41GIU5`[0=G@T'8[(D#E`D,:"P7D=8LC;/N4LPPY70 M0U@N+^4]2C0ID8L\FP^F7LDV4_ZUO($E67NHL&#CB#OBNAS;-^%FTH6D&LP, MVSUW<@@?0U<*[A'^&`_F,#QE"?^!'T-HRT_LF7#*KI?Z2\J"5.W'LL(G7TAU M>22ABSBUOAJ!H/XV9]%+TK1:B4`/#4M?I9SY6M-<&P!/(:#UVB@K>W&P364I MZA2.83&WM,H2>'_K%8T2'@&3*3H]$/F*?930=]ZDIITIL'==2!SE:0+UM'U;+K`3]@Y'222IQ M>YHC!49%0%@M$0/:6:(C!\II\'<3.*"\+3IP8.K3S7C!LN2E<;`?>-VBJQ)O MHX?Z\&6S)"9UFN]E8,_V]3:5<^\<:WN=NZ'S=U=[1_W#(0F\DF"C;3?;X[V[ M'XG9>T\)O:3AP^8B?3^C1.;=`09UM3$$W`.W2/>)=DEUJ/BAK=R^;?@M*1[8 MMNP+W``W.P*&1.OOCFB[!=6?$ZTE%M;E4YO\X3L/B%XAN=L3T^9'YP8(9/FX M7CRL;O<,EBX9W[=T^UVI6WB?]4\*M!9D)CF<_0(*A0.'60\_L:W^&0Y;`3?8 M$^BY(E7VA]=Q+QL/X[YA,&GC3LZW"JDUK!5@+RE>*.0/XFMJ2)$H4E?=NA M,X;PYSU:P[:]0!X6LWEJ0\GF24\)6VHIQ%ZNTON)\@74)"4!TR*5X;C=LK$< M7M$(R3;@(GSC=W69RI7)RVS6:WU!AQEVA2J+6(L.T]D@,4V(X>SLC<691FG? MAD%MU#CRTRDTS#S2.*S^@DQ< M5;CP0G?..=7`@:%SK++WSL8B/'Y%=9Z7@1`@1G.*C8MUNTDN84C4=FKN M/8@>3)=Q;G1%,\=)$RY4N'MD)1%U_!\]L.KT/+F'U8D]]"E4#*:^5Y`-]B%D M%L>A9B`RA'X:_1ZL.R/N!0$ZA30Q6MDFB":H"&.3,+OI,7NWN/G&[G"QG;?S M,E1]6#$HAAT!7BC?>U>G`0K16?21`9U$+M+5S[&U.!CY"'=>9-D9%4K<.M!4 MC\29DJI>G!75RY/FIN+5-^^S^M2\%<4/F+C&R[)RO@BPWQYO#W?'>80AQ'BEB>`G(I:<-2%R4 M/;Y#7*H\0B2C+>:CX#<%@_E7I$O3M`O3-/]SHJRZ-(V4V-4&%S2-"$:!5>@9 MH$R*L=W4>QU\ZN)T;>KR/!L-D6KOTEF`W%HA?@IR;(PXWF_4[`C/>3J@\D): M,1[V;L4$WQI-&EI!H7[4#(H7/!MW-6-D&.$CI<3H:H6+%_P'!YHC=G/L[FLRDG9XTYYG`$?S/.ISR[ MOJ>44QBE-\Z4@1NYQR//Q#`B&YL$KLRK[-5Q18CIT*-\A&;E'`.T?UW<(I+6 M[C%73C+VE?[!*27C?()Y/WDY+?C^C\CK>!7:868(B,1F.6[1=."0N%X=%=O9I3=[4>ODR M?/H?^7`'$9U6C'O%+3)+>!"GY49C!Z(]F4V`A&;_7--,+.P M*=`*A5["X;A0/ZN\*'DPA[Q"AWDY*[-?*,(,5B$:_9&L8$S?)VC$F6(^S@A6 MW"B?S(U)B(Y-C"(N0>+`;BUF18:?OC&6?VSS!VPS,YW<9L6@A,<&Q3`;#BK\ M-IMDU6!4P:#?4^`@VCGAVW`&GY5S?&"$:5@F-ZY?9TF,P,\I!07GQ9A=I9BL M]@*6Y`BZ%/:UHKZ"Z$&#%>:`%4,0;7DU++R^PH(O87-7)31[2(_-VKL[PMZ` M""D&$TS6&\,X#0K=W6I*.7SX`'Z#%HP'\[EUX?Z;7:QFUHW;:K&T^!FHG&*^ M_))]2P>47^+.VVT85DZ,_Q[(082IS"&&6QX4B:P1V)1]>-DR;@_G,KX55[`W M'/Z*92J#^UL1`/92HLR[WT"6U.>\^,U[E()*<`AQ"%@$E4:LD&NNV"=B1FOV MT<2K07$W-$>,U7GOAZVZIDO_37DNV:-_FE7?&X-'LLC5V11QC9449QAUP@CC4?GF?DM$EN624:;)7H]Q-KIK=!IK8C/587W),T: MV)'?3'Y]]^-0XRN8"+2C7*YN_PZJJ!PGQF5UAB/XO_['_[07P?_WI?+S;S$\ M7GPS(:'3I\&'@;)YV8P_96001_$]6MC^YD)./;1*W3%F?G($=;G"P[P_/HC^ MM$-_AM[IRCM_Y#A,VMF8A$2Q1J+`NZ/+`;JXK'U1WIKWIVU5GYUJ-^?O1U^6 MU,@]#7.@-95H75[;<2.OES:`G?"H82YP2R0Y\"9/+/:]J7L.AVY+8`-%4B', M/X.<>B'TSKQ98W#)VD5$-##'!9`D&/BUWCC$3&.5M3YCX0XQ*"D26Q$-(=UY MWCB"EZ[/^9+4P`B#::["$?D<+]/2+WJUK_$9!US,CQ7T=F/T]XU(\%NP?4[Z%#M>5N^1:=XLT%'T= MBP[GF6Y,TPA*%-1_8A?:2>Z<)@M3VLGCA<>823')2PX]W0SY:A]X@>(TTP9K M0;@'H!7?C.%WMS^4"?]+#RA:PM9^JV[C7;&8$ MNS_I>HW1NVVW;U8R70RM*7-JG&GBGC96PQW9 M/R5($U<_W'PXV!A7QXVQ1^0,\@6?PUW)??Y@+!/A<.!F7)."5)3J^?ND;2*< MB%\VFR6A6;L4!!<"+)''3WDGXFLYKAT-U\H]+3%"1D?YK(M>K<^-T6EG@N'H MPH+D%AOIO5!IB%EV9:)\?%XE+Q3>!K*C'ZS^QCCG+C'M_)X",;A@G7UKVI:' MOF\FXO@W#-N@C"!*M$(&I$%FAXHHR;`Z7K4X.0>!E;A_#`N4W>BX98YK%!'8 M;84`30V6^-RUBAV6$`;W1E,4PE3B"#`@^R&\X##(J4@\/$I2Q!^_=.`Q.J M<.>6&5X\B;73AH1@7UTRB8?:M@AZGT<460O+D6W86')6P@BOTC"I*,5"@$54 MZWB59$(NP3*'`%8+L1&O+"`G'PC8"]>%8'XP)$)3T##)`[V+&H^+D`Q:9VE@ MJ#%AK,?=*5MSM5>=Z1AARORH;[^L.5QH0YB>!*]IMF/O$><.AF-^U;_=`5U? M@X"P07S]=S?>G>]-QTP])A,&TU%OH$S8%[!^C2&,=#8\=U4*LVH;,E/0/CQX M](Q>LJW5J?SW;NJX9[%X=H'M:G"HM-[=)HVI4_[+/&#;W#+H+>-=^YPP4M&G M,`ZH(^&&VYIL&!I.#`BZ!\U_^>BJ15T3.X'*.S;4HNU&^(XX9:Z2WNM+3:29 M?!_VT3.B7;8,C!^;Y(Y94DF8EFQ/RH=-\@0Q0N!#K"X8*JE8M>'8/>)4J'3][-.143/2JQ8D$>ZHN&X8BW]ONCFT#="C5$E8P M2H7'K%7(,&*BUTDYK?9R>CI[G./ZC:T^#G'IP^;N@`$3?9[Q0*#V\D>]7MC] M2]0CYA6WA%#3NI%L'8YF!)4$[=U'Y+>"L>J\KOBWDPM]&3&`Q*O]C[B3+#=D M917RIT)VFD_08#!?B./K7B$O"[Z5&Q)ME=(MB3!89G`+0=*Q2O> MFA&G0-99#H3C]C,9*D)KA[VU:T"G_>/^4#_$1D*#A_/:$`E_1+OD?=+0VO:L MSO!+`8N0F@67<(/^;8I8[>5:?:O_&D"`BN5"94RHO"+]X$X@0>^%#`5&B6ST MXBP5*6)FS0;<[!AW&6=4/>[V*9]#]E0E9(N#Z[L':F\+)2N'Y%.9R%+/`FS# M>$EQ=EAY.FH)+9-U'@6(<9Q,0`&M6B14C\:ZC>XL##0A$P_)(K*R6#?YB&="IX62TL#XKNUIK'(--!5 M?)7%@663&MP3N(>J;.(J$KHQ,UNTM+U25"'$NT$*HYHJGT:"]$X4#B(G">:Z MYL@*CX58\\,@T:CXWF[I1A-E5-R0XT2M%^\5;G706&^@CG`_(>0=6.'+S>[< M&GDW1'7@K<:S__4__N<_??C]#?H5E6V"XXQ7/A^1XVXU5DX]OGA,HK7*C"?F M[/T-'\3B3?Z&9:E`4^UZ(:-Z%+-R_94Q_U>[Y3F#H7CM_'A-S8Q&A%D53D2BAVM>P&^#M>"QYZ\6-61%Z.4Z#,LX',VUJ\ZP$+.+Z'#/>AU1V1&0Z=ZJ:ZY40X3"MQ/KY`-5YE[$\(8B M67G=&1$CHVMT3:!ENOTE&X1E@&`HW5YS3)77DGO>356N;-D-V+PDL=F4`:0:37JM<:TQ+Q+/2&HPPH'-;3'!H`AW MM`1OHRV-]JVI:\?A;GPOY`0),<`JL"VW?4S@=&Q"79H<;J/*UGMFC[:M5Z`% MF\PBRVUV%JW=D$V[5XC1:'D.PF?G7*4H8V[8/:;#9I*%= M02X!_>^`X"A56Z+FOK'`2JR)A/=^M=V:6/Z_P+=[#NK9IUSXC8]FWF=?S&XJSF'\6MN;88(_E.B<\1D=Y6E9#4Y]'OVY,/?FH2`U;Y5" M!ET[8@TH%)6'3*]6:Q#X,M\S MY9F<3-0%U8#`'7:G29#YUD(6\G!8^`]HT.UB+Z>O.X>LO1$4HHUBU`PZ(%(> MIW;''&8FIP/DQX%,\>+AUOM)AL>>`&+BLC,8@,P9FMPH.82&[,$X*Q-LT]X8 M6475'_+]M\5V[Q,\V=5II!1?.EB(CWT! MS4`PS053;].[(!`>S)T"P\AQBH^:6/0MG]BH<*5L]QZ$0-5/!@UT@0)P+.,$2#1!D%T6!K9,>#F%`#3 M$`2(3Y5]"GQ,P0V"\'E`J/C[U=]KPA];$$6*<]L3::-")%DDH+TO/%NN;B8+M MM"."Q?J+Y8%E$JA]NT M?E*'(ND:V%2:EMP-?]U3L@?#M-CA8>,*@EHCM8>%Q3:F=*-U(D(OD<:;]APV M,"64^%O_@42L>SY;X0WH@G51Z*>CL?O$H;MOS.VMZW-AR6`3H4Q20]"[P6]$ MM>KT?`9G0E:+FE3*O]?A91-I*+=>%()[@*Z>]O-LP?!N%F#6>)P5NGCN;J9> MMBG9/VA*:Y74TQ'\CP"^%/!@O#T\X\L5,3.:$&7=XL2=%U;3^2M:JQ[LZ,=` MWM-!N4]$]=!Z/.?5?JM+6*U5YOK`+UVY/=4I3#`SC:Y.WL$<-5%;!X&QV%CC MM%L#=&>IF9.1'XNZ_UO]S;K;'H-3VTQU2>[)^AC_+TR:5?":$] MIDOS$>MNZ.K%#R@1"-WQU0;E(IJ[WUY\>$7V;DG;`O5W*:(O),7%7'8)46_& M,G;WOL0QQ0S$I-4ZT:$EM28JV&[Y@N]@UB,<45]%\`E2S4!`_TS?%E#(T@)J MH6\9X>X1A6*W9ZP$&^4=(2V@XV#!-F MG)=.&Z()A:;4NVPIVL M?\3#@[O?.C2=$7"C)ALV,% M"QVC.>7X((9T+2"<%)#*4\,XT[[7W@VA2%>)Z4QUDXP7(-.,)JJ2U;SG].(T MO6K)IJ+&!PN%=M>AJ2%-Y?+`L"K`OAUV'_G+82P[\;%IBD&4?+/&5+WXS3IU M'`$<%T-_=#9YZI!_(TYZ?3""=^_YMKT<(9LZ:AT509O('X]U:37)]\Y"@1)R MJ*)J>358%@^.H*0_WO.Q;$U9?&O!U1FUU9]#Y.*V5[G@*F;1^>F2B4[0CN%U MRSD3QW%W@J`9K#A"'F])F,](Y/:PQR722*J*A,6,S/?BU?YFG01FD?QISY', MS(U@)+:15_9,^:*9""C"DH=2K9?!TT6-_$68?DW2,=GCMB2[N0R M[2YA-&T"1Y?#$NJZ16>NL93:M#`;ZZ:=:8M#4%=BN\<;W!.:7I>C*9K$(7,D M7C^SZ;?UP^P7F)%U<$YS$`^Y76$E?N8V?';A4@=_I9,3GS,\Z0Y\2R9N/%*- MHUQOVYWDS%@GM;NT")0WFY/1P&4H+6J\(1EL)K[EV7;9+1VT2KA3F/#^.6G0 M?G\=BKJRA/AQD39A3VZ]QLRZ,RHY09X:=5_4E'K]=;7;K`6`0XP4N64^,F), M[#,38DV_F^UJ+4J"NZ+E5">9&F1`I6%Y MYB`F[RFSP+BR3;I(+OTAV;EP",A(`$*WK#=1^_+&"_U\/S;<7.H3:6,I\"I8#0`$CLLMDGE*M&0 M8LJ`_8[RITHW3.%T?EG!XH(+T6./%A.J78'0\!Y=WVB@^/NZJ!I],'5%N./# MJL2@@>/(,NS"7XC@6%/7:E\7@9[CT`%*A M%!A-P)8$7YR'@[-7K>S9TS`1BP\R$M;GUI:9RCB0W$@Q"-1^&(?$M-PH"M(] M>O:<25ZUD._3W!?7G*?VBFVF=F=#XR@"E]OUI+SR4$7CT$\PNIP%)GVX7B#ESIQSJC@ M>(^5*PG?L;31]T=0*V\%^13=]+6CY&%CF[NB?2&JOUMQ7Q_A&*;3S&X.RG&! M<_J_UX*-92R(B6;98#\4"3F1EMOYH3%6*DW$XI/ND_`U-81Z,.0)>;3Y$NOX M(B*3@IHB!3'QY)GB]HL)/4&E-LC^8J#>Z:9NLL0,`94,K\`F<<3U&JZ'4*&[ MD0D;I!D^EIA'RADRU):^()2E9_$\<[!=/8[7*WN+7\MVN% MVV5#$O;F3"/LKAO"(4+[!,;$F[/=LS_)$;:P!%_?H-(O'`Q!T[79UZX"S+'B MX!Q,)&,$@-"4EAY0E"JN=V2N[3VH*3(SN:#:D]V5C4E@2Q.M";>4AQL$)WK@ MB[Z`S/@MAFOUJOXJMS63NH67++SK>/:HMDZ0:WD)0L%$'#J#X6UX:OA"28(+ MFBZ]!D2'38EN]HQGAD*9"#$+;55)UR%"D$!9?R)\%QBPLX_4Y@AF3X4TF&2A MUQX#3ZJTED+<"M6%[%4AN*($2YOT4,VL\IJ]UA_(QWTE1L5#=KTP5W-)&,6: MWMA#U7W\OI9\4!L=8$.??"?JCI2.1ZDI#6+[@3W_;`;:'//^H"K27Q53[[RO;52GBM6@4L(W MSL;Y:$:D;R."A.X"Q^:I*_/A9(8S5N35J+13-\LGDXJG;I:7PU'3U"%(:Z^I M*P=%>NI&9?'CIDZ(A[BMHZK(JO:90X#:_QU35^7CZ8BF;M@U=2,U=<6T[<:)B>.%IL/VCBJF%VAFQ>!?1R5D&_<']? MZ%N>\,?.G.@HQ@0+7L%Z;I_DR>CYDSP^=8[-5Q=&.\_M*!\QE3L"AQ-8.@Q( M48*@G4SMMH1QB0XZG:[,P!JOO73E,V39?2F1JBE+KSK1=&(%=.^D3.CXT$N? M/DPGT)H>?Z$")%X)<28"N^V]3SZM+=7H.YLT3JOZ+=J%_H*!V_O.\^QL-BQI M?`G-^VQ6C'FT*TMUF>[T38V&8V5_O#71H<+=R#'!93G+R@HJ@R\+\N<9+9-,1_6\\DZX43^L*%%&2C*J(>^&LF`UE M_S^A(T+F#&M]W"GMSHI\.!0]HC2B;3J4F2DGWV5FSJ:S*?$HS(DOE?K&;`]/ MF2;6&&"<)IW['7HWK61JYA.C+HWDE\KP37PD$Q`O?I25%B5#[*POX M;H*&;9W7IL[4:?.C,>;/#+B\=[DQ,?^\%CC,P2/_B`ZO@"#Z(ME:%3R-Y)9\ M5YA7<+^9(SD]L270\!#2`K5/0T:S%45I+J03@2HPGY:H$!1($3$$B1#4;I,` MUZJX5)M0)E&\,&%4F5CM0)[]'6 M]NI2O-*N @V?`^SD8E$0%1M935B3UJC+4-B\U&Q0 MSZ"348;6F27?P"/@UYIR`I&^)Q]-0!]\]9(TQ?&4-<9J.,G>K>[J[,,M9:SL MLRJ?E25^G^+WZ6@FZI;B]!""$D/>@3^'H%Z8V?[=YK=+;I-K1`'K&QKQ^B7] M7LZ+[.Q2?H=CW6\(JO`S.-S.WKS,YL.I-*.Q$E!Z08E'>I$2O\,%Y-/:`5E< M(1I3=O86#^A\4J)9X>P7/+HK.K3_@G3G4SHWKXRBRQF['&]TQ(I^=]$3KUA! M\!+@0&FJF&!H7);,M3L9V_8*"*T;BG((@S:F29C0;1HF!08UG(QY1=,`5Q;X M#BWT1T%*+>$Y4$5@.D`%G>45R(S7F]UV8_-],5V:]9VSO[ZDZQ&6-Y]/L530 M7KA4*0W:-H%%P`14,,-3N2^.YM;&1.?9O`.$\PSLSMZ^]8M@7<[P1C"?44-@IN"-))S!(LBZQ0C(&C;US M0#OURN":O2@]AG8/&UI$1D2]B1C@2-WR+2`R9\@'8_LSH9LF4I"=X`L5D4+^ M2@Y)730Y)Q?[1#.$9A9WN^W(POFHR85;SCR&^34TGC2610IP+HR3-RBSAJ`A MQ`@-:=X='8S.XU7X#AY&=U.MDJB=KD,5W"\\(EW0RB>B3^ILVX0^WU&>B,<9G1!(XF)(4JH^'B9JSQ0ZDH?400J]BUPH;5U9 M4PS5XF;SM>;QSKT!=Q$(#653:#VLJ;U$>YI1KBF>MP&0E9)E%P]_UHUFG9Z< M9?*QR<>D?8[\EFP:5<-2%QBV"1$BBM!CZ^@1(:A)[<*8=/BY5FD37C0(\;% M3B#H1VUXL*+RM&"(U\K:HV65UAGT'.A]K6A]:O:8^MG_B^S-$4&"H20%EN-P M?3@&IACV7/3X4?^%GUQ'GL"1:H09:1%*H(8` M8!?'GG[>.2T#V[([&A;?-'!8<.#Y_&?>LGZ!"I$Z@X-HK"#*I`XN71`%H5$;$G2D5J;)H!GZ6YP:BT$#5&-HI/L1Z]1?WWJ2;UYI`6L MY`=J&]$6"QNXT&DX*N]7V4XQ08.2I8S#;J>:2V;:S)PWC(78*3/NX3>;'Y,6 M&+CH_JH&G*]#:Y\`CLUW]H[**D<#2#"IC)_6BSL$2*&NO?:R$BERG2'0Q0!P M95,@3J)0TO4==7TJ"S(.KA;0;8O<*'K8%\-%IIIGL`E\0']R%+3Q,T70?-LO MCWL2'V0=HB/Q-,N:CW4$=_M\.)D3@^^HF-+/:ER)NH9DSA61.<\J-$S-YMDO MPGIWL5\MT%Q$S+XC-/SFZ"<34T->5LCR6X)&AZ:D6;/AC8;HG9[!L('%.!]S M`$=>E!/ZB:8.:2$:^Y!6>#K'JB:CH(5CZ-MX/,[&Q5S:-H);^W@XIB]G*JG0 M5#4:9M5XR/:M*7D1)WE%@S+)R^FD-Y9#8U"6?@C!"V%6G!Z@B[N6>/:4"\$R MX!)<^*T+1=.ED[-):QF>G5U*]]Q87D+5WN-$-2ZU?0__=K#LJ)?:N$U8HB_0 M*6R^#?OHM[!R8$(F$Q?4'MX[S9-HYIJ@+>XBH6>SOCER\1"PO"83"@>BN*[A M,(HO4'@CJ.D(>(J,N6]#V:\9NKJ)S*&4H+; MUPTN33+D%/,!/,7?RP*_VZ=,?([DK!6#Z0S+&U*I$_WD/9I#IX.)^!VF@YG\ M-AL("P//%0\G`=!AQE0Y&J!,@LI!?(!N.QC.VEB/+][OL]^=@RE:*]D^>%A[ MH]C.V)`79L).E%I')J8#(K2QPR[8?E1^$,08.3/?")00XDS`015]_KY^$$CF MUQ+QC?`VE`IVAFSH&!AI4CK1^@N-0RS`4EH MW@Q(E@Z[M1H-II5MZA*]'",*WIB6@]D,=?F[>L7\QECR/4=8PWXG1?BLH`BA M8E@-0'8W1!]``\H)"O39=#"<(B_Z1$*/_HE1]@PXD*%L^4IH9E$APP*/A]ED M`,?;&!L'A913TW:^YP4OC?)IB:Z2Z00C`F&]%>2DF+:M,Q(COXO4Z;O@.`S+ M()G^R)7G->__-TMP1(Z,P7C:<#*L*?N`NG3Q$D-\IP4<.P-0#-32G%.\XJP: M3(>="Q.7Y;0:P'VC:56";D1NM^E\,)K"VJ@*\O3811D_7A3\./K&!R6^.QFV M+K_9A!8?R;EJ,,0Y M:G(&I[.W89OZWL8J?^UR9T0/>H_6HM4MZX.XZCX1N43?+:&2<>0\W+D">;\( M6\6/WBW<[JZ]0H(1(PYJI5FDES,HU^2!A:4(2\=(U`JD;#&",V^472J@T3-< M9B1/B](M6X*7,POWK")O,BZMLFF]\K[@)5L,)RA)WW3(3/0$CBG.>@Z2=TX+ M[Y5!ZBOQ(*=`,KCD4A(GS`-[#W_C$#.7$&\;S1.&<\&_>7EX9(`V[^A4+"X; M'X'+B)D"*F5B\7A?/X+\?!+Z0&@SG(2Z+*9ZE,\HOD*^)BWJD!V?3;%[A=_B)=&YV!;$E M$&48VFR,'_RL*"L*HZ48W;.B")-T+H+8!T9O-="*DDMV1C'8YCL5R%DN]'\. MT/5*H>Q0$&N@64_'&49:CS"P'",T<>#^01D(Z5$*1,XF7LO"V4[-\XN,HD]( MD2KH[LX'`65BI'/'4#J;=?J[=>[FF?O4QV?!Z6_@R1:_J+QF0H,WJE#WJ0]4 MH:8HIYQ",7`VBQ5I'C-Z9L2/TG\HK/Y5U/X]&QEX_+6X!"'N[2*\(E!B)2WG M,[2KO\357T'QL.ND.1_LLN>9:5:/C?/3\C/W\HJ9]_D'WNO_DS:#HB".)MA&D(D_F(\Q'&E:0?%;.)Y%\,"S])X@2A$36# MQ0+(5#F`7/L_P)L[`C#^1G08[#L7LDH.""TH_'.F#@MLHL-G>F.BHV()O,/3U4B6EK*F'K2M#9%O'B#NY+6HC0L>_*$4KU4TLAU)N]!6IRVEXTA>U= MI3QP]#9C*8U*`CKYI)5/+J+_X7O=,B1\S-+5N,Q+NG;`_^T].ELU)G@HCT:EXJ;0*_&7JDK&HK=)*YH MLH.M6IR9)ACNRC;!O46.HTM!O")WPL\,'LE+%.]FHP&\]1/\F../"DWX/]G, M2GZL&D"9U0`T&/AXU*&_>Q70Q7(Z`(6:OOG%C@>C,7P#G9N^O1='3`#'SF&K MB6:78_7-+[E$^SA\FT"#X1:<6-0M8_)*QD2^S>/"9R,U)-^UV56EVH[/4UC' M44!S'%5L\AII;AP-@]]-%&69B#V?:MJ*C>9,2<)O5QIZ]/J5U4VG=U+9N&+4:G'KDH3.&`^T M>)E]`!%&Z:J8E45K\7<'JGK%8RU/E_[3G]:;IB>KE]E;"J?F%*N?LU\WN\-G M.C'7$@ATC@0\:(9P'#%H1"FMVNI^=S$J-QM$#R]'0S109FB&Q\]_<7A)5#S" M2S^>TS!.X7P"L3QJ>-.9'R3F[Y2&])](TO>!)?DO)G_#78&1'\;J M;W9.V\[('$A2Q[8`R05W.`%$X@YQ9HU8,T8S%+-EPZXIAV@]G!H4I^9=,\L< MXM;[&A'\*&`/S@0&_.$?5Q:`U"&3SQVV%_S*+<2-#,<$=[)MPXT)HJ>:L`,` MA324T6<]1:M$SZ3^O7/>QE;HV5];9@YMV7UG;HA@,Z.B<>:F.'--\JX$05?" MB!1=\JX@Q30Y=SPS\B,U=U,WZ?"K1+/":BEQ++KGCAQ==,`69#681J%NU_YE MQ%P%DHS<5?/5SP)&KPGY+NMN@ M)IAN^$>.L^:QP",)-3E*1!]%-Q"%L)BXZN,PIN>DQ3NV3SN'M,,JV=R4"ZOA MP:ZI>9*3JB!/+)J^O$G%@1XFYC+P791C:Y]U[B'Q#+$UMV1XM1[.''OCC(UI M5N&,N5WW"\B&4&E!G/.S=6D+$[KX]![2=2U2OY5&^9]AA5NE_#LL-=U`26?VZZ.D ML>%LG/VV6=]&'Y\G>''W!H85G6GS?N]Y8?,NTLV/T4/MY*.A$6D8$D(:@O'H MF@T##/8[YE5B]*=@S3$P=C+E*TPXCRP`7N;NQA3LCXF7V>YA=]-LP@7]5OR3 M6^$9=,)9X]2 M,1[,L]>@X`EQW&UR/&2*#>EM,;%;K1B5&$7_MG4XI2ZIF1VU4;R;/\D7SJ7^ M3A&_7'!\4[2G'5%'&&E#27XKC\#'1$A%.?P$.W]3UTPI?VLR@^;X*?)R M.%,)NXE$V&PTG]OD7\ELA"9_66T1::R:#+-+3@;$3J,E;7._^?R(`.9PHZ;F M(G48/#LS9H\8=`G!O?DS^4,%%SQ>S1Y<4SA)14%`@@$SVADZ\O%XO-0$SWHR MX8EA-;)PKMY'!:$HFLV46@)GF!=K@TF'VV MSBJ]U'.*9-D>%(HFR-B%OM!J_$#&ZJ-?RMF,AE&@],@B30&6!0QX$2.#.C32 M%YB"1LAJ@_$X!H8D%G5B`&PZX=\[8L1+3>KLX)8=V46>X'7M&M MG<:%-*:F.E/17A9S?#8!59QX=LRGO)1HTLU3)=EZ.FMB">6WL9I$-_Q70L'# MZ1P6J.:U,'(VS8?:(?Z+%\S-R7;Q!,>&_[0P>3+;H3"261:R[IFQ$7\?%?Q2 M8YJZ7-(OC)#IIYB'W^5,4\ALFH1@+B-')Y%-T2XGF(-=#,NLG!9\TM@P@C,B M!B"-N:1P.XHY_,V`Z^W#X-*1?7SD1*GFF#\SX:02UTMQCUTZ^*0,N@I_H*@6 M"7#4^%_W1+2[(7J7U8[CY66YH&33]Q(#"Y6K`N1S!B\4PF[*DB3?ICVI&+*-'O-%#S M*`H[N7)GL/$-M6`G..*9Z+W@\>R/A_N?]]O%;?U__+>M$`#]-UU;0T2QOKWH ML+3T=OMEAY;%UP893"AD=*"?9SL^\?$+2Z4::RH-BA"A=TP9_'1HPZ3^M%RUO7KA8]'-")MKO MFS$)7Q`#P0L4.JH?T,2.2O`]\C!/LEAN(Q<4H<2(7\#J5XBV;$X1`;MM5Y)6 M>R%(]PO\K`HTS'!&:V\Z`8QR[\/#LGRW#6S('<01&E."\9AY5O("M-J(A`2> MHP2^RK%7J"#^?^!%@$%Z',A/=J&S"DU$70T@&REAQ$R&W(#A?.@W8)*/04E' M6-8"P9@O7\)?IL6DNRG$-,#!\B4Q,W4UADZ!?#:D3#'R"DP)X#Q(G;:3I*+` M;7!4`V4GW1#OD3/\#V.EC#&\8J!1#U7792UY(%X1G;/.K]`P4QK[S2&;J7.3 MP6^OU3GW[#XKC;UOM\<]D6C3<($]8>TTXI;>=R'LED=ZOGIP_&YJA9K4%MLP MPGPC?.7W_[?/V^J/`1/-*?;G?6HXPB!3W`'/7(W?@4"V1TNC2TY-Y*(8*Z*H MV*EP]!JQZDQ*\*I%[7Y#-/),?=.<=Y.2OA8Y2:<`HB1U[5*(K9H&V=(SJ/H, M`O4>ZZ-5!W*:,2N6;/:$[X=O>$6%!0<;=$&P$3!^]ZN[1T8-Y4ZO@L$`G4=T M0P.S[0H@=9*H,=0>;K+G^`+._Q^'^KBN[\\[*G$.6<5N3X1<&%83%X=!H.T% MOA6:>0-,JN(>,&"!+Y1\CBW"XDDF(Q)+1IA2[^Q-Y)0>$>_'4I"EJ2E>"TR< M4+KP9_:/8FF*46#L>?3[2.P'[)X>281]:BQ">IIK$-SH(C?HKKG#3Y?<*JNY M\1&#Q::;$!9-=]O:%9U%N_R3'A>FI.JY&4D0$^TRXYP1PY6?5B96`;2)JT;V MV")/X$.Y5#7`(0+_MS7`8P@WRK[N"U?).X7-]@OB;0H5V7NO$U>V$[J*"SL& MI[W9SV+3LA9Q71GS*"?ER>2^-/:3L]%F`$75;C"L$M")&-+-"S"@N2M99@N?-/OM;A&_\465SX<#=7/]@5625A)Q_(J>3+E M1[B\\B''Y$F-977J$E,F;/MKKX53.'0#.X_^PE'0`U1T$7D5+LDAV.T[^/!E MLSN<$_@=OA(CSN+'SL78;K[LT@7>;3`%[WKQ2(OB$LXXF/Y;7/=#!L$=V@!N MGL#7PJA.V*4F&-;S>4['I1F(?$2(C^4P9E9S_<7[^-X&S82.\;05]^,7VI$( MY&Z@]G`C;7>K>W?:D"_=P@;"9W!\;?'N(#<]OI,APMCB%IT*Y*XVOG]G2UA3 M^T@;A/-HM21F"]07:@,9*2VGG=>@XR`!VV>* M'>`5IF##XA# MX9"RLJMA4"Z%8."C2`P['V&QDL`]\XMU32A'636?(B)8-:6,[\8G1_`D5`Q/ MSB?P)(_EOEZOPNDAK<])"DW`04$.H.6VK%MR]3=N4__39^[28C#U9^:WS5+O,1D[E?\PF@P]U_@+2=/ M8YAV25\X\TU-F$,CI_35M8B0E]@TM1Q,_&?#ILZIJ2/;U&I0-HQ94>:<(CS! M-B"'W*`HQ\W#BSD=.=Z9B&^N?3%7P[%M2T&K5TKAP1SL/<=F[* MXPM+"V0&W7?"X4//#/+5P==D,.UZ&!^D>>:@?EP+^!7-;S"X<#Z7L/GP MJV.C5B,["J/!9-8VQ>@NSHOYT(Z"A,SXQX^+GBP*<815.28&!D9[$0C'-:7P MP$;T1(/<--2)8L4$NF'O[]-G`=QD<)A>+ MH$)08)$0%&!!*668'/5:L6LACF2)"8,2".:WV60K%PPT">78P4"KF^7*-GJ' MYNV">CGTF^L=18J21]'9I#U>VX`8NCSH5^X:24!3UH.M5Y`7D$,%W;J"U.!U MSM-IIQU/$^N9/V=O:]3(D?Z2:1D(2!N!'H@M$9^5AK)\+-8OA(YR13+T MW5DU)LBXLY)B6#AR16`@R?G\@C*B\?82D4F$\0TNGJDWBVLR)RQ5[(GDL#]B MBLW8-LT$'WC!^C(DH5?)=^9R5WA)9&U.2GPGBJ)2.`F`@AAE!&6WJV5T8$@PU$#3*T MG-8AYNSV;%5MJA:%[RV<730(\NZZ_N.0';[5]U]KM#L&M]50_&GW9Z5N^.&#MW+E9?ADC#_'0SA9M-6.9ED[T@"H'^#4XF)-5+, ME[!B*L[@QN/!Z;`36)^3X01NN,C.C'1*,SA;RGQ*OY=P/$V@_G^RQ"T8W/^- M)NX,32PF5G)D4#8IBDH`Z+`,A%XG7H$Q`W.]%A)<(ZA6AKH.UN`YK4%'".]E M%<"&=J9[W!L;"D>T#)F\5>(B$N1>8:B3.>@)KI.H%E$.OY?`2I!.VTD-87A$;>NQ3X41N*%/K;G\"FY,:-_P?@0:C+=+ MK-9H&JWD)R@9`TJE&PX8\W.`2X#'12S0=3KV0;#?):WL"2K(XDP8,4N&CC-G)L'V-A#TCXP+78Q.AR)X?P,72E MX![A#\SH^0E4/?@/_!A"6WZ*#O/%?7W^$?-'WK$8)2>;(2!%-ZFDI60?;K_` MNA(QSGK]-8+IE?S]7+C_:R808>@I:C[NV18GH14O'A M^,`),^Z6Y#)P>-N#B/^T_GQ<$!Q]340"%*]DO(+E'#['I>#DLN#]7EBIU MU$'J89%(<-EN^2Q%U!+E;W7QUDT+A5.AWNM4*#N6K#M?;HXWA[OCO0D.X/5* M4>\&S+&5Z,V/>J!5$4+_:::WA5_[TM2^T+53++U!)[2TA!1B!&I%K=@JXTRO M,*@NX99MN@7XJRP>&/]S?XAZ9"F@^E_A@4[FT+$-'=Q+8+H<6\;88.-6YG"+ M1_"S2\%_N]*Y1X6T`BZN?5LQP;=`'TFW@FZ1U`R&Z1YW M-6-DPX4(@*3LW0[09T"9F`V;&F(B/L[&E)\QZ9-/,39T`2:/PLPX,L`?:MS\ M=XGL`)=*^#PC^J\2JDG&'@(:*4>S[&^;W=]Q`9OX\1+ZC!!W;Y&!\$N]=*R% MF(TWSN:S*3L'QGS?',VC>V8KZ2B?(L]TVA&AN%QM0)2^.J[NEW2PE_FH(*Y. M6("_+F[A:E7OH!U.E:63?_4'FX''^01M]3DFX)#$Q%1@3.78H367L8J@.+AU MS^"9*<;I3\8L4S7"]+)67(<2O>52&$8YVEE&<"''=3C*AQ,VR4Z&B0NZE<"@ M.UTN#HOL[--Z<5PB]\O+9M^I.N#_D:-1[Q_3$CQZ]=/U];LWO[[Y[>/%^W_. M+B\^7D"-OUU\NKSZ^.;R9=8O4]#(:)J@`K2_K,Q@%$`B+[,12,8,*/(9,8D/DX!D.9@@Z/*ILWB(\,(1OPQE\!HK# MD-&#*^.7ZM=9A@7)AU,RX@C"8YFCH\A0P89]K:BO"$=(?&>8A@`2*:^&A==7 M6+@E`CN7T.PA/39K[RX"9PY@VX-*BHXRN`Y-!H7N+I(1(K)S@>P_\$"%RFB4 MZ:W=]-U3)BYKI&=Y"4]\^G"9G;U`0Q=((K/HGE'G MO[Q#7.$K#&'[?^([>=MNE0,@BN'&!13"P!E=U1*5$^B$JL24'4="K+9;['=#HW]EE37ZL_&";XEVE7$C;$R% MQU+-.7/(RD5`80(9$A98B;FJH?[LWQ'$CN]Y+@OKH\W"2L00@KP3RN@H'RE' M`&DS%]$HC].C[%HBJ5JYRH'*'2=45!X5UUR:/7B:C\`DGW5+%\J&A>(JM>=: M.YOWJ*L<=^)=J1,O7BW)]2Q_/G5NW6NG3<2H:51L>8U3,6I:$_;5G@,*8K*C MH'XC"JIHLIP/"HSD3P9?\3Q3H&K&:N7[29+OG2IO\-ASDUM,/_M+$0 M"A>5<1`H'13BUPL)VVPR\*R8)X293!J?_J#HTV]#V[(0#2#$&5FU8GLG+EV% M!!&WA6[C3'8-9=Q27QHMZMJX'9LC*#KUD0>B=S=+[VIR>#"FEBFEZY4?(@ST*A!?9/\@B;>V>)1YWFOX9RA+[W[XMUMG=;.Y_ M[5$?26:'Z+2G2JZ+WU]?91<')O@B0QS^$R:&.!J@D[6QY$A[3HO^]LJ@K)B+?H=D[G434MP+X7D(;@ M$W01G(GOX640(T*;GI-I7DIZ#=HJ=V(7;*'Z(L,D%+FN%9$(0S+F(6,+,\PD M*&*V24Q)[6H.$WC#=:?SG4]8Q;Q:X3+\I2%D.M.T<%I0Z] MU<'%$-B$B.]KOOCK8CTPL;J1$OW;YNL`S5Y)5?A#O84/YVE5F-X<^.(6.C0.DE(7"PQNY3;K__,_#;[;B$6S7>%!ZZ9DIK M.KOO74P(^WFBP(OO46C,@O0="HTQ+[]#H3'&XO,++2-`U:<7B@=$O;@[Q%=V ME^MQQZ7;[:S*C5Z"U7B^/#Z064L`B>$(84M5^'##Q1X)W&MF/4U$Y!S9\&5R M37:)\(G1>%`-(X>[%/M_0[58<2@*BX[<-Q0VOLRMT1JZC M%D^+P3@N^?W'*V(V*1R-B+L52*A]&G%(/SLRS[8]5#4]Y$XYEU85PA/AH2Z_OJ[%>R_F9OUHG%:5H"]U\T=!-JAFM"VWGSI#C=2!,6&%XVS.))K&N"V]APV!$9-!\PWT>PP#??UB!QOJRV-@LD7F\F)E<\ MPSW7+2SWKI.P^73/1%(]VKMSM]X3*=K`"+,S9(``EU M(UBD.57MIQS)V-JTF95%\:T10DHSI*&)(3*DIR4*9_I$!@"\ERUAH]%88=RG MX*36C+291@_<[C:?=XO8#21CT'L"PNUDH_CE6&NNH%O:^GA_?=Z0$0H@+C(*-S+HERY;P-`Y^`BI'9+U,MQH%--VD+U3E9Z-L&T>B\^0/&!]6X1'/>Z>:T:0'1 MTXV[-+)J'+%OD6Q#G1TV\<5^M4A:N]+>@@1R\+G_7^+JUE0<^L5K"^Q[:LR# M,A1YU5WL=G@",B>5L"?(/&,5$VIC.HTI,[#L__R M*X5U1;6UC.1S='X91PS4A&,*6^G\&VD3E7<-D-=/>:>*WFFQ&QO+K@M@C8J^ M>+_/".V<^.)3-UUZ!*4-&<'H'IC67^%,AOL(&D0MDP.]6_\!%[O5/E&Y=A4R M'H#_`MY`(W&M%/Y2 MF^927F9`9_(]VJT+M$/3<(5(3(%/K](X%UX.GN>9U$8WU,76L-UX?+Q=RCPM MD:XK=O7SA=B209,`)8+,=GABGE081\0@Z!#'_&2C;+EX3,LM`Z9_/'Q!:;+03."^G_" M>$/Q7##-4IV)%PAJ\:J(3D'E11##.\L%'CPNAPBH6N>.#?W4!W[==CWRN3<6 MQ-DEF^A,YB``1&*#MW/32L\=W]4XB^1;+S-3S?Y/?MM,HD%343#>=%;!",NQ M1D0&2WCLW"*KV)JF4Q5+)C`D>>$WR9YP4.Q><8YART3U[%M%R MDPZH]*9C\0BU6ZD2/IJVD)[0@G0T7CE,%OQQ]5"?_Q.+]GY+TPPO2_?3RX,F MOOFCOF7GY^]P([F-->KW-6S;V]KIJ/O^U\D](_[+SLDNF8S$V2U9NGHJ?',I9ZC"M,?:O%_M_WY^!S=\!Z>1NL:4 M@S*>V')0%=$?BT%517]\0UGLT)^O&]3L4[:P8IY:.V61^JLMS@8'/:Y`[,9- MF/#0;LI340IYQXTQ<3?JO-P\]Y:9FU@;C?KZNU.V M?C?*UF^;-:N:N:*WDR.Y/4`+!RX1=]44>O9 M$XHF7H?`UU%)OQ!.?EB$K$E)NQ4:.QP[#.@\J:PWW#MF1>O_[O^.-1&%`)$T M1GM7K<%'_^7B9D^8E@VK)%)TS`0S/6)R&9V@]/2LQ*Z][U^T6K#?O_"N5?X# MNA,LR>]?P]>6_?3CYH=O<,\OWJG&!LR5+!@)]5A"(K*BL,?>)'U!/[6FUC%L M;(8U$Q33[]4,-;9A::/PS"_+EEH=-&IHLH$I.O&5]A7VE/+T$DJ]WT_;(`75 MA-3]4+7C^<>%/1!T.SN4`FU8.TD[\"QR1E(O6>M8^SM M57XO!<-_X:F:1E!MSZ/>?\NLY/ZJ0K*S__'Z1FH!)72*-T98$P)YBS(1F2B: MU0@,!&+KVRGBOK."S\:,T[(,Q57R/:M]FGK16>QW5"RZN[!>/G%2@M7<6[6( M5_H/K+1CCWW'FMN.XAL'>-&>+6(.YJKK8'Y&8YKFH;,M#;;$Y[2E=7H:C+Q* M9RL;E"6_12W*0^/$)%6)WL4V+O5GE=J^EI^L^_2VJB;5HO/^[VLC7Y^T$F7^ M/T5E<29]9]%OSC\1!T_H`FAZX6VK:.Y7AM>ODU0'>:=-A3Y5&^&FGGSO_X%^ ME-YSY#>ZJYA39NZTDML&LOW`^7ZSG)_:YA\G&J)0V%;+:Z.O2877'S!$["`N M(PRX9*?M5K6.]=RT1XTPR.B!1ONYU;CZ%]JTK7A`5L0U)HGB''@A56TC)UB' MJM\U23V<30V2N\>;;8X9/T7UG'*(KSDOTP%49-=^@B:%?YT:W65*O4XE<5Y* M:JAN#@'!,?EK:V#7AWKW%7<+QG2%GUUI\/;&E0-=.^XH"I@\].DH[#"8DR%\ M]Z9R@LCL>@?32,-G7A\QKYUB'/[!(?PF'\7)V:K)"?)F4WU,SE\3W'6X&+Y3 M,B`Y*V&8O]2+^\,7C`A%^A6\M*1\@)/!+':235/NM$_W$@V?+E@=@)P)%N4: MCE*E)@->1):1('"4I/ML:=!0DZG)DV2SA=+'!WGLRE?WT^E]K'Y)S":EG.B) M4VNG9P649(_K*E-YUR9T++7`&N*N4PD*S+;3DM[@7FK,92#1(^)XO_A*R:[0 M=,RW@$[@+$2[G/I1UWN^NJ`2@HU1F*E"SF%9)S?"??Q';3%3[XY\Q<8//DBU M5[;:ZT2UJ5XY8\8^WGQOJ3Z3"'1,Z-(N9>4C'Z8(_"EY[2K+C^+F*+[Z814E MHU?)Y7VY(AL?PBQ$+R0WB7B[B)*$@'^CUY(>=3_ M:2;96_N*19M7?-5-9Y,2_S[?9>L+V]WF7_D@,1ME6-'*Q8:S#M-?.(WM<&*JR7T=-%+@C17ESHP!8WT M^U?[:?!AT'],O*<;`I\N0_0*#L?;;H3Z\"B0#38U'T,*I;-X6'L\,HJF([>H MO,GC<#@83^*3SVMO.DP*J9BB%\,3WNTL\\GO=NGFZE/EC\8K!2Y9`Z=]>JY< M`N.8X1,:^=Q#"-6?PU+?V<0S(^X3'>JE=>:M8](-L&5LY/:52`#0?H=S==F& M&;,G-J&FZ5/RA:$OZF4`O14?_]X^/\/,JL2ESA),)/5(P]V"63@.`2?:\7Q' M:1X!-\!^+*62A-$$NY%M%LH2[-Y+FY=ELO.4@O14R7$@N8P=XRR=;VXDGNPU M)^P?N]?UI_4=/Q^?+*G+P2)4+?OMOIZZH6`FI730KGY@XVC)"));`CU3A^Q)!^C_IZ=RY,;!DWH(Q+B/=LW,1B ME&AW0B&"SL1/C@>CN-;Q8)(*\QW-4W^,5;9J4*9>G\6UEZG0YN^S8CK-NM<^ MX)K!5>O04:O4/'NK+;[,I%?6++4&1_'*"H?#FO+L!U$2ZLF!Q-&\#,OB'+Y% MV%)A8]+,\!\_;OO+F5[A1?<950A#@^,CYS>+V[V@-;[P3 M.42`FTW"&/$+9EZM+E'MK5"NF/%J^$H4E%S[XC\<-SC>% MM>Q9B2%;S*]$7\]&A2O"X;AUM/)G[S#+/RNBN7U>:7@)>$(/[O2CBEZ=OG] MY_@'5=6P2)Y=6Z=!X/E3\Q^SCA'X(9G(KS@#V`7P^PUJUA1W<+7>'ETA97P- M/.7E)Z[]4^OH6.JG%M=_97^?DAL6\JF%=Z[;DX>U[S(]M>#.5?EIO6DJH&I= MD:TO?H?5V%7^"2NQJZBGK<*GE=IC!785?-+JZQS&IZR\KD*3JRYM\]S'9DU2 MP(A9T-C417<6J2O*W#+[M&?V/ZK7MN,YFER;Z2HRIKRW3S5X-6>;XX$8!LC\+O8@6.^?B9^=]MT5# MUOZ,A)+LNSMZCBX++.W0BX<4T5Z1RC/ZZ&H-[2-;M`E]_$%G>&L#GUU%2P^? M77:/(7K2^=$Z(J>6V#(`IQ9U8G][2:W>?>TJK6<_NXKIT@O5Y\O14U.G]`#VS(!X:,]!CE$7G$A0\]6=%Z M4+?18T-^I$HYMRA[1%M=2LHA$/B[XF*M@_"D.+JH9@.IJ0KLP*W']//;`^?V M,8QJ1V"NC4MH0FLMTG@KI,`3E>E20(K[<^>\=DF%=XL4Z-%%"_`L^0YTM0=1 M77<2TT*=XGM%4Y^$O!S]H`@QMKB]W1UC3-%KAUOU>;-94H"*D-[?/WH!W3>U M@5'##6N0U;9'N"HFL--22*EJ'HBUU7",)V/%TE"K6,)G&9/64+/TZ]O=)J/% M"07919H;K%(+!XP@+OL5)=RH18F3E#^K'HI+Z*XD7H9)+!V\80H2I^`\PI+Y MLMJFD6D8LK1>MKLYBF1,6Y2=U\)WV-Q8QR=X:.03;'[;T0I&3HL&_KWFLJ[6 M")1*8>_O-4#NI0/(C08FB79SX2(FS@WA)K[V^]@3A1R4(-0=:4WO[DR0VG$_Q&1"I M#Z.H$]`$=/@CHSFUGB2G#@-)C+W]]T2!-WNT>#\ M"-BHG@VGQ23`"'I,R23-<&/0_W>US'2"**F1Z0^$+P'S4=I1BLZ(1WB--@%8 MTJ8-G?E:WC2%A0HY4A/B:LMX7S@@_7<2*8Z,/B;1X.34E#8"VVBL>ATK?>1Y ML]1FBT#$')!^+/V9X+-J)H(@DBU\XYT'WI^X5;-@0<7FW@UZNDTM#W##U`,F M@C%UXSBE_10;UOY(L*ATEAPH)6])*7E/J.?[7@+T.9L98^[W!^+GZ'5%H'@* M9*+)WBUNB'V[K_7S]F#)9+MIU$X5 M=S*M`1$`QGZZ,A-!GI&\0"W'/>"H(I]07](E8:\/_JV6,X[T!NW`Z=:<)6HPW1,;R.M)CVJ"G0<-Z)Q4H'U'>'8;N65; MCR)5PL;0?VSF?+ARAY.T*:':1H7T:>U25#K/:&MI(*S4Z%,FAG]# M;E1*S+XSUS*MNB2.<=6PAS\F+>S-PO.ZOK^'-;RS]\]H*]3(I0W"[]5JL^=R^BRZP"6"C(#F,(.S MWHIJP]IRZF*TA;4+9O-8#U)J2]:L4E7^(;G'7*'MV#6.GN=#C:YP%G($#GQ< MW-\_9E%A_+MSM$_J7P\"ES8?UMLB5O(_MEL M2$P9T6FD12G(1=$R0A50LZ$I(\67)(/W+\2@O=EE3*F=6ZLMM(/>@-;4=WXFI)Z0PM%N--/R;KJ9_UT9OHDW&S$J%";D(]&A]QO&UF):4ZTJ\30G\!J MEGZY?23ZO=6_%9RM_7&#;U.N9VN%X8?5H$CD-1`%^!(M5G0DUD)D5R6SB8.+R[&&!V8+W-^ATC`5`2XM[S,FI$NX-;06B MYVW+%3T]7L"2NN<>\'*+;*%C4=/!QZ)=+@-M#ZF:LTN8P\\LF19[VW\]+O^> M)1;Q*.9!E._6%K"K([#_DATD6HP7R/$9]T?6XN MLR\23.**A+6N#D>1/'"XUH_9`\6>05EH"TG>:'MLAG?-5DA+!7\(7`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`*.ZRMQ MO`\%DB8+!$C:8)NTV$>MK<1"9=FPK&[R[SL'+XE#'=Z\VN2('`Z',\.9CQX/ MWG.,#Z$X_\[@1B%N76NNZ-<&%1C22Z"]RA=Q0H>8MI**#WF'1X%91AJN[D;@ MST-PS8BYEF[+:!W%:(=9@$BL$PVU!J8#3%LPROY+\CAG="0XL0D3=OPM'FPVB3K,@.] M#O9!DB.^B^4XVOBI? M\=G,B:PQ9Z/9N$:;DEY(.7J7Y`@K<2Z/1$*<##:>>XW#XM=K]M58$3LQ+IBL ME5;KDQ8E3-A&N6_?4GZEDKY8_\!R(1W,X='W7(ZEF!87)M]O^6#P`A)%$_4> MR[U.,^(8YZ;K3[?+):%&5M3]`[]+U\:5L.4U&EU7^WR0K M[A"2T/EH6>T!1FZ:Z>:>483R$))^3WJFHXLJ2^NC$;;_-##AR52VCSB<&V31 M=.)W6,SF#8/R)6G!I[R%J'%J[G%J M/KJX;%H-7\I5/EE+;EHWF8_N[CS_I1)&*HQ;[#RD+6T(X3U2`;5X(N$(S27X M)%:)LNQ*\BG\./.ILJZ2A4\2%N%'0?/.1:J\LNTK8_C-94@8KJ7^NC$ M&IM*Y&O;?7KD)^_E@%X%F#,<9D0\QJ&N+XD5CMXJ3%Q%@9\('^\,#27.CN)R M6O=/BKMP0++$0_8G4KN^)!A)\@I9*(./>(V`P9G&<:33OTP.P+^OZ\6GM3SA6R:F,R-:TY*JU#I'?-7+E!''M1&_$&I-Y9J8[RD MDG.K0>:4!&(43]6B9=GN!_M**WFI>M/)=WD74DY0E>AU&X#?*_RY9S!1S>EM7!#A7=M>Q M)X-FM_<#.XKZ%:=VU/V<)%,^,.)]H8ILXF/)T(U9NH533R07R#-MD3*C'WY* MM5>>5\&Q6_A".3?S'@6:JL`4&#GFAZI[\&`GA80L_VDFXB9.#XW.?3T(Y<5_ M2QKX!/)^%(JK6JKE+,.F&TY#'[?.O:NGV0SGA-PSSL"5+W,5>[I\I#J)RK$@ M,JJ]8XN8^6I&V4L,QWS<@:(CI8'6$NP%6]9UJ[.P[/^ABQY-LC`DK_/!E-A9]YAN[)2J:YM8SLZ4L% MRJH1#HMWC\?\P70>&(`\@L$279"&@9F*2@YL\T!,2%LE6N/"VD01KR099B_R M:C*:2#_/T*WS?AXC#8'=$HESR=V;3K&M]^L8^>))29PE9T_O^R2Z9P5/^02F M/OPK%;/PX]M]@ZC*-8HR.@"DBQ?=@C\]C+Z45):BRFNMYV9'`6WXG8UO>/0\ M\%W3>\/#LT^@+Q(*BI\^C#%<7C,;*Y>97#)RTNZJG\2'"#_5=(56!X?_RS._R+'144A;F-2KCOA.Z!AB4>_?F]AI`(``,P_```3``````````````"``0````!;0V]N=&5N M=%]4>7!E&UL4$L!`A0#%`````@`DUQY1TAU!>[%````*P(```L````` M`````````(`!U0(``%]R96QS+RYR96QS4$L!`A0#%`````@`DUQY1R@,U,,P M`P``U4$``!H``````````````(`!PP,``'AL+U]R96QS+W=O&PO M=&AE;64O=&AE;64Q+GAM;%!+`0(4`Q0````(`)-<>4>#!>FG50(``,T*```- M``````````````"``?`3``!X;"]S='EL97,N>&UL4$L!`A0#%`````@`DUQY M1RI@K4F.!P``^"$```\``````````````(`!4=Z$H2UD`(``(()```8``````````````"``2L> M``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`A0#%`````@`DUQY1^H0FQ?6`0``L@0``!@````````````` M`(`!*"4``'AL+W=O4?:F9H)=`(``%H(```8``````````````"``30G``!X;"]W;W)K*0``>&PO=V]R:W-H965T&UL4$L!`A0#%``` M``@`DUQY1RTI$XSF`0``:@4``!@``````````````(`!8RX``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`A0#%`````@`DUQY1VVP;,^D`0`` ML0,``!@``````````````(`!NC<``'AL+W=O4?"45UZHP$``+$#```9``````````````"``90Y M``!X;"]W;W)K&UL4$L!`A0#%`````@`DUQY1[]> M.ONC`0``L0,``!D``````````````(`!;CL``'AL+W=O&PO=V]R:W-H965T4=AX"QMI0$``+$#```9``````````````"``2,_``!X;"]W;W)K&UL4$L!`A0#%`````@`DUQY1VZH:Z:C`0``L0,``!D` M`````````````(`!_T```'AL+W=O&PO M=V]R:W-H965T4<7_I1?HP$` M`+$#```9``````````````"``;-$``!X;"]W;W)K&UL4$L!`A0#%`````@`DUQY1T_\=U.B`0``L0,``!D``````````````(`! MC48``'AL+W=O&PO=V]R:W-H965T4>)4SP^I`$``+$#```9```````` M``````"``4!*``!X;"]W;W)K&UL4$L!`A0#%``` M``@`DUQY1]NF\LFE`0``L0,``!D``````````````(`!&TP``'AL+W=O&PO=V]R:W-H965T4=7!QLII`$``+$#```9``````````````"``=%/``!X M;"]W;W)K&UL4$L!`A0#%`````@`DUQY1\*XXFFE M`0``L0,``!D``````````````(`!K%$``'AL+W=O&PO=V]R:W-H965T4=Y"R^"H0$``+$#```9``````````````"``6)5``!X;"]W;W)K&UL4$L!`A0#%`````@`DUQY1XN++/BH`0``L0,``!D````` M`````````(`!.E<``'AL+W=O&PO=V]R M:W-H965T4<=A)5`L@$``!8$ M```9``````````````"``1-<``!X;"]W;W)K&UL M4$L!`A0#%`````@`DUQY1R#&PO=V]R:W-H965T4?O%U'TZ@$``*H%```9```````````` M``"``&UL4$L!`A0#%`````@` MDUQY1[),XV4Y`@``]0<``!D``````````````(`!X6,``'AL+W=O&PO=V]R:W-H965T4?,QSCXIP$``+$#```9``````````````"``5EH``!X;"]W M;W)K&UL4$L!`A0#%`````@`DUQY1TM)PN^F`0`` ML0,``!D``````````````(`!-VH``'AL+W=O&PO=V]R:W-H965T4># M[5'7M`$``!8$```9``````````````"``0!N``!X;"]W;W)K&UL4$L!`A0#%`````@`DUQY1];ZVE:I`0``L0,``!D````````` M`````(`!ZV\``'AL+W=O&PO=V]R:W-H M965T4>G'0I,WP$``$4%```9 M``````````````"``=1S``!X;"]W;W)K&UL4$L! M`A0#%`````@`DUQY1\92^<.F`0``L0,``!D``````````````(`!ZG4``'AL M+W=O&PO=V]R:W-H965T4<+'][8J`$``+$#```9``````````````"` M`<%Y``!X;"]W;W)K&UL4$L!`A0#%`````@`DUQY M1W-@+!J"`P``FA$``!D``````````````(`!H'L``'AL+W=O`?-N/0%```")0``&0`````` M````````@`%9?P``>&PO=V]R:W-H965T4>!\,$DW0$``+L$```9``````````````"``82%``!X;"]W;W)K M&UL4$L!`A0#%`````@`DUQY1ZF/#B>%`P``I!`` M`!D``````````````(`!F(<``'AL+W=O&PO=V]R:W-H965T4?D=7PC M'P(``"@&```9``````````````"``:&-``!X;"]W;W)K&UL4$L!`A0#%`````@`DUQY1U7/04O*`0``X`0``!D````````````` M`(`!]X\``'AL+W=O&PO=V]R:W-H965T M4<'RGY#Y`$``!H%```9```` M``````````"``3*5``!X;"]W;W)K&UL4$L!`A0# M%`````@`DUQY1\IY(??D!```:AH``!D``````````````(`!39<``'AL+W=O M&PO=V]R:W-H965T4>-,MW__0,``#<4```9``````````````"``72@ M``!X;"]W;W)K&UL4$L!`A0#%`````@`DUQY1SKN M,GN``@``?`D``!D``````````````(`!J*0``'AL+W=O&PO=V]R:W-H965T4>V9M.600(``'('```9``````````````"``8BL``!X;"]W;W)K&UL4$L!`A0#%`````@`DUQY1RK-L`KW`@``VPL``!D` M`````````````(`!`*\``'AL+W=O&PO M=V]R:W-H965T4?&"K-&L@(` M`,L)```9``````````````"``4NU``!X;"]W;W)K&UL4$L!`A0#%`````@`DUQY1["RS"#*`0``@@0``!D``````````````(`! M-+@``'AL+W=O&PO=V]R:W-H965T4>T2O&((P,``$4.```9```````` M``````"``4J]``!X;"]W;W)K&UL4$L!`A0#%``` M``@`DUQY1ZQ4EY44!0``CAX``!D``````````````(`!I,```'AL+W=O!KP%``!J(@`` M&0``````````````@`'OQ0``>&PO=V]R:W-H965T4=5]]I\^0$``-T%```9``````````````"``>++``!X M;"]W;W)K&UL4$L!`A0#%`````@`DUQY1S&.L2O. M`@``.`P``!D``````````````(`!$LX``'AL+W=O&PO=V]R:W-H965T4<+8Q^110(``&X(```9``````````````"``2/3``!X;"]W;W)K&UL4$L!`A0#%`````@`DUQY1SAV=R!R!0``+"4``!D````` M`````````(`!G]4``'AL+W=O&PO=V]R M:W-H965T4=&7YL3;@8``!``!X;"]W;W)K&UL M4$L!`A0#%`````@`DUQY1_.;3\_5!```,1X``!D``````````````(`!Y.0` M`'AL+W=O&PO=V]R:W-H965T4?O0G^A2@(``*,'```9```````````` M``"``6+L``!X;"]W;W)K&UL4$L!`A0#%`````@` MDUQY1P43F6E1`P``8!```!D``````````````(`!X^X``'AL+W=O&PO=V]R:W-H965T4=:VJ\O"0(``#(&```9``````````````"``6'T``!X;"]W M;W)K&UL4$L!`A0#%`````@`DUQY1]9(&BWN`@`` M4PP``!D``````````````(`!H?8``'AL+W=O&PO=V]R:W-H965T4?Y M]7&YTP$``"`%```9``````````````"``?G[``!X;"]W;W)K&UL4$L!`A0#%`````@`DUQY1Q<9A>D;`@``K@8``!D````````` M`````(`!`_X``'AL+W=O&PO=V]R:W-H M965T4<2!<-7'@,``/0.```9 M``````````````"``;(#`0!X;"]W;W)K&UL4$L! M`A0#%`````@`DUQY1P`C?UOY`@``8@P``!D``````````````(`!!P&PO=V]R:W-H965T4&UL4$L!`A0#%`````@`DUQY M1V[.,MHP`@``Y0<``!D``````````````(`!YA`!`'AL+W=OCU$7N,!``#X!```&0`````` M````````@`%-$P$`>&PO=V]R:W-H965T4>*[6R$Y0,``&D6```9``````````````"``6<5`0!X;"]W;W)K M&UL4$L!`A0#%`````@`DUQY1_"?[8`3`P``H`T` M`!D``````````````(`!@QD!`'AL+W=O&PO=V]R:W-H965T4=^ISGK ME@0```D;```9``````````````"``0(?`0!X;"]W;W)K&UL4$L!`A0#%`````@`DUQY1S%?HYA"`P``GA```!D````````````` M`(`!SR,!`'AL+W=O&PO=V]R:W-H965T M4?UOZQ;9@,``&\3```9```` M``````````"``8\K`0!X;"]W;W)K&UL4$L!`A0# M%`````@`DUQY1P%*&PO=V]R:W-H965T4>X;Y84'@(``!@&```:``````````````"``6$T M`0!X;"]W;W)K4<: M1NZCL`(``$<*```:``````````````"``;4<":QC3;0(``,0(```:```````` M``````"``9\Y`0!X;"]W;W)K4=)RU/H=0(``"X)```:``````````````"``40\`0!X;"]W;W)K M4<=3SG830(``"\( M```:``````````````"``?$^`0!X;"]W;W)K44<_ M?W#AY0$``)X%```:``````````````"``?Q#`0!X;"]W;W)K4=4;ZZR9@(``(X(```:```````` M``````"``1E&`0!X;"]W;W)K4?QJV]B!`,``$D-```:``````````````"``;=(`0!X;"]W;W)K M4?VS9PHY@$``%`% M```:``````````````"``?-+`0!X;"]W;W)K44<" M3DI@JP,``$`0```:``````````````"``6I0`0!X;"]W;W)K4 v3.3.0.814

Benefit Plans - Expected Benefit Payments (Detail)
$ in Millions

Sep. 30, 2015

USD ($)

Pension Plans

Defined Benefit Plan Disclosure [Line Items]

2016 $ 163

2017 164

2018 164

2019 177

2020 175

2021-2025 870

Other Postretirement Benefits

Defined Benefit Plan Disclosure [Line Items]

2016 15

2017 15

2018 15

2019 15

2020 15

2021-2025 $ 67

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlanDisclosureLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of benefits from a defined benefit plan expected to be paid in the five fiscal years after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of benefits from a defined benefit plan expected to be paid in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of benefits from a defined benefit plan expected to be paid in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of benefits from a defined benefit plan expected to be paid in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of benefits from a defined benefit plan expected to be paid in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of benefits from a defined benefit plan expected to be paid in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_PensionPlansDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 20 R55.htm IDEA: XBRL DOCUMENT v3.3.0.814

Segment Data - Revenues to Unaffiliated Customers and Long-lived Assets Including Property, Plant and Equipment (Detail) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2013

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Revenues from External Customers and Long-Lived Assets [Line Items]

Revenues $ 3,059 $ 3,120 $ 2,051 $ 2,051 $ 2,202 $ 2,157 $ 2,072 $ 2,015 $ 10,282 $ 8,446 $ 8,054

Long-Lived Assets 20,774 6,317 20,774 6,317 6,276

Corporate

Revenues from External Customers and Long-Lived Assets [Line Items]

Long-Lived Assets 332 340 332 340 350

United States

Revenues from External Customers and Long-Lived Assets [Line Items]

Revenues 5,069 3,417 3,353

Long-Lived Assets 15,513 3,126 15,513 3,126 3,251

Europe

Revenues from External Customers and Long-Lived Assets [Line Items]

Revenues 2,434 2,383 2,189

Long-Lived Assets 3,876 1,790 3,876 1,790 1,649

Greater Asia

Revenues from External Customers and Long-Lived Assets [Line Items]

Revenues 1,545 1,437 1,344

Long-Lived Assets 569 555 569 555 519

Other

Revenues from External Customers and Long-Lived Assets [Line Items]

Revenues 1,234 1,210 1,168

Long-Lived Assets $ 484 $ 505 $ 484 $ 505 $ 505

X

- Definition
Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9038-108599

+ Details

Name: us-gaap_NoncurrentAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_US

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=us-gaap_EuropeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=us-gaap_AsiaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=bdx_OthersCountryMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 21 R78.htm IDEA: XBRL DOCUMENT v3.3.0.814

Acquisitions - Fair Value of Consideration Transferred (Details) - Care Fusion Corporation
$ in Millions

Mar. 17, 2015

USD ($)

Business Acquisition [Line Items]

Cash consideration $ 10,085

Noncash consideration-fair value of shares issued 2,269

Noncash consideration-fair value of stock options and other equity awards 184

Total consideration transferred $ 12,538

X

- Definition
Business Combination Consideration Transferred Stock Options And Awards
+ References
No definition available.
+ Details

Name: bdx_BusinessCombinationConsiderationTransferredStockOptionsAndAwards

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_BusinessAcquisitionLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 30

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 30

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477

+ Details

Name: us-gaap_BusinessCombinationConsiderationTransferred1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 30

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 30

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477

+ Details

Name: us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireBusinessesGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=bdx_CareFusionCorporationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 22 R104.htm IDEA: XBRL DOCUMENT v3.3.0.814

Income Taxes - Reconciliation of Federal Statutory Tax Rate to Company's Effective Tax Rate (Detail)
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Income Tax Disclosure [Abstract]

Federal statutory tax rate 35.00% 35.00% 35.00%

State and local income taxes, net of federal tax benefit (3.60%) (0.50%) (1.20%)

Effect of foreign and Puerto Rico earnings and foreign tax credits (24.50%) (11.20%) (9.70%)

Effect of Research Credits and Domestic Production Activities, (1.60%) (1.10%) (3.80%)

Other, net 0.60% (0.10%) (0.10%)

Total 5.90% 22.10% 20.20%

X

- Definition
Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h)(2))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319

+ Details

Name: us-gaap_EffectiveIncomeTaxRateContinuingOperations

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I)

-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319

+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I)

-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319

+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I)

-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319

+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I)

-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319

+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsForeign

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I)

-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319

+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 23 R46.htm IDEA: XBRL DOCUMENT v3.3.0.814

Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Details) - $ / shares
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Stockholders' Equity Note [Abstract]

Common stock dividend per share (USD per share) $ 2.40 $ 2.18 $ 1.98

X

- Definition
Aggregate dividends paid during the period for each share of common stock outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

+ Details

Name: us-gaap_CommonStockDividendsPerShareCashPaid

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityNoteAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 24 R33.htm IDEA: XBRL DOCUMENT v3.3.0.814

Acquisitions (Tables)
12 Months Ended

Sep. 30, 2015

Business Combinations [Abstract]

Fair Value of Consideration Transferred
The fair value of consideration transferred was $12.538 billion and consisted of the components below.
(Millions of dollars)

Cash consideration
$
10,085

Noncash consideration-fair value of shares issued
2,269

Noncash consideration-fair value of stock options and other equity awards
184

Total consideration transferred
$
12,538

Fair Value of Company's Ordinary Shares Issued
The acquisition date fair value of the Company’s ordinary shares issued to CareFusion shareholders was calculated per the following (shares in millions):
(Millions of dollars)

Total CareFusion shares outstanding
205.3

Conversion factor
0.0777

Number of the Company’s shares issued
15.9

Closing price of the Company’s stock on March 16, 2015
$
142.29

Fair value of the Company’s issued shares
$
2,269

Fair Value of Assets and Liabilities Assumed
All of the assets acquired and liabilities assumed in this acquisition have been allocated to the Company’s Medical segment.
(Millions of dollars)

Cash and equivalents
$
1,903

Trade receivables, net
530

Inventories
813

Net investment in sales-type leases
1,208

Property, plant and equipment
499

Customer relationships
3,360

Developed technology
2,510

Trademarks
380

Other intangible assets
185

Other assets
321

Total identifiable assets acquired
11,709

Long-term debt
(2,181
)
Deferred tax liabilities
(2,034
)
Other liabilities
(1,299
)
Total liabilities assumed
(5,514
)

Net identifiable assets acquired
6,195

Goodwill
6,343

Net assets acquired
$
12,538

Summary of Pro Forma Results
The following table provides the pro forma results for the years ended September 30, 2015 and 2014 as if CareFusion had been acquired as of October 1, 2013.
(Millions of dollars, except per share data)

2015

2014

Revenues
$
12,368

$
12,288

Net Income
$
1,276

$
1,191

Diluted Earnings per Share
$
5.92

$
5.55

X

- Definition
Schedule Of Business Acquisition By Acquisition Fair Value Of Consideration Transferred Table [Table Text Block]
+ References
No definition available.
+ Details

Name: bdx_ScheduleOfBusinessAcquisitionByAcquisitionFairValueOfConsiderationTransferredTableTableTextBlock

Namespace Prefix: bdx_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(2)-(3)

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

+ Details

Name: us-gaap_BusinessAcquisitionProFormaInformationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_BusinessCombinationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the equity interest issued or issuable in a business acquisition (or series of individually immaterial business acquisitions) planned, initiated, or completed during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (b)(4)

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

+ Details

Name: us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 25 R79.htm IDEA: XBRL DOCUMENT v3.3.0.814

Acquisitions - Fair Value of Company's Ordinary Shares Issued (Details) - USD ($)
$ / shares in Units, $ in Millions

Mar. 17, 2015

Mar. 16, 2015

Business Acquisition [Line Items]

Number of the Company’s shares issued (shares) 15,900,000

Care Fusion Corporation

Business Acquisition [Line Items]

Total CareFusion shares outstanding (shares) 205,300,000.0

Conversion factor 0.0777

Number of the Company’s shares issued (shares) 15,900,000

Closing price of the Company’s stock on March 16, 2015 (USD per share) $ 142.29

Fair value of the Company’s issued shares $ 2,269

X

- Definition
Business Combination Acquirees Common Stock Outstanding
+ References
No definition available.
+ Details

Name: bdx_BusinessCombinationAcquireesCommonStockOutstanding

Namespace Prefix: bdx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of acquirer's shares to be received/received by acquiree's shareholders per each share of acquiree.
+ References
No definition available.
+ Details

Name: bdx_BusinessCombinationEquityInterestIssuedOrIssuableNumberOfSecuritiesCalledByEachShare

Namespace Prefix: bdx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_BusinessAcquisitionLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 30

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 30

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477

+ Details

Name: us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Price of a single share of a number of saleable stocks of a company.
+ References
No definition available.
+ Details

Name: us-gaap_SharePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of stock issued during the period pursuant to acquisitions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesAcquisitions

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=bdx_CareFusionCorporationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 26 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 27 R73.htm IDEA: XBRL DOCUMENT v3.3.0.814

Benefit Plans - Fair Value Measurements of Foreign Plan Assets (Detail) - Foreign Plans - USD ($)
$ in Millions

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets $ 575 $ 574

Corporate bonds

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 33 35

Government and agency-U.S.

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 1 3

Government and agency-Foreign

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 101 100

Other fixed income

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 48 47

Equity securities

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 206 237

Cash and cash equivalents

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 8 15

Real estate

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 13 10

Insurance contracts

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 90 78

Other

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 74 47

Quoted Prices in Active Markets for Identical Assets (Level 1)

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 364 357

Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporate bonds

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 3 0

Quoted Prices in Active Markets for Identical Assets (Level 1) | Government and agency-U.S.

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 1 3

Quoted Prices in Active Markets for Identical Assets (Level 1) | Government and agency-Foreign

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 65 59

Quoted Prices in Active Markets for Identical Assets (Level 1) | Other fixed income

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 46 46

Quoted Prices in Active Markets for Identical Assets (Level 1) | Equity securities

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 187 221

Quoted Prices in Active Markets for Identical Assets (Level 1) | Cash and cash equivalents

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 8 15

Quoted Prices in Active Markets for Identical Assets (Level 1) | Real estate

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 0 0

Quoted Prices in Active Markets for Identical Assets (Level 1) | Insurance contracts

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 0 0

Quoted Prices in Active Markets for Identical Assets (Level 1) | Other

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 53 12

Significant Other Observable Inputs (Level 2)

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 121 138

Significant Other Observable Inputs (Level 2) | Corporate bonds

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 30 35

Significant Other Observable Inputs (Level 2) | Government and agency-U.S.

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 0 0

Significant Other Observable Inputs (Level 2) | Government and agency-Foreign

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 36 41

Significant Other Observable Inputs (Level 2) | Other fixed income

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 2 1

Significant Other Observable Inputs (Level 2) | Equity securities

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 19 17

Significant Other Observable Inputs (Level 2) | Cash and cash equivalents

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 0 0

Significant Other Observable Inputs (Level 2) | Real estate

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 13 10

Significant Other Observable Inputs (Level 2) | Insurance contracts

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 0 0

Significant Other Observable Inputs (Level 2) | Other

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 21 35

Significant Unobservable Inputs (Level 3)

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 90 78 $ 83

Significant Unobservable Inputs (Level 3) | Corporate bonds

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 0 0

Significant Unobservable Inputs (Level 3) | Government and agency-U.S.

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 0 0

Significant Unobservable Inputs (Level 3) | Government and agency-Foreign

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 0 0

Significant Unobservable Inputs (Level 3) | Other fixed income

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 0 0

Significant Unobservable Inputs (Level 3) | Equity securities

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 0 0

Significant Unobservable Inputs (Level 3) | Cash and cash equivalents

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 0 0

Significant Unobservable Inputs (Level 3) | Real estate

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 0 0 1

Significant Unobservable Inputs (Level 3) | Insurance contracts

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 90 78 $ 81

Significant Unobservable Inputs (Level 3) | Other

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets $ 0 $ 0

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlanDisclosureLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits, at their fair value as of the measurement date. Plan assets include amounts contributed by the employer (and by employees for a contributory plan) and amounts earned from investing the contributions, less benefits paid. If a plan has liabilities other than for benefits, those non-benefit obligations may be considered as reductions of plan assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 30

-Section 35

-Paragraph 50

-URI http://asc.fasb.org/extlink&oid=49178875&loc=d3e12355-114930

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanFairValueOfPlanAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_ForeignPensionPlansDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=bdx_OtherFixedIncomeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=bdx_InsuranceContractInvestmentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=bdx_OtherPensionPlanInvestmentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 28 R89.htm IDEA: XBRL DOCUMENT v3.3.0.814

Derivative Instruments and Hedging Activities - Effects on Consolidated Balance Sheets (Detail) - USD ($)
$ in Millions

Sep. 30, 2015

Sep. 30, 2014

Derivatives, Fair Value [Line Items]

Asset derivatives $ 32 $ 23

Liability derivatives 30 14

Derivatives Designated as Hedging Instruments | Interest rate swaps

Derivatives, Fair Value [Line Items]

Asset derivatives 19 3

Derivatives Designated as Hedging Instruments | Commodity forward contracts

Derivatives, Fair Value [Line Items]

Liability derivatives 10 0

Derivatives Not Designated as Hedging Instruments | Forward exchange contracts

Derivatives, Fair Value [Line Items]

Asset derivatives 13 20

Liability derivatives $ 21 $ 14

X

- Definition
Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 20

-Section 50

-Paragraph 3

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4B

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624163-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 20

-Section 55

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226000-175313

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 860

-SubTopic 20

-Section 50

-Paragraph 4D

-Subparagraph (c)(2)

-URI http://asc.fasb.org/extlink&oid=51814546&loc=SL51823488-111719

+ Details

Name: us-gaap_DerivativeFairValueOfDerivativeAsset

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 860

-SubTopic 20

-Section 50

-Paragraph 4D

-Subparagraph (c)(2)

-URI http://asc.fasb.org/extlink&oid=51814546&loc=SL51823488-111719

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 20

-Section 50

-Paragraph 3

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4B

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624163-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 20

-Section 55

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226000-175313

+ Details

Name: us-gaap_DerivativeFairValueOfDerivativeLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DerivativesFairValueLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 29 R57.htm IDEA: XBRL DOCUMENT v3.3.0.814

Share-Based Compensation - Additional Information (Detail)
12 Months Ended

Sep. 30, 2015

USD ($)

installment

$ / shares

shares

Sep. 30, 2014

USD ($)

$ / shares

shares

Sep. 30, 2013

USD ($)

$ / shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Income tax benefit recognized $ 59,000,000 $ 40,000,000 $ 35,000,000

SARs vesting period 4 years

SARs terms of award 10 years

Total intrinsic value of SARs exercised $ 96,000,000 69,000,000 54,000,000

Stock Issued under SARs exercised | shares 691,000

Actual tax benefit realized for tax deductions from SAR $ 34,000,000 26,000,000 19,000,000

Total fair value of SARs vested 22,000,000 25,000,000 30,000,000

Cash received from the exercising of stock options 75,000,000 17,000,000 64,000,000

Actual tax benefit realized for tax deductions from stock option exercises 20,000,000 7,000,000 21,000,000

Total intrinsic value of stock options exercised 52,000,000 $ 21,000,000 $ 65,000,000

Unrecognized compensation expense for all non-vested share-based awards $ 156,000,000

Weighted-average remaining life non-vested share-based awards 1 year 10 months 4 days

Shares were authorized for future grants | shares 7,242,000

Share-based compensation arrangement by share-based payment award, equity instruments other than options, percent deferred until retirement 25.00%

Number of equal installments in which deferred portion of stock award is distributable (installments) | installment 5

Period over which balance of stock award distributable 5 years

Outstanding shares under other stock plan | shares 50,000 58,000

Shares issuable under deferred compensation plan | shares 345,000

Care Fusion Corporation

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Unrecognized compensation expense for all non-vested share-based awards $ 38,000,000

Director

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Deferral plan, shares held in trust | shares 119,000

Shares represented Directors' compensation in 2015 | shares 3,000

Performance-Based Restricted Stock Units

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock units vesting period 3 years

Performance period 3 years

Granted, stock units weighted average grant date fair value (USD per share) | $ / shares $ 148.04 $ 110.58 $ 72.14

Total fair value of restricted stock units $ 16,000,000 $ 10,000,000 $ 0

Weighted average remaining vesting term 1 year 15 days

Awards outstanding (shares) | shares 1,139,000 1,255,000

Performance-Based Restricted Stock Units | Minimum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Performance payout, percent 0.00%

Performance-Based Restricted Stock Units | Maximum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Performance payout, percent 200.00%

Time-Vested Restricted Stock Units

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock units vesting period 3 years

Granted, stock units weighted average grant date fair value (USD per share) | $ / shares $ 136.30 $ 102.74 $ 70.99

Total fair value of restricted stock units $ 181,000,000 $ 45,000,000 $ 52,000,000

Weighted average remaining vesting term 1 year 1 month

Awards outstanding (shares) | shares 3,067,000 3,015,000

Time-Vested Restricted Stock Units | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock units vesting period 1 year

Replacement Awards | Care Fusion Corporation

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Awards outstanding (shares) | shares 1,500,000

X

- Definition
Number of shares representing compensation in the current year's period under the Company's Directors' Deferral Plan, which provides a means to defer director compensation, from time to time, on a deferred stock or cash basis.
+ References
No definition available.
+ Details

Name: bdx_CurrentYearsCompensationDirectorsDeferralPlan

Namespace Prefix: bdx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The total fair value of stock appreciation rights that have vested during the fiscal year period.
+ References
No definition available.
+ Details

Name: bdx_FairValueOfStockAppreciationRights

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of equal installments distributed relative to deferred portion of awards under the Company's Stock Award Plan for certain key employees.
+ References
No definition available.
+ Details

Name: bdx_NumberOfEqualInstallmentsInWhichDeferredPortionOfStockAwardDistributable

Namespace Prefix: bdx_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Shares outstanding, at the balance sheet date, under the Company's Stock Award Plan (a plan which allows for grants of common shares to certain key employees).
+ References
No definition available.
+ Details

Name: bdx_OutstandingSharesUnderStockAwardPlan

Namespace Prefix: bdx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Distribution period, from the grant date and subject to certain conditions, of awards under the Company's Stock Award Plan.
+ References
No definition available.
+ Details

Name: bdx_PeriodOverWhichBalanceOfStockAwardDistributable

Namespace Prefix: bdx_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Portion Of Stock Award Plan Grants Deferred Until After Retirement Or Involuntary Termination
+ References
No definition available.
+ Details

Name: bdx_PortionOfStockAwardPlanGrantsDeferredUntilAfterRetirementOrInvoluntaryTermination

Namespace Prefix: bdx_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Description of the period of time over which an employee's right to exercise an stock appreciation right is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, which may be expressed in a variety of ways (for example, in years, month and year).
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod

Namespace Prefix: bdx_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The total accumulated difference between fair values of underlying shares on dates of exercise and exercise price on stock appreciation rights which were exercised during the reporting period under the plan.
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The date when stock appreciation rights expire as specified in the award agreement, which may be presented in a variety of ways (for example, year, month and year, day, month and year, quarter of a year).
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward

Namespace Prefix: bdx_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Share based compensation tax benefit realized from exercise of stock appreciation rights.
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockAppreciationRights

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Payout, Percent
+ References
No definition available.
+ Details

Name: bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePayoutPercent

Namespace Prefix: bdx_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Period
+ References
No definition available.
+ Details

Name: bdx_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPerformancePeriod

Namespace Prefix: bdx_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares issuable under the Company's Deferred Compensation Plan that allows highly-compensated employees to defer salary, annual incentive awards and certain equity-based compensation.
+ References
No definition available.
+ Details

Name: bdx_SharesIssuableUnderDeferredCompensationPlan

Namespace Prefix: bdx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Shares issued to satisfy stock appreciation rights exercised during the current year's period.
+ References
No definition available.
+ Details

Name: bdx_StockIssuedUnderStockAppreciationRightsExercised

Namespace Prefix: bdx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of common stock held in a trust that has been set up specifically to accumulate stock for the sole purpose of distribution to participating employees but not yet earned.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 25

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6418455&loc=d3e16701-113920

+ Details

Name: us-gaap_CommonStockSharesHeldInEmployeeTrustShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Unrecognized cost of unvested share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The total recognized tax benefit related to compensation cost for equity-based payment arrangements recognized in income during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Disclosure of the aggregate tax benefit realized from the exercise of stock options and the conversion of similar instruments during the annual period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (j)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (j)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (d)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (d)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=bdx_CareFusionCorporationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TitleOfIndividualAxis=us-gaap_DirectorMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=bdx_RestrictedStockUnitsPerformancePsuMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TitleOfIndividualAxis=us-gaap_ExecutiveOfficerMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=bdx_ReplacementAwardsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 30 R109.htm IDEA: XBRL DOCUMENT v3.3.0.814

Supplemental Financial Information - Inventories (Detail) - USD ($)
$ in Millions

Sep. 30, 2015

Sep. 30, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Materials $ 384 $ 248

Work in process 280 260

Finished products 1,295 987

Inventories $ 1,959 $ 1,495

X

- Definition
Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.BB)

-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section BB

+ Details

Name: us-gaap_InventoryFinishedGoodsNetOfReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51655945&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.BB)

-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a)(4))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section BB

+ Details

Name: us-gaap_InventoryRawMaterialsNetOfReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.BB)

-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section BB

+ Details

Name: us-gaap_InventoryWorkInProcessNetOfReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 31 R76.htm IDEA: XBRL DOCUMENT v3.3.0.814

Benefit Plans - Changes in Benefit Obligation for Postemployment Benefits (Detail) - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Change in benefit obligation:

Beginning obligation $ 184 $ 186

Service cost 18 20 $ 22

Interest cost 6 7 6

Benefits paid (25) (30)

Actuarial (gain) loss (22) 1

Benefit obligation at September 30 $ 163 $ 184 $ 186

X

- Definition
Changes in Post Employment Benefit Obligation [Abstract]
+ References
No definition available.
+ Details

Name: bdx_ChangesinPostEmploymentBenefitObligationRollForward

Namespace Prefix: bdx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of gain (loss) from a change in the postemployment benefit obligation from changes in actuarial assumptions.
+ References
No definition available.
+ Details

Name: bdx_PostEmploymentBenefitActuarialGainLoss

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of payments made for which participants are entitled under a postemployment plan.
+ References
No definition available.
+ Details

Name: bdx_PostEmploymentBenefitBenefitsPaid

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase in the postemployment plan's projected benefit obligation due to the passage of time.
+ References
No definition available.
+ Details

Name: bdx_PostEmploymentBenefitInterestCost

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The actuarial present value of benefits attributed by the postemployment benefit formula to services rendered by employees during the period. The portion of the expected postemployment benefit obligation attributed to employee service during the period.
+ References
No definition available.
+ Details

Name: bdx_PostEmploymentBenefitServiceCost

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The carrying amount as of the balance sheet date of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 712

-SubTopic 10

-Section 25

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6410138&loc=d3e79691-111665

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 712

-SubTopic 10

-Section 25

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6410138&loc=d3e79708-111665

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.15)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.15)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

+ Details

Name: us-gaap_PostemploymentBenefitsLiabilityCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 32 R86.htm IDEA: XBRL DOCUMENT v3.3.0.814

Intangible Assets - Additional Information (Detail) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended

Sep. 30, 2015

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Mar. 31, 2015

Dec. 31, 2014

Business Acquisition [Line Items]

Reclassification out of developed technologies $ 42

Intangible amortization expense $ 346 $ 84 $ 83

Estimated aggregate amortization expense in 2016 558 558

Estimated aggregate amortization expense in 2017 535 535

Estimated aggregate amortization expense in 2018 523 523

Estimated aggregate amortization expense in 2019 519 519

Estimated aggregate amortization expense in 2020 518 518

Crisi Medical Systems Inc

Business Acquisition [Line Items]

Developed technology $ 49

Cellular Research

Business Acquisition [Line Items]

Developed technology 42 42

Acquired in-process research and development $ 19 $ 19

Gen Cell Biosystems

Business Acquisition [Line Items]

Acquired in-process research and development $ 81

X

- Definition
The amount of technology, determined to be technologically feasible, acquired at the acquisition date.
+ References
No definition available.
+ Details

Name: bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Increase (Decrease) in Developed Technologies
+ References
No definition available.
+ Details

Name: bdx_IncreaseDecreaseinDevelopedTechnologies

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(2)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_BusinessAcquisitionLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=bdx_CrisiMedicalSystemsIncMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=bdx_CellularResearchMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=bdx_GenCellBiosystemsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 33 R81.htm IDEA: XBRL DOCUMENT v3.3.0.814

Acquisitions - Summary of Pro Forma Results (Details) - Care Fusion Corporation - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Business Acquisition [Line Items]

Revenues $ 12,368 $ 12,288

Net Income $ 1,276 $ 1,191

Diluted Earnings per Share (USD per share) $ 5.92 $ 5.55

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_BusinessAcquisitionLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(2)-(3)

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

+ Details

Name: us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(2)-(3)

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

+ Details

Name: us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(2)-(3)

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

+ Details

Name: us-gaap_BusinessAcquisitionsProFormaRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=bdx_CareFusionCorporationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 34 R87.htm IDEA: XBRL DOCUMENT v3.3.0.814

Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail) - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Goodwill [Roll Forward]

Goodwill, beginning balance $ 1,090 $ 1,109

Acquisitions 6,716 13

Currency translation/other (269) (32)

Goodwill, ending balance 7,537 1,090

Medical

Goodwill [Roll Forward]

Goodwill, beginning balance 482 511

Acquisitions 6,585 0

Currency translation/other (261) (29)

Goodwill, ending balance 6,807 482

Medical | Series of Individually Immaterial Business Acquisitions

Goodwill [Roll Forward]

Acquisitions 22

Life Sciences

Goodwill [Roll Forward]

Goodwill, beginning balance 608 598

Acquisitions 130 13

Currency translation/other (8) (3)

Goodwill, ending balance $ 730 $ 608

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

+ Details

Name: us-gaap_GoodwillAcquiredDuringPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_GoodwillRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

+ Details

Name: us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 35 R77.htm IDEA: XBRL DOCUMENT v3.3.0.814

Acquisitions - Additional Information (Detail) - USD ($)
12 Months Ended

Mar. 17, 2015

Sep. 30, 2015

Business Acquisition [Line Items]

Restructuring charges $ 271,000,000

Care Fusion Corporation

Business Acquisition [Line Items]

Percentage of interest acquired 100.00%

Cash consideration per share (USD per share) $ 49.00

Conversion factor 0.0777

Acquisition-date fair value of consideration transferred net of in cash acquired $ 12,538,000,000

Product recall accrual 36,000,000

Portion of goodwill currently expected to be deductible for tax purposes $ 0

Business combination interest and financing costs 107,000,000

Acquisition-related costs 59,000,000

Business combination, integration related costs 95,000,000

Restructuring charges 271,000,000

Business combination, pro forma information, revenue of acquiree since acquisition date, 2,000,000,000

Business combination, pro forma information, loss of acquiree since acquisition date $ 242,000,000

Care Fusion Corporation | Customer relationships

Business Acquisition [Line Items]

Risk-adjusted discount rate 11.00%

Weighted average useful life 15 years

Care Fusion Corporation | Developed technology

Business Acquisition [Line Items]

Risk-adjusted discount rate 11.00%

Weighted average useful life 12 years

Care Fusion Corporation | Trademarks

Business Acquisition [Line Items]

Risk-adjusted discount rate 11.00%

Weighted average useful life 22 years

Care Fusion Corporation | In Process Research and Development

Business Acquisition [Line Items]

Risk-adjusted discount rate 12.00%

Acquired in-process research and development $ 110,000,000

Care Fusion Corporation | In Process Research and Development | Minimum

Business Acquisition [Line Items]

Technological and commercial risk 80.00%

Care Fusion Corporation | In Process Research and Development | Maximum

Business Acquisition [Line Items]

Technological and commercial risk 85.00%

X

- Definition
Cash to be paid/paid, per share acquired, to acquiree's shareholders.
+ References
No definition available.
+ Details

Name: bdx_BusinessCombinationCashConsiderationTransferredPerShare

Namespace Prefix: bdx_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of acquirer's shares to be received/received by acquiree's shareholders per each share of acquiree.
+ References
No definition available.
+ Details

Name: bdx_BusinessCombinationEquityInterestIssuedOrIssuableNumberOfSecuritiesCalledByEachShare

Namespace Prefix: bdx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Business Combination Interest And Financing Costs
+ References
No definition available.
+ Details

Name: bdx_BusinessCombinationInterestAndFinancingCosts

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The probability of success, based upon the applicable technological and commercial risk, assumed relative to in-process research and development assets acquired.
+ References
No definition available.
+ Details

Name: bdx_ProbabilityOfSuccessOfProjectPercentage

Namespace Prefix: bdx_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Product Recall Accrual
+ References
No definition available.
+ Details

Name: bdx_ProductRecallAccrual

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275

+ Details

Name: us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_BusinessAcquisitionLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of voting equity interests acquired at the acquisition date in the business combination.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

+ Details

Name: us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

+ Details

Name: us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 25

-Paragraph 23

-URI http://asc.fasb.org/extlink&oid=34752592&loc=d3e1043-128460

+ Details

Name: us-gaap_BusinessCombinationAcquisitionRelatedCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 30

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 30

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477

+ Details

Name: us-gaap_BusinessCombinationConsiderationTransferred1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.
+ References
No definition available.
+ Details

Name: us-gaap_BusinessCombinationIntegrationRelatedCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(1)

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

+ Details

Name: us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(1)

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

+ Details

Name: us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value. For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (bbb)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueInputsDiscountRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 5.P.3)

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140864-122747

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.P.4(b))

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section P

-Subsection 3, 4

+ Details

Name: us-gaap_RestructuringCharges

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=bdx_CareFusionCorporationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bdx_DevelopedTechnologyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 36 R71.htm IDEA: XBRL DOCUMENT v3.3.0.814

Benefit Plans - Fair Value Measurements of U.S. Plan Assets (Detail) - U.S. Plans - USD ($)
$ in Millions

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets $ 1,157 $ 1,255

Mortgage and asset-backed securities

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 192 150

Corporate bonds

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 240 213

Government and agency-U.S.

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 78 153

Government and agency-Foreign

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 95 126

Equity securities

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 335 393

Cash and cash equivalents

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 96 26

Other

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 123 193

Quoted Prices in Active Markets for Identical Assets (Level 1)

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 401 483

Quoted Prices in Active Markets for Identical Assets (Level 1) | Mortgage and asset-backed securities

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 0 0

Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporate bonds

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 100 105

Quoted Prices in Active Markets for Identical Assets (Level 1) | Government and agency-U.S.

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 53 124

Quoted Prices in Active Markets for Identical Assets (Level 1) | Government and agency-Foreign

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 46 74

Quoted Prices in Active Markets for Identical Assets (Level 1) | Equity securities

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 75 56

Quoted Prices in Active Markets for Identical Assets (Level 1) | Cash and cash equivalents

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 96 26

Quoted Prices in Active Markets for Identical Assets (Level 1) | Other

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 30 96

Significant Other Observable Inputs (Level 2)

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 755 768

Significant Other Observable Inputs (Level 2) | Mortgage and asset-backed securities

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 192 150

Significant Other Observable Inputs (Level 2) | Corporate bonds

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 139 108

Significant Other Observable Inputs (Level 2) | Government and agency-U.S.

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 24 29

Significant Other Observable Inputs (Level 2) | Government and agency-Foreign

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 49 51

Significant Other Observable Inputs (Level 2) | Equity securities

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 260 337

Significant Other Observable Inputs (Level 2) | Cash and cash equivalents

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 0 0

Significant Other Observable Inputs (Level 2) | Other

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 91 93

Significant Unobservable Inputs (Level 3)

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 2 4

Significant Unobservable Inputs (Level 3) | Mortgage and asset-backed securities

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 0 0

Significant Unobservable Inputs (Level 3) | Corporate bonds

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 0 0

Significant Unobservable Inputs (Level 3) | Government and agency-U.S.

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 0 0

Significant Unobservable Inputs (Level 3) | Government and agency-Foreign

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 0 0

Significant Unobservable Inputs (Level 3) | Equity securities

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 0 0

Significant Unobservable Inputs (Level 3) | Cash and cash equivalents

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets 0 0

Significant Unobservable Inputs (Level 3) | Other

Defined Benefit Plan Disclosure [Line Items]

Fair value of plan assets $ 2 $ 4 $ 12

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlanDisclosureLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits, at their fair value as of the measurement date. Plan assets include amounts contributed by the employer (and by employees for a contributory plan) and amounts earned from investing the contributions, less benefits paid. If a plan has liabilities other than for benefits, those non-benefit obligations may be considered as reductions of plan assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 30

-Section 35

-Paragraph 50

-URI http://asc.fasb.org/extlink&oid=49178875&loc=d3e12355-114930

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanFairValueOfPlanAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AssetBackedSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=bdx_OtherPensionPlanInvestmentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 37 R25.htm IDEA: XBRL DOCUMENT v3.3.0.814

Supplemental Financial Information
12 Months Ended

Sep. 30, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Supplemental Financial Information
Supplemental Financial Information
Other Income (Expense), Net
Other income (expense), net in 2015 was $21 million, which primarily included equity investment net income and proceeds from the sales of investments of $9 million, an acquisition-date accounting gain of $9 million on the previously held investment in CRISI, as disclosed in Note 6, and income from license and other agreements of $2 million.
Other income (expense), net in 2014 was $5 million, which primarily included equity investment net income and proceeds from the sales of investments of $13 million and income from license and other agreements of $3 million. Other income (expense), net in 2014 also included income of $3 million from contract manufacturing and other transition services relating to the Company’s sale of Discovery Labware in the first quarter of fiscal year 2013. Additional disclosures regarding this divestiture are included in Note 10. These amounts were partially offset by foreign exchange losses (inclusive of hedging costs) of $(13) million.
Other income (expense), net in 2013 was $9 million, which primarily included income of $11 million from contract manufacturing and other transition services relating to the sale of Discovery Labware, equity investment net income and proceeds from investments of $5 million and income from license and other agreements of $3 million. These amounts were partially offset by foreign exchange losses (inclusive of hedging costs) of $(10) million.
Trade Receivables, Net
The amounts recognized in 2015, 2014 and 2013 relating to allowances for doubtful accounts and cash discounts, which are netted against trade receivables, are provided in the following table:
(Millions of dollars)
Allowance for
Doubtful
Accounts

Allowance for
Cash
Discounts

Total
Balance at September 30, 2012
$
36



$
9

$
45

Additions charged to costs and expenses
9



40

49

Deductions and other
(3
)
(A)

(41
)

(44
)
Balance at September 30, 2013
$
41



$
9

$
50

Additions charged to costs and expenses
6



41

46

Deductions and other
(16
)
(A)

(38
)

(54
)
Balance at September 30, 2014
$
30



$
12

$
42

Additions charged to costs and expenses
33



47

80

Deductions and other
(11
)
(A)

(50
)

(61
)
Balance at September 30, 2015
$
53



$
9

$
62

(A)
Accounts written off.
Inventories
Inventories at September 30 consisted of:
(Millions of dollars)
2015

2014
Materials
$
384

$
248

Work in process
280

260

Finished products
1,295

987

$
1,959

$
1,495

Property, Plant and Equipment, Net
Property, Plant and Equipment, Net at September 30 consisted of:
(Millions of dollars)
2015

2014
Land
$
146

$
93

Buildings
2,414

2,313

Machinery, equipment and fixtures
5,602

5,271

Leasehold improvements
114

88

8,277

7,765

Less accumulated depreciation and amortization
4,217

4,160

$
4,060

$
3,605

X

- Definition
The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.
+ References
No definition available.
+ Details

Name: us-gaap_AdditionalFinancialInformationDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 38 R50.htm IDEA: XBRL DOCUMENT v3.3.0.814

Earnings per Share - Additional Information (Detail) - shares
12 Months Ended

Mar. 17, 2015

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Earnings Per Share [Abstract]

Number of the Company’s shares issued (shares) 15,900,000

Options to purchase shares of common stock excluded from calculation of diluted earnings per share 0 0 0

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Antidilution

-URI http://asc.fasb.org/extlink&oid=6505113

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Diluted Earnings Per Share

-URI http://asc.fasb.org/extlink&oid=6510752

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Contingent Stock Agreement

-URI http://asc.fasb.org/extlink&oid=6508534

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares of stock issued during the period pursuant to acquisitions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesAcquisitions

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 39 R42.htm IDEA: XBRL DOCUMENT v3.3.0.814

Supplemental Financial Information (Tables)
12 Months Ended

Sep. 30, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Trade Receivables, Allowances for Doubtful Accounts and Cash Discounts
The amounts recognized in 2015, 2014 and 2013 relating to allowances for doubtful accounts and cash discounts, which are netted against trade receivables, are provided in the following table:
(Millions of dollars)
Allowance for
Doubtful
Accounts

Allowance for
Cash
Discounts

Total
Balance at September 30, 2012
$
36



$
9

$
45

Additions charged to costs and expenses
9



40

49

Deductions and other
(3
)
(A)

(41
)

(44
)
Balance at September 30, 2013
$
41



$
9

$
50

Additions charged to costs and expenses
6



41

46

Deductions and other
(16
)
(A)

(38
)

(54
)
Balance at September 30, 2014
$
30



$
12

$
42

Additions charged to costs and expenses
33



47

80

Deductions and other
(11
)
(A)

(50
)

(61
)
Balance at September 30, 2015
$
53



$
9

$
62

(A)
Accounts written off.

Inventories
Inventories at September 30 consisted of:
(Millions of dollars)
2015

2014
Materials
$
384

$
248

Work in process
280

260

Finished products
1,295

987

$
1,959

$
1,495

Property, Plant and Equipment, Net
Property, Plant and Equipment, Net at September 30 consisted of:
(Millions of dollars)
2015

2014
Land
$
146

$
93

Buildings
2,414

2,313

Machinery, equipment and fixtures
5,602

5,271

Leasehold improvements
114

88

8,277

7,765

Less accumulated depreciation and amortization
4,217

4,160

$
4,060

$
3,605

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph b

-Article 5

+ Details

Name: us-gaap_PropertyPlantAndEquipmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 2

-Paragraph 6

-Subparagraph a,b,c

-Article 5

+ Details

Name: us-gaap_ScheduleOfInventoryCurrentTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for any allowance and reserve accounts (their beginning and ending balances, as well as a reconciliation by type of activity during the period). Alternatively, disclosure of the required information may be within the footnotes to the financial statements or a supplemental schedule to the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 09

-Article 12

+ Details

Name: us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 40 R75.htm IDEA: XBRL DOCUMENT v3.3.0.814

Benefit Plans - Postemployment Benefit Costs (Detail) - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Compensation and Retirement Disclosure [Abstract]

Service cost $ 18 $ 20 $ 22

Interest cost 6 7 6

Amortization of prior service credit (2) (2) (2)

Amortization of loss 18 21 21

Net postemployment benefit cost $ 42 $ 47 $ 47

X

- Definition
The amount of gains or losses recognized in net periodic postemployment benefit cost.
+ References
No definition available.
+ Details

Name: bdx_PostEmploymentBenefitAmortizationOfLoss

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of the prior service cost or credit recognized in net periodic postemployment benefit cost relating to benefit changes attributable to plan participants' prior service pursuant to a plan amendment or a plan initiation.
+ References
No definition available.
+ Details

Name: bdx_PostEmploymentBenefitAmortizationOfPriorServiceCreditCost

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase in the postemployment plan's projected benefit obligation due to the passage of time.
+ References
No definition available.
+ Details

Name: bdx_PostEmploymentBenefitInterestCost

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The actuarial present value of benefits attributed by the postemployment benefit formula to services rendered by employees during the period. The portion of the expected postemployment benefit obligation attributed to employee service during the period.
+ References
No definition available.
+ Details

Name: bdx_PostEmploymentBenefitServiceCost

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CompensationAndRetirementDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Period expense related to postemployment benefits.
+ References
No definition available.
+ Details

Name: us-gaap_PostemploymentBenefitsPeriodExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 41 R97.htm IDEA: XBRL DOCUMENT v3.3.0.814

Debt - Summary of Long-Term Debt (Detail II)

Sep. 30, 2015

1.750% Notes due November 8, 2016

Debt Instrument [Line Items]

Interest rates of debt instruments 1.75%

1.800% Notes due December 15, 2017

Debt Instrument [Line Items]

Interest rates of debt instruments 1.80%

1.450% Notes due May 15, 2017

Debt Instrument [Line Items]

Interest rates of debt instruments 1.45%

4.900% Notes due April 15, 2018

Debt Instrument [Line Items]

Interest rates of debt instruments 4.90%

5.000% Notes due May 15, 2019

Debt Instrument [Line Items]

Interest rates of debt instruments 5.00%

6.375% Notes due August 1, 2019

Debt Instrument [Line Items]

Interest rates of debt instruments 6.375%

2.675% Notes due December 15, 2019

Debt Instrument [Line Items]

Interest rates of debt instruments 2.675%

3.250% Notes due November 12, 2020

Debt Instrument [Line Items]

Interest rates of debt instruments 3.25%

3.125% Notes due November 8, 2021

Debt Instrument [Line Items]

Interest rates of debt instruments 3.125%

3.300% Notes due March 1, 2023

Debt Instrument [Line Items]

Interest rates of debt instruments 3.30%

3.875% Notes due May 15, 2024

Debt Instrument [Line Items]

Interest rates of debt instruments 3.875%

3.734% Notes due December 15, 2024

Debt Instrument [Line Items]

Interest rates of debt instruments 3.734%

7.000% Debentures due August 1, 2027

Debt Instrument [Line Items]

Interest rates of debt instruments 7.00%

6.700% Debentures due August 1, 2028

Debt Instrument [Line Items]

Interest rates of debt instruments 6.70%

6.000% Notes due May 15, 2039

Debt Instrument [Line Items]

Interest rates of debt instruments 6.00%

5.000% Notes due November 12, 2040

Debt Instrument [Line Items]

Interest rates of debt instruments 5.00%

4.875% Notes due May 15, 2044

Debt Instrument [Line Items]

Interest rates of debt instruments 4.875%

4.685% Notes due December 15, 2044

Debt Instrument [Line Items]

Interest rates of debt instruments 4.685%

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_NotesDue2016Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes1.800dueDecember152017Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes1.450dueMay152017Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_NotesDue2018Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_NotesDue2019Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes6.375DueAugust12019Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes2.675dueDecember152019Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_NotesDue2020Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_NotesDue2021Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes3.300dueMarch12023Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes3.875dueMay152024Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes3.374DueDecember152024Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_DebenturesDue2027Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_DebenturesDue2028Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_NotesDue2039Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_NotesDue2040Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes4.875DueMay152044Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes4.685DueDecember142044Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 42 R37.htm IDEA: XBRL DOCUMENT v3.3.0.814

Derivative Instruments and Hedging Activities (Tables)
12 Months Ended

Sep. 30, 2015

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Effects on Consolidated Balance Sheets
The location and amounts of derivative instrument fair values in the consolidated balance sheet are segregated below between designated, qualifying hedging instruments and ones that are not designated for hedge accounting.
(Millions of dollars)
September 30,
2015

September 30,
2014
Asset derivatives-designated for hedge accounting

Interest rate swaps
$
19

$
3

Asset derivatives-undesignated for hedge accounting

Forward exchange contracts
$
13

$
20

Total asset derivatives (A)
$
32

$
23

Liability derivatives-designated for hedge accounting

Commodity forward contracts
$
10

$
—

Liability derivatives-undesignated for hedge accounting

Forward exchange contracts
$
21

$
14

Total liability derivatives (B)
$
30

$
14

(A)
All asset derivatives are included in Prepaid expenses, deferred taxes and other.
(B)
All liability derivatives are included in Accrued expenses.

Undesignated Hedges
The location and amount of gains and losses recognized in income on derivatives not designated for hedge accounting for the years ended September 30 were as follows:
Derivatives Not
Designated as
For Hedge Accounting

Location of Gain (Loss)
Recognized in Income on
Derivatives

Amount of Gain (Loss)
Recognized in Income on
Derivative
(Millions of dollars)
2015

2014

2013
Forward exchange contracts (A)

Other income (expense), net

$
(49
)

$
(3
)

$
(1
)
(A)
The gains and losses on forward contracts and currency options utilized to hedge the intercompany transactional foreign exchange exposures are largely offset by gains and losses on the underlying hedged items in Other income (expense), net.

X

- References
No definition available.
+ Details

Name: us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4B

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624163-113959

+ Details

Name: us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure for other derivative instruments not designated as hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

+ Details

Name: us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 43 R52.htm IDEA: XBRL DOCUMENT v3.3.0.814

Segment Data - Additional Information (Detail)
12 Months Ended

Sep. 30, 2015

customer

segment

Sep. 30, 2014

customer

Sep. 30, 2013

customer

Segment Reporting [Abstract]

Number of principal business segments (segments) | segment 2

Number of customers accounted for 10% or more of revenues (customers) 0 0 0

X

- Definition
Number Of Customer Accounted For Ten Percent Or More Of Revenue
+ References
No definition available.
+ Details

Name: bdx_NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue

Namespace Prefix: bdx_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.
+ References
No definition available.
+ Details

Name: us-gaap_NumberOfOperatingSegments

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 44 R67.htm IDEA: XBRL DOCUMENT v3.3.0.814

Benefit Plans - Pension Plans with Accumulated Benefit Obligations (Detail) - USD ($)
$ in Millions

Sep. 30, 2015

Sep. 30, 2014

Compensation and Retirement Disclosure [Abstract]

Accumulated benefit obligation exceeds the fair value of plan assets, projected benefit obligation $ 2,339 $ 2,267

Accumulated benefit obligation exceeds the fair value of plan assets, accumulated benefit obligation 2,265 2,186

Accumulated benefit obligation exceeds the fair value of plan assets, fair value of plan assets 1,650 1,738

Projected benefit obligation exceeds the fair value of plan assets, projected benefit obligation 2,394 2,324

Projected benefit obligation exceeds the fair value of plan assets, fair value of plan assets $ 1,693 $ 1,784

X

- References
No definition available.
+ Details

Name: us-gaap_CompensationAndRetirementDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
If aggregate disclosures are presented, the aggregate pension accumulated benefit obligation for pension plans with accumulated benefit obligations in excess of plan assets as of the measurement date of each statement of financial position presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 55

-Paragraph 17

-URI http://asc.fasb.org/extlink&oid=58242635&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 3

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e2417-114920

+ Details

Name: us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
If aggregate disclosures are presented, the aggregate fair value of plan assets for pension plans with accumulated benefit obligations in excess of plan assets as of the measurement date of each statement of financial position presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 55

-Paragraph 17

-URI http://asc.fasb.org/extlink&oid=58242635&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 3

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e2417-114920

+ Details

Name: us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
If aggregate disclosures are presented, the aggregate projected benefit obligation for pension plans with accumulated benefit obligations in excess of plan assets as of the measurement date of each statement of financial position presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 3

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e2417-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 55

-Paragraph 17

-URI http://asc.fasb.org/extlink&oid=58242635&loc=d3e4179-114921

+ Details

Name: us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
If aggregate disclosures are presented, the aggregate benefit obligation for plans with benefit obligations in excess of plan assets as of the measurement date of each statement of financial position presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 3

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e2417-114920

+ Details

Name: us-gaap_DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateBenefitObligation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
If aggregate disclosures are presented, the aggregate fair value of plan assets for plans with benefit obligations in excess of plan assets as of the measurement date of each statement of financial position presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 3

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e2417-114920

+ Details

Name: us-gaap_DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 45 R111.htm IDEA: XBRL DOCUMENT v3.3.0.814

Supplementary Data (Unaudited) (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2013

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Quarterly Financial Information Disclosure [Abstract]

Revenues $ 3,059 $ 3,120 $ 2,051 $ 2,051 $ 2,202 $ 2,157 $ 2,072 $ 2,015 $ 10,282 $ 8,446 $ 8,054

Gross Profit 1,430 1,174 1,046 1,045 1,103 1,111 1,053 1,035 4,695 4,301

Net Income $ 181 $ 62 $ 216 $ 236 $ 301 $ 326 $ 287 $ 271 $ 695 $ 1,185 $ 1,293

Earnings per Share:

Basic Earnings per Share (USD per share) $ 0.86 $ 0.30 $ 1.10 $ 1.22 $ 1.56 $ 1.69 $ 1.48 $ 1.40 $ 3.43 $ 6.13 $ 6.63

Diluted Earnings per Share (USD per share) $ 0.84 $ 0.29 $ 1.08 $ 1.20 $ 1.53 $ 1.65 $ 1.45 $ 1.37 $ 3.35 $ 5.99 $ 6.49

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.23)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDilutedAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1,2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_QuarterlyFinancialInformationDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 46 R61.htm IDEA: XBRL DOCUMENT v3.3.0.814

Share-Based Compensation - Summary of Performance-Based Restricted Stock Units Outstanding (Detail) - Performance-Based Restricted Stock Units - $ / shares
shares in Thousands
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]

Stock units, beginning balance (shares) 1,255

Granted, sock units (shares) 352

Distributed, stock units (shares) (139)

Forfeited, canceled or expired, stock units (shares) (330)

Stock units, ending balance (shares) 1,139 1,255

Stock units, vested and expected to vest at ending balance (shares) 542

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]

Stock units exercise price, beginning balance (USD per share) $ 83.47

Granted, stock units weighted average grant date fair value (USD per share) 148.04 $ 110.58 $ 72.14

Distributed, stock units exercise price (USD per share) 72.12

Forfeited, canceled or expired, stock units exercise price (USD per share) 79.12

Stock units exercise price, ending balance (USD per share) 106.07 $ 83.47

Stock units, vested and expected to vest at ending balance, exercise price (USD per share) $ 97.09

X

- Definition
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Expected To Vest
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest

Namespace Prefix: bdx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Expected To Vest
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest

Namespace Prefix: bdx_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(3)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(3)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=bdx_RestrictedStockUnitsPerformancePsuMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 47 R47.htm IDEA: XBRL DOCUMENT v3.3.0.814

Shareholders' Equity - Accumulated Other Comprehensive (Loss) Income (Detail) - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

AOCI Attributable to Parent, Net of Tax [Roll Forward]

Accumulated other comprehensive (loss) income, beginning balance $ (1,001) $ (516) $ (802)

Other comprehensive income before reclassifications, net of taxes (787) (524) 228

Amounts reclassified into income, net of taxes (A) 50 38 59

Accumulated other comprehensive (loss) income, ending balance (1,738) (1,001) (516)

Foreign Currency Translation Adjustments

AOCI Attributable to Parent, Net of Tax [Roll Forward]

Accumulated other comprehensive (loss) income, beginning balance (270) 74 51

Other comprehensive income before reclassifications, net of taxes (692) (344) 23

Amounts reclassified into income, net of taxes (A) 0 0 0

Accumulated other comprehensive (loss) income, ending balance (961) (270) 74

Benefit Plans Adjustments

AOCI Attributable to Parent, Net of Tax [Roll Forward]

Accumulated other comprehensive (loss) income, beginning balance (705) (558) (815)

Other comprehensive income before reclassifications, net of taxes (80) (180) 203

Amounts reclassified into income, net of taxes (A) 44 33 54

Accumulated other comprehensive (loss) income, ending balance (741) (705) (558)

Unrealized Losses on Cash Flow Hedges

AOCI Attributable to Parent, Net of Tax [Roll Forward]

Accumulated other comprehensive (loss) income, beginning balance (26) (31) (38)

Other comprehensive income before reclassifications, net of taxes (16) 0 2

Amounts reclassified into income, net of taxes (A) 6 5 4

Accumulated other comprehensive (loss) income, ending balance $ (36) $ (26) $ (31)

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_AOCIAttributableToParentNetOfTaxRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e681-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669686-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after tax, before reclassification adjustments of other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 55

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=51821188&loc=d3e1436-108581

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669686-108580

+ Details

Name: us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax of reclassification adjustments of other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669686-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 55

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=51821188&loc=d3e1436-108581

+ Details

Name: us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 48 R9.htm IDEA: XBRL DOCUMENT v3.3.0.814

Accounting Changes
12 Months Ended

Sep. 30, 2015

Accounting Changes and Error Corrections [Abstract]

Accounting Changes
Accounting Changes

New Accounting Principle Adopted

In June 2013, the Financial Accounting Standards Board (“FASB”) issued guidance that requires the netting of unrecognized tax benefits against a deferred tax asset for a loss or other carryforward that would apply in settlement of the uncertain tax positions. In March 2013, the FASB issued amendments to resolve diversity in practice relating to the release of cumulative translation adjustments into earnings upon the occurrence of certain derecognition events involving a foreign entity. The Company prospectively adopted both accounting standard updates, which did not impact its consolidated financial statements, on October 1, 2014.

New Accounting Principles Not Yet Adopted
In April 2014, the FASB issued amended requirements that limit the presentation of discontinued operations to only those disposals that represent a strategic shift that has had, or will have, a major effect on an entity’s operations and financial results. The amended requirements also expand the disclosure requirements relating to disposal transactions. The Company will prospectively apply the amended requirements to disposal transactions that occur on or after October 1, 2015.
In May 2014, the FASB issued a new revenue recognition standard. Under this standard, revenue will be recognized upon the transfer of goods or services to customers and the amount of revenue recognized will reflect the consideration to which a reporting entity expects to be entitled in exchange for those goods or services. The Company is currently evaluating the impact that this new revenue recognition standard will have on its consolidated financial statements and the Company currently intends to adopt the standard on October 1, 2018, as is allowed under the FASB's July 2015 amendment which deferred the effective date for this standard.
In April 2014, the FASB issued amended requirements that require debt issuance costs, related to a recognized debt liability, to be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The Company will apply the amended presentation requirements on October 1, 2016.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingChangesAndErrorCorrectionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for reporting accounting changes and error corrections. It includes the conveyance of information necessary for a user of the Company's financial information to understand all aspects and required disclosure information concerning all changes and error corrections reported in the Company's financial statements for the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22644-107794

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 45

-Paragraph 23

-URI http://asc.fasb.org/extlink&oid=6368906&loc=d3e21914-107793

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22595-107794

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22499-107794

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 1.N.Q3)

-URI http://asc.fasb.org/extlink&oid=26874127&loc=d3e30840-122693

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 1

-Section N

+ Details

Name: us-gaap_AccountingChangesAndErrorCorrectionsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 49 R62.htm IDEA: XBRL DOCUMENT v3.3.0.814

Share-Based Compensation - Summary of Performance-Based Restricted Stock Units Outstanding Footnote (Detail)
12 Months Ended

Sep. 30, 2015

shares

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Percentage of target payout on which performance-based restricted stock units are based 200.00%

Expected forfeited performance-based restricted stock units (shares) 68,000

Units in excess of the expected performance payout (shares) 528,000

X

- Definition
Adjustment of expected forfeitures to the amount of performance-based restricted stock units that are expected to vest at the balance sheet date.
+ References
No definition available.
+ Details

Name: bdx_ExpectedForfeitedPerformanceBasedRestrictedStockUnits

Namespace Prefix: bdx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of target payout on which performance-based restricted stock units are based.
+ References
No definition available.
+ Details

Name: bdx_PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased

Namespace Prefix: bdx_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Adjustment of units in excess of expected performance to the amount of performance-based restricted stock units that are expected to vest at the balance sheet date.
+ References
No definition available.
+ Details

Name: bdx_UnitsInExcessOfExpectedPerformancePayout

Namespace Prefix: bdx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 50 R43.htm IDEA: XBRL DOCUMENT v3.3.0.814

Supplementary Data (Unaudited) (Tables)
12 Months Ended

Sep. 30, 2015

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information
SUPPLEMENTARY DATA (UNAUDITED)
Millions of dollars, except per share amounts

2015

1^st

2^nd

3^rd

4^th

Year
Revenues

$
2,051

$
2,051

$
3,120

$
3,059

$
10,282

Gross Profit

1,045

1,046

1,174

1,430

4,695

Net Income

236

216

62

181

695

Earnings per Share:

Basic

1.22

1.10

0.30

0.86

3.43

Diluted

1.20

1.08

0.29

0.84

3.35

2014

1^st

2^nd

3^rd

4^th

Year
Revenues

$
2,015

$
2,072

$
2,157

$
2,202

$
8,446

Gross Profit

1,035

1,053

1,111

1,103

4,301

Net Income

271

287

326

301

1,185

Earnings per Share:

Basic

1.40

1.48

1.69

1.56

6.13

Diluted

1.37

1.45

1.65

1.53

5.99

X

- References
No definition available.
+ Details

Name: us-gaap_QuarterlyFinancialInformationDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the quarterly financial data in the annual financial statements. The disclosure includes financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income (loss) before extraordinary items and cumulative effect of a change in accounting principle and earnings per share data.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)-(j)

-URI http://asc.fasb.org/extlink&oid=51825399&loc=d3e1280-108306

+ Details

Name: us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 51 R29.htm IDEA: XBRL DOCUMENT v3.3.0.814

Earnings per Share (Tables)
12 Months Ended

Sep. 30, 2015

Earnings Per Share [Abstract]

Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share
The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) for the years ended September 30 were as follows:

2015

2014

2013
Average common shares outstanding
202,537

193,299

195,157

Dilutive share equivalents from share-based plans
4,972

4,410

4,036

Average common and common equivalent shares outstanding — assuming dilution
207,509

197,709

199,193

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 52 R28.htm IDEA: XBRL DOCUMENT v3.3.0.814

Shareholders' Equity (Tables)
12 Months Ended

Sep. 30, 2015

Stockholders' Equity Note [Abstract]

Changes in Certain Components of Shareholders' Equity
Changes in certain components of shareholders’ equity were as follows:

Common
Stock Issued
at Par Value

Capital in
Excess of
Par Value

Retained
Earnings

Deferred
Compensation

Treasury Stock
(Millions of dollars)
Shares (in
thousands)

Amount
Balance at September 30, 2012
$
333

$
1,920

$
10,435

$
19

(135,751
)

$
(7,769
)
Net income
—

—

1,293

—

—

—

Cash dividends:

Common ($1.98 per share)
—

—

(386
)

—

—

—

Common stock issued for:

Share-based compensation and other plans, net
—

50

—

—

2,537

15

Share-based compensation
—

98

—

—

—

—

Common stock held in trusts, net
—

—

—

—

36

—

Repurchase of common stock
—

—

—

—

(5,485
)

(450
)
Balance at September 30, 2013
$
333

$
2,068

$
11,342

$
19

(138,663
)

$
(8,204
)
Net income
—

—

1,185

—

—

—

Cash dividends:

Common ($2.18 per share)
—

—

(421
)

—

—

—

Common stock issued for:

Share-based compensation and other plans, net
—

19

—

—

1,431

3

Share-based compensation
—

111

—

—

—

—

Common stock held in trusts, net
—

—

—

—

36

—

Repurchase of common stock
—

—

—

—

(3,574
)

(400
)
Balance at September 30, 2014
$
333

$
2,198

$
12,105

$
19

(140,770
)

$
(8,601
)
Net income
—

—

695

—

—

—

Cash dividends:

Common ($2.40 per share)
—

—

(485
)

—

—

—

Common stock issued for:

Share-based compensation and other plans, net
—

30

(2
)

1

2,839

(6
)
Acquisitions
—

2,083

—

—

15,959

368

Share-based compensation
—

164

—

—

—

—

Common stock held in trusts, net
—

—

—

—

5

—

Repurchase of common stock
—

—

—

—

—

—

Balance at September 30, 2015
$
333

$
4,475

$
12,314

$
20

(121,967
)

$
(8,239
)

Accumulated Other Comprehensive (Loss) Income
The components and changes of Accumulated other comprehensive income (loss) were as follows:
(Millions of dollars)
Total

Foreign
Currency
Translation
Adjustments

Benefit Plans
Adjustments

Unrealized
Losses on
Cash Flow
Hedges
Balance at September 30, 2012
$
(802
)

$
51

$
(815
)

$
(38
)
Other comprehensive income before reclassifications, net of taxes
228

23

203

2

Amounts reclassified into income, net of taxes (A)
59

—

54

4

Balance at September 30, 2013
$
(516
)

$
74

$
(558
)

$
(31
)
Other comprehensive income before reclassifications
(524
)

(344
)

(180
)

—

Amounts reclassified into income, net of
taxes (A)
38

—

33

5

Balance at September 30, 2014
$
(1,001
)

$
(270
)

$
(705
)

$
(26
)
Other comprehensive income before reclassifications, net of taxes
(787
)

(692
)

(80
)

(16
)
Amounts reclassified into income, net of
taxes (A)
50

—

44

6

Balance at September 30, 2015
$
(1,738
)

$
(961
)

$
(741
)

$
(36
)
(A)
The benefit plan-related amount is not reclassified into income in its entirety. The reclassifications from accumulated other comprehensive (loss) income are included in the computation of net periodic pension cost and additional details are provided in Note 8. The reclassification amounts related to cash flow hedges in fiscal years 2015, 2014, and 2013 were primarily recorded in Interest Expense. Additional details regarding the reclassifications from accumulated other comprehensive (loss) income related to cash flow hedges are provided in Note 13.

X

- Definition
Tabular disclosure of the components of accumulated other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669686-108580

+ Details

Name: us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_ScheduleOfStockholdersEquityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityNoteAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 53 R100.htm IDEA: XBRL DOCUMENT v3.3.0.814

Income Taxes - Components of Income from Continuing Operations Before Income Taxes (Detail) - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Income Tax Disclosure [Abstract]

Domestic, including Puerto Rico $ (408) $ 532 $ 288

Foreign 1,147 990 877

Income from continuing operations before income taxes $ 739 $ 1,522 $ 1,165

X

- Definition
The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h)(1)(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h)(1)(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h)(1)(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

ZIP 54 0001628280-15-008984-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001628280-15-008984-xbrl.zip M4$L#!!0````(`'I<>4?1((^1=CT#`(K(0P`0`!P`8F1X+3(P,34P.3,P+GAM M;%54"0`#9^-55F?C559U>`L``00E#@``!#D!``#L?5ESW$B2YO.LV?X'K9Z7 M$NY#5EUC.%7LI4H2D^J>?FH#@2")42:0A8-BSJ_?""#O1-Z90$3`J]LDBCC# M_?//C_`(_/:?;Z/ANU>4Y7&:_.V]^$%X_PXE81K%R?/?WO\8W%@#Y_;V_7_^ M_K__UV__Y^;FO^S[NW=N&I8CE!3OG`P%!8K>_8J+EW?_C%#^\]U3EH[>_3/- M?L:OP(H$TU#^[]LG)7K4I%!7 MD18$BJ(+IJ1*AJ`IXJ.JB)+^6-_M[3$;QI_(G^_PBR?YI\?H[6_O7XIB_.GC MQU^_?GUXC#Z$Z>BC)(BJ8,IX-/5I85HF13:9GTKN\"%'X8?G]/7C]""Y2+X1 MQ!M9G%]69AD6Q[;KID?)A:I(HKXBK^K*-'O&IPORQ^D9LPN&?,[ M58?(*XFKKY2D25*.FI\1%=G'8C)&'_%)-_@LE,7A_+K]%ZU>D*&GK2/1/N*C MLQ/S.&P>`C[0,("\&&=;SL='&BXH\YOG(!C/KWD*\L?J1:8'&I2-CV3I$.6- MUU1'FB\B>MM3B^53 MXUT`3?(B2,(YY-XV(/I+KLX63=/\6!V=GYI'32?BVXH?_^O+W2!\0:-@<7*\ M_^2;^=M@:OJ/W\C#/N75D7OT]*YZ^*>7"GB8I6YFE/0!O\C[Z5&BA[^]S^/1 M>(B']+&Z34UQ89H4Z*UX%^.7]EUR[7?E7P]N]:39.9B#XV)2_6;VJS@BOWR* M4?:N>A.T,HH9-)W;__?^=X'\)PJZJ?[VQ\C$+S1A86#XSF9\]^MWCD[#=3"6V1V2V^ MK?9=_!H6&-VT"JW&3U&+`(M,GHML=N0<$?BW%6PD-H8OR)<>/K$:F2&KD8ZT M&OGR5E/)3&%(9O*1,E.N(+/:S!1J!;9J9LO#OQC+*&P,7[G2\&4VAB]?:?@2 M&\.7KC#\163V[VG\_N]O68IO4TR^#?'=K23R_BKC,LMSB?G_LE M"%_B!&63Y?.^H-$CRN;GW`?)\]I5<1*/RE%]7IN2GU,P>B8O6O^N_F6$'_XV M'L9A/'W_=U&,SZG+"M,7_W2`:-[_/CMYAVQ^^]CXR*/?9R[:I:DF'48Y/G/_C=C3.TE=$KLGW(SMXZP&R#Q74-6&^+&B` M^3$PM\MX2,JC0-/5R:OB`&9N"[(^%D>![N)7%-TF.)!YCA^'R,IS5.3VY$OP MWVGF#(,\KQ#Y&+W]^QM^"D)9AB)R&,LX*+"4!R]! MANP@1]&W8+)4?F,)KCM'O\#,,<-O$5(TM(PM6A./A-1#AH*\S":#(@U_/7ZJF60..4:KRE1F)0>N=*I]+MRT<3@Q5%,P`&MZ/CDH`%5# M*``N@A4704\``=.87?3=7RM$.+YV`.Q`'SM'#9QIOCB]70I`T1THJ`M*+P&C/U'Q.8B3NS3/_2P=N2B/ MGQ-RX&OVO0R&\=,D3IZ=('_QA^FO/U#TC/CU2)<02\\@>.**TX6@<11`ZLPV M2O`/!=GC,^\7G1T@`*9SH],7L@-(Z`$)E1/T9Q$/Q$\=!M77(IK3VLDA&N(@ M&J*AX?`2O@X@R"P$:?&+)^P;!OAC$W^TKL*`0(N60A4O?A%@U"F,N/!M@*$. M]6.O*M^(^C$5]>7S+]E!_'TIF;R+B_BYX@X.7.`R&%1+" MM$R*;/+OSS9+JM\ZGO>_3P?TZ;/=9C2M7)CWCE?@CP%G"OPQ8%F!4\?U]R#! M=Q=5(...R!BK5L3R/\8G+Y]_"3(F4!"^BW^FKYCG!1.@T`T4L/!%$))K'N+ROSY9!]FSZLZ'U9P\\ON)GX$/)\U1L4[/:S,'L,H\3E.>S M\^9\UMRK=5SNN^\:BA[7HF+2O\ MJXSS:CN>.1Z=($-^2<0\8P7\XQJJ^\"96V14@VJ'D"X%;18XFX9V\%WMFEM) M]PN*2/&(/50>0'@K8P.N.Y?K.`93UQ1',9@I9;8^.%X6'!^+7)?AWTS-:3#) MB5QODQ`"NS76VR$EB.S:YS_U,OS'?='O.ICBH.K()I#/+RLQ&Y327U'J[*ZJ`I$=QY$=#:!>WR4("*\SPFOA:W%':!H">(II MJ\4`O@54RL`_E/'/M3;-/$+3$#O13D)MQTXM;#I^D<)MWU'&7_GS,M0%N*"; M`(Z<:H90A-GIYM9#$4B%.$N%KL4_YR?H?4<7"PGO^0U-P#W]Y9YK-6!=9&ZC M[P#K_0P!U&UH9ZT.ZS9<.%3`)[?X;"/9W+Y+XNP,*X\#]H"U8[?$V2F+@3&? MJ!VG4:_,TC'B4J?+0V->JXW?2P([930RV+53!YAJ:TD,I:V=`(7VH4!#/GL2 M*P#5\\8(6[\5U9CW;4SZ,0R&YLQK8\:/D]3KL)".Y/5?BQ>4Y4Z]LSO#^MTT M=I)5-XR.Z>#N<-W"QP=8UR`$9.QH]:A(&VB7_WA[JYE#H-5)H-6YT4-.Q;.I M-^94@`%&,ZBCBB7@S?DOFS2LD@`K[]^*B*-X`1)P7JS_<`NP#> MG+4.AJ-\,ZBW'U[ZX+0<&)NG-+R1XZ'BUDG%K7.NA_D3GEG^\)`.*)X#8P8E M\F2XAV73$*RSF&8X^*@8C[>80_4ETK>X@22MPLF;\OB["%D%8C?:(W?:&P/?(B+(?KZ M=)M$\6LPY+FG;[4B\-Q261?R*SWB*0\2@0^DR8]OCS)J%"['O;1*F(S2?_+Y+PV!> M2UBT5.;%UZ=!,&1QH]`=`UQNJ5P;(;C"0X`Q0,-AG#Q_1@G*L,$ED16-<&J) MK3T@IN:]C;$VN`7-4:/OH>,\`5#`-'T`A@I,PP?3T!+3',$T)*=;*NK?HR$^ M*^(,-R2CVS9(X)M#^`:G+"C(PA=L:RYZ1<-T3$Z=&AIG:%E*T_:-N8?<BW._UVM<$$]%6VUE?9\O>I0-NT:+N-[QVY MZ"E.4&2C!/]0?!L&B3TA?UIYC@H'AP+/:1:CQ7?';Y.\S(@X''S7+`B+V^05 MRXV,=7V7F?9BA^3K[5BJNO7KED[6E^$&?_"(8E MLB?S'__`:"$S$Y,[,B^Q>OO9.;?)N"SRZ@29/1@?H;X:Y/OUMQ/>9[W:`>I? MN-<#]7^IMST,/DNOMQT_3/-#0]8/%`$4`13!$$505RU:WQSV&$99I)/!T,M) M/1\XA&X.623(JQH#UJ":-5K87GAO8`&6>WW+!6/AT<6>&;>#EZ725L'+`G&T M/Y,+M@Y^F0?SHF4N?'?J"[8%ML6$;5TY03RG2`1E9P:,$,K.P`\7[$H!?@!^ M`'Y@DQ_:Z&."\A?/C`#E+]8YX%K=*WN+61`F\$H*$"9P0!%4EO!.33P@L&"- M0R"P8)(U.D\NP&RAC,^:I5`8@H/#I-+RP&'R1@,,AME@Z.!BF;"MEM=GGVQM[F+-48]P>(D0$(`'01I?01J5@)0O M"4B@0$HB.RKW#;WH@B+@/G:YCX;"XL6=,7`?C=S'I9L%[F.7^[ATQL!]-'(? M#6[V$OWW3I"3STB1O[R_RO@U&';5=LLVC@^8KM\E:HZF[FEOEV&^L4SDP5YX MG_46>V$I^_W+5'6?TU>4)624+GHL!B@LL[B($?/K.[BPQ0-\UT%JY,B)`5NT MOL]YG5HNE-;Q*C!N39HLV=HK:XY,F7V[H=P'2CP8#.\>1NJ%I1Q0[TBS<9KA M8WS%H5S8X"$UE%WJX\AI`3O`=W:`'HZ*:6$;`N"'_LR6`#O`!`QP`TWZ-E^/%SGVP#CX]9U^F?\!SPJS/];CAQV`QKV@]HR2,B;Z[+L]Q;]2'BITC M`^?9FN9SJ'[\AJ+;)$Q'L),/Y:8XGXO=T!E'1M>R5^5A2R_V\U&(LB'%A@%5NP`_][<<%IH`67^`,6CF#PHH^5")@DH`RMH"* M1'T-GZL!>5^M,+L(5@/"N@68RP!R@+D,8`>H30!10&T".(-FSJ!HST_NK;HO M&W3R;#><1^*\%_\A$H>*/U3\(0R'BC\%;`$Q>%_R]KY,$4+>#K.$_>M3Y-:L M>]=4R+/E4%CQ@I@MK>%L/U!=:@/5`P`?`!Y")`Q]`W@W9`\S[ M0?8`\WZPKSC$"?L(`?85APAAE0-4^M?O_$CB`D4#@MI\&2)?GWX,O$J,$"_T M9CG/:6"@B3G:CAY48([NF*,O@04P!X<`9,8P!8,SFG0RA8M M]QMVSQ]]R588:S]DGU$@V/L6+/3!CMI<-]2]6^Y+6,_2,B+V?7+? MH_PV5RAWSR&\EQ-96K#,/G?THYX(%D[WE_+`CMBP(Q[B>;;-"H)OL+)V>G+! M#T*++GAH#KFC#STW?2FT0<\-U-=:8X[JF!V$/[$Z>8TY^D(<.W0)O`&\T;.: M`&0M4&:@FTOZGKWT:XZ/]_8]F.-KDSN@9Z^/<0CO'`)Q"'#)M;B$+4OGHF;1 M,SOJ1VT`9O/I!CW[".-D[1?;,(:%6F!K/>I+X2+>@KX4B`2IX@X*5U1".086 M:5+&%OVHO\`\4#\B#9@'@D@#LA0(."!+H9T[^AYW,%5-A!`$"I34,PI$(_WI MJN]+3RQTU4,G+-1+@3*@7@IL01=;T%OSX-[">UJ@X-FJZ)^%X-:J>CYEP+-5 MT9X1BZMNSBR;4VPY2*C-N76-O6O!Y?3@B[T=$&-F$Z7W$HC%Z:(K'"QD`B! M*#>B<".(\YO.CRU?@9)H=OX:X5*P8H,P0JP#;`-?VRS%*S(]%56YL86OZ'H-@G3$?++ M),HYM[,Y*AJ'W<-<^7(31],-7Y<9@;]"]%%$>:!$^ES@W;UJAFVL7&>5"7\T M-$V[OS^X;>K[')D)>L>9@TO3E/]]D#RCE1M^B9-X5(YX,&*&(N.Y'A8OM**( M%FEEC2:ZI)7=G@D"'.8#'"JK.KNGH(Y!75T52/,B0T6<(2*CE3OU&X$G2(?I M*8KUE,UY(:1_FUAAF);X_9)G+R_B$<:P/7F8C%?=\OSD/"]'XP+K(<<6O&R] M[.'G$`$L-0D=*`'>4C*[S+$=Y+D5XH0CC\G`YT5D)\B07Q(!S%;$XA_9`\*6 M(=:EU1UC[%FRM7_*`9Q3'YS3M4K2,D3<_8JXI2-)3;Y2JG=FEZD;OZ(L)WJ. M>`#5GJG&C='VRPO27CX+WJ!\1D7Y;%D1/2N?L;*[T8$>$9I13EA2P\`.29<( MB#CO/J%MK=R\5^C[$UE"IAW@:\FV(JR'? MAO@:^GV`'J#?!]BA>W:8JF[QA8/N68)[DSY(YAR9-OMV1+DOY")]YMWC]#U? MI6G^AVU+@3E;E`1^PP0?K&@,.``[@ M)3[@WGA[XLS[8#445CS!G4(1%7PLE6Q!0[4*2L50`.N:#_I>O::P6QEH`1J@ M@1U@%IBKR)]W2X&XNK[FQV"1N5G/*`ECHN^N$W&V;>>`L/A0L7/D"L&:>,A; M^[*]7P\-M&4/W/>=_GI2!^\+84`='-BB7ZN(N#?IOBSYZ8/==-NGQ;VI<-Q4 MU0?KH*>#"4)/:(J"B),&;N!Q?QO>&0'VMP$>@#H5=%Y`G0HZ,&`F#`@#9L*` M,^CG#,Y[.GN3=$!/)^0?_-8A^+=?GHL&/%M(?V)N+EJK(>:FP*M"_W=]#6_K M*GD/MF<7P;I*B++YZY.!^ARTWD`=KLM,F[8O67!KOKW[[`3/ED-A=S:X4FCX M!K]Z4790&.J@^9'$!8H&)"S,E['R]>G'P*OD"9EX_QIJ3D,%35S2=IZN4,HE M;40:IZ&%>X-G(4JX@J'WP:I:GD$#`^-A]@MLC?E8E8MYY:Y!R_D,+O@L2HRU M+XDEN$'(+9GTS&Q;9M>@9Q]A'7<==>^A^C)?0G43$OO^J.UY$UK9@OYY$^XM MO>>3'&!E-%@9N&@P7/#8+'!)"_N)`87`]F+`'/PQ![5]#5#"AE8).KFC'W5K MX(Z>A1W`'1!W`'=`GPMP!Z7^MH@QN^8 M4:IC=A#^Q.H$$F&;1';H$G@#>`,Z(Z!&`)T1%'%)WVL%/>E\[@MY0.7:_B@)M%O.X+S$'WQQC`+`9ZY]YZ9BS[DGME1W[M]Z>^Z M@=@9&GGHY`Z(ZGM1A>?"K4,5OFNVZ'NDT:>^H;Y0!O0-`6\`;T"Y$'B#/M[H M1X60R>R$>_ON6RK1!SNBMGN&>VOJ9ZL+SS;5KZH[[U$M5-TAKH5\N#?NN)?) M:Q\LBMH(%TK3$#13Z8MYJ$V[^+[R=^5?#RZX369Q?S;(,)"RPL5O1&`FW8C" MC2#.;SH_MGP%2J+9^?(J+&='SH:E`K`$6"Y@*1\)2^4*L+RMV?)"F)RN&E^6 M=L]!>*!$6O.X\I5B]_2W.UVV6.QY?G5OA7&>=Q@<<]G_)Q@@SY)1'%;$M=_"-[:-@RQ'HB M9,<86PR5U1L!1\OZP:'RVOF7")5O:V!\"3)1!W1TC8XE$EC3]25(X!9(@%(U M:Q1R_2+]C4EH?A>_HN@VP6_W'#\.4575SNW)E^"_T\P9!OEJ6/&0!1$:!=G/ M'#!S=,G[<'DO@I=U@??+B]$`^=OD6Y:&^*'W*$=D>L+"`R/3#^F8"!GLH!4[ M.$@+8!Q4&L?\['M\4[1R_1?\S%$Y`B-BQ(B.>,.YLA?/7]$V&&O;QNJ4>9&. M4':/AM4M\Y=X#'%<.Z:W0_9@"&T9`KGGE.]0](#"ER0=IL\3,(&KF@!YIZU2 M!_`S%[(%;Q"R]2=D6]9VOXSUDB5TJ$"`)=(^C=#4]`=3"33,)U+0>E?W*8M? MPT(6EX@IQ#E-U=M#1FD'PR`)T>`%H0(;AQ5%E32#X=)LO3W!_QBG>3#\G*7E M.,>W&)91G#R3<_#SXJ1$T5?\=G66M`C;R>%7E$WN@L=?6"GLX:P=84W#[49I MM8C8JH=9/ARQ:^=?K(=9_BY_7Z(S`"P`=AO%"LJ13??:-;J;E_L&<:!19&58 ME!F6H)/F1.PD^,A>5S.R:O7ORLGL@6W/6!=AV+;!,MW[5]<%5B(O4#XURE\A M"N7(6$R]TNJ<$^'BC<;#=(+0`&%SCM&R9:P`EGU@(?'+X`6[83O(4>2D MHS'6`:/IW5ZTD/!CUV![!I=3@Q`@%K9#D+K:>;C>@2,Z:BOM7/,0>7:1=M"D M>>!Z]O5^C(\'KN^"ZZ_GY<6#YG<^H\1!PZ$=I_DD+]"(MU:Q+>-K4;^BM%3S MO@JC[YR_PX,OAT$VF\_D3+W-PV.:MQM2^6T*GAT?(+(YU=>GVR2*7^.H#(;# MR>UHA-/$+`Z>O[SBVJ/]/SQW4PEG,='Q!41P&0X[@,SOA5.%=JD]AI^QK ME*\(OV>EBJDY?']PVT3=63U->M7-I$"O[>OU6BT?RK'N&4B9\S;;C0(.F'O[YMY&R1ULO7PH9^*# MY?WX&-@/K^7/1@%#L,L0;>#C-HG(_M5'8^1'$I+?$4U%BWL,F^[!'FJ.%,KR MEPF.E`I76#IM(PHLGR$*BS(8?LNPT64%@YLGG;C[P[:A]Q85)+O%HHC*L.B% MQR');L-XF=?_J3D*Z)^/'.3<'!5RD+XC`.*"+N."-FH3IV8>+'/#R8D%U"B@ MNDU5=;N-R!$8@@6&:"."@"I5/ZI4+4VQN_@>KY@Z7]%M0I9NDO>^C_.?39_R M]=["%[*'K8/OF07A^F;&?Z#HF6Q&AG)\;K"Q5NK/%,NW/H2BM4O7-D.[2\-@ M9:U$M3Z\/LE[(RM&&5P3O4O2&]\(;A;U3O`=\2K-FEJ\1(.J+O7H'9JN:P#; M5-VSMH=Z>T4P53!5,-5].Z$>M['D54Q5`5,%4P53I;W__X@E_H=^P>!7,#[@'OGG($[NTAPG+U-@+=G7_ESO+S@S;^D')ZX$1[+6Q]Y@6T3ZOVN]ZI[K[_S'&0=;7$@1/ULS%%!\-ZG5._2,`%2O#H&^69%Z@SDJ(B!A+E^ M_(:BAQ3+#9_%'W1)A-HX1*:]Y4E9++A*AC/7`QU?WWT6N(L6$DP@$L9=QV7+ MWV?T+/`'&29;#KC$[+Z4;P]:W;D`K7QZZN)AO*+WR@G>/MP>('/F<7S9R2?@ M7N#>=I>J76(*`JBW[0D'EIBWC85U@&)`<4_B!XB#(0ZFD(T/QC%,4O1!R]"\ MPHP79K#NWO:&7T&<_2,8ELB>S'_\`T.`?#%SD6_/<9K(",:S"C",QX4684@1F9PK\,^+\H_F7`?WOXOTN39YR; MC%ST6#Q,QFB>X?^9%BAW2_3W,D'X&HT]+#8-K4[MF\?&@5YET&NW>M6NOC$E M^"OP5Y3ZJU8V9H5*#FWXATH.6_B'?!WR=1[PWV>P`C(VOT3\DF;%PWK*L]:T M>1CM@^R1 M18.F^;'I<[=W:D9*=74Z&J$LC(/AMP"_YK9P=_)#FIP*&('&4/2%T'I\TS_[.C#<)MDZGD M:^\UNH6?!I,DBD.R-FGUA(V%&H_%8GG`_.I9XLDF(+Q=?HE(=QKH M^NA1,@XHJ/II-D(9+V75'67-_0-MT_ZE&\GH8%J-IQ)Z#TO83;N10KH`Z0)+ M>YY">-)5F?4*'TJ9!AM?@DS4H;0&I;5S2VNB?OFD2/E[.13$&_PGI$;=3@+H M1WH@_<*IT<7[5("I>LI45^^5V[VN4_R@J$)4HB_!1%3QE3I[\-JSNG/+"%N, ME;I>DRU_D(5:`EGX(DJ")'.GY&U#9-Z2C]&RH:L+G$L*ATIN'&&/=*Q\T`S5 M+9&+PFJ,HB()"G^*WC7,'FD;2P"C7.1.O2OC8EZ?A\=:U;A%DT]]SL;5H[@* M],FA?0+?5`?H\VOQ@K+EHSPI=F2?T''!JLT>TQ\''K<_ MVH;^FCYI6_L@5W4!JWPN\T+D,B7>.D;F]7QDW*4(W.EV95S,QUW']L5QJD^) M%WT>F>="7L0#WT+]D4%+/:;^"*N%.-8QS.8SJ-ECZE70E<.Z%SZVFQFB9*[T M"5DLY?H\/):"ZE-OO"ZLON;>FF&NGANKA;4F7%LJ]$*R;\=7WWF)I^YH.K=? MXKX[NSV,[ M:]P]`Q$)T:2E$`T01#F"EL(VZ4IAVWFD,C\+"\=-R\?BJ1Q:824?!J/X8X&Q M?_0](YB&S[X!QU#.,=1]?JTAF0168I65:$CV;FM``9I81--2""1?*00ZSV,! M/*@A&QJ\UWHC(,0_E,<_+;BBTS(L#56SNC(B?W]PVU3XZ3+# M)*LN*J=;>F< MV1UGAY<>0F[9](0RCQKO'.>I(HGZIQ\#]X2[AF5>I*.UT&[YI6`DRM'+[*'[%>E_1#+GFSW)$6@#3E:[[0\?Y'RMOLW:KI8>X*$E'<;+],5/\ MD)?.]SYG_6ZS8XL1[I-14FX$UJMO,L8_GB#[:32Z5:W3XZ?*KM] M=QX^-MZU+#+T_&GX>,@=R="L49H5\?]4P?_7)Q<]H2Q#./)_14F)WDUM^!X] M-<\!GKO(9M$9.[W1H);TH@?X"XKB,!A.4ZIW$0KC43#,__;^1GM?DV\0%C>2 MKPB*90F^:MBJ(KN2;8N&8*J6HDB^K;OOWY%!5\.HF$$2ZO]^^[A7!HV22I^" MQ8@C/(:G(,Y><1*%\@*-RW&&PC2+4)0FP^D:EP@]%M4U^,[;Q+IU>)8B*[(G M*+ZK>9HF6ZIG&I)FRY**1ZKJPOKP1&W;\,Y[\659X'SO'I_\G,3_@Z+;Q`K# M(@!3S@[!=3H<, M=J>PMEQ;"WQWBO-L*>P2\>RV6!\^_E428J-WTKS(KQ6);<6AYRF>HUJBIGB"I#N6I=F> M(?JJH-N>Z+O^'D]QS-AV"63)UTR37R)E*\]1D4_)DCB>I66B^!C.9R)GFHG= MHV&]4.HE'N>M`'#5X8JN9TF:)PDN#DL=[!QL@C_'Q0&JZSG>NAAE61/VR/&R M(KF*\%T<.@_3,8H>4/B2I,/T>=(4IQS(HAG^S30-&$QPF#HB:^+VR%WU+`Q? MPU0]070,214]#%_5T`P<0^NFM`%?Q;R6U!MDT:7,#]P@`0V'.*K+R#P/V21B MC[05Q?*Q;W==QU!+BUQU(WJ M.LYR10TG(!+1!)$\)AK5VN!T41*,"XC^!-E<11V59>&0-4B>X_D5[6M!4DU+ M-7U)LWU9,73%L$1I2C:Z;HGR9CJH7DL)C1+9)?LJU\2#(#)((A+^/V?35Z@* M1EL2&WEW+503-,&R5,.S#4]P9$T2;:TN81FZI#G6ND2V2^*@][O"`)7=`Q0< MV[$U5Y-/(<-W>$#9:'K3;8J;VSHIK*3#.*JS6Y*7 MK.[;5._1D3S/YC2.GONXBY_0((P1:WC M1,$U9-F5?,O6W__^3?U7_4[-SUB\P@OF(10GTW9$+&8O+[!D"C3[.ZJKU>G3 M[-0_\;OY<8[3R'_AI&9WWNRT04X/YD095U0\]/L6]UD]VV(L;E' M>X:B>IHC^*YM:J+K2I*",RA!-%S\:]OTU77MW8@KKO9L66Q(=7;=/]/LYU.: MA>@>165E7S._,#G:[%75%G``9^-`PG-]QS(<7S-$/'3-EAS9V3![M6F(![S8 M)0?3GJT?-L^)):A(LBD[IH8]GZXYV-H-P5),6Y==4W$N+T,R#Q'AWV!`DP+Q MC!5R%V7Q*Q[R*_*#."/]HVBQB=%NVYI?8$_F/_X18P%FXL@JP4RJ!S7(0UX.#737<#5+=&W;]3"[FI8V:^+017FE M6C^;I:OF29;DL6-`9XQR.ANY>NV1 MXR!7E03/<63)]@3!)Q'4>> MZM+BF9MS$A*F]QSQ.M7V0C&R4H3@C,,\IST,4=6/@\Y#V)KA9,P4O0% MS[=-V<+1I.%;BFY*%G8`NH'YWW?=C3A^+OVSY,F,7CH++$5?4TT!$Z]JN99E MV;*"R8CHQ58T01$VRJT]TTMG,:9K>I9DJ#8.#$S=T%3#4V:<*QBZMAGP*ZND MQ99ZKAROBSCF\#S5$UU9<7Q!\6Q]*DM5,O2-8A,CLN2EPJ")#@X$#8@89>@X8#5DCQ+NOZU" M9G[(+.H8)7FE*3?.4%BD65XO@0J&9.YJ-S0?XF*(OC[=)M4BOC)8)8K9#?=U M:0N>X>@X\%8M4Q`=T=9\93ILW=$ML;'^LQCS,:.9RX!\<^@VR8NL'%6`?45) M0/[&B6Q,]K_X$B?QJ!S-FI:]-W)?1,[+@F=T3YZP?](H0U%L,>CJ&RX^BI&.\/O$X=(WD;=WOSN2@5-,%0<1V*)UR1%%Q]!D M53$<3UDMS5.H5._A.2VU9G[.C%TL* M.'`E"X8L2=05Q7<4R?.()6!7(VN:+:T/3U.UU?%M?8_3WG67*Q0LT;)4T21M MB-72'5FS9J[;EKW-YF;=5$]XV3A!T50]Q#\,QFF!V0O]R#$[!\.0+&VLIO6S MUSA$0=U<1!B/M,DLJN"S'9#(I0W+Q90E4E]_8K[T[9^&HRO^]`<>,5FXA9^2 M+[>7?'WZ,?"J72!6[[#F4>[)_/_*#;\$;X3&]_D1VQ(]6])P-((]M2O@R$FT MR<=-/0W_3E*4!C\B?!`40Y^KXO)B!B7.E5C[XGU*]`7/]371MPW75Q45YZT" M:3)2#=_$0;[1%`Q@)0JJUHH2RV+R#64A/J&.'YH6"\J;TU&?4?J,7TCM3 M":6Z=3;Y]V=[61++$T^F+EN6J[N8[P3%54W,]>HLR;%LLUD.NC@+C#9>]'IC M^#'8-@9-UFW7P!:H"H[B:8I.M@:8CD$U5XI$BS$HJKQW#+.)G+R:5(X?2^*) M/I=!AJ,_1)8Q$CT&R>0A]>,WL@"<+.GVRR3"+BQXQ=HG:[-(6_$KVIH\;-_F MP+,4Q3!]6=<\T9=$!:>25QC_PN^^D`D.;D-LLGZ:/2%BNUAV M3VDV(G&PC=T]V2Q-54V14&79KF?KMBZ MT9`$:<9B\*>\Y'R(\W2<;'_Q6"Q2=C]+1^0SK:3W$H%NS^= MBX.@OY<)PM=H^YJM%%45-0P)7]).Z@F M:52RLL9D7XRX[BB.GU].Z%K'=BJ(DF^HOHJ1+#BFZ=O3P-+5+'LCFI&WC63+ M"YWU[GLR!5&R),GV5$=Q=4%1-!%;YJQ'07>EC:A14EM\]ST!O6[8EB$;.-*5 M7-TV'.SYYG)W96\S7EOOHO&%57R15/TR6R2[ZB*KSA3O!B&(V@;$TRRM&:W M1[P\9NPJY9JE7G&R6?M:7R4XP\WW734#3<6.R!(,SU!$R[5TLAV$>LGQ- MVYR%65W1>N!;+8TB0J,$1YE73Q'>0]2WG/_H;T]LYTW_0,'&$X*@X< M;4O&0O$-AVSF05;\;JR_PXGEJB#V#>S_LW=MS6T;2_JOI/*P;];._7+.*5?- M]:PJMN6UE:3R2%.0PAR9]))28O_[[0$X($"`!"22DN/$#XE+ICC=W\ST]+UK M#%Z!=GEQO>41J\R3S9S4M\O9?#K[!'I2F<^>LE%F95%8OW'Y]7CB&"8>:2(" M'#XX2Y1+5\M0Y[M!UWPCUC@>",X&Y,5J5;OIIU\,_,W??_Q41@;*<`%8)*F/ M7X_Y0\VG)<(OX+\4-2/S'.YX\-XC8FT('AD/QJ'5Q'IX+^"CFXJ.L8OOHG:C MLEYW\WM<1A)V:B;8%O)%>AB-++:/,$$<) M<:;6ND"V8P],T-`L6<66N5.[UU4ZN]\2C M57"2!:_`#HQ2!U=K95)8U='*VI&M4["PP6?=!">_WNNZI-(XN2SFZT-_L7R] M6);G?D>OP:Y*W;Z'QL$CA!5R`:Z@!255UUG#"A/2-`\VC3LS_X\A\=@,=O7N M-H,RAH`\@@<"!]"[J>4T"QJEP?C]ZAD<,GD5EAI$J*22(!FU1CYG/RN.A%.G M9S#\W_WD]GS3:G9U/O_YU]GTU^P]?INN1>H*6>G_*=W>SU:5=R'533^<9Y!# MW,#3P:4(B&$=L,GURQP4@>:I;;7)Y6VV#R6\1J+17J[*Z/T1=+;EYK?ZW3A; MEDN;15">(ZC_`2&>//@,@?J\9E$(*OO"N7SCR1A#T('4\[W4H\BM<%P:K4&J M@"1!F7H.Q@SOHQX]COJWDU)XKBX7Z\K[37D@J,?%E5W.KFZ*NEM6GW9S,;U# M_`7B^U3=VDPHO^[58M+7=4`U+7X!,B<:T'*L#SYZ.+-8"9)4`,H8Z=B>&K?5 MU0?RM<%C?6FOJ^8"6<$NW>-C;AIIE1I;I9%@!&Q.4`&P4CS?,^$TX[U:FEA' M+/81TJ4V_;CZ(,B>8G8S[R%XVR(Y+(:0UVF$#_J"!KNP,9$@SD3@2!*+L5?8 MY]H+(VF@O=A0NH5-/]O;\*QU6]C_]Y^*^569(I"1XD1HJ;Y*1SW'O1BP5N M8S&&QUY<+B?+F^(.KLOB_NZB$N!C_+9F6?W;0^]$#`Q4"*H=!8V)P(8SD=]; M4/:U[>&5U&TXCTAW#Q:+Z\L%O&4-\;EESBZN5_?37]_#"2A6B^L`.YZ,J-*C M?$"?LQ$]JO=[L_$9X^CJOG@]^8)YBHEV3QMKFE4"CIL(@7/-C+;*I@0,H4TR M3!CS_<$G+07;WH-#\/J&X*=G8-:4\"^GOV*""-V/OR`.(TN<)D%&#HH*O`T5 M_H%8@?I?!5W.8/@;_U[\E>2;XT_8?O@)Y];`T:>.6@-RUAN#*OB3I]OT"2"` M7U/Y-_R]\+,$OZ_A9P/P6X#<*A`XPD?GP.@R05;P&T:)ZG_WM=;B;_A[X1=G MM(3?W-^DND=86P^('V<<5U)J'!7"@:<6V&D#+$(.WN#0OP&\^P0?:P.2KPN4 ME?(%7T<1'F'K;A0,&9B,EB$5&:A22A.4^\L['8)O>(,?N/B&Z*YAF_3.?ZN_1B0_(<>FOX%,TR.W-@1J+]^_)[-Y=V#`F/`OUC8XSSWH M*HY9"L93O:=&TTX._8M63N0XH@[F82@,["3S6%/ND9"@?!DCZYP?(6TG_-(. M`Q^%A]:,D7XF!G((+)$@*:@F!DS'AM'*BX$TT%U(JO/Q,50HC"'?8C<80'F,\/8Y@'QEAWMP8`WOGC$KY.\8H&H,E"J1AYD@IKCNGM)U--4C/ M(90//40:4S!\*&8>K'JKP02J\P!$")T&`^UFV<0UR2'`16+M!."HM\ M,L('SDI@&HP%[$#A\MJJ2&4=X351=@D_)N+Y-C_FI(`J+$%C#,XFK3@@"C*V M.BE$:1&ZP]B&Y4V#G`/H'C@HW#N?2HAI5&ER'.A8,;_I(172[>^,;I5![#^Q,6'VW7.S<[Z MBM)JI^V87,MJ#LQ3)AQ86T)))R*JW=8J2M>?[8Y8D\.C$?Y4<+#=<'`'9G9, MNG]2I*..8'76B>*>]CO1$)7\3PP'WPV'5QHC@KCB$8`16@DS%'4`3T/ M',OB;O+9_9KB)%7RZOSF>,Q!K:`B:$()J""Y[A.G1...[L3:!M@C&&N@TO)1-;Q7I:\C?)Z6+6J? MP:6W*`'(5%`[O% MAW7V[,7U^_OI%"!(JO?BMV)ZMW$,GF)8W2;LO,G,WAX$8+^\GORV6)9%%BU$ MS^=`8R(VSQ+:]"=(%^Y8)8K".V(14E%Y*R.S4:9Y96#(6A-1W%$1I;(,&(?M MWWLQKM*0@RD-KS4-DELDX45*_3W+O;!@K-G^!%GUZ*U(:;/OBNGD]M9,I\O[ MR>W3C^E@%"DG*/6PRQ8>'L134D4DFL)!E%W7'&WKZCT\U`RNYW54EG9=D&*N M?KNOLE(O%RE#=7ZW6'[)XSM./K;9[>^&GG^Q>+.8KQN=#^#G#$?!6"(%YRH0 M1()T"AD=J+,`8M=D:/=H>`1P_3N!8SV_23-'4W?3WR6U_0<&^:AV#@6*N M<;2PX\X$'TBV'3@H(QWK6+7=FKN(>`25>WM_@G9DF0>SUQ&6>H'XW/-!"NM4 M=YH,:;>7&4%F2LN9IE3J^4T2,LO?B_7XF,A59[5^O!0TS/"HD,I%]-1BC5AE/'U27"`1:=1UV,0Z#^B M9KE,:D%I*WW9?&2=\5F&,_.$W)RAMRK9NP1U=CUM&)Z%5%-17%7)S+ET^7+Q M4[';_5:[1BL7WI9HUTM'>KNX'>E%3;RWRWA(7C12&!2ISKBBE'#4]Y'7* M;UGQ5\'Z3$C]R7:J=2FV=NO=^Q\'MD@S@:R-+!@<-;RIEO"UTT-J>'K[VH43 M)=5?:8]^+E))Y:(U\T\)"90IDF)1@EH2P%++<9N8 M.@WN&@:OY1G23[:/#\3QV]GB!]_0YMY2QZ+0@07NN8K61\_J?F*!1[-K;T$/ M/A/\V]W<-0$_E:LWO3PW-\OB!E8^3\U*YJO9M%S^@4VRD$\>/,]#%#B-]ZVE MHE)"]33T:H4LGHJGTX&XM9L;^V2=^@^&],C)=$:XJ!C81I00L(JTLBAWQ1:< M\%3ORGZAKS'W)\)N)"M'QG)KU?"Y6$YGJ^(M7/]1M6U-">`-4S1B)(Q31OF( M)R'U,'8[?CDX@Y;^E]5,N9K>(OO_485!H5`@23%DE MD2&<(EWGUGD4RU-W(#2CZ3T9-.L-2+&!2D<:%G)-U0\CGRJ5-`95/*31=Y[G M\!\5BHD>U8])P@\70K@QE_4'CB;MQ0S;4WJ!AN(5XSP`$CE^`_7V[/3 M&K=4G&%UKF55;G\Z&;N^.(INPQ>"ZH\DKR`*JMK!UKBME(>XYHZO5U MZB.ZX>CIL-NGSHQ('DF]KYT-+C)A-$VIU31GZG)F0\?%P]E1-)K'@IY,B`[#)T,NJKHX]&X M24.5C)*!Z6)$RCNG.+=()DK3OHZ1&-'3`==FYXE0.Z8%`U8+2SW.)#9.L-1N M)1N!4B"WW?6MX<.@[$S2IP#U6?2CAI5ZB+,"4V2YE09A2Z/AR#-3YRFF1ZD3 M)*?TE/)R)U=/@>,N.V@[QMR\[I9'IPE!'CDXE5$X(VL7N+*A[[JGD5Y/`>") M[:`1P.TS('GT&(,\E$(9)BE&-@.G$!6T;\BJ)()]6\`]S(!DNPW(D-HQ6\8= M0UR!!:EB=O-(P\QV.]B&`:G.V*%._,/8_/I@WF.G$XR#%ZDW>4#6HE0HGY4B M8PC;Z4U3\@S)OQK,!SA^M4N5AX'*Z)DDQEB#94VX"D#T@@B3"IFX-+ULE^HT2>4C%Z--?/N`^/40N"4!:3 M2*/F5@06D"'9$PKGN-6,I%8+$'Y.W$^L+0P3<+37S$X0IPQ3RAGKA[H MRR-".U\W<4;9<\%_LD=O-=([?HB0X8I%0P%DKG'@1`A"<\^W8%#L=@\0!PN9 MQ['U)$@>3W_`'EDDJ8\!!TP)!BLM5VD&+:,J0WCZ-2$'J`]'YNKD"!ZX/D;TC)]*?#R(X],!_^!'XP!)@T@4Q$<#=HKWQN,`EGC=\3L% M<4I+!;W&\E2BYFC<#FS(9F3BNV)RF]N2YRT]WE0>I$6J5:=2,L&9=E'JG(_H MD=J.A6_GDQ^5]J="9"!0:%0(E!CAX?&W1*9:EGS7(Z@//5K"GQZ1@2"?`9-, M>992PU-!L1=:U$$^L'F[I5TC`M)'0>3#GHO]X;/,EF-F_9W75= MP]D>35^6IUGZR=LK-^[IC8).(13?\-1<'H*"4<0(YY MC,C64QEHL'T50)1MI1B.(ZS!S'K"3-EJH))T=K%<+OXH"RP_3::=$K.*#3PT MUBI]:>KRWQYGM6"(&N4]=9V"RQ1_I.Y'\')X7QO M6D"TOJ)UYE/S]_2*3F[?3CX5RW7O]4'AXX/2DL!1APUWDFH:M!+(8?S\+FJVL]60D>./F)JBC%6B8B<9UIZY@DF65.'D\O[$BPY MV>17CB5LPTD26JE70G$%GW]3_-$_A./HS4D./]E;D07-L#2Q>C!WT> MP]E&QKGN$,FML7.[46@"=7U_^VIV7<`YG]U5VFR2>?=W<'`6UW<@\L=T#N8& MGI=`<>I%#3M,F<_#G)24V*!F+&G4FC6%/R^6_X%=GA;U@+54B=MO&NT;"1EC M^2I*HCV62(BH54Z_\`;33O%\N\?##BH>167SV3]Z*P:OO30"264XQ=1J)9,* M@+AQF!@0'SN.S+-R>0$78E+-'B]97&W?JCQJ>S.'IOIYQIHQ3$!.<.^- M0SG_.@US[7#7[F/Q2.YJ-]&.TOJAV(90AHK4>UM;:UQP(/"HPBKB%(<6MI.( MRT;0W*6IY.*JF/W#`+!7"=QX.[D9(=LL/%HQH*"!0@*$!D2S;!..@&WS\AIX M*O[UWYTOKY=TU;34.%O!%OY23)9A?N4[G=+Z5T^3U8Q!J4Y:>QJ)TSE+5*6& M5=^_?/$"Z1<45>OO6JDFQ2^FI=Y>?:+2T"/\;(]KI5$G(1++QC"5"NT]\3'+ M4,4B]]^_C+]49.Q<90<=B=*Q5-`TB)5[N+?!<*%A4U16]K%7J4M]^JT^.NI5 M.E14%([?%>&Y@\-J4<38:`-Z32[#D9$Q+BH:FAO3NU*'CJ0SC%A>>8JDU8'& MU//28&OJ*70J&H*2V'KQ0WOA]-7U>F%^ET8L%YO&_'[^H=C3VF6S,*+1 M!`K/2F#$<^VTSD$(]]@!V(.P,,EX&'["0JB[+D\KQWF8#0#$5G)$6T7O(VN:@NG;OBD^ILS*\ M9"#/QQWFX)&,'$GG)5(83C.G.0D\@)KW_"`W2R6 M8[;51&\Q=8[2F(9O6J1D/LXR=:KY_N6KU#'P.S.=%K?IL0:SIERC25EKT2V" MWMY_N)U-X^UBTCL+FS0WLSF?F%H/+YAA5#(P<9PR)+<<2(-#65=K@[,'^R@) M$4W2&LMO$?:NN$ES*B;SNS>3CV.N'@L@=2BQ(`$LE1$%4,6S'@D7`Z2/#>[R MXLUW_MS]CY!GV$QPN'7 MFH>4>;A^HXB+]ON7;Q;-Y;=6V%K_Y^+V]H?YX@_0.2>KQ;RX*JW)Y0@ZTL1A MI2TUQ)N`X*T0/C;>2MDYSCN6*@F:E47__]B,C7NS2.][[KG8F_8Z;MA<4JCB M[//_LW=MS6WER/F_Y-TI`(UK'E(%-(")J^:V8V^J]I$CT6/5ZN*0THR=7Y]N MDH>BA<.+2!Z2=O9AMSRR3`(?@,;7Z.ZO.0(VVQ3;)7M4585X=$CH67*SIJ*D M-R%((THMLNE[`&[)K+=,8^"IOJ*OW@L90(E&<8>G'.CK%.:$2[4Q@ZXY>AN31&M?'0GPWPY*]S)@[.2[;N_ M1I]>>%%]GS'MNI_,FQW.9*5N9U[:]./-IZ_WSVCZD<[*7XO?V[9[)'>-)28" M@EPM\DFML1U1L&0,&C]T*!17WUL/?=TY8!76]VK53E8+&J,MVH-3`90WR5A) M%B:K)H:M8.!M9X:SH39DNHI42=ZCB\H:*%T&!#D/IHW%#FQ#=Y[J*VSH"\%& MZ:!$I8HT1-%SYJIQ$UWVJE8GVL6]L/GN9TD%=P2WGCUF9DF^5ER&W#5"4ZW< M-1"XG'E?E"7UGIRZ3*YWJL2&A8P9ERZ7%JG91#NBN!C-?RP:KT]_'7WAX-?" MO7B=?*HJ&7SF,6D-Y(.CS)UXE(@^-E+:6BR?G38/8Z^1;GIJT@6=C#56?M`Q M:`"7\AFLJ=[DZEO8^9H!MT/9=\";\(T&HQ;<)[288(2# MU'6V=Q6A-JJATBJ]]X"?[KAA`@OI/\<-Z<^WXQEKNK]>;2'UZ^3ATWA"7O8M MN;.<7DCT:J9(_KH%260UT-92+?NL2/M]V:FPNFP;>J#ELQ[:L4=^(C@V+3<9 MI.1T(C/EL12E7/W*G M\<_MK-6F.H>$$$`FK7)PLAA9BF9QA&*U-+HV?L,;+]2&6>\RP*-/KHWJS)-F M^+,>[I=1G67JS^HB?2`/Y7J179"E5T"[-@D`YS9#SG`12 MFV`QQXJ^'^3H8SL&QLF8>3PEXCH;R^1O3Z/;FP]?%KKG'?/:'BA$:TQV9=9F MA;>C<3.9#KK8<@33[D3PWP^<[R>T]>;\=><-6)0M=)N2?Y]L2I&,-Z@98,Z@ MKNV#D>FC5N?#"S8)=C5IXP\-13$%70KV/W&R#XN=M;)G<U-\9;$!%/["FL4JNCS.?#Z^-_J&0 M%0E2NI=H=L@/!,N.A^3A-LXLM_:^K-V@SV66,@*12\L]W^EN)XI$EU$7Q4-? MFY23-TY<%EDZ"+GCFR4ED"4DR#EU6L;L132=;XJEI\G+F]ZWBF\4SGW,DBM9 M<>5:)@J1BT^IV&7MFLZB912=:,2E(+;)=57(RDPZ.`O"DV42.G0)S)5L52,5 M]D:Z"R//YFQ\28X@:6Q%*=\X?5DF_2#DCF^8(E="*)F\ M"QY<]L&JV.%ILFP-$UR683H(SGT,$S=_]DYY,DU=ESAVI0)2Q)17!'GD# MSCN\;6B0^*)*^3F?_&(Z-O)G+CHSTBITW5V7E3S/$5$74ZBA1N+NQ.8SW:+H M94DZT&6*6G':O/K'*K#[@_/]H;P,J-'.IBTU68VX31NL@>X>;R)R!(T3>0P1 M9L(Z0YC:5[>9TL M96C9R]8Q'3R%C2GU5H&/.7C43EDK3(JI"QT6YQMZJ;5K_9O73J&[8:;O'];\ MV_ZJT]_&\_T[7O2MGZ=(KW0%W:A%_]KKL7]DVVY%LA`%310*C5$U.')J.CQ] M;(/P?1MB6'C.O!;KZED&6`LKC;21.[4*3P8F8$Z=[UXLMCT&I&P)RO>]&.9T MB^&5,%D#T*6:HIK5/G3BAW183%M\;-OWM9,NQNWMPQ43TWYI#RXMO9^^ON^% M)<(<)9*KAI7^SQBF%PMQ9]!Y?0GR"@P[C>R(DUE)=V)&OMPE/_)GKG*)%7XQ MHUCCZRV;HNJD(QU1`V0I(^3HA*.;R-2JBG.M,,_%H_"<`#@EE^7=Z';[.ST= MAU"Y8SJGP`>.XKNEWZE+F[OSC>R'[G?Z6]`OOF$+-H`J%EF+2FB)?TM1NX(Z MAT*YYHU#MB;CHK%Y-[Z]O;G_XX?Q/;'66\ZQN+XCCLOE'IR,M_BJ;3M(.PA, MWASM)%^SL^29/^O%NV8'V?;AXG0H;=&E,HX+E MDLQY5ANM9$DBIM`5>58K=&-2>N*ZIT-IBT@="[LD+,:\-!D MSLJSVGHSL'G4&$UQ@JR#(6-(;+H$ZQ%T@>25%LWSBS[_R@YD)4,(1)50TJW@ MM"LR:M-9R5BL:DGD.:WD'D@<8B5M],0?-7%LDP*Y^,EV2A"FZ_&__Z=MDVCU06DDI_N7#RS?=5_O6 ME0P`+;"7Q9JLG`.%W1-#$C4WI\"WIV#C@`X:^Q;B6]#*J.BLG&7MKRX8;^Y9;B1BZJ=X1YT@!:Q(B8%?+K2RT3SN@VUMIZ,$?3[GK2`(\ MF+6+VA>D&]WIPEW)JR?DK MVZ?KN2HMSG2U%I]51A.6Q)EV(M]]!7/]!_*%W&(IM6A=++FF9%:-<%8YZ6F. MQ%>R[^OXN#J_8PSZ%#"T9_MK&`JPECV06UNB8DTQHY:J&9PY_IW`L$W:R1I5N M/4V1T:*2W(](&0BA9%66I:6R#4MYND+/.I-A]/5*+`XC*^/4!"8Z?MI=BB_) M-K,6N#GK-P+#;A3`52<4<3V(&8`U,?72'CH/J:$`VO2P[MT1V)3)4$,V9.M4 M`&[-7,EBJ&58*EMHAB*5UH=L2CVDJ7!66TP1B5@5K1)XK;M4/FM*;&)L=`9/ M-)?7F@KK68@4139!%$138^IFXD&)YHQXW5,K=5[Q`@&FL@V$M"`ZH7-F'&&&,BP"W63DU%$$48BEK2:YIZ9&[M\/O+O.= M6$4;6<=/>IF$3BGX4+LY<+[=F,HH@8(1C/.B8(R(Z$(*-H=0!+QJ+Q*G.X0NA=T4YUH?%WIUKR?;P,B/=WQ($7;?]&?XQ_^?#?#^RI=?J>TZX$K6DR8/ZF?AI-I#LT MOKP^:I:UJ!%<+B5QD#T:$(H``<@9BK*K67Y=QT2Y"L@^T]R*U.2AZ@$E'U&(]3$$-"M,3W86C10_O11H1_?B' MAX?KOVYN;Y=-J$>?\[QU#^`X6HZ!\YM43PQ:AN;E M9^?9'0N3XQ_#KR.?#I3QR4LE0Z##&)*&!2;1Q;9%A%1MY//XF/Q&5/-^AXK- MH^\0G\GOS,2QHBV)KGTA(Z-A=0&32@\:RC>QC1TF=C@0`V\+?FB0G*,>@XT^ M"DG'90Y$ME;FQI$AQZ<-\NP+!#[<_7YS/\\N;?*PO[WF?>1P$U62$JR-*%SA M(H#N#5RG5B)XK/5'0\3/C4WU^/YN&O9B= MO45/[I.B5G)06?B")B"0YR&CX!0%+2R4)-HW4T6.R0&@;9O[#IBR_>4,P]5O MV-B,<[>F.#^,[W%\>YMN'J9?IFSYM^9^^:R+M+WSEG7.C2A"5M74]:D= M3^)!Z/"V^V,R.KOMEC(3+\1`1#&ABR62U2;;S1HVQ53;V.[0Q&MWG]PV3#IB M]?9^UEY\5N:R<(%_F3#Y_N7#XD5E_.Z&6,L*!MS4,UX]/HUN3XY@#B([))ZM M%3FOQOE([H>LR6J?E6[[6;Q1NGDR'PJ,/1!?L-J+@3JLOL5J+D^$&#%)))HA MLY`$=8P0@L=VLRX;'+T:ZE>@L`WCA2S*_XZOWUZ3N;CY<#-:%I5T#X1TZZRT M!J&_>[JC'[8Y,D.]R7QM$K)'KCYB>+-.$%31=`US(T+Z[]!VY)-.['(/'PC$ M8#BSKN6BZ<:?HUMV"4Z/>:X*-?=Y!"ELK&+6^Y`Q1^5`0.NU!]$391@2D^'@ MGV?ZS']S)EMY>OBCY29/2J22JN%7`J/*?,L7/@`-7P>UBX=[1$A.@SY]RIC6 MF_[E.8Z`D,$[;8T6"!'!)N_F1X!;^;71T:XKU"G68`68P58BC^=NR?O1YY6_ M_/GA_JHG$^\D*Z+0@?+6<'O68H@F%KU8$<<.;2L6(F"7UX[!$!IL:;A]^H?U M:IFG<_3H+)"!T'(,XEA@E/^B` M]J4*(ZKWH5;Z7\:(7/#?A5=;Z5)R?I\6'RY?17DU>NVA`T6E&M`%5#E?.K MB?7^L"$+OB\I9P`D!L-ZY2>G1SOX"!JB)C_0INHR\0`[I\?D);KVVC&F+Y5H M$#`&`_SG\1D85PD%%;$ML!I#3(6,"\R!SM[JT+;)E3N]QQT"PG``+WG;RM_] M^'#_Q_OQY"Z/?S\#_,GKJF,H(*SQP@;MR9S,K(I@G:,V`"&')5A;(?H.%V?Y M[_G;'A??]O[+I_%7]_??[Z><<\H^P>_;;FM:2W)7;-3DSSBT=%_7Z"W(:%6N MN6V%IV2K6?=]K.IN'7)/<]20+F\DHNQRTHE5Q>7"MY1`J].*S85!R?-N'7A[ MOO'=X_C3"B9?QQ3?WG?/Q[^-[Y[SI;G5SF%OYQ/ZR2)=X=W<<7Q[?_7B_!R] MN!?)+GI14M2:RWLL+1EZ@359"X"=B^G=/ M=[^.OG2Y]XNGJ;TJ-NF.(\)ABY!NII?MBR5')B-6;6IJM0!T2Z3W&./><\Q/ MX_"?>.M-$LV'K3S;?"&)3/JI:WF>ZK*X> M*UUN]UYT)KHRT*,8=9\SH?0=!E$R!V,@PYE5;T6,HF MB>P2`3O&J1,!?7(:G_8^]:E]NZD?2K3.6_O0`:#:"G:K<* MU]ULS2:NQ'D`C44GK%'$*5+*Y>VW0>H0$[!.^TO!5!`"V@S&9F]S["-'>,2TE^V^ MI[Z;^KW^SK):_W3[875SL]B]E'K(G=OOZA+H839RT0A?W]"FX(L7'*,Y\+@4 MN6PKT;<0\].NRQT8!5+RC@BB9%R#E"Y.1(;)J2`Q4O5WBBU M,X0GRGN:[C_=_GQ_M;YBC1?7/RPVR^O[JYOM`^W-]Q^WW]&?L!S(:,U?%R($ ML**BWRA`HFH7'Z1"WQ:!:CI/G5>5O4WV;*,^JT'?K\)B5X<^?\,ZNYV*TPO4`J./Q=\9\OZZD= M=WDJ.PJ>E/=DG9&VP[9!S@L#0U<'&/*)4?:UX_-[T-G.PLNH@TB0D=<8C'20 M>LZQ4FR3X^$@5WA^(WFHY)-5/E!]G27():&4==GW6(>8I6EV))BQ)+R?Y-L1 MV_K'DS%;?Q>OUNL_V=D&.$:K`FI"@:QE!N$CH1:H['%3W8TL`T^DR)3FX&RYTRL0@1,*A?4 M0O9L6=K:%K^/]_L74V0234:II'BC2DJ9VQO)0:K#,RN!XE"!VERBGDN1?RD$ M2!<$8=`8BL%$`3D"A!Y^-,;V-<8``N3>9GREQO]B8&CHDHLBZ%PD]V:@ZHO* M"F-HT9*3[3O>K\CF7PPE#4I]TN6D3M%6J'F7ZRD!V]RJ;%5L<*M>H]M<0$;X6Z,DB"U!.,9+SUAO'96$'CP@.3#OS MW4)/7KKMOQPTI9:DR6MV=Y%,!FE,J?B)4!&`-#3U^5=D\R\6C35([R+%BIE4 MB>2)PL[FI<+[M@\37Z'-7S@@8,5Z2T$$X9/,R?87:8[KY3)0&+]H0'BW6"]7 M]4AW78_LTF+WY\%';62U24"ILBC6>QUI8P<>::1LPYQJW[8<(M\9%9LY=4L5 MX]%R>X_&1V^*HL?3B>Q;8L@W0R?*7T2QF0,XS#X+T#%J8W(IN9#O>G^7N-%O M%-,M"LCQFJU^_75YMSOSXL]WV!@?GK]6>.R7'\L]+XJSB!0#<=-H31UU?V@L MG9#/JYF__+%9_O5V>?.?W]RM[Q??_.4_CI<#/Y$C.K3)!F[8Z\V"SV2QXU10 MDENP@^6HPXVK#_](R]^6UXO;ZQ[%L5KWW=5R`*YREOZ1;50[#RV"="E)FZ/H M?1?TLY.U1\!)^9;0[8S*#-'XABC(U^XH"_:*G2&DN]83HU6SV?M'Y51 M;^7G5V:.BI$P%G@.D,Z[#1[.&%,"X,EJ<1YEW5^OOU]N#Z.MMTN@^ M-WM<]:DB)HOZVI=S&D'@4%FDZ`@\[DFC@P8H0A3%L3-*D7WI1F1LC4U#;*3GE/M_%C>SWNFZX^ZM/*_'=_?!J/0=B:P"B(A0Q MBZ@E!)=#1WN5/#D8T%UN"Z8)Q4<5FK;##L7L0)^3`!77/`0K("DDH3O,?\O> M"&%`?@!E#&^M*15VLAPG[Z2OJ8I,X&V],D49#$5)O;Q!P!`!\.GR'G'Z7XJ" M+",%E86R7(_%T!\6A.Q;6)&6#>VY``=*-W6DGS4*;XM!Z2,@%9:Q.UF&F%OF MN2.D^^=Z\[,*Y!H MQQ4E#HRTC\MSO-QS[88OA9<:29R%J*" M*`=/(0(%IW/7)5FIQ$`ST=Z$[BWVAO^U(G37DOW'Q?JWY8?%YL?5S5X%\J=G M%=(;M*&R96GN[HRT_4PK=Q(M\1"BP'E>1U'O03*+RU[174LE2\U5,^+`NXO]I:[?4-'; M;S=#C.(S?A&L%10QN"V%FNW9]4Q"JG4UYF!MZ+NM3(0Z4<,8'N,HFA\XI MKTOB7M@5WPU]N`KUWDHX5#J=).',>MN0%&)A^\*B]O%Q^7=P8L>G7`:72H4M%3D1,&^":AP\2W73"OO MM$BGB3\W'9:SR8%]-E26VU M,5!L3(MTFOBST23ZQ$F0NY*48N".WH2=[\0*%S%P>#OJ^B\B_HSO*)&X_@3T MCH5G?\G%=FD\Q*A:6D9LBX_#Q=^5**?[CD4.?4I[=,0M5>9>$+NJ6FC=QAT8 ME7Y$HI.$G_&<+-!)4$$;]G@./UX%W'F.5\FV8^BZY95]0>%G_":&F,"Q\QMA M$;2,,G01WREN'AK+#[R_.%CX[<%0A118?3A'UG)>&LZPV6OD?JQP'VZ[TQ_' M7VN\YTT[9+6/7.?09"Z!!>3.!XM$Y.8!N2[/#T'(EZI@H\G`:/KG4F7&L7Q" MBS8YDJ2+TCK&CJ+=61R:1AQ+Q0=H4G%`CGHL2AZU\UH9LJ&RL0L//3>F4RT% MLVJ!9)_\[OUEF@092)FD4P2>*GB4EE`ZF0"$'.#K;(/BE%#?WF[NUO?;"]ZK M#T-<5@\2GDQ=GSRH+%[FL4C+420YOC<,DH,Z19FQ2 MBVU+PK.KJ<^O)I$/E2)>>,W)*-H2LW)&QI",MJ(E/GX%:A[EMBZ8VD87GXC+ MA*C(%L%Z9N#*QPC3]/^F]]NWIZG:@_\6:NQU'= M3_MAN?E'O]9E^>'1, MDJP\2(5C!IC2[45,,NKV_`_\>7:&ZOM2=DW_"AL)]@ M%#PQAIUP_-=K##=['^2`LDS@E8:DC-(*N\=0$J2VP\8P]A*,L0V(\BV7/=?W MB_^[^E-RJI;S[@&EPL\(D:)3.7"H$-H9EY)UI8)]#UNDGG1>C$6XF6"+I,6' MK2GV,TO-?24YGUR0MJ`M/L#6+%PH2PMRQ"SN0HRBWAJ+SXU"LRE4QVS_K#+Y(#"LR9!,!4`CY5WX># M\E%C3%N3^%A""6.I!BYE][!%K$Z?.HK2LU:QUD0*Q4L(2B7+\7475*).FA/0 MB%4LZ(LQB]ONGX-8M/O$URXOZ]OB2TBCOD7,V2A8W!I9'MH_E778Q9>`E3[RCS%BDZ MF@HR$?FW.(WL)143U=4<;1W9,&*1RW$4PQ&E6L3?_WR_N9/[Y!U;=PUP.UXH MF%2"DB5N;<*.$H/U(U4;7(Q-MM7K?`N;A,B22@9PCHA2KG/@#R?82&FL*+$7 M4ZOM[#!?Q5>T.:J#>-%B"49R*=*U-`;42!6OZ6*J^)T=9O=%O8`VJ)27TI@* M>*V<[NS@LA]I[?`B6KM'.R@Q6Y=F(2S7%3(E;>I#I`*]'8KT8B2YJLO:%TK. MEEW);0E_Z[/#("OO?.AA$I3_A`SZXLX]'NT`L_NBU(E)Z8J1*J*BBBG;G[1+ MD_1(OKBP?:%G]P42>"ZO*`?6NSY1\-#=>'*ZB"-Q\@7B0\5/'R`LEEPLPB,? M4UPOKI?UK''+T]IK7#_\M]75;?>%3NO'[5^XBBPZ"1VC]^`C+[TSW'=H%-RR MZF_^ZQT8G<9TJC__F>P[^*V'"8=SW3]GR8VBCQ%MT,78PHOA=_=NMF33DG:] MD>W3K?U$.XLV,[>(*#GO^$A;7,%(JLA^$@,M0G.G^Z;E%O^,RLQ=4&..%9@K M<;QT4?-?=>X"AO:NN4=\HUH$JU.TV4U#G,O10M):"JR: M!U,MGO9^,HXA+% M-QG#X+S?C/%-'2;U)'@L1QWN'*U*T0O.W9)C4/\*5@^\M[8M\=/!8O.W[*A1 M_GN]VAQH9AN\!:L02\0*/F^SECLS6Y-D;,=K53MM-2S'4:).HF2:HDPEZ"#% M]2A21M?-5!4;4\NM[,8KHD-$/1@Y3ULTH(L*":P1%?(FZIU-?3!$#?(-M>AM M0T(<(>7DLZ&$/G.YS]84=5 M=-*VK@J6V*@8!16O5.YG(8:"FFDYI(^6E/]OBRWX<;7^_6I]?6"*`^<1*-3B M#;F&R!7096?CY#GM-=B-$R70M%AGT60R`V8?%>3`H M=YZB"?^E^[>'4K`^$N0_MQ.6_O;ZH3(\<)U*#.Q2*'VN0R4J<,?VD#9C`A!- MW$$]6O$=+NJ+:3Q)[Z3(*%P= MU=JX*SB+$4W!.3CM?+0.3ZK^HRHFWOP$2-YHKI!`9Y^B[%&0L66$:[FM)X4Y M1>S)&)><#H[3N(=0H80B^.X46F-N7W],E7E'27ULV832%4+4Q13!99/V(<0. M",=RJ][6TWL:?+[\V%/Z248RG1(E7P,N=["<31*8G`1X_F_-FXWT%<_Y_.(? M44(9]A1=L8N^5UP.K"N*MK;>H_B2O%"+0;UOI+$-\J(.YH"=L4K*D/==K/]+=DW6;H3\M5H'F1M5DXY%W5H?/'K+5 M[3'6^&GAD;HM;Q==:56_UW_XXQ&W/WOS MB"2Y&?CJIYP7]9>_6VWNUHN[Y0X2\Y.?],G'9R`R10A;,C[*]4;29F%"=V+$ M;16T:")#Y=`)=KH0D[^KOW%U>[A]DY=NA,GFKNFNV"HG2%/E#;$S>'+&RG4JW/J[Q9;LO+-WU:]TA&UP6BI'J^XXF1_*:63 M;8Z-]-#YU]FL=I'+<;3_@\_")2K2&U>BMC*:[M**BS!H"Q,QV!9>HO5?9[PO M]=07@E2Y5)A+9YSH+I(<@FD"TK^7XWR;`4F6BN>F"N^#5)S6J2/`SL[$EN-= MMN1#K\[Z[];+U?H!]*PB8^WF$B\N2:#4`HD\:>$3QR9I17>_HZ-K'X(/7IV] MA`$O?9&.WBW>*('Y]1U6YD.#X!^/4OR.O,)Z50O"%(V"DB8 M"I#6[YN,JLTGYVD@OOY%.GK?%*D,F1Q,0:PLWD5W#`!UZ"VW[(E#R#FO=TG> MK]D@.Z2;W07NWV^6/V^OE"ZO,XG1H5=;+&!7`KDH4G:28K$0%(7FQ.,,2[2/ M^;Z*=3J^90<5.=D4%9&$@F!#2@^+HHO'IEW\^A?EE68>;E>"\R6G1)12]$9T MF\?6Q?OW.GV!S6.3H10KQARF+-`36-PN"H(HNH5(>RV+\\]JRV^_%N>7-3F3..<,#P9_]S(N^*1 MP?W;6[9N';NII%)KML>WM[\M-G=#=/"GK<_#FYNY97H!-VW#'"N MD@(94DY:(X*/WN'81-`QZ]XOX*MS@%T&?ER5EUK_G^H]__7VU>OFJ1-\__&G M'_/MW?+NSR_M#HJ[(6<+JJ(D42;G*#C)GB&U+2ZTIW%?FSMTG_EA<763-W6E MOO8(@"&KJ%3.&,A+HY`J2_/_LW>UO6W>2O87!1ARAL/A1[X,<0MTMXN[W07V MT\)-W-;8U.ZUD_;F_OHEY3Q*4EJ1K"@RY:A`D\"1`_@<#N>59Q)$H6QS'"@_ M.;)/G)_:5V[Y%BJ6D$/*Y$K?R[&ZH6W0]$"W:$:3W!KGG%WTQIPN9U6!9(TO M@0OX!F@S4,..ND3UN$3F.1Z`LXM>S[9FSRRU^+XKGDS@;%HVZ5MJF17*F.<\ MHX/P[3EG[1N7:LO,)%FU46M4O[)]`FT>>WKG?-#T=D)^C"FI"H"U9"2Q%^2R MXL=S%&N&Q/E8=_/MU<7KWMW^?GA1??"0Z9#E2PRFA325)==0H.]J_M`X,XD> M6V;^"Q"3`;=WM29GSHB2I&];<*X&OXCX^>)X?(S[XH%M*$>!ZZ#6?\AS5EJB M$YSZEN1X"]6[5$3Z!I#^.L?(^#YDUZ!Z8OSVGSDPBB8D3S76$(S)P.LM[B8^ MM'U^U\+J8]#Z[>;VS=6_5B7L'W[^:'!GD_K,A*>N"D?.)2:M'@MVP:OU7D5. M-#2AQP5`C\!E4CSWGQ-38*^!L<;^UB!*JHMK0)?K")Y_Z$G7\=&;UM>ZD*WS M00L:RR9Z%^HR2M1'[(;07&R>&Y_[/,B01$7,#D^RJ-^-CO=WN MQ*^/WK0>V=86WDFD'+``*Z'H(KAI!4;%N1>[S.><&)[[!X0%>M/TDL:PID7O$L\>!#T'IY^.B&G[5@1;6DI';>SF91AK13=;/H!EM4*[5@-';)&F M*902+`[>PP-/!Q\=;IXJROO/243;,,WMAFTI-TF"XA<]!\-^W.?^8EP7.1&F MTP8#H*:!Z59[TXMMB1*NQU&JUC)FG-\,RON_.6LA00NMJBD5J40RP2_QE6EW M\)@^'>_DOKU^<_?WRY=$:\#';,0)K/\E.^'X.G'FAW?N8VI97.:_6)P?DV.5,2VFS`3ENV'[A M=GH[<5PTL-X+M#N?Y.F7#@X#R*A M.NW[;1<<@\\/:'#S@_+/A\5QU2&J-[>K_NG]UQ=YJWC]:HM\U8R'MV(EW6=1=- M__F`G?.N145+8%O0"@4-6W\_\<^)DT,:==^^'93WK[@&%I]-]%TW#W-MJ*Y' MU*V%(<+:)2PX'+!O?_M]];CBO^XN7^6+UR_[`XVKZU_>?^C#ZXN.5+_H^_:; M$68\&,P[CDI\C#9]++CH%$LRR=7D'5..#A8?ETLT&]:"H?@M<.\#T^F!_X4W MR<=$8`MZ`6L+.;)1']63UR+B6FRB&O85$V\[]MT'$?L-\F[@@HZ8O1Q.; M@VTT],UYBU(%2]JX,]"=,!>'BUN^]$9"X&8)Q8=8G?75?5@6!<7$3=MO#9W! M/_"-I*9=1JYBJDP59-W,*?,Q>%"T2^\D0HTO%N@3['6EDSEA'9Q!Q4@YH?!MW+*-](TV=;'1`23 M-`4N3B.QBOKB;8N1)"5JMQ1MVMUZTG[Y<$0<]D8*S28XVD3*IKC($75)'#18 MV;2-??(;J?]K/_S\\W,VXEI8C9N!;+B? MB`]$Q6;03IV8`SOQ6GH,J\"V!50EB=;%9+K*OFXP&7LHDYF-IVE2#O0D@3!# M"ZQ,R!!QO?.JO^_8X%-884:TP8#0CP37;U\__D^D;(YIC[X<.07FHZC&F)_S072UR0;2G%9,Y7! MYHTYS9[)Y7:X3I>)P]J*.'%.,6?T*=DJI&EI0Q7"3Y;Y?D+,G@7YR8AY"JV- MC>5XD"I=.;W/"$3;=Z'']8L!J1O*\7OWJ)XS$X M1#5ZYP-54W79`"%`+M&!RV1')Z9O&7W9\/K^YOJ7'R]O?UO4##:I(,X4>A4? MY<2R'Y.;S`#XGM@YK6,5RL%2K<3"%2DD5WW+ M4FL)7@,Y8Y?FLVV_;/!AWY*IS10*HJ0"KK:,U3F)R4@R2T%!+=@--1Y'9[8F M,+5JO,N$UO9TJF#PWJ_O2<1-!3KO#EIT."IYNY959PL>6^R!(6(!R=99CI5D MR7T+9+$1[4(]VM'KJD[%T6//*)G*H0$FB(]]2YN+DP[?*TH'+[%R=47+@4DNJ ML#KE9;ZKF/+)YH8)36MH`D_\(.=3;8K@4^9HK6UP6\]8RZ*J`E[+H`=D:8>' ME`,:,Z&WORQ57W)$P2B68$N)T2]O-GQ6D4%SPH+?X<7Y5\#J24?./CU=J`$P ML_I")4'.T2ZZ=Y!IF-JQ`XJZ\JE2D4V!5,(CB)]-+&G89`/WDF$ M8VKT]K?-J#9ZSFPQUA2#B6'1(A7$/"R2M Q@SZ)]\`M:U-0(:-L'.E2PW)5E?Z*WD[J(U.CM_=! M"Y$C>QMC5.^R4EB+X`@[%X?UP9;LU\/J[C\NKK[VUIV#*C&Y3(ZEA6=&%=4` M0UHV9*,K@\S%+MOD/X9B'M3V/E]&7.]K&XM4T;=8(\4Q^,,M=1/?G1&W_\+5EGCDCJ24?3.7`?AV` M!1XUI0T>&*.W=^TK=W7MVO0[W;X@*FOMM$G4%@ M$[&K^#2GD,%7:4CWYE")0T+U>5CWP.KTX-]_:2]7Z6B3,=DGVW*Q%J>LL,:@ M_,B-U]-B/>UEVXX!AA;N=/2A^2C.&=[#7THQS^2HSW%KHV+LL(7D06W._PB-`J@IN4`_\4I`_ M(/)UT9WC),<2O`F6(AA!V\*SC.8>W2P*?BB?N5V"_P."O-I>>?73V_OS_TY_ M^_WUS;O+VUD/JV%@)JC5Y99Z]@4-9DD4U%=\8!OP#GANP.!0R,UQ$#G&DDIM M*0/$1$XXPKKOR>*'+L$N9=S]@%O&=NK;-^TG7O[BXMUJ=6:]^N.R-C@N7O_/ MY<7MW8_-?U]>_/SFK[C.6U4J+B5O3#-U#,Y%=>1@O8:H$0V@F?H&ZX]_7K[^X_+?&LB_WIW* MD0?-6K`X:]K_Y(PO=I$:5\-UN%IV$7)_%%"G`OK^O1'G%X!F M!WGO\ZO&(O2=C=K%]!U5);]>!\7CXA>SRZJ\XT!Z\_9D0@\TKB1-*!3Z,KCL MU^H6??'OV&@XS+EM`,T.\OX2SYXLL$DB4%T+F!TM0BYB8M(AF&OG>1)(?_SU M]O)D+MQ<)1*D%L0Q0"`.EI?6/T;W@'L[Q,%=(30]S/OG>YG)M!.;U1,+5YOK MAY5F9,>CRSMDRD<"]<^;4SFYV(YN@I9::XMZE5K8@.ML+R0[#*T3,Y MQ/L'"BF86@BK!--B!+"BZPUQ,;LQ4#C,J=T9T.6)T><*C_,NCA3!E@Y7""@% M8BVU!#&^911!<[L?'E7IW8S(K%#NO^C9&@1!2IQ`JQ`%E66`0[F,1FYV&'XY M"G[3]HT1G.DOT9P1;[L.JRJNCB(#N3#.7CTS*+]@U5,H*3D/J.WXI3X_M!YG MH#Q.XYI=YK".@M^T?=V6Z%,5E`B97:F2R<354<2^K)0GO!7G:"@XPFA*3(C& MIASZ!J=E^)0AY:%'VTL`7^\HUHNKV_^^>/WV\H>?-T&W_0U">K?^WGSQYO*7 MF]NKRWNT?GKUS__][KH!VO>?K=H>#8+OKO^XO'NSBB+NL3KN6/"'SR\_>WJW M_N/?KBYO+VY?_OKN^\L_+E]_^L\OG_GN^O>W;^Y6'\!M<1D5TW>]`,0DL9AV M#7$SDD9T,F3S<._(#F/L#U+V]#3?WRT?L/]:+._W]NJ8I(,UV1:;@GI+V1?? M@O,6ADLTQCFN8UJ^PU#FA*0OW_/WRXO7>M?Y>.[6[",V+^*%DC4Q'9D1\27MG!B9X$%_LW>[/'0J5E M#)J\FI(4EHWG8!T,\TH]2WM2S#[_MNJT8H[-Y<:NU1P#2+`%>DCH8O<5&B5E M9!G*C7Z',>LS)T>_KLRVUF@@FUKTESS9Z+HB&N&*9I66EH;ANCKS.Q>_=EO# MR[1P'F/D[+`KY9-"K[QJLER2E,=M.3[S.UVXX;%FYP,W=TDVL%40D):Y6XO> MEC+NK#W=:WJ5Q]6K?_;%Y2]O?GN2H'YS'8^=&AL%2I&:L3164KJ9W".X8$ED-P[1=U MUJ%)]][1FQ;\M(!WKKSYS.SN?E&4F*TD9PJC4JG5K^YCSYZ`9?"+)\OI$0J; M7YQ*1G7@P!<`BXYRC>T2[3&H4.][#8_!3]TWSD/)43-)D:K(D`G[4$Q,8O.* MY51+A32J;SQM$]!WFRVD)8CFBD;KBN6J:DTWOUIGUB`L8WZQ4X,L%("JFD(M&6 M@G!ODU!;[C/.:[H=7B:?"9K:^8(OV#7\8HNO3``A6WN5T"D&C1B'5OB9ZWFY MWN9SV=4BQ?>]#UBMV-!2GGO[+D7C.#Q\MN_Y.=_F1;NR M;RE)'E#X.%6N\\7=K_'Z5?]-__'VZH^+U].5BDF-316P.&K65DHF735D)&B1 M:L99L-,L+\W'R%$KQ6I,21AL%):40LR\Z@=(5^PW#X@'G$F>C^1MCK0OY*XU MHEB0%)-&K:L28D!RM8Y++,[LSL3N-I>94VK7M+-DC<]9.55=M5>#KUDJ#T+% M9W:/E:`ZSRZ`=8X8,``[RG1?*:RQV>"0H.[RGO!,T-P):LM/[_OKB2BU/V0; MTWW20L`)1D'Z,^?3<[[-OU9KIB9[)O;WV]NV]^5RY_>?*5ZQ)>FJ"%4DV,T M+9)UIG*S.UR]F,#:W&T:%Q"2:QGRE[,1S\CR]EYJ\MZFODJMIN(A M$]VS'&/R*,\G2ST"O0=.4[,14*K@O;*U8LCUR?N6LA3?/&L=9H*[8M/9`F>/ M8[#5U^3K_P_U35S&R M9>NHA,K%T(]>MA%S2XYGG0"W[0G[%6)S3GXU`4P-7/^]2F(-!7WUHKW$K]B358M1DFF*F"UVS[O3R@)H->O$KV';Y8@K1WN)7H>^<;," M@N@[QFR[_3/]J^@,J%U-?_6<,#_U.+#4P*BE0Z-E9+9#,&"7S08VLKGCMO'9 MT/5#=4[R%:X8` M)1ZFPM%I=M,S*[IQ\7;`7Z+FJ+E?>`<5@L"8KRB0=YEO=L(E7O7H[X+IT'>+AC)2Q*`:( M''I<6GR*>VW)H#U([5=N:L%L^KJM$YQS,J;ZU*2).@",/KJ`;H&];KP76ZQ"591$BZL,6)NKNT<7%,`;YFFR_X;T6I%>%('PU?K=EAXT`45E M;+2_V:D[>.,I4;P7S&.C48L"6D+V7!'5? M[9@GR@QYS3G_MK!9[#=VAT-.`Q,E%D.(1PT,2`EA4D/HD><-FS,1:M)8F6M- MQ)H+^DB'4DEU+B>:AM4O&_73%>U,?[C(K`59:U-?2#M/IU#&+,U6B_>A'Z/Z^E1G'#]Y%R\,Z5#FUWL!F\ M1P?>Y1V^R?=?M)J7>#=\'\>&[3?T:%+0<&/S@*KMJ2(/6W?0QLUSWG'95>GWY`]G1=]K<". ML(/K*C?58+NX)R0L8C.RF\5T/8O2'\XQ^K6*6"PUHZQ!E9,_%'^3TSK-*UVX MJ7=%D)R3)OL=LZR,2)FM!`C5CC29J"<>4^_VLJ7/&\J/8DS.6IH+G,1#<-*_ MS/'8R,GD)A61"^L>WE!^7%9IBH$$G!1'GB%AVK%G\AE;K#?VO%S_SUMR.2%A M*SYFDLBT&RJ#U+*I_\I4X)97[SRC>N73_HRZW0DH&X0Q_KD$+M MOPXW';W7,CW;VF9)XO@]N_^VPC7H#V8QU3_3+ M-X#6?B47I?3\6/B(%<@GIZ.#)D,Y$4E!4.8"\`WK]6*]Q+G*$G*_Y%5\\KZJ MY)KV[C<12ILX]W:_UX_Y$N7F&@IE:<3>U''/J.)8UA&"1$I?V9.S5:S7LS+] M6PM7012'1)Y%U10]Y>/44>`TY3G;[**N#Y!STJF+V46G$3)C,Z6,5(^%8@:8 M7.P-X_5AO#ALZP4I`8;N3Z$AA>:&0JE2SV%3U2F+N:&[)G07FZMF7JLC\]5\ MZ_3I_&YHD%+/BWS=_%#9&=%]ZO6>')H'W\RT*$?I]%GWZ:FVYOSTSH:W.:NR M>H#.R:"H&$%G-DL<;V$]`MP5=8]0`63@7E!KBZ,8&$BGE*SH2FP5[/=O2OT&P+7!) M""5'IK&73/4XRQ2LSH_BM]E]72$DYZ14SC5:@MJIU)JJNBI#AT(]@6FN;EW: M>3>0'S?\6[3$9M4CC@$U*6:'-^E)JLI#`HDWE%>%\A)Y5M0>#G,P*YZ]N9#R M_BHKYIX374\E8K7+SQ]^6%%":%A""JXT(;;F]KV6:&.]S=SJ#K<;N/YH=I%; M7>&4.Z4V&5/@,EZ?[CML.CKHJ]M#=T/]2?JJ,5)LOFD62)PT<3B@GF,'?A:` MPP_[TAW5(,9C&[EO; M6+>+."3`C^\7->C44_5NVP7"-8!QUOHOM.0TUX M5PGW$K\ZS73O"G>B/^QP.V%RC#ZK+]E$@.)1 M+4E"E/D1J]OFT[858W-.?A5.VC2[A@[0BSET![ASX!PG`9"X;7Z]G';Y:8K1WN)7J6%,=]-E:CU'+9:41CI*UJ%'E-? MS7#2^M>$:,CFR@I$3AUQA#(ZZSTII329E M9MCV$.GU[+=?[K=J85>H6,<6:S17W>[U&TNFJK=[M3I$EV@R.6$,(502"`;- M:3E*5TJ1-@E\W*[J2H!=G#\2-V*>Q"WTU$=B/^Q! M'7I)E8@4"W!(I')4`#"9`8T/B-!6`+[RO]EF`=4[^ M;4,@H/50N(.?1TVHR4$SNK*T,-W2C4KS/UO\%Y>'%XTN^4:Y)FUCD3L='M]T M8A:8XFV_S04M0(Z29_?S$"TB3%IU2.A*P\R%PNNS>(XK]Z#2<,J^'D5K>4D4WD.XYK] MU\K!6'R-TD-[8X]`)B:2N[5\S#N M>.BNOMF]E-0Y_5KU]L_OP>+Q`K/D>M3CL:"C2JC%`([Z/9;;M*5JR.Y?B M.*E,/,Z94XHM5"ZUYQ5M'U1VWNP1Y&1)H#6_.]Q6Q+=$F5X`<_.%QO;#'O,) MQ$/&!^:%YJF?50]8;PN;)0:M:M4+1T!`CVI,?!C*<09UGH9.="VQY>6Q6=R^ M4E(@)C2$QH%:#U[BX258"VWN3/TH;MB'&OKI_KZGK_]K?W_UT\MW;^[^O1M. M=U]]>`BPV@$+_Q;^^I?ZJ!3ZN:]3C^*22\V$>OC$3#2$YSO^3G@43:?PX,4I MTY+?`>::S\5M1]/G4Q)]&PL)Q&G6$,E1&0MAN+OUFO5[)^NNX'@0@8.>:0&F+/O%S/)-#UR.M*C\#&44O)%(M:"6.W6DU8:]F[=Z&"-H5> MU^7>SY)@>V@HI;.GU9X=UNPD'I=]1^?KS*#^E)GSM=B8;J'5HSUFT!H]&(E/ M5II$XK"K54&,!&$J'+YX1N?B%EK](P`OF"(WCB'X[**I\#ZTXAR5)_=Q][]+*%5:E4%B["+I*,X)7Q8G);]^&LR,9TRQ_6$-O[T[O6>73Y] MV!>[YF)B>+)BXIXSWW_X>'_W\>W]W2#+7_VD[[$LQ];-&%,TE]!K"3GQ\:T6 MX;S5X84_J5X^V6-5!GQ\#RV3A$P];Z((A8`JA4,+F"G.Y8\7A*=T?GZ$M9ZN M=OVDQZT'P1S$7.R1L+J6H;;C^X<@;3YND$])1-=MP-\@%M1S2D"?LP^%U>48 MCZ]%R`E])6GG4^8_OM]:'_O'++^\O__X]O]>?NP?Y8___;N7;]_]Z_L//YHQ MGO+L68VMRTX-'5"VY!ZJM MC."T'$=@:BISB2.=$NL\K0W_=/_V_?V?[^[_]G84&SY\U/N[UV\_;NB<=N95 MW^]Y:[YV=RG6['CKMEKTX!ZQ^Z15NWTLN?_WKW M\OZA2NB7'QZ_G(8/0-X[*^0;(KIJ1P^8<_CU!-N[3SLK_K/[)Y>^^=F_\X_\ MHPU`WS0`!.=-H7@I%E@#U.-SO)ZV_7K)]A<&B/E\!OA]_SS]^'\C(3K3;(&CNWAIP)N*&&[*NT M>IR&=8PVS0^?\S*N(U!"\B%CL6&D[L4U0@O'FP>A32[]B?W5'^X^_NFNQU"O MW[XZ_-LS./??^G@F%@)/*:/SK>9.@TB'X#+EGK/7Q^Q(_;HAUFB]I[R?ZLR# MEV[#7$+QS5PXW,_4I.`LE'&"X]^.)1]]`!V'$%QUI3F'K?M_E'PT&P#-*^;\ MI4_@)09O'BX1N5@BD1OZ5I*RIGZ)CUP*2:?W5OZ$Y'`[UGO2^\O955'NZ58; M:IL6Z/-!),ESFGU"0K`=2SZ^XBO0M!\T3+F[.X^Y)OD2-7/VI34'F?"8 M5$1/<=*QN33[KB-D!O)2:L]*U3QS'%)`QY#90>79:C^*?'='X=#$WA!I(!!T MU]>O;2<-#S6TO+F_>S,*[]_XSJ\.E3QX5@/G/-%7O0X?780V`,;O+^WI^R M+>?*S'WBR]5O'6NUUL,3XX@NUT*U!3J6/K.O?I;G3GC"--T/_HAK,_"W#K+7 M'(5+*=;$&0S1\^/2IV[PK]2NCN?X61CX3_?O_^?NU6_WSDX,NV79`W7S:D[5 M/O?38K:IPM#=Q0D5ZG-\SE6:^EL'NO:0LQD4]5E:-6C-[#B'AJ[.1(AX0D*X M!E./G]4CR]>[!R<;RI0"1J^^@I<`K4J.]?_9N[+F-G(D_5_FO1VX$L?+1`!( M8+MHS=N\/8$OE-G=HT2-2[O;^^DT45:4#Q>(ADB)MO_1X;%+*3.2-Q)<\ M6^Y4IK+3VU1=BVXSAOI4&.P_)6*_Z7$SC@,5?J,CV'X1,E#(9CLBB"QIS9+:?S!4Y5I.Y M6U3A.TNI=9H[>LH7QERT0,E-E-8D'I-,%E,WO@V*LITZ$&P#J'DP9EY/:&/1 MT]D$Z!5J#C*H;)/P75?0\5!C@@NYS13WN0OM`(6*]X%B&@AKK,KDL8/.L3'GBA\QD;%=6 MMCY8@_4UTO,9F=\/:)B]CSV8X(7V3"?&D@#EP;:(#]HIGT7]UHMO<\%T(>?^ M(_;V%:*'7'P2G#!\?I4CNR$WS57\S]N MIO_77/_:++N'T'C7_#9_]#/H)\:[V^5D.FO_+[^@T7X#T4D4*5OI,`KCC>ZN M1WD<\':C6(C\XO=N^P._E`/9_O.9+[RJEX(P/8$12"KI)7.7K M^ZMM!O[.6.AG>X_H',^H;#)&6]21(_/8:CU&;TR-8//C`%YT*\DP&2A;7@PH M92FO2;I[A9]8J"Y,3B[M1W@8%Y2P4`A-.D:6DLP,`D.P?<(BP%<`?UM$T$>" M.!N1[0]\+**(4@3T9;,0U;"I1^?C'FPUD[[-+=V!!'2VZ8"SS(GH98')B%;& MG'P'Q<(B$]6K_2WBTSF*;'^=BBY'Q5`H="@#B0LZ^0B+K'Z?OT5/Y$`".MM@ MZR$'ASD$Q#*TP[E-K'_\FUDU=WHZG3J/\)@=:0G9&U!I7UXW8+M><85H@&Q@ M_=`60W.["*B/FAL&2L[:<0ED*8B8BA%R:8`B(F\G#[.V`L)N&^['9'*^XMP? M`LB7=_E)"BLRA4F!CG=SM-HX6=7B6^G?B21XME[/INR\TAY,Q@226Q)KJY!) M:.U])=1O4)S[@^'%H!DWX#+59XH%:Z"+&&3,:3?,^T?S;+_N)_-YE>KN;6#WVOB]$MSNYA^F#;7M53$$[@"'ZT%PZ2D7%8.@K$U:F`*RC=JABS++SC6!`FZ& M!07'$=0M.8D/9`FA6?[9-#?_:";%QQ2S;6_E?LQP'G2$0`6%&;/V@ALMC47H MUC?Z+$(-%;[%BX2-)WAV&O!CI*3/[#"9X)4P&(+*B"6>6.YM4B&YF.JE)'R+ M;L!E*<3W-UXBDG?1R_+\F)+W*#Q+N5W-2-[!Y53?>FW1-#O',[_T8[+2>6;1 ML*A,YD8PU_EJ(QE4+91M+B=?X9A^C'WNKP$Y&B.=XCD&(X-RP'@[<83M54`] MT`ID\B* MK!Z81FA=0-08K=FM(W*.AWWAYV.06T3-F539HY+*"=.>3W9"8XW$>0(7_3^S M)5&Z;-9LG-AU&TCRQA@FLN".H389I.W0]H)#Y0>;!0Q&6=Q`XJ$9'-_VH6-9 M&IB8"K(`05"4-3V">78A#3.H#LU@F]],?[];WJMV^<+#<,VZH8[UM[S">,@J M:ZTP:BZ"E[Y?8,-XE3W*=>,HXW0=@I-:_YYF02&IG')I77AKT&NN.XS@X!U6 MXTIK066.STFM:$\YD=)(KES4%I)/SL?Q&VX8A=YC9;R8&BM5<(J$1/6(Y8/9M4?.#>9PO"Z,^S MIOS!WUP_WBBU\Q$[!@Y2<"E'#]QY'7L$?7#:502#&G`4F^DZ&"-]M"8;6,QG MT^OVTS\OFT]/&Q?_43Z=*=JA2,X*X5B'_FE, M=745CSMU?K=@GS+8M%]KJ_`?IE^:-Y? M31LJP@;]!+R6$FYPT)8T0!:09L^DCEX'UF,THU$UE"[H M@9N&$S)R/+?"0W+(#3HH$#6EAV>Z$47IT-6O-D=#Z-D(XJ1N!;*FLHI":Q"4 MIVKFI>UVLFI2JQH;"0;JK&]2B%NZ%8XZ:>8LBS;Q++0U'<"="]%4H]=B".3G M)/+;D%XEHZ*)EFO)G*+/4XW=;6:T&FM4"NM>2Q'@V&XE"A-YL))%$3EE+$:9 MOFK-MLJ`Q_/,LQ'$:;,5IE(!Q&2UNG=BNOE?N>6HC;N14I M'&H/$(25TJ?R)KJS1IY`5MF>/DC*?#O]0G_]Y3%8V,-?MEWC'?';=9`@*;HD M(-,!8DKUVUZ9Y-4=^-`NK,TT'8:)1XW4[L,_WRR6MW?E^-Y-%_\>ZI>FOZY: MYSO@L09;>2L'3OWO\Y^;R;#+$7H%_*J^"$/UN:BJX>5U.O*(^7(J)"8FH7%(8`[`L"FBH[HI5Z^N7 MB4-A[+`R_64Z^7TZFRZ_[@B\*YTIO7XF/5-$9&2Q:S`K&^J7O7R@P;P=78=C M9CW+C2YX+IZ./4*X? MJ?K1W?Y+RL8"U@7/0`_E12)]$,:B0XQXN+W\^7X?V/P3588?RZA'^4)YV9`^ M?&BNRO?_66K#>=EYN+%2[BI MN8PR'K[>G^R[9M82L/@X_?S4^":+CWDV__/^LB%?.Z*>!=O/AS^GU%>$@?NZD)RD42NZYI(K)!W#!L63I)+G)TM!YUO._ M`QV^[^4DCW8(-OFH>*FW2M[G0U:0J/K.SB?%7:YWC0ZA_IWL%.A?"EOTO:;[ M3G%^W2_;IMW^\Z_Y\6R4#8QQYI)W0.[#1A3=[`W8@?O<0;8W4+6.E_G-I_E- MLYSS/RG^1TE#)/UG!S$W->+`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`*N<\$(]E@6OV-FSCN#O5/67%5GK>Q`[KT%UQTY5,N^ M_T@E09@LIE?;N-@G^$IEQ91$QQ&%#EESG;HI7/JO>3;%T?VJO_U=O]'R@=Y! M4O8A5OV+_VL]L:8LO`9D%.E$CM(F3YF;)CZDS3RA;8A4Y>*9@A%A[%&+E"+%:)T&5@)3!99^T(Y?$6V*UA)"> MOQAZ3*QV1R%6C1#K76"L3>9L]%91HE4'MXA*ZSE:(SS?9/C8P?@P#@W$#TYJUNZ>01^,D:83.)-F(E$$[X=<2 MR]\(<11BQPP,>/:"DT#14R&;3;)Q16PPTL4Q8ODQO`&,&IB'L@Y!QXP`+BCP MAL66V(A:4GQ81RQ[(X]#[)B!88A2D4M-.>9L+`5KARVQB;,,7*TGUA[#P.H< M\S&Q(I,SS9`":6TVT0%'V:=67IAUQ,HWZD4&AM/9W7*[1]R/R5400@$5H/AE M+#B=`[HNX$K.PWI_H$8\[3TQ^Q$\'G1)4[D*EJ?RFBL&&<$7,TM`:0Y3F-:; MF31'(WC,+Q1H32-E%D:90)E"3,RU!&LJKIQ:J[T4>.%H!(_Z!LE]::63964G MK$:?5Q(V607Y'/#^2?`]'L%C_H%\`S^36GD\Z?E#P3#&W,3AA*PE2(#"2IL8\,A6L)#N65G\+U!+.1;/>% M!(\97+-@.K0$(V5L,LCU,4X<3R7&C(XR2.EM3.6^FI&M43VQ MDG!"RWD>"\KJ>`2/&)T3#&QV5)AYJ[4(.;DN,)>=.FLE+)_`TFY%\'W/LANW M*S-;;V]*P5R6%-'_E/+^RV0VO.-R0P]2`?G:T'?,TG!O@3@P@DMHT8)["!8#57O\I[JY^DJ,;>@Y*D5G"@:5ANB2 M"(ZSGC'0]2S!3S7`R0L9ZZ=\?IO\5;X:5QU+4N.'F]UM]/`QHA'C6J:0K>6. MZC-I,\4!J[U4WDN43ZSI`=%(,/&E;;GW7)^^_7)A[?1R*>C4V4Q&F2-6H'DF1P\8KS723I;P0>YE5`9 MVHO(/KX8:BU^*H9L0Z+",QIPR5-!'UF/9%">E0R;YN6)8=-<(=?)(>-!.!04 M+AFRV/6]39G7.D\QM`.:#_-A._ME$CMIZ2W<"X$"L;ASTXTR=FL[VYHF3DE_G59-9_KMD]KL1VY1^1[7)V#(P9%Y,D4H%W+M'8=EA'P&-0Z=8:SYWMI;3T)J0PK?<4;\/QC?]9;QMKJ?+Q?V3JIT5W/NLF/&F MK![B0:(MS;56P9,S.+Q`ACFS&[\5F<=@=%RCT8OL70&C`ILDF;**O8,V?$V! MP'ZFYFV:ZH):??EM*/S**QNJ`7).FT.F"B#-F@=YZR_ MQ:'Z?`VK?,?LXD2LCNNO_'_VKJVWK>,(_Y>\N]C9^[X$V&MJ(([=Q$&11T8\ MLMG2I$M*B1I ME>\@^I=+9+LWQPH#_.ES,YDOFNBG[5Z$9NB_#&;#^?OIU6!\^^\K1/`OTZL_ MFJO[`(RW\1TM-SPG[8M(V:DL+>NP/2/:5;(W&"A:ULDX>4)Y'3MJ?'_1%37= M*5TR>FLI-%H[[2Q(7FMX)D8R^;ZF-/F\Q;T8O$*7NOQ/]7-POP6]Y0H5CQ5Q M"`V,9;9$C-*[3F`KE/CAQW?P![`W,CV"J-8RL;_\T$0OX>7KP,#MO\E_US_N MWR\=2_"96^O1I43O>*FOWDO0&["<0FB3SL.'(?Q19+'E?4.&#,HK`UHQX9+D MK&^\$L91,$5)GS>>CRRV/(G4<8]D=):07)V#,M*'&S._!J2>#+D^O2SJ?IBJ M?/6K\]_-[&(T;]Y>MJVQ;S_O_*2R(A;T=>!%KE,%KAAET`OV*5-QU.O3]N0' MY^&Q);1%B2*(8+P0.4K,N;RHV59G4&*19'+NWJCHV0IHBV8)F=%YLR*-`\<= M>G3=!;XV2KK+9\TCZFDE]/<%AB^KBKG^5Y319(#IP^2#KZE%&[CNKU!<1^LQ ML>&":2@Z9M#_TQG<3R8WYKFKCN?II^; MX?OFXN-D.IY^^+IYN[,JUA7@HL1@-4O2AJPL9`SV3-0RK-_N?+LZLD$RSTZ" MW<_$Z_G5]%,SNPT+LV5+=E*1B2`#!CC>68P*DP"4(UHIY3*P]$W*\?7DW6Q: M5;"K%/G)<'E#UX.YK?:*,Z%X<;(HJ]$$>*69A<(,,SHJL^Y=$"7*7[9$W\\& MP^;38/;?+=>Q8O9C;&6]")I;=""1H_!R\%;JI(5]^.MX:_'O;7?+U-8-GG(*$3![,=%W4_68 M">N-^!^/)J][C>[O\^;R>EP70FR=[MTW*D,?T/0!V:BYNV'AU]H)NF+FWPS^ M'GVZ_M39^)M6;8Y!OPTE2%36(G24/62^#)#5#S^^X^R/6U+=@=OG*![\!>O$ M(ZQD2D?M+4^HN!R*Z[!UN0O@:BU7/3OQO$.?6R?')\.[WO^`&P19AYR$=#%# MBB:)'F#+FF)T+7?+YW>##A/1/;<[!V215#ZF@@UN\")Q$0AA* M7EQ_NFZ?^>Y?\;+MR=0YKZ3!6$]IS)DK+(;JL$VXDH%N4W,$+WM_$D_!X>'7 M838=7E]<_3KZ\/%J&ZA"A>-VD*&:4\S78G"\JZ\8[1U=?4M*M<]86'LFO*O7 M+-1==4P)[;E."M.R*"P&X$S5-4F*E/X)W-,+D-N:6._;SF93)_3#'DW>0'2JTC8XW%S<74]&*/*?FYF5VNJ5:MO;Z:4R$HR4C/K MLP_6];A-8.AZY[K[[>4);E,5X$[QN**>&B&<#+G8*$+%][8`8#`\3W1SPCE> MLXW;%,`HYSDZNSH+P(,SK'\7D"*09R3'SO$^J$?R=AA-#AD9540%_C7H#D#O5V MOI200M)."VTDCZ)TF+%UMJ70@)2NY7@!TCO`VX4<,/.(T6$X7^IJ9+3@/4HA M"_0-&,XQR#I6<#M[.TQE(98`A@F1E?(Q>-9J:4XZQD@7"I*6PQ-*Z];/+'M6 M?D$IO?_2C/]JWJ#(/L[W\WSU(5QB]!T*KTA:$'/L:I,%O"+,*D6>1X\C]PC. M_V@&LX*?W8]C)GBVH+G$^$6(B`Y+=]Z+E0QKS,B1''=D'LOI]'JV'Z="U&J\ M0&W'<,9'#/Y5UV$&:"^)GU;[Q6WWDWDDI^\_SIH]#Q6/,5;\!FX-QNJ.8S;9 M=4H%5FB?L**='0?2>2RO7Z9[*JQD'D+0,D/6(#E:*]D=*L;H%-I^O^CK7BIW MY?.G&5GZL76#H./1%IZ-4X7%R#6(+OK&<[R+1-BNE]Q')5N*CB?_44+KC)EI MQ@O+\%S!5D#:3F6-BP+(TP?0;I4SE<0Q<;,JMJ1H,I.HY-(+SZ5N/;)TF+=[ M8K+W"OS.02@'A\0VYHK9F&*HC=0,K7VO.470WB;K]C%[YR"9`\)=X$7QK"I. MFVNM'-OVJ ME62=!9>J2*$@BG:-G^ZBQ+2F5B*D?0+5?VS/@/F[38Q[D*Y(KAT(TS5W.<M$O MOVL_WC?MW.RAVN(SNQ\(7_L__G/4S&IOZ->?J\JL+KM=;4)L/P!WNRAOOO)6 MZU"9-?^[KO2N_[Y;GYSW'41;JTLI8+(3T6RYF%+)V3JK(N:I6DC.-C88[B?# MLY8_?RKYNU*7@*/C<%G4SL4<7%?P\MY2N,0U)?@7=`SBJ8Y!JI!8'1BP==5* MK5%HVZI!5@QU86/_Z!G*_[3",MFG))*L>]^"0I]N(?2%/*"CHF=V9]4+,=T^ M>9VD*3:J8'(H+)9Z9[64H!2CV?8+E?_3F>ZZ1RP[Q2&C^\1$J$(5+!-"HVFK M$-#H[04=PY.9;C1!"9VH43(I"`&5(?%6#;3ER5$LE3.7_VF%%9B*/J&YL,4F M`R9$V[^]@J"K/1_ESMXTN']3H7<27@1I%1.$UBK6F,/*@$'XQF5OAPCR M_$_BR2QY0`L>N=`@66(%BM>N[R`"0>N20%N+7^2!/)E-1Z.D2I$F\J)1(3RZ MUC8KM1;#RU5LW.>E&J<5&RBO>69U81H/8,"FT$W!8!2M]OHV4D+RFGO\?M4"I^P6@Z^6DPFM2%[AWHSMZ`.,DQYIQ"5JPKL40P MREH=`F8KZ+_6[")9TUJQ,W4/QM06K)L@K(E")2E"S5*SK:@W1O*4HA&6]KV] MVIIT[^(#6ST5^#!23J_&IVW5[!7Z97J9GCI]INT/D_F^$'O(^W M/K!U%_2ZK_UU-/_OZO5?D-+MBNGNWQT[M/SM'4$="D7WU[],)\.>UCL_ND!Y M[7<55TSM%12+%DQ^\:%E3]FV:%2C18HREF"3EBY(YGI4+ZWI7N971.<>^"`> M]Y#E-W'(6J!>IB@#+Z;BBGB7>TA;%6C+YBNBI,_ZD-4W<<@8><2`YU0?"5)"_+CG/+K%F5U-X5$N<^GX]&PEHFBUO]'ZS(J-62OK*CY9X*8?J')`5($T]ZSE8Y73Z73X930>TZA*;(+- MEA4ZR5B75-*HHAC/=U#V15B*EP?`Z/DM?_/NY/22["]BAY&T%.=-$U6=BO_M M8H37H=G6\1!`U\42&!&@!P&K%0L=E+1R6:Z99Z=B/B4K;YKAZ&(PWI;@XH74 M/DN)MT7%*(7KM@G;%M.#]O13W[@?%YLZM\'SHI``ZRJF`@3-&3!G)I2?/KGEQL:N'TX$L,GC-5-Z\J&V+J,#`0VA6E*Q0&0T&*(E0%*HBHA&BB;2*\B&.O^GZL['8_,O[/!0UE9>6C,>I\SZJYSP6B=ZO">%\9RB"D$ MS84A;:!:2!I*;F*I)736#--UK10-`QJ,9SP'IW6`#F^W#M;3I^+S97HW[4*#`+9=DZY* M7>R4>&D/F2FMG'0DD#L]HUO`<3'!EAB5.P\%;."Z1NM(<.9>5U--;J5N-R4^ MRA'=29#NLQK]$>+7-/.WEZ\GP]%?H^'U8#S^^OK3)SS7V6@P7O/3=Y&='NH. M<`R616'@;2PI&!M]R%8Y5M]^2E*T8'BO`SZM0!]4T9TT,F41>;%.^V`B"-/> M(R>9EGK="-^Y;WWF:@Z*_C]Y!1D_Z8,0>(1RX9]D+)&F1Z_H MU-0!9)Z*S=/<9;BV>8R63':N!*==BX757=TM)J?N!'2DYK(*Z[/ MF<_3:`J&.S8#8QY#S:ZNFHF;R\OEXOAWD]_&XR;MY<=C[\C*03` M7/P+WEY<";BO8Y?,;X>ULIU10EO]\DWPYMU\C?+">I?_]7,OOX\^/,+YHO;9F"M%'7L6<4L M4&V-L$'?F*4ULY/WYKL[B6I5R'4.ZMUL>CE:"QL-_]ID9WS@05G\7$J*I1PQ MB[`Z9BA%8BQ)*GTMBM1=RF]^_SYT\4UT,8ZV3V<>DHDFQSN>N MH4M1-W@876(372BI(IGRS$N60T#Q8416Z0+,QL(*T/^R5KVF-'H877(37;76 M(D)=MVZT`NZX3:6E2X!`/TG!"X""RQU*U\:G?Y]4"6B+>D2X?+4;<*#)ZO^3#W'NU^=X+R]&% M04A<,V>U%?4;-A,7B4%D:BVNDE7LUAS(LR-BG+>:^&DX$NZ4",<"0=!KLD)#Z1KT[WG7FE9/,,K MSKS/0D&R2[JXB+0/2FJW\_UZ_>GS8#2K#O#MY<_3R8=V.'8Q$OM^&IJ%OT.G M=GGL&^/2+4X^=!'(WL6,/8(Y5,3@785)];I&=`I%U:4]21CRID#$M;-85H79 MAA3U67.QK:^-")#EFY!@[W8G!UX%B0Y+AHS92A$A]=O0,'DA.NQHBK*=JJ.9 MV+;SS@2>7,2@('K03AI3N@E6U&Q##1'0TL,C<+%%#8L'<)'Y6"1GO#@O MUX.$.FMVT1 M=3:;&#@H8!8BY]#-N5C#$J,Q.=#]\T_']9O19(JI^]>*&#-#C?&3X>JWY/]= MCRIXS-7'Z7!C(]@VJQ\\<$R/(3C,TJU(+';X,HEYNK@(ZN[GX\5T*'_G)M?3 M-=AAIFLE5&A0B`&TQMRWF]-21@9:FG:&Y&[?#^;0K&33.O@8DW`9,T/%M*K/ M*UU[@%)^#3`U78+^_5C.*UDLNK`*3HNV4&+RKY/E7;D5%8V6E1SM+_I^I(]P MI+N]5%0KF5)&:RFA-LWF9'B7:];PG@(/4LBT;_(XMT21'O,BGS$\@&2EYE&( M;BU[[0YC-(=7M$WD&Y;KZ2*%K$2P(D196#*9`Y@N4K`\Q#6S8YI6+;\?S(-' M"MSJBND;C?0>90U,A&XB3$=-'P4P4_FN+V=>5J[#"UE*XR-ST==:9NX7),9D MR9E:^@C^_4C/)E)($)DW+CL\0.ZXR=ET&AI-$;0#D+OOQ[E#Z45*9K)TI7#M MK0LN\`Y`R@13`AVA$`<\6;Q8L9XN4.`VAH('D"-XIJ.K+S)=9"S06=$997W( M8](W?S+[1@J,.R=CCD5)JU3`""[D[EP`@.X3%?HA:O'?C^6$D0+4V`!,"%%P M*7+,&KKW%4B!CI'8[S;P28YTMTC!)^4+48KUK M9F$P'UW\]G%P%\-F_0L"7^FT*))[]![U!;6N/X:^5Q$%)N\\+N&O:G_+#S_* M?QB]CW!6B'Q8!FGAXS:#0COTDZ*@88X^H59GU^]F`7G7.M\PJ/\!_^?N6GOC MN)'M+[H&67Q_9!5);(!U$CBYN+@?)U+;UD:6O"/)6?W[+KZX;Z[W,E(V1:1F/!XKP18S5M8]FUXO7$D5QNI=5M"?"GFH4&N-]3ZELLT M3JN2"I(3.CHYA#.NZ%4@S;L0WA#(]<:J42#6CIN@ZFA0DB8.7*GF7ZXV5F6. M`W(\]?OG[OZ7CWR(;_T@&R-(,I+X%"TJA<+>I4^5(F^A'8-BF]3(;>0[(+"I M'#"F0[SYV)$2%;1\AHJAKPIQ$+ZFT/1,@";"W )=3F=,(7G=$:T:^4]ZC7 M=J<[":#]W#K&Q$$A<01H)(?Q+L>A*4.&U^^<#,D$34A.*Z8*IK`+,3D(0@W>J61J#QBIV@3^0P%A`WSJ>(?= M33=:=S+%10&*T2)[`)&A@"BFOS"FR#QNY&)R7/A&E-W$G;"9X)*AXHJ(:,A# MU$'U`5!*?,JO'*YX)'$G#(-C%PY9)+,,FX!0(LO;>Z#D4U.5K5<0_0VE_WT]F\AV^SQJL%%H*9TI;!XJU2;R?7V-M&V%ZJI* MB`FY#H%DPF@`,J)AGZB\9[93&[CVW>FLRFZD=F_%W?L)H$R]N\G@(;$5H0J\ M.PM@ZCV[=1C:?=2*SK'T;.\/$ MNSGKM5F]$P8IMA9RPDZL-%Y3MC$E,M8;R,-N]3FT+;O4JAO@O82Z_;MX<[GHM?JAN^BN MOLW^N.ZVIR_(JI18)ZO4>D?,4O69F"Z4:-L"S!'I-Q?OD,`FK*><:.W$.#NS7 MV6/]>.WB<'$Q9VK>]ZV_VL$FF5$XK/W1F$@+KYE>R*%ZIF3=V*2R8R1H!TF/ M`G;JD@[188$Z\W\S%76MH=QNCJ6P$[Y2]K9W:BF`7[R4B9X?8K M*RJS:7+X[BK:U6Y6PY4(J.3],(D8,.7X9;'8=MKLH/%7VU!3'6=1AN$=M?7@\F7Y`U.\Y_$P30=RN?6B:6)W+1&`[8_9D<`X M>/+:*KSI.S86ON\O]BD4,>4@O>!/^:*D0"W8[^OK",GFGF2EZ M855A@\?XG$7AD=ID8K_!1C^0Z!-VXX,Q2*`Q16EMG41D^I;X%D;.ZO_IAW4? M2/8%RQ]2N6CV]>I^=KW+14(0QD=#:`PQ5]"U58Y^OLNA!L@&X>,JV0X&:2IP MA(0B26&T0N'!FM+/%?(0D=J^>W8#]G-T4%,WG]Y$`,^\U&I*P-:7ARRQ]3V%_+$WH:W22I, M6X*VW@[59J2=;]#9#4[P300]"M8)TU1%VVBRE*""CM:HP=5ZFS*V(W[@+8.= M:CKEZWLNZZ1@T20BF"&0LC'JYF`)&UP=[H#ULOMXQ?].M^B#QD''[.;35;W> M6'PV_^>I#>IN(WE2S:PUV0H)P?*:"BK]>D**:J2]70MQ._D.#^Y%5]FUOPT? MW\_^=3NGZ]G=]ZGLO\]GE]V7V?S/JW-1_^[JXU7]H?YW7(_]CBEMDE?!29-(24U9`1.M/CSW(!O*./8(>U9U MKIME9$!'Y76]T[4&^$]6Y^'5H5#S(`AB))PZ-[K3[:P(R@G(3F;AO75&H^[O M@[73KU/"WM[..H2R#K>S5+%2%&M,W= M_=U3.+#3P.$B.22A*,%(E71Q0*9/*\%DVF?UL78BXZ+L*.]41\-,Q*<8)"/1 MYUBSD8?R6W"V<:=C]^4'E79D3 MU9&2."["+JU'UF#`$1;9T2Z$RT M5OH^)*64VPM9-NJCB3IU25Z\K4-H:MY*/2X6_;.?3$!KV8X`;/MZ;R[J$]W= M>NFE32!1(3#K)HX\B+/?0[RI.$9"5G4,"8NC"SN&8H9V*#+(1CRU>N.L$V_7'"1!Z)-G MNA2\49B55SO]W7[4"^5R)L)][$XDIR(F1@KB^L`%>"][*_C:$`(^FP M*Q=W)_$F%M=`AE1L4MH6=CL%@^AM#W-I!RRHL73=:?'J(Q?-[CZ7Z]N_ZAM7 MUP\1KBVY/W3/S&4YENIGAB#A/6/Y?->@FN+.)=8K%2,"FZM,TM1GYSX3`EQL M[RA'@M)#2+U2$<^SI)=L*-X/[W_K@Z[A8_CX_&)XUKHU+JJV.9=_]^J&.OQW_?BT_>L1KXP&;T MDV-H?.;(C'0MTO%.%5UGF!&O2>'0US57/RN68XWNWJ2^X5SZ#A:CLU:8$CVS MR3H@*2WT'0R3"&CR?%=NZQ]1Z^I<6J>:.1$#:.9M'(M"\!876H\H\DCH],;T M?5SE9.9^F2.:`L['%%W1.E;E@#+U"6)5N'`F%9F_R<&K8E".64>`V@R!%R`L M3-(RV11U1OU;,F'FBB-2,NNF(;\%?1^9#+`QBCH;B9@,!$,JECX(T9+: M,9*'LLEE'LECN;JYNOO<7=;;OF6)Y8?NKIM_>YWQ,O7"-:I&[,V17'XQJR6=0[)E*%4Q#++;8B;'WEKVPW!_]W._ZS/ MWK<7W=T^B^`(30!3M(H&,(94AJQZ4;)IJUW&TBPF9=H?P[IEB+SY^`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`8EPW`A MP"ZIG;C5UA8<42-_ERO[X$`K90J)Q!0E>K!29_;VU2NBA;2((;#9UF[7VXRCY;">G)Z:HF(Q(B#HRL0,S*#F`;]NF MK&/:)U+R<34"TFIE(N;@3,!"V9OGK%IL;V]&VE5MI9*;[I>/-.\N7_ZV` MY6=8Q/J;'X?V^K\]WM3^^O?=Y?/M?'[[U[)LD+^S(J;:#^SPTZG[X_ZY-'_XZ7XT=OWV ME'I0^=I0`:-6O"EDU)A[1F&C<&U3`2%&CI_-U3&IQ_>S_UQ]>?AR"CVNU@I9 MJD/IDTE:0''!6>P?1=B$=/L^93;3RBIPK[1R_U3_]UMW?W^]V-7KF^L=;]"/ MJ[TF9?`QY@39J%2+T9_J:V/Q#:MO!S6N1O,]Z-O93=_I9E.V^9W4_N4=G^<` M7]ALZ..?!2TI3AR9/G6"[2?\*]O`%X*GXOQI91<6Y8I1TF#3,_" M8WLM).V^TM]\^KV;?ZG'Q4[7*J2TL(Y\3C:X4-/82TVZKNGL-I);2P_;?WM[ MV=;=IRA-.@>=7*8:A1H45CS)AIYW4./WV]&)V\CX?G;_,%\XQ`_=U]GCPB'_ M\O%7=L<75U]GUS_=U)S,W__JKK]UR[S,+5-)G969'5E*0O.?7)#0)X[GI%SS MX.S,B&7L(>WNN/^_F\W+U;<-]H)[Z;P1E>%(-W!,EX`\U&%(3_&N36UC?`E[ M`N[%W!/H[<-\NTWO,)!R!H/5QC)!H0#]`[(O8FR`X-B>WT',_8#^_GG>;;FD M@8H1@)$R6#(1#`W9T)@16\*A#["D"SGWA/K7[98GCPRVA%0$L3O*R7F?>^*9 MI2P-A_`'6%$6I(?Y\>]_=R7=\`%QR MB#M[K&.-Y=12`I'TMD:RU7GXJ&)NL2\*D(E&MRWP"*:*)#2T_-TAX9YUY#3),EOV*7))56C.W\:FX6-P32(_6 MKYN* M'DA>Q#0LXB0^SYZ!HN;M)W)V6J;G181`8EVR]EGP6=Z)%5]\^/1P=R\W.$S9 M$28T3D>LS0<,4O!/*\AL-*EU/37/@G!!:J2=.D&C-E$K74>()&DM)#DTF08' M;;9$VV3ZC.BF*)OVDI?-!EZ>7"!*DU[,FL37\[1JWXNU=QHXT-9=#I&0*EDF5-879V(*8NB)6/'OAZN[J_IT,ZP$S>9=>:B=*ONW)/[CE!LSA9U8SO`63F?V.^01Z&3($D<8RX59=FR9$N,0IL']V,J:KO8-*9L,-72 M(=3,KU)":99ZJA,ZVR(,=50W?3H];1O^)8.U"L@$:P)OO<"'55GJB;\CVZ91 M?0;6CZZG[GT=3!W@*RS<"D*$A1 MIQB[*(8>]MX8U.V;XU'?`G:".!58JMI^+!5,IHYWU42J],_(UM@QB*A]+,'5:JE5Q96;E^7'N\";@>%&=BSIA8$Y)9$2F"M:% M4F1N+R+E<<.6S='N]#B0K,S,EX2-*H2`)5FA&*V56D*6:0SMJ3C`@XYU0JP_Y)W;IY/(D;LQ0-_[^Z1LFFIH*]`C3IQ#[[Z4HO.[!;7$ MG`MBUAB=::23-6Z5-:2J!YXK4([W2K2=%YJE!DUIJ\,HT:B&R%+$5E%=*!GD M<%B:0V"\B)Y'M0\"&2,-(48G(&>ZMK*5^(+U;3[,9NYO>F5?7MMY@62)QE6Z MIC;(E"-45US>*DHQ@I260U/"ZS!*\P-!V8!?@[/6H:X4`+JJ3?,V%8*253&K MY,]:FSY4_05 MB@\RVQI4I2L7`5N]J!\43('#]9RWKS!7NZF^@M8:@.(:2K\5R!P2.8*^XX6N MB64[;&0C(>)>L,/242 M?W-'"<)BTZ75QX_+VWU+(%,<:90]4/@A9*07A-)7+`,YL1]!?`[FT8+&8S+] M38'-)I&,RYOWVXVU1EJ\N$Z+]?H+_:OM)L*;;KU<7?V=3NB!9CO%U'\O;J2Y MD.;^6P[[)(G^D^%+_G:[_+V[_'"SNEZ]7W93C!(*,CA;%#D_2I>`!-NY M&D<"TA$'>*229SBJ;R[!DS>!3GO.9-V\09$0M+*B).^K]@)#\L9941\=:S_S M.>?%Q\7[;A/_6JRONBL.C-C.4_PJ?UY]%N%"A-.>2:@6@ MR#]WMXV;X,UZ]7E)GP&__+%I1$MMZ7#[J>ZZJZ^PHAK4"2L]DB3HSN1@ ME>XS`^DA,44N%/'E2C#^59>@TH3,:?3 MPDA5//DZC1!=PMBK1(Y/[!MM/[E*.]YQLA7Q\G;Y>0>+M?M-].^><"5SM-5I MY:-54LJ2Z+OUJ7A(.$+4&WBG\&DBGU7[B4LK0$4,,M#7+%8W:GCLVZ12"\WI MI+U@E8A7K/U43I5DD91(%3+\658%UO:!3*LQ\3+,2$7[_-KO(#1/?_,-?>U4 MJS'D6D!D8W-/4>U%4'PE\`(X[?;31#ZK]A,WWY!/M59H(14"N22OQ<`R9RK? M,+L('$#Y%6L_U&D)C/0OWNDX(B_>Y`OH/Y`WW[BJY]C8)O0'-G"O'(<2')DV?2#!?-F&)/+M+260+:O88;ZFU<=/JYNV MX/X@U8Q75]L!N,5U8W;[\>8K/>=4NMF(UP(J"DYRLAE$K:6_LO28]^T?/J]Z MK:9*.71#P)VJ7L:6>Y9&-R!+B6@$]L%'SJGN6W%^7I5Z6OCVX^YFLT,!^K!8 M=[B@6__F*XK!Y*XS!/IZE6(+=)11JUSZ%!:=S1.IQ#-J^UMWNZ`\^:HLUC?T M:J?TRJK117AEHJ9P2E53?!]&.%732&WTA`]0_RI_W>?DI07GA-'>I2QUR8TU MJ($&H,8J+3,.(X6.)XBF]HFF!"H!4EBL(7AT;75B*UH*3@:^-J8XY\H31(-] MHED=R#/FDJS1)H,W"'HK6LXB.>1(&6K,.1XKFMXKFBJE5OIZ:5M]HXC4A:UH M-8(IG#<%."WN4T3;2TBJ,EBA=`)I1>NKA=J_;U.-YFRSTK.2^!-E>Q9'5(LR MSEN3!62;0E;5]GH&\)65"UY,O1F.J$I?);B8*"3,D1*CK/I<($=Q%M]ZE$HG M<404\>N0JG/:1;6QW1%$&:2C> MT@6URDFD#&8K6B!/Y!)?0I*G%&VO(\IMM1\*YE@T"!,SBK05K8W!F\"7C\=* MY<=*MM MF./IGPNSSY8SBSU1M&=Q0T'07="VH;[2-;4Z#HB>SAC-@Y074^]P-]1*$DZ! M3,%*Y:J2]3Z5#94C9KZ82B=Q0T$;L.`I!";W4!"CZ.^IEPGV@K$_K[8SW9!1 MI5&_OGD\J+]?=Y>U]I?WFZNWBNMNTV;`M%=#, M+BN`1,$JV8\#DXL->@GIT MQ[*_B;!?/'X[>J7'[_.%3PR>##%\QYUV_G7 M$FURTD1%#KLGB'")0Q> M-(#59`",PJ)\ML+*(6H3BH-4&+X6]"QZ7>ZT^?=[-<3-;HC"E8HU%2*+10[=`DRH:B6?9Y^'[/LZI4 M[M:K3U-OR==07%,61GHS3Q;O3';,^QB,C)2!2G*0PE,VU`YO/,LF.R5%]C(X*CA*&( M[%#V_`!%B)$Q5#O0VXINY9.][Z#@A?@)6[A'-LC?+I\ M9S)D,I>J0+LD70)+E\O%WHED5(J_$N#5B3/H]G1#EBG[@HQ@8\$V'P/.#%TY M%?E&+R>E?A:]#C%DK9"+J#08W>BI!0X4%.3Z!6_S&\/WL)Y%F1F6C/RGBEA* MVT2N%%>J-/#:1O"\OF/LJ6.7>2H=9,FBT[$4``.4`JA4L,&;?345$(%E`>#G MIFYW[>__Y=TPH-"__4/J:P])=9P'1]_`2>M<)5=/GZ/Z!F0MDLI*?AOF;W9_ M"9FV;\1\3)('\@X_?<)HA$%;4U$Q0B(W$4GH(8X,6O-FF52&/>41.>;+.=$Y M"QA\:]3J6,%+""!R'Q*Z!I?-PW'!/OY)Y)RHK,IB*!$J5;>E0(L83.Q35=O6 M0?A6)W=G!\NYJX[4NP:'\Z_E3:-;Z@MK^:Y+QX#U":"<(A;*36V)FC+5G%P/ MUB<2KR]RFOMYTAVC6)L;_=PU#HB9P88(@4)6K1WJ$GQL8UQ##R\XQ\<0V##? M?`F/5'!UMSY"09ULXZ$7(B4;8DJE1;/]H++C.YL\)I\OX7$*;EE*CM"PX9.* M3*[-8)&`$8WM-23C8#CJQ/$:WHMXI(I_K8Y14)`A;N.E,@HP#FK,0\E;I)'6 M#(L89PMXC'J_4[#8+=[==@>0_SQX@J(Z;*@HWN8*)D'NZMXZ' M"KA/O=]:8?\_K4'1_=P]RCGW>&'2T*O*/FO,54DD1^_Z31U`*,Q[ MM@&9\1*.4)"#\5G[\CKI]1GP"`Z4<]]A*IV#%!F$KK5U^#WTQ+N4!!C-9Q$< MRR0/E+.U(=?=![JS%&?LPL3W&SH.O]QL_BX6M\N_[>[ M^F&QO&FQ9%PO-W3Y\UTCSMTME/^^^,]LVP<-OADI]Q?2&0H:JQV*F46*R&?9 M%#FN/`\KC_&7 M]..;]L?I!S=7V]_Q9K6Y77>WRQVQ];>RU=6:Q'M#?_OZ;;?^O+SL$OW9'=?N M,>_6>I0N("0=&TMX]J"'#F0JG(+]@B]VO+S6K_XC3%@#!Z`*A5\^H4!R:)2Z M])-)N<3$C.<%[]Z]O-:O_B-,U6J40D"ED0Y?6*DHONACGZ*]Y"]!C;OK[^,C M8/=NM>Y^ZRZO%YO-\EVC"F]K5O2[?WEWC!T)&HSW*6:%T29,$"Q:EV1(Y/Z! M\]4J-1Z4'2?NN=6>.Y]X>7GW\>ZZL:^/N)?[KS_55XG>&Z.\TU[[6M&3I=Z> M:0UM8 MD4K6Z]7[9<+'6#Z!D@Z,XO@`%#$F(_VP19&`P;QHM MLL;(Q7=B^IYZIN<(_3RBKQ3YU:(AA*Q,=JU[(+,&-Y9['UR)^ZY/^JC@ST1A M4:+T.#/RV4Z@TDLBV[GKT5U^V3YWTF%7 MA!I]_$<_#$$A97+.YZJ=R.3)@ABVK%P,[%[,RPF/5^1%SFKB#27MZ90:_74J M0@FKJ^BCR$;1-P(P-R^*_,Y.:^+!`09!=TMI4V/2HJ9L^P>'D!-;#9GK<)[A MM(Y^53F'X%`JRGK)YU+LK?*`A22L'8&#F16XG%"1J5YH"*GFI!"-S*Z-S.1^ MZ#^*(MCX^(5^,4TFKJ,UX*4V062?#,0BVP[V5QX(J3FW\86#64'`;$T.;BN< MP,HWHK8")BAKO?>VE#I`8S;P./X9E9FE_!-T>9GSFKCV"B$4D8(-;:K/2>-Q MF&&N5C)++P_O:7^7QS4U`N"EJ06CBSJ1;;<"^FE=RH@3\E7963;BW*?UQ\VZ MHY#MFW&"7VZ^B>>.GRIYN&B@*'R00:%/5M&K4YBQC4EI\A'298Y2><#I'"7Y MG-?W10L%F`Z$2/EAH%+<-R9A74N3!E903'+F_?+/Z^[ MKY->?Q^#G!J(:SQ8.;H4R=_$8(N/_3"15UI*%@4ISASYF"!'2KL?,J*%)]50 MP&9"3L8[6_L90XR1/63'>;P.E_:GY>+/Y?465?38<4,*L()-CN2#;>MF]_=!UMV2#[_%]&O;]]6ISM^XV^(7^X=-JL[C^ M8;VZ^[2A7W%]=]4>V"@^_CU%=/OQYV[]Y:?%GW\MUI-[9=[6$(URT5`0EQ46 M#][2Q910&Z8A1S09/3I^)L>=F_Y>SLV!]ZDD&=#ZY+TPJG'Z:.530#\"8C/^ M2(X[MJ_SVK-#5F>#K](WELN:VXI%[I$%/"50?"%WW&P^*L^31)^*'GUL/-`& MLPKMD$5T?,,S0382+4*$WQ#1Q-*Z&A*7\+RHGC!,CO/5YP?E>18>?>Y M`+K*OE35\!D3V?8YOME$V\S,>#WHFQ>U7;.IJ_6:]NNRZJVU?YJN#9ICV MLU^H,K;$2O&]""H(.FAE^@4OEPSGC>1LM#,E/*UV$X]89\"V;>,#9$1LV&T# MZ2=],F9_^*5Z4>VFBG,53'&EI.I+*0WQ`P:<)LR\E"EYY'T&]:;?UB&U-U?! M`>7N@@)"J,5@&#H=!?GJ*%W;`U4[]L4=IM;4&ECT%#5:%34F12$ZI1&]U2!W M[=G`H>1[8"^BUI3#":"*E[70YS*0,I0>580"DR)XB]=S!*$3Z/5;]^DKB>@O M[](]Q.-\(@YCT,KJ&X%!2#JUI;VARY1&:)[YDM:T5$]68N*JU6"#2+H4KPI0 M=@50U9`%YLB7N,1+*#%UL=`I+PMH`=(W2HS<>UERLY$S29Q(^,WM^N[R=EM6 MF$]B0Q$OW9(,BLP4&A<,:O]_Y%U;;UQ'COXO^VZ@6*SKRP*LVV`&"9S$DUWL MTT(CMVT!BN31)3O^]\MJ]3F2S:,^?9/4&L6&`,V<]]^0]<&A^`"773(V*;YJ.^UV M1DYU[A1&JD&LM$2>.`Z]EY?]=Q^>:YMW@?=RB[4EE0NGI#K&.\5+ZU"_\['O MMHI_N/QTTU/D[M2>DV%[*N9IT?U"" M:#,H9S'6%-K0UL-^3E8:W;JH8' MO#:5\OVG M(&VR=RJ1HLR_C6\#=T50"N37WWJ]?-T;[\',&[3=]KK5 M@$`W?PTF($`.'7TIV&)S$4@%#1P5=R(>R<'-J_:X\H]IM*GZRQ):[]9<_4.:.LOJ2JAQF!DN($+JLL"VXCWP$5FVN*Z)SQVAI*P5L=3*0Z M.@<'FGWYB')\]8;T21DZ3E_AFRI$S+1@$3D*P?.R0DG/D>AI[HU;2%6NJJJ(*(SI^ M=EJ6=272X0O81V^49W5#.EM-57%U\1A.G'UB-Q1![;$9Y5C>$T4;V0MB+ M\B'%5$(8QDI"-DZ"%;MCB(:>VZ";N:$0*[4$#4J'@41OLAOZ&P*1C(8VRA1A[2+P$4YX(0_:VU2LR_4JZ[>WL@J&.YYPJWS[5>-ZK;7@(;DI.X4FO MYPW/BM-[7K)&S?HK*&[3#XXXQ13XNRKCP+9E^YQW>*4U;(J2$D(PA MC&FPL]9%$NJ6>`#GU";;/P0RGJ7=)1#$A.-@F]O!7:/:#6?Y>()2M(^<[)@[!C19EU% MLYR+SV%N_A&+94_2@ZTT?M^W5<3`_^`ZXZXCYU6H>H]!):><1MN3TN%Z`0Q3 MC.DR8=I>QL/KN"Z*4;:XDDG9IIV-*6+UPX.]MR`I(Z:NT&/0<:V_]H#5&G;" M!:+%BJ[=DT-BFGA^E^[Z272\F\G<=7C(`1KG5/2V]]7QGV*S`;S3VJ#W7`VK5*'CXB9]PYU M+N4\TEH6"B+Q-++LM:T6#YK`R]ER$J$SS[S_=-^+(/IZ\%=X?WJ#\`JF^9IK M&0/_E_BTLJ%JC<.9Y4Q3MI_XB?Z3>0MM:]&QN^/N[W?H%]+*^4BHM/(=3;EW MAPX3#IS)@$A9_$2_T`YR/H&BGX(S1SX& M7CP-`774OFK#'FLD_JFM"O?[5`K^]?KZMI_:]Y]^NKSXW$=!RN(?V_^.0CVN:SA[$REF7KOX00VU+"PVHWU^1B:U6=]M-CX=6-(8KA6"!=3:YMX!$U?/0D,!9,#/)N(MDA=)E#N?3%NAA,)X0'KT*B M>^Y9M!,(?6L/UY-J,CJ`61F!F)Q+*?*LM>^?=? MEY%J_=?BZO3L>H>8CE1*(1;JU21?8XLE#?[`&I`(ONO=]Z1,^VHPLZ5*:@BZ M0Z?5H@%UAI%^L185)1/MVG5X$@WF9KTAZ>)\[LQ\UAK5^;I&`LD<95PM*W_; M:C#=6R`G*F;?8,BI&J&$#C[DBN;LI@Q=M4JA)!?K2)P3TJ^19R_1U_(U:DJ. M@R_E4(/V/00>FEA+;RH0I6[MI[;.WJ)O#5E%4'7L8S>V&AM-,&4<;R"$*)PH MIV&;V_Q')*CMQ%YG[]B,R<5&Z+.RT0%`'CQF5!I%`[89:,] M4VJVO>C1GY&^_?W;U^\'+=/MV?G'<;SR?D[SY.+S]Q_\^>1?G5YW>$)XR/WB M3-^0WOC8.-%N`UNX[_RF_C_^\Q=C_V<#2]PK^$H,D4&6#+E?+L\_7O,'QS_\]8^O5Y=_+J;:TS;?.]FIU@%# MG7\XN%E??'GYNYWT48[#-(`;K^*S99%0PHX>VSG;CX+^_=1[9.EKI8'S1 M9%.$P&%F#4,>AM%6Z!YZ#^/\MCA=G/UY\H_SY0/:3AS9V%3G2M:D*!;CC+MO MDN2LR\NV'I!L,I-B["+H6H0M@P$I65L[RT-%A65$V&I-4GZ!`]%HN)&@WW%= M+/DB[TDZ'D,F7?VHN_+%SHC.B4,<6Q0917QA&>*<5W&,KR/4@DDB7W(`,*'A MP>1_=L.\$/4/&0@<1^D.8&$YG7(]'6&K=Z2I"5"9=W(P[8U:_?#D0%`I\+T1 MM(D1R/.Q]KA<"^N33K*N*-]ZWNA2[,(>Y'S0V'3TCJKA(,?H[/VR=5@U=C@B M)WS]5IYY%N*[V47%5PJABGRQM-1&DGA*;8)1;NJ&>;V&>1G_6[&#J!NKG([! MI5KUR`.=.=26G"*RN_"-6OWP_K=X5*YR$-AZ;TWSK6.7KNH&Z.3#Z#OQ2/1& MEV(7_ZN1<\F8(YH""8K#=N=_7:@KM?+:Q\ M7]/=J[_)*V\+M#XQ1"&3RTZ5D M&K%TEAW93R?HS.W482Y5[WJ+T+)5(0..X.$Y5G%=3QS-+<5]O-O@3ESXL/BJ MX!U_174_X'ZU^'AVPQ(O.[7'?M3^8WZZ/+D8_F+N;`!5HFQ-]:;UI,A6+*;P MM;Q$(9F"K5NG[N/M"=OHB_3UBO7EKP?7%Z/JJ)`I>5"A+5W'1Z-WU MO5Z<7)U^H0L.4OY:U` M^X@^UT6'3?E,.?5LETH.D8:V1Y.K;,FR4Q9_(M%G*;T(0M,`S19K05/P0YW9 M07)BP-^A:/??2O0',,5?3JX^[]#4ISIT+A7^J"LLKC;-+"&)O3=)VR"WMYR7 MFY)C9T&?#%ZTF>)"ZPU93FE;;4F9O5<+5&+I#NS%%'TR7/%&"I5/_5?S7F/! MAJNEK9;SYOE>VY=1>/CK@!T- MQ@S!H<]B71Z3;O6/[R;=TQ^WDG4PCH.%_ACK.O&API6::)T2OO]EU=SUD!'? MP'Q7D%>/0 MS;5$E8J]3,L5"7.NU5A,_=P3&?(.)5Z;6W_L]Q+RZ0]6Y.N*G$J=2IW7A!P' M4DMME6M.2\:PEU5SUX.%655,?'D5SXL::^?9ZEK&:CDHL^*V/HHUW?E\V>(+ MF.:!/"IT`-&DY9KJT"JX@[L1.CV]NCTYOW_QVIZ>!LEW<,3`L03P'K1]B31R MXH]1)PD8_4XB'6PDV.%4>8:3&7Q35G'J@!W;MX`K;643WRD8MES%8[#%SL=7 M65V4RY#)VFJR,Q'N3.$0BP08DZ-?QVZ1[<]XU)X3XIZ$*)5;"@%7N\,D\')P M]%UXHA/S87%S<[[X^-]G-U\N;V]ZF0&V/OZEA-B_/IEZ7+)#:O/T'L`7Y-LXMD(-4\J@4-N560)%):$F7I59=G4&ECA$[$CG M'>B\)D^FEI550-':"?#78(ZM/4'!PF&-+2GX%&((C4);V8.=`6U[3\S;X^:D M%WGKR=4%?]?U#^7?T[,M.W\YU&K(08DN`5*LF8(=$`M0)2O3;`UR)FA>J+UU M6#N/E3E@Z>.[N9D2BPXE#,",EF""0%.C!-+=5H?+;R?G-]_N*GH/29&W'Z0L MD32'AE1C=;@D,,G!I62M3:G9>0KO1T795>"9-VS.&K.MV0`$TAPLHD;3.<>5 M;X:HB<>`IQ=XKF;G.RH'5IUYU1LB).L"9R+.*>2@1O26R>QC(X$_G)POKG]C M-WIQNQ`S;AML!-2F]M&M7+7.I2B#`XYK1Z62K$I!R1[D'V381;ZC1!UOM5+B M4^%3)UPO`8VR8TM$DI.N?#N)KLQ799O-`,2S4IIZ#.I<4;:#L:8T#`#;K.1D M)"KQ+GQ(LXQZ_65Q^?GJY.N7KL.HT_)NOZ?._OW]X?/<"F&8TF$@Y#RR?7B=?3-JVN.Q?Y=^J5N?T4CZ.S\"""&4S:^U7*2MM3245%&F.P>%.OI+X M!D19M-:R\+6O?.O)!YG2M#$S&?6A3OB]9?]CK M[[&^_KVCE!Q+;4T9RYF%(T)0(R(S:<@20D9+4H#GT6R3*"4&\OU4EV(S!]4> MXM`L6BAF&:48B8CS/,IL$:54#DU4/X0<>^1`6!(,1S*W+',_,)*A^GF5VBA* MR1A!]YIMU!4[M56@`;@A*;L^2N&\A.6I5*GH`*X$!XUOL>#! MQYR2C**4%0_D>\JW-DJQ[)_1-$TUJQH=7B!4F;_*ILLV&8DMA%AAZE%+2&7588$]K(&:[(#)R1,%.' M-,L!'U,B1Z:<\32'Q+D%M);&@:(R`2D!&@^;JF^LV09ABG$MU%H4%LK$CA&U M'E''6P%QHUOEGL+U'#9,:4:%V/B.;JJG]Q9\',Y6R!@'XQA"KZ#(F15);+&3-JOR M>*\=7\_7FP_=XA\X`2,7D6)R'*!FE1,&Z/JGWITC%G&B`?P'%;Y7;[)!8GL\ M=5=*`-62L\%DCKQ2&^#AH149MDX,C$U+LI.P<^?"]''/F)"]+2J^\E,9,)]# MHRQC1)`;Z7#"SO7H.&(+8BB*5U8GR'D8D/3$%[MD?7-R_7<5EJZN.M;9'5;: M_4=6(-?T?R=7'Y=?_JMC^E]\OAMLG3\BR^\9H=?ZP5@V1)R=WBP^+K%H?[^X M(P/Y='GU1]^WOUS?"FPUH_L\$MNA]0E2XH1SN#B#L'P'.'5/!8+/== MB\L/UOOMP^__S]Z5];:1).G_LN]-9$;D$?FR0)XS!L;MAMO;BWZ4+;I-C$P9 ME#0[N[]^(RE5F605199414FV`#>@AFPR([Z,,^/HL*S.M^'8-R9PJ4@9Z^30 MNML)HH)"$%Y9MA-@?%A<7\S??7ZS/%_\:W%^L^L(_7O^Z:::C7>?/R\^S5<= M?K.*"1F"1:(ZC3VB58;Y7="Q^PH!=R9'/C]^W[;?OUG6:J7;5L\:>WSX?YPOFXIOE[1=/*OL;&A*W0GZOG-(Z2:.`^?^,8%*M@,RZXJF1> MU7?68S3D)!QZ(<@+O[[P"7QUS/Z:_XT__#IQX%7.%JL_SBYN#@\U'4>.8#.SEY/3T8(44:;" M,1NUNYHX-DL[F67^Y#4;&#@WDW!"W([BW\N'=+``;F(I`T;*)E$M*Q2VY'56 M_K8P$M5NR_9W+*6P,WU*(7Q.8*Z_^.HI+5E$B+K&;^SA.TA!5#>@#2E#\[C`ND?!,X'&#"Y1!V,"J53?;%.I8 MC[0743%S[A71:1%=X^B_?5LQ=.NCOZ_?<_6[?__[_:C:&).)'#]HJH/GDK7M MN+D`OOB]_B;,!+VB^F!4U=0*6/E<;!3!(<,KP)/WHB^L;N:>P,7]85"=/"\7Z^POB]Z!4SF8DC(UMK4$=H[W`JMH)E[E M=2)D'Z6"@7*=5Z=*5%)'X1G49M*Y=CKM=Y?0S/!56">&],$J6.?BHV-0,5J( MZT+>!E9RM+NCZCNLH&9TD@SZ\T3UU\OEOUB*YN>_WE3NWC\<;8*LJR_%HQ'6 M!ZNU@F10-76%A02:OLP0K.>SG@*S'>X\?TP>EW6M.Q_(@DRZB,*Q1K2^&;.M M0R;H2X'?-CK^Q&#H`P+R[>+LT[S]OMTRZC$JUO36%J\@:R^%(E4XPO"QW&[X ML3:05T+WR9,^6:;UA4+X2!V7J*Z;%P)DCB%+1D$TA>`%2A1]F$ATKYA,H>,H M(<88V)]G6+25!DM;'1$T]KTLU5T#/P<8`[VZ:?R#3:_.&96DD3%J&>N8-(9) MMJ(#WNSSZ@AGRIX4L&?GT(V*Y:,B+B>-26R#G,($09/+IBWYM4K`7A#%3.`K MB`-!'-^8;3TV6-1(""4HKS7*(G2#98FX.P)^,X%I9N)5(L<#\W$2*9+($$L2 M9%U$#76Z3UN$O[OX9Q-%.:.3O"P\.Q3?W5Q?79\MSQ?+OW:.]'[^]6RQ7`\X M7%ZOF+TW9Q=U'\OA,?ZCU.(3NS(E:Q08J!C/2IU.@=L# MV/3#`#BT)<#7B7X4`\=L6;F0;9N)M+Y8#&ODY-N?&[8_UEK@*0L#%6'P-J&. M2D?^SZO&Y%$=.-J7%3E=]+;-GI>`R>/"-T5*>E\`;0HI1_8>;5.4Y)+*?<7M M4@+]/&A\N+P^NSAUV=AVM5^)RD6GBQ=))W8GC*QC8C$&*\@7[/0C/@$TVUQZ M>4`-%Z*M:6?H,`F#444H/F86GZ9"O<)BT#VAF)KER609GH M(=RV\-NVH2!1MPOUR/;>5[C&%2L9@B_>6V3!PB*#H?8)DG_LXM33\/^*T[1^ MW59SMP`#ADKPBK*%3"";R3.!+5='"\HC>[M?X1I7K+P-M7?:%?0<'P652CM) M(Z-2G0E!LKOUXR<"ZCE645E4F(LH5*=*"ZLC)?/]`6QW+MUV)\%):C,&LO"' M`/91"40532E2)\C.2<5_4C,)D?C_[-XB*N=.E`5^$D3;C_-75S=?;P]2Q]I4 MYJ8ZQ6"^/'_/7WN*#@&UV:2?DRX!@H"B?2JV+F]N-*B2:A.MY?K=D6.R&5O' M,33HL3QY:@3&+Q#>1`"="(+Y74L/4Y'>K3>.W"9I8R:W!X%1;-A+06#\^L!- M!(26V1&A3";EX"#(T'A['FV$?@18G_U0"/QQ><$?4Y?4GTH/;=5>:!G`&!F$ M@R(="M\N,Z^CX$4O!B"G%H)MICP]"..KHDT03)T<6^J&!>\%.!:(9-MV,?+4 M"X(!,!F$H/ M38?`;3WEN\_KWU[YF^LOEZO%_\W/>TMN]C]MU3WID8@M:`Q:UD4VS6PM(FU2 M7_6H!372E)A]-(S#H7>-*9BO/BVNSCY>S.\IS;UG<$OBR$9;J%MJZG9UJ9K' MHTT2G.@P#HNNU!,IMAD+4(&TUET".,E MWE\6'P^,$49%R17B:$LFPQ+M@VZLABFFNYUMQ/?VI^+CQH@YOSSG^&)QV[YT M<(#5_DFCV4E()6O!]K2`E>RX-T4+JLC49WI'Y>%!DD[+P..M3S]S-PU0L"8Z MK".!?+V2(*V`YH(:B_L'`^%,C>&-CT'SJ-S?;M;]V^KR:F\QZ/ZV+\&:$Z/` MX!TY(R5QC*,)?'2:_UE9GY:AWMH>.4?FT43=ZGXX\M$MN>WM[]Q8_%HHQ%",>.C!0I$;0%)DY2[E.! M:BHV3>!;'\&>^V*/2""4\^"SAHS*:B\:"T'14]\$S_'Z+$_-H&'!A[HG^"#+ MSK*40@4#.3IV3]J0EL"J?;I?JYD>XREW&&G/@YWWQ')!6^%5]")"H5Q<-*&5 M4L\DYU$Z%J=DY]50+W-,'R512#X$)ZW+T0:,M2+R+J@CF?<6D1#.[!`! M'Y7("F:P.U%S#UD?#RN! MCT/>>&KS3L_FCK$>6S9*A&06WD6^50@:P!?]W:=#5Q=PT.X"CDEH?3*6CO5Z M\GW,'!L4`B.])Z69J1G:Q6ZQ.GK,4ONG>RMIM]7OQ^+K6&\B&_D9D=D+DBDK M*$%'DU-;'^64]&N^VK?N!;&UF]+=#FODL`"M)'391]9P2N@H4;\&.<<4> M3LJHK!S>4PI'L%)F93'X!!(,LLLT#DP%5,K-2_8EO`4;DY`,H&963?VR, MA&F>_P:GH\B;R-9#:8F4,2E12K/?HJX,5+W1L>Q)1XU,R`ZG%M^^,3O_SMRN MRR+]\OP#?_@5.V37Z^]:;U%\P(9$S9"/\08OAW54[#Y6IU^3_\CZYZQ7/^(?EV?+YA>'%GM+B(D=H`!`+M7ZL:#8^+A0:_AT5P"GI*@?LW5` M>_GU:W4`SBY^._LV7_VVJBNEOQY:>!M5,)0E.G9],\7"=H+!LFB3=;KKY]F) MKN5A$A\A>]:SL$DC3($B&,-BL&U>P;J*\]D1.5SVC'-D0EW;[#SC"`BA+;7V M14UY1^^R+F7^$>B(>\JT\3U]T&T-%%UAFVZ+$AY*=`8CWU:MM;(ZQ8Z">8P2 MK>?>A&L87T1HC4NR:@P%8K?<\1Q3^FI4'WG/G"ND8C1^XG) MK")4)*=5T,I1*-C4$))RF/94<0JC'DM,#?#?^)*A$[^AHMC5T39*%YDS6AFL M;5](39$&,=ZNRPHZKP.:JJ!_$K MS3_/5ZOMC^X4#UT=8!^&1-9#-(9RW0^5HV;?"G.640G68GMFY[U\[KV?7Y\M MEO/S?+:J[Y.'^*2#R+$:PE0D>U.9>10KGY*QUD*73[]T6U1>**.&Z"ZCZ]:_ M8CC^4!;K2ZIMGMY"B+MCCYA+W9%Q(W#IR^7%^7QU=4M5-U<'FVGE"363D-*3 M4\(Z5;0--CK=C.*U7EC9-7?0KYNVZ#D!N377S*KD"+S9F&N*A+9H(Q6[BP:A M&5R&>;C:7;6L2GOP?1:T#U1\2#YQ MC.12?:@4[+YIUXBT<9`Z;PA2*.SW1W3%ZT`[;QI.RYMUA"ZG:MB3R!\:G('Z*8HM)612#LK MK3IM5D(_O%`56CFX3,NWNT)])-PVD?ZI21 M@T@2E1*1`Z541S<62_ZK_7[9J0D=E+-"=,Y(`*R/[\H9S*4-FZ7M M7.1?:IO7!%3N=MYME7SHB,6LUQX9:30SOWW-*($#L6["2$\A;>I$ZI/01>D4 MF%H]@!*C;OV>$`IU)OB#=%.HS^'D'J\^K?$NH#299(A.F*A]Z\IG=N9/HSZ' M4SB*^E10ZBH3#"YYC24G1XUBL=K1:=3G<-H'JL\,T:G$CKM0',0(EL%-`.$G>8SCM0[U/&T4R!K0/;!^*S[8-,&QPI?N<`>P6 M/0M"AZC/.ILG:)&#AR(-5LV46UFUI2.K['WB4&NX=9Z^]HUI$@!;Y3B`I>(8 M'7GA@M"E=7<2);UY9=LB$]16;Y>9]!`RG-#QHPG#;K1:QMY:%IT8Z)4*NL54PF1B`OV6PW@'"8T"LA M[-`8HZ49_YP3`J+(I3J+2`L7H0A)!1K335*'WGJS2JA]+"#KZI%57T'4Y-6( M26MVP4(1F9*7B!!<73E^B*5!*J0B*B89NG8OM8YZ36?:LB'TOS_KWJ]V2J ME6%S9SSD`8?L6%V;=Y[.[_^TC?S9=DA:S3]=_K6LHZL_ MG/W[_]F[UB6W;63]^YRJ\PZLR7K+6V7'`,$;9N*MXG7+54GLC>T'X$B0AQN* M5$AJQMZG/P`E2IJAKA0I@5+_2"QJ2`IH]-?H;O3%80D;12]3A^<6T683G)LM M`28N_T^45#4=&W$MGBO]>N![CEL_G"8UTW3#.)J-E6P9JXMLVR&&2/.B7(AX M[F(C$@767I8$$^IO+6RDU;%NVXX"K@*J'J7$\4S=MTG@D*J\@NX%;OW(B9J= MCG7;ON0AG=OJJA.8Q"-4TPA9I-%I@8IK/*#7O6Q'C-5C`P%FEO_!\FE<<-X/ MLG3\*8O2;%YB-_S^*=T8"KZC8D&@>QP`-E?2.=%-JKH^125_\^W?1G5QNWM. M!XWW!`384>7`57TBC@0-1$Q;M7QD+"NV88EG/(VN>V(E"9*_(`$0>!Q6R+0%^G/1*V?'5C[;MTGF;(H MUI7DASH<4QZ[/U]:R M'!3XQ!.MYDFUU(380;U632\FO4-R!X3:&K>!=%J5[1&%6PW4=$KC8\#FR+9>;S:Y/2#WM;*^Y;A]C1Q/= MP<^.S3=DK@=3Q'4SZOL4_ MGRA71`Q<3SNI'_V=?L+N-,NX9=^"^JW;Q`H&3UGC=:Y^B[#_37I( MT]EO'/A):+%+AFL>WZ"0;ZHF=2D.'&PO"B\C'-2[E]3\DSVBQ0Y8.)PC`N)[ M+G(,*[`#1R>5MY9KZ'8]!PW[!'38@0[3P+;J:S;RD.M2AS,(KCA"TP*S9J?6/.,](<,.8&@J MIER[0PY7?DQNN"'-JFIJF5Q^U-,H]G4;-:>#<*_.ZE/&'&8YE"K%JJLU9A^KT&U-(V%(RQ=-PDQ;I[J+/%WCNA^N]'V,N4Y1KS_01P+- M_\#)XX;Y@Q?E)6UV!8U1BBSL.QK"GF6*.GNX"OBP5>S5O)4U07$RRFQST'A8 M)8;J(4/%%G5,W2/^HE@-GV%-W-4/Q$XYC3,@P/!-GYH(FZKC&EPB8NPNG!N& MI]6<_5I-6^H#@1HA@+,*TEW+%W76':JI@6&BBC2N+A,"MCGL,'&Y@1MX7-U3 MN;GK!NJBF9_I::BVT]4S-Y@YX]!%\7(?U_.)\?EX9VLXO\>M0$NG@>,ZJNT2 MBRXJENFFZM9J+IUM:YGBS6!P(U@H`5 MZ(B(NLF(*Q`JM6VZHD('M';>T?DFX#Z$V3=N'9KNL'3H#$157@S[)J MKJ9+)6$C9%'?(LBP5%\5%>`,OKN8%0-B0ZNKYMJ!^^X)J;?#YZ+;FJJCP':Y M"'&)B@+3KIH&F#JQ:J=*]7@:R69Z!J@16_,=XG&Z8=>SB.699!$`IIE^O>7J MA9*PF25C>%0U;*KKU!'11DR3JSA+4Y!JV%R47K!,S:D+^YIGN6OJ>6PX'30,\\,ZGXAK8F1C MC0L42A?%$*D:N/7)U4Y9]QU:J_,Y`X@07VM+UU2B:YJMFM32G<6>[QOU.DT' M8D@R0C7S,'N.C7WD&+[(*,2N:E0DXJ+;#>J>J0-WI=9IM$/-HP03XA.^_6@F M-0S-\$VO0KYGONRN*C*VI)C/692YP,%\^A;A=K5MZ;9+J@P=@V_>=;_2@=J< M9)1J9AX9JDM=G6I4G-MIMD7UA>]-6);4HW0@86? M'MFZ&:B>:$FJ.:@J@V!2UZSE&QQZKK>!1B^:_%_ MIGDA4KGVTK.>]=AP59%%@9!.+8\;;UQO7!3R]*QG38JJ7%`-E8?3RPDV'&LW M\UVS=3Z?+_%]G9BNIYJ8KZ6'*K/-PJZN&NOF.U,'))WOCI89HK6N8Q+DV::M M(LO&[J(GIJ4&=.WZ4E,]S7P_CC:]Y6`^MCU*;(MP2](W=5\3P;5&5:1`?1Z7 MN,C=IQ13LGNFFT?9[@QW<*ZKJ3:WAAR="VG+5T5'T,H%+)IQK:V+04T347EF MN(-7#9]H+K?Y^**HU.78Y#M3A4W/6MLZ2D6FWOT,:P\Y81X-#N913]-4"VNZ M*?Q#Q,6^Z2[J!B'DKZNU@*F.=7.?^:T?8YNSV\&?MFC6ZA,:!%S;UOW`H%7U M#$MU++RV01PELQZ\$LQNEQPEHO")I=H>5P9,D?3N+]Q]AN:OJYZCHEK?KL-G M=S_\?CNOK?9K&>WW.RL^)%QO*$5LE'A1Q@9%$"59A+'(*QB6_^^?>XN!M&CTI>_(C9^YL1 M?^7;43B.XA^W7Z(QRY7?V9/R1SH.D[OR;WGT7W:+T:2XN_G[M^+NQ>-QE+"W M#R4Q;K&*7MU-PJ&8]]LBG=Q:D^]W8KQOPSCZEMP.F$CDF'T3)4-^=4L0OV6/ MGZG>&K-1<8NJU\Y?(JY7QY&D&5_W9R/!XI[%BPM!567`XGA^S_L;ONSB.I^$ M@^KZ<`*-P^Q;E,P&&4Z+M/HB*X=5?O,4#8N'6[Y&?#SW:39DV=M!&L?A)&>W MU8=5FHEWK0P\6WP2"6EBN$G9JC)+GV:?\>+>=\5P^3%;^X9R,.]OB*5/OC][ MQ_+=:]^W?)0V?1#CQH]JASVX:?+SY>7X+:)!&,_I?9\613J^>\9O*E^K569: MO9[=_^RKV6J+;W8.?JC:`0WZ]CS2AY8%E4K'\N'$_N M?L(&FA%$W+*@#A_">FHOADMN3DZK-?2IRY&6*%1>/LTDQWT:#V\>1\._OR6I=-D*':I-+O]:3!@;#22BFF/EX_! MM)AF3!E'232>CI58J%[*9%XH5>%J&8L>AWR1IPF[>+>9Y#1OG\23\FGR; MAEG(-PTVY"(GCX;3,%8>1?VLO,F&J7:@M1VP_;6/*)6V!2=9EOPLJ+F2+?UK MPHF:<"A%946)+A#4*B7/"JW76%-/MGLO>:6[_;QU=MK;9H&=[&YQ.*J,TDR9 M)L*MQ09%)'QN;:K8^P.U`]OPO'C=V^K;B=8]20.@O=:-]'=6*,MC"KZ=*I_# MF.5O14R&,CND@,UUNR6(*0%+$/;/?4GX*\OS6T69%\91)FE6EK=*1TK"!`!7 ML9B76"P$%N/.L-@[R)FM[8^R\`28BF?=X=XH`I0+2'Z:0;(;)8QP)6R83H6V M?(R"NG'QYK]6GHK7]#U9UJ0]9_(NVA[C;>Z"E)TH(-@Z/SU[P7`N"E(@_*>X77I'\=BLC;2/#'J3K1Y#4+`(*(SZGM@*@ ML'ID!)1NO&H8QM3T.?74/P@3[.4$>V\/0TA1=R%%K=/VD(`B^9BPOR&4U\EJ M&K`:L-II6&UO!_QA^RVGR;5XR>8U1)0B5=()R\HTV$.\S1`0>=T!D<2$<,B3 M,<05;X2GDS.]<&A*(81ZXB-2U!KN-M!&EDXI&L%`?2`:X93>ZDH`">`T]7# MJ;W8\RN!$QP!;"#LEY2KA2^BHKIAKJYC8&6A:#_"7*4Q<374WAE"8X+)PCO@ MI9/42P>B#$39;F^=89Z?8++P#H@R$&42L2.(LL-$68N1'5;% M&`ZHOY`,XJGXL[A]5H8A*EM:C2><;[A5"349Y*S)8)XZH[\WI0?D+EEP\1.$ MF@Q0DP%J,O34?`)6@YH,P&HRL!K49#B6*S^S[#$:L-(D.B=NI3^5E2*-4!Z/ M4?>)@K(L_+&.(H@LZLA1#:G,9Y%!_4AE5MO+J.PURX#T`NDE"2N"]-I?>G7? M2ZT7+'.L]()0R)5$NR9NAXOKZV*T!2Q9EKCK#1[V\0M&0VL)1(`&0$/OT0![ MP]'JDT3F8*?]:<>B?==_PZJKWB2+TDS)*U]ZQH91)^K6Y;2T?`W=HMMI/`L. MFA-L98`[P!W@#G`'N#L[[J[=I?=2]8S3O)ONZ9=6Q:ZK!J:7ZST'9PC`:?,1 M54<5.P!.`">`$\`)G)--"?L[*Y3)YL3';O@,"GNU3;Z+B!/6.JK$?HUUO<#C MU%$H'D@RD&2[)1D46P5)!I),1G8$20:2[/Q&:),J0/L4]5E4`/H\>&##:O_BC_'?Z>G"U_H%!J/-EDYFL+'+U1UE:(:/+^E[/FV5#?F"NN^F_)) MARJT:*54HZ40-R!N0-R_']S5)^XUKTF$VC41G\UV*@"#ZSH;*AV20CMGV[@Y-<7]" M.O9/?$I#NFO9A8`;@1N!&WM!1FE(!]QX[=QX;#(VZCL?NFDV2;.P8,I]F@P/ M2<1NW9R6A22M16/V*::2M-9`499E['JC.NM^U#X#R$@N65CI.B4""`00")*1 M2Q96NDZ!T%I'"EF64486!XD`$J$O$F%V8&.I6&V-!V19S],[%O;TTO3>X_`O MD9&:E)E%(M4F_,:2P8^W7W_^O#W-Y>H+,+977^?2` MLWXHCX`X0!P@#A`'!\1=FVO[Y$!>2]1FMIJH`. M0,>EH8-`SSY`!Z`##IC@@*DMRI;9MLJHS'^*ROPG<`ML+:?97E^A2_<&@/\- M_&]'`*TU70^`!D`#H&VNO`HX`YP!SOIHGET\XJZ]_:O_US0J?B@Y&TSY+1'K MI/=K[Y"D(O`#@A\0_(`;6Q^WUO(#X`'PN#AX4$`'H`/0`8=(LAPB]=U*<`D"1QO\NY<@#/`&>`,<`8.;D`<(`X0=RF( MN_8CI3]8&"LL+\*BDTB_WF$(0^DV<`>".Q#<@0`3@`EL(H`.0`=L(A);(W)Z M!%HG[((`\0! MX@!Q4B`.E,D.+;C+,M1VMVMOBJ8.6F6?%52FUAJH=I!&%MX`)Z*\>]6EH4MO MS04/Z`)T`;I>I-RV5^@?T`7H`G1U[N"X$IC!`=H&P@9AE"F/83QE2CI2)G&8 M*&&>LX..T0[@,,(Y;)A.[V-V%`RE=Q>TUKIN)_EV\FD?FM[I9FL%K9L33!;> M`9]N3^@(D@TDV^Y:Y!VY\T"R@60#R0:2[6Q,B+MR]H!D`\D&D@TDV]F8L,6P MAJL7;"N.MW=%R*>^]OZ5SROSBJ.$O7U@I93"*GJU,D#:;%[TJ&EM&]K*&@Q8 M4K!L(S57WO),V(@>(>5;HF3(WU!>K_Y,DF;C,'X&)"SN6;RX)*\R8'$\O^?] M#;HIKSGO#*KK-73Z$HU9KOS.GI0_TG&8O!SY.,R^1;BG]6<.ZBC3#M(BAZN:K"@"V.MYWT/ M#V\YM/@.*F^G;&UO;)VV M7](BC&&$L<@ORY5PXRV?V:1@XWN6+7^6 MH#>;[E81;LTE>'J4B,[%HSA]NGV(AEQ-Z>!\6Y`/L-`*%OX]30LV7)+U4Q9Q M3EY>1QMQ80^*Z)$IOX79G_.SX'5WC=(5EO\@M%9!]HWOG)TK+QYX_2M[9+&" M#Y%\@`9`0U,T?.8_$XTX*9*-DGP1I;[VC_H7$+(09\"!TAK4>RR M+.,FRQ#\&*?9K$$$]$P$0!%+D`4@"T`6@#H`(@!$P-6+`%`'3G\DU'MWPK^$ M4$K&C#\IVJ6&WU@R^/'VZ\^??V[BRKJ>`!\!#[_&`87L`.``>HA0`P@!A`# MB,'13W/Z_<'"6&%Y$1:=!-GU#D,8LGO`J0=./7#J`2X`%[!-`!P`#K!-P-E/ M!X3]D.333'28Y&-(BBPZ'&2!XPP@!A`#B`'$`&+] MA1CHAQT:99=E>RW:/;>.I@Y:#E]*;84=I)&%-\`1*-'F=&EPPBK`">`$<&J) M7.TU6@(X`9RN'DY=."FN!%=PS+6!L$$89%2&?^MK[ M5SZOS"N.$O;V@95B":OHU7BQ(E7"3R.PS^14NK M,KL4M]]&!5_TP>R;I]E8[M-X./OI(1ND65A$:7++N8ME8L3+']V\=///O[R[ M'WZ__3QX8,-IS#Z.[#A.!^7K/H[F+?0^Q6%BE^Z_+V)A9__C/^WP.__\Y__] M[__\\OP5SC3G8\AS>_#7-,HC\:[_9^_*FAO'D?3S;L3^!T3%5JPK0J7AH;-J MJB-T6!NUT75,V3T=_0B3D,1IBE03I%V>7[^9("51MF3K`"60PL-,%V4>0"+S MRP.9B?YC[@*CB__$X.*W\2`,N`>#%A^\C6C`QRR*F+OA0R+C'BY^L/&G-Z.A M99C-?S3^N!V^(9X+/U`G?M\;#5N]D=T<#?K=P:`]NNY;=L<$,_=3AD9KP5JG3PU2;PB M)WF@G#QCAX,TC&G5FW:'W'F^#Q^1\LZTF1:.G<".N02$XB^O]^79&HXD7I(.D21PN?DB-0/'+@^?&TP_-KC!Q M4D4&>LBG<\X^+/[Q\:GN60T\OW.RU%^-C7MB.^R]B,'`\RV@SJNZ<5U#9X]V M#WW0-`]^M+'?@_MM/)UMEW>[O=$Y#+PZ"[V6UV+B/5=?4D#A*/XN,EW$W^UA MG2TG8A=0IO@*%95WEO0^YTNM'->TIBR'0+N71X4URN`]FD;-Z.C6>\6!4+6P MYFL8.,_@YOVZ`<^G-`)CSN,\8>XAVJ]R1?I6S6KIPYJU/IKO6JKO=LPIO[VR)0T/BIDOR=]J0C6 M*)L$>[H]GS-1K(B"GEKSE+O896`CB3BWV_[/M@V(8G8/-FQ3W*"QW:>WVL-7L#@O?I%C;E+`D;TKT"$]F,QH]BC`^C/;] MO2`FB9;4S"RP!.E)PB3F,1AA@".$BN#?,X8[9!@W;!ZSV1V+5L$RVZ@17`\I M[T^W+*8TF,!RN$F$P\=-BT>0'OQ'0!@0V`5/#FIX&B8<-,M>.U]:3'84D]=V!B]03'X7/[SB MA9]K<#U8)CIAJT7_7[#P8R6'.L23");C1`]E=25\%1W9/5+T^]07;5=I3+XY M<;AFV4L[X;>X".U9:X]JF[P>':]5@$;*![55XEN?.QJ*0<4LA&MDVQ$TV3EJF MUC!V8>]UGBJJ[`FFN`_#O59!N(9^HN'A<<%V"2E<:$@>-<4BA>QSX/B)"PQ% MY_,H_.G-:,S\1SFUJB:9R6RFF=;53K+DNF2._19$.\T`",ZQ_0(>Z12Q]W15 M4[W>_`1O&-"(C1*\O885K'#_O1MQ).&=N71K"/"T!+Z(R^UD!>#@> MLKOX^F=:Q>ON7<<],@>#EFU'/J$SH#=WG1QQ6Y MBU%G2CA\C/%%N]<5PY$@C.'W!Q8Q[-KCNI!AW1+X-_6Q?''_I*LAW[V=K=>?R^MD>6V5N MHY(]<3_;[L$M=/=L9[MZL'GP6`_^I&E6LO>NC_'>KV@P'6"[JXR6:W:(-?_Y@C-X[-J(N[<>R9%YB\`.N'/P M`R$#3=8O-$[@?8]%X*WZ?0NDB\.QW>(5XUZUH%@G)6T+U-0;3>-MBI_$31A( M]2,QFZ*MF+1L&IW1<%0F31DV*JRN+I(^&4-<*HI?9F5;MUUO%=^;NM3Y_F^+ MLP.JI>Y;=;O=S*O[7C))P*@WA<+?YU""ZE9HM^1MN*NR[$5K+*V8"I:!L^J? M9MV0EA>HUN)N1,TW5C[6/!W&!5=965Y]0HJ2G<$F:K+(N5K?X M=I):]UV"BV77.^LNUBJB:NT#X-5UL.RNM,BR*HNN'2SM8!VN?;IU6_I>BU8R M%^E@-;9KGT8AVJ_Z0%;M)I\_ M;+1_"JU:])%TH.^+99:B*#/A[R>4SC_T'`=3UX%F@_1@U5[@7D=1&`W"*&)" M-_%]"C2'[4&_T3.[`\MH6M?7ACTP[>R@W?:H-RC^H%U)ZRD+*E%,G*] MN+`G&.?AJ'6&JN[T\O54?N2`'*FS.@O0)3TWG.]Q7YL=W M"ZMWDGBNZ"L93VE,(JQZCT#,\1L!B\5KPS'8Q@`WX22`8;DDIC_)'0O8&*OJ MZ81Z`7:$(BY+CQH7?Z>GI1Q_"Q'>Q MC8#_B!74\&#LLQE+2W9P(`F,+XKA.^+5\S"MT.=U0H`P:0I`CC(PT<7D*+S% MQ3=Q[%P%\PK]>T9@6;'L/Q9?FT=HX\/$^93,5VX$]\#UXQR45SD)+,$_WB? M>06^*+XGU/U7PN/T]5X`CP%O!?`&OFHQ$#I.`C1!^N)[LEE@W;:@9MIHX#Y[ MPSV,#@=`D6[`:GAB=@S#A'G>KBJX8<0AQW9<,!P@&$V%CH":G1*ZX@6>\0*, MQ:7@Y=3(P]0#0KE@UX';0SQXF0/_@2^#WA#V'L7WC)>,!6^(Q3+`LS#,[(S! M+->O<60A^:DD1[K<*P*V'&.TY`^0L6-1-V^W+7LFG!#8E@T3&EOD%_Z;P5(F MR8@9OC?S8G'_',0:ZP#CK(\'-N,(D5KX@G#.(O$7`0!A@'T3IB%'#."`(]3G M"]S+7@/"QT'&8S;Q',*GWCA.;YA2#O]S:XAC#Y[OP\4]J\'=,_HO^(F-QR"1 M*"9T(;4+L#7;'WE^'%C[MA(R^&KBQSP3\8WSA4&&V&%BT4X")PB0FD1L_;X\ M@"VFEX]B\");$1O[R)M9 MQQONN1DKX@M3G4"1_\-(,$_*O,AO$#X*`Q6_.BG#4Z6`3)4[JDP/1MK?8W1 M@`ZI%HR!N=@]]9.,3^&>3`T)!A(4>XV\*^E#5MM)?2V)M1C0:C2@MH'/Q32% M(A6W+3_U3.MU1.>3ZP:"WC MS0RX4^;$$=QEC=+YE(%ZA/4"T]1#;QE>X"8"L<@X"F>I1*`U*HRNI2")`:Y_ M:Q-R/L?*-4VT-N=GC-1ZI5/4,FYP4"1@/88`_(!_IO[29_@((5J_3ZUX/1\-1<]BU.]U>NV^E<81.JV->ESR.<)/`THJ5`QA9.5HYJDF1 MSM83Z10]YTYL7GX3+MGGP`&M0JZPS6_`V;L:K,[.I\KO-4>9"/1\CKDI>=F4 MV')*P88I'8)Y"#-27F1M.H/\H!$]`,A)>=-_6W([[RV<3M`1,PIZ`A6NZ!KH M+MKK@=?+4A\:%VBQ;*BPP3)U&`/=O,1J,#O3OAVKA\2EG*EW)<\<'(%<.\'W M0L_G_',,FZ@Z>)+9H[D6AU/FN_G%@L$/?GR^^2P,HLPC254PY@Z15DVL8;:< M8@5!0%$2Q>]I)(A.(L8DKZ(EE1!RS#`-@B^"X/.\LC.#8/-B,="TY>+(>3!` M[B3J1X]*R^B2'S"4M63_;.J*KGO*L>@+X0X!`4\E&<,_DDAXBTL&%C&;+$2Q MB-0\W4K(_,:UB"`*,DX='3#;&CKV(Q^2OA$9Q&A$:PYW@ MACPR&DE;U^)R,K)S(4GD1`3&KEIK,?C8N.%QUZ,H!M1EY$?S&'>/6:S\7)$$-.Q3U>LE]ML4"[* M5U/.F`>,44PSYY6!V*+#C2`NMM)_XB!I?N"CJ43].,@43DN63[H5&: M_(1;6%EZ4RPX/,IS.-X%&N/>X9OYS`U MWMFZB7ML/^P*]1J73MO>0K6N2BA`Q>ZJZTXZU&&F]I4<7);4L?/)`QEI6[ZLX4M^UG"+(W) M#9O';';'HA6KVH;(6+7.*=);%Z(49>M*'/51CJ8'=O%M7DK!,OC0Y2WN$[>J;H-U:=I;E<4O6DEK MITE=2BEGM507-QK2&F`K(PJ5`PXM#J<3!ZU'C[9"=W1_2V^>#A>=2?@J=;\( M(7IMC[`ZQS%.[W'H*3A<$&8US`UZ&G0 MTX);/L&5=S:O%MPB`^%E-U-VRO629CH?+8A5V&LKU9::-`-"E66L7@A/Q_Y+ M:_IHL*P26.KXKD8`C0"7C`!-O>-YM']U*5L\9\Q`JDZ@I/CR$%78I6A=K%"$ MLJP.C4(D5,[.N4!LDKCYHL%)2Y:6K)5D:;5?G/U=,3-;E4RJT@G9E2E/RG:D M3;6W&M6+AI4N_TFK^TL&)+NC`:G:@*2E31UI:YXL!>DRI$VWFSHF!4D:,QY" M.^6]1-T'(/^<+6T73OF%OZ#`F]X5J)YYI9'ZLI%:7A=)Y1?^@I!:P\S9N4W# MS-I^D8:9XKS4BNT7G3$MJW0Q(EM:89`JJU^TEM9ND[J44LYLJ2YP--H:.+0X M:''(GNOHLH&CS=!+*1M0)9^I.MF$5Z;NDJ)&PH%",:S2I48I1+OR6@X7!'KR M2A4UZ&G!U8)[,L%M:6M%U82M:IDI.^5ER3MR8XT9;6!&-TSN?"8O@[(2VW&[ M4JD,VW+-@EKR;B"+*HQ0O3"AWE\HK76E\5CC:?T:3C6(*-!1H/,AN=: M\G*Q+@5EO-&"=?V0/Y$M+_ON-^_MH^_#$[X7L/=3 M)G#8M(RW3Q=W#9S,%L[SJ,A.[_B8(D8ACIIBH:EUCA,F0DOSRD8[D+?3=]]>?@'CX= M1MXK&82[3JKU9$ZV)6].3P>\-1`$/!9PC\?,A17] MSL:8\PY`*,;RZ4VK_79/#,X>-`]]KG'J#U9S@OLI.`6C0)W#$*BS`-5G$'KU MQ?-]D?\2CL'B`WF*^#Z*>W:5%_Y8W'FTE.-?@^C/XD7D'D4.HSKXEHA/[HJ2+N:R1[SZ%+V`/GNN_$F\^@Q'5R%<62YEKX7F=K\]#IWOJ M=$_5LB%UNJ<:=J%.]ZQ*#IY.]]3IGCK=LR3;6K^"E79.>54^_JLSL-:<8WU. MMKS8DCH(HYS>TSASV3C3E=?'2?6%EQAYN\A$SW[B^3@TG>(IC.):0][!IJHL M<=&:6"O<2DN$;>I#A;0_O!MAOU!GZ@4L>JP1MMB[$#L98^]GG$3%G-)5GHD,*JDG!9;7F=NJLN7)?N%_W**&?3T'>)-YM'(+^HRLY2M5`Z M03/EN5"OT485;M$NED(:JVKRU)%7MGTAXG10TH8V%[6YF)I+,0:/!O M\8.V*7<@::-FF2>K4E6%C[27II`NJYY$F?+ZH5R*1&E'K?3EF,I;7Z>KTZQ$ M[EBC9A2%8_N03!7NT8ZQ!C.%V%&#V5[DLFLMXW35Z,ISCT1S;;=SKQ;__OO? M$OY^0NG\0P^8!;UTZH^\@`;@Q/N?@S%6"N.O0X\[?LB3B-T"&?I^Z/SYRW_] MYW_\??%TGW*/?QM_CQAG02P>Z07N#1#+&\."!7%VHA'PXW6+L$H: MB?N#C3^]&0VQU.X?C3]NAV^(Y\(/U(G?=_M#NWL]'%D=LS-L=JQVKVFWVKV> MV6[WK4:_\^:7)XN5)_PK1F.=9Y[B+W*+,O7TMU.&,:-P M!J+V"%\E@S`03I2(("V9C]S`I-+-?1%)^AK&L(IQN,/M0)8^<^(PJ)&AY_SI MP?UI-&J0?I1C'#N,UXGO\,S\!;\_'@Y M1/.0XZB^LPC+&NF$I>\&$`HP\YS,643X%.:. M<3QQ'MER5`1_!21VLLC?.`IGZ;/0.L8R!G';L2#@+!><_Y*_&X`,'O43A"Z,LAX#YPU6L8@U[W MNM'J7K?[C6ZCUV\V.N9P:!@#J],PFB>%J\Y"H'.Z:TW`C0($?!SZ8+`B$Z2] M)#!3QW-1@*?B@@BZ$EB[Q(]3UL2_('-PY`[@J#QOU`B263`GEL<2RHDW)@/@ MP1$L'C#2E+JIL%)<1!16*G#@&\``OL(4;[!?YK%=*)H9&:TG9FMKG^B#IM$^]-'& MP=\\^,G#IVD>3-H]!UOZ1A_=PP"UNU>CCQIA/]'VR.ELL)!H(?T_3M-TH5Q1 M#QT5TOPC?4-%,U65.L5(UP,RFQ*=@7R:%2O%B@4U+5(&"C,?K"/96ZZBJE6) M5)JK-%>I8,LIM)]G*]FZQWDX\L;+1J=JN@8JQ+W$XN$98I MYR5H---H=C2:6465EEXBFI7;W[1D;\^6P37(F!:?>>UPD;)14G.=YCKMKRJC M7/#XEL^!$\Z8MO&TC7?*P[J4%)SG>8Z[:\JHUR&GI]@O4B\MG"=PY6K^FG33_'7,8NP!%ON9(LJ5_\6D"\T M`))QSPB=1(QE9R<%`.(.S!(FO:@R;XH7-&JBEGW1;&)5D?Z<(`=%6PWCK907 M$0^K0AB/L;'%BEUK,-")']Y1G\R8BRJ.Q,R9!J"M)H\DZ]N1=K^@XC)B4P8L M`.0!+H_'H>^%R"?S*'03)^8D:W@!'TAK\M.W"FX!;*030=`:W#9F*5?!&^__ MG[U_;6X;2?+%X=>[$?L=$#[=9]T1%(B)DR9KU/GWQVNXY_WT)`D41 MTR#`1@&2.9_^RJK+Q7Y2_A*QI+."?."A[`/(8S M8CAX,-`]B6!@8#CQ'K@:5'Y+`6,(.??@EC""P<([6[B(#KP[%OG$0*D`Q^+( MU@Y&O0:^Q;^E/1'Q`DMX$M*.;>MWA+B@.0']9C0G^I`+1JN(34#5N-BQ!$$X M(N$(&.\:X=C+TQMV&EWAFN0VO<:')#8UF7-FMJI M>"%TA+!!?+-?<]*W+<2B>+3])+LM#D&MH?DOZ*RXH+/P<47P%@V28CT![XYM MJ>0='X0N!5ZA7CN//&=Y:"F<3'?XHX0)H]NA[_5M$#IX*RHYR[47>#LB8(2E M)R/"S1K>4I.:V%Z4SVSS?'#<9EBMVVM?]D?66-6>FUE6Y#4:N\2=NC78"LV#4BJ/LI)Q1/]1;]'1*5M-4!H@SBJ_*9#=;R9@* MP>>4Q:'0,X1P,Z*&Z/'"LI_LR.4^Z,];OI&Y#K)L]D[;['U]/M-FC(\JV>+/ M3];5M\?/X;;YCT2Q2DJK+_L'+*UN`AL9U'.;-_P/-K!MLL%ZP5[`<#X,4+:= M[[NKA'_99]FTG0",Y05VM"@'#@2/OV'C"3<""GCM<[V#E0-UOTT?%5@SG9+[ MX=WK4^_;$7M=-OXYH"?.QG,VGK/QG(WG;/SQF=!4J+!LN8`'DUC&$*C#J#DN M?S99UKEL]SDRY\A\N\VO,(`YDJ!-;"<.HTJ$Z]3Z"&\XSL2-A-GF[96QIJY< MSQX9JWI/Z'3L7_>R;6ROB,W?J9L_?;YR^S.;^GSXE3H?;HK17BUEIY![;M2Y MCT&OW>,]:;;PVQ'V?JM,KL[<*F-?C7=9==UK([8YFE$4VXQM-*-G<_:G9R/X MSJ!ZK?GVVD'WSF[7<6F:]J2K&:Q>-U,Q-.0"J\*-6]X^5B7T6,Q5EI'CXV\Z4491;/2QWD" M`9(MTSHX*ML"F=#=PND2(6-OIEJ%9WX1W6\KBN=ELB"`OF>//1_&B!W)P4&: M81MT57Z7S'41G9=#`5CVH^WYM'.K2DQ7>T=3U9S,AX$S2WQL&FW9[C\3JC_S M)B#^$9T)+#X\URE4EHJ;[Y;C14XRP\T)!XL#IQ[$A^*;*F.SXQ4ZT\[^6"#, ML"P,=KS0H26,\`JH^R6!O]5PE*;"!N\P0NEE3;?]O/KW`IQ>V=J[Y M],+6*7-SE..S"Q54$J()PS("\&K0;A\S0US[[0NN)2SEE%O7'3ZY49T6.BUE M`P&K*S2&#+IZLF4%(M['PIU!E?Q4'AW=FV&:ON^]C@(%\&'D[[;BQ0J=X79&PG>L+R(%W.!@&NR&F%KG$QU6[V.L1*TNBP^ MFZJ*"/LI0@3$>-&RYKZMD0DQTIRCD+'Q>HYT@VL^$\C&:\LL3B)AD"+2&[EA M(*?>G.T5WM=O]:\XM&)[M1UA[\2C\,%DN0708#93SQ^FNNP:DR\V5"=NJ"@# M.+.C/]@XD7$:L6EBT[0=87_3)WMB.WCPU%DA/(C"UNEYQ"\&NF3;M(N`52=5 MC1.>?L]86^2ZK#%;ITHQ,#P\]^=-/#NW3]E!R4H,U0MEZ$:)OWV]QL&M7+9=IF=I M];;7ZHZ,N7DOTB5GE@:A!6Q]!OO<(Z@[D5:CV=^*-3$<32E)Z_2-X8^S0)VU MB5.YBHI%[*#1U7%EL]OJ&3QN\5JZL5"?LI54J9(U):-U,9/U372\O6Q==H]K M0QN1Y*A(%JN(?CC-43E!.?]QDG:$3JP?..'>.,_NJM6]-K8%7)>5Q_L.GL-F MK=\LK<^*O:F*_>]AZ#YYOG^,F+Z!"KX_,%?EQ[#F]=!7;`#8[6?KL-'MW]_3 MWT']&<+=K0O=:M5OLCX`+H=M*5D79C!H0&L.:UMDQL/#EZ*R^EBJJO]"5?5? ML:K^9ZJJKPJLM##'RL%+5[M>!B_#">00DHAW6H`'M2U7X/$5#5P*S].8G!ZA M_K)`F]5,1Y#>.;" MA._COQO?#E=[;F+[Y8FBHV##G2^_72HRZ??30]H-9>N/Q;3;Q[PDHUKXW4-R MM+.VHE@Y'CGC%CDK[W]7PC!-.0(9I_RL)R^>6AZ0*WV7))3;56&2&X>#@I-R M*PQ!R9`&V$W1>[,GS:/PG\+!H1(X-GJWTDIBS_?^Y2'&=@`R@1"WECV'2VUG MJD9H6Y$G_[C(8'81KQNQAI7@P'-7%GDO.]S]WLAS%`GM&2)__TL)\!PN5BC) M\>:%7:)D'")PKYF9K:9?]WF,M0"+*`E`@F!U]:R<,()U!JWI:H;".2ID3=1V MJ)P>:)5\#Y1Q<8J($ZWX)'03T%AYP:\&1";,:1_W9TMT2QE:-A7+&!G$75/G MO()LO(5TKWF.IYHP$U1R)!2@]8R`C!5FMQW8"LF^A3#5()#$HQ&!4\.?+0L1 M0VR"\H["<$8K#FOD"#*`"F,N MX7<_@0ED!;)&@916$W.1A#2NM`I2Z!$KI3(YNTCE;(/>,3/!GD$]TM(R[LGU M"B,=.\Y371DO4P7;(HAO<\40H"\?@"-I164R1F3UV`-NS1FER=HB3JNVGU41 M2*%,5B+Q@'#R=!@TJ_E&"8I1>G6#"_1!?5\HYV"NH8*TWEW@11NTSHK*AO78 MX#L4WU[P1+>6[Y8E88D)O=[W%TNM`)P0_&=I/\)0P;F-0%D%80R20KI+:!(! M:\SM!>BRA>W3:1_J9R`+SLTZ,G@(CGFBNB5?D7IHEEX--$M.DS/1*QO*V7/5 M`OSN)^ZZ(&JO[%^WV[%F"E_=S&HK_QDU65@<]`7Y*A*UC134'0-=%.TG42Y` M3S331OB,XN]:#`8%*J-&:C=]@ZK2HYV_^\>%&[XD.!S]:%!3[&-H6'8LP M(*IL\(Z+X;`,_42UNM*&0QN+XJA*3C&ZM+(D*6-T4$%8E'G#]$>@@W;2%H_P M!C#B\*Z))WR=D''4.]'3M9>[T'D!>#'@[BKMA=\6)EFA-U.M`*9G=AHJ;]GP MX\540F!2GZK%&K*O3MSH!C9@7K1;),A]R#]' MK>)^`SUDU0^D;0P7\#(5S*XTU#T";`Z$".]$]K/K6CF>W0>W%E M?7!(`@I1O%C98$S#X1.!OA%M#(D)A-">"!P*;$&7)*#9"S.V7?!H/!GKUH8B MBD*=[?5FV'P2W!OX16@(X:F`=T[I)4]A]`?04=H3$2^6*0+##DO*3+,"$4@= MB)F'BA5HLND[U-.()/8W;P:L9(5)K/K?><&&O.5R&E(E)VTGB86BQZ8LYAJE MMX\,_QJ:L5@%?9V)%!%L57IP[P;4?1"#OEBR&2XN<4P239EV^QNV601JB^8J M^?NT(6M+]=ZT';7R'[40$R/#FG\6P,@P^R2B)!:9U&;:A3LU!=0@F-VP('J! M%5[M3]DJ*;O,7YCD!(N+!/.6"!:5"*9\$.7M%)(>9)/\4L_$7*$6V%+W^('RD.BU#4P]'H6RR@TQG,^\OC3+ZKBV9D;6&W;-#@TX<0N#H1PPY57YB]9V MLHM=BR$^42W-NW1/VD,9TUZ)E-H3*K\0M=>CBI[ST'W9/5)12683LUWQ-$$, M3Q7?!+B'>#^>@RE.$MMED$^NW'B1M;1&]YF.DEEA]`#>O-H2P2\7(+8SY3/G M':[A4ZL8!2T9ZG*HCT<;O"!)/7=,D-E>!':WN/50'*6VK#I"Q/[S0#2XAFBN MND(WU-7[/;`3UT.Z?(I"ZQX[%X.;EW?5;ISFR])JAVBTCN_)CW%H:6XOW>#Y'1@Q>H;$E@WZF2JJR&_XC#%JL@8CYFB& M8E,6.R/]1]J8.*03I]?7BC2QE+.3#<@/<2\MCB-OG*@VY<"'A?C#F`O;L\8U M->N#GE&S7K;7#?0E\]/?H>^'3^0%$&=@OLIS17K*)+3(;&0*H?9G=OTNXXV(:@"V_VQ:_W4ZC7J5.@SDO!S'Q70S[]HFP.:3@7 M90NW0L4W!S0F'J:RY!1SZ^!SV5NC'AT>@GC7K$514E2@B&Q/K=<+?J7W?PL,!\[S(E@U![.E?'0ZQ MI_;L@_>]!LJG0;JL=E$":S/69J_69KT1:[/C(GL>7Y/5!U[RJ.T)7T+,:QHE MF>N8ZSA>K8UQ46B,:T]6L8_'/EYE/EZK-[PZ/LGJPCT2S'7,=1ROUL:XW'E^@J54'^P(2Z8(]-GZ@N=]V>5C ME^]@+M]E^WH5(90]/@Y?Z^6?L"YC7;:%+KNLZ!CU.>HR;@.U[KZO:\M>[3&B MN$5B@DCG5`";U\TJK%G$N\M@+JGH/L.@36MFBP#%]C?$AL-F0W%H`2-ZCZ+0 M>DD!V\X0K$"_^]VSQ-NIFG29FD7*+%>76IM(N\[=5X6E@]$V*J,LJ575&,(4 M=Y'6%<9;FGW9!@WFWTQ8T5&O=_5Z,XJM(E\UU2IEZ@;(A@@2B,5=A,+7V%S+ MR&CE/@B;4=9?K^E8;EANFB$W+B(=(Q3^UG*3MB1I$1R3@A[%MAX:QY]EB&7H MS&3(6\*$))%81MI53Z%U73(06+ZH[M,(QS"`%^BQ@@2&^8>E1M@91!/\7!!0%U@LLT`!)]$(+ MYFW$L=;8;*MY*-U3(L7[4\T9@+F\^6I/OS#2>,=+*X;A0$!8D+E2+#5D09Q) M!P&AX3$(1KL>"4ZEQ-+%"03"PMH13`L>K#HC/&9]#/-V''9L/86)[UI3&WXF M(#AOL@*JB2!QU.0HRCM$(3"E3)\MW!:\-J+7KQ]>>1`9&B:EYV;V0O=0TGB8 MD^1E;JI!@E)]Q,M3Y$GZ9@7C0354*D"5/U_D6UL9*`#X3[Q(4B^5"%Q>7-$E ML-XE$/],H?Q=!+?H<;_WPA1C^&VFS#L_ZI^S;[H__M#"KC^1]PA,YB^`%L"K M'R-/3JVQ%Q;Z#3OZ3<324[O831@C[\@3U%REU'65K@6"1@@Z^X=8X"/S)G6V MOY">:C,:HD704HX4\+UQI%JUJ`8R6F1_!>+C##5`J_4%XGNA@Q)0N0\")',Q MIX\J]:QA9`MTE<()X=+="7O[^>.7CTBK+W9@W7GB(;Q0#=U47Q3?6D,K5VCA M)?-`K5&R<:BF)?_S\+ MMWGFNDW.G)K,E)@$+EEF$%_8M#"ZF0P\,XE#C:[L8B<81%H-2;_\/X&M9`/K M0X()&="M1:X.$:]['^H#TR8^7/-9-VK$/AY.NS3LE6N6)U%FZ(TM'Y_A=-M] MQ"YGN)[(L+C1,8-`E$!1+>14WQ>^)=&.*)^7&H*"O MZ,]OUJEWU[,?`O"<@"VQOUN4E-C^CR!\"HBU$>8^G,>AP$W`*`P\1R'0`]O( M9<%^P5SU-PS[BU*#7Q;X)`QCQ?8)LO'AM#.'VE7+IHG[6!B[^$D[B M)_3;OJ3-P=;,[R9!'9I.#L+;9&)CN*Y>!S8@_+]9G\%<7*@'R%3,PDT72/UN M?*-,O#CMC08SGHH`]5:QK9>V27D3,R).JO'!?8[`APVP4V?AIH*);L'%H.-@ M*6@-(GN^4,YW:J"#))+H!+O2`V?>#1WB/+KWA:RS[ MVQS*_@X6Q0\E$.TK2.M[/W3^^-M__/N__36]Y=:FAF@_8XLS^3'0_:%L_TL: MZLG?)C_#(\-HS9.HW0)\^"PF/[VYOT-3]3^#__UZ]\;R7/@"%NOB_NY^,+H= MO1]=W0_O+GN]^]M^?W3U?G!ST[^_NQL,W_QM20L]E]W8I%]V2`F\RNM>\;&_ M8!N+BZ^+N;`4!6E%LR9;8'0=`2P-"GM_Y_OHIT5>S$*D)N#*L`FXD=3"!)A. M-2V@'B?7K>R(Q&J_[8V)^F)<60ISS;=?[;9[G9%9"'QU'N11Z&T"+U#]4RYB M9#Q?,9X*:D&#SE3\;4=`MKQ;!5Z%'(D0Q)[$K07\E&T%ZHYCJ`6!*8(\3[#% MJUO9NX4;8EJ6FNE1:&]D^A/0R$8>=$&F"7=+=-?'2.C>]-B9C5#/8_S@8=_- M\8+F3]U$_$6)6"W5F5'JXS]2@]>OZ<1PUMN76\RF\II3- M;3[V_F5W.#>'O3]X)?9^?W1Y!%#ZO6\]35#ZVIW6KAG$Y/8M.\QX=T6%OLK0?'4<;R;BN_T$EC0[J#^1<`9/N@BK.E7J;]>,][?Y8V,-[ELR4 M:VO-[45ZHB<-Y%Z]\_L*D:]]-8*Y4I93J%3IMOI=M2EQJLN2'T5JSL2D M_QX`4=4AEQT1X[:6(*.4/*IHO>T.S)6(OT25G%>JL^?&V6GKF(4MV8\WF!C% M4P&Z)3.FM;!1*AW@,.AB;R^H%<2&QY77@_>28J$]5T.J4%>+FT`K&Y]L7%^" MW.MS),CV?X>XYUDNKK>LM-F0Y5(3[AL;L8UUX@D/%HUJX MEH5"F8GD)R62U3AA54,?%:`(5_V]NJQ),W"1JB!E)0Y(MP8]:AK!=P;U;!,A ME=)3.3W#IXR>WV"+0VLL=`X`JV>22":V*HE?/>M6/G[U#L]:75G9>;_>CX9. M\@VZ?1BNN7-\/^)`AQ4,M']Y:7Z@HPH&VAM6,-#K"@;:'0V-#[37J6"@PVNC MXU3G(@/+?GB(Q(.MSL8;8E*S`\6S],*>Q")JR"E+/%\[$_$T=%4M#R9&78&G M4;T@+:JP2VE3)Q*N%UM^**4NRH!K9!'E(,^92FNIC,I*4ZZ/H&7#>>+GP`=P M)5;KRA@K%":>.NSJ^+:DJ!XQ8,Z&YQE<^6:<>G7P85>)`IWHY*& M\:'%=_.133T9AQ'5!E+5C"=PMO@H*Z+:7AP@%?.&,3X2$5L41)XN6,FJG*>( MMT*E+6-=]F#-(ZQT==!7G]G1'^#3NXL`5L;!ZA)$/G+"((2/6+>@`&%DF\X] M;W/`FJHRBR>W]SN6:R_@T2BG M-%PZ%P^/PT)N8*P4W1">]`2"`TL.LX"%?K"Q".M%F7B:P@VI$*F*TK$H;S>H M!7[N(8J0&^7J"3R-XF+%^4'O_$SE=B>^5RMV7E5^LU3((Z/J/+]_?=JV[O^OY]_^YJ>'/3'0YOA_W[R\H+=DI' MMGM+6KEKL,9$?7RYD!Y):A5H:L3<7%7M;M.H13YJ)9]2Z5'?!T7\,`6I]3VX MQ"TH/ZD0KVS0H(B,$R^,>0#Q-!)@`N&7*1D:$*Y56N[GM("F0/@?!+Q+(K`, M\B50D#6"N(7XE`4NG,T\13*\$=Z$59(@O4+N5RIW>W\YN/W0[5]U0>(^].XZ M@]%[+7F7W=Z']X>7/)."MBI6.?W(.)L-[G02U3,5^WMH0:F(M"#=&J M4UM:K6X([_.@MK646(N4`#L%]0H>;A`&#OJ_/I6]'3:/-C*[!I6ET:YZS(-6?LB_`E")CDBBFTP M(`IH+@M52JHZ91I/(?[:\WD4?O-F"A7%#!-=7YKE]ZS?!3P3TR_D.F*>"LM9 M-8C`-W@J)K\T/HQI4**C.OBFPY;*,]%_]QY%H-$-4IY44)H$*>W%&I(S3^Z5 M>5GGC\F3@%LQ/'#(GT!X*AD3MZK4'<4(&.L3.+8"K)8:`L\A!$B%R:AP*D!G M)L'$?@PC>G28Q(0ZJI$H"N."]RB66QJ5C7!C\:)M?0PPFQE&+J7\**'Q>_M+ MNY"MA)]1_EVZ+J$E1/`,6,4Y93B+3X8YP8`\.14Z26K[,H7CAG6B`UI1.*9! M:]G6J45TL!1%\+>W&J`$B86S$L&C%X7!3#EL0#70PYA'"W+.$*@T-GD>' MIPGE[H*F20EA!+02\@>:\J,'X;^F5K:R,0+9(8Q*(C%K/!;@ZI6GIQ:"D(\Q MJQ[IK+KXAF">*NT.%ZEC+WZ1&FY.#3!YK262V(^V1]YF"Y;.'GL^YI*\0"81 M+@H-&*\.Y^"WJN3US`YL!:'>HG<2"*PFJ!Y8JY`=A[&$&7AG9FQ;>CZ$/T)9 M+)VW=8%40'>%@YIFS]=AQ2#=\6`"I?93S%!$F9YKB$65KRA=YF"V#4OW*])L MQG4`4/^_DT"`N>L,6]9G$>/6"7'IUP)8Y1I`P<]?/Q8A!"U$G7-IOV,V]Y'? M2LG[E,<(1D4S_YQD^(57/LJV]1X6*D1<2>*#>O$J?^/86V,"W;@C:U/HU M;.=FO/>N,[QP'B]ZEV#/2>[O"(T1EOT6L19;U@=;P3%FW\/R?A7?;!0DF""J M-/&08G7BJ-_?P;`(*5=/?C`"]S-%1@,FG-!?%NY-H1D'>X'I$Q>E"*&4"0L1 MY`,>3ISO44)64ZREWRG#U1=G.BAX`-D@C*,)7"D4/\<>P?B0@@-.G0O52BI5 MZEH7K&-R!6MV`8\%-E2;-E'H)@Z!YH(F"?UL3PD?\;,=3.T94AO<6T>G?6AN MKJ#1DP)_M",/D=#TH_0FG-[3"^$CMO'QU.SU!IV<*O3>*$P>IBVT&`A21-"U MH.J"!^`'D:)1(_@IIE&1;U:'2>#4JIN#<,G3P.W".$J`%7W[22J_O$!'M#5> M1,L@8MH-I*7Y;SM(\$T@&:.6WDD%IE'^B\8+5D'_ M3")T-0+U>ML"*7"1M*2)'D/"8L0IA\H3'"=H7%73KCBGX"SGX!9=XWHN>9$3 MCZ+E!84/D\0OW:'DQGZR:=\;WV(F!#)["@E)H1[?01J+I:M8(**PP@[6T(.JS$DFN1^.9S88.RNHDU MY#-X^+AY5R2%[TW(-:?7:?XJ/61%?1*)_SOQ"S0>$8F[J:]+,C0!C8>OST[3 M6/?:5MSBT0@OIL8$D=13+*L7D`3W0?7I6;+.I;'U9_[+!%8LKMZ",(:17OG, M@2"^GTSP1,GS8Z'F>`496^-]E8:'H4#&(]T7QTJ$_0VT=#E1TBT2=YF&*\0& M:^:MX>P(DL>HE M]E!*/ER6WV&K!.V,]SPG$/J=OK`S./G,\.(PJ86D$Q,_KTG]:8T\V(VCEUCH M98;^+6/HPJNO6AKE'0B9>ETEQE[#R)K7M:+=8KR.1W"G6]%GR2WL=5H%&/HU M@UE/CJA*G-!?Q&3QC`_2H.!JQK.P?W335FS(X;`.$(Y^#K1DN)A M*Q=9AW%JJ$0/\\Y:M]MO&]9?*9#[QODK$KTM)[;C2(Q1.O/@)X\P,?I,8O%# M3HG2.J2K&`GL8['6RUM]?X;;GL;1..PR_26FNZC%DNINF$4N%&^J2S_^`['2 MIWA*$H+@EZ>]]K4[OH5B'7T9O8?^$/ZP.+%13-5<@2>6X25#$BI MP^D2!Z4Z0^W.Z,/]-,BE"Y>L4F&4++-* M.*9Q6RF]:%%`N?J@S2-#/B&>*U(0WJLY)QMND;4*+@3V4`)VQNT=5$9Q'((; MLB@=_,XD86[3W!INI\$@YW2%@H5Y$$4J.(<(_KH MLO.]H5-/:SWI0=%1+4N1%]#FH&YL1&R:?K4Y$,PS$.6,1W'%J%4)4K-%B5M/ M-=H"^T7^O.ISAU$>43/M.84)XB!-YF4B6F0.N(58CEK^N!>)%%%>W='2:3:5 M=01;[H<+:GA::#NEY.3OU-7JDSIJ@,_]+7JP`VWO2[)+"4[$;VG6GXSMK0+OJ,U2*-TG,T7X4383,ZSB0CW801##+`UIBN6,RB? MQ3P9^YY#_F%D_\O##0DO5KW@\5"?B^=L5>GDH_(!+MQD-E?!"A;1I(=4,#$[ MPW)(LL^/MI,D,^S\1"W&XF2LJ_W&?ABZ6;4@Q=GH!ZE79^U;?HI-,]S4L],(+QE+S_7LB#87Q3=%8I/TS8BP#XFU*E.'170`H/5+@3N*!$AU M2M8V1JV2&B*V#2LS[/L0M46IQ^/-+Q]*S2GSZ"C+^ZU4&N>]0+-6<"D?SX2- MM4N%WJ/YH2147+%N;$:S`A;/^RJY"1TWPK9I>'9G[:(HH5"MA[.%,'6HEA]WVY2&FL!-7%_GU*VT7K^68ECY>A:J1 MWK?,V)1*0W;0!C@M6M#JPQ0;&&L9E9Y6S6?_!=0/==B-4^N:REC+(D$LVHO" M#A*=YL5#@5)97'T,;:(W3DENU"E(2ZO9S#D"XE""%R955ISEC=4ERZ0\@'0G MED:6:8/"#E:8'C^P+M,2YOP5ZC8[",*$.KR&!1.;N?*J?"15+"J`39O'HT+/ M:=#*@E%]A%3MRIB M>Y3Z6'.>K[W*=4W9HC#"Y2O[NVIMS11SM8K=]E++FA]KT\$?V@(P=3-"=>G:4@G9Y\PP[=QZ&UPFM5Q_7D2 M*X6B`$)4*WG*>"4H3[1W32==],ZEWOO*Q](BN7,]3'*$T=+1ZI0?5BB3QOYW M8'ZH46P6P]Q.\?QPM-`T4AY^0@8D*ER5]<9MY<`SX"6:'"B_P4J0,Q04R.RA1)-LSTFY[M)>"3O)8Q&D>M8!WXH)?*<&&&6^B2S*;E8XPJ95IH=T` MXR)7?L'9_(7.GM#O8;3(CX+11#?F9?.41V.-3QK3;=HMPNRJ)[):B8QK5)KB M10%_2^=?=E7I2Y';OZ#@)_#D[N"FI2>92?B7#[=TQ&4Y(YHZ7<3`:F3J MB)GJ4DJP/Q-?[1G3"W\1LS`"WDG(I`^EKM:L5S== MKUQXBIR*M3%2^)2-)J2H%Y9,RT9A(LCF,!8MH66&6"%_>1&!([T2<%6^IFG' M[G#F2=%:?A](-J$+4L(1UDL$J:[1VXW+[U^="(4GN,'[B&F_KR]8(KI0OZ(P MEG#]$1)MM3/UN$(&_#L(G_+-H+95.(9G]8;%/,%SMB_+1.:K^Y^EW;C'T`>+ M2(K4DT!+60@9\J=HP:U.49G42WC?H;K9'D3+EH_%Y3Z?77;)\G/Z3UDJ>%TI MCM:[:\[/9V[R%_`SILOGZ/\NPNC!LY=-;!$6%;3(S*,P1T*+ M>484U-U.0O47A5);Y:]!*%DZ)E(^'_)U*HHU#\6*`;@QVZ')%$KA9,JFAV;Y MS:QZA41WHN+_M%@"R+1R!*%5#%G2DY+DSR"$7>+$R^-5A0?JI%)VP(_.VZ?! MLT*#6RP=25#S=--;=#_P8O5R>C(QW\70*D.'_7H$#?5FBK/5Z85\ZQRGCVD^ M1"[$^B9R4]."5W!-LS,=8[`"%S-U&(G"*\I_I+O":X11PS$6JI)LZ]%["*/" M:ZA4-'^+3*U84QW'(JFQ:!?KWKP`+!%:T'&(T2^5\J8J1IG^/#9`*BD9`);% M"+5P2CL[WJ@7SXYP0UNKO!`WJE4161(INJ;0D2="2E7_3(D1*T@H38='O?1^ M3Y%0J14HI;/'I*7BP@%'?#@>7P[H5-Z'O ^BSD'%02.%]X#5R0NVD_9^6^ M-WB@CA;X#_!G`ES8@HM*GLL$7M8J>*KJX)X'4[W$9A@TEBJU99RXGGX]8C<(`HULXSX-E4#1X.@E&'YC53UQ:X9HZB_HR"Y& MX:BE,Z<8&79FH_ZQ,!Z-58&SQDT@K+[TY._<7JBR>W!R@F2^31RY!O)N)P"[ M;;'O=D>S_X<'5UW1GU^]UKK='O M^J/AL'*-?FP-_@51#2[>4Q%-D:Q&E'GE$*!%KQ(5PD,`OZLPC_8/J"$U02[0 M-%6MD%/T`E'[$Z0Z:MMVV4-,D44]F3_<59CI5!0"<[[`^:=)V!1$B@[/HFL% M'E'TZ#GIF:.TY-HK[N/@#73WO\*.DBU9"7&BCT?@H9?8 M3H,7P@/>7.&OZKF*$/HX&.HF@"Z9/MVB MFX!^`$_L+A&I7^!3+18269WK]]`@>_'R;G;9%NM#]%3C2-5C.5,1S75W@`BE M=KF^4;=RI-@W@*9'GUL(7YMYR".OYD)-/90,1 M&SK*LA'Q5"R-,$H4(HA.B!++ZY3JFN=EIQ**Y**\`AT@(_-$I$._+J<=+2&, M-:TFU,CVFDUH/^N!ZB/(4_PGUH"M%X!F!&%?2QXX83P0WZ6-2J0Z&JZB$UGB M8CHIF'5<*9R611)*E:)P$A`WLJW`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`F[HP M#D>2-;)VW:L_]HA*OZP%5NF.#)GM>(7NV]+F.9H!?)]R)C M-B&'U&T-JO(/=B%97;B'@V%69C5B1U9F.R;$S647SEZ5%9RUO]")X'77'VQ@ MM:J.58>V$`<"46\>"E4*$15:$Z6.UYO(1+C+4T6`68@77FH,LY8&`! M&B%%:LYA6SS$\H^%=0V3R='.]0#+<"Y8=*GZ"B9S+!0T0M'ONM;8<*?+7#&T M+,2M=9)((5.4%R&`:I-;55S#AH>D)T[R*RY13("VFW\6B^DI:8XN8[1C\\5@>H-JB!15\R!^CHU"FNA,3:J MB)N"L5WJI9?3B+#1$X7&,[<]_5PC*Q&$9A:TZ`;F;DK&F3:K"OKFF_*^TO0NWS6M0!0,'B9_RM>+LXD;1..NKG@OZZJZ3PN>5X3+[O>10@@U::GH%6_(L"/ M'JZ&]1=WJR;$+^M/Q.(W76'"$\ZL#38['9=_(;H MVZY&9P2KX:5&!R=/.GY5CQA+$_]B4\9T9&:5LR;(6:_9-?,Q.>ZAH=6C+-82 MB0O2C.;6+V(@(HQ[8*=QK,ZYE,2;LM@:@Q9%-(<#TP#-A`2/6W!$'NNM^H>: MT40!Z=ZQ`)$0&N;9BNUO&-FYV(L)@[:L:]L,O99_93C[RR_Z02&:QJ!`%)"_ MH:ZV9G0U^!47W:PSUBS$G4CA$!!CF*A>FN2[8L=K)45:KI8PV=!7\G27$2_O M(:`!%/5BV>;BN*IMF.J(H-5Z65],::J$3NM;Z*\587717H/E2WW#4@.:ACB! MO[_"SUUJ?RME,LO;H(HQT"+%*"UUT"5)QU=MR&_JIL$O)$<-!>).Z1XGR M@7CPD:O0X)]7=KN[W=D0B,/:G2/> M&E+I^.AQU_L1"&^C3ROH<3>94?N4&;4;,FH[$)`9;$L&ZQ6F<8PZN#5T/38# M?A(1OL167>^^TF&(WPK9SV6VI.,0V!GF2^9D??CFJ9Y(>/+O^=:"S=.6)3\D MP\!?>P3\M6M#5S\/@/\QS7)\3ALF_(+]$+UX486^K3^:IW%Q>"TH;\VXMUZJ MF.%/-Q7UM0>7G>^5_J1=5\SSZH-WJ[G>`W)?[8MFS!5MA>\WAT*I(E/-)@S`=5^O)J@%*:KRYOVKWAY=%RF3GK<+/?[G>6 MPDW<42;ST]LE@CA#.,S>=?5>8%WXA$.LFEJRDPVQKHTY?1QBG76(U6^/RB%6 MGE'M[:+`3S?`ZE\;RRS79=$YP.(`:W_K<]WN&]]K82-SE@'68+/U&51B?4XG MONJ;RW)P?%4?:6N6(3O1^.JZ?7W%\17'5R9*UNF@H*X;*A5*J$KOK(0DCNQ` MVDZ\K@*F5M#"ZJ%TS*^V>/Z'@Q<^$L6JP$N_'NRRH_HZLC6"BSA,/NB)\QJ4 M--2+/LT!JCZZU!VMDI"J,M<9<2JIM1T':P%2"#O$"IB%KC=!3)@"WE(&AZ#! M,&4<)83PT;9N)%41M,!WL!X0*P">XX=29A6[#P$,B$I!-TI$\ZE>"H8F$ M3'P%6!;.-7Z15"-3/V60$NLFU;;N0]\G[!<-1Z&OT1/1L)7/5Z$NX9/JTE<% ME#"C*19!99PHE`HY88)5_KID%<:W:N/W6;_+KE$@$S,U]'G]1`5@[^ICL82" MGO0S(K)^1:2^NW4-Z/8AQD8`WA*L[#OC6J=Q%;6J7+;;@3F9JI:]?F6U[-7E M]WL6@^Y[7__`+QP<>H+U)DQ#RLPV^_NC_73BJ+(2IQ,J'S-.V[5`.!Q&59*D M9?JP*#XOBEMOM?%&YL;"Q&&Y,/%7D(&RVSM2[0&.*=6UW^CC*L72[OBUN81L MW5>^ZEQKC?10[:PC$ZXN;E?MQ905-"OH0[1(/[V#`*:@*T[XH+6Y$VUU6?2J MO9JCBL@R![PB,E7YMAL&$&K(SOI1]42VN=DS)D>GHB\X/[/1^H[*E;Q9P[PJ M3?#IG#;OMGJ#ZH_$UH5;SB@94:4]?V_,GM>(8,TU]*>CC2KP`$Y>)YU[_#UH M7Y<]`.J:0\]CI\!.C#^N+,](7'(IO.G'=[BR# M:BU6S'`EV(ZGXP`/S&&2G+SCR[$EGPRHKZEGG72..NG<@W$&=GZ91B/VJ>L? M8_)V^*D9Y,;I"=X.YQA\YWQ-^ZIL?Y>WPSG^?G$[G.&M3S"0Y.WPLS'TIZ.- M>#N<(_"=#UNW>R\5+'9[A`*^RZ'LT_6RKQ@%G*-.WA'GJ)SU!4?CQFUQMW>Y M!7A`K\M^\/-1>:?+?7TYR.1]\=H2[@RUTC7OBW-4OK4G<.B&DXT3IWZ'^QW7 M/M#D;?%3L\>-TQ.\+@BW@_GR'MWTS_L#YXY$":^OY6>==(XZ MZ=SC\:OV<&M7@#';E'3QB5,.0/F$.@?HK"\X,#=MC5_&;-LI+WR&WB\#J'-$ M?G2+SH1CG<0ZB2/R/>BW@MNZJ6)\P!7C)%O7QF2K+BS`\3C'XTTQTJPOFJ\O M.![?V,QDXT'UG7#)SM#E[?<9N.T$HTD^J'XVEOUT=!$?5.O<.$W!!]4Y_MZ5L+_%\)OEASA^$&M,PK::V?EF'"5$.X% MD=R'?K47X^^.KM!V5?G[N^JU=,+.WA#LYKUQJ+,'5_6!J]PP&?OB=F&(5)*&ZK?[06!;J1;HU@HU.+X?5+`7&]&$%SPK>U&&" MUM!@32OK][+7^I?8ANFON_Y@`Z,16([P?A!5.+-OWK4<8HNLOK%@$H$S@ M%CN`_T/H.X_APZT=B?M$>F&@GSN!=Y7>,%[0&V[#&=!FT;)LN":)*!_N>M)) MI,1GCL'HMU\M\BQ]C9`^`QNM)R-]V6D,$+X!?N&$02"<&"7JR8NG2GAR*;.= M/Q-/>OA[M;+T'/&*_M@(V(&(Z8%^".)W?90#D]3\"@2P'QXB\6#'\%<0)+9O MS>PX@1L\H"7HJ?+&FN7"3\$#46X"9('+%V##I04:#+__@JJK7(C2[U`7XRLK M#JF%H04$)^J&/@0B\IWZL9!TM%;HNY<'/;Q="/.,!A!0,<=0P.<%3! M`+OMP:4U]GP?!,+<2*\K&6G/^$"!4RL9J%F2/J^,]E8TO0H4C793+,>>>S&8 MAW^AL@Y`M0@9@VJ6H-)!+=CPYVP.$0&\!-0/*AK\#?\&]2WC*%$*'-3Y/`I! M=4G9MFXLFH7ZQNZ^]_4._4*>8",GV)#]OLV> M^BM.?-*G)Z6NQJ'OZLCD%V7UR*ET46-$(,B)0RN4X!K?]3+W-;K*1P&[`]W:72^'SWJLO)X'Y_VKN$Y$*-ZIA$[][500LTX M]]'MFZM7:33/L/IB]5435F3UM8/ZJKX10R-XYK7JZ]S!*&ZS;35WGP3$:\M? M&U?EVJ^H&.!T)8SS>2Q.F\6IQ^+$XL3B9$JPA##KF]A#V)EA=>(>S=#7-TK$J8U5VR$9MK,I8E;$J M8U5V-%5F\&3'V:NR<]]\^)A&EW/;R4/&SR];$X55<7:A9 M*_2/VBBL_O;'05]-E[IP`N>83]"3J@MSL9I9ZQ<9/$_&:H;5#*L95C/KU,R` MO9EFXY'M4_9?B\%5#RFCX[X2&,.Z0B0"9_"*L2-\&\VZU#!A.V(9H2$<\+9S(L1V,*:")&# M6XPCSWT0EA_:@36Q'<_WXH5%Y7KT)%@!)PS@)1%\YR_R08MO\&H"U]#`&_9# M)`0]'^ZA>43%J;6M&]"O>`/M+T\0FH)N1SRAB&8)3Y%"T\F3B-CQZ+EJ/M@U MR[I^`4Q)__W7OR3RXL&VY^_NQ#B^\Z3CAQ*H]!4X^;T?.G_\[3_^_=_^FE\3 M>8\PDD?QD0!#"/KC)G#_2[@/,*@;!WXB?*,U#T+2H'Q\%I.?WMS?867U_PS^ M]^O=&\MSX0O;B2]ZG?>=4??F:G@Y^M"[_]#KW+_O70UO;KK#X>VP\_[#F[\M M"6"1N5Y`V5BGD9]%;ND:1&JACRMEF#DUK0(YB0$U0:V!,PC<"P'3*\-;"N^S8EC9-O"QXC)1#AX*3'ZAN<@K:9`*V3\ M6,RD-;7A"A`4K4I`?."A6D44O@,7%F4J<$1+";PMIQ9ZM9)`M#)I&@OXKAHD M((*D,\E?=/D[2@P]B6GD1S!F8JN)@NYOB8B4_J'V&8''0`(B]_)+7_:D<$[S:Y/R4A!W>'-<(EVZ/!E@9TY"^'_BQTBS?!1$RQ)]YO8"_5/U M[@@L-Z@%]1DFD@"327@\S87T`D)824LFSK1%HWD`30-#P[96$O63\A'DDE:! M1\&CPX<`$^N6-YL)%]T0&)"'RP5C$4I)A9.)%"F&'$6&X3-%M,907`Y%?\7'/@"P&P&AS?\$7Y*8AG;"O5Q15P* MLDX&V!YU]\*P>1/FH-+@5J.)L<#^^J>C_FP;J?@3C M3V"+-#I$QRV]!MUW+W0Q7>?K,*,\'_EDSXNO1?-?#"]^1XN;V?V5.UM%U9RI M7C3(L`[`_-[$$SJY\FC[^G+7@W@%'2$!04/\)$10F!!$%G9 M&R^`_NDS,"T0J#2!>Y',%5*Y,B&PAN#=S3-C0K21Z:R50Y@Y06`EA$?6>&)[ M$>*B)P+]DRS@2=VD9O`U!#!KU[H\X\)4U>RLMUY;M%OIIZ)7EO$^)F]RCB=W MN4"Q"2V')&>`;!#V-P6\?)PI& M%-<7?%E,.BJ_@QDRGJJUZ>->B&/^!)2R+> M#-:XW8=T9;Y9%HHBV^B<6XE?E)Y2;*`2&&`9X5&3),8K"DF%[7F`!%BO*&B$ M5$^@_QZYA_3>,>"*Q!0\=Q5/*%\>0Y=5<,F]?'CKXV1I3?+XY<6502HA=KH* M>Y4*'ML^9G0.0:(;QTEF6F^'!R%7/J5E'HJGH2S33L5[/JBKS%2%EK"C`)@8 MU,6C,GYPS0ST(#*V[TTR,=$Q*%G=_*5H?O'L6234:3.*8>&3(@&.(EN,M8*6 MR09<.A;EX>E(/N7O5[N^&]8L\_%T/&HHC@#KJE5.`.K-ZO:L&5PWI54PX\1? M&=UHR7 M9K=1P<]@CM_7(Z&4;H$W%#=$:6<$SL@+^NUN[_)[,V.EFM5H/L9[^?GC^]\^%YRY MO4*E/:-,)508<.<^7K;ILJI941SB;&.%)J4]S=*]Q4T3BF7S_0Z#RKE[;5@W M&\OK]MEHU,1HG&I&7"4!,!-N?4@SI\WQ"+-,<0(VUI9J=]G#S?>GJ8=6%Y,L MGG^A5&36%TEB-CGK+SFS@V1B.Y3+P29)^IS*/`K=Q(EEV_H"3B*$L(X=H`)R M(#96N6CK*8Q\%U^`R5HGW:OWA4WQ;^E2&EDL?=NZ)X/@S50:`/XM9Z[Q.(3*@+MJ')1A6KMU3&^>S4(74UDYT=)#`/EO MA2WFE>,`;&MFW-NKX_`/LW)INR5J!S!JE# M8J7.68P#&V1ZM8L>,!T#>Z><7QBP>ND'?5(27./;,"`,,EJZ]SH?_F4JQ`O` M5+4RWG[HJ-/.U+0Y/S"S]GA3(8;(@A*G2(5T5T`B%O/!-9BDIW*4M%5^>`IN`R%4WB@=XMR@T?&M0USZ,P>/&%_9MQ$XL(]I4*F M']Q912=@'XU]M#U/9[&3QF$@AX&L8BI3 M,3UN3\QQH*'3:G3BUEZ.!JVW-[N'2@FHSH\=)@-:*5LQ7S%XP"O+$=B%OLUKF%2"!0Z>_>8_@1/8( MNKQ'P-N0O`W)*J8Z%9-AX_4.QD-UX8?#)K;./B;DLZFU5_[U8<_:$8XYCJ/" M/4C&9U/98S.]-[D*Y,N.&@>%'!2RBC&6=]H:F855#,>"6YQ-]==%A-;;]WP^ MM8[*ZU1/=?4K2J>?XZDNSB7P^5369*?FH)VC)BNX;G\AO.&UUQ?^+LSK693J MWG%.K1G#3+8V#7Z=AZL0E0>=;:2DS)Y5(>W"$NS"HB^!79?4+B&OOVHQ3=1F M81AAJ-XT2)R`6U)N+X'/VKZKBQ MO_-RC-&NKB=]8Z`_R)<8_M$-)2?61VI9O??TB_[78=NEJ$.@2SUJ*IE'OV.8 M"6\F,80`8"BIR:$PUU;GNZ[9IM&J#Q4V87P(O'^=4AOZ?!J@>Q&T7[5QDB)= MDDPWVX:69FAV9?)&[,"VJA]\L9G;:G.U4B,VK]BP+>^[1NWAL???QP!Q^]6S?7VAF*%-H+5O@L^T`O"]O M3E]Z4B;4=0E>(47@A9&5@-?A)#@HZKN+G`<\&6#G3#!,V5/6=0ZVG3\33WIT M(3SP%ERF^T3"IXS]]+*M-LO3'98ZG8[%H$SG=G1 M'TLT*5!X#LL38K]%X0@W_7+=I(HDPFN(*JI;;F$V\):9IV<3:REK(>&`E!%U MNTT)AQT>\7WP.$U@>(%R*>]@+(7VTFF_P$B`LD5EKH7W"7@1IHA\#@R`/V`" MER[UR54MCE3+2)#V!8[#R@U"!C>N?5@S+JQEW8#%UR+N@CCXJMFIA3W"(EK" MM`=9R?ZM=AJ3)7]*FRJX<*7?H^IOEW9][)>T]VJSO0C7-GST='SP*U#?ZF\S M;!+*3:*S_KG7JN?:-D]>Q].J%7/*V#OIG;7#(6O<#%?NZT:29.IH;?\ZM.ES0MFZD)1-G2CU4X0)2!D88WE0[26SI#8P>94J)N%BXN1,!ZY'. M)Q"2KDTE27S3+@+U-%>7ER\&%8,BT2H)W6P&.E7U@B7U31*FI.>1]/7:;I;% MQI=:;I66EJBF)=I*MXE](NE)OQ98O^B_0E+K]2Q2)`#ES;/4G)&_@/D]`'72S?[4W3320KW%/*G=6\<^/U M=7O4N>Q7<'(@%>ZK24X\!@+06\M1W@/IO>_R![?[%-W5C,&K-W) MIIK1YZ"L];/V(G/"A9/\[[_;Q5SUVY_79H[K("&?,R>WF)/._]8;-/DD5[.& M=9A&05TVEW]K)]_Y<+M':(!;JW:W-Q0GLK#781JYL-=R>*_JA[[)%]Z^(/G\ M6E%SUW/N>GXX5C-V%IM9C5GM>5;;&I::ZQ%W!F0PVBZC/L2LG8@WA7!53X2?8VS*EMWUI^U8TK6GP;U9PVZ]K#Z9/7)ZI/59Q/59T7` M@JP^=U*?.^-1['34LDC.07J6EFO+MS@SRP`0+Y^D7CDR'09K2O_P=U4XY"RL MZH,J%3]1P5.CBIHL.#V0-J.K@F!Y\),@CR3*[[-=8D(UC+X=O2` M)_1U8=!XL79P^`Y5I[S`D]GT8M?R8C&3ARLN3WO<']U77O]KI_-;RYZ0Z'E]=WO?Z;ORWQ_G.*;I,8;%NET.T=M.)B M_?903D[KW@OLP/%`2`I+]"PK;#O3JZKK,1"A8AF7`NLN(C"YQB8'LJS89_6\4BI4G&+\L589E6!OU9*+=+ M5P*$QWZ@8D.J-8QEII53_=Y:JE&E] M8$]2,Y)9#P=,I>V1^1&.+:DD++9CEJN1Y M%,;"@6>078%_@;O<1-41:_(HQL,ZPR1.L!XZ93.8:^*K6B!<&-L%PR[%JDDC MDLT@2J45*9.'BMQ+--*+)=<6D\/89S!0HHF=B=!8Q$]"8''H-SRT#82$<%A5 M@=*]!7YH%TH]_46KQ`ZE82BFD'IQL5!;OE#`#VLI8UP2"`D>I@7^*/+H\K*7 MJ>&&NOB*MN%UQ?E+'$Z%6)%-)7GP)TI]HJOX8&C`E,"2S9#O&R1!"GFU5!.Y M0OQG*D#7EKB5JA7QT]/4"D%E>L6:N#<:([A&/J"]L:[EB4/E=>!-$ M<&X+I`#Y,/%`S;LXFYD=DW<'?!5&*<1$6IFN*XM50;F_N="U1?6LA2^LIS#Q M72PX1V=%"X%Z#,JH#5<@/5-RYI>O(]4+_M8SOM2R"U3VE#)/ZK<),CQXB33C MSVJFMR@]7Z:P?N]!F-Q/&D9@%W?JJO^A?_MA-!B^OQY]N/[P_OZV,]+NU(G3'I/*[X2$>N"J&45"=H,82_JO0<0-Y!=21,:TX1LU)-2B29Q\\X-X86/K#GPGHV364L#Z!@;#>ID7DOBR08`X_JK4&4WP%5D'?M M.8)8>.IF2@O)TK"^W'R6Y1&I^[1#T$*U-<%J51B.)A":1K!-"BP!KTT"<%U: MY!==@"C&&Z_)<033T1&M&V(DD&\*#C&"HA38)D,?*6EMK#XNK9\.4E'G092: MZCVRQ6E9O0JQG4PIE^Y'4U^"FE@_A@(4W1;H%I*+I%>+I+N=CL&RZ-XKRZ(O M#UZES,6X=1EHO2>X6U;Y:&>U-V].U*M@A4]Q7!CBG`?#9HNP-KC3_ZTS-WL&AY]9.W%VHNU M%VLOUE[-8$767MMK+W-=21O-,J_57KN'E:<5/7X1OH];:@HZ?>8%GHPC=?QA M$U+]%KF.*H#0=LAW4<^4N-5EX:LV^VS=3U@K*Q:' MU[I5-0H3JR3L9R&!I,Y4'6(3C$/YW2@M$)ORRAICRIHW6'E44]=&(73,@VP M5""]^AWP8."]KKE=A_VIV0BNXX0/ M:\BF\"IK2(,:A*4B+4`OC6TK&M!,HZXGFN1%(Z[D&LK[O(SSD5D*V15X`@<'`DY(G+.;$+, M]?='23NZ^G]N<"6MVC&L56\UBNT4XA-&(L8;\`F.H=D+ MCR#[=B."FL!\[H.'!!Q/'S7"Z/+$6XI@,AE+!`Q5^,!XH;1G(J49`1\'BCB$ M5T$BI821G$,2TJG]2,5N&LL2-`)X M(%HD7&\R$0C>G>-;*[#RZ`\1:UCJY>?I7A`H0?A;^OX,#3C[0M]>OIQ06,%T MXOQ055J8FX#!&>'?":A,(P^Z0`\MA7'&B0$1A:E1@M(V.$C4F4J3%0!+42VA M'9J1@EBW!!;H3.(*T"$0V:9NS-A#B'=@$*7:Z7%*>F:A*WR%!9\@5#8^4>&( MXG.4_`GW`NA$5@LT:#)3YH%A1JN`&;UZ+V46(VQ+YG5&/NR(043GSWYQ\4D$J+9IZ;,T^ONP#P,T$"ZZFPKH-9\!\BPR9 M;OBC+->18%E%2-5F$]N!!TE5Q2"*T326*U"I"-4L8(F53%T.:Q*%,WI3F,3S M)$XKSLKU#%2UT$J+';`F`;[,*E3PW%0ZI?*$RE4M(IIY@2J#F,/C140U;_!+ M5J&CZB%TP0B.Q,-R-BR6*`W?C@H3C$-K3*/'4CB49$6`:/WY+JRZ<)=6@-Z9 MC'U/3N&KW]M?X`F1L&42+51:WW*2Z!$?9(&2@;>F]8@TO*P4!)?,"V0<)3.: MBJIIM*0'3&)'M!!J:.4]@S6#F6%?9JQ/"F)_`2OEP/WP^Y^)'<%4\*OT"7F) MH!I#7I`7AS$L`,P]@C%YCG8T4T9(%\:UW"3"15V1GKWR75Q%?;`J:H.0!M=7 MM80TN#*+M&`0TN!R8)A@Y8+XK[G>!^4@L=K=R'NNKKN@*L)$`B7,D%372M92 MAZ!AP'ID.5&ET66]IZ@,%I/*.$N@(>#-_8L58W,5([E.L**NM$RD$E;BR(?VI0BD$GSHB,T*= M+V(>B]E81'F2H]]I6>8\)(*(F=K!0^[#H:>D`!&F`L+=P%71,LQ*H10P#$$E M,`3=_BMQ"/K#?:OT!X>&!3CT?7LC--0;+^'D*#EJ.S[IO4(CO;=]&>&0[MGYSXK"4T^X:!^W$ZMAS+4/?6K/;>8:@KVBWU=]-,VH/;AF3<.:AJL[F'`G1KCM M@^L#$K'VA#MW3(J_JX*38_I0M?$.NJU.?VB*$G59X*J=`-:\VQ]'>+5T'%PB M^H/VT%B?3 M"<>$XPQT+0AW[AGH^S":""\6;LMR\`0-0A:$$:(?>9%!3[Z"$X4U7OUK.V/6X1WW*QXI]^^-(>1^0)YZB([G#4_LN=9NY*@9M&/Z=.T^HMZ MT8^S[B^??%^+YU*-`NP#4[IA@O@G*5>>9K9^V.I=K2)='9R&=>$V3BG6U+Z^ MR%I\OKY:[=8$938:MCL5I2I8F;$R.YPRJYBR^OV$^&8J(V!>FB_;UU?,JG5G M5;:[;'?[?6.G>-GJGON.W3\4NC1BJQ9[E"#H]/&3``V/]3O=PY&J+OS$.PLG MZ$'4A;D.YR@T2=&,KMK]PR45Z\(+K&A.4-$8\Y.JB(_-G?5EWF(CQD:L'-3V M#I=*K@LG'#YVK5%B[@"U8]10X^A![&GN9`]:P]YJ7Q=.0_'FSQFX$K5G1\ZH M[Y:JNVIWS17RL3)C978D97:XG6QS;G4%ODE[5$^47N95-KQL>`OW]:JJ=3M' MLUM(!_R%FDFNN_Y@`RL0[=D&J%UDR&+CS"ZV1#5$5_41+W_GQ;!LCOIFM=%: M'#I_6+_-XUW@_8_;UQ5[1M^&,V#5A36UI16$L?6@`"#A43B=4$W'DAZ>Z.]U M.I=MZT9:\T@\>F$B_87E>M))I*1R71`JVPOPUPO;^3/QI(=W6P+^C!>6_61' M+O6*O;4C<9](_.U)1`+D)4"!Q$+?P/K%CIRIU1VJMJ^6%\2A]?YN:3Q/7CRU M;`>K@R,;;\3#!AYVW5.'<.O=&FU$<^O= M6FZF#LT5`9WZ5BF?^J@HRN%#':]BJR:HF.H7*3GY>ZB(1/9YK4L2A)!X+>WAPU^U4;SZ';NAX:B^'JLOA5.PBL ME4^X)^^HU^[W6")8(HX=@S-]SHH^6_NY[,YNX\[6**3BEKQ'=W/?7G?,H4MP M0]ZZA.&-U?'GTY!WU&\/JQ>]ND@1IZ9KZF`RX9APG)JN!>'./37-#7E?[\YS M.UYNQUM7U_W4VO$.^^V!N6-^W(V7)>I(YNNHUT]]PVYM-_NL2/ZI@?NW>8N-&!NQ/.NA46L5QQ7UW> MQCE+/Z+V[,B)\]W"YT%[9`S>@I49*S/>DZY68/OM:W,'XNI#LQ/C1C:M;%HO M:Q!FU85U#$;[-6BED?=]*:],0UZ4X5%?+06<;GB\S6U4M M_6"*NS#<2PU'2TJ4>@Z_B@=-8#QB'NE54ZQ2R#Z+>22D"&*9-;I-VPTG\S"@ M5K$YZ"5VO=VAE7`+6\JN:TS<7NV=NZL0/T>PHOA4WC+XUI93*Q*.\!Z!:),H MG!'1A$JIP3!66PE[@9G>P<::!+>,C6>U6<$^#Z*FQ::&U#MW* M>846&)2X;OID/6*#I54MGW*$N]QVW9`>8>W?2.U_V:NE0!N6&Y/:W[2Y+$GT MLX[H=H'']7XN9'[;=KFF%T,$[>%2U+-NYGM03'W$R]]YH/0\1WVSTBOMDXC` M2LZPK/GBO8TZ[[.0H!\=#"2H'[?U>^#%6S=Z.ZY+7YS-F&83Y;-12C[!V5B. M[TTFUB/\:(;7XVDD5EOU[25_RM#8DUA$9'A<.R8;1=$=V3$I]"P@7K-B#Z86 MAW3I;3B#Z'2AV'+4ZPY_A"@N)XEE/]A@^&**!&'J$)5Y_'XF;)G`BI/C-X&8%:P]V^V&VFT!S$W=.T#=:\]- M3H'CIZ"[@$TC$2=18+W-UGR3`"BQ+[))P:M;Y:I,2.*I'5/:1,#;''JP)^0/ M1"M;]4J&OP,,/O18()CP@D=54.+8<]2[;=">KA;D=8/S0U2-(IK!G=@8$^A$D,8J\?!BI`YVUF]@+\V&BA(ALCM/^7B$(SBPAZR1!; M=;XW,R)84!MBOMG<#Q="E-9":4%-ZI:E[(?.I*U;NW1I"BQ$"A2O;Y0*G=A> MI&,A3Y;G/;.C/Y`FV)D>:?>\D.F;EBP67B\":5.T[80@6AY8+\_V_06FW\*' M@()U6\ID1G)LQ_28TGI8O@"OSWH"?Q+B?*#]U!.8MD-IA$';[C\3DCO4_#(9 M2_%G`N)D.5,[>!"4N%.Y/?0?<7I)#"(ME'SG/D.A6Y!+25+9MJQ[>*2RM_CP MIZGG3%=T1WX#&>59Z'H3-,P;S'@+QKU`D8_$#(9)02G\#91/1UI8$TWV[)DT MEE;.:V'D/7@!/$/_`.1`LD8N$9545T9^)$``;UE:J?SYCKH.9ZHU6?JZ*']C ME+9C7Z<_)QFY@C`&\QOK!^WOL!_4A;P!]IG-4*$N\<:S_B3P$_A3`0X3:0ZW M&I';M>4 M]J@Z2YR(GXL/#9!Q_!+S=CO%;:V=-A:+9%G>2%P:N=HJ[(+)3/>2'>R&/9?B M7?K'RL[4^KW';+MKN!;`;(NM0QK+3V^N^M_ON&NI;^P.][VQ*?=='>2%NVWM MY(!DBL0DV;`;1Z4X?X???$"N/NQ!G>C$AGYHO\=PY-:#O4. M8I5\G/<0'^6?_H&!TK;\RL5D+\.;_N;$82GLJ"NVL.WX)CH]..C;)>K'BV)>W&:HQ[3KH%:[\J5#%NPLJ!6!VWXH]KUJY- MFK4S:<+*<=R>30Q-("><-V(D]S'DW<*:&,W7L19O)U:KW1JAS#I7[0XW,N2H MVQ#]/J0E.'&HZF\W^B'O#^>'--K=N!P<#M.U+EQ4M4_!KD-S)*K!'D*3U,SU ML-TY7%13%UXP:.XW8UDRW"3#3=8<;O)]6A6^,LU]GF:TGK]4)_Y\E?$V@FFL M+),%KDJ!,Q`=U%K@?A6$/I(A%DRRW4J-_1.D?WE8UN\(*=-*_NR>4G6^@E$P M59E^-;+22CHS@FP,@N:R9WIH!#LC=X$?:Q0.+D*`/.DBM0S9AF`J%#Y$&8IB M:TB$%(VX,@S%$\8^,H99V.UVVI>CFA'J.SRG8V;U-J-\[LFU&O1$,ZTIOC"$ MUF&0+Z[,@T:NPM9425)#TF^0I&;Q?MO6^Y<`J("%$S^6S^.9M11V6200.2)6 MR$5%[+_B'2D.($+XI#!8<'TDS)$I,(0LEKLS6XLV^$D%3,":Z?RV=6,(BK)J MS""%2[?B,.284"COQ(\(:[?3`AGBL>ZZLH:]N(P<%C/`5=W>DA]W#+17#%$O M_J'T<9-Q7FD>VJZL9:84'3%U0A4.VW_;08+(7B@+:O,)M*N-%R'(%?"FEV&@ M$O9>!IM'4'G6BV_-WS<6P/*B_,*F8LZV*+R3.`_FGPB`&V"P(#FR!0&!HFD,="R MB:W#D8Q$["ERZHIZGD$]3 MI:M!^("X&DC005!!6)X-"U<$?,P';@G?>_#&GN_%BQ6,2(30]'TK?ED:-J!) MEF`-=T63Q,%X<(L3JR?`.Q2`'4[8=IPP"10A0E"#B]P&H@>#@(0S>%SD8<>( M$(8]#R.L9\JNHC<_MT;44B)%R%/@>)G!M5([>X+8Y-7B+&[!2XRPN$?2=5T6 MDT$,&<30]'T,8ECGDQP,8L@@ABPFVXL)@Q@RB&%%0V40PP.6-S&(X6ZDZ[?6 M13UG!F;8[0S; MEP=##ZV+['`H=R0TPVH8[6R@#/NMSA6#?_&>80U,YNM8BS<5J]5N35!FW4ZW M/3*7S3I[;7;N,??64(:UUG*U$<]>:S0\G'36A8FJ=BG8+"!,4[B1C>KSK!MIXZ3^)$*WX&A[/D\"K]Y6&[L+PSA M6IC%["DC%B1S76_MA`$07&+1,X)W1.+"=E0).M5!PY_Q(H57@`MN[4C<)WAY M"RM8X?I'+TPDS-GUI)-(*=RSQ4K;HJR94=+V'I))Z*9>>U@W0GTW[+2O5P&7 M]WG4MBAI6_!KG?'16BPTAQ2:D5E[9&CUOAMV,S.RRYYA@I6E^F0!Q/#R M[=!FS+A9[8XAQ$R#\&$'\6SL&:+G*.1&1")Z".":9X!P$`8(PK5T78H`1]I! M;!!22XLP6,Q[[=]U+\V";1:0GT0A`ST65F'--(Q9*F47JU+F>Q.%Y51!H-(> M&07@LW14Y::@5B^SIREE\%U_9-B<2!DZ'@&"97B<>0R%D%2^[2@0+BU#Q9!* M2"?RQA!263=-DBP-(HK_J83=#)M$"R!TJU9C`(,5=M:'7XM57MS'`,CCQFV M>H->)1#PFH,3>'9$J@>-X"2)DT@G`21H)E<#]_4ZG8'UR;<#1([,@>ZL*=A$ M6\/3$:>!XI*3!:KDH@&=VPOD.T3WB\+D86H)#Z7("D&_I4!Z\R1RX'&(OQBE M0YP*7ZG)2-@RB1KG%Q;))!.$B_10_#;,#@V?)B#>+45&MQ-";?V-%EZ!M")# M-06D=87IU11N4)/21%)/QB;4.Y(F+48(6!G.9F`0]<+#.I<0+#7P)O@&63&7 MSEB:";@O3?6GB:P9(L%B*P\;ITJ3!^_$%1,11=3.(_9\C;U:0.`D!,_'T(>? M$2018R$O(!^GI7*UBG2$D)D^"M$L-17P^_Q=*8EHS\0SU,1G`G&G&2*)/Q,; M2!`$^(\7@('U?27$I#G'^HSG\],BC[=F$U.IW$D4SFCD>:*X!;IM_$_PW8N, M[83@5^`"DL=KW8MQI-&#.X.6@CH%?R2@'$[*#ZD;J5,!^+@E@Y3F]6TWG!>Y MHV"?FF(AC";43#6@T(XA*B\C3[SLU+:SSB$:Z[24DU7TLYMJ[NY`ESMQ&&E` M00(WMNY(68.>*QI`"(D>/=HUM&8"##R*,6EUT''J&:4HMZ55BC?#/#[]VU)0 MYIDIT!#*6`LFIPK:O&$QHYG0L'M=8220>Z.)C%M(6[6<1MY$\.[5#![B6OA' MT,;C6B8MI51,^0LF,W4*ZCMRR2_(\B@D1IA&R0#IYV3??M=!F3:@A01:$DPP M8G-;F:!!C&$_@K4,X#E`GYU$E9<%XXR*'__NM?$GGQ M8-OS=Q":.7X(<;KX;5+DJL^J($M*&/Y!=]+K8X^ZQ_,U]_^X]__ M[:^%9\U#X)>_1V$REQ]3_L)7A(CXGPCWM[F(Z/DR?W'V,!)B^/!93'YZO?&\ESX`J3[HO=AU+D<]OK]N^[EA^ON\$/OOGCRZO^ MW9N_+OG#Q" M]>`+VAB!;X%K*'C$3<*?<=?C"^:4')&;O-Z/Q$<002ZLG^TQ*!]!FXK4^D0K M,KS[QGU$B^-:[[T0C`TVW<2?0#9B;''4MH`[I50^%_TNW$+X1^.H*@G^W7!@ MM@%9*40%T8LO4*1PNK;[3_!WT@"=SI$\T+RS*7OI?HV=YN,JVFDRWL@.G``! MV$>SZ;`?7OJ`]A9S;\BPFGTIWY(I#&/V]KO+X=!P MWSS:R<9T6CZ7PBS73\?O4N^`+(LLGR33EAD,O\`P1UMV^ON M>)8,9R(+-"SP()()1AQTS`[=X)`V`>#70`N];@>E,D\4^4LOF,`B4"(V;4ZU M:C5=[::A14CF2\-H*8<>K>.$@HDUF^$251LL/$PR=4>+;9N4>`>@Z`J/22UL M^5X<3MKA*57GM^`<(D"$K=K>P3]JDPT8"UQ*7`*[T/[AM?RN/A8W>`K[.9YZ MWUM]8N&'%L[*C,IHCCRD+4R!_F'FO:\](_$RJQ67VZ;=@2PR*#X\/;BD!(6. M5^A4B.81S"R0?*#H;<$PP-*WR(OWBJ4#-^OXYF9A2%-TU.=\/3;13SFPW*LJ M'WD%O:JZO5=8(-Z>*UN4C,>%.8M[\H]UJI7=08 MT4Z-G;AQT6;:KDW<18@RR/50A;3D=GW!UX2&\CV$5CV-F6:6Q2F.5QBJ-51JK-%9I MV5'5X].K+JSS6DUV[BBQ>IN0]J@W[:F-Q02+Q/26<&Q_VRDJ/=V^?A6X%G5A MBZH=!/8#6"Y8+E@NSDHN+D?<%_G5[E>-0LLJ"?NSD++@<>7%8U5(TDM[5*?3 MMK+R;-`.Q*L+JW$RJ`'&CD64191%E$6T%B+:Z_58-#D!>:@$Y/K:DSKML-2% MF-Q1YR@>Q0FWU>&$%:L;5C>L;EC=L+HY-G.QNEEW7__*6%W'V:B9K9H%OH@> M]2K$IQ)\U`<[PJX'\I.("''J$^%O[X(.U7U_W[GI#Z_[P_>7W:O!]>#NYGV* M#M6Y''8/CPYU;%SJE*982F\159_ECMH4N;^WI>=8HCAZ0C\C"`&L_4]R/!*- M1K+2K29($"1N%:>ZU!_@SO/I46M>%8F)3]A*"%(8Q@A[9_L0GOL*QYH0]YPP M\6$$CI-$EC>Q"(U005N$D<8#20%#"#$48=M$-AX"`*5B?83R<#R:3:3;^RFX M`\0>+ER]*[S;"S+UK/SM(GF=SN75X*K;Z]YVKT>7MQ^NKZYOE.0-AU?WOCC>2#E8](9".[A;A;JM_I!]`P% MSBA_(,"1O*^C0+C1]6WB&5KC$-`:UZ]%UNCO"Y,P:`H0!`_T%1L('$>OB-QK M]_5.LX*;<2F8U1B7@EGMM%B-<2E>RY4W:X.30F+!6#+2)#TUMU-HL,+JM4GE M]CJ]UF5_6#D%JZ!&[7*\?.:MJCVF\Q/,[G6_U;N^9L%DP63!K)=@7K:ZEVPQ M^2BJ`?K1AAB"^JM\.;9T>K1]`M2FXZFE!L@O=KHU>`CZ@($_30'M M7@];0Q90%E`6T+H*Z'6K>[WU!CH+J)$BE(,-[,6CS^NIV-N3BKV##;9T;MM@ M'0K=]SLVA$T[3R\W/@XGUBTX^?<)XG99MV$T#U4]D/4V=?5[G1_S2[(ONS_^ M@*4=O]B1,[6Z0^HA?EENCDK5%&X53:N[E^UKXRUUL3UY^<2(+:VY'64-H[/& MT$X82,_5A5-MR[IQLV;5A8:55B0>[,A55/=DN=]T)!1*4YX MF@HJ;?`BU9Z=1.:)2HRH_R]V$`]B[\)-]VC`$F"%DJZ`*KRH;=VO*6DPPLEK MZR*4=!IY?LO,,-<>J=Q+J! M7M?%;\LB\XR,%)G\>2?CQ6*X]65P][87_0-[F>?UJG*74KC+T6AP=?7^_GIP M/1C>?1A^N+L?ZE*XFZMN__K$2N'NO<`.'*R,_!C(.$I4[V64&22D192T?A$V MTI%^VUO+/U>`>HS:VL]8[$G-WP\YTTJJ[B8X@4><``GJ)%M3+U_3EK))VMT( MI6KZ'@DG?`C@B5D=KDP[<)>?-`]3SR0NO*X%\@PT1"[K=(Y1+UJHX$F&'*`):']%M2]1SUO+K"?OV%Y5+)^*ZZ#!'\@>6 MX<-;@#.L>%Z3$;#ZG=:V$6Z],">.-;"O86S[++`LL`?@M?])PEBX.5D_19XC M9/[9>_X/0GMPO=O2'V#[Y>]`A(L[91TRS(9_5ZPI''\Y\!U,5$>[#%MTR4ZJR M1N1LL`X](!&;0+C:$(LYCCF..8XYCCFN/H1CCMN'<*_$PNHVV2'6,8>,O3C1 MI3>S,!`+:T;Y7QPA, MK`-8![`.8!W`.H!UP-8L8+09=%W6DW4!ZP+6!:P+3.B"JO8E3R$/$XM(R-B* M[%A8\LF>\U[D(;.F+_;1J@SLZ^#A2O7]3>HB5%6[+BQ9+%G5&GX6,18Q%C$V M7BQ9+%ELO.HF8F=_>N`^C)[LR$5\NZD=4"^$((YLAT\,'$49'1>\H`)K7Q$, M]>DV:V%Q8G$ZJ(EGN6*Y.G>Y8C/%XL3BQ&;J^')56=WGJ.F1*J'[6%SD>2CU MM8,XKFD*M`\!:Y]M,G88YO6=J9IPC*8[Y"YQO!G`JJR.[,BJ;#=59JY"@%49 MJS)69:S*CJ7*^KWCTZLNK,.:C#59C=B1-5F]THSGJ-)>>2*FR0=B7L"7^]FS MQY[OQ9[@LS$5[)+4HR],[>C#_,/\P_S#_,/\4T_Z,/\8=2;/I5JX^G/7G'LX MH%*K?5AH+K5P"IF#7K=R!O.9J'KQ0MKHE-?C#1PQ)JSQM64=3NFV*0N$E&U"\/B M<,+BP!"U+!(LG]; MEQW74P',XZK5TP`OJ`M7'0ZCH$E'8KJ=T<'H4A=.J-IU8C7#:H;5S-$13^K" M$:QN6-VPNCFHNND;.TS!6H:U#&L9UC*'S'F=L)8IY+;^$MLPP[77%_XNS`L! MS2ZF@G1)M]?Y?N,`"_>4A*X#S$/$\0+0)^IS\:%!&,ULO\2"7;PF>S"-V'*$ M[^MK?GK3>4.?83F<]/,:DG[U9D):OXHGZW,XLU=4V9/GQM-WU]?M4>>RXWR(Q8QASB?#MYK) M/=UNO5O+.>`?BL@,.]&G)^5BCD/?5<]Y;TM/6N'$NK>]R/J'[2?"^D78,HG$ M#%Z^AT-]=EI^/6'?_N+YOA<&1%P7'>9(_L`R?'@+4(4(O\I"5"_47\0\%K.Q MB'+*6OU.ZUGJ'FNLO4YW4,N!T?$/%E@6V`/PVO\D82SQ`V6Y+[6TMR547[3:[9?Z%ME?+/3*G*&I&SP3KT@$1L`N%J0RSF..8X MYCCF..:X^A"..6X?PIT]WO#'0,9>G*!';/O6+`S$PII1HM?R@DYI+8 M`RDX/K5=($(3#F5W6YT!0VFR%F`MP%J`M0!K`=8"YZL%&$28=0'K`M8%K`L, MIUS.!5#\(VXP"QE;D1T+2S[9<]Z//&3F]$5\Q9/!3^Q7SE=UD:FJ/1<6+!:L MBI&G6,18Q%C$V':Q8+%@L>VJEXB=_?F!>]VE6'QSIG;P(+A=<9T[`#1.)_4J M@E9<)4U=!*IJH\_B=,;B5#DP,LL5R]49RA6;*18G%B7J\HJ/T^DSQ.7 M>1Y*?>T@CH;PRVN?;3HN/JSUYQ[.*!2JWU8:"ZU<`J9 M@Q?Z67&5#*L95C.L9NJ8H*P[!["^87W#^H;=&E8SK&98S9RDFF&WAL$&=B;@ M+7P'(Q-PIQ,&TG.%VF6U?-Y6Y0*T>CI!9U)WQN+$XL3UG"Q7+%- MEBMV_QAVP"SL0`7G?CF[R'4A1TD_GD5=2._Z^/2J"^M4[6NQ)F--QIJLL4$B MJS16::S26*4U/SYG3<::C#49:S+69$W49(4`3L25;T`=%K\KH_\:30!.176;3B#-5UDH<#P1VEY@8R].,'S M,[9OS6!6"VMF1W^(V+(=!_@DEM9<1#,OMEP;7F)%PA6S.9VWL0/7BN&Y$]N+ MK$?;3X2TP@E^)04\^%'(>";P`78DK+$MA6LE<[@/[_DS"6/X/(\\1^`HX&VQ M]RCTN^&=4?CHN7#%>$'73T,?B65-O,`.'`_&6ABY;%N;YA>)F>T%>*=CRZDE M_DP\&"F-ZDG`L%96;R]UUVWWAD-K[/D^C,;((XFX9@8'E+!F1H<6FQG9%S&/ MQ6PLHMSL]CLMJ]?I7M:,AC"D516]SX-:P)!R+HC7_47;^C(-H_@B!@%;$9BI M\$&\0N1^$*^9'2<1[1S0K/`"QXXB#R3$QG-P,FY93U//F5KV'&3GFP2+X$EV8'[&YF:*=#,X2-#^U@+,FY&' MM1MG&*V9L&4"`KIDU9!;)ANKK&DAO-6FSDXXEB)Z1(<&7C9/8C2:CI^0473`*(.!CCSY1VMI*`L/ MU8B31"`#+9P%T#G`SY$(G(4EYV&<&F&<1SI-]55#EO#G$-^$HNZ*<6QY:/4= M=(1)-]HST`1P@TM:4JG!\MKZ*_=K1G"+:_B2QP*DLZ0'@[6CHF[)U'(DLN/* M\)B?!1@`JY>OY3+/33T1V9$S76PQXB=;FG)DNNVKNOHQ@W;7\-#8CS'EQUAW M8#I!$R$3QU,/-,B?B1VA"47=Z4D(5,FR$%%:=%FJ=$%6?5M*;X*^C!E.&5YV MS'J\.`D_M+'L@-2JM%P4Q,#Z[P1,)LX(YG5E3:)P]NHIJ(]X^3LOAB#;*2BY MKRCR=R#R9J8%WF5%HRWXM:ZIX0*7K6I"%6P&(:Z).35HG(%`U61:PDJ50T/, M*\4-X68@Q+0R[1T(SA/@9R(*,IC_%0CH"5U1!3;9&0A M*)&>CO)O8-HZ5>&"4O%#Y:Y%X@&<%JU_@!V*-Y'A5:Z20#_-^A5XQ;I>MJJR M,,HM9PH^%D59KG;7(.P:JTL6%T^T6/`3#A.S*.A^I/X=A`&N\,EQC]6C5ES% M]$D4[X%R?`A$&@P61PA.!+@8:B[YD'[SE>2S6#&1N+V;Y\-,GI;.,Z<3X+N*!L:4G31D MNE$GS<#O]!=`SSCRQ@DE)=-9:FFA*0&%MEHF4T'X=_TKPTK.F*O7&YD=&?`( MT#-`?P6(2=%^O"%A6-(=0.J_B^!6^#Y-#O](T+__#%H&G?/,;_QS26 MC^&/"CGS6\-$Y:'T;S&1=BP>O(`2N!@RK]-'I#]`=9G+YP:A(?^J0!6:JYZA M"OZZK2P*!.6I_NP7Z:5B2B0":C9IB8!L',^J1_\:!B".240AV#W*WC](]GXI\-)!)M_O&%9%'[5^+6G5K6)* ME?_QX+,7D?)QIG;T8-)\#GMFC50(A>*V;%:!>#4F.V+U0$APXZ_KAN<;(0@E8/'^/^,Y'*$N!^QP*?;L_4OJ1V M*=>]B6X-,I^X?.E_%CWD5II$+WK01!-\AD33'^=CEBM!:&'+4P^D'!RTBNZR MG>ZM8ESD.1XP:_R?M,&:.@DM'4QD5])V#IH]5*CEK&&KD`(N9R>+N;8.V33R!+\^V M@],`KML]775^&P+Y<'QKJ5CG#L,"N:2LA$?[,FHPF!BD M/.`\&<,2D]B"5#ZB%H+QJ!#."QY#_U&Q,YUN$+8?3QV5JG!!X46+MG679&&B MCY)@2>5M8U(!J"4+4?6ZX3GPF'`&UA+U3PM%-&NG1NM M@W!+IRTL-X1?@S"&_P.!?3HB`E:&MCM\-#&1[9?O@`"BL&1Z&*]:.35^M='B M4>SL)K@U-T9E"BS6MOXK?(*G1N@FP.O5RV0ZH93,6A6"7IU@5-/"%ZJ'XJ\A MK.=#3CZ5S<#43H3:?)$^I#Q"M0N4[182RPMWT_,TA7BER,%FT.]H-$G!A4YP20A%*;90SQ?4Q)`HNB4"0^.34D MU6@.R3,H:*SP";-S\.3"=S*98Y0*WQ=D>V([:1(',Q(ZQ4G#C%2F+TV*P3(M M(/1%/2>(BGER,%\Z4%4Z!X9*0?'"$[QT2CRO>`JGD+V@H!^LP-8V&9RM()S! MKV6N6T]85(GY+.'N'8@+!CZ$<2--L@R,_6B#DY*G"/-G6Y-$A;LXMTAXLW$2 M295&F*,DT?YT:<1CX7L@X\J74SO<,2Z?P+UO*W5WT3%\;A*X3J#[_L3YZM,D ME(GP9%F%KFI0>"JJP:G]*-29&>4LV2Y*H2#/!A0`)DTQLL]6D0P9/3#21W"` M%L]+8OKW7_^2R(L'VYZ_PZ"/8KZ[W,/Z"C+XW@^=/_[V'__^;W]=N?*WR7TZ MAH_Y=O4GE>/!U8?;/XO)3V_N[S#`^I_!_WZ]>V-Y+GP!\[@8W5W?7]Y>?1A> M=4?#RYO;VYM.YVIX<],=#B_?]]YWWOQM26<4I?NK-P-2_RJ>K,\AJ/:-VJ%6 M>R!\2H1/B?`I$3XEPAG7;1_$IT3XE`B?$N%3(GQ*A$^)\"D1/B7"IT3XE,C1 M3HGLFU%Y+D]2SJRHL/E61\U?<<0V\9*\"5SZZ*MTK[HYR\]LD6WI#N]O;RZ[ ME\,/M_=7P]'=H/N^I[(MH]'[_O6'@V9;"$*^M$EV=?A-,DUM*R6W52!P,SPF MT!FX-^(O\HR+3,:@SCU[.5D[20)'>S194L93"2A@H.*WP/[A7*2[/&DU7(`; MR6IC5V6IZ&W%"W$_01.0'"`0S]_;7]J6BWLX49IK2K.J67Z+PAQEF@N7ZZ2Y M]EU@-E+OB4G0V!REHL$^&%GU;6O(BJIL[^'H8M);;CE8Q##PGC@D=P0$^5) MYEUTV/W]^]O+VYN[Z^O><-B_N;FZO!OIC/'UZ/K`&>.N06E>KZ!RHEF*:LW0 M2H5A:XU1C$J+N:NTF!99>/)N[]EML9(EC)3.$@7P<_&A:ANZO-AX3?9@Y5H[ MH'7T-3^]Z;RASW)N.^GGW7GPR7/C*?P)<](P'+0!/I?B7?K'RE&3?%!%O-P< M?>-J+0+R%I"[-)B?W@RZW[\([%&&%]$W[GU?[]`OY`GR!.LXP=W`L(\&.+\9 MRV>TGRG);WL5W/RPWG#S>!!`1&:HM=Y_6)M=XCX&S%@&&&MKO+%S5F+KJ??V M%Y5RI.!31\<_[,.'_2/PX0M4/C9G_CT*U^``;0@D#CJR6WU:OI:#NZ%CJVPK MS-L*EM%59LLS5W45!CS(]7(>F$6"18+-%ILMEM%SD-%3-%N5M5MK<+>U3?MM MV?%N;WE_HQ(!.R"=FZ"9:D.LTU7IS'',<?!<;L[?R?CXZG0-H4W M4*`S82"GWMQ86]U7;_*<0O.=)K70Z;?ZPXZIB==E)?$^;F]_/*O-6J!A6J#; M8QW`.H!UP%GK`%8!K`)8!9RS"NBQ!GAMLJ!&":LJ"7N'5:3A',OFA3,-8*8/ MBWU25[U#IJYVV%BM(M`>C(:5IT7KPA]5F]X:B5GM;/(9"M>E.>>518M%BT4K MOV]TW6?18M%BT:K`)1Q>LVA5%HF=5L#U*0H1FMVBD>UU]NXEN6J<^'1[(\Y7 M<,:R*CO3.'GH&RM[9G%@<6B\.'0';!Y8'E@>,O/097%X;4Q1HP"^2L)^Q2Y6 MV'FADD#C=`+X0<>8RW7R`3SGQC@WMLM1A"N6+)8LEJP*)(M/(;!DL615D7'@ M[9SJ0J_3BK`^V3$AI2-8.^&85R)9QT5DK""%T3=W%N$%VM2%43CE5R-+=6KR MU.L:._'-\L3RQ/+49WEB>6)Y,A907;&_QWM:9@AK!LEN!Q[K`X^Y88*O>8T` MUCX58*Q2\D7RO10WXMB:8J:.K1R^6J(N%#Q<4423,EH]@Z#<+]&E+IS`.:_Z M&+ESM&7,/VRFV$SMMO%B#N">K11K&;92.T5U#'#8)HYF-GZQ(/-@1CL** MIP)^<2)A2R&M.-1?E$,VF#W^*RU7Q+;G0U!GCV'YX4?+QJ-KB1];X81NO;4C M<9](?(F-Y]PDO=[RI#6/PD?/I8#0^C6,A77=MKX6WHXOUR??X*)8.-,@],.' MA8X:+3N;BK_`F_P$'[:R#'M9L<&U!1?Y\'0CST-BZ%%'P@D?`@J$DSD0@F@4 MSD"L%HK)1[WN\$=9(A;/2"F\7L(S`M?Z,[&C6$3X\\23(/76`GC2 MZG6ZE[@23\+W\5]#%.F9I<@S=/C/U=G#5!(?YO8Y/1:I*3$)DRB>/D>))9[R M-!MN>=P2F?2?PHD/P7.C;LUX[N\B0,)GM/8B&3_/=($I6G0/*G\O<5O;0B:2 M1<7X)")AS8$4'K%".)F@6APOZ'GP#M2/W@1,,3T4--EKYZ$^XN6E>K"[3$%^ MS11DR_I5K!X4WI=NM50?K>T50,MR$Y$:LES#./"7+](E7Q+S92;QX+LEI;OT MFNXR$]TX3A)YUNT"'"H!-\B6]3%PVM5X"3W#7L+'@KU7>5O%Q^+;7`0@!T_& MS$I_<&68,0PIXX%9!61.-8[Z9D<&@F3D02AK=5I"&,_J<*@9KET8:X!U_)\4+Q1YWAJ:`? MO"/'\ST[=8`>PM!]`MJ@4SQ.)`Q8HA/U@&'5N[WGN6D:A7M*V:[.$BWP<_&A M`:9`_!+YNGA-]F#*'5D.A`3ZFI_>=-[09SFWG?3S&@)^]680)_PJGJS/X M28<]>6X\?7?=;_>'O7[W^FHTZG:NNU??IQE>!^AKSZ5XE_[QXW*V-A]B\41! MGL,_J*LGD1-[Z*&BN0/SRKU?4^15=#F9O>MC0)E M';`B(JJ2MK$%^FP`S5KQH?UV@AB^K`TOD(:?_8FPOKB>")PA+&3BLQS3!^6 MR;UE\FL8;V\?N41S`UO^/0W0;?+B-J?^C`&/[$._C8NA^9XB]MIV^#-W'.X5 M2/554*H"&/MNMW)B-8)G\#ZN;JJA5\*$8[W/>M]\^Q)SG9@:S3.L]VNJOIAP MK/=9[YOOP=?M7+/F-Z'YS[VZ_"8_>ED)W%3CH$(*)UU,25A=UKIJ+XEM.M/G M;/6&N50OJXL#&%+S#/#V9I=3'#6C#"L*5A0-\L%KE%:HDK"W212)P%E8<60' MTJ?SP7$8[C!>OM^KS-C#`F8J>N>N0CZM43+.:]!<"7&K%V-A+EV9I`)5[7_ M<$8:SYCCP0J/Y9857KT(M[W".R&%9@[7^;PUUKGO@FQ]GM-8%Z!7"]LI[-16 M-^<*<`A'QI1-7=;Q]!*\M;/*3!_6D>>C(Z\ZQLXCUF4=64:@CWC]Y M[7G!P[58WVLCN.X1]^%:(K\&-*8VB;ZKUJ@S/#[)ZL(]9Y0_KIT;PH2KA'!L M!=@*O$2NH<$M0K8!K,K8!M2+<&P#V`:\:`-:EWV.!*K8N?T+=35<>WWA[YU: M'Q89"QM0%F>UW`K1VC2]=0D:U2AQT-F&,\O\4%6#-YCB+CSQ4@_+DJKK7LV_ MO8Y-3$!X81;L55.L4@X^BWDDI`ABF?<876[87NCUGF%A#G^4*TW:?9BX]RUM M)K_4XGVUF?S@^0:MVPB;L7ZB+$15"M%.1SD:*$0?`\=/7&`H>P8F#T0)1"KQ M8R"A-8G"&38)AY$$EK/FN`LFC)^$2AP7!S8X%-?>,I#!T8PW,3VX<5\F8S^"7R@$"%N?_KW3ETFK@)?'4B[)UD>L6IH5:="Z M/-CV_%VZ47X3N!^#V`X>/+C\1DH1R[M,^WZ%!7COA\X??_N/?_^WOVYQZZ?0 M]YQ%=ALL>("+^%E,?GIS?XV-Y+GQA._'%\+IW=7LWZ'N[ MWM7=AYN[P=7PYJ8['`T&MZ/W;_ZVQ"7/J81-#/(_LZ+@:L=]]#V%]$8P#6!GT&T(62(;11?:Q:ZPH<79^OJ2?TZ?'1L^<(FQ1`H M*[_T0+@`M0=X9T@Q>'8"`X-[8-HM/55X'@V81@H/LL*YB&RZ6(H'>@H\,PR$ MNLT:`\6>UEZ':F'\N!-/*##>$%C`G;2[M4$[K$> M;3\1>)>]-/N6)>"U,_+@%"_8Z`3#(V`4280A)LZGL+0^A;4K3$9:XILC MA$O/$/!M;H"61OE"\%LK[:,IMR13L&X[Z!/@AYSR+[`#?A,+9QJ$?OBP0+&# MM_P3R)CID*W90ZW",H-\W'[W=IZYD3, MU3M=I+@,%LL'OD`5!BP"DA,OU)I[:%TC8;N+_+48+2"E@?`TT,SM+@;W+K(% M\E7^DJV%H,!M*8?*9"S%GPF9D;#XHK9U]PQA\"&Y9 MIAN-I`?6'%3=*\L`4S7RH-[J$9:]QH.A#JA#I00I*0$Z`F7F`N7'FHEX&H(" M4?YOSLK*+;"4N,/=8I+X%DJ]S+PAS>1S.]9N!8KZ^N6:@QIWO+GR58PO':C` M>JW=X+!K=_^L3BZZT\\H)+5^:L&TMLA4]M-4!$7#I-V@,)(Z(:B4$[FR4FD+ M!]??'GN^!VI);0HD,42ZJ8^)$;V:5Q)@%A)S__"FW"@I'VW)(]*F'U7F.@NK MU8^M3192;,/3\3=EZL0W]+Z6;"/9ZM*4(4Z7*J#(4A=>T6%6.R`R?2U8'E*. M$/L\:S%+_GUYLMI/E-I_]9W$)W2%?LDHI8RB>4TA`?R6WZ:G];DZ_8 M(O%P?SD<]-[?=_HW]X,/@ZOKZ_?OKU7B83CJW%_=5IYX,)E66$DB*.)80!W1 MH&0!I?`IN4^^EYI#C'-0LHJKZ@4)\F)!7O%:9&Y22Y8(,(996_BA7$=);NKD MW=YDV6*Q2]G8SA+I\'/QH0&$%K9?3D1UB@E<8RGSI9&KI'BW`W/2)XFWMM)LBRPY#>:G-Y=7W^^8H-]KW?H%_($&SG! MW;9WCE;WNGG39+2?BAYM-#)O?U'[H.3_N*@Q(KD76DC_"!6Q+U#Y>VHW3.8U"Q?W]([I`->%%&?9&NG26$U^7981[^/. M2,CUCJ;:ZK"/K`-8!K`-V.6'!FM^@S'&K3[&+L=YX%;WNQ5U%#Q' MU&I69:S*6)4=2Y4-^A5U:F95QJJ,51FKL@-Z957E/L]1E;URUZ'QFPYW&ONQ MDL*RWUP& M]+R/]W#.H$8.`:NA9JFA2W.[R:R%6`NQ%F(MM%>)`:LA/NO,9YT/+7=5]0[? M3)O3ECY.L;&T/2-MYFI46=I8VEC:GMW+/I2LU45L\#X^)7V*LG="):V]H;FB MUM=2[;R-(TLN2^XNDGO-@LN"RX+;/,'M=J]8^4@=0^>,W1PO2ZL=;CS MZ4W:#AI4Y&JL(4M=&.&UP3MK&=8RK&5V2Q!6M?G%:H;5#*L95C,:_ZA?4?AU MPFJF$$C]A;H5K[O^8`,K$.WX/:VQ\SL,.XBI2^K*N'=\K/J(E[_S8F`&1[U( MM_N^QR;9MV'6)/NWO$GV>S$)(V$]VQ=\GRER]VWNOEW_WLTGWYSZY"?8D%0= M=]\V0N7G*5FQ_:?2>1)UW.HGJAMW<2O M+F:BH:ZM%6I9:T]@[_-\FK>1)ZT]J;O/@UI(=\M)8(7@9G?-6AFH%%/*N3\: M6C-5)U`S:G[7O[PT.K26%0DY%\"?C\)?M*PG`0RNSF@"<;V@JMJ[3Q%(B>=: MXMM\"BP MHKPY[FB+/&TGF26^C:MOV3,(SV* MN[2>;&F(^8?M2Z-RB0P2BVCFX=1HY$6ELE"+_10FO@M+[DE8]`E>!7]DY"!Y MB<3,H_#%DYJ_;`>#9(@"U_)@QG\(69"SW&8*3@7&16'QQ2DO$Y8!Q-XDK>M9 MLAF1XE+`C^"V$O]R$PD74:"N&([)PG@J=`BY>Y\4NAZQ>)B0;!X&, M`??&/BH%G-QM.)O;P8+<5Q_OXW%8-SVUQD?A1E%`SBL2[`W-HT(WF&59?K+YJPHJL MOK977WUSK7D:S3.O55_GCG'Q4>^366XB<+O+=OY,/*FV[_;)3+Q45MRXLN&^ MN0Q67=:\:I//EOV$Y:%P0(WE@N6"Y8+E@M/MAIRO]%0N]MRA@TCSL$)7['1: M*U]6#_A7%Y;A=$T#C-<)29:Q73^6+)8LEJS\OI$Y=+]3ERS.T97=Q'GDA=&! MG,3&R577V,F#NBP_IR7J8W\:)P[&T.)8&E@:&B\-/6,'WT]%'#@WMQ%J)ZT9 M/(+7=3IA3@5I\9./=SB3P)D$%C$6,18Q%K'FBMBY9^U2!S+U'Q5ZQ4P$*0`& M@B`0/DQLQTE,?_K>S(-/E;F5I];3XVW7W/[4EK0Y[X:[;/[.6=HJ:CW!PL;" MQL*V(FQ;E[.SM'&F\Q44+!3]KT5)K(8-N8^":?*=!'+`Y9"[*'"6JP:>!ZLR M5F7U`4%A5<:JC%49J[(30$LY>U76S-Y6"$^]3-42@CGB2ILD\__SXJD"Z\XA M"7"/Y-:.Q'TBZ5-@_6)'SM3J#A64OT+A3Z'!"3_^R;*MN1TA_GP(?^+1G9D= MQR*2EOT0"=J0(7AO?##,UO:M_Q*V#Y\C(1,_AOE;DRB<+?_\G]*23 MI5%Y@37Q)#"^.BP$X^JTK=^!2E$&BK\R@I6!AV,@LXVH]3!L)/$L\":+E3$B MY+T#;[6T.?RQ,:=V4%?!Z M.A@0;7KPW%X0B#@,VI[/H_";![-#S/P5MMM+4<.X#+>A*:0YK+0'!)'+DZ?2 MJR/M_'8;!I3J(T9*\SQ?L`U,X44)K#\(I9$R+,A<@`&9;XHP&AIO.F!F6 MX:Y*!MOTC(QK`",/JKZGC)''&.MO:+3EXNKNQGXD*C=<2ONX%/5XG+5"L<<0 MF[6MNR3R=(>:@J&6E@CP#F:-4V&-HDL5B7D8Q9N5NRUEZ'AD)\D9W-P3QIP9 MJ*45J&U;2,,#6^JFX.F&`/::D-888)1!2.<@3S\?^5>BPB3B)`NKG%"0S$86)A'O`0:2V M.@/G[^0@]!)O`% M*1$\PX>/HP`LC>J4%8FG,)J'J3%MN'K";2\>L.[U2#6)2V$?M;&%J/2?8;1* M!&R8ABWZXM55:6U\8DX/-,D/H#PCVX?%"$'E6O8$=+`I`G563R6=L)!DT:-7 M:`ZZ<>M>];-3'04G[_:>X:8)%.XI98G/JBW9U2O;D@T.WD3KY+MV-6:@O(+< M=^TUFQFOZ*)CX$SFL-YG,KF36L/VJ9FQBGW3K+ M4!=G5GSF%1\SVPJS_9SW"6>.8XYC]<;,=DK,MH=ZXT*F#6@12'4L"?<` MTCV[8\IR[8\SUJ+K5FU.NEX-N'/IP1CBC&TBZYGSUC.,*,3ZYC3U32/:1M9" M&36CU>@E=TIF]<7JJU:LR.JKEHY6(WCGM6KLW'$=/T7A7&`](6:8Q)^)-\<3 MP_ND0T\.7K\"6:O+JE=M_-G&G[!<="^-N=`L#RP/C9<'MA,L%RP7:^S$-=N) M5T<;-4JC5-L4,K:#!V_L[W0NBGLW\$X+IRKK89Y.1\1ZK4[?'%HU"Q<+%PL7 MVR\6,1:Q`]FOJ^JWN$]%M,Y]^^?G4(.1.)%``!#'CJ+%)(R>[,BM)!)KG#1= M]D>"L'F?U.-O-!=H%T)NQXR_`#]%$\G M^+_J&S-#>Q.M+NS$>;<&&+8S$LU.16UG6#19-%DT7T/'_K6Q)!^+)HLFBZ;) M4X05M=`]0]%L"+!B<\6R>=+5&G57$>?//#_#$G'&$M%K#OR&0B6"):(+)/'%;"O"RW.:$_K'[:?:`Q/'Z03>]9R0N`U!'T[N.P=/2.P MRF^[DNV(++E+YP!.Y7$JK\9'0LX^I</:6./* M^V45X)N6N:H/7.6&"3;(-=;O[B2@3+>E4A/@X;NM_E5%;L4:RM2%%SC%S(J& M%P6?B`+HI?H>_KR7L\DU;S&=) M;0[21[^]64U?[T.J6V!!VPLL>Q8F02PM^#.>"FL>>6%TL0#ZP9]"PJS4R8BI M_2BLL1"!%0G'MZ7T)IYPK3@$-@PF833#/_$!3A)%<-?J(]JO7H1U)._W4G(: MXNV_BT!$MN\O6I8K)@(F`[.TOUDV-6DNT$%(9%U/3N$"6UHV$$8F?FR%$RL0 M\,\<'A/#L"T_A%LW0SA93UX\M<2WN1(D&;>LK//AQ=1X67(%4N+0\B;PYLR-80#V,=!9P#7!+D+[$ M343*C-B@UPX66>)]^*.T'OQP;/MP^T48/=A!828>C#A]%O`6]4BF(:LY/*2< MH6@;A%NNA!T)^"A#:X8TA?^GQ(09S(43XV#7$0^GGA)W(EQ\-XT&EC,62SP4 M3^T8GK^`4<6PZGJ-<,%I^/`C$"]PO#F-G\:-W!$_(8,8T2?(JD8>1$,V-:35 MPHE]'M00U76#NCF$5?:]DD"GS(.,D\1AM"`NBY"+GI$3,9D`6[O:FR:=*%>TJ&M[/&SA8?&H#]L?T2L;LE6TQ.!@B3[^MK?GK3>4.? MP8-RTL]KR/W5FX$$_RJ>K,_AS%X)/YX\-Y["GS`G[;R!4^;;I7_\N.R( MY8,J[E=ESMSUVBW*+7:\:"P_O;F\^OY%-['LD^H;N_U];SST?3Q0W@*MTPF% M"FCY?$#G@!(448$2H_T(B+?1IR>E1\>A[V:FTUB2GEF-6>UY5C.&A\2LQJSV M/*MMW36"JV4V<.7]QFC"6!ZTLA-_QTP4]R_;G8-1J)'GG$+,7A M"->,QMWU%=!FM/EFZ67I9>D]'^D]]\8L7V@?!G-G9MHM--KK!B-;>(IBTNG;3P?R^+"XG*J MXM)M&P,@.0]QX73G!@I^H&,0Q6-&Z/%]2H`@H?79BQZ6XO>==MY)#>A3,A@0+6IRAT$X?.!=_@N5XZWM[B<%&% MBYR,Y.P*9U>V%A=CI=4L+BPNIRXN_;8Q;/[S$!=.1C[7?9?VEHT%#T=#7SRF M2';,^7MGC\#(F8^J,A]G*9IO.^:<2X8W9LEER67)/3G)Y9+?$P?O,B^=EVUC M342W)E0CA;"".@:6O'.6O%ZO*KO(HL>BQZ+W+`*4P0,N+'H;G="&H#@>!(4+ MD>SL^3P*OWDS*A#2`(L(QH6%\D+OPDOXTR=D/03A@E^F&.'8"X)B?+0C+TPD M,`3<&R$.'7SY-/6<:1&O"S@0?ADG$B8LI?4D(F$&.>V[;J=GP54^C-/(`UO& MQC4R.BYS8'/?75\:IIAG#IEO]8#M$1=Q+>#+<1=O+3#(?B32H([>H_`7"M:R M)-L:>M&.,Q%7<)]&WAY/HS!YF%J]3L\,%F-#@`^_%E3BS'9%H133FMN+&;PT MK\B,Q"0)7/@,?YN1_-Z@8U8IG:KD?]?OUY=2==-)WPTN![4EEAEM^;QZ2?_^ MZU\2>?%@V_-W'TFLO]K?[CSI^*%,(O$5],I[/W3^^-M__/N__77EPD^@=YU% M=A&"5:,F^BPF/[VYOT/Y^)_!_WZ]>V-Y+GQA._%%[[Y[>7TS''9N/GSHW]\. M^A_>=ZZ&-S?=X?#VNG]U\^9O2ZJO.-D7X$+7.?7/:LYN;TEU=J_,J4[U$2]_ MY\405CCJFQ74+$5,ZRO6M3?#'OP>$%`V%>C+4ET^@3$C1C+XYX^>"Q>%"*WM M>A*\['%"\-II.5>AY$LF8^FYGDV>^-,4_6R9@"^^X4Y\"3S#2>4D;_8A@PP^!ARC38ULJ4N(UOOT$?DX`PH0WQC13Y>2D>,1> M8`>.IS'$!)GG!GH:0%$,Y0H!&!4`>C[,5$5Z<1(%%+D%R4Q$Y7B.H-`55CXA MBJM[[(3("[<`Z1\B?"AB].,#QB)*8\A_)I$G74^%D;AL&8I[\$`4!B^3M.,* M?GOJ=.)38*1X/5SIT8-:I=`25Q>1Q6W'B1+;5W#D&32\$)]AQLLH+UMX3)H2'![#=H\$!ZN7`*/;UNW\+`'H3,2&Z#M M0;WZB4MJ1:T^<@;J#8D7IVTE8,JA2^T"Z)'$M*Z`I9EYJ*=P.GBV#0:WK@L` MS/')CB(;EMQM`64"^X'41LKWV"\!]$T82:67;:D:6>1J<`IZ.HP6+6(VTDR3 M)$8)2:]H*41]W%A6LEG`U]?#EYD:!)T/+WU`?B,R@UC[;LZ;"+$?3&GD.'E: M&6\:*@*L::&P;D7V]HV67)XEO^@11@ATV-TO&EWU!W?O>YV[_MW[FV[OP^5E M]UKY1:,>_/3A'/TB14RO*6Y18<`DN61],Q,-LJ8LS,2+)`ZBI?\"CP7X`Q0M MR-/,CO[8AS?7L]T*;\H8I7IWYAS<=M_?W_5'P*##[E6OU^^-[K33?MV]NQR> M'W-^F8+"O_@*^M7*"=L0/E5C1]M@>?G8E0RMW./@=J-Q*L="3^3+R(?$Z!V6QZ+&C#)"B$X@6@0=`R#QA` MQ.M=_@D%!M@T"RU[2.YWR>NEESZ1:VO/Y^#4@C,/-\:^\KV7VX658\*VA2[^ M+U2/7*`,3#2=G`U/<95JAV`-YA7ZCZ#5O4>(U[QXH8)@D&G/$2JJH^@VU`XT M\(H4%%`DLP1_Q$9%$"%(7P3[/S`($CIK#-3%2#KE!:EY`<9"F9&6WMMU M/9>",`\>YL34D`RM'FT>45'.-R7Q-E M"S8$%O%_0<9>JW6+?M3+/20 M!"%S/8DVW`OP`;I%(AZ%`/D,`\I>8/(2K@(]@DDGK??T8T#XTLC;L>34F^@L M!V;/IK;;0CU&B0QLT->"JV?V/S$)H!$2`NIW2%+[?XN=S@KC4!F\5,A4BT&I M17SM?*FQG_@V3_-3;K8S4;ZNJ,#2Z2E]9:=IO)(>H6DL*1/2P?&FD6QZL"(1 MZ3HD`2K]"7K'995Q:29#-JH^A@6;LMC$D6`5GX`JH+.3+#]-K)/^J?R:SKBB,*V,M5UB-*!#GH9>2B-K,T0,1!1[B;RY]"&K;66^,F)E M:?5L-)CA#5R:)AE2NBQ[U8K5&[4P[^=)E3?$I=-+K9CD/R6X:?Y"=1/-?(_4 M\&;N$6;/L\Z'.&Q-R@*_-$=4]E/?^AL@RCBFJ\D%Q120;!7SZW:1G>EBW[/' MG@\LVM*\J15WGAT>VSX]34X%F$=J1^O"NX#+W/1@G&I]2Q*!WB@Y79D@T0#+ M[UJG.5=U9:\PDA7NT:[N\:QI2#XMT(7VMM,6N##3>!^*@SZMTD65GS) MI&?-1O@607*G-QR^'PTN+_MWMU>CT7WG9G"KTV4?KKN#[N'3928=M]5<6#*; MV=$"V><+>$[>Q'-L>&S1<\/UJ2J/>XSTWWM;>K3?6N2@9F3_R-6"I2%IQL6Y M+9J0/+3^4C8AX'$K,_SRY4"6]Z!QPJ!EW7G.'Q`AAPK5-54A;U%Q%,+SI?:X M%*'G_;5!L\QMM:].`X]4R$Y9R=_;7]J%QM'PLZ"`L!`+SK.HH6W]/[A'*\K- MMA*/6LM`ONZSR) MP)G$47T2$?9FLQ_TMG4628/?#(J<^EOK0\ZYOL=O'=MW$F4N,IU.1MDO:'7T M?'\#WW0"KX;94O*1S#XLRA>D%NU\]SMFK&XMDO.%0!'6H:3TFR.C+WMV>F=X M8X=I+02I"Q@JMD2OD>(V,.T7X1-V2R\=?MV/!"@]<92:%7T M#S!8#+`9.UQ=/$>0G;NG7M'9Z8*T$?P)L=^M+:?6!_"`P-MOSJX0C5KDHR[N M!^$QARF,"U2L[\$E;FGCB#2QG>X0+8P=_*5=H71#!Y0G[N<8.D0:JRTN&&FZ M!7-"_,=[D[PW>;"]R49)QM<(JQ>0_MIQ!2_ILW`$Z#QT^IHA(D5C^X!GMJ0^ M-EI.DFD_-PBC&5AA\`0B9?]+IRG57@]F82DG1>2)LT))C M2DN4D\W`3$F)77ZV)_%@6>JYXHZ3WG'#1*L(Z!-:I#DJ@31+ MG!U:(W\Z3,;Q)/%S7R=+9LN-?A'B]5+I(*K_*!S3-#0)<;M.E-/):Z@"E(/P M+SU?5SR@J\[!T>',PK%+O$%M`&*^&0/D=,"8`K/;UDU^Y@^GM7DPFT@I5*;\ MA7'09F1$Y_G6'/A4V4@T]_`%^,^T[$Y^1#'CG'3;4+;T@27+703`N(X^2"I` M78?PD8[PZNW*O`#V1L85(^FQVH78S71V= M=;,SVD*;CPW,GL(B?(MPZPVSO)Q\S:BA;'U)]V(QE MS:1!`S-UC>1.*A4^3CS?50?!C3QZ`@Y-O6AFJ&BO0+.9[4R! M+:/%LMB8JH$T%C88H^$JG,@K:4CGF*:@4M&_`>'7Y5`OJ`WTF0+PEY]L0Z7C MWPVZPUHB/O2OKNN*^-#O&P:C`!^VD`67M%6M#G31J-4QNA+`P.GX$G\/0U=M MW<),">?:^AC$8,;0\;5N\,1B0SS%KQO"NB30(DQ;1=G4Z#!FGBQ_*-+!"RY` M)SCH<41IG*VK)_7K ME#.%>@\M19"0W[/T0.U6YR=?D@!#*9QVZN)0@#NAZ!:/$03I,2X\7BD>U`E5 M//$DU&W6&"CVM/8ZE*GT^$>HSB3@-@+(O%@4VGOIU(8K:FL M3S*ER^.A/$#PC_F"!8T)V$D?!9K`/2J5H@K6RK-OE=Q1VML+TKIKPD("1Z&E MTFO*H(KL+M>C^=6/J> MV=P75-4?6?88G@E"C&6SZ8%XS,QAU)^F>,IC`V6CE$:,S":G%L(&RG)Y?I8Y M*]\W%JLS6[4I.HR*E,:&,`\W.F!;>JLX>(E_E+]E:"`K< MEG(H[J%#A$9F)"R^"$.-S83!AQ3.KV1DIAQ$6A:-V0:45G/Y!D.X1<;B/E/Y M#_+K6UH)KN9W9B*>AJ!`E/^;L[+>1U3BOC;ADS(Y)L656Z%.Y:Q;KF*^R?S2 MU2YF'QQV[>Z?U& MI^-ORM1EZ`Q%VTBVNC1EVB?R9/'\L5=TF'7A1OI:L#PJ+;6PGK68)?^^/%GM M)TKMO^;GVC)'Z(1B\5M[3K\C7;^$D_@)EJ89?D!QY%*/O"AR=(B=7)STUX(4 M8K@X1L=-XRW1&;``+#HHW):E"@">WPHH9_YOUF7L/%E%OM\-Z:"G8E)#)MBD MVM3Z0R4>LB(`B&`?!!5ZD/%"P:+ERQ>G>,:F5'GPX(=CW#O&)9J3VX8%I$D$ M3\6-',*405'W=&5H"$[6`VV4;]IUSW:/O0"C'K5J6%_SXNIFV(*_IV%+:RU: M7BDAE`1T5!@/(J7S]:3>V7>*WX++LU0NJHOQ4[>G@,U7O##*J].5XQ&JV@`W M]'U,]2OO*U6061E?I)`!47D6+L_]&Q7G95$K@5\5JN"I(NY)8#99Y@^ECL'<93,K&)`01Z M71KYP<9C&'1B0F'*??/`2?P1'$-TL2)5,:"Q(MQ2T6_^^`B+#.'G'[.Q@U.B M@.LFWC=U6WK@"X_$_6BEQ[I4[4+YG&-^=$X%.;8,\2X*#D'J"AE&1:'"Z.DH M,OTTPX!YW$*_K"Y?UZ/:FEJ_5IDB+P2+J+A/7FZ1$VY;IB&13&:VH_ M!`FKSK$A%(B:8N'AL")"GX',EHO43>DQA:?`D%41:W&MRC73NO;727TR84W)G:1/HH7C6L$AO MC%_PF$%*7X2G_W]X(;X&?Z5*L4?;\_'R$LIBHD]YBD>;IN9%[@4\!"O1UXW[ MZZ?2L%;JX'!%U3(5SLZ65[8:/6@: M;=J3KMDT[L@MCYJ2.6DY`6Z;1C-X M\OT&>\I+C7,P?(B$: MM/NWZ8B&"[/!XQ!9;@>6!8U"3FHP#3.(G_R%AL]16.Z82M=(&'2YXA1]"^KC MP+T`LQ/EU2QM\+C'JFZA")N^]J'JD>N>@LM(QJI4NZ$XPL*<@5?KD*\@O.46MA\#UW[/#IK2N=G MLBY7!?`;[9>L9>#]&2WGA^O]V"B_;;OF>B^BIQVULM*;S]7Y"M?Z+_B/KP`4 M9%/.SI4F,$TGH.WR4JJAHM3!%^TU$G>[:`L(YBW-S*;84<./:=\\1W<_*C$)`==^0B^6)0TJ+S[!NRAF\TD M[W,2%=*;2Q!645B\9=RQY0BRED!FC2@+<4L03`5[H,H@L5DJ1)\ MW,Q4,5GU,0?5T&+(A1$E_-LJ4+D`'N+E_$(SU)D3.H!8]';T2A2R`!HX9#GU MW,J!/+*C!."WST(73T*D.075+&7IE'3I\$5:;$YO('#6.NQ=`F54V\]X@#?0VP++$]"!"[6>Q8=CUL5+-XYC.F&90?SF/I9Y/+)GA-ATH8F M,-14A%)/5N5("7S3#_41#KRWP`]MZ\95M;IJ2R?>M%2**:1>7`S_5T-Z&)V7 M(PAH_R+MGICS1Y%'EY>]3`UJQ$H[\#AWM;_S(H=/5*Z$DK&A*KU.D8PS\*5F MR/<-U3/K,_1J>PE+F]3NTC+Q"W19EO?R>1Z=*BBWD"GUP2V`29'8E81L*<+` MS"Y%2(^4\H9A2&!V&I:^%U3K+$V38J,8Y,/$`S7OJNI=%**TL8S.C.F,?CF- MGY:%KIEF2VW1Y5]H?.TQ,"&02PM!OAN`^5:D9TK._/)UI#HA=X*;SG'3.6XZ MMPJHPDWGN.D<-YWCIG/':#K7*`?B0Q&D],NT,2>8$;G760NQJL_3D]4OJ3XU M=[1[N#4,<5NNN"F6"=03)+D!B&$.3P;#[_EE!R)_51&5/M=]+MY`T/0Y]ZDM M6`_WVIT4XBYO)I.%R*`7"74\&T^,0-5/@D[\B\CQI/*QX0Z80G9"KGCU";'F M[PKH[$.ZD=(,QORJMDOI\(A6(1M07W$9\0@UAM"[HR#GIXT**I?2!W^(YTL2D1N<%]%O MV]:-*@=,SVHJ@7&]"1Y12$'EBB/F/3!#>V"@PB[>DX)$MP;6L$&'EK\N><,4 MZ\@U-=>DJ2^4'7`*TR3/7\1I1J!$@F(12B&00J]G<^&)%/J$;D:Q9HNV[6?@NF6"*5^"Y_P"#`]BJHL/X4P>T_?HJ MW-W=7EX.^]>=F\YU]_WE;??R_95N/GC5N[L^;!O24=5M%32M"/O-C`TS..3L M/O-]!:LZ^K<,4IZ>T-'=_*RY8ERJ;T)S`L))6T(Z.!:SN1\N1'[2J9R0HO"B ML"F!>1PZ8KB*#Z-2^RH+([.;YB5!L:803<13ASQ3K"3P)I3G3"*=V-<=",%P M_PE6T)M0DC8[D*,>A/DG5>J\]/!LRC35XK9(GLK0*:84QUU-829L%%IU5M)6 MM=)NE@E8"[:JR;;\3IDW'\B-XFNZ$-362!NW81^R_DG4?R@?KNY.N)SS`8H[ ME'[/6E$1/UQ<75H/49C,855I],=/7!*S4)M3,,%O6_[2#!!C;920); MI1R6":FY7Y&2G.[-0EMD=WP>N!3Z-2OK59C2U[PK&&45L)H5'Z`W#-7PBT*( M9UJ\6=9L02?(U@GB!H\Z[<%7'@.]5.W@%/;;54ZHA6<\<4N--`MNY6'#GS2E ME_);L86I'LZ%G.,8(MH1R@B5K3$E1^V9.KI:9A.-ST`!+^;ET[U@6S\($]ZS M,2)=_;%#+DH]KC;F@`I/]W!N);,FUJ#7MNZSVNI"E,M+H@>03ZB M?"1EZA5?20T&\/""O,T3H&*/,`4D4U'A2/M%=/@=62 M_W\5N1^7@ZXO:6G"BTY]%H4$J7K8K?5(\ESX4A%$-=MNA#-[OX+[&;_QFM M?00-YJ^C^=7CW'R_'A^U;UODU;51@'= M.HS8M"8?AW$'&;!+BY;D]P@C?9S(D8[ MAO]E4N>#[;YYGE3:/FI"=.??+`K+K/_3H?_M1LDS"FC$8AH>(GO9NZKG@;)E-G#*+O8K%**F9$[&\QY!_G^XV;$ODF=76L=J`68U9[3"L MMMH'B5F-68T-*+-:DUF-#>C)LII^"VV7K+RB;GRXM77=+9J%R?^(=1)X(B1P M%4-^9HLZ+C+5MXFE[8A#; M&:7&<%@Y.>JR\'C?S@<[3?+#&=O&PZF9[N>N@*BA5@8+J5DZK1K`,:R_6 M7C5A1=9>6Y-J9"S`;C;+L/8Z!^U5%VZKA8*JC0XRMG-1^W5G+7,.6J81!J\6 M*J@9/E+U^JD1',/*BY5735B1E=?6I+IBY65">>V^K7=:NW&VRJ4:Y\RH)^R'M.*`:@E@I^)>"O:Y"FHP2 M]JAB]K;;JWXC:Y5UJCN(8)R[=BFQYYVLJNW824E>];LP+'DL>2QY*Y+793%>)= MH1WH-#!6O\&2Q9+%DE4H$S26B&#)8LEBR"Q8+%@E5! ME,6"55G2\+1R@[=)%-N>CUVH_R)%'/O4D+JZ%.%Q^WPWXY3K"S2J"^M4;=/8 M=)VQ7)F+N5B:6)K.79K,%?*R-+$TG;LTL<_'LR5B3L29C378D M3682-)M5&:LR5F6LRHX57AZ?7'7A'%9DK,AJQ(ZLR';SR8PU#&)-QIJ,-1EK MLJ-I,O;)JMCF_$MLP]3777^P@16(YGN!N)@*TGG=7N?[XU/MN<'1$GL!*-CX M7;\#PF)RM%^GPK)GP(2QM.91^.BYPK7L,6AV:Q)&^-.+T,FT4[M$99Z6)&8 M1T+BSFT,KXF$X]M2>A.0%;Q,;GJ@I"<&`I[LQ(D=>;9/SQ,2GF/'UI.(Z&GA M0P"3<2TO>,98[$@4]1$O?^?%(%>.!KMQG&26^#9VN@MA,K"^X0PF-\7-:J"5 M%\!G8;W%8:Y""[W._GF!IM(<+@Y=V;:LXCXY;HI;=AQ'WC@A*;/B$-<..$CU MXI,X.C]QB5*T$C!P1Z`*MM0-3[:TC`SZNW[/@HM\&)>1Y[4,#:MW:718Q)^& M"-8W.S)882,/ZG76H!L?<0EA/*L[6,==.QC2:B9Z/Q*!EL0VFJ!)_$7;C*'H M&384U9HUTZ-%L[94>"@DV8Q(ZT'FRI=5B;8:?C*;6S*966,1B`D8_+F]0+)* M[/(:.AY9Q2+['C@\$=I_=[^TH8GS.=J/<">I]8+#53;^IK? MEQMVF5V4KZ2TGL#DY@.81.&,WEI^.':@%=_`FW;UCS/T-5(O`VGM!3%X$5*= M*2-C#AR-3X3K`K*N:&L]9\G,KLS7D^IMZ"SAJR:>A$C`6H"4J&DQ%[YR2+X, MU%UJ/M)X*\][S5<\N:0"2+2Q3;<2+3H(`"BY*OKI5$0$=[:?7>V_`8 MD,LO4R%0II4H2:&]5W+W;?S>]R$N?F<\RBO<4TH!8:Q5)#Q^+CXT"*.9[9?2 M&UV$GNP\JX=X?OZFI_>=-[09XCHG?3SFM7ZZLU`4?PJGJS/X2:P]>6X\ MA3]A3CK+X`!M[+D4[](_?EQ.#.2#*IXXSI,+5VL/DV]Q:)D&\].;P>#[%_,6 MY>R)OK&[[WU[W]B4^QHS4)[@AOMZ!WGA;N4$1ZO=V9RJ'.UGP48[&M@-E3O# M>E?N.`)=53/4HD]/RGJ-0]]5S_FD7=Q/:&YWH&#-^*MVNU',82F'_88ITYR& MGTIE/=OZL@]=3\.TO*J])(;6+;FFT)C6^A?3TCR`]+U#Y MV-RY-CO+BOK5BII9;1VK&6^OPZS&K,9:C5FM&5J-J_4W')-8H>KM,TGDY].V M^W+N`0G=!)&O#;%.5UM M!3K&6LG791U9![`.8!VPBPX8&`/CJLLZOE8'5+5=U/Q,PI>TRG6,,$M64;*,^:PL62Q9+%GY?=S/G@6+!8L%JU&AUXE% M6!^+J`952%7CA&=D+)*JRQISCK(^1J9QXF"NH1&+`XM#X\6!C0-+`TM#9AQ8 M&EX;3YS+5LXG`GZ:B<`E+"X.X)\CUMO>P3)#.:_9Y0BG5ESVW,Y#T)^ M8W]D.F%VVD+$:<.S%I>!L00'BPN+R\F+"QL7EA:6EFUSY\;1)T];6GC/ZH5` MIP!C0CUDDIEJ2V([?R:>]':$-SG#W,,5%R=Q5J]&-NUT)(L3YRQB+&(L8BQB M+&(L8N_"W53ZO1NO7VPO6"O;C$GEP$9\+%<3@AR0C"KAC67/F=Y8'EH MO#R\[1H[Y7H>"7*6EC.6E@IBD[H(P.%#D'/9./HBXM@77.C$D3\GUYIIITY' MQ-[RN6^N:6*Y8]/&IHU%C$7LW$7L[/>-?HOAMY;E!8Z?N$):<60'TM^U2=GI M)CS>CC@]R.E!3@]N*2U8$:"^E MB.6[?42]7T$ZZP4J-D$5>]&'^X0V,O38P'KP@@+$5O*A* M`J23.=S8;8UZQ@KY3_Y8(VUQZ0O>QX?Y^?CR%C%4EW$&61Y8'BKT MR5@N6"Y8+DY7+GB_:!-E/\SF?K@00%OX,?+&"7?9>;&)$-HL8BQB+6&U%[.SWBC3@@+3FMN=R&N,!VR;TN0TWWL>[ M0YSUVT9<&!F-Q87%A9/D58<[+!>D5XOD$0GYW<&I9)XHE>!F]XV5];Q(F;KP M`F>B*_L;EC=L+HY?'*G1AG9 MB@A+'Y\$#6D<^JYZT#W,6+C6E]B.D\UYH$K:%A^2Y,TW`/7AS]H1CCF..8XY MKA&$JPVQF./.@>/.?I/O]V"B'+RQ0FFTPC&\:-=SJAR:"JLVS"@2@([AN_>V[X= M..)9DA]JR%^FXKFC[KS%>72S51_9J1WAF..8XYCC&D&XVA"+.>X<..[LMS@) MBN>8J86Z$,)89-RDP-?8#D!=5A'OXY/VQ[/0K`$:I@'ZK`%8`[`&.&,-P`B> MK`M8%[`N8%U@.%-P+FB^7VS?CCPA6]:3_2"D90>N%0F?MK"\6,PJZ4)R.O!D M;[OF@*(8VK,NF<^FV?%S%#QS6-DL=RQW+'=;&[Q+%CP6/!:\PPN>N;/6YRUX M9[]M_'.((Q?1S/HPF_OA0@CKO:Z1_2VKD:TF\'L!>KEY4GEU7='AX\W$.6WI MY+0MB]MS=8\L;BQN+&Z'\CF'+&XL;BQN!ZNGK0A;Y%S%C??]-I'P5Q%;-E6R M%0K9JF$^0U6XM6_+<[CRW!>9M`G'%0Z*I'3F*2_.-5=T2(HU'6NZ>J$UL:9C M3<>:CC7=Z2-"L:9C3<>:CC7=Z:-.G;FFVPN.ZO!:SA!MZ..6J%,WCI/,$G5: M/WP1#.!08W7"V3P24Q%([U'`,.&SL-[ZH90_6&,Q":/LR]C^)@Z,2U4!7S3> MXK%'P/S#_,/\P_S#_%-'^O`V[G/;N'%D@Z>%9W8M6TH1'U,JSRC,/84HMH*2 M\=IS`-Y7):X$Y]U8W["^87W#^H;U#>L;UC>L;UC?L+YA?O0<83F1<+U=6!Y8'?9^Y M4_4L#BP.C1>'08_%X;6AQ3GM&]M.G-B19_L6'LVK0H1>*D(_)72V5K=WL.+] M,S\/S!G*`YB_LY+=3M\!@CM@;_DP@GOV^VO- M@[JJ"^4.5Q/E8RK&0.B+;$CDY52:&_Q#;,?]WU!U..!>KX7B`NI@I1J-OK M?%^B_A60FLCG!:"FXG=]I+U)^MV'$;PZL.:(713"O[ZMB^H)I6AB>Y'U:/L) M`1CYB:M0F.*IL.:1<`0.U")R6D\B$M;*I/?2")?#2PNN\F%`1AY(/9Y-#6U@ M>&BQF9&MQ9-J6;W.FO:5QZ4A#&DU$[[/@UI6).1<.+'W*/Q%V_H*7#E9Q\_S M*/PG7`:\.]9=W\*\ZYM)QAV..G5EW.&5:9EBQC7%N,2YZU@3%'$R`[;%*90T ML_-GXD4B;5QOQ2&IY-MP!E9X\9_Z`@V1$DZL6SL2]PD*!+SL!LP+_F#[ENM) MQP]E`L.!1SW8D=+G4Z_\!+@;9>C1T^K_UQ#>>=W>V\+E-+G>SWY=[^AK/S>8 M2LWKIX(:`DWCQ5,@;(Y@N&[-@;[BFR.DQ(4K+;IF`OV4N#267)V\'/QH4$8S6R_Y!]U\9KLPM-Y0Y_!.W72SVN6\*LW`PGX53Q9G\.9O1(./GEN/(4_84[:FP:'U[?G M4KQ+__AQVB\F\/NT7YF;;2CU=UP)&A8[RYW#I@>$9FA%GU:13;./8"T5_)E_8"XC_QA.\K\_@9>4?[)N MR%\RE87C%#5;*(`U,4H*9*[G$K8&AZX M"FWQ`I6/S=-KWQ`QE!LK2KVNKWC:%\U7[M\3[&JJWA&4NCFD:;5-JA7+&G=6'% M6JBA*BA5A8[J79D[]MUHKF$%=@X*K"[<5@L=52,UU+\V!R)0][5G37,.FJ81 M1J\6:J@IKE+?("Q@H[GFM0KLE3@FC4\PW3Q[4O:8VJPN%#*FEYKE!?6NC&T4 MU&4EJW9VV*=A+7!B6J`[NF(MP%J`VX[76TLR_YP/__!>^:8R^[R.OER/5\N< M3%VH5HNT2VT\GF[KZM(<]G/=UYZSOR?D`]2>VUC3E#7-L#]B3<.:AC4-:YJJ M?9IK8RUO:[_VK&E8T["F.9I/,^*S,WLDOL&$'L-J_X+F3*)R]&K%,?<3+WWDQ<)FS MNJ<>QG`G,.EL'HDICNV14![#F;#>XFQ6RW7WH1D\,@Z)5NG\G5#"Y-%"$`15 M`"MF33P)4F8M@"T(;DQ\FZO:$KAW;`J>[^WP^H>ZXO-US<+SK<-&W)]S%:?, M8=TB$7N1F(%T-8"-S:QQ15-0(F:&>S(16[M0QY.W7FW%K5)I:XXQ4Y61B#`) MW&$_"(4X.5<8@HE4<(^NB$4T\P(861E7U0LF",E'&)&$HFI+#2@H&36P$M3` MSBM1`R\O]T5(ZQP8RVW``SWJ0!N":%.[/$,VW-=VOCS-LGM&>&!6JQO"`[,: ML]KK6,W8%L:YLQH?(-N0/UCA.NSQ>PN!?25"?$":UIXE>=/M$&:#.8XYCCF. M.:YA''?N);IWGG2`+6(KLF/Q?,YW3SEE<>0H@?F'^8?YA_FG+O2I*DO1;;P_ M\'O[2ULWJ7M[LPO<_^'V&O$BA1C9W_KZ6#'1*FNQ<)>^:)8\E MCR7OX)+7;U]77\+,DL>25UW.KOE.^GT8"7BP\M./&1/62"V9.RU2EU7&^QA+ MJEE)DAH)Q,@8WCT+!`O$"0B$.>1U%HCS$`@^S+:!E!_28K-(Q$D46&D]D8)$ MJV0;F8][<.C(!XR8XYCCF..8XS@]MM4>-D<^<-^P;0YUM"Y+S)$/IP)>(1!# M;C_"`L$"P0+!`E&WW%CSW<]*=F=/\S3)97M0_3FNNO!%U1J)`^(Z$*Y&LG7% M$/"U9!&6+98MEBV6+:Y-?IYBG^V8NFTA,JP(I(*I]`(G$K;D6N4Z9S9.20J9 M?YA_F'^8?YKC!9Q+HHUKE7>IF.QQIJV6+')*NHIEBV6K3BS"LL6RQ;+%LL5' M)KFB>$>*]-J#:U.$J,LJ5ZU?SEV-G+I`7+%`L$"P0&05Q3UCF\`L$.J.:GUVQA>2%N_._`@5]S5/L-P2E+-',<DM0Q_S#_,/\P_S3'ZI_CX;/W?/CL^(TRZL(85:=0.4*I`^%8MEBV M6+9.7K8.T&:&9>O,98L/G_'ALY6S-B,&*^=0_>BIC-H(!/=W88%@@2@)!/=W M88&H1S*W\0[HX8%&^$P&1XY\"H@YCCF..8XYCK-C!TC,AK5_%D_4YG-G!C]:FP:^+/)X\ M-YZ^&W2V6?HREVY_\<[!SRY,^-+2E<.E*YSG:Q;31)H:AC",1>Y&8"7BT';CTE9C-_7!!7XTUM`Z&VJ\68Y:/1LB'@7K%6LO'UZFPW")>@]Q66C:)!OQM3>")MF\MP&F0 M5J_3O6SA?P?_?_;>K+EQ'&D7OIZ)F/^`\)F*XXZPW:)VN[HZ0M[FK8BNI:O< M[Q=S=0(B(0O3%*DF2+L\O_[+!"F)VC=0(L7LBRY)Y@(D\GDRD4`F-,+@0XV] MBD"P.[;%6,; M*="&K'IPU6GE375,-@JRIPR`W6P`K,<.GT!VL.CSYJV,0'Z MN_1@FA+>U$RW_J'7BT>)?1=#P&T7R+]6N4C0"+:`\>$P\+G='T,=(&M'+NX- MQ3\K$;Q(6V@EE!Z0@%"AWC$*@O!"A?M'/0'PAQ;XCK3'?&`#38`[$TP1A$)6 MP*?^XXOW?0=NZ]3;KIX,]J?4^C4+KROZ!HT#`%_X#+ M%Y=O%,XE!S^!/\^P)Y!F`))W6"_P!_K=;U*X#K.C`,9C).ZD6_KO(UGYX^J/ MC(?)7YZEY^'+H>OX0RSP=%?_Y>.?0>2O/'"F^]H'`0L7%"%^9=P3[.ED],,^ MO&G4?*7O!IV4,!`14+CX,8SOMKGJ,YQ9HVG`]R4JY(*(T0E60W]D.E;V'B?H M<3\"_S\SCQ[UC:4Z]^C'E^MM05,J%?`6K76ZC4:8L7+5:!KB M?>B#(=IOM\PT*:UNMQSE#!H*`QH@)H7M>_X`*`#^=20JKYK60I"Z'.@ATLJ6 M9A?-%G/#H_DC!N?\N+-7Z;KP$U@B)[*A*=VW6)M_Z)>X;V:$]T^KS>`B=U$E MUIU&%1@0R+>9$F5*J.B!]:3'/5L"ZB3(S0XU)>H>^U&HD!@7,Z@'",">!W#K MU/G$0>5V+(`XUY#9XE-PX# M"7T9NC'X\`\!VFIW45-P9`,_[9'N;&/3`<;FR&48V=BJ81O;"%]P-^S9'RP/P=1+R-.>1-Z_:IGS-YX"C%0*E<83.3M&& MQT?[%;F)8@9),HLI1]D0AT_LML9]M7[%LE>7^9S1_*M+RYC(P5\*'A.(M,6X-Y%=+&/:U'<)E`+Q1#!>S5 MC\!/3)LS$-;(%J).VG8T2%SW)8&LM`.MC$DR"I0SG5BMSZO#29NZ M?7K_8=KOTRL(AOR^^"M>?B-##I/?^)>YXQP>1O/F4:[M-Q%&@8?3IJ\8,.TH M)<+5>PMSX^;B/&(HA M2M,MD)`#,]"P#ZT,D=]`>\%\*S22GMT?\.!/YO"0OT^)3/=-H:Q>>"#]2*5D MQFP7_X77<_2J7'SC>&:-"!D_)KX<*,VW8Y&>(EP>8:RA9<4!1J)4,:^WJU;K MO6*]N!.@H=#CMV2*BW$QF.&C5H^B&6`790(@#1V,P<)K`MF-`&1\$$?D5-3K M25NB/NBH(2B!"QSOCE\3B+^BQ(R!&@U=T"_4:Y0$Z@DJ\6`4W.-H&M\TR#!D M`K-TQ/,($:.X'CY9X%(H#R,U#CPF03?^0U\/+P6%%TFH9Q+#>X;>!=K")N@= MP0Z5.5Z$3!!W-16A<'P1AS*X%T)WA]@N_%W)9T^"`#@&5^.>.A,Q:5R"6%"^ M,_(L'H+6XZS?B:8]L M\YPE/O\4Q[PU[3N(IT!MLWUFW)':NG(),783&5G#'TR!N738_ZGH_PY4-2$E M69R+BB!+V7Z-#=2F%'[8MAV[&.4I[?LE'*S4M2_H!>83!5-!H5PV,3DHJY.BCPN'J@8%,V"-[8A[2PPDUW9B`(; MEY/WR&CB=P!S=$+0HKD.S74VME/;%,,Z8=^N10?AT%R'YCHTUZ&YSM8VI%HA MAVRU<2&/C.8Z.3)')P0M0A;-=3:V4]8E_&\;C3E=!Z_=VL9HE\+#HPE/B?'0 MI/G_`#W1>&V917S8;+-XTBX4A=&IDO0]UAD&TIV@VHIK5URQ#B:[V?WI!GJ^SAL5`3S,%O)%X$5=)1V))9\P,U1? M_DDX4C?S:R"4'4B=LLGN@^B9?1Q@8;%)>=A//MSDR?_&6=X=6U<5JU8JM1-* MJ/PXSI,M4)+QHEQ*4)4!#]Z8W_U/4L\N3I1,8S^S%A M&!HHQ)_Z4:.,1<:[H"8,4WA%.'YP]RU).D[*7^C2="^^"T]RQ70.K]9>3-;# M-,40]?.UKR]*:E[Q@6"A'(@X?=%W79V]*=6?\&?PYY_[`%+`F-+ICJ-:FL`Z MX.8'@8C+%DR_$-5Y=&\J,UB+`-NIXB2\Z9M<^2<6F_J!H/=L?R!.0^_UJQT! MLM)"N(FSQJ'%\4MU(;'U62ZY!T1\/N94JBOFI0=8*7&N9[OY%X:JQF#>L`^# M-5LJ=LQ,%TFQ`.C(B@(9(T"^<#=*5+[/7[!*9,B#9TR)U]H]D#^,E>NHF:K@ MFD:9J?JR=4-M&W'-3%T%9:[L;,TRU-01GV+&.-`_#C46OAN7?,"\Z9$F86$% MC[MO2NH4QDF9R?G,:JRN,"Y-.%6?(B'_BQ'1QVR.-XRH6-,L>D"CD@Y3'!NG MML]5;-#5*9>)/2X_(5@?".XZ3\A76W\6B.IB:+[!D12_@ M*@PB&TW=!3+!P'=T:R^8*V*'S8&.(4WH_@Y$$QOCD&EXE?L;@`FPW6]&^%= M;SG+6UM@-TL^3DI^C"N/I,N1H%(.^-M%4O84S3R,-OY[P1SPPM'!&%=$36MN MPF)XOQ/IFT8JE=1)&+L5<54F-'0W0_K2>HJHD;YMTEJ/_)<.W<7M&%2;BZ_')3L!?N0OJ_TUT MN8O5+">%:V,T3!Z'6&5_13P(L;@+`ECJ*ACC(@_HY3D.N/-)/8LTCG31V@VD MFKX)2T7]L/%QF-J<%./`"UZUDZ0KPB;(77`WSBU@XH%DH@MSCNH>XPQ+O*:K MQ_#DMR4=GW9O1:`KI\.H78P*9G@XO988W1VKO:GP:KH*J=)P2H]8Q`_8`*L MF7=L*+#:-)J0,2NCE*?NPEH_T!`E$-VQ4='U?NRW\?/B>712!BWM1$Q5/9HM M$H>>4"V'$0#9@.2P.@!SEP-W1#>QP,GMEUQ$=9@"!B4,5-H:*=E4"!EB$ND MZ!HV&M!).?&XIG6/RR!V(=/UQ#45C)4HJ6(U58H)[TT7(`^%W??D7R-/5'K# M:%PB?+JN=^J-,_6`4Q`$!HWLT[4]-U2(+ M%]X4CXKVK%*TG"XX%H^8"0>)RN[,AN:MYIYU=VH'K[M3*TK]'.H@=9`J)U'E MI-.H&/.DXXCHJ&UJB`]>/"DNZ9K+YMWJJ3AZK/ELWV(O-I=-7>A9TRZ-S>-W MQ'F;JMKOD1\*9R+6KX$$#$^^RWP6DNOH5=I),S_%@>97VPDUS9&,B4.+@']HUZ!^ZA7X%97X-\5]P>4 M8Q$(,S?".EU+0QI'&D<:1QI'&E<.C=LSJ=8JO!/WR0_"9]S"I0^DQG#:)2J( MT#NQHD!OFCWFG#0G7]=-=7MO(PCWD=)QL.`\0[` MJC$=R,MX$A<0%Q`7D#]`'$`<0!Q`_L"^7)#52E'QHPQW?C#T=6Z8SJS=):Q5 MGIIXU;JQTEXG7Q2/(L8&(L;E@995(6@1M`A:64"KMLU)!`0M@A9!ZWA3KI.' M6.D7=O^%R/7&Y1WY,Y;2N%R;+%B6>K&M;*PNTJV#NN^O'I3?@!C]=ZX>[:`W=+/\>_IK@T M1<]R9*L(680L0A8AB^+2!#&"&$&L0!`K^]+/^L,?=H55!F7XCYNR6C66];!. M-GE1#HH'YLA,G1J>:N:**Q"<"$YEA].U17`B.!&<3*WN$IIHC7/8^41E1&5$9 M4=EIA*: MNC$?SFKM=VN5;EKUDQNM7>^K'OJ%A[ZO5I2&4@>/VL'M5AR.MJBWW,ZT=S,S M>)O^]AKS<==WG?@YYY^DZTK?4[C2X"`E!NJG+:SRN"-K3X7.8+EOC9172]8& M0R6"+&7[Y(?<96LK8A^K>5]Q7:F#ZTJY;-XMA_;98-QY/MOW70Q#,>B*8#)W MJE4N2M4[??(#X4S$>O70`*&)]_EZLJ?Z;>!'NY+NUC8=!;$1LM+.- MAM?('HC"RZ70 MN-(?M_K)#\)G_BSBLXXPP':)"@*.W4XUN(W/>?,B)V,[L(JTC\IJ4&%9BNL8 M->'$`07C`"JF2UQ`7$!<0/X`<0!Q`'$`^0,'7RDJ?I3AS@^&?L!#P;J^YU!- M_=792Y:Y\HZGGIY$$6,#$>/R0,NJT`GE!"V"5B;0:A.T"%H$K4),N4X>8J5? MV/T7(M<;"+A3+^T^"\]^NUR;-5B6,P*MAK%)5EY&G$*9^3$^Q<-#U5@J)^&! M\%!X/%2O"0X$!X(#K?K0JH_9*"@\'FC=Y^#K/H6?>-QQU=<+/C9^$#`- M>>&N\+8Z9KB$%$UHG@1'`R)2YS M.[]+@B9:XUIV]A&7`7OA;B3P@.LA'GG,X],I,]&P&FB8XT==5^P%OMQ/_(U5 MU%PKOK5Z6H1:G-9%M6&NH-G.(LN+]E!D]GA.!9$9D=F>SED[H\D.41E1&5$9 M4=D!4XR;YFIA$I41E1&5$96=5LBLC$26"J;]'.J#TQ=[">UZ2]9:U1@]I-(#/H4?FH`-0V,:?\7+;V0(*F/'OZ1/DM>O M=H2-1U=(W[L!W10!-C`)`J8.0&??-\NS7=73-"]@1],]KU7-]5S?AY5@V5!X M"CJ6#F`RFX?BV0_@:H?Q+I@T^`/KZ:[*N*N3E&+\Q8T"H-(/_N*?9I^7KI! MM@\]4B&^-1!*HNPD=\,TNK6I=K\'AZ-&W75R@'@)0M0+%!,^M/OZ+^G7X4-#5#\'AI#A$Q#YB;K,-'*L@DL;6=7/T[UTDK9&0W@>O$X. M.#9.MQ7T(O`'"!(!7(/B9B_PKQ^H\;[&UGM]J1YFWQ%NK'K0*"5&S]#0`W&_ MP&/U\T9][2H1O*`I9OCE4S#"[1\+#@M!_BA&_A_BN!G M1W`7X/%7Y(?XJU0J@J]J"/#!VR8/FF@P_"KQ;WZO!XR@FQQC+&[:92!<+06' MA_R*_>]8&^*+-I?PM!KX0>!W-2DYS`,!:(I,UJ&&@?\B$5+=MWA(D9*Y,Y`> ML`3 MLF2Z(5XTZ$*?$0K8)&`3?&@4`N=X.%)F4*W+)>;75TBJ<9RFEZ!TEM]4L9&T M>9IS#D#'A^#[2]M]NXPI*39-J$'@ONHJ]?./1`O-]"R"A3Z8W[X4Z)P,0?&! M)]!^C[TH_9I*X)1,+GI!);+L1_N.6QM*"GVP^U./^7_U< M%H][K/'/P@>C/@1@`;T\HPD&NSME`!;(YGC,OZII;QN9)_.\5`H"&&?%Z@\/ M&V;%YH8(YCR&F!F`$:8L^8@=8O"K:>\W=JN790=?H(Z#*D-+8GR#+P(.`>+: ME7"9@PH:X`V!B)^F;2R"`R[7^@V*'(:N&#N?8+A%3X;@]+_%O]DAF*80_.'$ M5J6@$%-%TOZ)AFNG1CL&S@AGL5-2"J75B02%,UI?)I.=1:9KLSGK`C$IY0P M'Q)ZLH1VHA=P]./L,`H$3FI17R>^4%\XS_%;YDR"BM`-V\`)/(!%^+@QYT]Y M^\G[MF=[:!+XB%H"LS=#9V#2KEN"]\8]Y&&J$PM=$3]R$>MPNR,`_`[>,@3M M\&$&Z6W8PYKQ'JYNKN>'RYO,SF$VS<0/(%87%2UFW!0WJ:C['W!7-$_B+/W/ MRVB8W/_3[L24V[!?)C-T\`A=_U6;CW@&&0W0^OQ7Q,IG][GWC+X?#@7^\"8X M3/1P$NNPN5[MTHCO8A@*G!I-I%6K7+!JQ9K?T[7+\S4)&7D2-&E^'6"7!R%I MQJ"9VC\Y1=6)F@]TZ`HML&:[$4JE-X29XXT!'9_6HM0]4\M>E1ECA=_3#_7\ M8,#=:9N.UXP?'"N7+5PWN>;#6>5,?U=#;H^^+Y#CDQR`*GX6K^R;/^!SBXFO MT@G[-]?75^U*H])L5ZM-Z%^[\6ZTT&*#>O.A$C>C#^]GUT8F34QO[1VOK]07 M;M7>8'.P;MF'LW;MW=J5F^GUH^1&:]?[&@=YX79[HH^6=K!$:R]&WNV1QYE MVG_4SSG_)%UW%'QV4-T"]=,6ZX;CCM2.D)"P1LJK)6L#)8@@2]FN3^4]5LO. M_P?]VUPV[1%][HTUD)(9;;.&X4\CQXE MOI,(FIK;.THUS`I3PZQ`6=:/2>FDKSJ;WD2',T^Q'C5Y.K$U3I\VDW-8J[TS M\IQ1O8([:!WWWE+%"A0+?1BP296`25\N)BG`22IUG*L(1LU(H[)._;QBWS&_ M6I=G8'W^(I)27NDZ3#WI1+;DP9M.7)=A*#!(A$G16#EMB!4<=&F?-YT!FQ3F M&I=6\'6E%5"^Z1(/;`C>GOUV,:G#E.1.CVEUQ\N4_P)9P`3=R.9UFQJE`_:5)P=QK5W<]F\).X' MCF0^V[?8NM/4\J$6[C0\JQ>/29&]&5Q0J1-I(VDC860HRY$1UI8]FU<=^TB,*GX-Y-'V!YS.ET M7D1B;.-TD;8_UXPE6N5E&+,V5$>U1QFD^>107'E1I7(R`A$"$4+.Q)4752HG M(52($8@1Y?8 M5WE*H=`1!ID+@.PUX8QP1C@CG!73>23$$>((<80X6B#.>KJV20YD:6K"5J@J M+`5&#V6."@>/IK$T54('H>/4T%%K$CH('80.6F"B!29#DM79MJRG\Y^DSG^B ML,#*X\+:%`V@^%MNC=8)`@@=-`B M4EX6D8H^2[GCJJ_WN]GX0<"(`2!016B8U6DBCPEE_+13@CG!'."&<4 MX";$$>((<:>"N+(O*7T3W&5"A3S,9*=?X3!D4>DV"@=2.)#"@003@@D9$4(' MH8.,2(YG(_F,"!@7[$=/10$>?PQM\,*`V[2:M%I@U\8*SIY\"("";A1TRY4U M(\01X@AQA#A"'"$N%X@C9S+#&=QI3=36']>^*YHR."K[J*!JU8V!:HUH\J(; M%$3,KZTZ-70UC(7@"5V$+D+73,JMN4+_A"Y"%Z$K\P!'26!&"VA+!/O(9 MN!L)YO?8T.4>XTJ)K9;1MM"P&FB8XT==5^P%P]R'"XP=7;=6?&OUM`B'WC5: MQ@I:[RZPO.@.Q70+(D=B-F*V];7(,PKG$;,1LQ&S$;,=30FMK((]Q&S$;,1L MQ&Q'4T*#VQI*3VRIP-O/(8>N+[P^]3G5+U=ZXK(O-$M9U$:*?(CT'GJ"_IU_C^<&`NU-`LO":\8.U>)DM M7#>YYL-9Y4Q_!]VQ1]\7R.E)#H1BG\4K^^8/N#?;\@$/GJ47-Y)'H3_Z(38? M^I=7Z83]F^OKJ[K5J%;JS5:[UJPV6N]&``#]=?E0B9O1A_>S.COI13H\.]'[ MYL+(^P817MVT#V>UUKNUD)H&=G*CM>M]M4._D#I('\G#NN>,%6WO M9FSP-OWM-2;PKN\Z\7/./TG7E;ZG<,W%04H,U$];^!SCCM2.L`2Z1LJK)3MG M&XW+]LD/N1NOE%K-ROO4H;J+[/U77/#JX(+7LBMNN8OY98KQI9=\%\-0#+HB MF+RV5KE8=G6U8AD+"1X>)7AR<<_U7V_ZT@$W)8/U;10?8<$(%GZ/_%`X$[%^ M#21H\N2[7(J+CAW*%\$^\>#/9"UXT54]/Z7R']%K1;$O?6:\KCR^X?PW\2)< M9FW#?(0&0L.N:/@.KY$]$(6WE,G'N]07_K&K1/"BY[!+KOCH#:-Y#9]\KY*J MDZKG1-7_\/R]];FVL3[3_JME^Z_TD:H?]9&J-YEH_P'E6`3:R(VP3I=O2>-( MXTCC2.-(X\JA*[L3=^<'0#W@H6-?W'&-;Y_=.4#F%+0=%VCA0,[:+ M/2_#N&QF2'&,PQAKHH""40`5L20N("X@+B!W@"B`**#T%$#NP.&7A`H?3O@7 MDI(W$'`G'I?*GX5GOUW^R8Q:I/=`:6RB4I_6%=5L58DG1>!IV"F_FQ/X7#0^.:X$!P M(#@D]]6-U08B.!`<"@\'6@:B9:#=CLQA/9T@)'6"$,WT5]J<%DWP*8:6'RMU M0LAJ$K((682L#,)H!"P"%@&K$#.NDX=8V<\H??@KDN$;4\*.X!(IMDGD.]W8 M1;5F;%Z5EX&F6%Y^3$[Q\&"N[CWA@?!0>#Q89!X(#@0'6NJA(G"["O:.J[[> M:&;C!P'3D!?N"F^K0SA+.,>WS!T:>>I3>XJ>4?2,D$7((F2=GGM($".($<0( M8K3TL[O\O@GN,J%"'F:RR:YP&+(HNX>">A34HZ`>X8)P06:"X$!P(#-!:S\9 M"/:CIZ(`3YB$-GAAP&U:]5DML%:;9O44.,N/E3H=9%'@C"!&$".($<0(8L6% M&/F'&4[*3FON-3[NV3B:,CAR^%1J*ZP135YT@P*!.3).IP8GJTIP(C@1G`R) MR]Q!2P0G@E/IX91%D*(DN*)EKB6"?>0R8"_VSH<\ M&87DB,J(RHC*B,H.&`VMF5NR(RHC*B,J(RHK_N:#TC-9*I;V<\BAZPNO3WU. M](,; M.;@]/QBB6,0%PZ/8V?/T&8&@")>SOT\JR5ZQI[Z(XY\*`Z#I4SU2EX%6<:5D M3$?7V78EQ[[3;P(EUF,!X)UN8(_0,M">)CM^@IDQX:!M`4+!#0NG/QUP/_C M!_#_X$\1XF^O?6GW]5_2/<>'A@%WA'/%_G?H$_8#B6($X<4/8"__J!&J\NM-[K2[$/`]\1KM)RA"8J,7H&O@,44+[` M8_7S1AWJ*A&\("*RI,Y`>B!AN\8-2`"@^4JEH^'F:00A8+.@KXPSU M$`T5*%$"&E`0>UDQP0O\J_8J6>@S;H/M`=X%=6&NA*L7`&FJ>B>1\PA_C0^CC M#]U<]RW5#SV$<'F`)C1IZQ6+M7A:C+&/HF&=_@,V,>:CQ8,HI'[6HK%D*5++ MR-P>"#FNZ[_BD(9Q#Z(!=`NN4[$F];GW+``<*"K\X0V&4#$4N,/F>KE+([Z+ M82@&71%,8A*UR@6K5A94V=OE^1H41IX$39I?']WE01=CPSX%L5D'.R&M@>"@ MXZB2VLK&%JX&CQA&H;K96=.6*5+JGJF0365&&_%[^J&>'PRX.VWN$KQ@V/] MLH7K)M=\.*N\P`[='WQ>(\DD.0!L_BU?VS1_PN4#8JW3"/GR$/B51`9C4 MNWRHQ,WHP_O9B?RD4>EM*)-@0'7A#J,-=K+HQGPX:S3?K8TS3$<[DANM7>^K M'OJ%U,%"=G"[+5A'V^^X//+6WLWJM4<>^PIR$)213Q`N!`:@_?1KJD<[IHB\B+R6BJJ-K$7L1>Q M5YY4D=AK<_8RYN$76V7V9:^R5Z'JV&'$71:(,`H\YD_M@EJ]^KEC2.8P(9?3 M9_H3LX2D/Z0_I#\9R2>S6&JEZ.;OFW!YJ+=G^:,-07I#OK'@:@EKH%*989I$ M'X7ZRP.Q[$-7!"P"%@&+@$6!DR7R^QH%=I\KW+RON)MDAX`#&;IQ`LL%ID%E M`;;"88H.)J.)_0&,4.%P82R"3V@@-!`:3@T-M`%R65YEP#W5$X%BYWX4_J33 M>+$\@Z^S26T>BF<_6)=?7?J9SGGV4YUY%=I6*$?4LFURE"C"0!&&C7%G[O05 MPAWACG"W*>ZRWS!5#MR5/?#W\".NVL&PV-&H@DAH%PJ-$*[6FK;F MH>!4#@M'8".P$=ARZT[F:&)W]#SOPYTHM8MP<[\)@@K,Y\N!+V.E>8IC[>Z& M$*41I>TG+CHS@YB,F"R7ZDA,1DQV)"8K^QH'987G@/7)*I+^D/Z0_F0E'\H* M-YH5ODTHMH3[;R@KG";41Z'^\D#,W&(0`8N`1<`B8%'@9$OY45;X$?W!O"A! MUM:)C-`)X\(RMK^,X$!P(#B<'!QHP^3:O'#*",^)1W;R\QT*)%`@81MK1L`B M8!&P"%A%4ODTAC++CZOSZ4'":5YGL-CA3^C:!CG/(8>N+[P^]3G5+U=ZXK(O-"U9U5*.(P/AX'/[3YN MY.&V#9JJL_%Z?L`&T'GF]QATF`VG!=%-!''%_H#&!RSL2S5^U`5\%:#2"NZ# MVT?7,AX(%@C;?_:@)0Y#PZ*O%*#9$D$3OT`(-9X]M=Z/FLN&T$_?N6+I7O6Y M@KN%'<+C0I\YPN5OHU>$TO?P]1SSZP/)7?;,I1?O$G=]I4`689^'<+F*W##> MQ)0L46E9*!4-AO@0=56,X?ZZ<(B2<<#Q1%F_`INZ9\H\5V9$AM_3#_7\8,#=:=;`:\8/UH3$ M;.&ZR34?SBIG^CNPK3WZOD#.3W(`:O!9O+)O_H#/.3VOT@G[\!'ZE%@`('"7 M#Y6X&7UX/TO:DT:E8W<3XJ\NC-5N$/[3C?EPUFB]6VM3IBU;-: M"UFL*:V1\FK)VL#C(LA2MB9#_33;)E5;K6K&TE5)U4C55JO:QH?JT#KQ$JW\ MGDPE<4IT3-SF/BAD+IYX"N%"RURUQ[P/_+[10%K7R&A=PRC-)/93QTMRNP\X M%QR4A:3,$U35W'I&H56&V(O8*R>J2.RU.7ME?TIO(51F7_8J>[;91YR#"Q5N M.[T[W8(>5,^#@G!4WF9T7XO00&@@-)!MH*CY5H+M#'SH^G_Y:$/5,)!^,-Z6 M90?"D9FX6Z=3,>,\^QE..3(@*4!S`%-&N"/<$>X(=X2[H^.N["&]6=<3]^UG M`KU3*[UA<,L"E8VB8$C9X50U5_.0X$1P(C@1G"@X:42PGT6X)#?5Z"Y?*BN0 MK?A.8I]PW=RTM_1E!2CBE-%6/&(R8K+U3&9LKP0Q&3$9,1DQ&3'9\57'X"1T M>:FG@S4L-W5WL"!1JG#0:/KI=V$4XY6+I/B.$LO**+%7$0C&55)OATKL9%)B MI[UGA9WFP2OLU(M22";?'2QS`1H#\>E6ON/3V1=?F*ZL-A%F=Y-R@*2'5`CI M*%I+A9"H.DT."R'14M:2,F+4]#4B*9&VP"OEOWK";&[],LI172Z;T\8BS=`(;(+ M[\-<\27ERH8N]U+NG<)T<+_'YOJURVL7^HD7;&&&V"[/9]QSS+1T82;13DW2 M*?61UP.,">>*H>3Y`!`7*A8(VW_VX'H'DVOV?5W\%2^_D2'`T1X%J>QH$+D\ MA+?X(=P):!X,`]$7GI(OF-8#WX69OF;4A7.,J_UD9F"[HN<'HUZSD/\0:E07 M@7DB9'P.40O"*]T%]5`93A M3"5AF1\AZTD%WAI[`^^!264*QC6C*+XJAB]S'P68JH6B[?E1$/;97P"/$*0- M;DM:SGG#.;;X#C##O;>T*\`-:4.M:9;3[3X/GK$ZD/)MJ6'_*D'8D1>IB+ON M&^L&/GS$?@-:]^\"<86%M`'YW(CD.&=NQ:QM2%)M;S$2:>1D_\ M;.`1+:'-W%3V"F[J0'`5!H],V MX%(G![J2=Z4K0QP]:+160C\IL+2@UPJ9O>"`>(P7?KE@'B!U_!VDY(#0PH``X!,4S#YP1 M#4]NF'H4_,J&@?\BG7C"\]D'G;Z.U7VCQRY$HPH#P%<\CL@K+_`@D5"+QJ6( M42G5^L98UNXV;S(:U[M9M,EMF\4=5S4F;7"MICF#.^](Z5_F2D9\YR\P'HI] M]+#H![J#7X&OB^%//*6@WP?J>O%=F*WSX`V8MP MH0H*L$@20VPC$.IB?*B^?W@2#=OW$%12)5R>:*!&+1^_%[L>>?^PZ]D9E M^_2[S/%IPRRAFHABC)PL,_.["U.^U'5N!64H3&4NF&#:[S0HJ_DUPMW\!D3F MK,^`$U[MEXWPKJ$[ZRVG<8P6*8R)1!>OC)W'$0O\WY5VF*59ZAGF.V#3D6O& MK/-_IUA*C1[>DS^TO=/1+XQ)XH-]3\QPS$7"3^';$%<5P%6`IRF)'@1^Q*V&"=T2A?P%."H1^@34YNPW#% M,W\6E[@2(>+9`\A,A*,?)G?KO]E<]9D`L;QP%]WG1!)Q1'4B",<@259K)0V. MK?:%1I]_^3E2E\^<#V^^8N3']SJ>\P7C05BM,!"AA`D3C-0H->!^[-X]@1&_ M=7W[SU__\?>__3)^2.`/11"^H;\0PJ,>8*R'^("O/K@;;^.;XMGBC_";Z'TX M>[S'3O]>__?3_1F3#OP`GN!EM7;]<']7J=_>U^JUQ\K#[76]VFQU.E:KU6[= M-YIGO\[X'6G!K"D+NV@=;*7;8E5G_)9CN&4CX5YH=RS4B!H+N!C>V:0+PW$7 MQ*@+VJM7H:9;'L?=+I@K%%+I)%KIB"%,Z62R>PD))W6\XQ6[7_7G9-X`;">' MFA?'8ZBN40QL2X'THQ#?Y,8;J1$+W)AYOXBQD0;Z,F^CMD:,G9F MN`K,AI$'U0W%Z]'>1,YD.+_/?$\9NNCC]8%2F1P@^+5U6[/K?]Y4;FCE-C.-VQC%1ZM>N6M: M=ZW:0[MZ76M6&ZU&8A0[U=IC^Z!&\8#68H'!NV!X:MNR[:LCCQ>IO4>%\*D0 M/A7"-_9"*D!.!;R/,GMRF-E#/'/R/'-M+L,P[P._+\WL6QFDZ![,[2@VO8M;?7(%Y*H7 M](E@/XU6[2YFENQZ\D>(^V2SP-3I%'QK M7#0KYJI-G;KK1C/$`QBL4P)7M66NO-2I@ZOL\Z+?=M@[03713;I+D0/#XUVI=[L-!ZM>J->J3PV'MKMYEWCL7%[ MWZS>WQ^^PHJA@=5?YZO:_?'UZV\/GQX^/W6^_9O==YXZ[/R/SYT_[C\^/=RO MSM8L48KX=?.J?FU5J^U*JV*U&O6ZN83QJK5GQGBM491$[$I1&DH=I`[FO*'Y M[B`50YBULPMJ(5Q@>6PQ#!GX.4SUL0I74IH:IYE[G.]"!BO'B$C*N1`B"!$'1,3>U5,S1$1`B"!$'!P1>Q\5D2$BPCXA@A!QX%G^ MOP6?K_E-Y0FVT\IOXD5XT595"&CS1EZ")KE?7:<:9-.%8RH-2K&-ZR9DO%TU`WZYJ"PX4;?D!<0) M$25'A+%SH`@1A(@30(35HF-7"!&$B`DBZC5CD69"!"&B\(BH7S2O:1ZQ=S0B M1Z'0+`7[683LHV?[`W&P8!^Q3IDJ&%=K=)0O08N@E06T+((608N@E0&TFK30 M1\@B9&41L&G3%F2"%D$K"Z-E+NYS\M`J^_:4!QYXT#*EBZ]]Q^)K-Z9TA\AG M\P3M#&15!/F0_I#^D/Z0_I#^Y%,^I#^D/Z0_&%6EF#YAB["5";8LRO8G;!&V,L!6YG M/J?ZM>(TL.D&INZ94AJ,8&CA2`]4/_Z>?JCG!P/N3NF5A=>,'ZQ;S&SANLDU M'\XJ9_H[#(<]^KY`I$]R(!3[+%[9-W_`YU"GSW^_N6Y>-=M-JW'=KM);_;\&#;&;Y)2IQ_4V\""\2 MRA1F;$2/ATTZNLBPKE5Q$B"!%I1#2,U4,B1!`B3@`1EF7L*#A" M!"'B%!!1(1M!B"!$C.ZK7]0J9"/VCD;D*!*:I6`_BY!]]&Q_(`X6ZR/6*5-- MVVJ+SBXF:!&TLH!6F[98$+0(6EG4.JO22A]!BZ"5!;3,S4X)6@0M@M94,+1- MF439Q81.*_3SP`,/6J;84`3L>Y\'XL:4[A#]T''.I#^D/Z0_I#\YE0_I#^D/ MZ0_ISU'DD]ER=.$/-;SE2MH4'J'P2"9GOM7I6'#"%F$K&VP9.T^1L$78(FRE ML=4T=C0C88NP1=A*8ZM!.ST(6X2M#+#5O+*,I>:<@K'+-95S=C6Y[SH?];&F0!QTH"H4^T0`@0!(A4S(4`0(`@0J4`'U4D@ M0!`@1O^Z8M'U!VM82FASAXVEM:L)JF12BGRGI2@1KIVUFU8C78LRX8.=0%(Y,7LD#T7&'#B[G' MN/U7))4,I>]=!L*%USGP=]OE2LD>J"3^X8I-;>I7N*E_W'C\#*^TH_C>7N`/ M=`^@D=A)N(N]]GU77#J^ZT*KDON@]1W%_![[Q`.[SZS6A6[OA;XW/GT+GL8! M&/P97N`/!KX7OUFQ2,&?0))X*?QE&(6ZF?IQ7=SI`QUSF!-'?IB8;WLB@-'S MI%)1_$3;]SSX`SR,O_CU3L47KP;LG=CU[/#P9:3$_`%+>N;__YZS_^_K=?1K=\$TK@2-R+ M%^'ZPX'PPH[GW&GIBN"[WPM?H8E??5?:;^,GH+R0>+Z)WH>SQWL`&^-7O M(@$B2<`7B2?V(78`S?`0!8W1!,)#_9P+Y@H@+F[;T2"A%F`.L)+_32BID_K& MQ(^A\)3`QPP#:)`<)A8_;`%7S(W53G[S_):Q71ZCB1ZX%`V!'04!##MTR]5\ M`V3[+$`(\?@`CNQX^":#(SWH9(A01]:*A0P&AK-GUX>G,'VH(LA3(6,J/PK@ MJ4-X.-(IW`S$!=)_T48I&CX'W!$Q80)I<.\M=@S;5:OU7K$N$*B'`RHG1,34 MFPK%0&W+;CM1U2S9A4%DAQ'HRC/<^RWN?`>8_P5Z)=3]F,^WX;I.I55]N+MK MWS6:E+HGNNJQDWQ:\4POW[/$8[RBMWC5PXV M!FV6"]-CM3I3=:U>Q-.OY"S:C34E]=BIV6YEQISC]_1[/>11=QKS>,WXP7JJ MQ6SANLDU'\XJ9_H[S"/MT??MJ6@`^)9>W$@>A?[HAS@VH7]YE4[8OVG6KZ$] MR6'!-KK_0R5N1A_>STY9)PU/KU1/IKW-A1/[#1:[=6O@GG9C^&/MG'IZ?CZZ MM;7KG:WK7>^L[]S8YLYW[OS.]L[OW+V;1Q!0NW+P;E:MG>_D6R.CU9$09)KTA6A,%" MR*H@D\3E.S"N=Y/9]=+(^_DGZ;JC%>]X75W]=#HP+0XTD]AF(@EK^(,IWY4. M^S\5_=^!H#L??,YTW>=A,'3]-R'8DP@&TM-K>:1\9;&A1Y(H`2@`E@.8%H%]"N)B==\A?(T02(O.`R"?<7IWI9#1'%2RRK;(8 M[SSD(?LNAJ$8=('I:A6]L[MN"L[YE*7Y1))_YE)@"4'HS49S[)`;V8VWGE:- M69&E4LQ"(KG+X"D0*'-G?(LB.&(S8C-BLYR!DMB,V(S8C-@L+SI&;$9L1FQ& M;):3@I4YW.RQOP@[2D4#X3!7\JYT9?A&D?#\KA3DAHDL*CM#<#@Z'$@^!:&+ M#!P7X@W"!(-X@W!!\LF'?'+#&S0],1+IR&=,TKALXQI2NAI94MHMES'* M,K%/=@<('966JG1.5RXUA*!%@BLI)]6SWRM+E$3((L'E7G"YH22K4B5.RJ.& M$+1(<"7EI&K+(D[*,M9T8B$EKOILR-]TN?MCAF3+Q#R%)ICSEK&)V/R89R<( MX\BA3/4"2XHC,6>5/D39TFQ$AP1>(#07R^O(D>"(!HM*@UFL]Q,?G@BLB0^)#XD/B0^)#XD/ MB0]+R8)(# MH=AG\_LOTH%/=Q*S>>ZF.F1=`-`;*C8,)`#'L#5+!`N M#P46:)>#(92M]CH;#['A#'\QO^''`5!I$=1H%@?A0J M/PH0%/`:_S_"#N'I@MWYT$#O+7Z)]&0HL>'28SVI0/SL#;",D>OF%6,=4`M\ M#?SLP%]=7\&3%;3FF0>H,/A`)>*V+^HXAW;`NU^D(QQ\Q6?$N_ON,YW^*W=<;MN!^W_0FD M=>OZ]I^__N/O?_ME\H`7X47BF[#]9T]W^"L84/MM?#4TW$-!?Q.]#V>/][A2 M\WO]WT_W9TPZ\`/T^++5KMP_5A]J[=O[9KWZ:%4;S8=FJ].Q6NU6IU*WSGZ= M&_O,9MZ0(+Q8].I,I2 M8MU9R].=:\_TK58UK/6CAO<"?X"*ZH!N:0963`+GO@W1\&@6UQW[+VCQ:U]X M#'Y$SD6%[_DN3((0#3:\!=[$69^_"*!IN&X@PALV%(&*N)+PHT`DX))@3-@\ M"+CWK`L",/%#`F+>,T>X<&7P!D]1S+?M*`C@K6@81/`B;6C9Y/&!`+G`G]^/ MVPYV`YX.;>_)'_%MCH!&#:2'+/D>;:4+A(\6(FE_;$&P_=!)(5^T(R41^5SY M>)I"\"^[4::1\1?D1SJ M'B,#))V:N?JU+^T^M``N11)*6R"?T')88\0$L5@>(I+5C;1BL,9NIC MW,74PV%$8FLJ)L.%MTP_)O44:/*%OCP]5M!9!0,9Q*86A`7ZX-N:]_`D%@Z- M%W&=!];E"GZ-AGA=J&)Z1$U0X)K&%ABZ?\4^>N-N)60+(ZS"*869NB5N]4QC MIR05A=(%C54,5-SQ@TLU%+;L29OY7;3Y4^IX/HKT5"OO__?[EX?Q5^O]3Z/A MD+'8XK>G7S0RZAH9L_*&N[2W,I*O^W;%_C^\$%^#?_5\T(07+EV\_((!)_)$ MRI'2!L@5+UQW30;.)3PD?%O<[J>O4\V>DQ@H86_RIJ05GI`Z]4&WQ@.XP%/F M91UC<[YQ.*+Q,*D0_+5P?IA6&[B=>="T]1_QX+0>CY&:1F?,#6,ZU)IM1PJF ML9A!`I/488B;'D9:HQD,`-(#Y=;*$0*,5`^^(/_($%0$>2"0ZD_\!6RWPG=K M@(Z?FO@6-BB<*T;D)3T%-LF-,0@C!P^.P3,BRF2(1Q[)W-^U=S*"LO9/\`OT M&KHLN7LQH6+HLB/$(!:+[E'<[\WZT,L``^[I*1N^%N82\<.6MCMPIEN-P5K]EOCI:&G@R8]+Q#$KVXOQ=<@MD)QA(#Y?@FNCR;<=1$$Z>`R9V'UT&/ M4L[3R,+&5^$?$Y]'.$D814=#4%@)(A.53?R2A0J\_?1SS>QQ:J[YW>Y#>USQ MI=EV/IZ>MNV;U_C'SZ6FFH/LJ/%0J-@0! MJ=A2\HET04FU>,'''S:Q-;MMEO\.XL:VSU9*:7FR>7S7>.V-GM:R2Q18CTEHN'^3]J(7*!PU^0&\B5PV'MW422NUPSKYZO$1`1ZT[P/Q'XE]DE6"SW\T_2=?54%&::#LZ2`K7-=IIQ M1VI'8(LU4CZV3IM,R"3#1*JV6M6,'RU!JD:J1JQ&JE8,5MMZ1W-.DS>,[Q[^ MNF(!XI@XSGW-:G-)+^L4K0@U;*H7M9JQRIRY'WN\CS+NF*0/3%,+HY8*& MBN(JU:K9/E M,B:3%ZGE(NR2&X_'NF@V*A3]I>AO\7R`W&L;,B6I3?50M9IW!RV=?)`"<>-R M?7&Y*;N/161U"N^O"22HC[OER_*JLNG&/5 MS)_V?KI^UJO`4G$J*/;4:&-`N4)/_E@YX\Y MR3RQ23CIVHI"17X`/VU\$LE!VW:'QWIX]ELN&_>$Y=C=]7N"C]6^CO.?2(6Z M/#I1"5')`31N5$QNJK;9:N4C6*)=B[?Z\73%W M)O4Z@4SP5*![Z,M1T0S1#/'\';,%;0E M;X=HB&B(:&@7&CI`+DG']OQ]LX+YHGXL$G^ M8_.(7#J$7I9!5OR4\6`L`8C@0'`H/APJA`?" M`^%AC`="P[ZSD!Q%1S*M%SJ`+H8J-0D1#LQ/0C^9I$S/1=AY9Z=MTNL`MFY+ MC='!."HR&^:.;=E59GE1O:PM7(X07%S35QYDQG)L5ZVJ.0TDB!)$":+FC*>Y M8@2$3$(F(=.8'`F8QYNIGM:$=*/]T\:B?7L#[116[`NU,-^PC%6P+\<"/`6" MB2)*11$M8\Y(7H8Q:V>?*(`HX*0HX+S1,+9?B+P$H@BBB-.CB)JQA*9R,`0M MH9O;X9M)L/%D@HGGC0.35-$PMXY4]H*`!2*)XAK@\B"3 MREP31`FBN8:HP1Q\0B8ADY!I3([F%@3+#LRR+PENM(D\HYR%&JB;XT==5YA+ MYSB)70N;2JD0NQ>LBU96F1,/$0]MQT/737.I+<1"Q$+$0L1" M.^P=JQ,+$0L1"Q$+';7F>$8!I-*24"J,]'/(H?\+KT]]UA87;QUAVV;P7>F)R[[0NF55*^]F1W&*NRK8S;UPL]5VC.4A1),]W*M#3WW< M^>^)G@S9T.7>92!<'@J'<;TUADG%/#]`K_;O@H9]Z`',/!X)7>9(T(N7:6?.0S\%YD\\[,?"M9>W.A$`K@Y M*&XR=-KFJL_0L+.^<)X!=?",GE0PMNQ-\$"Q.>7894P6QEMW>="%L?;,KP/N MUAX<%U-MFJ]*M\_$:&`'X[?N5'+X1W M@I8^_$"E%5=F.M*9U_=`//,`Z4^CQP@L5Z%A(;RLVGS_=K6AO_P>\'E/X"G.AQ?!.]#V>/]PC6W^O_?KH_8]*!'[@=7MY?WS7N M'RK5V\9#M5)MMEK-1KW9ZG2L5NNVU7ELG?TZ0_&KS/DRME]E(6;=!>TA20^F M(N%-K3KR'PR:D)X/DGO5BJ;=FD0+E-:['I^%N)-A`(16\T>N_A)J7OFO,,T4O![ M^J&>'PRX.P4N:\JCW,JEWP+SL9-N5:!/R6P+/$:7#Y6X&7UX/SL)6NSU3SS- MYL+M"QMX[;HQ'\YJK7=;3AB2&ZU=[ZL=^H740>I@'CM8D)KWR\,R[=U+5E;X&0B2]D^^3!U MT8[:IH;XH,U#-YUI/SV7S4MV5X''FL_V+?9B<]E4D]O0:$F(.&^%JOT>^:%P M)F+]&DC`\.2[]'*)D(X=RA8G'OP),ZA0\]B\CSIP.<%+3"R3 M[U5B&&(88ICP_1^>7VPDU^A,^WU!_RA_"(?%ZW@WF>#^@'(L`F'F1EBG:VE( MXTCC2.-(XTCCRJ%Q>Z:86X5WXC[Y0?C,GT6\+Q/#:9>H(.#8*6%'<)?"0^'A0&L^M.9C:`+RZ`<"7D<3_E6BNS9WJ-.IS_,IE$:AM"WD5#=77)V0 M1<@B9$V01-6G:6QW*.&!\%!X/-"RS\&7?0H_\;C#DZ=PO45%>R@R>SRG@LB,R&S/[*%*1I,=HC*B,J(R MHK)#;JHWE[U/5$941E1&5'9:(;,R$EDJF/9SJ$]-7W1]ZG.J7Z[TQ&4_/N'< MJE;>+6U@ZIXI^%9`J;1PI`?,%']//]3S@P%WIU33PFO&#]8M9K9PW>2:#V>5 M,_T=AL,>?5\@TBC#^]E1 MG30J'92<:$9S891Y@[BF;LR'LUK[W5JEFU;]Y$9KU_NJAW[AH>^K%:6AU,&C M=G"[%8>C+>HMMS/MW>S_9]%\-0#+HBF,R=:I6+7#:U6K&,U9NE>2]QW@I5^SWR0^%,Q/HUD(#A MR7>YNC+GL9K=L4/Y(B;-_,2#/]>MMQ^KK3T_8!]QFH4*E\L6=N+-"F-IGO\F M7H0[^6YMXV$0&Q$;[6RCX36R!Z+P\NE#K$^E.%K+NDH$+SJ.E,?F??2&T2J& MJ1+#$,,0PX3O__#\8B.YMC&2:3OILNVD\H=PV$?/]@?B)A/<'U".12#,W`CK M="T-:1QI'&D<:1QI7#DTKO3'K7[R@_"9/XOXK",,L%VB@H!CMU,-;N-SWKS( MR=@.K"+MH[(:5%B6XCI&33AQ0,$X@(KI$A<0%Q`7D#]`'$`<0!Q`_L#!5XJ* M'V6X\X.A'_!0L*[O.513?W7VDF6NO..IIR=1Q-A`Q+@\T+(J=$(Y08N@E0FT MV@0M@A9!JQ!3KI.'6.D7=O^%R/4&`N[42[O/PK/?+M=F#9;EC$"K86R2E9<1 MIU!F?HQ/\?!0-9;*27@@/!0>#]5K@@/!@>!`JSZTZF-V"O+H!P)>1U/^U>X8 M'?]*T;0<6:S3@5;+V$2'D$7((F1-[FN8JX5/R")D$;)H!8C.4]Y9?@]_13)\ MVRV-[W0#&;5K6O>AP!X%]L8^F[$X`\&!X%!X.-1JQHXF)#P0'@J/!UKW.?BZ M3^$G'G=<]?6"CXT?!$Q#7K@KO*V.&2[A')]6?"AZEB=;1<@B9!&R"%D4ER:( M$<0(8@6"6-F7?M:?_[`KK#*HQ'_!4>CB1=2(X$9Q,B*;ZV>%J$6IW51;9@K:+:SR/*B/129/9Y3061& M9+:G<];.:+)#5$941E1&5';`%..FN5J81&5$941E1&6G%3(K(Y&E@FD_A_K@ M]$77+_C\R\^1NGSF?'CSW>X+)W+%EU['=7V;A]+WOO2^NMSKZ.C3$S[V"61P M"W_]\]=__/UOORRX5:EH,,1;U1]*.-/W@'P]%.(WT?MP]GA?K5B-W^O_?KH_ M8]*!'[@=7M[=-ZNWU\V[:ONQ4N]4;VNU>KO9ZG2L5KMU?]UY./MU9E#2`GZ2 M`Z'89_'*OOD#OIPB4[>[TA.7_?B`=ZM:>3>%GR:`10^Z](!QPYL:HL?DJ#_U M!8M/EQ<.XZ#;^K#,B0A9!#)DTF.."$4PD!ZTC`V%I^"/<6!0>CT_&.BQ@B<% M>#?K^3!^KVKUL>FK9+"!W*;HNS(C)_R>?JB'372G1&OA->,':XUEMG#=Y)H/ M9Y4S_1W@:(^^;S_BK]()^_`1^I10!"#M*H=%!ZP@R5A:L, M&\2U=6,^G#4:[]:2SC3U)3=:E5UOW/&^.C7TJ`W=;H&$UB#GL'J,-<@ULESM M5MC`GB)(2:*]FP#Q-OTM-B[07]=)TA7`YIKRNDC52-56JYHQ!Y]4C51MM:H9 MB^^77=5H6\:\*!=KW6<1LCM?A9F`^(`RS;U*4I3V$&:#-(XTCC2.-*Y@&E?V M?+Q[J6Q0BY#A$PJG7AA4[ M[_R42_@J2-M,"*- M(XTCC2.-H_#81FO8-/.!^UI7#6,A^[P,,OX@B-L$;9* MA*VRYR9_XZ$^P\;V!UBU,BY3*3T[$%Q1KG*>(QNGA$+2'](?TA_2G^)X`64) MM%&N\C89DU6*M.5214Z)JPA;A*T\J0AAB[!%V")LT99)RBC>4B+5J_JU*4'D M992SYI>RT\BI`Z))@"!`$"#&&<558XO`!(AR`((RBC<]'N-6>*(G0_:E"R_4 M2[];Z"!EW.4^PG!*J":-(XTCC2N*X'(CK$)I7-DWH]%!&469()X2ZDA_2']( M?TA_BF/UR[CY[)8VGQW_H(R\*$;6(52:H>1!<(0MPA9AZ^2Q=8!C9@A;)<<6 M;3ZCS6=S>VW:5*RPA9A*P>"RQ.VC%7W M(6P1MM:ZV#^'O.N*A=>G/J=ZXDI/7/;C,B%6M?+N&%W1;6:V<-UD5#Z<5<[T M=Q@">_1]P;N?Y$`H]EF\LF_^@'OOV;+&+YIYO$HG[-_4*YL,_;26;G[QUI.? M;91PW=!-3Y>:V,]]!M-$F!RG=WMU,4O^ZKC*9Y$2#@M]YHA0!`-X/?-#N(4- M?14&(I2!&`AX-/<<_9,8#%W_3?_434KKX'2.2:_G!P.]Y>%J;Q@3/@J!#P/Y MBKG&QU-?,"==KT%MBI9ET(#/K`=/Y"Y[`Z=!L6K%:ES@_^L:8?"AQEY%(-B< M9'?I0.WJNO'.R),N3#6H;:A!6EQ&GE2_JE=,"2D0:BCL4+X(]^V*L8T4:$-6 M/;CJM/*F.J8:9%)U*MFHCC%'^)>?(W7YS/GPYKO=%T[DBB^]CE+18(@ZI?X` M;7S"^YZ`1F]=W_[SUW_\_6^_S-]S&RG05:4Z]E^15%+??/N6^O8`G\*WCQYH MM5#A1WB%<+X$^._4XX'>/:3L;Z+WX>SQ'G7X]_J_G^[/F'3@!VZ'E[6'=J5R M5Z\TK>ZV;FO7U>LLU]G;,(J!V"9.5AE4F8F3\V9^15^ MG[4Z^KOT8&84WM30@3!MAOA$TLS!;:8]+@/VPMU([S@%&\3N_`'8S;=X"M*N M6JWWBOD!-)L';TSU.8P+DWINZ4RVQ*FE_R9B'.M/R`0^>I1A/_HAGK7K7V(W MM7&-4_@N#+`(,#K@\J$2-Z,/M<;+6OG6^O;W;B=TWZT9=#EKG![-PK"V_2WN:JJYY\2Z"/Y.*AT@=IF,C#N M2(V*">T_1\Q3H##3^9@?@O<[:[E`!Z-0A>#40:MWT<&#;D!>IXK91N#3,`5>S")0*SA#Z9\5SKL_U3T?\7#6.6JTFH9 MRZE<)YZ\Z,KAL582F_#&)?A/TT+H0A[8*QZ]:I*A[Z1 MA=]P5_1&D=PD19"[PS2ZV9;XE:M$)I:[5NRF'C7Y]ZS4!^]CFU' M@WBEZ>O4*GAR:M?DT"[UM.TRXF.SW6C6[AKMZMW]@]6HU.OMVV:KT[%:K>N' M^NW=P981IY:Q1FN$U0S6".U8K+@R-]I$X(\%R'J^7LE3RS8GCDQ>PL='3[Q>Z#:NVQ`V&GE/5" MJK9.U3:N[4O!J$W/3X[G:HOG%#N5M%RKN53NC3($#\N5I''F5OTJ!69`?=^M M>):>APM__BY'QM-2WDDMY='Y&>2E%[8>&G&`&0XP5M$B+^.X+P=D-GTJO/?P M700ON%W(]E6XBZ]:HKUX[4A[2Z&GBU[.=&Y0!>Z6=.'3N,>""YR\Z?N?1^8JZOMDG,*6^&_'FU:@R$ M&\KFM+%(,S1"V_(X^Z&PEA?8T`POXQE>.JN(A^R[&(8"BU1,@&G0RSIHAFI> M!%V,)-3\K-`WS16UVEE@>=&=K,.]-*,F*B,J*\"&0Z(RHSGQ^R>MK\N&QT(@ M_XMU0+[TOKK>9#\IA!TGG:MH,.`!7*=TZ98D!_]BE&Z? MU.H7T")#-><7NMM+*D[M\GQSU?$7)F3M\J`+3#_251RZ8]@B>\N092"O&R M*"$'E]$62T.#VER%+!>ZW=9 M(,(H\+#2KSZ<+9YR9%($X3`N2;[BI[3NMDR6WX3+0QUR\$?SW+YP'7,6MH0[ MPX*I0-D`,+0U6>]PL^>H-09O(]J)=`<<<-( M>L`]UVO7)\2$-U8ZM`&RW).NX?037F;-&VHZR"I+F)@YK;4Y3W M<:?)+D4Z*=)96/7;*=*Y#;N5<):8A8=*9N"TS0#%/`^^CI"7H:=9'<4\YHEF4BIFI^$XB:)I1D1I*Q#25B+E!OF3^ M4RX?_4#`F*6S+=?D6#:LNTKC[NZZ5JDUJW6K4[&JE='!QHW'9N?T#C:FG,O< MY%SV8G6EM,OM<)7!0=)6=<],RT;ST)F6U:*<"$T=/&H'*5>6N#`80@FEU"X@U\#F/QL$Z`E-!`: M=M6W)S_,J5&(0Q04;Z8B!;G..,_%_MN"%"G(7%2%T)A]8\Q4MW1W5X#(B\AK M-U&UB;V(O8B]\J2*Q%Z;LU?VFPD+H3+[LE?9]Q)2UE1!F?[$+"'I#^D/Z0]E M;1[8_%%]NF)LLC_U;:8TB39`_>6!&)6`)&`1L`A8%#BA.@.YQU0&_F!>E"!K MZT1&Z(1Q82R"3V@@-!`:3@T-M`&2JM%D6H'[8%/HTZY&0Q$&BC!L@[OL#_8B MW!'N"'>SN*/J:U1]C:JOG5@@L"S5UR@T0KA:;MJ:AX)3.2P<@8W`1F#+K3N9 MHXG=T?.\S1V/0W5%,Q7?2=05S=R!+V.%48IC[>Z&$*41I>TGKE;[^/+*B^H0 MDQ&3Y4@=B%TEF^Q8X>G[H;2 MA)JVN&TA)W.+000L`A8!BX!%@9,MY4=9X4?T!_.B!%E;)S)")XP+R]C^,H(# MP8'@<')PH`V3:_/"*2,\)Q[9R<]W*)!`@81MK!D!BX!%P")@%?1R*22??_DY4I?/G`]OOMM]X42N^-*[BQ<[/GJ/7`;_R]T( M?OL*L]2.3G%[0D$]0=]N7=_^\]=__/UOORQXA#\8"D_Q4/K>G:_"1S_XWN>! MN.5*.%_Y&VYR[@0!OD?O=^ZX\#!]]9?>Y,+9IZC;-VS'=`M`_SP4]3?1^W#V M>(^SY=_K_WZZ/V/2@1^X'5Y6KV\K=[=6Y?ZA_5BYZ\!P-1O-5J=CM=KM:JOZ M>/;KS."F1^%)#H1BG\4K^^8/^'(;LJEN-&=4HU8UIQKQ_J:^8'P`L`WC;>4C MR3*_![*:2!2^J)`%J1Q&A9*_[*+HV3`>)-PD9;N1`[](O,/3P2L>"B07^">^ M!IX,E_D#P22\4[&>#^/YNJ8$P"J!;2#D*6-8F1$J?D\_U/.#`7>G,8K7C!^L MX<]LX;K)-1_.*F?Z.W";/?J^O7J\2B?LPT?H4\*W0)YM96"ZTR^[)7V7/'O@O7Q24U7'WCSD!Z4H4!#^6+8.(' MKK^)76(=)U>SX_]G[UI[&\>1[>==8/\#D7L;R(_OZ1L)W;BEVQ*)JFSP/;$B2U+Q3JG'JPJNL*.N)9E MX:LV^[#N&L/!$98A!AP`!^7AT,%$IX/=*HG"Q&KGL&=,I/ZP<+@"^DBC9,P+ MDZKTMC2:B>%4'O7(HBA(RRA@J31"EK@SH($L(`O(>D,61JTC&;>;_'K^WY,P M"WG%^WE1[$Z#HO*]DF%.R@&IA:0#D@Y(.E0X^@"X`"Z`"WUQL5?/"L(9)7KD ME=BM5Z.!7HT*$%/;7[3QJE']8TLVC`TB>[Z9EK!+1R'G,Q`RG,^"Y2 M,L"`(PPXPOP?J6Y4[@?$@",,.,*`(T6#2J@:!AQ!U610-0PX.GC`T21->1Q1 MB4[6*$(5P"R-L/1E06@<-`X:=RS!'5AB;BIO36\I<\*\Z)@.L"RB$+:35-TS MB]_R:0O;\9%E&?GG4"U\/",-"E",`BQ+6*I-EG4$!X`#P`%E*C\<8:,49%G' M0SF@J@2<^C'#=WY\TNL!3='9[*`E7I?P;<+$DI"[T$_VB5T;U`8N[F!LW=O` MD142D!5J#K).3;,VS7K3$H4@+@*>FX\ETNL`3YK+(NU=1;T^M M+#JJ1MNL-/LCMND>7V"RZ`X2NJ`RB=015%9*7"U;7'X<5`8J`Y6!RH[EE565 M^VPBE35]VOHU'=`TI4$EC65-[*U`6A#Z`_V!_JC3V]64`L[K9$0S]O#'1*+T M_I04IX]+XVJ?6K:X#&BSRWN0,Y#((0`-J45#;7&[R6`AL!!8""RT5XL!:`BU MSJAUKAMW=FVUF->=EU8DP4V_'.HDM81>QJU MM%J.N*;60Z76;.,(Y`*Y99#;!7`!7`!7/>":9D4'&0.Y(CQHH/8(A>NRJ%9] M]>DJ;0>U*G(U5HA%%D4X-'@'RX!EP#+E$H15;7Z!9D`SH!G0S&S^D5U1^*4Q MS0@_S;O46=IKSN2^I@_YESC+TTEQZ'>9H[>OKMMNI]WO=;MNZ[;?L]R.XTZ/ MWG;O1VT6)3U5G;T]?\K=?ACG3+G]ZI=\2]N7W-!T1+L4/:K"/CA$O MQ['<1SJ6NWO@J=R==MUG.MLU?V%+E<.NZQ&,(IDQ''8M1,J;)8O#KG6*:"`? M0%'08>`XH7G=R,\+IVU\(G\D.?/S@@EE/SV^RK'S5:4^)>$@ZZPC!R>)V20]3$#0(&K/6]O,06\L>XN_>"S';A5-89I=S MY_HYYVLB/4V2K'$U-QN)9I"<.1+GR!_,Q: MZ^L:2];WFOI%?J92$ZQ/B;IY9K7$%4GH[NLJ%%-7:<^OT%`CDZ'7AXTJ\`"T MYZ2FQ]^MB^ZR!]`;IV'TAKB9'U!FXJ>^+K9E"#ME0);UUR\4E\X203[@"_`% M0O'-@FU?&,;[1/@',UQF7Z6!#G"K*ZXQ2G?'%[$E*@/D-?7@I"9R4M.#\\`( M,K$O+J_!UX>5NM@71U2^LR=@OZ^-2_WA=%O<*F/:]'6L;4/8X#A95EV_0!S; MXKK98^5X`MOB",3+FU]W>5O\;4:+56:[MX%>;JM4R4"SO5R%`D@U#+E$`E/7 MPNO#1=@/1^1=WO0[=FM#15PU]E\Y:)EGCBW,T,NR]HB_CU/&!NNL,5,@_D;\ M75:PSK0U_)H^T#B?I$N]80MU:84]QL"VS8:Z4V:23;-]7X27V`F7U_*#DYK( M24V/QSL7SLZN`&:V3=&%BE,$H*A01X`.OD!@+MH:;Y_95BHOW$#O%P/4$9$? MW:)#<.`D%P5(PV^4)\O$(^O M/-+%*KK9IV58PH4JB/^+BO8KSG[&XD2?O\T'9&`/N25N+I)&M!T M+A-S_$RR)`H#\C]&\3^-7&%A0UWV%IDLNM6@H%TZ*P?!52*X+9#<1W[2P_A_ MCTYH92E_?U==2B>L\8:@G/>&4&L6=W(_#-9 M=TNK7/.G,,B'ERUC%Z)=5K#=WUPZMUM&P:(PIN=#6I@+TS(^O5^0)0XU._PY M#UE:$14:/'M]T"-6":H[.DYI1N,\(^S?,$G)),ZH/TEI0.)B)SC,L@E[$<8D M'U+2&Z=AQ,_Q;!/Z[`^]^`V2T&T0O):@[SMF+ MOI?2VTD6)O'LN@/V74O?\/!2?$,_&3'9O)P1C[UGDA;Y\"#,_$F6\6L^,*-_ M<3#D@3XET"=@HU4;]+U68S#PM?@O_"2.J9]S1#V%^7`*GC>4>?[?DS`+^=^K MQ=+\_;_\-,G.?WC>^/*[/Z3!)*)?!]?T(?\29WDZ&?&GO&>RO(H2_Z]?__7/ M?_RRZNT#FK*'O_>>>^P6\ZP7![^%WD,8L>>@V3W_VM=K<`'PQ;FC@\\GM]>< MD_YL_??^^H2$`?N%Y^?G[5OGVK+ZW7;OJN^T6^9-J^]VG%[/=-QV]]8R3WY] MM_J;H+YNX3>^*!L'Y1M(34`C8/&@=Z@;#HIVQ[T MAKZ*-]TF'8AA.6E0222F M')K:MK"A9K(L.K)Z\I@=Y?"`;#=P`5RL\+H<86=I`@_`@_)X@)W`+E!9P19' M2542W#?F[*B.P".=FWYH"/)N=>3=F@--0UQ>#M`$-`%-87*TNQ6=7`!H`IJ` MYB%R-+LX#O4X@2>R-/IG:/+,[%;D5*R0CBRX@Q0RB`='42C1"-V]! M-"`:$`V(9M7GNHX)F@'-@&9`,XH4&C2&9A:2-C_E'GO"5>^O[<86A!:%,3T? M3H],-2WCTS)>;>,=8#OL=2'G,&;]C^GH? M4?69"GIA3+Q1,HGSC+`?\R$EXS1,TO,7)C_V(\W84TTK(X;>(R4/E,8DI7[D M95DX"&E`\H2I83Q(TA'_D5_`GZ0I^]3'2UQLUH[9S[_\-,G.?WC>^/*[/Z3! M)*)?!]=T0-E%@WOO>7I4<:=,^6X2I*_+]^_=<___'+JFNDX2.[ MCT?Z)<[R=,*/T,B^Q-_9O5'^\]?!;1A[L1]ZT;J;C.#?]=O?DUW]^&(9N0/^D3NDI&WWMCMHK%684(ND-5N)@#QX$:^_(=F0 MTIQX*?N)_DCIC^D?*?,$V+_Y$U?$@&:,W?@?SLC?$T9U@Q?VX(2M^`_^W[_SIE>-DWSA`H1IMP0[KMD0LQ@H>6;QH MS/#E14M+:RYQ34&BQ*=1-'O/YQ/CI'C-+(0_?UU>XY["(!^R']DSS8P3,SJ1 M-\[HY?R'G]\;FK>;6LS'OQHK=^46S`X9_>)>/I]TVI^VFL%EFSO[H+GOYVK_ M0CT?4)&=FO5^D_"CV$]_#Z.(,>>4+CF>TJS,WO3K@^"8^P^R_4['S+`_T/0M MR+.-,[+.0>2F'$&RL"`9FBE2,W<>%X,*[S5*7(0-"QYI=K[%]ZM$UVN4M0HD M(8VP]&57:)RX.=+ODS_*D>`7;MEHEI.4T1[)GECT5DWF4HP9ET5L%:6]UPM) MA:RWN(D$VZ0BBQH-0_RWA\ANIV<&$?KL#[WX1['QFJ>>GR,,A(^V9Q@()PUA(,)`4$R%_2(& M*`9QH)AJM23W(N*]CP;)JI)*F0K`I6_BKJ\R?*NFJD!I=D7#LP0F]@BP#8EM2%",5K-[9=&'>A-;C8\)49LJ/?G+HY[2"0X:AZAP#Y&A M-A4>F^B]R8K&?^KKJ"$H!,6`8LKDG7:>S`**02RX0VUJM"HB)*=7J$^5D;QT MK>JR*TJG-[&J"[D$U*>"R71ST)K(9#L-;2\[5WVN1$?@&F$SD\FZFU_EX4XG M*K>,75"RK)Y53=IE2U!&1;<-NUZB79,/NS]H,47T9O$P0N0C'O1`O6A5"QH? M21[&?C0):,#GHG]XYI)?-7W)WWX9LL`B]*=?_BVE8R_D:=8QC3.:G;&;F,[6 M)[GW3&>#TG-VR4-OH/BZ+2/_=^`6@%0)D`H(4*4#Z>I8O":@]GP_G=`WH$H" MQ\VG=`@X86/=Z1UA-DXR+_HW<[#&[*)<_DQ_V:_Y/E$8,U%]'=.T.(>"_SD9 MT=?OO9J>*/&='RC1BX,>TWS^-B_BGXZ2;)+2K,P)'[UKQ[TV;WIVW^G=./V. MT6WUIB=\N(YA6&ZM)WR\/X%&^`D?=S2;1+,#/1:D39)7<9,GRC#A98QA(Q8] M9I<;M6P?!"]\9HFXFG1LAFD=>&Y&NU/WL1*6*N=?X`&/^H"*-#[B8)"J:G%J M/7X!)WW@I(_Z5$U8_A&J!E7;K&H[CV+`'OS:6.>1LN"FHI)#;%&)%I\66U25 M-Y8T<:\*N^[8=0>E@=(DTB%0&BA-(G4$I95K)D%)Y!%KP/4*,Z?[DV20)J.U M>VH/=)!,=YKY6XO:C'TR)58%X\I*Y#V4<"UD48NJ'03X`<`%<`%<-`H7;;<# M/!SJ?DD46E8ZCH5FV8+'1<9I\AAFS!VK`DG;]JB$REPWT[2W\&11-22#%#!V M@"@@"H@"HE)`U+(J.C2H@=!$`G)K`O*,Q#2O1N$$[;#((LSZ-E)4VB\YQA:P M+!J!A)6&&[JR*!?H!G0#N@'=@&Z..2"K4]]<&5DT06#0M=OXF(V]YG7U@Z_I M1[\9#*@_;77GU[[WGN_8U>\H^W8_C,+B>^_Y0Y9I+&_UNJW^K7MK=6Y[;O?Z M^JK?;<\:RUM75W97K\;R'DF7Q,5;'?,ABTHIPX,7L;;[SWOWD9>A*K[@KO7NTIG1;E1YJW.@!N3>XH,)3 MXGHV/Z*E&ZJ&EFZHFEZJAI;N0[7R=FTT(2R`KVR+^:@9CO:%N(Z7;1)Z4QN% M,F-O?/=)2E72S%+4)[B9J2GBH%>H'=_]#:]YJO8_BC& M>T<)>\ZESM*BV(OGW^>Y=^XC/]"8#D)A-6!*>\.G]H6P-B*EG5YAYU#!)NH, M%^-">#X6<`%<=(6+>2&LMK\9<$&Z'Q?9LP@23D+O03 M0KTT9O<^/>EE_B;N[_DI#4*!QVUKF18]M5KB3)N>>5%Q1Y7*`UFUC*&FT#,% MFDE`#]`#]':&7O?"`?*.Y+GJZJ#>T8SYHOZ0]*>.9^&07B4DB"LH(\!R&LR\BRK*KL(Z`%Z@-[&,^8$%K@`>FN=T,/' MCY4?_[5NCMCSF%V(!E?39IMOW@N?4):5'QWF&M>N8][>MCK6C>'VS9YQ-1T= MYMQY3(>"8WXJ44,[\JGOGE'CCSJ^/4/=FJI;&P M3@DX_<#!!ETK=M'E1$&2Y2G-P[08JROE+<[\ZIVQBEJ.M;&I*;SHM-18#]D+ M$\0-2M^F4"JD,LS.SJ/K]I:'+"O//X>2%`FSA>`9_7FF^F9<61;^4)II>N<1 M\V#*-+'M/)GVX"V'^FVSL`G&LJQMU288EE9G/`BS(;K``5'P>AM2ICEF]^GF MVAQ3+-"X:.^1(?"KP1QI!"W$.HAU=K939>IG-?;M'&V196\0Z\A@7]?"` M6`>QSJXVQ"HSHKZ)#ID#CPRQCD3F2"-H`5F(=7:V4^8Y^Z>,QNCKX+F.L'-E M9%E@!#SR6!CE\-!!_+_>7@AHA-JE?VE-[].M%Z;_\:()[649S;->'/P6>@]A M5(SZ_)UZV22EP=?XCOJ3-&4Z=>5E8?G.J)M6R^C?N);KMHW.;>_:ZMVT9YU1 MO?9-IZ]79]3]D)(!DRMYY((MVA(&8>S%?E@<^93EZ:18H#-^_E,TX3=&\F&2 M41(G.4FIG_R(V14#DL3L]Y3P8U.+ZM[E*XV3+"QFLWKYPM>=$=]C*\4^S7[] M01WW>9SO=,R^_H&F;ZQF&V=DY7G?^UR_F#DKY$HKSX7>[Y92RL#M95DXX*(, MF9!]/TD#)GI*GL)\6"S,F]3),*0I'Z3[PM];_*WH?BN6EJ,%;7#S-KAN]$U M&`VXEM5AS^>VQ37%FTSQ"*Z54C9-%O,CC%AYHDB+2)+.PY%P&P`&P-NO;G),EI\";6;VGHT^SM M=2CGA(_BT"GF+WCI7W3+^(!CW>(@2B;E'4X3^^3T-_I((V+"1P#E MU.(CL*$!TP4D@XED7>BR]>'C*:/Q::@C+?W)1Y/\@7;,266M]<6&`8,`X;) M?_Z_.%$;R39.WSH`],5E`^HG:3&)]I(]*DWY/NRB6R:**B42I\(<6J,051"< M-,*"QD'CH''0.&B)9S)'E83[A'K$7D5$2TQ7%^@P@[&Z9ZZ@):^%5@IP`#@`'``.``>``YK*`5,5 M<"W3$J8#LJPGN`!<`"X`%XC@@JKV)77(P^0TI5E.4B^G)'ORQMB+K#-KVJ`I M0N(.D==]BA"0!60=U_`#8H`8(`;C!60!63!>LD&L\=4#MTGZY*4!H<_^T(M_ MT&+T6.KYJ!@X"AD==WA!!=9>W'FI6T0C"Z"J-OJ`4X/A5(6)!ZZ`JZ;C"F8* M<`*<8*:.CZO*^CY=U2/58KH/09-G7?15`HXV@V.03/B,XT,X2_ILD[!BF*WB MVZJ8*I31F(ZX7/_>`I-%=ZIVN$!EH#)0F0(=`J`R4!FH#%1V+"JSK>/+2Q;5 M`9.!R2121S"97&G&)E):@\]=W3)?;N$8/U'J!C,@V[DPTLD'^@/]@?Y`?Z`_ M)2"SID#BRS M,M,0I2:R(*)J%P9PT!@.&%$+7``7,!.``^``,R%3I[T.H5J;8:!HCH,^/2J:@-LX3,9$%IU7X!D`ED'CDI#(@"HH`H(`J( M`J+-@"C\6UEV7'49F(>N53V&%\BB5?7-*%"I),8TW-KD(HLF5.TZ@69`,Z"9 MHT\\D44C0#>@&]!-K71C"RNF`,N`9<`R8)DZT-+GQF"70&4YY".&',^&3Z>O&B<9*.O&A)!4W^GM<+ M%W=,?!I%L_=\/C%.BM=L.?SYZQ4BO0]'-"-_T"=REXR\#U3V%`;Y\++;O7"- MMM%Q+:O#GL]M?YKK!5OOR!MG]'+^P\_OU_CM%AMG%M^WD&F/]`^*)`!DA.)?F=-@45JO-NI0HNZOOD0GO?U]7R\J+X M0'R@S@=NMHUPL%G>Z]:JM9VQ:NF;XV$.;%K5,&A//K7'MLUN+>>*^2&+U:A3 M=O0PGF+>1H$WOL\YY3XG49_TJ!^3?],@9>0KHSR-V5`\?(L)=>E8?KE@C[[Z M0>!'829<3TZ88_X[,+Q_"Z`#PCM9"/V@OF:CA`UO63R3+*E:QV]*]U#OZEAV MS<@7R\(_`%@`=@^Z]F<:)JA7 M[$_8R61"/\?M"%"MF^X=ZO^^) M.-?,-[OE++[/M@],?+TOX2A-YHS(2)GZ1R1DP#,HQ"]DB&F:.7^.$]XXG<'D9*[)X(#E';F8$KWS`7``K`T5YX"Q``Q0`RV"\`"L&"[S()8Z>,' M>I,NQ>RG.Z#A'4.[8I,[`.2.DQQ-I15?BL840.DV^H!3B>&DO3`R<`5D>>Z+OC:`HZ+ZY<9[F_97V'RE8N8AB,8^MAKJ MO/U;B\P4[=$]Y0*9@5S[&I<464.;>9+T";&./E`?Z`_T!_H#_3'3/E`?Y1.)LN2+ZP_]AJ^ MASV2FO'+0G6NA2)X#E;TLT*6#&@&-`.:,=%!:;H&@&_`-^`;3&M`,Z`9T$PA M:0;3&A0;V%B`7?$W\69,7.E&(?<]-MYE)0&V59&`9N8DJ"1Y9X`3X(1\3N`* MN`*N@"O@*M>XPO0/90?4EAW0$/<+[R+R0@[B?BQ%7HC3/KR\3%$=W7,M,!F8 M#$R6VT4B*`V4!DH#I>5_?0XF`Y.!R^/[U-^ M=_#*^:F<2RTZYQR MG]_(I]X($9T'D?OCTV^__O+QY9W_B"+OP0^"I_.RM"UQ<,7Z9Y7>A6/9]3]K M?]U<5(COB3]0-SFQ[>9%NVNWNS6[9Y^W[7:KT6PT.QV[V6HZ3:=5^?1LG.9E M?N,/&2??V`.YBH;T==J27Q.*(F9$)(KQ#^.]XGZY&XB1G+[2&Y3+EZ8<\+9W5"^TILJ M\]9WKB&;!=JVGLE"'L_?-(SB(0T6Q&?+ M;SZJ#[Z7#$[;U7]4FT[5;C=:+=MJVXUW4YX0,`_HB+/3Z8\/SZ$]>\5YA_Z, M'FI+MVC6V!/(7NVL4JN_6\D\B_PWN=#>]KKJGA]8V_<'0C"Y%,QFFV<'VZ!^ MW?:WMF-\>5EV]#`FR]LH\,;W.?HJF%T0/9=,[TF&BOGO&\R4UDZHU[%UO7G" M_9QD72:;0.N4[5?F23FHFG=B&0CY`(U;H_&??I^1:]=GH8O8=6`2F#0`DUG( MSA9>![613WD/?)KZ.0C-9G'7;)2PX2V+9^I:M8Z)8]G*:@DK=:A.]#Y;L1L; MMF=$3J$.2:GWM-9M6[NP!^\K[[?EFVIB^'/M=;LROPE;N>07==Q_TY][LO(@TU@0C-V9MF%9NQRKX+LG8\ MI[*4YIW!5H2=6GW?K)YL:BUE9&/*.!;/P6N<589\P)'EXT91Q!$?F MCP,@G_T'N>6:0/,2]6>U+<4N/+-U8%?RQ<;B@:+^BN-C:AS76W7M7B93]$+W M;,=,>&GP3':Q60"?MY[H(753`+"1,=#2RT878".PD9[94=-N@(^T+4>*M>HP M+YPQ=X`[$%U6P?HN*-5?(7HN-,X;EG-PXO,%.TID?_8N&D(!*=%<+`"L`*K MQ-54N$4(&P`J@PTP2W"P`;`!*VW`<;V*E8".G=OUVF]NU/IP7K%D`\KYKWK> M"I&\]GG+'#3C1HDU:QW-7-0'70W>Q"=NHA.K>E@N4)W=&/W<34U4E/"27K"= M/E$G#J[8*&:1])1%))DP$@W&HHW?GRJA=G\P`F=Q0Q+ MGU( M-@KER"&(OH1ND'I"H>A0F#P!)0&I-$B$"$D_CH9"N6+Q)B%QEX2[2(?Q`QL[ MCN@WK_G_)$MOKE@$Q)(*,@7-QHR%S&_I#&XBR!%646J$MCUDNY M/%K7"-7_03IBY.0=Q%\]\8]!)+N=2PS?T5B.Z?CILULOH#1F9!1'][XG7E4\ M\UN4,-(6]PQX)(XGM/!B*+=:[S@.&8X;Q2JYWT);</*!3R*Z^G+]A5`A[L[5_RV<^6PTY"G)P(^? MQH4O&YACR:(CYB;^/0L>07PE(3X%D>E&$Y^B"7<&F3]8V,VF#@)0\D<:".Q< MB;O3V!U,0=?W8YYDI_2C-!;8WB?HIN=_?)_RDSM*1Z?7[H!Y:<"^]Z=;YC=" MVN=!Y/[X]-NOOWQ\>9Z8745#=L[D+&K\^X;^O!#_XV+0.Z'7&\^N;N1SG^XE MACR4PWC%^F>5WH7\MC]K?]U<5(COB3]0-SFYL-K-FM7MV=UV[[Q9ZW0:MM5H M=CIVLU6W.[9=^?1,3]XBA==4Y"TUFU_E2^!D:B>85RC':=69+OL5Z=V-4`4A M.Z%>F>Z)L=_5BHP/Y>FG?B+0XCY-AL78D)Z<^'8C.8--I87X/F(Q'6ON>"C) MY$0QF$MZ`6]ET<1M,Y67ZLP)"Z517AJ)(;6#^UR:NZA_^J:6;T"%RP9]@1ZM M9X,LC^=O&D;QD`8+>F%;\XRJS(8]>_.QE;(M\4T3UYXKV]"/.#N=_GA!BLO- MWHQIG:6A7VN8K>QESBKUQKL-+>;D0GO;ZYQ]/Q`?F,L/W&R^=;!`U-=G,6BVIT1')6/4HCU/53^SX7.R.L0W@SZ,D`505]KB\IIZ9]^Y4)G=J6OLE=4 MFFR&;N.E*%UY`/O8KFD*B2\NP.#W`Z)>%5=;>3ERX`EX*B^>6DW8)ZT30"QJ M56H54D]5BZ\0FPO-JJ8J7&5,/`65@A2O/]4J"O)4^MPK5M+43'(R0U:(CM`$&46'RBAJ[)A15"MH M/DKA$V[P@7G_P#*G3"G8^&B:O?&!)*B$D6DYB-NTKP@3_:9#*G?#5IBF24A03F*;"O>EQM M*DO$-&4DY75(M#RO>XC>MJ99D6E>(\:'V6ZG&MI:Y"2]$3Y.`7 M5N`7+@^XZNHFKX`6H`5HS=45:Z_=?`/0`K0`K0VFA$UUQ:Z*#JVR;]M>QI&7 MN@G)WFRKV+M5N,H=?&Q'62%T4T89'DMS[$SN\%!5EO8,.``.N8>#78-Y`!Z` MAR?S8`,.NZXI#%K`ZQ3L34P]-J3Q#RT+C>(LX&N6NIJ(15_`PS<&W]@FH0@- M(`O(`K(T(`M1"$`6D*7#XX#M''U+KV*ML"YIPD)9(SKT2)2(\[0@JV@]SJI5 M=;$()>EQ!I`*>RHBG*O`$/`%/RA94#E1K!J*MEM MH&/HI*9:?(7HI-8\;CJ:6*V,G=3@HMU^8@$R`YGM)JZV!2H#E8'*3%1'4-EF M:\WCJJ4L8!AD!C(#F8',#E8/H;UVISI064%Z^3VGL6FOZ-9(;:-KO;6J-<@M M;[*"7D&OH%?0J[S("GH%O3*@38-!*\K]]NCZ5TC1I- MRX7@C!$6-*X,&E?V_*".^W?JQ]F$[F041R[CG,2,,QJ[@RQIR!L7X!ZRPW:" M-D5>Y2S7KR[ZPI1QW-57;[X[(C\&J8QV!_H#&U(J&U)3ME%LRC#"A,"$Y&OI M8M#R.<=5Y58D>!6GS,C>3)H^4H+,J]2BZF:`)\7N88N3+:,N@/S!3,U&8;+^H* MW,-*@65@I39:<;U/J$#(TO.7_/[X/N4G=Y2.3J_=`?/2@'WO?WE:LG2R%4LG M]/Z((N_!#X(;>>\;`:3S(')_?/KMUU\^+KO^GH5)%#]VTS@6OQ8O$@,92BA> ML?Y9I7?A6';]S]I?-Q<5XGOB#]1-3NH-N]6XJ%I5NWI>M9SJN6U;C6:G8S=; MC4Z[UZA\>C88\X*]\8>,DV_L@5Q%0_KZP,Q='O@A.YDFB#C6NP6-:0AER*C# M#\4X)Z=5J1TJ1WLJ+E^\-DW(-1LE;'C+XID65"TI-.[S1"PHH_[IFUKQUG>M M(8L%]%C/OET>S]\TC.(A#1;$9@AH"/.3J<_/CSG^]E+Q]KK;O!Q;S`W.2!/_Z]*6U'0.UIGE7#V,PWT:!-[[/T5=!];Y@'$$V M8L8E\!3SW[5X3364==W891UT? M>.-'?E>>*7M,PO]&\0_BAV22.=EJ4*/Z8,LVYS#*M;9#PT@`>L MB]<3;,\/?3Y@GC0H7NIN5XX)X<[3Z^QCIZTIN`LASUA4`IR[R+'=4M=8ONS0 MS,ENFW&P1)`=@NP6)PSM>GMODC%%%["\!=&`:/9,-#5=*Y,"$XWB@,RW`BI? MB<+\QI)S%K*^GW0CGO"-@S!KO5K':O;:C;;3;5U8%]V+=G47Y%9:]9?.^[+-L'/"2H MC0\21)K>_'5-==&CI@^\O`Z!VP8&;BFEF?7-7MDY2(>D-!"4K5U6N5`9L!?8 MRQ!5!'NM+:H]%%O)AYQ\IXLNGV77'K?:DK M:V+*&.LV\+#C!89#6]DL&7``''(/!U@'P`%PF&V2`PU``]`PG2L!#4`#T#"M MD86ZV3L[FPSRG>L4[.>?(^;*/IXQ2](X)%%(1@$-"I`4W'J\![9COZ- MK)>JHR\00;EV;9)BCYTLW7:L4,C3OPL#Y`%Y0-X+Y-E`'I`'Y.T=>6,YM1S; M4>8$0'0G(`:(`6*`&"`&B!D+L;)'RG6&D?C"_]!$5F.-^F04^U%,^+3Z1SOQNZ4*>H5W66-7"+M"&\BIIJYU/)`% M9`%9LS1!=;W2@2P@"\AZN@XU%@$L`$L#L!P`"\`"L#2LL@`L;4[#8OD&NVF< M4#^07:C?^P]5-JI?U+6JT#4O2F\#MA,@C7=LJVO3LTI\A>B#J*Z%PO;R,D5U=$\F M#*(XXV898#(PV8YQ?.HV;\%D8#(P&9CL0$RFLF@VJ`Q4!BH#E1UJ>7EX<9FB M.2`R$)E!Z@@BVVQ.IJQA$)@,3`8F`Y,=C,DP)].QS?D^H>+3EYZ_Y/?']RD_ MN:-T='KM#IB7!NQ[_QM+SEG(^G[2C7C";^3];L3'GP>1^^/3;[_^\G'I-3TA M7N9=)S1)GUTC!!M*Z5VQ_EFE=^%8=OW/VE\W%Q7B>^(/U$U..MWZ1;U::S4^ M=WJ?&Y_M\TZSUVAV.G:SV;WH.)\KGYZ-QKQD;_PAX^0;>R!7T9"^3HYSEP=^ MR$X&+.-BV['>?.Y?^]2/R3T-4I854)YU>#LF_4S"XN%2Q-FN+1T*I4XXB9D;W87BH9Z\12(> MUXW";$>?RHYQYU3L#$C4@_BN4YG&6WY^2!Q4P\1/P]$":&G[ZI=6\) M<0W!+S"_)>0\+WAY/'_3,(J'-%A@-5N>\W3C3->)RX)@];NL+\W)=;EX4'_C*='KA9%-'!0O9>GZ&TMK-@K9V6 M"$\OVS0[8,\5IH?%:J25'3V,K==M%'CC^UQ.`JTNI;E5->O%(A0:]J1AW\5\ M+I[)\'(AFF_=^=Q>WWBRQ%@;#F7FX.42//KJ!X&@%2X7"IZQ1T'B!OC+"*RY70.&@<-`X:!XTKA\;M6,'1SO,L;^()O?/#4+S; MW&3ND*LT4^2B+)XJ3U%1SG&UH:S:ERDC*:]#=93#&6VP0.Y8P&J"!<`"8(%2 MLX"EK(.D*>,(#@`'@`,VX8":LAQ\4\9Q5P[0M5V4?T_"-8OO?9=M6KUM_6.UI=IA5FP0P6U8:KC4E#DX`!?`I?!P@7$!6H"6=7WGRJM/%ALMV+-:L="9 M*V/"9>^2=#AN2T+=OU.?^QN6-RFA[Z&!Y"1X]0RR:<5!%ASG@!@@!H@!8H`8 M(%8FB)5^%ZKC)BF-?1J0(.*<'-U1/]RJ6TSA/"`UA.7"(0B'X%,VK#KW.?`` M/.0>#T>VLBC7(^T9.$W`'TP;3!H@!8F6'6.GWC;XGXM^.B1^Z0>HQ3I*8ACS8M$E9<1T> M1RVX!^$>A'MP3;0@DPEH`5K6%`=J20(-0,-36@30L.O:I"P;2B\SD0A-R#4; M)6QXR^(9L*J6%I=!%'LLGHJJ.OI)O"B]#1CY'RO[3ZU/8?(T>88M'L6CP/>> MGG10Q#K'-4<9:K<7ZOH"RC$9P!>X#U\@@#T!ML(NY0`V@`U@FP%LNP58`]:` M=<%@K;"3.&"M>$U>L*5W=T##.R;K??2I'Y-[&J2,1'TRR@K:<\X2?KH-U*L: MW%DKI)@'*H0[%/H#_8'^0'_,E`_T!QL86VU@W/EA*-YM;A:E98%4F.!&^[CE M*$OD+WQ8([P/B!S>"%S-5AW@`K@`+H3E`V*`&"!6>(B5WI.=54P+2,R2-`Y) M%,Z[L'7`+7>H.G*0^B*O0S`_PI?76$/9J#,(/``/&N=DP`5P`5P4%Q?8+WI- MLI^'HR!Z9$*VXA]C_S9%EYV5Z61P:,/;9I"A*@ZR;$M92SE`"]`"M.#(!L0` M,4#,6(B5?J]H4G"`DQ'UO?^R=W6];>-*^WH7V/]`Y'T+9`$GE>3O;%O`B9.> M`MVTFV0O>LE(=*RSLN05I:3^]X>4G<2.'<`"N"@C+K!Y])IDOS_'M1'J M_IOZ,?/D`>[L,_>QE?26`.OP=\,99Y#9VA]DP1D'B`%B@!@@!H@!8F6"6.FW ME#07106(]L>U`9=?B7&AKF`I]HT`ECT'"XP(<`%<`!=:%R)EV3?*N33H;.;I M^132^^,O.*PK"YW;6FCEG@S"D0?@K@-Q,Z./V%6+7T+8%E9.VAN0.!?G_N4M)O5"TY,VN*CO6\Z9D M3-$%>**USP]`-"":6:)16?T"1`.B`=&`:':Q"@/=@&Y`-Z`;T$W^SAV#/+*: M!)M=/K"L2;=1X(T?="%ZS#QRG=`D?=T/I*5L<9XB+[X!,$<_C1,<-`X:!XTK MA.",$18TK@P:5_I-OK_#WGB"=SO.TDBB6_&B=>-4L33%TG0FUJ_15I?V957! ME#NH#R80+`06>G%4H*KL_"=8""P$%@(+;9*]N-4`"X&%P$)@H1VRD&,I*T@- M%MK`=V2>"U/KMF%G(/J8Z!WCA(8>B5F0;6'Y"1MHJ4*R/^G)#FUUB:*0VM,4 MSV?1['@9@:/D#3UVL=;F!5_IMXZ^1;#F+!^1\ M,`RB$6/D=')&]MO3&5D]"[\W4B\7#Y6-MJ;@X]>%L]_HA-L6<%MV[A%P`]P` MM[SFG$W`#7`#W'([3ZLIMTA9X89]O]=$>,D20K.3;%,'V?0HGZ)3N,:7Y.Z;2EJ$<(5<,RF5W.4%7[.F("DP'9C.K&Q-8#HP'9@.3+?_&:'`=&`Z,!V8 M;O^S3I6%MWB8$4!_H#_0'^@/],=$^6`; M=]DV;A)3,=.2,;N$\RXL;,\]?QX:Q\7J9PYV%L M"PEN<[`Q>V:#]Q@/=AMX`!Z`A\E]ZJ+J`0?`H?!PJ#F`P[9+BS+M&U,W26GL MTX#(T#P=$'KK$/H^96>KV$YNA_=+'@\,#V4.YJ]4V+6JZM)X`[O`+K";%W8! M7``7P"T@<&N8+><#W-+OKQ4OU94IDLOO3'"1-OGE>L')[_!O.5@*GFOP$'AH M/1YJVV`AL!!8""RT0Q;*+[.=*7H@[\,F/4@&))-CMB5,='0YA=XG5/1_X>\7 M?/[P/N5'=Y0.3Z[=/O/2@'WK7;+D(@T]YETG-$GYC7S>C>CE:1"Y_WSZ[==? M/LS?\TUF*^J*CMS3Q+]G_#)*NHP+H)=NQWLWH7$LH6*8TOI!Q MF)Q4I<:IU)J;/B/!1%19`>B)MRSJD3OJA^.BT#)&A+W,/S5)XR1N\YZ'DH11 M(JX?!Y.($2)BV.\8H:XK'RPZEGTI5(",A!'EA$GM69P$BCRP6-S)Q1V!,%%\ M>5*H93)=81QF+(?U0N[R>OJAH=2\8&:H;/F;IP=GP"(N"X+);SX>6`?9M:`' M]_%Z?0UZ\+VD?])N'[>LNM5H.4Y#]*]5?_=(;H)_`CKD[.3QPQ\O.>>YB=,> MX6?>JB_<&UC!J9PU[>.!TWKW)B7.DO;D1GO#^YQ&SB_<^#ZG*`U%!W?:P=<0 M]O0$'?&KBY81*\]F7$&2+)XBJ]9FADG>EEW-)1:7 M!U7NJH47PO3^)[/'G2=[O,;TVC`%-&[M:IA\.6FF#B2^X7+?M<"E6TN5 MTQ0[$E"UY:JF+)@3J@956ZYJ*^<$T77ZL_`!L1=1_$!CC["?;I^&=RS;$(FI MFW!RV,&!@)WO;YLC.)U:F.T`3D^Y9Z?9A^SGD(6<_5YY_BY4E]S:("$73#MS MK8XU>5NVMS9GWTS1Y&*4SM(A2AWG@I3E.,JYK%8A5!76'?QIG%*"/Q7RI[*4 MB:!/T"?HLP!*"?I42)]%+>I:"$W5%YZ\5JCEM#AKC[&TKX1>DM?ZO\BE.`[, MK%FK,/`KF^X;QX6]ZM5<9_#?BIF=(5>[,1WLNA':%'@;I=]691>WCJ2>"YF. M0AGMG'EZK*E+P]&X MV)MX@O@]#>1S14_"9T\N^SF,>!K+HKHQ(P&-[U@@GM_K<9:0V]'"QLEWR/#] M.!C)R.SLQ1[Q$S;@9'HC?&ZHUI30^%+^_,1/Q."Y4W[`IRK!3UX_LLC9M\F8 M'"LCG45G'W9XCN&5DQ5_I31.Y&`^/>9+F#U\HY,0G7;;.FUWVU7K_+QST6QU MNTVKU3AK6HUVK=:QK5Q/0M@*3SXLWE^Z_OO[]Z_G?YY?WG2N?I!NYZ9##O^^ M[/S=_7)SWETY?F7OCQXTCFMMVW%:5M.RF_5:3=W1`\?>\NA!M5Z4.'*K*`U% M!]%!PQMJ=@?7F[/O+!+F]:6?\CB.!=&`%3F+9<.$#,5TD/?E_'5\#G&=X&7# M)&J<;^VYN>VR!R^O$R!99@!KI!%^'Y[PC5LD"3SZ(I\,ESJ0E MB[?F,,D>PL>>"?&S!-&`:,,UNF,:V*DY+75D2TP=_6ZK9L@IMX5WH MG^.(<_(]CGJ^LAQ&8.'5*VMK#E?5P"\5JZ8L@: MY.7L`^N\S3I*A;A3.G*JRI9P>^\S!;0`K76@90-:@!:@I0%:#6ST`5E`E@Z' M30LAR(`6H*7#:*GS^^P]M,H>GG).XU"TC&?)UZYE\K435;H#\EG]@+8&615! M/M`?Z`_T!_H#_3%3/M`?Z`_T1Y-\M.U%6T5?E)Q2[KMPCL`YHL/O>.S`IP]L M`5M:L&7CM#^P!6QIP)9UK"Z^&=@"MH"M:6RU$$$%;`%;.A*S'-?45:;?=VQM MNQM=>,]/UP_2A'EPP>9/.85C%OM876XY4_1?MW$&(/8:$%8+@``@`(BG=9VC M+"<@``%`[`$@6D@;`D``$,_>B2IR)+SNA'B?T-N`+?S]U.>I?BVI!C;;P*E[ M9I1&>C`RX?BA4/WQ]?1#PR@>T&!&KVSYFZ<'9RTF+@N"R6\^'E@'V;48#O?Q M>H%(;_P!X^22/9"K:$#G4)?5?S]I-XX;K89=;[=J-:M>JS??/=;6[@>@[M MG8@(@8B@(C< M$3&_HC$'$4D?B``B'^/5]D5 M"^>K@`@@8AH1=67YD(`((&(/$&';RDK!`1%`Q#X@PH*-`"*`B,?[:I6J!1NQ MM3?"($^H3L%>LH1\"=UHP'+S]8%URI33UFFB=C&@!6CI@%8+(1:`%J"E(]>9 M@YT^0`O0T@$M=:M30`O0`K1FG*$MG"32YQ/:+]?/.8U#T3).ABPFUWT:LQ-5 MN@/Z03EGZ`_T!_H#_3%4/M`?Z`_T!_JS$_EHVXXN?%'#4\I]%^X1N$>TU'RK MH2PXL`5LZ<&6LGJ*P!:P!6Q-8ZNAK#0CL`5L`5O3V*HCT@/8`K8T8*MQ;"L[ MFK/WV-IV-[KPGI^N'Z0)\^""S9]R"LBS*?JOVS@#$'L-B!IRAP`0 M`,24SP2``"``B"E'!_(D`!``Q.-]]>.V,J_ZO@!BR@GQ/J&W`5OX^P6?/[Q/ M^=$=I<.3:[?/O#1@WWI_I31.6!R,+OR0AJY/@R]A+XH'-/&C\$8^_4:(XC2( MW'\^_?;K+Q_FGW#%W.@N%%WTO@@P)'[/9UZ'`^)[X@KK)4:=Q=EX_J[<[ MG8[=;#OU;L<^;]EG5KU9;53MZMG!IQ=C.#T>-_Z`<7+)'LA5-*"O0W;J]KG2 M:=-8:0E@O-21[-H/I1!.JM+3HU)I.D%`HAY)^HS03+B$3J1+:.B1X%F^\N]2 MP,0/Q<_]R0^Y+P>4].D]([>,A80&0NXT$;]+HNRQ9]%`X&$T)J"68S?_X.1/ MYDD<$<[N!J);QV2ICJXBO`FQ-%YPSPMYOE&2;^I%,XQF/3YE,@KR>KHEH53L M8.;%MOS-TX,S.!&7!<'D-Q\/K(/L6G"%^WB]OGX-:'SGA^-&TC2)'K\8VY_L MFP??2_HG];:DW$E!.$%1`1UR=O+X84[EGAL>+S('M87.SJ[FJ?(=_^D$@:()+JO&DTL7\]TWF(6:$ MDVJ1G&G!I$7?43BCO)^9,":LU#T-!&\K*VBXB:2,W\-"OO?9T[1M=:D%C1][ MA4N'4IZFO8FIQTC,7":H1DSU>(6$;)W,[WN\TJXJ"[LV9;3S1TM);/:7\%Z8 MZ2CVUZH]7,+@FA9B:V";5I2?3/+I"V#Q1+I:I/>&B]DP/TI&0T:$4+D>L!4. M4W;%L92=8C!E\&&J-`GV>QP-1>='%3(,J+C]<:4YE""#\5J:HUK=U@N,UYX; MK[.4BT:R6*RM@FSKB/?](>R5O*]:J3:PM(*]6C'`FMVS0)@LCR3,[8>BIWBN0ZQ6V:2V`Z4-5X^3_K.R?6N%/7I:%+PDV%NKJ`2L,`QAR2 MF(3@.JH#HXN0]W(KX)HK2-BB5T3Y-9(M9_&`>.P6NTQ+977H5.R6_F(S\\JB M+\I1N3ZM'(-=]A54E_58+,_$)/3G])D8K*;&2+.J-55(`Z!*;>+&O@K-$,MU M=;5;;-H51V&XQ;9R`ZCWV4J.724+CHR:8B;-=70[0X*LU=:?\WI".*1H"`V`J=QED`##MWTOK(*?]F\_TUZ"_JE`:+TKE MRD*9==B+Q"VK2JD0"5R<2KVJKBK96Z(Q11D4&M#MDT`J2>'X:GI(GL2IFZ2Q MT$!QP>)[=CJZ&0W%W\XBGJR3`K+IM!O-ZNEIM=&Y:)^=GS=;7:OE5%MGS7;] M]+S5U9X"4FN*QQE)"6IUXY0&XO_$O_>3D4P((&5"'JCTUY->%`CKR$^6*LR; M?9E)M[AR[Z8>.T/(Q<^_V*BUA^KR+]J-+1,PVJWZQGD4FYO>V-48QL; MW[GQ.UL;OW/S;NY`0*V-4WANW%C'WOC.C1N;6S<1?KO]`A6RTN!8*[O3%GH% M60&#.Y<5]`JR`@:A5Y#5_LD*&%S?.VOR(O%U!W=[,YG)V[(KY:4E#)-<<4N` MZ8B_6!^ZJ]?Z65."B[7O?#`,HA%CY(;%`S_,,A1"^4,R\K0L9"#H`"H`"H*0`=G_4\[&"^!D0"D28@,CO!J74Q:E"LKU*C+41MDQ3S-EJ3Z4+[_*='H.$^]2=D]E=QUE5J3< M:=(*!$KCC&]1!`&`$.D$]IZ4+#Q`6\`5Q`/N`- M\`9P`?F8(1]C>`/+$R6>#C-]DLIE>]:G\9VL/!,1]E/&,#,C?91E8A]]Y4%V MFS"MH5U`IH!*]_P&T(+@"BPX8SBIIC]6%I0$9$%PQ@O.&$JR+0><9**&`%H0 M7$DYR6GJ+W2\+YR$J)H_SBCODR$=#5B8K%-?U3`1%8MY"DTPATW4=Y;WX:2Z MP6B!?`K")M@X!RX,P@7D4Q#>.'0LS$(P"S$;+9!/4=BDC37-6FR"*)TEM0NC M\,B5;A7.DB1@2CTK!HFP6/2TG\[>/,]9F@(OW?U.>(/`'3O)5 MG>3PD:MZ ML\B[^>![2?^D9JU"`+/*L?J/UW.P"K581P<"/V1'?9;1F.U8[UX.Y@R4[8;L MYU;>]<[VNU2BAVNI^5P7M9:D&PC$)IP,8W]`8_%K$K.`)DPF:/<'0^K',KJ. MN%G:=BYT+2:4^*O0<3% MD[EHS1V-I<+(!W(V;ONBCE/1#O'N>]]CGGS%921>9=>.E?'#A_":WRQ!@3 MWO>'4N6.B1R6HT".RP1+%?(@AJ0O],X-4H^14.BHN&TH>&8DD!=0T7(:>H3] MFXZ?47GYVF%_Q.6@$C&,&=R6*^X:A+MH4&9(V'HQ"/)Z^J&A9(!@9MQL:YJW ME5G*%RT?VT+;$GV:3%$$+P=TR-G)XX2> M9(R8KS-;?.I(]6"=I=?\&DJ#E)=+UA4\SF*=LE49;P!'$U1MN:HISYP$58.J M+5:UZ@8+QM6\*(8ZC%5Z+!9+]7$1ID5)^ MV9W=<2BR>H'*!*YJ2YF]`K@`+H!K&EQV2YEC:._!57IO\N>8T83% MI,-]J@-8A<./7:G7E$4VF3+*<*F88VH*B(A:%4Y&(`*(>$9$55VJ_'U!!!QN M_V/OVIH;19+U\V[$_H<*1W2$)T+6@$`2ZIZ>"/DVVQMGIG?=WCTQCQA*-F<0 M:"ADM_?7GRR096S+MBX%*N![LF0)5&1E?GFKS'RS%7XI7LL[)S2;X]68G9[" M>-RV9-.%H1!2J(%6:Y5PFLHFI4,X(9P03I7":0X<".=>C%SX@EMPU8K.-3B1 ML@F5ZG!DQ30Z/:>ZUD>Z,`.B3D`:($VE2.-T;'L`H`'0`&@`-.4"C=$O*439 M8*!!%?VZ5?19T[&L&1S+N\%M$Q=!J2F*FZN-Q('CP''@.&T)U_H#D"BG1PE= M^LGL=_KKMWYJRY$>1`$``ZV"`:MC]I0%"W792:``4``HL!$*]/K*9C;KLI.Z M!NKJ[T&@GGX=D7*&ZK)P33]EA#!0%4<`&R-<9F MOCPKL6'&(.KIGUW71YM2!%10._PH#WUTEX`\0!Z6\F!"/R#4MB9ERZND;XR_ M8COH6XE0@$8:J3FBU3>4F6X0+8@61`NBA1C;%@0\B9-9G+AI.3G7$J9>[C?U M:I549_V2-KHP"`(2&NFHQLF375FO(\@3Y*GY\M2'/%71A0@>ETZU_-I[*=45 M^;_+F'4X,]PS.L-A=>7_VK,/XD=`,XW8$6BV$;D&'4O=7%&`&<`,8`8PVQ^8 M]136GK0>S`K.YX^I2X^^\OLK7O_TXUP<7;ON[.,W[X;[\Y!_G5SP6Q[-N3A/ MXNG9]Y0GD1N>S`71EB=B'/FRZ5'6\RAO>71\_PN/KQ-W=B-W9IQP5US*)5P2 MO8[#V/OCY[_]]2\_O?R9;_QZRJ/T@L]BVM3H^DLTB9.IFP9Q='R_^'!Y#]J; M2&[`!9]\/C@_[1EF_U_V[Y>G!RSPZ1^NEQX-SP;6V?!T;!\;9\>6,1[9ACD8 MCL?FT!DX0^OTX.=G&UKB@YS(Y\^2KB7RNMB1M\^F@O:879USXY/L\^+MQ%N M2!1*^"SA@M[3/MURT64O.'2;A_LM5G(;YBVXE+F>1](N>X@03ZE9HVE\8'2O M:9R\3'%MM5C:Q&0A:41HHO>]_%=ZP^4N?'J.V8]++(;H'G&_OS+J MND:4+UO:YP/;^?"N2GFJV!87FMM>9U3\@X.J'W#+ZT85_YY=$[I4SC#]C:ZK M22__UVU!9SM%+R_+WKUH,7GX:Q"&I+J%U`Z^!+9$_+"!Y;Q^"[82DECO4/EM MRGI2[R5ETE::D:JE"BE9V-AYT[(&R:@M==E)>UZSJI/*"?(?'FSB]FI%%+V4"<&P8.-J=_A`C M8+1'@4HR(%J@`=`2:*DQ6EH&1N4`!;1(4]7?,_^?8,+9-R_@D;?1&,(6]HJR M.DY/74N;II=KU"A86$_+3B,"Z@7VK46G(="I@<(%=`(Z-0"=AK8#=()PZ>;G M-*%;"X#*CTW-*:OVZJN]! M'=@(\;WZ1?G;1!\`/`!^;9(Y'=NNL*]-';BH>?A>SZ@#Z;,M=6(7H`R_:%L M9)0TK1I0!M$LSQ%MF+^9%[VJ/!'Y'L+5#JAZ'6N@K/Y>EWUO7H0+53=U!."& M(X?95U;-#>0`<@`YVH,<-DYF02*055-"RW]';AC&GIMRGWU)^52PP_.M)@DB M?+,,')J=06__";:7/%>C`R--#+V6&*K^I83#JAI13B]E`M1;B7H#=0?F@7E- MD=P2,>_OP#Q@WIXQ;S0LJ645,*^^DELBYGW9`O-:G\C+$W;L/(FG[(0^#Z*Y MS.,M,GIQ)-@QG\0)7V3VV*7[7?,FM[I05JOV5]J<^Q^6=;IV!5UTX83F!3"1 M^JBIG0HX!AP_*^57.&`+@`Q`UIM.`&1MA!"`O!J0S4$?@%Q[0-8+:-#D==,F MKV,A>+I5)2V:T"'G`,+I3#B(*C@.A*L%X2"JX#BM[>2&I0/1VK7=;;EZ1L?H M*XL_Z+*5S0LO(-Y;1_4"N&P87-J=`6J\]46 M>J$`JE/1\[5T9+(Z(ZND8U!H*Z9S^+&>EJ%&!-1+60#=5J/;T%'6:Q_H5A_A M!+H!W=J`;AH4F@+=6BZ8U92/OTE'6M%J7[6Y>W*N>UE+; M<;?1T.%T[#Y&2&HO$4`.((=VR&'U87-`(I!K4T++DSB9Q8F;TGFI!ZZG>H./T2AI3@-Y3,#ZUHY-> M:@R(#$1^=IW9Z]AV2?$#(#(063LZ`9&U$4(@\BN(;-J88%!_1-8+:="?==W^ MK"?N+)#1CK/O,Q[Y03I/MJM]13\YY`U`.)T)!U$%QX%PM2`<1!4FQ=]K%Y$0;$?.NH6X"53<-*=4<:=-E'8"6P$E@)K%1_H+OGM61M32&"J:Z*/,@%]HH;UM.HT(J!>4-]2;%(W#@G8I(]H M`9N`30W`)MA-$"WM/+R&.7*O]/XI!9K>*8*N'T(I"RB]1QI=N*5Y`:=ZFDIM MA^UVPTYE#>$!.X`=P`Y@)[NNI,(PH$Y;I0G9M;=[WNQ8#;:!#"JJ[M4^S%)= MV>^[G%J'$Q/]44F6YB8$TX5W6A2BJZ=QJA$!]=*ST`70!0IT04G-,*$+M(8R MZ`+H`N@"Z((GNJ`'7=!&7:`7E.V8NJ]SD"A[^Z)[T"F?)=P+W#2(HSR;/XV) M!O_-_K%-B/N]A@ M@!O`#=UP8Z!L,"QPHQWR@,1M#5K\-*@[64F3JS>@F2[\U:)`33U-)8T(J)?. M`+2MA#9U?1`8 M<`PXUA&.[>I:>NK""]H"[^']BM^^#*9QJU&LCGW&4S#\<_["RP,IBVTR.6"5-? MHI0G@E]/.5V;\%L>S8F[W(2S*$[9U*5/`S?L[BR58/=:L/MQX]G="^<^,=2+ MQ]S*VNL9C+X4KHH=;W,_%D3,+02D63QAZ0UGKO?G/!"!_->1+X]4W=$=^)$? MWV5?.2%Q/9\+N8I,]S@]<_A),)]/>))P_T&LV94;NI''Z99NRNY<01]XTISR M61K3ZTG(O92Y;.(&";MU0[IBRETQ3W@&#O3]E\MA$C_B*ZE?$O!#O++80#Q!)6F_S)+X-O#S M+_P6$VB.Z`="$RRHHWMJ]U6U_^_N4@SS"4*^GS!A_+90]JZ(`S2>\*Y MA/'I+(SO.7W$DVD0Y;O@Q2(M('N^&;=+3AGY"2,*%MH=VY)Z>6]0S3[K*U-DWPY0^LW!H' M*J0E*N2T+2I$D)=0(+^%C"0.RA1_"J^Y5+H M"4@[ZI%TH/9I7WE,20&"U2#7;/$2/NF;].""L,V[R0Z'^&0XA_$L@V+"K.O$ MG7XJTB\#5WI\NL?BXUP[+>SS>#(1V7WB*V*V#)Y%49H[#)(FG.4J304G7!M$\ M"UQ(/)+&*4G^_`&4I9Y:!=2DI"X?D9K\@U"^H)]QTS0)KN:YF$JK.!]X2*OS ME_<3\22](TNUP^B+S'WF-82<0#Z1+M=W:_H[JS0E+L#9+X=IF++8$&H M+#:4[P0]Q7(C2"<2Z8I^AMP+=C9/XAFG9_(E&DLJD%OB7B=\$3(BK%;TM(J9 M[VT[2'ZT@2VT4J%KZEPNGMB?9[Q*._?4V\R(XB;)?:9J>2.64:\-55E$A)5!0J<\#ZXHQ9'*Q.EQ=2)(DM) M<<1,AOC=6\+.+"U4S"D]S^J\R$FOH..2>'3]*S0+8WEDC?P*\N&NTO72"6LF M>TK*]IB]4BQR:49?7'YY0AQR+>,DXO>B\%\VX7RU;,ZCQZTCL/(#3[(OB73T MF&YSR9DF01>Y;S8ASY;^YV?0)B1Q0_=.S(-4KH2P(Y1>SK4K'6YV?-IEY[3& MB4P)D?V&%G"OMV3'$Q%AQ$:=]GAPQ[VC$_9 M]Y;OS4\_=-C=3>`M()8,$S>Z)T)+XBW3G'X.S?(;@L2*=J^0ENL99A_&2TN, ME[^WQ7A1%BMSU&)!!E0KHI4+R7T"X:0">3#+@BC9.0U25![GOGB\*HN=9-$T M;R'Y,D6?P0$!<88R+A-3@E+&"0M2LB[N(IZ(FV"V](1>*#LM8T];!=V>1=L` MY.+IV MW=G';]X-V2LA_SKYEI?27/"9C)U$UU\BLF>F&0`Q]\?/?_OK M7WY:<0\9ICZ64>J30I#Z0H;H"&>Y_RVE:_\=!:D8WY',CPD>;LDNO)1K7-Z; MR<0YO;G@D\\'YZ?20_R7_?OEZ0$+?/H'8SQL6./A\># MX7AL#AU[>-H_/?CYVI;C%$L692LGC$*`2+1Z*,ERQ-5)+M2^0]Y`.2)7GIQI)^(8N@@.[A++R+&HTPAR%`2(7`8DGA_?%,R*JN?#+&LHPVPMGP\&UH<-]?#B0G.X[85UN6Y0R0]N9JR@ M=OR%!.S:IK($6JZ@7T&L/2Z#/@5*[-`,)7MWE\/:51SZ"^4D]=\C53-+X_'M M8?!VH[Q]K3J]B>>"U)[8W>*%F+P0$PMB\ISA_C?[!_>UE(8Q;9-[S1\W_9?$ MI17JN-13\LT>UWGN!@6C^#\RG[R%PZ9T&$?M>Y\>+PJ_W91]]=+XB=NAKF]E M:?V:]]FZR.ST^B]=,DP_U8!'&J9JE9LBVG,;IBP7KW.LKJUNO(_N>[\KTNS8 MS[SV*CTSY]ZQ/4O&%VTDQ^HKZ_:JR_:6K8BA;QL\Q]*TG:YA0R3@':Y%V-.' MVDUUZJ29ON"A::F;Y/,>A1[YI$;MCY6%7C42O?HJKN9,T!KVNJ:ZCO[PC9KM M&YW'R80'\B1'3%24D<]0H6HK(=&ACX:S+*-J0K5;T4&?[3<5OU^U-E*IUMZA MCBZB`S^N_"S?RN.%*GK9KSN%HYD.H-E1Z0%N34-=&*[L(*5&[6,XP/2FZ4-8N1/152-G/OXWF*C@4M$;BFCR#\C6?=H/B#NS19 M9BOSBG-9N9V_"K*>MEPL!^\MKRF4KR_$0UEE^L!A#Y5T:@1965OP?D_UTK)^ MP$+V+Q22L,$M#^]+;@^AHK7#1FTCLCN.9X]SVBXDF^_8.>+4=DY.#>O<&IN. M-1P[)V?6,.\<,3P>]@?C!G>.^#:^0%<(-%[8M?&":>W8><':NH&"79<."MM> MMW5/BJJOZ]=EH=50%+TL:GB`1O,B_4Q=HV5%&Z4!+2OJV;)"Q[6=?>>)%XA" MGXI_DL.V=F<*B.UN]-F#J*Z?FH#8:BNV%WSJ!A'MLI:K.Z'_)JZ7SMWP460N M>3+5\WS=H;AOR:-UT7 M6JXNGC!?AO,V0#D4(Z#EF/*JH(ZCKJ%)XX_=HHB@))\+-0([L54MD,;IVN5W MM-!E[X$TFB(-"`?"[=&YKI"(VA.N[45,:*M8K'8V+&7U@;IL<-E&`)"WR8T5 M+;L[M"`2$(E].]J@3ZOHL[8Q"YMU'9M5([^IW(K\_-`*VKJ^T]:U8_>=RFC4 M[GYW&HF>7BC6VL:N3OFBIXL4(0*MJ8D)PH%PB$!K0;BV1Z"7S:L[R];5LHTU M_SX+$G2Q7M.@'Y34UPY=K!&BT;$(;[]1<O`/.[V!LMF&Z%J-`$\E]@EZ\%>.;G4`,V>( M%OP`LP:`6 M`-`T$&B4V4EE^,?JSOJ"MZ#$H,2>.K6]ZD+)NG!"];ZK1H&Y"FK'LH$:>W=B MFYG)MCO#WLNY+@A#(?G3`E-">W9$1'VS4-V@:ZHKY`.8`!5*%XHWL)UO;)JW=JH=C<>ZK[YK-?-Y[%N/N[UZTR^%%N/=^WU MC-Z)Y0R,L[,3TS@Y'9T/!_EX5V=X:TG13'GM88EYIO7*U8[YU7J[74U6*4K6QACCSN.:;1ME-EZU!ACK&4=QEIB M&JU&<3D=6D_L1VR7A-595C`"5MUJ,0(6Y@%&P.;WP0C8+3$$(V`U2HAB!*R6 M2;VANF*4IJ?L^!-)HB#0@'PJ'[OA:$ M:WLOC['WYSP0@U^I!(B`1^_;!09]6T6=M.Q?F[#KFK$8N%4;#[MW,/1P9ZKH< M8#"L+FYX;3&^/8-A':L[+%_T=)$BA*8U-3!!.!`.H6DM"-?VT#0&P^YNSF,L M+,;"ZFJZ-VTL[-#JVNJ.^6$J+"1J3^JK3?0#?>I6DJ$7_1!PQU38_9Q',:W1 M_FFH"[A8T@ANA6J%: M"]<-2HI(ME&OMCTA]S#W==\>?=T==[,ZF=2%=9`F:*"MH`MS83K>*TXU9DD# M:)H`-%I[PCUE87CP%I08E-A3]Q4:#!->U9:`8<)KB44L`\QW11JGE7:$]NR( MP/EF[K/==92UMP"8`+4:<3E;/K62O+7%5B".?:FD;Z_#\4V8K:Z0?/>(F#/?> MP-$G(&K*>;$[\:"*'H\RCK33(Y8I9!=\EG#!HU0L!]U>)VXD#S/,9W&4C8I] M;'HII][2]X_GISTQN?'3L\<'SO'BT'+P[%S.AHV:]#R)?'5Q`T2=BNGD[`[8A0NTF": M=5E=\)U/;R1#90S)B*/DY&46NBE)%S^ZDCO"KH(HG@9NN.#>[';95K!I[/.0 M[N/*2XDX\H[Y>&-YG[O%X*HC-Y]719RZW#I,/RYC^O%@Q^''_:T'TE8^! M_0Y$M@?(`$Y&%U_3,P,X<0(LL-.STYVS!_O(2'1,K"QY1*G3.9_^D+*=V!W; M\86T*>G?+QTGDDP5ZU=%%HM%T^KFNU`WJ-N1U,V]]/VMU:WNV\UNOTU8H")E M7Y.(9CSBV7-Y1\2&]:IWJ<]KPEK9)A\H#Y3'4N7QW!V4![/']UR=_#XNE3@D MSYQ%=IY58K,VNI>=+H;SI[9Q%@G.].S10;`"ZG8\=6N;]+45=:D1'VH+PU9- MHSJ7;?+,:"K**Z!RV:KJ*5`7"@0%VE]"W4MG-P7"''+=<3FOB8:AO.BKI4== MVJR,'SRMF_[L$5NY;)Q%@C.L;V[OLG>\\U:A;]8+SK2^>9=.=P]/NWYKT:J? M-V]7V']_P=JM"TF:W;-T/&`/V2Z;$7RGU>SV/;B[Z76NKV>;$>ZZ M@YN[RFQ&F'Y4EU_Q3&I7,'U2(;@+J61C.6)XR-[HQ3XJMK:RBNH/P8L"HLD0 MFP],;#[H'KCYH-T[=DK_WKL=RG+?<5ZP)'L=UL]^M.>TGO_&HZC8Z)<,2:AX M2L4NFQQ?7J0<9V)A%T1YAZ90-3V[(!`86J.5_TRHM(-RV%V,X4TH)D[M+N5D MTSK!0>/V$=R!*[UNZ0W<(!FK;?7!*0>3`M=I&:KI_E8VMB@.9I(6>:ZJ\61BC%@3KO9:M,?X$87I3Q$)JD=A>K?1 M-#4^J&-M>A@S&#,8L],%Q/5%%VIORC3GPJ]*6%^7W:Y2Y$=))#M`W!:G$.Q< M=-]I=7SOIMES!_UKYZ;5RRXOS'X9$J*T(,XF^S%\Z'^=G/#RQ5!7*GY711YU\(ZGJGG]@KKKO'3F5 M^^BY\7@_K?=U2]+.JO=?6=IIMY[5><>'GOS2EYVG9GTYA7L/N449&GSV0Z`]I2A'6.#:R6 MH[9J$)9899MTM"CLM#":/[=TUI&-DES0.-RIXRU#QEY3C=H5;Q2N/T[R>.NL M;%2O6*.7US2B<<#6UA5K$,]QM25M:4V!\EXKSKS)O*AJE8= MQY:>-CV"A\,'%^`"7-2*"[?A];2E&(`($%%Z(N`IP(5%(1-KIO3@`ES`7X"+ M';A`AOFZ@F%4C(C\+B[9#-^I]X7SZDJV!EE5RPV-@\9!XVP6G#7"@L9!XZ!Q M6N9#T#AH'&SN2"4NGQ:R-U+)`[*.@<=`X:!PTSA[!(2<#&@<;9[_@ M:I^341R`2-9!+16#1(S+8^#@"1H7I&AA`QK3$7 M+6W5N8$#<"@]#G`3X`)<@`MP@42,;<3A-5I^!T2`"'B*V7VNML,RJH(#,B]V MC&*9X$BK2*LV%%LK'%LTQ;1'L@BX\KJJZB#6ZX(LD`6RX+R`&!`#8D`,B%D@ M.&NB?D`,B,&+`3'+$*O[25!+.[E&+`H)CTF6YB)#(AQ6CT@"D2!*!`% MHD`4B`)1(`I$RX2HI5B>,DQZWFHTN]JV2AXLPWJ?(0)VX5YW8;>IKVH2R-4< M(ZY6*/B:1C0.&*$9^<(F&1L_L/058]]I$,]Q?5W*>$2/JEU2'W0+H0RC"-_7 MUO>V]*/I<3I<.FQ`I6R`UW#:VO:KV]*3L`*P`K`".[RTZS;\I@B?(&!%8&`X25+>@/ M]`?Z`_VQ4S[0'^C/4288T!_H#^S/;O(QE?3AEG_"-JW2=_[!NW2[9,)2(M3I MMKODW"$T@M`(HH]V#`Z`&!`#8D!LRWH@GGLTU:IV5C'(`WEP;G!NEB*&!!$@ M9INF5`PQ>#$@9B026;$$D<6S;KD0.0O)4/;S/J0ATKT[8+#4T!_H#_0'^@/] ML50^T!]-,PWH#_0']@>9(GID^47EA5P\4,&4"HTG+!8TXW(N1^.0))F\D4PB M&HL&B5F&P`D")XA-6F'1ZHF8OH*2(`MD@2PX+R`&Q(`8$*L@8C5,#W$;3=]\ M\B/@`EPU]%_:ZI97'JRZIX.L"RJ:X*MT&!D8!MK2[Z8=$OQ.A;EP76TC-_`` M'DK/`_P$N``7X`)<6)U&9$WL"UR`"_@+<&$T3F512/AH^YE&+`H)CTF6YB)# M(AP6.K$64U+?!<2`&!`#8D`,B`$Q(`;$ZH58#3/B_#;(LE%!*D86G!<0,Q)P MK%9<\3.;Y&DPHH*19*A2XUZBC$982]*0I7/)N)-O1"01#\G?G>(?D-M"1K9H MCFGG!A\&KL`5N`)7X`I<@2MP!:YJRM5I63IEL/#<;[0ZS6.+JMYGB`"X&CNR M\Z;C`#>=N"&E<8T$KVE$XX`1FI$O;)*Q\0-+7VGUG0;Q'%>;[=]'=M9'OS]H M0_4]E2O#8,'W41#@:`I1X]$![$R][8S7<'M=6!I8&E@:6!JS%2BDJ7%:,#4P M-3`U,#4H9`TS4VDS4\V$YW.WZ30Z'7UA51R!#OK@Y.'D]S!%W4;;,5^.N!Z& MJ.ZIXY]81G@<)&.V@T*AJDL-J[H@XP!<@`MP`2X6[FOWM`5VP0-X*#T/\!/@ MPJ+(AC5S=G`!+N`OP,4.7"#E>%T552I&1'X7EVR&XFH?CMX[S/Z8DBR#`;)& M6*6UW-`X:!PTSF;!62,L:!PT#AJG93X$C8/&P<:=3'`')E>XY9^J3DOQG7_P M+IL.F;"4"'6&[2YI<#&@<;)S]@JM]3L87E8%Q\4`%4RHTGK!8T(S+62R-0Y)D\D8R MB6@L&B1F&2)#B`PA8HJ(Z>;C5!=@9@J2@LVNKWV:+V M1N#J5T&4Z92-,H?[^H'?^9<BUN9CB\9DZ1::<"<)*!Q*2XK!PA86K%<.W=A,\ M@`?P`#\!+L`%N``72(4#%^`"_@)(?D-M"1K9HCFGG M!A\&KL`5N`)7X`I<@2MP!:YJRM5I6:I8!B&X`E?P5^`*&8J:!7M-(QH'C-", M?&&3C(T?6/J*I>\TB.>X^A9_EM3-E^H6)OE#Q`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`6X`!=&QU@631J/.?@*\C1E\C'/4M!% M(M(D,3@4JTZ%Z%;7^&3(%I5!N*8$SJM"9&E;]0-9(`MDO=[7U;>[LNID(4:W M/$R_Q/Z7#0MFL.-("&TM/@:4M\KPH.B,VM M$>S@9<_@"49=U9GFX/`V1!*L]%U`#(@!,2`&Q*P9659S`#D?/TZK5XQ9/"^` MH8H@J.W-(J-9GA4_1GS,Y2=CP\JJG?=Q[NI;G]I2-M6N_8/H"&A;3YNA$ER` M#;`!MC>P&3KCI:ZT(=*YYP%79M00I3YUBZ\2E0-:.`T&42X;1AXP93!E]A1! M@2F#*8,I@RFK0+64VILRK?75=RV4OJ;>^K]IE!?K#OTX_".7@AL^2UWL!T%1 M('S`11`E(D]W*KC>:S<[W5[O^J;?O'&O;SN#_JT[+;C>Z?5;=^WJ%5R?UU-? M*"?.8_)&+_9Y_,JBK?L\J*&M/6_K(NSSH&(M3%>3WH;,]FI2RB()0_Q8%,2( MI"M7\1%!AJJ4O#16V3"/")VQ4;0_H&)$0DE)\:L&>1KQ8$1HJJK%9YE4`_I( M>2PRDJ4T9$H_&/^JN)37JJLF:?*5AU-U437FAXGZUJ(%ZJJKC:9E$P);8+/D MWVM54-X_M*!\Z]CER(]=_[Q9ECKMI2DH;_<+HA`]"M$?KV1S?^Y:7V>UTL5N MZ^N.VM3!S.U;V;CY,%W7%*TB0!L*F""@!*-6#:-V(VP1] MNT\RNMFU(X_D\#R2!O$ M7J?L(\%^.#_:/AC1]%&=%Y_(YHA9'H`ZC#X6#)7XM'IO6SK?M)/&I,E>25DW M:JFNW6AJVW%F#0J5,QS`X7@XP(\>/`K=(C]EW;H`V-9 M)6.)^"XL`"Q`G2U`"RN>!\^OZK+$<$,I.H$2LQO#[%%74S[8HLBE&6=T%@D M0NO&.36T31H77V"<0!;(>B4+;M_<^+MBPVQ;,JE*!]FY:ZA4;%W/+;$O&E:Z M_">X^SH;)+\+@U1M@P3:[*&M=;04I'K0AG)3AZ0@:5/&?61G_2P1=0`6[]-X MTIWM'5^CP!M6!:HWO(*EKK>EUE=%TOJ.KY&EAIDYN;;!S"RM%\',F)NE5FR] MZ(1I6:6+$?G:-@;9TONFO32F3?9*RKIA2W4-1U/;@J@GR$P^ST573V4;[EKM]^XMWGJ/OHA,1C]G%B!5VV/6<'[[O MW"7CY+;5>QX4V>D?'E-448B#7M%H:ET0)'F<"?(DK\A83)+A\%(;!#__E(N+ M1THG5U^"$0OSB/T^_#>-GB`%'BLA?F;# M7\[N!BI$\D?S/_>#,$#^0L:9!=-O]6^[;8Z[4&WTW+N>DWOMM/N]/MNI^NU M_6;_[-?O>FD3DNLZZ-U.YK$<'V17OC=G7E,OWX\8>9K)B]"IP*10QN,D)J(0 M&,F%_!./238J_C+),SI=T4Z&Y($*'A1+VR&/$:2"WFY^%$:I[1XY+.\0Q`FWR]<';F2[9,/H4+>$ MV(;5UO_%X/16QLFW,-Y%6WXY:_D_[.@W9C>ZS7UO//9]:.@!WAQSK#?(G:)* MP3NRW#S6#J019.F")+K["5#=5GR:>A[YOE$X?8[.-0JH&E1MLZJ=M$P!5*U. MJK;UXAD*CZR;CZZ\GKZE/H`),`&F%C!;#;<%CZE[R:R6N9L# M%3OG7]DL7L[^S/E7&C&U^#),D_'TUQL7?F:=XCBG"J] MNYJ`NKU.HP-``2@`M1707L/M'6_W:>4!W7F'PJ:D[1V2K9?3M=GC6`Y'/[-) M(GLI?ER1WKU%))#.AD0'-Z,;>WCJ?W-&<3[Z7;IZLM;?#(0N*R/OO098LY9V[TX-L&D6. M^DTREJ@_O\R3.A_E!"I]I#'_OR(7GD;RF],\R*3ZDB0=TP50UR1ZP'YC87*[)'S>7L]Y^/L=R^_<3_^6#Q= M7OY//F3D2\!9'$@<%F]:^LOBK9?D?K89(!%%_66U%T`):O[5L_;(261(XB13 MU9EC.3$M5C/4RX^X?/FTN'3Q*5)R5,I.Y%$V?2)_$:5ZW/1KE]L[_R9I*P17 M=9]G+1DFJ12N>K\!IX]Q(J0K$/-7ON:)^.X!XI)J\T+1#9EO4*$+.!B M6M+O0CT1>3W3.380FT0**IR""&[J6BH6N$9TY#)+YY0 MU<_1\\M>B+GXU.TK7U.V\E\I3](+^7">J&T9Q5<4WSF1#5&I;&'Q."56]7BE MW),\E2*63QE)`3\P%LLV?^5BJITI&T82@N+[8VD+I89=S(6Z3L8ZL@ M^TZ?+DFA`:NN?&-@]K$'\MVU/&<3HH4"S`CGPKFU]7O>[+3+_W][7-K>-(UM_OK?J_@=4=J8>ITI.1+W;WMDJ MQTYVLC63G9MDMNI^A$G(X@Y%<@@RCO?7/PV0DBA;MB49E$'RS(>))?$%:/0Y MW6@T&I5L4+K+*GE_5&_951)QCX26\%NE1_/B2I*.ZN-*I(M-3%SM=1`LT71$ M-\R(7=*9J\>$:%KM7,I99C6"A?28DH-<;(2ZVR2Z.,@4J&_IONMB(&)"6BB$ M%PBYA+@?_ENX"\KT0Z(Z/US5!F5>DEVO;[E*B0#3'(U3&E).UD3(L\5S.^MO M]$-2K&\BC#(R,)QN)\.3OSN7C'ZQ)P)BA>26'>6M5HPG^52DM\L;R5J9BK&T(Y5;+)&T#W_J%E MEA*%Q43K2_VF7[+D>LF@`:W*['F[::A68EW>7&-<#E[^5.$M9)"_6(E\ MKK\NCQA=(N;;?"#4Y5=^F&\&5.,N8Y_8*J)WD>!2 M/UB90J]D@E4H.LXMH8Y/$P3FNN^YUGN94J2UIWEW#'@A\+/-#U#*'M.KU1OF M4>@K/Z.06TDC%V*IB`5-.ZH/^SU++ER2_()IE*ZJ66I0\$T!OE"J&5=!)DNY MDGZY-!T*26MIE&]$$*A_5ZC))4]4=%U2-Z4='E$,D>."B9?$2AJOWYMIC`OR M8.G1*[8])H\HO^HJ=RHI.'HA`Q[(:"4(Y08IWR._ MGL9-ZW8:T7P]MP=D+/W`)R(0N9S2S-/&0^_+["Q4+'=,0]WWU8_4XVNN[4CA MU6%%FJO.ZZ:YFH3_X!I63?,"^+?/-X+0T,$):X3+;_%:*B! M7XQC:>#/-I#[51!%7EDYUENR8),5&14WD&.>+>&49N0@TU?DO[R91[I)*FD8HI/E3O^1Q:\*3 MF7256;A28WR[:DW@$_%X11:5>YM&071]N]8B5P^`XD&M9$RZ"?G*U&XB-Q[[ M91I3#KTV8[I-5W[^,*+=J."L0G):_'&PY'-^INQE1"KJJF$]YFKVJ7]5^D64 MFVB#G9,5#V[_H^TAT5A$-C$WJM2SR%MP]!]^`?ABLJ&$K)^D[Z9Q.;N'675U MH%2KF`$M\5(>,,5CWQ?C'"IFT_:R,()$X71G[C:H.:VR.OED@WY5SZ>+H[FB ME=6SET",0E=+B\SC?)Z%ZN]\MOKSQW^]+I%4P`M;71+[VQ*A%_VZ)RR->B6" M7"-%+O?<9HJM6KPYI63U@;C3_9&I M^161NIG&TB`N`:/G.;>+"`F-HE@4S%A&>TR`I!'E,$[Z;_KC7M\Y&4TF3O?$ M&9DKCN$,GUD=8S`Y=`V([H%?.*I)<8R3`[^O-D5##JTPPR86&WEXV=?XIO*C M7_T@6-1A\A2Q)7*7DF3+CO2Q8;]994@J4<**+9&W#<%9;',!56@H`JKMT+AG M%@5RZNP-Z_L6*?LO..NR113&#N>IT[ZW46=X=A80-*6D00Y[K4"8@4;@"W!EA:S9;]KK,R8+2/9/+:T MBP6J6J:J_\Q\?5_\'A&T)\](J:R0RZ&9I]^9],P5X6UZ998:!0OKZ=E9)$"[ MR+ZU[&2P1#C8R1IP@9W`3@U@I_%@`G8"N&R;YS5L.O_6+\K=)/B!X$/S6(IMT M!H.*#GH!O]O"7_6,.H#GP?/@>6,\WQT:V[$,G@=_51&_L2@4=M#MI(M:=?]< M5IK[J&O5[1.&QB88+'Q`<#8+#E"%QD%PM1`(Y!+F[)N8]$^,A=#V%9HM:E4UH2'&",&]X%ZO]G#: MR-A$%)Q6'VA6.+5];VQJ:Y&\0&7V4]E)=PPJ:Q^5V07-UB\!YYM>369$/L5P MM2.J7J<_,K;_WI9Q;UZ$"[MNZDC`#6<.9VAL-S>8`\P!YF@/RR^PW=>Y&B6,-#'T6F&H M^N\5)*M:)#F[C`E8;R/KC..^%.>]D7%')*G!>?9%; M(>=]W(/S6K^0ER_8L0])-&<7]+L?9FH=KUC1BT+)WHEIE(AB98]]Y=\M+W)K MBV2M*G]E3=[_N*KLV@URL443FA?`Q-)'3?U4T#'H^,Y6?H,';(&00PVGABKM0]VJP\XP6Y@MS:PFP4;3<%N+0=GZY>.UTO" M[I\_V;RB;#2[G!@K6FW+<#"L9#CYT'`?MG2E>SHW^@'NSS)D>=B;ES8!&]J4_T MIIX^DT4"M,MT@-TVQZ9/3G!<&=@-[`9V:R*[C4^0-=5"=K,+G%AYTRMO.Z^X M[0!'E)YJ0>FIWJ@SZ55T3`%J3\'YM$Y.=IDQ,#(8^^BG:\_QZ+T//3+-EO[ROJ MR6'=`(*S67"`*C0.@JN%X`!5:)S5WG+#%OQ0I;7EA;2<@:ENVS*.S8LP(.9; M1]L"KFP:5YI+:;!E',&5X$IP);C2?$+O$'XE.,"*E:OZ3]*K+\_:F(T$CKDB M^M@F8$_4L)Y>G44"M(OJ6\I-YHY#`C?9`RUP$[BI`=P$OPG0LFZ&U[")W`.U M?RJAIB/H8P%E)X2C2W:TKR`4SU=I;;3=KMIYV`%X4$[H!W0#FA'WU?1 MQC"P3EO1A-6UQVO>/',WV`X8-+2[U_HPR^&V_3ZIJ77(F!B>5.1I[B(P6W2G M12&Z>CJG%@G0+CL+6P!;8,`65%0,$[;`:BJ#+8`M@"V`+5BS!3W8@C;:`KNH M[)E+]W4.$NF/]ZH'78HX$:[/4S\*\]7\>40R^(_^8I\0]U,%#RJ0I_5:AZ`N MY'.H@B+`%_0'\@&^H#\V>Y5M692TH"Z/]9-!L"X$T+-)1>7&CVNW] MZ`V-90+;,LA5TPO@>9V:)?+0K4U--5LDB`=MD,4-M&:C-7=Q'45AMD@MI`;;'%>GJC;3=MH&/0\=U:$:/#U8JP11-`QZ!CT#'HV$8Z'ARNI*'WI[U)/`C\4Q[.\DHW3Z_[X$EW1;6:N"()B5'YZU7VE/],0 MN(O/&][]U9\+R3Z)&_8YFO/PC#W4^$UQGAO?2V>G@^XV0[^NC-M?O'.H:1U<4J:>ICF(I$BNNYH'L3\4V$&6D73P0+ MHY3-.?WJ\^#-LU$)=:^%NK]KO+J[0>:10MWKYE[>7J_+Z*)@4^QXG^RIE*H;>H(X]J(;? MF(HD$=X"UNR*!SQT!3V2I^R&2_K!5>Z4Q]*(_IX&PDT99U/N)^P;#^B.N>`R M2X0F![K^?G.8:@[8H27L<-$6=N`A0=%-2/N%4GI#9#$9&&<+FE<^1IL?ICR\]M6?7$J1RAS7BC#HP>KR%:^P M-.&AY&Z^;";9#2%3_>N5E],>>NO4_T[/?.`=I0>_8>>DKNHO'C#/EVX0*?)1 M-'7-$T\_UQF\85L-FA3+%VP(@::#BL6OHF]"@9Z(M&.>24=F>_M`-Y4$B%;]W+)%2_JD*ZGC MDKC-G>GD$(\3:=2/R>Z(F73 M]"S+1BZX74G0C/P,.QBD+>6I1]Y=;\T9N&-NB-"?^^K\H[K\5!U$YKMY8[X0 MDRMKHN3)/1HO7U([M&DK'`\C?88A:HDA>M\60V2*FTW'.@H.C1-_SA.Z6E%O M%NB)PS2)YCE+DT-)]_IAI@,7BH^4<7[@(;7.6SY/1M/TACS5#J,+&;\S:P@$D7RBIER9BHO<>5YY MNK/!4CZ?(//A<`Q[!H6@=&PH'PGJQ7(@R":2Z,KS##46['V61+&@/GF*C944 M:%K"KQ-1A(R(JPWUUK#R/>X'J9]V\(4V&G1+)Y=%C[U,ZRJ-W/IL4PN%)\FM M-K6Y@N>HRQT;K1X$IBNA+IB)P-,S4$O)PL4<8IMX:;O*+2 MDD#)I-X-K!N:<)STC:^7*`M_'?KEQ=726E$T.>DN&(F0KQ\V_$G7I9J+RF='=5Y]Z:]`8Y+H5']S\@LR!2 M*6LTKZ`YW%6ZW7+"EHL]%:WV.+U*/'+E1G_^^G%-.#2UC))0W,K2MVPJQ&9L M9N%JZ(BL/-]5ZDN0#E?+;9PFTP1TF<_-IC2SI>\\36U2"3?@-S+S4]42XHY` MS7*NN9IPLW>7;]@':N-4+0G1[%<-3B:E9I-$91HHQ="B'SX4X^3A?:WAKJLF M&>K=ZD7F5EM/#`,CEU^#D3NF?L MK(P][15TNQ-M`\FU@^0^MH7DE-J;06M_4,V20-6^YKJ?67:!KFZU(UJ:-1E; MS*K&B;\K*LX"\G7SI7]RV](T$,6LL@A!*\KVR+\C\<590D_1"TM+P;D!/9$M M8M3TH]PB22Z@OP*5NJ\R^S?/CN`LMH5'_]$6'LVS8,/RE"Q/OED%@XLUV6>K M_F-]+>_"TT5S=.<)Y-2>?#P-]3[_6%Y?TM_<.Y_][T(MA\?D3](\E'RK^=.E M;K;MW^A.]_H]<]W3]^D%?!4>2'PA5VYQV4008[(@4M/M8I?#\;4@[S@/546Q MR&.YDJ\M_RP@I$?OLN]'KLV(Q_(S]G>Y4\_)SZ7-V5'CR"S7]!X]Y47E(_?P; M4>74=U_GZQ.Z0NXB%N!+/2%(?+5:0:[S+ZI/['Q.TG)YAUWPD'OTK[KO_:_G M]UY4"&D>A3>"!V2+Z!$?:9QBH0>KZ$V'_>I['A'Y>U[8Z?.I>O[KQU%BC89\ M7NQ8HV'(0CXE7R(WORZ9SVB^,(#YDD\6%U$<&65)GDZ2QW2*I`^:42G:>,-^ M44')P/^VS.-8CDDN7;7NI&XC]4IO.RP.>)'LH"9H^AF=NZ^-9[=21X64LNJ8 M^=X"?DA^I7O6K$CWSB"HS^6'AHH4@G7FZI8-CS%3?Z?EN3%WNM2G8ELW&9:` MQU*<+OZX9SLV>PH=^(3I8RP[N MYI8VJVC+9M?FZ-=\"J:F"]G MK<$"-6.!?F=@[LA'6T82+``6``OLQ`+]X=9AJ[:P`$Y>?DBR>1[*/A/5)X_L M:\R1?+W.H&]LT0&G[B$*!'"5P=6?&+-7`!?`!7"5P>5,S)TGVW1PM3Z:7$Y& MK@)8M<./TQD.C&4VV3+*"*G88VIJB(A!'T%&(`*(6"&B/S`6'6@*(A!P>TBR M>MM6);.6)S(TFS.K<3H]@_&X?<5FBT(AI%`#J]8J<#I=@!/@!#AM!*]@HK%%&1!U`M.`:0[*-)/.8#`"T8!H0#0@ MFFJ)ICNL*$398*+!+OIM=]'KHF._Z*)CY[KHV#YQ$6PUQ>;FPT;BH''0.&B< MM8)K?0(DMM-C"UUZY@P[P^U+/[4EI0=1`-!`JVB@WW%ZQH*%MHPD6``L`!;8 MB05Z0P!$E<93PM)HU MUPI.O7S9I==^1?NL[\O&%@5!0,(B&]4X/`T.5NL(>`*>FH^G(?!TB"I$F''9 MM)??^EG*X3;Y/ZF8=<@9[G4[X_'AMO];KSZ('X'-+%)'L-E.XAIU^N;.%069 M@L;K]_P]U_?9O+XFO/X](NXGHLP_2SB MB&0<7E_ZT@TBF27B*W7\71"Y?_SM?_[[O_ZZO'[FQS%==QYZ/_/0"^C/BTBF MO]'DWKU=WD(R#97@/HOI3Z\^7/:ZSO!_!__W]?(5\SWZ@KOI\7@PZ(_ZYQD_^IO=P:B+-2O_EQ(]DG)97T6D%I)D)$:V MD"53PGR\]L5C?2IS@>I2N8_]GKD^WN_`;-$!5W6`\40P/W2#S!,>_<'N]>C9 M0LV;(()@T0+NS?W0EVG"4_^;8.)[+$)Y?UUJGYZ^>1R0]T&U%4C6<972-S-2 M#I'(]W]F?GK[*4K%!C1N`:WWEY,/EY/>N\N3]_WW@Y/N^^Y%-X?6^/)\V#VI M'%HFD;0!-Z1: M,OE`)X7N)+L1A"\NV30*R$&4IWOW>HO17?/;NG?=]?+&]](9_4E]*OP",NL!CZ4X7?QQ=M>4 MKQI5CMRNPO_]C<'X+8*_NC$_O>KW?GS2TUCW=XH;G3WO.SGP^PY]7]/[-ZE) M.YL^?G5II]UZ5I,#.AZ>X$WV,_.39P59RK43EYUXB97H#5)]7'HN.00B,2._ MS:[?132?1^&VSLY!FZ;]]]6`LX]29L*SLJD\7;7S-YZL/OR+!]DNB7Q;JZ9Z&"%I8:N/<\ M"4E>NY00!A:`A7W5[5),19)8B@5RF54C7_T@()#J\+^G0M:)?+V/1EK"RC;IJ%XR*GGS1Y;. M.M)9E$D>>CL-O&60L9>JGSR,I'W`.)]'&T827162JF*+L;&C4^JM M,^H^)`I;F"@,^@)]/5+B]Z17??WL6F@-"`P$9HDJ@L"V)[!N9]"OOH!2+=0& M#`8<05P6#;,UCU1RS40F7`7I:REU'!U0.31TY_V!F;.PGO21&N].B%9&@< MSL:65(!;>!WP.HPSW+@S-G<\#?CM8=D]LV9M[1?K/HE4;4V.YI74K*TXG\<\ M\):[2WO&B-Z6D:[:@X?!!RZ`"^"B5;AP.KT38RD&0`0047M$P%(`%Q:%3*R9 MT@,7P`7L!7"Q`RZ08?Y0P3`N9XS>Y1,VO2?J?>V[_>&`DJP#`5DCK-HR-S0. M&@>-LUEPU@@+&@>-@\89F0]!XZ!QX+@7$QR.!-9%&MG1#\Z;DPF+19(7LZZD ME@5B/\V)_2`F"EP`%\`%<%%.B^U/C)V7M%?NJRTH0D4DP`5F!&;DQ2(%2,4` M+EJ*"]B+%N("J1B/Q[>D*G?+?'W,!YM2;_- M@\9!X^P1''(RH''@./L%U_J<#'T`QO$5E\+3!XTO3@1B//18E-*-+`YX*#LL M%%L?!X#(4#LC0XB8MA@70V/5N0$'P*'V<("9`"Z`"^`"N$`BQC;BZ'6&_3$0 M`43`4A3W.<8.RV@*')!YL6,4JPH<&15ITURQ!X5CBZ94;9$L`EQ]355S('8R M`;*`+"`+Q@L0`\0`,4`,$+-`<-9$_0`Q0`Q6#!"S#&)M/PEJ;2?73`0>\T.6 M)IE,D0B'E5RL6V'="K@`+H`+X`*X`"Z`"^#"SJ!9K6-C?6/U[0"'UL`!9J*% MN$!>W`."_2SB+'%G7`H6355FW#*J506DKJ+$$\E",D[\G.@*QE/V1<2IF%^)9`7C M?K?#>EVG;TH9#VA1C4OJ!]-"J(,7T>\;&WM;QK%J/QTF'1S0*`[H=;HC8_O5 M;1E)L`!8`"RP0Z<=I],?]$`#H`'00)MIX`04``JH*054$*ES^I/.:&0\0-+L MH!L@4QO(P&H:H8E)I]<=@"1V(0ED;S\@P4\B97[H1G.Q@T*AP@3!N,&Z60@P)(H"8;9K2,(C!B@%BE40B&Y8@4C[K MUIR/$5ET*IT#P6H>2I3W,Y'GHL2NE&%@<\E!T6BA2!$P1.$)NT@M':"3%S M!26!+"`+R(+Q`L0`,4`,$&L@Q%J8'N)T!OWJDQ\!+H"KA?;+6-WRQ@.K[>D@ M#P45J\!7[6!4@1MHR[A7;9!@=QJ,"\N_@^0VT)&MFA.U<8--@RX`JZ`*^`* MN`*N@"O@"KAJ*:Y>%DLO&2P\ZG>&X\&A1=7N,T0`N!8;LJ-!MPNXF80;4AH? MD.`['O#0%8RG[(N(4S&_$LD*K?UNA_6ZCC'NWT=VUD>_?S`&U:=4K@[.0K^/ M@@`'4X@6>P?@F7;S3*_CG$S`-&`:,`V8IMH*%$0UW2&H!E0#J@'5H)`U:*;1 M--/,A.: MBQT4"E5=6EC5!1D'P`5P`5P`%Z7[1B?&`KO``_!0>SS`3@`7%D4VK)FS`Q?` M!>P%<+$#+I!R_%`552YGC-[E$S8]>;H/CIXZS/Z0DJP#`5DCK-HR-S0.&@>- MLUEPU@@+&@>-@\89F0]!XZ!QX+@7$]PSDRN<^D]5\U)\1S_TW@RZ+!8)D^H, MVUW2Y!#[:6'L!S%1X`*X`"Z`B[6J)A-CR1;M2&X%7%H,%Y@1X`*I&,`%<`%[ M`5P@%:/"^%9^H*TO928\-J7>[@,H1%81RT2I3[-8'GHL2NE&%@<\E!T6BA21 M(42&$#%%Q'3C?7UCU>``!\"A]G`XZIE6$V1G`"P-!8NQ^GVVJ#U,!W(R]A9' MKS/I&RM=#42T!A'-M0]'(SA3NSA35:5HU#_>=>[^F?G25R$N606TJJOWWH`X ME_6EM:LV4EC``,36'+WN!.<[`EP`%^P7(`:(`6*`&"!F@^"LB04ZP\[)$.?8 M6:DD#4-7"PU8?X1#KZN+*1X>4R^1*5<%PFH')"3%8>$*"U<;W+?1`'@`'H`' MV`G@`K@`+H`+I,(!%\`%[`5P84NN3NGE1=A6(9V'2^G#W#P<3WY-*6P?W MH=\W5Z!M;X'9HCM5.Q06T9QUG@:H#%3V/'$-.H/QX8RG]=H#,@.96:2.(+.= MQ.7T.GW'6&T-L!G8#&P&-GLI-NL9.SL/3`8F>RDF:V:R^9'3"(OQG:33L_,SR<0\#J);(9CD`4]N&0\] M=A6%F2R>Q@,6!SS4WWM^0J^+$EEZPOIE;^HA[Z\D#"4C4A,E5]4W=\;#:R'5 MEHY[?=CQ%?E'=?FIGQ+BW/REYZZ;S;.`IS1`$0U'HIN0B!F-E/]-T(#29_'< ME^M75=6%HR"2\O6SGZZ?=2,2P;ADTR@@CT*>[JTY#RE&Z9XU0]^]HUWJ<_FA M893,>;"FD(ZZ9OE@35S,%4%07//3J^XK_9GHUUU\WB".K_Z<-.R3N&&?HSF_ MYS[=^%XZHS^I3X4=(48/>"S%Z>*/L[LLOFI4.;%B90E&&W-FMLC-T(WYZ=7` M^?%)([-N'XL;][ZO=^@7HH/HH(T=W"UKZL52%!_V*R?[F>G)PO[ M87Y^]8-`'62JK+2G*#&1NTRSEQWIOT#RXA-2?ERR+ADJD50IVZ\1V7E3TR!$ M)J!KC^C:ARBAKQX_2.2EVG:1T0PJ=&^M;-S7A(/H4EI=JW[GW;YJ;SM6D M"E0"*CF`QKT3H9CZZ4JNOP7\B8/.`0Z`HQW@^#U,!+WK/\*S$A"_1%(*N1IU M2XW:!9DK=;M/#8C'7%KC%U:?FB(1(D M*DJ0``TUGH:&3N7BL&7@U7W(HP3-@&9>PMLQN$T=W@YH"#0$&MJ#AOH3L)#I M1,U6%GG^YX,)>NQ*3*-$L$2X`9?2GY(`!>``>EG@`&IX["[$H.E*E8,_GU$6] M.6PQ"1%JSU@:%9.4];D(.SK?*TWZN35>FW-.U+"B':([R,P6U:O:PEF$X/J: MOO8@\P7*,@.B@"@@NH/QK*AL'9`)9`*9SY$C@/ER,]5F34BWRI\V%NU[-M": ML&)?JX7YH3,RW>]F+\`C$`R*:!5%C(TY([8,8]7./B@`%-`H"C@:#HWE"\%+ M`$6`(II'$7UC&YK:P1!80C>7X5M)L+$QP<2C8<]D`?D[20GLWE?6*2V(H1D4F3;)DH_*L**VO:BN=FU M`[S!K=U/B*8I<+3N:IB+4$3 MUON>DZ%L+(R^C^RLCS^@V-AZ[+?3[59?7A717T1_040@HD>(J#?&(A1H"#0$ M&GI1&AIW40,:-`0:`@V]K#=D;*=IRUFH[7O:40/:C%LP&9NF[V;C#@LB;8;+ MZ,3X,8.`"^#25+B8R[\&6H"6IJ,%57BJG`+9%YTQ*32D4C^0.M*<315#<^M( M;2\(6".2J*\!;@\R4>8:$`5$K8:HP3WX0":0"60:DZ.Y!<&V`[/M2X);)9%7 MM&>A3^KF1=E5(,QMYVA$UL*V4JI%]H+3&5>UT_D1T30[BH>8-W@(/+0;#YV, MS&UM`0N!A^ MB+DB"(KN__2J^TI_IJZZB\]%<\L2&Y%XRLW_ZL^%9)_$#?L*[2_>.<*VR^`'?BB.9T+KEM/K_GAW%->XJZNZ^2S<[)2. M\7`(T60/G]6AKS.5^1^*J9^R..#A<2("G@J/<9T:PWS)PBA],$&&_F%^*ID( M4S\1Z>T;IAYX;P\!FR;1G''7S>99_OAHPT:$HR"2\O7BR3S16Q."S-.O9'2# MOCY+]3/5C@25G!-3UR+/=^D/>@I][T8R93RD'M#`JRMYP#R1^ZO`^[7'C4NIMITORK5/@]B-T(KA3_G"5VKU$`9-*T>SWU! M_E%=?NJG!'XW?^7',*5WDI:^_ZZ45KPQTY'S^_J>B&N>*/K3Z#$"R\?0L!%> M3O]^_W:UH8^QX5W3J+T!/R2W.SWM]Q:VTB!=*G%HX$<)-8,()TL2$;JW+$UX M*(."/+Q_9S*="T4@=*&6?XDIB#"5C(P,_"ZK-OLAA,L20'B:)OY5EKLOI`6J M9S>"_R%"I6=JGQA]\3Y+(@WV0CA^SI6_D'!"=CZG=[E<_WXN?!]%MZ0=8LITP8:,AXX9&[8>CP?@UH\L"TB.;AN^'H\G(;,/,C>,/3L\Q M+#/R$6+AIH3W@!QK=H=-"KP3I*6,7%\;Y1L_G6F:W.C2W_=P[Q@I\GAIIO*? MI7]-I$_?2I%\\UUROA-!#D;N6M^Y4#$8=].,+`012$YEF\R>K)/=`^=LZ3R; MP4^O;R7E.&-;":??K9)O:NEA+6AOZ3XI#BKH2'UW'=+M3SE5FBZUO[EABM,$ M7]X0,,RJ'QFX\@26Q$OCEB7BSB16BL5X/C39U(8R$3DUA9&V3;E3O:X+6[C7 MCVK"NL-LHZVX/Y6PT7KX\SEY)\IQH*'[_)2+D@@>:`RO1><>&J,[+\`DI_;A MNB=B2<7??WV;R>-KSN/3+VGD_C&+`D\D\OV?F9_>*IZX7-++5[).[P*ZYF__ M\]__]=?%75\3[HGST-/EWK+KA"L:*B9'BH2(K\AX)'*Q:!%&R9P8 MAY0H(>M%LZ6K3%+S91Z,R0.S,@MR$M/B258"T69.IOF2C(Z,^7G`*"="'83[ MQH-,%!/$HEG_3[*8IFA34M1(O7*Z%/;ZLWT]45-18-6.0'!9!/'(`.M`$GT2 M!)M8,7#Q"AX0P^J4<1U^BK*K=)H%*HR\8&2RI%(S=KIJT7*WW_B,9H$R]14I MYY/,Z"I?"LU%N#31*U[?(!62G"]5G%LD\SS\Q:6*7X=LYI/\57PQ8.*["A<* MG=T>+H+;RL?-HXUY@YG'4_Z&G2]ZE=N9AQOSD"B58&3T5#MT\#BAKJ]&/R9" M"E-MGDA2KJZU13KENWZLA]V=\;!P.)::$R=T(4W*98?->?('Z8-W&Y+BNC(G M;;+Y840?%4?E3I5\LW(I%]O>5:-O2,GI_?32Z5K\E:_+X_XPWQ/2#7E/Y1%? MC8Y2!%)>OL3&4O8TAAGY6D&@YATDR%WI?2NB7J/VWZ7XY_1]H7]R"PZ_&#F7 M@_=.MSL977R8#'J#\^ZXX/#)^8?NJ'T<_GM.8TLAUH>TB9ABGBS#5@64"7F: M87,OTU=+R"'I_)R% MOE>DA/;`YU=^0!!77)"(;R+,BJ>+?'51!0CIAZF"6'DE/=3[O#3#;)(#,:(* MZ`6%<5)(R0*/[`*U(UF:C'*+=\7N.A(U2$E#_CB=1E$:$B?^0A_8=_U5$JF1 MGJ5I?/KV[&KXOKT-J;K29OTU/R5?O;; M>P^GK__Z5CW)/U7_IX__'U!+`P04````"`!Z7'E'*V/!ITXU``"D/P(`%``< M`&)D>"TR,#$U,#DS,%]C86PN>&UL550)``-GXU569^-55G5X"P`!!"4.```$ M.0$``.Q=6W/;.+)^/U7G/_ADGQ&#('C!U.1LR9(]QU6>..7+9M]8(`#:K*%( M+TDY]O[ZTZ`D6XYUX06DE$WF(2-+0/?7C0;0W;C]_O>G:7+TJ/(BSM)/'ZR/ M^,.12D4FX_3NTX?;:S2Z'I^??_C[__[W?_W^/PC]\^3JXFB2B=E4I>71.%>\ M5/+H6US>'WV5JOCK*,JSZ='7+/\K?N0(+6H=S3\EH#Z.#HZ/<\2]25BH[T_V^OSM\0".5'D4V/]4_'(R&R65I".XSO>7JG M"N"JF?]VGZOHTX=0/H&HEH.9C;6@?]M8OGQ^4)\^%/'T(0$ACYNB^-Q#R,$_A=%?`=="+96(0V9/N0:9Q-'WCZ7%SF,%3P_/GZGN>J.`?V2^Y- M[*4=X7[D2HM8JKPRC9NC:=@NHNHR]Y=J;M_$H5LZ0L MF@M1DY(QY#<\3&H,=9LJ=,)QHE(5Q>67A.\5:N=QKNP_%2]F,++=%N"(7*A'E=CGZ<-LB:N]!DSR[54K MM]`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`-:IVPG;*R\BV5S** MY[LDL,Y99>E\L]%MH>1YJH/_63GO=Y?1"2]B`:8VB9,9U/J>6JLFZ!-")UV= MQ2EX`K$VC=7I:.W"WPZ9VY`:#'O[WF28RV`2OWRIUZ#7U#,N?#.&@^FAUFC4 MGF`G.>:YL1O^M!/@FI*F.+?O&LV(F,*KA\HL74TNGN79=+[V,(-A\M6'.E$` M1:U4;2J5,5:F9)^H^7;2#C+M)&$*ZY<\>XR+^0ZVE:\W:;"I')W(FY+Q2H'K M+N(DKIC`N*?TWM]$Y[]G998_0Z$KB.!NLN5>YWDX#@[VXI>F4AMF:$H/+YFW M/_*L*$93?3Y!;Q1*<\![E\;_5A+*-=H=:8BZ*0EK32,;RW=$4?+T+@9Z\RU7 M.T&L+VX40Y=)HS$EH\C?CNEO?VLE0'V"1N7X?B3X(\ODMSA)3IZ76QVNU9UV M6%H)U9*Z40EK=KEME3KAN>:)N@$"%^#\J)%^,I+_DNU.]+FN+]6[=:$/C7+'ZH[>8,"<&4KNJ-9)O*=T.AL\TG>KC3YJ'2HLYJ MS?9*/>#I,&BUI=>'%*][TZ$[GA9E/%W&^"N)U>LR$W^-'AX@\IV[YE=Z8:'X M(P=35')2[6J^4@]97E8;V_,XDS5'O[V"ZD&?;S\7Y95*N.9_D[V6;[2QS#2; M'F1^/<.M\LIR4S$O5.UZCT6U-1/:ZC:-(5J=E?JZ"CVB=9#?#,L#TD6S>74` MUGWJYIKGINU@*\E>9=$JO9P/5J9EJD.Z3]ENXJGZ!QC/(#VY);,>Y*_G^M2H MVAW;?99(<`NUKU<^UT&TMH)A'"OG/*OCK./54PP765',$]+UC:([==,2=O/M MFM(RC/[E^/X8X@4>IZNIXO>E6XK5AYOC8ECB^B/4EFK=,+U,4O%= M&D>QT$'IRPUA7[(DKG'XL!F1`?!VZ/>FZ`\@I='6,=Q*#U!-1RT\69,7:QHY7L/'V$W[(\KKG]HS6]7J78F$?[K&IF\XPQZ%7.>G-$(R+] MXLVY5"N+.Z,DR;[I&%;G@";9+"RC6;(8?ZICW[RXKS:QSVJG4H9#8$I3^;/. MK=ZF?`9=7\GZ`FZHV!.NFCY5W?H]H6S:([967XM1\$3HT`6,Z0(*+8IJ6,VO M89TS4$^E2J5NP"XL-EV<:IIZ[1G*-./VMY:^(*EP`)(D$V\L9,&]NM0WXD58 M7<$[*]`=YP_'VG2.55(6RV\J8T+86EP/_+?%U\%R_PI$#2$,/56Z^F4;V;D$ MNQSD1F#)A6S^+9;>QINR0FVJ[E1_> MT#Z>Y?H6F'G)*J4\T##_GG'@$>I'EL,1%Y(A"2,;8A$HG]KN;]B_^L8!M-8/US=6!X25M-`^9H\5]H'O18I*T#<3S$'2]ACR)!B% M(N!`^YYE,SMJUT_HKWYR,&WVH_6693)_7N+2=A;O_DP6?]`M]J.-_QM7/0>:#S;RAZ&' M.[[#7.01UT.>JS#B4DBD7"4\['%)HI9I5N]GZBV'WFA[3KXNC_#,=^)G:7$? M/QB>)NKS#4Y.1NZ8CB83JR9X#-\ZKDM[;Q M:H/$E.=_#6'8K\P"[_2$NNQD?&:[E+FN37QZ"DHZF]"13SU"VEDS^V7->VB= M/;OU56)WTUTE/7KS:_D&9Q/7.V&VRT;.Q)\0YPPTYQ."W0EVR!D;MUPCP[\L M>[\M]:,Y[RO?#.2NKWP3"$L0S@A!-CAW*!0D1,)3-B)6%(7"\ER_;3B[LBB& M?I"><$@;(;HUTH_6"3YGJ9CG;U=^6WUX8*A-5[MP!)39D:*,(#^"$=)V.$98 MFPN1+B6.H)Y+Q<^RO:*UC?;8;_IHP1^M-RTO?+SA3RL_OFIFH,ZT"T808FHQ MS"R$;:*0L'V*A,(V$MSV?>E8ML=XY\GG5U\ZI`;<`_S$XG)ZSE>MF/M\^BJ\4?6$.M6/;OQ]]MJ3>]SWYY M==-E+D'J_'E^K_R6-[IZW/.O7YF)Y>+2W9NF].93\6N5^EFW$$-P%>O;X'<(Z^\5PVIXOO+L,DOIM;X^*'%;=65QAMO-%](#\6`G#H M.')%AL53""M!3KKZM..6.;8QK0!&;9<37R(0U$',$Q0YCH\1S:/A(62.!A-T0D\IR0A2$CLJ5]#K3.-ZR![D7CAVBG3=L%VM:POO=%9,:'%/?6== M@-.L^ZRC$!"?.02[$CDT5,AC/`1_3%@H8CR2CLV9=';VH'TFW?9@1*84N1]# MVGI3\/R6X/D#F3?\J5G(U8!P0&GD.]*U$(T(@7;P//"V7`?)2%(A7=O%T4ZO M]H`T]EF552JLRHXL+D-X&6.*WO19DVU`*,54>00):G$D(K!-1S@^PB24'N%> MR%CWFV4&]LIZL[;=$>\^&^9@!PT0^4L>9_FURA]CH?3[&N-LSEUC=@^=?=M]ODQRRR?_!8XC*,KT8W*>= MKV,3\(@P[$/K$DXPLAW"D46TDV/;PK8\B$IQRTUX^XNU#]VZ#35$+PM=[Q=, MBC4K)CI3"]U231^2K-K8L.TMYG[6<8HWZS4`"&PM7:9"JLGR3\6+&0P9X^T5Z^O2@]+LOR^^VO&!EFO6+;A8*J!B_ M-FF]E;A^L=Q>#PM#3X';LGIZ3CRHAA(!4<)U7!B; MJ<\P(K9+D?0A`!'PN$(<\61$RD?Y.46 M8@I3RJ.0>7[++27[6DHTT;`[9]YN*MR/=[C<4=787E8K!J[EVUQZ+D1^2H"@ M-D$VQ1*!6R-\R[$L(@_Z&,6>#*:C#O=C, M@N6MA,<=S&V%2A!R#Q.A(KU?*$26%Q&$0]M"'E5,A9@1Z;?<%.[\1P]J)C6Z M'\MZW7"QR+MH_).9NLFN55G.7YNI'A2:Z9<%D^K/;6>"#'$('!Y:OB-\%$(' M132T&.(6]%$7>FND7$$67DZ@U)/* MA"Z@/]>".!<"7C9_12*4.**' MO?78>"-EO2JOQ<&EM2AVQ/ZUZ@7*A_%3!ZLLI!!9*$\!B,NEV_KR^F'. MJ@UN+#UIM1\CNEA_DKM![<#"+K%]19'/X1_+4@HQ[*IE?Y`1PRUOZQTF$M^S M@;348>^>YA`G!K]6K:ODZ%'E_$Y55VH\+%U7E4_C5+];_>KR#N'0-L5TEF5E MFI6J-VR+8[!7,/_D,U'.\OG+HWDO+X]NX];;0=5M3/LRPW$VG<;E2]R750^Z MJO3]P^@],QOT6*L^/YTEL:S"Q95S)/NY;V7G"L0B$:ZB2%A41BB2'D%*04"N MI`)OFRJ,/2O4I\GWLY0[!SC>>;[I3;G`9HJKT"7(4\I&CH-M1/T(Z/N"R"C" MCHG#$SU.F&V:)3.KD"&R@HLGM/3_5I[1&I5CGN?/T'^K_1Y;&KU6_4!(FTHE M0N38H8L4Y@P17P(>SCQJ"1KBR#]\8VC5DMDP^AK"5JJ]-M?WX-?I"R-?WQ39 M-KIMK!.XW!88Z]V$CA3(]2,7V;[/X4]%)',B/Y(ML[S#Q.?F;,*DCH:P@Y47 MQ#ZK(A+GLS?#KH`=S;+5WVL-V\-G:>3.%>B/(M3*`"#&PQ\W[T^M-MX^F$8 M6)&4%O.@*[F60$R_-"PC:#G]5H##;<)HV')CT##QO,D9Z4`4/(3YOKS\]GGK MA3"KQ0)0K<>H`.7:2B`AF854%-J(,4ZBR(H(%2US@\,\Y&?.5#JJ93`?I6[$ M\KYP8-O$\Q6-D/2TV1+*463Y#@JEPSDGOB]QRU6#8=ZP,^R5=%7.(/=V;'JM M:WL?WU8M$2R/)]31*@#L1_W?&2[W`(5$A>+[^;)"214D4+\UN-)6<%]NR&FA@837V!<""RX8IX%(Y4$A.MG3<`ADF M%:U4B:S4Y;N?9XWP&5CT6*+U2P*SB_Z]NDSAG,\B'J,\H_S!=)D\;:>T*+Y(W_"].5F?CW__(+' M=;!,IY6BP+=84#I9T&J]/8KINV:+('1\!>Y7[Y$=&IQF3MC3NZKV6^.7BG16 MLQ@D>2_>>@2G@P5I90(16`Z199%=SSQR2X?LK'EZ0&P:I@CJ/L1ZQ/=VA8N/ M\[+Z3UC@?@[L+]@9QVRQ7$!)J:HI4ZQABS3@I,C>8$A8>@KIM+DP=P`F#([0 M*TP9':6U-]H[N^"C+CE)B)8BWDQ!#TC!,W"K&(LF!YMZ!HAMKK$=CH47`6[C MG,)1Y-OY?.>C=VB_S*$[^5&\7_/^!\JVJD@N2HLDZ]6`NBT/B""'$+.5EE%T=94VEQ; M33^.8"[_HA=YAAVX^`EYMC@K%(Y;U MMI[J4'A6=.9@4BF`@C[D+*PCQS1(ABZE;%_+N/<:FF=G<\Z!IL40OTEI+;K[ M(7RK"X]'[.[96:`3(A'UBP?IE*QB4P052@\Y*4UNIXS:7O25,@,/_&`H->+` MXO;197-'T6!WF0Y#\:)$XKD2F8(/HT%'BDAY,#)(XVU1]I(3JL,S83"@6I!A MLX$;<9TV/)$4!\MV2$Z]8M%6\44+3&8+EE`DLVD*1B>$[*N<2W@E)G=<6:, M08!J$B%MW1Q]5%R\NT!7#Q7R&O5E$2BLM-X!]Z[^2[AZ9:[5H:=V;G,78H28 M82C,FJS$__\-&J^=;W_F^S*>WF)\?#+OA5X6G6PJ&0A2#TKX!%*'",*8;*PW M7(F>$U=SIV9X(@V*6Y-EBL-GI78M-+QPP+4@R$DYX!UH95:D\B$`=[A.`DAP)N3J)19GK4S,]-Q3UF8E M>U0Z#()7JVEB?K-N[L&S44\>[1(J%B35Z:.)X$M=Z"K10"XQNI)R$;[GVF&; M+.FY@[1C"C@3GR9![_?#JQ_"C,*SN^7/K=;OBWX/%NXJFI#]0VUS_ M%8&EZ%E,&$+?HPAMXI^!63$*8FV.1:U"=8__%A;U]/QR2[6J.LYIKT#DX<(= MS]KHE!ED&POD*L6C.Q^_$_/@E+'#Y#[PF MVMZG^#XM;I>K7:IY1Y?M8F`A)^*<0R%`(OE$I:AR+\0D?4P7K3TRT,"/"5B+ M^>'38BV;_^THW^'YPQV+(D@O,D1=CP(GR4`%BK%CHOG.F>RXZ;D3LI%0Y\`3 MP"`0-T8/CSH7$)6/AHC<$C4>/^<0XMSEF M?3^7OB-D3V3>X<)D!#1U-4J:B9&#J-H((@0'T47M'4.3^VI'M&%7RT%_=H9[ M!'3;;$HD6YUF=])AOU_C:K-.M2TTN'>WXN'BG74R>I4T>1,J@(JI+M]S\C"2 MT"XE+U7LN8>I32IF0EZ-A&^3Q'Z-)'^@B7Q]J(:\P4-N(6IV?]1DSW)_6R(V"\#3LNM]4?+\I8TLO MZB26[:FG\T&0:=<.$BL)K)<2?&;D`J"FOYQRQ?9YCE M^^GW3FK\_KLX*([;K\+.,N\9RPP*Q=\0O6:``0D=K.O(TD1I>OKQ]B_(NY$@ MG]:8WIW0J1'*LY,:O:SJO@H[;9C1OBB(C(:AB*#K'@\U6^PO:&\'Q'D:MFW$/K!OG/J\>&<82S:)`DPF`UQD!*62!E]YAL@2QEU33F"3)+#$2F<,P0 MCB@N>L_FU,N;X^'Y)_)5Z-@/,D1O#^@CO<;*!:CKEM,@2$2BR1N"1`F_K70+%T6@NC97J?!F1/SGC1@*Z">6VOI2WLS5D MJ]L%7I4=7=G\?C_U>E37:1%JS!THZ%81,-0+,#`R8(5%J4S*L>1^%&QSJ'=* M!K;!>T)C>Z?4_`S*TPWN2S5UK!3CT'KPV5AP.4M@07CZ1@5R(3W]JN<4..V2 MZH1&=T"L)\R)/"CL#IP3.;+B#K7SC!E>Y:9M/7H50)*C#"9SXUFP(JJ>:UQM MMK]-G1,9#^?6MOD7_/WN2[LJWSW:JF!TI#%^L7PG5="B*D(+E\DD6./!* MK+.H*=3.#*+4D5`LY%W($'446EK6M3JP#DQW`'6GL MCJBI8S(R"F?(P-=P:JU#G&/(D)QE(@FA2[AHC;(+L7SC0-V">G_[(^%R^2G\ M<:?JN,E"[SJ-)M[2%+3"$6=8F&,2^Q)RS;"!1/2 MLC7P+8WN57D[JX#>Y.5I!G=WP2XRFWQ-+B9K#01;'-2L(L7SL=C"L^2I9S)W MVGWB+8WM8-!.F#M[.UNF#3Z8STF5[:Z'`J"L`[(`/'$&*C,#FED$8:T,7A:C M6<_9K(V`T]29L<%@;6)02\&TNBHT#W\)-Y_QE[#"JYO=$.ZSGR=4TRGI$H_, M@R^:@2X:(9I`L;9-@3MF`P\];V%IX\4U(]C(J(XN__-(AN>Y>M'CUK02Y'G> MCB.DK/:4ZHQB6I/Y`._HFS812SVB2Y%_2M8+7X]('DS'C68_'@0T]MN'A^[<[O9`W8FT?J_L*-H0*>0&3"?`@1#9K?XK,':4D0, MA@?LN:C;9NH:GD(G<+0I[E.S>N_-(=M7A@Q&ZS/>V`57@DFF$+0Y`V/UTNRZ MZQN=*$D$1M;GLO=$3TKLMLA/S>RW%(=\I3'YBLM_W8;K6?E6,RO+?V#^C.?Z M`$?5W5FE9'2)U7M2'/"B#5@T$30-<,PQH9<]I7_;;*V9E*QC0=PTV)LPOKL7 M6*=P?)U'?CN[OMV_L?:%$EWP,GDL#-!Z!!D")_.F#`B58HK1VYC3(1J/=H;U M@"HB]>6N&^LN[>G]R75UPA(,R2`QKA3()FC0+$6R^,)J'26BONA[0089[Y-U M*L]'L='IZ*U^[,YDWD]"?3EV4JV=RBX[91EX[05H7>_JB75C3B#+&XI)25WT M?8OCLVUL/)NDH9^@]$-8SM()<_;Z^8Y3?!ZU8^`0.2!%[J!=*(`R(1J=(61';?/U5G=I&.JBX;3S-8]1KK/ M7'T6@A^X_AGT7`_W/`?L,P7N*72^]/L9KZ8K;Z]OUGA M`I=5L>%Q+9M[87["U9>Z5GS,&?>&K>@*P\"C,1!\J1O@10+CG`"54J@;_@KV MO=R\#6F'IMK)3)YR*)HD'N\%H(ZR!3N>[FJWM.8(W"@)&@6'=1A,/_&2G0W! M7/15*Q?+@:,@'0*C5F%^5O\_G>7T;-RZ^SA(N/\ZO M]R7F7R[4!:.,4U&#]QF!@O,(6N4,VC*1*7@B_"[:BIPW;#LX,!A.369\O*8Z M/_\=;^ACN*Z*R/FWV8*'O+=290),!T M(*M8EU)%,9`%*^1N*5>TS`SQHJ]`&I0?0T.UGQ8[+Z>^5];Y?!)!@ZFR`18#`,?Q?V-S,)H)WI>1-OH M!,00O&B,8)N$SB8`.SQO/'FROYP+D=LU8' MWG,]N(UM>RUT&WP8VJUX$&AWS;S;''MP=>)9B2ZZG`KW')B3&QY;V@PM[.MPGGUDTB8M6#2_ORR3N?[W@6.HE0@$>R MOUZ6`"&5#$;9$"G*$%%-MFGP\L+55HNL9X_4*XTKM_I]=Y76[+_'DWJK2.=0 M4Z\\^94.R7_0*8,T.8(43BEEHG*Y9Q*KC?TUMHI/3;!JQN[+$>V M:B-MLKRZV784?PC759#UXQ?$`XY%BR9.3II?Z4W+V>>;"LWF_-]HF#S<;S!J MY6VY^/#>7W!Y>[T1_]H5/$WJP[[.R'H<-'8V_(B^/4GY[0%JH#=T2`XB"]Q! MX3I`9"H",\6`U-Q9+PHWL>?2\13;&(LWJW2EW[?S]J?0\ M5%^'"25R+@!-9B#(:P6+WH.GD6*8/)?VX$GE"TJVMF;C"/B.$Q\\&+31?)-Y M6OLC=?,`P5#73+[;Z>'?]O34U?AO:.J`/'WY6(/V]#W_7G^QF-]\)0)_QA\W M.J?U-\N-0F65GKA=;3ZKJ[(^>E9W_6R."3\[L#R=<_2D(S_?_A9Q43_2A_/, MRZO;U7(5;C(U><^\>F)-70H^8D0%BED)T0H.-EH-/##FC/8RZX/[2YMB\JP+ MATY0GU1/YT*)Q6,B/(J`D)B"G-ƱCEDR_M!>]TW[4\9^W1;:%7[.S#R^A M]2";="K?#M?8:1>X5;HF:D4$68H'SE0&%24!9%26Z:*7`2=GWB@8C^+?W.F` M5]N\G1=Y%V:+_PG7M_@3AN7M1K5K!"MZRMN;NA&G-.S[?Y)=WU5N0F/^9KG$ MK0963_MZOKS=*TCP8IG.V^)%H"]$LJSQM#/-`(_ST1,R(^+5MO(D?`O(I;W`>R+8\>#`3*;18[=QP9/ MIS&RVM"1P/OKM]B2;-FQ6E:[F^I!YB6PXR99+'YD5;&*5=;5L]8Q=1J(NAM6 MQ."DD@`#R&F/7*()*>XQ\M:)1$)T^/ACFZ+[:+F;T/T@FZFSNTK1D+PQ$E$7 M/++"TQPG;)#6PDG&^7)F ME\LZU6"@G8JA`7JMDB-8".F1(3(GFS0181KL]DV6ITSYGE`J(^I'@-)YV-H+ M4;>W3<@4-(L?=A$>P/ZHG9P"I#Z=51=76'!\0:\OY;NK=X*(RRNJQ:41U%R# M+.P94%A&L(^&G0*8(00EXDA48`]$_/:@F;^1 M7':)1M&5GLCE%/,[A&F(ZATU0,?FYJH[?=Y+GU?>$,PTIBABXA'FP%ZP7C2B M%$NOH_3N^)5=H=G]MNA.-_ER@\I&)1VV'.%()6)!)\2C=\AKHF4(,/?0LQQ- M&9'U]F5['@0W%)^*1%@^)Q9^V/W?]C'7Y5Z5<#C2MD^I3T+*JSNM/*>,,[#T MM853,#ACP52T*J]#<-Y)3'#/=!UG0E./Q3^&IS&Y>1;,M3GI)WHEL#04Y\Z'FY-Q4@6J M#==8(R^$1()+CY0##<@G'D1HWR1.VHU6#!<].'46'.0KM\1LG?K M?$AW/=*BXH&FD(!:D;!#P!&.O`]AZUU(S!%\IKNIEZG^]R(G/%K=YWJ:[2L" ML"COCH2&GMA3%7FDU((A"GOQ55(S9'V0R#$#BH(R'(.*:5]1$NP<*E9YK/3EUYEQ M<5W/@8,?ZN_949O/_7Y`^:F;BACF,(X!"1!*B"H&IHDE"DF0&SX8;D&+F:(2 M=B;D#,'`L6_OX#C\7N=2T-?-8O^Z\<"]Y-F=<%-)Q#=2H'0;N+,Z?:K=#2N6 M[Q2)\THU[VSOI=T4;UQ)9\'1`_-LA*G_I;HZYAC5<3,E0@2S))5>Q`D/`NH02AX-)42$4F_3K_2&7\V6D#,BZ@E!I,PV" MGOL!5JL/8+K;5]1ZFK.#(26TRF_U-`I2PD_)"!O4"@&)X@/5/8N=E:HP,3XY\QPK"MI MB)RNM!QI66G'<^D5T,,=G*9@?A-D\U65#"QO&B859E,^6\;06H;G64F,;$5H M?ZAT=U!ABXU)V,/FD/F1,%!CVNZ`K)BM8>GNX:/\JO%+DUWR=GZ_S<18?X_;OYSQUN.!E(?Y9(). MK,W]^DXJS)0P/";DC0"Q1*1!.%&/<#`N&2]!23U3(KR7)_%T;2]6S]?VR<?5.&DO%-83CK%]%@P::;`ZA)2ZC4S>V(. MOO#>)8(CF]WB_\:H!R0QU-!8XXB M`I%>KUX16-ZKORIIJ2+A`;D(FD#"..3\E&##&ARU,8Y:]79[?\RPC`D!<`CN M3@]YNRJ;@T%OUV$%2F[T5B=D%6Q.2;U!A/N$#.<62VUYH#TO$/@OC+TWL'*^35W9^4T/G3^-* MQANA\#OEIX,_?:S\]&^E:'A^=Y%+VO^H9[-W][M"Q)_C3=X8I0@:"UN?[2Q^ M@=X^1+N,[;O[S7/\^0VP(-;?\[#G&76T8F*O&3Q_LSSVT;*;Q''E;5O4[[&. M[%4-I][J@4@@^-D4.F3MJ5U5SCMA?,Q9R(5''E/00(*0*#HL)*4>>W(TKF4D M!^JFEM*&SF?S>C:+/^IY?;N^W56/^]*\BYNE[2QR-,K9MOOLYOUG9AYZL8`]@$ M=5C;V2[1:OM%V,5:]X3Q&T>M`O5:<"N082QG(*(1-$5AD+4^N;V2S;UJ`=;D51^]5.'@T)WI,&KK#Q04K!$2?:YZL" MBUAP!.6212IBYVS?L@F%[N2FC>VQ%V.4NY3!#:%+H('^\)9E12@J\P-L20OXJY]"$NE\UBO_)EMZZ]C9M\[9G6L_OC[$WUS)XQ\7;V]=;^/N)<-]&!94REV$Y/;+T=P@IU-RW32K>7,D M5G,8BC[%[W&^AIW5?)W;E%KG3`R7Z^4*S,G%LHT0`GW\\=TO&)JS=2XP=3#Y M0`&J1]L)N8K6N[SC]C-:E1JG[/YXF80ER)*[UAL.N'R_7-6WNT#CO=)3GU>- M__/B[@[$Q\:7]RF+KN5O[0U:N%HOVC/MKEGDS.O_CHNZ">/MKA?G\?3GY>I3 MS+W.;[XTC]_O+,>RE#TXV($O[2*#O&L_^@2B;E'[7,LML_?KO%[MUW/[:U`Y M^LG53>UGNY@`SUK.?-SLHO-3\Z6^C?^!59L8PD8]PK\U,U"KEYM\MR7&N/!^ M?9M[B:$-\LDSA4]@LB`YKX? M?O+SU].FJPA(1]L.#X=2?3.O4^VSLN9]#NO*LKF9U;X^W[AE4?HJDL9DR=W= MK"VY86#I+#K2M!([;1160Q2P@;%Y##%FBA//B\.9SOF;&I3":5X4$R*+/&N<\^ M(M`/7A#";,XHX;O(ZD!Q5[-*^4BR=PU1+A)*5FG$I"5(""JQL5()<:8L?`?) M/E9MH[MA)84A"7.,L`9D2P.3M4)BY!563'(E;+!3EOS#+6F&80_)5;VW;J>Y<'H<;51$[%2W6"`M07@5G%`5E*&*.4\(M"\KV M?,C`_^K8&)1K);"QY_6XBH_>8/AY%MO%F8>+V^P%_E^W0="!I*&&J)SFE@B% M$<,V(!Z9192!96:45#97"!&IYYE4J*3*:!KK&5E\%KMT/%?+D7$7-L2]^.Z' M\/8<:G'5K-TJK6=;AT36'B[M\ENN*M[^7N!6?G&?0VN^SNTZ`!)#R;'&<[0= M'/(X"O[YC_PG!V4<<3MY>G:@``$B%"``4`!P` M8F1X+3(P,34P.3,P7V1E9BYX;6Q55`D``V?C559GXU56=7@+``$$)0X```0Y M`0``Y%U1]XH8LL)9S'D M`)Y)[J^_$C:.,V/'(`2V9_9AQP&IU?VIU6JUI.:WOS_-T[,OHBB3/'O_#OQB MO3L3V22?)MG]^W>?;\[)#;V\?/?W__WO__KM?\[/_Q5:9'_=Q:4X>RJ37\O) M@YC''_))7-4M/U35XZ\7%U^_?OWEZ:Y(?\F+^PMH6>AB76MG"?77>5/L7#TZ M!_`<@5^>RNF[,RE?5K:@ORKYJWH[K=85-@L[%\N7ZZ*J[BO27U%=%OB^?U&_ M71_GZ\M7!.ZF MOTSR^85Z=4$FDWR15;++Z$.S&L%8Z** MD[0#6RVH&.,XC)/BCSA=B*L9*4M1E22;?DCBNR25[T4IG\GQ-NTL@@[9(62B M^?PQSI[+JT):E;AXOGF("U%>RN:;UKOHBQ[A8>3*RF0JBEHU;HLX*V>B*'K+ MU(JH,7EN%O.YA.YJ]JG(0Z7GUZ)HLDHEF M#,M<;N%&CI-/>5D)V43^K'RJ50E=@7NT85[:#8@E#R*YSSZ)3/F92[!_%W&Y MD);MAV-KVJ M'D1M!`M1)4LNJ/RKLSC=B1J39]5N_?M/N=Z6:[C%?)'&+VK_8O&[]U,/ZN8D MW#9)*40UQ&E)RACOK7S1W16,\?&GM!0/LM/(%[F"N!?U$N^QZ311S)-,6O:- MSNZ,;+\&#B9GF.=5EE=B<'FW-]1/[H6-E4' MXZW="K(#A<$X;3=Z6Q/HQ2?-Y_.DJN=).K,S39%I/#0N'\(T_]H%S3?K#\-E/G\LQ(.RWU_$92;+"UU^=U,:A/->S([&GZ[2 MMJ34BW,F[JH]+&T6Z=V6OI%L6;LWAVH7:KI(Q>7L1F1)7GS.2C%1`8&/TJ/I M$J_7(]:?_R8"?9E)WTS.T[7++^>53I$%#4KF./^09_>WTJ]4#[MSN[OVD!Q> M)OUX?*EOCLN;A[RH](%\HWIO'EMYF]\7[-END7R1)D--3::&$=6/IN)B9P7LYU.GEG!N[8W#@HM!Y$6M7$D M^)Q-19G<9PI.]5(8[K=]]/M)*=LOJT0N@O>YH%M*FFJYQZCO1,04OZO]\*L9 M2\I)O=*5/M#5XVJOOV7W:Y(S)4.[<;>K?#\N5L?.I+)S*6WUO-%A^QAJ4;47 M;SPN5""P_"2*^A#*'GYV%3?*@_[PT*!DE/-62O9V):/\?!,$5C&K/%L>-OI< MBNEEIA;_BVHY[JYF05PF$ZEJ+$D7LM:WU+2Z8$@6>F$5)IGT!!*E&IO3T=:- MOSTRZY`:C7?]T62XE=$D7C]4>]!;ZAD7OEN#H^'0RAKI$^PEQS(V=AL_[65P M2TE3+>L/C6Y$3/&K3&6>;087PR*?+_<>%M),OOA0@9"LB(VJ7:4RUI0IV9E8 M'B?M(=->$J9X_53D7Y)R>8)MX_$N!+O*T8N\*1FOA73=)TF:U(U(NR?4V=]4 MQ;\755X\RT+7<@5WFS=GG9?+<>E@K]YTE=IP@Z9P6$?>_E'D94GFZGZ".BB4 M%9+?^RSY/S&5Y3J=CC1$W92$K::1G>5[E(S7XHO(%M*FY)^S>#:K MYU4QI8NRDOYB4=_LS+/[#])-7PTTZ4FF"W6+6RYSY!JF>E:G4^L`^'\6R6/K M:7U,%DQAU[$VY4&X*>'T=*E-X04+V>QY7#D M997,FS7M1B#QILHG?Y''1[G26[JBURJ07OZCD*HHIJP^Q7LM'O.BJ@]R%TD^ M;6G]#LK4`'B^_EU6UR*-5?NW^4OY3@>I3#3I5+J%RM>KGMMPM+6" M83XV[C76US?IYJG]#WE9+@.P[96B/W73$O;S[;K2,LS]^KHZE>N%.,DV0Z/? ME]84JT\C1R!OJ^%MKA7#$K>W4&]4Z\?3>I)*[K-DEDS4HG2=$>M3GB8M+MMU M(S("OSW&O2GZ(TAIM'<,]]*CK*96+7&Z+6*TE^-VU0?EL8\.]:8\J&27V1?Y M+B^2EL<=M.D-*L7..-I'T3*:9ZR!0>5L-T=T(C(LOT4\%1O[.B1-\Z]J#:MB M0"Q?W%6S1;JR/_4UY[A\J`]M+UJ'4L;CP!12Q;.*K7[.XH4<^F+:7L`=%0?B MJZ5/U;;^0%QV'1%O5M_*8UQ,&C97/SU M29VJTK,Z-;<;-4TR)'\OLW&<3\4L7J25)GL[Z0S$;#Z7CGE_7E^1,0:++Z!J6M#$LE2;+:Q?D@RZQ**IZZ)^U= MTA=/E7X?QX\7 MRMA=B+0JFR>U^3NWP"K7\]]6CZ/FA-$&CU(L<5F)^1J(-+X3Z?MWDH&H3;4H M\#"FMC2U#@,.E+^13:#C^SY%G@VI]5K05.6USHL&W\$D?3EKL87Y,GC>^.MV M\ZC0%NF[DHH(MX'M.SRP:6!Y&.'`LE:(8.[;X3Y$7G2.%).SO)"+_??O0%-K M-:0[S4`J^?@079J/BI043#ZH[=&ODS0OQ?3]NZI8B)>'>5;)D<27<[TT1CX$ M:+46'4`AU,]""/;*$6FI&J_J1J$#@``P[:PN,J7>\[L8@ M/=Y>JPRB^7-KV-$Y*Z>H6.,K5',"?GF051KSA^2QW.G_M*@5`0Q=.;]#V[5] M*@&U`7+7/D/H\^/R@0;KP7PHQ#2<7*:^AI$_BNFMF#QD>9K?/[_IXNXL'V'D MALQQO9!;V,9^"+FS9A5P-QC)>3F2SC6)U1B#O=YHGP%2,I/@`_6(0``'$=+/>Q35X\AL!M#9Z[5GMZ>->^Z3(1< MV^/$A1SX=D!\N;R#P7I5#P`9R30.)QFGQ[=RF[R,W)/TH_QD_M^G&S7$2QS:4JAQ9' MR$(T\'R(&CD\X$*M?AQLB66D'WO(?Z!=P$_2TU!'%>^E`_%'KLY!-=]:*%=; M*-,W.ER/8.1XV`$<``O)A21!B++0?L$WU/.SQMQ=ZG]Z913D-"(L#5\TG]\E MV?)Z>%P^[/H>]K>ID[^)OVA2BV`HQ;2PG`NE+81RD1+2M0E$CN9,/ICI,*H@ MX\%F1CN6%\,:35U^4>:J4/^JU<;'A8+N:G:C/CI3)\2G<9J*:?#,X\E#1]7I MW50$`+6@S8(`$08=%W`:K@$"-M>;D@:+_8RA5V-C.N8TMSE\=@P=T&)R:T-& M#CU&0.!1QZ&N[\K1ATAS(,"#`6?'%38:=$H;`*]1=B2;S#"KCVVO[N6H9*MO M[3[NKA6Y'$GG$7D.I,!&!*(0K-U(Z&&]2+-S4CIA#IXQ5*!QL]Z(JG[S!8#/ MI9@MT@_)["T=Z4,V(M+'`Y:EPJF6#P),/,C6JP@"]`R+>U)*-")^!YJ>KM<) MD"^G<@F0S)+X);'N2GJ5V4T^3M+EA[!4ABN%PZI_M\/2;78;BHO(0K9O6PX% M'G2M`#N(>F#M(D"NMY..3TJ'CQ=NC67`IR*_6S*E+OP.S[YE[8CZEB4G"#EF0TBYRQESUBY"2"V],ZC>26C-<##I]?9T,:FDNDK? MGTPFQ>+ETZ_?=^UW1:-`.G@8$11"Q#PG!#[VO89!AV.]19=_2OW8%Y-#Q087 MQ>0A+L6G(ID(=9=]4MNM)H(RX&6;@'K))3K&!`U$T-JP@^;F:SK3_VVCPWM)!'Y`628 MAH1BZ0HBS`!FZY`I"%W-[:33B#8/#-:!O.4-:.I3B"J#WG9EZ4XD8EX@H?4L M;E/"H>LA&JYW;5B(-._3GD;L>7"X#J0P2M_OB[B?PNP@$MF0H3#P;$I]@ET7 M`I_!%0(^=*G>`AV<1E!Y<+A&.6BBLH7*2;#.]TP?XF(C"\2V$R=;BD>$X#`, MD,/]P`N8Q4+F-X>J_!!#S1N0IQ7_-0#,@>R#=-%#E3!C(V_&*LW^U:RY2'B3 M9-*5>L&+294F4MBM:Z'!VHHX]B"0V*'`XV$84@>O#X?XEH-]/44[K:#RH5$] M'BUMOBA[5:B\MJ,H:_$:70]"S1GRM&+81P+NANK^ M=O$ZW9")%$3K[1[)^C*.N2U^^8/E).*^Z[K$(C1@+O$#/W29%7J(`1`XC-E[ MKQ(-(^DA_2STG4NDO[YB3JAE3\X^KI'A?#)Z?*B*&2%]2>Z MFWSQ8VGTCN8CA#QID5R;,>YP;/,@A$Z#>@A]O2CV8;:^CD*OS>!\:MK=?)7C M>21U7K<7^19C'K4=%%)&'1\1CWDK7%T*R"E=[S@&_=4%ULRAD#9LQ]O8_B@J MQ7E9J=!'DGWS$?CV1TH&8B""@&/BND`Y\BZ1'GT8D`9,YM,CRS!B5$N/&NE3 ML[,[/Q,TDMW=V7[DV0@[Q".NSP/D!MAR`&UPQQ[7.[E[F#W*8[##IH`>SR[O M<(>V9(XS:X[;MQMY%@@MVPJP*S%T?4;DJKF!CLA.UM+1P^Q)CFB%!P/XP+JY M)?G=")JYI=6(NJ&/*?!AZ&'`;`?8%#2P>1XXI;LRA];+_O`>6"M?DO*-H(PO MC46!BQR.?$)\@"W;=BT:-.M3-W"0WB;<86[>'%H'M5$]\"*J_G)VB^N$H[0; M<>I3XE.5@)0!SV.^AYL-4]?"1,\H'N8*T:&73"8`/K65TJM`7`W`(2*M=<.1 M%<@)R)9P8PY0'8/2:L%Z:HKZ,<\FR\&Y\>Y#GMW?BF+.Q-U8 M<:J]?$0>M%R7,6J%Q$,.P\!AP3J\+?5%3[U_WHTOTXB?FN8SL4QS=!L_;;Q\ M064DQ=_'1L0\QPYMAV*@XN,VMEU@KT,T#M`\Q_#S;I@9!OS`T8?:F=IX/$(, MXMLF(X[=$%#JLC``6,Z3++`:.X&Y['`]#?WA-\N&`/?4C/#;FCMPBU$8<,)] M'%J.C;A#0\AYLP;!"'B:Y]A_WCTP?6Q/36\_BM$<8U%%/L$<4Q)XR,4(6WZ` M>+.#B#'1=7U/8Q_L.#`=0S^;Q"]O*%93)/)\Z:38(0LHI`A*=GVU6;+BWK$T MU_JGL0/5$XP#F9K!D]M*?:8>4E_S83YWI,M*@V8K%UL>T#02I[$A-`)@XUW* ME55,I0S%RBU?LW;"UW(9=@(()>PN#Q"2RR3'<5$0 MA`[&#.']GR?^\:[E!H'%_""`P&,(^CZQ/<[7B!`RU@4:_6NYK;NT[[7<;DC] M!-=RK="R(<2!^O"$9<'0=>5\N`*$`=U=J\ZJ,^RUW-:]WO):;C?03O_*I25' M)[&AAYGK@WPGE<\V#68:B&LQ%ZI[#0%!Q*,!``X*&.`^=Q&G>@?S#[,7;TBEQL9T#"^C M'A>KP$.=,/*3*))\N@Q(;/KI;RV`V]*(D!NX&!(<(M]FR&(.!*SI"$J)GM=Q MF'UN[37P0&"-HBR*R3J7^5O:L"X4J8U,Z''@4N8!A*7%Y2^^F6/IY7XYS*:Q M=G?KHG%D,>S7MF\5JB39M+%^9D+<^UJ)./$]Z0=BY"`H?<(P\+&WPI"'MN:- MB,/LYNIJU.'@'#,^OEV@'RTVKLX@2>\SI!;S?4`<5ZYC`;`"-PA]#G[&E)4A M86'HN,SVD?23,/MS6WCR/8O MX?WXB%?/3-7N)!4GM;6?6(K-)*HK2RE)SL3[ZR\HF;3L6!8)@0]Y)I/*Y"%" MP.E#H''0Z`ZN'B]8R2]/&V]MP-B6GC5#CFE"'`P($C MRE*`9E%VA`YET5S:>&OXVZ:L[(3/$&_X^]E]Y7YL/JX>AEZ#4FY^6Z\VK_D' MIQXM/+;$F[C'`@.8>U:E):I'BSD^&9$R.AO.]S8S8_2/6/'2[IH91>+[:1WU M)&[M3349UQ@*3M+6D7$4]%2>C0=GGA.;8YW='R=]WWGIL8_FK]GZIL/%G$[- M%@BK.!US+90F$7;&P#3OHA$LC4?CJ.9=>30"?A.;R_(%#WM`.%!-6)7YA,L0 M#'KT&6C:JC>.&#_`;-05KYZUT:N[V]O9^GY7=WI7K.A#N8D[K\U;$T21TQA8 M_,5X4Q5.ER0(18@-&A#(TSDYWYX@2HTR5>HVD"`#[)(6R3TB(?XD0]5/2!=$ M6YOT7$&T&U)_`T&TNN@0J*)!26L"B]_G<0V(4CPM@F-J@FAKJ[<41+N!=OEB M5QQ;'!R17J#H(TF.*-"'\8*R3%^>(-K:@IU5KS2LWCY'+D80'8\:$Q-$L11> M5*DO@E8$E$!:D]A=!U8@$^ST*Z>DPM]2$.V&STAO^.9Q,[`KL=OM'7_^=&$5 M(O&MP`0PM0H+))FOQBR8)=*D%E`?98.8ZG/FAVEL:NPR\\%?3PAO2>W% M3:A6"(!AI;05NDJBA6HP&5-#!:,DRG)9Z;(:'L\A?*R7QG%*A3GZ3,&KB@B6#UV#6HQ#QS?6W(,MAP-01.@\1(II/C MY&BU`1UWF91I:X7%7@E#ZM$"FMKM[_RLR`S0$'38Y15^O]ILU^5VOMZYUD\` MZ<:0A-8*39R).%MM`7&,L?&!/F"B`8?8HFJ$+I9MMR M<_@:O/ORZ2HLM_/M?4UQ*D:# MV?CD3'#PJ8()03"AF$DDM?!>2R.:B<\(.MUM;8(=7K+D63A`@)I9*+LD"JWSC'\2.LY_M M['CXN2I4@4M**9:$,.QEB+1NT%"0=B.^MTU<%CN>,?XA[.B^58/\8VFNKU=W MT8=;?@V;[?PVNGCV_F/LQ0DOJ.^N^"YN@ M`]4#?..2INKT2;VXS>,%,IX)HJQ0\6V1@!EUT.P:=$#3]<;R&K4U8\[&[N_" MG,GY?-,GS(A$J:KG[.]/PFI]J#J<=#W:-E%X1ZR4E#"OO4,-\`ZWG$_,N M\QKT&%OR8C;.R:6]KW[=U69R$9ZOJW55CJEK!,715@I,$%,,66FI#U1+!*P! M6=N0EAJLNQXX0;^F/Q0'.<;ZM:WQ8W+NRK1I,4)DQ/QG>;,/L8>[Y-8 M%97_OELX+56!#T"-1B0$I#05E/''#530B94M MN^?UGJ!OGP>QR[^#3GCP/#"-D80J(X_TQ#ZR7]GI^O5G6S`A.V<*5F^?(Y/S M[:='C;/=N[QY"ACX.'(#(#7'UK%*B*V[:PB[P,2M+>%OF:>@&S[CZ()_EMM] MC9OY],&"<]KE^3.'@RL8P%_5[HZPFT<2AS M4`JD<:^[R<@OME!0$WTO@B0VTA&A!=:L`=<@1)((,V!4>[^$R8'92$I!@QD[YCO_WZ[;[[[\%N$]D1BE6T-%P-1CC3E'<5[%AK+0+/!&69<6L?\^NR6F'=NKR9=_-OVC=;!`O,&FDKD<]P;:T+ M]4FP<.C;;'E3 M9S_?=7-U^WVUK)+T5Y!5L0?5H\?$\CZ^JX@;3R285*$J6DJL1+0Y"S#8)J;) M$)?%M:F@F[(5WT67S%\(7:G_?Q/?E/@OJR_U1_\L?VXA=G*V^&\Y.[IA/[?= M@@6IK?)QPF<6-*.5.9JA!Y:V<9.71ZRAD1QGT?R]G"VVWRH9HWH;/J[+Y4WU M`NR"GLH;6*U/LBY;VX4*1&//<%!*:^-UW/NRQE/5,NVVN[HLYHV%YCCL^[38 MOTE'QM:);2?:*ACQ7#((7%`=$/.4-)DI#%8\[0*T?BOLRHM>PH+XOEQ?QV7X MW9>]M.%7MW&%GE\_R3CW;*U[[9%"\>"=U9:`4EYHC"UM)E_)56(L$;HL>V=& M:9Q)XN-L_;7<-JJ76>R,-7^][GV79@K0FFNC.!,4:\%\4-8\3I4\+7@%OQFQ M.AMRYTP+CZIGG12FSF(H)]#R^3<^J%;1SXX0'@SDV"@^KJI4,^'V^V*U*^9XY%2UKZ\J-*48"4!( M!AVPB."P1P$MB,1ZVQ>F=4\$W03Z_6>U_K_X&ER7'\J;N^OM+KQ@\^(IZRN? M+J@BGA@F,`,+Q&&I3(.7U8_6[$:""].C\P%TALI7*T:_=N1?\]GG^6*^O3^A MY[5HH6!"1C@0BQX8HRR@.#K=+-8Z)):"N4!-N#_0\KW+'\H*I/GRZRD&M'Z^ MX(H@C@,Q&GM$+;.\"3@RVI.T"`I\@=)M7Y`-L?^]*G^4Z]ER?QRV>:W"Z+-/ M%H(&;SG$CBM'F4-@4+.7!VP3%8\+U4_/`V=`H<.MEMOU_//=]N%6<=7?1Z_Y MM,+Q^O-Q`QS(;]%' MG2VW91S\?>6'SI;W'U?/[H&]^W(U^U&5((E_%7W1Z*16W3^R;F3^EH)!]&R= M!QG]7:\QA@A'#4OTEM(T$W*!@NJXP![P+5?]F,.[,776@U_BR.I_>#$0\.T-^J0(O2AB)MI<\-7$GNW9NOY&&H)OCRG# M,Z27`BW#$V1X8O19?$.)Z!L(Y3!3V&$M`AJ## M^,4WL!7"4LNP!(C+N1/&BQH3I_7$DOWF)TW_F(VSWAS=+7]8+1:P6O\U6[>0 M\#HV6%`OA6&2`X!703-$23.%$Z,2#W?'%6)2MV*#0/@V+DY*"8(ASX,C0!61 M6#-7CSD(/['[^GT;-N$F93<`QR'-P5VJ3G0Y>*Y0S(GX&G))0)"@I>.RP9`# MF7Q]L8&)D@[=.!0YO/[4B2.'#Q9*.\!,:FLDC4BBZD9+@Q_HR=<3&Y@D9V`W M#DMVXGYTU&XJ9ZV;CO?TT<)9JY2W&B@R!&.L(.AZM)C*R5^['I@I9Z$WJJ>R M>3^;=W-W#Q\L$!C*!/5,A8@A=EH$WB@3SJ2%+PT8K3:.?Y*"W4@L>NUQJ*^\X0.",8>4N4BJL^>E14P8>THE$#QO4-OA_+AN4XK-K?1=B! MUFT6.GRPJ#)72$HYEM%YU*'*!X8:'1X2W>X!`_\&9LT9V(VK/;\8D'6N_GRJ MT8()+'A0CB!CI336"TL?$!+:ALF?:`RC06>&<1RB]97PD6L#-'!A`N8D2,`: M<#-V929_DIK?R(E9(+L!.:)[O?A0;N_6RW?+1!X=:Z1P'&D7WUJ&-?8!2^YE M'3,EL).3SQTZ`I4R83G2VG<0>;VQ]P\1V=VR$QUIHW!2">^(BYL.1"V*7F*S M"@C)19H@,(*P/2"7\D`Y654J<;;JU'+!%>,6!><-\X8;2<0C5A3021;!_@^;[;KV777#,S'FBF(0])&"(3!P'APB@G7 MH(!=FN,_(4BFUX-(@Y5"S M!A"1=D(S?J^7U_@_=>-:VU4)+8"RB MI(,*TD3[V.9VH/#2#W9+*95IV;EPFGT]83O@1:8Z7=[3&Q0O7--X&%:=WV;^ MZOGA^8T7&ARF5DL*S`>D%/$R-(L.B#318D#=M6\V#@[Q%$EY,)I6TV.6]@LO MH:KGAXVC-!@@P?@&MV!LVI(\X,Y@:M3,@?(D'<.<#F'A@5/B'!;*&VN-=]HU M>&ANTTH8#.@(CK`\9T5TK,/-DWE$]VEM/\Y^INU#$KZ@`*))L%6P)0".FS8K M3*,0!:[3SM='SOZ9<5/2/Z23)>.?Y?;C.L[I>^/N_./'\*I-,^S<%&WYM07U MW#$J#4=**.$,I[R>7.)R@]).*X;*:;+CC M&((S5<29(W50M:2(3OX4YB*HG`'YR?*W-\8^(J4#88P;X1'HN%W9G>'72`G. M)R_13Y^CJ5@?L+*_C*:;%RX25)IP7!/*IKA#K0Z_FLZT[FJF7AW$%]25=QZ4 MF9U;]N]R5NV`;CYMJKSEY8]R0?]8?K^K^_CF$Z]2H4)94@;KHW%7D@DXKNLM=]CX<%C,=3I=8;$JZVM>E;BU6YX MS?Y)O/I:WD#++0)#L-`!$0-8`',UF(;9M+#H225>;4V7+(E7N^$YCN=V3CI- MR0(83YE""EE/A92&/[SBR#'-WEKBU=;V;)U7,PW!M\>4X1G22^+5X0DR/#&> M>K#[OC[I_LGLFBU;B#L;PDP(FFBE@%>WOOY[+ MH$%@&V32J7?0]K[Y[>_S( M&^#INL:Y#7V,1SW"^/>EU>3\Z(MBTX@LV@N^>_'WM`-]_*DBC@ND%YX;08FC MVG/I&F=0D;2EYV5P"/ME(`ETHP M%@SE3DL,2+/&O42CH\\4`2/L;)R;L>?: M64HYL'I\4FD]79>F%RL^C[7.C-O;X\?D?)-ITV)X.GPH9XNPJ<2"DQ[(\X\6 M!!R1"%L$Q`?FG:"A&0WAD%B7O"^W(X-55ED!>=V\+U88_F,9U[=]]>OE+A+D MC^6/5!'[=?NP8(*PK0+@)!02.R*YM:=QURQB>7:RF?-7N!)L.W^NLZC M8-?6M">?*[A06!*DL94N\C*Z1=K47?=@TC:0O87QY;5L;G3&V0R\FK1DO[6I M+MHLK^>+>98Z52E?5%A%%3.!$*U0X)YS#[I&,OKADR]$E#.B951H1TKKT5,^ M41%`2.\89](X*HD3MM:)L'4L;:AWSO[];7WV:; M/=:0X7`!"N"O.=*,45`J,=E1GB4=F@]E>2DPU$N(\;C ML&UW>^]+N=[8.5%(`\"O3!9A!]IW#J/7E+-VBH)TQ: M9ZAUUBEKF!0U%L%8GW8)<)P;-&VM>M8-FFYX_7.#YM4`<*>XDP8Q+)R@UD"< M25%CLO]G[VI[X[:5[E\:OI,?20YY$:"W?9"DN+B?A*VC)L9UO'W6Z[2]O_Y2 MCK5V$MLK<2E*JZ1`T,2P7GCFB)SAG!E:5RL'-F$F?3!=BE30C,/S_.HB!!7( M+;,:F6,ISB7LL.$<8\+YG'+J1>TYN$`B#\'U,>4,LNO+)$A]8BRE.D(H!QB@ MRUAJ,)$$3OO]WBAXK.4IG5P=,=C"9:HCQL&VINH(BD1WN2XM'8"U"AB+!Z!# MR`O'%U4=D>O=3`+@>F7L'AWO&CTFE)%0`Q1=7[$6)95TN6Y/:4.?I&?/@_'[ MI=7B?*2S8M.,+"I6'4'1""NY8M9!9(0B]?+@7A)/EN7R3&2_$=41X_!::74$ M2BF)E$J+%)4`,>$@_8W.A[P>NXNJCBBWIU,*Q?-3OWMCC/`$):30@/,8#,5# M5$`#6:Y+,XD5!\O@\W!;'S\6YYLLFQ8+EEA;)8GWW<8`D.2=V2CAL#_@%5W8 M\3T%3#!*8CT.G66)##/[^K]\L\8SKS5-+Q=U,!$#I_+P\5BF\LZ3F%LJG9FZ MG!R^=5H$A3ZO@T#5IO752%4:S#7+FI65R).;*+R0:?6W3G#HD0"6 M61YS5NE0;S>Y8G MHQ*11".,(HH[\.",ZY&25BY>GES3_9H.UXDER.&O/]J+_<-@-G?'"*Q?4XQ! M`R6"!(Z6,R?1,J?!:^!@&<6CZ_6:-,4(#E'PKC)(&.!R>YZ<4 M90:EL\Z!@F@%V"YQ>_C$/?ASRD05M>=@R6@>@NMCRAGDI)9)D!F2E?GM^(_V MEP?KF!`BID"`*H$:G3/]:)7$H]5E<^\RC[;:T\>HEP*H!AV>.._]"T#&,23C M;HUU4FK)#>_6=$^)%^3PT46E\D@S0^O]7-),C]D\ZTT?#L?;?9ISOPJ*?TY> M^ML_VZM/[3^3R_YAG"\\ZLY-_;O=[-[^N2U'M_L;-L8:CHC<6@U()),B')"A7N?%7A5GL1E9E@?A4LF5 MGO_2=E+N+9L`DH+A$J0#HX4RI*LJNO_T@LE;)BMFQ>8F6`:("Z58W-Z^Y(-E MWK%QAJ"W&K6@"I13S"BXQ\89FGEB1,74V,P$R\!PJ?RZ_%1X!NONV#!+M0.0 MPE$M7`C1'F(?AY!YYG;%'-C<_!J/X0+YU8TB)B`W5]V8;MZFT*?=_+Y_,:@L M]8B&/5YV0C M$A%4^B,9:!&=M+PO!#26L:-YR#7E9(.5(D:A)%,)`&L%B;TV01NN:FT`%,C) M#K;J23G9<7C]R,F^F%(@W)%(E7>:B2B,DH+W^G:-+M3*G$R8DQU,ER(YV7%X MGE^F#0Q#:Y1!XUU$1C0]-%74-!BQMISL8'L.3KGE(;@^IJPD)UN?(/6)4>^D M=*>#Q^B,#."]BLEG/W1`TI[%Q9^V,=J&F2>EC\.I:HN+B5LWB4A,5\$9%:31 M!\D]]F67"?-J)SHMT&&9!,"JU*G:8\1"$-WFHV?,Z.0Y>M%[C(;: MS#8\"VG=--A^`UHWY>$U%R=H%B=HWXK3,Q^1&*$MC00TE;(_!=`HLC1YQGR< MR,-K+DZCQ-Y>,VSH3)YBS<2*8WI M=2`:"I(8!^H0=VJ;5\BYJ!9OY;9S2Z%8117_[9N>T,(+M:-.<0#D3EJ@5)I^ M]M0Q_7"YH<\D5AS&BDL.6PZQFCRFE/,T`]NL+VVTZ%3@P6_OOG']E.[ MN^Y<,?N^O;[H(!A'B*&W:!1P$:0(1-(H*',>D/:CAV`7=KQL>6Y,!%3%[,[# M^X_DR*#K&^F4#\&0Y+\Y)IUA0L?#M*LR3S.;+)HI3Y`I4'J9'<]W"XV7?[7O M7EU?;#^VQUN$?O/+C3'I%1FE7$;!#+*Z4.\Y83,VYF:3!9=_KLM`DL5GV]S\\%> MO^O^U[WSI\W5BRV`AUS6,-45FSMC/8)FDC,'!]""DGE%/9,IDB?P^,J!4X," MK]O-5;CICH$Z:O:O?[41CB$&9I&`M4%TW8P/B@7(=>[5^9CZ1$`REN)7US>W MN\WU1>NWUW==RH9V[CY^86-E$$J2&*F2J+C3(!ZF)^+R9FV]?&M.`D^NFS5) M4W;GM$]NH40?*/4V@1#[^,%8P7269X+)D^5!N1<$TF,U3'?3KF^^H,(B$M.A2(B-!XF-(*Z]A=^5:+#KB M@SI&XC45!FE+I4I(),IS2B`X2]T]%B(0=D:%08.M>E)AT#B\%EL85$M)ZRP8 M3BFG5D0J,!#*96\4KT2M@WPFS!4/)D2>DG8<@.N5/$JT+JC(O96&$.YB0.AQ MZ`Y16FXZN;2A3](^YL'X_=)J<5GHLV+3,A1RIREI(Q<)Q6B$X*!-!,70]V.T MU!QU%I>LI!ULOQ%*VG%XG:>2UF@""9^@C.A*H4!I%_HQ4NT6EHB>CQ-Y>)VG MDI8)K92@5'&B.57!2DW[,08FSEI)6Y(3>7C-LXLV1[.$@(0H%ID(``$C8UVI M[WT\X<#F!>2+JCW,C9AJX#D7STYH2VZY="1]AZ"(]<)"--B/#V@PRPV,)K;G M\/[D60BNCRF+BW7.A2`SJ"Z3'=IW;[I,\LWC.OYN(S]<[R_W?X_LG9!WPT9( M1XEWR;GCBG&%+@'5(X.:+BPX*F#AKQ69-6!;9Q61"@EQ;SD'$K@5@0?3QXE6 MHCP\DZ'/R;@I8<7"Y2!YN MZ^/'&?@T2Z)%?3K*EP;;:CL5-N=;1<828$1H%JSNRAM,=-P*.VI0ABA,L(2:_O-PBM*\ M@H092H]R"3(%2N=4C01`T@R9)D(,*@1DU@C;CXPKD===:X9JI%S[%X'E7*N1 MK%+:2`[<2>.`6A;$047H/,TK:IBA&BG;D*+M:(Y*2)0VY6NAI M,)NXI.'G=G]/[C1Q/7&2J$__6GU-0UJ::01+I>_Z%8+PA'Q>G;E,/SS>$G1- M-0T$+%IG`%G7,ET*!'U_B*(4:9FJU1ZU0$W#8*N>5-,P#J_%UC0L0[\C(8`) M0<@@:?2,=">H]V"")BNH>!A,ER+ZG7%XGI\J@[AH(U=6.<]BB`1\-/TGSA4Y MJSYY1>TY6)Z1A^#ZF'(&N:YE$F2&)&C^*2='C^W0E'IB''H/*21,?]/R,%HT MU8YZ.UF3,]AJ7V<_RP)4@PY/!"U?`#*.(1EW:[KOS3G>"?2%)A$]4P='T\>8 MMSTR6<*L/&FFQVR>]>9-N_MTV74IN=F/6G,>7=D8\7Y8EI.G`#5/*3HSSU^W>YO=]>_/#HE>!1%GK]-8U1PVAGJ#0N&.1GT MO1BR6W2U[W.X>38M^U[Z['#?7 M#+EAH[70INO'SY@*)"`3EO?(`)B\=6FR/'UM2DT`X1+(]8^$]/=ZG*-!6_N[RX_^EH-_SI6S2HJ2$B>0:1H<`T ME6O2S^1.!Y>7=IA,WU";445`FSB-_7C?ZE^7^P_VXN+VX^W59G\8R2^_75V^ MOYN)7^[1U[_DB>^3$&H__G&U_?O1;D@'6XV'WV6:;IYYQ,0YZZZ:KQORD.3\ MM[_<>()".B2>48/)L:+*$2:E9<%&3M71)L<3C^IHJOV+7VQDX%P'T&ENM3J" M,S%]+/>C85[FQ6V%<^FG&.'KQ/DIH_^1&7\QL4.%0"TC"1*M4`B>>CC8!$FM MQ,2XS'@F'XJDOL2ZQR)RO;!3 M/2V2L<7FBL,GRX),P M:$*\,EHZ/,WL?BOAJ]3&H/C<\302QO*A&.4L:!0>LX5D>+@CH'T>;/!9`>9%C+X!,C,M((\ MBMJ>'-2C&.Z4=27[,8V$%`R2Y.L[86/G]VOPAW789KJX#WF>!1)L`3!.K,/Z M5YH7/Z0QV$_M;O.^?13O8;MO=Q_3K:_?/]H#7WUK$1LI$X MU6C%40G0U--%S=8BUG@2!//"Z:[`T+/TT=QCH8C+K#F8I;7(8*N>U%ID'%X_ M!%0OR@,,8\8FE\Q(1X$1P[WJ3:84JT:^"5N+#*9+$7W5.#S/3S43)$<%4E#A M01H6J-6L_\0UC71M^JK!]APLG\E#<'U,68F^JCY!OE]]E762RT"448%ZX)9: M&WMD0$$UR=ZI8IG!%BZCKQH'V[KT54(:82%PEV+18*S2AI+#V'EU>CY*+K+FKZZ]INKBVZO(,723Q=GV=]N]KO-Q;CBN&)/;91,KBA'1Z`[ M.ML`:@P]QH*;Q/HN\I#VID""Y" MFF@"*E2<:?N`)`);_%E\,W#J>/5[/8.%6"1J[LW`=>5CEZ<(.HE_GAU#,/(MWWK_) M[4WMMS_[P,8;*Z4TSJ"36I&8(K!#V!6)RMO$FKDGW2PN>RF(ES:#?S.N"1SU M%Y_1*.062*1!>^:B9H+)PXSD",L3("W31R]`HA.FY9)F6#R-)_=!1CRQH5(3 M`\FR03HP*C).:8]M=YC@TF?A\Z5X,:,L3&`3M]O]];8[RW3E0IO$DT[.31)5 M1*1>!8F&@A5$HD\K_]&N<&L2VF@+`2FUBG-N#?(H0-UCX:S+C&)F$=H,MNI) M0IMQ>/T0VKR8)XXR01B@\D#LDKDFU!H,Y@N180VX_`\/_F$ M]2;%],)8Y9%A#$RA[L?GTC_6)K09;,_!.HH\!-?'E)4(;>H3I#XQYC^TA5)Z M=VIK?_-*C[;AK;"25->BS M^TBEP5KL+M(+>![9+SIR9>,""BX@_1=M4`:C3%:X-X+7L59[O\R=H8($V$Z) M6PVW^VUZTE>('(WKG[TFX28!=#3&!E"**2!@E$P91FEE'F'0ML#>`CU M#IX81H))X\BR4,U%BY%<:`)AS$=B!8\BA*`-0WP@>ZBE0\DAP"DV&F#[D=!D M+.1//?5NX[-]]]/EYK?+J\O]W\\LZ$,N;8@60.C_N+O6YK9Q)?N/LG@_/N(Y ME5N9)'63N5O[":4KT;9NV6)6CV2ROWX!VZ3MQ)(H$*0H3ZJFG!@@T>K M^7+<=ZG%XOY1L]OWJZMZ??<0#'"^.Q2IB/N+`78YZM[?*6!*J2#*&^P`0W'" M44Y'.XK^O7&0#DF6Y.7:"R.131NS1Q@,YWDNR8%/ MG_LR^JN"]$5E##ODY2"3:_;H,>*^+B%=W.-.&6:$]$;8N$JWTBF&S'1/EOM0 M=9#UWNB\-1V8W$GR%*CO[W[<+K]6\YM5?5M?QWGKX`'BJVV#X"B%\<914BL< M\U(KU@R1*C.QTX/^2-=E`1GC,VU+(OQ1U=?KV;>;Y3QN8`ZOS'O[!*BL(!0X MK*0S1FM,%&WD@X;DG?F?[E$^YP)="IQ1R'^P^YZ/].@DO;=/T`93@J7VWO&X MV562"M?.<(2*Z:[4!3C[50L*H_3VM&%R:_:4E""7_$TU?W==?_^O^PL/ZY^) M>]S\)=&.G]'^^,_AKR^O\/OTR\`!U@XSK;@%"&FKL'5/$Z$:+8RO8XF?_IC7 M/2$8EJX_]`&Z_M`!&8$8-((8Y3"FT@$B&L\#LIG%CH>KL5V3/J1T-)M_1I%3KLC5IOI8'7+('^P7N($^%6#F@'/+A34R[BL>Y<2:32SC M[0#>LI+PG$$-_&Z[6U=_1@[N=G?-@:3=56:W7A\^J#GM04''];:EW-KK:';\*<^JP`,3`0.<@5\#1^6UJH=J.)5>;=>O[V="@;LE$. M*A^+-7S>K>%[6,GE1.E$8HXRS[<_K:CO[^R$.\CX+1!S,UUJM_EI=S;[7ZW0"^'0< M_*]JO5B^6M$A]U&!Q@74`$R9)4P@#B6VH!'0<9D9R00N0`M&@BQ#)W[1R\_5 M>A[GJ:B;Z5[I8C=_R"CNJ^1HG-??J_6^RU>G/RAH3!SF1`("N=8I5%C#5N%] MYF5;>`F^W%$`.\.Z\1@+;F;K]<_X3_?SVD.EG"8KO:V.%BG(?F:01C',&?0* M>N2-(P:U,Z@D-C/MTR7Y?,?"+F.FL;OM,R4_D%+P]X:!,LQ\'`=0AB(!H3*Z M-9@$SJPO`2_!&5L$D/[K@HH_V=W=M_N$`+/[-,`/>M1M-=C;/0"KM`*6(2[B M'ZJ3QZ9U&3N7&>5X"?[1`6$:X$I-'.6FOETN4NHP/;M-J5V^W%3/RC\6O-VR MYTV?9^F.K6[5FE,[U?IQEM"]T.'BU9[>@1B4DYN'?<>-E7I M1#J:G)@QA0T%VHNCAOD8\AV[8O5*Z\"0XI(XC[4C0*(4EPP?Y"+>&)YW_;]X M?9F>G/R6K[HO#I.]6?7EIEYODZ,MR9A"UX^%<+_6/EA`F%):0B0L9`1A87D# M!J0H[X!VX/M5O4C]-6"S`"JC1.K^.L[C<;JO]PC:.T(4LP!;98ET%)-6-@D$ MF'#,=C^NCC'?"Y^WI0/C5Z:SD#C/+6>WGV=QPON\3C&P=P>O M61WJ$K"1@'H.$/)(6J+B>$DS8"7)Q,JA](:]'@26#!Y]-'BK=0:;QSL&H`P# MSA,WW#S@?M@0V],C0`L] MA<93I`A&`F(M92.;-2+OY'C@FW0E3;$RN)R+\_3CNCJ^)!_M&ZP%,$IFE?"* M4A$_G&:O$_$3C$_70.O-8`>-*('5V]>1R1EPTU.-_L;<;%WY79+>U.MO]?IX MSNT#/8(2"C%K!216>PB=EK@%PF$REG>FX[)?$/YZ"'S&BB+;=O>_O-8\`.:\ M5X*<5P.D#%(-G&`RZV?S>_SM!^QN'YO'!2C MEEDN&<$,42P1HKP]1Y1ZK$S89[.W>D,R/LE'U]K7F@?@((N80!7%TQHB;%Q[ M8(SB[Z9K:?6AZ"#;O9!Y*[Q/SL(Z-]V]K:OD_/]0SU;->P]:5Z\W#LAYX1D' M&!JIM1)<"?04WN'&RO+:<>7MAW-=&(U1G)GKY>*Z2D,]:EC]VC0XQPPAA%,M MC),\948GC328/<673\.J*L)M(2PR/L8O/U>+Y?R^PNT+00Z7`CS8*2#.I$`$ MVS@5`<.,)?AIT%CG^9H'BSXO]G$6166,C_2EG7C$-OZ]<;`F"J*55BPEVU*< M(<(:B0ST>2F#3D^R<#;;N#UKTM@Q&*DG>;>`&F(2OG3&NF$ M$'*Z-G(?J@ZRWAN=MZ8#D[.7IT!][V4ZOJ?:;)?S@ZZJUQL&8H$$1"JA";$& M(NM5.SC@Y&B9T;LMQ_TQK@NB,7J4YG]7R^N;:$*H5!#ZNGJ_VE;K*,*>^W^G M/B((P*CQ"D!!A:38,L);NT;IW#O$X^C"A][!_0/!E&-V/Q_)G[._4S(47:_7 M]8]4>FGV+9J.>^MV=NH;2)S6HJ')+8D&*Y-`$JP>18#*L[SP@,%V4:68'@J? M4>>!=K"=;F<\M0[,<8KO"\P!KCG43I)6)HR.EWL:=^,UV->=C4C&A_S7IEI\ M7M?SJEIL/EU]K'[XY6JVFK]>=_-PAZ"5UUKH=!.6(HGCIA`W@L.T*QGIK.$, MGVPQ4,:WIN,NOSJ:!&I?EZ"I=<)*2K2A\6>H$&CU$QJ=9YL-EJ=PV,MVV;", M3WJ:93K3G1H'B36`.(6@Q4D(>&.C(=LN-S*S1OI@J00'OE5Y.B!C4/S/ZMMC M.KI/5R]LB`-,[^T3XJSE!8QKA;94J[AD>-+XY*,&\[SXC\'R_I4FO!0N&2MR MDU/P:_T88-J$GGYY"%=X\+$?6Z9/?$J@ABF*K,98&<`D=)+[1BS-3)ZY/5@6 MOY)K][!(C1*L%X?[Z>JET_XQS7N7/5G.8X('UE`A'-<:,,"0Y50T*'B&\DSU MP3+\E9X>!H1J;(7IJ!"!.Z>A8%X:;IP1*=\[;:2@GF;>O!PLF]^0C)^(1<8: M\)I^/7H"GM*0?%XOXXST;7;[8'0^*Q.]9TWH^=1`H-6,6>@,H(RP^%?31,=! MX7QFO>+)>]_&A^YB0ZG=^B$MW;+>=X;3_\F!82>$ M08`J)BWA4&G4?C"0DZFE`"PYUXP/WYC70Z,<_XZV=&(F)3J]7BW_KUJ\7T1) MEU?+%,Z@-IMJNWFTQ1=JM?@0_SE]*\MJ$W\705E\K%?S!VOKV>^:--Q'=KRC MCB.PE-`7,J&5DD0IQZ!OO7_2T\P4I9/WB5X"V#E;\Y<+_*?==K.=K19QVE8I M\;_[>WXS6UWO2W3:L7=`#CEJ#:0\BF"$$@&NO"W-.9 MW7:WOE?/YVZD5K;WJX_5W]NO/ZK;[]6?]6I[<^P2;?9S0X0?:&P`BDL!BJL! M%J2YM`1==H':BW';C@G>Y)0LE;/Y^N,U&ZW/XT(T1"'T.O+`8"KOKCAM_)_( M>)MY;?]B',,C8#9-34K5VHKJ4GI@<`![HDPZ1^$<68L\;)RI"`.8&<\S>;_S MJ*A-4I]2V;:2ZI2>%R1!P")"L8T;'II,@S9:`DF@,N>FR_%*CP#:-)5I^;WH MW)2>%R"BVDCN;;H"G.)J.34-+HZXS.QDE^/P'@&TC"W8*SO*QA$2=XWM*9VI M-WO=X*<\(G!%O&?:*AO7:6,]H8:U2S>G>66!T47XO`?$Z1GQI2H6),F_S&^J MQ>ZV>G_UI5HMZW5[Q3_E='B_V>S29?^4L'U?=O]+R=AN"*.,`&[BWD0"!C7Q MU(LX@X/XY0%DCVGE*#%&.1G;.8&$0,:0-V8*O0T7,;T M\P^3!C(5P0$R+C782.T$1E:A1EY/V81O\/5F\.1\D'E8O7T=&5\W,E.%GD\U M>IOI95.%(B*@B#,G%<9:!27@G'D10=%,&@DRW=A#V>`%X>^8*O0T?,;:PO=- M%:J,7R4:E*208]T`.]N:7P"43H%X)(QTT!EHH@`>$?%'K">;W?SF2[5>5IOZRD5#/M5HO]?6/=]WF8<'*:%$C`+"XTP%.-$2D08$ M94W>N<;H%V).U8RS`3C4N?/N[FZV_ID*G#^+^RY.V[ MGW]F;Z(LN7)Q\9;"&PT4C(MZ_,\\4LLDQD?W'U,]Y%;.,45,U%H=/Q.M$+#P M42Z""!RKLD;6(7=G3CH<=G2MB/:O^A!ER%')!F+50DE0GJ-F;$D6.VR*3<&MW1OB5 M:EC96$S@3`(CKK1PF%/O"9,*>\P?!TP5MGG;[[$=V=GDE4$EGT9Q[WNUU?S^ MM=VYW-\O`"@QL9,#8[NP>A!:#IM\L*KK.HJ(9G-%I MM@!Q@%@C0:!ESA/NZYRR:AT4_HCH<`[YH&+2RFE&'+/,&22SB M3XUOCC(D\K:H8SNH>Q*5A\5$SFXU,,AJCCSBB`.$@0:-1XY2!/-FR,'N?9:[BP>Y=EZ:T M(#2]YE($.LZE3<,`H9!&&^CCI$Z$%=+C9IM$#=!YM),+/H1!;L2 M!9MC9*,@QT09;;D43"@E&M.)AJ@\+*81XV+3<:(Q+$X-'B4S MV*#6H-(XTZT^V'W=TOP5PF4"02X,8VJ@@!H(ZN/RC)`EK>Z!S/)[PZ69+$]D M"5AZ?)*8THAQA9H1#RUCC5R,X997D3\<&GL2K-7!I9\'J-2 M/#>(2%4:+89-!ZZ?M3;5^ M+M)!,O>T#M&&`@`0"YR#0G`<1QU79@-$JJ?E9>8^X1)<,&40N:28>.<4Q=0A MBIQS''$C>1M)B)D:*^2M9^1S;CQD$5"&CF;^/:+X_?+E""XNIE@(*@Q"*.X` MB$7P?N\M&#,&2>(T.FI>3S6FF-J4$%02@S%BBC@1=>=1+NQX;I[YD[^FK)CB MSIQTB"D^#8>W'5/,4GDBC3UT)DY/'L1UHX&5>S"62O2.*>Y,::>8XI-`N:28 M4BMPE$!PH*4SA`J@&&DD@XZI2XLI[DI4M^#2/'3>$O_C\YX54SPN[26#K$Z. M*;8@I6!EAF,&;=RM&89D*RO7F1O6D3<[G1$^'%-\&A;3"D8E#'$)E*(<&>XM M8(0))IP"<>NG45Y\Q]AG6]DT%H1F`I'B!G+`%0;_S]ZU;;>-*]D_FH7[Y1'7 M/IF5MK.2]/0CEV+3ML[88EJ4T_%\_0"R23N)+%$0"4$^W0]I.R%(U*X"4*C: M*$A`-`NS$,5.A0[[2/5CQ*6EGG,GN0[0Y1BH9.84.VF9\IA"`A7`7&.`>">M MQ3Y-9;G36P?.HFE8Y.84!^O1TEAG@33&<4X\[3I'#4G+;.5.;!VHJ#0L"N$4 M1^:79,Y2P"DV2ENM<9P&,&%`"Y[F8>;.=R4K<"QH8AHHI!RRGJ%.9&)%6J(D=ZKK ML+DT$8O,G&*CH9<4AG49\[B/8=;AKG,2P[0]7NZ$UH&*2L.B"$ZQ"Y,Y"2ZO M=``3JR#"4,1)0#+`A52)'(_,@$ZK`$`!F+WPIG@EWU MT5H+$[D;IQ!T&0>1S)QBX!PVP1E66$5NDF56JUY0F7B:.SNG^#`O-!&,S)QB M9K1#RG.LA`8`4,[#R90,N(V.2@ M4OS('NIJL7ZI/J_#'Y7/)V2WTBN$OJ5#PIE'PRHC6V@B$D`!]Y`FE5F// M3F$=AWXW(E!3TUH_W33+50&5[N+]">]=Y-9MS2K)*?1*44J]5$XRA'$G*47"Y[HB:"O+]5`E M-9/A42S;]4?)=M-=-SY?<0,I!C[,+MA@CYD3A'1@8`'22AY-S'<=1[L_F\P( M\.18KG_IYT[JXRLM*N65\RRXDBY`A<->G%O5LV MD%_W._BO9:C^"%YZFG^U3<4E%5:&U=%"XYSV"$C6 MR6<4*NSNE+$5/Q8N66=YW2R7S=_SQ?4@]^[YZ8IP`,(N4FD9YD#O-(=,=3(Q MF%I^)HNN1]@#'`Q(KH,LGL8H92S7 MA<_'4?+A@.0*L>U6[DL9>-BK$!ISS\):"3Q$O#=4ZIU)4NID.=Z1E9H.Q$1! ML/7.LOWQ4Z-<1+6X:I9WL_C+4>_)&MAQ.V]CM";FG(<$"0]Z;X6ELE##>*\CDEYKS#%!E'MB M"`-$N^/$$E-DVGV*/O&=%=>8\+`]TPXQ"[@DW/48< M3(N-9&X"X..\_=\=`JQ8Q M&E9OU3**BXV69Q!'"Y:Y[QA`;/-[2H"A`JR0:^`EXP)'=/Q'7B0 M)M87G8ZS,(;*-D?.1@$HAR'\0*WX>_9UIP5L;E`QCIP3T"+NM&>:&.Y5)YD1 M/HV>-EEX91+5CX),`D/-S[_7EY\;?]O,XM756UEI&Y^MF.?!-<+*8LAC5#>( M^3SIP<3L]F1AE%&5-Q8H.<:J:>[NFLOYZF'P=/U*BTH)`Z$T.$!$;3!')%3O M"",&"JMK,,EH'0>:O$[;B_W.;T'V]TW;ZH>G;<_'^G8==6IOYE\3=H2[7U@! M@*3S#DE*@X=D"+'&],AXGG9>&^QCCH'G?T<6?;RFD)UEZZ69QL&1 M*C-;UOX^2F^:Y==FN5X?M\:KMK2H/'%:0"&!48(Z2S&1/1"4R\2K'*?R"D:$ MOYD"G^$CO*TO_NNZ^1:`^%:WJSB^\=//4>/XQ,S08>MO[S)B#PJB:>8D2XV*7._GPTL>MN\W3YT;7'^N+ MVUG;SJ_F]:6]7P;_#;<>`FV%U4``!KAV/0(R(%-J,B8O%VPB.//,>A?+ M>M;&P@?K_[];^-E\^3^SV_OZ_.JE+/U?/X'Y`F&X==(;X?VQ\"Q51C%B#.<. M66Z5ZW$3L-@44=XY+S_2"6[W\V@XO_I8!S?TT]=Z<6F:;Z%_EX_QR?K#LKE> MSNY><$,%M)$:2^R)C67!/="*]?L3*],HA9/5@\IK.--BF3<9>=8L[II% MO9HM'WYT-'\/*_R@[./6-U1,`.(\4T(1AESP!B#GG>S6B,(J@A^;$STFED=/ M:@S/^OOGRW6%]>:9J[K\OZ)D9.8H.+YJYV5U=U!+7^T"RCO-LW`E-\ MKD)A7XZ]UQ[!/)_*P MB7'[.RI"+(_'KJ%C4L6HCB;]<(:4I3$Q)BL<=FS#&Q?-2<[.#03H<2RTYPO3 M+-KF=GX9]SIZ=CM;7-2?;NIZU19QYJSMW=WW>YTIV]"N8L'QX9Q;&IQD1IUQ M2,6RC1PPK($Q1SHSUG>T?='[EXIX'SL23$`_;":O]:P`&SS`Z\7ZV5V'RJ;[ M:$5,V&>86!W86,L`-M:0#F6(02[*QCH4$[8+TTJ MI+D42(9U&H+@]`EJB.NDLT@4?/_LH>K:J?V#$'IK=E!<$K\4]1]C1_38Q_I2 MM;]$/7>7Y-K=NE(*N@`@PM)"J@5!"CS+K/-=2KP7*_``U?VRP1D;HAQF<=:$ MK4C7\9UFL.'IB@O)I6<"2XF1B4$MW(\=8'UAA7Q&5_OAD!PKO'=HK0(+/9`. M(T0*&$I,Y")2#0I)=:4)R69LVP'HR9'YD`J`+,X_U\]F5^&^P\W43Z5U0".`H= M5MAY9Z`"F"+<28\P*G;1R&@FJ6`=,]E^[&JV?[R(\ZSY"V4D]TLJ*`N0$2`8 MC=/Q?E0<%B8F@H-B(>0B6-/."'`Y6$U74)82R(`P6@-E@LOF"6/X"2,.D4!,2.^AE0`PRSKI`&$%EXT]5%U#,[=I"+TU.R@NKEJ*^D\Q M0PL9JN649RC4)Y!O)5DG#`XWA%/>#S,;(A22KI.3JEDMHI-8Q0I'JJR MO9)Q^P&4J;1!<_=8@R&.@X[2P4Y&#&E:&8)B M"P&FNA3C(7A$*]FY<&QM5R$HK`"0.X@EAX2:`&0GI\>\X'NZ1]'>,(LX"*NW M:QO%>17EF<0^IK"Q"LGZ@/?3F>[O7P,.]=;*?Z\]7GFLO$8*2$DH0RR([&2_ MEGI;6%9^)-";T8'),9B[(];GBR='YO&ZTHN'C2OD6;/:>J9AFPLQ\I[C098G_"E(K*A2'O<[M$5HJ]B^0[3P[5?H&.B#E3!BR2( M*\XY)L08K2RSG;H0RY9LW2MF4IPI9Q]J":K+$N3?1X:SV=V`^'_:&RL'#:8V M9F,=U4IKR&&O.N! MS[[\/5MN#VYM?KA"QG"J@:->2L4TXQCUG0R=SL:2&AAUF%H5S__RJN_^CWN8@#FA=$6PYDHQH!YIY'J_'I,TVY[LVI"3M^VI%),E.]PTEW_/ M;V__7,Y7JWIQ?G6UOC*WOOSZHQY<['.J0<3 M<4&JU<.+1//H'W.SY2)85QL\R4\WLPE2YS]_8/_\^7C?GDAA/W_FSWI^?1-Y M$M^"+4;>[]U=LUC_2_M'&V_+B!=EW*\>S30,L%D[OPC*MO/;^]#JY[=-A(V? M+\)D-(]J>$DZZ0M`_%[/XH3T`W7G*!\OC7#1=W)=/25VNZN/,:_;IXY?GB\^ MUA?WRWA'8GC@K%DLNU^CM@=1*D;]3J40_H'^FBO5@G;%<&`-$.7FRQ/TL$F3!^%PFCHM+IV<5Y7Y5?A[ M@//N_FZG$G]X+DQ0CGHA(0E_$,^`U(YU_%GT./L^3(\O MGZN@T:8^O4V*2=.QD?FUN4-%8 M_QB%F0L8%\0Q3*M^`#&*;+G>U6&*VJ'U@]!Y2_HOSA,K0>T'L^S.FE7=VOOZ MO^\7=?A'MI5EM_GABB+"$">`8$F91I80PWM'5)&TZ7TRY^M0I)N1\<@Q1KN$ MD;KXZW[>S@>4D'BE164L=$K[8.3,D["R<2[ZQ0PRE>9H3UP^XOA+^3AH'LM2 MXH_+>O?$OK-MQ975U@)FH2>0Q'NBP?/LB#`I=XT_6(,#+&(,K-Z^C13G!Y1G M&@=[!;_5"U/?WNIYTSZT,>VPU2UXY>G*&X^!UU@X)B&'VBC2`X"Y+BPH,R+L MS=C8)*@P?O7^=K;\6+=U:'ZS58.;'ZX`HU(H&JS8(.LYT0K@KI.$\S0%3A:- MF4:!HT"3H+^/=>QR<#_,K+UQ08QOL]M7:G9L>[SRC$E)((1&!Y_6>V-T'U%2 M7*9=IC'9(#QNKG1$(!,T_OML=;^&>3G5Y]NFN7J<]BIO%M$?M-C4G2C M\@>TK`P/?=8>2Z\HMU9B3KK]#4:4%C:6CV\'XV.:)Q@S6[0?9@]QM])C^,QE MW!J5V=JR4C1.==Q9";4'@!*).PPQT#HM/#,9Q[X,SL6XF&9AQ==?5L\$,#^[ MJ!\/NFPQG->:5$YYZP#0"C.FD";.(MM)!SE)LYC)F.ME6,Q(8":L/C]<,_5E M96YG;3N_FM>7\;1'C)G%N>]STT^#KRQ%^[ZFHHQ(X8F@S%KF(-0`T7X,6)5& MK)F,/G[\=6EB@'/&#TQS]V7^>$.`69/%KX/-AY_:^>438WS(M7();ZN(U8X& MGSU>R\8\0Q)[TF-B1%KY2O8VC2X?SCEL;Q.?^<_YZN:/1?.EK9??XE+];O'U M?M4&.)O%19!C+=/'']!<*^+S,JSN5_6R/=MZ,^9$7PP[4,P9=T*&'Y!608ND M7Q&`!VDVS-^V#9>AB].Q\WXD9[7UC5^MA%$T;+2(B3=>`H08$UWP!AOF79*] MBW_L/8\^2@4%1([(CL,*1,PU\&3C"><]L.\ MV!-./2#ZX<4TYY?U7_>QJO@.!M"`UA7&A!L*#4)$6LH)\99W0$&>>)G,R9R* M&FPFKQGJ:,@>:T?1]WDG[V-`ZTHJ3AP,#HAG%&CK8$"SQU/#@L]7C:K1`3[\ M.,C]9UA-<7RATHVE#"-I^PEX]ZUW`YI70D)'*0&0,`&SD0KJQ&HA_Z'_\UKY>1E//POOY6WPYW:+:\X/_9N[+NMG$L_9>P+X]8 M>W).*LE)W`_SQ*.2:$<]LNC1DFKWKQ]0$N55$@6!$)R:>DC%,0$"W_T(7%S< MI=*`":"5,4AH2S0T@,%NYH2`(FON%J73I`/W:FO/VRE$;54'^ZF\!M!I@200 MSCD2#CI<[#\O"\"'4'62"+K/XI08QK\OK4K6A2X`.NL:E`"^1UBR<5X78L3*(H3J(M7D]0A0+1% M%!BOVKP2>UT/"IXK/+MX3L3A=2U.X"A.X$[_AYYS"[TF&B%E!9?,='-TWA26 M4OEZG(C#*]MMZ%+]N=Q4.#]U"[I_L-*.>:>AEX@;"YRQE#VM>-H7%K53QM7# M11#F($,;S!"F_BJFX3P/\=Y]5.'8*!6@@$G(H$::>J&Z^;<_ED6A6.$U>>#) M08]/\U6]J)>K[Z-5_51L=@?,:C^'(^3HV4-%H;%(LJ#$ZG%F3Q61@"-#`0!$>F0(U)3L-U3I MXY32P1201$09%J1\6L=YU#C8IE)0,T.EQPP3)7Q`U>MN?FV(3!0)!@LA242" M5'!DB3=[4K9Z:)KO/%U![Y&D8;%3-NR&`BK":#[JX03'`LMK0*8*2`1?CJ661NI;@R7FN@2N?;;2E+"%1%EMDF\ M/VG?WBS^&BTF^V$]J47]6!'?644L),I+(2032@IGJ>E64=YJ7&6M."DXD0VL M*$:\&T/T%->FSETP$O1:>:RTU5`23T28/I,`=B8BCH!E96F?Z3B2$[7,^LF9 MX?!'&U80>:&MM9)Z!J`#@B+4S31LXJHLQ33EOI(4F"L[_`]4?&9?]F[8OM-5 M87EW8=Z_Z?.1N('W'ZRL8&T23&H0$A8)+HET7F`+@>5M-?BF63:-;%^K,_+];VN15-CS26!YI4 M;6)MPC1KDR=PY1`C/JQ<1EINJ20VESM@+R^O2R3Z.H@[#1Y9L@2\,]33Z04/ M-JJ<9<80*+E1U$$7)F:8;X,8@3>6(EFNR]7E0NO!@HM0^AWY4)RO5$DTR"_^ MKZN?]>)+,Q]O#!JK%V:W$WX.IYI6."BKPC*G'4*FS5(1-MPP6PW#!JMQ9`Z: MX1)5)A!;,RA".?A@Z]LZ#'82ML2M+?9+O=H:NXXGJSK8JG4RY((%T-I4)2;@ MQS'I]E3J5-R9/SD+$FF)Z0&YEM"?:'NFW)\:5EI(YBB"@E,@`LDIX'PW4^&] M*N02(H/HHS')+/UG*]19'_W;=A4AB#$"&0S0!=QX6ZAY/\^PB99AZAM.]A=# M%`-&HY.#`/^>3Z7*U MF/[YO"3SU]O=1=>/]9_+Z60Z6DR/IGSIWTE0IBQ5A&(J.#'(2&0Q[A"05,4E M'$J>F3`Q+P;#)^)JZ--\4M_/I[?3\_J,?-W7SZG\U*I>MY@'VUW$/RK9Z/9IMK MC?FD<[)3X_%BW=K8CZP!T;U6W&.FBXL)]^(N"'?3A?&10%&^29]U+OBCD M`JQ44KE_/]3SY;$+PPMZK0#!#C`BL"3A8PM[+9;[E919'I>C/WEJNP)(%0=8 M'@_JW;#_JYE-)Z-'=7>WJ.]:?]]F-ALM3F;1[M6^=T\Q2 MU[=!:7[6].C5?!*/@.Y0E_6EWQ;-KVE[@1'.",_^^1`LPP_H92K3<':I6T>F MV8_5:+4.7\AC>*@-Q+AI6EF.YH]+=WM;CUL'N-UOAA_BC_7]_6CQ^/7V'XMF MN=RN8(%0![;$X<Z@I M-)Z$\S)'`@"_65BA!+J'K7J8F?X8_ZPGZUG]]?:=P2_UX[.?3N7./+>K"@.+ M.$=`,R,EU(9*8SI$N!9Q6E'B%)EI1-ID1:I<1Z!TY6RU5H0*`2"VU".IF+`= M((Y&ICX8.('E<%+O6[7V+-"R^(8,6I'4$2Z1IE(IJ[#1RC&]GZ\"JN#*]!=+ M\.S2I'%8_?X<*<^;J#AJ7'Q?8!;AQ7_4D^DX:/O;:JM!QSU>^/1(DTIQR!AB M"H5#K$:$8X-$-V`*92$.(0,(H!D$H!B))BAB:XD4W&'&H)2880>10%Y(9Q@& MAI*XFYXK%K&-DF(*:"+DEZ:.-!)A1%X:9*@+W5,J`.MF;(2/"[89+!AK&`FF MP29"A.^4_?J^-U)\F@1U?WH['3V=P+=3G;R,C`Z_6]_7$]MF3&H>ZLE-/?XY M;V;-W7N%W3*\M0+&:\\A`9(0*P'0FL,.-JMU:1Z?*0^/Y<&;4_M+,>/V*GTC M_OKS]%?[X_M6KGZU"H<:1:4M1E9JZ#A3"DKB/'/[S=F90GP:![6/E`OW()<4 M+T?T\J;BY>_210GZ#22;*]JC^!PS>T;U4X4%14N%C)7>28>]X@`)RHVF2GEK M3[IG)9W>L1#$L_JH"%,,6\5=F]0=4Q?1O>GK5YG]E1912$R0"D--&3048QXAP4)*F&Y=M)!)-Z? M50G1_'LSK#@KZT-8>'[].[GZC0S3K2LA#*">",< M,$88I$A0^3O\@':%90#+Q8ZTJ$68&K\MFLEZO#HAY`-/5I`RA!5H$RI;K"&2 M"*IN>(B#TC+6#RS4-"CE^,QO%J-)?3]:_,_I[_KUHQ7CFA))D;=>,&F"GD]] M6+009I0"!^-<9`=+PY7K0[X0ICR^T:MZ-JO'J_5H%F@:CG^KQY/B/]RH"@!) MY9"@@FB_=0,11'A.2Q>KF)D`RP/)0X>J0_PP)R9D]!]7$2(DM,P-FA M\`?0^S61A/\RJ0.%64&&1;$`1IUY5HWHK<**<*F5!-`C(9`)9[O]APNY0^5: M1`:3_GDL2XCJ_S.NQ:8X"\E')EI^@OUS/MXGXWV:T>S=&9U2I\[NJT+$0Z,9 MYDPC*XBST.PM5%#RN(P(@UE5!I7XFV#68;$L_2`&H298$DHT841Y[,*LNMEH M%)DK8S"+2DYF7`C5E>WYF_BT.`/^IFGED/+*2D4IU,9K0C3:TYR(4E+KY;G8 M'@BT*U-$C7WW15*2$UA(IZ M39&14C,BNI.Q!L@6E/DM'ZD&!C&#W]OK\.]NI/JQFST>\ MX@X^6TF`)74>2$:H`E0#(8(B`0$T2D+F3MJKAIG34UAB-^+^@;XO6E1M#4R@ MF&168VO;XC.6=O,3(-LQXV@\[P52.1C$>PD*Q3JUM6D7-J]\]?6=,N(>;54V>O%=3EXL4S ME>1&(-/N<0AZ8ER;=:T;$@N*9AG'^@OA;-+,/D(@GZ>W]8_QM)Z/CY0W>/_! M:I.7GV$,+!:!=B+P#+>#0P!@+DHSQ5TNFHLAN%;R@;B,)181I@7QX;1.`O7" M(I&%TOP M[.P3<5C]_API3J,JCQK74)[;#.MMW.9D^FLZ68]FL\=/]_=!U5Q,1[/WTCZ= MO+*+[;*BD-*`"9"$`L@8T9[OE1UG/EX6E-[2?J.39P$P![VZ7?A[,YOMRD'W M,$`^>[K"2F.L+(&&%CX!B` MC2&?2&9T-WI@32$7M$GP/R#+,R'(*<`N(X%=+Z;SNV]AI6GZ?*GO-:NLTVQS M]8>9A]IQCM7^;(4)+NQ<.(2@$\"24_@WB]%\N0W44O/)M_5B_'.TK-5XW&8+ M#A-0DW^MEZN-L:D')\[HK4*.2-=6_`.`"FO#T?MIQT(TDBJ#A=(,097AT,IP M`SI0-NG3>I\@PT$?\,,SPS[-K\94`$0:&7XNC7=(Z)IKEJ]\1F> M>XOTT@S/YR%5[*UQ.GLI`19I)AG3"B(N"+7.=(`@I..">TK+\-Q;ZCT-J>>! M]O&-9$XA"KCEC,$VW2V4P.-NON%(4'#FDHLE>'X:WRBL?G^.?!A#ZO6HRB;SMMSP_+IX'"`'?D&4'E"`57.28$! M)I`+(6`')E2V,#M;4F6V:*2C5J&'Z6HTV[YN\^=-O;@_N`"]]W#%!`C?IE(6 MO5>E'_$8"_7]]_&SUN M[#]/=@CUYW*U&(V/E?F+Z:Y2$AIHN890&L@PX03)%A6A$0W+?%Q,;\[\YY>? M@S/@5AJ;S,G*]A&]55YA"H*2`#4"&$"BF%(!$Z(I#]J#RV5)Z,HQTR5E,:691ML`VN6*)% M(UH@U\*KZ\1LVW=964?:Q(70#C;'AZ!&WO@V6>JY@OL5"6B#=IK\2 MKV_['JL`ND`4.&4=,L@*3=WV4Q30$A29UV>P!'S),?V60EG;("&>\*5Q:U M]Q]:'G>[&-;EX^F&]+DH)L/ZO^Q"E4:KT9!]GU_#/,EK=R"_>*MO%FT5H='\ M<1_6>,6D";LA?*\?VHPF\[MG`^WC44\H%IP!85TSE.J!-G>C2$EG4`G MJ^\,[7IS9!+Z;+9C:=;*:X0?&$*\[[#:IP8C1ARPN@8"F-!Y9!W,%!#,L5 M,Q#IB3.`V%\K%2E@RZ*FOAGH2?>*0TTJI9&D!`H`"&+"MQ505#<[23`HU_/F M4G&=E/Y%"/UN/"C.NZ84\><7^]>P?H[:);#3"4_&'AYH46%($0!`2FTP\F(3 MD-7-K;U3*>PRZF(1-4/`DN=+W_H&U5^:^6ZPI\LS'6I3H:!QF?8&0W.HG?+& M^&Y^4D(9)_;AKH92BST5,%D"D0?)WD7:,A:.2V`D$T!Y1AWOYDFEA9D(4*PF MF!*]/.'J,;F>("*<,DN5)AAZ2JB$;C\/+'"YJE\B^1Q-^A2'SL>5=G$*7@E" MOMA5\?S,7LHQ;XT0$EA*+$`@['#=D)"GA?FI1L)Y,+/7>;./$,@EF;TP1!X1 MB#D51CJ%E0S_L!]<9*A^ILQ>,:*Y&((LJV%[5_*]_E7/U_67^IB[WJLG*V.# MDJ@<)A$T.<3\:3YN[NO/S7+I`S3A3!`P6`<8 M=F>X-BRO#H#4V^=N1O\.E)W.F\5T]=A685O4R]4F???S7MS_KJ=M0;;5SV;R MY-!^O+)9ME%4E&B''+!M%>(@1JZEL?M/S8@XAZJA5YMAZ%DN[#FHO[U4/<+* M[0,59P2'H2L.N1%4,<1PM\0K!%S<]C28!]Z@A(E")($FV878=.5A?PV M&\U;DK:T?+@_[G?>OY.*8,(1:]=PC&@X##.!.GU*!43B.#&8E]R@G!@,M1R\ ML?7#HAY/=[X(#[-ZEQFE9\67/LTKIBFD8=4SV#&K&(38@V[6SIDXL^!@+FZ# M\0WS6K>K.K?W(LD"-T;[RP#GE`.=#BL4,24=9A)"=7)^O*_ MJQ>)AP)`(Z2@%%E'E#:0=+AX@G*=>"[W(NDMX`1>).>!5JP7R4`W"9(Z8H10 MAGC"VW1?B'?@")@MA'_PFX3>)#CO)N$L],JU+5N)M`B;'Y`8"LLTD)!U\^`` M?]R;A+[R.6IDCD/GXTK[H]TD9!'R%6X2$$&2$8&)QF)3A,$CW`TI[):%)8Z. MA//@3<)YL\]\DR`]Y>5A%:MD%>E?$ZD1)8/MH_I5M!5`.I>84`\K#M*05W>R, M1@5GN+M47'T=+>,0^MUX4)SR5(KX\XL]G9^M$Y0XUX:Y.NX(`\;Z_5[G`#II MCRK$S[:WB'KZV9X'R\?SLY70"PJ`#)MFO-I/CXNSR--*HN# M:A0H#*A#W%(;1K\_!REBXS[1G'ED4P@T'4`YUNS/8=YW&]*9MJ;0<37O[<.5 M=\(YQT2@%5+&"@$\VG/4NY,Y*A+Y5!6KX5T,67X2M.EN3N[7AYI4&A!`2/@X MW/^Q=V7-;1O+^A^=._OR.&NNJW*CE&PG=9Y0C`A)O*$(%0CZ6/_^S)`"1,E< MAP`(,DY<%4?",O-U3Z/W5EX(R`!ELCDS!*#AJG*GD&HGU4]&Y]IX8'"JVA!( M?_+7_+::?,GO'F?%M'B8[`G#;;PV"WO$'$,J`0,60R"IL&][UGTUUCGP^WTZ MTD6[@"30;#V'\N;>YO=Y6>;CU^*3+;3;>4^&&$9`,&D=](!XY"SSC1]1LK1Q MB>K?:XVJZR,LVX^OP)V3* M<&0P`U%,$6N,*DU']-M/@UR:+SMY!__D,PS2C@1 M&LG8Z2<(,/#F5<(DL7:[L][(O?!'ZZCU$G!?=0^.0\ABK=*BRLO/Q7WUGU&9 M?WIZ'DW*?179AST@HT8J9C4G&GDCO`(`F<8+J7R:/.$7R2^=():@&?P@UVYF M>2SMCHW!XS"R5U[>HBD<>'<[$[V)Q?WH3?$9 M![7G/BSR6USDO,J?%[&D.Z(_+F;3P,_AN_6(L!@+`=:\OHEAJ'UFO0B?>JN5E"+Z MHJF33?:)`S0MRP9>EL^W383.\.VSHZ?10SY7_QG%+_A2P![^D=MP<\:!-P:( MV&S'*,44D*+9,;6)'<[@9;J%6X>KWXR;SWE5K5J@!&UPL;/=V?:;,JJ\-Q9R M#6#8+$68^\9)Q3E,U*@OTP_<&DQKC-!!IZK7?(3YE^+K;'1_/YE.EO[I8$,6 M3WD9Q\U]<#8$;6RZ&`>TMO9K.V,WJWHWRXZ2X97E+&B4V_?24'D'NZ<^,O-4 M"N>4M88#%3X)GA.VZD\>"A'SX\QL?W0-ED?[\D$10YK MX8#@W'N"O<>X!L59U5=V6F*Z>+=\L*U;UHD@]J'*O'[2UE=Z:!^E'^^)JAID M1GAF!=.*.17.;GU@M8=BN"GD+=!L,QK`&0X!13%6]3P1U7]-/+LIJ:@'('G7E([O.>@R=$@(0 MX%3@?4<]:O8!+5(78"&=1I^=[6?3T+E<:@_7`CHCD?LG;M/BZ_`N:?6@/^JE MYAH';4-0)I!THK8+":=FT,V)#Z;#MH9H21CT+Y_R;AS2.6<>;5YE6<9"W:72\/)VR>N1X[Q;GV_9XQ!2ET]Z1<8,]-,%,(T@11;FULL90 M>P?Z"O/MGJW4(ZMLG[S4*]"##3*O=A36N,=-\NZZ##!")!;*1F\/]!YJ_CIS MCAM(55]J5FKOL;Y(_]'=>0*&O:C=R;B\[6PVCGE1OXV>]C>QZN)UF2<(,<*A M=\7*KWL[O\]_EB=_>W`V_/%/=!O[%:(!AQU4)X4F_$B-0< M\\X<4V>E9=$YOGV(LDU+O_W\=:]+<^=]F<)$2@FUA\[@8-T[+YI]AI.;)ERZ MRQ@8`A]U`6R2I'F>CN[R9H=[VDINOCJC6$-&-31<2VH9HX[J>IF,)W:HZ2[% M8`CT;P_.7L1&A&:/\=9/H^V%T M7+\N,TQRYKGFE'-",2=>F]=]6$#UP+3N5NAXPO[[H..7214UB$^S\>3;9+S8 M6TBU\?J,4H@0,$YRY+"GW@90ZGT)1-)Z,/4W5>U,ZE,;6)Z%1_Z<5(_+SI4! MIOGCY/E+X6;5I'K9ZR<\\DF9]=*H@"``QL;Q)EZ+YKP@(P9<=W4B;?=Q2B>X M_;-Y:7"JX+!9J'_6<=_SNT4U^19V<3^YR\O])4(;;\@,!4I$?X?&2&GA(."U M,F6APFG-9CM3)CNCV\<2HC;`ZH,-[*3,[P)%]I+__869"9!(96TLFS%$4*?J MK"YN23@[P](]^R+[22#U0>[V1O]2R!S#*DA/KRD*ZK?!T@L.+-;(6)#6:[B_ MP7!G4E+;0?-L%=)A>9.&$P,AMH"2PUXW2^52IKAJJ(G4_#HJ:]I6%T_ MCPQ.Q1P>:YP<'FQW(+"-P]HTT`8+),.GE80?+)?+``G2=&!U$RW"?^!`X./P MZ<5*>'J>%B]Y_CDOOP4]=O-G\\OHN\YG@395K#)8_XW['O^Z*R>YG1?$81^6 M<:X@Q-Q*3JUH[#A''1Y:A=7Y4I//@G>"X$F&:)E%H9YC+^W)\I[;R<-CM>H5 M^4<^CYT(5XV/M\BO[E^<`06,)$AR1HAQ09$DHK8"G4%Z:#/[^F?60=)A`$P< MAY?,;^Z7E_3$ONNOS&"P>E"T8XD)]@X13*/7&D[N`4MLL'Z^-)_+8-P3*#`` MEG7?@WD^F>?S3[.ZWWQ53H(^?;>M1?(95I$I0(&6&'ONO`'0`,EY#:MQ)JV> MJ;O&*]?!V.T2)877X[H^S>>+?/QU%DBV9YU;1>Z1C\F";N^E9,%BB`6VABN, MZEQVKXQ/B^]VU]C[3-S6+:JMB<8W7?DV7PV:6Y5:KY9U<[]EW4<)OL1W9)Y` MS`3E@@%+*!`V_+6&))ZI)$;KKF'XD,1:/Y`G<&$SB^I8UMI_8^8(9^%MADN% M#7:Q.U,C<:T1:1WFNQL<>1Y^:1W'/OPXOY?%79Z/EVT@EJN^>5Z&OG9]VPZ^ M-W-!#27*4RR\TDA;;3QJ]JMQ6C"PN[F3Y_.^M`WE`%V`.\3EZV;;\P;N?U<& M'>+48*69H5I9'OO.U7AZB8SU\.Y7HZ]-]S3SPHR[XP3C@D85#EDF4/6LQI.(6QBJN15!GX& M29'!,OCHI5A4X0=W^<;9@A7_[2CJJ\\>ETH="TO<;,84^4 M-\9#PYP0@GO\JE,*0+5(LVD[G!9[@=K0F6EVV69R# M7([NJL5HNDP-.FF%>_%=6_\^HVORL>9M&;?6IH(N6=&594,BFI"P8H M-E0'$]+4^`)O$M6Y:PJ[#HT&%\WCJV^L+\K7'\7K=CER^UU(9@GAU!,I`B4, MQ8[*NN.="(2`B>K8-0:3!TV8RU;#&M1^6^PIB^YM#1G@/)!`RF!!4H&\)18V M%B2G-+'G_C6&LH=*DT&?B=6.7BNCYVI1/1;E'I6H]7=EFGBCC,*40D:AU!)* M7N-I@$IS&:.?P>OVL4^(A?Q>E'&-==I<7$SLH;KRI-G\/B_+F.M;3:;JOLK# MQZ>:E,NMW)2?9M^*Z6)6CC.APM"&`#"@A"'!2FJ`= M,AIT10QG>DWAYR'@GL"2]6$(@C]F;@33>#I="OY/LS\?)W>/]:HW;,U. M8M_FOQ;5EJ$[;3X^\^%@$N(U5$(*21BC&C>ZEU1I?=K1M46.SP1WBBA<:M@W MW_)RN3`]FL8HW;'L=>13LG":J*"<(8V8BEM4]73ZH*TXE]@O\MH"LMVBFL`L M:SZ[U4=[K1ZF%K);..206S.F(37:0.V<8@1(9&GC^Z!0I_EET36%$SN"L@][ M(&#T5,R6RUPM^W_SZ?C3K/8=?"D7\VKUBQV*_N$/R;3TCA%D/1=,$"RI`$VP M1DF9V!?L&J-IG8&:TN9E-;'SW_FHG*\#4?U7?1M,=LN:H9V2&QLQ"B6G` M#KJ@T&'+ZBUA`Q,MO6L*!G6-:6HVVSP69<8OWU(`UCK5^NIV,,D13\BD,T)A M;`)4%')'@0*Z$::8IE4OHFN*BW2+Z!J#M#:*=S-&8?%/*P>;+THWKR:K(;8W M]TT2P'QKL=W2O,S'=E&&+_-M_AQU^SJ#>?YS#.Y67A/`,(F#F0,XT!I9!0/; M`1,8`9@XLVK?Z>H(M8L:@^L`,L)1:8+"3X)^QRUE-8;*)39!'=X8W(-9I;,Q MN,(]Q7'\0S=5H]F/0[Q^`>A^$@`C47 M,%,46*T$M-HH@1B5@D%*:E2E,G*X75P3N:./X:)IH/YDV7;0[9]5CQJ#>U&< M>@8.W6PC?%:WG_3^=^^S/-/0?,,]GIU.ZHZJ84X]-V9)P88%(C&O08&&T]\ MK5=9H>FEC7[NT(H9&"DNCO5CS^`XW_B/(L[;F$ZJESZ9?_/;,Q$PU@AKX3G5 MV!+@J*TQ!YJEM;H:>`\D=\@# M%H1.(W`\UFD>A2'G`0R*^4\@16^LOZL@76\I2-^UYYC5M;=;3"<$X1X[,57"Q>3&)$>/QAG)EEOL=Z/M4>K(7RSAR_%#[C\C-YNYT\+G=.`<$@]T19* MJ:B(!JM#`J2%"4<;,<<\PM"8&L-PVON*JW4=O3V853J+ MWAX']&"CMY]F0;;EGZL@9N/[?HT,$7'8':'?/K34.G%ZY!/PS,??LEGP6R;JME8C9\"\,'H&\5A\:_3 M%?=SP%'/R3S4QB%B/+2"::GC_*0:AX"M&E:LHQONZ!*Q/CCG-I_GX3V/8>4V M_Y9/B^<(SNNR]_++`7=GT#%H@CU@G)/+.;88R7K/T9$PK*!`-US2/DX)519K M\X:7WI%\O'/@\K;+,T."O/,,.2JAQ90)3)4PA"CIO74X+5VE,\=WNP1M$9@^ M3K>:+N'/QYMMJOUCE`][0&8)(L&X4@)XJQ4%4$%7P\B(3&S!-V`_;JKSHQ,\ M>W.R?EX\/8W*EYO[M1;0RXN"?*O*28S++!.ROH:7K;<$_.EPWK,,UK5S&4A`VS[5A$DF&C)""UYN7%*5E=EV,4_5@TN\LESD. MPT'$ZR^@]D`)*RP'"%).N9`6QU%0-6TP]L-UVB9R1Q]%"&F@_F39=M`=G"_Y M@CGU9,?!)NU^?0C,?+'3D7#H[9EV1CI"$(VM8`$"1L'F&Z.P3IQC=5%U,`?3 MLN@_"7)MLN0Z7(E)V1`O:@#BYC`#0IS(RGD3#FM:S8Q6%Y+\5C'S'FVMM7' MD>^RC\_[O-D!9%MG`7R"`,-6,JL1Q`:;6L;B('2OI?3L6@[/2=2[[+/S?BS7 M6<[.^R5D%$FM,#1!W8;$&J6`$#7ZCNYWPU](Y=JUG)V3J'?99R<0Y3Z?G/OX M_+"*S$$!O?:,42+"'QA3;6L:($'2C/?AE<-=RPDZE8"I73[[T$.;&L$BRHDM M7JDSK2;SW!,@9#!Z@326.H\!K&&&AJ$KT=+23?_+(9F%7*/_ MMG=MS6W(%0"#_KH!-/H&*Y5#C#-%%$1LMW5*0MB@Y7;.IKL\,C_!M7L@Z\][ MP;[%*@Q`&82BG"EM+(1>*'1??"_RCTHXK';E]%32GV;IYN7_>:_?IY:C::[? M`^<8(+4`1/%SA(`H=E:*^S)GD7_&X&'QK]/3='^:]9N7_^>]?N_M5NNF6DYS M\1XRP8`TP((3R35@6"L-H-XY?21RPTJ%G+/1],Q7;D;F3]/@VDGE5&RQ!TXT M)&,]LAH"#HUP1E''4:&?U(>JR`$5Y09C;UU7FLKM+Q_'!@[:FVI`.+<*8^]125?C;F#@'YC M*8\:"VF1@4PP1C#SPH`=_!YUK]3S3GGLS?J]*8^'83B)R_D9Y(]!Z#F"S@!L M),">$DQ!BZJ$4)]+RF-OZ2B12#8,U']$=AQT)Y[R>%:26EY"7[H.?/CX9Y\* M6J_W"U@`B9S4*!)(C4((&]?2R=A`R_YY943V9O7SDENC`5M"@/1Z&=7>Y?)1 M=:D.7>V5'H%;)!B6Q$,L(3&(*R!:VKC2PY*H#G?GGIG6-@Z:IY*4]&=3=9]L MG7T#H@!H8EPJ.>4$=(":';W$3[D"\-$<["$18V#U]F5D.B5N@ M7R?J3=W2!X.UUG_#!W1S9%8T3XZQSX M3.)*]$9+)UC$"+=<,0<`A-`*_Z"Y*2K/327.:`.=,E_>R`J94.D$Y;V6T%!% M+/7:F& MT1TOK?'#GG.9GDIW%C:VC(S[61;AQ%=>P$X[2050PFL3_Y4,[6P_FNNW8M(^ MMR/KS7K!OL72"PSIR2E+"N"58>L MZ_&>Q1RSD)U;`ZFN=L-#WSE9N1^=,TN+[9T@D42RF\BDI19)#U`"A'[ID# M(2'#WO::WLJ;- M\`W;$IVQ28IB_EZ]JY?+[6OE)RP>L'>&V]FE>;[K42K@T*$"@II@+81"A#/. MH)!"^OA75,48Y]U^T),BTI7[?\@P(1YGPE.E'<'&(4GU(R2TXZ7>4]^;WI^/ MO3_F4^=#;K+Y^A]7D=STI>V^D4BN%VFW[\@)V]LO:*6EC>@0XS2)&SRQ%+?@ M4,Q+&9H/R@S+P_T?U=H182MQ2?QAFITI/2^V#]!ZC0AE"D%L,64B'OPM71@3 M,=U4KY'X5>=#Z>U(P>22N:;$_/),?[0??HH:_?)Z>W&X^L]ZN4J@=&:<]QL@ M1.P8A4(`+"VC1-L4D'Y/N8=H8OD$1W+O=8UC/(@*"X=-^%=7NEK$/U8IJ7XY M3$AZ#!2T]YP:#BD"B@L@X@(T+1("PV%F]&QNL&S",CY4A87FMVKU2\0B*50^ MPF:KY?SK8J-Z-?]>SZ[G7^[FBZ]FMOSFK^N_?JVNOE;+0T1I\/`!.X20\=)3 MP;W21"&QV]4!&/@T>#8_338!*P5@$;'[W5RHU:J9?UZODO+^J?YCUD2T(HV_ M?_DT^[M?Z-P!HP3J-:=0SK7=*[W6$=FW21;$6;7%XM-_?+T(V<)[B=?-]^25W1YL3!5$S^Y>##Y MW-<+>]+ZE*6W6]-4'__8\\9!1$X[3Z76'"BK#8P_MBY8*X3HKO>7F:K.^M9/ M&@;I"9;*2,:(<]UXZ2B%7 M4@.I-)0[<`C'I73GPVH4#N3O0;ZFPX`Y'R^#)1A(&=$R5,0SC$&M34L79LJ< MJZ^I-[]ZN1N&H?1VI.#,?$UEF5^>Z7&&-_5B4S^WT\S[K&WP%"L,E9)*4.8U M9-*+EAX-\;`(W<(>I-X\J<=%HXCE;*?3_S&;7T7E>G8[7\VNNPWZ^_H%;[&1 MS%I'M$V7:R&\;>FDWDVLE-*X7!\3F3*VAW2;JJ[!I`2S;?6E:IH?WK7Z,<2X6P0.&28`DQX# MIRR"BJ@!GGF\0T&)J86"CRL8&8$J(2Z?FFJV7#=W_4[_%UH'C+C2TG!#I"/< M*`(]:._12F$RB/GT/)A_/!XE>'RQN$SSK&RU_>_%5F-Y8DWKYX8]<*2`X^W9 M8PN@TH1#HRP6I,4"$#LL8"1?R8/QC$1Y@2J2H/ALOGNM0#\V#AJ02`DB2ACB M->(.(+ZC2,B)N4VS\>N95>A(H(J?"9NS;)\%\(76@9D$@\?I[H.TU7%?W<'C MG)I8":]2S#\>J1+<_ZU:/3A:]_#]2;M@!*!8R%0&#W*A(+4:[TX]RR962ZH4 MQX_!J,AE8?Y]?E4MKI:/#!DIKFS?Q>"5+D$Y`K34"!FK(*"$*MCJ4()A.$P/ MS'8)*"4!(\%5[,2_6"[7U95=-_&2N_57;W)(7\[9[-((#AHL("*5TMIA%__1 M*9"1RQ81Z:2:UD6BJ,:0$\@3BM;V#!Q+MO:-%K3A5"MA!:=>QRN:M%BUF$25 M:YB)@KU1X1H1R3(6[C;X?OFI?L4XNR'F\X_$?*BV+PM5'ZOF^_RRVI+_H;JL MOVZ9W54E)?>G`\6.<0"]0A`J"G5:S"W:E-)AIRH_=[F=&.P#*H\\4@=^K:[C MK#\UD:(4P?CJA:M/M^!5*O'NI.8>J+@@N:,/:@7%PU[X$N]3QWTZ1Z`A!9H**2!A,$4\P1:YZ7D0^4$@C.4>\B`DTY8!N*)22C`D!O-!CXM^38,ON/C=_)+VW'B\WR,0.+2T=1& MAML?7-S:RYB[3- MXV4BY8@L5NKRLEXO5HEQ]?7\VI';S?#7HTDV]2+^>;E]^?WW9BLX M%XO'+>:+R_GM=?6N1\K%T6,'"AEFW@(4UPYBEA*A.(2;[#'%K.W4@Z:%65=" MQU'C!LXEY`1Q9[C#1`N,,+W'2A`G2P6`[LW_*"@1SUQ`Y;"=;';)AT1F1R;) MKDV0A*NH!BFJG1-(>FN<;8DV2)1ZI?R@K)%";/XQ*G$@9D6B3M/6AH\%!-.'AG`AY10.Y\G3\KSL2`4IR\KR+'P?X;Q9 MWW0R\4F[@)`P!B%$'?)6:DL\,BT=T$VM3-@@#M3CT5^$C[._^_'Q<;N@G.3$ M.V$51]0PP[3W+1W(T6%':[9+]BA\/(+^$GR,ND)4,U9WJ8S82BTVA;]OMY7! M/\5)="A-/7H'2Q$"FCK`&$FQK`S)5G,5V`\LXW`XS\]`G1H?S9-*4)IS9P9G MC]X!I+!$"C4'-%*+%6=XMVJ85FJZBMFH'.TK+414OZD+2WDAT>OY M]57<7SNUC*<-@S<.0>X!2Z7JC$'9/220,R&FIBZ/RIAX1F#)ZY.6W^:)J M[AX3WD.K?+57(`APBSP!&`@$I3!`J)9&I)?\6,E/ MLHS3W?VXN+EMZN]5OZS1OD,$SPD`R%FND31806"XWJT#,#`[*%NZ0$X9R019 M"8'QB075N_GW]!3?*NKD\ZA\J^6R6BWUW?O9?^K&I&II'5>8`T8)1$@%&`"I MM"V12`(D28L!Y0-?@SM<;,[@*I,/U1-+UL/IDX7A_J1H1S9];PB9W+3I'P1HA/KNI/E67WQ;U=?UUOJ?^ M_>N-@^;.QWD)I0C5V#C&>6LTEE8,K.F;[1:4C07UR$`-X.8?L]6FFM;$EP=#:P!G'T_6ZV; M>53--V%Q*:RL;E:?JN;F8O,\YC:ZX446]^@9/+-:,V5]W+KB)8T`2%JG@U(6 MEBIMVI/7Y8-<\N!X4O/GG\OJR_KZW?S+OH"I'KT#!5!BY+VVA!`%TU&(6IHU M)<-L8-GVB=,%2(V/99',^>JVJ2[G7:FJCYL%[+TD.+T!`Z`!B&AG'J@09%@U MG&Q&C]-)Q!&@G?;JT&OOZ-,],$>LH-!*@@#SBA'*=E3;B.L@47;$403K>KY,&S2,[6M_GM;03CU]GB*@[^=7LG6RQOXZPWVF4BB2`B=99P&_LBATY3?M[1>\HM@:"(12D4:D@++L MGM:XZ$6I(J5[\Y=RL.Y9+?OQ0)IL(I)>+R-0R\>9LQWNZ5=Z!$JL\\!3Z!VB MCF"*G=[!+%2I5T8/-L3J(1&5!G`:B(R25J3/$N M<[51ZS=J4X<6\'*'H#6P0'CB-)1$4@X\W^E:6O)2K^!,0`D8!:#3L+YS6W^M M2U`<*JE0U+$-``IJ`O%NI0`G^71/_&/9U+C]M+9X\V[5_H$;:'CAB'!,?#26&:\:NE3FA2+Y>MW]!_/IF=\'P>8 M$HS_X;33L^O9XK+Z^*VJ4M#!@[W/SI?)8K%NJJ6^BS]NZ^7L^I>F7M\FC>9Z MG9)Y4ILZ64;7U=7O\>C=OC[?H4*4F4#@U#GE&/%`N516'H"DH6^1IP:7>K1] M`BK))`$O$IMR"`V]8IP'CA@((CP>*=@K*2$F2C`N'S1_"Z:K($U->)X]*U&2 M(?\([6.,)J?-_:2R>K0A:#.#[U5S]V[V.?GV]YJ`7FX`:.<4, M$SN5V6LX+0TP.ROJD0$KL?/\OOI6-5&#K;>4+[YNUY/[.ST:L,^MN+]C(%8" MH0F6W%'BG'4>DI92*5BQ?:3WY2"WAW%4O,K=&=+;73[BM:T=NRWV_1#;WJWR M=_0/`E(E%(-``5]7M M(TO[EI:+Q:J*9_#J8F=Y_Q`A3`7F-TC^TL_)-,)7`B1$4`V=QIH+AM/BVUGF M@?3#7!?9(M(+B-[IP"TAH!_JN]EUFGR"[_%&O$?<7NT3C-/6`XR-E@Y"K20" M.XQ-7('3BE$O(#QC075"I>=P;2<`3*A#-J5M4N^UD*FN2>LNM&J8\3M;:/KI MU)P#@2J2R5(WU?SKPJR;IEI7"8:T@:4#^$.U#8/>(Q?]!PE$6HT% M]]8;$/]EU!K>(F#AP.,F6_QY`5')AEV6$.'](;-)-UM$?LVKY=Y`V7Q!NZ]F M$OY6K4XTI6PO371\-N5A?Z@NJ_GWS034]77]5S(*+:/$V7K]>?5E?7T?WYWR MMM.+M)O[>OI]PC#G]"S.-OYZGWR#)DC58,2=5B88T1 MDWC4(2.'ZW+83396^H'HW>X1R?]0+:LFWL)[%"?N-T!`GF))G(?0`VFQDQCB MEBG,BU)VLH,\EID$XE6Q&Q'`$HKE_HEW>F[Z=`_4<^BY=Y!R+A!F&C/>4FTI MGG"X]=AL/4AJCD+O9Y&=R;GXSD%DRHO*;K8O:+6=45W=G0-FDF&@I20>``8< M!H"T%"-JB\7U];NOCLO$'U_<'ANM(O;.+>UQRH\O.-WOU^SI%J@26B''-->` M$TB<=3LJ*2P6\CT%F1@1IQ+2\/Z^H.[%8C\JCY[MW",D`T8+FC-NN.6<8FB5 MHU1!L[M^<#PQCW"YZU5^+$^ON-Q'Y0S67.[[!R/B/8)'"CTC4GK"I;(MW00- MW'^RR5!6SAZDQ`S#[_1R8[[-FJ_5U:)Y>SFQUM=YX'H9;=!Z&",H1B0%"5@D#5:0?\QWU M!N-A87'9`@NF(TV#(P!S^C!\^E>U1\%>_V.VR M^=?_I?_U>;:LXH__!U!+`P04````"`!Z7'E'&_6%&_9]`0"S[1,`%``<`&)D M>"TR,#$U,#DS,%]L86(N>&UL550)``-GXU569^-55G5X"P`!!"4.```$.0$` M`-2=6W/;.)J&[[=J_P,V9>+\7Q(,/!X(___G[W08\D+Q(LO27-_J/ MVAM`TF6V2M*;7]Y\N3I'5\&[=V_^_*?__(^?_^O\_!_^Y7N`L^7VCJ0E"'(2 MEV0%OB7E+?AM18JO8)UG=^"W+/^:/,3GY\U?@?JK39)^_8G]+Y-`'Z67U MBW_\[?U5%>=YDA9EG"[)&^H&`+4?>;8AEV0-V/]?+M\=E0%+;/+\R16819!9I#O,HC^\4K;H^F8+TY6* M>_CY966+EZM9[#%T791XORP5VD6\% MCN:Y/O1#VPAQ8'B:9SB![T.(O$5UO05)S[]_2=9;?58F:_]C\\C-ME#Z-_^M",RV,?0\A`VJZXX MNA1IX&E\Y9'.KZ<%1DE*D[LDWH`]F8!^!8+L[CY.'_]8@$9S<;Q%3ELK`W$W M@PKAI&&C&&1K\)*,>ZK/P/5C]XE_?HZOZ=^P`$`5P>3D%#.Z#ZR*JVXNW%4= MYG,L3V*K`+4OR0-)MZ2(J$4AS9CR--X$VZ+,[BC0$$V)L_3F??)`5J@H2%GX MCW\AV4T>W]\FRYA6%8F+J@WL%/N1Z^E4HVY&?H@"WP[-KI^Q+5L7`_OD,A6S MOXT'E!GXDL;K=;))JJF1+B@0IRO`PCK?L+A`'1A%T7*S99,MX%.>W9.\?#P# MG^BER^KSX?]MDWMV!PGW%]/?#[Q=RJQO!?%>IPFKGA!KXSIT.[S?NQVJWF@_ M/E`%.*>.279U#>J[3G:/S*Y[.YT31WO`$U?.X$[R+UFV^I9L-E32N[2D[3:A MI=::<%(L-UFQS4DWOG*",+!"[-N^&9C0@ZYGNHZ+D(LUVX/14,[)+50=NEJ= M%9=V2MMN:J?U=-,*7%;V8$5-E1;R M8!@$5$S@.I[92'$0-`RQ;%9>^8K35#81D:5L`H*E*"^:N7"6*;$">-/'TW@O MGA>^9"LC;H??&65Z@YT=E,+)KZ>9$%=IB$>3+E5V"M"W*[P6J4;Z;*:7-NZN&=-AG+\MDI04W9RO,%P% M_.6%J%IKQ6$Y1RR^\&H0_L0=GAWF1H1R%&=C[1F.K9)>_#;;4+<*-KM6/G[( MREVJZAN1'5F.1VEI0LNUC"CP7-T)W:#7&-TI>\,=`K/`-4(*I%G@,D$3.?$M!MB M70_SI#H_$_+)C2E3>*MR4I".#TCRP!+7H@.N'EH>I->T+3,R=.1:(0QI@H-U M+7!,7;,'MD"12ZMK<'MJ3I=''+"DIR&-,7`F[694")F\^XDW-XCO$[9WE,0% M*=ZEW:ZIJS(N2;4YZN/Z/1TW9_EN*GEO;Y,3?><)K+;L%7+8$U`@)O]^3M"`^2?:0%.V&_%T[I;UTM4,OR-(R2;B`VF@';QOU/\QI48C;[4&+1NKJ M<"9\GB34HXM.JNT5VLG$9/B$0HKL.AKZ7U$F2Y2N(OKSY"9])LLS`AN[D6%J MFF_86AB%OM'*,@(-B>YJ4J%EXAU.%3Z.$Q[4X3WI$$;L@E)2>?P[HDY=;V-V M1U7U0,CU@3NG5-;G['H"Q>'V[*A2;[-`C_`ESXAA"((=12:FA4AU_+#3I&.0['.0+H, MU=.CV[N[.'^L-A'E65$`=)=MFUYA/Y8JM6RC$2:__$KBA?Y)ZT><]T>K`C#E MH)$^)\[S&CT(\`Z9BL29Y7:KK=N^^3^#K9)&5"7CP. M91M>8"/L1-!Q'!@B)_):.9$58C&@R]6@F.:M6#EYNF3[>5%].N?%.=U5`&/T MWG,+>[KG!&DNBP<16DVES0[/BL(\RF:5M@J`.5ROR;),'G8#@,NX)$_W^3]_ MO`(C%VJV9_J>KD6^%1K(:339;N0+SJ\K$#+YPQ`1H;=ML_"]I??W8P4/%@<[ M)6%W)DX7:_=[8;*KJ#]>O)^XZL09OZN'O5GWJKJ>U>V,0,]O]B#:*ZS#V2%? M9:Q'N:_<8,Z]"MUVB=WN-]-R-.S0?R./^HO\"&%7-\/0]O/(] M"IVD4V]/>.'-JUL3Q-V<2>,;'<;!+0EC;1G<9-C&AWHQA:RZI12V=%8U:IK4 M'?K]0G>\"+K8P[X;A#H=5P>1VXHQM<#D2934*%`]B-T3!;)N">H,)'6++&EW M>]]N4^!,@115R3#&G;XV^`CXI"(Z06?U+H-*K;P>Z))]G0C9I MX3S?12[5)EY:58EK=5#<\E#AR/3\O\,D*ZC#^I%K&G;*UVXN>%VN9F@T]U[9T77=LRW)=9+?%6B;D&C>/+4MU MRE;K$DS9A`WD2]FF\$XP96MV1G>&S2TP8D6Q<6J(V\SZFETU0N0SD`C M4@Q9PBYR$6L*`\6`U?=TSVEX=<2KUW$UUN1YT6IT-(=A)<>DX>L4S>:29EA[ MK'0K='Q;MVT<>)9O&SI&4&]+-R+,-2109)?@Y<59C>2LYE MA'9/7#M5-B.<#3.O;Z%`KOLSP9OLJ)XO!:@PC1]W=4IXK'2D^:'M&%;D0-=W M[`@9N\30T`.N[<22BISEL%*6G9RTF\Y)4=HUH\PYTJ[7O"&TD^/^W&@G*:IC MM)-I&C?MCA4;ZBCP0SVR?,^P(TWW-+-;LK""P.`9B8XM:YJA:*M2D'/"1O(! M;@H/!#B/3K_;4^\BV'+??/1"NIB)@U326@OSPM79-_@!OR)EE^7_K&\)?FG MC!;7R6B?7C]TFF>(=0CU`.H1MF#@(!LCO=43HI#K;&1E(A3/]332JG=\3&TD5SBM1(.GJD%WGL<\3CH6M;@'N,IK;2;T51]G-G%S&,CE MZ]7W!--]G!!HV39E\6^8)2Q]I*N8PX(#!>_5IR'% MLE8%$B8+?"6/W*S@=FTH+%0:)D2+1A"H%(%?^[R2QHMG)O0"0]2PV1!#.(`7 MR!AGQ2!FM-O.Z;`KWOP/B?,P7>&X)`L_<`UD8.3H`6;O[+5=#;=ET9('/:4W MJ@#%Y&CW+*\K8>"1*@/L_9VKX>=5C?/O=8!,8AWGG'O[:$KM&A-%QS(K@'M= MD\"18UX<0X\)$HV)`]H$3=9_K@P0\,.*+L<]A:=,-0- M+_*Z85&$/;XLA._:T^0@:Z8)+!M1W`D(IUU#TP]U3@DE'Y4<$+QJDK3,XTG\ MO7F'F%,SX,0H^2]RCC$V#*)#.XO"WG6Y@%9DV]@R=80<'#H6\MWN^A#B0:=M M2(XQ_RYUPX)+7X_X"--731"_^E3M_+Y2)3)Z$'1M M>-M79Y@@!&I!TXP9#IKP"AC$#)L1(00#.("*,59P,6,W*(GH3XH%#-FQL`8; MBQB1B0P]\K2V*-?6?%YJ\%Y_*F[L3SVLF3(!!JT6!'R#?-QW7UML"$/+UH3SANZIBAG1BP)JJX:`&IS>O MDT*=+7QTV#D2]3HB@0=/0C["`#%;9M#N!85G8^\(_CT3V=U=EEZ5V?+KU6U, M[XR/V[(HXY2=T;DPS-`-;->"GAWJM@D]T^U&/@&$O!LHQA0UT6Z*2B(HF,8S M4%0J0;:3"=[6/^MY@DV)ST/7/":S6&@)I%8'KFIW:X%@3^$4VS%Z#.K?FR'# MV1F`268T+W=MR#.)`V&_D@#2260FU3"=@Z%U!1."O'IMYV) MK33P[A43I9'IB"N]4!KKY&QX-#J0%RB28PT'A?Z>;;9I&>?U,G*QL"RL&8X6 M0=,-3,VR3#?J1F38"@?O(A.[^C34>6A5U5M`>.9=!$T;RAB5?@FQI1-4;P11 M.]5RT(->DHCZ-1N""`?P@ASCK.`9>M4;TR[)?9:7-$.JWBY:+%Q7TUUD&:YM M.Q9V=-UV_;8\!WJ#UX!&%3+1<*O94YFWZNC(B\GC'UT)6CEX7*7>1;$156-@ M)ZQ^1>T4=#EL2?\8:IR+LV'-V#A>CIMD&,-!GD_;ZTVRC#997"YTS49F&+B> M;FI18`<&U*)N==MT.>=X>*X\#6/N*T5@S21Q61$$%J,2#JMT<: M-?9B[T6%B$>SX8.0^!=0$+>`Z_6G]9$#']?[Q\51VC0T;FPBZ--'!H6:$.UE(&[;4-)46Q8E+#8M*VQ.H"+Q(66F-2*;[!)4Q M+=Y/=S;42,]E$'YD;?[>$#\V7%'&2[%Y,.2KUPJRHCZNZZ-`4;IB\G)RRTZX M>B#-3]N^QLKBM[&+5(:-3VA*CD]@> MR7VRI(_3Q!X&J*J.F;1Y9>%ET]S5G&WZ`VE>9O4^*XH%AJ:/4$#_QD@D9N-,.",H/I-Q)W$RHCJU\@";6)E4P,?UY_A[ MO1N9_CPG-"?!I/Y_=\*P9>FA'F(-A=B#OJ6[7D^-!XJ(J>H'*_BDZ7UHWWN(>O$U;@ M3*`\9<39R5J+1/PWK\RJ5S"7CY_SF`Y5E\V9\]5WF_J4T-6_MD7)TMTVE@6* M]"@PHB#20]?RL8/TP&[5&I$OK4M0*%%Q-]&^H&[92`?E3BV(.[F\I\.?JC[' M]QHSJ4KI/4E;T6U@8"^RZM3DO=C`+KAA6<+D_8YX+0GV11/<%K^#_FD*%SCZ MK,DJ14H_-N2(_NI-'`?DFCI;EK<\SZ1#+DAULG,A&KF>%_J+E-RP:=OQ79E* ME8,`"&L`[@,!TX M/M#N]H$4_[V--\GZ,4EO4/%7LKHAW>ARH4-HNPX[6=E'/AU%.AJ"K;!(=&L6#KR\I'5QODG_3'NOMAHHFQ0_@)D[2`E"@+>/BENTI_09N*]%G(*UQ M%=]E6[;ZW_ZMQ$Y,4AV.[ZZFKS[I`ZZ]$,`N!A`7X*]-?$?AA%$+H=)-/FA]8/.@;4XYBXO6PCI-OH\P]:EE\EBWAP!\LAJ=&^VG"_Q8US"Q]8/[D4O: M;`CZ_O_<75V3V[:2_2MXV:J[59,LO\"/1X``4MYR;)<]KGW(@TH><3S:JR'G MDI*3V5^_("E2FK'$08,`R5P_)!X[89\^#1QTXW-;K4+'3WG*9/W*PC#V/!\' M:6<`!X$/&0?4OVI9QQL@,N.24*#"#&!&35CMD`(31C4^K"A=[_Z`4L$I6HC2 M:``OQK8.G9[^>_;X+2M77N!%:NRT+L)-CM3(C447KD4>>[T_1V5CRN MM[E6?U?E!]#C+5"CU>??9,5>KV\I>*O?`XE:4L^'0K_4][7<5^[]OV_S[>/A M\6B$.!R+.'$#^8]`%J$)Y6%GA,L4`]+_85^VK`!',,"N#R1'K?/;XP76_8\X MT!\MDJD%X`4-`Q*@1]="1$`3?&&BQ4"%8/W7F1$WI22M[UV(:Y6A(O)"WAEQ M`R9`0@#ZLFTA:,%`A0!&CJ(06.,%*`0MCMF$X)R&(2'0HFLI0J`'_K40C*!` M60C>%_EWV;$>6?:M>6RVJ3TH]Z)08$PB5WKORGP#]Z)#_11TR$W+@&59J#'] M4H-"-:J;YJECO>D!/?K4%,,Z=#8;!AC=27 MMOY<8F1YJ816/T)B5T2=33&0O\F5":>68N M+I,#4!L@FPO5&Z@7;RB.%BEO:LZWS5^K#\4^J]@A^^]#GLF0AL?L"7M!Z$6! M$_@)#JG'@B"-^ME4$BAE-",^;UEK&E1(PD(U+E0#4U28,90-J\M$;,&4Y0)1 M"H60,<8VQZ=0FR/$+>JL9'17N!E(Z<:RN9"<;K0;A=E&9D!W MZM^669=.1H11QIR0N2)PZ^,7D7,J83T?M(=QO+49M.@&=1AU*TT#).LKE#U^ MQVL5B-K)=.L%8T`%TV-[P5JFZ9""JHVA2JEJ_2W+TVRWH]NB>J[VV6-U3.%$ M*GQ'4#_F8>)&+DU)T$NI'U&EG&K,]RUKF(2%:ESH!`Q0A6F3]G;A.@5?,$VZ M0)5.Y:K-F7KI.@5W>K6K'HL5GZ\4KV,96D#U.MJ%PER#`>AL;>>P6Y>? MLRJ3_\/#T9(3XB0F6&:MJ<=$%%#B^)VE(%*[0F;$YRVK;(<*=;``>J%+V-L2 M.P%7,(7]B28=?=7E2UU>)^!-3UUU^%/1ULL.7Y'6D>PL0%G'>E`8:RHSG$5\ M+U/O=_40L")>R),X]'P61R*2O[#P.I!.X(#.H4R+S+*:GPZUR9*T\:PDE'W1`H50"?LWH.1YI*U]4#_]=A^V.]JP\%KT08)DG@NFY* MTY`*D::TWU])HL15K0&T#5@>-WI<[360V0D9(+W59^_M@F`2XF`:?.*LQH3X MQ)RI%P63<*=7%I#CW:+%_4\-#^T?UGNT+C/Y-[+[RX%,_GA75/MF#*O_/"_V MZ+$;Y>1?WM>#XH_F1/\AEX(JOY"=_^'CZ9@_*K-FUK9]U_2^*-']-E_G=]OU M#JU/X^GN)$^_CJM3KL7@2J4R.F0+J%7&^U`8;,.`4>#W]?Y0UL_5-T_3?+S_ M\E"4^]NL?'R7_\C:BX]7:21M4>$G@N"(L<2/@FYSFN]AK#PI9,*6Y;&A@XB> M&HQU7ZUJE.TFS&V/LZK[8-WE]MO'YGWA)_G!AW6E>OF:,>K?'DVF9ATVL/2$ MM_#0QWO4`$0U0G2".#6OZB/.U/SJ#3ZWLJT^_MRXF^:[R9Z*:BO;]-U.C@?; M^V;\J:XU_&W>-'PIBE6QVVZ:A[2_K:6QNTS^+UFV'SEZ*/!Y92`Q&8D%C"E& MW2GL-%CP&8AU7GU:/]IS&^_R:E\V8[!8WV5M6;?B1##N.)3X84@\&G#F ML&P4@Z=(V8EFS:EQR_.^`WC1>#\*PRT-4*WW0O?QOC:;]OFZD'[61\OJ-.ZV MZ#.Z%0Z#)!9!C$/&0NZZU/%PKX*,*"T>6C$\:795YU3GQ4W=*IJ4"S4IU[YH M:YWF)T"A:3X:;U?SLP9"=]VNKNH;]3O!135>5`-N*_W;XJSNGS4&ZI7_K+'0 MFP:P$1.5HAY*U94*WQKC"RCW[?E63-!D-8^PI,7CMVW>M.&TR/?;_+MLTO)W MU58RW?QQMVKZO`H8Y3B@A&$9SL8`6!U(^FW&:"'U@%47 MKYRHL4Y4^'??4YJYF48!I@GU]L4&GV MMC2/@=]+0?N0[5=.Z$=AQ.-$_L:C!`LOZ(L>1S@@D9X+HV4A[[`T[XVVZ^_; M]HWEXM`\.K3+?LB(N3?(:_[4/U_,K]#FT.QEJ]=@VG4;5CX.P1= MMPZZ.7]]`?TIO4+G;J'6+_32L?-'&AK?CKL@;U#O7_-0X)3@1)$ACAV/'\\(P[L[#^FDH^/2#GQ[. M"0?`LUUG?\-14+,93#D2VF\!(9NA^-WCDT1>HTT?UN7WK%H%'J61SV3YF;BR%DUHY"6=-98PT)TRFB8L MCTL-*G2"A8ZX@$.++G]JH\($U,$$'Z;']YO?V3RQ[UL75LIB^W!J?:UMR`DH<](Q$/L4`^[$65N MC*.48D+\D!+E=6RC5FW/^#?XD$2+3G!1@Q>=`'=G(F'/;5H(@<+B]6SL`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`67BW=E` M\NDXCG0W_%,W(=R+L10D+XIY?0U0/\46>B#!&&'&=M:VWK=W4M:[Y_VCR.!=ANFR`3F5M M_IJ?+E4\P=I=A-4FWEX@W)36)_NIQ^*`,S?MMQFZ200Z(6_>NF5=[N?!M_DO M3V5Q5U\G579/1-:U^Z9=WP*\=V`Q$FHB/&\08!)\CA6IY,'SS`2`*1W07GOA M68CR6G2PF*JE6S@U^;Y_.';L M/?CQ3TOQ>'M1?-Y0P#3W[QH%\V;CR_<`;IW8Y7\!"O47G M-`Y:ZE)HXHC0;V5152ON$4%80C!V:2IH$%"O'T:#6.T.>V/&+`]:#0B4KLOR MN=[A\M;C$)8(54O])^529]2Y?H2GP;>7.ZW_]>F%)0%@G$_CH40G++4CS@^(J%Q[().XE@P;WTJ MI(>%SG&9DSIMWD>+WQ24FY5#>#2F5L@KG.IIYM@`+5]%1WNHKJMFR#2U',C_ MNML=-C)U^JTH-G]N=[L5B1/JN@0+BKTT26@8Q-T5(=3Q&.A=-N/&+:OLUWS= MAJ29<^Z[_;I!:W:A3X-X(ZM\=CG77N*[5DK_H\>+.L#_N:S%O9\(U5_9TX_- M0A36GG^P-;VQ1()>MSR]H4F^5?MR?;=?!8DO*$]2$I&(N3QU1(SK1^W\%"=) M&+]UD&?DU^UUV.;]JQ,B]$>':?J3@Y>8&>AY(ZE<2/\:Z\6%EQA'DZ+<5[[< M/62;PRX[>T"[!G";_;6GTLE_KB(B`HJ9B!*:IIP[OLMZNQ&-'$CF,=J8Y4SC MR^'Q<5T^U_>V-P!_:1Z08_"WK,>SJJ9%DQ(*4Z4.VHG,?4?F\8I#5,-$#HMW@8TRQCE"U$O<_X4EMHF8&&YLUDT[P+*A.-!-LELTS2WD^$4!TZ"(^)* MW20NCX@7D\ZP$XA$=3'9C+7I-.U#L<\JU.,$+$T:XO7M1>'I*=57M4;*>H@@ M4;-%L/IZ[_1$ZZWQ&B)<95E7B9(K2[EFZ5S`\JUAAPI;+4\[W7WYX'EULNPX M+**)CP4GD:`Q*@?SC60\>H3"\UY)^%4?WQH^#PE MO6=(EY0`7R-1*04>'8'%)<'C/;J:!ALB2RD1KD^-RF:Z3XMJ7[W+ZU=X.HE] MJ;->XM%8VN1;&]3)E">BP6Y=H6'[)*2.?Y7Q)5OMYUEW16)-_4*5&S-D3.GK\@G$:)'U/F^*X(W#CU<2)B MG[GU*^$\!-UN8AF*[<'I+'OL\*.Z(:'.`]2[T'3E)L5L5VF[7/I9OZVX62X#=!A7*A&LAG)QY8-=;Z^6%A.0K#X:R+RE>2#TMZSX7JZ? M'NIK$IN[%6+L<9_&W(FC2(C`%\+W.X.<$="Q67TKEC7\'(_>Y2\C"%34V4FX M@TDHB#8[6GB-E2&9&\WD4A1LO".OQJZDWU_;>YX;T#D"#=,8Q&R.*0D MY(0P=C084.'&(-W1MC*I[NA=@S*"0D7EF82],\8[ M\EI[#%'SIO;D5PA`^Z90WT8)+UPGZJ9``I^FH+T>@,_:+@7*3`[; M):H1`04`PHU:][=$"ZSSUR#FZOHG`@8ZO@9+"^GV.LB+T4T$L!7B8WV5?)6V M645WA;_KB)B[410(^^OQY6 MX"3FG#"61@Y)XE!$0=@O.?$(M!G9&@C+LJ.[A?4]^-IK^^%24[9%1`HF@5:# M9$4K=4D>$%7K<5N(^MKWLYBX0T`+P?4NJXZ@/F3[5<#2P'4"%\=NY(5,L,#Q M^OFOT`.MVD._/9'Z0FM`*$.*5:!%E:B,YHPW]= M"(ZB05D5/A3M8;=\W\K0RN=!E$0Q$0YE:8HQ%;B?%O9OFG3+:^?/^Q_+TH3T<]5ZP^ M*I6$LLZ*6.0PGU,1]4"(XZIN8;)C?3(UNSO-=W3`FWLM7.<_9,-#CT5[#4;9 MS9;\H_\?5"7.8HB&I6\9T=&2Q(_W_404ZB$CB1E)T.B(>L48V[_J^/R.IRUJ(5#9_:9%V97N8W0`L8`.990>+J=KRB#L:[V6"NJ%9+G^S M_R2;<76Z&?UXBT'`');X(@H#)R(.\=T44P\G29)&,<,.[%(!HY9M;QIY<3-J M`Q<=\:(&\-F;`./OA3$2"L4IQ]FB`!OK#`?`^CV/;W(Y-*]I)28+J1\L.3=P M$:1I"@%/HPR9OO"W[>X^/XD=4=\1$RKO4#@++6GNY>]@AT1$'S=*A1?W*Z*+/M]_Q3EE?; M(F\-OL!PW"::1M*Z'Z7@`;]BTK MVE"-!%4X*_2KB=[;%V7?Y<9?3-O_.J_WV48*CS[?R4\U"3LHI@HF_/J`:JMY9MAF\U?9V<:IB:FF'9SE46"LP- MZ*91XA>BDF9]>GT3AGG"#"A@;?FXY.,0%H1>3,/8=Z-(N(&?BEY]$PZ:CC1B M<$X%O#GV3+W59#-\CU5`2U0;5$!EEB=6P!-S6@JH0?SB%5#')V4%U"8,KH!5 M=7A\^G_RKK3'<5O+_A5^2QY0[T'[@GS2FFD@D^[IJLS@(1@8*INNTL0E^4ER M==?\^N&E%JL6V^(FJS%!D'15V^*YA^+A)7GO)210U&E9C7W3S@>-(R-T7=.P M8C]V]-@Q`RL>%#BV0RX5%&UT/B4\(J5I52+'-O(H9Q3".=GF%L-S1%^MNME$ M!J>(HJQ.6)HP2K/KE#C*)4X@XC!\@?_2+/V(:/1#6>6X#7K4#U>(2KQIJT\@8Y(9<5_"]`_32^OQ3R;9$HB?:9HQ),, M,L4GBO?#0E13B6D78QAET3<]TN=]3035Q/J<(.A?@(TSJ0A1+@B%O M0WHD43,]QCK_CC>?BG7YA--#L>G]1LQ&8>^&6FZH;M](V:43+I9D>_)JA=] M1T`,U6HX"#HO(NJY85R6';'P7*_&P<_T2CUJ>>*KPL/&UY32.N^L_$`NQ=A8 M0$D<`?"EC!>"]:;I?QWRYN46KP]5WA!'KVO-LYW02G0C"$S#=!P]2+RC`IO^ MI-IM@DTH5LD6%:H'6*P747,2-\WSFH$S-O7LZ#HBNMH]U1\R<\;Q$J1R(8Z7 MJ!5O;[&60 M9^`$IN#Y*4^+5S@Y'57+$[E*2A+CO$>FJLD6/RQEYWFFL](/J&,Z)16A?B%^ MJ&2C+IZ,BE,FH(2_X^8+KO)RDZ^[WT9EW:S\P+9C)W4URW8M(XC<6._/9(D0 M&TRI;=(:5:R'!!7:=Q%?4&]I_SJA=4U^%)9!7KIYE7`&IL7%D-XFA7JF8$;:(;F MZH$;&8[OZ+XU2'.@:<;J&5?W);\X\K7*,F+'`*='0W3*N`?O)6OOLJBH%D795$& M;2(1R.T?/]_O\H=VS\C7',W5/,\D_\::D>JIZ_1-QVXD6/V4O3W5D75C)=Q7 MY?_@-23GWW?CMAR`LIZW2.&:5P[5TBQ#"ON?CA"OKH'O2&/2/W[*%ZM]`B9= MCB`6I$O$$SPT9'D>/)55D_\O;?OS]M[=".8$/-(W$/O^6['5%&E+7X MX5XPN"D]6Z\/3X<=_6I)JT>MRZ=]A1]!6I\A%POBI<0]2J%NXW8LY^HQ*?XE M!8O&:,'1!+SH9T!\YH:VN1S-,WRR^9LR.F:QTBO'NLO>ISP2)0ORERHOJUM< M/>=K#!L%484W>;-*PM0*`S>$&*+`]L,P2OK4O""*`@7RS`ED-K'>`SY4MP#1 MFJ*CVYN+%6W>KI4IX3/TJD)!I^A1!Y]NK:*?6PN6*?`?LRTL]X*=^$.)OZBM M7%.!%(*GA;N_PW.[+YNO1)[^J/$FRG9KT"IZ;3!%DQ6;3P7135S3;>2(:%=9 MP'7"+4 MQ#!40>FL`S$-ZBBLC^8-TPRPA*Q?YR4X/Z_\ M&/TO8[(!FQ`@0V`5&IDU3#70[[UE[;P3C?J]MXX^9/G]SI#NL/C^YXNRNWO$ M[8!_-6+)`,85\0$[3Y$XA^@EQ[L-6A\JXAF6S\19A%\>=TO76?V(MKOR&]K3 M([Z;UO7,:Y3M]SM(R&A*HA>;_#G?'+(=PM_W;[Y8@]+0J18^NL&$O"<(I(%V MIH@.>$4%/?+OSIU[58//_4,P#41%[Y^(,[SNF[:`",4K$U`N9="S1*S3NC;Y M!T6_AE4B<>O(WY3;_J._X^]-2F!ENW_BK%I9B>N'7DS6^U:8^I8)H4H#J,2* M5P5^@,?<30QO5PYHDC3ZK32^PSX]"'FH)94="^OAH;`>'M;@&;4&-&@]?`64 MJR!6H2TU"[T0NUBBP-5WZF6_9R$=J:(JXG$#)1@Z[_@5L`*U9J!_+J[C&(+\ M%]6!G*D`\W3DI+P!43I/91?,UDT+F.%G-+:\QD@0W@[_-YSMFD=(K0`_XJ[" MQ09C2*=S4Z7.B1 MPB8+C(HL(@`TRV;$C'W#NZE]S6Z1L=G0XDW@*O: MWV8DGFF36U6G+G:G6YG!%[>[U5(MH/Y_[-KIZ`3`E67$MFNEB>V8?J)9L6D, MUZ$'NF`5^SIZ0(>A# MUYQ1]JN+]P52F<1:5@C)J-3#8U['G\O.UR.5"/C*FDOSB#TW>%9F.2;\.G@Y<]T"P9 MV$>%O?2L>/FI[E[54=K2#3K4AVRW>T%U4Z[_(C_?E\6&_`].B]K`IKQX)O8] MM6>4]&#J,7L&7P$7J,8/5;L_3+\`F_=53H^F?NZ?"]N_Q,_;?N#9EF/JOF/%B1<&QV6&/:G(HY*&%<]&QQ'>8D39 M@`W.='L]@!T!.N[14_Y=V+<7Z0=>MWZF+I#AT7<],:J>EUL&'WX&6KG=^%%>-NK0\;ORO%QR>/,SE%3/G+LI=`S:2IJCXN_XG7Y4$!>#;UUL<^I M"8K-9WA7HW%235LX/L3P5K5_OLN^XYH>-C1!GW!),&*`C-V3$WW8TT/ M[/[BBB!*],F1ZU<%J?JHMXWWJ`;CNAB1"7E-9+"#??U/#5A(%Q?O4U\91/^Z M;\3EV?>'>1G8IN[N/3C:A3Z]?@^(:8C:AEX9U]_+T9K7_T0-A'F?UK$:;$2_ M_4COPG3OX8=Y)_@CW`ET,L#;H3V$B#UD>5%3%P$&.>Z2)>',JB@;]()?Z4I& M/GD,-G\7:PZUY?#3?E>^T-IRX]#SUFT9GOWZF41]*IQ!X^1MV^#^!XB$/ZU< M&4#%+^1Q>8W_07.[7]D!S6P.&+R7-ABU[J-1G_O"0SBGCX??O:]S`EAH=/]H M14$(/NQHW!W-"(#P_2K'9*)'FWR[Q158W>4*@*%=^`9Y4)MJ.HJ*A6<.0RH; M+N*\Z5LE[D.-_W6@SR9(,Z`EIZX7L0=(+BOR7>+$;?!S#J>-0XI"?;BOFZQH M@"K`+NBEJ1P7)UR\10S%!?B'R^"A7)A&,GBF;]L(^M3OE/`\@GX*]UWYA4A7 M,BA:6ZC/-'7-237-3?Q$=PA&ZYCTF3B3,N^O!DZU)SK-ZG^Y)+K[G M^3W(UFVLNTR@*4-]M(=TWM,YZL^I'^$LSY8MI7KG,K; M-[*21-]ZM$0I.KBPR&.HF2G$Z66?9`XZV=R*`1$:(%%W8!;"ID_IG\V'Z7B$B[YW'"-Z=[(:,MDF]D\GW"&=SRT&:IT*V+ M0]5NA!PG5,$I\`3])V8QTQK[W+R+)JR+\L^2DSZ!FQ,3APIV%S"9*#'K M@XQR^;2)K$&^XJ:&5JA/5S$%_BQ80BN2CA:G&W" M.H?WN-UBA%\UY8?^ MU+@&L/QECYJES7ORV18[`IVW@!E+@5&7%T3"E$U.A+G%S[C*BK:4;*VO'#.) M0SLES_0BTXJT--"&?)M4#YGN:&5]]A5FH/Y(8,VPS\--W?GY9@[6V&:6`#B30,++V$)R1+CAEW)>'+[4N8C,6E5^?P#-@G!>:/08C;%*C<3R MHM0+'"TRS,!.H]#H&@]CV^/)F1-L4;6ZT%.\-I*^SIZ)=M-8,GP,?N)+C1/E M>9KHS$\QFQ3UR7!C@%U&'"7^"/(Z.7#GB3NC77*)7XBB23;JXW0WJ91-6MVW M9Y@8U^.F?SUD1'0;C#?A2Y=!F^7>(2(/CS_10;#YO;UM%^-0+`@!>66GB M!%&VP-D)K5RW!F)!BNIXZ;S&E[I2'NE1E;W'[_/=G2-4S]BW*`-60X*;J-([J\3FRW7>BL6 ML"5S-=/+ZP]*QL5:>*C)"*@)RJ?[O&A+``3W=5-EZV;E.Z9ON(:GZ;KG$B\I M(:M%SS#"Q-634/.GKAV$VE`WK_2PT!@7^K-']M\S+Q3.L71F?2"%W(4L"^38 M4BIX^U@W3=>/>'/8X<_;OO5@_:]#W@;;UN'+Z*>[['Z'5V;@!:YCF:F;NDD: M!+[NNA2'GY!_#:;ZH-(;5^S.]WAAOAW&Y!CR#?CSHU^@/RGN,P-TIDZ9N%][ MS?Y@W-"5WQ5JMGX9*3VW-ZRJ=Q:BJ>KL>[N[K)9(9H]FU-YOY!>?&OQ4K[3( MUU.+_">(`SLBFF\D3MMFJJ5N9+/HK%!#BC7UH\&+_@1XB.)CU4XQ4MG<1.5\ MMH!!;AD/:=6P[ ML(Q(3UQ3LP"`'^IZ;+"M>.6UJEC<(#&]12-1WAAY%1*PXYI8^O'WX``>0TC$$&1:@3$<.^_22K('JS_H*KV\>LPG&^.S1XLPHU M2],<+W(!BTG^"6P=D$26%<2Z/2G13&'SBN6Q@X%Z>%`9`5&`Z.<_;F/Z8PT_ MGAG)L_4$MX[.V0ER!77HER]]O\#U\13U]:7U`JUL&BNKCY8KMM(LO*RZVBX_K6BLJ^'1AR8KI$&J6['5N(DIJYKH1.FODX@L(BM M<&.JHT^S^I'6Z&Q&-![!=U56U%M<57B3$%S-RZ>"*`.NF_I371]H MD4/X`SULL0+/2"PWC,S8<,PP"&S;Z2$ZML%U\#$'+M4+9XURBIW3\9RE"[FC<1;1>^+!.Q#J/S($C2RY0:TM:#`&M=;0FFV]/=>/ M^.'M";8`(>7]O9`9X2JF7PX_FHG^22D+#/!NX6:/S_LV@*K8!-^R:E.O--U+ MR:3G.YYOA+IN66DPS'V!8TV:6&8!LH29!("CLD4^NAH%M]J444,88M+5=][Y M*65Q_28^AYR>0A"%CSK\]'J"8'D=-CUK8%$=QYF+YA0?R<[29)H/48TM#T5O2F+NG+NLL-,\VV M`\;)(_^.7D#V:JY%S1&?NE7:!,JE+\/DLJUTG;7<%=2Y^A!*^N+'6P,QV,:_ MR&$E<+)N_L$]F)8=NFGES*L575K+JA/"!%`U0TPHJ.8*^7!,7(YIDQK:I?%C*L ME9E7SO-ZRQS<=_A[$Q)R_EJ93NPY8:+I06*ZEFSW.WJS`QG-QW$=9TV&?OZCR`Z;O,$;UG@)671+D%`U3,M5SC\!)*(H M%R68`W>\.LE._H\@CQQ6L:@B+VF3Q?!5\-J@O(GG6*:MFX'K&J%F!+&A^41] M74M+[=AVF`IJ\;6@6.H^[SMODC4W@).O:>*EGBHVK7H7](J"IJT_`$<($+KP M):,W'ES-Q_N0L3,*)<;P0@1)T(A2YDO'*#=0-^OS]M>RW,#FURVNGO,UKF_+ MW6;ENKYI6[;A>IIMV+%IZJ;3M>@D9CCIPFL)S:B.G>HJ]^VK$FJPUJ@FH!@U M2(3$:4(T$W]L:M131V'1$Z\>&+H]2Z(2Y3E-T1GYD<#K0C1(AB6E])>.N1[Q MCOSMPZ^X(-[`#G;C-T]YD8,$0JV%S5>^5:0.%H81T:4Z&;B1*%N]:W[ MIJ:SE2F6TJ3JE6"+LKV$\!5`>A\A09^(7(GVZIWU905D#99!K_B&I,//Y)V8_R,=^4>]H#Z M1FW7,ATCMKTT#EPC\8*L3E.Z^0AE M$[A77(Z074G5SM)T1LSDT+L0#9-D3*GB#12+,J1'@NTUCQ#B6#3XH=W=^=K> MN-#=^V=$KJ;93JI%D>DEAN]Y@WJZB3EI4TLI`,7Z-LJB^CO/511JR3^O=XOA M73SB`8U`T\"Q$6S4X6:^"E9=OP@%`<[?/WS!?R>'!I3\/="`OZ9$>+O%ZP9E MZ+[OUO6H6[\]YNO'[EN/&7'@[S$N>M^!.!2'BE[5!+KIV@%#@+H;F&/Z[ MK\HM049^2U85947#F@X[6N.X?>2`/1^]=A3$#:I?X,[XUW\%CR8/>29Z,_HD M_+8>;FP911]WE6I?L_@+>NC7.:_7.-W36NM[>EI&RBV":XF:[M:KK*"H*C`K M&R7A$T=MGU4-=/DO%,=3]C*P.3RIP@^D45SU:UK(OX$_;_!]0W_114W7F/0V M>3"N!5-AF&/D&-#G(V]Z=O@RHACW_R> MRI&R_>XQ%Q=VN;EH6\A"B1__!SO:`D1,5H]A*(WJT*21882V'X:^X:1N:,:F M-ZR\##.Q602$Y_F*->2H'EPUL+@8FR8:JLEBTXVW/%VG>M4'G)S1#Q$&%R(A M0B:4\EXH1B'I\T7[[9LT2C3;"%U3MY(@\733T`>]2E(K7A5D64)\HVDRPOKT M2:/";T?%&,CDP=$#XMSA969KFH`HH8E+/`9^KK-K^X:(,XK!2]E"U((;?BGG MS6%6B6?2""RY6T7JFUWY=N2FMIE&II5JONN9L9X,[=F!R7)4Q-V(XEW484SD M/'X'/W53M6,&UEA%I(?4N2`W0^&,V?7D8W+."HL@GXM1&%$[WDF-%&*F+W%@ M>_'WLBA?.T.]TKEA:*>Z;_B.I1MII"61&?>M!F;$5'Y-L"G%^D/1=>)S@PI\ M9A`I(7+B(F@^#AG70Y2^,;)A8=2!FWUM=):J<\LD.1PO1*%D6?-V\223)`8/ MJ5^II<10N+4O+^#`X9AV$.)M6>'VUZ4_\?>M?4VCF/IOZ*'`:87 MR"Q(W4CM&T5*O05T5S)=U;,/]6`HMES1M&-E)3M=U;]^25ULY^:0$BDQJ<4, M,)F4'7[G.^1W#@]OU,X912Z M-&;182H(4Z5C^S;A-EQ`ZD:]Z(C-DYVMH4YYL-2Y;DSM'_W<"6.5LSU[Z)1. M(.V!;#(G/3W4TO2!HZG.Y9,^T%WXUIK@G-APT4>/AHD+/E'>51G7RF*;5=_; M-WTN1+1I'H4MVTVULV6_DWGV;$)M7_^R)`):2Z[X.L&Z4CRMW!K*S)X_B6Q=3C4J%9+V@U4:I\NJ6D; MSU?'MC_FN\LUU^(%(9Z'@SBB<9S`"$-$Z2%GB8A/U),(30T;SBS$30'E^F2N M?$PPQ.__!O@_.6(071Q_]IOM3']S7;?[A3=*,L=Z9HAX3NB4T3)ZBO5$2"^< MSG<<<#.;[7;B7I55NT/]D<[:.)D][P9I"=;D32O%6)=M9V59*X'#KK!9I"#D M4T9$T@`#%XGT%Y/#%COFABI9J-I?-IQPRKSW:/Z.E3.#:1A;EHR6@>#/W:6B M2(%T?W_\]%67[J)8=!YH=0Z=6_<2T93CD:,,\\ M[Z>81(QD4RYKF(Y(M33AN4?X6EYGN]'I+%5GU$R$=/H,:W_8TY=DS18]Q+Y=J=X6N>I,Y M+Y@I/ETT>MD*Y2LQ9Z:RTP-&1]6@AOG&$ATU9IYR=6H,C49*50\!I30)B8=3 M+V`12RAB'H?2`P*!TF7'YE!,J+\O5$NT*K!6!^DO7YGSC:E:5GO;3%'?E;4X M_;Z6JWG9I.4*'M%4UAKF92OUW8BA(PI>8Z@=5PU88,#2$",8`QQZ+LT)5[2;ZI&&!$PI@2IVI;AE+&#H[\, MJ=X,>K9M:88^8@N!8T:2K2E:C78G%=T:QQ->HN2'98V>W,I00RX MC`8A)%`<&PEI#R0(8Z5E%?VM_PB%235W:"Q-&O.$R>)D+YWS3VDE6!U;H!SD M(4N4U:"!0XJ4(Z@T5:9\`"G`,`HX%I=XA(8N!O3P+@GR$%.ZC=HDCA^M5*GF M)"/%2F/^L:]<:8^Z*WE%7\ERD*^M5'Q#IHXK6XZ@=VP58>'SH!.`A&(<1R$! M`$+2KXTA1F$ZIG0IVX;AXN7+50/-Y4MI3D=5#[32J:UJ8$>I0+U$(,VF)7(V MV@RYDH`B+=(R],Q-P,>GB(_/;_)FF,]B!E*>`Y,D8B[C;1."*/2)#Y5.AVIJ MTG"*>7(GNNI9-EV/Y43:3O>JZ?C4GC7SP)\N1YP)"M,[ MVY*X,8/ACU\2G(EZZ>C3ML"_0[X5]8(%@#>"8AJ*.]A#BC8\/XLD2+!H(O=709 MU8QTL%0=X6U75[R/?1T#H"& M%:J[TZ[+15I,RFGF+(Z3S#AM]YEBI5/-769R1P.4GDLCY_2@)2H^+P>/D\OY M'2+U1.QO>;VKBJ58P=J5RS]^WQ8[44Y>E]6M>*_PJM[_FM]>Y]4B3FB4^+X; M8!8FP`64P$..2[Q8ZMB3U@8-:_X)IG\T/G*.R)T&NM-@5WAY5!_7YV5]-IK5 M9/IY/IT3E`Z'Z7QI@X^UJ+O72W=% M=X%1W;BEK,23HN+9S_ML(SZ>W8J'545I9YG5-Q=.MN;CR\F<^BY?%NN"^_.N M>;95?&)7W+:/GOYYDV\??N+@9=[JJGNB5`"[S7"8+LQ+ ME&Q?J=@*6]I;O;7/E#1X4].\:%I'*I;@)_+A/-.G5YD?,UG2Y]:W,C72:+'J M1$@WV>:C1EM?^'#(G^KFY93/-]GV\J[='E@V=[/GJ]_*S28M*_&E!8I1PE+H M^J$/_21P0Q\3#$/^'QBR`":31!@ST&V/1A?]JQ0GACOM\T8[;KK3V=X\/]%: MSW_SG>ZM M1W+#[.B*^E,XT:8,H16!!4]O*,]DB(=H%$`4DB2.^Q2'>I&W:"LJGW99M;,F M19#$KB+;C\V45_"F5+47E8<+YSK_6FS%SFCG.MLT)::?FC,"YQYSM[T#6!.Q M#7C]S03K]Q>36[OF#<>*/>K'B<2JQ$P?A`>YSH+X^S/_$[OZP_:JB3<+#M]W M0>BQ*&2Q"SWJT;["X,6!K[2WSAK0AF?E#1HAC?4A\MH79E7]/'>4->AB6X-L M:[)XUZ8U^MW$V(>^G"7$#NQ.[S["#N5EL@`[RG$6Q-=_-=G!`7_@1C'Q($4@ MA3ZCA`",>_Q)@/!BFW_-^!?FCK"*L*7D-VKE]]1":15F1=T^*=7$V9W%@5;5 MX7,'6A.>MCS0MB:_PT#[T)>S!-J!W>G=!]JAO$P6:$[HK(^`@_H M"7,'84-=P/(X?+#Z'8;B)QZ=)1H/[U?O/B"/H&:RF#S6?1:$Y<<%@XF9;65.S7521P8G`Y]\N\O%H9+/I9BE+5*4^@!'*9^<190%2>H!V)L" M:>C*GD"T%;_I7;2G*MK";`YFY1U*<>!+_-K)=NHB^W8ZR?DYC\W0#<]]G/C\ MW"?NYC[=YQX>%7EQZO/Y9.ISW$_3[WWM&7`^ETUY\CUT,/DCH[::,-4)5*L[ MG,PYTYD<^,*Q5=N[DP6G8*VGJ'P[ZF#?7/M_\N+KC7@2Z3ZOLJ]YLX;.LEV> M9D7UKVRSST^WC,>^AXF/`Q*!T$4^"!-"Q99Q)EY["WQDQY8O,[:]Q_-:/4%. MQU"[K\@1'#F")*=A2>I]M/?1?^\Q;#3/2D7^< MFID9^J:OK!GL!F\JFUHPB&*7121Q0Q02GT`W/&2*D>^'5AY:&V_6U.?9G/Q; M7BV+.G?NJF*9/WN\;=13.&^"]3>4SVCM0>\FB?D!,Q?+TQ7I?OK_.MR_KJ.;KM4(LHI M!0-.^YTD)G_VPI]UPO^U$?Z5$/ZU$/[[9O9J:W:BO7/-G:+,V:MLS5,>'R_\ MX=(5Q4YAP3E%?1WWW2J^'KUKDQ\##R(Q2#T(M)#&!\N),B M]4WP9F-&P#4'&[+<>!7[7I\A`6ZOLMB"!"D M.*$D2)#;6^ECRBPZ*:S;-&L/$5_HF;*^4;?8<>QXSLYF^XEDR9,8=I]8UMYM MK3K,/&?W?2OGG+5W8TO.02OZ?KXCTJ8ZZ8]Q>MH8>],>K#;;":0+,3]795U? M5>6ZV"V8F[`8>-!-H<=PXA(*0B]T?9+Z`,:^I[)D#12GQ:*XZJ'$ MCMS2@REBU)(G.4Z,%%U."#A3^QA"DR4EB$'0R_&]1''D)UDE#HB)5]A[+2N6 M9+MBQ4;L@>J/$R_2%(`X\$#JI<`#R`<(0"_T_!!X%`%/Z5%:76T:5HP>9C/W M;(#^EZ)P:"-73E3FX%5-<`Z47O647C@-RJ8VT.&<[Q"[)(%G!$NW"RP1,^UF ME69[K@X17/`D*Q5WQA+B8Q3Z.`P(ZQ0W]'VJ8D^;6YA$F;X3,>%*D9/#HZ0;M`D&2AE$$^=#$'D,^"MVX;RY.`Z5]7T/; M,+Y;O(U8UH^A#JC"*%)EV-)QI&S&*R-I&"W28^FR^IIMB[^:0@,MMW6Y*59M MU6&[NN(=L2\L7J[38IMMET6V^<1_TU0CZD.8]"GEL1$G-(EI`FG$H(M"1`B* M_<3#2':2.@T8<]GF*?X+YX$%3;YY:H-3KIV#%<[1C/F242WLGQGPTWK7$GF8 MV.ARS@&ENAEK>9.O]IO\/19!0@!%RO<`5[_F&GNLG/:0X2:36T:?`83@=^%QEJ]SY+5_FQ7UV MO1%[73Z2D40 M;8T:EO$>79$/U^*QM*H*[X2,#E?9`TB>C;0BGYU.0%Z[12 MEUTO"J-6XJ15\*HJ[_)J]_V*]]@=EV2Q;G\GDNUCRSB%?(X/$7$]Y*>(11#" MOF7(D-*ZEX;F#"M?C_#":3`VR=`!Y87S,5==.M?!L)P43DRNF@B>Y75^#7R= MNS/JIY%X2W1/IT6EL5ZJL//^JJQWR>W=IFRV*,7Y-E\7NT]Y=5\L<\K_;<$\ M&H4IC7Q"@)LRWX]ANZW((WY",)#=!S^Z(=.[TELHSK)4VI`[GK_S&C8Y=8KJ MQ9MWCMB<#IS3LTFG9E-^L_&DK`[;^OOY)G>RY6Z?5:+R?->6`;L+$7G.?-UB MKIULUU],)(YD[_BW[K@!^=$MW2=%G>EVO\G$"8NZM;1V>$[%1;/]:ON5G/]V MM:]$C:/Y6\TAO_]T/C=_M^I+XN*?#D/2T9+S^T&+1$J;4*!P8IXRQIR=0'0C5$:G4"!T9JHP1.SQ6%=ME ME6>U^.&Y*'3'O_#WFL>Q\M]MU'@F3*QX:./QH?EV5M?B](F(-<5M;B(@G'*H M$A$&<6]K2!AFS&LQ801%PX,"N17YR5_=2ND5SR.J/C;Q#*=HP7A)$O@LH@$) M41A@B)B;]&""Q(U'!0LM"`P'D5.,8G3="92'3&S9X!PKA7H\,3#F3.X$/;'H M@5\NUTX#_#B5:J!KB5-ZG#,R?DWNI!%SL%NQ"-=/>AX-%^%,_O_;8<-G4\OR MZ[;XJ[V#_^%&'"8[SNZ:2B#_=Q%&>7#D MY"V+.W'Q\=\?0;K;5_5>U!+YA[/VXQEOHU\+40;H%17Z/ZEK.L%C9,HIBY`**5QC!,&8]HW[0-$-`9JJ?8F M#LL;CDFOTLNQJB7H:B?43(C]92:.M<9.[5SKB)1?LV);BV@CNG%39AP2&,U' M)D'>\#BD1/W;B#IJ)JG%F`%TR:_8/^A%7?-U>\^R."J_K?,%00'&)(U(1%)? MQ#(4^7W37AR[BUVYRS:22_8:VE.**`=HTB/RHQAE+P\NU05['01+KMA/S*UZ M<,F?Q);ZHKMRW^D03KU2_SIGYY;J-3)NRUJ]3I,>+]9KITM:YYK-X%L^6=SG MJTL>0QMIK9L3L34?[-GFYZK)XB=8Y0NW/D+5BG13O?$1Y%.L^,7%..L604&S.OG*9_JX_N8VL? MMLO-7ER`^"RXW_+[G/]BD2),_0!`#+!//9Y7`8)Z)+Z'LD6%E+3_3RPCG@=9Y7V0NGPSR]G"J2>EY137G('E$U9N%3735+ MYKC$B2,J;W,Q+TTY2\]^),[7996W'_RQI'#@B(Y[9=SHRY4;E MA8]^$F;\1^O5ES[:>;7[!C?'ACQ:W0FJ^;5!-]L3(J8U6R8?-T[[N&#"VTO6 MZWRYNUP_^^\++T@2@F+,J(>C`,$$([\'`PA$:D_+F\&@(C>#GH'_):_KDS`@ M]H/=%S6'9H-TO$:?JE!HB3D*8*7^"QQ&40N8`P`!,,$49=$F+RV,V+TWS>7Z#^]7-6>FU0' M7)VJS*@E0VR\':]<03>0&.FA\^A.^H_[V^N\NEPW;=>7^UV]RYH'>]I+);TX M"7'H`DR\&(8A`(1&/0CBTE"E4**W9=,[N;IW,[C6W9;;]IK'VBF/*)V?VM^I M/K*KF7\Y/9N/>C61>_)L28M4;$9JL3HG8+O+I2?6/B4JSPBB&9=8HI*&C"NG MZ-4Z]+2[1_0)$K+Z][[>B?T&"^93XJ9AXB=10&E,24"3'D[L(J42M"D,AC6V M05C%*N4@W6T;K@@]2H;%+JSNQZ-F/Y/H]VC,W:K,,\N11:$XW26GQX$"_^?OCQOPL.J5K> M?/\EO^>L?ROJ19#"*$TB-T4@"I,D]"F+4^PQ")/(8[ZKDC-K:M)PBGQ\J_/" M.:!SO@AH9XI^1CF6$\X9Z%73RV',&E%%.:[.B*%FLBW10-U6E49[Z%#%^S7/ MQ)W0S2,`3W&P\C8KMHO8\TF"@`M\G$*$`C]P00\B87B8\&EI>3+].QVD+;;! M`JB'XED31`H;I6?MC>\5RTT6;X M:RY2U84;)TD`8N)2SXLPHC$-O+Y)EZB]33*F'<,Z^,]]*>9V5U5SWV.Q=
%3HF24;P2]MNG<&%->4K71](S2,+=K,J`>31F,`DSX%!I@-PS] MODD$\6@-DVW'L(9]*KYNBS47J.W.N=S=Y)5S>2WN.VHN16KA]I+EZI`L:7J' M2Y8)9G5)EFN39+F#)$N57HLE2]D4"3KD2IK:X7)E@E5=(+E2I==BN5(V M14*NAM$C+5>TK.[**MOE++_>?K1\J-E4B(E8H")'3M=ITY)AU5\%"&.;0)Z^W:"7!FU4F94LW!=4/(-)AF# M>O[US_^ZG6@@J)EE,3G;A&`Y9?OSUAK1VX,T1>9$"9Q0/.4Q,$3\U/M5:7YX M98O,JLYID74!\:9Q'P=QDD1.@GP,?1Q!C\IP9QP$Q),J-Y58W$0,.^BRQ:8: MB@7+SM79E2Q`6WQC.31$!868FZI(E3)OB/XI=NIEE:J!,J'VZ7SZ.RU^YH?V M-&UG*8JH'0B`ZZ<>C%SDT;IXT-@@%I*Y!1^O6=/:.?\[!JOK'2'1MGLN8].J MM1)9 M"*2@VJ,:[(O1X3K9*<%%9`K."*[%H^2$8$\A_V*$;+,)P0F>IN8#5=!K2$:H MQI>7LX'J"!(6J2]Y=DP:.K3U8NAA2$@"$7%LA!(O]6U,!C&47**0_G#-8L3P M6#D')"D_\C2)28Y6AN1DAI/38ME*6%ZR,2$FLXDS1$#FXZ\4/4$2A>*'LGFJ MLY)=S%SRMC`?RA]Y>RZVER?D)U[@.VD*`I\$+@YMS^NM8@<+[1Y39$JSB`P( MK7T'4>;B)Q54OE]-KLRBG-!<".S162-XI\?^5U9 MQ>LG=^&U6.]3<:4L5U:1IW@3.%JK,V9-.S`60S=4FE70*GD M7.)JU"X7=JKIS67%J.+DG^ZSMB'&Z:VUHJ^.\R-#4-J819 M`^1>H3,O)R<54B3>@3R_*\K\T-T]QDP/^R8_W;%OVX-<.Y\D-F37+=JA'46Q M1QPXF'=1)+7\KOA6E'R00'NJZW6>L[][J,K;4[7_U[@O"O`AK?E3 MDC@D#J,@"&(008Q3+PA(F""A105-IC6_J%]9.RDKSNH\?>*YQ_)6J;IB\'Z& MMS']$ZX<3#F)8G*@R*2&\HS=259U$BY M`=FC3N^J59[;98-8PFN3#R55>9K??F@:UK._9G^R,VU#^]RAKHFSXY&.P.&A6G!2,F*U#5N^1U;K$*OC>J7$KQ4O1WSIF?3M;S+6VR:+Q M(5\T^IH5^GGC\R646:O)]3^:/F4]5=:WW*KS?5[\R`__W7_!0MS]/S1=.]^B@7WS07R_29J8%*_H_G3BL'0CAJ2N>PK1X M"+5=?O^G4K)HOC'ZBZ"CE7#WKE'!N:J_/&7E*;>O[/F@9;CWUCL M?;%^^?.6\(R*"Z*T'DIP*RAX>FB55#2>6'(4:XO5X/Z4&LES9(K*C:MS*'RT">+NP1%81R[`?0@B`%( M<12$'<0D=2&2N[EX360R;]>L^XR?KS:^I5E=KM:F:BN_B`JIGGB3MPBH(5*P MB>O5]N^3_'8%;O]K]K-=?*5?]'^7_'S,RR9GKPW]LYWT+OO56Y9/!9'O)1#Z MJ4W_[WA^$#IV'!`4`S<-I>Z1U`A#^Q3Q!18_5_2M`W;S[N:&U0,BEB(9$@NY ME*H':%&P7:_D&_[U\(,.^HWU*F(]_/6WH7IGBN[@&2+P:WCZ>O_*.N3. MEV^^[XU^%V=U?;ZKZK^S^M#L/!\X"7*=T$.^A\/8P8'=6R,`N'X"@&L#.`AOFJ1"QRL6FM`L=1R$4DE[G[0E M$J:4+U62981`20N2,)5&"Y"X%T*"(TG*?('YK:9)QLY'J1T`+_"2T`]I6A>Y M;M1;L^,PD;E#=J8)*8&1ORIV>&O:#D_6*?N9#SG4C?6=85RJ.X)*S^9D=:=[X;)02% MT`8>LEW;(6$:##D5\,BNS+]GI_PP4X9F6!1ZF:+V91J#$WZG!DQ6UH-2E03- M(7BF,NEB5IU,77@>(&XM6J])DU&P!92;*F=+7'I/VQ;3-5_H_LA/.^Q[3DHP MM/TPQ*Z#DB!T!ENALRR]$C&P97*U5,B$")RI7*JY4R!5%!);ZS50L2@R&8F2 MX=9439+RX3T1DB=DCNI\++)OQ9%ONOU<5X]Y?3JS4ZDG5/+UV4>V-7V'$A_: M)(%!ZB1!%)#4"T$'`V(@M_=5M6W-,TT],#ZQGO>H;JSC!?M\Q5)#OK28K<[[ M`IT;8;VQ>K0WO#-(VU-^0+R=WHGP*2:%2B-CGDJJ=>^Z@&J@<:&V=HV#R^*4 M?V2'<;I3_W$(@1W9"<))DD8N@@'V>@RNZ\?+A76F8OT5[YM>,\"_>&88G$KA`!5?HZ@_P5M?5M(J6%=6$\C%;5I;X)2:H2`E7HZ2["P`T` M@#",0C>":1@Z_>PCM%,DU6IXB9UU5CM5IYR"'"[6/J7T*94Z0=O.B_?CK2?_PC MM[*'ZJGDLZ/9\6@=>L+I(SM^7JVLL1[I1U.;_+'FQV9.O%\&_9>'MY[WA3T1 M)JA\8QA01;X!'0J4N%&I?29G9J/M]3_/#>_B"$#LA$[HV8#X41Q'?C)DP(F- MYZ2CLPRM5;U?'01FYJ?S6)5+4+43JBI#W7*OS%LD":2HB[@U+$==YLN5)%4! M01(7\[">S?L3[Q"`RL.7_,AVG*`]'1RY8?2MX4WAV=HV(E0JG=2'7A!X7@A0 M"&C]'KF>[6/1-TR=07VOVS.,?/V@0VE=8%I_]4#7O[Y&D,&)=U%]%`QY,34X M]NHF'#W4B??5V-_GAZ=C_NGN&13Z35[_R/'Y*_VX3W=QU9R^YC]/F++SKYT- M4@`\2.(XQ"Z[P"'U,(42QD%D^RZ4:JJMP[[F7.3VZ>$AJ\\L5W_^;J/]OGZB M!4$7O;-L&PX=H1#3T:VC(*>H/=K7$>@`L[YS##+[!0;:^NLKKZX8>(NC7UMF M9Q`\(;@ZPV6(]&IU\64S$NUT"LLQ*D_%H3@^L=F$2V^ZY.?^^'3(#RFEB1U] M?6KG*C[=)5E=4J3-Y[SF'540GW_8Q20E('*`"P%"-@2$0N*=W0%.;5JAR@CT M.HAT+V<\\N94K$_E(_V5^ZS)AV[K=]:^;2W=-E?*.\\L]DQ:^^RXYY,[].=L M;H8107^6=UY>>BY):OU*<193?_-"+#<>C/&/^\PFST(Y\H&%LO>"-;EK&]S= M6*TG*P\-2MB?&"S6C:XAP\?*3E=;OE"20\Q'6H+N8@\C#!SL`@>"*(Q"9LN+ M(AC:P(8$RHP00A^H6>`9!DD)%N-!3$&54R`G@-/>:U$M9G)"=*0(,40SY#!7 M"YX`Z59VQ9%==M"P3E4/CW7U(^=7;'7GX6"$$K;TD!*/JD4,@>]V1B%P0ZEV MF,LL:7['!W"2+_I"^L048#WFY*1AP,5G'L?(MIGNG^1I0E#4\&N(TBARYE4? M/'44"6O3[]G^OBCS^CS>Z-Q:=$(?(NB''H1VXB8I]J/!(LUJI#K7+3"C694& M9#>7LQK\7;LK?IZ>)EM>*B=43*I6XE).IP90ST]8;"-2UQF:4"@%M!HB3RH\ MJ90_<[)E3IXU_+*1UU+H)$EH.U0/0^#AV"$AH(8ZBU$4265,"\SH+HEZ9%8Q M@B9;)"U@4;!T6H=`R8)JX&[[C.DZ05/UUW)6#1$C%9Z\K-54D2,L1E>/A'6Y M&;!3Y(+4C4*<`,='#DE[JWX`'9G3]PM-:=[,.WF<;]A)0%86IA<>U M`VV([J_O]\OEQVV(7YX-L_XS=IJ`Q(Z)!TB*4FK6<8;I`)(0H"07%C&T;29, M$:K*@X5879@%JR94:0X\R>6Z&?!TARHE]!JB@FI\$HJ,\FWE.Y2Q#8!.G:(4`P\@&Q$?&HT1"[RH1]*I;/++&G.40=P5HO. M&N!UNVLGMM3JX%5,L-:C5$ZQEK"I1;$FB9J0+#4$&Z)9BIRI=#R#$@T#XKIH MBM_S0['/CK?GAEIKJ.G?X,)`Z*:&Q49T M:Q7#9G7@K`X=>],D#KDO(W%:G5;E3U*8KE%G_=5B$Y7YY1R*=PI8CD6QEC!ISO5^-'I?A1DL\PF^I8'/A3]8&91#^+9H>Q3>PP=1/L M1&[D!78:Q+TU'`52^V=FFM"?4UY061R6]1<#-B.7G,6@+2Z@T)T]^N3T[ MB61+V7E&ME"<%MIRS1'E<:[J:*!0@>Z\R]Y*RM/BD-(>24*-51]9/][5GUG$ M2"A0_5C5M`K^HRIO\^\LH>X2+$R<)(A]$`;03J.8^'&*>H,(NU+MC.9;T:Y! M';!VC?!X?*\SI&H21?5G#?YD!:C#=&-15+]VL.3+*%4:=(6A21%:RJHQ*K38 MD5JR8[ M_E973X^L-CP^L4,7['>J\E243_GATV->B^&B8RH&0)9LT+V@"V.V/HC>\CGU86&T"6HN(:@U2??<^*J1;G787IB&#`L MU(:,*::Q4AG]?LKV$94!PE[-K@AP@1O8Q(8IBB('NBCT@^@RZ4FDFLGHPK#J M>-3<6`-R:PS=NF"_Z<1MWM2"ME")C4,F1$G!P++-Q,1,\B;&"MWA,$3\M;OY MLD'J*K2*=?AG-G_D]9G*TM]9G7=ECY/0$8`$*"1A@$&"_-@/APG@%#NB2_4S M/UZ_J+:HK`Z63`?ZF82]ORR_`E?2TO:8OOK_A;VDK_ M34>O++,O9,6`!?:E'E3*'A%%VS:;.&N;`7XLRIQ/=N]2`@$(73>`A`0.(3)SDU_K%J&M:MD&VS/YU_ST_W%87T(V].',TN M=#P4(M^Q<4"\U'>3(+)[XRF`4ET$U5C4K)DM+*L8$'7WD=?J#YG;,:7'\1G MTP2.ZX8>=A(,<1#Z$+LP&O:*VE$JE52NB4NS@O:NL*;;O2\W5D.]L;*+.VTO M-2H!O4?LEK2L\^G&JL=>6=^I6](M(5<,M)A,FQIC.3$?PAN/P\L_3JL[9D2%@8^(? M55FU\]'E]UV<8)+:$,8X2AP'HPC80]H?TQ%09G29;T7S6-%EACPE/!9[5A'Q M+7,5OS,^^TY#,:>GW0)6Q:1\'4+EA+G#U,TY\.US`ZRUKQR[1L^$5BZGU!#E M4^#(RRO$%%$CK$I\M^K84&MZ9T/72P"!<>)[:8K#R`Y(;\XG2.K\P%P;*RH2 M6R5D-[-9#UGY=)>-+_AK!8K^M&P'$HM=)$0%K*&9:]LUZ%193=;>8#5W'6QQ M.,3$;(U(R$D91_1,P#I56UG'KC`SH6)+N31$PQ:[4:E]Q"3U*ZWJO/A>QD]U MG9?[\U?VFM+7E[ZG+)=C4P]?\NQ8_#L_[-R(8!@&*4ECF_[G>R0.>@3$D2OB M%9K5K'(=4G85UCW]^]PZ4G!4O'XIV":)AMVR1'7K/C]\9^_>OFI.S3\E14ME M#,1T;"/ZY:2M9[Y':8U@\D*XFR9E-7(+=F7-$V=Q0@8UA,(09=3A6:7].9;8 MJ72Y*K$OGT?U,CZ/ODFSHO[?[/C$;TZD>="AVTK%`;=74_,&*.W_AGL5@R!Q MV6W4*438B7S'\5S;<6SLQS8@"`GU9C<"J&Z-IJ@M#KN]Y'0$W!HAE]@CM#EC M`KNS-L>H3_J'2VT_W5G#+.K((0N?GWT[>@`^33P`5GOSK+[T#;' MJG]'FSE/BLA^.=T!N;+SSICGP(`]?.9P41GXHDI6CY.XFV?`7ZP?-`W;4EZS M/Y\C]2&$Q"9>`.((V#`D&,`>:>HZL4R5N0&\E3.=A\>L//^CL3[5AZ+,ZG-[ M>6]CM0Y(UJ%;1%.L7C4\D#.3F^KM(:NQOIVG%XA;KZA.6KU?2T8J-<6P^A!- M%,T;/@^&%-=;,E`9\W+.'JZ^Y/OJ>\DF!CX<:,Y9W!7Y`35-?FJZ=>T#*@\? MB^Q;<>375=.?T>3T\&)4Q7[HD"@,4R>P$SL)09(D/0&U%WJM]0/_#2,0$H"V_4CAR1I M#\.S4S1G`ZTJVYI'DMNGAP=6V5`QHC`MCI/*4O-TE-[LI)QUL9%A2\+EE/^M M&F=D^5)=#68TM+FX`F/?1PC@ M,`0Q)AY*8R?T`X2"./23D$3S*@%S\&O6^$[.AQU@KWO(S*X1S.%0NHXP![J^ M$4>^F]#V`\\&$1(J/,Q[7@P9`(VFZ&H!8R!6V7/3/RB4JCY_R?[^G0*KB^S8 M_)&?6&W&-@'GS<[WTB#Q7`\!.TJ!Z]H8\;.+:4B2`*9`[M#T8G.:A[D!E?01 MZ>5$B@T^*W,H-U8,X&XL"L\:\/%+#=O)JA;CZB>CWR-M0KX5,FZ(VJKTZ-6! M:,5DR6O9_U7UOSZPNF9/*YWGIJE@0C>@5I+$PX'MQ?1YZ4VGKBVU'*#"GF8U M8\C86=7'%MM<35M"J*2HK<3E;%7K&>T0&J-KUWD3$38%K)NF;"IG`2T/7#K`?)0!!C``!26\:AD1J6XX*>[J7+SMD3-P. M3WOIF68EE$JJVTILSE:W@5,.T!AQNTZ;B+@I(-TT<5/ATC5Q4T:7O+CQ6[$) M3HB//.A$!.,H=*BMW@9R2+J[W%TO_MZ)?+"47`T8I-^R8NHU4D"/I"*I9F:V M]*Q_Z?V8`Q$=D:'*-,&0PGY-&>0)F+$@U-VD\R5_K.KV;.VP+(7/W0^[FZB= MT';B,`H]#Y#$13AV7.`C*D5^E+K`F[>@H\Z^[D7WT1:@_F*I`?5X&?B&;58= MKIYZ[[;V]<(CN]:R363F[\M2&!3-:R3"S`JM<:B/DR%JJM7%JVL,NN@4.C_; MW2S=M;X&+HA\-X0NAB&.PP2G`/8&/.`+W?`L_ZFZ9_Q;,!+G"R5)F=8YO7S( MJ5=_Y?N,COV2G(@?D-3'S;S3C!V>A5WYGWGUAJK.]]R`\WLS@5=+@RZA:Q^+ MN_QV7^34EZ:S$J5>@.(T)3`*P@#2VA;[O97(CH7ND@2[_0< MDMX7.\W\R"G>,VKFZ-XE30WKB/IOX);UXMP17!?CN`VXXB: MK@J7W\QA#@I:@BQ.RZ*&I%SE_O4#S$Q=[MA7'46R$L1M;CA9& M22\NU@RVVGF<,A2S9J]6MTUCC=MQ8T>W,9X"-C8R_8C87)VNKV`SLGT517,A M6U1A,RY+W4F!A9INOF55]ERO1F%:HKJ[:!)[<1P['EXM#!A&GJ0J1F%KZ4O/X8\S*(( M/D%^F:T7IWR/?Y<];ORS"EF:ZI MV[[F:)&I:[[M16>*"ZB2LOB?KIAK'A[OP5`KAK@))UJWPTOJ@6)CE4N,>(), MGQYG4@\87:N(`CR;:]*FY5P).8M`L(.8D:$`N:Y:P9H13U.P@ M"9,XD6'$UH9CFEH MGN-'L9YH5F)@T4D?>?.=F-:A%).BF.>&RI%4JDVK'B@:_1A\)T$T;SN.\L:9"I"(RAJ8@K/V@IO M=6&0K%<6I.>ZDQMT+-`ZZ_]DF_TFA0OK+S#ZLZ+#0.?)3C@"`MR/D3RKUM:% MG-AU'0=JQ&F5A/!"W%59UN1*IB&#BTHNP&)G>(T>$+EZ2>*KI*O6RM2@FT#; MT;&PP'3U.#3ZL*KGPFCUBHJGG,8]Y97`\DX-E:%^M7K%L"_::@;6N[1X%ES\ MKQA\9=D7A6!'T0RLD??_TR.F/,BW* M[%&!QRM>S,-Z@I.E."?K,UZ5?V75#E0[A!?M=5:2EZ#*`7[R"VE-C;^)WXX2 M84!W[ZK>Q)M0*W.3"4[SW", M+,\"V"UD21:QX$IM36XPF/EGT`I^4-#SH>G9VS!@XMB6:WF!X?N6J9F.IEE] M[KQI)4R7)"6*5;WY.*OUM6MAO!Y_F90#S<9&$V/,R5(#+>_>]?!J%9V5P6Y# M2,%L$L=A88PGT[(K3"@=/&J&#--C5C5M14D'IA/FD)_YMB+MRN]?CFE6U,FL M*SOTH1,%KA482>@E4-.,L),.8<+DM4D2.8TG5W>$W_1E*DDA2D9JE(4P'2W. M`"X;)0X4!)V&H%/Q#@R4G)@-Z9`;84+)T"^$!65;E2N=KPRAF0]>Z/<#"O%; M7J3KZK'=GY%C&$N+7#N*=!U"3T^2.+9@?W"9F(9&>XXH2]XTO%?45,,*L)*@TQ(\SHLQ_=GC'%ASGT*>#G5A-O3[B`XE M*C^-S`QF-_EN"M;=F&0'D*[7F&/)NG_^@_YS\ITP%\DC\^:/R7?VF;K M1J4C*K)\`\HC6C<=JY[>WFN!I>_2$N3XE\6OK,1_CI[Q`VHCTW?6#2PX"_Y# M\(H^Y7RX$J"5/9L6$+"5;E*N[N5CK4#7K\G?M]_RP_,W/+G;3E2/>8":,N]H M\WV["G0-SQ+',V,K=#0]-@T_Z!0('"=A*K(I3>HTB^?F5+_AZ>9_3F55QW+Q M3^NT*-Y(EES:LU)Z:`YMP0[M\4J+W^,RW;/N+R0."=T68Y[18%MMSSH2G(F6 M7VLUNVY_>#R>$.A4Q=^9NJ0>+88C^PWYX["0+8<"PRXK]2F"CN[^2]/,KSF$ M[GN@PYXL'O.^DW6\5VKJONX[FAI9F0L>.8ZV/_KB>H5/?CE$@6S&G]@J! MLD+'KZ?C@%=9KH:H0/WVQF1NP-EHDT[IN4>"X0K/ MS"/"><%'P9OIRY]_DV/1]:;/"VB5J M$<8^D5Q%`OTF/^SQ6DOVHQOT5*6==E&`5U(]=#S7,)S8AEKB>(83F(8-35\/ M+9Y$?<4J39P2.K#E*S$&$&M`;4Z_*'86`?PGQ*:OQ"A`K`(I.T=/.;RW%]&% MCBS;VOK_:U#YKC(L:'#YENG''2+[^_-`]R/81O;:8!X>?_(3S1P81!$HIH-@ M+$_>8%SQ`F88[04X!W-8?>6"QZ2@TU>BR4D2!#EB?T:'-?9@RJ=7KH3S?^AMZ M3O=@BYC;9BC$GBZ@N`S0V59SHC,8*`U:K>]`HRKH=`5?.FW_F+H^#B^L(S%' M]4.UD!CD!(9>EN"9"%IJ3OZW-#L0I;X?R(ZR<4'*591XV&>(`NC[GN-[D1W[ M?>W\6+.9R@SR25"\^2)*$0>+',40/ZU\2?=[@/#Z5[V!_-LDV_J^0W\->$X.?UZS[!C-Z!$P%\(30GTZ)QETP<+([*K#]15>T18=LFFVUEPR0) M(]T--!T+MPW33?I46-?5J<+E$L0H]L+.^K3Y,MQE6=D!I*2N:;!CI*PS]9^U MN@/P!H2*Z[->`C3&3^*H+H67)%ARM4JK(#CTQ06KM$+GQFE^8ID^#/W8#4S= M<7V8F$[BF9%N1*X7QDQ)?8R/5LTWG3:\C1\9@:+C&(48L?$*`SQJ2OJ]`V*$ M/S@16PAG\&I_69!/!`1V;HCKV`BYOI,?R*ZP+ED?NTGBQ[:MN]`/-!\&NM\+ MM5R3J@6B'$F*F:/1"9R5XNM-(8@F(Y\H!Y*-7M@Q5,LRG\%#0SI"L"Z-@\2, MN49)$B"B9J@+66U)^\@R-=_'=!C:I+2-HP=!V`DS'4A5:5Y,PL2,Q-O:@A,^ M.BI2CYP8!)37$:X1PS'A7".H!&YS*G%6D`A?WG!^[$J7_^CK?.>V"8T M=0A]Z-E.$NB.GWB=H$`WF9KGL#]=,;8?93(W^/N`Q0BG\V"V$3@0,N"Q/(`@%?3GL! M5=BO0ILX+0[9X;EK02A7`CEB%J12YU?C"33=2,@NSET*)O# MKUU:H"`MT>9'^C9LMJR%4#</QT*4#?^/N#':O!C`V*F'%2NUQ?8\(S1D] M.WP+X1$1"ZZ=QO."05\P\.*RVGT33-_E>XQ6V9S4/>3[?9(7)*UZ9?J)E9B1 MIL/`ZD/]=L;H.=GRJ+8^BM#NB9E"3_P7&NZ,7"-]GA,&`<\*6LM1PI^"$/58Y`E$P,)02BVDCZU#4!/H&$-@[%".!" MF$;(A+$X%!<<]">`V2MIB;TI![E885KN5C"VM,`/#".,H*[9E@WU+J'3(\;1 M4Y_/78%G["Q.%-&%T(ZX'9=G;'*`8=M,-:G.T:G`ZWSC*=09B>>SO>&)W\JP M?`B#(#9C_+\@-@S#]3M-_-AG*I*D0+SJ0/K@8'P]T*ON<%QWJ0%'_`?XO3P@ MUGO]*@:#8?LVWSAP;.^Z_/Q&W;8P75NSY'WZPOO$AK^CNFM&DA=;E%6GZ5TS M=JAO;1'5C-M"&%:EA9]M,56"*I'GVDE@8CTB$W:JX*TQ M8_D"^?+GXN4S&_-N796,AA`O3S80\HBY4?FOR,QC8+-3LY2A6S8WRS&1CIPE MPLEPG:DK6EX^YE=N)]0:/5UJ](":ZM3H)RI>LW5;\W30]:*INV6;L>-J>@(- M78>V'I!EI=/;MFVFA+;9E9V)]YFO4\T]IG0+PNQZJEL]!J:1\YF+.U[@?,=K M;!'IK02MF5W)ZH&ADU\-4SMD(VO08F;+0A:LY>#QX8[;4A2C[Y(TB%#].]IC M/1\+;$.)W;@V9IY`,XS#V`_<1(-XQ75C^QRRLLV(MO>1L"#%2U`;@"UK[[?N M=DKZH=0ZO4^X=:BF`$_ZIC^3XLK7 MRN?O)Y)=3;9;Z^'D;>;I^SDLV'3G%AB?K%Y2,5Q`@QQYMN0*)IEX=D3?BL_T M-=_38ABX>F2ZNJG;[CG-UK5LMD-+$4G*SRT?T!%_LB-YE);KD1;HGA_JEJ.3&J):5SW"=\48BU?DC-0EPEC<"'-0EU)HI7!8>PS9Z4B2 M-,H*-&K.R6=7D*,E-E'@E\APPC:-49T6NYNFV=PS]MQ">KU;XC09]!!UV*K>ST!_%BKZ_`:"S[_14QC.6H70`Z MD1M^6F)$@6V%01`[@043QW&2SF'2;<-O;_C%!\JM&H<(EK?RO3;4[R7^`ZK+ M?8N\FT:+WY+>(TX+;M]-8P-#Z&Z:'4;0"73+]&(C]+W$CONBO7[BP^#]W33J M-X1'%$?LXH>,-V6NA4K\FA4MH@MY:81,H+AFQ08'0S77LBJR-9YNM;`_#UE5 M/OS\LZTQ!$W+]WT]2/0X-.W$PS+;NUUNJ#D6TV983)+B'?!C]H*^_B?6$)%\ MF$[1]I2U5I6YV*L0KG2;X>D@9=L!?XX@^()U*_^8KPSL"%@CW"0'Y(6PE"1C M/M2&E0<158+-`SKNTW73")$4U.A**]IFH#MVH(=NX-N1X]BQ'72B'#>Q:?-J M>)^OF*4&:C6]B%GR/+@QNYTN,P5-1+P=J:C:?GP$S MMOT4`G(AKIV@$9=;4`F0\+/,?V75[@'MZP6KW&7'QSP^5%GUUO5T2_P0QEJL M:6$4ZI:1!%[8J6&$GB?$/X*RE;N`9\W(79!&-]Y6C]*!YR2N"3%G]2,YX9Z& MU\9Q8V$\22.P5"Z49=XMEI0*(WW#V]]H?:JR5ZS*-ENCHO4)0UN#7FQX,#`- M&'BQKKE1)TV'9L#4\99/A&(V[+4"K5JLK6XY@:.CN0DP8V.S#W#-%8O[')D1 MOA*$:>$Q_!^B`MEF58&N'G\2_R3_1*G'LR'%=J.NF&_FN'7G] MKC*V8Y.IS>U$*BFFH/O#.G]!H$I_@Z=&45`T]Y;_.7;K9]9!HO2)EC<^C#Y4 M:T!?1>%ZQ05L!FCM`.1-?_V^M(3G`-TJI/: MSU6!18'?J?H4(WC[T"BO/MBH3Y+A\8AY+VO*.63/NZJL/R.)&GWRY4J#6NA; MAN\ZEA7&9J);7N?OQJ$1^+2'O@M05?&R\A,^E."UT0@TB9@,IZ$+P(?B+'H! M6JI;?&K-0?!AK0$#^T#P!H;?:VULSG#;?)RAF:"QL_V\M;2]L/(7FQWTQ^X+ MT%;]"7Z$RG61'>M!SK>@VJ'VI:]_RK"#F;^B`OS:9>L=2`\`M:O(WTI0$*M( MP!O]1L4Z*Q'YO+G$GP[G3O.]K`2''.QSC%T!\(I)4"!3CMR>Q=\KM^FZ4P)E M=2'@%)2M^X2_WM3TN0,O:?$/5)U_@Y=M_$6L\C8O7NIDUL&7&ZU?TC?L(6,M ML4XEF>WDF@9X38L,56]$WJ_TK01?\`/P=U)L'ZIOUMYUQ%A0=^>B=K MRC%?CM_56TWJK;:5LWO#F[HN?^5I-)]_-N5TXG?9JII)TC7^^].>W,X&FVR[ M104B8:DG5/U"V)O;IEG1<$R]6SL=\!*^?R/AU+:8")Y.Q/>K/QU$UC;G'XX% M"8KE8YYAX^W]PK+/#`8V39TAXAX6Z)@7@Q!_HT<3_L-V+Z>W.&C\P#/I6#^)._7#^I(-.X3[-B3>C_S.$^L\&ZIL.S;SX,_@=$\]I"K&I4EK"2*K,M MGV!:"TT7356+IIN/9KN=HD65K7H3_V2E(EE^Q M6(4JK12O@G!=D>NP[S,Z&_T!B+EC*QH,6,(8"ZS8X)->J9^_N&2L^ZT[J1EZ M;5U7LNGFA)EI2ZUZ*)>PS,]C^,WM\#304SD(29H5]4[ZNM38OM=7AB1-D65Z)<$SV7 MM5;*`)5^`9P87-$`]OM9>WT;6NW2"NS25]1.ZN%N=)N5:_PHLAF5LQ6]C>&5 M)4LB^`M8AV1:DRN9H8S7`W\4^1JA34F6K5KT]SH7>;"7C9W`L&!BFUX"`R.( M@C`Q>L&!R72)6%R:XG4C3,L=N<:'LM?.=R2O4^L_DK>K?R7S1G7&FWX2\!Y? M3>:!FFU!Z71KM]`UG*UZ-"%/)9?N;N(UP]ZQ)UO M-5[IL>':H0D#)[0#&+DP#GI&3GPS47@E6H)V"XRE#7FUW[*S$NP,XTQ'R,L> M8C8"Y[Q@_?`N*!,/@C+OUH!E7[>^/3`C*\5\DV`A*\N,`(C=QY8^%/3]9'@3 M,2Z6UC[QH@Z.7&1?V)KIP=@W@M@-_/\C[UI[X\:1[5_1E\5F`$^@%R7JHUZ< M,3`;YR;9&2R"BX;LENW>:;<"J3L[OK_^DM2CU>WN-I\2G9TO&>1AGCI%G2H6 MBR3,@1.%PXZ5`T.F`]I&`9ZK:_5@<<#=0&$4A:S/_9F`5?/6THG0=M"P>OM\ M$`(/&E:O^KAV-6I076V&]P:9.U3UO)LT@?1VV&*0@S-S5TOPN'=R9P>8P+93L;.`FR27L(=?4U&Z!Z3>;RE.=;I M=M3D,8WO*A*S0M<)9^@(43(^?^NA2,IV52%'W@'LK7FW%_#=/N__RAA?^]KB M]:;9UG3'L+DA%Z]L'XM-%RP_[N]5Z>Z/0'F:PSR`3H@R-PMR-T-!#Q_"C.F^ M:-,P:PY((T""%VH9PA-K/Y\A<(T.7ZV]ULA@BUI,=M4W^P7;>.Z(7;=EB#-X M^P4-@3U1-Z%QMC*;A,RW=*IZKW1;_QAW^ MBPO7"T"$87NV%T';\<,L]X=Z1)"SGPLT#_J4R1<%=D62,`+-N$C*YW)3DC%M MWGX3.5DWI3[^$%/*M!Q-V]1Z4ZD:ZQ0S)V<;^VW6U$UH`OW79'!B[$R>R$DX M4?_.S&E+ONPM^9WVQA]L-@W=U@L\+?P$H#AR(]L&GAV#H+N-%=IN'*63[.'H M-6&&@S;U\-1\UPU!-X.FVOW1/",T[Q.9,QE,3?]:`L8-%/OS26]E`TK*RSJV MJJ:9=F]]4VLBEE1M?TWI5`,B_?BC)(>FRF7\O:R+A_)325YV MQ;^?5IMM7=#6='K[Z,*'V!Z4Q+D?.:X7AVZ4Y+V1H9L#,Q(`'99IS@MZG%;1 M`L5)08=T:`HA-Z8;DQ1HF3QSYPISSQM34X@1+U?6,%,[:JR!&VM$3GNG^P^3 M7PC,C%G2#ITS^(?/1K22-UF2HG\*J#U#^*':M.?QJ7D-S:K&?YY6S?9#M?U7 MN?TT/!>Z\&(0!5$$\BS(O10D#K#3'K"-4O5G";6@U)Q3_'.S?V#U\.:?LGT< MD9XL+-9K:U-M?NXN16A&T8(^RJ#E0*$>I[/E#V_#WWRY`,2"&X;]#+F8D!Q!??Z!WOC.&(CZ2/6NH=5X8$F$-($+D[.$$KID_\K6E!U35 MW6^1O^#"/J]%2AUN.KRAD&?:-W]\\MU]WIU7[Z-R"@X M*68.E_KG@V$Q]*I_8X.D72.C?Y38>M*A-5>U+&]8[&HZ; MGWZ8$N,1Y;.4#T7=;HAD&DC,9&4_.=?I%\H6ULT]_=,FWFT?JYJNP!(?I7$: M>P`X`7"B)'*BL`>:VC%3K_A\Z'0?#J=XVH>QB@$532#O=]L=_MT';-MTS4+B M7M2\MS>)`R??GVNMHA=^M1-A;]A;B7OG'*,CODE/@K<>Q^0)4!6O%+F"Z8#3 M1_(T8+7I[P(FPW_$7^(O5!FS\KZL:_(0S7:UCN^Q!G\JMZN:@K^IKS??J_5N MLRWJ9[(3MMJT1PG\!`=,QW8".X;0M_,H2E,$`Q#D7NZ$(&0]OS0]LBGB4:=5 M!SM*Q:&FC6MEWSI-*UI-*]N>@]6HYZ#:]QQ4?<]!=^C)6G8L63M"DU4/%'&< M79EA@KQ^VLGLN<$7ZCI;1M?=T]M.B#U6:Y#56V11DRQJD[4WRKJIK9%9UL@N MLQW-?@;);(>+'3&:R?$L1X>4TWWF9-!\;C7@X,^,QE&5/+F_ MK=D6ZS4-?]>;/\CKQSW.$\9D*W)`Y':W+6[7Y0+A],GW4>+$,(*1'P0@\882 M:!1[K,G)9(`TYR3[15))+*&916\*.?;0OBT]Y!'?.LG:OQ5")6O56,NQ5=:[ M\<^Y4&:K:=V[*/,F8AT8(V1SF1/)(QT MJEC^INK&;\SGIH'W1V]^5[6%$I2K,G9 MX_,0<#X#(`@#-W&#F,")0S1L!^1YQES14#RNYMR@:[BH,-XN#[AM$1^'_Z5@ M?%#N!X;"P8PNX"P+M.P3J%V8[L"JBL[*V>=8S<_H!;%8.^`A(?-;=Q9X>+*+ M[B-9RV);6L5F:36[VW^7=UL2;OM0B>5ZN>JJQ2;GER]TC:GM]EXIP!?:-CFU["%J MGG`@[+Z;49P[6!+^)!F[6'QP)F`I=9\!44JM/96F><[9#Y72643':L?^ MM5POKS=]5^R7>M=LVS]8)!'*`]_-4`@#Z'L1@/9P040<15P/PRH<5G.,:A?) MQ9I^CU?]Y_:(X9+:[)8`Y6Q>4DDY6U?23&SS1:P69"N%5WW,^K7C>3C;0+'V M?SQQ#Q$[C1>:@S3XPI"N'QV65=HG,D?^GN[J&F<'_RJ+NAFW$V6K&B\UJ[KI MM8(*=@K(NQ.1!Y+$S5'*!:0R#CS/H5L\Z>_L_'ONQ> M4'/T%9!%V/'<)PN`N\YOS]A$O`IH:UHG%PBCC^C`CU?="N%;77U?+?&8A?54 M%IMFV&:REMV_/`#0U\U63W1#BOQZ99$NN/W>5/>N)?YW14.JSLU*=GN)RY]G MUA1ZYH0!BPM-AE6Z/R?>>_R;ZZ;9D0(;7>/T.U!C/'3X*$]A['FIG6?`"7-@ MQW8RK'8\8'-=P*]HS&E"YZK#VLG`\#T>Z`=G34PI\Z^'S;E(YPN:'=\]S*X\ M-O1A'$11SI"IE&_.2^)GX%U1N#R:^4'M?//P\?"_X' M0REL'Q.;8EW4SU=6L=FT31ND4YLT9W1[0F0#J:^FM>W>)UK&):,AA[/.Q$(= M[C8@$FHQZ_@2=2VT,1?=XCO\P>S69'K28Y!DW+I\Q$/C27B]P;.L_*UJFB]T M(\I#+D0@3G+?2W,W`DD$(Q0&H6\G09*'7%>6*AU8TN=3Q`:[5PK7<$ M\$_65XKY?SE+<6H=P5:,F\T'?.%1,?U:"G(\5%XHR6GQB"%%.3VV51-,:7%- M_5+C%?"Z/>FW_/>NV9+DY!\E/5;N(SL`#L2+F"@+@)]DT(G[T9'C:B%#BO'>U*9=)N<'_LR49;_," M18)0"-+0`:X=A]"&&2*5H18%]!RFH\2:AM8LG!TVNLALU"BE$L*Y%7-JKL65 MLT-JG:/>7/EDX)A-1E4ZRSPY56K=>5E53Z*(O'XHM[\4JPU)?1$F)2L;G!70 M)+G^GUVQ7MT_D[O,B^81K:O__%HN'\JFP^;EKNNF*$(`ABA._-B%7H_-MI-$ M4'3U`=(LQ>0F<(R/7!U$P)-N.YQ>D8TI@M1JH8K+LD9'<8NU&3X2EW",WR(& M])4!NM%X["IS=5R8?C9UU^]=\S1_`IO/1X*I"%==^_T-QZ_K;?G4+%PG\;T$ MPMCU\>B!`T?UDC!,1!-P-8.;50,FN"T*7%,AF,,K2HO!>ARBM2#,Y(LYJ\(# MI_*587[WF*?2BNT3JQ"+$LFNOC?I]3CW^%*UF0<.$S?W7XJ_/E7K-:IJL@V\ M`"@)@1.%KI<@"`.4V]Y^@9`X?!MO"L?5K;D8ZIG\[(IF=]6]A1%;7PEFJP/- MK;P\]=,L M"KT0V"!RB++MUQ0CVY+;N7E*:V6ERC,;,=J["9B6W/J'Q>R^T;4^17 MEWEB6:T@C;TBN9]L(VDX,,IAF+O3# M/.@AI7'"U0^A$X?FI/?FA`RW^HOEER"WZF/H5]:F%8)M\1=W\5FKR]CTV11O M\6DU@SYW#GN!?D;EEN#Z@HI/X4%#%'T24ZOI/Q!.I3\>D)2T&8)0=_2GO0)G MP)AZ*,'A)TH]#\5A%KG)OL`=QEF^V)0/Y*>RB?^DT)CT)6KU96P%>TKX5.W( M/1M[U2_).72\%N^S\K'X6^]BU@M6Y_$D6T0PSX5"(>+8C'8+DBW)O[+ZL[0? MNPO&9HL9*KUQ(8C,XG1#HLH\ME<&?'6:"SU1F/B.[]J9X^7("Q!,W:W*)KYMMG5QMUUX,0I`'D5N%DT5(T=[`C58;K/^K8OT9_PY]XJ/)5LT=CA6[NOQ2_K5-,#E_ M+D",7"=S`I3#+`PPRC0=<#IQ[')5[:8&I[F4]WGW]$0>XB&/#JX>-C2O(IWC M+S]JWIK=Y%YD+.29[$#.ZM[(%/(F_<@8>BA_;`YQ\&"0M;?(VIMD?25&6=2J MJ75;M5R^5N7=[<_U&N'A[)N_;?R[IX M*`]?O:3G=?=@W!B&+@"YEX>)YV<.2GV'@LF\$`1>Q/70L18$FB-+#]7JL)(* M$KVRLKM?N:$U0EI7VK6.IA?U)D6SNJ/RE:W6]#&8O*C)?GY#BDSMO^9]_UB/ M`]GBS?R^XPLJ/5[BBQ@%)V M,:?W1'_[5IP00PO45J#EK-TDHP_7R/09&=<(K*JC$L M7D6=G29619X=J$9%'[UO?W"CXL@\Z_;9&O^]SL3VF9(KBUAI43.MD9U7%K'4 M(J9:O:W6IXNS1$]HT.V\2Z'%F(EC2F@RAY#CT&8.LAE#8_[7M_(.KV)^K\A5 M1.O5]IE"AQAJXGH)1"%(O,RWH, MP7$"?QH3'H=9LC?VSW0L546=R'D?H,]]OYL4\8N,;O%XCP/8C]U`Y`@@)*8'(BCS[79R'=]AZN;0^3GZVYM&S6R M_E9M'G[&/^/)(D"MD;\$GT(3XI-M*:";2O%V8!D6M425$U1=T'<98@U16BD3 M*G7SC.,=XP_5MFRR78E=&/1WA0=N#IP0^D&6.9'O.`ET^U%BWX,+K(ZW%-@_F*<]R&P_V91:-829V`?JN\4F@6O+`*4XVE<$?(NJ\P$K/$) M3,L31D.Y8>B-54(2^S/!FLD2?`V8ES26-W9?6GI"3"4I,>#%7!GTE9)YP:N> MSGL?V%A)_E$\D_=WG+`?SPUQBIA[(4#(#Z+80U[8C0=B+V-^]EUJ$,U9'(4U M5E.,SW(`5=*05R2$B634U"DX%%#7CL-C]H2U5IA&3M6=@DX)_16GE5F-SS!P M29=E23-%H:7M.-9J-<3PJ#:TR7A9>4<'.AC4=B+/SX+P3T2N37DO2 MS"'RY\FXK/0*2#1'[E48\U+SE5'$6^R`_2AI0A8"-A[)2USH.UD0].'%R<*, M2^GY?K1F:???1X?2'G^K5^O^$X%B*WAFVKC*'#H8DRAS0,DR!S-)0F4.'63) MZ/"R(^V]LO(&9"UO\%)ABIH*HC]=WA`C@5W4S9+016[HAK;K MV8D-^A&!Z_#5%,2'T:RB%-A!UDD16HZ8CDK0R:BITS`IHJ\=E=D+$H4%5X)- M3O&=AE49(99AEUFAS])P2:WEN3-%N158&:67I)E9["^1<4GOE9!HBN2K,>98]152Q%GX<.UN%,>!49JD M#LK"S(<9C)!G]Z.D`6*Z,%CP1VN6=N^]>Z8CSG')5^+:0@M[=N9XJA]:2!.O M?KBV7/6#G221ZH<6LN2K'ZZMK/K16_AJ]8.;"E,$51#]R>J'(`F\DNETH_AI M[(2>'Z=)%D8P@'$,^QT\$#IA(""9K#]:NV0Z+CC?1.PZ8F+`3!R78NK@3$(Q M'4G%9"9)2#%UD"7?1,Q$&J=R.JS*R4N)6^]88!M1<[U>'5" MG$M&79V$1A&)[7A\P:"PY(I3R:F^DU`J(\02U#(+\SD2+FFT-'&FR+6\(X'D@=:"3V!`@&R#7S?PA:-@)TYL5TH-HEW!X6"#> MMT^X/K_L"!+)+.#Z.133;]B7*L?T62V\R5CDUF[];,I)]VE6E2KW20HN"[<< M:^;HMJ0=+V5;!3%%D=![ME#J,@Q&M[T6WPD M[?J-ES47-OA$1%R&5_94?!I*!=/QT&][#%ZP*9.22]#*GY9/0Z]D:BY#,T]Z M?I:,5U)T>1+-D7L5QIQ(U551Q"3\67F+)]NN[LL[_:&3%,(LRE,4AG;JQC"S M838TD=@I9#X.(OKS-8M\V/8X[]&]:-%S>0[\";/XNKA/02"?I(](ZXJR0J?Y MA#EC5^XIN!/3ZZ.)1[!);@6>L?6,',LR8X`(2YM0J9LH$H+;GUI)G2QT4Q!Y M*(9.[@4V=(=Z.HBA*RJXK#]?L^`&[\/7!)?G))XPB_R"JX-`6<$5.I@GS)FX MX.K@3I7@RI[3.V,KH^#R,F.@X'*;<$%PQ>C@[,?P^D8Y)\@B`(,XMC,W=;PD M@6Y_?1Q(X]3A[\=@_M':9?;LV3U/[.P>.VF,A0I]?(E4)EI!]23/[K&3)-*+ MH84L^>XU3]W9/8_U[!XW%0;HI@SZDST8@B1PJJ7?]\@!-\X]%\5AE.4Y2H$= M./UYZ@`"FSDS%?C1FM7RQ4GGHX9?7ZSAEYTY'LG40IJX9/J2#;_L)(E(IA:R MY"735]?PZ[,V_')3891D\J,_*9F")+!+ID_VZK)AK\[O2[8N"CT`',_+[,3U M$W<:R/]YO\\>#.E$8VAF. M%C`.PLA)8!3W@R('\HJWQ$C:%1QCN]#S("+C,KPR:_E$E(H).N7T<#/>EU9U M&5JYI7TB>N7T78IF#I$_3\9EI5=`HCERK\*8EYJOC"(FX:=O'Y%'8L@;,>1Y MD?[\M`UMV_8S.\\="$,/CXP03&V8X'"#V!XXE?GYFD6>PK+6P^,X2XR,0W^$ M67M=S*<@C$_"6ZZ.'A(2$&UATMBE>@KRQ`1:D$0623YC]!DAEJ7(`/F5-J%2 M-V.DWG3[;;4IK[?E4[.(\S#((HC2Q(X=V\_Q?VFO[)'G<;TG+3J&9LD]>G_, M^DJ0612:W$MN'"Q>EM\I">238#'N)GB_;2#GA-JHHM/(=]P$S+CXEILH+R%WP_]2=37/;N):&_PIWDZYR3_$3!.\.!,`: M5^7&GK;[;GJAHB4JX8PL>D@I-^Y?/P`I4K0C2_BDF%7<22?GQ0OBX<$!"/@L M3NS'.(F':`%`0LW4&.YKFSH0ZNJVHC#YQLC>6LR2YO8KW;HWS MYENVJ?[=H">&O'RY6V!$?=^#P*>!GZ9AY,,@"M(TBV!,O#BXM"!L)(:]D33( MXI>PVV.,?&7`^]9CKA#*0G[N69X'SJ5E=7'5J2KXC;[;)Z M+CY739,QXTC9+#L1Q>JH@;7@;OV8_UBD/HP!B%*,84#=)(L#"'L-`4B!V.7> M5D++D$7IZN_/1=/\P^DT._PA88/5GID)A2P MT[9J@D=::T2?8LHB/C!#(9!(Z`^$L)VOC,;L\OO'G M-&)/V28\3K4\G^7HU&O1V3%IP"SAD8A6_[-O=GS.U_`:"DL"VLKM8_5'P6TI M-P5CP5'>8R68)PPY08B8U0D(D>=3+XY"-\K(H!LCH>,=9R/6,@5&[7-V%9L4 M7(`"_Y_80U]^+S@='&Z(\S*:6_S\E]A/^6ARP?]6M7;RYVK/8^;+_]N7=;'Z MA^0\\>K](CB#O+I.>W/+4=-NG$/CND6U&_Z4#`UT^"3T\+;YQ!OY&_]CR5GI M]::?MGOPS`MM-@_/3%Z'\_&CFNDHE]Y/\5(7R[)%._MY4_`?T':%GJMZ5_[= M[1@""4(^]A*6!03(CV(29F$?.TMC)+>YPD!`ZSLMCAJ=?+OB[ZI!G/16"Q,& MB^Z[F-A;V4T81WDWSB"P=1@).6QI0\9EU\[NSC!H^DPP:[9-/^W;,&Z8^(+J MM[PNTIS1%E?/+\6VZ:+Y&8HH0#3V<8`86U,(DCY:DLEMXE`,81EIK:K?G[@L MEJ$?=4G23-4_P:5H^]9)+D*/7,-"KME9>C[IR[E%9STC9T(AW5:\7V@V88I, MM;$N6#!2=+_>,M:MB[KF>1[/`A_S'T6S\%/L!21.4I"A!+M1&A+OF-5AN-@6 M7_-=L1(N.1J(*325)Y`&=J+[6L..R)$%DR%XQ+DWHJQ*F>GW.IU[A M;\Q;9_#Y,/5^/.^SK7+N9>O.5W0-6C\3L!ENU,]U7>.6:6!OF-3B_*7-P/%88CQ(O5Y]4=Q&*5!J]\5L::G?LHO(-&2> M!C?1!0"&OENAL(@.(J`H6[:J!/; M>OKX6.>KPJF/DBXL4T_AMRHOK1MM$IF]V/9%U7V/.=)[=6B>\5**FR;Z9+;H M--*XB_0T9Z$&0+-RFS.7QK%=-Z1QZKH8()_Z)*,9I(?8%$&7ZG)3(:1U7/*U MUW+[O>A6I_@X;G(F['?^%YT-UZT_]U:Q6A69MCPV2*6BL&S!9928RZ22MTB#43=U\5+7J[Z MTB3]P5=DBCYA1&U%;!&F*(MH$@-(0YRX":;9`,PL(8$NNXR(L`ZU@TJGZ.2Q M^>ZJK^RW2R?M?*SBBK699Z975&$X77>8I&3?/0>YH]EQI_CJZ!2Q58JI1OMI MMK`UV\J+%+9@JH'JXWW^RG-7OCUGN:SW#%W'!8I%X,8ICH(L)!"X%(`(1\/+ M@KB1T+U^EB78WCS?E\1>.I$W;]:TCV`>K^L8JU3J]8UNR7*R;C%;NSS([C8= M=L*=SR*=,W$5\YR]2N5,(_TU6UB;;:5P@=.@J3JY-'M3E-7VG@V$NZ=-^?7P M]987A#[,_,R-O,@%6>8AT"_QTQ"EH1Z>%8-:!O)!E5,-DO1S8D5WE;-@^\:: MR7L/5G.ASDCIU1%ZVD"Y#%>O#V:+2=UV7 M-W6-DH(;_BWDU0GYD:MR^XMTNV:VE-1OV>7]16;,F^C$LT5,(Q@D(8`8HS") MO=#S^D5[2KTD6^PJIE^,G9:E2"68@VJIY?2?OES^^;RLZYV`=KFOQ%@\HVZ2 MX[.Y$\]^J6/.SK![HJZ<"<^G:JW1X\PD3=;E_FV[(4C\D#42D\3+?#^&`'@4 MPLRCR5#*H+&)DRY-2[)<:!CD&N>\\;[1XOTUN\4H]T]UV*]RTJ5D)\B_"FSU M\KQ?"=9:+?9JL&NZ\"OB/G]MSRUYK%!W%!/3R8+O7GD19X>V*\I^]X7_+XL$ M4Y=D!/@>]K*$("\*^Y/Y*$)$(NGN&NA:Z8"5MMM*RR_APK,C*K MZH=JO?MW7A>+`"440!!%:1#$28*3,.G/IJ`9ZXWY@=!MZ;XIMT73%-U!\GS"??B3U0+Y,'8A"%)` M,`BPYQ%_F#G[F>QW!$9#6T=GJZ0IN\)6M7:>!K'#4+D9NNC^-'/;,T[*S&Y-=,C,>&JV;9=FN.8,%"?JB.2D M;$N3O,QUMSZAI?MSIB6)@PR&&`"6#4!1CK? MPE46HU;,%\3IM7V7Q.HX*W7>=6D0]ZJX6@,[74U)F6JG:[N%AK-@M%GFZMN?+G?4%-N>C/;1M;8[_5)[G*SM M;1+NRIE@?:K6&MW+)&FR+O2[,[C$=UAE,4A)0E/JNX22S/@:V MN9J69+F^,<@USGGC?:/%^VMVBU'NG^JP7V6;JV0GR+\*;/7RO%\)UEHM]FJP M:[I2>?N/XN4P6;E;#XN6I'C:+5",*``4IQ3C`).8D*"_=XHID;LYUDQ$RX`_ MN;-BQ81I%+`U[)6O6$_CK$Z)^M-1HE.MW^RC(&>-MEZ2_M`[P1JTOOSLX-TR9$>BI>BM/O`ELU<%=+X^OO7T>W+TRZ4Y[)H@Y3<-GR#C=%IT! MG!&SA.DVQNF;>''BDCA*,851FH(XR[*@/T3AOKNVE]P\L$UMMU_5[)B@SV:*/U]3-F*4T M;1RI:%?S3U3T%C0D;@33.`!^AN+(0S!&PVI^E&'5.:2)V)8GE.,)SQAYQ^.? ME;8IF>X`^8GFU-YK%=G&J.RW*:=F:N:MU&8 MK_3'LFB:Q_Q'6FR+=;GKOI\Z=4/]*5%N&`8PX+K5V?0>#.'(L%ISP0*!)IFSX1ZIEKS06'`B$D3 M;;-E??@7FY MV\0@.J,>DX.LN1V7O]0V2VO;*X6[:.@ MENZ!*:%\VDQY!FMVRKR1J]LX,<(:L5"\$+Q>%\O=W9K^6+9;L?]@,^B[;7O@ MRW;%?^&'FW[/-^UA6F$:P"@F)/.S&&64AA@-NZA"%T92=5^3@6V7>5NM?)9; M'-0ZK%L*I_N937^WAT.LMBNG.,J6+>P:[0K!.NZU>D&R;#MT0"_4X4JY\;@W MOOV!BKAOIT@KX>2YFJR-#ID)5NVT[7W%U9Z!PE`]'>V^J,MJ]?XRK@6C.``) MS=(P#C%.(`V\`>QQ&@&9LH31P!,4(49WV`WWVI6C,2TTG"?H`C&87LU].9A^ M2,P;I]/JG+AC<&*:REAYAJ96>F0F-+73MFJ"1]H(31%+GNOZM=Q^_5>^V1<+ M'`]4.JW,61#RG772:%2U?M9,5&Z4$`SU+#-,00_Y M!&8T"0&%41*B),11']P-07J@(-T*KMZ;B2K/P%Z@^$C=5(T\`7_AD2GJ^2\U M,H4;I30RY2P3'ID/RV_%:K\I[M;_O6=O[J+>O!Y62?+-[79=U<]M">\Q?]H4 MC\6/7;KA:^09B'W?#3,89#@D7A;[((0`QRZ`.,*IU(YU.PHL%]5ZT;RJ,\AV M!MW.2+AD"F.I0\12FNOWA5R*(]$-SE^M:H?+=EK=4Y_I0%PH!%1)&;81+YVA02#',E#G7J3)!(U$YU%EEPT@R-+IHX&8\Z M)9)$DO1UQDR2;8D`E93,$>92^Y'U%];@?5VS3/ESF3^5FW8+\S^+YZ>B7@11 M!B`!_/!7'P,_"4`6L;BI%\2.7]4.9IE1I%@73%F[V'^8`A1-6SEOE4LR M2M]:,5)-ZJH1OF5`534'^J$J9J@G#&UR[C[]5^#O^CH M+[[DKY5,\(QY9Y)`$Y;/)/\STI3*_!-I@&C'Y'.1P@30R/=@'+F099R1&\>' MJ##+$-&%FD2HN7%M.T@W@#89R]7I9LEMRX#[(F#T9(P[BI'$G(+W,R:=2FL$ M8*=LD@KO1C/K'K)AZ`,0>L!C*2/+%^,DHF`(BA-5W"E$FI)VFZ.\%GD&#D0OO6A#RW0D-Q!\]PT4(WS(20-EI667^&I59M5\7SMER7 MW6:7GM:O(U9G*/9\$H4Q@L!+@HP%0AG$,(DC0AC"Q5=QM4-97]5]HW!("%_; M3/!WN530E+LBB[Z3&BN["/S6T\]'3[]))O55=,];S6&PY^9(1'RXO M&W-P%LO-YEI367G,I%/FNEA67[?EWVVZ?K@3H!G6P^^+;;[AV3O:KFZW#*I% MLT/+9;TO5HLX"P`*(0A($,89^P%Y_0HY)`#[1R?))N"C?AE=L]+S^=:M]9X_W-KIM0MX?Y/\" MO#\H-[[A7DOW50#O%>S5YCW0^S_JC;E*G]%7[_6[0U4I-IL\AH]5WLV ME:!^%!,78R\A7A!'7NQC;Z@CP50J;S<3T3+#^7BOB]5^V9Y;SG[<\$NYG%W5 M`OU;IUPV'S?DM1B)I[=9MLPS@/6@\,89-#J=2*=3.3%:A9P[`U&SSL\$EX8; M5=E\6%416#3W>;GZ4NP6"?93`!%T0X!0X`?8`RP2SOP(ACARIM MVZ&W:S^6Y!<&JMRMK>*:)+GL&*:**>;5?>O5EW->V272X(@(?N3MFQMK%%KP M$5A4S1`_0'''<,4K\7?KX:BP^ZHIVW,JGII=G2]W"]>-8)QF21BX48A)$K@0 MQEY`:0@(]KU0]'@^$['LC9E!7KMD/1S"URMT_NHU3G[RGH!O9T:64=MG,M;, MMNG],7KF#1,_:OAXE>=]7M_5K995>X;J?5&WUQ7ZHMO\>'UT+;_CDTX#^TZ4OEUP\5X`VWQ4S0:*-EGUXIXMA\Q0`BI;+_?.^W5/2GKS) M,?'_U)U9;^,XUH;_"N^^'B`-:*6H2U*B!@&J*H54&H/!7!B*K21J)%+&LE-5 M\^L_4IN=Q3976<$`T]V)8[[G/=+#G61D**JF?"FZ.:LO==.\D06]#&/LQI$? MX"S-,AS[<)"5(;GUE;:U6$;MGNCNJ%_P2C;X@TO^1[]Z3QFQEM(DR]WS9T@= MQJ<2U<^O]_F:$::53!=BM]UTS@[HEL,]2/DI;!;:,?N]8*])M![Q8`194S]!3I#X490)C>)/K6J_N0!<' MZ`(!5Q5H0P%[L8!6,-A%T_4#0!L/8`%U'YAK6L4W&,\UO6H[D2V]O9I'81OT M^(,FP;FR.(/=T&<)NS[ORR/15.";/7AI6;V^*TKV+R*"%FF2Q"Z.0^KB+/1) MAOW`&81D%`F-MMDKW7+U/XCFYQ%UJL5Q(3G?9C%#IVOU\R='KOX>\S(*%JZM MSY\.\=KX_&E1JW?QZN]MLQD6Z19O7J(MGP[BFYT>"I"WFR_XIX3?J\U#OFGK MXO%[V7>]M!M?-^UWWO;7HC7MM6@KUD?3K+"5TG"@:K:;TAE4PI8#K*=Z.R0J MUO:++ROZ:UDTS=7=H&M/3M<.6(0$^Y253Z/`I8CXU'&"L5+'?B9:EQHKT'+U MV76/RHJ]JEQIVPA_V'MQ]][YH5FN4&N:L_]T17D6Y^7JQL[TRPIT(GD'=ZPN M]RO)3NA9?!:O`<_BMXE*;_O^T?_PL?],]:!H,@Y4?<9S.8/:SGQ,M<6'7Z). M(]NFK%BQ2?UT6U;MFW`]'B]PN6)/>7E7\M'M[J8#O/SOMEP7J[Q:[1VQRW[' M7B2^,>ZRXD\F?SG*ZD?^6#0W3,J7@CW?S2(+0B?$E,;(=_S`C1!"_<[;Q'=Q M*GRBXXPD6ZY7^=TBY2B/4Z;A`O_D?P@>6XD27)^1;P(U\(S4VJO#AR#!7I1@ M%R;8C[._<08,D;8'R.S?K-H'V]Y(<_GJJ6D#!CQB\.4S/S7B[8D9J;;?(IG? M4R32RI@N10?:*3-\1F;0TIFC*_6L7VR)UE:2/Y>;_+$KH/W_FV+]M(#(\3.$ M<>I&"?60&Q,GS%"*?!_SL[:%[C[1^'K;*UH[55V#!;`O>)*H?E0=.]W`F,`L MN<;`X%.GZ*+[)[B9QB_QJG4"W]2J017_1"JJCP,^4*EHNC.#"D`W@MK8HR*[ M'W"_M&S+YQ^^EE7YM'UBW6?^.#6LIBC*E[9V&`Z.P+&;N&E$7#=.7.@'4>#% M7`LB7IAFKM2A=%8$3`3GX:7I9(->-QB$@YUR]IFR6;(_^7>1K\'7G'V^71PO MUFK^9K((UFZ,;S=0VC?4"L^3\;H" M/W2<*'6)Y_B.&V"(,9,2D##"7DBE;A&T4;YEFK.W#EK$K[#+YNEKPV#[\/W& M]R#<_"P>7]@'ZVKS,/5%6PH6&\*M;,(^(6VE0]2`K9J=5EA[6=W\K'E[HEE` M-PABZ@<0.F'@11A&7J\F)6&(K+6>)238)VYDD;@R7IN'KB6;K7#W8@^\?+2: M*6\;O7,F[LY?0]!52-@GY*Y*E!KH53;5%GW9XUIT>E(:."X*W2R*`C^&,$I0 MUNJ!0>8FF=!",^LB[!,8V26PA-]6&&S'ZFDHS+5_!@Z/'ILCL7S:/B>+%>+4 MH[&JL99XG+%WII.#/=8LISX?WO8")W1#&)!.3I+2V&9S6%R#?1K'5FDLX;8- M&-LQ>A(6<^F?`,6CP\9(+)^S3PEBA3"U.*QJJRT,ER]]K8`005[H4)Q2+_%2 M1$+:U0K(30./VL2PL`;K&/8Y?:A+)*ALQ/YE<&&F*R6M$](9<5`-;BL8ZW4"?AE MNWJ97_::U'P5\WU1+*44[*2><3&4C)/'7GDK&9G+:VXGN`\.CK=EH=G7 M>7?*8)KX84C<*'(2$D5IDL;8'U3@R)6^C,=@T;87K1Y[M17NO3!IND&(VO'; M%D7/=]ZJG)FZ()7/RF^F9"64M!EA/]:3+7DGP4*\W?&=76MQN M^`9:_*ML%FE[-S:)70^E+@P\'Z7\$B;L)T'FAIXC==&`4@FVF'/74?+-S4O]'UARAEYZ5,R&49A!OS\HW8(DZ M:=+Z*2^K!"A4:8 M<]*]::C3R9#ACJ2A%Q M]$QJG_P0VD?.@?]TTD3AK6^AQ"$?4UFI>-2'NJ5")WXIL.E.CB!#LT"GQ4.K6M1MV\F'-&)X.WZ%%TS%"G2CTTZU(7( MJ=#$@FV:/#G/K,1'K@@S1=+$ M65)%-H:C7%$R1&B`B\]W?*GS:BBI;PEY-$,9C!S?36)",(HP\D:&953X_D[% MK[=,%:X*<%GC:R(QRJ+JV.GQJ@G,DF/)>Y]4AJ54#1,?BIK`.+7A)R4#14:< M/H[XP"B3ICTS&%G2C:`V]JQ(-MK(NES=%[R\OAQ*81($0102E-`X0H$_S%&$ M#.5R)X1+?[EEK'9ZVN==LGTF;Y-8V\RJ0W(LW3/G7.-%;]TXTAY3-FXF;3%U M_;6A)TBB#?;C=[4JF6'%ZG6K;T!3!&/D!7[*^I).`I,T\'.0' MVG*&[)I!F\Y4)+7Q9TFRC<R;BV93+O<61`2I$SM! MC!$)@C1QO33#8RD.C1/1KJ?"5]LF3J](9IF3JDFG>Y66_9&$R;XU*IU'%8_$ M.XR6O5+K)(Z>K9@JS7[A^P`/]`4UG)A!_T]'?6WD<=#9+OJOHKQ_8!U-_%*L M\_OBLF(,8CJN6>=S@1P8)AGF9\FC./13&$3C-"TFGM#DJ?%";0_?[;9$KMHM MD3][K2#OQ(*R5PO63*[.#E,MZ\6:>&=Q77*\[^T>U$$FZ'6"02BX/FJX_4VI M1PP\TB8TGH.9M!'-QW5L'ZLYX\2F,O;+_IK_XL=9DGJ]KG^6U7V2/^?+LQ\[41HX'H6Q$P<^[@MV<0:)\(R&D=*F(",8R0B>.IW@=A`*EKU2F?%Y M,SX+S'=,;K$"!MMKV;OF:B\1C!I!T&K;G:KCNO!!IHRHX-[?FJ$H(AUJ>RG8(-3+_ M:HK5]W6]+(I5BG2_#L<^($VGP&G9M#0,Q%%;?3QT9K#YA7!(O:)X_HQ^Q]#OY,E M*271V'B,J<;LM=#73S%O7>[-N_)FB]9TM9AI*A/5QOW2G**^.6K5!#/37(#P MG+24>S-IVNE$<'0>6L$,889<%\_]]3=7=Z_ZIPN&K`RYK*(@:4@PJR^R8-BB MX2:L;!F4J)=BF2@[8;QMU[R>59$DBX:58H"9QD4YSKPV\+R=R8/^',&.OJTS!=KF5>#7+!I@9Y)QC<]HK!<$C.;;?W2:67:CP-I[NN MY\R`'.M&\V]JT&L%@UC0JP7]QC.5;JYQ\\7[ON=,@N)1:"? M;2LK,^A\6PNMMO]02S:QO[`RK^Y>;Y%)NF?V_>Q/YJ1)B!"_WL.!#O32*$2# MA@QZ4E,R1@NV7+%]/3A-WS;,=YO"EMVFL#NYW8IV_UF MU]T%Z+7JS#J;:=_+&'FDR6\E'S/I!=B)K9[@@=:`ZB*BE+@(9G$2)31!:0QA M.)019J'4[6]27VP9BKMY/<":,\7:(/Q.>R8/-Z-V2<*KKNZ[<8?7&#LCH00) M)&S:#`DCKOT(020-$!I-^(A0?0MC=_':]W7)VGW/^2-^JK?59N_JRT7@I@3" MU*6)$\(`LO],AI-)740S5W1TP;8.R_S9N^)PN7>5[%.^*L#M[[8K]5AP,(G> MVSM);DX/.!>QD;]H`L`[$4PIW2)#U+,*6UJ@Q9[Z>$# M%+PMG;_DY2-?H'8!FNWMW\6R&Y`X_N;U;]U%WRQ@03[GU>__:XYTE#0'-#2] M/S#`,55&9S#@,5FH]?0OC($!D8/+8>,81EF6IAAB$A'L(13$@X8X\*6.W#5: M\$0#(OG]_;JX9V_T'@@,#'JH^ZT^Z#&)U88&/0PLM;+4D)*E?BBIO:?W\6.;,IJ]EQ;4,.\[HK^>B:@K^.;X1[9JW M4Q;0IP@EGA-B&*=!Y&+BC3QWHT#X:+LIM%C&ZR":4[57?0&>.MV[O;-%IYQ] MJ-_DN>;:9?;F3Y&UTQV>N25,#M+OUK*-R4OVDM?'L-N'VT:F9C;LFI?D>MB M6=]7Y?^*U>6*R2WO2M[MQTU3;)I^@GJ%J]47]F/>NBB+AOV.1;;ZQC+03:_L M_8Z/>(\+LF#F)XD+$<$X#C"FT,W&!>9Q%F*I8ZYGI=QR,V`W;]!N%L\[V;+' M:<_*,=&SNFF1SN8\GZV9]%9G:L[;@]CGJ5)B0?'K8B<4 MY%PIZ_1V4F56KIHR^W17]AP^R]4X[R;>]C2"5B2@9[188E'P&:Q6ZU0:L5QH M7:^8)8?6\QHV=`9=/^,AU?:>/]EIJKT:ZFN^V:[;>FM_5\PH\++Z5OS:W/PL M'E^*KW6U>6@6*.Q_J6'NM>^B@@@R@:A%)7SMI58GL1R3B!E5?5EKVB M3V,$?.;E\54/[`*P5P[*SF_9393@A-=L2]C?W[2!;5H!' M`+H00!?#U/-B.GX?FRB;)(\SZ8M,%.S;J;0)+;9#^W\7^?KF9[WP$'+=C`0> M@BZB,,-1.&R$])(L%=J%:%7`[-@>V62[<%HL(-U&1B8A.1?.2"X^EW(&?O?F MFL*V;*X^(ZVE8]2!M)JA%MG,GM1B01T_"W#"#\V((B]-OGA;14D-J0EK=4:/W*!PMP MAG6LN%J-AQ8E=;-I%A$.L@R2%*=92I(T"$$CN,N41B*+F(Q6JAE%(\+^Y8[ ML;N=&WSAWMWNB#`N6&*QA5GS3R]J.9OO%%C&B`L\#/7,0T!6&,$S=# MK#_C)/P:/*DSZ:?08[G>ZL6!9E`'-ODOE5LZ)\F-6+]A;FF1J]9&]:!3!)BD M]A9/\#J""Y!OP)"^,8JW?W0!OA>LG&.[]*UT+@SDX$A78\H,SZ3C,6G(]?E> M*`M5`E=4\+T`+(>/X^>*9A'$-$*9`_TT#=S(]Q#!X:`)>M`Q71R_E6!H=,UZP%M'/YB?"O'ZL"]PT9;!3X[(?=T2A-5J^+\KY:^!'% M3ABZ)/%@$&(?HAB/M0_QG475CJ.O;LP"7UZ($$+B#B'O-$OBI*5ZIZL%QO=M ML=[4X+IMUS M9OP[DS7AKIZT3T1UC2`5<*YKJ26.7Q<-(]+R84$=UFMP(B](0^)Z;D0@)(,: MA")D'>3"2J8F^2"L!T)'[I0%U&S*);^L<[5=MN.SF`?;34M:I;AXSFQ@W&R> M)N3X(/QS@'Q0:XSDTGG[E"B7CU*+Y8JF&H7YU>:A6./5W]NF/\_5@TD4QPAF M;NC["*8D=78=A#"0NB?!B@#+HRZMGG9XQ0*&Y=TV!V&K1MM"<"L:[*F>,W_? M.JQ)7^6$?2+VJL>H0%Y-0S6YF]35IJRVK/M^]5RT9X16S<)%3NPGL1]3XI(0 M8S\.LT&![V%&6WX-G0YME8J58NRH4/C]O^%_8@2O:J;J0-6ZG[90.B=N?F2B M-"VU,C%K1NI%)D1&`^8)\S`M[LJJ6)%N>NH[>WY_%.N7+(PKGG`N<"N!<`J@@"`B"ZH+O\%E75`=&L-SQMPTM1I=F! M_M58D^=4+,N.`Q6@DJZR/3C_55Z!BA%;28X:*\0+ M>DB@2/?>Z$F4(VN)?I7#=NB5;G6LX;6X?;M65S$1SF!2^#ENEE9\9=L]IN! M80[:)P0-#.HSPM/\;;9I?DIWL"//]`TG\/3$BIP(S_$]HYWB!UX<&#R52<(: ME5R71&2#//])9GE$'\X84X&JK*BE?S@K-I-,_)PY+AV82+ZR`WVJ76^.9"'$ ML;U,5Q=KI7N4[VBU7.]AHV=/'N6[\K)YP&OT#'?L7?PC*RO\H3_R"L\\?=_P M3=?1;1`!5P=VX)MV7="31#`*F8JY9X0C>1.SLX*LX:@=3QX!>_%"&/X4,4:K MK2%_;>W1J$$\3[/-Y-#A*:"BON2;_?TGN)'C`3[UW#GR?;[YW,KTBI\07G\2 MEQ=PF@(WH0Y^@(]D*EG6Z?[0LE\(H MO=RMO5!'^Z6Y.^=7[5SDWS*Z`MCE!;UEYY=#OFN;X&7TT-^>]OL4S1?WJXM5L\7%J0TI;RN.-#Q?,@?NW_@W&U:K$.Q[3Z] MA[[$-Q^ISZ@],:D]C%%O/Y&S%]VBLO[XYZ<]H+^35:[H_E7/]"=[68W]6DV` M5C-`#RO/O#:5Y,F!I>S2?4>1E>_B-.1J#6E!$9[;N))%KN!"X3@2"J+7,"3W(EW)Y!P9) MS];<=???E:3*,]]DY$NT[UGU0$+V`?\LVV6;.H6;=H=`!457A;B>&(@5LF3> MF/U+;?^O&F'@6JP1&OC#.ID3DM`^4*6E4B"?KR>,B/D*=E/%IP=24^6RC@T]PQ3?^4\RC,C8J?<'J!X&)1L/&-$F\,%S,'I M#_0=;C9D`YQNB>#!BU/U/T$WS`[I+[P]H#8!O`(PE#D%L MV8%GF99C&'K@AM"S8[[3,7*12`X^&+S68=.>PL<=7JL-(!O'3S[6V*#]2:WX M/\[8(]EY;+%&';_QQ1;I+I,2/R:Q/1`OYO&B(O%A)F/S)08*I_YC'&=45(]D M@43>C8K_OF1GNG!ZO,/?!']DY3IR3%,/G%AW73M.'-\U?=`V;251S*/R(MJ3 M72O40%S1O9OZK<`K3#QGQ+^O_4F`\LJU$*[91'ENFCG+>`0P+$5=&6@;T%"1 MI"NBE$)-RN7U45&J1QJ.\B.>EZ_U(`[)+>M`=W"C%@2NE;1-NP&$0E2/HST5 M5*^&*DSW>-B>J'N2B):@>V]R/*_R=<2-4;X1M*NN?&-,8E6^T70Q*U]PR0ZD M^NUW=+Q'Q3H)8],`B>X&MA6$GNN$MMNT@AO5N1[?Y/QJR7K6HN'-\O(2Q*9+ M$KGADZ`6B/9G#65NG7E*Q("DC&1,$?48BSX7TFTX->'W=/.0G5#QV)>BIDG; MU$%D)K9NZ9YI^%ZH>[!M$@9LQTA$M"-9+:[0GL9D3NV81"2;D,S%(9^JO$+? M4B(S0-*`XHB@5A'Y$6)*+K[G<0K3)Y26Z"$_;,D9V>M?/AY)H7:]<=8*([!U MW8PC$)A^:$%##T%P%4;=YTJ*"VM4LF1=H6E];)R*)8YA-OE:A%P^+>L@UH^V M_I3FI92-E;\!F1/N`D4T3[Q=N>2^RW$H.,P+=(D6W1,B[_:UDS7\4W3A$%@QVYB`>#%]K4UD##E`B8V(7O[OT:V MTCI@JZZXG>>8_`06WQ;P/F(7'D70!CR60Z MV?^JY:](L0"J%)!C$5;D0OO/3%6*G[(3^EBA8[EV#-=RDT@W+0.:;N38'FP3 MR="-(F>.2D5V-)+%_O9RQ$Y[)/=FW&;[$ST<=ZJ>E+GEAVQ#IS\$M$91SU6= MR.$TMDT'M?S%%ULF5RDR^4^I4L4K[1+*%?E=JLCNQHP&"RI;'$OU]"*>KR7: M70Z?LAU:.[KA6V:2!)%MV]#P==,WVZ8#Q^;*;XMH;[8BGO.UP`1U!287"E0[ M8*2B2GAXN&93Z[EIYISK#Y?PU!BU3X,,SUO`T]$VIH!G!.F***90DU@+>$;3 MQ7&+Z[E`F_IEW[65)+YM69;MZ4:HFW80AUT;G@WX7J?A^&+).M;'0H=8VC^1 MCWZ0VY1X)8R/.#:MDL89GRCU8=WU#VX^G"G>0[/Z`Z*M:/5ER8SOR'"/R;5-W$^C:CGMM.\(S-1[)$-*@ M9"FI,7XX$)!XE=2B;)X#G#(G$D,WF]#,SC2?`#4D4WQ:![!^]6_)61$+;P.R M)91V1>1,K$VYQ'[*D;OIOCU,SUE5'Z\F9Z\O6#)N\UWU/2W0.K%]V\$]Q?=< M!_IX*0J,Y+H0=0'3<65QK4D6OJ^=L&F;#B:](8/@U,H&J'9,?V3'RY$C3R&( M[K?S/?,SS2=\/673>@BU%J+68IR?7/9\T/PDCTL-W3V@?K@F(3S;G]"VOEWK M?"G.>5G?!MU?+JS(\R_#`X`N*+99=<&-_V-:AHF)RU>236+]H$#>2;!!N:PN MRSG/'FBR?U/5.O$-X":.F5B.Z4,8QP"TR3`8)Q'7"4)1;4H..O`GZW0R(/OC MK^231.&LL\VXER"<+_8,QINGEQC./.MFY&Y@XBV:?47FWL+-RN5V6DYAO'W( MSN?LM/_O]+3%']O7%0*G\HR;I@V3^_;*M0[#T+'"*`E=RX:!&9MV>Y4%-(&? M\.BBH"9E)]P;E".W+D7QRJ9\"U#*)WPMP)760J1[Q$]!TKM5YW[:CXVZ`=T3 MS+TBLB?:JEQJA^44/;J[$:2;O]#V%FTN159U5:J1'B8@C/#\$T)@X#\9EDF? M![,2:%H>5_IY2CN2Y>UW3/2>O-Y#4S4$YX=["E0KKT@Y)6\2JVPZ-Q>A?.(& M^_1UN)8Z<#1`TH",B:!6$>T28DHNON=QJM0_T\.EOC_YM/V?Z]6W3=E.&67E MYI"7EZ*Y;,QRL"+&B1FY9A0&T,631'K99!3[41AZ7/>6FC8$^P:=UR3N!3/['\2U%$+BH'-%*.2Q1134G&Y7/TZM'*>CCD MWU-,#ZF,_X)*5'Q#Y?4F,S-Q+-^.$\-(=#^R8M\RK*;UV$T\?9RD3FIR-BWM M8-)AW0*=<)6B*-)YU7,VOL?*YB2J)>OE$'E,0BF$?>444HQ5KTJC0-($:6)S MPYF3`",!26PX`'BFY0:6"]JV(\?BNEI(2(.+Z^'(^Q7%L"U""B40+5H(%[I? MD86WT1K(2?N[4$!>F[CT;Q1A[#N";9-)7D3YY;[:70[MI+19Y5NN[UIZX/MV MHNNN'ENZ;K$6(2W4:#%>UW2\6X,"Z&7<(9R76GZU%E-P2Q#TU'#SP/.+$)8KW=(XR!GG"5IHAO M7:GDQZ?1%T-(<(O8+(@&6QWD^4<1995HX,C4R%@JV2\7 M;R['_'@:7I)_R0\''!R^I\5V'0`7A"`"P+&,",:.`XWP"@587+D2&>U++Z>I M(9-+71@VM`ARK8'.*\52O,,FQDL[AD^.Y?A$SNWG_,0.:+),-RFBRE)-?'Z+ MNG0Z!25I@O1`?K0.O<3$30,K<6W?3VS@PZAMW#;Q\O-,GZB]K=*B$I&K86V7 M9Z@_A\@\Z@.TSTXG,NMJ8`G-S#!3+"(U(X-7P;F9U=LL+Y";:3"-3L[P$J^( M*`HVBBL],XXR0<(7/J3%'FWO&ZW&<%<:IL:(#U82TKKZWO&:I2\>Y^2G"%",N?P@W`)#3O? M$-CU!65OG3I:0%9?(7>TS$YUUKN0WMCW$3*/_@X+'=4YQ\WLXCD6 M4BXDF%Q9FMKA5$I".UCC*X?X/?`NA'*,77P51&.)$[P\=P+?"1/+=8T0AI;M M@!C"JQ:;5M(LS^.3$#5D;95_<=X"9!ZV^!>8UN7O>,7(RO*[&)'<1HU:,?)1 MQG[I:E:>\S(]_%;DEW/Y\;0Y7$COHUELY`8&B`/H1($!? MY[?@SDLTL[YC)/D1W59X34:2,TTTN7U`B*Q[VXVO]-!!*H-'+F/J(X@..6-C M!C[0@]@P;"LQ0.@90>($3NSH#M>1%U4P2XX6M9G:U[D:>Z5?$&8P13!:Y*@6ZA\^0SN6(@_*G6&12)DLK1DJL]AI6+N9^N MM6VZ;UF1YP9ZXNEXA1B[T/5:$WPKXBHH4PGWOUWL_32ZJ%@EMR@3A.7T)+Y` MK&@G>J>Q_!-#&;6*_>H_)J:/H&;VN#[6?3Q/\VT0VI8)=D!ON^]F%UQ*W'99 MHG)M6Q%P8\NV8*3;,4P"8%AMTY;C<-TQ)J(]R;&TA:B13JEA3]%[L<]%3O-( MW]H':?C?Y9M.-%NTFIMCOBCSE-X>/L)RAW#^1_G>XFQ`QT4RKHC^"C7IY:-\ M@NGBR0^]E%EX)&=M;G9P^Z]+61$IO\L_%UE>?*89S]_2[/0I+\N;4ZO=`=KE M!:KE_R[]L8X")[0M-XH,']BZY41F&+1@`8BY*@Z703A312*>'I[31WH\HT`; M1%^AHCI0/2`JM?QYIB7*]-)S"6K!7*!)=%B;A9;)K<9=, MBV`MFCJBUGAN=C_]Z'.8%K!MPW(,QP2.G@2Z!V/0PH2&ZTR.71*Q25\)H`]5 M^D/;$^W"HB4J0,GTUH30I(BCQ`2E?KQI5AK-_A2.4Z_]DI*Q:+Q;>*/0#!U` MY?@SA_DLD6'POT565>ATL]M]00=R=NHNO\6BUNWN?3UEU3JQ M3=L*DBBQ/-,V'?P_SVE!!)'E\<0"L2W+EOSK;LF^@:WA7HLV^?Y$7@/DU'[! MI+-)_')\\REYBW.E-4@QZSNMP4IVJ&Z;Y$Z+5R.`9Y9J+C('%%F.4Q017DG& MY7/T:^YJ*RPJJ*S:,[R!9X:ZX861&^M^K`>.842>ZX:AX?NZQW]W2Y;" MW@GX_)KRGKT0Y`DE@\4:X\A39`B-AO^BZ&$*#=S#@+X(V7LM=ZV#"$2FX^&9 M"G!Q&T&B6VU[IF%P+2)'-R)[8'10N(OKQM+&6@DW`V.\96LUI/H=68V).ZE2 M\IP;!DT93:=BXC+>CE=49B(QX^3FXVES*0K<&`[CD>[9KNO;1NA8+A8WIVTL M"4)[7>48UPBM86Z!2VBN8)C'SAWY%2UK1]!F^"5FD+];^D&$9H"<,9Z5=JHW0--C?1'V9O*\AIE"/GV1P=Y(9?E,B<-@%A*5 MA@H&.>$E33$AX8;_BH2,HX$]]X9VV0EM`W3"?Z@^XTX#R_)R/-/%\M<2;U(AJ^@.'/"JZ=DA9.E7;O--Q?2 M$/W5=^KB)S:HZ^IG,P?,*9T.Z+ZET\F`<))_,AE8SI$+3P86-#Q?>@QQ+B)O M-P]H>R$I[#`_DKP=;9EL?B5Y@U)-T=8)ZG6[;KFB#RH\0S8]WS(LMUH14GT`0AUUV*:EH@ M.P_8`UE?$D\+$HAHD>H58LP':HW6V,V[>%635<:%KIK@Y4UD6GO)CNK+GD'> M9:U[Q'V_1VA]NU=:9SGYEO[G7WPCO=6#$-!6'>KW?,46:,K M3E+^GL1D=+A_B9P\5'9;X<9OZNE)=UUS-V5YAA)/0%S?@G'D>8$7^IX1QT:+ M,H`6UV68,T.37Y35)LX*^08A*JK;$-`V>SP7:9/6'OF3[ M!RRTO^'>1$I2HTM!8OL7=,X+&N7KLZ;CH_H\[N<-U\IY?GP<_FG$)=:L&G$I1]G6TEE%J`21W M-&75XS.D!L3P`D>'81`D9N29H96T2/70@E-#F&1XDL/8[>5X3(M'*FCP2ZG= M7*JR2NF['0)"CVS7C0\_"GE-3`CJ&[0:F'!0J[36+#6CT#3G<$:BF7J"PM%H M+@88(M*LSA`;E9K8^0HR"#W?MST36FX,S<"+R=LW#3(C,;AN4IP!SHQ1IS]7 MEAU^)OI(8+B9SSWRPLMU@?/.HLD@]U.CAQC'OJ=H(Y8,?%D29_*""ZO^/6]+5PXW3(A[LCJ`.\D"$DSGS,B MR74#4_7G6Q#OLB/Z)X:)MHQ@GP54.P21;H;0=/TH<8#M6.8U9Y7X"6LYZ,(P MYPM:Q)`/M27BPI4"##+4D+XC'X\,8C=-$-."EU44Q#IMV/'/XED=SGBBFG*= M@KWZ]!UUCG'EJ!C0Y9`6M"2\>985RP&YZOQT.=ZC@KZH\QV1#2VT_9!^0T6Z M1]J>)(.U;5HA;4<2R-](`IEFERLB)-_J_E1T_:FD_>E"^U/UD%;X*TE+G:1H M^&>DU7NTSTXG^@/<,,+_-7`>45JLZ`][X/"_O=G(ODY4\>/&T_8D4Y[3/<*J1O MRG0/!74H`N"!.(Q\S_&MQ`CTV$W<^B'=Q$@@8)IN26I:\A2J@ZC!,4_NB":: M;:&^(,=\4Y@6*-7]%UPK\I8X'YL#RV=);E%D=2S+NE)[7N3`Q-"-$/J>#N)Q6ZA\;5?;VSJ[C=]P[V*-9Y-VO ME$?@^'U'=NXD[QH^(8=I]V\XC7E9]R[:7 M]'!X_'@\XJ5:D:6']G90N/G[DI7TO:OR=T364FO'(A!CG+(BRWH\DN=82YI\@?"M72WN9O2-D4=' MZ,H))R$DPQ(24D!X6E*6=Q-N0&IC9VOKQUSF9/ MD+8JW6Z7F]VZN_B]N?^H/L2'Y:ZDJ[9'F4)Q?`]]MTADFDM48`(`(D+D*3WN MTB3(3*QL8;QY-6"S^A'MCYC_O=X_E%M#17/*O9[078MV4_T;X6T+&'K$ MT1%R-,)\)6'48'6"7OJ(46`RZL7%-]35'YWZ:\!$PH)E(D^DY(E:;S(A9/_[ M,Y+1PQI0;NXU5X"7?K'^"K#'8#!HRZX<]>+B[^I+GJFL!39ZIN-^:\FCY_CD M[[RMOWQ:[=L\1@VVP[N:A^K+JGRU?(@T^[A0<@YI$D.8@.9&3`(SGN<%9$CK MMKP7`)[3B^'4]1GXJ'LU4W?1Y"<"TW*,JY.OEV0\I[M)+OHG@X^(`RF/-&'V MC/YY#50@6NG7QWK&+U]3@^5RVVR][M0RLBV7/QI4^BYQ+BF!&-",I2E6_VOJ M-)D$22ZTSL#-K7A6TQY8I+*8[LJ6IH):\#=-)N>A3D\+!]8^]JQ=4^[>9.B, MIMFS&HAP.7"D=OW!:4K0<6VEDIB-2F*4),KMMM[R>KLM5UT;CSLEF3)(OGPRZ/@@T+CV".4\!6G.8/Z'1D,,+[2?5](0&-?3TEY`%=L-WDB>O*(V>A[-K!S46RRF=QRY M=DS,VHAHQD9_??!JNPT#KEZ9OWRS'D!C#*_NU?-\O)KI_^MOWOU2+>^J=;7_ MT=5%[-7\^JNBK_L_BR3A!2<((LZI4'\E.<$]%"QHH5_EZ@.%_G&H04$L&\I@ MCS.:YL+`2P2F+0^N3;O>Q/;&DZ#1@'?F!8$!>V>6!3YC$42)B)F&8@9;A@5)+>*(!$+C;EU^:@Z?+"P-[6I+&;=V-W M#$M#+@]C]E'!T7QVV9+&RVG^3/P9:]\KV>+-404_SLZHWN/4\S%KV.'OH8R6 MW]J'HNLOZOOL'F&-OBWONXY]?SY4JP?UY]M]M:H>E\V_:X[0U`]5^W5Y'SUM M[ILV@-'C\UGJ41FQ[)9WD;TWDG5WK`>0FCMTIO;Q8=K."72U?UHV-^G_OJPV MO]2[W0*F)`5)(H$H&(8Q1["0O>4TCD4_,=Q.VS9R9-5@BK@UV6T_X(I^^JJ0 M_1RM%39;=3.@V'#2\$2KRYDC.E+<@(Q^:F#^?`6*+6<1OU2;325TF$:^MM0V M'^_/4:-G:GY8#7NA33/5%[/%Z?9H]Y^MCOM&RR%NR^-C?CYFF!-F=:89\["$ M.M=8>'1IPK$ER^MF3YZ#3*0QHH`UC5,+5,"TAY(4`NB6L_O`H+_5HUWYSDY' MYG(??59?4MOE)H+@7V[W86I4WO'NPV07'>P^Z-$Y>C M3%>':;X#-6TK.(`8Z>6U'L/C1:_-"#XCV9XC%HAJ^_:RGG486&OW"8I%EA4X M!0))GA20)%FH3KK2&L#G3P8Y7"YKF#-&B&!Y`0%-XC@FA6E!DR':R.F?IS4<2LB++/);IS#E!0F&(H M4B)5"A/S'$O46V6DR(%B7 M(4*`W2Z6%TB>=[5.][%WW4&2&M+MZ=*`W5X6O43,6#ZO'2PG,MOW$1E[T5Z5 M&OLQR/%H\^OZFFS`OYYV^PQPN!KOU>O+)BN)+1.<_4M>L]UCX4>31W"H:#&6MP-J#55;D^<.I1ES5J:F11W2@&' M#]:#U4H+ERX*H2U=%BKWN=SOUV6[>?#:?JB4*$UB(%A""(HA$+1'40B);`7/ MRKAW[1NALU8\.YI-Q<\_OPYU<`0VR!ST')E:XN@D*L'JI!OO+DJF0Q(MU/.W MILGSX4+F0N`$9A"B.&-YD4M*`0"]U;2P/\71,N9='5LT-VK9OUH_W9>[<>]K M:[74H]54'=WSZ5`-6W"7N\7,I'UCJK2TSHCC8+7-S)N+6F9!DM-JD!PCP0AG M`.8XS7+!!!E,PQ1SW6I=%S9GJ,Z573?J_\=E(%-)#G;@6;AD4`:B1Y>#8MIB M66U_7ZZ?RM^^M,O!W:[<[\8E8BF.,9*$)X"R+*-,8`8/B'#.I*."6FL8GH\? MCO697Q32Z'L#M;UOV9:3M&BG-@2:(R:F>_=['IZM+:>&' M6D9[B6NC4EIG`0Q6E]U[.KFDUC&Y%BK^*I(%RFD!)<)4QBB161'G13R8)U2X M**TULSQS>>U1JZ\^VE_E2VMHVS$>[#BV=.OBH'5!F^U1WOI3N7_:;G[;C!!P M!'*>QB2-\UC(.$,B8SV"F&=:3XLX-.LYC^IP1=L66%1OQ@F4F[,](ZZMCOA\ MT^SLI&\=?1IX'R5&5]?&MUC4/_>S"46P"FGOV;130'OR;-:C]6:_K>Z>NM*+ M']U=\W*[X!G!@B=J18P`9"`A)"$]@`QARTHX4ZN>5;+'$:U&^.R7EZ84&Z\F M9V#7R>)QC#.Z^Q'U2*^NC&\PJ+QJ@[=7J1/6"8ZIREXO+BZT=VIE<$CY MJA;CKFN!#6(9K()[O(@1<5@) MIV'UO9;`Z1!KJL@>&?55]!:2O+Y*GVF9FT$`@I5+2[=T"MN,:;,YS*BW9?5U MTS696OV0?W7=`S\I[3A4J(Q0`0@`9P5,8"*%%)1GR7#$DF($%]_+[5UMGNTZ M!:,SM,>X@ZB("Q!3T5^KPP#RPK[VS\SN?/5__P+GU%/) M#G<@V[EE>$ZM1YO-T&S>`6BJ+?9/NP."_@'7A(.,*6W`-"Y2)#E),1_D(>:6 M)]46ACWO(7;(H@[:RZZY]M5^-HP;9U'SD.TD9WK&?E_*=[6GIW6XU)-+^Y"$ MJYD.?+LLG*X(=*J>"R8!+@C.I"10K:!%##(T*#<2Z6)?[Y=K=ZIYT:"66@[8 M)H_B?VR^="/V[C",C1^6P^E:OZZZ;ZW_+^PX8MU9^ORL\/9;D?!!BSK!`)@##+'U9E>OJ_OF="0Z0(]:[![R36A"U:QG3MZN?32"[4VVM[N/!3UMCTI[_Y\ M]_K+'UF1I@I4+HG,*`&()4-QJ,@$LU1W9S@\ZWM[^&(OS^YH-Q;HJS#N1**[ M2J_FOUZ>^=E9N=6CP2(4$A"0BD\/61X$U&P;.`,A_09&: M5;=5<\SZY[)YD["I,=R6ZS;WKE2>K5MF-$>0IBEY*-$Q>^>S`]^&H^L\\QQ_ M])KBJR`>G(A&7LS]DITU[6=$?\:8!J+]%`SCY6=> M\!BH6:>&D1\WT=&3P*>'5]EW.$/81?>=3A*63EO.$RXH][=+OQ`%@@GG,2:" M,D8%S_D`)$>,VQU1VEKW?%[Y:[F/EMV#Y\>->=^;[)+JNG;T_M#D+71[/^]K@M'YI)XGOY8;.J MOY6L_%)OR]OE7\,^?I'DB63-VQ%%$8M<,$R'8EN)HV M^5N-?6GN.BAGHI^:QR%^CNY:I_H_W"__*GV='$.Y]M MKIR'9@UBB+-3\W$<&>B/JW\:D?!L"GL/\];$F+J>S5Q_2N]Y MCG/.A8N9ST^`O,^''[=5O?U<;K]7JY*KH<^WY7VU/\)-:)ZC`@F*89[P&&(! M^]+:#.'$L@WZ/!@]K^-:>-&NPQ>M6G`SS8#6T?,[^ZS.'@?->Y' M/W4$O,=S[3.:/!T23G-BS>Y[?F><==,RK+T1Q,(`$4<107 MDM.F[35/^L?*,@A@,L_ZS@C:+.NYY;,G:&>:R\PBY7<"\Q>B4&>MUN/N3\IW MN3A[+60>9B>K+^.=3TEVOCN:AQP$8*8CL$4NDS1%%`M0Y!20MJ=8CPHCA"SK M#5Q">9_%!TZ#,<>YE-,X!#6'O*_YPML,H1_I]SPG&'CK]+!)D^3)NL^6NZJY M8ZZ&DQH9[4X>W=Q_KI1N?:E6R\U>@6S$K-I\_5BOJU55[F[+O_9,$?K/!4TR M)`23%*(,$H"S)4:JS<^85B.?ML19[VZUAA%Y3\_T&8IKB!Q,# M/;U_E?Y6_4?0HR/VJ`YL"8*@CTE:&_)]1;%;5X[ILI>`94DTI MMJ-SFM3.QJ2>E#Z#==,)Y8_HC\/?KZ>6Y^@ZHX9.6`Y$[=SX4GOX#'75:KE[ M4)+9_$W^SU/U?;ENVY*_,`Y5OLLRE=L6/,="`)2HS/=@/*>$:,F6$XN>]:M! M%XW@Z8J6&U8GJM?LA&K*6,-EDP"^)#4D29O"X3EM[G;-_M/+PW2`F0T$3!G2*WL:6,='@R27.!,1^K,K7B6M\\/]7;_M]OF M4NX1HZ[(67`X3=CFH4]/S(Z8`E*O-XDZHUCVY`:B4@XO'B"$TI,:5+M,L*PK)2$S3)!T4&DBFM9'FT*QGC>R1 MCM961\07WYSTSODTL;P2W7IR^8SI$XX#TLOI;)Y13`\A"40S?7A6>_^>-77S M4[DKU0\_B/)[N:Y;Q6[./NIOCT]*9#[77_9_+K?E2S!9$I,$IH0J-"C+\XQ" M-"2Y7&`="?6#P/LQ[&.U7Z[;7D4]1$WU],3\-"&]/NEZFMKCO8E&B&^ZP]L# MZ"$.`2FL$$ MXCSF!%%.`!2DVG_\`I'K&1RMYQX:VDGT]W+S5!X:DKY6))DE-$XPYDG" M$HH2DI!BF"\*GF@FS+;6/,OP`6`T0JB=&UL3.C4/GI-+W9SWA,:@4ML+S)U- M8UVQ'H@&.G3H)#UU2]5D3?O\4#T^5INO2E'_4\W_-EU.3LH@XS@%-`49 M)4BRM$A2.E@G&=?:3'5DTGN)8H>RS6=ZG&U;(]W]4U<43Y.Z*["KIW=O$QN0 M[$UC\8SV.0Y#(`+HVJO:Z[>KW?5B6WU7">7W\B2A%$4F,OHU`!21H;U-U M1L0<\!N(<+GPY*2%@R-R-,H2FRX0M\N_7MJ3*4NI+%#"4,93C@$]'K;GN=1: M=AH;\5Z6V/9=N6V>?-"N2S3E;9H,S4*9G@@=V0I(@][BZ6QAHB6U@>B/O1\G MA8E.B)FL/7*YW:AT;/>QW'Y^>.6D)`4)!!SD$.19+G.>H>)8B0V(5M]D6UN> ME:B'%STVIY$/^D?"UEQ.DZ4Y:=13IX'!CSV#`:G4!=K.B)4KP@/1+&?NU'Z^ M2TT%^\>N_.V+W.VK;\M]N5L4F""$"X(X4\D:9EP`W%O!B=!:TFG^:L_ZI-`T M34\&/)KJI,O3-#'R2)&>]KQD)R#E><[1&:$Q)#,073%%7SOYHK2[*7U[+#>[ M]ISQ4]FVYVOW@$_N@_`4I"E.F"1%FE/&$S(<.?(XU5J"N;+I?8=Q5@Z2G MM"?4C\$&)+:ZE)Y176_1"41^_?E7S_29ZR>HWZJN?U);T-SB*3=-J]&3DU>-7.4'N0A[L9 M(Y@!Z>9T,L_GJ:XC$HA6^O#L-%OU0][TNQ;+:OO[E;%!F34HFQVPUR4>S@B>II,SL^QGD). MH#<@G9S$YAF)=!N-0-31L5,O+S=XH$RG1?Q*6=EVFPC5[I_=HX;-/RVDD#%@ M!'&<""(2R=-<]"9CB`O-#O'&=OQGA4=H;8_X%EK48-/O$&_.YM2L/6W'#VH@1B#B M,05$Z2;B)%62B3-*,UX`1C$S2N*,+/E.WE[+)[I&I<>\X[_*98/:*I4SHUDS MA?/.L''J-D)VS=>!SC(U)2VS8C@0!7/DS%MIF`.*IM^YVJM?_E"O%6.[IH'6 M_L>O]7Z$X`B`,"9BQ@N5[.4@5I):I#"+,4=4%#$"L=:U*V=6YSA7/@#]MZB# MJGOERAW#T\3L.N3J"=L88\]K<\8TUKEKRMQD#L](GOLX!")_'AQ[>?G*$W4& M]Z]&64US%:R\_]I<"ENI?U7MJW)WQ$3OU`\N5_M%`9+F5JR"`P%+:(<[`QPVLQ;&-7Y<) MX4L0(($(Q1I:&+_]7O^!M'A8;K8+&@8>0H"PF^;\D,8H#KU^S0"Z7*^DS5I( M7X3JA7/^:D43CU`B>/)&*,50"D M"X:SGZN[VMN&A?_,'Z[S-[&*AC]5`I`%L2 MJR0I<_C.72D0<=QK5'^W\VKW=;G+O_U8/G:K1=#+LMA-/9@1&I$@@70X,TQB MRG77N>`2BN-3+Y53UF(Y52T7_]5&8M!-BT@:4.,+10-@3"*'B60J!AV&YDCP MF8FE)5%GKA9O;C&2`,K).'.]_KF@FY_Y^GM![XLE&T'H%Z(0$M_'J>_"),M( MS;E>-H@NF-0Q)O[7E7>)U4(YWPNG%VMB;)D!U_&PH@J_"<:U>$V/9?3]-A'U7WP/!=3XVAN.J!`4*66XB,'A: MK#>[7Z]((HX3UT6)7^]GP[2.VUZ,A[*`%P&N42K1-11'UD$LYZ;;88IN+(5! MG$;@=.#'%V]?H#.]BWP'FR,4;BZ:EG"XV6H6QJ`0!X**.9A\(PSJ(D"-(D&:2AT)O=\#%?!,51J^\6&,LE MKZ0HPP3BQ4;-Z//%/"'@]?5FG(2.MS%#GBTLB9BJM9S2DB$;U,GQ]L!R7?'" MC:B;Q%Y"0^1%R/4#@MU^03_@>^U*?!4C45.LT#D#RFFA40^*,J*?F1KGN_@< M"7'S,;4DBDE0I)#M;KQ[SF5U5^]N?W0+=T0SR0CQ@R0.0$:R!&+@HH%HAA'G MR+K0"JKWF[50[(CE1]/QR7^+D1AJ$[>8R@'CW&#N825T)"5I?WD(F&.[RUE` M6A)C9BKQ>F,[+Z^)49)^["L^7?RS0Y!C0R^,L&X$FAM_9X!T/K#I1$PV95\X`'3X!W9$X M6.6K?]P6S__5:LRBH-_]S.*?/XI_)S`Y$-EDH6@X9DE3HY#K7#-ZW<;T-N_/ M][X7A#T#?;^LJLW-)E^G3V4=%#_E/W>N]V>QW=U5G_+=@D2A[Z4(U9MJC&@4 MI"Y%0X=,&@:+;7[+KH;_+M8BIU"R25]*U'XIWR@Q^0OZ(N=JN.&M5N]ALVU> M4]B\;;QS=L7+K_.?[([]W/FQV=UMML[N+G>V[%X,UW,>&DUGM.FIM/HTHFJ3 MI26T`;XZ'7&8%LYO3(_?F5&OLB],JXWSJ[-GJ4X?Q7"QTRVDA%#?#Q)9# M#7:VA-3JUOI(2Z,VT#D..:YW+ZQ[K_URQR+CE[QD=_HM;_-%`E/J`I+&*0$Q MB``DV2`!JB7C.]&0MJSBXXN]EFSN4PAYX$X]6T MHCHOLFH_2I@*XM%S`^F6L"2>JM#LS8F`(O!XGM8N\V65IWG[OQ^VHPN:QP(- MO^Y.*T9'&.Z"AC#$"8Z")($P\U*8XFP0+G:Y6A_U2*0XFC94K,Q7S$G73DW# M;]CEFL_-Y9IW(J4L37::RJ-M,Q$OC6[E=G[K-?B]W@(Y^W?7[W/MT3_KSX8G MO1B@ZCWQ^?@?Y<\Z[6M)N->L]-MGS;5#/FE^Z"4%?;[YFE>;[;?'G#UH\EQ+ MM&Y[LO(O97%;+A\6@"2(^,BG09KZ%#9WQ?;+XQ1-NJ1&]IJ*`_V+J"QFE$Q8 MIV+2.JM67.?Z5QOQG<=68H[Q&JG8'P_M)F'G"]XCQ#_?.(V<3B.HTTGJD%_= M@<@7LXA/'W,RA;S8\)-,"TP9BN)`YT!24X6O!0-42M0JU+JE<'/*IV+[4&SS MW;+\M5^Q^'-958LH!D%&(QSC(/*R$",7PG[Y-(FQ6!O*O#45IYY7I&3-CD3']]S5?%[7;S?_GZP_;S[BXOV6/997Z7;ZOF7U@5#WEV52@FFI$3CVU57Q31^D_=LN?SGVM M2W.\TRK##@\*IDY-^D?ZU+]F"M4AF97D9(Z:*;,W;P2WS<82^P"O]NJI7_>, MW>CE["GF?.B,W7S^RAE4=#H=351:51B*MX=0EU]8EX9,8,`S4*?'("),/]\U M6XL/V[Q??IM7@]R+($@A#3W?S2*$`X0\$@P9U@TCP8GFN:MJJ"A4M?LVN8<] M-EVRX:,Z'.V*[GQILR^X^"9@+OS3+FF`VR8/H.DG;W>1'P4ONQ`%,.)&S+U\'%NQ8204[,'.XC-L=W7/#`MB3MSM7B]XY(! MRN2(\['8WO:+)4]EF6]WBSJ6N21(_(@"2`%PD]#'<01=&D5A&$63KGV?\_<5 MQYI.#.>Q+5:PK'U?2]E^A]:UG)P!1PC":=%&-7I\H>;C@!*3Y\KI@?QSN7LJ MFRLI-`><`_`C@@A.ED0#(=$/S!:*J2]0 M?CK8:/!AVTPQLI\_W]#-=KE=;9;W7XIJP[+S,,CR/?^Y([7V_[-P@Q3[/G$# MD(2I"T,(*(D@QA`GV`\#KO?Y=,NF.`JUC1@5&R5,BFU5W&_63?6?+.N/K7+G MVUV>.D&&=2!4^O&UB2`XRI_VZ=T(09!')1T\OV(FOUJ=BE>;6Y;6Y`PM7;N%.4#"ZYXNWZCV,>BO5^I^3J^*`=PS:VQBU(2^FF6!("@H%..(.&> M"YLU4ISW_K5=#YJ*70)]'C!RIT:;E=&34-LF[!$$;#['>0'!65:'9O6O7O)M M]2KAOH#17`)[*!7WB-B4B`VZPJ3T?0ZN:EW2/PO0WJ4*9R$];P5O6>9D6>5K MUB>?;ZMF;5R6[+UH)CGY]?*1+\M?[%>8O9'W^;%Y(^+STZ[:U6&%O1M1W-]W M3[0OXK"6#OG0C9,TAAEU79K2V$]=+T3$HUS-[(9$5'X`5XO\QS63V1GKY8P4 M8[&NA9GU`4555 MA96.5F6-NH4M.=8P"F^JPA88Q406_/34--R0.((A!3'V($`0)FX8#((BF.#% M8TTCBG5-$,J=]C0X44:>P/=:G>DQ<%>S&Z?HP]AU7E.H+0MBU]T9\&\5TXI[ MTMB`2;5G,05VM"*!73FM9N>;N5KY]20M3B^XO'S%"X"Z5"5D"FU9ZI_U!]G1 M]I+3^?:ASHR8BG^I=VC@[.;=, MP#J$K=L[Y]D[`FW>NW*6J_]]VK0;^#_Z&>;ZF_!<+\GBH:$D)F1Q/6E,M;'- M);)6,U8"_=(Y1Z/=F26S`_91F,[F>,.%)+19$$A.:?/-,3VIL0C[H:J>^J<3 MVC4;\:KF'W8R93_S0#ZJ$L]WFIBUY`LP M*4[M7]PT:].4]Y()YQD%1IB81@RA;SQ+]/J,$H7N#,$-_;$$H,Z.ML1WA1J^ M#M^JP=2VY:!%>9-O=NS-1[Q=9S\?-V7[MGB?6Q8XPC#U4H(P2$-$W)2X<2^X M2P'B#.;&Y=4=^V]:B?,ZMJS8>=D]>YFA9$^>;3,CVU0&JTIN1+.PSO)QD@$8>'Y"TJP7 MU(NBK*LJ95M-Z9)?0OZ:4J^,\.:HK8E/+R=9&>O,UA:F6O5"8MD,`)37%OA, MP1>KKD\+>OV.H/_.JYJ#MC*RN[?8=VR!HA2D(*-A#!`B`(,8P:%:3R!?W[@) M`756%ZZO%<0`Z03$-?:Z+&_5+ MIS=OY2_R24Y>>DVJY\1)K36-%S287F?:O_7&,@KW6.)>8%.N,@.`Y#W67%.8 M.`_Z[WQS>\>&CI[S@Y(9?O:A61WE0BI.V)58TS;^,$"D1`F$<8A#-R`NA%UPZ`7 M/T"8&)U-FB6YEHFE(<8NNQC;M]\YCTS(\0Q3<=,UB#N__>M;RGYVFMVPP6&F M>9YA52Z7Z@[GD<`O,VN;3]637>GOE9^GPV(F*7.:35XFKK@:Z(^J@+,T\Y(D M38(T`-@/,/8PZZM'F8<#ZD&I6W2-FY_,PMVPUM'1K#9F*\[-.GU%4GZV MU$WDY^A*?*CKS#*U/)/.R=8&'.M<,K8):'BSMC'SZ`M4T*V,S^=3 M"9WJ&1<2VDW'T>OUSMNCM!-!1J>,,$"^FL0F9L?IX+G^\.D0KLL2T`^L8VR1$K%^R2''-\GD6Z?U'UN;Y_4 M;Y.Z*5/Q79"5WK$N5LW#*\W2E^0E>XJ=H;>\XF2U!1JB!9`/&IJEQR0'V)5E MOF"85-F&1F'E%];<66HHK7/G@+2A!-(L]'D9>%7@C=-!L&QV),,YT7 M8JF0WW"Z+GO!67]W+[E3+_1P-23I-VE;\Z5:2MR&(V5;)OIYI._C(UJ#]LY( M?8?I?V97=@D8^%1:M]3=;$KQMD(D^3XP]>;46-3@5V81I1@2+R,))BF)/!P# M,!1H"`23IKNL8MC3 M+"FV2/+*=BHQ$AZ&4>Y0;6=(KU_"/:>)NX"92`A,(L# MW\]P&GDQ')Z7Q2Z-8IVG2"KDMYA('BT`:3Y)4N(Z>DZ23'N-K86@BSE)$C"P MPI,DE>YV(2=)2B&2?)*DWIPFQ@P^U!)OMM5F]>_E_5.^R$CF$0+"&&9>2C%V MTU'5"Q!DZ.9>3BGUIO+E[6W9/*GH;'HQG6`_1@H6[YA'5X%BKG=<8D%B-B8J"Q!R#&:BX+`OL+N(TR"*W,`%+D0)\%&" MAZ=E288S3^@N`S.B:KB^8#K1LK1HP&U^[;4!E5:WI`1@P0F$$EOI.<=2>0C3!&S\^EOEJT_P[7UD=XN:8U_5)'MU_]1\KCO& M[(CX/PR=)DRUD^QC!.G^<<[G!_+!D'%PH,A$1@C2_@,/"QCY(2(H=DE-ZP#, MB)^FG<2IE^!);Q=9(*;JDDQ#A[KWB&P@0;Q6U,^`%!K0'OK3O2GTH;^3^(P\ MPASS4>@9:FE/__U?/Y6,MC!B\WC"["88RSZ^FNB*H%$OD*N((J&0J,PRCA&6 M\N91BT48)2%*0A(#2@",(Q\%22^T3]QDL6W.[D\4-NR0=5)(0VU(&ZO%R5=& M[R^99RP"%M5/6A29TCK>\O+*D@W41<`US+$7M2XB1F`^32`O+\%@1%]63V7) M_*6E,9:=O+Q!6A.5$;?P!;*9&6`H)#1S362$T]#^[:07(I:"(`PIZ^WU/>!G M04C#7NB4HL`C&E/F3\6Y8[]/RN)SQOD-1$?<8M?(/&9`89"XC/71);TY(08 MXC0+O,PGD1MFR$<^[83.`IBZ4_M4[9!61ZMJ>Z#SZK;RDV3G[UTPGVJW"XQ> M,\#06C#G,Y&1Z-6."[3O(N:K^L?O!?O5`5T\3`@)4Q(%<9)2#R.WWX)F'J"> MJ5*Z-`6T%-F[N2/63Y1W\CJ[HND1.O1@@_G]GCS_T+\--.(:]NP..U_#[1/# MK:]]+YI?V]79*,_'S.TGC?B:VFWF;S=/]_>_AC'L`R'K]W8K^K#\Y5SG[#:R MY[QL/GND-=*RW>A4NVFB>=+=Z`+9GWR,%))"108UV;;`9F275`O[RXX-6MK`]@0L;*R-09%Q[>%O8V\QSM$$/,-X M%X,B#Y'!NL8CUW]S!O;&6'H;(02:G04)(C&"O2H1P:,WD[BPM-,[SGGP=]<#`K_ZWYE5[C7X^9L)5[&%I1U_! MT/]8O6KWLF*D6)N;B5.]-\&HB4'-@5NSRW/J_^3E<_V!FZ)T-E7UU`2DI^V: M1:-W&"&;*JZEV3PSJC=RX\=Z^;_KV#+GF[[GX)D7R"^E0Z2GCBO1G!:,0Q_5 MAA`*`(R\"$4!"B'PF4*=-F%(J1VCTK-4T'+&=Y*%#G/6UG!/F5ZBGWX:_LCJ$$U$:@A@0T;?/X]D-/70A+AE M['"Z?8R,CTMQF`ODB"I0TC9V+M&HRIABQ35T=E0C4%/CP'!60`)B'%`AYY(X*J=.=&HAATL\]3=`_903\E. M9(!ZFO,?BZCG@=L+;*:>DKW.(/4TYWU*ZNEG?$^"/#/IXIMJ?.<2^:8BI%3R M397&M;H7,\11`G%<"YT!$D-"`?1Z56(O0I;D]$D=2C*/4CSPM1G,9#+U4:!,8&"16K M9).R'PPE' M"LRI]R8SVV/25[?YG,\$YCRS6G,SAA3?NT!&K`LYH[=H2#2^Z;LUCF\%:(R2 M!`#HXBPBB0\\=[A2#A&76'#CQBSY[6#$X_%\>QBP-!_13W5-N(<]G/8_[%UM M;^2XD?XK!.YPEP">A-0KE?U$4M*>@,D'P9!0^Z6/;JT6X[4/3O.KS^] MM-1MNZT6*9*BG<-BL;-C657U%/54D2P6CSMYF)NW2AM>1C3^T#;,IF>B'YZ5 M4PUDCH=:J_8845K6F_4@6?YSEU7#LOZEAJ9>.U]:C6;VJU%MY4=37G40W+<4>.#/V]1Z2,TW>8M4J'2$^?$HGN M-&S'[$MZGV1U]PR6;[9%LMSNDO5U6MPOPIA%A&$O1-B#+/!MYO0]64)F.7.E MI`I,F2<[+3IUZP9/G;Z@>O^]D1TEQ`>*_KQTYC%B3HHZN+3:8P&.P`#7[V\` MFMC=1,M`E+B<^CI;-:GH<4;Y:MYI6/+([YS9ZP$FCYIWF%*J1&N6*@%)3I[G M*`#WFNZKUE+H4M>&L>7$,759`(.H+T2SHR"8[9B`/A--2TP'BPKFK.+6..IF M.%=@YH`SZ,R!<'7!;"FP(?Z>\[R"F:-:7\HL4(Y0_]USVC7M?(,TM^HZ^Z!_ M'+[1)-PT%%6>F9AK4,S:)>;$2O>K9F$O(([E(.:$=N`YL)Z4],7++@GG;A4C MTQ;STO"C;3H#^G9('3D=W7]6=9IU[:/-6/_E]?)L]89*/2O MF>4$O<'@KV]WR!A1&:!PZ(BGO;H)[G, MT+/[I/O&GQEGN3XD&)(@8#B.8^Q'P:'.`*'(W&/[HA;-FV[-N:T^TPC2GZN9 M,7C,R>7&[IGWJ!B4\2D MMI?C\MFWL)]I#V/LN'%,"`M]M](WC+V^S1:)P_G:38NK/'>Z:M[V,Z_/Y]UE M5NAN0S>3]>:.JD:-&?O""D?/C-G?.]CL59;)*1X9;S154XV*IAW:24X[FVSM MR@]W2?*PB).L:`2485ID/Y+ZNO&2ME_7U_KC^EB[O]*//AX>Z#:)KRM9]/%_ MTM5=E26&:9G=;9IGKVO]%P[#R&V78"]=:`Q#W3V78";QZ/G^I(K4!L)OC4F_7UD`W#,)EP$: MJDNR]'K^61#<&](8<9N4-XTE>[C_6$?'/Z;K;=G]31,O/T#TP49-Q%3OEQ-1 MTJ#!,'-D-`F)W+@OE3,"OA1'?F;EP@F]F-A12-P`,6PY+K.\3AH-,.2)7H(B M%$>>O5;@2"WPK5:,-WZ((CB.^S6`Q\?;(K@I8=_3R`PPYT0H#6&]J5;D4L?7 M9+8)\[KT.8N>)N9I]>#B'DY`C64?7CO.\H\0,*,9J!.4KDBYEWVY*;=%L\#WY_3^ M)BT6A*"H(C[+#D+D4NQ8!!Y$4X^+C&3(4\Q+1ZDJ.*A;+S=VW]Q!XY*3J*3` M/8ZS="/-1U_G@`7?6A5U<]D(U`9H32;FAC"<5)-R=4.4D_<^Y9M5+WTORL>! M'\0>MH/`MECL$6SW21X,XU']U:>\7R.O?7/QU M`JD!OIJ"JR'\-,F$7-XPX\Z[^H^Q7R3[F&W2RVUZ7RZ\,+1]WP]=UW<]-V*1 M1:Q>*&.C:JOE2-+'21?@L`0.OM4:@D9%WKG@1&3')E>Z0.5-JZ;@J2BC&H!J M,)>2`;$A+"7)F!?YDSR(!)BKE_GY]O"7I"S3[0)Z/HPQP4&].4TP@M0).MG8 MM4>5TTD5J)C'&B7`ZN`/8=*:`BHO=VG"4Y3"0*/*,8]=@%^+O"S;'\S&8Z_# M-HK.)*!N'*O)L.E5P-`J^,%J&P`!R-`M@&- M&6WM7??0WI3#28AM#F[J_GBM.9K96XX/!KA=LY,-87[=5N>S?ED2HT:85>2V MC;--LEEFF[OVF;]L[G9)>[?AZDM:9JM=LF[+!S_?-D^LKHK\(2VJ0`<#[#L^ M0Y:+J!]:H>5&7J=R3"B6%4I4ZZDXOAQK6E\+V:C:'KGA3=EG]>;T0&.2(V5' MG]8VT!O7/_K$_9V!795Y?ML^MP*=D0;%I(GN$@Q4N@;)&XA>VJ#@"&EZW:,N MSH7I;5H4Z>IRL\SOTP5RK2@(`A(SSZT^%S`5R>\9P9@>4IY#*# MAZ`SWVJ`$#5W:A"8!+,ZHB?K=?Y;?=@ISHN_5*JMU]4SVZ*=G" M=E$U^0I@#%TGB((80@]V6D:LQ3Q$:4T.B2B>-+[,>5)1L M5L]6*1,/"\Q3:O41A7-2Q;.-=B7:_G^+KBT]L* M'XZV%7A+LJ7#/R[^S(H\7T09$4'JAKLO-GATUW5S(CI4]*W*.880N#K[GI>+ MJP52;%KR,2W+O#CNL3"\+\1VU;QILUVX86![CNM;CAWB,(XPIOV4*224JV)3 MBT*JJYPJM?\$]LJ`A[QH3MCFMV"3UBQQ3!AEP]+U&]MIQJ2=%67^$Y@YF."Z M:?.#UH*G/71&[M_OC9ES$B"(_]A47[5[#8D'>FT>2MOU`*XG;GRJP-^KAR)H M$Y_Y=1.ZP(N81YV^?,#V74=;Z.#027'T&)'*M^341YBK-L+H#!T\+M00/11Y M;[8`9\1]DW MF[\J\O]M^M&_^+V%;Q&?AA:TJ!4YD>=#1-T8VV$UR<(.)9SM28PT07&T.K() MW+3*@;S7#J253>FJ;%HMW];G$=J6S=5*!U#Q]97@?2UO9Z<-6_UY[T MJW=O^L[A/0(GWJ#]2,PB,`A= M-V3$#2BE)'*CSIXH&G?]L_%&O(E$(1E\BT&IPK3Q-'^RH&TH&9PN#+_C'24, M0[\Y4\H@9?S]&R0-K#3Q>48`P]SXMA0#"CB!#$.D.H M36)3,@8Q[=]$JO#JCPS*$@0'S_SI@?IQ8W!><-0<[>E#[R@E..G@F7*!:8/M MWR`)F`B0QN@OPY53PGYG`:?:+S,5XL8V#6)*(70=U[/\..A5=B*/JQ_)G'HJ M#N57`PO[9FP.Z!L1PE';R,$@)3X?XK)H+#9Q7B[+7WSA5OLH,3>PZH?B?`B= MR3TS!,O3,=[!S$,^02X):6!3Z$3U3>^MVBZB7)=XSJWK&PB:"F>_>H>%[JBI M?D08$CD-GL7*=)V6(#IMT+R[0#H1#F7!5(:;1@?4MI_`UVTEMRZJZZXK;>X$ MI$[(?#MR0X)CBUFQ$WBH$8E\;"/7YPF&4^0H#F2M:J#7K;^"6.QZT$F(CHLC MNL#DBP'B."IA[`&0!MA6!K2&,*444W+Y(T\.0W6W!B(<8HC\"-F!CQR70KGXG,UZRU:J='/AW13IONKMF*;Q-0B,`CJ)1&O8L4HZ&2%<3CJ"/(D M`8HYJM%KWQ$-_&ZOVN^;TT0CR6D:?,.J1&7ZTF$;94OFRO] MVI6[V>%[H@XGC&T?19"VROUA-(E7QC7,#`,;-KP\9.T).I8"SLPL+,>&7.)H MXS:HW<5ZDV=VF/7JZ?#Q<)'%T^>>G?#MX/6NY\(+`0H$/"7)L M&V''<2+G[#E=!M6[=5!<_W>>[*FO*;\%=91CXW;HR[?=UT[G\;I/]JVEH MVGV+54YUN$:',T?5[M%Q6:W)SN0+/K\VWOO8>*]RU-X]IEIWO:7=<=.Z_3GUM:(?Z/!<4V MH[&'8B>,;%3IP&(WKD*D:\'J;^&H:W)UZ*$XV@@WQ>1(GY6[ZOSDQ"0O\841 M80>!;XT-H#8"-%;P3'F4^VS\S,@DWXE-H/3X<,R\:R*6KTS/='G(@%F<-E-S M_1\`YYQPO[=Z4X7Y9+E=Q!`SWP\HLYB#HIA&$<2Q[_D.C'#D1EQ;FIRO5CTC M$ZF;X45GW/1((3!\8:E5!'SK5-&]J/\4B($9A2!BADP(1+7/I0P;(4+8-R7K MA9'JO;;OQ\3U/$HILSV?=,((M+CJ_L0DJ$ZA]UW8)M`$-V8\;*$2+A'2Z-MC MSLT>SX`Y2R*B0!K%)<)&G*24:9!P=)LLOY/-JOY/],]=]B-9U\L*9,N2HGBL MTIZFIFL18,BB(,"A!:G/(DA)E>#TP@/.*X)E2%0^>2^_-QW&TX.*VOL%CL!I MX,N2B[,A7YIDHUYT\I,/V>@OL=EX^OH]+[;7:7%_F(F4"\L/7CP-$ M7.;'G4`G8@'/URF@ZI(=PDP9!<]FCCY*`O_05<]6I(U^C:L2@C-,0(.R2$?@PA@@=A M#M?Z@Y@$Q=QS722K].CVL2J1WHRN_IF(W3C>40\;'^=\.<;J4]U\>9[&_"=Q M&2";:3@:0C03CW/WMW2:6LC[!/'8LS!`2&AZP4VZ[3U2,#5;'@F M%34MI1AT98H\[X[CT#?@V&D;F&.[XH^[2NMMW+4RUDV#$^59QX4A065N%"8U MU5?D%([C/C^JM^?%8Z77@EIVQ!P6PH#900@=$MO]'@"V^/K7<+U8<0CI=,FT M7[-WC,+`ARP$EB&?GYCN+PZ-"`/`MTSU9(EZ0:+0CRT6HQA2-X0NLAV_DX0< MONQ+X/6*A_U5D3XDV:HKSZ_BXFI_K3G8)C^KF%E'S[Q66V2QBA-)CE4J=2"* M+$\]VZ":8UWJ"2#G%J3$T#.$3*98<&H):@H88GO<"U;-.ZT88XP(J>:AQ$&Q MU0FA441Y;ASF>S,7G?!?)WQ=_TJ_3SM]9_L\4@([VE)!FK23/>?V]=AMZ]%H M&4(/@LH/;5-S0C":%*Z*_"$MMH]U3Y%ME=;7VW(/=_5+%7TZGA^Y3 M77NQ`]\"-T*&C'M^O9\?@!(S?-3)I3C;9-OT8_8C7;%=N(Q1:F$'1\RU6!B3[C,*@GC<^5A9LI2O^;=Z@2>*\78VD`+J<`XZ M!YY\66FK'6C4`Z=QG0/6\4=]=,,K=IRGWJM8[HNM0-(>UTZ:3HMU3\Z;_<9& M6:\`@U7=:;'Z2==^$R3+*EP6[3'N!-SLRFQ3MVE![\F/_>^UH:%N(+K-J/K?.;J*W!0BS<,383Q?`#2AR#G+F^E M%Z@4`Z=0U`LBQ\E2;6"*!9K+ZA\U%;2@ILX8:_@"N MOULB35;5_W<09,MDO7X$ MMVE2-@KL'JK(5,>W(ZE-=)L84`9]\$HHD>,W`X*()$-RV4-:9+?M,%C;-;=F M-<"NI#$O".J3IR&A,:5N)P\YD+\F7$2(XK#1-1GK%..:NDQ'D&.O335X(CMN M1Q37K:GK7RE\#9USVV]3`#5DI62Z':>VXJ8#PUNK67?&8OG]PZ[Z@K_FM]O? MDB*MI;H^\V/+H@A!#WN6!8G?I\IQ1+F:V$X4I7H=Y:`=Z-02H:*I@(XC)(U8 M%^A[/6L4KM M,+)J?GA25UP;W%=`7+4%Z?-6FO.X MF8N%#?>P$($KJS<_&/FV2\X/=IR/(3,.$+/"SYQ`J*T]%W:-2$WND;#ZA+IE M4X)#3*PXM&(;]4L2.*#\2P3<$K2L#PB5T`DBQK$DH!0LD?6`?A%@+I8]"/;R0$Y8#/G2>;4^64[+:?3H;_ECEMQDZVR; MI66=H&SSY3^^Y^L*D;*N,=P^'MI,.8YUJ]A\_>K&0C9` M5])1-X30Y-N5*QZNXJ3XO-L>=L,(PRB"0>1$S">5=-:G5!2'@C3(*T9Y@6B[ M!G>DH3C#<4/(S6DJT1-F,0-Z;KX.T3C6$L75/)X2MN1U9IH&SOC)UG)95[N6 M5\EC79#:':O"#G$(I@[UD1=XD1]&!VG(CD9=OC=1A&(.ZK0"#ZU:O!,R0=Q& M3M#40\8Y8>O0VFLTVSG)D\`,S>FF(6D(U4RUXOF<3P8H/!13[-+52VY;V!@B MSV.![R#$H&LS;/5[L6[(5TPF+D4]T=2*]7T<^(E&%+W17*,!.&ZZ:3`[E>_H M9YS3\`R3SD1(S>&=J8:\I!XIT(QFG^C^89T_IFESY.*D8(FF(V^)NND:#ZGWY*[_5I(T2H+LFUZSTM/$N`=1U-ZD>6C MJTZW#QV2!O#66;P&^$L>UH;PF$2#!-)RRQC$H$.:Z,2C%H8AG5'K=&JYE3JI?X MG$^I)F!J"!5),.1T2C49F@GKUPO;10@%Q':@!4/FQ$'4][@.<$8WV,KW919OB&; M55->=)67VR+=9D5:US>&Z6VV25>T:76PK1L3E4>:'14A1=2/0\CBT,*>XU(< M4H8ZY3S/1ES-N+1HI+JJ(-_QIL"YSA:TH4D'R\)@JCF#-OK"`T0DPQ<#6$F*:8\ M/PDF#9[1W#10!LE0Z"#J,Q+1$%63/\NU>C8,">:ZAV^"&-4[8[*JKZ<@.8Z5 M-('(1TK'2OUW5U]-MMLBN]EMFV:'VQQ<)?.6+`H56DN`VQ"NDF%)+GTL"F11 M^::1N[\8.:S^8<@GS'=H%,,HZ&^<(5[`V1&&]^4:\J5\`\I:(=#0DO4+^$\$ M'I("_*@5_!-(=MOO>=&T-^D>\!QX`6'S+RAK7BM_`5E9[HX>L6WKPO.L"^1U MC]1'YNO/IDDIJC\X`WW@)#EF?!*FS"?\F5?ECD:7"]!HM_(JV:`,3XO?G5JNFFF*RODFQUN=D?[#\2OT#$]@BBEA78D`0A MPACV:^J1A[GNKI(@3C6+[3MX5`R3_ES6;5CRVP.%\>[?_Q]UU];<.&YT_PK> MLENE20C>^0@2Y,85[WC*]FXJ-0\JC@39W,BD0U*>\??K/X`WR3<)``&*DTWM MCFV-^_1IXJ#1!!H*V.5\D3\ML8)O]`=P@*%CW';X%N!0IJ9^N7^2LV-O^=41 M/A/M4NG1Z_?^JLD2N*Z]3EEY/T[+G"Y,*[1:[1YVS08HW'0F;W8]H2"`!FSN MYDJ09=AA;SE!CM!!-@7F-.M;CQ"0#J+P'>[C">63M(FY%).T@<8>'?CE`!_H M`/XZ^5WOIR@[HF@*^9Z)HJGTZ,V5\(K)XFR4/PAF4P.J_DFV5$[[M^>WY:ZJ MX1);<8SCQ$FL*+$L""$[$MRGBBCA.JNBSMI4;P]7Q0,[M9(*M,I32.EQ23L/ MFV/6BRU$P#"R=&W8G]'"G)Y?D;[Z4_,LUU^_6=:QQ<7JL&[2E3[J`J2@9E#! M+YNBI$N1E.*G"_AONQKD10VVV4-6-Q]<@#+]]BUK/_TK8->\[!Y!]4A6V:;K MH\]^VZ!/G2'V6UE'_8IZ`!YWY6-1-6C66=7605F+??H7Z=*GIG+VF#9WOY". MQ6ITXWV.(+TS5ZD/\"P:\2MUJ-`U%@13[]N2I-6N?#XH8L2VGT`K=A)H)S!, MH@B'0YD56@Y(FM(V%YQD+Z/@O?RQ<\I0)!U^BKBL.4M-8#^9%X7/B-/PM M(4?2[A'LS23-'N-!H>Q1$C^4U"?LS>X:UH"[)/=LI^`3:7>B7185NSS@:G.; M_E@FOF'9B6E[`71<;'@0^_T!!60'PD>5E-K6G&(?+FR+9I_9ZA`PV%*LTY_+ M$6'P6!U/4RQF,C:UN??V9(]&&D=L#5D:,;:"(`YBQT((XI":[*_=1LAR+)'S M/A*_7FALRI[WD=D0,M&F!:'-"MQLSF1TC?'@Y.8$03*4-;IAB26_*C#K=L7X!OXL2U$8YM,XABAZ9#CN%Z"'D8F7[B1D([NA78T[S6 M[B`"G-:IZ&9N%6SRI1M3$RF6[+>;5W5N[*]]JAKO10555W=LH,&2\-*J(B& M1F387H(=)S"@G_@6AI`BBJ'0YDJ5=G7+7`>5)2(OP#9+A`XN:/#2$B9;-!4R5-_)M>Z,=?228N'M(L MIR+ILB9W08!BP_-,V_-]NS<(/=L142MY*YIUJAE0;Q*+KRTX4;$:P27GQI5) M:!3V\OY.';Z1< M6I[AN`G&<9@D7FQ'=NCBWEQ@)I9,'W%1&YJ5:+]CF90/62ZR+7PT>WSJ,P5Q M8MHS<#9``E];4%,+SP?<')&=L6S.1'1&N_%!T^]QM'`=3FE>FH=IQ9:&^Z,8 MG;W`-%S3,+'I.Q:,K,0U+*>WY_H>5^_+T49T%[48MD\-.!#)G489Q^%QW9F4 M/L&:%(,%WC+'(3^**>0_9S(9E7+'2T90RG.`XYCW[ZBT,L)F<%Q#C1^%XB=) MINOHBTRTLX>AD3B6YUO(,JTHM&+;BWM[MFG&PCU'98QH%FKIOJ)2A/%E@Y-P M):;*;4_15PO1\^2#'[%S)"$<3>A,,L+Q?KS73'0\,2K*^)=93B[854Y+,_%, MWX]LR[!"-PB-$%I);]OS#*'&?4H,3EK09R"[UV\-3/"5`04-4H4E?@&Z1]?Y M]3`]IM@O2?+4Y?^!.+EW`.*\ST3GU/K$_S9`EC`Y_>N,7A?;;5*4W]-RO81& M;&#;@!&U%R`?(6]?^\,&%NP_,\[6I*HWC$.&$'001\F=#+L22J>9V#$B)\JI M?G5[2Q:OL(V@>8Z:-L:=8W(VFJ912K:,H65%"42.G3AQ'/N!A?$^:XR#Y2,I MLV)]4Z=E+2]B)\V(#+#7B+C'6IANFZIX6H,;&OXF;0:6L6@.Y"L0KM-DRJN5 M4@852-0,-$E0B+@9G+'Z\/O`(3F"A'"]17C/#JJJWQ??:9F\;]-4&),<\[4X0';'I!`+5P-F:=?*TS.HXH4J2?V\FS$\K]L MF)Q@N9<.HXGF>?7`P\4'KR"4TCB#5Q%J_2DT/6^CZH7W:7E'JJ45)#!*?#]V M71-&;F*RCE5]1NO[0HWSI0QH5OD61M/XC?Q@[X!$6TW+L293YM-`V*BR7HOG MK`6\%@)WP4Z0P3FFD\(^'"W(21'"?WMK^MR<<*:KXQ=FER[-5L/`MV&$K03' MR$'[97*,H-^WH[L5N)=5UA;7<'G9F>Y60F;2ZAX\=A@%%4:>1CZ5T4N=E-+T MD)INF2]`37TI[0?<')&\"="#!]Q8E8#!G4)![ASO!&MT8]F,K=XJCDC:=ME!RBU:K%3ZW%*?:D@73`HT+Y)&B5USV] MC"I1O0XBV&.<@>:]X4U0\>1YG['>C7"*0^W&4C;NA6GD0<]&OHD]A)#ETX6N MT[\TB4W?-;H7IG'.V09=RHCXZ](>CY*7I2F<\K/A]X'G[)T:( M0#^_,GM*ZZ9O\-"=#N7K?Y+U'>M`L:(_:KH,OM?2)\8!3NP@=.+0\2+#]G$, MFY8^H6N8L2W43TFA22G?ZB_T+$1W=/Q01$F:58V M%SY<;=BW4561NKHD3V1K71-&<[;-FI?1A_O<0M_R;12;9N`;L8,=.O]T2]08 M!B@4.L<^,33M^M]X`SIW``.^`*U'[`89YA,8KJ!B/P6M7PO0>`8L\-*W<;MT MIXX[[R0RVY"+3BOGBK:F&4=E7([.06=Y`&8S*YW'^S?SU!F#,&+FHA/H+MU> M$[HHRJ_R/<";.MMNV45K2QR&H6T'.`P<[!F.$:#(Z*%XOF./FY[&V]<\![70 M`%63M`$V>LY0P+CLQ#`MV2K4OT4,]D$XD'W0P&YN]SR[M)]D5DB_U<5IMB*M MT,632JR:SA%R^X4^_?=I1:J;=-O>,+%_2[QTH0E]T\#8\7W;-Q/73^(>A8L- MP;*/4M.:17;`M@`50]?4$@Y>H"]`3HZ\YIB$?%G1G8QW%7I[$(@&[J*]28AG M*\-$2GN,3B&151*7V>JK&N].2JM"$D>HZFV9YM6&RDY(ZN^$Y+\W]V\V*)I$ MNUK&H8OBT#'L.#039-E18'L]%.@$(VLLX^UKUMXCZBS#3 MFMP5I4P-74,D9'5VVB"H$-M]5#K(X`!S6],XO]Z>I%5(=-4%:;;*J]#%D_*K MFLX1&IP4)8[UX?8^J"E).JLVJ MV.5U^;S\+5R:D6^Z,/+M",66Y02Q09><[6]F-Z1Q]=X3^'6:5>2//&,76/V+ MTK=FZ[0-^*TD:0W",JM3NGIC59G/1*X-*<'=<2372)Z<8? MGR]N8PS^=?'Y-WSUNY165&3U][OBZ1^=/TPJK/X+IA+6@4KL?7Y'$20(.?/H MET%<2$=_;`YQ.72YLQS'\6V41%9LN&;L.721TUL,`D^HT^8(,V?()2ZE>VJ. MH5,RJ=##Y/C$@HO$:;*+@2*1#$.G,HT9,GA;SO^2.AJG=J[)*ST M?4WR.F[;77PF]=*+8))$T/(,S\.>CZ,@"GJC5N@*2=,X2]IW1N1UNNT[?32G MRXL>+]@V@$7;DX\CED^DIN-43*<&7*`%M@`,&NBP+<#G8V]`]?0K/\;4$;E2 MP_!,%$N1,Z_;ERND2%:WDEV]*\GO69X][![Z?@)X1]JZ4;T,D6,F+@R-.'8] MUXHBTTEZ%!'R@Q%"-M:T9F5KX8&'%A\H6Z%;%0\/67NLE>U$RNGSPXZ&;=G" MMM,[L-XU6U7I@'+':=_HX$B)X91Q&:N.79`ZL&#HWI46"1$2H584W0T:?&"B3&+!`4-&M3S5.$] MJ^.%6")"/Y<6RS@H)\?25&I09/I4DA9*'!MVXIK8CCP[\;TPP1$>B@H),O1H M,K_]GT"5?6VJ+!`FU;JL)T+:E9G!GKDV#\PJ46?Q./UT^BSAHK1"R]*I7J,3 M.BI:)"BP7<.VD6-X09`DCN?:0_[NA('0+A,-YG\"A0YT*;1`D!0+M)[XZ-9G MAGK>\CSPJD*=Q8/TLXFSA(>RVBQ+I@9ISIZZ22*P`\_V$<9^8D6QXUF>-92V ML1GX>J29V_S\I=DTM$DS?Y!42[.6^&B79M8`:=[2W/.J1)J%@_332;.XA]+2 M+$FF:FF^O2NNS%>9Z\$&/ M+HM$2*DL:PJ.5E6^Y0C&.25YCV^\(DO$Y^<29!D'Y?18FDJ!K:SYW2TI'_KS MTM&@+.B![:-=AJ%CAA#[U)P5^;9ML>;D?8:>8*$3<:.-:19;='=7-O"*[RY=2S!?.(Y*;=B6LF@?:+A>!BZ.(`]N@5H\4V^W?4X74B:JI\Z?-QM@E1(EN3W_&:/]P[S$>1.YOAILZCHSO.%9#%=:?PEY+4 MZ8_VEKEKN@9AYF\+E/^1;]*GHF1KDLNLSNZ:7H)_DG*=K>JE0Q>5D6$Y+K9= MW_1@8&&CQQ%[0SD5F$1"P[:>%V%UV"'C"X+0#*P0%FL`<-_IQ),/BO.#Y[4.2N M/*:PP>T^.FE5%:N,78#6W*W%:APOQDLW2.B08BWUZ*?2NS3+J[KY(,WA']/\ M>0&:8ZKT_W56ESOZ0W9F=9-N:5J:KNEOJ+.J.2B2?J]V60TV&;O*Z]LSN+Z] M`+=D=9\7V^*.G=;Z^[B;EF5"\LY,J3VZ,[B)6:]_Q43#1&!.?363?R%T>-"Q MN-M=DO5LQ\Q=Y0M@)C55!']KG96C9L>79@6%#+PS9/3LA'&;VQ.2>4368 MUCV?#A#9>?2R!\G&>5VP82!?^(\-S2N;#.-AOZ@RVY:\<% M^\S_=J1B4VI:@<>TK-EGFY4B^\.JJ.IJY$0G3N$'TYS&6,Q@DM/I73')`SVN M3M/=&Q>E9?E,O]6L5[\TEZ-=Y*N2U/Z]N59\Z='9"COLE@S# ML[V`KO@=UW2"((@L#\9NR)V:2UO0G:'WP$`](!/)/^69XTC4)R%-,%\?^-J# M`E];6+S='T<2)Y"_3T*@G)A+$LF5I'_D]D>Y^FB:9B#."IPH5#XY@A71B_Q+ M6:Q(55V3BM"_=8_R=0>"/5N=<10&U+81>WYH1::#8`#CP3ATA)KOJ+&H69XO M@5UR0U-68NZH[4D]52/Y/:L6*G M"IU/JZ``AKLJRZEMM/K?+JLR-I<>OJ#ZLV"9\45.-814=?NIDJR7#DV!V;U! M;!.&B2PKPHG=H?$-E*#E$RF_%;R:J`F$R``^Q"NY#R+K`(*T`R@HD;I"P:>9 M,XB!F(CV@,$!X@5X&9(6-1A@`W0R-%I458[<(S*K.5HST5W=7A:3#@&!RD"/ M)"H>OF5YL\*)TNH^*O(J6S<'V8KAQC<*@:*\N4]+LC03"L7P`COTD6?ZV$NB M?I+P+001.8%Z#!`6HFVJ#!/8>@\-UJ+![M.\O'-%O_@_UK<3!6^@QF MT1R1:+\@?ZO:G]X76^K=V%>:DN1]4$O1'8H95%JTNUA,]V2/FPIC^CS6S_U$ M?%%5.[*^*ME_V7;QSSNV7KK:W)#5KLS8V_DHW6[).GR.T]5]BQ/"R#!M'(86 MPJ;CPCA*!IS0CDV^Y\U2) M"?T_+B%3!T*X"'(H=Q](':0:AQ$,_$/KG-_MN+_'%75SBKFBL,FYUB;FP%-OWUCAE!FYW: M3J`[F/0]KMU:*NQH'LW76?7?3^GZKUUS$&7=(1/9*:N$3+[:Y%0\BJUT&2K0 MP`(MK@7HD9W83ZM%X(Z0=$3/5%`[$_E2XDJA_LD3%*>^KIAD[.;?R^R)K&G* M1!^\C"9)[57M_R;9W3T=MX@FZ>D=^:,BF]WV,MN0);(B#`V#O2`R`AAZR#=Q MC\E'4"@YT0I$L[SUP$#:(@.[!AK84FR"^J8W'GP".)M0B"ED#QNTN#]M&7"P M1PY:Z`LPA*M##UKXX/)HN+3(Z!BJC^CL)!&Y=G_ M471KP@X'9^F`KWM+^NULVZR"Z<]V#\R9-=E\[-O2L.S`-IP(^J9KA)YC M13X[^Y81H%AT-4-(]E?PN!NAZ>45!!]!@IRHB)YV194G-C;Z04%+M,UM6?20 MDJL\7S\`;Z(OD@$2`.%Z*KML"R=/`B<3MX3%57579GN*P]ZIK-8FVS62Q@KN M4G@%_;8JZK^$*JU)HOCCXQ!+L"L66T8(63V>#B/[LD,Y.J&V!,ST%;C)V(7LXR/;DZ"_ECT^[FB79R'Y\-$06+'J=TRVNH*13SD[ M#<&1)[*_8RE#O],QNVP=ER/.;(C*=J,!>YS232K5]7JQ4,5*!M#HFNUV7;60 M=01#&+C831V7(#^UPR!$?3M^$C@"<4G\PQ4'H0X3JQ1'0='ATJ`24\4)C'&% M&;5D"<>4AJ<6#\":>!(*%6KYFEK+5(PW3C%^8^IYY9W.BADR.P-_*:E[2+C/ MTE7#_UH5FQSO&D[I?_^]++<_BMTN^?E(I3W?7F<_25N.C4U(VGKY!$([0KX5 MP,##GAL@#\<]2`\F0L^'ZD6F6KK+JJ]R>->A!9MCQ5Y+VCV#O`/>'3'=#N#! M;5D!5OSY\5BQ4CFB;WMH]J[8HIEYCIVX+/;B0DV/>05ZU$U]Z!/N99X3D4HZ MQ^J57N<:MCZEV7B.:SFZ7#!GJX<==+RKNA6S':NA'K/:KFO/(6X:(2^.0QQ` MZ-@A<3H$H0/CN0<(IS:K.&(,ZK(9+[H7)[#M+#O?MA5PY^^U3*9_\E:)#N9E M['2,<((.*(@ODZYK?^(,A6+;"W/]8)CZRK3LX\5].>1QZ^:WO#Y45*&/5;&_ M:Y\!J-<8!VD:N7X21B@B%DE):/5MI8$3B-TNG]2$\BL6+U!U+]/H'H#O,7-A MJ,TBTI!!-<^&4F+/FI]@T'EU6E8/V9?]+?NG';)/^?Z87]UV^W#Y]X+2,LJ< M"!W1F"*F,_`D8$6%W="-4)*F:>P'N+],$5I^$,[,0Q2C6R1=>:Q*T%A#$Y?! MJA7-7!J[FCK^G66@9J:UW[:V`79I8C4_KU'M]IG%972`YD25;M:5"M MKRI6H9,+K^=BDH9Q:J4N"0EQ+<<9\"+'(>M]\]3P]EIV6%.`E4OLPE;LWIBE M)LCM6!G(NJ5O]:V%=L88NA$'L0.]$B*$0SHO)2$B1]#H;>V]2)3/*D[W=AL M="RE76/?'/?ZLF<3>7;"0'3A6;/G^(*6N4X3BU2]'8VS!M^M^B/YKT_B]_:` M9EV[LP@T)H$_&Z,`LPHT9NDNK"K5)Q=BTC*^-R00+61\:<+P$ZY\39/^G`6^ ME-+8/H%PI!"N'KM"#'64TTB9M[]WG?W,:T*_J`_%9IUZ`?1C.[0BST6IATD4 M$P0A(19,DQ1RO1RF`X?B<-+C8-N8F]UQR]3FZS&O#B7X5FQ*X0K9"AW"%S=, M\858E&C1@/]BN/\;,%$`)^C@A!W<-.!!]_L-_!7H#=!>9WLRU1?$7X<##9%Z M+::^J=2MBUZ5,DZG07EQMU];H1=Z*`K<.(PB._8CQX=`2O`3`"M#:`U0K-VSZ3\@H#K>,(LZ['/JL;"5\V1X&JE*U9?VV7R=6-"A&3ZT8&2%R`]"VW.& M:)"$0C72E(%0K\!(@P+S\:U.@Z53K5.%&?A/H,,,IF0E%G+;)]9B,3LEJ/$$ M8E7J<4H'SCH*;1)C1)#O!%80!6X86!V<*'1L5[$<C7F8UN9&$LG M6J,6,^SF2S%#*5>)A7SV>858S,SY.CR!5J4R7#SE:Q<[*+(LZ$<.\J,D27$4 M]G"()?:ZN2H,RF78L33(,!?;ZF18-M$Z99AB_P0R3%%*EF$1GWUB&18R4X(, MB].J2H89E+2H-]F.`:NO[_,JSVZIAJUM#Z=1@@(:*"R,X\B.TZC'AQT[5:C+ MTT&I%VJ;#EC'5ZO6,YRB1+[U^$./GC-;0&M,H^TU.)ECML2?]8(\S9_OZ,\9 M!"38/2\JR"*>.TRPJBI7M]^S'3L(SEZ^7+NAAV(86)Z/7)+8.`QB]^*&QK0=:@+G<7GH"411F?&JME2TQ6>Z(:-.#/%H_N MRRIO"+F@<-/),T2J9AA0RNI'HO<%\QW]Z=W?J895V0[OMWC[4.R+^E`U='%J$P2C,')HXST(RT%8Z#Z@U)85BTX'MKDHEKW`V90HI4!% M;_O)Y9U/G9:C7$RY.IPKT"%M:'^)%?1@EQ(V(2XOB)X:GQ@BB(J,>WU+3B&% M(N7GFB<<://D](!#UW;7M)U`.[83VGX2^K&5(M<)^Z;C)(Y$Y%-&>XI%\]NY M5RVF2:84AOF$4C>Y8O+X@M<1OEX3EY)$#M8N"*%,S@V1/ZDFO:T8*)DNKJ=% M1L4LNJ*>75NQ1Q/2%#J)']K$]2%R?8QBS\-AFI+$Y;K).ZL!Q6(VPO6WOM3M MQ^-,(G^7E4L;=6)2M3AK_$^/:&%OVO,CTUCD>83DG-'OZ+04C@QXC&2^#:7$ M3B/ZI'M;H3[??K_/JCQB3Y+%Y0/3_+8.42O_:^(Y7AJG&%DIB;!OV=A.>N&' M7BBT$2^I2>6K@B=(3=WW[JDU.F<_E*!FT/_6ON#VV*W3BC[>+HEYO@1T`=(% MA;T'"+Z/N'WAA>2C+%_-J^M!,OJ>SRR9YN8L4T;QJG2E2.@Z@+$B>39D/T3:I)I;I>.579 MWFN8E`]9L5^'./`2VX%)"GTK(HD=VE;?-(QLH=U>&>TI5K9Q^;XS([(%.EGG MYG`MJ'.::!;3.1D,JU6]\[3QJ)X$TDU3/1DFG5,]:73-4KUZ*&W8S;!1:">^ M[UEV$#@!07Y,">S:AD[L"CTZ(J5!Y;LI?1W2T_@<#T_1":T MO1H5?UUH3X6'.4'-FTR\P:(WW28.U9M)&/]!OJQFVSGLG^1?Q^(IVS7G"7M$ MI*@WNY*!6H=N$F++MV!H0SMR(C]%N`?`OA4ZX">M5<4"R$IK%XA6TP/&;AF<[GY8@1S-8X])ZBZSQ3R M4GCIK*%T-QBBC@H,>WTV41%U`I5*J7K0\?XM.^0DKR@"=LRG*XQ]&("LZ72< M."$D7A0@UPT1='$PR+0O]GJ!K#:5:V0+$U04)ZA_9(^B@BB-7#XY7()7,3$< M*&40P0EC]W;`"F2'D2IJ+RG*1=\%(93M`$-D4+I9;RJ#JJ"-?X;<5AF-:5K* MIN.L,FF5;0Y-^^\IL1=:@1/[EF5Y8>K$GAWY7@\C"5.QW0_);:M>+RRK'UFU M!?G/S3W]_QQL.L#"$V;9G'/.G1>D6W`:W2(%/5308^W>63$C>Q3D\]+D6I%G M#)%09>:]GG(KI9'_:$VCW>\UB.T(QGZ8NM#U,$H3F*91WV#J6M'Z4!ZR'>=I MFLFM",GD`(A[\%ZS/^ER&M&C,=.9XSP-HX4TP0,P7?9G@J2=Y>?2,9?9G!HB M4Q(,>7V811(UW-(S>LH)W]2-^JWM-'5"GV:,F-#),[*Q!_V^*=?RA"K\3OE\ MQ5G9")*@VDPBBT]G5/,DIC#C!^G^[/'HWG]XAY(+HC*'0$/D9)8)I;S^)&=" M6/<0GM^3,Y2@P$512+#E0FR%C@OC'@LA8@MD2@!\\JGA3/9GS0_U$2]IDDAS MJ0&R&6G5%&;%IXMR'&6(>JJUD6_B*)-0KCMQZV>#$!."X/OSF,) M*P@3(A1"A$.4$#_ND\F`+1/RWIA3U+QB[1U0@]M.A47%5R7UEZ77$-8%-W4' MPONP-T`>[VH("J\VC_!?Y#/`,].N^:GQ$,\UP&F4O1/K-/!OP!5"U1:6VCJS M4)1CK]_=T5Y-OZJ+;?<"7KS+ZKJX+?(MOAQX4Q=')+)#+_40A09#B\Y^.DB. M12!_N%.+0WGX/DU+)`1' MQ=X2B9+F>&U:N&R<\=0XH[QMLL>/QA6H\DUYMR_^3?V:U>`QJYH">3?'NMCG M=4W_\.&FV+=_1E5V7U.AI5__-C>XSF+Z;)35XS\CPJTF4TO]PV/Z3L%[K=I. MBB)"2.BGT+(3"_F.T[=JIR$6V:F4%#-H>`J')6Y_:;H M2NO]4>YOA_\8839C&>XRB7R[$7/8-V1I398UY_U'B)!9Q`SH?\N(@"F.2(I?8#@Z= M&`E5OS<)M_*CQ`PD8`C!R5!PLA2TIH+N%QMCM1]_U>:.BT=HS>L4AHB6D=2\ M..E0@]@\?YD8I%B.]4FL)#51^> MH.)FR)`1*8KZW;-1@D9S]^/^#87KLBFL5N5?JY*.PL,S>W6!C3(VKII"EVO/ M]0('DC"(7<^&C#(5EI7*.ZWP^U2/54[GC"Q&TJ]W.?N"E=]^**M#\>]V#1)&ONT'K.QL M`@F&MNVF5M]VPBHR/^753+@Q4 MJ;0;,D3EVO3FS2#IA`D,RYO#:09_G?\\1-3NO]:10T@"_31A5\\\EZ:B4>18 MV`\2+XQQ+/A(\K0V%(='!DOX/;>);/&M`.H@2FSICR$:+>:!/QDHT*#2?;CX M##D7A6@>G<9HSTPSWLB-#%KX'PW:W.?;XRZ_NOTC/W3/G[$7B^KK[&8W:MZ! MD8W],$U\)XU3Y$>.35P(L9M$ENLX7%O^LMM4K$`4'/B:[^L^YE\=[O,*?*5` M*QH#ND)J#+?H>T&R*.>3K278%I.Q'B';P&6D]\]#-BBIJ#&<8#EIXR3P@M3) M=H$ATB?=K->/`2FA;9HTIL?]-M]^/V2'X^OF(Q1Y$9V7Q<2+H.?@)$B'YF,O M$-J4D-6FZI-/[1V+8C^,U:N;77'7Y,(K<)Y)5,"2XP43)EF'5),J71-D$R\69S?#@VSVAT$G%2B/K+ M/OFYR>OZZG;8I[ZZ9>K0BL-KK*[O)@@%".,@3&/;M7S<8[4%"YXL`E"Q&/KKTZOBDJUH0Z=KNL?.)'%U]8H]LMG(ZU)P4">B[@B MQP(]PK@PLP0'9V/28@Z9$L#J^OCPV"#[9YUO7S6//8PM3.+0)P[Q8BM(+3@T M'R36Q)@TJTW%8>9_\^+NGFD1?LJKC.;W([2`Y/03V4NM^SLPCD?3(\T\^H6# MAS;F9\2#$=\,I%'*?HD_/K&6X@'S]%>.6>ZF&D'A(J@".[;<6JV8,<,KBOT]ZLDTZYJ$+J9WNZ4IXE MW23)Y"*42SKENL8X"95LWEDI54'CE,2S?7^/*OJ%])>X*"+()A%V`]=-'<=* MHQY%X'GQQ/Q31M.*!?7,BRELV/_SM^^_25EDEN,"X1Q4-_LS4M$!JLFK#1Q\ M\J6F,AUCG+S*M>Y\HBJ?Q`GBVFY-U5_V/&L,)$&N9\>I`Q$AH>UC"+T>#0XC M9YK(2H6@99^O?K65UT_PNR'?R?"63DK9]/_W_(FZP`5?]H_'&1HLUU.B6KR8 MDZ9K\ON^,E>>12CFDFDE/C-.KM58>5:V%9+*5:KF_0#2E8M[#>35L1!BA3&$ MD1_%:8C=.$Q0VJ,AELV5(RN&L%RNW-=N%$^757OELE0;Y)")4GWU(GV^>M<5 MH)5I$;76ZB/^VC2&^&I:61H*Z+C+*K`]';&F0^=PGX.'[/_+"E!S\KNR8N5H MZ/\_,O]EK?_HM[>=6Q^[;.FQV9[/]MO_H7]9-F=)^U_)'QYWY7.>@YMNO:KY MW=_`]7W!XCG]M8>VMSQDS_3[S>ZXS5?@YG@`].?[\@!VQ4/!UKL.Y:J!=\BJ MN_P`LA?3M!&^]K=N7U3=R;/-_4N[GM_\%3L&R_YRU^1X[*@!S39>?=1]D5=4 MVN\94O#COJ"?^NHW'L9:=$M!SJS*,[V/O9-7:.JT!M3BT6%EJ54)!/(*=HR[ M'7:L&W9+?F\.EKI^Y#JNFP0$QIX7V-`?MD\L&'--`*4UIOH4T0N,+\]@"T0= M.;Q^G`-HIU0LVK_/YBFN3XKHF90X3'^3/B0RIL! M@4*N/:6B#C9_37!T/.E=9*/#2J\WA2S7=VV?.)&/4[;ACJQX6+?$4S>X-0#3 MMW[X]@0C2W_!&:& MZ>:N46JP_>.52UT.$*R8=YW]?.^>KXU0$@1.E%IN"@.2NDF"88!Q$"?(&B MIVS7%,RCR7IH>PZ!V$^1Q6H8)6V-%#ORD>,+*=O"4%6GS111L]::GS`):N32 MON13V4_D1C&=[@T#(\M6X&0;&!O7;_KTYC6N'S\9V5FX`D/'2'@ZAA+!5^NR M"R'#D+YB2-`QA8W2R`&]9.!KGK!KGSROZ:?D%#S]RWKMNBAR?.@1DOA)X"51 MZO@]]M0)A:XQ&P%8<1"\KK)MSI[YZ`&MP#X7K;5C!%%+!$,=3C4C)+:6@OX1 M]Y&QGSDRGO&?KO@XM_O\BE%R-B[P"X:N"20HC%537;)(<#I?B1UY;N!CA&&81"Z,`LNWXQY\@!*ABJAF(%9] MPJP#MFK.E!Z&!\KV%6 M'_H%8Z0$4A3&3%DNXSH;+7=B6A_*A[SZEN_:(Q;WQ6.]1I:=6IX5L;>'`A@2 MG."T!XTAX2J?9092U3N!'2A0C5$)G!E>GB&.P]S+@]0;'+EC(WX_-H*A6WS[ MO-V"_QSZ\F#5'V(WHIOPG(M7[HPSA^K-Z00&G,@WB(S2Q'&Z4+)#V+5(FJAM MK_/-_;[;WNQW4-&R$Z62'6FX%2P6V>U06U?06R8<'HT%PH;[ZOBZ:S;;-#/O.^GV(O:,AJ MYOC^%\MI9E&A**.9[Q[M^4QS!.LAJ_ZJUQ%T_<0-,0[MP/(\:,51?XX`1KZ+ METAC!.#I.*O6(%DH1(EX2F^JHLA)!F0HG\KIRZ0CBIQOT!(+3R?0G7Z<,&G( M.B:X^!=+-J8PH"C'F.P,E:E%]A[2YC'5+W0([^^*X2_621S&.(S3Q`J(C1`) M44!ZT%:`52^62$2J..%HWZ(M!E1=A2[U@4BF,Y4E(@OY46-.^OOC7 MF/F)3X6^]=D2E_W$.LLO>`YT#ANZ+OA-<=(B$:^+S:Z38`BAXWM!G%H)\AT7 M]DC]R(W7A_*0[?1'.4YX0I%ML(1_\X#]"77#2`3;,#=L>2X8[W@]J#_&*7"> M$7%-<"9F7B`[.UO7)D"8Z23! M8!NG+Z-,FC;G^XXYY_/OQU5>/J7Y7;T./1>A-$U<1D(_2#$(TKC?FT@CM-[G MC^)(R=4R';3Y`8P2QN@@C&]B'2V2`M)'L<;'N>>@KEC5+B;^X8@3@H>?.`9]Q1Y\ MB4]#%JRL6;U#!U:7&XT&K)A`X^MRF_&_P=MKBA$#28)2%@/,^UUI[';U`J:\ M*R;165D6[>NBS9Q'OH1U\OL)VL,R*7JWMP:)UO1+M MPO3RWE\I,+#(=S+KU[L@1G$>-"WXG4G,(B,'0[@LIH1&F+D!]&F0,(_2;@X3 M^R`D?>&RS`2A#-0I=1P13G)`X]!'VL1O%/NT.8,.81&BIQ2UC ML&E>V<(AV+JN911SYKU*-6E6>-0?YZ[ML-Z;.'I34[L2Y+]#+Y(*7^?TK#0- M<[PG*?85U\BR^<^JS/;586P:K#F$)/1!!&@:T0!`EL3=85?8#0%:?\_+NV+& MXI/I7RTC04.44LXQVBQ,2,FF?LEVMWG]4NYO]LT[!V&YJ^HRV]3KQ$_"T.-MBX4T8BF%'FJW7U-& M?)S(;.S1\/6:-^L<\#EE`]`I]LV)[^T#_2_)JD]'\L<5=@OG7:YV:\$ZW>WK M`MP'IR7BMB="O-U5;G]WL$U?&BR?V#,*JY$E2W169X2%L28OJ;FB?-MO>&76 MJ/S-PY_[LB_H5MEKB["BKYO=R_UV_TB:\^6J+WE99]L]?V-5T->L.5J.?_R` MO[HM=CM6E#^R\GZ-*0(19"BBOD=IBA,W<(&;X)2D,8R]42=:60-6LY[_')\X MQ&\88;/8J(OQ@]-'Z;1A.LG3+>FT)W"N(]YI(C#$"0V2*/;"&+BX M_SH$@_5S7FZ+^Z]U5M;C;'+J-\G(UJ^@Q@]^9OR_FUP<+WNSJ8N[O'2`I`]- MSN0X^S"1/CG5/ZGQAN7Y1&;.J.K<7%HBAK/#*-0V,372\VF_*?.LRJO;O'K9 MU5P:&8^<'`]\7GN,!C1$*,0NHQ!`2@#J\+#43V6*=VT@-!?E'4#G_B475=/@ M0&S9C2+Z>)BE;&8I4"1]XI[6EI@>MB.>7&<`W`Y]O)A?>0%51YG="JLPSG$2 MK#JQ>C2Z/:;D2U.$\4]_*5I!6C,8Q)[O>S!DC+HHI#2).G1N`*$VQ9X.R;!^ MMYM/G/_F6=EL_'LN#*CY#,8T:+L9LK0K?7^7"9S>>D_F7Y51C"? MWVNT!051SS$)54G78QE?.*KR-]A`ZD4`X8`F?AJQ$,(X(ATV`B'39AA3`1FV MBVWB/T,&NW1VB*>9Q'Z$SXJ*,R.@"?]J<0ON2KXFM>U[M<;!>OQ#+N M[+G*;QZ^UEG]4O,7G[=/V\,^\FH-,4L"+Q#+N1EE*26)'W<08Q![XZQB"63& M'*,SC.H(O=G/L1/@Q6J.Z@!?O-P=`Y`X+,$XJ>?MQ%HV)R[^;&G\M#^][L;A MX3BKPAD$=#C^H.'XYL%I@Q(O/U\'Q^//P+"9Z^F7ZCZ6154-KM:][PO`[=YY M&38$4?[==0VA_+G`&#[T/[;U-_%A\/_3B]\BOD.H@35D?]94WK/Q)K)#R73OZ(!-6^HQ-J=T] MA?%AC%SI(Y>64?5\-^C4/>O;_=N[L,6&?\1(1!(`PM!#$-+8QV+#/_%0&OD1 M=-VQMS^J^C[]B^IW655M'[B+'A9-O[0FWH)UZ@%:B3),6;XOE]!+I%JN-.Y' MWO_18?RG*(YZF,YJX22/KV&72/:TVE11TL=4B2.3YX;KL?+;.E&>*TFQ)E:8JFD)+6Y1\W-AVOZWSS]OO M^?VO7SD$1`\-[H_\M5[]R'??\W\7^_I;M79=%P+F4I#"-,:0K2JMT]B<-;)'A_+9ISVM\^L\$C^?"')Z3G=/(V;F+.((KD*\0#\ M8X/\[97('YPA>J>%+PXU>JV=0P3.(03#BCLOWV<4V1"1EBBVJ6B+19X6K8K_ MGSPK5S^*-8W<,/%)'$$&"6%NB`GL[0=2H$_HQR*P2]^Q5GT?S8H.6==!B`DU M%[BYFA=6:WB;7&72+4O652JV=)"SA'I:2G7J,V^N^9K`%)$D\7#J!6D$09#$ M:0Z,-BET:%^C1['C#:55DZ*.9T6T.U7:H%2K59+47:]:BT7YGR] MGI!6C8K-^!.SAB3":9"FR//X/Y1$OM^/Z*2,:AP[&0W!+KV.M.OU.%YTR;5R M2HRIM4!NO5@+D$JU6HJOJY5JN2AG*_6$I.H4:O[9-44A33@@#!D*8A80'^(> M34B19J$>`\$JH?;.+!@RRHLVH59-B3FAYK]COU#SSZH5:AF^KE>HI:*<+]3R M29UQ&/=?^?;Q&Q<@\CTOL\>\.<;_N5D.^FA"+PQ@)#62O21.S9(O3N<7>&:?Y&V0 MN7%Z?RVDR9G"[\\&[R)SVM"<06R."$XX]B`\<8^+TP78_RT1HDTGB2OCZXS+ MV-!*++$B*U)Q\1#SI>B9<\/$SQ@O(DRWU49L`[KE]?<:41HSUP]=F@K_]4-R M1)FZ/IYY^X1.:)JMJ\/BE!S,_)LHM)(TU;*LX4>%2[TQI5&.],'IB;X]2[2I M^RUF4")E1$:XM]9[S$1_^;%_G&5ET_=G2#M(E2Q02@, MO!`QC[@QQ`@!TN&&:1*;]9R98'6/F;7H?G]#DG%;FLNL*:,R2.J2UM6W#A'G M1]Z\G@87.)$+3<120SM/G5:+4]1JWHWIJ6:&M$7FS=[2?J439BFAOP/TTMHI32%S` M/!HF?LQ"/_!1/[8:`W_NK>R:4-DQ);9X67TVB8IJ:#5$62LZV@.?41VK3+T9 M:3E3N7LH!)'+59"BV(TP\Z'G=7#]F&J;@%>)\9T.^2BE4?UHSU(,:A_H>5L% M7^$CP1)NHQ)0;-X#S:E(@TJ34L9+0,+&SX(G_DK_F;W%O_GCO]M_L[_`5!+ M`P04````"`!Z7'E'B2%F.A/Y``#,%0T`%``<`&)D>"TR,#$U,#DS,%]P&UL550)``-GXU569^-55G5X"P`!!"4.```$.0$``.P]VW+;.++OI^K\@X_W MV6,"X'5JL&PTG_*T/*$YCTH^/OD>EP\G?XYY\>UDDF?3DS^S M_%O\&)V=+7N=+#XE=U[]NFI:Q)L:"K#@_%^_7UY7+)[%:5%&Z8B?"AFO`-R-?QEETW/YTSD>C;)Y6HIQH`]1>L\+@54B__4AYY-/IW?C M)\$JL`P/&9+1OVUM7S[/^*?3(I[.$L'D>5LJ_C./BUB.T6X"?FRJ#3<>CZL/ M47*13K)\6FD-XV44)RW(:@!%&\5!%.=_1,F<7TUP4?"RP.GX,H[NXD3\S@OQ MG3"B<6L65,#VP1/-IK,H?2ZN7$AT-?8V^B+&N!^^$J+>,SS M2C5N\B@M)CS/._/4"*@V?J[GTZD0W=7D2YX%4L^_\F*>E$5[)AI"TD;Y3727 M-'!UVSITHH/PE$_B\DL2[?1UFYIJPZWNZUI"T4;Q8L:Y2)??7=TE\7V%K_YA MS19DAX7G:LV2#C2:>2XV4"/LY$M6E%R@R)YEH+1LHR$1QM5*\DN117A>M%U=1]EAK@OOFZO=;/TG:8 MVKCYS,M:M]/Q5?G`*R>8\S)>4$'%_UJSTQZH-GZ6>*O/?XHD6N1P\^D\B5[4 M_L7CMQ^G#M#U<;AIDI(256"G(2AMM#>*1;=WT$;'G$3/(A!PX\B@[CG58HW MJP>-Y],X%9Y];;!;2[8;@KWQ&619F68E[YW?S8BZ\3T7TS$O"I%.E?E\5,[S MQ<)-OGNAITG7WFAKED&V@-`;I%',,S:IE.IZ.XIT$ M-NC9%V7J:6@WH!WY28LLB:[_?NA,IO.ZY*[W9( MO5#>B=C!Z%-5VH:0.E'.^%VY@Z3U)IUQJ3O)AKT[4RAWH<;SA%],KGD:9_EM M6O"17!#X+"*:-NOU:L"ZTU^O0%^D(C83\W05\HMYI=7*@@(D?91?9NG]C8@K MY9?MJ=W>NT\*+^)N-+[TUT?E]4.6E^J"?*=[9QH;19L_-NR(-X\?A?\/A5P2GBX=F=K>M?36W`=A'4H&LGVOPHEPN!Q1>>5X=0=M"SK;E6&M3-0P&25LH;*=G[G;32\V81 M6*Y99>GBL-%MP<<7J4S^Y^7"[JXF)"KBD5`U%B=ST>LM-*4AZ).$3K(*XE1$ M`K%4C?7I:./&WPZ>54`-1KNZ-6G&,AC'JR_E'O2&?MJ9;X=P,#DT\D;J`#OQ ML5@;NXF>=A*XH:4NS.JFT0Z(+GJEJ\S2]<7%(,^FB[V'N7"3+S$4X8(4OM:U M+5?:4.GBG?'%<=(./.T$H8O6+WGV&!>+$VQK7V^38%L^.H'7Q>-7+D+W49S$ M%1+A][@\^YO(]>]YF>7/HM%7D<'=9/59YT4Z+@+LY2]MN=:,4)<<5BMO_\BS MHL!3>3]!'A1*6C;_'24*>ZZ,.U_Q>!BQ* M3"E"U\IA0Y-[KU,G>JZCA-\(`)/TI,.ZAK`Z)W6IMM M_BE`ZIURV:;8U:CAB:7>\/4OA>66K#Q=,8O+**D:CUL8BV8LW3A>^H^HC'91 M_6-+79C5I[%V0'31NY:GKC")^+<.]I8MF\UC7<$.S%.K,Z"ZP.OB\2M_Y.E< M^)3L-HTFDVI>Y6,Z+TH1+^;5SE"J\/ M+E[.8@MS](LRGM8Y[=I"XG69C;[AV4QD>HM0]*M<2"_^D0M5Y&-6G>+]RF=9 M7E8'N?,X&S?T?GLEJ@=YOOY^5%BO1JX:QT\]0$=)^\W<13_H=0GD$L61%9#_PW"WT:=.U.VT.6C$58*&.] M\KD)11L[:*9C[5YC=7V3KI_:O\R*8K$`VUPIND/7S6&WV*XM+,W4KZZK4Y$O M1'&ZOC3Z8VM%MKH@.0!^&YFW/BR:.6[NH=[IUHVFU205WZ?Q)![)I'15$>M+ MEL0-+MNU`S(`O1WL7A?\`;C4.CJ:1VDFNLFL)4HVK1CMI+A9]UYI[*)#G2'W MRME%^BA^R_*XX7$'97B]TS;[B:IPU!KWPVFR-:`>F7WCP:\[5]'9PD MV7>9P\HU();-[\K)/%GZG^J:VYXV74H:C0)>D\F>YMGJ;1G-A^GS< MG,$M'7NBJV%,U;1_3U2VM8AWN[>F<;T*JK<@->7W,LVYC.[X&]W=U"_)\U?= M9.553U9>!79%^29H&JD4WDLOH6\!:J1UL=KKIYI%NQFL=KJOA>IIEO4VP!II MOQ%I!M=+]8\@==*;R5UUO?3^`%(/O0K*4/Y(8H.1G^6\D)Y/SH:7HM6RK839 MOF[R`@-_*GDZ%C-0A4'@2++1)D8J)B91<5=Q,B_.[J-H=BY=\SE/RJ+^IG+6 M9P98EIO^V_+K\`6:RY@)GY?'Y?.G4UBCC_+1#\K\&LJRQ?FL*I5Q-GJ(DU7T)(NM#Z$O MV7`C(=A=6?_Y6_/OXA2VU28?R!_4YR-I-KT3H7Y3^W^O6T@(98A8/F:`$,." MA.'%^%%@`F3@_=C[!I)E4I)D\JI,$T-O!B!T3(.9C#`CL&R*?8]!YM3<8Q-8 M']3"]6A$-H#(!S#EQBM01VSE`79-Z$!J&H0!WPLP0S:T/,^CR#8LS]^/E;^< M!ZV)7Q\7\KSVOYOUX\P;N&\+*L2^"4S/\HE)B>$Z8JHRC*5$'-\S@Y_1\AMK M23:H\-=\0.]&MT8J?HJ+!O;VID>(7.8BY&(?^IBXXE\/^35O#C/,#ZI8_>G` MEFFFF]SWI5/R8\XYRZ91G+;4KE=]P\`"P(4&-(GA4P\0#]EFS2]FQ/F@>M9Y M^!NH4Q=!OZ]8/ZS,BB]"*A@/YD5UZC&?98M;I;_SZ1W/-VC(CAZAQ1QL!I`A MQQ*$>]2'ME>32Q'>F<#WH1?#J8+BT&5]R'8('Q/$:5SRZFC]V^MJY/GWZ-\B MGTXB(:+WY[(64$(1K!.$111O`MLP#2_PG95,80!5%T7@@?N=P>:W_L9BS_KX M0OOG:+I[!FP)*71]&[A68!JNZYO(PRYSK-4$X-"/NEC7B[HT5TD-0S&$6M9W MD197"H3!/L2S8NL4VZ!7"!QHBVD`FK;I42%0$ZQR)0<'NS/JXYEF>QO]K"]I M*\1@3+YIE,WD]MSH( MW])1Q$,HS(4\8S=:/"/"!<('6:1OH?#RX,Y.+6K4/\3$$W9B^(Y+D.`?`P^L MTF0`+-4-#_/G5:T^Y#Z$OGV5NZX[\L)5FU`DSJZ/;>@#SR38$_D+)*O,%X"= MVX1]N*2/E/6I2GHP3=GI?]9:A3ZV`#(L`_JV*[BF-L'U=.P:PN5^T%Q,81`W MJ8&2$(=0A-^%2YW.ISM5X56[T'6Q8Q@`$,AL2(GG85R[/M=A[D?=$%$:RDR? M(`=1B.BIF4*LMPNI8_K")@+#1\A`E+@>1#4?+K"AHD(<>H:D12$Z"')/6UZ7 MXHN+DD];[J6NNH7$%>&7*9)UBP$+BL_(Q#67)J3&/D+6CQ1Z:!3^GE3L"\]' MMI M[9'G=]F>=V`5]&6W$NH?!(5UP0WG9>0-*?GB33Q>%@"^R:.T6(S8VV<;WJP: M*D(+82#8-!P12XH0`(K,-*"KF1]9RO%TIQGS")1K.)'KT:S%A?9:RQBAI=IU1A4"0`UH,D(09M"R@4^# ME8"`Z:M&<:U7!%[[O^/5RJ%'9,BY>MWXMA@>:'>T=2L88;@,`^)2RZ*V9PO; M1;@^H^%"XK,/&B[V.BOW(/A!#B/4A?4NTMF\+.IKS;)6_7L'#[;W"FT?B6P- MN1:DP$08H@"L\C;H.JH[,];/J%SZY#R$+M4AYSO;"F]>8KHM^&2>7,:3]Y2M M"]@0BW@7&(;<3S`\0!SL0K;*_S%0=77VSZB-`P[$GF;>KZL7+2[&0LKQ)(Y> M7DI8B#'^1F-X7#'32'1^I)G=PNB9-FG^4CNU5Y-Q+?_YJ/R99%A2^[4L'=( M/<,04Y8P_@!2W_89LU;13T`-U6/7[L^D?OW)6TUMQO-1*?1>)%IX-,KG4;)= M1WYH&A)Y0QEA%$#$7"L`GN.Y-8&6[ZCFQ]Y/L&:C09[[6HF>YZ.'J.!?\GC$ M9:FE435^]1,W_M.,CZJJ.T^,2Q8K/U@].M5R@5H93\AL6V1IEN'8CHE-Y+@F MIJL!L7V@J)?`^)D\U2$,C9XUQWK!:?W%%EE\?5-8UQ9$Z!'('!I@ZH@(&3D, M.&RU/`\"6WGK_P!/20^Q1*A+T'M*0-9$4YWQEE6F-RM:>R`A.`N0\GWN0S]5,%3\KT?N>](\:3CW>=1-\[8`"4W(4$!M*GJ*@PXP./:0RF;'E$/($#E6]RM]ZR.+JM-(UBW9-G$JE.(&O.K)6>6;ZF M=36I+S-?QZF()%_DQ81!8,'LQGRT-URA[[@0"-DAXOI!$%#+61T_]`S+\535 MM-/FQQ$IZ;Y'Y'`TW(_R5!AJ<97+IR\&4?3V*$,3819X-#`"Q#S&D`'A2KHN MA,KS>O/ME5VU2#^0VO<^/@,4$EMM:`KR%^OBF];#/UAE,6AA!CU?Q/\!\'!` MQ=]!X"(&`#%=C':F^/UPNL_*8M0'OHO%'X!QX%#"&&&U1)S`&>Q@Z"%5%FNL M)5TKB[43_G%5%G.P2V$``"3,-P$*?-M'-6_('N[$\:$?A&^L`PTKB[63^_%7 M%J,F(M""T/"0+^1E$8]Z-;^6R3YZ:43EX6]=6:R=H/=>60R9%-FN`Y&/`T)M M:%!C)0B3&XZ\D M[4)+>8O]*!RE@L+U>/JL\^@:VX$81=\JC8 MZ.B')2"$P'>P;0.9*-M89,P!P;4PF4<_4(TQK1I^T*-T;/Y]ZWNU`_G[K?A# MUT2.A5UL>SY!-G$,"]!:[H[KJUX4..HKA(@:L>$FARWQW(8JNGKGA.9X M0]<`@6$:Q+&%#&V/81_7^SXV%H.LJ.R=;B@>@7X?XN#L6:\WU/X=0*LW8`VI M'7@.!1X,7`:Y3;YO8AH-5/?.Q7;G<=^*I8W".+=]\M8Q:"6`?"^X5XM`@8N(SA;@= M"S#`+'ER<^5!&%1^`>RH;W@>0HK9>:R.S2H&+1"R]#,(^E@,-;1,AP:&[UH0 MV;5$+8)42S0IW#G-RBCY2_N[C<^Q:?SG+!TMK'SMM\LLO;_A^93QNZ'6'W?2 M$;K0L&W&J!%@%UG,`18CJRT/H2^J=M)\1_:@KC<<@H7H'K1C,QZV5)N;Z&GM MQQ>I#&0[N\@(F6N9@6E1!\BM$],Q;6"N%LXLH'R^I_D>[FO3^6N2Z6OL]KPJ M5,6(:U\/L#;T%F7H.W8`*+590(`C9FU&C-KE.+X8<%5E;[Z=>]3SQ(&-S[%- M">\K?\\8PX#XV/>\'0>KYP;M]VW_4OB.@S.$HM>US=[1T+I) MZ'HB`#,#1BBD"`IR/;E!MZ3>,I279SIMGQZ1-BD*ZK6&YB']0R/1E^E2_;#%F`0#,RB]+FXRL>"C_RY>B&C M6+RJL:C`4+PF[YA+,%!B44Q1`*%O>XQ`:IN(D,!R'$8=O/.^[L1]7U04C,$P('2+?&#,,&-BVF&^7 MO#&@OIMZ>+K4W[`W++303M3'7VC!L`C$)G0=9GL^A1!1NK)/%`3*%:8.3[4Z MCWCKV@KM9+OWV@JV38'G&"9C#@L\YAF&@VIR/4)5;\8?B2HH#EW#V@KM9'NL MM168(\0&10!N^P0):_(LRUY)S8&NH@8=X!N1^YRG5.6M9R.I-A3YW31+K\ML M].UJ7A9EE(HTY[[Y]M`.0"&TD8%QP'S`J/O_[%U;;QLYLOY+O%\>>9VSP)Y) MD'AP<)X(C=W)"&M+`TG.QOOKEY34;3F1U=U4WR0E,)PX5K/)JH_%NK%*V5:!_EBLYLN'G=OG\'@XY69H.D;`3#..%/=8 M$HN!I0C:RK`V*E=QO[0[_&WQV#>A!P%:FN2VM\LI)%4?"BD3$`AYO9>[>$:T6#Z74[28>4O>6X)04T9KBF&(4 M+2NO)1=[&CI/LJ][M;Y\/GJG@5P\CL>,H>,GQQ=U;;$3C8"UBF,351ELI>?: M>@B!9MH+:"R^O=B)5]9[RBR1.&IXW$F(Q)XB$OGL1I83-OW.`\:YL9-V]+ZL MV`FF*LI5QQUB2%$DK."X7)MV9)2*U1/Q235F>\/823M27W[L!%%#))?<,4LUSBTQ-$%IG<[QU[*0=;4>/G6!FB!$*>>*--TAH[$M1G>('M6?X M94,ADW5-ZU*WHNVEQD[2A1`CI#?`2@D595S#:I5PG+K4UW=.Y=)["%1]G+VD M6E_KN^5^0Y7S+]:_K9;K4\BJ>S18J)%5T:KTRD-J2:JX5ZX64I@;F;L,^93! M]&6O]/WE&#KFBR!*H'AB:(,M8EBKI%J4-&04Y:I3$Y2`O6!T/%9T$PU\;[*[ M4.7?.]-X\:#^/5L]M+B%V&K8`*"(R@653$@4R4Z(5]4^5HSD8O#2HBIM,3@" M[2\:Y)W7[8,W!M:<+0.``M![`^_WY^>EI MMGKY\*5L3_FI6#]'H%Z;RUNR2'2.1*2VX,`@E^K+(:0=ATZ#^DX,U^?RQDJH M5`35<\^=WU;>XUN*2!>_T"@-ST9P>3<&QKDN[W;TOBR7=[K_Y+#`3G"M'(GO ML[!'L5S6-71YMZ/MI;J\ M@9'0D_A-645-//"18SNJ>>!Y=I.6"3I\QCRG.+I MH`5`44Y#Y"'6`C+`B4T[B1&-N#+7?;\M@_7U>#J3Q&/#:MN2*!K?Q3]/AU0: MCQ$L02PNFU&J"#+0<0Q(6K_4$%J4;;I-4(P-#K%S"#T2T,JIN]EJ,5]\77\L M5ML$8CM_?-X4#^T05S-8T(``P(3AB28X_E$T*:/&$*(LI+GJ^*6YJSN$7K<4 M'\!E>/>FM>K%>P:Q9H9"Q[B1QAE+M.([OZ\!""!3Z_YN9`B=5,?>:&,-TI&W M#-A]BW37<0+_>L>:ZONU@7,7=P%S'BL-)8.0$E`2SZKZ*BR7I^RMZIW#?W\L"B]+7`DMYU``0P,)JA$N*>@)SR[A-6._J!.V3XX99UY(Y"T'A$EHG2]I08'/O5\QX@63Q\*C9QZZ8,33M?WS\NU\^KHH$A MTF*4`"R7'%I(XM['3D#I(\>Y4ERGW+CZ*VD]I0S'Z>\FOZW)_G$99UNM8L^E M]>MJFNS_W"&#LU!*F"QQ2Z1ABEH%2PHYY48Q/@8XL'H!T8_IQ\/P9`!IH1X> MMC)N]G@@W7;933#AD MVNLJULWSGAJ,$T@T%B3VG!'`%5`8&JI+6E@*1BGQ-#&1T1@N[ZJ\W3-B"(7V M]*R/_+8F5RIKO""P%,!'TU4(J9E,[1U`21="Q"C7^@8`:$_@60[/DK&@6I=I M]>XS@7JOXR$MK"0V_F$<6%.NC\:U7RGD>@9#`^CED'\(>$5;L)A_7>QUP-U< MWTS_W0RNEB,$$]5"B+EQB'/HI8M'#BG7+KW([HMQ@=!K"8;E$`0?Y`YJ/LIJ M5RN5EQ@K3*363$,KF$+E:CT8IX+B1<*K8TH/@:OW[=8Y^8EGN<\O$I:#T'\(9'Z:+;X6-=9L M]9E@!`/>">RM\]'2*57)7L2LJ2Y3!MV.*K6V_F3U'KT2]W<18UBD.3QX.Q M`&%E&=TV5?2*&%_&'*21V85X)IA5/HQ.T0/1QX5:FG2MB[O)XP$H2Q@2*1X. M.?>08.,K]5NZ*[JJWBT(&B,LF]:#(BQEV>W*`?GEZM!ZJSWKF@X1HA6I.<>( M6&D9M`PK8BO26GI%JE"W8'@/:=W2>YPXG7Y)W[?YGR:2Y^MRE5(^VP:2WQTE M0`2(($!SC:W#D@-/*B)+[7+KF$_=N3-6^+@K1@P2:/EYIK4GZKO/!`6,5T91 M8F#JNRXDQ[!]W7"ROLM/ MGPO(:^@Q]19;+;$!$$7;=S\U;%QM9;8+#=)VQ_HNR#J$K-C=Z7KML%ILN@TK`7(."(D9)O35 M"'$2YJHMK5N!78NCJ1LZ7WZ5.D2=I8Y("+A/I5VY1?IUSX@KLO7/YGA&8Y8V MM!V]2AWQ-JY<><\EA=J0Y%,KIZL0N:((:(>L:UBEKAUMQW'QO,K6?S8H5]?H M^6"YEI0+R7Q*>6:+;_:0BA#`^YY!>_U(`!V3(. MC/]XW&W)=];6"K8U8P6"+.7$.\JP=(!8C*KR'0H*FGLG6_Z":8]LR#CE/Q:K M^TB7#U]V;BR[?(IJQ_S^3?W('P[P4X\$09TU6FKDA;!,0JAQ=1QP*K+3'<%- M`J=CBN)]?XPP4M)I1*4,`PE(]8)K5Z%-\W- MC(._HBX]L>`<0?7J?"AY!X@1!'@'B&2`(TLJ12BW,3D>9>E+E M`.*J$XIG`&5GKQQ4$T_&S?-3LK&W)<2W15*24;TJ_DIW8[X5NRQ@77R)\]S] M^V[VO5AOE<2-NM\\SU;SV>,[?NN^7QF2)DJ,PI9A`*4%4%%8>:D M`.ZD@RP2A[QZ71W+]8/#VPS93(1-&3C^O^7J7W$_W1>?BH?G^\TVC6U]-!/B MQ*<#%L@B11@D7GMD(!>JHI>6"11Y:+K-L$IWE#[#X5QZ'G^>2-G]XZ7&M=Q@ MA$`8C^0`)&JI!!,'XNIDI8=(E]TN^Z9"&_T1O#N!\JE(&;;SQ=!G7X^VM,NDLT+Q8!!6%%O=%DE45LJLGU?OSSU7=,^XTC;Z>1%L3Z< MR&]1TY\M-D5<_$O2YF>+E[OE#]>9/WSY//N6FN3&_TK-U+X5:?KO''P=OR40 M'^T#8SV/5H.5$/I(CI(L457,=:JAVXT!C,NA`^#VU7RHK%WS4ZIK^8NC2=#:.C7Z[^/5LU0 M$ME)%9<:56B,E%H<]D#^Z[C\S[EG!%CJ#/)8(`XE,>6:';.#E6_Z>UL'Y/-F MMMJ,>11WBY.,F@#M^#$.!@_NX+9"W\%S01##XJZF''F&G.2&\HJ&U*/;Z54Y M,.+R>3`.U@[OT+8"V^:$Q'A(NM>(X4A*D.XT5_;R\G=Z4`Z/M#":,`[=M M5"H:4`_)B&IG;;Q]-!BMA;!:>@P4@A`*[V2Y6HAY_R5-WEYOOB'0G<6(4;6Z M]#DJ;KL^T-#)>$)1C"*JHCE!KG4T=X."K0B)$KE)X$:^1<<03#:C%P#!?[6:'2N6QHTPY2)'C'DH/J[4+-5C* MU\3B?=UA)K/P?#N^C&A:/WXJ-L^KQ8=%)BS?&R08"J2)0H!`":V#G%I>)ITP M:/A@G0]&EY(C8+(CIHQTN!_= M3HQ3ENN1O-S`X8"@[(8G;S%YA5&U`3ERC6&.S&.LUV3.Z%[E3,`>'2$0:R76/DI089CU0EK%R[5;2'-[_S2/ MN-VT/.V")R.9I[MBD.8Y#A8B&4]S0CJ;B1U#9TOO*`#:Y MV8>MBP5-RE\]NL>E'5=&0N1S*H+Q.;+^>;V??'TYBC;#!&0`UW%3,@4]HEGA>']9XUK/'5"[N\U]%L@AJETMNVNL-WQMP)8:@KFB0##!C**8EE(J'H`@-T+FH5PQ)%6XC9JF0SIPS=3K;_16R7 M;KDYY9V2;M&NTS7:HM=#Y=AK@HAZ@J*&0N^,2NGL!I7W(CD&N/\HXZ]#9&@F M3G8K]`;^5TI)APBABEG@933KMKE<):48I65[F2(%*0P"11F*OE"$"<,/W2X0:X^&R)*;;(:4Q"GYJ>-DG M*P:):QP5`57#Q9:!YXS1`D+&&Q&-1V.B-F`4DH*5-&%6Y28V3OLR:>\`^C%: MT3MC3H/UJ%@\NN[3=6&;/!:\CMO76,R=4EA3#*1$Y<0E%+D";ZK&\U!8ZH'V M78&FIL!KH^>"$MPK;JVA)!KK#DL%*[P#[W-A,]4LUM%A1>B5"\.$RY7)9<'!`X?0;H;O0C,R6WF[IR:71#;6J_ MQ.S,.0+^H9AS2(7`PQ]NE'8:I$P0,QLE`JJ3^Q3.EK>I$K]9S?UT5+/=XF M_G-ST5K?/[XKV+[_Q^;CYEJ]N?GEH?,\G97_B8)E"T')P-J:PA7K*#L5RU:3 M&?1>ZW<<'.9IY:O!$WIB$8T%PX:\CQT649B_'%4]Z')4*]]^@ICGDF:.5KZ, M#)F*/>L32,K"9!TZ7$AS[4&XP-9:(_%ED.Z]_:0P%SOKN_=:G3+%HHB"`X[* M6$OXM+X$0?M9ML&I[OH&E?_!#7O[(3X%HSY5FY[F^LGT]S93/7"$)DNI*24O MO7,9VX*_2G1K]S,=NM.QK:?\;Z?`>`I^O;NYVC[E\F[N7T[_VY_>O4TWVZ+P M]*1;W8`-N)!CLA&#$RX%L&1DAXQP/$NKS5WY M[@^_/]J'>[2YPP9HDG:*`H6<6*#"9EW[-; MXK&2UI^7L%>AZS5.H]$D@\X*-!@!G6%O.AQR$I.U3)V8BT.SY&LD'$$&DW+Q MR1_VY!O;K^I]_:FFK"O;:"*243(H']&&G>KAY&31%7/Q;%@B?(UN1P,_CY7* MO^_*#H2B1;PO4MGT]YQ\=90FHW5&ZT0*@[ZKU:Z_C)Y&QKMMQ<7EU?'9!%-,X7->R4TY2D]`X21L18\'Q&LHAO%G_6 M5$KW4C]9S946_N7^9F^W5]?7?]]<]]MM]X[61&;6VD?V&"T4/9<"=)A8AVM+8UH\ M6V#PL_N[A[O+#Q?WF_NW%]:9M:/2B?TPO`K\V4&.$%$Y"C.B<=C(;]\?Q M9R+4WNLOW?.[6.X.**QY:/M8D:H(_IXWVU\WFYL7]SJ/*/;C[M[1FE1,C<0( M.K%L>]0%KVV'B4!?J\\NW3A;+(&'EMA,JNXB.EY1UM3>HE-FI[UW"E7<.5Q$ M];7NBRZ@G)@J10FD9P&#EF;'>1"U&K$2TY$6SYY!Y#43+EI M[]X61:@B0>W3R:\W-GAA*C)D7E/61P7HSC$)DW?;I*2A'(3W(R%W2:3;2S!+0NIP,HX-9R6BKB"$K(:,,9J?9B+#737#J/!N6"#TRC/H!O](,HVB,$<98 MAT6S!N'3+JLA.\QB&B@*+9:Y^1EW.FTBLR1`AJ=W9CWK\FL/G=>X=+X)EA:Q6]CY]?;`FJ."<+)/++OD< MDY9F=P"0LK7->Y>^YPU,E^HXU$HYK"M$1$?KD@V<,J`HIA%YVAE:Y?"9[-Q= M2-#_<%RI#`3I)X]E[9)C!?8[DZ1.JNP"K1O`6\_F.5(Q@XVAMB;+TKW$L[)S M:*FL.7C?DHFZV'(8T!3-FA@U=$B`JJZFL72GRJS\'%`@YQ&@;Q(G*):CT-"8+ITV^_;"ZW?\S\ MXK%KS7E%QR<%(M'QRD?#Q`P6,B%0&Z+3K4\%.)_+D$')<'!T?#_X)XE'J>_ELK?!"!`K M1,Q%"946HXO,N]/%FEA['7R*9.LI_L]C489%>@I>/05)W!8]8Z=_?`)(/ZI5 MC-80&^.,]KH].((4`<7N[ M82QC[27%TDDWETIWO`CFH5[GJL@/VS+WSQP6WVQ^V_[PZ^;ZX^:?MS?;#_U( MV6ODIL"N,X'*H"-RMAREZ["*K&=I';F8V)B#B;27IF,*98$$_M_-Q=T/O]X. MQ]OG`1M/7L<8-9&#*(PRF';(R.!J#>:E[ZZ+HFN=+);*TO+]KSD<:X=L$A@) M7ALP#-ZA]:+-.GU^AY.O53Y/+UAA;J962&.A7,VW#Z^92)4C-NQ%#.2B0VG! MLE7>PC,V[&7UI=KI12S,S-0*82R5J%:,#=1^PMC@41M5Y$+D!?7[9KN?_BPN=M<_+1]U0LUU%@0SG3.6AI#-!8,,7D[J__:FK$;@+R3BK2`?K#5I= M%#LLXM$:I>>NDZ4E@7M3*M84Z9#(8,YHC;(%`"(4N0OU<5[;M;IQ1J'+49$. M_01Q/I$.0K/(T@9V"C-Z:U!W:68N86^L`1&G8IQ,S>)`C!YJ)& M[@K;N:#R+%W'9KUY/I@,G]<9&@7P20M:C5S:#[/P;=&*;*&L/AD=8E=IHF`^ M3U?8U1RLH\A@4O9-6MJ/E:9D08)V65B+14G5UM9/AV;!$.*"T7QWPE+18^#*7Z4#V$HSP#'9GA#FJ3>U>.OGF M\L$-)8A)DD#^/-,CBI)&QY*M!HB:#8&4QG<[NJGXU"@8.+DO8#?0I2 MA=N[7V[ORCSCYE_;MYO+AX)_F>_>`_35YQJ7!"B3A8D*@O$&2>QCT[NW?;C]N[FY:Y8'>;VXN6PCZ,>O0(1H+&I/!)(S,*!4' MB+);/21::X_SX4DV$N(37A?\,?^>9#OH^<:P#2EY4?0.5H:]0I=W!X&M[N"W M=*5L>*:-`??K-/MZZ>Y\]=OFQS^WUQ_GS^T099Q9@410%$"=MF M![O;?:@WR>S9<>9(9"O4E37FW![\Q@G>6BKD?T/-F026B-REM9$ MJ]D!_K%A"JX]D-S9T&(4G&MUVE':T3"[4'1P$T.2,E`!(7=6GR=4KI(B_JPH M,C3,ZRG&D:/`9,M?HZ`H:P51G7?K5JK6C;-T0VJN&X_C13`/]<8J5VMB`A4D MM"F,0NU>.TUG%(%\%#$JJ]/V`W^^)*YW;\\T?PMU!#!.@8QM?U!(J)Z* M`*F,'.195:IU)(TU69170$L!B4ERAT42ZJ_\K1YT.2I_JY\@UA1(S@1>2ZDE M8988DY#:/*^<@\6U=A(=B1YU@>3]9+#>0'(3B9/-.I#Q0FC.*4*'0]O"=:5< M')HE1P62]Y/!:0:29XT%Q>P1-3B?H1A`H5LC26_7SK-AB=`CD+P?\*<92.Z= M@()/LA[;)#2PCE.W1NEXK3$D\Y&K#OC3#"17Z*Q%*:T63DN;R#C9K3$I_"N0 M?&ARU0$_5];\]`4>4A3"JJPP`:28E6KSQSOS#*C6@EWZ;C>-^3"%2.:BZA&M M+$@;%N55!BLH($'VL5L?R%2[!RY=>QN9#(>WLN@%_R01PC=7VTW;W'J[N7]9 M,J!ULJ:;;1%+SWH/=0,V:%B*P$4)T59I&[D`U2$3G5RK63$`53Z/'IX"_W4F M>]E4$`^D-8BD"9-.OK.PR$:JK3"X=`5QKO-X*$&<7K)7D@FR+*]<#AB"+KA9 MW:T/#-2&<)S>9C<`!0Y.]NH'^A2D>IPG7US^?]FO#P]E?N6I)D+(-D3O#)$5 MY2>A.DN+I')K5>\&$/KM6""?;M:@*H`)="J1:W,^?&;M=Z\@+%*0@&9+9[?-"Z;4FV`]/LI$07T_6(&AO-4L?3,K92U61I+#VPIQNTEBU=C4GFR'6ER!CP+R>/`^18DQ2F"RB"#D1);][,T1(M=;=TM6A MN9R=QXM@77D>6I0#/CL&TJIM7I.EV@6N\-P9H2/010)/80 M5=MKP6`$]]PTU;19#&LMD3T*78Y*].@GB/.)XS*0P*=4L#,=4"#(#21/:)AV` M08C=NJ6I;LNS=-+-I=(=+X)YJ/=V<_?QJJTS=?^:X?_J#DR"O12KAWP>:KVY*0+9W&][<^OE@XV0$"2F;)';Q*LD1=G' MGU?J(M;VD%WZ/C8UN8[`?!YV=5W>O]]L'^YNOGW1#[T7U[X^3.-M8L=>!J^2 M5VR2>[XZ:5599_>V&C\ZL,L_,>]F\_YB^_S957)O,!G,PT3Z^?9N>_6?1SE_ M^]-WK7Q>;-6AB/FJW_YWR("-<^A\6ZI-*9M$B@I)=\@4ZM0>NDN__9R:FR/( M8@DL_5LQP^[_<5M>LG[;Y5='::QAHXQ-68;DM)80*3UC\)B(/WI,V;GLED.) M8!X:?K^YO'U_<_6?S8_?;+;MY-NYQX?-#[=O-]OM]5-N?QL,]7#77I8^_BIZ M4;3J&YJB0;?U!Q,;0M76V!&ANW]BLJDVH>GP8+9SH>\4XIF'VH\A`$5@/UY= M/O]O;\OGRT,TT4DOL"@^646,Y8!QHCM?V"6NO9[K'TAWN[VX7B\U!T%_@EB3 MET[X_[G:?J#+RX>?'Z[;?>/Y8]_^Z_KJ_>/XYU5=5)&6.9(A+A:K"388_U0Y M7X)3:G\]DJFVBEX2?%,,I,O-_?W+`"AZ__[N\:3X[N[V_QZ-IS\]UVOCF6)" MC95D.4J0+)-.QH)@[*2CF=;:Q&\4`N_=S!8HT7F.Y>&`>.W)F=ZVUYYL$$3T M$3$&0L_,E#!UTDF)U$I=IZ?^O@THTU-_XXZ/W1YY+@V3#)!19$(G3R M8+7:BBNG_HX-(F%F$MMIO1H#G#)#?G.C73#"DD"*[-LF@2GG#FL47%M18NGIV:?UB@PA MNBE\1;?WV\W/OUS?_OXB6JYU:YV78PASEHE(,J!5PE@M^2G0JQ#)6]AK"AV4 M2=UBG3['^O4`JT,>:Z(*WN3@-1$4UFO-0G:33^36&KT\BGQO1\.](O7^BS/8 M$S9UT',-.&F+D9@"$`3+%#B:;NK%@%QKY:M9*',$\$-QYI4HA<<(A;Y<.F2\ M1J6$.OJ`9*Q!)VR4J5LJ)CE^?-09<6P$@8S#O?8VMYYI[=--X.2Y[>%GSGAO*89//MB8I+5+X#0I:V%8Y`^GV(*LNC_SF213"2T$8(,T.&B_TO>E2TW$T M^(>@UUBZWF"-270VC;?&.QT-0X%8A8R5Y%HKQW1`E6ZZWIR&_Q#,?"JNW**< M1\,9@L0..`0M,H1@:C`BSE6R,R5RN3?V(&?WW.L'\"'(5AL=GQL43OCYQ\%` M2YFV,,HB+<<8<0WKK0)EQYK&3J&.;+76@`Y"D;HBQ*_%JP/0K>S?HENOXX/_ M?8@WS68(B&FHJ/2.(F^\H#I^*CO9-<`(Y9[;CWTO;,."O=7\ND1Z<);Y30H4 M)5PVF2S;/T/00A--,#&6:$:0^'NV91F8[*O5YOYA*]0?J^(F MA[^'9@@J97@H:R2UR!(#N`>LEIV[W(C=V$\<^Z%DAT@/R[*J#$GE6$VV)U8Y MVK+13($)9HER4ECAB:<86B(J+#P1N3&]L:=Y]L*Z/A`?6,?-MRN\R^]HM54W MF"A8++05T&J%(]X>(>!UA00G)#<+?^R]>_K1>-T#/BSUS-UD<5M$>Z$K:_&4 M"8-U`A-H/&+"6@FI8HQ4R"B9G7LQ]BY!O5"Q1^`STL7>_T2J8..;USK&LG83 M!F2!-(QIJHV7"AOIA*^$M0#F*CQQ_2P;%/C,I,2?$XP:\:G)T(`PU1AA[+AE MAA`.&:U-5L!,KGZ2'X,Y/4!\ILWQA:_]KE`O/.\V6V;V8P(#T86'T;'25/GD M9`E@:A-#9?L3Z;S\VIDZ@O48(*OQ'U%;WT4YU&.QG-P6+SQU6\0UNY\M9HO; M%X>`'^J&&$2:",UIW*%HRISWE#Z5`D?<`W#TZ^E;#PW9KTI)`UU$@FJ1"O0; M'#^B"@NHLVN+COT@JQ>ZM.I7==I"?)P42XFQ5-&PE$PC@*$DYJF1:L2%XZLE M:$_DZ20#\[0EN;P,3,>(Y8!11`U@$CND!'Z23PCDKY5R/9.A<0;F:?!_I`Q, MI1EA#G+)'3*`**24KY`!_+CA06`T!1(1)8(5U M%<:4R(]SFZ(5`8_2^UP+=IZ/XHUX1X5+V)>;Q?KW:`B=]!VT>5!@SFD/XF;I M++><8*&>D;0`YZ8%7A[UST#.XSU'AEO9R_A&JGRCS^7B]ENQO*]:5V74#NSV MT<$JJP5--W^0`IIPQJIV"$@0:Z[54KK.[ZC3M;Z,+RNIC-^^OPS%?UI,E\7D M8(V7/A\;N(_V-..0*$Z1AY!C#9_M#B2O-&'].K^HSM9Y]`[.3^?3??LV>Q\8 MC%2,,:FEU4QPZ`&C=53$0YX;.[^\/6DT;DU7:S6V/>4GN7IP9@X^(W!+%(`> M.6&P]@)3S&K5IB'.332\:C^F`S:VV"BZ7,_1?P^]FUW]CW\E[HTBH/[K2%^#AY<)Y% M-)R6S%K"G'8.1I2><"'.YG9X&SM!>R)/)WEPIRW)Y>7!*2.%850J;BRVWF%N M126?CO]RI93KF0R-\^!.@W\(>OVVOBN6Z6K$LMXG7KWW.VDL!XB7,5M`"#E` ME3`<6.69Q92R)TP,@9)\($J>2))R:/"O)R,I^E?I)C>,+A;UR'`7#9Y*;@ZD MR"3=V'W771'?^S'%]@ MOC&]>HL]GK9`G=V=[HZSG3\C,&R0E4)(3CS35D&H=]N-],1QGAM>;Z5V+XFD MYUZ1OL)\FU6$9+7ZO8C&RV:ZWBSC>YN[R?+V3&T\7KW(-HBRO4*LINO9XVP] M*U8-PG:-YPC."(H,XYH#Y%+)5LNP0)AKB86GXF@>_IDP>"9TD\OR.=,%`;"D MV!F#%8(8(^"53L@8*3W6]"S7MOK1%SVPI1Q\`ZX.4H9;>>U4L'XLC\?HC(X-VEA(*XA]>.2ZM M9Q`_R6J-\&>I!=YW1*!#!AS:>5JC/02SOL4GO4'D:-!][YB(&P-`>"F5`YPC MPH4@E7R0DZ.'LI?#ILY6NNP'VR&XL^O2611?BY2HL)@61Z/F>T8$S`%EWEJG MO>>.&**9K623R)_E?+`?WG2POF4?F.:438QV::$GR0=_<1"_EP/'A@2)0'3( MD46"8FBP3W6IJA=.B4+7$S+IC@0=@SK8.=PKV9L=MKTS)%@(/,5<8(41-AH[ MPETE'4'(G>/*P]@ITS&H9S9_FQR4-1D>D.=("$,PP)I%TT_'_;J2FG-PEAS/ MJS2$M83X7I4[D47`08^.AHL13YYR0V-IGC>P&R^]\V-Y3^[J>+-?# M4:C-*C=@SXG@9MC)[SUU>X@549]-_IS-9^L?>^SE)D,#%!1`)*-&-@89[F'Z M2_4MX6NRF[OF14\0#V\2O3Y`/&H"[7X>L/30>"$<8P@:YI&SM:%GA*)9\\X,@4=_4UJ! MN4K0,0B5D[7L//L8O'FOJ6MA5S^`GXML:CI=;B9S=?.OS6J=OIH3J?;3^/21 M&2!(E-MS1@Q#7*-*;N!9KM'4JK'4Y3.L+/)O:!V#IE;W%P-@TZ$]@QY.-O`V$=(PV%$*LL!@)YARCFE`JE=^A6A M@.EQI>$\T4?_V`7*4]SIM,8VC6<+`'F$*+;&"$TXT<+3E"DF#)>`$7RMA]S= M<*596DZ'^/>D(4QY?S_;;G&K"(PI%RD!N5A,9V=2#0?>Y]0K^,WG"<)S3)TP MR$)$--+,(*WW M^WJB3#G@6@RO)-3-S2Q--9E_6GPOE_>[^PIG+>!Q!OT1C45AM=?26TK5FQ]+ZGU_0+"I6Z!2UA.J-)!Q@U*5=!QY=ZU5 MLGNB0-D#YD/XFY_C=[Z[CF0FJV/INC__.$2W1[+TZEQ[822RZ2CB22+#>6Z. MRPC-S;9+^I8A;;$N.U=(JALY3TZXDI M+9;V($NRT;N,UI@H M6LD'#+V[9L>W4_VC@DZ.E$$2^V]XYP1):EPM4XE M-/>L=X3ZI8,U?LN:CE!MSII5,?W;;?GX/]LK[\L?B32X^I?$%_R"+T__.?SQ M]1UB//_/P`'6#C.MN`4(::NP=<_?C+JB6&<'ZU6VA*_?I?Y%'UCJ7W1`1B`& MC2!&.8RI=("(IW<5R/IK2H#N?*E/AF\0U^+M-OBY0:[\_D$!4TH%4=%#=X`A M%XTB5^V?0DJ>2Y"Q]Y?HVBOM"N!![NH\%,MM:97/J5+RZO<(5VKULE@5OQ:' MHH`'QP5NH/<&8@XXMUQ8(Z._]B0GUNQ:6VAUL?)O[_!TB/,9^.0WZ\VR^-_9 M8G:_N:_RX>RF,)OE\G"2SVD3!1UM-L^@!LXQSK`QB/H*":-$;@+]V(O@]<^X M;H$?$04_+;[]5?ZSF"P/;98GSQ4XL=0Y3R1@TDK&%(6FPH-)GVM/7]P>.A@1 ML[$?%Q?C4XONV%C/%EPT4SU#-C6^]X)K;XVMT?3;W!^1C+OJC8J0O M-\O."%E/%I0D#!"B*.!2>D^C$U;O%U1G-Q9NGO_]\?B8"_ZXZ#A[[$X_UI,% M220G0EDK/#:.WQ4JE MFQ[%S=\G\TWS3+CW!@=HK64,8(4PTEAZ)G7]*7G$<[-DY4 M<,]0=W:S?O&!'&A5\O,/`V68^?@>0!F*!(3*Z-J.%#B[13$<83&7CC54:S#; M;VPJ_I/=W#]L:S!.MGVI=AQLMIWM'1Z`55H!RQ`7\4^J4WRO/O)P+CLCO%5\ M_R)8T1/$O5TT6ZS*^>PFW<[5DWFJ`OSUKBC6Y[F+6B=3_O;=SQ;Q96:3^9=R M-7O9!;Q)"O.!X2%^E<89C@4'.BX`X\HYSQDGP$5E+([JNWXD5ZM5!+V!C*]_ M&#P0AG.I#3($.J^=`Z*2QM%\[3UR6[/;E2X[A'@(JW+W@D^9$HTY\^;W(0)" M,.=>4<:TUB;=[UR_&P+/<\BP7R`;C4C8)WEY4[P'J00ZW M4CWPKW?E"`&5BEN_ M(NG@XDF.Z"+G%G@_/6.L3&K^0OG1!M(AJ/%E63X4R_6/U'D]]5I)3N=#VC(/ M;S:'A@4OTQD7`1$GPD2D/Y5US,U0E7OX?1G>6^N@4H?0#D&@7\KRYJ_9?'Z` M+-5/`I2``8D9\-Y!K;AFM'8BHM65Z]9?AG_6FAB9,&8<,$8S>;8N/L\>BQNS M6:W+^]3J;;Z%?74W>UB]KQL:C@R,L%0*`PDBG*'(6*\J#DOILTO)C-;AR5[X M?@#-X(,IET741+9X+.91.=W4]8_VN"1'QP1DXZXI-.(<:H\LC=:TK%[9`9-K M6UR&?]**$%WB.IB7\BDNU>)V]N>\V"%PY/[_GB'!XRB;85(2Z[!5VFM-*^D@ M`;G[QV5X+*WWCXY@'3"V-_O_75?:303\:_E]_5>$ZS!U#@\,E)OHFB$-(6"" MH6W!MDI2[XX7I;_02S`=$:A3<"\P1/QKN9@.'25^?F9(D$:E+B"BW#(H)#*L MPI=1DWN=L-6]FDO@Z]F78N!@8".:OOO[D$Z4$=9*1#,">8L\AK7Y(*3.W6#' M?KNFRPVV):;#A0./Q@&#L\Q`*PG6%"J$F3*XBGE)[6AV0L?IMV/.$0'L*#OH M1!0'N9#PU)DT-1*(6FY=3O]]5\[CVJQ2K&G]HT$V6=,I@B(00T2>I&[:8T]%MAK;F)/X`],O>:IB_L'!4&M$R!^D=*1"*6*TII:N6IQEAK6 M0URSZIP!^RG6#O(A2&6+/QND#+WX5:`.8VP,]H#F+I3+.A^>Q*6C8P-1AB"$J(%8&(^5HM)6\B*:;5J/OOI>]YSJ M&NL!]=.GQ;2\+[Y-_G."?OIY3`#1I67:&BLP9-$905S51P"`95=R'/MY7'_Z MJ37&Y_'&3O+"`J80PNA4$("`-<1+5^?**@U9KAE]^GG,>,5U=/XEJUI^EE]!5..U=P#U(TF&Q6*6U M6]QL0^9?RBAXL9XMMQ$S6WR?+8H;72SB/ZQ3%MSJ!7*->-?)_,%I[BTPWB+! M"(T?KS:PPHTQG%M-]H)L]GYH>H[5&>P([E2J[A\4,+`:`QC]&.<$98&$LX\!R1>CNPZEI3 M[WJG57>8#\&KK%._`Z@9:`G4_V7O6IO;QI'M7\+[\1'/W6S-3'(GWKH?48K- M.-I2I%E)SDWVUU]`$FG'EB4*)$%:V9JJ)&,3(/OT`=!H-+JY44Y;&$U51%$S MK+.-`U28*:@1 MDA@H::$0H-D[.R9RKS9.?8/GQ]V/EV MT_[B=GXZM<2YQLD;K*2$`.XN='J%`=&UQ%[1W*B#J>\,!Z!7[V!GW6YIN/SQ M2P1B\_=J$9E>'PK8PAAL@'J"5CYW-._J>_D M>N3+4%B7F(UNUKN@HL\`P$XBZ5TTE&L M%+0ZBE;G.E`*T]Q3GJFGCQB`2YW!G4)0>8=@\L`P%(X:*>(F5G!BB-&J`0YG M)Z*>.I5*1OGV`?P3FA5)3_UAA^*7:CN_G2U^_I0KRE4-`$W%/27!@!)CX\Y% M"!X-%D>8-0B>#;(8W-47U?!^O1/EKBZ`L+//VWG_7FL=J'&:2%>V*V\W_BIA^V7J(?_5,=*'+1H%0@`1J::XDH8 MCH2#E#F[Q\LPZV.>(_"J7>;S<-E?-JW",IPS!A&F,A4X(-I"ETM M&^+9:=*F[PPLR:4LK(L[=_;?VM:[LW\ZP&C+"P`AE5!Q""A01C=CP^E9#+C-?7S0+<9>+$!0,Q7VNUH0B M$;>E6ONH4`LY/AN]-(RD*:-U_-0/Z]6W><15__CG)L5J-R5]U>UV_FT?AKL+ MX'B(/SO\,FJN!2;]O"!0+1Q7$K-4!4ARIZAB-7I,_PHE73HP:C4!E918>W8) M3&I/XFE./CX7""(:,B"5E11SS1U`MI9#N.RK:)=3JZPSI30+7I(P6P;VST*U=TC""T.'"[I)F@D>+3^M3$"1Z$]QT+4*&"FK%(YXKBE650_S?LWJY8(MZGG-O"K`U&10Y(1 M!9&#G!)`?;-&*:-&2=-[_<-@8FHMD[XE$B)N_Q.`\=^+:KN_':2^KM;;^7]V M/S\Q$-HT#TPJA0R4<>;`*B7M(Y[44GO-LZM>3YS,TV'3B[0QO2NM2$Q$WT\2#IPV?\^W#T@;B"V7FGDE#:":6/@(8W:FV?86\%@1AY,EZ!!Z&X>O M#3J'FP0M3-WVG026TBXP!*$E0B?'BO/-%L%A>ZTY<=X0;WM2W3CDK;.7U7?7 MG]3*O(B_)_H)2!H-$(8N[APH`EX1C!]Q$,/G)AQK\AV"*V?IV)\FQF'D_NRT MRB7BR^8!`.*X!L`PA1RRWGGA#E([)<#PU;N.\N^**-<9\W&85E?#/)UYX&2[ M@`6SPGB&."*&Q06%-1T&HI6G3G(F'#$22.-\,_:\M,/[.7\I3@Z@DG%-P4,BV^2[>I&9-,LF M/-5AP(!K0[$G5C#@&*.&-L/8@NR;QU-/WC*J:=BC0D::5_<)MU(RK?>?%O/[ M-H>DK;H($!,D//*`0@J8]U"QVN'@B-+E$D#^`G3L104C^7S2W/XDQH*Q<=U.,H=+,@S<$<%EH0) M8Q21'!((:[^")562Q,.JI`29H^F\.Y2X6:G;?S_,U]6KQ>U/$+9] M)R'N%('U-BYT!L:-HH*4B,:/IK*/?Z;O.R_-H.[47?!C$W=X58UH$^R<:D>@O-PN>*VG8!5`V%`K/#"&$$L`K('W2I)<+VE[ M5_TO/N,.HZ?I>Z0&\T0%IS'33@"E$5#44:@QKY%*"!:+];Q>-^HPJAB1M(=4 M(\.Y42]\0?"<:2N==@A89^/\PFQ],./CMG7XY+[7[T8=5B6ES=X_J[\.*\K[ MS\T&,U5\:VGGOMH^**X<8\YH9PPV<;VSN+YN%4'(OO`Y]3MRI5ESPK#M2S>E M.9FR?GY8@;$G(XXV#9-X)0Y7TGFO##&&HOD#K#9"Y:=6F?D5N0FSL M13$EJ/ATV+0DX&M-`I?`<;!RV\L`@CA(6SEA$N,6J\%B`[0=.;]8T6F_OZ5DWI M9?B)`#OWPA'@6J[)+7H*CEA`A>:8(:\XA4IPU3@JJ,\];)KZSF5LD@ZJI1*, M==]OJ\WF9O;]4.-W?U)V[/[]9?SMU&\`A&#A@431L`:>(>.;8SGOG;[6^I4C ML[FDSDJ:!N\_VWD"='FWN8=%X33HR1PF'8#$*N:6X* M.ODKKL@#`C\>_52SME7[8#BVJ>`A=9Y)(:"`[.`[$P#;[``D M""YEW%\[O40BK+=7R;MNP%\/X:!"5G@G"7."2J(D,;26&Q"6>X((+S[0WA/. M+8N63AZ-;I?!_H1N1>KLO"S#^_/WE*^XL_^*A.O+;[NL"$^;GH*V2`).!;-0 M"YH\9HAX@2W$4&KKSJ;W&FP+F%'*Q$JLE3+Q3ZN$)%0!Q6I9++"YJ@A+ M*7H6U]#8G/:K=36_7YJ'J/GE[8^;]6RYB5+L,Z?O_F^QYTJ3#;9%Q9YA7AB4 MA]X@;SQTG&C+%#2T1A;Y[/.TJ4_-)3EYP7`HILBQA\@A25*=3^[#*H):;>?K MW7QT.&1,=](WO8V1#F\,:>OZ8B3)_")V-S?&.-'X]:>P/ M[<*>RQ&=E?M7-Q_3KF++L1;!(9[R0WHBHVT$I"?&8<\9)\!3PO#9VXX%G(_M MKGZ^?#XXP0BF$"O.D09(692JI>YELY1=ZXZWLZI/.1TSP2TQV7^<+:K-G]6W M:OE0G4YE^^S)H$E<$:-`F',)`<;`"EW+8I3(M7RG3I2.BGU>L:T3J&6L@4U< M5_ZV6MVEXC(?J_6W^6VU^;AZQ.BH,?!:HQ`%PY10Q`6@B%J,(68'"9G#>OBZ M+-=`F][P+3+%5(O8Y_W?JF6UGBU2_OF[K_/E/$&0=FJ'V@FG9IY6'01)E&-` M6X.,@]@QHR&I)9<8Y.8@F/I6O.<):0BLR]R>W53Q/>EDW\;Y=+':Y>D\3ZZ3 M[0+E!#-DJ?!6<>0$]JQ>_IG7IEQREK?,J3XA/DVE3W??=_P`D8,[=L0?A#JU M5MPS?9HO=ZKX^>3@W7);W>^C>O^L%FG'DN;78^?W7;H+&!D.`&4I(Q(6#DDA MFC'#'GPD.>/QH@`M@X;@WST'B%)-&\D4:+ M7*-IZO=.^C>:.J!:Q`]0M,Z4[L"7(DJ:^J*T6-LZS)Z,L+FX.-,>0..4$Q`@VQ'<^.X:Y_9V-$>]A M]DB3;K"6H4B=L7DO=OW%)[ERO$F0U'!/L3>8>"!3PF?H&NEH=EZMRV]:O&53 MN"=TBYU)_K%:KGZ>#,_/-J<;!JXU]5`BR0A$W@!GL*TE5?AY=?[7] MDDYOVY0A*/@5@0%K9;J8I[6W!B*CK6PL!NBSB7ZYA_PMVV+3U5BY41.E.@SL M0_3668:_:!$(=,I0Z"6#P'HL%)"PEDUSE+LQ@+^6X[T?=*E M@-R89FJ6BN2FN8"_EB=^0,@+95C)N%[G`8M+.E>>"H!XFIJ%:MQ\%N4&/L++ M'>]O>:;J@FF1W">S]3).G"E=09UZ;7[;(@KJ9+M`O$%66*``!A+'O3EVS1@@ M#.8F,9VZT=1W-%2?($_#>(J2[(38B=/)DOJIIV"I5,9)I%7:S+X$ M.8=3PVB+[Z6+;A!QZ\R$0X``YQUE\>\Z^)%1KH:O^SF.G38,O?J`>`SJV/GB M85O=95ANSUH&83%'3$(-H\F+C%?8U3YP+KBZUJMY0]MNW6">C/5V$*,7^^UI M7P$9Q2U`UE`&%4P',%"F<[<,;\V"RZ9)C@W700$3M.*RJ'E1KX$**&D$ M!RFL#$,"F,8+P#&WN1$@;\V2&X:D0ZIBQ"7Y\J4XD#@4*7!&""V9`@!"56^H MN#70_R(675\TZP?F46Y\?M@!]Z7:SF]GBY^_Y\U=_X28,&!9_#,:4@`K[97E M$">'J*/$CG3]\^BLDTXJ#TF%C_[^A/19_07(A)<\;E@T-PZ"N'OQO,8&`W.M MU1<[4V55'OR!YH&G)>N*#O#TXH3+8K5Y6+?)C7>\07!Q3N8(NPB8M$Q@(9!- M]8"Y(Y(+=?:\J(1T-Q%3O3A=C.65%D$C:QVCWL7%`A%,B=:ZEL^HJQVB7;7] M?(3V@NZ`8U#=W3L_GHXZ=XMXR<^I/G_9O9I<6KK=N3IP)#BDCB/M2-`1DX*!`]R M>6-X=I[GMSDL6VOYR+#LAFR1*]%/JR+?Q->J[_-3`0U'GP\6$*:4EA`)"^,T MAH7EM5R0HE$R,`Q'DFRM/K_AW`.6HW#$KK[.YJ.1`KENND_=W^GSH'=@2JTA]@5[=_OMA MOMEM",[8&J^T"-!"3Z'Q%"F"D8!82UG+9HW(#:.<(&GZM#;Z07,LIJ1_KJOS MEL?9ML%:`*-D5@FO:#3K"9>@P4^,DU9N&/9TUG@+!G7!-L<>B8+[AY13VJS6 M?ZWVWL;3YLCK+8(2"C%K!216>PB=EK@!PF$RRD:W'!4R5;<:`ML2T\IOJ^7] MMOU.]]CC`3#GE6-,>$T=1("!QZ$C-CG&244?FE6EKUC&6)B>&?RTUU^Q!UD(1^ ME1XGG@X0:N%$A,@PCS$&&CI;RT0INZ)];D_\Z`_,(AG5X@?.MWYV.U_,MS_. M&!8O'PZ*4LF/J5TCYMC,ZHEN?)6?OBV.,!.,@B M)E!%\;2&"!L':JE0_-V5GLYUT>])JF3!FF%F)-_?;ZO9LG[O23/C^,,!.2\\ MXP!#([56@BN!&HG]^5JC;\?,Z*:C5<](%O%ZK>=W]U7ZU+,6QO-'@W,L%6[A M5`OC)!<$UV<`-`($T?68%[WPHB<<,R:!CS^6=_/;77+8GP0Y.1F<;A009U(@ M@FV<`H%AQA+\^-$XNS+DU&\7]39#]`IOB9GB9[/IC+7Y\N%@311$*ZTBV:E0 MG"'":HD,]+GW@CJE?WYCUF9G5,OSY(_9U_,>K=>:!$8L1MII[@V0ABAH1#,* MA!#7>I>LBYY/4B8;VHQ%)[ZGVFSGMR>]%\ M:Q:([LI:]0AK^K>MOK9?69H6@1ACL=4>QZ42"8(TD>#1M"Z8(OY: MEI=<:(O'!OYO-;__DJZ7?:O6L_LFI?#_DW=MS6WC2OH?S<']\@@T@-U4S213 M2?9AGU@^-FVKCBWF2'8N^^NW:9OTY5@2!5(4J4S-0V9"4.BO/Z*[@>[&9_2M MNB8+;GE%88B2D!RA1AHK>5!"M]([SXX2_8Y.K`PR;$LF'`[OG&CHY4S^.ONY MN+V_]=5J5?U8+*_@[!LZXG>_-@5%7<86`NTSNNTZ"'3_E256MI\&0[-C`7D M?];EQ=^KZKPL+]:?+C^6/])B>;8\QQ_?L&IL'E!XE[PW7KKH);,<0WO>"$YK MRWV,,YAIJWY00,?W<=/9>>ENJ_OEKM*O]X847H9H@I7"@\0_4\=(RVT*/C
H&98M/>(^K0']-S(X^_5`M?(;V^PCY[RFL%;I5!=**>>U M=\P881L4K.#9^9=3[U@YAD$<"/2<,_)7TD'UO40OL&;_MYL%NH/E7XME/;,W M%ZW6S]7')I]K;6XZ5.__YD+Q:`PP(IVR06CJ/&N_/*I%=LWJ">]+'P?Z,\0 ME(N/U?+\T0E]\7=U"4>'G8Q1YU$HU#Q09;QS5C@7%4WM;K)-\CC7;DW[$YB# MHG*V7%Y[*)_N[]9W9\L+-!?N$I43?YY?GRVOWLLXV&-TP2*+,@"5&D4`XZ)/ MK<5Q`-D);R>\P7\X>,>J_GT^\[Z[7SU0^^768BO;A^7'\N?=UQ_ES??RKVIY M=[VKCCS[O07"3SP'PM`$,;1"W(BF&))&(;.O[IU7-M4`WN:(6I@<6_^W/%M] M_?&>@]KG=05ZX90FCWI0&/^IY+1L-M<9I)#=/J/7B<6I<4*STP1[G8[\%K3,@'^2Q$S5_;;RNZSW%58P M$IB0/&`,*6NOITV&8I:X[-7RMSM(&0']:;)R\7W0U;)^7T&9]&!U"G4+A;J` M14MH<(DB9O?2^^W.:$9`/R-6?B?T;W:[,+QOC[JA6F\\N=GG%85V(B7E@POH M@D!(0H)JO1(M92Z=)EBA/F34?$",7Y!FZ+[^7\ZORXO[F_+#Y9=RB5]LVZNE M;NSS8;V^K[NVU%W^UZ^G-+,V_X%*IRFI<\VXL\K81%PR:$A(`BG5?-O\:T&% MH$JQ`"H:C&0=;^1RPF8?J4[S4^VCV"Z=_?<"<\QC@O[]=@D3T6DN5/3!6&$< M,-_B)-P)->WNI=F._7;W0_-83!FNWRZC0(E%D\7!^F@X"XXU\J8.R^=\V--; MXWOWV]T/VPS_<=A^NTP8:O!SD@9"<-02K54R"(I7%BS)WLR>!Q4R5=>QW^Y^ MV(X5X/;MM^O`1:HM8Y"4353C3YD&)6OLR=9O]C,]`T!Y#(+D]MN5D7I(#&/G MR"@/PD?62A84SVVN.<%EI9]BN_7;W0_-#)ORT/:5_B$DN;@O_SK[55]\0_7N MKKL;AA2:LH@2*R88B\P%;GQL)LQ8_A'I]-6_K\;>]MX=!M%<"J@_N);AOG3W M5_?K.XH/V=TDV#BH$(D9L)%&H(`")":">IITJ,4Y'5,Q-`V&PC27"/P/3AYI MN#J_QI]G?#2[.;EYD)+_)5:XN MU_?GUU_*U:)<5Y<10^L[?.AA3=R42S[(RPMKJ65*$J'1EA(MO&6B`<$%R#U? MF6#D,A2KC@;^(4_3[V]OSU:_/ETV)_\/I_UN>=&T+7@\2Y_U47I":X+1I`.C M`U/6VFBI40J`XAI@S4AB=Y+#'A M*'=)CI0\U4>[U9"HCN$_O/HDX>S;`I>;NGBJ`U7>#BD(+C2!2<.XT`HE\HGP M1CI&:7:*U._)F9[PCDZ>#X^N3V?F-,\7&'P%8H125E"07.%7(1NYDL]V$O8/ M46I3>QJTR<1V3,[\?;:X^%ANL[1OGBQB#(IPICG11M87F4C3+)XN(6S'V/N: M+T_R4!W#2WP94)V`9^C0V490G2=))=`A&-Z<-`ANY,X=F*DF6;H8E1.`$8;' MD,8[1@)MY&*"'N5BT.-]CIVUW"'C^H5[KM?._WBFF2N6)14H]L:`D7'E6+8W$S.X6HZEMZ_EZM_5L?4_+[*>N<& MZFQ8)Y#^A%ZI\R9R+=$15=;QQ/73A*7#N.9T=H^'5OPPB.93P#RD6X3R_.%G MN_-@\[B"4,M%O6]F#!.".)QU:K"0SN?FRT[P('-X,@P&:S]#8+H:`M-,#GR] M2A&<(/?,"!I4XU1+&G3NX?74(_[#F($\4/MIO$/:XZL'"^^"5S*R@$$4L]S@ MGYI34ZF8R0TJIWZ!YV$TG@?J1))>/0$6O&:)::8)X\23YN!42D9SU_L)7C`Q MM/*'PC27".P/]9!I]\K>=.#"MG%%4$%+FP(S)%H?A/8.FJDG[7,/"29XA<30 M=!@0UE[&@)&.QJ!YL*#46/!`$UHE88*QB3!ZHTRAU"'7N'(#"Q2JQ M.D0!UOJHGF>?+?3JW3,/W0^$Z01J'13G$JBAGAB9T%%A+(B6M\1GIR!-,"=U M>!(,`6F/I4"+\-KCZ$:$S>,*$!YI*@P0X,%9%3EIZ1LANPBNW^4$B@!^6NABK1[/8'_9J?SX4-@^&: M08E/=]?EZJ5(6XFPX>D"W5)"B`@D1FJ,YCAK]%&`F/IN]62SX[]>>X.35_\P M:,ZKY-U%C")HT1$_*/S:$,::A$TV&@G5/]>XQ.V#V+F969*$*HI390*8BABAH`_5#' MPRQ&=WRV928RU'>N6`&<,US+HD'V-')%G7\[X@P^S#Y:[E!FLA^RLRDS4?7] MX9XG&@%7KT30K7F22NA$3IDOV0KN5&:R%ZYS*C,)AJ,$1A-O(PAIB%.BD8RB M_W2BC.FGY6YE)OM!.W*922#U[24*-%3*?6I,>/!@"T9'+3*(-RB4NJ:".<.TY88U3+0)/ MN>J>Z<%R3S.0!^K8929(0V\AQ$`L0-1:)-E,3H+(/5.>Z9%R3XWG@3J1,I,Z M!=:J&"31DH/S`:/H>F'B0A%O=*[S/Y\RDVSE#X7II,I,C(Y:H;$2RMG$*<;. MFM531R)+)VWNA1OS.7'.IL.`L(Y<9F("?VCWKCQQS$46DF*-R"*8W/.BF9:9 M]#,&F:".7&8"GB8K*7HH7-8B8`$;8\O`LU.!/J-=@.'@7;D,A,2(P>,31QW=:)E4,&[5E";W7EFKF4F M_8*"3%1'+C-1X"-S27-G/"%$:A6?9;39_>7F6F;23^69J$Z@S`0X,,^D("0P M%NJF&$'5KHESS@"0WZ#,)%OSPT`ZJ3*3A#$*4\2Q1+D`F>I;0NNI!\`@QI'L M16$^928]V#`8KO.J.*B#6F#(=(U^#:,/%?4-8M&SW./$.58KNQ.Z%4,8D2Q:@B"%U*`-K?O2(,+1<\ICV'GN?ACIOIQ? MEQ?W-^4;O'?5+6P;5E@M:7).2IFLBU8QSO63I)*9E+VC.`/CT$?OU<$@'L-( MO)[D[E*&=Y\O-%#)2<+UAP-/7$4C1",7-R2W!^K4J3.,KM\2:`"$C\*",;%?)DV=-/T;MHDP7N*'YI=8ONS.*\=I0^70)J M9[&YTG[WH$)8C-6EU=8DR;AVHG:#'B54%N11;H0^!GWV5?A;KW,HA,?@4*I6 MY>)JN1>%-HXIM)4F6%RH`X48?6+$JD8^<.PHMS_/D$%#`3RZ]>JRI?+^@()H MYX5.-)AD4F24R=!8>>5Y=CG^Y*ES<,\G%^)1R>.KU:KZL5A>=6+.\].%T(1@ M[.Z\19.>HM=4N48F1?.[1$Z=-CTUO(DPVKK`U9)Z`5PE MHA,A]06Y*).F22DIE8ZC,P0?J#.=9&[6YBO)1!XSHJ9)V49$*P)%&F M6Y++%"&3$%-/_AF8'?F('G`C]<&$KE__W-RV3-%I]-&"TTX'&H$D(W'Q=1QC M"/3[=IY3C[MEBN!Z_,5_96R;-D,+[9+P,B1M/:"#2S@-K<3:ZU,-0?OJO^/6 M:2;,&:?US0RJR_J'X\_SZ[/E57GQ\$UN(TKGL05(0:S4CB(0CD;MF'&-"$1D M7Q4S05,^$#D.!>TH<4)+Z-='>NO]%IU-@PM"@O:6HWUR.ODZ:=79)XF=2N(H MY?]S7G8&`CICX6D.>:%:WZT_/+:C>^)WE[6GZ_""6>8-"A-53"`2>KV&-8)$ MYG(-U=1SA@=_'=Y<87ALCO'OUK<+8[F<':< MW9Y>:?9;"\I4M#1)184A@N"_/"KMG/:*>!YVKJB3P:F+A>GSVB(&&Y*P7D8O M-1!A0J0-4BR*4VU&-@JY_B-.'4U/QUZ&W,7%HG[QV9)903+YP%P1V3.@FHBUGESA3.R>"TWMUD-?.=A?9<:,;K_'X5B+9" M1]%@A+S/+HX[X;6I,ZWZKTU92AIG'_8_9?F\6/]K1TK4MF%%%#&8J&R04LED M!3#"&RFIRK\@\O2HN"\M.A`Q4POC<@VJY<,GV"F%:MNP(DG!K"5>&D,P5C76 M2-9(*33-/168(]?VU_Q&.O4&>L1\F&9KK)ESUYR8]\<5@AB'LM'D2+)*&5]G MF#?@T=V^QNP)U4?W[R?'#(+T&(QZ57;PX^S;3BJ]/Z!0FL5H:&`Z^J2\`)U: MQP),RBU:G'J"S$$X-`C$&;N3:?&SO/A:I9L*)5I>;2UV@BA\*T#$6#*AN;RN,WG]U-CX;1A3.`*46.$(D`U*9 M&=>Z@$R14VUS>Y`E8QB,CQ5]K?\+9?^S6J_]KZ?(X7-Y\Z#7]?7B6T9_,=&<@MW%,056B8!@D M:9FJ*]"\HXU\7+#3O>#KL&RH#H/_*);U;'V-YO_'TYQWV]7WGB\@>OQ0P0@2 M?03M"+7M9RJ5.M7RS@$4_=:D#@#O&+3Q]^O%LEROW?F_[Q?KAV.5'19SPXB" M:S`A!$T8%T8$A=^8;61S#'*3EB;MO8]E!8?!_%A\JO^X*G?O6^X<6T1OR8,+ MZB($)J*DPK0!#:'9U^9.CV.]-=Z!07VPS=@@`!0\X32J)52K;]7J00M;MPFV MC"B2B-Y08PDX(V.07-@6"*EM;OPW$RIDJJXZ!+9'B_MV++E_=NJ!U..]!;;N<$^'CR>]!'#4*/)":NM-Y79[_<55]_\=B^;UG:,**2-QCI(QF!00X'3%-J0AFLR6FW@ M$?HHC4*%ZA!J&/M(YF404C9A\M?*EY_+\YNS]7IQ^?_L75MWVSB2_D>[N%\> M<9WCG23.2=+=9YYX%(NVM2N3&5%*)_/K%Y!,6DETI7@3G7Y(.PY(HJH^%*H* MA:I9.K6K1>#;N_3;$J*W>;9\+-ZEA_*2FOE`HAG%R$H9O"DE/2,6^FJ/,9:V M?YU>;@"9G\P6?T[FJ_3V?IN6ZM?/S-SB,#RHC1MX?^QQ M1I51C!C#N4.66^4JO@DX_L.T;K5P]R*KX:Z_+*O;^P]I<$$_?DFSJ\(0':2(TE]L3&?IH>:,6JN(:5=5,@+ZI7/P;0M2N' M;EW_=WGVE&?I=WF2WR\=T8?*G(/#'-"O6#]SE3ZF[OT\C4]/W M^2+2>]C%:N-S"2(,8F\ULTI#'JL."UNM;(G:;P:ZW^$:)\A[DUW'6CE=KG>0 MFRPM9QZCU27)I^GEP^]("+$\5A6$CDD5@]&:5!H!4E8WW6;H34W[1G"S8NG[ MVN!F816WFRI@'1:B)_2V?F2WK]Y,=.#Z'@)7=R8B7":@?Z)V:Z/K+(PG27`HD M@YD!03!^!37$E=195-LE'SK\+I7U4>C48F\W?L5FCNE4%;^$/8\7@#_^=*(4 M=(&!"$L+J18$*?!"LV:O!U+G8N`7-Z%I7G>!KW=Y,.;+B1_%TX[1"1>22\\$ MEA(C$\-4N%J$P/I>ZNQ>(WXNY^VUEGNPT`/I,$+$,6P)=Q;HDDKF5-TLUJ$C M:(`V58-BNM9Z$(I)P+F3P'%I)=.0F6KY8DW&:N`W(_ESZD&0P9-MX+K)&@U>H3:JRMF9J1]FFW]\]C\?46$XFT`2VTTY`Z81U#V)=TQO(% M(]T:6X%2DYR^KMH`TGCA7,S$Q58P!37DLC));6T#:]!7T1H$3C-L[=8@*BKK M\LU9USYV/)*O+];Y3*WKM1S2T MQ`E,$%&2"$NQ)P9(PRE>%]-61CE&>N]LM).VFVQ]F2+^?'OO9UG8]&>3^?M\ M<]^X`NNY/4D:^%("B54XV`D$&&HAIT$9ZY*?F)+Q%YAL$8('NIQT+[HN=LX7 M"M?YEUM:_EV^/'BD552T%]O$IXMU"?I@(P?9_,*3TF0^VJ!E4/-+@`(`*BBM M#JZ>,P1H29[EIN5V<]:Q[OE]++GK$7C?YL8?6R>'ZP35WYF;/T`18\0PCE4\ M@DCCZ;LC7F`+83!9/3T:_AH,GUKL_A`V'P:$T1HH0YWPA#%<\@@B.];>RIW` MJK'N#^<)Z9K2*I%1WEJ'&4&0*:J#!ZF?*1,B[!B_X5<7"J=E39['_VO+FA32 M!6.;0"&]AU8"P"PKJ0.$C;7'PZ6R/C5K\CSV7D=6&V3,0:>MDIA08#`*%F%) MDY*@;D6+ZX/,N3(^(:OM/-Y>:U8;T7F<[JA$4_Z45L&T,D)V9"\\ M\%2BB34<.VJ5\,@@3R2#)8T8TO&V7.]Z*VQ."#T"[>A6>/"Y!$%A!8#<02PY M)-0$1I9T>LS'FGW;B.A/@U,M1M>HN+4^`'@N`O+M2YH5Z<'JV/N&)QXKKY$" M4A+*$`LD.UDI;F_'FB'4D/3RQCG<6X6BW@MD`V0$P"@XOU1KBYF"3%0V*<)U MPYQCK"O8O$_8EIBZ@'-98N8V>[8FS2H(.[O[OI/0HR>E!P#>\)<2)B6"D@,% M"<90$$)]>SA:8W72,E)LI[![10\5:4E@@)J#W5 M-,:CCJ:X=1(BV+Y]$TAYD=[6+JJ_GX728RDU'#6DWTD$ZAP:WDV>3C@"KO?&Q$&#J8V9&XYJI8/Q!2O1`>?& M>CH\-.1=8DO7EF:-L/MZ!E_3Q?<@JK\#IP\&W7,.?'88"<$KCONK@U2Z> MSD3=^[)Y6?][Z'N7!B5RP6HY^0,)HM)X327TE&)`/=+(52$(?+S"RI6F%5W] M(FE+PIUD).7Y]._9?/Y7$/(RS6[O[S^D\W4CN_SC9+YE6?Z1S0Z=4Y[UGL03 M1+#VUF.!"*+A?X)6T0V+Z]Y+N*@MZF^DMR[(]A,!/J3%:AX+A^S)97B-*0%! M[)1C$;0-ES&F:#R7SS+2G+&CCDL'YRJ'4?TA_9J&7YQZI'+2RQ+/A2$40`$$ MB7=7.5"EF:))@/%(HQRM@>?0L4@;$NG-<-PH\2WCN'$_Z_PO),A1J+6$"#)N MM.7(6U'QCINZ=5^&'ISH$,T]B*DWB(>I;KJ*[ME'SP7TL?)S_FH`W+!8NCN$/+CFBA,<]G->DTA`A`)`,(@EX=YC M6L4!M?&UBQJ=[Y;GR\E\?-!L41;M^QM]5@CNS:$`0FAE!9#$015,M7A8N\G^ M%HP$`?7C4&P5>3W'8Z[ADY]9+;BKV238,*84TD*@8%Q0Y0T4I5R_==#_O6_I^DLJBH2?X@4DBT-%7Z5;&;W M(7V8Q4EERY@UMH.F?4,3`YTU3$D0;#(`)9;8F)(&[%U="WFH:[MYV>:-,OAT M6_<\@)@T5I69WX1%].V?Z:Y&%WO')@(!:Z'B4@)O@_4%#68E!2(HMI'%`#J` MR&4<;AXCFVO`2Q]VBLG\7^EDX<(F%_:5/3#9-SS1AB.%K&+06(R]H!S8DHY` M55V/9JBG\:TBI2$FMZ50_&R>+DR8ST.^.*Q.?AB98(>H"5AG&@GM'$3"BXH5 MWM8-CP_U++H#97()?YM'1TEL+(RV!Q;;0Q))/*668*@4LXX1I7DU7REK^Q9# M/;%M%0\7,+8](&RRX@YO*#O')L("J!"3V)I@U@N%`<+5KNAYW;,']IJA<0F' MV\/(RR;GPV]VY9D?&)U(!ZC`*.Z$R&.%H!>@I()34+>H`W_-.+F,QVTC98/B MT[&R-3Y0(HCR`?'&2JVDQQC0DA(D:]==%K_14I_+S>-%A6E-UU.;3Q[V8.2' M,8ED`@;/''BCC=(Z.&`4EC-62M=MFR9?(RXNX6QK$9#8I3G[N,SO_N_C8V!- M<;M:%LM)%@.LA\,A!QY,$';<4$ZDH`Y2+`7FU0YJI*Q=E@.\1M@TSN^VL/17 M.I__,\O_SCZFDR+/TNE-4:QVWH$^^DP"#<46:.>U\%1P:F/9I9)13-2]#`I? M<02V&5:W!9X_\_DJR&NQ<=SW&3`[QR:$6(`8\!)S@P$AF/MJ6[7$U>Z#](IC ML9>QN+7=:A/]^Y!^R1?+H/CB,=]>8_?0(PGG`')%$*>4$[SC9WCDL@H`H[PP7$P4JC!DG@JS@`YK6M MF%<06_3R)$Y*(]CV2"$@!T)IQ("%G%$*D MV3J%03O`H#CJR'=#X2DY/7N?23P$CDFG!&8@$$8((Z2D,;88&=GI?',RS]OA M<$=K1/7U8;N=[>_\*[ M=>&)`P!LY/V)B1TY)$0$(Z4`1A8P\LPW#X*-.[)TG]:0VHLQ.;W(K M4L&(AX!XK@357,1#K4T2K,4<$G$TFM)VOOE?Z>SA,?9>^)HN)@_INU6LX'=[ MO]%U:QF("\A=X06/*&,CS6G._+L;(WN;L][G>TZG\B MX#E.OY[^'T4ZOZ\GQ>QNG2T?=&`Z_?EM(S%G5?`_#';$.F0ACWF< M`'#('#=(2:%ZTB$'L;9UGK*6T0&RSWI/@L.&*!@"0F$-&0-`&5GR0B'#7IW. M.!4;>7=<[\+.W3G_9S7P"Q$O9=3.Q>'Q-R:6&(4\<\'/U/C2MYH5#N% M[&IMV481V3C_>\-FO'FUFY;S=>.^-R5&<\D-5"Y8[I(`[!T@)2\`\G433,X_ MA^GVNF]7VK$AOK=D2_E9-LGN9C&@M]WNS4]FBS\G\U7Z-IW$&WH_=-_KU":J M9K)U7?`$N^C08XEU'FD(#)%8,:P$$>SYDJ$'3!UO+-`=I:?X40>?2Z@6F`:4 M`6&)H$803'U)JU9LK)W%FI'_SQW1&^3T`-;ST*+Y;2QUS[F7EF-N@THW!B@E M%0(J%D]`P0`X&C1LF5)5%.E:0&]FD\^S^3H2]RRBZ6WV(4;G8BPY#'B79XOR MK]&^/MH`K+%O)&$W`H&+U`'*`Q.1"W\K>2AE_5/X:U8A)^-JGPKI6"I=F+`? M)ME#>J2I5C4F80`;9RQ7QC(F$,*4F'+^E(RVP6X/`,B;$4%G$-K;N&?'J`01 MQ(UPPE`)H6442`I+&KP!8RUK6$.(NV!0BXE=`.'M+)L]K9Z.0N&'<6%)..J% MA"3\08(6EMJQD@X7%LJ8P7"N*//F&-D)(";?3@/$]K@$&JV,DMR*R`7M.6*N MI`,2>[0[[)7&V1H!Q`6,[`(0;_+L(;#UR::?UQ>+CQ@>NX8GVB'./*6*P\!D M&+A!*YAK;.H6F;D('F,U.QH00!^P.MK=04DM;A[&R25=V(_%PIY0WSL@O%4+8!V,KE.[+E['DB,18ZI7U8(,R3 MH$XY%Y4&A4S5M5(ONO@RUEVG&1GTA:_XXR(]O@<=?3;ARFIK`;/0$T@(L1R\ MZ&.$>XGAM8.YBR5^`H(NX6V-S>D?:6;2^5S/\N)[$9N='-R=]HQ.O/$8>(V% M8Q)RJ(TB%0,PU[TXQ]U!H*;(\J;Y6D/\\:NK^63Q(?`_//YX4/J[!R>`42D4 M#2O`(.LYT3%G]WF2I*?DZ6L2?B-L[6(;:6++?7-"7^I&OY,HQ)P4#&$KN.?A M/^I1R4=`0-W#@*'>\QR.?=2G&&NHP@]I7,'APV92/+JPJK].YMNI*3\IPWW# M$\^8E`1":'3P4KPW1E?A+,5EW9RGH0>*>Y)VWKA$:D#G[609K[I\W]S+BEFK M^6+Y*3BQ-UGL;K`GT?/$)Q/#PYRUQ](KRJV5F)/2]<6(TK%>3NH?4,T+IYLH MXR0KWD^^1]V](\_@8+CQX).)HM$6XO&'8=:56,80&Q' M.%T`,4;P7E+%_.3N^&W.?8\D3GGK`-`*,Z:0)LXB6U('.:D+O8N,N#&CK2%! MU-A+*_IO[^,DS'Q2%+/[V>;V:`P.1P7\*:]T\9Z-]=S7))01*3P1E%G+'(0: M(%JM'ZOJN@D7%64>(\(Z$$Z7(563/WV>96NIFW6_FH<@@?!3,9L^-ZTIF;NK M8OP%;TN(U8X2K2REG'F&)/:DXHFI7>3JHE+18P1L=S+J-(:SE:W]UVSY^$>6 M?R[2Q==H7MQD7U;+(K`SS^X"'<^-9;>YN1;$IT6P2`)08D>Y4Z(YS7XQ`0QS MQIV0X0>D59`BJ78BX$=7`GM8BV$80KV>!5.IA$X7SHU<#'N'":$&PGU7\BJV^>O@2B(Z'F<;)X2`^%_G<_D!"D M-<W+?QZSY=W3&?^]!JT#QH0; M"@U"1%K*"?&65W.&G-Y:F=(127.,MIT)9ZR-2CWFLVY^#5H'J3AQ,)H4GE&@ MK8,1S1I/#6\U'JY3.C38#EP&^UA46]H#`TR47+[ M63-D;C897Z>$:$"V"W$?>*6M?_XSSU:EK]S3V^Q[MFB^V)[H(.BR'HI6QB"A M+='0``:KF1-R/DOS;^QGT=EZVYU\1M.#+Z>0M/@>[2=X#:#3`DD@G'/$:L5% M_85:<*N1R%VSI(ER[$@&@W)Q=WJX!00V7XI?M@K6*02AM%I@9..R8JGSU1PC MR*D!SE?#LVZ)<(QN%P,_%KE0$KE0%80GJ4.`:(LH,%Z5F29J,P,*/DIX]$V3 M*PWXLLXM])IHA)057#)3S=%YR3>Z9GC\8M&/>Z3A\ MQ(T%SEC*#B:)]C>_YQB6#J_=QJ;*8@A6E0$W<>J_Q-VT"SYHW$>(7[-4@`(F M(8,::>J%JN9?_O5&N9C*@F(8G(?@V9MEQ#Q;;S[.-IG-5G'P9:&A/3";>@XG M6-:PAT"AL4@R2S07&$O!L.*U<419JL/)U++599_6>ZJW=X] ME0Z^)1+;H;?39RU["D0"C@P%`!#ID2%04U*;SM*G;HBG;O)UQ+A^T1[.,FO' ML:-M@H*:&2H]9I@HX2.J7E?S*^/!!HN7&K;P0D=LZ@K70<(]#P9I`[/^E:<# M]!Y)&M6OLG&A%U`11JLY89`<6S?UM6X:MOWE`AEQ63SX(7>R-I[L+@@G.!9: M6@4P4T`B?#A;LC;9))NZV7\109JMDEWBGI*#J"RJ-R_?7JS^FJWF];`.IF,S M>J5W%HB%1'DIA&1"2>$L-95>YZ55.H8.G"Z?!@,ZB4VOQN0=8DQ56ZW50:_! M8Z6MAI)X(N+TF02P.FPORT"EE@F M`>B`H*ARU>;1)#E;F_-*#?\N5\E.$9Y`$,R(E:O["'(Q$"&GL>?:``H5IE[M MJQ)+QQT9QVWW%X=:J767K#MX3(F^A8HHA39A"C-B?L*3F9FWJ;OAU MM.KU\)+I2?9CY'41_W^@YP::(\3K0(U`L:7`8ZDY=8:A(S;%=)S M0L?]S3C*XY41-]$%IYH%*(3C'&D/L&?<>NR5>GL]?T&@;60_@6.3IRX<"8`H( MJ322WAKA@8C:^S"P<2ZFA__*&HNGZ`C(0=(]S1;1WLX^?C;$R[(KS\8K&!EE2P:S5QAD>"2R'H=Y@*GG@1.Z$JC@V6F$^R&4!)V#WD< MYNY4X8]LL[O'.YU/]VBK,E"."Q:_AC(SH8D?!L>DFB.->YCK5PV7"O=%3MRN MP!R+,`==UI(SAX9!"\D<15!P"D34?!1POI^I\%Z-XBUR=;1)QG-@YORTY+52 M-B_;!4(08P0R&*&+N'%)':OG&2VZ,6Y`KX4W%\,Y'FW:JIQ7FP:-C#$`0XR` MM0P``5RUK`LHD[="$TK_/@AYDA$=@C__MYSGZ\TJ__-QD\W=;%56U)? MOJRR+V6@7[%8S%9G2SPU:A\/ARD09H))0!A2F&$3=P?1TO#(RJ(HY&?FMZ4VPOEW$G$ MC-(BFBS.,MU<*O''>I/?G<4AJ=?@"6**N-K7!RGMUJVNQ.J/.J=AA"#,.M+JUFLS_;Z):I^TX#B$J:",VQD5I# M0S6B;(=0-/2`3+5QIAYW.Q&BIDEAHCQ]ER^W8JLWM^5.XN=>RE0OFZ=WV>9K M,3]4+SYUDCK@*`)S4248PSF7T=*(5H;FLI*!=LF5#MK?#0T;M#21+V$@L?5O M*5:7'K=J`0**F*261T.?82&UU6B7+D<9A*.N&L<"?'&_70Y^_V_[8XS2A(__ MW7V?RWEU`M+&":%QIP$S+AEU&#,/XI^0LGU>RX@2\6(4OY:1E4ECXIQS7>A+ M"J,XQ&S=^^+?S&RU>KK?1;&WXN2K'03*$'2*0$$5HUH8J#FH9FX!_AW-NL[X MUP7BXW&M-;>")C*N]G&)180YA`A`N/Z*RJB*,9QF;HI++1$>A3O_6$4[K`UW MM@T"4QYP1#EU@HFH?B4ALIH9,"+5OV'JF0`&X4X*PJ-PIPQ#WDEPL2C^*AWD MVQ#I9>O`B'16"0P058``:(6O(;2(IKKQ-?>:D3M6+;?W&?,;X]7%@(_E6=S2 MGSAH1J&W&@,FA"90N6@=UK,2,%4YM?>QN4'EU![?\=Q#/ZR*;]EJ\_1A,5N6 M!P_E4<.WAQ1OT:,]!>48!M9A[J'CDEM/]]5+E<$:)7NL3]6W9B"N]0#]>#3< MVH(^7^:;[&W^O4PG57Y(K3GX>C?!"(R`!$YIY[PD"G--*Q0(8:G7TA>YSUP[ MYSJ!>F3"I?$K2(T(1PA'$`4IW8$$K,Q.#+Q*#>R;JF_,2-QJ"7."#_/K+S^V MVSO3(GCBXZ0Y`,@8XI$B&*MJN,R3Y.03[7U?KM>DZA;C(;7+3RY!]9@;J)?7 MF@4C$=900$$!LDP:(YFK=:A+SAT.?^<3]`Z`[O_^+-IQW_-U;.N+U<\WY4HA58S_B3U%\69F= M,$HWA5RGVP>EM51>0Z,HM(PZRRFJYJVT'R4!Q753K%/`!R3:WMTFBO!,C5([YIOQB[57]U`/2"M:C#:LNI(PQ`-+R<`DT`# MH(B.:MI4OH!8&)=Z4GC-5V87DJH;I(?<2>V7\?;<:M9!((YI"BFU1A!-$;1* MPFKFR-M4P^NBL/,KY5@OB`_*M9W*O8!K)SL(JG3#9(AX)KEFU"MTT-P(FE1] M=E$D^[5SK4O$1SDA:DVR8W-U4!GMH"=:(.H!%`#7^QIB!HQ9O_[5LENH!PW5 M;$RGHW-398)/@+3FVZ,O+GR]:Q%(IKH"M+\=NWX:=0-Q_P>-'[.[8GF7+_)M M!^_O]PMXN;U]C,)]B@^5I6,_%Z5W\6SYM';W]]E=65)J_W]NZN@14,LA,X(R MBJVEG%BPC\,VD@EWM@A'/_.L(:^'7@+_7')J\ZODGCU\`H\.>@\R8J,\P1[& MS0,F5"I3XQ:1'"4_\NC7%`VI5(PMCB'6J":S>G:D]DJ]DT3N'NLV$.FB]@4L MBH?`:!,*K6@M(<12MW_7?"C:)VD[DL-4V%J&/D0)YYL&D=VQ%EPSL`/7^SU@^/3X\S%9/[^^WKHN[E&_K]_='DA'>U($*ILHJ MX"&WI*S*2P&2^WA@&],\VU(LK M05[,/VUFJ\UP:]YTF-,LYVU+:8W(Q/B=K[+9NKRK6#\NXG+_I72#5G?_>AXBV^@MLZU$K=KV4V.V7M_K0];+1:? M_E#LYI6@DEN^('A"-<(8$>&]`]$<=T96R('T'?/473EOXQ/H2JR3^R`^E`SH M[W,XTGV`%DG(.'4&6^D%(5JJ"C5%B!_,!?7OCV$LH8[X*=BLUT^A5?;,\-M['['/Q*=ML%MGV MS+B\'YY]6V?O[W>N#?''V_PAWQP]E.WA+8%P;RBBVX2OSEM79LBH8-$PN>)% M\U/;O]E>3$6ZUW4"$]W]@/>G<"XY>_,W6YE MU?\MQ;9J]_KY6Z_VW@$)&2T[)CFFAI>'6Q18QI6*Z!)-U-G$"?W,\]/=UVS^ MN(@*Z64EE1>NPEMY?(X2T'$P_SZ!PP6]!L45B6L_EM(@@B3AAL,*)^G@[^BX MV9@ZQ5AB&&)-.LQF-X-?4M57M47B6EL'J[:F:U+/02!39O\H$T<4FR/$N5>IYJJU^S->3E1>Y=# M;_O6S6SY)8\#>YX?=M!MZS^*8OY7OECLB@4_&T^KC6RK?@*B&@$E,?86&"6X M,8G@^A_*(6#31$>TZ"IH+[HR5@DKLH0:.>5:A$1?ZU$NZJ6]@>Z), M,:`L!M(,:C[?WG:4,6=Q=_.P[6Q$']MQE(:UDG*@H:<2`*:,YPYL7:*A!,R= MO]+HV\S0C^M\F:W7/[GQK/733W_;+D*-3(MF704,+.(<`@#ZK%H5/Y<99DM'F;Y*7_5LVV#(UPB3:525F&CE6.ZGJ\" MR24T)DBMBR7>@$&78)O@#V%6\<7OLGE^-UM\>EIOLH?2?>E=]O#GJR4(SC4) MBD/&$%.(&E3FR,<&B6K`%,I1"FP.1X9$X16]@)O"AFRQ>%S,5E48[VD>O/IP ML$1&HQLS!J7$##N(!/)".L,P,)2D)E^=H)]Z3PSH`M8$V?\C6Y:OUGFQWO'N MI/"//!V0B"/RTB!#7>R>4@%8-6,CDO,Z7W2]<$W2[P;7D8R*N"/.WI2#;F=/ MU,T"I>4VG4+C260G1P(`7\U2^V138H*Z8TPK-17O!*52O=T4#W_FRZU5$_'^/#]G<9M^S1?&MS*IQ]W59+(HO3T>44\]O M#PIIBJ:(?5D%S-^LYQG]X>Z9L?N M'$ZHW0%&$;3%R$H-'6=*04F<9ZXV4UUR9N$):O%./X_IBRIA`:AB82J?Z7SY M\JM]O1Q5B]:!>55F%(1"($:(TY@[[H5"S$HLTPO63)!Q_1Z=]H?Y$)I6/12K M3?[?O;MU"^5XNF$0R$(-532YHZEMB?9^GS4HHNBYZ#_MW9Y=W[/5G\5T[_12 MS^D[17\(GOGC"O7GN>S]:__(?FP^_Y4MOF?OBN7FZRD>7M9Q```0Z(&#EEC- MB8M?J#GL-P=(?G<--\^I+!U4-M-C\?]GL]7GOXK.R+OO+S@)A,%*2^*)4AX( MKDC]=1,';]2':HJ<31/)1*D:7W_J_F;K8DR&V2;1AXV.\7;LV0[HY('B,:?(UGT$ MPA3#5G'':!G*![FVL)H69GJ4K*&34P:-95\,(X:15RO]]&[VKV)E%K/U^HR? M9(M>`K+48^8IHM(Y:37"7%882&%OS:._1Y(T7Y,N%,+(1#R,_8_9PWD?RY8] M!:LH+#]OI:,AP*"C&/$*"P+,K1&R5[HTIV0'HAB"EN9QO2D>LM7';+'++_0U M_W;]@LET^07>'WJ3_H@!V5V@/P:A7 M_"P^YE^^;LZSZDS+()01Q!OA@#'"($6BS5GA!W1R=JBI9\X8BF;=PI]P^_]A M5JZ)L=W<`]A.+YO)K- MLX?9ZM_G-//%XM\NMY,%H'BC_ER_>LD=0Z_E`6`I')(T#`5 M`D@N#!?74#&42J*QGTX.Q:C.D!^&6T=WP@U\#PU;"A:ADQ!98@+.#H4_@*X7 M9D*2<^"/U4H:SO_0KR!&0,J&?HB$UC*L")=:20`]$C']&J+UW(?<7>36^B!) M<'JB3C.*=B"2(6CZO9C&/L[OYL]#DA=OCNB4NF[<5H:(AT8SS)E&5A!GH:E] M05#RU)1W[YRB[:CS*J5POT+YG:3O3*%=0B"]&NNMC@@_';DDF-1.!KW04B%C MI7?28:\X0!5&WEY=2LO^[:,AQ'#A$YIMX=.T(YGMJYE#RBLKU;8,N]>$:%2O M7T2HB]P!'`GI$BAQ_BE,"OJ7#J*:3CL:Y#486@I&\47S65*2$UA(IZ39&1 M4C,B*@VD`;*I5T*O046W9V?/TA@HJ.]EN92JM_I7=2'V6WX?R^E\N`B_L(!0 M*$!8/IS`GC@6%A/E(8!&2,EA4HSD_(^)O;V0::0H4D\QJ;*V7 M0EA:C4^`J]V?]T2"@UD0VX`^A'Z*M;&V];)>S/=3[O2C[V5,"$XUY(!HHQQ! MD(6_]^-T.OD<<.SD:BWVES3J$.1!R+37%:=^5+-T(]R5E6D";X'_:)\T[&F7RVS.9Y$8@HX$0"'IBG&"V7E)9 ML+RN5=II/YS-?\YGF\EB\>OFX2'843!]NI36844AHP`9)0`!DCVO-: M`3OSL7(NG\V45\;J(.`/0"!SJ<%F M8_74]J45VP([)%&^/I4I/(,JSY[.L-(8*TN@H1QA*2@*DVX_)A3LPRO=0;40 M[@&:I(,Z)%'.8$<6-']8?CD&8'O(0"0SNNH]L&:P<_%=P?=OZ\ER/3PQDL1Y M@!H-$1V2#U7J4;M9SHO[+UO$SSGU>..US#K-ML>EF'FH'>=8U7M43/"U;M3[ M8$P'^`[)HMOEI%CM[D&J8O9ELYS^F*QR-9V6FV(=!J!F_]RLUEM_Y!GD:M!: MAAR1CGHF`*#"6DG4D^V&:#+GQF[K],&Y_F`?FX)##GO-K43.&110T]:ZJO=< M\-3$)(TOENT4G"MF[YLX#?$<*!AA:_Q_I!JNS#A#G-548Q.D&)#'?%=#-\Q1 MZ4_FX>P[QN!5V%4Q^VVCUJS8\]FM9A+((.X`E^[#AJ1\=5;F:$8:`L,QEY@A;PWT%1CI/YJTR(,3;JVP/>D MB[Y-`M_#!S[%[/MQ)OAY,2FFP8CZFD_S^<_G45:#:J:GSZ_.T#]O/)U!1X0T M%E*"/8**$R=WY2:`81B>SNC0S[C,Y'&^GBQV>-\4>[@GBSHL8O7Y[E.^6I7+ M9H7#6[6;:0J0=@XYKQ&FT3!6U@=SV5&*C0072?+4S[QOQ927F74&Q/R"\W\7 M`WL9`[7],D"A#8NW#C@KC"EA2BNX%RYBZ/2^NV\]/GSM;X9]+.P'%!0!'!DV M59KN$<%&4WG=D_UL/K2M\-T,YO<5P4*`19I)Q@)XB`M"K3/5V!#2J0=W(Z10 M?V(_,[2E&=3O/[3%*40!MYPQ&"M;QSH0N!JOU/"*3)'6$F]>X;L1M@G1DR8, MW(=NE(4IEX_EDU7:H>C*/K"] MT+)R3E3)T;*(2@NO`7<0A]58,D7BH52U&$-P1=4A+ZFG4O%.6&`2ZU5.WJI7 M^6>^OBE^YKN3HGD1MT*KI[W0@?5JN`YDGE!`E7-28(`)Y$*(RE+%4-F/4OGW M;$ZUK_S;OY22=.HS+\/VS]M\^7!0G;[U<,8$"-I"*0NY<4A`J6-&%BOB:1K& M/G7+-\)UL',J=8+H$/KSMX[ZS7JSS/^8%_.'S<.7R:^M-^II.WR&+R6EN4Q) M:*#E&D)I(,.$$R0C*D(C&HR6U!.L5D$.[X!G`V(^-B::S3+"W1$1]ZUE7F$* M@KD,-0(80**84CX6=*4\V-'NBEQ<_5*F!3_31#$V>MX4MW^7L4#5L2U(6H,9 M@X1(APEC@!+$%>-HCXS5E(K4Q7*$2GFT)$V6Q@AY&LM3=LS4NLG,.A(K1$#/ M.<&2,6Z$WZ+#8FI%G^J*&:%B'S-74^4Q/K;&ZI3=DK5N,5,HZ!J'HX&."*"0 MQHM26VR,#=NTU'5UA-GX1\S55'&,D*KSGQVOJW6+60!=(`J- M!;0$)2>T;I7S_^-1-5$<8Z.JW>2W/_)E/KE;'R^_E=IF)IRQ`1KN':-84\5= M]'5%?!CW6J=NJUI5)/]@=&TCD`O&$+WPFK[]T.I]1QIIY1&#S'L"8YH:K@Q@ MB"&HK+=8G'9^#;""_.;+OGGIRWY!NMM2Y[MQYL=NVG7S@0QSYAVW`#@+"69> M*"PC>L`";KR\2(*DX:*2SN;.L:5C*/`'5WPO!F;GRWRZKA>0W3/?B_O-9#DI MUGD^^YJOMFD5_FNRV.3;(,SPQ*RJ^I/(Y99?S927..@#2+PQ/HPZ[-/H'F-A M'+NBK#]#$7Q8B8R2]78O^9LBJ.-C4:(M6\XZ%HSS`/OO3NKA?IR2+.HF\_ M\GQ]?!/0\+@]L?DL9K&*)7TE0IU]&`CH23&7)QT\#;L_OM? M\\=8SRN8H*!V\7T>@0Z_XGK9K-ML'7D\5-<5('P\]WGQSS> M*"SNJP(NQ[P;A][)C((*,ACK!7L.C"34D&J,6(,/-W?/EOE+QT9'""=<4*H^ M;3:K=?F0+_>)&/.9+Y>W>?$E7TY#1SXO_RB7P63^FO_,B\U;1Q7);6766>4D MLX9SRX'%3GM>#U&!DPGEWFD.J\Y(-!3R_:N#.@?/,VT0!F#*A\=)\:NN-74E M"D)02PQS0;]S!C$&SNO=)6ZD1-#Y)_T5/8VPWAZ_[/@SH>A?^U^>G][F[-8R M["V3Q!DC-.6(2J6DKG!AVGPXI7(V3P[FO.D+^T'\CV6Q*A?SV;:WVPMZ)[+> MO/U"!HT/"I.&\6$IC0N?PPU&DJZ[(/?(=9>':9?/(_RV+?V9/L.?A.AHP7)MYVU!QJIV(< M7#4^*:%,Y<_8-TZ=\ZAQ87"3KT<7+8I\MW*-EL9M!F^`);%X6 M6SGFK1%"`DN)!0B$Q;?J$O+T:J6=)I>#9;&;P9@@V39EL3%$'A&(.15&.H65 M##^H.Y=$"UX`H*Z9RG-&[^JE$[ M@5(K'XV]7-:@]D3WM[+I2,XO2=0*XR'XLKM#\ZEK$^>CU=^0\RA76CK$7KO'L@X(SA65N"0&T$50PQ7 M)H]"P*6:>J/7VGTR+PG:(4CQ=)-\GS^WNEC[93$I(MLCOQ\?CH?NG]](1C#A MB$6M@A$-)@\3J-KDJ(!(*KE:Y75Z[^3J#?XA"&CS(+CI?!_R][C(]Q5AU4-$ MZM_;GQ^AWCFO9TQ32,,Z;+!C5C$(<:P)N!NU36TZP'Z MT<06^;)<%^4ZOY(8(T4A!\0Z#H1$$EC$<5@&E'6820'\R5(_UQICY*$`T`@I M*$76$:4-)!4NGJ"/LIELSI,.8HR:8?^.#]4D=<0(H0SQA,>RU^@)4WB9`C@C M=8*=38EFAVJ-!##>0S4KD19!>P*)H;!,`PE9-0X.\-4>LW0CW*.':LV@'>10 M#1$D&1&8:"RT$4Y[A*LN4<12<_6,7MII1% M:N-<,C`YE3]=(3P$@[HK3PX\A)9BIL/U-, MCW/AR"N9Q4%#!_H#ZA"WU(;>UWL"16SJNC!"ETQ/9.@.W"&4S*64%P(R0)FL9QH!5Z2"VHCV*$N2T4Q0.E_7\]M\^J,H%^7]_(3; M_\UGLS!&S#&D$K"P>X-`4F&?QJPODMQD"(&G2*GL%LQKN5P#J/;&.\N`)Y0# M344L?%)I9Y7JD&M5=O#*S@AZD$/":O,\GN[S7555Y'@*MJ/O9(AA!`23UD$/ MB$>A\[YV/$IV16ERNY5@V0_`@P3__];?FR"\XCX6Z3A]*>#HBYFVRCDE$?>( MDJ1'4HW>&.Y3)[6&>4CBF/+A MKWDQJ;V8.X?FUWP1*[`=6HV:-Y)Y1@DG0B,94TF%114\N3`Q2;Y^WJHHTK40 MK7/X!PF9V!70F/\[=O'A<1,$\ZV\6_\=8+UY>)S,EZK;2?BSS>3H]W?RN+^4ZP?OJ]\ M5>K/P0">?;X[LFR=W4:F(0AL9P([8L(FQ&$DZS-@S5AJT*G\B+SK&_V4 MPY!\6MX7\YWGPH=>;0MUJ]D_-[M4&+=E3(M1!)G^VI\OSPXL9`DM989""3D# MW!"`%:,NQAE45PD$2DU9"<$'\B7TCWM+KW=Y-WFR!V?!&KP+G?RYK0>_SA\W M\1IZE-NL+!9A+@1)/,SRO]:3XVSK[@.9U6$J0<,$#[LA1Q7P3""F,:(*2VA. M7J\^1,*/ZE`?5!R#Q`J4<7<3TPW=Y\4TS*+IQ6W&>?B[.2_+WYO.9]2(8*%8K*44\-:%. MUB$$#M#40#]X%8FK4HG7!=074-]V\C"YSU?J[TDT0K:K_/EZ^HV7,PZ\,4#$ M_$A&*::`%/6(J4W.N`>O)$%51]JY/?+#AI5^R]?KQ79E#;;QYF@"OL,O951Y M;RSD&L`P6(HP][7SDG.8O#?YT"<6G>']C%$])3S;AR2M;LOOQ>3N;KZ8;T]3 M]@4B5ZJ8O?`?!5-UL9D%Q`YF$;R2I&B$>@(9IA8*P95WBJ!]51>)45`UIV9& M3R.LXQLKR6VSS`9XET786AR6V_GYT5(:SI337&*A+<`PX"8,IC5:WGV\^MQG ML^=@JK0!Q#!(K'.5G^D?>7F_G#S^B%=_SLV8]O*=3%#DL!8.",Z])]A[C*OQ MQ3*UUTJS@5AQ*'%:2SD,&%/_O*?G)E![_4XT_"`SPC,KF%;,*67WZ;DET1Z* M:^59>X&_'2/?&N+S*;3*I_]Q7_[\SVUIZ^6OR"!<_2.2!S\CS_['V?=O;[#D MZ9<9=_3_V+O2WC9RI/V7>!\?>>X;8-_QP,GL8#\U%+L3"^M(61U!\N^7E-0= MV9;4$M4')6LR"`*[I2:KGBI6L2Y'*1?3[<<*XKB&7EBKD1:6$B]030#@\;4V+VD/$2U0M9?"B/EX MU(B,WP\5E'`/G312.FK"Z0H!KXY:@K5)+;O*]\ZY12@DDS$A?GRW>`H4,FNU M=+!"<\>3!8/`"P MIY>]D=H.:JYQ.%$%90)))RI/CG!JWD?G MZ*,9NJ_77A(Q^P#&B8JU#G8<0%#J5Q:>2N%<,`4,!TH*YCEAM:OG^"`]^J[W ME.N)3;T<@,GS/XDU!`("J8!QDI6W!*#:@&1HD%8Y/4"N>]XWS`0]C>Y]8.B/ MZ>1A.8O$:VQB\/K1`CO")1?*`VV-H51[6KLAF/O4Z]_470FX;L/CZ\T M\OSE6R\PEFVYTK&^0W`MM:/(68,$$(@9K:54C7CN.I9]5*^>0'<=%O*?HX+8 M)WUC`3"Q5@NED`20:8<#N2KZ0.E2[W-R/S7.Q\MY@[X2Z=^+!9)JP^E?+V)G M,9U[I41.@V_;+RVTYP(&FD+LM5-&4X=KCE)"4PNA1^ MTTL!F9QBFKGJZ0MEK\?N]LJM7K60>GQ"$B'% M'.**;7QQKAUK'HW1N;6_F[NS6>Q9MMI*,!%?0W25EW_"D-_SWE%P@STTCAF" M%%%!&*VL:>@=N-9$P[Z0M]]OZ)5OO620K!877M<0,'[Q7`$8(1(+96/<&WH/ M-=\,1N<&4G6M]Y@#`.%U$LH9;.C%,4VFR^^=31YCT<8?HV_-/>F[>%WA"4*, M\&A>>.E0("^J>&.N&\J/<95$"JKLO^XBT'0';!H23= M]_UY]%#6.VR8"++[Z8)B#1G5T'`MJ66,.JJK93*>W%HTQ\SB'+#3'BMZT5V1 M-`T.1OU,X16&C@$$D15NU6D&BFK]6B8GJ>?8E7]P?R*5ZKVAIOE\^_U401E5 M&CBB+"#:>4VXJG5EO*PL'`Z.=Q&-A^KC!,A"+-F,,G$&[/C#P:;R(Q^.'R>/XQ_AQV5B;O_/Y@E*($#!.2 M)WY38;TT*E`0`&/C8#>O12URR(AK+>4_$QA-,&N5Z+T4>?\L'Y:+\8^PBR_C MAW+67.Z]\P.%H4")Z#]JC)06#@)>G>(6*IPZ:"%#"Z@SGK^N`&^#T'U`R(YG MY4/@9B-T7CY8F$`2J:R-ESY14,@5HK=.0]2\XJS'^HX^,G8.^]Z\0^_?7^>_BK+ MC^7L1_!"=N_QT^BG+B?EE_$B5GUL_\;]C/\\E)O:S@OBB$/+.%<08FXEIU;4 M'KRC#E]M^X8>,??:/QV"<0EG?3*)5DD1ZGN9_N.OSXMUIW0_U7.8]W4 M>DS)'I.A^Q<70`$C"9*<$6)<4%M$5)RI1]A.4Z).`,5F:`??>SG#V, MY^7\PZ2:5[68C2?S\<.^Z28#K*)0@`(M,?;<>0.@`9+SBJS&F=22G>R;,EZ' MA+3+W12AB>OZ,)\OR\>_)H'S#>O<>PB<^#5%\/:]E`QJ&SNH&*XPJNH`O#(^ M-72>O1L[$&R[94]KROJW/W%?KD>0K_L,K)<5?/_=ZSY)%2>^H_`$8B8H%PQ8 M0H&PX9\52:)P)B(V^Y%!.2G:?GB7`.=Z0/"I&&W^8.$(9^%MADN%#7:Q15Y] M!E@C4F_\^`UXNX#7.D/ZN,;[6U:KOOJ_"S8>.[:,_6[A@JA/E M*19>::2M-A[5^]4X-9(O;@#<=_G6-D\RO$H^H,`WFVWO5KGY705TB%.#E6:& M:F5Y;$=:T=-+G-J:7-XPWM(%<^L\S#J8^$K>:_?PTW01^\`TW$/T^?J"`BR4 MDT@[KJ5P%,JZHMM#P9.["(*;Z+0>BNR.KUE+T]N;>-B%U.QX3>$`-YX'XB&' ML(PS72RLJ*A%\@4VO$4NVY>.\_F7>A'R^D,.+['UP26+ MRAE,S=JHVDV$3[^)\(_P%8O:Q/R[C)=GY:/Z4?IS:#+FOV7+;[1$"X?7WB( MP\KJH045`=!$4Z\DD@!0#!1EMN(,.J->XQ90'D`L6^3T9AYE6XUB&@FK+,@(K#,:^6(A`@KCJ1V%1\Y)-LJ]X2!\Z+:?7`S(L6EO6I[Z>SS8_B M]FK;9R-_LP^3%]7@:$S'Y%5VT\ M6>UV3VBL]?<41`<=`0%D0`E!@)/2!%N7T6#Y.LAI;G8,T>KS:\O?!!J0KR& M2D@A"6-4X]IXE"IU%`>Z%6WO1/)`?$O1QRM?X^Y'.5LM3(^>8WCX5)R>^"U% M$$LJ*&=((Z;B%A7WM>WE7'+;XEL%]6[%VBE[$E"W=3&[-D&VZO\JM;\':L=\ MM&`:4J,-U,XI1H!$EM;W4A3JU%M\=*L_WHFO#GC2A[\5:/1M.EDM<[WL_RN? M'S],JGN=3[/E?+'^Q0%'ZO@O*;3TCA%D/1=,$"RI`'6,4$F9W'OT%@W>ZR%U MQIV4_G_+6:36O\O1;+Y-B*IGZL;$'3T?T'XG?4=A:,P2EI@&VD$7C%YL6;4E M;&"R2WX+9NY4@UTR)S5-=1[KZ^.AOE+)E=VYO;H#:#OA&PKIC%`8FT`J"KFC M0`%=JW=,4PO1T2VNMS]+M!/6;"&MAS'B80/?UO>S?CIS\\5X/4G\[DN=6C/? M6_*\NA@H'^UR%@R/^_)[=*:J&HGY;1;YFXG0T$`*"2.QXYT2D&L28`!,``$P MUNG&,H>.;KTO:A:Y`\@(1Z4)#A$)9BNWE%4T5"ZY?WSNA5-](:^S6>2G\:T/ M[R-M%KD,7CGQP0O'S,D8#8945_O@"`_2`?RB&NT>#82#L\A/8T,6P<,+F$4. MK`[:P6JC!&)4"@8IJ:@JE4DNVLX#FPV]\RYKM-=._9;??S^>_\?/RO)#\.4#RA;W MP:'H0AB.?7?AB0$&!17%O08&&T]\Q6HK-$V-E5_\&=`B4ML2DHYX>G$R%.<: M/`0__%_3.-'M.0"E3RG:_?9"!!IKA+7PG&IL"7#45C0'FJ5VB,S^S+D2.6J% MJQ`\D=\H`%[55K+H]UZH7/.\B4R4J*SN!I M;S)TJ.F(WM-TY-">8R9F8TNS3EY::."DD1X";S@G"/'8"[?24B8YU>(=Y/^< M)34Y,#/K(^==MJ>12FVO]@[2GGH_P@;F?:^Y!Z_+ M,-?CL"=?/TW?T.:63?`VIDL]#GHX;VA;S.L@E.XUL?%LF'2=!VY<<`A=7Z_QFA M$K=T.+?@P*<*8A0"G%"IH4!1B7M/JSVZ8(Y=*38'`,FT*Z8,"+S&!(*#GRN` M=XQ2Z[G3.+K*#`)4[Q,FSX_+'7RML/XX."41NI^JC/DB"-_HN9PW!O3?/%M@ M281A'!`JL`UG@^2XWH_DXEKS\UIB\IOJB?/(VXLK7CZ'[_SZCW(27)!G-7E4 MC]_&DUC.%BCPH]Q,?&Z&TDG?4WBHC4/$>&@%TU+'P8<5'0)MU97&-KJ!69>D M[P."]X&7X3U/8>6V_%$^3[]'XFR6W0B\(SY=0,>@@2YLW$EJ8IL2)*L]1^_Z M2H,`W<"M?8(G%.>HA_\NQ_/QEM>S%RB''B\,"1K8,^2HA!93)C!5PA"BI/?6 MX=2$M;,NNB\!#"T2->L+YY[RRRQT3@/"(?5$6RBEHJ(B?_#14Q54[N?A\,YB M[[SKI33B>860\G'W[C:J^E#-Q%%?4%B"2""O$L!;K2B`"KIJYXS(Y&:_N:.V M1\R\KJ+H@C&]1@T^+K]]&\U^W7W9FJ:Q>BB8%8O9.$8M5PG,?TW&B^T&Q+<( MPIM[7!1TG?+48A#.:^45L5RM8D/$6!$0=8L@-)\;T"EJK%+4L33V)"%QW(!]8A*6&$Y0)!RRH6T.,X:K7B#\;6&P!*AU4<]XFD<2;B7 MV67%;<]-FR\/WM,<^_%".R,=(8C&=MX`@>#YU6*O<',OA@N%UK"@F';.J"PT MZ\!W00"%!1S!N>W.8L=V@/;A+TSKNLT7Y\0_C[Z?.SG\[B MAP;)I]VUD()K[JR'B#`"B:.($:$$9.$/9);"03(@LKV..AJV_4\;2.?IE4A7 M1B,\`D1,0(/"W$@*.5-.ZPHF!LO>*GN_KY*G/RY<5&IM=`6!]L`,AI:+AL M:7R9MI]!U4@1B$\08-A*9C6"V&!3J6P<=/BM.OA*I?`L&%RV$+X<(#N($+Y< M0D&1U`I#$QQF2*Q1"@A14=_19%?M^+PBN1;"2?DU7MO?Q'"@8<8G`N&RQ3`P MY4LY'EH2WZRB<%!`KSUCE(CP/XQY'Q4/D""I5X+'IW+=A'$@83P7"Y$-9`JRD\]P0(Z8,-(HVESF,`*S)#P]#-(6SK]O-RN'PE!UMCFX1L(A"G MK+30!`L5[!,E`4.<`.:4B:K;4JX,):FU!V=5I5R-D%X'T]^+`& M^$7H1AO:[T0+=0NFR5<'+^_(\5<&):RP@M0`$^#E"0("= ME6+3RC?PSYCD2Z[7`#>+<;U MCN6_,QSE&1]KW&4NH;,3%UK$R"JR&@(.C7!&4<=1Q1PB3.K@KZL]X+./JG4+ M@(MHI>>\5DNBAO+37>-#90@;M22Z?#\8&@#M:8,)O&!MCQYOF51^GCP*Z' MB("O88V?1K.OY2*L8[I;#Q/U\*.?SNR_5*K?+T%?RLP=UQWZ\H%IA M%S;C.(%.:.P`(+4LJ==-$Z[FGG<`H'7$DF&LLH^CV:V!V4&(>,D!#7]1I8&D MGA$D-K:U%X*CQHS]B[W[RB9?;?L2Q1D-'66*6NR4]<8[[`6D@2,BCGM-O<_* ML&*^+]@.6RU_&C_[O%?:,Z%^2UGN+67HY;V%$HHJPXC3SB,@"0I_5QR&'*7F M4M_2O8!I-/0$T@`+&5N-TXG=XBHU(3FG/W MR-ZAP)S%^`RDQ?TL9P_C>=FWP+QY;T&9H=)0+8#7@`N&)3$5Z;"&W<^G?B=5 MJSE(S;G`4.JU0QHC@!VAGE:DLUZFWDO?RKTS%)QSN9^! MX.3CW%#%E74$.:P9I$YBB3?M/KTCW-YJLZ]*=,[E?P:BLTZG59/'EZ'YH23J MV.44%"FM-;6:Q40!CY3\'WM7UMW(;:S_$O;EL;`E0<9S)F=P-57Q5J!VX.=T]0F&M']L#1M0FQN`!9 M>C!!ZSFY@PK-J^]&;+1`$AA2"FL/'-%`&](9'G*'2OZ!H3$!("B)T?4^B1-0V0ZV#YSSDUGJ5[K-]R.>`J!E(1#>M M4A$#B6EWB]I>66TU-6`%<($]HK1)T7O$LV\C*-V!?*^B.AIR2A#75PF0$L2U MU:(B%TX0"LC4,#%(`0O[4!G"V='0V7;2S5E<^T1.`0;P-!U4#L)*4(F@'ADE MDTG3=#H&KY)I\Y$7G)V0#@^;`J3S='*G`*&];)%1":Q)($$[*@CA6CFUCQDX MQG)MX]:R_)%<*9KQ!4CCDV12`6)WYFHB#TI;FWQ^#%X82Q'!^QH*;7#N72/B M0[X&3%YVR.$"!.FPAOBUJJ]Y3G]O5\LM(^ZO;K]4Z^^CVY^'%A9=L/4$'^&P M$LAJ22W;YY.=);FUG?)#O,:S&CMB=@G1F-9G]``2.,R"HT'<<(H"82$8;C72 M?N^+4Z]SG43U(9F]!UW&`D$)$GOXU!];--NO+-GX&AAAV-8#X@1#M>;<>]P< M2Z0\9'"I/T1^WRS)$/Z6M+):;Q?6A@9Z#?C\*+Y.N4A0C#5Q+0;#?.\>! M0O;]Y>A#<@:T*R]B:@'R/UKR M&.>6CN*9SXHK0;Z&8GIAQF!O`I:W@(B"8CP$`.LD3^1S0>R3*1!<]N"1TNO/ M)B)!@W!UI&EE]:8>DI8?4\N.@0V!=\8ZH^L&9$2)!"F"H@X3KKUG)_MG"VMX M> ML]#_;8.3FW?4$]K[9MT4M/V3Z\UV,:/%>ON&8_/T!OMV!`'2D60:`W*)F=@9 MK!IZXX!RD]0S'@U6YL'0-:>G(%GC>AU8!,^3IE+6(\D(M<;YAIY$B-P(_JQ[ M`,J4G4MY.YBL_'YZC[\?V.,N:;';WB]?=R?P*7'I^'-1"X<<\O7T0:T-`J2T MW//7R+DVC(\9O!J7A5,X1,Z9\M7;MV)0GCM/E$%6&(6)4@P]T+.^"0C-M#%[ MHO'<2_DW!7DXLWNF/K>_#IGX.',Q$1E!G)=.)&YPRJE#AC8<\9KFAK;F-Y.K M@*1(/SR=D92-+UI1&RZM`."281:288PY:VC/-.2V;[V[Y$KG6!]'+%OBH0A9 MW+0*JOT]RV2<@BA#-2U,+(UFP%ZTK$@'*"`JA MSHIP6V=`_)Y/VN46#G M4.C1?D8).25=PZXF!J.#%81J03PG7&+G]_:(@I!;6#7SB59CE8GTS^'1++KQ MQ\1=N)PH'$A#O$GFLTM6/BB$]J:SD2A7E&8^@FH\ZZ]W%D_A!&L_^`?W>()E MK"9JCZR17C%:7V8KB)+[EC5(#JO*%+N93YT:ZP3KG\-3\,3:C*+J_9O1U[>5 M&\25],0%`.R>V.7(Y+:ES'W\5`$U71CS&3_&1;V" MG+4:#&-26!Z$9])A]1`7HAZQ<+*NL2>=>/U'=7-_6STT0665$GVIX7Q,!7;U MC:B4!"ZLH2')AC%.F29;2CUW+GNPY+S-A+.1]U+9C<2W(6R!W>+2Y^"_BV.] MHL]^%PU5VA&+A1*"T71B6&0?]A$"H=F>6^'X&P$(J^[84$2`XB!='G>VO/E\ M>[7\^>I[Y59U:*:7.N##GXL8!TFP3[:'U8@&SBA'#54USK[+J'1P9T*KLT+< MSC@R!,[?,OM^_==O_ZA.-!+S6)+N>-'^8$GHG1$":I9P%1C9I,OB%2S-PDF M]S:`$AN.1C_'N^'!6/BJ_[BN3A_/)Y^-A"-DF/48L/<*>\3M?K\LV%$26F*M MHGO[%_ML#[?XEK_13\;!>5!Z M%(>FL):>#-AV)3%#\'0FTM7?U+"V:X@0@M'8L3Z\2&:A8=K2^'QVQBC"^'P)T3H.UBF--7!63Q.5U#?4QY3D]@N5/NSR MW4OA13"8MA#NRAY&%<+G2X@2)+?,>VJ]-!$0 MIBV&#W,O1I;$5ZN((CGZC"3'WWL`XZQ!#C<\H-;D3BV;\54#9ST(7.Y!^.L)ZS,11HOP\*0+1IMM_+\0N:N.S8N M6TW43GM.G*'"(D=X2,0U>Y7G9&Y3X&P=POSHYW2X/).#[47;Y-8%=LG&"E>+ M];9TOY@,1)N51K;5VEPQBQ7E$EO!][QT-KOEZJ)$WVR$=!Y,?R\"7+C41NJ- MUUPA4,'8]%\MR#[6;:09+)LXU\Q'/R)4H"IHB:1IR__1B>.%*(&6:XR>FL0I MS9F0CE$=O#2BX9_@/K=$O[69G1;X^VH2AO:[T0+]0FG:JN!YO+Q,5=!RC
IA9HL\#(+;.:(-*3[; M`[[XK%J_`!AT)M2VVVGS?`'O?,*3U,[0`!!(LJ>G6ZKWD@ZPUX!^TN@&M]LUIE\?:HO;4L3\58\@V.+A2T*`20_]SS'S:8SU M1*4094(0Z;0+BGBDE'O@#1!IYSK<9"A$'YP<52Z/!_%DWF@K?7IR;$=M-'&; MI/]W\-IL[K_O_BY#J+KX4"0(A*;@G5)&6:VP][BAI`%Z4I--M)QG=&D9@7EC MB<&S^9+U!N'/A(WKQ8[@M9FTV8VZN;Y;_$ALOT@4+OM8Q)#(:#@":TP@3M4Q MDH:BR-+R+_#W MR[V`_6<8>`:,PE M%I:#LT&3DT.RAMSM(\+/.DG/?4=4G"2;F@2BO'*">,*HDYAZSUA2LSKWC"P] MH-85,EZ>@3W1?3#YANOK^^_W6Z6YS7[4&BW])"FUQ8_JI]5F\VF9GJY&O!>B M+V5@0V(O8P8+K*P*((1F00K)D!%*^Y.S4/K9[5%^['A1<^74U0UM7A-I`F7@ M8#RCUA/-C5:ZH83Q,OL6IVFKA+/Q\7+D?7^D'\3[2WS6'0-B+99Z5",<2;?5'*=4_B06Y_>92G+^NKY>9VQ[Z; M?]]O[FJBG+S/X+P7Q$0[P7&=E]1.<&95W0A#`X?A-W1>F"4 MN>KK8EG=F&J9_G!7YZXW>6@[XT71A""YE9@3!%(AE239[BT.BG-;0TK/WO:& MNNYI/C#Z?J[N_I9H49L((9'-59O%M^76F%C_\_[J=O'UK_H:Z*O-'^%V]9^_ M5S??JDT;3&:_/E)/"$F.<>!*)N^5`5'[D#L6)@?%[S.;] MZ8RY^&U?%0DVC!JE@+!$@^2X/3&AIYE:Z!AW$S>B9&8-`\Q?[">[NUHO? M[^^VT??5YRU]D_C]\O7+U7_/FPC3XBV1!R,YUI)0$Y02P2/Z>+P8/$IH950, M9L#C)0Y[(W]!VK'9S.7*L7E31-XRZ[2DDB.NZV+Z0/9V-D&YLY^G,8VD%]#D M*I#_5-N\;CO>Q3E>O[MZXP M':&#N40KHAT[AJLKN+G97A1X=?MIF_3O_<*<,\ M(^_"+T:LD^C@9"FS3MY$\HE#1](M+G&@S_JM8_%M=5779J M$Z(6=_D>T3"+BU;[;9S:"2Q`"IZPY!J.<:MRRP#/=ZQ&N_=B6,DJEJ5C"N%O MRW5U=?M4K_R2;(/UXD5A2'8,9B!:_^H>]\WGY:V6B>K=OE8B?/0(/#LUS.T?*F4C#CBK%&!@F22 MBH=1+4XB??K&Z9[+%T]5R#[_8=2!40U)A4I#L9`:MK[4;C?*^MP^F@(3-5VQ M]5`58@X]IUO8ZF4(VG..95).2(.I3>&'?=:TFZU_DL?M5J6K[6@[G=)5QRA* MQY?VEBL)R5PS9B]B5("=.V8N8_99I:OM2#P$=-(*OS\TA)^LT7KUVQ@X!8H! M-"@N@L%"!]7LQV":V]9?.F0N9.ZJ6[(.$M??QTT_7RUNDG5Y]>?B[NKV=%G? ML>=B<-1JX9QGQM6I.J6":_;)P^E>IXFF4;N%3Y`B$95PBX((=$\%4+.=E]HMPGJD^!"X^[*NKC;WZ[_.LY#>^'6D M1(+15EJF/9,6&`X/5X8Z!?G#[TJ?_M(MBBXG[*"^_$]G5)&__G%41E$?N#9& M(G#&XO1_FATI17/;42^RAZ;AJ.?2<`A4?%I>U^BM7+7[WT_+U[&N\TJ\6[XI MTD370!W"8)C$%AQ5K*$%8BZW[Z#(Z&$^$%9#$GD8-?1RO:W"Z=$@EG9"&"C+ M@B'2(R+W.U)ZWB79O;'_Y(B6EG0?W/K96FW'3K0W?AV%K,]]'^3]_.$_NO:[:!7B5&EJC<12`>;UI+3& MV'-BE/NE9P2=2X@]B/N_^+&XJ98WFR?!TKKQ])BK?^"1")XAHPTAU@%&G''` MC0^B!,6Y#MGY;OU8-49#@:DCR@]F*GW:;.ZKFZ<%'MO+4]Z>IWC*E&KULDB8 M!C#&4Y_^8^JF::D;BFB?/?:N].#`H$96GQP9$:.[`[XKD!Y[6S16<@/**N4.S[TY%3+R3"`0C&P+&IM4)#;9S'HL!J/76:R,#@B39TO-'BXE3EPD\]4B.GJ,24\SE8Y!4LERW6G_X0IT3?W"` M;55GL]BZI^,?U=T?J[.1=N#QB#1VR&"E+68"UQD?U%2D:)D/.8P^,-$:W`S$LN`Q;(ZWKT.4H&`>.(8FF-R#U7<8&IL1)\[0MH M/[J'?1GT7K\CLB1VAKMDBP9E`+BC&.K]$Y7^D"B5YSIHR+[7.#SWD\(BP9I@PQA8@TPB9* MN&;GUN&YWG3>%1X.]_IT1?+!M,"V5'-F8LV%9X93SPG!VE!+@-:4ME(X"&ZD MRY:>7.GW:ODYEYB>>$E,!Q8'#]8:[:W%P1`E'O`6O,TNB)BZB)^+C5=VL[J_O_;N[+F-FX@_9,6]U&U+SBSKK+C;)S4/J(8 M:6QQ0W&T/.3HWR]`\J2)EZOHRK MOMUNL/GM;R\$^O&SG\XG\YOI9+8/U%^>UDFT[Y\*5'D$+63>"XY" MI:XU=;T/C'U?5VEY+U M4"'D7U^L>5'/XQ]OMGCZN-@Z*][-7WXQC:A[V/6V/AIR?L:\@?-X\2.(1^7K M,-$"(TP;7A$GW^")TAD]_XI&+R>'(B4/THI;ZCGMOPF2<.4A4U0[)Y#TUCC; MK-\@D?T^=.$X*B3T[PL@9+*]&&S:RV,\?Q4`I8X981A15"DC,/-[&CP4UUK" M*4.(/X)!%A-+`.'#=#Z]7]^W0N&;[P)"T7!""%&'O)7:$H],0P=T5]LM-$N4 M=7^,+`*(R3_=`/'RNZ".]*KJ*'3:7FIS_B(EILCPZC@Z4(`4T=8(RDM'J&)&]HQCZ[ M*\RE@V<"W'P9O'(+<`Y::/!K!J"%L1TDD#&2'2KU6`.4( MN>Z1PV6,I;5X>DEX!]/IX*A`$.`6>0(P$`A*88!0#8U*F]P'TTO7A4.B MJ#]VEX#4^Q08EE[EEG&Y^[^\NW]8U(]5MTJ$7:<(GA,`D+-<(VFP@L!PO=]0 M(+L:SZ57OA@2;`/QO@3R?+R9KJKWT\?J]ET4ZOS+--J9:KFL5DO]]&'RO_7" MI/Z"+0;_";,$(J0"#(#4QIU()`&2I.$!Y=D/99>.OW$,_^$$,S(XG]?^Z^2^ M_3)PXDQ!$NI@5`Z<608,)A8Z^+Q1^;5&*0X"E^Z0[$$46;G6Z;'XYFY>S^HO MT^JPJCW\<=#<^;@NH12A&AO'.&]<>M**[`;.KQ@OY\FR[IGC&;#X;;)*AW/4 MZ'\L)K?5_63Q]W%H'!X0$*,2(:2T)HYYS+EP^[UBN1^^#=WUPJ,WKI>I59=G M!+SO4/_W[+D#A2SYKP'"4"%F*1&J4B"C/@#\N:P^KV?OIY^/15]U&!TH@!(C[[4EA"B8C%C4T*PI MR?7?7KIB+@_"X812I%QH%<5Y,VVKA??RLX"]EP1C3`2`!B"BG7FF0I#<8NG7 MZN:#Z?$FW44Q*?Z\^IK9.,!4ZW3V.!)O)O%WY6"424CASCT>_XPGNNT MO?2ZLN,8:T.(I,0)=V2U+WO#'SGD.LX0?+QS,4^1QQ1)I9SCO+G9*^=MKC_E MT@O(CG?.#2.8(AFH=].'A\B,_YK,;^/D7[:.HOGR(:YZEV*T7!TMQ-1I@@"4 M,10;ZPW#1&GD$&G\`"J5?,Z$Y*67=!T/DH/(9=3DKZO*,%4,0TB<1D9A:X!@ M4DG/F96(*\)LOI\N/GEVF$$3='I=(EF_2<:4.$(;56.X4II\(9 MXIEO.(5D=C'H2W>$]8&=[T/'RHFAB#WU,OEUL^"G+F`\-FQ3N=H[S8!61&CB M4DN6ADH+&+Y2A]<`8.N1S66,\^5=W`SI/\GG]CB9)1U]`JJZC`\XJE?-5;0! M-UVB`446-'1+)7*K:ERZTVL(>`W`[Q(X>WY0Z(ZM@V."\H`K9+'45`&A$K%X M1Y^0EN4Z42_=H34`GOKB<9FZDY/;*H)_4T!FQXOE[]5-%;?!7[-J2\`1/'4: M'QQU5J=JB``Q#Y+_!.SI)ISE)K=>ND]K`&P-P>]29]4\"O7IM*/J1T,"Y`(X M;PA&0$)GE;/(-=11I7.3(2_=)3702=4#BT=]H.X.J*Y3!*HL@4(1%0EVI'*(5&*\7?N;/58S>K-7DEWD^]>`KHC M,&N^P!$4""?_L/?Q>B.YPG1__IOVZJIG-Q>Z&C"6X'^1F(IZ44V_S,TZRFX> MEYK\_Y$OJ2]#\QPPVXC[A-,Q>\Y`*9301%/$"!#%(:*Z:*0A!,C6T"=T(KH: M@)820IG#,]JSZ^I%$\%3#LJ6L7%3*H@8,PAII"@22/C]IO0&Y1Z*YW4>>IV@ MZYO9)9^WXZYH'D+3NV=WA'6;("2.`D4`5X(Z33PB:D^YX";7$#R]R=#KA]D@ M'"\3!;N8/D8)/E8GJ-/#@X+UW#$A@>'1QJ5*8HW0WO$(3';2W!M\+>B-RV7< M;JD*^!^3?TYQN_UX2'!$$^4\19IR0PP#ZOF*+J7+5G]O\H6@%QZ70)";+.:1 M]'VKD^Y`:AD9"$`8F!1=*[ETTG#JGYW40&17A'J#KP+]LKH$K/Y<5A\_N^5J M>C]9'6UU]NV'P3-!*?/Q$JSC6,;Q??'7>G M3A48Q\H+S)A-C5DPTU3M+4=CLBM%P3?H_1^8]X4.OOOI)H!DN?$5;TBIYOO` MY:YG7\=)`F:)AME/AD]@+I^[Y-WRZB4![/QW.Z9W5(^>EE_D"9=0P!3BU& M0%BJJ)>;EES:(2+L2/WGGKMO_4B;$Z6E$O2!$4%$*U\*++P`!#`LC!2PH8V#[-J" M%V@)]R3C?W5%Z(.O8V$F_7%1M9=I;AT;.(C;#`))/7"8.DPB.QMZ(4:C-,4< M!D=G2[P#@L[A;4:=(K.(/_PA7N)NXJGZM$SE'^(F.5YO^,`IE4#'1H2@(@D(4\@H48YC65*FMU1AR6[(L5S MKGA;T9+%T3)X63S4B[A'?JWGGZHOG?HZ'1P37/P1X^+920AU7&#ME=O11Q#0 MV<^GKP$QIXKX7YCIAZGEHAGW1ZN>S.*UL?IT5U4II^;9$?/L2UKJI_B7AWHY MF?VRJ-G.UJGG6?IF\SJWKFX_/E1;UW>;EBNS@*`%`XQ%EDMDD&/80LL: MS@.BI$R*Q)#?@H-G5K[9,X8C#4VRDRA)#;M031U3<.;^,_9 M&0T7CN=+0][W@>Q%I)EQ=]VLX+%:/$51I>3(H[?6'W\<#.;&$^D523TMN=+< MR6:1-K_BR*5#;G"9UCUSOM#=Y(=Z96DF#QM&O._0\Z7[),$+!BDT0%OA7%17 MGNF&`]09DEN?Y-+S)`:[`0_#]Q+(VU3IB89UO=US\R];(MP_*43VV(/2\8%! M600<`4!R(2TDA$O5;%>JH;W67LA#8*$>D/'E[D3OZ^721WZE^BJKIP_5ZJZ^ M?2Y#UGZE:1D?'-=2>(X=-4Q"Y8EGH*';0G&MS5L*`&X(_I=\>S+U_5_3^4:P MGU;5PPNO^9:6=_,HLTC'N[T7_??(PDFR=A-IOW1[I>KA5X+RF@A++.)&":R5 M`;#Q9U"E<.Z[Z%FWZE<+V_$$4Z2.1/TTF:7%)_:]U`9'H'IP3!"4..!QRNS$ M%(IH&6/=T!?Y_=;LP1Y1V!?/1[0%3S<"`Y1:>@D<1YH;#)@79F^$0)S]J';I M>;/C67\G^60UTI=U5A?Y]\_1#7O(B+7_Y:K3Y^3L7L%H]'\_7;!P?"O&%42H*D)QHQ M$:_46Q@SAFWV\]:E>R\*0^90J=^^Y%+&N;%;]/_4B[_?S7];U#?QSG$R%`^/ M#M0Q2I%!P"E((.!6<]S0'+5^KEZ[=,?&A6"Q-\$4!6/J1+F\JVY3G=G3P7AX M=,`4`Z0DX\XP`S%F1OB&9B_@M?:QO1`P]B:8HF","^V"NOA9<(Q92'0T'E7J MM^0PE*:A`EA:S@]11]/QS<'K=`F,9,`?K-D>*?AIT;?`Q$23"7+``$9.4.XX MM-&&DA)S[Q!R(^6UO9_,C_D!TO\.G&H`%:3"2.L@\AK0G1>66N?]3ZN\%['7 M9W.^S.-.Y%DJ*)=*Z-\_+.K'+;V_+.KE\92T(^."-)8K:I%'$&"EH?)-WD3\ M1R9RAJV=B[`^15(">A\FD9WS:O'T4O.TX>[PH!#IL`Y)A)@6UAB*9!,7 M31WP^EK;Y(T+NM[D40)Q[ZO)LKJK9R>==(<'Q3V%D##<(.9QZNI&M>`-A1JV M._5>Z7/?R(JT+WF40-Q!"[L-=<<'!@$V^8>6\<@]+`4D\=*RHQ1;E.L_./UA M\#5>\'*1UZM,2J!/W=RL[]>;RIRVBH*-_-B6+(FWPAW7U'V]6.TX>I"^(SCM MZR<"E,X`)`CR..Y]R-=FQ8H,(KJR@T M&$83!AN-%6FHA(KGQD:>7COXYZF;)9&1W&R;L/CEMTOYZ4I[`0UB#"=`...T M<=!("]&N^A=Q6/#6JK3#\.[3S5UUNYY5'S^GPIL-5?^]GLRFGY]2JYE=3][3 M2MB=,6N@\9`5G"-,D=8",(R(:_BDG:$.$:JCGB&17:OT)UTYP[54ZHYIL9[5\ M?J98>`BQ@5PAS(GG5D((&XJAY;G1M&_#09B+Q][E,I81MYCV'K]U^KS>M;H@E00?K*\V^3-;G3#S\?4X^CBT&E.B-+QNFB( MI)0`E"X'UDDMB&[M$#4,[SHK_):BH2?-$P2,EZ1XF:&&4,,!,H*+Q(O("2VA MAC^MO#Z`5)<340G=^;S^_;D4*6G"FOZ(ZV@I>--M@B"`)-Y23;Q6ACOIY28X M9D.YB<;NE8)S('@&OME>)#]X2WM<\DN#OA5BQX8%XIBT`B-BXS6;&:2I?%8/@.:"Z]+](H." MJT>&EU68Q^V)]QWJ%9T\5_#,"HHUD"DB>.\6%H[B:++]7M'W7JB)R\WJUUX++F2[V5/5;2 M6(Q3/1U&#=A?^Z2RUVI*7@Y`^Q',^("UU>UZ4XHBWT?X/$5@4@D`-="&$B81 M10KYAGJ,9*L[_^R7-KF%Y;SZDF+;WB(PLZ4Q/A;[TN$I$LQQ[5BZ[AF##"-[ M.TEBDANN=W)X_E:'N_F;Q&&>,(9_Y%T\V<4\!XCADBRF,:_]J:>3%0H.)D%M53]5C-U]7QD/WOO@P"&(6L1L!* MZ(S&DF*VH\<2BG.]FU>PNSM+^ON8PK,X7,*@W&1@_;:H/T^/(>7%5\&B:.P` M#)&'V`J'E`$[&DBTE4EKS/GKZ5=7"B7YW"V!D(C;YP+<1S#RS7_)7#B)HMY*J+P6[7X=!HX0!;#C`N4\<9V6/OVYL#TF1HC(/:TNT/+I7=)=D'0B?\?`S8[^$Y"S&Q$X M5)Y)"2-?!+:<<(9T0YOV-#?_^@+MH=+8R>-P\ZS]T$EZQ_TJIV?LG3!?$PC!(@7V!MBH>(NPS[IC)J#N7G#R:'MW/C/_T@?_S595O$O_P]02P,$%`````@`>EQY1^J4 M`@@A(```6XH!`!``'`!B9'@M,C`Q-3`Y,S`N>'-D550)``-GXU569^-55G5X M"P`!!"4.```$.0$``.Q=66_D-K9^O\#]#[Q^F0P0VU5>NNU&.@.WW M$..8DH\[T[W)#D#$HSXFBX\[C_>[9_?G5U<[?_OU?__GE__;W?WGI[MK<$&] M:(5(",X9@B'RP7<<+L'O/N+?P)S1%?B=LF_X">[NQK6`_O7,_0_<6Z(5!#`, M&9Y%(;JD;'6!YC`*PH\[$?DC@@&>8^0+*0(DF10*Y%Z'D"U0^!6N$%]##WW< M68;A^L/^_O?OW_=F_IY'5_L'D^GQY/10:"1T)/S#S']V*19@\JU0[GG&@CW* M%J+DY'!?OIY!CI+BA!(2KO5*P@"_AA6B?)D-R.U)V38`?LMY6$T0'Q#`BE:O262#K$IB12M3A(U>5*-/-4J\J_= MI-ZN?+0[/>@I1M8HVXF1U-N(&*?[D'D2;H&<%^ZBYW4`"0PI>[D4?[N)%C!6 MH/(Y(R)E/)4R3M_UD5&1)F@A([>[3/E:FQ6DA6&2&OT%,`=F%SGR-;_JBIL4 MIYLH/>0P=R..K2BI(#D?M^3)D;>WH$_['HU(R%YDB#ITB6VF>LD?NQF1KM)$ MC(G\1Y$]:B5.OF+ZUVY&IJ-`/L*M94GJR!_])4#/WM*YYZE44K\Z=38%>I@\ M(1ZV=I)K9(R2%AD+O3KP70B M_IV`77"!N1=0'C$D_LB(@)C*+_OEJF6J$4?^#?E5_2Y;(*X=%VFJ66JS[A6+ M[<)<+WZ:F+C9\G]$F"MZ3D;/E;;8^]1H[ZS^-EOZS/?5#QA-C"\:2'5#\`)T#S1%`XH,<3Q`S'9$OXG-. M5VM(7O@-\S&![.5^"86J5$8"4`M8VI+VG;TCUJA'_/\"P<)5Z#9`LTWP9^/ M#I"`1#CV$5,"/C!(^!R)4?D&P&^F:P?^L"7P.7X@QW!$7-KK/EJM1&.XF=\R M*A>+X!WB41#R3C#;B-FQ?6?!-N8@@14\@&("8BXCH-)(#W`6N`TR*G4:X3F4 M0ZEI(SP_:3I;9_Y/B`B"X6T`708:A=*6@<:)8:`1UP>*P#:;NM=(PY60)62= M&+JC`D#C4*,)0CTS<47B9S>S`"^4A,F+7.(@*^@4H`NUYX%:`@OR"TBWG-1EC;/:DRQ=7@2<6P$DL%8K&2"),(!I1D0(D&#H$6+O6NTUEGSG8G:TX_FYSL<>]^3\VV]?*V;7:RS\]KY(7(3YY!%>\[ M>4TS*7M^Y.O#/++6.?:>9YG MH6<9$U<7!WB\?Q7L#63M3?RT!^PJUH^8%S'_BL*D,R;^3;A$:NC`4(BUY<[% M7UU`;T'7CKHUB136Y!-?`14FDCU_450QW+^LJ)87VE",^XP"*"GL@OER+FG#TA!A=(;=]8)]$. ML97@2Q:Y*-FEH77D88^SE>7-=C]Y_SI^DLBQO0X3<4P0YW=(I*^1%T9,;[)E3OMR&VLWK^2*?PPKN3$] M4"`(8HHC-IEUG7>CN!!I;G[3J6E0U(C4]FX\:3*W$O1T[-+!0(CL"DINBUSZ4C M74N*J%=X+ MN^EYNUV0IP5B8D!3&Q&)S7H+F=!LB4(L1.T!3Y&.#:MCU<00+R\#^KUEJS*3L"!V9&E=&5&U+UV0!8KNB%5L:+H2RBWE@/4)71$! M#.J!FH&8!;^#=OCE&0#-8412&[\O>&YX35OA-2)4M7"/CLU&S(:=I7Q[;$+.#6EF&24#-3B$F/.(5$#R M%M*9\VXG&P$[O8L.RES;REBUL7B.$G(8:< M\)&+?LFJQ]^1O\!D<>:)5SAT6NIR)V49:AT:AUH)<9"CKG*'F#[(&(P@UEB^ MY\!M`UPL,?+0&"-;0#\.`SL[Q^?Y''DAOR&UBS$;]Q1GEG:W,4P*M'.;6!8@ M7*5QT6ATHV9,W3OM=@0M/?NAL6=OXP)C"F`!XI'XB.,%D4RM&N"+[U.[F4OKJ5U.,#05+L)D4FZ12+] MY%CNITP=-+U\^-LV:#Y#)H_)\%O$U'6P=C@J-9JSA,F1(4M(:``1E_0UM-MN M]UX90QMBS7W,Y,C0QU31&K,'&YZN?4Q-O>:.9G)DZ&@,*&UK?U,V:NFXHMRH M3XF^_?I1,+DBIL+'$2B5IE:UU;Y*E+8FW-E%&!LSI7S ME%J\Y(YP*:"\X2HOHLPRE9"J*XW%S*C?9FZXI3'A$A-(/"RC<'Z>Q'AGC=V= M6E&SC-Q-?7)*OS+!4G/OS0AG/0"]NO--,;(,)TU=?6LG&#.!/FZ2/I3WE1GJ MO8;'./*T.T^E8^GB/-D;?7V:D<3H2G9871/.#C0MLQZF9+2]*VQKKJJW]C_` M9Q?P\H4M7?P[0Q^01T6.&6`EE1C,(/F5LT">G(Q"REY$H3L8 MH@>:?&Y/;PK#3RA^T\%)-L73[C:5HS@%P?]&OBC7]J,J?1G8_:1RT*?D)[G3 M"(HQB#FK6ZMSO)4S;/V75')XN0ZHJU4LX^5WAO%RL;O?VJ%P",D""]WU)>HN MMB_5L`R*3=\)SVC$=[=ON]E[#H_=B5F"VX%Q7%0":QPHV^`LCE^+[[JBZD#3 M#JXA,:Z"6Q[YEDN,*&M#E!/3WRCUO^,@^/227`1YCQ9RIK4KY&T9V/$W3(!5 M\:^FN0EC,'O)+KF,>8_N$*/EGKP8ZUDRF`-C!E-IFEN:QMQ#_<I4VQ"R1 M\KVAIW0&<7MO57%!0);AMD+N=V]OGJ7=-2H9LKMK*%&#J0MAE0BZ MCK_U660\FH(A=,`Z5[@Y)YR8]H4DHR=9?XOMW&OBRY%.F-8+\^B,TUT- M^.6VMJ5VN:0L68J+2SI/>G6F;,>XVLD6,PG1$WAF?MI^\ MZLW![@F52;`^GK#UG[?*`7:'GA")1'Y,'PF$/GRNV6,KA$+7^07P]2ATS\BO&XS=?I#I+"[5F5EN.1:B6QR=T!> M.I"*I_(V=>M@("5,4K)41I`(^;/ZO%I\IC81=/3"$#HGZY4JS6GWQ+2(7,!W M:_-F>>3LDQQ!R`")"'<\95Y3SY)-&V=8):5=10KD:8U(2-+]DNS6)"UATCCA M48/?F'L[(IQ]B5-D2)]YB%?);KGV[N3!U#Y;TST(\B_ M4%^KNT-KRD+U*5&&J>^>N;^-7'9?JV9[#;Z6^Z"IS/ZFQ%,=W2*IJ0Z`^+I0NJ3F]A37XD1[?)12,)OHI"'(C\6 MYNWG-SVYVGVHLO.XP8=RNTMSXL1E,X'B^*1$`CF91H?:"+2MYS5>D[O=P4Y^ MH(.-4R+-6-]#]@JAR4S5[AG5*0LGS[@_NQO#B@O8LI'8I4I!=+9S*;: MEDE-XUZ".FBW>H)S20,?,2[GVL,71U"*=2P3FZ;/=N2I_`5H.J/USSPO6DG1 M!,EPB=228/I=W&O*N3[;U2J8]F!@B9ZFN]5-N,H)J(PO4(Q+G_S]2?+^:_IM MTFV.ED6\>L]P.Y.S@VW.J`U@CS/;S:B>+R%9(-'6SA$3)B'Y(U#5TMWA[L3' M[@?FB<&J'\3LU5V/6H#2$2QCO=%-^L#GFE5M@)'=4$'P''MRHXWGR=L1Y-(>#;#G]*D\1SJ6A'MJ2KAS MLQP9;9`1!PGU$3N3S?ME8KU96(+MU-0K.R,^YFS=?&+3[=JM?1],I@>&<.R. M]D_)KRV$=;T.U"6A,##MPG4!TD*A.31/3XRA.:-IWJ0[XE2T MGAC#L`W=,?RVQ?^*/(EWE&'W2Q?;D[1C79W]'M'09;C,Z@CW)' MM\^"@'Z7FW#D+MH+&LW">13$*:L\T'(.^5)]?#!JLT7R!PAA#PS5N2^7P*!D MRQ]N_QEDXJFMNXF`26:O#]9(&4$JY!@\0C$4DD=7'@F,1&:%_%9N4ZYKR>E/ MFW-Z,2C3IVA2@B,NJ2G<9ZVM)"QM\K0Y-S>@M,4SS+7&[M#]FBE8.M[3YH[7 MB-9_?Z?[R_XS]S_`]1J+7D,]BY\00K4*^J%\AK2I`)SQD$$O_+@3L@CM*'QG M_O._SCR1<'(EAMJKC_PO:#5#;`<0N$(?=QK>XR"0IDXH\FBFODHKB_[&:+3^ MN/,\8P'^('!9[8!0R/]QAU!"HM4'GZX@)E?BA51K!^B":W5^Y$$5]",6S\7L M5Y5)A5_)DR?_CL_<7,0WW<>G4%,-+(6ZJ*&?K"A!T@G+>LQ@('OJCSN>8(3# MC:A'YS!#PA]Z"TGE<]MB%10C,+.O#""3*1I,5 MC2M@--L6$[E3,6PT;7(_IM!L)K)7-5.F74)]UT1^?U)MVLUV/28&ZU2SNQFX M^LQD4XCIJ*Y,LL^I0-2//YT@LG7"=53)OGE9(&6=(8;9PS*Z17P*R+BI8BC5YQ'HD-G\O]2AZ^1[#MOYO?( MBY@(O$A>HA8@_]/+9^@M;:ZS"=H#;%")0OD+Q>3AP28?:JKS%J&SJ[OD^@]? M%,5S#+.+SN.N5E[I(1[C0(&J#O%F%W[H`Y:BQ2SQNLE@&V?T)^J@.NM^(9+$ M@*[%:`5Y2T(#NGAY#1.;V6R#@562E'O\&M8U\'B3'N5'VU9-(JX@^_8J5BU0 M_R]S56A26.3H_'A#D'R MM^QR]5\I>:)A[=ON"B52]9Z\*\A6BG47HIEZ89K9ZS)J8O?`C%0-*K8 MB4R/>0 M>E;`ZW*H/K=6K]7)]CP>16]"F?5^N` MJKN.XB\AWLP"O-"]*@V"2\KD-%?1(FVK]IC3">457IMOZ72U0DQN;+B%@M@M MHR*16)7:>W.9`;1Z.2(04A)/#0HU%AXP M1<#)#D1<%IH&UTZ;YD!FPAAL20QS`1)]PVT[^YT-!ZYOKH MS%`JNQ@`E^-RS=L!)I0,<_Q%X"ZRH_L7+LC+BPM*ZC27&4`W$S$F_I;9'<_? M1J+'+I1QO6-!=)/"%U*M6E9ZJU6?.N0NT$R\%D&!7T3H8'+PO@A:_>OA.6%9 MUI-F54X&H$I.=#%<%FI%*Q74GY`8*(?2GP(LX\X73/`J6B5K;9^?I9\A68[! M!;J3#')J;H!4=S==1\U+WH[V$+T(Y.B*U'U"/4(/]!Z%H:ZH+MN':X[D3650 MR"E^7.,5UGNP>&:;39,=W%`HLZ!>RA?*Y698U5?B,VLT%1ELAG`A=^LA/X9, MAM7[-0V%XZ)'>3%5L@F0+.X1>$>@GH"53J[G%K,+C)(MF?+JCF;O`KQ'IM( M/$'N%6)E)74J1\OZ`@,,_=+:(H*]7,.9&..ADBYU;X>HB)!3Y_!E':HO!B@^ M]52W(T]OB2&*W"*3'>.,ZZ0:N94=W)3*!5V)UHX]V=&6,#*]&4!R$84OMSJ. MZ!X^BW:F-Z\8JES">S*8YVJ>!L\TXPBJJ^[E'JKXVT@/]!(_R\V>3/MDP!6S$L*N22T97\S)%<;I/7[U,6YM?E.M0;;&:4TZ7F2Q<&K>M+#BZW MK8O(E_+T!E(+Y?%1#J2^NE7>0W`M4CLI4F:&#A4'UQ^Y*O&@OTW?3O.DDIO6 M?OAA^2+[@6BF[+51_8OZ*FF-.R)S\X1N18<6R.N!%AV3Z)\"JD8@Q=RC[N7P M0SKPI13R>$I^!LB<@G]$Z9<3W,6M:I_/3Q5TL,QE=!I?#.XV)A* M60A^E:<#BFY"-C5%E4Q585(=B>>VY[H7'UQOGFGLHY6^'ZNPT>`K)9Z>7,^4 M=2@YN.RLWC>Y,(\@G"Q(9_NE2A'#J>3;CS/S$V%RM!3IR46YQ\NX7ZQ%^4%N M#+O&?`D]U7:^P&>Y')#==W4KPIB'US#0 M^Y]D[XNUJV7:]24SN#::6HARGBZN>R]GXM=%M%JKA`K*I7.NOZR7FL*]_`#V M>9:DS69^;N;I/J\K9U/O"5AHA/]XZ.)WZ$OL"7Z?'!9%I:Q[>4&=[((Q;X9"(%%MFMDK1! ML\:"`U7O8._=^^.RU*<&]2P%!ZK>X=[A1+L;\Y;3@\G!H4&UAD+#5>O]T441 MC(,CLVI-!0>KWHGRM3A(U&A65V:@2AWMO3LYSD-Q=#`Y,FEF*3A8]00>%RD> M-9K5E1FH4N]$\Y$"GT4+N:VW)C0VE1JH8FK[V?2=09GRFT$K<%*KP!!VUCDH M8'*G\ILA*W`PJ5,@]V;0"DQK%9C^I[SKZ7(3A^$?:0_M<2^9-J\[^V8[>3.9 MSID!)Z&EN&M@FGS[M?P'#-A@$L"&/>8A8DD6MBQ+/RU"@`]&$_JP#!/Z:#2A MCTLPH;^+M&,I;3WUX!PLD('D;:0H/V3Y%GN4BKC*(_D'$Q9:J<'G7?OR]2?9 M&`K/$1E-[.V_!2#_9GF0)"P6>)^^GN+P)#-1=W!R!VQ`GI0`U5J?XXRGZZ@7 M."/^GSOEF(R;Q2F4)*2Z<1N?^O>5"AP'X%)DF6M$T3_W5)@'`;_83OTS/_94 ME!V$P'`*N6S&>R<;0D_%RS[!TD@N&H%:C]QO"PK2(J]K?$DC1*I%2TUDM*3U MK%^SG:!2PZG.VQ`*^1F"4,Y0]%=R2.CJA$N*BD&OJ: M?X'G4@7"PSCPW#"9[@P65UX.]M"XOA,JV0.&.(O4>T+Q,=5+821SG"5=OX&C M%O5,-]"(57%!,O-?B!J5R)1JR&3YBB<3Q;C=!^2(35KR1O2J MURG@]K_T1T'XL,?4`U8VAL;E.SYD17AZ1M#A"!^V9^H"4R)V3&KKYL9_<_]= MP`4NM6DVIW=\Y>L]4`Q_S8/K?,WI!E:G+U#2D,DCT$N:Q\GFD$/F:TZWGY_L MB$@].9P4#+=?@\8UQ1\[_UQT,"[EO?$7ZB&HD.+6U-YFU>DEJ`'P]PNL(U^R MQ'0EPT14;O+\)361X)8_6)969+GS+HBC3ND;A!Z[ICKNU03#3C$;A,N:3&F. M?4+6Z;R6$35YY]"@')"^48C=0N32E76/_:>NO1RM./HL6TM:IQFVI5R$6M;Y MTPF<1T4]=SR(,49;!EHN_HS"O#BB5Q+;DSGU/@B%']@F% M00*-#$D1)(H4NF?>39(QKB?X9T6CC8">]I'[2)X`IN8>75D)NXF^%SRXO<>R M(_!ET^C:=-VK_KI-3P@T"AT[@NP$34W>@T1-]>]XOI2JR2?T*PE"1L/[V-2- MU/S8OYL-741*B5KMLJ(IFS6]#U\E8%:%D(>?'@%ZF+PC`0C?@JNUI/7ONS/. M;!Z;<0!-#]W/V7-X0E&1H,<#-,4-Q2%9B90K1>1Z[_2F?_#"9ZTDD#<[2J/& MNXOR0P%=,#7>LM+49.-XID]VO*5+S+!-Y!D@ZE9)'[$?DFEG;4,(\,P.NI>*1-S!LEF3G=LD0&+&<@+V M5%;1[^XK9ED.*.))1A(09X_!'$I=.1O>.=#.#**_(C@RH&C#,2G9O.>U\"=GY*JC&$XY'@HY4Z'L`TJ+[2\@DOWD6AH_GVQ%D,I4W MS*XZE0D\@")(5$PKA^-[<"TZCO0-D;=G@*#)T(ZZ`B.;>L](RUU`#,AB[!F( M#JD%M6KZ649:LH4:Y!0F`V)QKV$JA>H&=5_JB22G%I%. MNRSH!EJN6VTKY,C>VM7#>GOA-K8J2@C5J>U9-]#J[)DGGTVMRM8H*]>CBQUN M$`>K\WZ54]4\*W+7@*L[0/?K8%H'63?0VAQD-FKCT(G'6*$6>1@,VH#4@N%M%($F#SR,RL4B@P^= M&FB%"IW,PU`NUCN,3GT$#=;KZ]ZWFT/C0?IM_K4Q;*=[1,*$@F$ M+;^IWM9@8_^I?TG8-?6]=7PS;Y>*I#]?+*_RQ=0D>P8Q(>V3755#S M"-V^'IIM2%\]NL-*'^W1[YI6VTC%L;3E2E`'TSJ_9H?Y_ M1W"(4$19_8I^MX#<.BE\#:Y0I@]%`NVHZ'(7Y]QS@V6]R.FJ@`\YM$-7)+0B M]F"?>\7D!S6B$)7=AU@3,2F)^;&WV4<&ELM35:L&X/_\`H;/P1-FC M/_\#4$L!`AX#%`````@`>EQY1]$@CY%V/0,`BLA#`!``&````````0```*2! M`````&)D>"TR,#$U,#DS,"YX;6Q55`4``V?C559U>`L``00E#@``!#D!``!0 M2P$"'@,4````"`!Z7'E'*V/!ITXU``"D/P(`%``8```````!````I('`/0,` M8F1X+3(P,34P.3,P7V-A;"YX;6Q55`4``V?C559U>`L``00E#@``!#D!``!0 M2P$"'@,4````"`!Z7'E''$[>7IVH``!(A0@`%``8```````!````I(%<`L``00E#@``!#D!``!0 M2P$"'@,4````"`!Z7'E'&_6%&_9]`0"S[1,`%``8```````!````I(%''`0` M8F1X+3(P,34P.3,P7VQA8BYX;6Q55`4``V?C559U>`L``00E#@``!#D!``!0 M2P$"'@,4````"`!Z7'E'B2%F.A/Y``#,%0T`%``8```````!````I(&+F@4` M8F1X+3(P,34P.3,P7W!R92YX;6Q55`4``V?C559U>`L``00E#@``!#D!``!0 M2P$"'@,4````"`!Z7'E'ZI0"""$@``!;B@$`$``8```````!````I('LDP8` M8F1X+3(P,34P.3,P+GAS9%54!0`#9^-55G5X"P`!!"4.```$.0$``%!+!08` 1````!@`&`!0"``!7M`8````` ` end XML 55 R56.htm IDEA: XBRL DOCUMENT v3.3.0.814

Share-Based Compensation - Compensation Cost Relating to Share-Based Payments (Detail) - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Compensation cost relating to share-based payments $ 166 $ 113 $ 100

Cost of products sold

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Compensation cost relating to share-based payments 23 23 20

Selling and administrative expense

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Compensation cost relating to share-based payments 82 74 66

Research and development expense

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Compensation cost relating to share-based payments 17 16 14

Acquisition-Related [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Compensation cost relating to share-based payments $ 44 $ 0 $ 0

X

- Definition
Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 14.F)

-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

-Section F

+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=bdx_AcquisitionRelatedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 56 R44.htm IDEA: XBRL DOCUMENT v3.3.0.814

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Summary of Significant Accounting Policies [Line Items]

Depreciation and amortization expense $ 417 $ 369 $ 338

Useful life capitalized computer software maximum 10 years

Amortization expense of capitalized software $ 65 41 38

Shipping expense $ 351 $ 299 $ 285

Minimum

Summary of Significant Accounting Policies [Line Items]

Maturity period of short-term investments at the time of purchase 3 months

Minimum | Core and Developed Technology

Summary of Significant Accounting Policies [Line Items]

Finite-lived intangible assets, useful life 15 years

Minimum | Patents, Trademarks, and Other

Summary of Significant Accounting Policies [Line Items]

Finite-lived intangible assets, useful life 1 year

Minimum | Buildings

Summary of Significant Accounting Policies [Line Items]

Property, plant and equipment, useful life 20 years

Minimum | Machinery and Equipment

Summary of Significant Accounting Policies [Line Items]

Property, plant and equipment, useful life 4 years

Minimum | Leasehold Improvements

Summary of Significant Accounting Policies [Line Items]

Property, plant and equipment, useful life 1 year

Maximum

Summary of Significant Accounting Policies [Line Items]

Maturity period of short-term investments at the time of purchase 1 year

Maximum | Core and Developed Technology

Summary of Significant Accounting Policies [Line Items]

Finite-lived intangible assets, useful life 20 years

Maximum | Patents, Trademarks, and Other

Summary of Significant Accounting Policies [Line Items]

Finite-lived intangible assets, useful life 40 years

Maximum | Buildings

Summary of Significant Accounting Policies [Line Items]

Property, plant and equipment, useful life 45 years

Maximum | Machinery and Equipment

Summary of Significant Accounting Policies [Line Items]

Property, plant and equipment, useful life 13 years

Maximum | Leasehold Improvements

Summary of Significant Accounting Policies [Line Items]

Property, plant and equipment, useful life 12 years

X

- Definition
The maturity period of time deposits classified as short-term investments in the consolidated balance sheet.
+ References
No definition available.
+ Details

Name: bdx_MaturityPeriodOfShortTermInvestment

Namespace Prefix: bdx_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The useful life assigned, for purposes of amortization, to capitalized computer software expenditures.
+ References
No definition available.
+ Details

Name: bdx_UsefulLifeCapitalizedComputerSoftware

Namespace Prefix: bdx_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
For each income statement presented, the amount charged to expense for amortization of capitalized computer software costs.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

+ Details

Name: us-gaap_CapitalizedComputerSoftwareAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.
+ References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Cost incurred during the reporting period in transporting goods and services to customers. Includes freight-out costs.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 45

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51667946&loc=d3e61069-111654

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Handling Costs

-URI http://asc.fasb.org/extlink&oid=51575068

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 45

-Section 45

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=51671805&loc=d3e60635-111653

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 45

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6408413&loc=d3e221937-122793

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Shipping Costs

-URI http://asc.fasb.org/extlink&oid=51575562

+ Details

Name: us-gaap_ShippingHandlingAndTransportationCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bdx_CoreTechnologiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bdx_PatentsAndTrademarksMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdsAndLeaseholdImprovementsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 57 R30.htm IDEA: XBRL DOCUMENT v3.3.0.814

Segment Data (Tables)
12 Months Ended

Sep. 30, 2015

Segment Reporting [Abstract]

Financial Information for Company's Segments
Distribution of products is primarily through independent distribution channels, and directly to end-users by BD and independent sales representatives. No customer accounted for 10% or more of revenues in any of the three years presented.
(Millions of dollars)
2015

2014

2013

Revenues (A)

Medical
$
6,460

(B)

$
4,573



$
4,306

Life Sciences
3,822



3,872



3,748

Total Revenues
$
10,282

$
8,446



$
8,054

Segment Operating Income

Medical
$
1,530

(C)

$
1,291

(D)

$
1,233

Life Sciences
839

861

(E)

907

Total Segment Operating Income
2,368



2,152



2,140

Unallocated Items (F)
(1,629
)
(G)

(630
)
(H)

(976
)
(I)
Income From Continuing Operations Before Income Taxes
$
739



$
1,522



$
1,165

Segment Assets

Medical
$
20,055



$
4,668



$
4,582

Life Sciences
3,932



3,783



3,776

Total Segment Assets
23,987



8,451



8,357

Corporate and All Other (J)
2,833



3,997



3,792

Total Assets
$
26,820



$
12,447



$
12,149

Capital Expenditures

Medical
$
414



$
420



$
354

Life Sciences
168



155



158

Corporate and All Other
14



16



9

Total Capital Expenditures
$
596



$
592



$
522

Depreciation and Amortization

Medical
$
619



$
293



$
259

Life Sciences
256



251



267

Corporate and All Other
17



18



19

Total Depreciation and Amortization
$
891



$
562



$
546

(A)
Intersegment revenues are not material.
(B)
Includes $20 million in amortization of the acquisition-date write-down of CareFusion’s deferred revenue balance that was recorded to reflect a fair value measurement as of the acquisition date.
(C)
Includes an increase of $284 million in non-cash amortization expense relating to the identifiable intangible assets acquired in the CareFusion transaction as well as depreciation expense relating to the fixed assets acquired in the transaction. Additional disclosures regarding the assets acquired in this acquisition are provided in Note 9. Also includes a $5 million adjustment to decrease the liability for employee termination costs recorded relative to certain workforce reduction actions taken in the fourth quarter of fiscal year 2014. Additional disclosures regarding these actions are provided in Note 8.
(D)
Includes $21 million of the charge associated with workforce reduction actions noted above. Also, includes a $6 million charge associated with the decision to terminate a research and development program; the charge relates to program asset write-offs and obligations. Additionally includes $4 million of acquisition-related transaction costs recorded in Selling and administrative expense.
(E)
Includes a $20 million charge primarily resulting from the discontinuance of an instrument product development program. The charge is largely attributable to capitalized product software, but also includes a lesser amount attributable to fixed assets. Also, includes an $11 million charge that resulted from the early termination of a European distributor agreement and $10 million of the charge associated with the workforce reduction actions noted above. Additionally includes a $5 million charge due to an adjustment to the carrying amount of an asset that is being held for sale and $1 million of acquisition-related transaction costs recorded in Selling and administrative expense.
(F)
Includes primarily interest, net; foreign exchange; corporate expenses; and share-based compensation expense.
(G)
Includes financing, transaction, integration and restructuring costs associated with the CareFusion acquisition. Also includes $293 million in recognition of the fair value step-up adjustment recorded relative to CareFusion’s inventory on the acquisition date as well as $16 million of favorable amortization relating to the acquisition-date fair value step-up recorded on CareFusion’s long-term debt. Additional disclosures regarding this acquisition are provided in Note 9. Also includes a $12 million charge for RTI’s attorneys’ fees associated with the unfavorable verdict returned in the antitrust and false advertising lawsuit RTI filed against BD. For further discussion, refer to Note 5. Additionally includes an acquisition-date accounting gain of $9 million on the previously held investment in CRISI Medical Systems, Inc. (“CRISI”), which the Company fully acquired during the second quarter of 2015.
(H)
Includes an $8 million gain resulting from the Company’s receipt of cash proceeds from the sale of a company in which it held a small equity ownership interest. Also includes $5 million of the charge associated with the workforce reductions noted above.
(I)
Includes the $341 million charge associated with the unfavorable verdict returned in the antitrust and false advertising lawsuit filed against the Company by RTI as well as a $22 million charge associated with a litigation settlement related to indirect purchaser antitrust class action cases. Additional disclosures regarding legal matters are provided in Note 5.
(J)
Includes cash and investments and corporate assets.

Revenues to Unaffiliated Customers and Long-lived Assets Including Property, Plant and Equipment
Revenues to unaffiliated customers are based upon the source of the product shipment. Long-lived assets, which include net property, plant and equipment, are based upon physical location.
(Millions of dollars)
2015

2014

2013
Revenues

United States
$
5,069

$
3,417

$
3,353

Europe
2,434

2,383

2,189

Greater Asia
1,545

1,437

1,344

Other
1,234

1,210

1,168

$
10,282

$
8,446

$
8,054

Long-Lived Assets

United States
$
15,513

$
3,126

$
3,251

Europe
3,876

1,790

1,649

Greater Asia
569

555

519

Other
484

505

505

Corporate
332

340

350

$
20,774

$
6,317

$
6,276

X

- Definition
Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9038-108599

+ Details

Name: us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8813-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 21

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 22

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8736-108599

+ Details

Name: us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 58 R31.htm IDEA: XBRL DOCUMENT v3.3.0.814

Share-Based Compensation (Tables)
12 Months Ended

Sep. 30, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Compensation Cost Relating to Share-Based Payments
The amounts and location of compensation cost relating to share-based payments included in consolidated statements of income is as follows:
(Millions of dollars)
2015

2014

2013
Cost of products sold
$
23

$
23

$
20

Selling and administrative expense
82

74

66

Research and development expense
17

16

14

Acquisition-related costs
44

—

—

$
166

$
113

$
100

Assumptions for Estimation of Fair Values of Stock Appreciation Rights Granted During Reporting Periods
The fair value was estimated on the date of grant using a lattice-based binomial option valuation model that uses the following weighted-average assumptions:

2015

2014

2013
Risk-free interest rate
2.20%

2.31%

1.33%
Expected volatility
19.0%

19.0%

21.0%
Expected dividend yield
1.78%

2.00%

2.60%
Expected life
7.6 years

7.8 years

8.0 years
Fair value derived
$24.82

$19.90

$12.08

Summary of SARs Outstanding
A summary of SARs outstanding as of September 30, 2015 and changes during the year then ended is as follows:

SARs (in
thousands)

Weighted
Average
Exercise Price

Weighted
Average
Remaining
Contractual Term
(Years)

Aggregate
Intrinsic
Value
(Millions
of dollars)
Balance at October 1
7,852

$
78.49

Granted
1,037

134.73

Exercised
(1,458
)

72.88

Forfeited, canceled or expired
(167
)

103.50

Balance at September 30
7,264

$
87.07

5.96

$
333

Vested and expected to vest at September 30
7,010

$
86.34

5.88

$
327

Exercisable at September 30
4,725

$
76.18

4.81

$
267

Summary of Stock Options Outstanding
A summary of stock options outstanding as of September 30, 2015 and changes during the year then ended is as follows:

Stock
Options (in
thousands)

Weighted
Average
Exercise Price

Weighted Average
Remaining
Contractual Term
(Years)

Aggregate
Intrinsic
Value
(Millions
of dollars)
Balance at October 1
74

$
54.57

Acquisition-related conversions (A)
1,971

82.32

Exercised
(900
)

83.70

Forfeited, canceled or expired
(7
)

73.41

Balance at September 30
1,139

$
79.47

4.31

$
61

Vested at September 30
1,111

$
79.10

4.29

$
60

Exercisable at September 30
865

$
74.82

3.99

$
50

(A)
Represents options granted upon the conversion of pre-acquisition equity awards of CareFusion, as previously discussed.

Summary of Performance-Based Restricted Stock Units Outstanding
A summary of performance-based restricted stock units outstanding as of September 30, 2015 and changes during the year then ended is as follows:

Stock Units (in
thousands)

Weighted
Average Grant
Date Fair Value
Balance at October 1
1,255

$
83.47

Granted
352

148.04

Distributed
(139
)

72.12

Forfeited or canceled
(330
)

79.12

Balance at September 30(A)
1,139

$
106.07

Expected to vest at September 30(B)
542

$
97.09

(A)
Based on 200% of target payout.
(B)
Net of expected forfeited units and units in excess of the expected performance payout of 68 thousand and 528 thousand shares, respectively.

Summary of Time-Vested Restricted Stock Units Outstanding
A summary of time-vested restricted stock units outstanding as of September 30, 2015 and changes during the year then ended is as follows:

Stock Units (in
thousands)

Weighted
Average Grant
Date Fair Value
Balance at October 1
3,015

$
80.03

Granted (A)
1,946

136.30

Distributed
(1,128
)

99.07

Forfeited or canceled
(766
)

107.50

Balance at September 30
3,067

$
101.88

Expected to vest at September 30
2,878

$
100.65

(A)
Includes approximately 1 million units granted upon the conversion of pre-acquisition equity awards of CareFusion, as previously discussed.

X

- Definition
Tabular disclosure of the number and weighted-average grant date fair value for time-vested restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.
+ References
No definition available.
+ Details

Name: bdx_ScheduleOfShareBasedCompensationTimeVestedRestrictedStockUnitsAwardActivityTableTableTextBlock

Namespace Prefix: bdx_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the amount of total share-based compensation cost, including the amounts attributable to each share-based compensation plan and any related tax benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 59 R8.htm IDEA: XBRL DOCUMENT v3.3.0.814

Summary of Significant Accounting Policies
12 Months Ended

Sep. 30, 2015

Accounting Policies [Abstract]

Summary of Significant Accounting Policies
Summary of Significant Accounting Policies
Basis of Presentation
The accompanying Consolidated Financial Statements and Notes to Consolidated Financial Statements of Becton, Dickinson and Company (the “Company”) have been prepared in accordance with U.S. generally accepted accounting principles. Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes. Percentages and earnings per share amounts presented are calculated from the underlying amounts. Our fiscal year ends on September 30.
Principles of Consolidation
The consolidated financial statements include the Company’s accounts and those of its majority-owned subsidiaries after the elimination of intercompany transactions. The Company has no material interests in variable interest entities.
Cash Equivalents
Cash equivalents consist of all highly liquid investments with a maturity of three months or less at time of purchase.
Short-Term Investments
Short-term investments consist of time deposits with maturities greater than three months and less than one year when purchased.
Trade and Financing Receivables
The Company grants credit to customers in the normal course of business and the resulting trade receivables are stated at their net realizable value. The Company's portfolio of financing receivables arises from the leasing of dispensing equipment. The allowance for doubtful accounts represents the Company’s estimate of probable credit losses relating to trade receivables and is determined based on historical experience and other specific account data. Allowances for credit losses relating to financing receivables are also based on historical experience loss rates and the potential impact of anticipated changes in business practices, market dynamics, and economic conditions. Amounts are written off against the allowances for doubtful accounts or credit losses when the Company determines that a customer account is uncollectible.
Inventories
Inventories are stated at the lower of first-in, first-out cost or market.
Property, Plant and Equipment
Property, plant and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization are principally provided on the straight-line basis over estimated useful lives, which range from 20 to 45 years for buildings, four to 13 years for machinery and equipment and one to 12 years for leasehold improvements. Depreciation and amortization expense was $417 million, $369 million and $338 million in fiscal years 2015, 2014 and 2013, respectively.
Goodwill and Other Intangible Assets
The Company’s unamortized intangible assets include goodwill and in-process research and development assets which arise from acquisitions. The Company currently reviews all indefinite-lived assets, including goodwill, for impairment using quantitative models. Goodwill is reviewed at least annually for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. The Company’s reporting units generally represent one level below reporting segments, and components within an operating segment that have similar economic characteristics are aggregated. Potential impairment of goodwill is identified by comparing the fair value of a reporting unit, estimated using an income approach, with its carrying value. The annual impairment review performed on July 1, 2015 indicated that all identified reporting units’ fair values exceeded their respective carrying values.
The review for impairment of in-process research and development assets is performed by comparing the fair value of the technology or project assets, estimated using an income approach, with their carrying value. In-process research and development assets are considered indefinite-lived assets and are reviewed at least annually for impairment until projects are completed or abandoned. Certain trademarks that are considered to generate cash flows indefinitely are also considered to be indefinite-lived intangible assets and these assets are also reviewed at least annually for impairment.
Amortized intangible assets include developed technology assets which arise from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date or acquired in-process research and development assets that are completed subsequent to acquisition. Developed technology assets are generally amortized over periods ranging from 15 to 20 years, using the straight-line method. Other intangibles with finite useful lives, which include patents, are amortized over periods principally ranging from one to 40 years, using the straight-line method. Finite-lived intangible assets, including developed technology assets, are periodically reviewed when impairment indicators are present to assess recoverability from future operations using undiscounted cash flows. The carrying values of these finite-lived assets are compared to the undiscounted cash flows they are expected to generate and an impairment loss is recognized in operating results to the extent any finite-lived intangible asset’s carrying value exceeds its calculated fair value.
Capitalized Software
Capitalized software, including costs for software developed or obtained for internal use, is stated at cost, less accumulated amortization. Amortization expense is principally provided on the straight-line basis over estimated useful lives, which do not exceed 10 years. The current balance largely includes capital software investments related to a global enterprise resource planning initiative to upgrade the Company’s business information systems. Amortization expense related to capitalized software was $65 million, $41 million and $38 million for 2015, 2014 and 2013, respectively.
Foreign Currency Translation
Generally, foreign subsidiaries’ functional currency is the local currency of operations and the net assets of foreign operations are translated into U.S. dollars using current exchange rates. The U.S. dollar results that arise from such translation, as well as exchange gains and losses on intercompany balances of a long-term investment nature, are included in the foreign currency translation adjustments in Accumulated other comprehensive income (loss).
Revenue Recognition
Revenue from product sales is typically recognized when all of the following criteria have been met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; product price is fixed or determinable; collection of the resulting receivable is reasonably assured. Certain sales arrangements contain multiple deliverables, including equipment and service deliverables, which requires the Company to determine the separate units of account. If the deliverable meets the criteria of a separate unit of accounting, the arrangement consideration is allocated to each element based upon its relative selling price. In determining the best evidence of selling price of a unit of account the Company utilizes vendor-specific objective evidence (“VSOE”), which is the price the Company charges when the deliverable is sold separately. When VSOE is not available, management uses relevant third-party evidence (“TPE”) of selling price, if available. When neither VSOE nor TPE of selling price exists, management uses its best estimate of selling price.
Revenue allocated to equipment deliverables is recognized upon customer acceptance, which occurs after the transfer of title and risk of loss to the customer and the completion of installation or training services. When related training services are considered inconsequential, delivery is deemed to occur upon the transfer of title and risk of loss, at which time revenue and the costs associated with installation and training are recognized.
For equipment lease revenue, transactions are evaluated and classified as either operating leases or sales-type leases. Lease income for products sold under sales-type leases is recognized as revenue upon the completion of installation activities in the amount of the present value of the minimum lease payments. The financing component of sales-type leases is recorded as revenue over the lease term. For products sold under operating leases, revenue is recognized at the contracted rate over the rental period, as defined within the customer agreement.
The Company’s domestic businesses sell products primarily to distributors that resell the products to end-user customers. Rebates are provided to distributors that sell to end-user customers at prices determined under a contract between the Company and the end-user customer. Provisions for rebates, as well as sales discounts and returns, are based upon estimates and are accounted for as a reduction of revenues when revenue is recognized.

Shipping and Handling Costs
Shipping and handling costs are included in Selling and administrative expense. Shipping expense was $351 million, $299 million and $285 million in 2015, 2014 and 2013, respectively.
Derivative Financial Instruments
All derivatives are recorded in the balance sheet at fair value and changes in fair value are recognized currently in earnings unless specific hedge accounting criteria are met.
From time to time, derivative financial instruments are utilized by the Company in the management of its foreign currency, interest rate and commodity price exposures. The Company periodically purchases forward contracts and options to hedge certain forecasted transactions that are denominated in foreign currencies in order to partially protect against a reduction in the value of future earnings resulting from adverse foreign exchange rate movements. The Company also periodically utilizes interest rate swaps to maintain a balance between fixed and floating rate instruments. Additionally, the Company periodically manages price risks associated with resin purchase costs through commodity derivative forward contracts. The Company does not enter into derivative financial instruments for trading or speculative purposes.
Any deferred gains or losses associated with derivative instruments are recognized in income in the period in which the underlying hedged transaction is recognized. In the event a designated hedged item is sold, extinguished or matures prior to the termination of the related derivative instrument, such instrument would be closed and the resultant gain or loss would be recognized in income.
Income Taxes
United States income taxes are not provided on undistributed earnings of foreign subsidiaries where such undistributed earnings are indefinitely reinvested outside the United States. Deferred taxes are provided for earnings of foreign subsidiaries when those earnings are not considered indefinitely reinvested. Income taxes are provided and tax credits are recognized based on tax laws enacted at the dates of the financial statements.
The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of tax jurisdictions. In evaluating the exposure associated with various tax filing positions, the Company records accruals for uncertain tax positions, based on the technical support for the positions, past audit experience with similar situations, and the potential interest and penalties related to the matters.
The Company maintains valuation allowances where it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances are included in the tax provision in the period of change. In determining whether a valuation allowance is warranted, management evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods and tax strategies that could potentially enhance the likelihood of the realization of a deferred tax asset.
Earnings per Share
Basic earnings per share are computed based on the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.
Use of Estimates
The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions. These estimates or assumptions affect reported assets, liabilities, revenues and expenses as reflected in the consolidated financial statements. Actual results could differ from these estimates.

Share-Based Compensation
The Company recognizes the fair value of share-based compensation in net income. Compensation expense is recognized on a straight-line basis over the requisite service period, which is generally the vesting period.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=35735333&loc=d3e288-107754

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 272

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=18733093&loc=d3e5614-111684

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 60 R32.htm IDEA: XBRL DOCUMENT v3.3.0.814

Benefit Plans (Tables)
12 Months Ended

Sep. 30, 2015

Net Pension and Other Postretirement Cost
Net pension and other postretirement cost for the years ended September 30 included the following components:

Pension Plans

Other Postretirement Benefits
(Millions of dollars)
2015

2014

2013

2015

2014

2013
Service cost
$
77

$
71

$
84

$
3

$
3

$
6

Interest cost
87

93

87

7

9

10

Expected return on plan assets
(123
)

(126
)

(116
)

—

—

—

Amortization of prior service credit
(15
)

(15
)

(13
)

(5
)

(4
)

(1
)
Amortization of loss
68

49

75

3

2

4

Curtailment/settlement loss
—

3

6

—

—

—

Net pension and postretirement cost
$
93

$
74

$
123

$
9

$
10

$
19

Change in Benefit Obligation, Change in Fair Value of Plan Assets
The change in benefit obligation, change in fair value of plan assets, funded status and amounts recognized in the Consolidated Balance Sheets for these plans were as follows:

Pension Plans

Other Postretirement
Benefits
(Millions of dollars)
2015

2014

2015

2014
Change in benefit obligation:

Beginning obligation
$
2,366

$
2,076

$
201

$
243

Service cost
77

71

3

3

Interest cost
87

93

7

9

Plan amendments
(2
)

(1
)

—

(37
)
Benefits paid
(138
)

(142
)

(18
)

(24
)
Benefit obligations assumed in acquisition
67

—

—

—

Actuarial loss (gain)
49

318

(11
)

—

Settlements
—

(7
)

—

—

Other, includes translation
(81
)

(42
)

3

6

Benefit obligation at September 30
2,426

2,366

186

201

Change in fair value of plan assets:

Beginning fair value
1,829

1,785

—

—

Actual return on plan assets
(21
)

119

—

—

Employer contribution
65

104

—

—

Benefits paid
(138
)

(142
)

—

—

Plan assets acquired in acquisition
54

—

—

—

Settlements
—

(7
)

—

—

Other, includes translation
(58
)

(29
)

—

—

Plan assets at September 30
$
1,732

$
1,829

$
—

$
—

Funded Status at September 30:

Unfunded benefit obligation
$
(694
)

$
(537
)

$
(186
)

$
(201
)
Amounts recognized in the Consolidated Balance
Sheets at September 30:

Other
$
7

$
3

$
—

$
—

Salaries, wages and related items
(10
)

(8
)

(15
)

(16
)
Long-term Employee Benefit Obligations
(691
)

(531
)

(171
)

(184
)
Net amount recognized
$
(694
)

$
(537
)

$
(186
)

$
(201
)
Amounts recognized in Accumulated other
comprehensive income (loss) before income taxes at September 30:

Net transition asset
$
—

$
—

$
—

$
—

Prior service credit
103

119

37

42

Net actuarial loss
(1,124
)

(1,030
)

(30
)

(44
)
Net amount recognized
$
(1,021
)

$
(911
)

$
7

$
(2
)

Pension Plans with Accumulated Benefit Obligations
Pension plans with accumulated benefit obligations in excess of plan assets and plans with projected benefit obligations in excess of plan assets consist of the following at September 30:

Accumulated Benefit
Obligation Exceeds the
Fair Value of Plan Assets

Projected Benefit
Obligation Exceeds the
Fair Value of Plan Assets
(Millions of dollars)
2015

2014

2015

2014
Projected benefit obligation
$
2,339

$
2,267

$
2,394

$
2,324

Accumulated benefit obligation
$
2,265

$
2,186

Fair value of plan assets
$
1,650

$
1,738

$
1,693

$
1,784

Weighted Average Assumptions Determining Pension Plan
The weighted average assumptions used in determining pension plan information were as follows:

2015

2014

2013

Net Cost

Discount rate:

U.S. plans (A)
4.15
%

4.95
%

3.90
%

Foreign plans
3.14

3.87

3.94

Expected return on plan assets:

U.S. plans
7.50

7.75

7.75

Foreign plans
5.45

5.68

5.68

Rate of compensation increase:

U.S. plans (A)
4.25

4.25

4.25

Foreign plans
2.49

2.46

3.28

Benefit Obligation

Discount rate:

U.S. plans (B)
4.15

4.15

4.95

Foreign plans
2.84

3.14

3.87

Rate of compensation increase:

U.S. plans (A)
4.25

4.25

4.25

Foreign plans
2.33

2.49

2.46

(A)
Also used to determine other postretirement and postemployment benefit plan information.
(B)
The discount rates used to determine other postretirement benefit plan information in fiscal years 2015, 2014 and 2013 were 3.95%, 3.85% and 4.40%, respectively. The discount rates used to determine postemployment benefit plan information in fiscal years 2015, 2014 and 2013 were 3.75%, 3.75% and 4.00%, respectively.

Expected Benefit Payments
Expected benefit payments are as follows:
(Millions of dollars)
Pension
Plans

Other
Postretirement
Benefits
2016
$
163

$
15

2017
164

15

2018
164

15

2019
177

15

2020
175

15

2021-2025
870

67

Fair Value Measurements of U.S. Plan Assets
The following table provides the fair value measurements of U.S. plan assets, as well as the measurement techniques and inputs utilized to measure fair value of these assets, at September 30, 2015 and 2014. The categorization of fund investments is based upon the categorization of these funds’ underlying assets.
(Millions of dollars)
Total U.S.
Plan Asset
Balances at
September 30,
2015

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

Significant
Other
Observable
Inputs (Level 2)

Significant
Unobservable
Inputs (Level 3)
Fixed Income:

Mortgage and asset-backed securities
$
192

$
—

$
192

$
—

Corporate bonds
240

100

139

—

Government and agency-U.S.
78

53

24

—

Government and agency-Foreign
95

46

49

—

Equity securities
335

75

260

—

Cash and cash equivalents
96

96

—

—

Other
123

30

91

2

Fair value of plan assets
$
1,157

$
401

$
755

$
2

(Millions of dollars)
Total U.S.
Plan Asset
Balances at
September 30,
2014

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

Significant
Other
Observable
Inputs (Level 2)

Significant
Unobservable
Inputs (Level 3)
Fixed Income:

Mortgage and asset-backed securities
$
150

$
—

$
150

$
—

Corporate bonds
213

105

108

—

Government and agency-U.S.
153

124

29

—

Government and agency-Foreign
126

74

51

—

Equity securities
393

56

337

—

Cash and cash equivalents
26

26

—

—

Other
193

96

93

4

Fair value of plan assets
$
1,255

$
483

$
768

$
4

Fair Value Measurements of Foreign Plan Assets
The following table provides the fair value measurements of foreign plan assets, as well as the measurement techniques and inputs utilized to measure fair value of these assets, at September 30, 2015 and 2014.
(Millions of dollars)
Total Foreign
Plan Asset
Balances at
September 30,
2015

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

Significant
Other
Observable
Inputs (Level 2)

Significant
Unobservable
Inputs (Level 3)
Fixed Income:

Corporate bonds
$
33

$
3

$
30

$
—

Government and agency-U.S.
1

1

—

—

Government and agency-Foreign
101

65

36

—

Other fixed income
48

46

2

—

Equity securities
206

187

19

—

Cash and cash equivalents
8

8

—

—

Real estate
13

—

13

—

Insurance contracts
90

—

—

90

Other
74

53

21

—

Fair value of plan assets
$
575

$
364

$
121

$
90

(Millions of dollars)
Total Foreign
Plan Asset
Balances at
September 30,
2014

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

Significant
Other
Observable
Inputs (Level 2)

Significant
Unobservable
Inputs (Level 3)
Fixed Income:

Corporate bonds
$
35

$
—

$
35

$
—

Government and agency-U.S.
3

3

—

—

Government and agency-Foreign
100

59

41

—

Other fixed income
47

46

1

—

Equity securities
237

221

17

—

Cash and cash equivalents
15

15

—

—

Real estate
10

—

10

—

Insurance contracts
78

—

—

78

Other
47

12

35

—

Fair value of plan assets
$
574

$
357

$
138

$
78

Postemployment Benefit Costs
Postemployment benefit costs for the years ended September 30 included the following components:
(Millions of dollars)
2015

2014

2013
Service cost
$
18

$
20

$
22

Interest cost
6

7

6

Amortization of prior service credit
(2
)

(2
)

(2
)
Amortization of loss
18

21

21

Net postemployment benefit cost
$
42

$
47

$
47

Changes in Benefit Obligation for Postemployment Benefits
The changes in benefit obligation for these postemployment benefits were as follows:

Postemployment benefits
(Millions of dollars)
2015

2014
Change in benefit obligation:

Beginning obligation
$
184

$
186

Service cost
18

20

Interest cost
6

7

Benefits paid
(25
)

(30
)
Actuarial (gain) loss
(22
)

1

Benefit obligation at September 30
$
163

$
184

U.S. Plans

Changes in Fair Value Pension Assets Measured Using Level 3 Inputs
The following table summarizes the changes, for the years ended September 30, 2015 and 2014, in the fair value of U.S. pension assets measured using Level 3 inputs:
(Millions of dollars)
Other
(Hedge
Funds)
Balance at September 30, 2013
$
12

Actual return on plan assets:

Relating to assets held at September 30, 2013
1

Purchases, sales and settlements, net
4

Transfers (out) in from other categories
(13
)
Exchange rate changes
—

Balance at September 30, 2014
$
4

Actual return on plan assets:

Relating to assets held at September 30, 2014
—

Purchases, sales and settlements, net
1

Transfers (out) in from other categories
(3
)
Exchange rate changes
—

Balance at September 30, 2015
$
2

Foreign Plans

Changes in Fair Value Pension Assets Measured Using Level 3 Inputs
The following table summarizes the changes, for the years ended September 30, 2015 and 2014, in the fair value of foreign pension assets measured using Level 3 inputs:
(Millions of dollars)
Real
Estate

Insurance
Contracts

Total
Assets
Balance at September 30, 2013
$
1

$
81

$
83

Actual return on plan assets:

Relating to assets held at September 30, 2013
—

1

1

Purchases, sales and settlements, net
—

3

3

Transfers (out) in from other categories
(1
)

(2
)

(3
)
Exchange rate changes
—

(6
)

(6
)
Balance at September 30, 2014
$
—

$
78

$
78

Actual return on plan assets:

Relating to assets held at September 30, 2014
—

4

4

Purchases, sales and settlements, net
—

16

16

Transfers in from other categories
—

1

1

Exchange rate changes
—

(9
)

(9
)
Balance at September 30, 2015
$
—

$
90

$
90

X

- Definition
Postemployment benefits.
+ References
No definition available.
+ Details

Name: bdx_PostemploymentBenefitsTableTextBlock

Namespace Prefix: bdx_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the major categories of plan assets of foreign pension plans and/or other foreign employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.
+ References
No definition available.
+ Details

Name: bdx_ScheduleOfAllocationOfForeignPlanAssetsTableTableTextBlock

Namespace Prefix: bdx_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of accumulated benefit obligations and fair values of plan assets of pension plans and/or other employee benefit plans where the accumulated benefit obligation exceeds the fair value of plan assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 3

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e2417-114920

+ Details

Name: us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (d)(5)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the assumptions used to determine for pension plans and/or other employee benefit plans the benefit obligation and net benefit cost, including assumed discount rates, rate increase in compensation increase, and expected long-term rates of return on plan assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (k)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_ScheduleOfAssumptionsUsedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the change in the accumulated postemployment benefit obligation from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_ScheduleOfChangesInAccumulatedPostemploymentBenefitObligationsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (h)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_ScheduleOfNetBenefitCostsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of net funded status of pension plans and/or other employee benefit plans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_ScheduleOfNetFundedStatusTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_ForeignPensionPlansDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 61 R83.htm IDEA: XBRL DOCUMENT v3.3.0.814

Divestiture - Results of Discontinued Operations (Detail) - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Discontinued Operations and Disposal Groups [Abstract]

Revenues $ 0 $ 0 $ 20

Income from discontinued operations before income taxes 0 0 586

Less income tax provision 0 0 222

Income from discontinued operations, net $ 0 $ 0 $ 364

X

- Definition
Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e1012-107759

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3A

-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721523-107759

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e957-107759

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3B

-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721525-107759

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.12)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5B

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721673-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 13

-Article 7

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 05

-Paragraph 15

-Article 3

+ Details

Name: us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32672-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3B

-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721525-107759

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3A

-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721523-107759

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5B

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721673-107760

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 20

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=18498875&loc=d3e38679-109324

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5C

-Subparagraph (b)(2)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721675-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e1012-107759

+ Details

Name: us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5B

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721673-107760

+ Details

Name: us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.12)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5C

-Subparagraph (b)(2)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721675-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.14)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e1012-107759

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3B

-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721525-107759

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3A

-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721523-107759

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e957-107759

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 13

-Article 7

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 15

-Article 5

+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 62 R40.htm IDEA: XBRL DOCUMENT v3.3.0.814

Income Taxes (Tables)
12 Months Ended

Sep. 30, 2015

Income Tax Disclosure [Abstract]

Provision for Income Taxes from Continuing Operations
The provision for income taxes from continuing operations for the years ended September 30 consisted of:
(Millions of dollars)
2015

2014

2013
Current:

Federal
$
50

$
225

$
177

State and local, including Puerto Rico
15

(11
)

(4
)
Foreign
252

217

179

$
318

$
431

$
352

Deferred:

Domestic
$
(238
)

$
(59
)

$
(119
)
Foreign
(37
)

(35
)

3

(274
)

(94
)

(116
)

$
44

$
337

$
236

Components of Income from Continuing Operations Before Income Taxes
The components of Income From Continuing Operations Before Income Taxes for the years ended September 30 consisted of:
(Millions of dollars)
2015

2014

2013
Domestic, including Puerto Rico
$
(408
)

$
532

$
288

Foreign
1,147

990

877

$
739

$
1,522

$
1,165

Summary of Gross Amounts of Unrecognized Tax Benefits
The table below summarizes the gross amounts of unrecognized tax benefits without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such unrecognized tax benefits were settled. The Company expects no significant increases or decreases in the amount of the unrecognized tax benefits to occur within the next twelve months.
(Millions of dollars)
2015

2014

2013
Balance at October 1
$
197

$
146

$
134

Increase due to acquisitions
314

—

—

Increase due to current year tax positions
58

51

80

Increase due to prior year tax positions
17

9

25

Decreases due to prior year tax positions
—

—

—

Decrease due to settlements and lapse of statute of limitations
(11
)

(9
)

(93
)
Balance at September 30
$
575

$
197

$
146

Deferred Income Taxes
Deferred income taxes at September 30 consisted of:

2015

2014 (A)
(Millions of dollars)
Assets

Liabilities

Assets

Liabilities
Compensation and benefits
$
647

$
—

$
546

$
—

Property and equipment
—

156

—

196

Intangibles
—

2,033

—

266

Loss and credit carryforwards
538

—

274

—

Other
634

606

398

195

1,819

2,795

1,218

656

Valuation allowance
(452
)

—

(247
)

—

$
1,367

$
2,795

$
971

$
656

(A)Certain amounts in the prior-year presentation have been reclassified to conform to the current-year presentation.

Reconciliation of Federal Statutory Tax Rate to Company's Effective Tax Rate
A reconciliation of the federal statutory tax rate to the Company’s effective tax rate was as follows:

2015

2014

2013
Federal statutory tax rate
35.0
%

35.0
%

35.0
%
State and local income taxes, net of federal tax benefit
(3.6
)

(0.5
)

(1.2
)
Effect of foreign and Puerto Rico earnings and foreign tax credits
(24.5
)

(11.2
)

(9.7
)
Effect of Research Credits and Domestic Production Activities,
(1.6
)

(1.1
)

(3.8
)
Other, net
0.6

(0.1
)

(0.1
)

5.9
%

22.1
%

20.2
%

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

+ Details

Name: us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

+ Details

Name: us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319

+ Details

Name: us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of income before income tax between domestic and foreign jurisdictions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h)(1)(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the change in unrecognized tax benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 55

-Paragraph 217

-URI http://asc.fasb.org/extlink&oid=51663037&loc=d3e36027-109320

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15A

-URI http://asc.fasb.org/extlink&oid=6907707&loc=SL6600010-109319

+ Details

Name: us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 63 R53.htm IDEA: XBRL DOCUMENT v3.3.0.814

Segment Data - Financial Information for Company's Segments (Detail) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2013

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Segment Reporting Information [Line Items]

Revenues $ 3,059 $ 3,120 $ 2,051 $ 2,051 $ 2,202 $ 2,157 $ 2,072 $ 2,015 $ 10,282 $ 8,446 $ 8,054

Income From Continuing Operations Before Income Taxes 739 1,522 1,165

Total Assets 26,820 12,447 26,820 12,447 12,149

Total Capital Expenditures 596 592 522

Total Depreciation and Amortization 891 562 546

Operating Segments

Segment Reporting Information [Line Items]

Income From Continuing Operations Before Income Taxes 2,368 2,152 2,140

Total Assets 23,987 8,451 23,987 8,451 8,357

Operating Segments | Medical

Segment Reporting Information [Line Items]

Revenues 6,460 4,573 4,306

Income From Continuing Operations Before Income Taxes 1,530 1,291 1,233

Total Assets 20,055 4,668 20,055 4,668 4,582

Total Capital Expenditures 414 420 354

Total Depreciation and Amortization 619 293 259

Operating Segments | Life Sciences

Segment Reporting Information [Line Items]

Revenues 3,822 3,872 3,748

Income From Continuing Operations Before Income Taxes 839 861 907

Total Assets 3,932 3,783 3,932 3,783 3,776

Total Capital Expenditures 168 155 158

Total Depreciation and Amortization 256 251 267

Corporate and All Other

Segment Reporting Information [Line Items]

Income From Continuing Operations Before Income Taxes (1,629) (630) (976)

Total Assets $ 2,833 $ 3,997 2,833 3,997 3,792

Total Capital Expenditures 14 16 9

Total Depreciation and Amortization $ 17 $ 18 $ 19

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationDepletionAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h)(1)(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_SegmentReportingInformationLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=bdx_MedicalMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=bdx_LifeSciencesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 64 R72.htm IDEA: XBRL DOCUMENT v3.3.0.814

Benefit Plans - Changes in Fair Value of U.S. and Foreign Pension Assets Measured Using Level 3 Inputs (Detail) - U.S. Plans - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Actual return on plan assets:

Beginning fair value $ 1,255

Ending fair value 1,157 $ 1,255

Other

Actual return on plan assets:

Beginning fair value 193

Ending fair value 123 193

Significant Unobservable Inputs (Level 3)

Actual return on plan assets:

Beginning fair value 4

Ending fair value 2 4

Significant Unobservable Inputs (Level 3) | Other

Actual return on plan assets:

Beginning fair value 4 12

Return on assets 0 1

Purchases, sales and settlements, net 1 4

Transfers (out) in from other categories (3) (13)

Exchange rate changes 0 0

Ending fair value $ 2 $ 4

X

- References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Actual return on plan assets, separately identifying the amount related to assets still held at the reporting date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (d)(iv)(02)(A)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 5

-Subparagraph (c)(iv)(02)(A)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e2446-114920

+ Details

Name: us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits, at their fair value as of the measurement date. Plan assets include amounts contributed by the employer (and by employees for a contributory plan) and amounts earned from investing the contributions, less benefits paid. If a plan has liabilities other than for benefits, those non-benefit obligations may be considered as reductions of plan assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 30

-Section 35

-Paragraph 50

-URI http://asc.fasb.org/extlink&oid=49178875&loc=d3e12355-114930

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanFairValueOfPlanAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of increase or decrease in plan assets attributed to foreign currency changes. The effects of foreign currency exchange rate changes that are to be disclosed are those applicable to plans of a foreign operation whose functional currency is not the reporting currency.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)(2)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) in plan assets from purchases, sales and settlement of plan obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (d)(iv)(02)(B)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 5

-Subparagraph (c)(iv)(02)(B)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e2446-114920

+ Details

Name: us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Transfers in and out of Level 3. For example, transfers due to changes in the observability of significant inputs.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (d)(iv)(02)(C)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 5

-Subparagraph (c)(iv)(02)(C)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e2446-114920

+ Details

Name: us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=bdx_OtherPensionPlanInvestmentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 65 R2.htm IDEA: XBRL DOCUMENT v3.3.0.814

Consolidated Statements of Income - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Operations

Revenues $ 10,282 $ 8,446 $ 8,054

Cost of products sold 5,587 4,145 3,883

Selling and administrative expense 2,563 2,145 2,422

Research and development expense 632 550 494

Acquisition-related costs 426 0 0

Total Operating Costs and Expenses 9,207 6,840 6,800

Operating Income 1,074 1,606 1,254

Interest expense (371) (135) (138)

Interest income 15 46 40

Other income, net 21 5 9

Income from continuing operations before income taxes 739 1,522 1,165

Income tax provision 44 337 236

Income from Continuing Operations 695 1,185 929

Net of income tax provision of $0 in 2015, $0 in 2014 and $222 in 2013 0 0 364

Net Income $ 695 $ 1,185 $ 1,293

Basic Earnings per Share

Income from Continuing Operations (USD per share) $ 3.43 $ 6.13 $ 4.76

Income from Discontinued Operations (USD per share) 0.00 0.00 1.86

Basic Earnings per Share (USD per share) 3.43 6.13 6.63

Diluted Earnings per Share

Income from Continuing Operations (USD per share) 3.35 5.99 4.67

Income from Discontinued Operations (USD per share) 0.00 0.00 1.83

Diluted Earnings per Share (USD per share) $ 3.35 $ 5.99 $ 6.49

X

- Definition
Acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; business integration costs, systems integration and conversion costs, and severance and other employee-related costs; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.
+ References
No definition available.
+ Details

Name: bdx_BusinessCombinationTransactionAndIntegrationRelatedCosts

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2(a),(d))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_CostOfGoodsAndServicesSold

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Total costs of sales and operating expenses for the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_CostsAndExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.23)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareDilutedAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations attributable to the parent. Also defined as revenue less expenses and taxes from ongoing operations before extraordinary items but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.13)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4613673-111683

+ Details

Name: us-gaap_IncomeLossFromContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h)(1)(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.23)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsPerBasicShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.12)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5C

-Subparagraph (b)(2)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721675-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.14)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e1012-107759

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3B

-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721525-107759

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3A

-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721523-107759

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e957-107759

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 13

-Article 7

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 15

-Article 5

+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.23)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section E

-Paragraph Question 3

+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Income Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6515339

+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.9)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7(b))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_InvestmentIncomeInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetIncomeLossAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 730

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 30

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51677171&loc=d3e3636-108311

+ Details

Name: us-gaap_SellingGeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 66 R45.htm IDEA: XBRL DOCUMENT v3.3.0.814

Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Detail) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended

Mar. 17, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2013

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Begging balance $ 5,053 $ 5,053

Beginning balance (shares) (140,770,158) (140,770,158)

Net Income $ 181 $ 62 $ 216 $ 236 $ 301 $ 326 $ 287 $ 271 $ 695 $ 1,185 $ 1,293

Number of shares issued, in acquisition (shares) 15,900,000

Ending balance $ 7,164 $ 5,053 $ 7,164 $ 5,053

Ending balance (shares) (121,966,516) (140,770,158) (121,966,516) (140,770,158)

Common Stock Issued at Par Value

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Begging balance 333 333 $ 333 $ 333 333

Net Income 0 0 0

Ending balance $ 333 $ 333 333 333 333

Capital in Excess of Par Value

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Begging balance 2,198 2,068 2,198 2,068 1,920

Net Income 0 0 0

Share-based compensation and other plans, net 30 19 50

Share-based compensation 164 111 98

Acquisitions 2,083

Ending balance 4,475 2,198 4,475 2,198 2,068

Retained Earnings

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Begging balance 12,105 11,342 12,105 11,342 10,435

Net Income 695 1,185 1,293

Cash dividends, common (485) (421) (386)

Share-based compensation and other plans, net (2)

Ending balance 12,314 12,105 12,314 12,105 11,342

Deferred Compensation

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Begging balance 19 19 19 19 19

Net Income 0 0 0

Share-based compensation and other plans, net 1

Ending balance 20 19 20 19 19

Treasury Stock

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Begging balance $ (8,601) $ (8,204) $ (8,601) $ (8,204) $ (7,769)

Beginning balance (shares) (140,770,000) (138,663,000) (140,770,000) (138,663,000) (135,751,000)

Share-based compensation and other plans, net $ (6) $ 3 $ 15

Share-based compensation plans, net (shares) 2,839,000 1,431,000 2,537,000

Common stock held in trusts, net (shares) 5,000 36,000 36,000

Repurchase of common stock (shares) 0 (3,574,000) (5,485,000)

Repurchase of common stock $ 0 $ (400) $ (450)

Acquisitions $ 368

Number of shares issued, in acquisition (shares) 15,959,000

Ending balance $ (8,239) $ (8,601) $ (8,239) $ (8,601) $ (8,204)

Ending balance (shares) (121,967,000) (140,770,000) (121,967,000) (140,770,000) (138,663,000)

X

- Definition
Number of common stock shares held in trust.
+ References
No definition available.
+ Details

Name: bdx_CommonStockHeldInTrustsNetShares

Namespace Prefix: bdx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
This element represents the amount of recognized equity-based compensation during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized). Alternate captions include the words "stock-based compensation".
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415241&loc=d3e4534-113899

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 20

-Section 55

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11149-113907

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 20

-Section 55

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11178-113907

+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

+ Details

Name: us-gaap_DividendsCommonStockCash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInStockholdersEquityRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares of stock issued during the period pursuant to acquisitions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesAcquisitions

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Value of stock issued pursuant to acquisitions during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueAcquisitions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (d)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_TreasuryStockShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares that have been repurchased during the period and are being held in treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_TreasuryStockSharesAcquired

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

+ Details

Name: us-gaap_TreasuryStockValueAcquiredCostMethod

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 67 R96.htm IDEA: XBRL DOCUMENT v3.3.0.814

Debt - Summary of Long-Term Debt (Detail) - USD ($)
$ in Millions

Sep. 30, 2015

Sep. 30, 2014

Debt Instrument [Line Items]

Long-Term Debt $ 11,370 $ 3,768

1.750% Notes due November 8, 2016

Debt Instrument [Line Items]

Long-Term Debt 499 499

1.450% Notes due May 15, 2017

Debt Instrument [Line Items]

Long-Term Debt 300 0

1.800% Notes due December 15, 2017

Debt Instrument [Line Items]

Long-Term Debt 1,246 0

4.900% Notes due April 15, 2018

Debt Instrument [Line Items]

Long-Term Debt 202 202

5.000% Notes due May 15, 2019

Debt Instrument [Line Items]

Long-Term Debt 497 497

6.375% Notes due August 1, 2019

Debt Instrument [Line Items]

Long-Term Debt 802 0

2.675% Notes due December 15, 2019

Debt Instrument [Line Items]

Long-Term Debt 1,244 0

3.250% Notes due November 12, 2020

Debt Instrument [Line Items]

Long-Term Debt 697 697

3.125% Notes due November 8, 2021

Debt Instrument [Line Items]

Long-Term Debt 1,013 997

3.300% Notes due March 1, 2023

Debt Instrument [Line Items]

Long-Term Debt 305 0

3.875% Notes due May 15, 2024

Debt Instrument [Line Items]

Long-Term Debt 419 0

3.734% Notes due December 15, 2024

Debt Instrument [Line Items]

Long-Term Debt 1,739 0

7.000% Debentures due August 1, 2027

Debt Instrument [Line Items]

Long-Term Debt 168 168

6.700% Debentures due August 1, 2028

Debt Instrument [Line Items]

Long-Term Debt 167 167

6.000% Notes due May 15, 2039

Debt Instrument [Line Items]

Long-Term Debt 246 246

5.000% Notes due November 12, 2040

Debt Instrument [Line Items]

Long-Term Debt 296 296

4.875% Notes due May 15, 2044

Debt Instrument [Line Items]

Long-Term Debt 334 0

4.685% Notes due December 15, 2044

Debt Instrument [Line Items]

Long-Term Debt 1,190 0

Other long-term debt

Debt Instrument [Line Items]

Long-Term Debt $ 5 $ 0

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying amount of long-term debt, net of unamortized discount or premium, excluding amounts to be repaid within one year or the normal operating cycle, if longer (current maturities). Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_NotesDue2016Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes1.450dueMay152017Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes1.800dueDecember152017Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_NotesDue2018Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_NotesDue2019Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes6.375DueAugust12019Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes2.675dueDecember152019Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_NotesDue2020Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_NotesDue2021Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes3.300dueMarch12023Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes3.875dueMay152024Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes3.374DueDecember152024Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_DebenturesDue2027Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_DebenturesDue2028Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_NotesDue2039Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_NotesDue2040Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes4.875DueMay152044Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes4.685DueDecember142044Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_OtherLongtermDebtMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 68 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814

Consolidated Balance Sheets (Parenthetical) - $ / shares

Sep. 30, 2015

Sep. 30, 2014

Statement of Financial Position [Abstract]

Common stock, par value (USD per share) $ 1 $ 1

Common stock, shares authorized (shares) 640,000,000 640,000,000

Common stock, shares issued (shares) 332,662,160 332,662,160

Common stock in treasury, shares (shares) 121,966,516 140,770,158

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfFinancialPositionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_TreasuryStockShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 69 R94.htm IDEA: XBRL DOCUMENT v3.3.0.814

Debt - Additional Information (Detail)
1 Months Ended 12 Months Ended

Oct. 05, 2014

USD ($)

Sep. 30, 2015

USD ($)

Jul. 31, 2015

USD ($)

Apr. 30, 2015

USD ($)

Dec. 31, 2014

USD ($)

Sep. 30, 2015

USD ($)

Jun. 30, 2015

USD ($)

Mar. 31, 2015

USD ($)

Mar. 17, 2015

USD ($)

Feb. 28, 2015

USD ($)

Sep. 30, 2014

Debt Instrument [Line Items]

Short-term debt, weighted average interest rate 0.64% 0.64% 0.40%

Aggregate annual maturities of long-term debt, 2016 $ 750,000,000 $ 750,000,000

Aggregate annual maturities of long-term debt, 2017 800,000,000 800,000,000

Aggregate annual maturities of long-term debt, 2018 1,450,000,000 1,450,000,000

Aggregate annual maturities of long-term debt, 2019 1,200,000,000 1,200,000,000

Aggregate annual maturities of long-term debt, 2020 1,250,000,000 1,250,000,000

Term Loan Facility

Debt Instrument [Line Items]

Short term debt maximum borrowing capacity $ 1,000,000,000

Loans Payable 0 0

Debt instrument, term 364 days

Repayments of short-term debt 100,000,000 $ 250,000,000 $ 650,000,000

Bridge Loan

Debt Instrument [Line Items]

Payments to acquire business secured bridge financing $ 9,100,000,000

Syndicated Credit Facility

Debt Instrument [Line Items]

Borrowings under credit facility 0 0

Maximum aggregate commitment 1,500,000,000 1,500,000,000

Syndicated Credit Facility | Domestic Debt

Debt Instrument [Line Items]

Maximum borrowing capacity of syndicated credit facility 1,000,000,000 1,000,000,000

Additional commitments made by the lenders 500,000,000 $ 500,000,000

Covenant compliance, minimum interest expense coverage ratio 5

Notes Due June 2016

Debt Instrument [Line Items]

Debt instrument, face amount 750,000,000 $ 750,000,000 $ 750,000,000

Unsecured Debt

Debt Instrument [Line Items]

Debt instrument, face amount 6,200,000,000.0 6,200,000,000.0

Care Fusion Corporation

Debt Instrument [Line Items]

Long-term debt assumed $ 2,181,000,000

Business combination interest and financing costs 107,000,000

Care Fusion Corporation | Unsecured Debt

Debt Instrument [Line Items]

Debt instrument, face amount $ 2,000,000,000

Long-term debt assumed $ 2,174,000,000

Principal amount outstanding after exchange 51,000,000 51,000,000

Commercial Paper Program

Debt Instrument [Line Items]

Short term debt maximum borrowing capacity 1,000,000,000 1,000,000,000

Loans Payable 700,000,000 700,000,000

Commercial Paper Program | Care Fusion Corporation

Debt Instrument [Line Items]

Used proceeds of new financing $ 500,000,000 $ 500,000,000

Former Commercial Paper Program

Debt Instrument [Line Items]

Loans Payable $ 200,000,000

X

- Definition
Business Combination Interest And Financing Costs
+ References
No definition available.
+ Details

Name: bdx_BusinessCombinationInterestAndFinancingCosts

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Debt Instrument, Covenant Compliance, Minimum Interest Expense Coverage Ratio
+ References
No definition available.
+ Details

Name: bdx_DebtInstrumentCovenantComplianceMinimumInterestExpenseCoverageRatio

Namespace Prefix: bdx_

Data Type: xbrli:pureItemType

Balance Type: na

Period Type: duration

X

- Definition
Additional funding available, subject to additional commitments made by lenders, under Company's syndicated credit facility.
+ References
No definition available.
+ Details

Name: bdx_LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Financing currently secured to fund the cash portion of the total payment to acquire a business.
+ References
No definition available.
+ Details

Name: bdx_PaymentsToAcquireBusinessSecuredBridgeFinancing

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Principal Amount Outstanding After Exchange
+ References
No definition available.
+ Details

Name: bdx_PrincipalAmountOutstandingAfterExchange

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Short Term Debt Maximum Borrowing Capacity
+ References
No definition available.
+ Details

Name: bdx_ShortTermDebtMaximumBorrowingCapacity

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Used Proceeds Of New Financing
+ References
No definition available.
+ Details

Name: bdx_UsedProceedsOfNewFinancing

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentTerm

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

+ Details

Name: us-gaap_LineOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(b),22(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(b),22(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 3

-Subparagraph (SX 210.12-04.(a))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601

+ Details

Name: us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 3

-Subparagraph (SX 210.12-04.(a))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690

+ Details

Name: us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 3

-Subparagraph (SX 210.12-04.(a))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601

+ Details

Name: us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 3

-Subparagraph (SX 210.12-04.(a))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690

+ Details

Name: us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 3

-Subparagraph (SX 210.12-04.(a))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690

+ Details

Name: us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_RepaymentsOfShortTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.13)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.(a),16(a)(1))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 13

-Subparagraph 2, 3

-Article 9

+ Details

Name: us-gaap_ShortTermBorrowings

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Weighted average interest rate of short-term debt outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_ShortTermDebtWeightedAverageInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_CreditFacilityAxis=bdx_TermLoanFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=us-gaap_BridgeLoanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=bdx_SyndicatedCreditFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=bdx_DomesticDebtMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_NotesDueJune2016Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=bdx_CareFusionCorporationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=bdx_CommercialPaperProgramMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=bdx_FormerCommercialPaperProgramMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 70 R59.htm IDEA: XBRL DOCUMENT v3.3.0.814

Share-Based Compensation - Summary of SARs Outstanding (Detail)
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended

Sep. 30, 2015

USD ($)

$ / shares

shares

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]

SARs, beginning balance (shares) 7,852

SARs, granted (shares) 1,037

SARs, exercised (shares) (1,458)

SARs, forfeited, canceled or expired (shares) (167)

SARs, ending balance (shares) 7,264

SARs, Vested and expected to vest at ending balance (shares) 7,010

SARs, Exercisable at ending balance (shares) 4,725

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]

SARs, weighted average exercise price, beginning balance (USD per share) | $ / shares $ 78.49

SARs, weighted average exercise price, granted (USD per share) | $ / shares 134.73

SARs, weighted average exercise price, exercised (USD per share) | $ / shares 72.88

SARs, weighted average exercise price, forfeited, canceled or expired (USD per share) | $ / shares 103.50

SARs, weighted average exercise price, ending balance (USD per share) | $ / shares 87.07

SARs, weighted average exercise price, vested and expected to vest (USD per share) | $ / shares 86.34

SARs, weighted average exercise price, exercisable (USD per share) | $ / shares $ 76.18

SARs, weighted average remaining contractual term 5 years 11 months 16 days

SARs, weighted average remaining contractual term, vested and expected to vest 5 years 10 months 17 days

SARs, weighted average remaining contractual term, exercisable 4 years 9 months 22 days

SARs, aggregate intrinsic value | $ $ 333

SARs, aggregate intrinsic value, vested and expected to vest | $ 327

SARs, aggregate intrinsic value, exercisable | $ $ 267

X

- Definition
The number of exercisable stock appreciation rights (fully vested and expected to vest) that may be converted as of the balance sheet date.
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber

Namespace Prefix: bdx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of stock appreciation rights outstanding and currently exercisable under the award plan.
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice

Namespace Prefix: bdx_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of stock appreciation rights exercised during the current period.
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod

Namespace Prefix: bdx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of stock appreciation rights that were forfeited during the reporting period.
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod

Namespace Prefix: bdx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of stock appreciation rights granted during the period
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod

Namespace Prefix: bdx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value at grant date for stock appreciation rights issued during the period.
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: bdx_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate intrinsic value for outstanding stock appreciation rights.
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The number of stock appreciation rights that validly exist and are outstanding as of the balance sheet date, including vested options.
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber

Namespace Prefix: bdx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted average price of shares reserved for issuance under stock appreciation right incentive compensation plan that validly exist and are outstanding as of the balance sheet date, including vested options.
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice

Namespace Prefix: bdx_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted average remaining contractual term for outstanding stock appreciation rights.
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm

Namespace Prefix: bdx_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate intrinsic value for stock appreciation rights that are fully vested or expected to vest as of the balance sheet date.
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The number of stock appreciation rights (fully vested and expected to vest) that may be converted as of the balance sheet date.
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber

Namespace Prefix: bdx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted average exercise price of stock appreciation rights that are fully vested or expected to vest as of the balance sheet date.
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice

Namespace Prefix: bdx_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The aggregate intrinsic value for stock appreciation rights that are exercisable as of the balance sheet date.
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The weighted average remaining contractual term for stock appreciation rights that are exercisable as of the balance sheet date.
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm

Namespace Prefix: bdx_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average price at which option holders exercised stock appreciation awards during the reporting period.
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: bdx_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average price of stock appreciation rights that were forfeited during the reporting period.
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice

Namespace Prefix: bdx_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average remaining contractual term for stock appreciation rights that are fully vested or are expected to vest.
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm

Namespace Prefix: bdx_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 71 R99.htm IDEA: XBRL DOCUMENT v3.3.0.814

Income Taxes - Provision for Income Taxes from Continuing Operations (Detail) - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Income Tax Disclosure [Abstract]

Federal $ 50 $ 225 $ 177

State and local, including Puerto Rico 15 (11) (4)

Foreign 252 217 179

Total, Current 318 431 352

Domestic (238) (59) (119)

Foreign (37) (35) 3

Total, Deferred (274) (94) (116)

Total $ 44 $ 337 $ 236

X

- Definition
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6509736

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Paragraph Question 1-7

+ Details

Name: us-gaap_CurrentFederalTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

+ Details

Name: us-gaap_CurrentForeignTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6509736

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Subsection 7

+ Details

Name: us-gaap_CurrentIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6509736

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Subsection 7

+ Details

Name: us-gaap_CurrentStateAndLocalTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Deferred Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6510177

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Subsection 7

+ Details

Name: us-gaap_DeferredFederalIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Deferred Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6510177

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Subsection 7

+ Details

Name: us-gaap_DeferredForeignIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Deferred Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6510177

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Subsection 7

+ Details

Name: us-gaap_DeferredIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Income Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6515339

+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 72 R35.htm IDEA: XBRL DOCUMENT v3.3.0.814

Business Restructuring Charges (Tables)
12 Months Ended

Sep. 30, 2015

Restructuring and Related Activities [Abstract]

Summary of Restructuring Accrual Activity
Restructuring accrual activity in 2015 was as follows:

(Millions of dollars)

Employee Termination

Share-Based Compensation

Other (A)

Total
Balance at September 30, 2014
$
—

$
—

$
—

$
—

Assumed liability

19

—

—

19

Charged to expense

126

44

102

271

Cash payments

(74
)

—

(20
)

(94
)
Non-cash settlements

—

(44
)

—

(44
)
Other adjustments

(9
)

—

(81
)

(91
)
Balance at September 30, 2015
$
62

$
—

$
—

$
62

(A)
Amounts primarily relate to impairment charges for assets held for sale, primarily assets that will be sold as a result of an information technology infrastructure outsourcing project the Company will initiate in fiscal year 2016. Additional disclosures regarding these asset impairment charges are provided in Note 14.

X

- References
No definition available.
+ Details

Name: us-gaap_RestructuringAndRelatedActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)(2)

-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB Topic 5.P.4(b)(2))

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747

+ Details

Name: us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 73 R65.htm IDEA: XBRL DOCUMENT v3.3.0.814

Benefit Plans - Additional Information (Detail) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Defined Benefit Plan Disclosure [Line Items]

Assumed health care trend rate 6.80% 7.00%

Ultimate health care trend rate beginning in 2024 4.00% 5.00%

Percent of total assets domestic plans 67.00%

Amount recognized in Accumulated other comprehensive income before income taxes for net actuarial loss $ 107 $ 145 $ 107 $ 145

Accumulated other comprehensive income into post employment benefit cost 13

Charge associated with workforce reduction actions 36

Change in estimate workforce reduction liability 5

Change in workforce liability 4 4

Cost of the savings incentive plan 54 39 $ 36

Employees contribution guaranteed by the company to the fixed income fund of the Savings Incentive Plan 235 235

Care Fusion Corporation

Defined Benefit Plan Disclosure [Line Items]

Change in workforce related costs $ 126

Fixed Income Funds

Defined Benefit Plan Disclosure [Line Items]

Company's Target allocation percentage for asset mix 35.00%

Diversified

Defined Benefit Plan Disclosure [Line Items]

Company's Target allocation percentage for asset mix 34.00%

Equity securities

Defined Benefit Plan Disclosure [Line Items]

Company's Target allocation percentage for asset mix 31.00%

Change in Assumptions for Pension Plans

Defined Benefit Plan Disclosure [Line Items]

Change in accounting estimate, estimated amount of change in the next fiscal year 18 $ 18

Foreign Plans

Defined Benefit Plan Disclosure [Line Items]

Net pension and postretirement cost 32 25 33

Pension plan assets at fair value 575 574 575 574

Pension plan projected benefit obligations $ 780 765 $ 780 765

Percent of total plan assets foreign plans 33.00% 33.00%

Foreign Plans | Equity securities

Defined Benefit Plan Disclosure [Line Items]

Pension plan assets at fair value $ 206 237 $ 206 237

Pension Plans

Defined Benefit Plan Disclosure [Line Items]

Net pension and postretirement cost 93 74 123

Pension plan assets at fair value 1,732 1,829 1,732 1,829 1,785

Pension plan projected benefit obligations 2,426 2,366 2,426 2,366 2,076

Estimated net actuarial loss that will be amortized from accumulated other comprehensive income (79)

Estimated prior service credit costs that will be amortized from accumulated other comprehensive income 15

Other Postretirement Benefits

Defined Benefit Plan Disclosure [Line Items]

Net pension and postretirement cost 9 10 19

Pension plan projected benefit obligations 186 201 186 201 $ 243

Estimated net actuarial loss that will be amortized from accumulated other comprehensive income (2)

Estimated prior service credit costs that will be amortized from accumulated other comprehensive income 5

U.S. Plans

Defined Benefit Plan Disclosure [Line Items]

Pension plan assets at fair value 1,157 1,255 1,157 1,255

U.S. Plans | Equity securities

Defined Benefit Plan Disclosure [Line Items]

Pension plan assets at fair value $ 335 $ 393 $ 335 $ 393

U.S. Plans | Minimum

Defined Benefit Plan Disclosure [Line Items]

Defined benefit plan, spot rate used in calculating service and interest cost components, discount rate 0.56%

U.S. Plans | Maximum

Defined Benefit Plan Disclosure [Line Items]

Defined benefit plan, spot rate used in calculating service and interest cost components, discount rate 4.87%

X

- Definition
The pretax net amount of gains and losses that are not yet recognized as a component of net periodic postemployment benefit cost, and that are recognized as increases or decreases in other comprehensive income as they arise. Gains and losses are due to changes in the value of either the benefit obligation or the plan assets resulting from experience different from that assumed or from a change in an actuarial assumption, or the consequence of a decision to temporarily deviate from the substantive plan.
+ References
No definition available.
+ Details

Name: bdx_AmountRecognizedInAccumulatedAndOtherComprehensiveIncomeBeforeIncomeTaxesForNetActuarialLoss

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Change in Accounting Estimate, Estimated Amount of Change in Next Fiscal Year
+ References
No definition available.
+ Details

Name: bdx_ChangeinAccountingEstimateEstimatedAmountofChangeinNextFiscalYear

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Change in Estimate Workforce Reduction Liability
+ References
No definition available.
+ Details

Name: bdx_ChangeinEstimateWorkforceReductionLiability

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The spot discount rate, derived from the yield curve over the projected cash flow period, that is applied to individual expected cash flows in order to determine the service and interest cost components of net periodic benefit cost.
+ References
No definition available.
+ Details

Name: bdx_DefinedBenefitPlanSpotRateUsedCalculatingServiceandInterestCostComponentsDiscountRate

Namespace Prefix: bdx_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The guaranteed portion, representing employees' contributions to the fixed income fund of the Company's defined contribution plan, as of the balance sheet date.
+ References
No definition available.
+ Details

Name: bdx_EmployeesContributionGuaranteedByCompanyToFixedIncomeFundOfSavingsIncentivePlan

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amounts in accumulated other comprehensive income related to gains and losses that are not recognized immediately and are expected to be recognized as components of net periodic postemployment benefit cost over the next fiscal year that follows the most recent annual statement of financial position presented.
+ References
No definition available.
+ Details

Name: bdx_NetActuarialLossAmortizedFromAccumulatedOtherComprehensiveIncomeToPostEmploymentCost

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Percentage of the Company's total plan assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits related to domestic pension plans.
+ References
No definition available.
+ Details

Name: bdx_PercentOfAssetsDomesticPlans

Namespace Prefix: bdx_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of the Company's total plan assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits related to foreign pension plans.
+ References
No definition available.
+ Details

Name: bdx_PercentOfPlanAssetsForeignPlans

Namespace Prefix: bdx_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Costs associated with workforce reduction actions that were not contemplated when the post employment benefit plan obligation was measured for the current fiscal year.
+ References
No definition available.
+ Details

Name: bdx_WorkforceReductionCosts

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Remaining liability relating to workforce reduction costs that were not contemplated when the post employment benefit plan obligation was measured.
+ References
No definition available.
+ Details

Name: bdx_WorkforceReductionCostsRemainingLiability

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
1) For defined benefit pension plans, the benefit obligation is the projected benefit obligation, which is the actuarial present value as of a date of all benefits attributed by the pension benefit formula to employee service rendered prior to that date. 2) For other postretirement defined benefit plans, the benefit obligation is the accumulated postretirement benefit obligation, which is the actuarial present value of benefits attributed to employee service rendered to a particular date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Projected Benefit Obligation

-URI http://asc.fasb.org/extlink&oid=6522206

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Accumulated Postretirement Benefit Obligation

-URI http://asc.fasb.org/extlink&oid=6503904

+ Details

Name: us-gaap_DefinedBenefitPlanBenefitObligation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlanDisclosureLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits, at their fair value as of the measurement date. Plan assets include amounts contributed by the employer (and by employees for a contributory plan) and amounts earned from investing the contributions, less benefits paid. If a plan has liabilities other than for benefits, those non-benefit obligations may be considered as reductions of plan assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 30

-Section 35

-Paragraph 50

-URI http://asc.fasb.org/extlink&oid=49178875&loc=d3e12355-114930

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanFairValueOfPlanAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount included in accumulated other comprehensive income (AOCI) related to gain (loss) expected to be recognized as components of net periodic benefit cost for the fiscal year that follows the most recent annual statement of financial position.
+ References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlanFutureAmortizationOfGainLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount included in accumulated other comprehensive income (AOCI) related to prior service cost (credit) expected to be recognized as components of net periodic benefit cost for the fiscal year that follows the most recent annual statement of financial position.
+ References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlanFutureAmortizationOfPriorServiceCostCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The assumed health care cost trend rate for the next year used to measure the expected cost of benefits covered by the plan (gross eligible charges). This is based upon the annual rate of change in the cost of health care benefits currently provided by the postretirement benefit plan, due to factors other than changes in the composition of the plan population by age and dependency status.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Health Care Cost Trend Rate

-URI http://asc.fasb.org/extlink&oid=6514820

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (l)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedForNextFiscalYear

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The total amount of net periodic benefit cost for defined benefit plans for the period. Periodic benefit costs include the following components: service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) due to settlements or curtailments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (h)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (j)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Target allocation of investments of this type to total plan assets presented on a weighted average basis.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 5

-Subparagraph (c)(i)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e2446-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (d)(i)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanTargetPlanAssetAllocations

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The ultimate trend rate for health care costs.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (l)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of the cost recognized during the period for defined contribution plans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 70

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

+ Details

Name: us-gaap_DefinedContributionPlanCostRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.P.4(b))

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 5.P.3)

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140864-122747

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)(10)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section P

-Subsection 3, 4

+ Details

Name: us-gaap_SeveranceCosts1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=bdx_CareFusionCorporationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeFundsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=bdx_DiversifiedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ChangeInAccountingEstimateByTypeAxis=us-gaap_ChangeInAssumptionsForPensionPlansMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_ForeignPensionPlansDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_PensionPlansDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 74 R22.htm IDEA: XBRL DOCUMENT v3.3.0.814

Debt
12 Months Ended

Sep. 30, 2015

Debt Disclosure [Abstract]

Debt
Debt
Short-term debt at September 30 consisted of:
(Millions of dollars)
2015

2014
Loans Payable

Domestic
$
700

$
200

Foreign
—

3

Current portion of long-term debt
752

—

$
1,452

$
203

The weighted average interest rates for short-term debt were 0.64% and 0.40% at September 30, 2015 and 2014, respectively. Domestic loans payable consist of a commercial paper program the Company entered into in January 2015, in anticipation of the closing of the CareFusion acquisition, which is further discussed in Note 9. Under the program, the Company may issue up to $1 billion in short-term, unsecured commercial paper notes. A former commercial paper program which had been in place to meet short-term financing needs was terminated in February 2015 and the outstanding borrowings of $200 million under the former program were rolled into the new commercial paper program. Borrowings of $700 million were outstanding under the current commercial paper program at September 30, 2015, of which $500 million was used to finance the Company’s acquisition of CareFusion and to pay related fees and expenses. Foreign loans payable consisted of short-term borrowings from financial institutions. The current portion of long-term debt includes $750 million of floating rates notes due on June 15, 2016. These floating rate notes, as well as additional senior unsecured notes, were issued in December 2014 as part of the Company's plan for financing the cash requirements relative to the CareFusion acquisition. The total aggregate principal amount of senior unsecured notes issued in December 2014 was $6.2 billion.
Also in December 2014, the Company entered into a 364-day term loan agreement that provided for a $1 billion term loan facility, the proceeds under which could only be used to pay the cash consideration due pursuant to the CareFusion acquisition agreement, as well as to pay financing fees, other related fees and other expenses associated with the CareFusion acquisition. At September 30, 2015, the term loan was fully repaid with no borrowings outstanding, reflecting principal payments of $650 million, $250 million and $100 million made in April, July and September 2015, respectively.
Concurrent with the execution of the agreement to acquire CareFusion, the Company secured $9.1 billion of fully committed bridge financing to ensure its ability to fund the cash portion of consideration due under the agreement, as well as to pay fees and expenses related to the acquisition. This bridge credit agreement was terminated upon the closing of the CareFusion acquisition in March 2015.
The Company has available a $1 billion syndicated credit facility. This credit facility, under which there were no borrowings outstanding at September 30, 2015, provides backup support for its commercial paper program and can also be used for other general corporate purposes. It includes a provision that enables the Company, subject to additional commitments made by the lenders, to access up to an additional $500 million in financing through the facility, for a maximum aggregate commitment of $1.5 billion. During the third quarter of fiscal year 2014, the Company extended the expiration date of this credit facility to May 2018 from the original expiration date of May 2017. The credit facility includes a single financial covenant that requires the Company to maintain an interest expense coverage ratio (ratio of earnings before income taxes, depreciation and amortization to interest expense) of not less than 5-to-1 for the most recent four consecutive fiscal quarters. The Company was in compliance with this covenant as of September 30, 2015. In addition, the Company has informal lines of credit outside of the United States.
Upon the closing of the CareFusion acquisition in March 2015, the Company assumed the indebtedness of CareFusion, including senior unsecured notes with an aggregate principal amount of $2 billion, which was recorded on the acquisition date at a fair value of $2.174 billion. In March 2015, subsequent to closing the acquisition of CareFusion, the Company commenced offers to exchange all validly tendered and accepted notes issued by CareFusion for notes to be issued by the Company. This offer expired in April 2015 and the aggregate principal amounts below of each series of the CareFusion notes were validly tendered and exchanged for notes issued by the Company.

Aggregate Principal Amount

Percentage of Total Outstanding Principal Amount of such Series of Existing Notes
Interest Rate and Maturity
(Millions of dollars)

1.450% Notes due May 15, 2017
$
293

97.64
%
6.375% Notes due August 1, 2019
665

95.00
%
3.300% Notes due March 1, 2023
294

97.95
%
3.875% Notes due May 15, 2024
397

99.37
%
4.875% Notes due May 15, 2044
300

99.96
%
Total senior notes issued under exchange transaction
$
1,949

This exchange transaction was accounted for as a modification of the original debt instruments. As such, no gain or loss was recognized in the Company’s consolidated results of operations as a result of this exchange transaction. Following the exchange of the notes, the aggregate principal amount of CareFusion notes that remain outstanding across the five series is $51 million.
Long-Term Debt at September 30 consisted of:
(Millions of dollars)
2015

2014
1.750% Notes due November 8, 2016
$
499

$
499

1.450% Notes due May 15, 2017
300

(A)

—

1.800% Notes due December 15, 2017
1,246

(B)

—

4.900% Notes due April 15, 2018
202

202

5.000% Notes due May 15, 2019
497

497

6.375% Notes due August 1, 2019
802

(A)

—

2.675% Notes due December 15, 2019
1,244

(B)

—

3.250% Notes due November 12, 2020
697

697

3.125% Notes due November 8, 2021
1,013

997

3.300% Notes due March 1, 2023
305

(A)

—

3.875% Notes due May 15, 2024
419

(A)

—

3.734% Notes due December 15, 2024
1,739

(B)

—

7.000% Debentures due August 1, 2027
168

168

6.700% Debentures due August 1, 2028
167

167

6.000% Notes due May 15, 2039
246

246

5.000% Notes due November 12, 2040
296

296

4.875% Notes due May 15, 2044
334

(A)

—

4.685% Notes due December 15, 2044
1,190

(B)

—

Other long-term debt
5

$
—

$
11,370

$
3,768

(A)
Represents senior unsecured notes issued in the April 2015 exchange of all validly tendered and accepted CareFusion notes for notes issued by the Company, as further discussed above.
(B)
Represents senior unsecured notes issued in December 2014 in connection with the CareFusion acquisition, as further discussed above.
The aggregate annual maturities of long-term debt during the fiscal years ending September 30, 2016 to 2020 are as follows: 2016 — $750; 2017 — $800; 2018 — $1.45 billion; 2019 — $1.2 billion; 2020 — $1.25 billion.
The Company capitalizes interest costs as a component of the cost of construction in progress. A summary of interest costs and payments for the years ended September 30 is as follows:
(Millions of dollars)
2015

2014

2013
Charged to operations
$
371

$
135

$
138

Capitalized
30

32

33

Total interest costs
$
401

$
167

$
171

Interest paid, net of amounts capitalized
$
313

$
135

$
143

The amounts of interest charged to operations and interest paid include $107 million of financing costs associated with the CareFusion acquisition, including interest on the senior unsecured notes issued in December 2014 and commitment fees for the bridge loan facility entered into concurrently with the execution of the agreement to acquire CareFusion. Additional information regarding these costs is provided in Note 9.

X

- References
No definition available.
+ Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20,22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 75 R36.htm IDEA: XBRL DOCUMENT v3.3.0.814

Intangible Assets (Tables)
12 Months Ended

Sep. 30, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Components of Intangible Assets
Intangible assets at September 30 consisted of:

2015

2014
(Millions of dollars)
Gross
Carrying
Amount

Accumulated
Amortization

Gross
Carrying
Amount

Accumulated
Amortization
Amortized intangible assets

Customer relationships
$
3,370

$
120

$
10

$
2

Developed technology
3,487

510

893

379

Product rights
128

35

148

31

Trademarks
405

26

27

19

Patents and other
333

212

232

163

Amortized intangible assets
$
7,723

$
903

$
1,308

$
594

Unamortized intangible assets

Acquired in-process research and development
$
203

$
44

Trademarks
2

2

Unamortized intangible assets
$
205

$
46

Reconciliation of Goodwill by Business Segment
The following is a reconciliation of goodwill by business segment:
(Millions of dollars)
Medical

Life Sciences

Total
Goodwill as of September 30, 2013
$
511

$
598

$
1,109

Acquisitions
—

13

(A)

13

Currency translation/other (B)
(29
)

(3
)

(32
)
Goodwill as of September 30, 2014
$
482

$
608

$
1,090

Acquisitions
6,585

(C)

130

(D)

6,716

Currency translation/other (B)
(261
)

(8
)

(269
)
Goodwill as of September 30, 2015
$
6,807

$
730

$
7,537

(A)
Represents goodwill recognized upon the Company’s acquisition of Alverix in the second quarter of fiscal year 2014.
(B)
Includes amounts resulting from foreign currency translation as well as acquisition accounting adjustments.
(C)
Primarily represents goodwill recognized upon the Company’s acquisition of CareFusion in the second quarter of fiscal year 2015. Additional disclosures regarding the CareFusion acquisition are provided in Note 9. Also includes $22 million of goodwill associated with individually immaterial acquisitions, including the CRISI and ARX acquisitions in the second and third quarters of fiscal year 2015, respectively.
(D)
Represents goodwill recognized upon the Company’s acquisitions of GenCell and Cellular Research in the first and fourth quarters of fiscal year 2015, respectively.

X

- References
No definition available.
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

+ Details

Name: us-gaap_ScheduleOfGoodwillTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

+ Details

Name: us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 76 R98.htm IDEA: XBRL DOCUMENT v3.3.0.814

Debt - Summary of Interest Costs and Payments (Detail) - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Debt Disclosure [Abstract]

Charged to operations $ 371 $ 135 $ 138

Capitalized 30 32 33

Total interest costs 401 167 171

Interest paid, net of amounts capitalized $ 313 $ 135 $ 143

X

- References
No definition available.
+ Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of interest capitalized during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Allowance for Funds Used during Construction

-URI http://asc.fasb.org/extlink&oid=6504829

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

+ Details

Name: us-gaap_InterestCostsCapitalized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Total interest costs incurred during the period and either capitalized or charged against earnings.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

+ Details

Name: us-gaap_InterestCostsIncurred

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.9)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of cash paid for interest during the period net of cash paid for interest that is capitalized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

+ Details

Name: us-gaap_InterestPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 77 R24.htm IDEA: XBRL DOCUMENT v3.3.0.814

Sale-Type Leases and Financing Receivable
12 Months Ended

Sep. 30, 2015

Receivables [Abstract]

Sale-Type Leases and Financing Receivable
Sales-Type Leases and Financing Receivables

As disclosed in Note 9, the net assets acquired in the Company’s acquisition of CareFusion included a $1.208 billion net investment in sales-type leases which primarily arose from the leasing of dispensing equipment. The components of the net investment in sales-type leases, which predominantly have five-year terms and are generally collateralized by the underlying equipment, are as follows as of September 30, 2015.

September 30,
(Millions of dollars)
2015
Future minimum lease payments receivable
$
1,311

Unguaranteed residual values
29

Unearned income
(142
)
Allowance for uncollectible minimum lease payments receivable
(5
)
Net Investment in Sales-Type Leases
1,193

Less: Current portion of net investment in sales-type leases
75

Net Investment in Sales-Type Leases, Less Current Portion
$
1,118

Future minimum lease payments to be received pursuant to sales-type leases are as follows: 2016 — $413 million; 2017 — $355 million; 2018 — $275 million; 2019 — $187 million; 2020 — $79 million and an aggregate of $3 million thereafter.
The methodology for determining the allowance for credit losses for these financing receivables is based on the collective population and is not stratified by class or portfolio segment. Allowances for credit losses on the entire portfolio are recorded based on historical experience loss rates and the potential impact of anticipated changes in business practices, market dynamics, and economic conditions. The net investment in sales-type leases is predominantly evaluated for impairment on a collective basis; however, some immaterial allowances for individual balances are recorded based on the evaluation of customers’ specific circumstances. No interest is accrued on past due financing receivables, which are generally considered past due 30 days after the billing date. Amounts are written off against the allowance for credit losses when determined to be uncollectible. The allowance for credit losses on these financing receivables was immaterial at September 30, 2015.

X

- Definition
The entire disclosure for lessor's leasing arrangements, which includes direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=25496975&loc=d3e45377-112738

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6452767&loc=d3e37045-112695

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 10

-Section 55

-Paragraph 47

-URI http://asc.fasb.org/extlink&oid=6584217&loc=d3e38847-112698

+ Details

Name: us-gaap_CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ReceivablesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 78 R68.htm IDEA: XBRL DOCUMENT v3.3.0.814

Benefit Plans - Weighted Average Assumptions Determining Pension Plan (Detail)
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

U.S. Plans

Net Cost

Discount rate 4.15% 4.95% 3.90%

Expected return on plan assets 7.50% 7.75% 7.75%

Rate of compensation increase 4.25% 4.25% 4.25%

Benefit Obligation

Discount rate 4.15% 4.15% 4.95%

Rate of compensation increase 4.25% 4.25% 4.25%

Foreign Plans

Net Cost

Discount rate 3.14% 3.87% 3.94%

Expected return on plan assets 5.45% 5.68% 5.68%

Rate of compensation increase 2.49% 2.46% 3.28%

Benefit Obligation

Discount rate 2.84% 3.14% 3.87%

Rate of compensation increase 2.33% 2.49% 2.46%

X

- Definition
The interest rate used to adjust for the time value of money for the plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (k)(1)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Expected rate of compensation increases (for pay-related plans).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (k)(2)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
The interest rate used to adjust for the time value of money.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (k)(1)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
An assumption as to the rate of return on plan assets reflecting the average rate of earnings expected on the funds invested or to be invested to provide for the benefits included in the benefit obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Expected Long-Term Rate of Return on Plan Assets

-URI http://asc.fasb.org/extlink&oid=6512046

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (k)(3)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Expected rate of compensation increases (for pay-related plans).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (k)(2)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_ForeignPensionPlansDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 79 R108.htm IDEA: XBRL DOCUMENT v3.3.0.814

Supplemental Financial Information - Trade Receivables, Allowances for Doubtful Accounts and Cash Discounts (Detail) - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Movement in Valuation Allowances and Reserves [Roll Forward]

Beginning Balance $ 42 $ 50 $ 45

Additions charged to costs and expenses 80 46 49

Deductions and other (61) (54) (44)

Ending Balance 62 42 50

Allowance for Doubtful Accounts

Movement in Valuation Allowances and Reserves [Roll Forward]

Beginning Balance 30 41 36

Additions charged to costs and expenses 33 6 9

Deductions and other (11) (16) (3)

Ending Balance 53 30 41

Allowance for Cash Discounts

Movement in Valuation Allowances and Reserves [Roll Forward]

Beginning Balance 12 9 9

Additions charged to costs and expenses 47 41 40

Deductions and other (50) (38) (41)

Ending Balance $ 9 $ 12 $ 9

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_MovementInValuationAllowancesAndReservesRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Total of allowances and reserves, the valuation and qualifying accounts that are either netted against the cost of an asset (in order to value it at its carrying value) or that reflect a liability established to represent expected future costs.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 09

-Article 12

+ Details

Name: us-gaap_ValuationAllowancesAndReservesBalance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of allowances and reserves, the valuation and qualifying accounts that are either netted against the cost of an asset (in order to value it at its carrying value) or that reflect a liability established to represent expected future costs, charged to costs and expenses.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 09

-Article 12

+ Details

Name: us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total of the deductions in a given period to allowances and reserves, the valuation and qualifying accounts that are either netted against the cost of an asset (in order to value it at its carrying value) or that reflect a liability established to represent expected future costs, representing receivables written off as uncollectible and portions of the reserves utilized, respectively.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 09

-Article 12

+ Details

Name: us-gaap_ValuationAllowancesAndReservesDeductions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForDoubtfulAccountsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ReserveForCashDiscountMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 80 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 81 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814

Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Operating Activities

Net Income $ 695 $ 1,185 $ 1,293

Less: Income from discontinued operations, net 0 0 364

Income from continuing operations, net 695 1,185 929

Adjustments to income from continuing operations to derive net cash provided by continuing operating activities, net of amounts acquired:

Depreciation and amortization 891 562 546

Share-based compensation 166 113 100

Deferred income taxes (336) (32) 36

Change in operating assets and liabilities:

Trade receivables, net (2) (7) (1)

Net investment in sales-type leases 28 0 0

Inventories 200 (189) (145)

Prepaid expenses, deferred taxes and other (97) (120) (60)

Accounts payable, income taxes and other liabilities 145 199 366

Pension obligation 28 (29) (51)

Other, net 11 62 (1)

Net Cash Provided by Continuing Operating Activities 1,730 1,746 1,717

Investing Activities

Capital expenditures (596) (592) (522)

Capitalized software (37) (61) (66)

Change in short-term investments 840 (171) (225)

Acquisitions of businesses, net of cash acquired (8,414) (40) (136)

Divestiture of businesses 0 0 736

Other, net (110) (84) (99)

Net Cash Used for Continuing Investing Activities (8,318) (948) (311)

Financing Activities

Change in short-term debt 497 (4) (199)

Proceeds from long-term debt 6,164 0 0

Payments of debt (6) 0 0

Repurchase of common stock 0 (400) (450)

Issuance of common stock and other, net (27) (9) 44

Excess tax benefit from payments under share-based compensation plans 48 27 23

Dividends paid (485) (421) (386)

Net Cash Provided by (Used for) Continuing Financing Activities 6,190 (807) (968)

Net Cash Used For Discontinued Operations 0 0 (212)

Effect of exchange rate changes on cash and equivalents (38) (20) (7)

Net (Decrease) Increase in Cash and Equivalents (436) (29) 219

Opening Cash and Equivalents 1,861 1,890 1,671

Closing Cash and Equivalents $ 1,424 $ 1,861 $ 1,890

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationDepletionAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906

+ Details

Name: us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 20

-Section 55

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11374-113907

+ Details

Name: us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations attributable to the parent. Also defined as revenue less expenses and taxes from ongoing operations before extraordinary items but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.13)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4613673-111683

+ Details

Name: us-gaap_IncomeLossFromContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.12)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5C

-Subparagraph (b)(2)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721675-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.14)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e1012-107759

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3B

-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721525-107759

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3A

-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721523-107759

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e957-107759

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 13

-Article 7

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 15

-Article 5

+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInDeferredIncomeTaxes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in outstanding loans including accrued interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInFinanceReceivables

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in other assets used in operating activities less other operating liabilities used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current assets and liabilities, other noncurrent assets and liabilities, or a combination of other current and noncurrent assets and liabilities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amount due to fund retirement benefits to employees, retired and disabled former employees.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInPensionPlanObligations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Increase (decrease) in cash associated with the entity's discontinued operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInDiscontinuedOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The net cash outflow or inflow from other investing activities. This element is used when there is not a more specific and appropriate element in the taxonomy.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3098-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3095-108585

+ Details

Name: us-gaap_PaymentsForProceedsFromOtherInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The net amount paid (received) by the reporting entity through acquisition or sale and maturities of short-term investments with an original maturity that is three months or less which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 9

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3098-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3095-108585

+ Details

Name: us-gaap_PaymentsForProceedsFromShortTermInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to reacquire common stock during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_PaymentsForRepurchaseOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsForSoftware

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_PaymentsOfDividendsCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This element represents the cash inflow during the period from the sale of a component of the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3179-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromIssuanceOfLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net cash inflow or outflow from other financing activities. This element is used when there is not a more specific and appropriate element in the taxonomy.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3095-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3098-108585

+ Details

Name: us-gaap_ProceedsFromPaymentsForOtherFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 9

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3098-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_ProceedsFromRepaymentsOfShortTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_RepaymentsOfLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 82 R3.htm IDEA: XBRL DOCUMENT v3.3.0.814

Consolidated Statements of Income (Parenthetical) - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Income Statement [Abstract]

Discontinued operations, income tax provision $ 0 $ 0 $ 222

X

- Definition
Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32672-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3B

-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721525-107759

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3A

-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721523-107759

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5B

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721673-107760

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 20

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=18498875&loc=d3e38679-109324

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5C

-Subparagraph (b)(2)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721675-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e1012-107759

+ Details

Name: us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 83 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814

Divestiture
12 Months Ended

Sep. 30, 2015

Discontinued Operations and Disposal Groups [Abstract]

Divestiture
Divestiture
On October 31, 2012, the Company completed the sale of its Life Sciences—Discovery Labware unit, excluding its Advanced Bioprocessing platform. Gross cash proceeds from the sale were approximately $740 million, subject to post-closing adjustments. Total gross proceeds included a payment of approximately $16 million received in the third quarter of fiscal year 2013 as reimbursement of additional tax costs incurred by the Company as a result of the buyer’s treatment of the acquisition as an asset purchase for federal tax purposes. The Company recognized a pre-tax gain on sale from this divestiture of $577 million. The after-tax gain recognized from this divestiture was $355 million. As a result of this divestiture, the Company derecognized $17 million of goodwill, allocated based upon the relative fair values of the disposed assets.
The Company agreed to perform some contract manufacturing and other transition services for a defined period after the sale; however, the Company did not have the ability to exert significant influence over the Discovery Labware disposal group after the sale, and cash flows associated with these activities were not material. The net cash flows from these activities are reported in the Consolidated Statements of Income as Other income (expense), net.
The results of operations associated with the Discovery Labware disposal group are reported as discontinued operations for all periods presented in the accompanying Consolidated Statements of Income and Cash Flows and related disclosures.
Results of discontinued operations were as follows:
(Millions of dollars)
2015

2014

2013
Revenues
$
—

$
—

$
20

Income from discontinued operations before income taxes
—

—

586

Less income tax provision
—

—

222

Income from discontinued operations, net
$
—

$
—

$
364

X

- References
No definition available.
+ Details

Name: us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721533-107759

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 4B

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721665-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5C

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721675-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 3A

-URI http://asc.fasb.org/extlink&oid=51719941&loc=SL51724579-110230

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 4A

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721663-107760

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51719941&loc=d3e2941-110230

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5B

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721673-107760

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 3A

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721659-107760

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5A

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721671-107760

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5D

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721677-107760

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1474-107760

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721683-107760

+ Details

Name: us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 84 R103.htm IDEA: XBRL DOCUMENT v3.3.0.814

Income Taxes - Deferred Income Taxes (Detail) - USD ($)
$ in Millions

Sep. 30, 2015

Sep. 30, 2014

Income Tax Disclosure [Abstract]

Compensation and benefits, assets $ 647 $ 546

Loss and credit carryforwards, assets 538 274

Other, assets 634 398

Deferred income taxes, assets, gross 1,819 1,218

Valuation allowance, assets (452) (247)

Deferred income taxes, assets 1,367 971

Property and equipment, liabilities 156 196

Deferred Tax Liabilities, Other Finite-Lived Assets 2,033 266

Other, liabilities 606 195

Deferred income taxes, liabilities, gross 2,795 656

Deferred income taxes, liabilities $ 2,795 $ 656

X

- Definition
The total cumulative amount of all deferred tax liabilities as presented in the table of deferred income taxes.
+ References
No definition available.
+ Details

Name: bdx_DeferredTaxLiabilitiesGross

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Deferred Tax Liability

-URI http://asc.fasb.org/extlink&oid=6510232

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 15

-Subparagraph b(2)

-Article 7

+ Details

Name: us-gaap_DeferredIncomeTaxLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Deferred Tax Asset

-URI http://asc.fasb.org/extlink&oid=6510090

+ Details

Name: us-gaap_DeferredTaxAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b),(c)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

+ Details

Name: us-gaap_DeferredTaxAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences not separately disclosed.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 25

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=51675352&loc=d3e28680-109314

+ Details

Name: us-gaap_DeferredTaxAssetsOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to other deductible tax carryforwards not separately disclosed.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 25

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=51675352&loc=d3e28680-109314

+ Details

Name: us-gaap_DeferredTaxAssetsOtherTaxCarryforwards

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 25

-Paragraph 20

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51675352&loc=d3e28680-109314

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

+ Details

Name: us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

+ Details

Name: us-gaap_DeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences not separately disclosed.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 25

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=51675352&loc=d3e28680-109314

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319

+ Details

Name: us-gaap_DeferredTaxLiabilitiesOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 25

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=51675352&loc=d3e28680-109314

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319

+ Details

Name: us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 25

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=51675352&loc=d3e28680-109314

+ Details

Name: us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 85 R93.htm IDEA: XBRL DOCUMENT v3.3.0.814

Debt - Summary of Short-Term Debt (Detail) - USD ($)
$ in Millions

Sep. 30, 2015

Sep. 30, 2014

Short-term Debt [Line Items]

Current portion of long-term debt $ 752 $ 0

Short-term debt 1,452 203

Domestic

Short-term Debt [Line Items]

Loans Payable 700 200

Foreign

Short-term Debt [Line Items]

Loans Payable $ 0 $ 3

X

- Definition
Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt, after unamortized discount or premium, scheduled to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermDebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.13)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.(a),16(a)(1))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 13

-Subparagraph 2, 3

-Article 9

+ Details

Name: us-gaap_ShortTermBorrowings

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShortTermDebtLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=us-gaap_DomesticLineOfCreditMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=us-gaap_ForeignLineOfCreditMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 86 R91.htm IDEA: XBRL DOCUMENT v3.3.0.814

Financial Instruments and Fair Value Measurements - Fair Values of Financial Instruments (Detail) - Recurring Fair Value Measurements - USD ($)
$ in Millions

Sep. 30, 2015

Sep. 30, 2014

Assets

Institutional money market investments $ 147 $ 1,040

Interest rate swaps 19 3

Forward exchange contracts 13 20

Total Assets 179 1,063

Liabilities

Forward exchange contracts 21 14

Commodity forward contracts 10

Contingent consideration liabilities 77 14

Total Liabilities 108 29

Quoted Prices in Active Markets for Identical Assets (Level 1)

Assets

Institutional money market investments 147 1,040

Interest rate swaps 0 0

Forward exchange contracts 0 0

Total Assets 147 1,040

Liabilities

Forward exchange contracts 0 0

Commodity forward contracts 0

Contingent consideration liabilities 0 0

Total Liabilities 0 0

Significant Other Observable Inputs (Level 2)

Assets

Institutional money market investments 0 0

Interest rate swaps 19 3

Forward exchange contracts 13 20

Total Assets 32 23

Liabilities

Forward exchange contracts 21 14

Commodity forward contracts 10

Contingent consideration liabilities 0 0

Total Liabilities 30 14

Significant Unobservable Inputs (Level 3)

Assets

Institutional money market investments 0 0

Interest rate swaps 0 0

Forward exchange contracts 0 0

Total Assets 0 0

Liabilities

Forward exchange contracts 0 0

Commodity forward contracts 0

Contingent consideration liabilities 77 14

Total Liabilities $ 77 $ 14

X

- Definition
Commodity Forward Contracts Derivative Fair Value Disclosure
+ References
No definition available.
+ Details

Name: bdx_CommodityForwardContractsDerivativeFairValueDisclosure

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value of contingent consideration liabilities recognized as part of business combination transaction.
+ References
No definition available.
+ Details

Name: bdx_ContingentConsiderationClassifiedAsLiabilityFairValueDisclosure

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_AssetsFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

+ Details

Name: us-gaap_CashAndCashEquivalentsFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.
+ References
No definition available.
+ Details

Name: us-gaap_ForeignCurrencyContractAssetFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.
+ References
No definition available.
+ Details

Name: us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value as of the balance sheet date of interest rate derivative assets, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

+ Details

Name: us-gaap_InterestRateDerivativeAssetsAtFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value of financial and nonfinancial obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_LiabilitiesFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 87 R1.htm IDEA: XBRL DOCUMENT v3.3.0.814

Document and Entity Information - USD ($)
12 Months Ended

Sep. 30, 2015

Oct. 31, 2015

Mar. 31, 2015

Document And Entity Information [Abstract]

Entity registrant name BECTON DICKINSON & CO

Entity central index key 0000010795

Current fiscal year end date --09-30

Entity filer category Large Accelerated Filer

Document type 10-K

Document period end date Sep. 30, 2015

Document fiscal year focus 2015

Document fiscal period focus FY

Amendment flag false

Entity common stock, shares outstanding (shares) 210,736,542

Entity well-known seasoned issuer Yes

Entity voluntary filers No

Entity current reporting status Yes

Entity public float $ 30,013,657,226

X

- Definition
Document and Entity Information.
+ References
No definition available.
+ Details

Name: bdx_DocumentAndEntityInformationAbstract

Namespace Prefix: bdx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.
+ References
No definition available.
+ Details

Name: dei_EntityPublicFloat

Namespace Prefix: dei_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
+ References
No definition available.
+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
+ References
No definition available.
+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

XML 88 R18.htm IDEA: XBRL DOCUMENT v3.3.0.814

Business Restructuring Charges
12 Months Ended

Sep. 30, 2015

Restructuring and Related Activities [Abstract]

Business Restructuring Charges
Business Restructuring Charges

In connection with the CareFusion acquisition, the Company incurred restructuring costs throughout fiscal year 2015, which were recorded as Acquisition-related costs. Restructuring accrual activity in 2015 was as follows:

(Millions of dollars)

Employee Termination

Share-Based Compensation

Other (A)

Total
Balance at September 30, 2014
$
—

$
—

$
—

$
—

Assumed liability

19

—

—

19

Charged to expense

126

44

102

271

Cash payments

(74
)

—

(20
)

(94
)
Non-cash settlements

—

(44
)

—

(44
)
Other adjustments

(9
)

—

(81
)

(91
)
Balance at September 30, 2015
$
62

$
—

$
—

$
62

(A)
Amounts primarily relate to impairment charges for assets held for sale, primarily assets that will be sold as a result of an information technology infrastructure outsourcing project the Company will initiate in fiscal year 2016. Additional disclosures regarding these asset impairment charges are provided in Note 14.

Additional disclosures regarding these restructuring activities and the related costs are provided in Notes 7, 8 and 9.

X

- References
No definition available.
+ Details

Name: us-gaap_RestructuringAndRelatedActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.P.4)

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 5.P.3)

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140864-122747

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section P

-Subsection 3, 4

+ Details

Name: us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 89 R80.htm IDEA: XBRL DOCUMENT v3.3.0.814

Acquisitions - Fair Value of Assets and Liabilities Assumed (Detail) - USD ($)
$ in Millions

Mar. 17, 2015

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Business Acquisition [Line Items]

Goodwill $ 7,537 $ 1,090 $ 1,109

Care Fusion Corporation

Business Acquisition [Line Items]

Cash and equivalents $ 1,903

Trade receivables, net 530

Inventories 813

Net investment in sales-type leases 1,208

Property, plant and equipment 499

Customer relationships 3,360

Developed technology 2,510

Trademarks 380

Other intangible assets 185

Other assets 321

Total identifiable assets acquired 11,709

Long-term debt (2,181)

Deferred tax liabilities (2,034)

Other liabilities (1,299)

Total liabilities assumed (5,514)

Net identifiable assets acquired 6,195

Goodwill 6,343

Net assets acquired $ 12,538

X

- Definition
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Customer Relationships
+ References
No definition available.
+ Details

Name: bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of technology, determined to be technologically feasible, acquired at the acquisition date.
+ References
No definition available.
+ Details

Name: bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDevelopedTechnology

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Liabilities
+ References
No definition available.
+ Details

Name: bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Trademarks
+ References
No definition available.
+ Details

Name: bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTrademarks

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Net Investment in Sales Type Leases
+ References
No definition available.
+ Details

Name: bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetInvestmentinSalesTypeLeases

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Other Intangible Assets
+ References
No definition available.
+ Details

Name: bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherIntangibleAssets

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_BusinessAcquisitionLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 30

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 30

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477

+ Details

Name: us-gaap_BusinessCombinationConsiderationTransferred1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of assets acquired at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences due after one year or the normal operating cycle, if longer, assumed at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of inventory recognized as of the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 55

-Paragraph 37

-URI http://asc.fasb.org/extlink&oid=35744172&loc=d3e2207-128464

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of liabilities assumed at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 55

-Paragraph 37

-URI http://asc.fasb.org/extlink&oid=35744172&loc=d3e2207-128464

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of property, plant, and equipment recognized as of the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 55

-Paragraph 37

-URI http://asc.fasb.org/extlink&oid=35744172&loc=d3e2207-128464

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=bdx_CareFusionCorporationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 90 R90.htm IDEA: XBRL DOCUMENT v3.3.0.814

Derivative Instruments and Hedging Activities - Undesignated Hedges (Detail) - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Derivatives Not Designated as Hedging Instruments | Forward exchange contracts | Other Income (Expense), Net

Derivative Instruments and Hedging Activities Disclosures [Line Items]

Amount of gain (loss) recognized in income on derivative $ (49) $ (3) $ (1)

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4A

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5618551-113959

+ Details

Name: us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=bdx_OtherIncomeExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 91 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814

Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Statement of Comprehensive Income [Abstract]

Net Income $ 695 $ 1,185 $ 1,293

Other Comprehensive (Loss) Income, Net of Tax

Foreign currency translation adjustments (692) (344) 23

Defined benefit pension and postretirement plans (36) (147) 257

Unrealized (losses) gains on cash flow hedges, net of amounts realized (9) 5 7

Other Comprehensive (Loss) Income, Net of Tax (737) (486) 286

Comprehensive (Loss) Income $ (42) $ 699 $ 1,579

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831223

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e557-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 10A

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580

+ Details

Name: us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 45

-Paragraph 20

-Subparagraph (b,c)

-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32211-110900

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 10A

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580

+ Details

Name: us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 1B

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 55

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=51821188&loc=d3e1436-108581

+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments, of (increase) decrease in accumulated other comprehensive (income) loss related to pension and other postretirement defined benefit plans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 10A

-Subparagraph (i-k)

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580

+ Details

Name: us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 92 R12.htm IDEA: XBRL DOCUMENT v3.3.0.814

Commitments and Contingencies
12 Months Ended

Sep. 30, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies
Commitments and Contingencies
Commitments
Rental expense for all operating leases amounted to $89 million in 2015, $71 million in 2014 and $70 million in 2013. Future minimum rental commitments on noncancelable leases are as follows: 2016 — $80 million; 2017 — $62 million; 2018 — $36 million; 2019 — $26 million; 2020 — $18 million and an aggregate of $24 million thereafter.
As of September 30, 2015, the Company has certain future purchase commitments aggregating to approximately $958 million, which will be expended over the next several years.
Contingencies
Given the uncertain nature of litigation generally, the Company is not able in all cases to estimate the amount or range of loss that could result from an unfavorable outcome of the litigation to which the Company is a party. In accordance with U.S. generally accepted accounting principles, the Company establishes accruals to the extent probable future losses are estimable (in the case of environmental matters, without considering possible third-party recoveries). In view of the uncertainties discussed below, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance. In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company’s consolidated results of operations and consolidated cash flows.
In June 2007, Retractable Technologies, Inc. (“RTI”) filed a complaint against the Company under the caption Retractable Technologies, Inc. vs. Becton Dickinson and Company (Civil Action No. 2:07-cv-250, U.S. District Court, Eastern District of Texas). RTI alleges that the BD Integra™ syringes infringe patents licensed exclusively to RTI. In its complaint, RTI also alleges that the Company engaged in false advertising with respect to certain of the Company’s safety-engineered products in violation of the Lanham Act; acted to exclude RTI from various product markets and to maintain its market share through, among other things, exclusionary contracts in violation of state and federal antitrust laws; and engaged in unfair competition. In January 2008, the court severed the patent and non-patent claims into separate cases, and stayed the non-patent claims during the pendency of the patent claims at the trial court level. RTI seeks money damages and injunctive relief. On April 1, 2008, RTI filed a complaint against BD under the caption Retractable Technologies, Inc. and Thomas J. Shaw v. Becton Dickinson and Company (Civil Action No.2:08-cv-141, U.S. District Court, Eastern District of Texas). RTI alleges that the BD Integra™ syringes infringe another patent licensed exclusively to RTI. RTI seeks money damages and injunctive relief. On August 29, 2008, the court ordered the consolidation of the patent cases. On November 9, 2009, at a trial of these consolidated cases, the jury rendered a verdict in favor of RTI on all but one of its infringement claims, but did not find any willful infringement, and awarded RTI $5 million in damages, which has been paid. On May 19, 2010, the court granted RTI’s motion for a permanent injunction against the continued sale by the Company of its BD Integra™ products in their current form, but stayed the injunction for the duration of the Company’s appeal. At the same time, the court lifted a stay of RTI’s non-patent claims. On July 8, 2011, the Court of Appeals for the Federal Circuit reversed the District Court judgment that the Company’s 3ml BD Integra™ products infringed the asserted RTI patents and affirmed the District Court judgment of infringement against the Company’s discontinued 1ml BD Integra™ products. On October 31, 2011, the Federal Circuit Court of Appeals denied RTI’s request for an en banc rehearing. In January 2013, RTI’s petition for review with the U.S. Supreme Court was denied. BD’s motion for further proceedings on damages was denied by the District Court on the grounds that the District Court did not have authority to modify the $5 million damage award. BD appealed this ruling to the Federal Circuit Court of Appeals, and on July 7, 2014, the Court affirmed the District Court ruling leaving the damages award intact. On September 19, 2014, the Federal Circuit Court of Appeals denied BD’s request for an en banc rehearing. On January 16, 2015, BD filed a petition for U.S. Supreme Court review of the Federal Circuit Court of Appeals decision leaving the damages award intact. On April 20, 2015, the U.S. Supreme Court denied BD’s petition.
On September 19, 2013, a jury returned a verdict against BD with respect to certain of RTI’s non-patent claims. The verdict was unfavorable to BD with respect to RTI’s Lanham Act claim and claim for attempted monopolization based on deception in the safety syringe market. The jury awarded RTI $113.5 million for its attempted monopolization claim (which will be trebled under the antitrust statute). The jury’s verdict rejected RTI’s monopolization claims in the markets for safety syringes, conventional syringes and safety IV catheters; its attempted monopolization claims in the markets for conventional syringes and safety IV catheters; and its claims for contractual restraint of trade and exclusive dealing in the markets for safety syringes, conventional syringes and safety IV catheters. In connection with the verdict, the Company recorded a pre-tax charge of approximately $341 million in the fourth quarter of fiscal year 2013. On September 30, 2014, the Court issued a ruling denying BD’s post-trial motion for judgment as a matter of law. On November 10, 2014, the Court issued a ruling denying RTI’s request for disgorgement of BD profits for false advertising on the ground that any profit to which RTI is entitled is included within the amount of the antitrust damage award. The Court granted RTI’s request that BD be ordered to issue certain corrective statements regarding its advertising and enjoined from making certain advertising claims. The Court denied RTI’s request for injunctive relief relating to BD’s contracting practices and BD’s safety syringe advertising, finding that RTI failed to prove that BD’s contracting practices violated the antitrust laws or that BD’s safety syringe advertising is false. The Court concluded that RTI is entitled to certain categories of attorneys’ fees that it requested, but that its total fee recovery should be reduced by 50%. On January 14, 2015, the Court granted in part and denied in part BD’s motion for a stay of the injunction. The Court held that, pending appeal, BD would not be required to send the corrective advertising notices to end-user customers, but only to employees, distributors and Group Purchasing Organizations. The Court otherwise upheld its November 10, 2014 Order regarding the injunction. On January 15, 2015, the Court entered its Final Judgment in the case. In the Final Judgment, the Court ordered that RTI recovers $341 million for its attempted monopolization claim and $12 million for attorneys’ fees, and awarded pre and post-judgment interest and costs. On February 3, 2015, the Court of Appeals for the Fifth Circuit denied BD’s motion for a stay of the injunction pending the final appeal. On April 23, 2015, the Court granted BD’s motion to eliminate the award of pre-judgment interest, and entered a new Final Judgment. BD has filed its appeal to the Court of Appeals challenging the entirety of the Final Judgment.
On November 4, 2013, the Secretariat of Foreign Trade of the Federal Republic of Brazil initiated an administrative anti-dumping investigation of imports of vacuum plastic tubes for blood collection into Brazil from the United States, the United Kingdom of Great Britain and Northern Ireland, the Federal Republic of Germany and the People’s Republic of China during the period from January 2008 through December 2012. BD, through its United States and international subsidiaries, exports vacuum plastic tubes for blood collection into Brazil from the United States and the United Kingdom of Great Britain and Northern Ireland and cooperated with the investigation. On April 30, 2015, the Brazilian Foreign Trade Board (“CAMEX”) issued a decision determining the application of anti-dumping measures including, without limitation, the imposition of duties on such vacuum plastic tubes imported into Brazil of 45.3% for products from the United States of America and 71.5% for products from the United Kingdom of Great Britain and Northern Ireland. These anti-dumping measures, effective from April 30, 2015, will last for a minimum period of five years. Subsequent to the decision, CAMEX initiated a proceeding to assess the effect of the duties from a public interest perspective. BD’s administrative appeal of the CAMEX decision was denied on August 5, 2015. CAMEX announced on November 5, 2015, following the conclusion of its proceeding, that it is not modifying its original decision. BD does not believe that the CAMEX decision will materially affect its results of operations.
On October 5, 2014, CareFusion and the Company entered into an Agreement and Plan of Merger (which we refer to as the merger agreement) that provides for the acquisition of CareFusion by the Company. Under the terms of the merger agreement, a subsidiary of the Company (“the merger subsidiary”) merged with and into CareFusion on March 17, 2015, with CareFusion surviving the merger as a wholly owned subsidiary of the Company. Several putative class action lawsuits have been filed against CareFusion, its directors, the Company and the merger subsidiary in the Delaware Court of Chancery and in the Superior Court of California, San Diego County. These lawsuits generally allege that the members of the board of directors of CareFusion breached their fiduciary duties in connection with the merger by, among other things, carrying out a process that plaintiffs allege did not ensure adequate and fair consideration to CareFusion stockholders. The plaintiffs in these actions further allege that CareFusion and the Company aided and abetted the individual defendants’ breaches of their fiduciary duties. The plaintiffs seek, among other things, equitable relief to enjoin consummation of the merger, rescission of the merger and/or rescissory damages, and attorneys’ fees and costs.
On December 30, 2014, the parties to the actions filed in the Delaware Court of Chancery (the “Delaware Actions”) entered into an agreement in principle to settle the Delaware Actions on the basis of additional disclosures made in a CareFusion Schedule 14A, filed with the SEC on January 5, 2015. The settlement terms are reflected in a Memorandum of Understanding (“MOU”). On December 31, 2014, plaintiffs’ counsel notified the Delaware Court of Chancery of the settlement and MOU. The parties to the Delaware Actions entered into a stipulation and agreement of compromise, settlement and release and presented the matter to the Delaware Court of Chancery for approval. The Delaware Court of Chancery approved the settlement on September 17, 2015 and the Delaware Actions are now concluded. On October 27, 2015, the Superior Court of California granted plaintiffs' request for voluntary dismissal of the California actions.

On July 17, 2015, a class action complaint was filed against the Company in the U.S. District Court for the Southern District of Georgia. The plaintiffs, Glynn-Brunswick Hospital Authority, trading as Southeast Georgia Health System, and Southeast Georgia Health System, Inc., seek to represent a class of acute care purchasers of BD syringes and IV catheters. The complaint alleges that BD monopolized the markets for syringes and IV catheters through contracts, theft of technology, false advertising, acquisitions, and other conduct. The complaint seeks treble damages but does not specify the amount of alleged damages. The Company has filed a motion to dismiss the complaint.
The Company believes that it has meritorious defenses to each of the above-mentioned suits pending against the Company and is engaged in a vigorous defense of each of these matters.
The Company is also involved both as a plaintiff and a defendant in other legal proceedings and claims that arise in the ordinary course of business.
The Company is a party to a number of federal proceedings in the United States brought under the Comprehensive Environment Response, Compensation and Liability Act, also known as “Superfund,” and similar state laws. The affected sites are in varying stages of development. In some instances, the remedy has been completed, while in others, environmental studies are commencing. For all sites, there are other potentially responsible parties that may be jointly or severally liable to pay all cleanup costs.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51674963&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 93 R11.htm IDEA: XBRL DOCUMENT v3.3.0.814

Earnings per Share
12 Months Ended

Sep. 30, 2015

Earnings Per Share [Abstract]

Earnings per Share
Earnings per Share

The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) for the years ended September 30 were as follows:

2015

2014

2013
Average common shares outstanding
202,537

193,299

195,157

Dilutive share equivalents from share-based plans
4,972

4,410

4,036

Average common and common equivalent shares outstanding — assuming dilution
207,509

197,709

199,193

Upon closing the acquisition of CareFusion Corporation (“CareFusion”) on March 17, 2015, the Company issued approximately 15.9 million of its common shares as part of the purchase consideration. Additional disclosures regarding this acquisition are provided in Note 9.

Options to purchase shares of common stock are excluded from the calculation of diluted earnings per share when their inclusion would have an anti-dilutive effect on the calculation. For the years ended September 30, 2015, 2014 and 2013 there were no options to purchase shares of common stock which were excluded from the diluted earnings per share calculation.

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for earnings per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_EarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 94 R23.htm IDEA: XBRL DOCUMENT v3.3.0.814

Income Taxes
12 Months Ended

Sep. 30, 2015

Income Tax Disclosure [Abstract]

Income Taxes
Income Taxes
The provision for income taxes from continuing operations for the years ended September 30 consisted of:
(Millions of dollars)
2015

2014

2013
Current:

Federal
$
50

$
225

$
177

State and local, including Puerto Rico
15

(11
)

(4
)
Foreign
252

217

179

$
318

$
431

$
352

Deferred:

Domestic
$
(238
)

$
(59
)

$
(119
)
Foreign
(37
)

(35
)

3

(274
)

(94
)

(116
)

$
44

$
337

$
236

The components of Income From Continuing Operations Before Income Taxes for the years ended September 30 consisted of:
(Millions of dollars)
2015

2014

2013
Domestic, including Puerto Rico
$
(408
)

$
532

$
288

Foreign
1,147

990

877

$
739

$
1,522

$
1,165

Deferred tax assets and liabilities are netted on the balance sheet by separate tax jurisdictions. At September 30, 2015 and 2014, net current deferred tax assets of $387 million and $355 million, respectively, were included in Prepaid expenses, deferred taxes and other. Net non-current deferred tax assets of $142 million and $100 million, respectively, were included in Other Assets. Net current deferred tax liabilities of $5 million and $10 million, respectively, were included in Current Liabilities — Income taxes. Net non-current deferred tax liabilities of $1.951 billion and $130 million, respectively, were included in Deferred Income Taxes and Other. Deferred taxes are not provided on undistributed earnings of foreign subsidiaries that are indefinitely reinvested. At September 30, 2015, the cumulative amount of such undistributed earnings indefinitely reinvested outside the United States was $7.5 billion. Determining the tax liability that would arise if these earnings were remitted is not practicable. Deferred taxes are provided for earnings outside the United States when those earnings are not considered indefinitely reinvested.
The table below summarizes the gross amounts of unrecognized tax benefits without regard to reduction in tax liabilities or additions to deferred tax assets and liabilities if such unrecognized tax benefits were settled. The Company expects no significant increases or decreases in the amount of the unrecognized tax benefits to occur within the next twelve months.
(Millions of dollars)
2015

2014

2013
Balance at October 1
$
197

$
146

$
134

Increase due to acquisitions
314

—

—

Increase due to current year tax positions
58

51

80

Increase due to prior year tax positions
17

9

25

Decreases due to prior year tax positions
—

—

—

Decrease due to settlements and lapse of statute of limitations
(11
)

(9
)

(93
)
Balance at September 30
$
575

$
197

$
146

With the acquisition of CareFusion on March 17, 2015, the Company is now a party to a tax matters agreement with Cardinal Health resulting from Cardinal Health's spin-off of CareFusion in fiscal year 2010. Under the tax matters agreement, the Company is obligated to indemnify Cardinal Health for certain tax exposures and transaction taxes prior to CareFusion’s spin-off from Cardinal Health. The indemnification payable is approximately $217 million at September 30, 2015 and is included in Deferred Income Taxes and Other on the Consolidated Balance Sheet.
The total amount of unrecognized tax benefits, if recognized, would favorably impact the effective tax rate. Accrued interest and penalties of $84 million, $10 million and $8 million at September 30, 2015, 2014 and 2013, respectively, are not included in the table above. During the fiscal years ended September 30, 2015, 2014 and 2013, the Company reported interest and penalties associated with unrecognized tax benefits of $8 million, $2 million and $2 million on the Consolidated Statements of Income as a component of Income tax provision.
The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of tax jurisdictions. The IRS has completed its audit for the tax years through 2011. For the Company’s other major tax jurisdictions where it conducts business, the Company’s tax years are generally open after 2009.
Deferred income taxes at September 30 consisted of:

2015

2014 (A)
(Millions of dollars)
Assets

Liabilities

Assets

Liabilities
Compensation and benefits
$
647

$
—

$
546

$
—

Property and equipment
—

156

—

196

Intangibles
—

2,033

—

266

Loss and credit carryforwards
538

—

274

—

Other
634

606

398

195

1,819

2,795

1,218

656

Valuation allowance
(452
)

—

(247
)

—

$
1,367

$
2,795

$
971

$
656

(A)Certain amounts in the prior-year presentation have been reclassified to conform to the current-year presentation.
Generally, deferred tax assets have been established as a result of net operating losses and credit carryforwards with expiration dates from 2016 to an unlimited expiration date. Valuation allowances have been established as a result of an evaluation of the uncertainty associated with the realization of certain deferred tax assets on these losses and credit carryforwards. The valuation allowance for 2015 is primarily the result of foreign losses due to the Company’s global re-organization of its foreign entities and these generally have no expiration date. Valuation allowances are also maintained with respect to deferred tax assets for certain federal and state carryforwards that may not be realized and that principally expire between 2016 and 2019.
A reconciliation of the federal statutory tax rate to the Company’s effective tax rate was as follows:

2015

2014

2013
Federal statutory tax rate
35.0
%

35.0
%

35.0
%
State and local income taxes, net of federal tax benefit
(3.6
)

(0.5
)

(1.2
)
Effect of foreign and Puerto Rico earnings and foreign tax credits
(24.5
)

(11.2
)

(9.7
)
Effect of Research Credits and Domestic Production Activities,
(1.6
)

(1.1
)

(3.8
)
Other, net
0.6

(0.1
)

(0.1
)

5.9
%

22.1
%

20.2
%

The approximate amounts of tax reductions related to tax holidays in various countries in which the Company does business were $102 million, $108 million and $95 million, in 2015, 2014 and 2013, respectively. The tax holidays expire at various dates through 2026.
The Company made income tax payments, net of refunds, of $240 million in 2015, $330 million in 2014 and $454 million in 2013.

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 95 R19.htm IDEA: XBRL DOCUMENT v3.3.0.814

Intangible Assets
12 Months Ended

Sep. 30, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets
Intangible Assets
Intangible assets at September 30 consisted of:

2015

2014
(Millions of dollars)
Gross
Carrying
Amount

Accumulated
Amortization

Gross
Carrying
Amount

Accumulated
Amortization
Amortized intangible assets

Customer relationships
$
3,370

$
120

$
10

$
2

Developed technology
3,487

510

893

379

Product rights
128

35

148

31

Trademarks
405

26

27

19

Patents and other
333

212

232

163

Amortized intangible assets
$
7,723

$
903

$
1,308

$
594

Unamortized intangible assets

Acquired in-process research and development
$
203

$
44

Trademarks
2

2

Unamortized intangible assets
$
205

$
46

Additional information regarding the increases to the intangible asset classes detailed above as a result of the CareFusion acquisition is provided in Note 9. The increase to developed technology assets additionally included $49 million of assets recognized upon the Company’s acquisition of CRISI in the second quarter of fiscal year 2015 as well as $42 million recognized upon the Company's acquisition of Cellular Research in the fourth quarter of fiscal year 2015. The increase in acquired in-process research and development project assets additionally included $81 million of assets recognized upon the Company’s acquisition of GenCell in the first quarter of fiscal year 2015 and $19 million of assets recognized upon the acquisition of Cellular Research. These increases were partially offset by the reclassification to Developed Technology, Net of $42 million, in the fourth quarter of fiscal year 2015, due to the Company's completion of project assets recognized upon its second quarter fiscal year 2011 acquisition of Accuri Cytometers, Inc.
Intangible amortization expense was $346 million, $84 million and $83 million in 2015, 2014 and 2013, respectively. The estimated aggregate amortization expense for the fiscal years ending September 30, 2016 to 2020 are as follows: 2016 — $558 million; 2017 — $535 million; 2018 — $523 million; 2019 — $519 million; 2020 — $518 million.
The following is a reconciliation of goodwill by business segment:
(Millions of dollars)
Medical

Life Sciences

Total
Goodwill as of September 30, 2013
$
511

$
598

$
1,109

Acquisitions
—

13

(A)

13

Currency translation/other (B)
(29
)

(3
)

(32
)
Goodwill as of September 30, 2014
$
482

$
608

$
1,090

Acquisitions
6,585

(C)

130

(D)

6,716

Currency translation/other (B)
(261
)

(8
)

(269
)
Goodwill as of September 30, 2015
$
6,807

$
730

$
7,537

(A)
Represents goodwill recognized upon the Company’s acquisition of Alverix in the second quarter of fiscal year 2014.
(B)
Includes amounts resulting from foreign currency translation as well as acquisition accounting adjustments.
(C)
Primarily represents goodwill recognized upon the Company’s acquisition of CareFusion in the second quarter of fiscal year 2015. Additional disclosures regarding the CareFusion acquisition are provided in Note 9. Also includes $22 million of goodwill associated with individually immaterial acquisitions, including the CRISI and ARX acquisitions in the second and third quarters of fiscal year 2015, respectively.
(D)
Represents goodwill recognized upon the Company’s acquisitions of GenCell and Cellular Research in the first and fourth quarters of fiscal year 2015, respectively.

X

- References
No definition available.
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 96 R84.htm IDEA: XBRL DOCUMENT v3.3.0.814

Business Restructuring Charges (Details)
$ in Millions
12 Months Ended

Sep. 30, 2015

USD ($)

Restructuring Reserve [Roll Forward]

Balance at September 30, 2014 $ 0

Assumed liability 19

Charged to expense 271

Cash payments (94)

Non-cash settlements (44)

Other adjustments (91)

Balance at September 30, 2015 62

Employee Termination

Restructuring Reserve [Roll Forward]

Balance at September 30, 2014 0

Assumed liability 19

Charged to expense 126

Cash payments (74)

Non-cash settlements 0

Other adjustments (9)

Balance at September 30, 2015 62

Share-Based Compensation

Restructuring Reserve [Roll Forward]

Balance at September 30, 2014 0

Assumed liability 0

Charged to expense 44

Cash payments 0

Non-cash settlements (44)

Other adjustments 0

Balance at September 30, 2015 0

Other

Restructuring Reserve [Roll Forward]

Balance at September 30, 2014 0

Assumed liability 0

Charged to expense 102

Cash payments (20)

Non-cash settlements 0

Other adjustments (81)

Balance at September 30, 2015 $ 0

X

- Definition
Restructuring Reserve Assumed Liability
+ References
No definition available.
+ Details

Name: bdx_RestructuringReserveAssumedLiability

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_PaymentsForRestructuring

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 5.P.3)

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140864-122747

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.P.4(b))

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section P

-Subsection 3, 4

+ Details

Name: us-gaap_RestructuringCharges

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.P.4(b))

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section P

-Subsection 3, 4

+ Details

Name: us-gaap_RestructuringReserve

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of (expense) reversal of expense related to a previously accrued restructuring cost liability. Excludes adjustments for costs incurred, costs settled, and foreign currency translation adjustments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section 40

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6394291&loc=d3e17658-110867

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.P.4(b))

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section P

-Subsection 3, 4

+ Details

Name: us-gaap_RestructuringReserveAccrualAdjustment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_RestructuringReserveRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of consideration other than cash used to fully or partially settle an accrued restructuring cost.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.P.4(b)(2))

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section P

-Subsection 3, 4

+ Details

Name: us-gaap_RestructuringReserveSettledWithoutCash1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RestructuringCostAndReserveAxis=bdx_ShareBasedCompensationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 97 R15.htm IDEA: XBRL DOCUMENT v3.3.0.814

Benefit Plans
12 Months Ended

Sep. 30, 2015

Compensation and Retirement Disclosure [Abstract]

Benefit Plans
Benefit Plans

The Company has defined benefit pension plans covering certain employees in the United States and certain foreign locations. The Company also provides certain postretirement healthcare and life insurance benefits to qualifying domestic retirees. Other postretirement benefit plans in foreign countries are not material. The measurement date used for the Company’s employee benefit plans is September 30.

Effective April 1, 2014, the Company replaced its current post-65 group medical coverage with a new approach for retirees age 65 and older and their eligible dependents to access post-65 retiree medical and prescription drug coverage in the U.S. Such changes were communicated to active employees and retirees in early January 2014 and as such, the Company remeasured its U.S. postretirement healthcare benefit plan as of January 1, 2014. The impact of this plan change and remeasurement was immaterial to the Company’s consolidated financial results. The plan design changes included, among other modifications, a replacement of the Company-sponsored healthcare coverage program for post-65 retirees with contributions to a health reimbursement account that can be used to purchase coverage through a Medicare insurance exchange.
Effective January 1, 2013, all plan participants’ benefits in the U.S. defined benefit traditional pension plan were converted to a defined benefit cash balance pension plan. Upon conversion, each individual plan participant received an opening balance equal to the actuarial equivalent of individual benefits accrued under the defined benefit traditional pension plan through December 31, 2012. Following conversion, participants accrue benefits under the cash balance plan through monthly pay credits based upon the plan participant’s age and length of service.
Net pension and other postretirement cost for the years ended September 30 included the following components:

Pension Plans

Other Postretirement Benefits
(Millions of dollars)
2015

2014

2013

2015

2014

2013
Service cost
$
77

$
71

$
84

$
3

$
3

$
6

Interest cost
87

93

87

7

9

10

Expected return on plan assets
(123
)

(126
)

(116
)

—

—

—

Amortization of prior service credit
(15
)

(15
)

(13
)

(5
)

(4
)

(1
)
Amortization of loss
68

49

75

3

2

4

Curtailment/settlement loss
—

3

6

—

—

—

Net pension and postretirement cost
$
93

$
74

$
123

$
9

$
10

$
19

The amounts provided above for amortization of prior service credit and amortization of loss represent the reclassifications of prior service credits and net actuarial losses that were recognized in Accumulated other comprehensive income (loss) in prior periods. Net pension cost attributable to foreign plans included in the preceding table was $32 million, $25 million and $33 million in 2015, 2014 and 2013, respectively.

The settlement losses recorded in 2014 and 2013 included lump sum benefit payments associated with the Company’s U.S. supplemental pension plan. The Company recognizes pension settlements when payments from the supplemental plan exceed the sum of service and interest cost components of net periodic pension cost associated with this plan for the fiscal year. The settlement losses recorded in 2014 and 2013 also included settlements associated with certain foreign plans.

The change in benefit obligation, change in fair value of plan assets, funded status and amounts recognized in the Consolidated Balance Sheets for these plans were as follows:

Pension Plans

Other Postretirement
Benefits
(Millions of dollars)
2015

2014

2015

2014
Change in benefit obligation:

Beginning obligation
$
2,366

$
2,076

$
201

$
243

Service cost
77

71

3

3

Interest cost
87

93

7

9

Plan amendments
(2
)

(1
)

—

(37
)
Benefits paid
(138
)

(142
)

(18
)

(24
)
Benefit obligations assumed in acquisition
67

—

—

—

Actuarial loss (gain)
49

318

(11
)

—

Settlements
—

(7
)

—

—

Other, includes translation
(81
)

(42
)

3

6

Benefit obligation at September 30
2,426

2,366

186

201

Change in fair value of plan assets:

Beginning fair value
1,829

1,785

—

—

Actual return on plan assets
(21
)

119

—

—

Employer contribution
65

104

—

—

Benefits paid
(138
)

(142
)

—

—

Plan assets acquired in acquisition
54

—

—

—

Settlements
—

(7
)

—

—

Other, includes translation
(58
)

(29
)

—

—

Plan assets at September 30
$
1,732

$
1,829

$
—

$
—

Funded Status at September 30:

Unfunded benefit obligation
$
(694
)

$
(537
)

$
(186
)

$
(201
)
Amounts recognized in the Consolidated Balance
Sheets at September 30:

Other
$
7

$
3

$
—

$
—

Salaries, wages and related items
(10
)

(8
)

(15
)

(16
)
Long-term Employee Benefit Obligations
(691
)

(531
)

(171
)

(184
)
Net amount recognized
$
(694
)

$
(537
)

$
(186
)

$
(201
)
Amounts recognized in Accumulated other
comprehensive income (loss) before income taxes at September 30:

Net transition asset
$
—

$
—

$
—

$
—

Prior service credit
103

119

37

42

Net actuarial loss
(1,124
)

(1,030
)

(30
)

(44
)
Net amount recognized
$
(1,021
)

$
(911
)

$
7

$
(2
)

Foreign pension plan assets at fair value included in the preceding table were $575 million and $574 million at September 30, 2015 and 2014, respectively. The foreign pension plan projected benefit obligations were $780 million and $765 million at September 30, 2015 and 2014, respectively. The benefit obligations assumed and plan assets acquired relate to the Company's acquisition of CareFusion. Additional disclosures regarding this acquisition are provided in Note 9.

Pension plans with accumulated benefit obligations in excess of plan assets and plans with projected benefit obligations in excess of plan assets consist of the following at September 30:

Accumulated Benefit
Obligation Exceeds the
Fair Value of Plan Assets

Projected Benefit
Obligation Exceeds the
Fair Value of Plan Assets
(Millions of dollars)
2015

2014

2015

2014
Projected benefit obligation
$
2,339

$
2,267

$
2,394

$
2,324

Accumulated benefit obligation
$
2,265

$
2,186

Fair value of plan assets
$
1,650

$
1,738

$
1,693

$
1,784

The estimated net actuarial loss and prior service credit for pension benefits that will be amortized from Accumulated other comprehensive income (loss) into net pension costs over the next fiscal year are expected to be $(79) million and $15 million, respectively. The estimated net actuarial loss and prior service credit for other postretirement benefits that will be amortized from Accumulated other comprehensive income (loss) into net other postretirement costs over the next fiscal year are expected to be $(2) million and $5 million, respectively.
The weighted average assumptions used in determining pension plan information were as follows:

2015

2014

2013

Net Cost

Discount rate:

U.S. plans (A)
4.15
%

4.95
%

3.90
%

Foreign plans
3.14

3.87

3.94

Expected return on plan assets:

U.S. plans
7.50

7.75

7.75

Foreign plans
5.45

5.68

5.68

Rate of compensation increase:

U.S. plans (A)
4.25

4.25

4.25

Foreign plans
2.49

2.46

3.28

Benefit Obligation

Discount rate:

U.S. plans (B)
4.15

4.15

4.95

Foreign plans
2.84

3.14

3.87

Rate of compensation increase:

U.S. plans (A)
4.25

4.25

4.25

Foreign plans
2.33

2.49

2.46

(A)
Also used to determine other postretirement and postemployment benefit plan information.
(B)
The discount rates used to determine other postretirement benefit plan information in fiscal years 2015, 2014 and 2013 were 3.95%, 3.85% and 4.40%, respectively. The discount rates used to determine postemployment benefit plan information in fiscal years 2015, 2014 and 2013 were 3.75%, 3.75% and 4.00%, respectively.

Effective September 30, 2015, the approach used to calculate the service and interest components of net periodic benefit cost for benefit plans in the United States was changed to provide a more precise measurement of service and interest costs. Historically, the Company calculated these service and interest components utilizing a single weighted-average discount rate derived from the yield curve used to measure the benefit obligation at the beginning of the period. Going forward, the Company has elected to utilize an approach that discounts the individual expected cash flows using the applicable spot rates derived from the yield curve over the projected cash flow period. For the U.S. benefit plans, the spot rates used to determine service and interest costs ranged from 0.56% to 4.87%. Based on current economic conditions, the Company estimates that the service cost and interest cost for these U.S. benefit plans will be reduced by approximately $18 million in 2016.   The financial impact to plans outside the United States was not material. The Company has accounted for this change as a change in accounting estimate that is inseparable from a change in accounting principle and accordingly has accounted for it prospectively.
At September 30, 2015 the assumed healthcare trend rates were 6.8%, gradually decreasing to an ultimate rate of 4.0% beginning in 2024. At September 30, 2014 the assumed healthcare trend rates were 7.0% pre and post age 65, gradually decreasing to an ultimate rate of 5.0% beginning in 2024. A one percentage point increase in assumed healthcare cost trend rates in each year would not materially impact the accumulated postretirement benefit obligation as of September 30, 2015 or the aggregate of the service cost and interest cost components of 2015 annual expense. Similarly, a one percentage point decrease in the assumed healthcare cost trend rates in each year would not materially impact the accumulated postretirement benefit obligation as of September 30, 2015 or the aggregate of the 2015 service cost and interest cost.
Expected Rate of Return on Plan Assets
The expected rate of return on plan assets is based upon expectations of long-term average rates of return to be achieved by the underlying investment portfolios. In establishing this assumption, the Company considers many factors, including historical assumptions compared with actual results; benchmark data; expected returns on various plan asset classes, as well as current and expected asset allocations.
Expected Funding
The Company’s funding policy for its defined benefit pension plans is to contribute amounts sufficient to meet legal funding requirements, plus any additional amounts that may be appropriate considering the funded status of the plans, tax consequences, the cash flow generated by the Company and other factors. The Company does not anticipate any significant required contributions to its pension plans in 2016.
Expected benefit payments are as follows:
(Millions of dollars)
Pension
Plans

Other
Postretirement
Benefits
2016
$
163

$
15

2017
164

15

2018
164

15

2019
177

15

2020
175

15

2021-2025
870

67

As previously discussed, the Company replaced its Company-sponsored healthcare coverage program for post-65 retirees with a health reimbursement plan on April 1, 2014. As such, the Company no longer receives subsidies under the Medicare Prescription Drug Improvement and Modernization Act of 2003.
Investments
The Company’s primary objective is to achieve returns sufficient to meet future benefit obligations. It seeks to generate above market returns by investing in more volatile asset classes such as equities while at the same time controlling risk through diversification in non-correlated asset classes and through allocations to more stable asset classes like fixed income.
U.S. Plans
The Company’s U.S. pension plans comprise 67% of total benefit plan investments, based on September 30, 2015 market values and have a target asset mix of 35% fixed income, 34% diversifying investments and 31% equities. This mix was established based on an analysis of projected benefit payments and estimates of long-term returns, volatilities and correlations for various asset classes. The asset allocations to diversifying investments include high-yield bonds, hedge funds, real estate, infrastructure, commodities, leveraged loans and emerging markets bonds.

The actual portfolio investment mix may, from time to time, deviate from the established target mix due to various factors such as normal market fluctuations, the reliance on estimates in connection with the determination of allocations and normal portfolio activity such as additions and withdrawals. Rebalancing of the asset portfolio on a quarterly basis is required to address any allocations that deviate from the established target allocations in excess of defined allowable ranges. The target allocations are subject to periodic review, including a review of the asset portfolio’s performance, by the named fiduciary of the plans. Any tactical deviations from the established asset mix require the approval of the named fiduciary.
The U.S. plans may enter into both exchange traded and non-exchange traded derivative transactions in order to manage interest rate exposure, volatility, term structure of interest rates, and sector and currency exposures within the fixed income portfolios. The Company has established minimum credit quality standards for counterparties in such transactions.
The following table provides the fair value measurements of U.S. plan assets, as well as the measurement techniques and inputs utilized to measure fair value of these assets, at September 30, 2015 and 2014. The categorization of fund investments is based upon the categorization of these funds’ underlying assets.
(Millions of dollars)
Total U.S.
Plan Asset
Balances at
September 30,
2015

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

Significant
Other
Observable
Inputs (Level 2)

Significant
Unobservable
Inputs (Level 3)
Fixed Income:

Mortgage and asset-backed securities
$
192

$
—

$
192

$
—

Corporate bonds
240

100

139

—

Government and agency-U.S.
78

53

24

—

Government and agency-Foreign
95

46

49

—

Equity securities
335

75

260

—

Cash and cash equivalents
96

96

—

—

Other
123

30

91

2

Fair value of plan assets
$
1,157

$
401

$
755

$
2

(Millions of dollars)
Total U.S.
Plan Asset
Balances at
September 30,
2014

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

Significant
Other
Observable
Inputs (Level 2)

Significant
Unobservable
Inputs (Level 3)
Fixed Income:

Mortgage and asset-backed securities
$
150

$
—

$
150

$
—

Corporate bonds
213

105

108

—

Government and agency-U.S.
153

124

29

—

Government and agency-Foreign
126

74

51

—

Equity securities
393

56

337

—

Cash and cash equivalents
26

26

—

—

Other
193

96

93

4

Fair value of plan assets
$
1,255

$
483

$
768

$
4

Fixed Income Securities
U.S. pension plan assets categorized above as fixed income securities include fund investments comprised of mortgage-backed, corporate, government and agency and asset-backed instruments. Mortgage-backed securities consist of residential mortgage pass-through certificates. Investments in corporate bonds are diversified across industry and sector and consist of investment-grade, as well as high-yield debt instruments. U.S. government investments consist of obligations of the U.S. Treasury, other U.S. government agencies, state governments and local municipalities. Assets categorized as foreign government and agency debt securities included investments in developed and emerging markets.
The values of fixed income investments classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. A portion of the fixed income instruments classified within Level 2 are valued based upon estimated prices from independent vendors’ pricing models and these prices are derived from market observable sources including: benchmark yields, reported trades, broker/dealer quotes, issuer spreads, benchmark securities, bids, offers and other market-related data. Values of other instruments classified within Level 2 are based on the corroborated net asset value provided by the fund administrator, which is based on the value of the underlying assets owned by the fund, less its liabilities and then divided by the number of fund units outstanding.
Equity Securities
U.S. pension plan assets categorized as equity securities consist of fund investments in publicly-traded U.S. and non-U.S. equity securities. In order to achieve appropriate diversification, these portfolios are invested across market sectors, investment styles, capitalization weights and geographic regions. The values of equity securities classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. The values of equity security investments classified within Level 2 are based on the corroborated net asset value provided by the fund administrator.
Cash and Cash Equivalents
A portion of the U.S. plans’ assets consists of investments in cash and cash equivalents, primarily to accommodate liquidity requirements relating to trade settlement and benefit payment activity, and the values of these assets are based upon quoted market prices.
Other Securities
Other U.S. pension plan assets include fund investments comprised of underlying assets of real estate, infrastructure, commodities and hedge funds. The values of such instruments classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. Investments classified within Level 2 are valued based on the net asset value provided by the fund administrator when such net asset value represents the price at which the pension plan assets could be redeemed at period end. Investments classified within Level 3 are valued based on the net asset value provided by the fund administrator when the pension plan assets could not be redeemed at period end (for example, if the assets are subject to a lock-up period).

The following table summarizes the changes, for the years ended September 30, 2015 and 2014, in the fair value of U.S. pension assets measured using Level 3 inputs:
(Millions of dollars)
Other
(Hedge
Funds)
Balance at September 30, 2013
$
12

Actual return on plan assets:

Relating to assets held at September 30, 2013
1

Purchases, sales and settlements, net
4

Transfers (out) in from other categories
(13
)
Exchange rate changes
—

Balance at September 30, 2014
$
4

Actual return on plan assets:

Relating to assets held at September 30, 2014
—

Purchases, sales and settlements, net
1

Transfers (out) in from other categories
(3
)
Exchange rate changes
—

Balance at September 30, 2015
$
2

Foreign Plans
Foreign plan assets comprise 33% of the Company’s total benefit plan assets, based on market value at September 30, 2015. Such plans have local independent fiduciary committees, with responsibility for development and oversight of investment policy, including asset allocation decisions. In making such decisions, consideration is given to local regulations, investment practices and funding rules.
The following table provides the fair value measurements of foreign plan assets, as well as the measurement techniques and inputs utilized to measure fair value of these assets, at September 30, 2015 and 2014.
(Millions of dollars)
Total Foreign
Plan Asset
Balances at
September 30,
2015

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

Significant
Other
Observable
Inputs (Level 2)

Significant
Unobservable
Inputs (Level 3)
Fixed Income:

Corporate bonds
$
33

$
3

$
30

$
—

Government and agency-U.S.
1

1

—

—

Government and agency-Foreign
101

65

36

—

Other fixed income
48

46

2

—

Equity securities
206

187

19

—

Cash and cash equivalents
8

8

—

—

Real estate
13

—

13

—

Insurance contracts
90

—

—

90

Other
74

53

21

—

Fair value of plan assets
$
575

$
364

$
121

$
90

(Millions of dollars)
Total Foreign
Plan Asset
Balances at
September 30,
2014

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

Significant
Other
Observable
Inputs (Level 2)

Significant
Unobservable
Inputs (Level 3)
Fixed Income:

Corporate bonds
$
35

$
—

$
35

$
—

Government and agency-U.S.
3

3

—

—

Government and agency-Foreign
100

59

41

—

Other fixed income
47

46

1

—

Equity securities
237

221

17

—

Cash and cash equivalents
15

15

—

—

Real estate
10

—

10

—

Insurance contracts
78

—

—

78

Other
47

12

35

—

Fair value of plan assets
$
574

$
357

$
138

$
78

Fixed Income Securities
Fixed income investments held by foreign pension plans include corporate, U.S. government and non-U.S. government securities. The values of fixed income securities classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. Values of investments classified within Level 2 are based upon estimated prices from independent vendors’ pricing models and these prices are derived from market observable sources.
Equity Securities
Equity securities included in the foreign plan assets consist of publicly-traded U.S. and non-U.S. equity securities. The values of equity securities classified within Level 1 are based on the closing price reported on the major market on which the investments are traded. The values of equity security investments classified within Level 2 are based on the corroborated net asset value provided by the fund administrator.
Other Securities
The foreign plans hold a portion of assets in cash and cash equivalents, in order to accommodate liquidity requirements and the values are based upon quoted market prices. Real estate investments consist of investments in funds holding an interest in real properties and the corresponding values represent the estimated fair value based on the fair value of the underlying investment value or cost, adjusted for any accumulated earnings or losses. The values of insurance contracts approximately represent cash surrender value. Other investments include fund investments for which values are based upon either quoted market prices or market observable sources.
The following table summarizes the changes, for the years ended September 30, 2015 and 2014, in the fair value of foreign pension assets measured using Level 3 inputs:
(Millions of dollars)
Real
Estate

Insurance
Contracts

Total
Assets
Balance at September 30, 2013
$
1

$
81

$
83

Actual return on plan assets:

Relating to assets held at September 30, 2013
—

1

1

Purchases, sales and settlements, net
—

3

3

Transfers (out) in from other categories
(1
)

(2
)

(3
)
Exchange rate changes
—

(6
)

(6
)
Balance at September 30, 2014
$
—

$
78

$
78

Actual return on plan assets:

Relating to assets held at September 30, 2014
—

4

4

Purchases, sales and settlements, net
—

16

16

Transfers in from other categories
—

1

1

Exchange rate changes
—

(9
)

(9
)
Balance at September 30, 2015
$
—

$
90

$
90

Postemployment Benefits
The Company utilizes a service-based approach in accounting for most of its postemployment benefits. Under this approach, the costs of benefits are recognized over the eligible employees’ service period. The Company has elected to delay recognition of actuarial gains and losses that result from changes in assumptions.
Postemployment benefit costs for the years ended September 30 included the following components:
(Millions of dollars)
2015

2014

2013
Service cost
$
18

$
20

$
22

Interest cost
6

7

6

Amortization of prior service credit
(2
)

(2
)

(2
)
Amortization of loss
18

21

21

Net postemployment benefit cost
$
42

$
47

$
47

The changes in benefit obligation for these postemployment benefits were as follows:

Postemployment benefits
(Millions of dollars)
2015

2014
Change in benefit obligation:

Beginning obligation
$
184

$
186

Service cost
18

20

Interest cost
6

7

Benefits paid
(25
)

(30
)
Actuarial (gain) loss
(22
)

1

Benefit obligation at September 30
$
163

$
184

The postemployment benefit plan obligations as of September 30, 2015 and 2014 were unfunded. The amounts recognized in Accumulated other comprehensive income (loss) before income taxes for the net actuarial loss were $107 million and $145 million at September 30, 2015 and 2014, respectively. The estimated net actuarial loss that will be amortized from the Accumulated other comprehensive income (loss) into postemployment benefit cost over the next fiscal year is $13 million.
During the fourth quarter of fiscal year 2014, the Company recognized a $36 million charge associated with unusually broad and significant workforce reduction actions that were not contemplated when the postemployment benefit plan obligation was measured on September 30, 2013. As of September 30, 2015, the Company’s remaining liability relating to these workforce reductions, reflecting payments, foreign exchange and a change in estimate which decreased the liability by $5 million, was $4 million. During fiscal year 2015, the Company recognized charges of $126 million for employee termination costs substantially in connection with its acquisition of CareFusion. Additional disclosures regarding the CareFusion acquisition are provided in Note 9 and additional disclosures regarding the Company’s restructuring activities that relate to this acquisition are provided in Note 11.

Savings Incentive Plan
The Company has voluntary defined contribution plans covering eligible employees in the United States which provide for a Company match. The cost of these plans was $54 million in 2015, $39 million in 2014 and $36 million in 2013. The fiscal year 2015 increase in the cost associated with these plans is attributable to the Company's acquisition of CareFusion. The Company guarantees employees' contributions to the fixed income fund of one of these plans, which typically consists of high quality bonds, including U.S. government securities, corporate bonds, mortgage-backed and asset-backed securities and cash equivalents. The amount guaranteed was $235 million at September 30, 2015.

X

- References
No definition available.
+ Details

Name: us-gaap_CompensationAndRetirementDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for pension and other postretirement benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 80

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=49170332&loc=SL14450702-114947

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e2410-114920

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 60

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39675-114964

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 70

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 60

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6414199&loc=d3e39622-114963

+ Details

Name: us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 98 R60.htm IDEA: XBRL DOCUMENT v3.3.0.814

Share-Based Compensation - Summary of Stock Options Outstanding (Detail)
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended

Sep. 30, 2015

USD ($)

$ / shares

shares

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]

Stock options, beginning balance (shares) 74

Stock options granted during the period, acquisition-related conversion (shares) 1,971

Stock options, exercised (shares) (900)

Stock options, forfeited, canceled or expired (shares) (7)

Stock options, ending balance (shares) 1,139

Stock options, vested at ending balance (shares) 1,111

Stock options, exercisable at ending balance (shares) 865

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]

Weighted average exercise price, beginning of period (USD per share) | $ / shares $ 54.57

Weighted average exercise price, granted, acquisition-related conversation (USD per share) | $ / shares 82.32

Weighted average exercise price, exercised (USD per share) | $ / shares 83.70

Weighted average exercise price, forfeited, canceled or expired (USD per share) | $ / shares 73.41

Weighted average exercise price, end of period (USD per share) | $ / shares 79.47

Stock options, weighted average exercise price, vested at ending balance (USD per share) | $ / shares 79.10

Stock options, weighted average exercise price, exercisable at ending balance (USD per share) | $ / shares $ 74.82

Stock options, weighted average remaining contractual term, balance at ending balance 4 years 3 months 22 days

Stock options, weighted average remaining contractual term, vested at ending balance 4 years 3 months 15 days

Stock options, weighted average remaining contractual term, exercisable at ending balance 3 years 11 months 27 days

Stock options, aggregate intrinsic value, balance at ending balance | $ $ 61

Stock options, aggregate intrinsic value, vested at ending balance | $ 60

Stock options, aggregate intrinsic value, exercisable at ending balance | $ $ 50

X

- Definition
Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Aggregate Intrinsic Value
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Weighted Average Remaining Contractual Term
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageRemainingContractualTerm

Namespace Prefix: bdx_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice

Namespace Prefix: bdx_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(3)-(4)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price of options that were either forfeited or expired.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(3)-(4)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of options vested.
+ References
No definition available.
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 99 R110.htm IDEA: XBRL DOCUMENT v3.3.0.814

Supplemental Financial Information - Property, Plant and Equipment, Net (Detail) - USD ($)
$ in Millions

Sep. 30, 2015

Sep. 30, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Land $ 146 $ 93

Buildings 2,414 2,313

Machinery, equipment and fixtures 5,602 5,271

Leasehold improvements 114 88

Property, Plant and Equipment, gross 8,277 7,765

Less accumulated depreciation and amortization 4,217 4,160

Property, Plant and Equipment, Net $ 4,060 $ 3,605

X

- Definition
Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.14)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 4

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6812-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

+ Details

Name: us-gaap_BuildingsAndImprovementsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 4

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6812-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Land

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 4

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6812-107765

+ Details

Name: us-gaap_LeaseholdImprovementsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 4

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6812-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

+ Details

Name: us-gaap_MachineryAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PropertyPlantAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 100 R13.htm IDEA: XBRL DOCUMENT v3.3.0.814

Segment Data
12 Months Ended

Sep. 30, 2015

Segment Reporting [Abstract]

Segment Data
Segment Data

Effective October 1, 2014, the Company’s organizational structure was realigned to better complement its customer-focused solutions strategy and is based upon two principal business segments: BD Medical (“Medical”) and BD Life Sciences (“Life Sciences”). The composition of the Medical segment did not change from its historical composition as a result of this realignment. The Life Sciences segment consists of the former BD Diagnostics and BD Biosciences segments. Beginning on October 1, 2014, decisions about resource allocation and performance assessment are made separately for the Medical and Life Sciences segments. Prior-period information presented for comparative purposes has been revised to reflect the new two-segment organizational structure. CareFusion, which was acquired on March 17, 2015, operates as part of the Company’s Medical segment. The Company’s two principal business segments are strategic businesses that are managed separately because each one develops, manufactures and markets distinct products and services.
The Medical segment produces a broad array of medical devices that are used in a wide range of healthcare settings. The principal product lines in the Medical segment include syringes and pen needles for the injection of insulin and other drugs used in the treatment of diabetes; needles, syringes and intravenous catheters for medication delivery (including safety-engineered and auto-disable devices); prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentation; generic prefilled injectables; intravenous medication safety and infusion therapy delivery systems, including infusion pumps and dedicated disposables; automated medication dispensing and supply management systems; prefillable drug delivery systems provided to pharmaceutical companies and sold to end-users as drug/device combinations; respiratory ventilation and diagnostics equipment and consumables used during respiratory diagnostics and therapy; and consumables used for patient monitoring and anesthesia delivery.
The Life Sciences segment produces products for the safe collection and transport of diagnostics specimens, as well as instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections (“HAIs”) and cancers. The segment also produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes. The principal products and services in the Life Sciences segment include integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing and tuberculosis culturing systems; molecular testing systems for infectious diseases and women’s health; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation; plated media; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological (HIV) and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing.
The Company evaluates performance of its business segments and allocates resources to them primarily based upon operating income. Segment operating income represents revenues reduced by product costs and operating expenses.

Distribution of products is primarily through independent distribution channels, and directly to end-users by BD and independent sales representatives. No customer accounted for 10% or more of revenues in any of the three years presented.
(Millions of dollars)
2015

2014

2013

Revenues (A)

Medical
$
6,460

(B)

$
4,573



$
4,306

Life Sciences
3,822



3,872



3,748

Total Revenues
$
10,282

$
8,446



$
8,054

Segment Operating Income

Medical
$
1,530

(C)

$
1,291

(D)

$
1,233

Life Sciences
839

861

(E)

907

Total Segment Operating Income
2,368



2,152



2,140

Unallocated Items (F)
(1,629
)
(G)

(630
)
(H)

(976
)
(I)
Income From Continuing Operations Before Income Taxes
$
739



$
1,522



$
1,165

Segment Assets

Medical
$
20,055



$
4,668



$
4,582

Life Sciences
3,932



3,783



3,776

Total Segment Assets
23,987



8,451



8,357

Corporate and All Other (J)
2,833



3,997



3,792

Total Assets
$
26,820



$
12,447



$
12,149

Capital Expenditures

Medical
$
414



$
420



$
354

Life Sciences
168



155



158

Corporate and All Other
14



16



9

Total Capital Expenditures
$
596



$
592



$
522

Depreciation and Amortization

Medical
$
619



$
293



$
259

Life Sciences
256



251



267

Corporate and All Other
17



18



19

Total Depreciation and Amortization
$
891



$
562



$
546

(A)
Intersegment revenues are not material.
(B)
Includes $20 million in amortization of the acquisition-date write-down of CareFusion’s deferred revenue balance that was recorded to reflect a fair value measurement as of the acquisition date.
(C)
Includes an increase of $284 million in non-cash amortization expense relating to the identifiable intangible assets acquired in the CareFusion transaction as well as depreciation expense relating to the fixed assets acquired in the transaction. Additional disclosures regarding the assets acquired in this acquisition are provided in Note 9. Also includes a $5 million adjustment to decrease the liability for employee termination costs recorded relative to certain workforce reduction actions taken in the fourth quarter of fiscal year 2014. Additional disclosures regarding these actions are provided in Note 8.
(D)
Includes $21 million of the charge associated with workforce reduction actions noted above. Also, includes a $6 million charge associated with the decision to terminate a research and development program; the charge relates to program asset write-offs and obligations. Additionally includes $4 million of acquisition-related transaction costs recorded in Selling and administrative expense.
(E)
Includes a $20 million charge primarily resulting from the discontinuance of an instrument product development program. The charge is largely attributable to capitalized product software, but also includes a lesser amount attributable to fixed assets. Also, includes an $11 million charge that resulted from the early termination of a European distributor agreement and $10 million of the charge associated with the workforce reduction actions noted above. Additionally includes a $5 million charge due to an adjustment to the carrying amount of an asset that is being held for sale and $1 million of acquisition-related transaction costs recorded in Selling and administrative expense.
(F)
Includes primarily interest, net; foreign exchange; corporate expenses; and share-based compensation expense.
(G)
Includes financing, transaction, integration and restructuring costs associated with the CareFusion acquisition. Also includes $293 million in recognition of the fair value step-up adjustment recorded relative to CareFusion’s inventory on the acquisition date as well as $16 million of favorable amortization relating to the acquisition-date fair value step-up recorded on CareFusion’s long-term debt. Additional disclosures regarding this acquisition are provided in Note 9. Also includes a $12 million charge for RTI’s attorneys’ fees associated with the unfavorable verdict returned in the antitrust and false advertising lawsuit RTI filed against BD. For further discussion, refer to Note 5. Additionally includes an acquisition-date accounting gain of $9 million on the previously held investment in CRISI Medical Systems, Inc. (“CRISI”), which the Company fully acquired during the second quarter of 2015.
(H)
Includes an $8 million gain resulting from the Company’s receipt of cash proceeds from the sale of a company in which it held a small equity ownership interest. Also includes $5 million of the charge associated with the workforce reductions noted above.
(I)
Includes the $341 million charge associated with the unfavorable verdict returned in the antitrust and false advertising lawsuit filed against the Company by RTI as well as a $22 million charge associated with a litigation settlement related to indirect purchaser antitrust class action cases. Additional disclosures regarding legal matters are provided in Note 5.
(J)
Includes cash and investments and corporate assets.
Geographic Information
The countries in which the Company has local revenue-generating operations have been combined into the following geographic areas: the United States (including Puerto Rico); Europe; Greater Asia (which includes Japan and Asia Pacific); and Other, which is comprised of Latin America, Canada, and EMA (which includes the Commonwealth of Independent States, Middle East and Africa).
Revenues to unaffiliated customers are based upon the source of the product shipment. Long-lived assets, which include net property, plant and equipment, are based upon physical location.
(Millions of dollars)
2015

2014

2013
Revenues

United States
$
5,069

$
3,417

$
3,353

Europe
2,434

2,383

2,189

Greater Asia
1,545

1,437

1,344

Other
1,234

1,210

1,168

$
10,282

$
8,446

$
8,054

Long-Lived Assets

United States
$
15,513

$
3,126

$
3,251

Europe
3,876

1,790

1,649

Greater Asia
569

555

519

Other
484

505

505

Corporate
332

340

350

$
20,774

$
6,317

$
6,276

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 34

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 33

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 40

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 42

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 29

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 31

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599

+ Details

Name: us-gaap_SegmentReportingDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 101 R14.htm IDEA: XBRL DOCUMENT v3.3.0.814

Share-Based Compensation
12 Months Ended

Sep. 30, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-Based Compensation
Share-Based Compensation
The Company grants share-based awards under the 2004 Employee and Director Equity-Based Compensation Plan (“2004 Plan”), which provides long-term incentive compensation to employees and directors consisting of: stock appreciation rights (“SARs”), stock options, performance-based restricted stock units, time-vested restricted stock units and other stock awards.
The fair value of share-based payments is recognized as compensation expense in net income. The amounts and location of compensation cost relating to share-based payments included in consolidated statements of income is as follows:
(Millions of dollars)
2015

2014

2013
Cost of products sold
$
23

$
23

$
20

Selling and administrative expense
82

74

66

Research and development expense
17

16

14

Acquisition-related costs
44

—

—

$
166

$
113

$
100

The associated income tax benefit recognized was $59 million, $40 million and $35 million in fiscal years 2015, 2014 and 2013, respectively. Share-based compensation attributable to discontinued operations in 2013 was not material.

Certain pre-acquisition equity awards of CareFusion were converted into BD restricted stock awards or BD stock options with accelerated vesting terms at the acquisition date. In addition, as an incentive to encourage post-acquisition employee retention, certain pre-acquisition equity awards of CareFusion were converted into either BD restricted stock awards or BD stock options, as applicable, as of the acquisition date, with substantially the same terms and conditions as were applicable under such CareFusion awards immediately prior to the acquisition date. The compensation expense associated with these replacement awards was recorded in Acquisition-related costs.
Stock Appreciation Rights
SARs represent the right to receive, upon exercise, shares of common stock having a value equal to the difference between the market price of common stock on the date of exercise and the exercise price on the date of grant. SARs vest over a four-year period and have a ten-year term. The fair value was estimated on the date of grant using a lattice-based binomial option valuation model that uses the following weighted-average assumptions:

2015

2014

2013
Risk-free interest rate
2.20%

2.31%

1.33%
Expected volatility
19.0%

19.0%

21.0%
Expected dividend yield
1.78%

2.00%

2.60%
Expected life
7.6 years

7.8 years

8.0 years
Fair value derived
$24.82

$19.90

$12.08

Expected volatility is based upon historical volatility for the Company’s common stock and other factors. The expected life of SARs granted is derived from the output of the lattice-based model, using assumed exercise rates based on historical exercise and termination patterns, and represents the period of time that SARs granted are expected to be outstanding. The risk-free interest rate used is based upon the published U.S. Treasury yield curve in effect at the time of grant for instruments with a similar life. The dividend yield is based upon the most recently declared quarterly dividend as of the grant date. The total intrinsic value of SARs exercised during 2015, 2014 and 2013 was $96 million, $69 million and $54 million, respectively. The Company issued 691 thousand shares during 2015 to satisfy the SARs exercised. The actual tax benefit realized during 2015, 2014 and 2013 for tax deductions from SAR exercises totaled $34 million, $26 million and $19 million, respectively. The total fair value of SARs vested during 2015, 2014 and 2013 was $22 million, $25 million and $30 million, respectively.
A summary of SARs outstanding as of September 30, 2015 and changes during the year then ended is as follows:

SARs (in
thousands)

Weighted
Average
Exercise Price

Weighted
Average
Remaining
Contractual Term
(Years)

Aggregate
Intrinsic
Value
(Millions
of dollars)
Balance at October 1
7,852

$
78.49

Granted
1,037

134.73

Exercised
(1,458
)

72.88

Forfeited, canceled or expired
(167
)

103.50

Balance at September 30
7,264

$
87.07

5.96

$
333

Vested and expected to vest at September 30
7,010

$
86.34

5.88

$
327

Exercisable at September 30
4,725

$
76.18

4.81

$
267

Stock Options
The Company has not granted stock options since 2005. As previously discussed, certain pre-acquisition equity awards of CareFusion were converted on March 17, 2015 into BD stock options with accelerated vesting terms.
A summary of stock options outstanding as of September 30, 2015 and changes during the year then ended is as follows:

Stock
Options (in
thousands)

Weighted
Average
Exercise Price

Weighted Average
Remaining
Contractual Term
(Years)

Aggregate
Intrinsic
Value
(Millions
of dollars)
Balance at October 1
74

$
54.57

Acquisition-related conversions (A)
1,971

82.32

Exercised
(900
)

83.70

Forfeited, canceled or expired
(7
)

73.41

Balance at September 30
1,139

$
79.47

4.31

$
61

Vested at September 30
1,111

$
79.10

4.29

$
60

Exercisable at September 30
865

$
74.82

3.99

$
50

(A)
Represents options granted upon the conversion of pre-acquisition equity awards of CareFusion, as previously discussed.
Cash received from the exercising of stock options in 2015, 2014 and 2013 was $75 million, $17 million and $64 million, respectively. The actual tax benefit realized for tax deductions from stock option exercises totaled $20 million, $7 million and $21 million, respectively. The total intrinsic value of stock options exercised during the years 2015, 2014 and 2013 was $52 million, $21 million and $65 million, respectively.

Performance-Based Restricted Stock Units
Performance-based restricted stock units cliff vest three years after the date of grant. These units are tied to the Company’s performance against pre-established targets over a three-year performance period. The performance measures for fiscal years 2015, 2014 and 2013 were relative total shareholder return (measures the Company’s stock performance during the performance period against that of peer companies) and average annual return on invested capital. Under the Company’s long-term incentive program, the actual payout under these awards may vary from zero to 200% of an employee’s target payout, based on the Company’s actual performance over the three-year performance period. The fair value is based on the market price of the Company’s stock on the date of grant. Compensation cost initially recognized assumes that the target payout level will be achieved and is adjusted for subsequent changes in the expected outcome of performance-related conditions. For units for which the performance conditions are modified after the date of grant, any incremental increase in the fair value of the modified units, over the original units, is recorded as compensation expense on the date of the modification for vested units, or over the remaining performance period for units not yet vested.
A summary of performance-based restricted stock units outstanding as of September 30, 2015 and changes during the year then ended is as follows:

Stock Units (in
thousands)

Weighted
Average Grant
Date Fair Value
Balance at October 1
1,255

$
83.47

Granted
352

148.04

Distributed
(139
)

72.12

Forfeited or canceled
(330
)

79.12

Balance at September 30(A)
1,139

$
106.07

Expected to vest at September 30(B)
542

$
97.09

(A)
Based on 200% of target payout.
(B)
Net of expected forfeited units and units in excess of the expected performance payout of 68 thousand and 528 thousand shares, respectively.
The weighted average grant date fair value of performance-based restricted stock units granted during the years 2014 and 2013 was $110.58 and $72.14, respectively. The total fair value of performance-based restricted stock units vested during 2015 was $16 million and the fair value of units vested during 2014 was $10 million. Based on the Company’s results during the performance period, compared with the established performance targets for payout, there was no payout of performance-based restricted stock units in fiscal year 2013. At September 30, 2015, the weighted average remaining vesting term of performance-based restricted stock units is 1.04 years.
Time-Vested Restricted Stock Units
Time-vested restricted stock unit awards granted after January 2015 vest on a graded basis over a three-year period. Time-vested restricted stock units granted before January 2015 cliff vest three years after the date of grant, except for certain key executives of the Company, including the executive officers, for which such units generally vest one year following the employee’s retirement. The related share-based compensation expense is recorded over the requisite service period, which is the vesting period or in the case of certain key executives is based on retirement eligibility. The fair value of all time-vested restricted stock units is based on the market value of the Company’s stock on the date of grant. The impact of this change in accounting policy was not material to reported stock-based compensation expense for the year ended September 30, 2015.

A summary of time-vested restricted stock units outstanding as of September 30, 2015 and changes during the year then ended is as follows:

Stock Units (in
thousands)

Weighted
Average Grant
Date Fair Value
Balance at October 1
3,015

$
80.03

Granted (A)
1,946

136.30

Distributed
(1,128
)

99.07

Forfeited or canceled
(766
)

107.50

Balance at September 30
3,067

$
101.88

Expected to vest at September 30
2,878

$
100.65

(A)
Includes approximately 1 million units granted upon the conversion of pre-acquisition equity awards of CareFusion, as previously discussed.
The weighted average grant date fair value of time-vested restricted stock units granted during the years 2014 and 2013 was $102.74 and $70.99, respectively. The total fair value of time-vested restricted stock units vested during 2015, 2014 and 2013 was $181 million, $45 million and $52 million, respectively. At September 30, 2015, the weighted average remaining vesting term of the time-vested restricted stock units is 1.08 years.
The amount of unrecognized compensation expense for all non-vested share-based awards as of September 30, 2015, is approximately $156 million, which is expected to be recognized over a weighted-average remaining life of approximately 1.84 years. Included in the unrecognized compensation expense is $38 million associated with the CareFusion replacement awards previously described. As of September 30, 2015, there were approximately 1.5 million of such replacement awards outstanding.
At September 30, 2015, 7,242 thousand shares were authorized for future grants under the 2004 Plan. The Company has a policy of satisfying share-based payments through either open market purchases or shares held in treasury. At September 30, 2015, the Company has sufficient shares held in treasury to satisfy these payments.
Other Stock Plans
The Company has a Stock Award Plan, which allows for grants of common shares to certain key employees. Distribution of 25% or more of each award is deferred until after retirement or involuntary termination, upon which the deferred portion of the award is distributable in five equal annual installments. The balance of the award is distributable over five years from the grant date, subject to certain conditions. In February 2004, this plan was terminated with respect to future grants upon the adoption of the 2004 Plan. At September 30, 2015 and 2014, awards for 50 thousand and 58 thousand shares, respectively, were outstanding.
The Company has a Directors’ Deferral Plan, which provides a means to defer director compensation, from time to time, on a deferred stock or cash basis. As of September 30, 2015, 119 thousand shares were held in trust, of which three thousand shares represented Directors’ compensation in 2015, in accordance with the provisions of the plan. Under this plan, which is unfunded, directors have an unsecured contractual commitment from the Company.
The Company also has a Deferred Compensation Plan that allows certain highly-compensated employees, including executive officers, to defer salary, annual incentive awards and certain equity-based compensation. As of September 30, 2015, 345 thousand shares were issuable under this plan.

X

- Definition
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51659978&loc=d3e25284-112666

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 102 R16.htm IDEA: XBRL DOCUMENT v3.3.0.814

Acquisitions
12 Months Ended

Sep. 30, 2015

Business Combinations [Abstract]

Acquisitions
Acquisitions

CareFusion Corporation
Overview of Transaction and Consideration Transferred
On March 17, 2015, pursuant to a definitive agreement announced on October 5, 2014, the Company acquired a 100% interest in CareFusion, a global medical technology company with a comprehensive portfolio of products in the areas of medication management, infection prevention, operating room and procedural effectiveness, and respiratory care, to create a global leader in medication management and patient safety solutions. Under the terms of the transaction, CareFusion shareholders received $49.00 in cash and 0.0777 of a share of the Company for each share of CareFusion. The value of the total consideration transferred for accounting purposes was based on the closing share price of the Company’s stock on the last trading day prior to the closing date of the transaction. The fair value of consideration transferred was $12.538 billion and consisted of the components below.
(Millions of dollars)

Cash consideration
$
10,085

Noncash consideration-fair value of shares issued
2,269

Noncash consideration-fair value of stock options and other equity awards
184

Total consideration transferred
$
12,538

The acquisition date fair value of the Company’s ordinary shares issued to CareFusion shareholders was calculated per the following (shares in millions):
(Millions of dollars)

Total CareFusion shares outstanding
205.3

Conversion factor
0.0777

Number of the Company’s shares issued
15.9

Closing price of the Company’s stock on March 16, 2015
$
142.29

Fair value of the Company’s issued shares
$
2,269

Additional disclosures regarding the financing arrangements the Company entered into to fund the cash portion of the consideration transferred relative to this acquisition are provided in Note 15.

Allocation of Consideration Transferred to Net Assets Acquired
The acquisition was accounted for under the acquisition method of accounting for business combinations. The allocations of the purchase price below represent the estimated fair values of assets acquired and liabilities assumed, based upon the information available as of September 30, 2015. These estimates could be adjusted if further information regarding events or circumstances which existed at the acquisition date becomes available by March 2016. Such adjustments may be significant.
All of the assets acquired and liabilities assumed in this acquisition have been allocated to the Company’s Medical segment.
(Millions of dollars)

Cash and equivalents
$
1,903

Trade receivables, net
530

Inventories
813

Net investment in sales-type leases
1,208

Property, plant and equipment
499

Customer relationships
3,360

Developed technology
2,510

Trademarks
380

Other intangible assets
185

Other assets
321

Total identifiable assets acquired
11,709

Long-term debt
(2,181
)
Deferred tax liabilities
(2,034
)
Other liabilities
(1,299
)
Total liabilities assumed
(5,514
)

Net identifiable assets acquired
6,195

Goodwill
6,343

Net assets acquired
$
12,538

Net Investment in Sales-Type Leases Acquired
The fair value of the net investment in sales-type leases acquired was based upon a determination that the interest rate implicit in the lease contract portfolio represented a market interest rate as well as a determination that the residual value of the overall lease contract portfolio represents fair market value.
Identifiable Intangible Assets Acquired
The customer relationships asset acquired represented CareFusion’s contractual relationships with its customers. The fair value of these customer relationships was determined based on the present value of projected cash flows utilizing an income approach with a risk-adjusted discount rate of 11%. The amortization period of the customer relationships was determined to be 15 years and this period corresponds with the weighted average of lives determined for the product technology which underlies the customer contracts.
The developed technology assets acquired represented CareFusion’s developed technologies in the areas of medication management, infection prevention, operating room and procedural effectiveness, and respiratory care. The technologies’ fair values were determined based on the present value of projected cash flows utilizing an income approach with a risk-adjusted discount rate of 11%. The technologies will be amortized over a weighted-average amortization period of 12 years, which is the weighted average period over which the technologies are expected to generate substantial cash flows.
The trademark assets acquired represented the value of registered trademarks protecting the intellectual property underlying CareFusion’s product technologies. The fair value of the trademarks represents the present value of projected cash flows, specifically the estimated cost savings from not being required to pay royalties for use of these intellectual properties, utilizing an income approach with a risk-adjusted discount rate of 11%. The trademarks will be amortized over a weighted-average amortization period of 22 years, which is the weighted average period over which the trademarks are expected to generate substantial cash flows.
Other intangible assets acquired included $110 million relating to acquired in-process research and development assets representing development projects relating to various product technologies. The probability of success associated with the projects, based upon the applicable technological and commercial risk, was assumed to be 80% to 85%, depending upon the project. The projects’ fair values were determined based on the present value of projected cash flows utilizing an income approach with a risk-adjusted discount rate of 12%. The launches of the various projects are expected to occur from 2016 to 2022.
Other Liabilities Assumed
The balance of other liabilities assumed included a $36 million liability recorded due to a recall relating to AVEA® ventilators, which is one of CareFusion’s respiratory solutions products. The liability represents the costs expected to be incurred in connection with voluntary field corrections for a portion of the installed base of ventilators.
Goodwill
Goodwill typically results through expected synergies from combining operations of an acquiree and an acquirer, as well as from intangible assets that do not qualify for separate recognition. The goodwill recognized as a result of this acquisition includes, among other things, the value of combining the complementary product portfolios of the Company and CareFusion to offer integrated medication management solutions and smart devices. Synergies are expected from combining the two companies’ products to meet unmet needs in hospitals, hospital pharmacies and alternate sites of care to increase efficiencies, reduce medication administration errors and improve patient and healthcare worker safety. Synergies are also expected to result from solid positions in patient safety to maximize outcomes in infection prevention, respiratory care, and acute care procedural effectiveness. No portion of goodwill from this acquisition is currently expected to be deductible for tax purposes.
Financing, Transaction, Integration and Restructuring Costs
During the year ended September 30, 2015, the Company incurred financing, transaction, integration and restructuring costs which substantially related to the CareFusion acquisition. The financing costs totaled $107 million for the year ended September 30, 2015 and were recorded as Interest expense. Transaction costs of $59 million for the year ended September 30, 2015 were recorded as Acquisition-related costs, and consisted of legal, advisory and other costs.
Acquisition-related costs also included $95 million and $271 million of integration and restructuring costs, respectively, for the year ended September 30, 2015. See Note 11 for further discussion of restructuring activity relating to this acquisition. The Company is in the process of executing its integration plans to combine businesses, sales organizations, systems and locations and, as a result, the Company is expected to continue to incur fairly substantial integration costs through to fiscal year 2016.
Unaudited Pro Forma Information
The acquisition was accounted for under the acquisition method of accounting for business combinations. The operating activities from the acquisition date through March 31, 2015 were not material to the Company’s consolidated results of operations. As such, CareFusion’s operating results were included in the Company’s consolidated results of operations beginning on April 1, 2015. Revenues and Operating Income for the year ended September 30, 2015 include revenues and operating loss attributable to CareFusion of $2 billion and $242 million, respectively.
The following table provides the pro forma results for the years ended September 30, 2015 and 2014 as if CareFusion had been acquired as of October 1, 2013.
(Millions of dollars, except per share data)

2015

2014

Revenues
$
12,368

$
12,288

Net Income
$
1,276

$
1,191

Diluted Earnings per Share
$
5.92

$
5.55

The pro forma results above reflect the following adjustments, which were adjusted for the applicable tax impact to derive the net income amounts above:
•
Additional amortization expense related to the fair value of intangible assets acquired;
•
Additional depreciation expense related to the fair value of property, plant and equipment acquired;
•
Additional interest expense and financing costs associated with the Company’s financing arrangements relating to this acquisition, as well as the adjustment to interest expense relating to the fair value of long-term debt assumed;
•
Elimination of one-time financing fees, transaction, integration and restructuring costs incurred relative to this acquisition;
•
Exclusion of the income statement effects of the fair value adjustments to inventory and deferred revenue obligations acquired as such adjustments are not recurring in nature.
The pro forma results do not include any anticipated cost savings or other effects of the planned integration of CareFusion. Accordingly, the pro forma results above are not necessarily indicative of the results that would have been if the acquisition had occurred on the dates indicated, nor are the pro forma results indicative of results which may occur in the future.
Other Transactions
During the first quarter of fiscal year 2015, the Company acquired GenCell Biosystems (“GenCell”), a privately-held Irish biotechnology company that has developed proprietary technologies that address key biological analysis protocols including library preparation of Next Generation Sequencing and genotyping applications. During the second quarter of fiscal year 2015, the Company acquired CRISI, a San Diego-based medical technology company dedicated to improving the safety and delivery of IV injectable medications. During the third quarter of fiscal year 2015, the Company acquired the ARX group of companies (“ARX”), a leading pharmacy automation distributor in Western Europe. During the fourth quarter of fiscal year 2015, the Company acquired Cellular Research, Inc. (“Cellular Research”), a biotechnology research and development company that has developed advanced tools for massively parallel single cell genetic analysis based on their proprietary Molecular Indexing^TM technology to enable gene expression profiles from single cells.
During the second quarter of fiscal year 2014, the Company acquired Alverix, Inc. ("Alverix"), a privately-held diagnostic instrument company known for its optoelectronics expertise. During the first quarter of fiscal year 2013, the Company acquired Safety Syringes, Inc., a privately held California-based company that specializes in the development of anti-needlestick devices for prefilled syringes. During the second quarter of fiscal year 2013, the Company acquired Cato Software Solutions, a privately held Austria-based manufacturer of cato® and chemocato® software, a suite of comprehensive medication safety solutions for pharmacy intravenous medication preparation, physician therapy planning and nurse bedside documentation.

X

- Definition
The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1500-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1524-128463

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7000-128479

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4922-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4934-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4926-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1383-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6996-128479

+ Details

Name: us-gaap_BusinessCombinationDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_BusinessCombinationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 103 R64.htm IDEA: XBRL DOCUMENT v3.3.0.814

Benefit Plans - Net Pension and Other Postretirement Cost (Detail) - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Pension Plans

Defined Benefit Plan Disclosure [Line Items]

Service cost $ 77 $ 71 $ 84

Interest cost 87 93 87

Expected return on plan assets (123) (126) (116)

Amortization of prior service credit (15) (15) (13)

Amortization of loss 68 49 75

Curtailment/settlement loss 0 3 6

Net pension and postretirement cost 93 74 123

Other Postretirement Benefits

Defined Benefit Plan Disclosure [Line Items]

Service cost 3 3 6

Interest cost 7 9 10

Expected return on plan assets 0 0 0

Amortization of prior service credit (5) (4) (1)

Amortization of loss 3 2 4

Curtailment/settlement loss 0 0 0

Net pension and postretirement cost $ 9 $ 10 $ 19

X

- Definition
The amount of gains or losses recognized in net periodic benefit cost.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (h)(4)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of the prior service cost or credit recognized in net periodic benefit cost relating to benefit changes attributable to plan participants' prior service pursuant to a plan amendment or a plan initiation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (h)(1)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Prior Service Cost

-URI http://asc.fasb.org/extlink&oid=49177896

+ Details

Name: us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlanDisclosureLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
An amount calculated as a basis for determining the extent of delayed recognition of the effects of changes in the fair value of assets. The expected return on plan assets is determined based on the expected long-term rate of return on plan assets and the market-related value of plan assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Expected Return on Plan Assets

-URI http://asc.fasb.org/extlink&oid=6512171

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (h)(3)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase in a defined benefit pension plan's projected benefit obligation or a defined benefit postretirement plan's accumulated postretirement benefit obligation due to the passage of time.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (h)(2)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)(2)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanInterestCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The total amount of net periodic benefit cost for defined benefit plans for the period. Periodic benefit costs include the following components: service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) due to settlements or curtailments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (h)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (j)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of net gain (loss) recognized in net periodic benefit cost due to settlements and curtailments. Curtailments result from an event that significantly reduces the expected years of future service of present employees or eliminates for a significant number of employees the accrual of defined benefits for some or all of their future services. Settlements result from an irrevocable action that relieves the employer (or the plan) of primary responsibility for a benefit obligation and eliminates significant risks related to the obligation and the assets used to effect the settlement. Examples of transactions that constitute a settlement include, but are not limited to, lump-sum cash payments to plan participants in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contracts to cover vested benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (h)(7)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The actuarial present value of benefits attributed by the pension benefit formula to services rendered by employees during the period. The portion of the expected postretirement benefit obligation attributed to employee service during the period. The service cost component is a portion of the benefit obligation and is unaffected by the funded status of the plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Service Cost (Component of Net Periodic Pension Cost)

-URI http://asc.fasb.org/extlink&oid=6525008

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (h)(1)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanServiceCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_PensionPlansDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 104 R85.htm IDEA: XBRL DOCUMENT v3.3.0.814

Intangible Assets - Components of Intangible Assets (Detail) - USD ($)
$ in Millions

Sep. 30, 2015

Sep. 30, 2014

Finite And Indefinite Lived Intangible Assets [Line Items]

Gross Carrying Amount $ 7,723 $ 1,308

Accumulated Amortization 903 594

Unamortized intangible assets 205 46

Acquired in-process research and development

Finite And Indefinite Lived Intangible Assets [Line Items]

Unamortized intangible assets 203 44

Trademarks

Finite And Indefinite Lived Intangible Assets [Line Items]

Unamortized intangible assets 2 2

Customer relationships

Finite And Indefinite Lived Intangible Assets [Line Items]

Gross Carrying Amount 3,370 10

Accumulated Amortization 120 2

Developed technology

Finite And Indefinite Lived Intangible Assets [Line Items]

Gross Carrying Amount 3,487 893

Accumulated Amortization 510 379

Product rights

Finite And Indefinite Lived Intangible Assets [Line Items]

Gross Carrying Amount 128 148

Accumulated Amortization 35 31

Trademarks

Finite And Indefinite Lived Intangible Assets [Line Items]

Gross Carrying Amount 405 27

Accumulated Amortization 26 19

Patents and other

Finite And Indefinite Lived Intangible Assets [Line Items]

Gross Carrying Amount 333 232

Accumulated Amortization $ 212 $ 163

X

- Definition
Finite And Indefinite Lived Intangible Assets [Line Items]
+ References
No definition available.
+ Details

Name: bdx_FiniteAndIndefiniteLivedIntangibleAssetsLineItems

Namespace Prefix: bdx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bdx_ProductRightsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 105 R66.htm IDEA: XBRL DOCUMENT v3.3.0.814

Benefit Plans - Change in Benefit Obligation, Change in Fair Value of Plan Assets (Detail) - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Amounts recognized in the Consolidated Balance Sheets at September 30:

Long-term Employee Benefit Obligations $ (1,133) $ (1,009)

Pension Plans

Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]

Beginning obligation 2,366 2,076

Service cost 77 71 $ 84

Interest cost 87 93 87

Plan amendments (2) (1)

Benefits paid (138) (142)

Benefit obligations assumed in acquisition 67 0

Actuarial loss (gain) 49 318

Settlements 0 (7)

Other, includes translation (81) (42)

Ending obligation 2,426 2,366 2,076

Change in fair value of plan assets:

Beginning fair value 1,829 1,785

Actual return on plan assets (21) 119

Employer contribution 65 104

Benefits paid (138) (142)

Plan assets acquired in acquisition 54 0

Settlements 0 (7)

Other, includes translation (58) (29)

Ending fair value 1,732 1,829 1,785

Funded Status at September 30:

Unfunded benefit obligation (694) (537)

Amounts recognized in the Consolidated Balance Sheets at September 30:

Other 7 3

Salaries, wages and related items (10) (8)

Long-term Employee Benefit Obligations (691) (531)

Net amount recognized (694) (537)

Amounts recognized in Accumulated other comprehensive income (loss) before income taxes at September 30:

Net transition asset 0 0

Prior service credit 103 119

Net actuarial loss (1,124) (1,030)

Net amount recognized (1,021) (911)

Other Postretirement Benefits

Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]

Beginning obligation 201 243

Service cost 3 3 6

Interest cost 7 9 10

Plan amendments 0 (37)

Benefits paid (18) (24)

Benefit obligations assumed in acquisition 0 0

Actuarial loss (gain) (11) 0

Settlements 0 0

Other, includes translation 3 6

Ending obligation 186 201 $ 243

Change in fair value of plan assets:

Benefits paid (18) (24)

Funded Status at September 30:

Unfunded benefit obligation (186) (201)

Amounts recognized in the Consolidated Balance Sheets at September 30:

Other 0 0

Salaries, wages and related items (15) (16)

Long-term Employee Benefit Obligations (171) (184)

Net amount recognized (186) (201)

Amounts recognized in Accumulated other comprehensive income (loss) before income taxes at September 30:

Net transition asset 0 0

Prior service credit 37 42

Net actuarial loss (30) (44)

Net amount recognized $ 7 $ (2)

X

- Definition
The pretax total of net gain (loss), prior service cost (credit), and transition assets (obligations), as well as minimum pension liability if still remaining, included in accumulated other comprehensive income associated with a defined benefit pension or other postretirement plan(s) because they have yet to be recognized as components of net periodic benefit cost.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (j)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 10A

-Subparagraph (i-k)

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580

+ Details

Name: us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTaxAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The pretax net amount of gains and losses that are not yet recognized as a component of net periodic benefit cost, and that are recognized as increases or decreases in other comprehensive income as they arise. Gains and losses are due to changes in the value of either the benefit obligation or the plan assets resulting from experience different from that assumed or from a change in an actuarial assumption, or the consequence of a decision to temporarily deviate from the substantive plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 10A

-Subparagraph (i)

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (j)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount related to the pretax cost of benefit changes attributable to plan participants' prior service pursuant to a plan amendment or a plan initiation, which has not yet been recognized as components of net periodic benefit cost.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Prior Service Cost

-URI http://asc.fasb.org/extlink&oid=49177896

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (j)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 10A

-Subparagraph (j)

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580

+ Details

Name: us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Before tax amount of net transition assets (obligations) which has yet to be recognized as a component of net periodic benefit cost.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (i)-(j)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Transition Asset

-URI http://asc.fasb.org/extlink&oid=6749452

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Transition Obligation

-URI http://asc.fasb.org/extlink&oid=6749492

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 10A

-Subparagraph (k)

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580

+ Details

Name: us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetTransitionAssetsObligationsBeforeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The difference between fair value of plan assets at the end of the period and the fair value at the beginning of the period, adjusted for contributions and payments of benefits during the period, and after adjusting for taxes and other expenses, as applicable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Actual Return on Plan Assets (Component of Net Periodic Postretirement Benefit Cost)

-URI http://asc.fasb.org/extlink&oid=6504192

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)(1)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Actual Return on Plan Assets (Component of Net Periodic Pension Cost)

-URI http://asc.fasb.org/extlink&oid=6504226

+ Details

Name: us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of gain (loss) related to change in benefit obligation resulting from changes in actuarial assumptions, for example, but not limited to, interest, mortality, employee turnover, salary, and temporary deviation from the substantive plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Gain or Loss

-URI http://asc.fasb.org/extlink&oid=49168827

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)(4)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanActuarialGainLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate net amount recognized in the balance sheet associated with the defined benefit plan(s). Will normally be the same as the Defined Benefit Plan, Funded Status of Plan, Total.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=21915240&loc=d3e1703-114919

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
This represents the entire assets recognized in the balance sheet that are associated with the defined benefit plans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.10)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.10)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=21915240&loc=d3e1703-114919

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
1) For defined benefit pension plans, the benefit obligation is the projected benefit obligation, which is the actuarial present value as of a date of all benefits attributed by the pension benefit formula to employee service rendered prior to that date. 2) For other postretirement defined benefit plans, the benefit obligation is the accumulated postretirement benefit obligation, which is the actuarial present value of benefits attributed to employee service rendered to a particular date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Projected Benefit Obligation

-URI http://asc.fasb.org/extlink&oid=6522206

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Accumulated Postretirement Benefit Obligation

-URI http://asc.fasb.org/extlink&oid=6503904

+ Details

Name: us-gaap_DefinedBenefitPlanBenefitObligation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of payments made for which participants are entitled under a pension plan, including pension benefits, death benefits, and benefits due on termination of employment. Also includes payments made under a postretirement benefit plan, including prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services. This item represents a periodic decrease to the plan obligations and a decrease to plan assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 60

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Benefits

-URI http://asc.fasb.org/extlink&oid=49170737

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)(6)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Postretirement Benefits

-URI http://asc.fasb.org/extlink&oid=6521376

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)(5)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanBenefitsPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of increase in the benefit obligation attributed to business combinations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)(8)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of increase in the plan assets attributed to a business combination.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)(6)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsPlanAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase in the fair value of plan assets from contributions made by the employer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)(3)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanContributionsByEmployer

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits, at their fair value as of the measurement date. Plan assets include amounts contributed by the employer (and by employees for a contributory plan) and amounts earned from investing the contributions, less benefits paid. If a plan has liabilities other than for benefits, those non-benefit obligations may be considered as reductions of plan assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 30

-Section 35

-Paragraph 50

-URI http://asc.fasb.org/extlink&oid=49178875&loc=d3e12355-114930

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanFairValueOfPlanAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of increase or decrease in plan assets attributed to foreign currency changes. The effects of foreign currency exchange rate changes that are to be disclosed are those applicable to plans of a foreign operation whose functional currency is not the reporting currency.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)(2)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The funded status is measured as the difference between the fair value of plan assets and the benefit obligation. Will normally be the same as the net Defined Benefit Plan, Amounts Recognized in Balance Sheet, Total.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=21915240&loc=d3e1703-114919

+ Details

Name: us-gaap_DefinedBenefitPlanFundedStatusOfPlan

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlanFundedStatusOfPlanAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase in a defined benefit pension plan's projected benefit obligation or a defined benefit postretirement plan's accumulated postretirement benefit obligation due to the passage of time.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (h)(2)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)(2)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanInterestCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Changes in the defined benefit obligation, not otherwise separately disclosed in the financial statements.
+ References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlanOtherChanges

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of increase or decrease due to a change in the terms of an existing plan or the initiation of a new plan. A plan amendment may increase or decrease benefits, including those attributed to years of service already rendered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Plan Amendment

-URI http://asc.fasb.org/extlink&oid=49173939

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)(7)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanPlanAmendments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The actuarial present value of benefits attributed by the pension benefit formula to services rendered by employees during the period. The portion of the expected postretirement benefit obligation attributed to employee service during the period. The service cost component is a portion of the benefit obligation and is unaffected by the funded status of the plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Service Cost (Component of Net Periodic Pension Cost)

-URI http://asc.fasb.org/extlink&oid=6525008

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (h)(1)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanServiceCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of decrease that relates to an irrevocable action that relieves the employer (or the plan) of primary responsibility for a benefit obligation and eliminates significant risks related to the obligation and the assets used to effect the settlement. Examples of transactions that constitute a settlement include (a) making lump-sum cash payments to plan participants in exchange for their rights to receive specified benefits and (b) purchasing nonparticipating annuity contracts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 30

-Section 15

-Paragraph 6

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=7577095&loc=d3e8001-114927

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)(10)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanSettlementsBenefitObligation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount that relates to an irrevocable action that relieves the employer (or the plan) of primary responsibility for a benefit obligation and eliminates significant risks related to the obligation and the assets used to effect the settlement. Examples of transactions that constitute a settlement include (a) making lump-sum cash payments to plan participants in exchange for their rights to receive specified benefits and (b) purchasing nonparticipating annuity contracts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 30

-Section 15

-Paragraph 6

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=7577095&loc=d3e8001-114927

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)(8)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanSettlementsPlanAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
For a classified balance sheet, the amount recognized in balance sheet as a current liability associated with an underfunded defined benefit plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=21915240&loc=d3e1703-114919

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
This represents the noncurrent liability for underfunded plans recognized in the balance sheet that is associated with the defined benefit pension plans and other postretirement defined benefit plans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e2417-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=21915240&loc=d3e1703-114919

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.24)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e2410-114920

+ Details

Name: us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_PensionPlansDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 106 R102.htm IDEA: XBRL DOCUMENT v3.3.0.814

Income Taxes - Summary of Gross Amounts of Unrecognized Tax Benefits (Detail) - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]

Balance at October 1 $ 197 $ 146 $ 134

Increase due to acquisitions 314 0 0

Increase due to current year tax positions 58 51 80

Increase due to prior year tax positions 17 9 25

Decreases due to prior year tax positions 0 0 0

Decrease due to settlements and lapse of statute of limitations (11) (9) (93)

Balance at September 30 $ 575 $ 197 $ 146

X

- Definition
The gross amount of decreases in unrecognized tax benefits resulting from settlements with taxing authorities and lapses of the applicable statutes of limitations.
+ References
No definition available.
+ Details

Name: bdx_DecreaseInUnrecognizedTaxBenefitsDueToSettlementsAndLapseOfStatuteOfLimitations

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of unrecognized tax benefits pertaining to uncertain tax positions taken in tax returns.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15A

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=SL6600010-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Unrecognized Tax Benefit

-URI http://asc.fasb.org/extlink&oid=6527854

+ Details

Name: us-gaap_UnrecognizedTaxBenefits

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15A

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=SL6600010-109319

+ Details

Name: us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase in unrecognized tax benefits resulting from acquisitions.
+ References
No definition available.
+ Details

Name: us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15A

-Subparagraph (a)(2)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=SL6600010-109319

+ Details

Name: us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15A

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=SL6600010-109319

+ Details

Name: us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 107 R63.htm IDEA: XBRL DOCUMENT v3.3.0.814

Share-Based Compensation - Summary of Time-Vested Restricted Stock Units Outstanding (Detail) - Time-Vested Restricted Stock Units - $ / shares
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]

Stock units, beginning balance (shares) 3,015,000

Granted, sock units (shares) 1,946,000

Distributed, stock units (shares) (1,128,000)

Forfeited, canceled or expired, stock units (shares) (766,000)

Stock units, ending balance (shares) 3,067,000 3,015,000

Stock units, vested and expected to vest at ending balance (shares) 2,878,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]

Stock units exercise price, beginning balance (USD per share) $ 80.03

Granted, stock units weighted average grant date fair value (USD per share) 136.30 $ 102.74 $ 70.99

Distributed, stock units exercise price (USD per share) 99.07

Forfeited, canceled or expired, stock units exercise price (USD per share) 107.50

Stock units exercise price, ending balance (USD per share) 101.88 $ 80.03

Stock units, vested and expected to vest at ending balance, exercise price (USD per share) $ 100.65

Care Fusion Corporation

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]

Granted, sock units (shares) 1,000,000

X

- Definition
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Expected To Vest
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberExpectedToVest

Namespace Prefix: bdx_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Expected To Vest
+ References
No definition available.
+ Details

Name: bdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueExpectedToVest

Namespace Prefix: bdx_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(3)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(3)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=bdx_CareFusionCorporationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 108 R92.htm IDEA: XBRL DOCUMENT v3.3.0.814

Financial Instruments and Fair Value Measurements - Additional Information (Detail) - USD ($)
3 Months Ended 12 Months Ended

Sep. 30, 2015

Sep. 30, 2015

Sep. 30, 2014

Jun. 30, 2015

Dec. 31, 2014

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Remaining cash equivalents $ 1,277,000,000 $ 1,277,000,000 $ 821,000,000

Fair value of long-term debt 11,600,000,000 11,600,000,000 4,100,000,000

Transfer of assets in and out of level 1, 2 and 3 measurements during the period 0 0

Transfer of liabilities in and out of level 1, 2 and 3 measurements during the period 0 $ 0

Asset Impairment Charges 72,000,000

Gen Cell Biosystems

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Fair value of contingent consideration $ 36,000,000

Cellular Research

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Fair value of contingent consideration 28,000,000 28,000,000

Notes Due June 2016

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Debt instrument, face amount 750,000,000 750,000,000 $ 750,000,000

Fair value of debt classified from long term to short term $ 750,000,000 $ 750,000,000

Minimum

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Maturity period of short-term investments at the time of purchase 3 months

Maximum

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Maturity period of short-term investments at the time of purchase 1 year

X

- Definition
Fair Value Of Debt Classified From Long Term To Short Term
+ References
No definition available.
+ Details

Name: bdx_FairValueOfDebtClassifiedFromLongTermToShortTerm

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The maturity period of time deposits classified as short-term investments in the consolidated balance sheet.
+ References
No definition available.
+ Details

Name: bdx_MaturityPeriodOfShortTermInvestment

Namespace Prefix: bdx_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Amounts of cash equivalents that are carried at cost and are not measured at fair value under the fair value measurement requirements for financial assets and liabilities.
+ References
No definition available.
+ Details

Name: bdx_RemainingCashEquivalents

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51824106&loc=d3e2420-110228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_AssetImpairmentCharges

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of liability recognized arising from contingent consideration in a business combination.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 35

-Paragraph 1

-Subparagraph b

-URI http://asc.fasb.org/extlink&oid=6911338&loc=d3e6819-128478

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 25

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476

+ Details

Name: us-gaap_BusinessCombinationContingentConsiderationLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Fair value portion of contractual obligation to pay money on demand or on fixed or determinable dates.
+ References
No definition available.
+ Details

Name: us-gaap_LoansPayableFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=bdx_GenCellBiosystemsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=bdx_CellularResearchMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_NotesDueJune2016Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 109 R34.htm IDEA: XBRL DOCUMENT v3.3.0.814

Divestiture (Tables)
12 Months Ended

Sep. 30, 2015

Discontinued Operations and Disposal Groups [Abstract]

Results of Discontinued Operations
Results of discontinued operations were as follows:
(Millions of dollars)
2015

2014

2013
Revenues
$
—

$
—

$
20

Income from discontinued operations before income taxes
—

—

586

Less income tax provision
—

—

222

Income from discontinued operations, net
$
—

$
—

$
364

X

- References
No definition available.
+ Details

Name: us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721533-107759

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 4B

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721665-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1474-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721683-107760

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 3A

-URI http://asc.fasb.org/extlink&oid=51719941&loc=SL51724579-110230

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5C

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721675-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 4A

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721663-107760

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51719941&loc=d3e2941-110230

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5B

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721673-107760

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 3A

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721659-107760

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5A

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721671-107760

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5D

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721677-107760

+ Details

Name: us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 110 R51.htm IDEA: XBRL DOCUMENT v3.3.0.814

Commitments and Contingencies - Additional Information (Detail) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 12 Months Ended

Jan. 15, 2015

Nov. 10, 2014

Sep. 19, 2013

Nov. 09, 2009

Apr. 30, 2015

Sep. 30, 2013

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Loss Contingencies [Line Items]

Rental expense for operating leases $ 89.0 $ 71.0 $ 70.0

Future minimum rental commitments on noncancelable leases due in 2016 80.0

Future minimum rental commitments on noncancelable leases due in 2017 62.0

Future minimum rental commitments on noncancelable leases due in 2018 36.0

Future minimum rental commitments on noncancelable leases due in 2019 26.0

Future minimum rental commitments on noncancelable leases due in 2020 18.0

Future minimum rental commitments on noncancelable leases thereafter 24.0

Aggregate future purchase commitments $ 958.0

Anti-dumping measures, period 5 years

United States

Loss Contingencies [Line Items]

Duty percentage rate 45.30%

United Kingdom of Great Britain and Northern Ireland

Loss Contingencies [Line Items]

Duty percentage rate 71.50%

RTI Technologies

Loss Contingencies [Line Items]

Damages awarded $ 341.0 $ 113.5 $ 5.0

Pre-tax charge relating to an unfavorable litigation verdict $ 341.0

Percentage of reduction in total fee recovery 50.00%

Professional Fees $ 12.0

X

- Definition
The percentage rate of duties to be imposed on product imports.
+ References
No definition available.
+ Details

Name: bdx_DutyPercentageRate

Namespace Prefix: bdx_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Loss Contingency, Anti-Dumping Measures, Period
+ References
No definition available.
+ Details

Name: bdx_LossContingencyAntiDumpingMeasuresPeriod

Namespace Prefix: bdx_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Court's reduction of plaintiff's legal fees requested as part of award of costs.
+ References
No definition available.
+ Details

Name: bdx_LossContingencyPercentageOfReductionInFeesRecovery

Namespace Prefix: bdx_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Pre Tax Charge associated with the unfavorable verdict returned against the company, in an antitrust and false advertising lawsuit filed by RTI Technologies .
+ References
No definition available.
+ Details

Name: bdx_PretaxChargeRelatingToAnUnfavorableLitigationVerdict

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The minimum amount the entity agreed to spend under the long-term purchase commitment.
+ References
No definition available.
+ Details

Name: us-gaap_LongTermPurchaseCommitmentAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_LossContingenciesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) in loss contingency liability.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

+ Details

Name: us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of damages awarded to the plaintiff in the legal matter.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 9

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14557-108349

+ Details

Name: us-gaap_LossContingencyDamagesAwardedValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 10

-Section 55

-Paragraph 40

-Subparagraph (Note 3)

-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 10

-Section 55

-Paragraph 40

-Subparagraph (Note 3)

-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 10

-Section 55

-Paragraph 40

-Subparagraph (Note 3)

-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 10

-Section 55

-Paragraph 40

-Subparagraph (Note 3)

-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 10

-Section 55

-Paragraph 40

-Subparagraph (Note 3)

-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 10

-Section 55

-Paragraph 40

-Subparagraph (Note 3)

-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41499-112717

+ Details

Name: us-gaap_OperatingLeasesRentExpenseNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_US

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_GB

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=bdx_RtiTechnologiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 111 R21.htm IDEA: XBRL DOCUMENT v3.3.0.814

Financial Instruments and Fair Value Measurements
12 Months Ended

Sep. 30, 2015

Fair Value Disclosures [Abstract]

Financial Instruments and Fair Value Measurements
Financial Instruments and Fair Value Measurements
Recurring Fair Value Measurements
The fair values of financial instruments, including those not recognized on the statement of financial position at fair value, carried at September 30, 2015 and 2014 are classified in accordance with the fair value hierarchy in the following tables:

Basis of Fair Value Measurement
(Millions of dollars)

September 30,
2015
Total

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

Significant
Other
Observable
Inputs (Level 2)

Significant
Unobservable
Inputs (Level 3)
Assets

Institutional money market investments

$
147

$
147

$
—

$
—

Interest rate swaps

19

—

19

—

Forward exchange contracts

13

—

13

—

Total Assets

$
179

$
147

$
32

$
—

Liabilities

Forward exchange contracts

$
21

$
—

$
21

$
—

Commodity forward contracts

10

—

10

—

Contingent consideration liabilities

77

—

—

77

Total Liabilities

$
108

$
—

$
30

$
77

Basis of Fair Value Measurement
(Millions of dollars)

September 30,
2014
Total

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

Significant
Other
Observable
Inputs (Level 2)

Significant
Unobservable
Inputs (Level 3)
Assets

Institutional money market investments

$
1,040

$
1,040

$
—

$
—

Interest rate swaps

3

—

3

—

Forward exchange contracts

20

—

20

—

Total Assets

$
1,063

$
1,040

$
23

$
—

Liabilities

Forward exchange contracts

$
14

$
—

$
14

$
—

Contingent consideration liabilities

14

—

—

14

Total Liabilities

$
29

$
—

$
14

$
14

The Company’s institutional money market accounts permit daily redemption and the fair values of these investments are based upon the quoted prices in active markets provided by the holding financial institutions. The Company’s remaining cash equivalents were $1.277 billion and $821 million at September 30, 2015 and 2014, respectively. Short-term investments are held to their maturities and are carried at cost, which approximates fair value. The cash equivalents consist of liquid investments with a maturity of three months or less and the short-term investments consist of instruments with maturities greater than three months and less than one year.
The Company measures the fair value of forward exchange contracts and interest rate swaps based upon the present value of expected future cash flows using market-based observable inputs including credit risk, interest rate yield curves, foreign currency spot prices and forward prices.
Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments, which are considered Level 2 inputs in the fair value hierarchy. The fair value of long-term debt was $11.6 billion and $4.1 billion at September 30, 2015 and 2014, respectively. During the third quarter of fiscal year 2015, the Company reclassified $750 million of floating rates due on June 15, 2016 from Long-Term Debt to Short-term debt. The fair value of these notes was $750 million at September 30, 2015.
The contingent consideration liabilities were recognized as part of the consideration transferred by the Company for certain acquisitions. Additional disclosures regarding these acquisitions are included in Note 9. The fair values of the contingent consideration liabilities were estimated using probability-weighted discounted cash flow models that were based upon the probabilities assigned to the contingent events. The estimated fair values of the contingent consideration liabilities are remeasured at each reporting period based upon increases or decreases in the probability of the contingent payments. The increase to the total contingent consideration liability in fiscal year 2015 was mostly attributable to the recognition of contingent consideration liabilities of $36 million and $28 million in connection with the Company’s acquisitions of GenCell and Cellular Research in the first and fourth quarters, respectively.
The Company’s policy is to recognize any transfers into fair value measurement hierarchy levels and transfers out of levels at the beginning of each reporting period. There were no transfers in and out of Level 1, Level 2 or Level 3 measurements for the years ending September 30, 2015 and 2014.
Nonrecurring Fair Value Measurements
In the fourth quarter of fiscal year 2015, the Company recorded impairment charges of $72 million to Acquisition-related costs relating to assets held for sale. These asset impairment charges were recorded to adjust the carrying amounts of the assets held for sale to an estimate of the assets' fair values, less the estimated costs to sell these assets. The fair values of these assets were estimated, based upon a market participant's perspective, using a market approach and Level 2 inputs, including quoted prices for similar assets. The remaining carrying amounts of the assets held for sale are immaterial to the Company's consolidated balance sheet. Additional disclosures regarding these asset impairment charges are provided in Note 11.
Concentration of Credit Risk
The Company maintains cash deposits in excess of government-provided insurance limits. Such cash deposits are exposed to loss in the event of nonperformance by financial institutions. Substantially all of the Company’s trade receivables are due from public and private entities involved in the healthcare industry. Due to the large size and diversity of the Company’s customer base, concentrations of credit risk with respect to trade receivables are limited. The Company does not normally require collateral. The Company is exposed to credit loss in the event of nonperformance by financial institutions with which it conducts business. However, this loss is limited to the amounts, if any, by which the obligations of the counterparty to the financial instrument contract exceed the obligations of the Company. The Company also minimizes exposure to credit risk by dealing with a diversified group of major financial institutions.
The Company continually evaluates its accounts receivables for potential collection risks particularly those resulting from sales to government-owned or government-supported healthcare facilities in certain countries as payment may be dependent upon the financial stability and creditworthiness of those countries’ national economies. The Company continually evaluates all governmental receivables for potential collection risks associated with the availability of government funding and reimbursement practices. The Company believes the current reserves related to all governmental receivables are adequate and that this concentration of credit risk will not have a material adverse impact on its financial position or liquidity.

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13537-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13504-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 112 R26.htm IDEA: XBRL DOCUMENT v3.3.0.814

Supplementary Data (Unaudited)
12 Months Ended

Sep. 30, 2015

Quarterly Financial Information Disclosure [Abstract]

Supplemental Financial Data (Unaudited)
SUPPLEMENTARY DATA (UNAUDITED)
Millions of dollars, except per share amounts

2015

1^st

2^nd

3^rd

4^th

Year
Revenues

$
2,051

$
2,051

$
3,120

$
3,059

$
10,282

Gross Profit

1,045

1,046

1,174

1,430

4,695

Net Income

236

216

62

181

695

Earnings per Share:

Basic

1.22

1.10

0.30

0.86

3.43

Diluted

1.20

1.08

0.29

0.84

3.35

2014

1^st

2^nd

3^rd

4^th

Year
Revenues

$
2,015

$
2,072

$
2,157

$
2,202

$
8,446

Gross Profit

1,035

1,053

1,111

1,103

4,301

Net Income

271

287

326

301

1,185

Earnings per Share:

Basic

1.40

1.48

1.69

1.56

6.13

Diluted

1.37

1.45

1.65

1.53

5.99

Certain quarterly amounts may not add to the year-to-date totals due to rounding. The third quarter fiscal year 2015 gross profit amount reflects an acquisition-related reclassification. Earnings per share amounts are calculated from the underlying whole-dollar amounts. As of March 17, 2015, the weighted average common shares used in the computations of basic and diluted earnings per share reflect shares issued in connection with the CareFusion acquisition. Additional disclosures regarding this issuance of shares and the acquisition are provided in Notes 4 and 9.

X

- References
No definition available.
+ Details

Name: us-gaap_QuarterlyFinancialInformationDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the quarterly financial data in the annual financial statements. The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=51655806&loc=d3e765-108305

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)-(j)

-URI http://asc.fasb.org/extlink&oid=51825399&loc=d3e1280-108306

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=51655806&loc=d3e725-108305

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section G

-Subsection 1

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-K (SK)

-Number 229

-Section 302

-Paragraph a

+ Details

Name: us-gaap_QuarterlyFinancialInformationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 113 R95.htm IDEA: XBRL DOCUMENT v3.3.0.814

Debt - Schedule if Senior Unsecured Note Issued (Details) - USD ($)
$ in Millions

Sep. 30, 2015

Sep. 30, 2014

Debt Instrument [Line Items]

Long-Term Debt $ 11,370 $ 3,768

1.450% Notes due May 15, 2017

Debt Instrument [Line Items]

Long-Term Debt 300 0

6.375% Notes due August 1, 2019

Debt Instrument [Line Items]

Long-Term Debt 802 0

3.300% Notes due March 1, 2023

Debt Instrument [Line Items]

Long-Term Debt 305 0

3.875% Notes due May 15, 2024

Debt Instrument [Line Items]

Long-Term Debt 419 0

4.875% Notes due May 15, 2044

Debt Instrument [Line Items]

Long-Term Debt 334 $ 0

Care Fusion Corporation

Debt Instrument [Line Items]

Long-Term Debt 1,949

Care Fusion Corporation | 1.450% Notes due May 15, 2017

Debt Instrument [Line Items]

Long-Term Debt $ 293

Percentage of Total Outstanding Principal Amount of such Series of Existing Notes 97.64%

Care Fusion Corporation | 6.375% Notes due August 1, 2019

Debt Instrument [Line Items]

Long-Term Debt $ 665

Percentage of Total Outstanding Principal Amount of such Series of Existing Notes 95.00%

Care Fusion Corporation | 3.300% Notes due March 1, 2023

Debt Instrument [Line Items]

Long-Term Debt $ 294

Percentage of Total Outstanding Principal Amount of such Series of Existing Notes 97.95%

Care Fusion Corporation | 3.875% Notes due May 15, 2024

Debt Instrument [Line Items]

Long-Term Debt $ 397

Percentage of Total Outstanding Principal Amount of such Series of Existing Notes 99.37%

Care Fusion Corporation | 4.875% Notes due May 15, 2044

Debt Instrument [Line Items]

Long-Term Debt $ 300

Percentage of Total Outstanding Principal Amount of such Series of Existing Notes 99.96%

X

- Definition
Percentage of Total Outstanding Principal Amount of such Series of Existing Notes
+ References
No definition available.
+ Details

Name: bdx_PercentageofTotalOutstandingPrincipalAmountofsuchSeriesofExistingNotes

Namespace Prefix: bdx_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying amount of long-term debt, net of unamortized discount or premium, excluding amounts to be repaid within one year or the normal operating cycle, if longer (current maturities). Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes1.450dueMay152017Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes6.375DueAugust12019Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes3.300dueMarch12023Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes3.875dueMay152024Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=bdx_Notes4.875DueMay152044Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=bdx_CareFusionCorporationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 114 R49.htm IDEA: XBRL DOCUMENT v3.3.0.814

Earnings per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share (Detail) - shares
shares in Thousands
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Earnings Per Share [Abstract]

Average common shares outstanding (shares) 202,537 193,299 195,157

Dilutive share equivalents from share-based plans (shares) 4,972 4,410 4,036

Average common and common equivalent shares outstanding - assuming dilution (shares) 207,509 197,709 199,193

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Weighted-Average Number of Common Shares Outstanding

-URI http://asc.fasb.org/extlink&oid=6528421

+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 115 R105.htm IDEA: XBRL DOCUMENT v3.3.0.814

Sale-Type Leases and Financing Receivable (Details) - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Mar. 17, 2015

Business Acquisition [Line Items]

Capital lease term 5 years

Capital Leases, Future Minimum Payments Receivable, Fiscal Year Maturity [Abstract]

2016 $ 413

2017 355

2018 275

2019 187

2020 79

Thereafter $ 3

Care Fusion Corporation

Business Acquisition [Line Items]

Net investment in sales-type leases $ 1,208

X

- Definition
Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Net Investment in Sales Type Leases
+ References
No definition available.
+ Details

Name: bdx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetInvestmentinSalesTypeLeases

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Capital Leases, Lease Term
+ References
No definition available.
+ Details

Name: bdx_CapitalLeasesLeaseTerm

Namespace Prefix: bdx_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_BusinessAcquisitionLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CapitalLeasesFutureMinimumPaymentsReceivableAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of minimum lease payments to be received by the lessor for capital leases in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 4

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=25496975&loc=d3e45377-112738

+ Details

Name: us-gaap_CapitalLeasesFutureMinimumPaymentsReceivableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of minimum lease payments to be received by the lessor for capital leases after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 4

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=25496975&loc=d3e45377-112738

+ Details

Name: us-gaap_CapitalLeasesFutureMinimumPaymentsReceivableDueThereafter

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of minimum lease payments to be received by the lessor for capital leases in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 4

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=25496975&loc=d3e45377-112738

+ Details

Name: us-gaap_CapitalLeasesFutureMinimumPaymentsReceivableInFiveYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of minimum lease payments to be received by the lessor for capital leases in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 4

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=25496975&loc=d3e45377-112738

+ Details

Name: us-gaap_CapitalLeasesFutureMinimumPaymentsReceivableInFourYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of minimum lease payments to be received by the lessor for capital leases in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 4

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=25496975&loc=d3e45377-112738

+ Details

Name: us-gaap_CapitalLeasesFutureMinimumPaymentsReceivableInThreeYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of minimum lease payments to be received by the lessor for capital leases in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 4

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=25496975&loc=d3e45377-112738

+ Details

Name: us-gaap_CapitalLeasesFutureMinimumPaymentsReceivableInTwoYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=bdx_CareFusionCorporationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 116 R41.htm IDEA: XBRL DOCUMENT v3.3.0.814

Sale-Type Leases and Financing Receivable Schedule of Capital Leased Assets (Tables)
12 Months Ended

Sep. 30, 2015

Receivables [Abstract]

Capital Leases, Net Investment in Direct Financing Leases

September 30,
(Millions of dollars)
2015
Future minimum lease payments receivable
$
1,311

Unguaranteed residual values
29

Unearned income
(142
)
Allowance for uncollectible minimum lease payments receivable
(5
)
Net Investment in Sales-Type Leases
1,193

Less: Current portion of net investment in sales-type leases
75

Net Investment in Sales-Type Leases, Less Current Portion
$
1,118

X

- Definition
Capital Leases, Net Investment in Direct Financing Leases [Table Text Block]
+ References
No definition available.
+ Details

Name: bdx_CapitalLeasesNetInvestmentinDirectFinancingLeasesTableTextBlock

Namespace Prefix: bdx_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ReceivablesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 117 R107.htm IDEA: XBRL DOCUMENT v3.3.0.814

Supplemental Financial Information - Additional Information (Detail) - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Condensed Income Statements, Captions [Line Items]

Other income, net $ 21 $ 5 $ 9

Equity investment income 9 13 5

Income from license and other agreements 2 3 3

Foreign exchange losses (inclusive of hedging costs) (13) (10)

Discovery Labware

Condensed Income Statements, Captions [Line Items]

Income from contract manufacturing and other transition services related to sale of Discovery Labware $ 3 $ 11

Crisi Medical Systems Inc | Corporate and All Other

Condensed Income Statements, Captions [Line Items]

Business combination, step acquisition, equity Interest in acquiree, remeasurement gain $ 9

X

- Definition
In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (g)(2)

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

+ Details

Name: us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_CondensedIncomeStatementsCaptionsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450189&loc=d3e30690-110894

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 20

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6450189&loc=d3e30700-110894

+ Details

Name: us-gaap_ForeignCurrencyTransactionGainLossRealized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35755396&loc=d3e33749-111570

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.12)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 9

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 11

-Article 7

+ Details

Name: us-gaap_IncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of other income amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) profits on securities (net of losses), and (d) miscellaneous other income items.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherNonoperatingIncome

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_RoyaltyIncomeNonoperating

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bdx_DiscoveryLabwareMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=bdx_CrisiMedicalSystemsIncMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 118 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814

Consolidated Balance Sheets - USD ($)
$ in Millions

Sep. 30, 2015

Sep. 30, 2014

Current Assets

Cash and equivalents $ 1,424 $ 1,861

Short-term investments 20 884

Trade receivables, net 1,618 1,187

Current portion of net investment in sales-type leases 75 5

Inventories 1,959 1,495

Prepaid expenses, deferred taxes and other 950 698

Total Current Assets 6,045 6,131

Property, Plant and Equipment, Net 4,060 3,605

Goodwill 7,537 1,090

Customer Relationships, Net 3,250 8

Developed Technology, Net 2,977 513

Other Intangibles, Net 797 239

Capitalized Software, Net 362 365

Net Investment in Sales-Type Leases, Less Current Portion 1,118 9

Other Assets 673 488

Total Assets 26,820 12,447

Current Liabilities

Short-term debt 1,452 203

Accounts payable 631 401

Accrued expenses 1,624 1,053

Salaries, wages and related items 647 551

Income taxes 33 26

Total Current Liabilities 4,386 2,235

Long-Term Debt 11,370 3,768

Long-Term Employee Benefit Obligations 1,133 1,009

Deferred Income Taxes and Other $ 2,767 $ 383

Commitments and Contingencies

Shareholders’ Equity

Common stock — $1 par value: authorized — 640,000,000 shares; issued — 332,662,160 shares in 2015 and 2014. $ 333 $ 333

Capital in excess of par value 4,475 2,198

Retained earnings 12,314 12,105

Deferred compensation 20 19

Common stock in treasury — at cost — 121,966,516 shares in 2015 and 140,770,158 shares in 2014. (8,239) (8,601)

Accumulated other comprehensive loss (1,738) (1,001)

Total Shareholders’ Equity 7,164 5,053

Total Liabilities and Shareholders’ Equity $ 26,820 $ 12,447

X

- Definition
Value of common stock issued to a trust (for example, but not limited to, rabbi trust) set up specifically to accumulate stock for the sole purpose of distribution to participating employees.
+ References
No definition available.
+ Details

Name: bdx_CommonStockSharesHeldInEmployeeTrust1

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Intangible assets arising from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date.
+ References
No definition available.
+ Details

Name: bdx_CoreAndDevelopedTechnologyNet

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Net carrying amount as of the balance sheet date of an asset acquired in a business combination representing a favorable existing relationship with customers having a finite beneficial life.
+ References
No definition available.
+ Details

Name: bdx_FiniteLivedCustomerRelationshipsNet

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 15

-Article 9

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 15

-Subparagraph b(1)

-Article 7

+ Details

Name: us-gaap_AccruedIncomeTaxesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e681-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669686-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

+ Details

Name: us-gaap_AdditionalPaidInCapitalCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net amount due within one year of the balance sheet date or the normal operating cycle, if longer, consisting of: (a) minimum lease payments due on direct financing and sales-type leases, (b) unguaranteed residual value, and (c) any unamortized initial direct costs on direct financing leases; less: (i) executory costs, (ii) unearned income, and (iii) the accumulated allowance for uncollectible minimum lease payments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 4

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=25496975&loc=d3e45377-112738

+ Details

Name: us-gaap_CapitalLeasesLessorBalanceSheetNetInvestmentInDirectFinancingAndSalesTypeLeasesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The net amount due after one year of the balance sheet date or beyond the normal operating cycle, if longer, consisting of: (a) minimum lease payments due on direct financing and sales-type leases, (b) unguaranteed residual value, and (c) any unamortized initial direct costs on direct financing leases; less: (i) executory costs, (ii) unearned income, and (iii) the accumulated allowance for uncollectible minimum lease payments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 4

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=25496975&loc=d3e45377-112738

+ Details

Name: us-gaap_CapitalLeasesLessorBalanceSheetNetInvestmentInDirectFinancingAndSalesTypeLeasesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756

+ Details

Name: us-gaap_CapitalizedComputerSoftwareNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.(a),19)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.17)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_EmployeeRelatedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51655945&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 25

-Article 7

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying amount of long-term debt, net of unamortized discount or premium, excluding amounts to be repaid within one year or the normal operating cycle, if longer (current maturities). Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate carrying amount, as of the balance sheet date, of current assets not separately disclosed in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.8)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_OtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The net carrying amount as of the balance sheet date of other indefinite-lived and finite-lived intangible assets that are not separately presented on the statement of financial position.
+ References
No definition available.
+ Details

Name: us-gaap_OtherIntangibleAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.24)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_OtherLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Other investments not otherwise specified in the taxonomy that will be realized in a short period of time, usually less than one year or the normal operating cycle, whichever is longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.5)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.8)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.1(g))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

+ Details

Name: us-gaap_OtherShortTermInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This represents the noncurrent liability for underfunded plans recognized in the balance sheet that is associated with the defined benefit pension plans and other postretirement defined benefit plans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e2417-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=21915240&loc=d3e1703-114919

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.24)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e2410-114920

+ Details

Name: us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3,4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a

-Article 5

+ Details

Name: us-gaap_ReceivablesNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656

+ Details

Name: us-gaap_TreasuryStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 119 R88.htm IDEA: XBRL DOCUMENT v3.3.0.814

Derivative Instruments and Hedging Activities - Additional Information (Detail)
1 Months Ended 12 Months Ended

Apr. 30, 2015

Sep. 30, 2015

USD ($)

lb

Sep. 30, 2014

USD ($)

Dec. 31, 2014

USD ($)

Derivative Instruments and Hedging Activities Disclosures [Line Items]

Reclassification of terminated interest rate swaps to interest expense within the next 12 months $ 6,000,000

Gain recorded on fair value hedges 19,000,000 $ 3,000,000

Gains or losses, related to hedge ineffectiveness 0

Cash Flow Hedges

Derivative Instruments and Hedging Activities Disclosures [Line Items]

After-tax loss recognized in other comprehensive income (loss) 16,000,000

Forward exchange contracts

Derivative Instruments and Hedging Activities Disclosures [Line Items]

Notional amount 2,200,000,000 1,800,000,000

Interest rate swaps | Care Fusion Corporation

Derivative Instruments and Hedging Activities Disclosures [Line Items]

Notional amount $ 2,300,000,000

Interest rate swaps | Cash Flow Hedges

Derivative Instruments and Hedging Activities Disclosures [Line Items]

Notional amount 0 0

Interest rate swaps | Cash Flow Hedges | Care Fusion Corporation

Derivative Instruments and Hedging Activities Disclosures [Line Items]

After-tax loss recognized in other comprehensive income (loss) 8,000,000

Fixed To Floating

Derivative Instruments and Hedging Activities Disclosures [Line Items]

Notional amount $ 375,000,000 375,000,000

Interest rate 3.125%

Commodity forward contracts

Derivative Instruments and Hedging Activities Disclosures [Line Items]

Notional amount $ 25,000,000 $ 0

Percentage of resin spend covered by hedge program 13.00%

Notional amount, mass (lb) | lb 49,000,000

Commodity forward contracts | Cash Flow Hedges

Derivative Instruments and Hedging Activities Disclosures [Line Items]

After-tax loss recognized in other comprehensive income (loss) $ 7,000,000

X

- Definition
Percentage Of Resin Spend Covered By Hedge Program
+ References
No definition available.
+ Details

Name: bdx_PercentageOfResinSpendCoveredByHedgeProgram

Namespace Prefix: bdx_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate notional amount specified by the derivative(s). Expressed as an absolute value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 12

-Section 13

-Sentence Column B

+ Details

Name: invest_DerivativeNotionalAmount

Namespace Prefix: invest_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The effective portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments that was recognized in other comprehensive income during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

+ Details

Name: us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of gain (loss) from the ineffectiveness of the hedge.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-Subparagraph (d)(1)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 25

-Section 50

-Paragraph 1

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

+ Details

Name: us-gaap_DerivativeNetHedgeIneffectivenessGainLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Nominal mass used to calculate payments on a derivative instrument.
+ References
No definition available.
+ Details

Name: us-gaap_DerivativeNonmonetaryNotionalAmountMass

Namespace Prefix: us-gaap_

Data Type: num:massItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of unrealized gain (loss) related to the fair value of interest rate derivatives designated as fair value hedging instruments, as offset by the gain (loss) on the hedged item to the extent that the fair value hedge is determined to be effective.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4A

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5618551-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

+ Details

Name: us-gaap_IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994

+ Details

Name: us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=bdx_CareFusionCorporationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=bdx_FixedToFloatingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 120 R10.htm IDEA: XBRL DOCUMENT v3.3.0.814

Shareholders' Equity
12 Months Ended

Sep. 30, 2015

Stockholders' Equity Note [Abstract]

Shareholders' Equity
Shareholders’ Equity
Changes in certain components of shareholders’ equity were as follows:

Common
Stock Issued
at Par Value

Capital in
Excess of
Par Value

Retained
Earnings

Deferred
Compensation

Treasury Stock
(Millions of dollars)
Shares (in
thousands)

Amount
Balance at September 30, 2012
$
333

$
1,920

$
10,435

$
19

(135,751
)

$
(7,769
)
Net income
—

—

1,293

—

—

—

Cash dividends:

Common ($1.98 per share)
—

—

(386
)

—

—

—

Common stock issued for:

Share-based compensation and other plans, net
—

50

—

—

2,537

15

Share-based compensation
—

98

—

—

—

—

Common stock held in trusts, net
—

—

—

—

36

—

Repurchase of common stock
—

—

—

—

(5,485
)

(450
)
Balance at September 30, 2013
$
333

$
2,068

$
11,342

$
19

(138,663
)

$
(8,204
)
Net income
—

—

1,185

—

—

—

Cash dividends:

Common ($2.18 per share)
—

—

(421
)

—

—

—

Common stock issued for:

Share-based compensation and other plans, net
—

19

—

—

1,431

3

Share-based compensation
—

111

—

—

—

—

Common stock held in trusts, net
—

—

—

—

36

—

Repurchase of common stock
—

—

—

—

(3,574
)

(400
)
Balance at September 30, 2014
$
333

$
2,198

$
12,105

$
19

(140,770
)

$
(8,601
)
Net income
—

—

695

—

—

—

Cash dividends:

Common ($2.40 per share)
—

—

(485
)

—

—

—

Common stock issued for:

Share-based compensation and other plans, net
—

30

(2
)

1

2,839

(6
)
Acquisitions
—

2,083

—

—

15,959

368

Share-based compensation
—

164

—

—

—

—

Common stock held in trusts, net
—

—

—

—

5

—

Repurchase of common stock
—

—

—

—

—

—

Balance at September 30, 2015
$
333

$
4,475

$
12,314

$
20

(121,967
)

$
(8,239
)

Common stock held in trusts represents rabbi trusts in connection with deferred compensation under the Company’s employee salary and bonus deferral plan and directors’ deferral plan.
The components and changes of Accumulated other comprehensive income (loss) were as follows:
(Millions of dollars)
Total

Foreign
Currency
Translation
Adjustments

Benefit Plans
Adjustments

Unrealized
Losses on
Cash Flow
Hedges
Balance at September 30, 2012
$
(802
)

$
51

$
(815
)

$
(38
)
Other comprehensive income before reclassifications, net of taxes
228

23

203

2

Amounts reclassified into income, net of taxes (A)
59

—

54

4

Balance at September 30, 2013
$
(516
)

$
74

$
(558
)

$
(31
)
Other comprehensive income before reclassifications
(524
)

(344
)

(180
)

—

Amounts reclassified into income, net of
taxes (A)
38

—

33

5

Balance at September 30, 2014
$
(1,001
)

$
(270
)

$
(705
)

$
(26
)
Other comprehensive income before reclassifications, net of taxes
(787
)

(692
)

(80
)

(16
)
Amounts reclassified into income, net of
taxes (A)
50

—

44

6

Balance at September 30, 2015
$
(1,738
)

$
(961
)

$
(741
)

$
(36
)
(A)
The benefit plan-related amount is not reclassified into income in its entirety. The reclassifications from accumulated other comprehensive (loss) income are included in the computation of net periodic pension cost and additional details are provided in Note 8. The reclassification amounts related to cash flow hedges in fiscal years 2015, 2014, and 2013 were primarily recorded in Interest Expense. Additional details regarding the reclassifications from accumulated other comprehensive (loss) income related to cash flow hedges are provided in Note 13.
The loss in foreign currency translation adjustments for the fiscal year ended September 30, 2015 was primarily attributable to the weakening of the Euro and currencies in Latin America and Asia Pacific against the U.S. dollar during the period.
The income tax (benefit) provision for net (losses) gains recorded in other comprehensive income for defined benefit pension, postretirement plans and postemployment plans in fiscal years 2015, 2014 and 2013 was $(47) million, $(86) million and $121 million, respectively. The income tax benefits associated with the benefit plan-related reclassification adjustments for amortization of prior service credit and amortization of net actuarial losses for the fiscal years ended September 30, 2015, 2014 and 2013 were $23 million, $17 million and $30 million, respectively.
The income tax benefit recorded for losses recognized in other comprehensive income relating to cash flow hedges for the fiscal year ended September 30, 2015 was $10 million. Additional disclosures regarding these losses are provided in Note 13. There were no net gains or losses recorded in other comprehensive income relating to cash flow hedges in fiscal year 2014 and gains recorded in 2013 were immaterial. Reclassification adjustments for realized amounts relating to cash flow hedges were immaterial in fiscal years 2015, 2014, and 2013.

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityNoteAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 121 R58.htm IDEA: XBRL DOCUMENT v3.3.0.814

Share-Based Compensation - Assumptions for Estimation of Fair Values of Stock Appreciation Rights Granted During Reporting Periods (Detail) - Stock Appreciation Rights (SARs) - $ / shares
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Risk-free interest rate 2.20% 2.31% 1.33%

Expected volatility 19.00% 19.00% 21.00%

Expected dividend yield 1.78% 2.00% 2.60%

Expected life 7 years 7 months 9 days 7 years 9 months 18 days 8 years

Fair value derived (USD per share) $ 24.82 $ 19.90 $ 12.08

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)(iv)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 14.D.2)

-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

-Section D

-Subsection 2

+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 122 R82.htm IDEA: XBRL DOCUMENT v3.3.0.814

Divestiture - Additional Information (Detail) - Discovery Labware - USD ($)
$ in Millions
3 Months Ended

Oct. 31, 2012

Jun. 30, 2013

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Proceeds from sale of productive assets $ 740

Additional payment received from the sale $ 16

Pre-tax gain on sale 577

After-tax gain on sale 355

Amount of goodwill derecognized $ 17

X

- Definition
Amount before tax of an increase (decrease) to a gain (loss) previously reported in discontinued operations in a prior period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e1012-107759

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 3A

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721659-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e1020-107759

+ Details

Name: us-gaap_DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalBeforeIncomeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3B

-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721525-107759

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e957-107759

+ Details

Name: us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3B

-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721525-107759

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 5C

-Subparagraph (b)(2)

-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721675-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e957-107759

+ Details

Name: us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

+ Details

Name: us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3179-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_ProceedsFromDivestitureOfBusinesses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bdx_DiscoveryLabwareMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 123 R106.htm IDEA: XBRL DOCUMENT v3.3.0.814

Sale-Type Leases and Financing Receivable Sales-Type Leases and Financing Receivables (Details)
$ in Millions

Sep. 30, 2015

USD ($)

Receivables [Abstract]

Future minimum lease payments receivable $ 1,311

Unguaranteed residual values 29

Unearned income (142)

Allowance for uncollectible minimum lease payments receivable (5)

Net Investment in Sales-Type Leases 1,193

Less: Current portion of net investment in sales-type leases 75

Net Investment in Sales-Type Leases, Less Current Portion $ 1,118

X

- Definition
The net amount due within one year of the balance sheet date or the normal operating cycle, if longer, consisting of: (a) minimum lease payments on sales type leases and (b) unguaranteed residual value; less: (i) executory costs, (ii) unearned income, and (iii) the accumulated allowance for uncollectible minimum lease payments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 4

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=25496975&loc=d3e45377-112738

+ Details

Name: us-gaap_CapitalLeasesLessorBalanceSheetNetInvestmentInSalesTypeLeasesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The net amount due after one year of the balance sheet date or beyond the normal operating cycle, if longer, consisting of: (a) minimum lease payments on sales type leases, and (b) unguaranteed residual value; less: (i) executory costs, (ii) unearned income, and (iii) the accumulated allowance for uncollectible minimum lease payments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 4

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=25496975&loc=d3e45377-112738

+ Details

Name: us-gaap_CapitalLeasesLessorBalanceSheetNetInvestmentInSalesTypeLeasesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The estimate of contractual payments on direct financing leases that are probable of not being collected as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 4

-Subparagraph (a)(1)(ii)

-URI http://asc.fasb.org/extlink&oid=25496975&loc=d3e45377-112738

+ Details

Name: us-gaap_CapitalLeasesNetInvestmentInDirectFinancingLeasesAllowanceForUncollectibleMinimumLeasePayments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The remaining (unamortized) difference between the gross investment in a direct financing lease and the cost or carrying amount, if different, of the leased property as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 4

-Subparagraph (a)(4)

-URI http://asc.fasb.org/extlink&oid=25496975&loc=d3e45377-112738

+ Details

Name: us-gaap_CapitalLeasesNetInvestmentInDirectFinancingLeasesDeferredIncome

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The estimate of the lease property's economic value at the end of the direct financing lease term excluding any amounts guaranteed by either the lessee or a third-party.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 4

-Subparagraph (a)(2)

-URI http://asc.fasb.org/extlink&oid=25496975&loc=d3e45377-112738

+ Details

Name: us-gaap_CapitalLeasesNetInvestmentInDirectFinancingLeasesUnguaranteedResidualValuesOfLeasedProperty

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of remaining payments as of the balance sheet date that lessees are obligated to make or can be required to make under sales-type leases, including any guarantee of residual value and executory costs. The amount also includes any guaranteed rental payments by an unrelated third-party provided that are financially capable of making such payments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 4

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=25496975&loc=d3e45377-112738

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 10

-Section 25

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=7661868&loc=d3e34102-112682

+ Details

Name: us-gaap_CapitalLeasesNetInvestmentInSalesTypeLeasesMinimumPaymentsToBeReceived

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The net amount due as of the balance sheet date consisting of: (a) minimum lease payments due on direct financing and sales-type leases, (b) unguaranteed residual value, and (c) any unamortized initial direct costs on direct financing leases; less: (i) executory costs, (ii) unearned income, and (iii) the accumulated allowance for uncollectible minimum lease payments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 4

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=25496975&loc=d3e45377-112738

+ Details

Name: us-gaap_NetInvestmentInDirectFinancingAndSalesTypeLeases

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_ReceivablesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 124 R69.htm IDEA: XBRL DOCUMENT v3.3.0.814

Benefit Plans - Weighted Average Assumptions Determining Pension Plan Footnote (Detail)

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Defined Benefit Plan Disclosure [Line Items]

Postemployment benefits, discount rate 3.75% 3.75% 4.00%

Other Postretirement Benefits

Defined Benefit Plan Disclosure [Line Items]

Discount rates 3.95% 3.85% 4.40%

X

- Definition
Postemployment Benefits, Assumptions Used Calculating Benefit Obligation, Discount Rate
+ References
No definition available.
+ Details

Name: bdx_PostemploymentBenefitsAssumptionsUsedCalculatingBenefitObligationDiscountRate

Namespace Prefix: bdx_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
The interest rate used to adjust for the time value of money for the plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (k)(1)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlanDisclosureLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 125 R27.htm IDEA: XBRL DOCUMENT v3.3.0.814

Summary of Significant Accounting Policies (Policies)
12 Months Ended

Sep. 30, 2015

Accounting Policies [Abstract]

Basis of Presentation
Basis of Presentation
The accompanying Consolidated Financial Statements and Notes to Consolidated Financial Statements of Becton, Dickinson and Company (the “Company”) have been prepared in accordance with U.S. generally accepted accounting principles. Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes. Percentages and earnings per share amounts presented are calculated from the underlying amounts. Our fiscal year ends on September 30.

Principles of Consolidation
Principles of Consolidation
The consolidated financial statements include the Company’s accounts and those of its majority-owned subsidiaries after the elimination of intercompany transactions. The Company has no material interests in variable interest entities.

Cash Equivalents
Cash Equivalents
Cash equivalents consist of all highly liquid investments with a maturity of three months or less at time of purchase.

Short-Term Investments
Short-Term Investments
Short-term investments consist of time deposits with maturities greater than three months and less than one year when purchased.

Trade and Financing Receivables
Trade and Financing Receivables
The Company grants credit to customers in the normal course of business and the resulting trade receivables are stated at their net realizable value. The Company's portfolio of financing receivables arises from the leasing of dispensing equipment. The allowance for doubtful accounts represents the Company’s estimate of probable credit losses relating to trade receivables and is determined based on historical experience and other specific account data. Allowances for credit losses relating to financing receivables are also based on historical experience loss rates and the potential impact of anticipated changes in business practices, market dynamics, and economic conditions. Amounts are written off against the allowances for doubtful accounts or credit losses when the Company determines that a customer account is uncollectible.

Inventories
Inventories
Inventories are stated at the lower of first-in, first-out cost or market.

Property, Plant and Equipment
Property, Plant and Equipment
Property, plant and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization are principally provided on the straight-line basis over estimated useful lives, which range from 20 to 45 years for buildings, four to 13 years for machinery and equipment and one to 12 years for leasehold improvements

Goodwill and Other Intangible Assets
Goodwill and Other Intangible Assets
The Company’s unamortized intangible assets include goodwill and in-process research and development assets which arise from acquisitions. The Company currently reviews all indefinite-lived assets, including goodwill, for impairment using quantitative models. Goodwill is reviewed at least annually for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. The Company’s reporting units generally represent one level below reporting segments, and components within an operating segment that have similar economic characteristics are aggregated. Potential impairment of goodwill is identified by comparing the fair value of a reporting unit, estimated using an income approach, with its carrying value. The annual impairment review performed on July 1, 2015 indicated that all identified reporting units’ fair values exceeded their respective carrying values.
The review for impairment of in-process research and development assets is performed by comparing the fair value of the technology or project assets, estimated using an income approach, with their carrying value. In-process research and development assets are considered indefinite-lived assets and are reviewed at least annually for impairment until projects are completed or abandoned. Certain trademarks that are considered to generate cash flows indefinitely are also considered to be indefinite-lived intangible assets and these assets are also reviewed at least annually for impairment.
Amortized intangible assets include developed technology assets which arise from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date or acquired in-process research and development assets that are completed subsequent to acquisition. Developed technology assets are generally amortized over periods ranging from 15 to 20 years, using the straight-line method. Other intangibles with finite useful lives, which include patents, are amortized over periods principally ranging from one to 40 years, using the straight-line method. Finite-lived intangible assets, including developed technology assets, are periodically reviewed when impairment indicators are present to assess recoverability from future operations using undiscounted cash flows. The carrying values of these finite-lived assets are compared to the undiscounted cash flows they are expected to generate and an impairment loss is recognized in operating results to the extent any finite-lived intangible asset’s carrying value exceeds its calculated fair value.

Capitalized Software
Capitalized Software
Capitalized software, including costs for software developed or obtained for internal use, is stated at cost, less accumulated amortization. Amortization expense is principally provided on the straight-line basis over estimated useful lives, which do not exceed 10 years. The current balance largely includes capital software investments related to a global enterprise resource planning initiative to upgrade the Company’s business information systems.

Foreign Currency Translation
Foreign Currency Translation
Generally, foreign subsidiaries’ functional currency is the local currency of operations and the net assets of foreign operations are translated into U.S. dollars using current exchange rates. The U.S. dollar results that arise from such translation, as well as exchange gains and losses on intercompany balances of a long-term investment nature, are included in the foreign currency translation adjustments in Accumulated other comprehensive income (loss).

Revenue Recognition
Revenue Recognition
Revenue from product sales is typically recognized when all of the following criteria have been met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; product price is fixed or determinable; collection of the resulting receivable is reasonably assured. Certain sales arrangements contain multiple deliverables, including equipment and service deliverables, which requires the Company to determine the separate units of account. If the deliverable meets the criteria of a separate unit of accounting, the arrangement consideration is allocated to each element based upon its relative selling price. In determining the best evidence of selling price of a unit of account the Company utilizes vendor-specific objective evidence (“VSOE”), which is the price the Company charges when the deliverable is sold separately. When VSOE is not available, management uses relevant third-party evidence (“TPE”) of selling price, if available. When neither VSOE nor TPE of selling price exists, management uses its best estimate of selling price.
Revenue allocated to equipment deliverables is recognized upon customer acceptance, which occurs after the transfer of title and risk of loss to the customer and the completion of installation or training services. When related training services are considered inconsequential, delivery is deemed to occur upon the transfer of title and risk of loss, at which time revenue and the costs associated with installation and training are recognized.
For equipment lease revenue, transactions are evaluated and classified as either operating leases or sales-type leases. Lease income for products sold under sales-type leases is recognized as revenue upon the completion of installation activities in the amount of the present value of the minimum lease payments. The financing component of sales-type leases is recorded as revenue over the lease term. For products sold under operating leases, revenue is recognized at the contracted rate over the rental period, as defined within the customer agreement.
The Company’s domestic businesses sell products primarily to distributors that resell the products to end-user customers. Rebates are provided to distributors that sell to end-user customers at prices determined under a contract between the Company and the end-user customer. Provisions for rebates, as well as sales discounts and returns, are based upon estimates and are accounted for as a reduction of revenues when revenue is recognized.

Shipping and Handling Costs
Shipping and Handling Costs
Shipping and handling costs are included in Selling and administrative expense.

Derivative Financial Instruments
Derivative Financial Instruments
All derivatives are recorded in the balance sheet at fair value and changes in fair value are recognized currently in earnings unless specific hedge accounting criteria are met.
From time to time, derivative financial instruments are utilized by the Company in the management of its foreign currency, interest rate and commodity price exposures. The Company periodically purchases forward contracts and options to hedge certain forecasted transactions that are denominated in foreign currencies in order to partially protect against a reduction in the value of future earnings resulting from adverse foreign exchange rate movements. The Company also periodically utilizes interest rate swaps to maintain a balance between fixed and floating rate instruments. Additionally, the Company periodically manages price risks associated with resin purchase costs through commodity derivative forward contracts. The Company does not enter into derivative financial instruments for trading or speculative purposes.
Any deferred gains or losses associated with derivative instruments are recognized in income in the period in which the underlying hedged transaction is recognized. In the event a designated hedged item is sold, extinguished or matures prior to the termination of the related derivative instrument, such instrument would be closed and the resultant gain or loss would be recognized in income.

Income Taxes
Income Taxes
United States income taxes are not provided on undistributed earnings of foreign subsidiaries where such undistributed earnings are indefinitely reinvested outside the United States. Deferred taxes are provided for earnings of foreign subsidiaries when those earnings are not considered indefinitely reinvested. Income taxes are provided and tax credits are recognized based on tax laws enacted at the dates of the financial statements.
The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of tax jurisdictions. In evaluating the exposure associated with various tax filing positions, the Company records accruals for uncertain tax positions, based on the technical support for the positions, past audit experience with similar situations, and the potential interest and penalties related to the matters.
The Company maintains valuation allowances where it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances are included in the tax provision in the period of change. In determining whether a valuation allowance is warranted, management evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods and tax strategies that could potentially enhance the likelihood of the realization of a deferred tax asset.

Earnings per Share
Earnings per Share
Basic earnings per share are computed based on the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.

Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions. These estimates or assumptions affect reported assets, liabilities, revenues and expenses as reflected in the consolidated financial statements. Actual results could differ from these estimates.

Share-Based Compensation
Share-Based Compensation
The Company recognizes the fair value of share-based compensation in net income. Compensation expense is recognized on a straight-line basis over the requisite service period, which is generally the vesting period.

New Accounting Principle Adopted and New Accounting Principles Not Yet Adopted
New Accounting Principle Adopted

In June 2013, the Financial Accounting Standards Board (“FASB”) issued guidance that requires the netting of unrecognized tax benefits against a deferred tax asset for a loss or other carryforward that would apply in settlement of the uncertain tax positions. In March 2013, the FASB issued amendments to resolve diversity in practice relating to the release of cumulative translation adjustments into earnings upon the occurrence of certain derecognition events involving a foreign entity. The Company prospectively adopted both accounting standard updates, which did not impact its consolidated financial statements, on October 1, 2014.

New Accounting Principles Not Yet Adopted
In April 2014, the FASB issued amended requirements that limit the presentation of discontinued operations to only those disposals that represent a strategic shift that has had, or will have, a major effect on an entity’s operations and financial results. The amended requirements also expand the disclosure requirements relating to disposal transactions. The Company will prospectively apply the amended requirements to disposal transactions that occur on or after October 1, 2015.
In May 2014, the FASB issued a new revenue recognition standard. Under this standard, revenue will be recognized upon the transfer of goods or services to customers and the amount of revenue recognized will reflect the consideration to which a reporting entity expects to be entitled in exchange for those goods or services. The Company is currently evaluating the impact that this new revenue recognition standard will have on its consolidated financial statements and the Company currently intends to adopt the standard on October 1, 2018, as is allowed under the FASB's July 2015 amendment which deferred the effective date for this standard.
In April 2014, the FASB issued amended requirements that require debt issuance costs, related to a recognized debt liability, to be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The Company will apply the amended presentation requirements on October 1, 2016.

Contingencies
Contingencies
Given the uncertain nature of litigation generally, the Company is not able in all cases to estimate the amount or range of loss that could result from an unfavorable outcome of the litigation to which the Company is a party. In accordance with U.S. generally accepted accounting principles, the Company establishes accruals to the extent probable future losses are estimable (in the case of environmental matters, without considering possible third-party recoveries). In view of the uncertainties discussed below, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance. In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company’s consolidated results of operations and consolidated cash flows.

Fair Value of Financial Instruments
The Company measures the fair value of forward exchange contracts and interest rate swaps based upon the present value of expected future cash flows using market-based observable inputs including credit risk, interest rate yield curves, foreign currency spot prices and forward prices.
Long-term debt is recorded at amortized cost. The fair value of long-term debt is measured based upon quoted prices in active markets for similar instruments, which are considered Level 2 inputs in the fair value hierarchy. The fair value of long-term debt was $11.6 billion and $4.1 billion at September 30, 2015 and 2014, respectively. During the third quarter of fiscal year 2015, the Company reclassified $750 million of floating rates due on June 15, 2016 from Long-Term Debt to Short-term debt. The fair value of these notes was $750 million at September 30, 2015.
The contingent consideration liabilities were recognized as part of the consideration transferred by the Company for certain acquisitions. Additional disclosures regarding these acquisitions are included in Note 9. The fair values of the contingent consideration liabilities were estimated using probability-weighted discounted cash flow models that were based upon the probabilities assigned to the contingent events. The estimated fair values of the contingent consideration liabilities are remeasured at each reporting period based upon increases or decreases in the probability of the contingent payments. The increase to the total contingent consideration liability in fiscal year 2015 was mostly attributable to the recognition of contingent consideration liabilities of $36 million and $28 million in connection with the Company’s acquisitions of GenCell and Cellular Research in the first and fourth quarters, respectively.
The Company’s policy is to recognize any transfers into fair value measurement hierarchy levels and transfers out of levels at the beginning of each reporting period.

Concentration of Credit Risk
Concentration of Credit Risk
The Company maintains cash deposits in excess of government-provided insurance limits. Such cash deposits are exposed to loss in the event of nonperformance by financial institutions. Substantially all of the Company’s trade receivables are due from public and private entities involved in the healthcare industry. Due to the large size and diversity of the Company’s customer base, concentrations of credit risk with respect to trade receivables are limited. The Company does not normally require collateral. The Company is exposed to credit loss in the event of nonperformance by financial institutions with which it conducts business. However, this loss is limited to the amounts, if any, by which the obligations of the counterparty to the financial instrument contract exceed the obligations of the Company. The Company also minimizes exposure to credit risk by dealing with a diversified group of major financial institutions.
The Company continually evaluates its accounts receivables for potential collection risks particularly those resulting from sales to government-owned or government-supported healthcare facilities in certain countries as payment may be dependent upon the financial stability and creditworthiness of those countries’ national economies. The Company continually evaluates all governmental receivables for potential collection risks associated with the availability of government funding and reimbursement practices. The Company believes the current reserves related to all governmental receivables are adequate and that this concentration of credit risk will not have a material adverse impact on its financial position or liquidity.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.
+ References
No definition available.
+ Details

Name: us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 305

-SubTopic 10

-Section 05

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6375392&loc=d3e26790-107797

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Financial Reporting Release (FRR)

-Number 203

-Paragraph 02-03

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_CashAndCashEquivalentsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 450

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6491354&loc=d3e6052-115624

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 450

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51674963&loc=d3e12565-110249

+ Details

Name: us-gaap_CommitmentsAndContingenciesPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b),(f(1))

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_CompensationRelatedCostsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for credit risk.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 55

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6875567&loc=d3e14489-108613

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 825

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51676700&loc=d3e61082-112788

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 825

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28088331&loc=SL29635902-196195

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13537-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13531-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 825

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51676700&loc=d3e61044-112788

+ Details

Name: us-gaap_ConcentrationRiskCreditRisk

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=18733093&loc=d3e5614-111684

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.3A-02)

-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355033-122828

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph k

-Article 1

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02, 03

-Article 3A

+ Details

Name: us-gaap_ConsolidationPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for its derivative instruments and hedging activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41620-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(n))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579240-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579245-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41675-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41638-113959

+ Details

Name: us-gaap_DerivativesPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for determining the fair value of financial instruments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13279-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 60

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260

+ Details

Name: us-gaap_FairValueOfFinancialInstrumentsPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895

+ Details

Name: us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32840-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 30

-Section 05

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6423966&loc=d3e40913-109327

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 740

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 17

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32809-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e32247-109318

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e32280-109318

+ Details

Name: us-gaap_IncomeTaxPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for major classes of inventories, bases of stating inventories (for example, lower of cost or market), methods by which amounts are added and removed from inventory classes (for example, FIFO, LIFO, or average cost), loss recognition on impairment of inventories, and situations in which inventories are stated above cost. If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28360613&loc=d3e4492-108314

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=28360613&loc=d3e4556-108314

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Financial Reporting Release (FRR)

-Number 206

-Paragraph b

-Subparagraph i, ii

-Chapter 2

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a

-Article 5

+ Details

Name: us-gaap_InventoryPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for investments in financial assets, including marketable securities (debt and equity securities with readily determinable fair values), investments accounted for under the equity method and cost method, securities borrowed and loaned, and repurchase and resale agreements. For marketable securities, the disclosure may include the entity's accounting treatment for transfers between investment categories and how the fair values for such securities are determined. Also, for all investments, an entity may describe its policy for assessing, recognizing and measuring impairment of the investment.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 6

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27290-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (a)(2)

-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.2,12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 325

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6872867&loc=d3e40691-111596

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section M

+ Details

Name: us-gaap_InvestmentPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PropertyPlantAndEquipmentPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Research and Development

-URI http://asc.fasb.org/extlink&oid=6523717

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 40

-Section 30

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6389767&loc=d3e17916-109280

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.15)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 50

-Section 25

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286

+ Details

Name: us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18823-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.B.Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section B

-Paragraph Question 1

+ Details

Name: us-gaap_RevenueRecognitionPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the classification of shipping and handling costs, including whether the costs are included in cost of sales or included in other income statement accounts. If shipping and handling fees are significant and are not included in cost of sales, disclosure includes both the amounts of such costs and the line item on the income statement which includes such costs.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Shipping Costs

-URI http://asc.fasb.org/extlink&oid=51575562

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 45

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6408413&loc=d3e221937-122793

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 45

-Section 45

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=51671805&loc=d3e60635-111653

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 45

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51667946&loc=d3e61069-111654

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Handling Costs

-URI http://asc.fasb.org/extlink&oid=51575068

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

+ Details

Name: us-gaap_ShippingAndHandlingCostPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for trade and other accounts receivables. This disclosure may include the basis at which such receivables are carried in the entity's statements of financial position (for example, net realizable value), how the entity determines the level of its allowance for doubtful accounts, when impairments, charge-offs or recoveries are recognized, and the entity's income recognition policies for such receivables, including its treatment of related fees and costs, its treatment of premiums, discounts or unearned income, when accrual of interest is discontinued, how the entity records payments received on nonaccrual receivables and its policy for resuming accrual of interest on such receivables. If the enterprise holds a large number of similar loans, disclosure may include the accounting policy for the anticipation of prepayments and significant assumptions underlying prepayment estimates for amortization of premiums, discounts, and nonrefundable fees and costs.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6378556&loc=d3e10133-111534

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 15

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=49124121&loc=d3e5212-111524

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=49124121&loc=d3e5093-111524

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3, 4

-Article 5

+ Details

Name: us-gaap_TradeAndOtherAccountsReceivablePolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6061-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6143-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6132-108592

+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 126 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.0.814 html 528 586 1 false 115 0 false 8 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.bd.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Consolidated Statements of Income Sheet http://www.bd.com/role/ConsolidatedStatementsOfIncome Consolidated Statements of Income Statements 2 false false R3.htm 1001501 - Statement - Consolidated Statements of Income (Parenthetical) Sheet http://www.bd.com/role/ConsolidatedStatementsOfIncomeParenthetical Consolidated Statements of Income (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Consolidated Statements of Comprehensive Income Sheet http://www.bd.com/role/ConsolidatedStatementsOfComprehensiveIncome Consolidated Statements of Comprehensive Income Statements 4 false false R5.htm 1003000 - Statement - Consolidated Balance Sheets Sheet http://www.bd.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 5 false false R6.htm 1003501 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.bd.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 6 false false R7.htm 1004000 - Statement - Consolidated Statements of Cash Flows Sheet http://www.bd.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 2101100 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.bd.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 2102100 - Disclosure - Accounting Changes Sheet http://www.bd.com/role/AccountingChanges Accounting Changes Notes 9 false false R10.htm 2103100 - Disclosure - Shareholders' Equity Sheet http://www.bd.com/role/ShareholdersEquity Shareholders' Equity Notes 10 false false R11.htm 2104100 - Disclosure - Earnings per Share Sheet http://www.bd.com/role/EarningsPerShare Earnings per Share Notes 11 false false R12.htm 2105100 - Disclosure - Commitments and Contingencies Sheet http://www.bd.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 12 false false R13.htm 2106100 - Disclosure - Segment Data Sheet http://www.bd.com/role/SegmentData Segment Data Notes 13 false false R14.htm 2107100 - Disclosure - Share-Based Compensation Sheet http://www.bd.com/role/ShareBasedCompensation Share-Based Compensation Notes 14 false false R15.htm 2108100 - Disclosure - Benefit Plans Sheet http://www.bd.com/role/BenefitPlans Benefit Plans Notes 15 false false R16.htm 2109100 - Disclosure - Acquisitions Sheet http://www.bd.com/role/Acquisitions Acquisitions Notes 16 false false R17.htm 2110100 - Disclosure - Divestiture Sheet http://www.bd.com/role/Divestiture Divestiture Notes 17 false false R18.htm 2111100 - Disclosure - Business Restructuring Charges Sheet http://www.bd.com/role/BusinessRestructuringCharges Business Restructuring Charges Notes 18 false false R19.htm 2112100 - Disclosure - Intangible Assets Sheet http://www.bd.com/role/IntangibleAssets Intangible Assets Notes 19 false false R20.htm 2113100 - Disclosure - Derivative Instruments and Hedging Activities Sheet http://www.bd.com/role/DerivativeInstrumentsAndHedgingActivities Derivative Instruments and Hedging Activities Notes 20 false false R21.htm 2114100 - Disclosure - Financial Instruments and Fair Value Measurements Sheet http://www.bd.com/role/FinancialInstrumentsAndFairValueMeasurements Financial Instruments and Fair Value Measurements Notes 21 false false R22.htm 2115100 - Disclosure - Debt Sheet http://www.bd.com/role/Debt Debt Notes 22 false false R23.htm 2116100 - Disclosure - Income Taxes Sheet http://www.bd.com/role/IncomeTaxes Income Taxes Notes 23 false false R24.htm 2117100 - Disclosure - Sale-Type Leases and Financing Receivable Sheet http://www.bd.com/role/SaleTypeLeasesAndFinancingReceivable Sale-Type Leases and Financing Receivable Notes 24 false false R25.htm 2118100 - Disclosure - Supplemental Financial Information Sheet http://www.bd.com/role/SupplementalFinancialInformation Supplemental Financial Information Notes 25 false false R26.htm 2119100 - Disclosure - Supplementary Data (Unaudited) Sheet http://www.bd.com/role/SupplementaryDataUnaudited Supplementary Data (Unaudited) Notes 26 false false R27.htm 2201201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.bd.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.bd.com/role/SummaryOfSignificantAccountingPolicies 27 false false R28.htm 2303301 - Disclosure - Shareholders' Equity (Tables) Sheet http://www.bd.com/role/ShareholdersEquityTables Shareholders' Equity (Tables) Tables http://www.bd.com/role/ShareholdersEquity 28 false false R29.htm 2304301 - Disclosure - Earnings per Share (Tables) Sheet http://www.bd.com/role/EarningsPerShareTables Earnings per Share (Tables) Tables http://www.bd.com/role/EarningsPerShare 29 false false R30.htm 2306301 - Disclosure - Segment Data (Tables) Sheet http://www.bd.com/role/SegmentDataTables Segment Data (Tables) Tables http://www.bd.com/role/SegmentData 30 false false R31.htm 2307301 - Disclosure - Share-Based Compensation (Tables) Sheet http://www.bd.com/role/ShareBasedCompensationTables Share-Based Compensation (Tables) Tables http://www.bd.com/role/ShareBasedCompensation 31 false false R32.htm 2308301 - Disclosure - Benefit Plans (Tables) Sheet http://www.bd.com/role/BenefitPlansTables Benefit Plans (Tables) Tables http://www.bd.com/role/BenefitPlans 32 false false R33.htm 2309301 - Disclosure - Acquisitions (Tables) Sheet http://www.bd.com/role/AcquisitionsTables Acquisitions (Tables) Tables http://www.bd.com/role/Acquisitions 33 false false R34.htm 2310301 - Disclosure - Divestiture (Tables) Sheet http://www.bd.com/role/DivestitureTables Divestiture (Tables) Tables http://www.bd.com/role/Divestiture 34 false false R35.htm 2311301 - Disclosure - Business Restructuring Charges (Tables) Sheet http://www.bd.com/role/BusinessRestructuringChargesTables Business Restructuring Charges (Tables) Tables http://www.bd.com/role/BusinessRestructuringCharges 35 false false R36.htm 2312301 - Disclosure - Intangible Assets (Tables) Sheet http://www.bd.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://www.bd.com/role/IntangibleAssets 36 false false R37.htm 2313301 - Disclosure - Derivative Instruments and Hedging Activities (Tables) Sheet http://www.bd.com/role/DerivativeInstrumentsAndHedgingActivitiesTables Derivative Instruments and Hedging Activities (Tables) Tables http://www.bd.com/role/DerivativeInstrumentsAndHedgingActivities 37 false false R38.htm 2314301 - Disclosure - Financial Instruments and Fair Value Measurements (Tables) Sheet http://www.bd.com/role/FinancialInstrumentsAndFairValueMeasurementsTables Financial Instruments and Fair Value Measurements (Tables) Tables http://www.bd.com/role/FinancialInstrumentsAndFairValueMeasurements 38 false false R39.htm 2315301 - Disclosure - Debt (Tables) Sheet http://www.bd.com/role/DebtTables Debt (Tables) Tables http://www.bd.com/role/Debt 39 false false R40.htm 2316301 - Disclosure - Income Taxes (Tables) Sheet http://www.bd.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.bd.com/role/IncomeTaxes 40 false false R41.htm 2317301 - Disclosure - Sale-Type Leases and Financing Receivable Schedule of Capital Leased Assets (Tables) Sheet http://www.bd.com/role/SaleTypeLeasesAndFinancingReceivableScheduleOfCapitalLeasedAssetsTables Sale-Type Leases and Financing Receivable Schedule of Capital Leased Assets (Tables) Tables 41 false false R42.htm 2318301 - Disclosure - Supplemental Financial Information (Tables) Sheet http://www.bd.com/role/SupplementalFinancialInformationTables Supplemental Financial Information (Tables) Tables http://www.bd.com/role/SupplementalFinancialInformation 42 false false R43.htm 2319301 - Disclosure - Supplementary Data (Unaudited) (Tables) Sheet http://www.bd.com/role/SupplementaryDataUnauditedTables Supplementary Data (Unaudited) (Tables) Tables http://www.bd.com/role/SupplementaryDataUnaudited 43 false false R44.htm 2401402 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.bd.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail Summary of Significant Accounting Policies - Additional Information (Detail) Details 44 false false R45.htm 2403402 - Disclosure - Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Detail) Sheet http://www.bd.com/role/ShareholdersEquityChangesInCertainComponentsOfShareholdersEquityDetail Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Detail) Details 45 false false R46.htm 2403403 - Disclosure - Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Details) Sheet http://www.bd.com/role/ShareholdersEquityChangesInCertainComponentsOfShareholdersEquityDetails Shareholders' Equity - Changes in Certain Components of Shareholders' Equity (Details) Details 46 false false R47.htm 2403404 - Disclosure - Shareholders' Equity - Accumulated Other Comprehensive (Loss) Income (Detail) Sheet http://www.bd.com/role/ShareholdersEquityAccumulatedOtherComprehensiveLossIncomeDetail Shareholders' Equity - Accumulated Other Comprehensive (Loss) Income (Detail) Details 47 false false R48.htm 2403405 - Disclosure - Shareholders' Equity - Additional Information (Detail) Sheet http://www.bd.com/role/ShareholdersEquityAdditionalInformationDetail Shareholders' Equity - Additional Information (Detail) Details 48 false false R49.htm 2404402 - Disclosure - Earnings per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share (Detail) Sheet http://www.bd.com/role/EarningsPerShareWeightedAverageCommonSharesUsedInComputationsOfBasicAndDilutedEarningsPerShareDetail Earnings per Share - Weighted Average Common Shares Used in Computations of Basic and Diluted Earnings Per Share (Detail) Details 49 false false R50.htm 2404403 - Disclosure - Earnings per Share - Additional Information (Detail) Sheet http://www.bd.com/role/EarningsPerShareAdditionalInformationDetail Earnings per Share - Additional Information (Detail) Details 50 false false R51.htm 2405401 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.bd.com/role/CommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 51 false false R52.htm 2406402 - Disclosure - Segment Data - Additional Information (Detail) Sheet http://www.bd.com/role/SegmentDataAdditionalInformationDetail Segment Data - Additional Information (Detail) Details 52 false false R53.htm 2406403 - Disclosure - Segment Data - Financial Information for Company's Segments (Detail) Sheet http://www.bd.com/role/SegmentDataFinancialInformationForCompanysSegmentsDetail Segment Data - Financial Information for Company's Segments (Detail) Details 53 false false R54.htm 2406404 - Disclosure - Segment Data - Financial Information for Company's Segments Footnote (Detail) Sheet http://www.bd.com/role/SegmentDataFinancialInformationForCompanysSegmentsFootnoteDetail Segment Data - Financial Information for Company's Segments Footnote (Detail) Details 54 false false R55.htm 2406405 - Disclosure - Segment Data - Revenues to Unaffiliated Customers and Long-lived Assets Including Property, Plant and Equipment (Detail) Sheet http://www.bd.com/role/SegmentDataRevenuesToUnaffiliatedCustomersAndLongLivedAssetsIncludingPropertyPlantAndEquipmentDetail Segment Data - Revenues to Unaffiliated Customers and Long-lived Assets Including Property, Plant and Equipment (Detail) Details 55 false false R56.htm 2407402 - Disclosure - Share-Based Compensation - Compensation Cost Relating to Share-Based Payments (Detail) Sheet http://www.bd.com/role/ShareBasedCompensationCompensationCostRelatingToShareBasedPaymentsDetail Share-Based Compensation - Compensation Cost Relating to Share-Based Payments (Detail) Details 56 false false R57.htm 2407403 - Disclosure - Share-Based Compensation - Additional Information (Detail) Sheet http://www.bd.com/role/ShareBasedCompensationAdditionalInformationDetail Share-Based Compensation - Additional Information (Detail) Details 57 false false R58.htm 2407404 - Disclosure - Share-Based Compensation - Assumptions for Estimation of Fair Values of Stock Appreciation Rights Granted During Reporting Periods (Detail) Sheet http://www.bd.com/role/ShareBasedCompensationAssumptionsForEstimationOfFairValuesOfStockAppreciationRightsGrantedDuringReportingPeriodsDetail Share-Based Compensation - Assumptions for Estimation of Fair Values of Stock Appreciation Rights Granted During Reporting Periods (Detail) Details 58 false false R59.htm 2407405 - Disclosure - Share-Based Compensation - Summary of SARs Outstanding (Detail) Sheet http://www.bd.com/role/ShareBasedCompensationSummaryOfSarsOutstandingDetail Share-Based Compensation - Summary of SARs Outstanding (Detail) Details 59 false false R60.htm 2407406 - Disclosure - Share-Based Compensation - Summary of Stock Options Outstanding (Detail) Sheet http://www.bd.com/role/ShareBasedCompensationSummaryOfStockOptionsOutstandingDetail Share-Based Compensation - Summary of Stock Options Outstanding (Detail) Details 60 false false R61.htm 2407407 - Disclosure - Share-Based Compensation - Summary of Performance-Based Restricted Stock Units Outstanding (Detail) Sheet http://www.bd.com/role/ShareBasedCompensationSummaryOfPerformanceBasedRestrictedStockUnitsOutstandingDetail Share-Based Compensation - Summary of Performance-Based Restricted Stock Units Outstanding (Detail) Details 61 false false R62.htm 2407408 - Disclosure - Share-Based Compensation - Summary of Performance-Based Restricted Stock Units Outstanding Footnote (Detail) Sheet http://www.bd.com/role/ShareBasedCompensationSummaryOfPerformanceBasedRestrictedStockUnitsOutstandingFootnoteDetail Share-Based Compensation - Summary of Performance-Based Restricted Stock Units Outstanding Footnote (Detail) Details 62 false false R63.htm 2407409 - Disclosure - Share-Based Compensation - Summary of Time-Vested Restricted Stock Units Outstanding (Detail) Sheet http://www.bd.com/role/ShareBasedCompensationSummaryOfTimeVestedRestrictedStockUnitsOutstandingDetail Share-Based Compensation - Summary of Time-Vested Restricted Stock Units Outstanding (Detail) Details 63 false false R64.htm 2408402 - Disclosure - Benefit Plans - Net Pension and Other Postretirement Cost (Detail) Sheet http://www.bd.com/role/BenefitPlansNetPensionAndOtherPostretirementCostDetail Benefit Plans - Net Pension and Other Postretirement Cost (Detail) Details 64 false false R65.htm 2408403 - Disclosure - Benefit Plans - Additional Information (Detail) Sheet http://www.bd.com/role/BenefitPlansAdditionalInformationDetail Benefit Plans - Additional Information (Detail) Details 65 false false R66.htm 2408404 - Disclosure - Benefit Plans - Change in Benefit Obligation, Change in Fair Value of Plan Assets (Detail) Sheet http://www.bd.com/role/BenefitPlansChangeInBenefitObligationChangeInFairValueOfPlanAssetsDetail Benefit Plans - Change in Benefit Obligation, Change in Fair Value of Plan Assets (Detail) Details 66 false false R67.htm 2408405 - Disclosure - Benefit Plans - Pension Plans with Accumulated Benefit Obligations (Detail) Sheet http://www.bd.com/role/BenefitPlansPensionPlansWithAccumulatedBenefitObligationsDetail Benefit Plans - Pension Plans with Accumulated Benefit Obligations (Detail) Details 67 false false R68.htm 2408406 - Disclosure - Benefit Plans - Weighted Average Assumptions Determining Pension Plan (Detail) Sheet http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanDetail Benefit Plans - Weighted Average Assumptions Determining Pension Plan (Detail) Details 68 false false R69.htm 2408407 - Disclosure - Benefit Plans - Weighted Average Assumptions Determining Pension Plan Footnote (Detail) Sheet http://www.bd.com/role/BenefitPlansWeightedAverageAssumptionsDeterminingPensionPlanFootnoteDetail Benefit Plans - Weighted Average Assumptions Determining Pension Plan Footnote (Detail) Details 69 false false R70.htm 2408408 - Disclosure - Benefit Plans - Expected Benefit Payments (Detail) Sheet http://www.bd.com/role/BenefitPlansExpectedBenefitPaymentsDetail Benefit Plans - Expected Benefit Payments (Detail) Details 70 false false R71.htm 2408409 - Disclosure - Benefit Plans - Fair Value Measurements of U.S. Plan Assets (Detail) Sheet http://www.bd.com/role/BenefitPlansFairValueMeasurementsOfUSPlanAssetsDetail Benefit Plans - Fair Value Measurements of U.S. Plan Assets (Detail) Details 71 false false R72.htm 2408410 - Disclosure - Benefit Plans - Changes in Fair Value of U.S. and Foreign Pension Assets Measured Using Level 3 Inputs (Detail) Sheet http://www.bd.com/role/BenefitPlansChangesInFairValueOfUSAndForeignPensionAssetsMeasuredUsingLevel3InputsDetail Benefit Plans - Changes in Fair Value of U.S. and Foreign Pension Assets Measured Using Level 3 Inputs (Detail) Details 72 false false R73.htm 2408411 - Disclosure - Benefit Plans - Fair Value Measurements of Foreign Plan Assets (Detail) Sheet http://www.bd.com/role/BenefitPlansFairValueMeasurementsOfForeignPlanAssetsDetail Benefit Plans - Fair Value Measurements of Foreign Plan Assets (Detail) Details 73 false false R74.htm 2408412 - Disclosure - Benefit Plans - Changes in Fair Value of Foreign Pension Assets Measured Using Level 3 Inputs (Detail) (Detail) Sheet http://www.bd.com/role/BenefitPlansChangesInFairValueOfForeignPensionAssetsMeasuredUsingLevel3InputsDetailDetail Benefit Plans - Changes in Fair Value of Foreign Pension Assets Measured Using Level 3 Inputs (Detail) (Detail) Details 74 false false R75.htm 2408413 - Disclosure - Benefit Plans - Postemployment Benefit Costs (Detail) Sheet http://www.bd.com/role/BenefitPlansPostemploymentBenefitCostsDetail Benefit Plans - Postemployment Benefit Costs (Detail) Details 75 false false R76.htm 2408414 - Disclosure - Benefit Plans - Changes in Benefit Obligation for Postemployment Benefits (Detail) Sheet http://www.bd.com/role/BenefitPlansChangesInBenefitObligationForPostemploymentBenefitsDetail Benefit Plans - Changes in Benefit Obligation for Postemployment Benefits (Detail) Details 76 false false R77.htm 2409402 - Disclosure - Acquisitions - Additional Information (Detail) Sheet http://www.bd.com/role/AcquisitionsAdditionalInformationDetail Acquisitions - Additional Information (Detail) Details 77 false false R78.htm 2409403 - Disclosure - Acquisitions - Fair Value of Consideration Transferred (Details) Sheet http://www.bd.com/role/AcquisitionsFairValueOfConsiderationTransferredDetails Acquisitions - Fair Value of Consideration Transferred (Details) Details 78 false false R79.htm 2409404 - Disclosure - Acquisitions - Fair Value of Company's Ordinary Shares Issued (Details) Sheet http://www.bd.com/role/AcquisitionsFairValueOfCompanysOrdinarySharesIssuedDetails Acquisitions - Fair Value of Company's Ordinary Shares Issued (Details) Details 79 false false R80.htm 2409405 - Disclosure - Acquisitions - Fair Value of Assets and Liabilities Assumed (Detail) Sheet http://www.bd.com/role/AcquisitionsFairValueOfAssetsAndLiabilitiesAssumedDetail Acquisitions - Fair Value of Assets and Liabilities Assumed (Detail) Details 80 false false R81.htm 2409406 - Disclosure - Acquisitions - Summary of Pro Forma Results (Details) Sheet http://www.bd.com/role/AcquisitionsSummaryOfProFormaResultsDetails Acquisitions - Summary of Pro Forma Results (Details) Details 81 false false R82.htm 2410402 - Disclosure - Divestiture - Additional Information (Detail) Sheet http://www.bd.com/role/DivestitureAdditionalInformationDetail Divestiture - Additional Information (Detail) Details 82 false false R83.htm 2410403 - Disclosure - Divestiture - Results of Discontinued Operations (Detail) Sheet http://www.bd.com/role/DivestitureResultsOfDiscontinuedOperationsDetail Divestiture - Results of Discontinued Operations (Detail) Details 83 false false R84.htm 2411402 - Disclosure - Business Restructuring Charges (Details) Sheet http://www.bd.com/role/BusinessRestructuringChargesDetails Business Restructuring Charges (Details) Details http://www.bd.com/role/BusinessRestructuringChargesTables 84 false false R85.htm 2412402 - Disclosure - Intangible Assets - Components of Intangible Assets (Detail) Sheet http://www.bd.com/role/IntangibleAssetsComponentsOfIntangibleAssetsDetail Intangible Assets - Components of Intangible Assets (Detail) Details 85 false false R86.htm 2412403 - Disclosure - Intangible Assets - Additional Information (Detail) Sheet http://www.bd.com/role/IntangibleAssetsAdditionalInformationDetail Intangible Assets - Additional Information (Detail) Details 86 false false R87.htm 2412404 - Disclosure - Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail) Sheet http://www.bd.com/role/IntangibleAssetsReconciliationOfGoodwillByBusinessSegmentDetail Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail) Details 87 false false R88.htm 2413402 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Detail) Sheet http://www.bd.com/role/DerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetail Derivative Instruments and Hedging Activities - Additional Information (Detail) Details 88 false false R89.htm 2413403 - Disclosure - Derivative Instruments and Hedging Activities - Effects on Consolidated Balance Sheets (Detail) Sheet http://www.bd.com/role/DerivativeInstrumentsAndHedgingActivitiesEffectsOnConsolidatedBalanceSheetsDetail Derivative Instruments and Hedging Activities - Effects on Consolidated Balance Sheets (Detail) Details 89 false false R90.htm 2413404 - Disclosure - Derivative Instruments and Hedging Activities - Undesignated Hedges (Detail) Sheet http://www.bd.com/role/DerivativeInstrumentsAndHedgingActivitiesUndesignatedHedgesDetail Derivative Instruments and Hedging Activities - Undesignated Hedges (Detail) Details 90 false false R91.htm 2414402 - Disclosure - Financial Instruments and Fair Value Measurements - Fair Values of Financial Instruments (Detail) Sheet http://www.bd.com/role/FinancialInstrumentsAndFairValueMeasurementsFairValuesOfFinancialInstrumentsDetail Financial Instruments and Fair Value Measurements - Fair Values of Financial Instruments (Detail) Details 91 false false R92.htm 2414403 - Disclosure - Financial Instruments and Fair Value Measurements - Additional Information (Detail) Sheet http://www.bd.com/role/FinancialInstrumentsAndFairValueMeasurementsAdditionalInformationDetail Financial Instruments and Fair Value Measurements - Additional Information (Detail) Details 92 false false R93.htm 2415402 - Disclosure - Debt - Summary of Short-Term Debt (Detail) Sheet http://www.bd.com/role/DebtSummaryOfShortTermDebtDetail Debt - Summary of Short-Term Debt (Detail) Details 93 false false R94.htm 2415403 - Disclosure - Debt - Additional Information (Detail) Sheet http://www.bd.com/role/DebtAdditionalInformationDetail Debt - Additional Information (Detail) Details 94 false false R95.htm 2415404 - Disclosure - Debt - Schedule if Senior Unsecured Note Issued (Details) Sheet http://www.bd.com/role/DebtScheduleIfSeniorUnsecuredNoteIssuedDetails Debt - Schedule if Senior Unsecured Note Issued (Details) Details 95 false false R96.htm 2415405 - Disclosure - Debt - Summary of Long-Term Debt (Detail) Sheet http://www.bd.com/role/DebtSummaryOfLongTermDebtDetail Debt - Summary of Long-Term Debt (Detail) Details 96 false false R97.htm 2415406 - Disclosure - Debt - Summary of Long-Term Debt (Detail II) Sheet http://www.bd.com/role/DebtSummaryOfLongTermDebtDetailIi Debt - Summary of Long-Term Debt (Detail II) Details 97 false false R98.htm 2415407 - Disclosure - Debt - Summary of Interest Costs and Payments (Detail) Sheet http://www.bd.com/role/DebtSummaryOfInterestCostsAndPaymentsDetail Debt - Summary of Interest Costs and Payments (Detail) Details 98 false false R99.htm 2416402 - Disclosure - Income Taxes - Provision for Income Taxes from Continuing Operations (Detail) Sheet http://www.bd.com/role/IncomeTaxesProvisionForIncomeTaxesFromContinuingOperationsDetail Income Taxes - Provision for Income Taxes from Continuing Operations (Detail) Details 99 false false R100.htm 2416403 - Disclosure - Income Taxes - Components of Income from Continuing Operations Before Income Taxes (Detail) Sheet http://www.bd.com/role/IncomeTaxesComponentsOfIncomeFromContinuingOperationsBeforeIncomeTaxesDetail Income Taxes - Components of Income from Continuing Operations Before Income Taxes (Detail) Details 100 false false R101.htm 2416404 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.bd.com/role/IncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 101 false false R102.htm 2416405 - Disclosure - Income Taxes - Summary of Gross Amounts of Unrecognized Tax Benefits (Detail) Sheet http://www.bd.com/role/IncomeTaxesSummaryOfGrossAmountsOfUnrecognizedTaxBenefitsDetail Income Taxes - Summary of Gross Amounts of Unrecognized Tax Benefits (Detail) Details 102 false false R103.htm 2416406 - Disclosure - Income Taxes - Deferred Income Taxes (Detail) Sheet http://www.bd.com/role/IncomeTaxesDeferredIncomeTaxesDetail Income Taxes - Deferred Income Taxes (Detail) Details 103 false false R104.htm 2416407 - Disclosure - Income Taxes - Reconciliation of Federal Statutory Tax Rate to Company's Effective Tax Rate (Detail) Sheet http://www.bd.com/role/IncomeTaxesReconciliationOfFederalStatutoryTaxRateToCompanysEffectiveTaxRateDetail Income Taxes - Reconciliation of Federal Statutory Tax Rate to Company's Effective Tax Rate (Detail) Details 104 false false R105.htm 2417402 - Disclosure - Sale-Type Leases and Financing Receivable (Details) Sheet http://www.bd.com/role/SaleTypeLeasesAndFinancingReceivableDetails Sale-Type Leases and Financing Receivable (Details) Details http://www.bd.com/role/SaleTypeLeasesAndFinancingReceivableScheduleOfCapitalLeasedAssetsTables 105 false false R106.htm 2417403 - Disclosure - Sale-Type Leases and Financing Receivable Sales-Type Leases and Financing Receivables (Details) Sheet http://www.bd.com/role/SaleTypeLeasesAndFinancingReceivableSalesTypeLeasesAndFinancingReceivablesDetails Sale-Type Leases and Financing Receivable Sales-Type Leases and Financing Receivables (Details) Details 106 false false R107.htm 2418402 - Disclosure - Supplemental Financial Information - Additional Information (Detail) Sheet http://www.bd.com/role/SupplementalFinancialInformationAdditionalInformationDetail Supplemental Financial Information - Additional Information (Detail) Details 107 false false R108.htm 2418403 - Disclosure - Supplemental Financial Information - Trade Receivables, Allowances for Doubtful Accounts and Cash Discounts (Detail) Sheet http://www.bd.com/role/SupplementalFinancialInformationTradeReceivablesAllowancesForDoubtfulAccountsAndCashDiscountsDetail Supplemental Financial Information - Trade Receivables, Allowances for Doubtful Accounts and Cash Discounts (Detail) Details 108 false false R109.htm 2418404 - Disclosure - Supplemental Financial Information - Inventories (Detail) Sheet http://www.bd.com/role/SupplementalFinancialInformationInventoriesDetail Supplemental Financial Information - Inventories (Detail) Details 109 false false R110.htm 2418405 - Disclosure - Supplemental Financial Information - Property, Plant and Equipment, Net (Detail) Sheet http://www.bd.com/role/SupplementalFinancialInformationPropertyPlantAndEquipmentNetDetail Supplemental Financial Information - Property, Plant and Equipment, Net (Detail) Details 110 false false R111.htm 2419402 - Disclosure - Supplementary Data (Unaudited) (Details) Sheet http://www.bd.com/role/SupplementaryDataUnauditedDetails Supplementary Data (Unaudited) (Details) Details http://www.bd.com/role/SupplementaryDataUnauditedTables 111 false false All Reports Book All Reports In ''Consolidated Statements of Income'', column(s) 1, 3, 5, 7, 9, 11, 13, 15 are contained in other reports, so were removed by flow through suppression. In ''Consolidated Statements of Comprehensive Income'', column(s) 1, 2, 3, 4, 5, 6, 7, 8 are contained in other reports, so were removed by flow through suppression. In ''Consolidated Balance Sheets'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''Consolidated Statements of Cash Flows'', column(s) 1, 2, 3, 4, 5, 6, 7, 8 are contained in other reports, so were removed by flow through suppression. bdx-20150930.xml bdx-20150930_cal.xml bdx-20150930_def.xml bdx-20150930_lab.xml bdx-20150930_pre.xml bdx-20150930.xsd true true XML 127 R74.htm IDEA: XBRL DOCUMENT v3.3.0.814

Benefit Plans - Changes in Fair Value of Foreign Pension Assets Measured Using Level 3 Inputs (Detail) (Detail) - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Foreign Plans

Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]

Beginning fair value $ 574

Ending fair value 575 $ 574

Foreign Plans | Real estate

Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]

Beginning fair value 10

Ending fair value 13 10

Foreign Plans | Insurance contracts

Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]

Beginning fair value 78

Ending fair value 90 78

Foreign Plans | Other

Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]

Beginning fair value 47

Ending fair value 74 47

Foreign Plans | Significant Unobservable Inputs (Level 3)

Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]

Beginning fair value 78 83

Return on assets 4 1

Purchases, sales and settlements, net 16 3

Transfers (out) in from other categories 1 (3)

Exchange rate changes (9) (6)

Ending fair value 90 78

Foreign Plans | Significant Unobservable Inputs (Level 3) | Real estate

Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]

Beginning fair value 0 1

Return on assets 0 0

Purchases, sales and settlements, net 0 0

Transfers (out) in from other categories 0 (1)

Exchange rate changes 0 0

Ending fair value 0 0

Foreign Plans | Significant Unobservable Inputs (Level 3) | Insurance contracts

Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]

Beginning fair value 78 81

Return on assets 4 1

Purchases, sales and settlements, net 16 3

Transfers (out) in from other categories 1 (2)

Exchange rate changes (9) (6)

Ending fair value 90 78

Foreign Plans | Significant Unobservable Inputs (Level 3) | Other

Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]

Beginning fair value 0

Ending fair value 0 0

U.S. Plans

Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]

Beginning fair value 1,255

Ending fair value 1,157 1,255

U.S. Plans | Other

Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]

Beginning fair value 193

Ending fair value 123 193

U.S. Plans | Significant Unobservable Inputs (Level 3)

Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]

Beginning fair value 4

Ending fair value 2 4

U.S. Plans | Significant Unobservable Inputs (Level 3) | Other

Defined Benefit Plan, Change in Fair Value of Plan Assets, Level 3 Reconciliation [Roll Forward]

Beginning fair value 4 12

Return on assets 0 1

Purchases, sales and settlements, net 1 4

Transfers (out) in from other categories (3) (13)

Exchange rate changes 0 0

Ending fair value $ 2 $ 4

X

- Definition
Actual return on plan assets, separately identifying the amount related to assets still held at the reporting date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (d)(iv)(02)(A)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 5

-Subparagraph (c)(iv)(02)(A)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e2446-114920

+ Details

Name: us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsLevel3ReconciliationRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits, at their fair value as of the measurement date. Plan assets include amounts contributed by the employer (and by employees for a contributory plan) and amounts earned from investing the contributions, less benefits paid. If a plan has liabilities other than for benefits, those non-benefit obligations may be considered as reductions of plan assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 30

-Section 35

-Paragraph 50

-URI http://asc.fasb.org/extlink&oid=49178875&loc=d3e12355-114930

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanFairValueOfPlanAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of increase or decrease in plan assets attributed to foreign currency changes. The effects of foreign currency exchange rate changes that are to be disclosed are those applicable to plans of a foreign operation whose functional currency is not the reporting currency.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)(2)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

+ Details

Name: us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) in plan assets from purchases, sales and settlement of plan obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (d)(iv)(02)(B)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 5

-Subparagraph (c)(iv)(02)(B)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e2446-114920

+ Details

Name: us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Transfers in and out of Level 3. For example, transfers due to changes in the observability of significant inputs.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (d)(iv)(02)(C)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 5

-Subparagraph (c)(iv)(02)(C)

-URI http://asc.fasb.org/extlink&oid=58740216&loc=d3e2446-114920

+ Details

Name: us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_ForeignPensionPlansDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=bdx_InsuranceContractInvestmentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=bdx_OtherPensionPlanInvestmentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 128 R38.htm IDEA: XBRL DOCUMENT v3.3.0.814

Financial Instruments and Fair Value Measurements (Tables)
12 Months Ended

Sep. 30, 2015

Fair Value Disclosures [Abstract]

Fair Values of Financial Instruments
The fair values of financial instruments, including those not recognized on the statement of financial position at fair value, carried at September 30, 2015 and 2014 are classified in accordance with the fair value hierarchy in the following tables:

Basis of Fair Value Measurement
(Millions of dollars)

September 30,
2015
Total

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

Significant
Other
Observable
Inputs (Level 2)

Significant
Unobservable
Inputs (Level 3)
Assets

Institutional money market investments

$
147

$
147

$
—

$
—

Interest rate swaps

19

—

19

—

Forward exchange contracts

13

—

13

—

Total Assets

$
179

$
147

$
32

$
—

Liabilities

Forward exchange contracts

$
21

$
—

$
21

$
—

Commodity forward contracts

10

—

10

—

Contingent consideration liabilities

77

—

—

77

Total Liabilities

$
108

$
—

$
30

$
77

Basis of Fair Value Measurement
(Millions of dollars)

September 30,
2014
Total

Quoted Prices in
Active Markets
for Identical
Assets (Level 1)

Significant
Other
Observable
Inputs (Level 2)

Significant
Unobservable
Inputs (Level 3)
Assets

Institutional money market investments

$
1,040

$
1,040

$
—

$
—

Interest rate swaps

3

—

3

—

Forward exchange contracts

20

—

20

—

Total Assets

$
1,063

$
1,040

$
23

$
—

Liabilities

Forward exchange contracts

$
14

$
—

$
14

$
—

Contingent consideration liabilities

14

—

—

14

Total Liabilities

$
29

$
—

$
14

$
14

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19190-110258

+ Details

Name: us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 129 R20.htm IDEA: XBRL DOCUMENT v3.3.0.814

Derivative Instruments and Hedging Activities
12 Months Ended

Sep. 30, 2015

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments and Hedging Activities
Derivative Instruments and Hedging Activities
The Company uses derivative instruments to mitigate certain exposures. The effects these derivative instruments and hedged items have on financial position, financial performance, and cash flows are provided below.
Foreign Currency Risks and Related Strategies
The Company has foreign currency exposures throughout Europe, Greater Asia, Canada and Latin America. Transactional currency exposures that arise from entering into transactions, generally on an intercompany basis, in non-hyperinflationary countries that are denominated in currencies other than the functional currency are mitigated primarily through the use of forward contracts and currency options. Hedges of the transactional foreign exchange exposures resulting primarily from intercompany payables and receivables are undesignated hedges. As such, the gains or losses on these instruments are recognized immediately in income. The offset of these gains or losses against the gains and losses on the underlying hedged items, as well as the hedging costs associated with the derivative instruments, is recognized in Other income (expense), net.
The total notional amounts of the Company’s outstanding foreign exchange contracts as of September 30, 2015 and 2014 were $2.2 billion and $1.8 billion, respectively.
Interest Rate Risks and Related Strategies
The Company’s primary interest rate exposure results from changes in U.S. dollar interest rates. The Company’s policy is to manage interest cost using a mix of fixed and variable rate debt. The Company periodically uses interest rate swaps to manage such exposures. Under these interest rate swaps, the Company exchanges, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. These swaps are designated as either fair value or cash flow hedges.
For interest rate swaps designated as fair value hedges (i.e., hedges against the exposure to changes in the fair value of an asset or a liability or an identified portion thereof that is attributable to a particular risk), changes in the fair value of the interest rate swaps offset changes in the fair value of the fixed rate debt due to changes in market interest rates.
Changes in the fair value of the interest rate swaps designated as cash flow hedges (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk) are offset by amounts recorded in Other comprehensive income (loss). If interest rate derivatives designated as cash flow hedges are terminated, the balance in Accumulated other comprehensive income (loss) attributable to those derivatives is reclassified into earnings over the remaining life of the hedged debt. The net realized loss related to terminated interest rate swaps expected to be reclassified and recorded in Interest expense within the next 12 months is $6 million, net of tax. The Company had no outstanding interest rate swaps designated as cash flow hedges as of September 30, 2015 and 2014.
The total notional amount of the Company’s outstanding interest rate swaps designated as fair value hedges was $375 million at September 30, 2015 and 2014. The outstanding swaps represent fixed-to-floating interest rate swap agreements the Company entered into, in March and September 2014, to convert the interest payments on $375 million of the Company’s 3.125% notes, due November 8, 2021, from the fixed rate to a floating interest rate based on LIBOR. Changes in the fair value of the interest rate swaps offset changes in the fair value of the fixed rate debt. The gain recorded on these fair value hedges and the offsetting loss recorded on the underlying debt instrument was $19 million and $3 million at September 30, 2015 and 2014, respectively.
Other Risk Exposures
The Company purchases resins, which are oil-based components used in the manufacture of certain products. Significant increases in world oil prices that lead to increases in resin purchase costs could impact future operating results. From time to time, the Company has managed price risks associated with these commodity purchases through commodity derivative forward contracts. In April 2015, the Company entered into cash-settled forward contracts to hedge approximately 13% of its expected global resin purchase volumes throughout fiscal years 2015 and 2016. These contracts were designated as cash flow hedges and the total notional amount of these contracts at September 30, 2015 was 49 million pounds ($25 million). The Company had no outstanding commodity derivative contracts designated as cash flow hedges as of September 30, 2014.
Effects on Consolidated Balance Sheets
The location and amounts of derivative instrument fair values in the consolidated balance sheet are segregated below between designated, qualifying hedging instruments and ones that are not designated for hedge accounting.
(Millions of dollars)
September 30,
2015

September 30,
2014
Asset derivatives-designated for hedge accounting

Interest rate swaps
$
19

$
3

Asset derivatives-undesignated for hedge accounting

Forward exchange contracts
$
13

$
20

Total asset derivatives (A)
$
32

$
23

Liability derivatives-designated for hedge accounting

Commodity forward contracts
$
10

$
—

Liability derivatives-undesignated for hedge accounting

Forward exchange contracts
$
21

$
14

Total liability derivatives (B)
$
30

$
14

(A)
All asset derivatives are included in Prepaid expenses, deferred taxes and other.
(B)
All liability derivatives are included in Accrued expenses.

Effects on Consolidated Statements of Income
Cash flow hedges
After-tax losses of $16 million were recognized in Other comprehensive income (loss) in 2015. These losses included a $7 million loss relating to the commodity forward contracts entered into in April 2015 to hedge the risk associated with resin purchases. These losses also included $8 million attributable to interest rate swaps with a total notional amount of $2.3 billion that were entered into during the first quarter of fiscal year 2015 to partially hedge interest rate risk associated with the anticipated issuance of senior unsecured notes in connection with the Company’s acquisition of CareFusion. These swaps were designated as hedges of the variability in interest payments attributable to changes in the benchmark interest rate during the period preceding the Company’s issuance of the notes. The swaps were terminated at losses, concurrent with the pricing of notes issued in December 2014, and the realized losses will be amortized over the lives of the notes with an offset to Interest expense. Additional disclosures regarding amounts recognized in the consolidated statements of income in fiscal years 2015, 2014 and 2013 relating to cash flow hedges are provided in Note 3. Additional disclosures regarding the acquisition of CareFusion are provided in Note 9 and additional disclosures regarding the Company’s debt issuance during the first quarter of fiscal year 2015 are provided in Note 15.
The Company’s designated derivative instruments are highly effective. As such, there were no gains or losses, related to hedge ineffectiveness or amounts excluded from hedge effectiveness testing, recognized immediately in income relative to derivative contracts outstanding in the periods presented.
Undesignated hedges
The location and amount of gains and losses recognized in income on derivatives not designated for hedge accounting for the years ended September 30 were as follows:
Derivatives Not
Designated as
For Hedge Accounting

Location of Gain (Loss)
Recognized in Income on
Derivatives

Amount of Gain (Loss)
Recognized in Income on
Derivative
(Millions of dollars)
2015

2014

2013
Forward exchange contracts (A)

Other income (expense), net

$
(49
)

$
(3
)

$
(1
)
(A)
The gains and losses on forward contracts and currency options utilized to hedge the intercompany transactional foreign exchange exposures are largely offset by gains and losses on the underlying hedged items in Other income (expense), net.

X

- References
No definition available.
+ Details

Name: us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 30

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41620-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4B

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624163-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579240-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4D

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624177-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80784-113994

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41641-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579245-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4H

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624258-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5708775-113959

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5708773-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4A

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5618551-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 1B

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5580258-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4E

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624181-113959

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 25

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41638-113959

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(n))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 130 R101.htm IDEA: XBRL DOCUMENT v3.3.0.814

Income Taxes - Additional Information (Detail) - USD ($)
$ in Millions
12 Months Ended

Sep. 30, 2015

Sep. 30, 2014

Sep. 30, 2013

Income Tax [Line Items]

Deferred tax assets, net of valuation allowance, current $ 387 $ 355

Deferred tax assets, net of valuation allowance, noncurrent 142 100

Deferred tax liabilities, net, current 5 10

Deferred tax liabilities, net, noncurrent 1,951 130

Undistributed earnings of foreign subsidiaries 7,500

Accrued unrecognized tax benefits interest and penalties 84 10 $ 8

Unrecognized tax benefits interest and penalties reflected in current year 8 2 2

Tax reductions related to tax holidays 102 108 95

Income taxes paid, net 240 $ 330 $ 454

Deferred Income Taxes and Other

Income Tax [Line Items]

Indemnification liability, non-current $ 217

X

- Definition
Income Tax.
+ References
No definition available.
+ Details

Name: bdx_IncomeTaxLineItems

Namespace Prefix: bdx_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Indemnification Liability, Non-current
+ References
No definition available.
+ Details

Name: bdx_IndemnificationLiabilityNoncurrent

Namespace Prefix: bdx_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards expected to be realized or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31917-109318

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31931-109318

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31928-109318

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31958-109318

+ Details

Name: us-gaap_DeferredTaxAssetsNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after allocation of valuation allowances of noncurrent deferred tax asset attributable to deductible temporary differences and carryforwards. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31931-109318

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31928-109318

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31958-109318

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31917-109318

+ Details

Name: us-gaap_DeferredTaxAssetsNetNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, netted by jurisdiction and classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31958-109318

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31917-109318

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31931-109318

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

+ Details

Name: us-gaap_DeferredTaxLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, netted by jurisdiction and classified as noncurrent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31931-109318

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31958-109318

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31917-109318

+ Details

Name: us-gaap_DeferredTaxLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of income taxes from which a reporting entity is exempt or for which it will receive a reduction in income taxes as a result of the income tax holiday granted by the taxing jurisdiction.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 11.C)

-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330215-122817

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 11

-Section C

+ Details

Name: us-gaap_IncomeTaxHolidayAggregateDollarAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

+ Details

Name: us-gaap_IncomeTaxesPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 740

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 740

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 995

-SubTopic 740

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6503627&loc=d3e59836-110443

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 25

-Paragraph 3

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=51675352&loc=d3e28200-109314

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (b)(c)

-URI http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

+ Details

Name: us-gaap_UndistributedEarningsOfForeignSubsidiaries

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

+ Details

Name: us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

+ Details

Name: us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

Benefit Plans - Expected Benefit Payments (Detail) $ in Millions	Sep. 30, 2015 USD ($)
Pension Plans
Defined Benefit Plan Disclosure [Line Items]
2016	$ 163
2017	164
2018	164
2019	177
2020	175
2021-2025	870
Other Postretirement Benefits
Defined Benefit Plan Disclosure [Line Items]
2016	15
2017	15
2018	15
2019	15
2020	15
2021-2025	$ 67

Segment Data - Revenues to Unaffiliated Customers and Long-lived Assets Including Property, Plant and Equipment (Detail) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 3,059	$ 3,120	$ 2,051	$ 2,051	$ 2,202	$ 2,157	$ 2,072	$ 2,015	$ 10,282	$ 8,446	$ 8,054
Long-Lived Assets	20,774				6,317				20,774	6,317	6,276
Corporate
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	332				340				332	340	350
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues									5,069	3,417	3,353
Long-Lived Assets	15,513				3,126				15,513	3,126	3,251
Europe
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues									2,434	2,383	2,189
Long-Lived Assets	3,876				1,790				3,876	1,790	1,649
Greater Asia
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues									1,545	1,437	1,344
Long-Lived Assets	569				555				569	555	519
Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues									1,234	1,210	1,168
Long-Lived Assets	$ 484				$ 505				$ 484	$ 505	$ 505

Acquisitions - Fair Value of Consideration Transferred (Details) - Care Fusion Corporation $ in Millions	Mar. 17, 2015 USD ($)
Business Acquisition [Line Items]
Cash consideration	$ 10,085
Noncash consideration-fair value of shares issued	2,269
Noncash consideration-fair value of stock options and other equity awards	184
Total consideration transferred	$ 12,538

Acquisitions - Fair Value of Company's Ordinary Shares Issued (Details) - USD ($) $ / shares in Units, $ in Millions	Mar. 17, 2015	Mar. 16, 2015
Business Acquisition [Line Items]
Number of the Company’s shares issued (shares)	15,900,000
Care Fusion Corporation
Business Acquisition [Line Items]
Total CareFusion shares outstanding (shares)	205,300,000.0
Conversion factor	0.0777
Number of the Company’s shares issued (shares)	15,900,000
Closing price of the Company’s stock on March 16, 2015 (USD per share)		$ 142.29
Fair value of the Company’s issued shares	$ 2,269

Benefit Plans - Fair Value Measurements of Foreign Plan Assets (Detail) - Foreign Plans - USD ($) $ in Millions	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 575	$ 574
Corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	33	35
Government and agency-U.S.
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1	3
Government and agency-Foreign
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	101	100
Other fixed income
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	48	47
Equity securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	206	237
Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	8	15
Real estate
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	13	10
Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	90	78
Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	74	47
Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	364	357
Quoted Prices in Active Markets for Identical Assets (Level 1) \| Corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	3	0
Quoted Prices in Active Markets for Identical Assets (Level 1) \| Government and agency-U.S.
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1	3
Quoted Prices in Active Markets for Identical Assets (Level 1) \| Government and agency-Foreign
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	65	59
Quoted Prices in Active Markets for Identical Assets (Level 1) \| Other fixed income
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	46	46
Quoted Prices in Active Markets for Identical Assets (Level 1) \| Equity securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	187	221
Quoted Prices in Active Markets for Identical Assets (Level 1) \| Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	8	15
Quoted Prices in Active Markets for Identical Assets (Level 1) \| Real estate
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) \| Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) \| Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	53	12
Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	121	138
Significant Other Observable Inputs (Level 2) \| Corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	30	35
Significant Other Observable Inputs (Level 2) \| Government and agency-U.S.
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Significant Other Observable Inputs (Level 2) \| Government and agency-Foreign
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	36	41
Significant Other Observable Inputs (Level 2) \| Other fixed income
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2	1
Significant Other Observable Inputs (Level 2) \| Equity securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	19	17
Significant Other Observable Inputs (Level 2) \| Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Significant Other Observable Inputs (Level 2) \| Real estate
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	13	10
Significant Other Observable Inputs (Level 2) \| Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Significant Other Observable Inputs (Level 2) \| Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	21	35
Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	90	78	$ 83
Significant Unobservable Inputs (Level 3) \| Corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) \| Government and agency-U.S.
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) \| Government and agency-Foreign
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) \| Other fixed income
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) \| Equity securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) \| Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) \| Real estate
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0	1
Significant Unobservable Inputs (Level 3) \| Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	90	78	$ 81
Significant Unobservable Inputs (Level 3) \| Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 0	$ 0

Derivative Instruments and Hedging Activities - Effects on Consolidated Balance Sheets (Detail) - USD ($) $ in Millions	Sep. 30, 2015	Sep. 30, 2014
Derivatives, Fair Value [Line Items]
Asset derivatives	$ 32	$ 23
Liability derivatives	30	14
Derivatives Designated as Hedging Instruments \| Interest rate swaps
Derivatives, Fair Value [Line Items]
Asset derivatives	19	3
Derivatives Designated as Hedging Instruments \| Commodity forward contracts
Derivatives, Fair Value [Line Items]
Liability derivatives	10	0
Derivatives Not Designated as Hedging Instruments \| Forward exchange contracts
Derivatives, Fair Value [Line Items]
Asset derivatives	13	20
Liability derivatives	$ 21	$ 14

Share-Based Compensation - Additional Information (Detail)	12 Months Ended
	Sep. 30, 2015 USD ($) installment $ / shares shares	Sep. 30, 2014 USD ($) $ / shares shares	Sep. 30, 2013 USD ($) $ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Income tax benefit recognized	$ 59,000,000	$ 40,000,000	$ 35,000,000
SARs vesting period	4 years
SARs terms of award	10 years
Total intrinsic value of SARs exercised	$ 96,000,000	69,000,000	54,000,000
Stock Issued under SARs exercised \| shares	691,000
Actual tax benefit realized for tax deductions from SAR	$ 34,000,000	26,000,000	19,000,000
Total fair value of SARs vested	22,000,000	25,000,000	30,000,000
Cash received from the exercising of stock options	75,000,000	17,000,000	64,000,000
Actual tax benefit realized for tax deductions from stock option exercises	20,000,000	7,000,000	21,000,000
Total intrinsic value of stock options exercised	52,000,000	$ 21,000,000	$ 65,000,000
Unrecognized compensation expense for all non-vested share-based awards	$ 156,000,000
Weighted-average remaining life non-vested share-based awards	1 year 10 months 4 days
Shares were authorized for future grants \| shares	7,242,000
Share-based compensation arrangement by share-based payment award, equity instruments other than options, percent deferred until retirement	25.00%
Number of equal installments in which deferred portion of stock award is distributable (installments) \| installment	5
Period over which balance of stock award distributable	5 years
Outstanding shares under other stock plan \| shares	50,000	58,000
Shares issuable under deferred compensation plan \| shares	345,000
Care Fusion Corporation
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense for all non-vested share-based awards	$ 38,000,000
Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Deferral plan, shares held in trust \| shares	119,000
Shares represented Directors' compensation in 2015 \| shares	3,000
Performance-Based Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock units vesting period	3 years
Performance period	3 years
Granted, stock units weighted average grant date fair value (USD per share) \| $ / shares	$ 148.04	$ 110.58	$ 72.14
Total fair value of restricted stock units	$ 16,000,000	$ 10,000,000	$ 0
Weighted average remaining vesting term	1 year 15 days
Awards outstanding (shares) \| shares	1,139,000	1,255,000
Performance-Based Restricted Stock Units \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance payout, percent	0.00%
Performance-Based Restricted Stock Units \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance payout, percent	200.00%
Time-Vested Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock units vesting period	3 years
Granted, stock units weighted average grant date fair value (USD per share) \| $ / shares	$ 136.30	$ 102.74	$ 70.99
Total fair value of restricted stock units	$ 181,000,000	$ 45,000,000	$ 52,000,000
Weighted average remaining vesting term	1 year 1 month
Awards outstanding (shares) \| shares	3,067,000	3,015,000
Time-Vested Restricted Stock Units \| Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock units vesting period	1 year
Replacement Awards \| Care Fusion Corporation
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards outstanding (shares) \| shares	1,500,000

Supplemental Financial Information - Inventories (Detail) - USD ($) $ in Millions	Sep. 30, 2015	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Materials	$ 384	$ 248
Work in process	280	260
Finished products	1,295	987
Inventories	$ 1,959	$ 1,495

Intangible Assets - Reconciliation of Goodwill by Business Segment (Detail) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 1,090	$ 1,109
Acquisitions	6,716	13
Currency translation/other	(269)	(32)
Goodwill, ending balance	7,537	1,090
Medical
Goodwill [Roll Forward]
Goodwill, beginning balance	482	511
Acquisitions	6,585	0
Currency translation/other	(261)	(29)
Goodwill, ending balance	6,807	482
Medical \| Series of Individually Immaterial Business Acquisitions
Goodwill [Roll Forward]
Acquisitions	22
Life Sciences
Goodwill [Roll Forward]
Goodwill, beginning balance	608	598
Acquisitions	130	13
Currency translation/other	(8)	(3)
Goodwill, ending balance	$ 730	$ 608

Acquisitions - Additional Information (Detail) - USD ($)		12 Months Ended
	Mar. 17, 2015	Sep. 30, 2015
Business Acquisition [Line Items]
Restructuring charges		$ 271,000,000
Care Fusion Corporation
Business Acquisition [Line Items]
Percentage of interest acquired	100.00%
Cash consideration per share (USD per share)	$ 49.00
Conversion factor	0.0777
Acquisition-date fair value of consideration transferred net of in cash acquired	$ 12,538,000,000
Product recall accrual	36,000,000
Portion of goodwill currently expected to be deductible for tax purposes	$ 0
Business combination interest and financing costs		107,000,000
Acquisition-related costs		59,000,000
Business combination, integration related costs		95,000,000
Restructuring charges		271,000,000
Business combination, pro forma information, revenue of acquiree since acquisition date,		2,000,000,000
Business combination, pro forma information, loss of acquiree since acquisition date		$ 242,000,000
Care Fusion Corporation \| Customer relationships
Business Acquisition [Line Items]
Risk-adjusted discount rate	11.00%
Weighted average useful life	15 years
Care Fusion Corporation \| Developed technology
Business Acquisition [Line Items]
Risk-adjusted discount rate	11.00%
Weighted average useful life	12 years
Care Fusion Corporation \| Trademarks
Business Acquisition [Line Items]
Risk-adjusted discount rate	11.00%
Weighted average useful life	22 years
Care Fusion Corporation \| In Process Research and Development
Business Acquisition [Line Items]
Risk-adjusted discount rate	12.00%
Acquired in-process research and development	$ 110,000,000
Care Fusion Corporation \| In Process Research and Development \| Minimum
Business Acquisition [Line Items]
Technological and commercial risk	80.00%
Care Fusion Corporation \| In Process Research and Development \| Maximum
Business Acquisition [Line Items]
Technological and commercial risk	85.00%

Benefit Plans - Fair Value Measurements of U.S. Plan Assets (Detail) - U.S. Plans - USD ($) $ in Millions	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 1,157	$ 1,255
Mortgage and asset-backed securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	192	150
Corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	240	213
Government and agency-U.S.
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	78	153
Government and agency-Foreign
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	95	126
Equity securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	335	393
Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	96	26
Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	123	193
Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	401	483
Quoted Prices in Active Markets for Identical Assets (Level 1) \| Mortgage and asset-backed securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) \| Corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	100	105
Quoted Prices in Active Markets for Identical Assets (Level 1) \| Government and agency-U.S.
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	53	124
Quoted Prices in Active Markets for Identical Assets (Level 1) \| Government and agency-Foreign
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	46	74
Quoted Prices in Active Markets for Identical Assets (Level 1) \| Equity securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	75	56
Quoted Prices in Active Markets for Identical Assets (Level 1) \| Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	96	26
Quoted Prices in Active Markets for Identical Assets (Level 1) \| Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	30	96
Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	755	768
Significant Other Observable Inputs (Level 2) \| Mortgage and asset-backed securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	192	150
Significant Other Observable Inputs (Level 2) \| Corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	139	108
Significant Other Observable Inputs (Level 2) \| Government and agency-U.S.
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	24	29
Significant Other Observable Inputs (Level 2) \| Government and agency-Foreign
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	49	51
Significant Other Observable Inputs (Level 2) \| Equity securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	260	337
Significant Other Observable Inputs (Level 2) \| Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Significant Other Observable Inputs (Level 2) \| Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	91	93
Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2	4
Significant Unobservable Inputs (Level 3) \| Mortgage and asset-backed securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) \| Corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) \| Government and agency-U.S.
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) \| Government and agency-Foreign
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) \| Equity securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) \| Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Significant Unobservable Inputs (Level 3) \| Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 2	$ 4	$ 12

Debt - Summary of Long-Term Debt (Detail II)	Sep. 30, 2015
1.750% Notes due November 8, 2016
Debt Instrument [Line Items]
Interest rates of debt instruments	1.75%
1.800% Notes due December 15, 2017
Debt Instrument [Line Items]
Interest rates of debt instruments	1.80%
1.450% Notes due May 15, 2017
Debt Instrument [Line Items]
Interest rates of debt instruments	1.45%
4.900% Notes due April 15, 2018
Debt Instrument [Line Items]
Interest rates of debt instruments	4.90%
5.000% Notes due May 15, 2019
Debt Instrument [Line Items]
Interest rates of debt instruments	5.00%
6.375% Notes due August 1, 2019
Debt Instrument [Line Items]
Interest rates of debt instruments	6.375%
2.675% Notes due December 15, 2019
Debt Instrument [Line Items]
Interest rates of debt instruments	2.675%
3.250% Notes due November 12, 2020
Debt Instrument [Line Items]
Interest rates of debt instruments	3.25%
3.125% Notes due November 8, 2021
Debt Instrument [Line Items]
Interest rates of debt instruments	3.125%
3.300% Notes due March 1, 2023
Debt Instrument [Line Items]
Interest rates of debt instruments	3.30%
3.875% Notes due May 15, 2024
Debt Instrument [Line Items]
Interest rates of debt instruments	3.875%
3.734% Notes due December 15, 2024
Debt Instrument [Line Items]
Interest rates of debt instruments	3.734%
7.000% Debentures due August 1, 2027
Debt Instrument [Line Items]
Interest rates of debt instruments	7.00%
6.700% Debentures due August 1, 2028
Debt Instrument [Line Items]
Interest rates of debt instruments	6.70%
6.000% Notes due May 15, 2039
Debt Instrument [Line Items]
Interest rates of debt instruments	6.00%
5.000% Notes due November 12, 2040
Debt Instrument [Line Items]
Interest rates of debt instruments	5.00%
4.875% Notes due May 15, 2044
Debt Instrument [Line Items]
Interest rates of debt instruments	4.875%
4.685% Notes due December 15, 2044
Debt Instrument [Line Items]
Interest rates of debt instruments	4.685%

Segment Data - Additional Information (Detail)	12 Months Ended
Segment Data - Additional Information (Detail)	Sep. 30, 2015 customer segment	Sep. 30, 2014 customer	Sep. 30, 2013 customer
Segment Reporting [Abstract]
Number of principal business segments (segments) \| segment	2
Number of customers accounted for 10% or more of revenues (customers)	0	0	0

Benefit Plans - Pension Plans with Accumulated Benefit Obligations (Detail) - USD ($) $ in Millions	Sep. 30, 2015	Sep. 30, 2014
Compensation and Retirement Disclosure [Abstract]
Accumulated benefit obligation exceeds the fair value of plan assets, projected benefit obligation	$ 2,339	$ 2,267
Accumulated benefit obligation exceeds the fair value of plan assets, accumulated benefit obligation	2,265	2,186
Accumulated benefit obligation exceeds the fair value of plan assets, fair value of plan assets	1,650	1,738
Projected benefit obligation exceeds the fair value of plan assets, projected benefit obligation	2,394	2,324
Projected benefit obligation exceeds the fair value of plan assets, fair value of plan assets	$ 1,693	$ 1,784

Accounting Changes	12 Months Ended
Accounting Changes	Sep. 30, 2015
Accounting Changes and Error Corrections [Abstract]
Accounting Changes	Accounting Changes New Accounting Principle Adopted In June 2013, the Financial Accounting Standards Board (“FASB”) issued guidance that requires the netting of unrecognized tax benefits against a deferred tax asset for a loss or other carryforward that would apply in settlement of the uncertain tax positions. In March 2013, the FASB issued amendments to resolve diversity in practice relating to the release of cumulative translation adjustments into earnings upon the occurrence of certain derecognition events involving a foreign entity. The Company prospectively adopted both accounting standard updates, which did not impact its consolidated financial statements, on October 1, 2014. New Accounting Principles Not Yet Adopted In April 2014, the FASB issued amended requirements that limit the presentation of discontinued operations to only those disposals that represent a strategic shift that has had, or will have, a major effect on an entity’s operations and financial results. The amended requirements also expand the disclosure requirements relating to disposal transactions. The Company will prospectively apply the amended requirements to disposal transactions that occur on or after October 1, 2015. In May 2014, the FASB issued a new revenue recognition standard. Under this standard, revenue will be recognized upon the transfer of goods or services to customers and the amount of revenue recognized will reflect the consideration to which a reporting entity expects to be entitled in exchange for those goods or services. The Company is currently evaluating the impact that this new revenue recognition standard will have on its consolidated financial statements and the Company currently intends to adopt the standard on October 1, 2018, as is allowed under the FASB's July 2015 amendment which deferred the effective date for this standard. In April 2014, the FASB issued amended requirements that require debt issuance costs, related to a recognized debt liability, to be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The Company will apply the amended presentation requirements on October 1, 2016.

Share-Based Compensation - Summary of Performance-Based Restricted Stock Units Outstanding Footnote (Detail)	12 Months Ended
	Sep. 30, 2015 shares
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Percentage of target payout on which performance-based restricted stock units are based	200.00%
Expected forfeited performance-based restricted stock units (shares)	68,000
Units in excess of the expected performance payout (shares)	528,000

Summary of Significant Accounting Policies	12 Months Ended
Summary of Significant Accounting Policies	Sep. 30, 2015
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation The accompanying Consolidated Financial Statements and Notes to Consolidated Financial Statements of Becton, Dickinson and Company (the “Company”) have been prepared in accordance with U.S. generally accepted accounting principles. Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes. Percentages and earnings per share amounts presented are calculated from the underlying amounts. Our fiscal year ends on September 30. Principles of Consolidation The consolidated financial statements include the Company’s accounts and those of its majority-owned subsidiaries after the elimination of intercompany transactions. The Company has no material interests in variable interest entities. Cash Equivalents Cash equivalents consist of all highly liquid investments with a maturity of three months or less at time of purchase. Short-Term Investments Short-term investments consist of time deposits with maturities greater than three months and less than one year when purchased. Trade and Financing Receivables The Company grants credit to customers in the normal course of business and the resulting trade receivables are stated at their net realizable value. The Company's portfolio of financing receivables arises from the leasing of dispensing equipment. The allowance for doubtful accounts represents the Company’s estimate of probable credit losses relating to trade receivables and is determined based on historical experience and other specific account data. Allowances for credit losses relating to financing receivables are also based on historical experience loss rates and the potential impact of anticipated changes in business practices, market dynamics, and economic conditions. Amounts are written off against the allowances for doubtful accounts or credit losses when the Company determines that a customer account is uncollectible. Inventories Inventories are stated at the lower of first-in, first-out cost or market. Property, Plant and Equipment Property, plant and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization are principally provided on the straight-line basis over estimated useful lives, which range from 20 to 45 years for buildings, four to 13 years for machinery and equipment and one to 12 years for leasehold improvements. Depreciation and amortization expense was $417 million, $369 million and $338 million in fiscal years 2015, 2014 and 2013, respectively. Goodwill and Other Intangible Assets The Company’s unamortized intangible assets include goodwill and in-process research and development assets which arise from acquisitions. The Company currently reviews all indefinite-lived assets, including goodwill, for impairment using quantitative models. Goodwill is reviewed at least annually for impairment at the reporting unit level, which is defined as an operating segment or one level below an operating segment, referred to as a component. The Company’s reporting units generally represent one level below reporting segments, and components within an operating segment that have similar economic characteristics are aggregated. Potential impairment of goodwill is identified by comparing the fair value of a reporting unit, estimated using an income approach, with its carrying value. The annual impairment review performed on July 1, 2015 indicated that all identified reporting units’ fair values exceeded their respective carrying values. The review for impairment of in-process research and development assets is performed by comparing the fair value of the technology or project assets, estimated using an income approach, with their carrying value. In-process research and development assets are considered indefinite-lived assets and are reviewed at least annually for impairment until projects are completed or abandoned. Certain trademarks that are considered to generate cash flows indefinitely are also considered to be indefinite-lived intangible assets and these assets are also reviewed at least annually for impairment. Amortized intangible assets include developed technology assets which arise from acquisitions. These assets represent acquired intellectual property that is already technologically feasible upon the acquisition date or acquired in-process research and development assets that are completed subsequent to acquisition. Developed technology assets are generally amortized over periods ranging from 15 to 20 years, using the straight-line method. Other intangibles with finite useful lives, which include patents, are amortized over periods principally ranging from one to 40 years, using the straight-line method. Finite-lived intangible assets, including developed technology assets, are periodically reviewed when impairment indicators are present to assess recoverability from future operations using undiscounted cash flows. The carrying values of these finite-lived assets are compared to the undiscounted cash flows they are expected to generate and an impairment loss is recognized in operating results to the extent any finite-lived intangible asset’s carrying value exceeds its calculated fair value. Capitalized Software Capitalized software, including costs for software developed or obtained for internal use, is stated at cost, less accumulated amortization. Amortization expense is principally provided on the straight-line basis over estimated useful lives, which do not exceed 10 years. The current balance largely includes capital software investments related to a global enterprise resource planning initiative to upgrade the Company’s business information systems. Amortization expense related to capitalized software was $65 million, $41 million and $38 million for 2015, 2014 and 2013, respectively. Foreign Currency Translation Generally, foreign subsidiaries’ functional currency is the local currency of operations and the net assets of foreign operations are translated into U.S. dollars using current exchange rates. The U.S. dollar results that arise from such translation, as well as exchange gains and losses on intercompany balances of a long-term investment nature, are included in the foreign currency translation adjustments in Accumulated other comprehensive income (loss). Revenue Recognition Revenue from product sales is typically recognized when all of the following criteria have been met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; product price is fixed or determinable; collection of the resulting receivable is reasonably assured. Certain sales arrangements contain multiple deliverables, including equipment and service deliverables, which requires the Company to determine the separate units of account. If the deliverable meets the criteria of a separate unit of accounting, the arrangement consideration is allocated to each element based upon its relative selling price. In determining the best evidence of selling price of a unit of account the Company utilizes vendor-specific objective evidence (“VSOE”), which is the price the Company charges when the deliverable is sold separately. When VSOE is not available, management uses relevant third-party evidence (“TPE”) of selling price, if available. When neither VSOE nor TPE of selling price exists, management uses its best estimate of selling price. Revenue allocated to equipment deliverables is recognized upon customer acceptance, which occurs after the transfer of title and risk of loss to the customer and the completion of installation or training services. When related training services are considered inconsequential, delivery is deemed to occur upon the transfer of title and risk of loss, at which time revenue and the costs associated with installation and training are recognized. For equipment lease revenue, transactions are evaluated and classified as either operating leases or sales-type leases. Lease income for products sold under sales-type leases is recognized as revenue upon the completion of installation activities in the amount of the present value of the minimum lease payments. The financing component of sales-type leases is recorded as revenue over the lease term. For products sold under operating leases, revenue is recognized at the contracted rate over the rental period, as defined within the customer agreement. The Company’s domestic businesses sell products primarily to distributors that resell the products to end-user customers. Rebates are provided to distributors that sell to end-user customers at prices determined under a contract between the Company and the end-user customer. Provisions for rebates, as well as sales discounts and returns, are based upon estimates and are accounted for as a reduction of revenues when revenue is recognized. Shipping and Handling Costs Shipping and handling costs are included in Selling and administrative expense. Shipping expense was $351 million, $299 million and $285 million in 2015, 2014 and 2013, respectively. Derivative Financial Instruments All derivatives are recorded in the balance sheet at fair value and changes in fair value are recognized currently in earnings unless specific hedge accounting criteria are met. From time to time, derivative financial instruments are utilized by the Company in the management of its foreign currency, interest rate and commodity price exposures. The Company periodically purchases forward contracts and options to hedge certain forecasted transactions that are denominated in foreign currencies in order to partially protect against a reduction in the value of future earnings resulting from adverse foreign exchange rate movements. The Company also periodically utilizes interest rate swaps to maintain a balance between fixed and floating rate instruments. Additionally, the Company periodically manages price risks associated with resin purchase costs through commodity derivative forward contracts. The Company does not enter into derivative financial instruments for trading or speculative purposes. Any deferred gains or losses associated with derivative instruments are recognized in income in the period in which the underlying hedged transaction is recognized. In the event a designated hedged item is sold, extinguished or matures prior to the termination of the related derivative instrument, such instrument would be closed and the resultant gain or loss would be recognized in income. Income Taxes United States income taxes are not provided on undistributed earnings of foreign subsidiaries where such undistributed earnings are indefinitely reinvested outside the United States. Deferred taxes are provided for earnings of foreign subsidiaries when those earnings are not considered indefinitely reinvested. Income taxes are provided and tax credits are recognized based on tax laws enacted at the dates of the financial statements. The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of tax jurisdictions. In evaluating the exposure associated with various tax filing positions, the Company records accruals for uncertain tax positions, based on the technical support for the positions, past audit experience with similar situations, and the potential interest and penalties related to the matters. The Company maintains valuation allowances where it is more likely than not that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances are included in the tax provision in the period of change. In determining whether a valuation allowance is warranted, management evaluates factors such as prior earnings history, expected future earnings, carryback and carryforward periods and tax strategies that could potentially enhance the likelihood of the realization of a deferred tax asset. Earnings per Share Basic earnings per share are computed based on the weighted average number of common shares outstanding. Diluted earnings per share reflect the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. Use of Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions. These estimates or assumptions affect reported assets, liabilities, revenues and expenses as reflected in the consolidated financial statements. Actual results could differ from these estimates. Share-Based Compensation The Company recognizes the fair value of share-based compensation in net income. Compensation expense is recognized on a straight-line basis over the requisite service period, which is generally the vesting period.

Benefit Plans - Changes in Fair Value of U.S. and Foreign Pension Assets Measured Using Level 3 Inputs (Detail) - U.S. Plans - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Actual return on plan assets:
Beginning fair value	$ 1,255
Ending fair value	1,157	$ 1,255
Other
Actual return on plan assets:
Beginning fair value	193
Ending fair value	123	193
Significant Unobservable Inputs (Level 3)
Actual return on plan assets:
Beginning fair value	4
Ending fair value	2	4
Significant Unobservable Inputs (Level 3) \| Other
Actual return on plan assets:
Beginning fair value	4	12
Return on assets	0	1
Purchases, sales and settlements, net	1	4
Transfers (out) in from other categories	(3)	(13)
Exchange rate changes	0	0
Ending fair value	$ 2	$ 4

Consolidated Statements of Income - USD ($) $ in Millions	12 Months Ended
Consolidated Statements of Income - USD ($) $ in Millions	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Operations
Revenues	$ 10,282	$ 8,446	$ 8,054
Cost of products sold	5,587	4,145	3,883
Selling and administrative expense	2,563	2,145	2,422
Research and development expense	632	550	494
Acquisition-related costs	426	0	0
Total Operating Costs and Expenses	9,207	6,840	6,800
Operating Income	1,074	1,606	1,254
Interest expense	(371)	(135)	(138)
Interest income	15	46	40
Other income, net	21	5	9
Income from continuing operations before income taxes	739	1,522	1,165
Income tax provision	44	337	236
Income from Continuing Operations	695	1,185	929
Net of income tax provision of $0 in 2015, $0 in 2014 and $222 in 2013	0	0	364
Net Income	$ 695	$ 1,185	$ 1,293
Basic Earnings per Share
Income from Continuing Operations (USD per share)	$ 3.43	$ 6.13	$ 4.76
Income from Discontinued Operations (USD per share)	0.00	0.00	1.86
Basic Earnings per Share (USD per share)	3.43	6.13	6.63
Diluted Earnings per Share
Income from Continuing Operations (USD per share)	3.35	5.99	4.67
Income from Discontinued Operations (USD per share)	0.00	0.00	1.83
Diluted Earnings per Share (USD per share)	$ 3.35	$ 5.99	$ 6.49

Debt - Summary of Long-Term Debt (Detail) - USD ($) $ in Millions	Sep. 30, 2015	Sep. 30, 2014
Debt Instrument [Line Items]
Long-Term Debt	$ 11,370	$ 3,768
1.750% Notes due November 8, 2016
Debt Instrument [Line Items]
Long-Term Debt	499	499
1.450% Notes due May 15, 2017
Debt Instrument [Line Items]
Long-Term Debt	300	0
1.800% Notes due December 15, 2017
Debt Instrument [Line Items]
Long-Term Debt	1,246	0
4.900% Notes due April 15, 2018
Debt Instrument [Line Items]
Long-Term Debt	202	202
5.000% Notes due May 15, 2019
Debt Instrument [Line Items]
Long-Term Debt	497	497
6.375% Notes due August 1, 2019
Debt Instrument [Line Items]
Long-Term Debt	802	0
2.675% Notes due December 15, 2019
Debt Instrument [Line Items]
Long-Term Debt	1,244	0
3.250% Notes due November 12, 2020
Debt Instrument [Line Items]
Long-Term Debt	697	697
3.125% Notes due November 8, 2021
Debt Instrument [Line Items]
Long-Term Debt	1,013	997
3.300% Notes due March 1, 2023
Debt Instrument [Line Items]
Long-Term Debt	305	0
3.875% Notes due May 15, 2024
Debt Instrument [Line Items]
Long-Term Debt	419	0
3.734% Notes due December 15, 2024
Debt Instrument [Line Items]
Long-Term Debt	1,739	0
7.000% Debentures due August 1, 2027
Debt Instrument [Line Items]
Long-Term Debt	168	168
6.700% Debentures due August 1, 2028
Debt Instrument [Line Items]
Long-Term Debt	167	167
6.000% Notes due May 15, 2039
Debt Instrument [Line Items]
Long-Term Debt	246	246
5.000% Notes due November 12, 2040
Debt Instrument [Line Items]
Long-Term Debt	296	296
4.875% Notes due May 15, 2044
Debt Instrument [Line Items]
Long-Term Debt	334	0
4.685% Notes due December 15, 2044
Debt Instrument [Line Items]
Long-Term Debt	1,190	0
Other long-term debt
Debt Instrument [Line Items]
Long-Term Debt	$ 5	$ 0

Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2015	Sep. 30, 2014
Statement of Financial Position [Abstract]
Common stock, par value (USD per share)	$ 1	$ 1
Common stock, shares authorized (shares)	640,000,000	640,000,000
Common stock, shares issued (shares)	332,662,160	332,662,160
Common stock in treasury, shares (shares)	121,966,516	140,770,158

Debt - Additional Information (Detail)		1 Months Ended				12 Months Ended
Debt - Additional Information (Detail)	Oct. 05, 2014 USD ($)	Sep. 30, 2015 USD ($)	Jul. 31, 2015 USD ($)	Apr. 30, 2015 USD ($)	Dec. 31, 2014 USD ($)	Sep. 30, 2015 USD ($)	Jun. 30, 2015 USD ($)	Mar. 31, 2015 USD ($)	Mar. 17, 2015 USD ($)	Feb. 28, 2015 USD ($)	Sep. 30, 2014
Debt Instrument [Line Items]
Short-term debt, weighted average interest rate		0.64%				0.64%					0.40%
Aggregate annual maturities of long-term debt, 2016		$ 750,000,000				$ 750,000,000
Aggregate annual maturities of long-term debt, 2017		800,000,000				800,000,000
Aggregate annual maturities of long-term debt, 2018		1,450,000,000				1,450,000,000
Aggregate annual maturities of long-term debt, 2019		1,200,000,000				1,200,000,000
Aggregate annual maturities of long-term debt, 2020		1,250,000,000				1,250,000,000
Term Loan Facility
Debt Instrument [Line Items]
Short term debt maximum borrowing capacity					$ 1,000,000,000
Loans Payable		0				0
Debt instrument, term					364 days
Repayments of short-term debt		100,000,000	$ 250,000,000	$ 650,000,000
Bridge Loan
Debt Instrument [Line Items]
Payments to acquire business secured bridge financing	$ 9,100,000,000
Syndicated Credit Facility
Debt Instrument [Line Items]
Borrowings under credit facility		0				0
Maximum aggregate commitment		1,500,000,000				1,500,000,000
Syndicated Credit Facility \| Domestic Debt
Debt Instrument [Line Items]
Maximum borrowing capacity of syndicated credit facility		1,000,000,000				1,000,000,000
Additional commitments made by the lenders		500,000,000				$ 500,000,000
Covenant compliance, minimum interest expense coverage ratio						5
Notes Due June 2016
Debt Instrument [Line Items]
Debt instrument, face amount		750,000,000				$ 750,000,000	$ 750,000,000
Unsecured Debt
Debt Instrument [Line Items]
Debt instrument, face amount		6,200,000,000.0				6,200,000,000.0
Care Fusion Corporation
Debt Instrument [Line Items]
Long-term debt assumed									$ 2,181,000,000
Business combination interest and financing costs						107,000,000
Care Fusion Corporation \| Unsecured Debt
Debt Instrument [Line Items]
Debt instrument, face amount								$ 2,000,000,000
Long-term debt assumed									$ 2,174,000,000
Principal amount outstanding after exchange		51,000,000				51,000,000
Commercial Paper Program
Debt Instrument [Line Items]
Short term debt maximum borrowing capacity		1,000,000,000				1,000,000,000
Loans Payable		700,000,000				700,000,000
Commercial Paper Program \| Care Fusion Corporation
Debt Instrument [Line Items]
Used proceeds of new financing		$ 500,000,000				$ 500,000,000
Former Commercial Paper Program
Debt Instrument [Line Items]
Loans Payable										$ 200,000,000

Share-Based Compensation - Summary of SARs Outstanding (Detail) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Sep. 30, 2015 USD ($) $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
SARs, beginning balance (shares)	7,852
SARs, granted (shares)	1,037
SARs, exercised (shares)	(1,458)
SARs, forfeited, canceled or expired (shares)	(167)
SARs, ending balance (shares)	7,264
SARs, Vested and expected to vest at ending balance (shares)	7,010
SARs, Exercisable at ending balance (shares)	4,725
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
SARs, weighted average exercise price, beginning balance (USD per share) \| $ / shares	$ 78.49
SARs, weighted average exercise price, granted (USD per share) \| $ / shares	134.73
SARs, weighted average exercise price, exercised (USD per share) \| $ / shares	72.88
SARs, weighted average exercise price, forfeited, canceled or expired (USD per share) \| $ / shares	103.50
SARs, weighted average exercise price, ending balance (USD per share) \| $ / shares	87.07
SARs, weighted average exercise price, vested and expected to vest (USD per share) \| $ / shares	86.34
SARs, weighted average exercise price, exercisable (USD per share) \| $ / shares	$ 76.18
SARs, weighted average remaining contractual term	5 years 11 months 16 days
SARs, weighted average remaining contractual term, vested and expected to vest	5 years 10 months 17 days
SARs, weighted average remaining contractual term, exercisable	4 years 9 months 22 days
SARs, aggregate intrinsic value \| $	$ 333
SARs, aggregate intrinsic value, vested and expected to vest \| $	327
SARs, aggregate intrinsic value, exercisable \| $	$ 267

Income Taxes - Deferred Income Taxes (Detail) - USD ($) $ in Millions	Sep. 30, 2015	Sep. 30, 2014
Income Tax Disclosure [Abstract]
Compensation and benefits, assets	$ 647	$ 546
Loss and credit carryforwards, assets	538	274
Other, assets	634	398
Deferred income taxes, assets, gross	1,819	1,218
Valuation allowance, assets	(452)	(247)
Deferred income taxes, assets	1,367	971
Property and equipment, liabilities	156	196
Deferred Tax Liabilities, Other Finite-Lived Assets	2,033	266
Other, liabilities	606	195
Deferred income taxes, liabilities, gross	2,795	656
Deferred income taxes, liabilities	$ 2,795	$ 656

Debt - Summary of Short-Term Debt (Detail) - USD ($) $ in Millions	Sep. 30, 2015	Sep. 30, 2014
Short-term Debt [Line Items]
Current portion of long-term debt	$ 752	$ 0
Short-term debt	1,452	203
Domestic
Short-term Debt [Line Items]
Loans Payable	700	200
Foreign
Short-term Debt [Line Items]
Loans Payable	$ 0	$ 3

Financial Instruments and Fair Value Measurements - Fair Values of Financial Instruments (Detail) - Recurring Fair Value Measurements - USD ($) $ in Millions	Sep. 30, 2015	Sep. 30, 2014
Assets
Institutional money market investments	$ 147	$ 1,040
Interest rate swaps	19	3
Forward exchange contracts	13	20
Total Assets	179	1,063
Liabilities
Forward exchange contracts	21	14
Commodity forward contracts	10
Contingent consideration liabilities	77	14
Total Liabilities	108	29
Quoted Prices in Active Markets for Identical Assets (Level 1)
Assets
Institutional money market investments	147	1,040
Interest rate swaps	0	0
Forward exchange contracts	0	0
Total Assets	147	1,040
Liabilities
Forward exchange contracts	0	0
Commodity forward contracts	0
Contingent consideration liabilities	0	0
Total Liabilities	0	0
Significant Other Observable Inputs (Level 2)
Assets
Institutional money market investments	0	0
Interest rate swaps	19	3
Forward exchange contracts	13	20
Total Assets	32	23
Liabilities
Forward exchange contracts	21	14
Commodity forward contracts	10
Contingent consideration liabilities	0	0
Total Liabilities	30	14
Significant Unobservable Inputs (Level 3)
Assets
Institutional money market investments	0	0
Interest rate swaps	0	0
Forward exchange contracts	0	0
Total Assets	0	0
Liabilities
Forward exchange contracts	0	0
Commodity forward contracts	0
Contingent consideration liabilities	77	14
Total Liabilities	$ 77	$ 14

Document and Entity Information - USD ($)	12 Months Ended
Document and Entity Information - USD ($)	Sep. 30, 2015	Oct. 31, 2015	Mar. 31, 2015
Document And Entity Information [Abstract]
Entity registrant name	BECTON DICKINSON & CO
Entity central index key	0000010795
Current fiscal year end date	--09-30
Entity filer category	Large Accelerated Filer
Document type	10-K
Document period end date	Sep. 30, 2015
Document fiscal year focus	2015
Document fiscal period focus	FY
Amendment flag	false
Entity common stock, shares outstanding (shares)		210,736,542
Entity well-known seasoned issuer	Yes
Entity voluntary filers	No
Entity current reporting status	Yes
Entity public float			$ 30,013,657,226

Acquisitions - Fair Value of Assets and Liabilities Assumed (Detail) - USD ($) $ in Millions	Mar. 17, 2015	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2013
Business Acquisition [Line Items]
Goodwill		$ 7,537	$ 1,090	$ 1,109
Care Fusion Corporation
Business Acquisition [Line Items]
Cash and equivalents	$ 1,903
Trade receivables, net	530
Inventories	813
Net investment in sales-type leases	1,208
Property, plant and equipment	499
Customer relationships	3,360
Developed technology	2,510
Trademarks	380
Other intangible assets	185
Other assets	321
Total identifiable assets acquired	11,709
Long-term debt	(2,181)
Deferred tax liabilities	(2,034)
Other liabilities	(1,299)
Total liabilities assumed	(5,514)
Net identifiable assets acquired	6,195
Goodwill	6,343
Net assets acquired	$ 12,538

Commitments and Contingencies	12 Months Ended
Commitments and Contingencies	Sep. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Commitments Rental expense for all operating leases amounted to $89 million in 2015, $71 million in 2014 and $70 million in 2013. Future minimum rental commitments on noncancelable leases are as follows: 2016 — $80 million; 2017 — $62 million; 2018 — $36 million; 2019 — $26 million; 2020 — $18 million and an aggregate of $24 million thereafter. As of September 30, 2015, the Company has certain future purchase commitments aggregating to approximately $958 million, which will be expended over the next several years. Contingencies Given the uncertain nature of litigation generally, the Company is not able in all cases to estimate the amount or range of loss that could result from an unfavorable outcome of the litigation to which the Company is a party. In accordance with U.S. generally accepted accounting principles, the Company establishes accruals to the extent probable future losses are estimable (in the case of environmental matters, without considering possible third-party recoveries). In view of the uncertainties discussed below, the Company could incur charges in excess of any currently established accruals and, to the extent available, liability insurance. In the opinion of management, any such future charges, individually or in the aggregate, could have a material adverse effect on the Company’s consolidated results of operations and consolidated cash flows. In June 2007, Retractable Technologies, Inc. (“RTI”) filed a complaint against the Company under the caption Retractable Technologies, Inc. vs. Becton Dickinson and Company (Civil Action No. 2:07-cv-250, U.S. District Court, Eastern District of Texas). RTI alleges that the BD Integra™ syringes infringe patents licensed exclusively to RTI. In its complaint, RTI also alleges that the Company engaged in false advertising with respect to certain of the Company’s safety-engineered products in violation of the Lanham Act; acted to exclude RTI from various product markets and to maintain its market share through, among other things, exclusionary contracts in violation of state and federal antitrust laws; and engaged in unfair competition. In January 2008, the court severed the patent and non-patent claims into separate cases, and stayed the non-patent claims during the pendency of the patent claims at the trial court level. RTI seeks money damages and injunctive relief. On April 1, 2008, RTI filed a complaint against BD under the caption Retractable Technologies, Inc. and Thomas J. Shaw v. Becton Dickinson and Company (Civil Action No.2:08-cv-141, U.S. District Court, Eastern District of Texas). RTI alleges that the BD Integra™ syringes infringe another patent licensed exclusively to RTI. RTI seeks money damages and injunctive relief. On August 29, 2008, the court ordered the consolidation of the patent cases. On November 9, 2009, at a trial of these consolidated cases, the jury rendered a verdict in favor of RTI on all but one of its infringement claims, but did not find any willful infringement, and awarded RTI $5 million in damages, which has been paid. On May 19, 2010, the court granted RTI’s motion for a permanent injunction against the continued sale by the Company of its BD Integra™ products in their current form, but stayed the injunction for the duration of the Company’s appeal. At the same time, the court lifted a stay of RTI’s non-patent claims. On July 8, 2011, the Court of Appeals for the Federal Circuit reversed the District Court judgment that the Company’s 3ml BD Integra™ products infringed the asserted RTI patents and affirmed the District Court judgment of infringement against the Company’s discontinued 1ml BD Integra™ products. On October 31, 2011, the Federal Circuit Court of Appeals denied RTI’s request for an en banc rehearing. In January 2013, RTI’s petition for review with the U.S. Supreme Court was denied. BD’s motion for further proceedings on damages was denied by the District Court on the grounds that the District Court did not have authority to modify the $5 million damage award. BD appealed this ruling to the Federal Circuit Court of Appeals, and on July 7, 2014, the Court affirmed the District Court ruling leaving the damages award intact. On September 19, 2014, the Federal Circuit Court of Appeals denied BD’s request for an en banc rehearing. On January 16, 2015, BD filed a petition for U.S. Supreme Court review of the Federal Circuit Court of Appeals decision leaving the damages award intact. On April 20, 2015, the U.S. Supreme Court denied BD’s petition. On September 19, 2013, a jury returned a verdict against BD with respect to certain of RTI’s non-patent claims. The verdict was unfavorable to BD with respect to RTI’s Lanham Act claim and claim for attempted monopolization based on deception in the safety syringe market. The jury awarded RTI $113.5 million for its attempted monopolization claim (which will be trebled under the antitrust statute). The jury’s verdict rejected RTI’s monopolization claims in the markets for safety syringes, conventional syringes and safety IV catheters; its attempted monopolization claims in the markets for conventional syringes and safety IV catheters; and its claims for contractual restraint of trade and exclusive dealing in the markets for safety syringes, conventional syringes and safety IV catheters. In connection with the verdict, the Company recorded a pre-tax charge of approximately $341 million in the fourth quarter of fiscal year 2013. On September 30, 2014, the Court issued a ruling denying BD’s post-trial motion for judgment as a matter of law. On November 10, 2014, the Court issued a ruling denying RTI’s request for disgorgement of BD profits for false advertising on the ground that any profit to which RTI is entitled is included within the amount of the antitrust damage award. The Court granted RTI’s request that BD be ordered to issue certain corrective statements regarding its advertising and enjoined from making certain advertising claims. The Court denied RTI’s request for injunctive relief relating to BD’s contracting practices and BD’s safety syringe advertising, finding that RTI failed to prove that BD’s contracting practices violated the antitrust laws or that BD’s safety syringe advertising is false. The Court concluded that RTI is entitled to certain categories of attorneys’ fees that it requested, but that its total fee recovery should be reduced by 50%. On January 14, 2015, the Court granted in part and denied in part BD’s motion for a stay of the injunction. The Court held that, pending appeal, BD would not be required to send the corrective advertising notices to end-user customers, but only to employees, distributors and Group Purchasing Organizations. The Court otherwise upheld its November 10, 2014 Order regarding the injunction. On January 15, 2015, the Court entered its Final Judgment in the case. In the Final Judgment, the Court ordered that RTI recovers $341 million for its attempted monopolization claim and $12 million for attorneys’ fees, and awarded pre and post-judgment interest and costs. On February 3, 2015, the Court of Appeals for the Fifth Circuit denied BD’s motion for a stay of the injunction pending the final appeal. On April 23, 2015, the Court granted BD’s motion to eliminate the award of pre-judgment interest, and entered a new Final Judgment. BD has filed its appeal to the Court of Appeals challenging the entirety of the Final Judgment. On November 4, 2013, the Secretariat of Foreign Trade of the Federal Republic of Brazil initiated an administrative anti-dumping investigation of imports of vacuum plastic tubes for blood collection into Brazil from the United States, the United Kingdom of Great Britain and Northern Ireland, the Federal Republic of Germany and the People’s Republic of China during the period from January 2008 through December 2012. BD, through its United States and international subsidiaries, exports vacuum plastic tubes for blood collection into Brazil from the United States and the United Kingdom of Great Britain and Northern Ireland and cooperated with the investigation. On April 30, 2015, the Brazilian Foreign Trade Board (“CAMEX”) issued a decision determining the application of anti-dumping measures including, without limitation, the imposition of duties on such vacuum plastic tubes imported into Brazil of 45.3% for products from the United States of America and 71.5% for products from the United Kingdom of Great Britain and Northern Ireland. These anti-dumping measures, effective from April 30, 2015, will last for a minimum period of five years. Subsequent to the decision, CAMEX initiated a proceeding to assess the effect of the duties from a public interest perspective. BD’s administrative appeal of the CAMEX decision was denied on August 5, 2015. CAMEX announced on November 5, 2015, following the conclusion of its proceeding, that it is not modifying its original decision. BD does not believe that the CAMEX decision will materially affect its results of operations. On October 5, 2014, CareFusion and the Company entered into an Agreement and Plan of Merger (which we refer to as the merger agreement) that provides for the acquisition of CareFusion by the Company. Under the terms of the merger agreement, a subsidiary of the Company (“the merger subsidiary”) merged with and into CareFusion on March 17, 2015, with CareFusion surviving the merger as a wholly owned subsidiary of the Company. Several putative class action lawsuits have been filed against CareFusion, its directors, the Company and the merger subsidiary in the Delaware Court of Chancery and in the Superior Court of California, San Diego County. These lawsuits generally allege that the members of the board of directors of CareFusion breached their fiduciary duties in connection with the merger by, among other things, carrying out a process that plaintiffs allege did not ensure adequate and fair consideration to CareFusion stockholders. The plaintiffs in these actions further allege that CareFusion and the Company aided and abetted the individual defendants’ breaches of their fiduciary duties. The plaintiffs seek, among other things, equitable relief to enjoin consummation of the merger, rescission of the merger and/or rescissory damages, and attorneys’ fees and costs. On December 30, 2014, the parties to the actions filed in the Delaware Court of Chancery (the “Delaware Actions”) entered into an agreement in principle to settle the Delaware Actions on the basis of additional disclosures made in a CareFusion Schedule 14A, filed with the SEC on January 5, 2015. The settlement terms are reflected in a Memorandum of Understanding (“MOU”). On December 31, 2014, plaintiffs’ counsel notified the Delaware Court of Chancery of the settlement and MOU. The parties to the Delaware Actions entered into a stipulation and agreement of compromise, settlement and release and presented the matter to the Delaware Court of Chancery for approval. The Delaware Court of Chancery approved the settlement on September 17, 2015 and the Delaware Actions are now concluded. On October 27, 2015, the Superior Court of California granted plaintiffs' request for voluntary dismissal of the California actions. On July 17, 2015, a class action complaint was filed against the Company in the U.S. District Court for the Southern District of Georgia. The plaintiffs, Glynn-Brunswick Hospital Authority, trading as Southeast Georgia Health System, and Southeast Georgia Health System, Inc., seek to represent a class of acute care purchasers of BD syringes and IV catheters. The complaint alleges that BD monopolized the markets for syringes and IV catheters through contracts, theft of technology, false advertising, acquisitions, and other conduct. The complaint seeks treble damages but does not specify the amount of alleged damages. The Company has filed a motion to dismiss the complaint. The Company believes that it has meritorious defenses to each of the above-mentioned suits pending against the Company and is engaged in a vigorous defense of each of these matters. The Company is also involved both as a plaintiff and a defendant in other legal proceedings and claims that arise in the ordinary course of business. The Company is a party to a number of federal proceedings in the United States brought under the Comprehensive Environment Response, Compensation and Liability Act, also known as “Superfund,” and similar state laws. The affected sites are in varying stages of development. In some instances, the remedy has been completed, while in others, environmental studies are commencing. For all sites, there are other potentially responsible parties that may be jointly or severally liable to pay all cleanup costs.

Business Restructuring Charges (Details) $ in Millions	12 Months Ended
Business Restructuring Charges (Details) $ in Millions	Sep. 30, 2015 USD ($)
Restructuring Reserve [Roll Forward]
Balance at September 30, 2014	$ 0
Assumed liability	19
Charged to expense	271
Cash payments	(94)
Non-cash settlements	(44)
Other adjustments	(91)
Balance at September 30, 2015	62
Employee Termination
Restructuring Reserve [Roll Forward]
Balance at September 30, 2014	0
Assumed liability	19
Charged to expense	126
Cash payments	(74)
Non-cash settlements	0
Other adjustments	(9)
Balance at September 30, 2015	62
Share-Based Compensation
Restructuring Reserve [Roll Forward]
Balance at September 30, 2014	0
Assumed liability	0
Charged to expense	44
Cash payments	0
Non-cash settlements	(44)
Other adjustments	0
Balance at September 30, 2015	0
Other
Restructuring Reserve [Roll Forward]
Balance at September 30, 2014	0
Assumed liability	0
Charged to expense	102
Cash payments	(20)
Non-cash settlements	0
Other adjustments	(81)
Balance at September 30, 2015	$ 0